,Unnamed: 0,Unnamed: 0.1,doi,pmid,text,link,label1,numerics,tfidf,Symptoms,Genetics,Metabolism,Screening,Treatments,Epidemiology
0,0,0,10.1377/hlthaff.2014.0743,25489031.0,service although however market neither class direction pediatric statute standard determine specifically essential child health define many review benefit special condition regulation benchmark coverage aca also multiple plan policy state group ehbs ehb marketplace vision study explicitly small important term distinct oral furthermore insurance year care address individual finding summary establishes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587658/,abstract,2,ehbs ehb statute marketplace explicitly aca benchmark vision establishes insurance define market direction coverage plan class summary special distinct specifically oral address policy service regulation pediatric furthermore essential determine benefit small standard finding state multiple care term condition important individual review child health group year study,{},{},{},{},{},{}
1,1,1,10.7508/ibj.2015.03.009,26025954.0,carrier significant pcr three phenylalanine variable family allele turkish difference structure prenatal azeri word population background phenylketonuria method frequency genetics genotype pah general conclusion report result group diagnosis frequent study statistically repeat copy key first hydroxylase tandem iranian respectively genetic gene eight number vntr detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571015/,abstract,3,azeri vntr turkish iranian copy repeat pcr prenatal statistically frequent word tandem carrier genotype allele variable pah genetics structure frequency general hydroxylase detection background key report family respectively conclusion difference phenylketonuria number phenylalanine diagnosis population significant gene group genetic method result study,"{""phenylalanine"": {""freq"": 2, ""string"": [""family respectively conclusion difference phenylketonuria number phenylalanine diagnosis population significant gene g""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""detection"": {""freq"": 1, ""string"": [""pah genetics structure frequency general hydroxylase detection background key report family r""]}, ""tandem"": {""freq"": 1, ""string"": [""repeat pcr prenatal statistically frequent word tandem carrier genotype allele variable p""]}}",{},{}
2,2,2,10.3748/wjg.v21.i8.2504,25741161.0,lam growth abnormal time defect monotherapy neonatal median elevated weight fetus prognosis effective addition capital virus medical pregnant initiation subject evidence event gynecology clinical therapy vaccination tenofovir curative china ldt result university efficacy length effect creatinine data good resistant change copy decrease pregnancy fetal transmission hepatitis score level significant ditan alt female log department normal hbv fourteen outcome method seventeen perinatal alanine development serum safety baseline treatment ten delivery maternal telbivudine january birth chronic lamivudine resistance adverse hospital aim beijing aminotransferase infant also conclusion obstetrics june study eleven phosphorus patient vertical apgar safe statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342930/,abstract,6,vertical tenofovir telbivudine ldt lamivudine lam gynecology ditan alt monotherapy vaccination seventeen obstetrics capital beijing apgar aminotransferase phosphorus curative log hbv resistant fourteen creatinine hepatitis fetus alanine initiation perinatal copy june department transmission prognosis safe january length pregnant resistance virus china fetal university statistically safety event elevated baseline abnormal pregnancy delivery median good maternal decrease adverse female serum efficacy weight neonatal hospital chronic defect growth birth score aim infant normal addition subject change effective medical therapy evidence outcome conclusion time significant development effect method data level treatment clinical result patient study,{},{},{},{},{},{}
3,3,3,10.4103/ijnmr.IJNMR_174_18,31333744.0,resilience difference among time moreover common shahid motahhari control effective disease status material respectively excel cancer strategy childhood cvds clinical therapy questionnaire value health support chip result effect integration data inventory cause term score mortality significant three one child intervention variance anova method social second parent mother urmia best randomized ghq sample two iran determine standard analysis background hospital cardiovascular trial general conclusion group different study patient randomly demographic deviation perception,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6621495/,abstract,3,urmia shahid motahhari ghq cvds excel anova resilience chip inventory randomized perception variance randomly demographic integration deviation iran cardiovascular mother best mortality childhood second cancer questionnaire hospital social determine parent general status score standard background support trial cause strategy value effective respectively intervention therapy material conclusion term difference common sample time control child different significant health group effect method data clinical analysis result patient disease study,"{""social"": {""freq"": 1, ""string"": [""mortality childhood second cancer questionnaire hospital social determine parent general status s""]}}",{},{},{},{},{}
4,4,4,10.1136/bmjpo-2017-000172,29637168.0,training delay fellowship new region almost representative information pathway uncertainty brief paediatric aged need territory common state coordination experience specialist disease month survey physician college australian relevant unit career clinical respondent health portal australasian support university resultsof conclusionsan guideline service educational peer surveillance one female smartphone referral problem database child unprepared private designa rural currency via paediatrician online resource treatment adequately year care list rare royal sample professional lack application consolidated hospital module available refer multiple dissemination diagnostic practice different urban last objectiveto patient accuracy australia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862166/,abstract,4,unprepared royal paediatrician fellowship conclusionsan australasian career currency portal consolidated territory smartphone refer designa australian dissemination adequately module college urban private resultsof coordination australia uncertainty training paediatric peer brief surveillance representative referral rural respondent specialist objectiveto unit list educational physician university delay guideline accuracy resource experience service professional aged female survey hospital lack database practice relevant problem need diagnostic region support month application state multiple online pathway rare care information common sample available new child different health year treatment clinical patient disease,{},{},"{""pathway"": {""freq"": 1, ""string"": [""support month application state multiple online pathway rare care information common s""]}}",{},{},{}
5,5,5,10.1002/humu.23542,29704307.0,specific disorder availability benign search information effort across several researcher severe variation practical rtt severity clinician well disease neurological contribute amount unique poorly user clinical protein findability monogenic annotate genotype result diagnosis effect data good interoperability cause thousand cpg type genetic level use yet case mutation main pathogenic phenotype problem syndrome database provide point management aid functionality parent loss online methyl important nevertheless mecp entry rare find within alongside variant function currently available general conclusion rett different study gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033003/,abstract,3,rtt interoperability findability annotate rett mecp cpg entry functionality alongside benign aid methyl thousand monogenic poorly contribute practical researcher clinician pathogenic availability severity unique genotype search neurological effort good loss variation point database syndrome currently parent general provide problem main phenotype severe management user cause variant online use rare information mutation conclusion important function case available specific type diagnosis different protein gene effect genetic data level disorder clinical result disease study,"{""neurological"": {""freq"": 1, ""string"": [""pathogenic availability severity unique genotype search neurological effort good loss variation p""]}}","{""genetic"": {""freq"": 1, ""string"": [""type diagnosis different protein gene effect genetic data level disorder clinical r""]}}",{},{},{},{}
6,6,6,10.3390/nu11030520,30823411.0,blood better difference content boy time median aged significantly pku glycomacropeptide intake phe phenylalanine subject evidence introduction dosage tyr higher protein range mol contribution result effect casein significant rate utilisation tyrosine child point week phenylketonuria day method plan free concentration regimen year diet help every meal age spot residual impact eighteen conclusion group different last study substitute acid dietary assessing amino variability usual isocaloric cgmp,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471794/,abstract,22,assessing isocaloric utilisation cgmp usual eighteen meal casein dosage substitute regimen residual glycomacropeptide boy plan tyr introduction variability contribution mol content median aged help point free intake tyrosine spot week better phe subject day range diet impact dietary rate concentration evidence pku amino conclusion higher difference phenylketonuria time significantly phenylalanine blood acid child different protein age significant group year effect method result study,"{""phenylalanine"": {""freq"": 2, ""string"": [""conclusion higher difference phenylketonuria time significantly phenylalanine blood acid child different p""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""impact dietary rate concentration evidence pku amino conclusion higher difference phenylketonuria t""]}}","{""diet"": {""freq"": 1, ""string"": [""week better phe subject day range diet impact dietary rate concentration e""]}}",{}
7,7,7,10.5144/0256-4947.2016.391,27920410.0,splice disorder blood tool exon sectional exhibit progressive abnormal defect autosomal aspm site occipito maternity molecular due genetics heterogeneous resultsa conclusionskipping underlying disease typical limitationssingle settingmadinah family methodsa frontal clinical protein clinically finder nextseq primary saudi university like effect date change cause novel genetic mcph capture non detection commonly whole rapid mutation main motif measure spindle phenotype backgroundautosomal centre instrument taibah child outcome silico designa exome disability nextera filter kit microcephaly genetically sample variant homozygous recessive order peripheral dna circumference analysis hospital variantstudio head intellectual study human sequencing isolated patient gene individual prioritize number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074201/,abstract,6,variantstudio taibah settingmadinah occipito nextseq nextera mcph limitationssingle finder conclusionskipping backgroundautosomal spindle maternity aspm prioritize designa splice saudi kit motif frontal silico microcephaly isolated circumference capture resultsa exhibit typical head filter instrument homozygous heterogeneous progressive peripheral centre methodsa underlying exome commonly exon university genetically recessive abnormal date autosomal sectional intellectual clinically dna site hospital genetics rapid disability sequencing defect like main phenotype order detection tool measure change primary cause variant molecular family novel mutation outcome non sample number individual human blood child protein gene effect genetic disorder clinical analysis patient disease study,"{""microcephaly"": {""freq"": 1, ""string"": [""splice saudi kit motif frontal silico microcephaly isolated circumference capture resultsa e""]}, ""intellectual"": {""freq"": 1, ""string"": [""genetically recessive abnormal date autosomal sectional intellectual clinically dna site hospital g""]}}","{""autosomal"": {""freq"": 1, ""string"": [""nextera mcph limitationssingle finder conclusionskipping backgroundautosomal spindle maternity aspm prioritize d"", ""exon university genetically recessive abnormal date autosomal sectional intellectual clinically dna s""]}, ""recessive"": {""freq"": 1, ""string"": [""underlying exome commonly exon university genetically recessive abnormal date autosomal sectional i""]}, ""homozygous"": {""freq"": 1, ""string"": [""resultsa exhibit typical head filter instrument homozygous heterogeneous progressive peripheral centre m""]}, ""genetic"": {""freq"": 1, ""string"": [""human blood child protein gene effect genetic disorder clinical analysis patient d""]}}",{},"{""detection"": {""freq"": 1, ""string"": [""sequencing defect like main phenotype order detection tool measure change primary c""]}}",{},{}
8,8,8,10.1186/s13065-019-0611-x,31508598.0,new secondly early world modification surface catalyst physical literature common prognosis optical onto effective firstly material cancer strategy recent screening mainly role protein fluid body diagnosis property thus biosensor stability cause term novel long type mortality detection remarkable signal biomarkers ingenious electrochemical sensitivity prostate many review approach toward potential technology biosensors important key fatality interface carrier wide amplification two sixth approximately field graphene analysis importance group high study magnetic playing performance highly total number sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720397/,abstract,0,prostate ingenious catalyst sixth secondly playing fatality graphene biosensor firstly electrochemical biosensors remarkable optical amplification interface prognosis surface fluid modification stability signal sensitive mainly magnetic carrier world approximately property mortality physical cancer sensitivity biomarkers highly wide importance technology performance field literature detection body screening long cause strategy key effective recent novel total material term important role common approach number new early type diagnosis review potential protein group high analysis study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""wide importance technology performance field literature detection body screening long cause s""]}, ""screening"": {""freq"": 1, ""string"": [""technology performance field literature detection body screening long cause strategy key e""]}}",{},{}
9,9,9,10.3389/fnut.2017.00005,28373974.0,major notably interestingly specific disorder huge menopause example physiological difference energy composition pathway gain present concern weight behavior homeostasis clear intake contribute account animal strategy obesity extensively health protein mouse body food scientist result metabolic situation effect specie rat period level mimic comorbidities modulation many critical review window model perinatal frequently stage dam expenditure limit diet offspring particularly public pathophysiological estrogen quality aspect mechanism impact quantity widely also withdrawal consequence different feeding study human dietary interesting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357654/,abstract,0,menopause modulation dam withdrawal huge estrogen offspring comorbidities window mimic expenditure scientist interesting perinatal pathophysiological notably extensively feeding quantity interestingly situation gain contribute specie clear physiological homeostasis composition limit rat energy widely aspect account obesity frequently concern stage consequence animal weight example behavior critical intake particularly period public mouse body food major strategy quality pathway mechanism diet impact dietary difference present human model specific review different protein metabolic health effect level disorder result study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""mouse body food major strategy quality pathway mechanism diet impact dietary d""]}}",{},"{""diet"": {""freq"": 1, ""string"": [""food major strategy quality pathway mechanism diet impact dietary difference present h""]}}",{}
10,10,10,10.3889/oamjms.2018.038,29484020.0,phenylalanine investigation brief author vitiligo therapy unconventional approach therapeutical effectiveness part pge treatment antioxidant well agent show overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816295/,abstract,0,vitiligo pge unconventional therapeutical brief antioxidant author overview agent effectiveness investigation therapy approach phenylalanine treatment,"{""phenylalanine"": {""freq"": 2, ""string"": []}}",{},{},{},{},{}
11,11,11,10.1186/s13023-018-0993-1,30700313.0,blood canadian reliability backgroundnewborn region early affect effort congenital essential positive july laboratory country initial insight condition frequency resultsa preterm common highlight risk validation objective disease material unavailable hemoglobinopathy treatable supplementary confirm user nature health data panel comment rural determination conclusionsthis parent online article resource electronic bangladesh discharge feasibility cord version materialthe carrier threshold public sample within variant newborn screen spot january community hypothyroidism birth authorized analysis previously program available research infant widely modality importance preventative cohort part study barrier prick total initiative acceptable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354381/,abstract,6,unavailable bangladesh preventative hemoglobinopathy backgroundnewborn discharge comment canadian prick cord july threshold reliability confirm modality rural resultsa conclusionsthis preterm authorized treatable hypothyroidism initiative january feasibility acceptable determination validation screen barrier initial nature affect widely carrier panel community resource effort insight materialthe spot previously highlight frequency essential parent laboratory congenital importance cohort public birth country region infant supplementary objective program user positive version variant electronic online total newborn material condition article common sample available risk early blood research health data analysis disease study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""unavailable bangladesh preventative hemoglobinopathy backgroundnewborn discharge comment canadian prick c"", ""positive version variant electronic online total newborn material condition article common s""]}}",{},{}
12,12,12,10.1155/2018/3235072,30154849.0,bosentan carboxylic propranolol case antihypertensive fluorescence blood amlodipine channel prazosin mass verapamil class irbesartan ramipril spot discus doxazosin inhibitor valsartan several drug nifedipine losartan blocker lisinopril angiotensin review ambrisentan metoprolol cardiovascular spectrometry pressure method hypertension rosuvastatin atorvastatin pregabalin diltiazem atenolol detection enzyme high bisoprolol ramiprilat acid quantification receptor endothelin disease statin harbinger tandem medication captopril antagonist calcium treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093062/,abstract,0,verapamil valsartan rosuvastatin ramiprilat ramipril propranolol pregabalin prazosin metoprolol losartan lisinopril irbesartan harbinger endothelin doxazosin diltiazem captopril bosentan bisoprolol atorvastatin atenolol antihypertensive amlodipine ambrisentan nifedipine carboxylic statin blocker angiotensin antagonist hypertension channel fluorescence calcium quantification pressure class inhibitor medication cardiovascular treat receptor tandem spectrometry spot discus detection enzyme mass drug case blood review acid high method disease,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""treat receptor tandem spectrometry spot discus detection enzyme mass drug case b""]}, ""tandem"": {""freq"": 1, ""string"": [""class inhibitor medication cardiovascular treat receptor tandem spectrometry spot discus detection e""]}, ""spectrometry"": {""freq"": 1, ""string"": [""inhibitor medication cardiovascular treat receptor tandem spectrometry spot discus detection enzyme m""]}}",{},{}
13,13,13,10.3390/molecules201119658,26540034.0,various self popularity production motif class short biomaterials new application nanomorphologies recent discus hold creation analogue molecule since drug block discovery range compound next minimalist drive therapeutic peptide nanomedicine method characterization paradigm nanostructures property substantial remarkable delivery nanomedicines generation assembly promise finding phe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332413/,abstract,0,nanomorphologies nanomedicines minimalist popularity nanomedicine biomaterials nanostructures hold drive remarkable analogue motif creation paradigm block assembly promise characterization class peptide substantial discovery production molecule property delivery short compound generation self discus finding various phe application range drug therapeutic recent new method,{},{},{},{},{},{}
14,14,14,10.1177/1559325818811756,30574028.0,male biological activity daily mechanical glucose without actual together investigate subtle motor control well stroop session however uptake vibration word home brain mouse improvement body color effect arousal tomography selective period yet suboptimal whole functioning although wbv imaging per emission current intervention week day test year age protocol function cage cognitive aim also consequence study human positron minute safe performance gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299320/,abstract,8,stroop arousal wbv vibration mechanical cage positron subtle color actual suboptimal uptake minute functioning tomography emission session imaging home safe selective gender word motor protocol glucose daily consequence improvement investigate biological male week period performance mouse body cognitive aim day brain intervention activity current function test human control age year effect study,{},{},{},{},{},{}
15,15,15,10.7554/eLife.12814,26744778.0,experimental specific example energy organism explain segment presumably frequency destabilization elife hypothesis activation classifier significantly explanation account cancer driver higher doi base change predominant quantitatively significant rate mutation prediction structure overall many model silico functionally hydrophobic association braf wide forest statistical analysis alternative research pocket genome conclusive folding pattern study equilibrium acid human position random org amino number parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749552/,abstract,0,folding elife forest destabilization classifier braf quantitatively hydrophobic conclusive pocket presumably explanation segment driver silico org explain equilibrium functionally predominant base position random doi organism activation prediction energy hypothesis account experimental statistical alternative parameter genome pattern cancer example structure frequency wide overall change association rate mutation amino higher number significantly human model specific research acid significant analysis study,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""wide overall change association rate mutation amino higher number significantly human m""]}}",{},{}
16,16,16,10.1128/mSystems.00031-18,29795809.0,metabolome correlation specific surgery cross self new difference mail among examine molecule molecular together open state beta diverse challenging biome remains veganism paradigm utility event much rather integrating clinically procedure citizen project science contribution particular scientist result effect microbial data specimen kind little plant united uncover shipping although microbiome variable one interest recapture phenotype temperature diversity room many population stool overgrowth work unexpected kingdom illness unknown categorical resource network association diet education hundred lifestyle earth protocol sample within untargeted reveal primarily community explanatory comparison psychiatric environmental emergent metabolomics research importance also different cohort study human extent power distinct another individual australia reductive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954204/,abstract,1,veganism uncover reductive recapture overgrowth biome shipping earth integrating categorical unexpected stool explanatory remains mail emergent citizen challenging kingdom untargeted metabolome kind surgery scientist microbial australia beta plant specimen room microbiome reveal power paradigm illness diversity lifestyle temperature project primarily psychiatric examine united extent contribution distinct diverse open little event protocol metabolomics utility education procedure network molecule science community resource clinically unknown particular variable work comparison cross self environmental correlation importance cohort phenotype state association molecular diet difference sample individual new human specific research population different effect data result study,"{""psychiatric"": {""freq"": 1, ""string"": [""illness diversity lifestyle temperature project primarily psychiatric examine united extent contribution d""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""importance cohort phenotype state association molecular diet difference sample individual new h""]}}",{}
17,17,17,10.14744/nci.2018.59862,31297488.0,case age however sporadic childhood anomaly mirror prevalence early pathway normal adolescent higher present child involuntary range girl corpus contralateral voluntary permanent detailed physical primary due examination also history extremity older familial movement homologous common headache diagnosis sufficient study old motor callosum activation adolescence year rarely unnecessary maturation migraine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593911/,abstract,3,extremity mirror migraine contralateral involuntary voluntary homologous headache unnecessary maturation sporadic callosum permanent corpus rarely familial adolescence anomaly girl detailed movement sufficient older activation examination motor adolescent history physical childhood old prevalence normal range primary pathway higher common present case early diagnosis child age year study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""childhood old prevalence normal range primary pathway higher common present case e""]}}",{},{},{}
18,18,18,10.1007/s10900-015-0094-1,26433724.0,disorder sectional difference lower mennonite necessary inversely frequency moreover common marked old testing majority objective survey knowledge unique screening higher plain health respondent focus never household change genetic consideration use rate one least overall child population unlikely reason minority delivery parental response important unsure western care challenge attitude age future alongside newborn north lack favorable access order community category screened importance group america study wisconsin perception,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779392/,abstract,0,mennonite unsure screened wisconsin plain unlikely inversely household minority marked alongside america north favorable attitude respondent reason perception western parental consideration category access unique majority community sectional necessary delivery survey old focus lack frequency importance order testing overall knowledge screening objective challenge change response future lower use care rate newborn higher important difference common population child age health group genetic disorder study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""newborn"": {""freq"": 1, ""string"": [""response future lower use care rate newborn higher important difference common p""]}, ""screening"": {""freq"": 1, ""string"": [""frequency importance order testing overall knowledge screening objective challenge change response f""]}}",{},{}
19,19,19,10.1038/s41598-017-06033-1,28720891.0,biological disorder autism example herein architecture autosomal deleterious condition wes heterogeneous majority well neurological pipeline mxra spectrum neuronal consanguinity interplay kctd family unique neurodevelopmental previous clinical htatsf nature consistent sumf candidate saudi ddx novo expectation genetic singleton whole rate asd formerly population private glt development exome disability usp itih finding kdm rare process variant recessive underscore function analysis either trio prodh intellectual high study heterogeneity human sequencing even newly total gene complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515956/,abstract,6,usp sumf prodh mxra kdm kctd itih htatsf glt ddx wes trio saudi pipeline expectation singleton interplay architecture underscore private consanguinity deleterious newly novo heterogeneous neuronal exome candidate neurodevelopmental asd nature recessive heterogeneity unique majority neurological autosomal intellectual autism previous consistent example disability sequencing biological spectrum finding process complex variant rare family rate total condition function human population development gene high genetic disorder clinical analysis study,"{""neurological"": {""freq"": 1, ""string"": [""asd nature recessive heterogeneity unique majority neurological autosomal intellectual autism previous c""]}, ""intellectual"": {""freq"": 1, ""string"": [""recessive heterogeneity unique majority neurological autosomal intellectual autism previous consistent example d""]}}","{""autosomal"": {""freq"": 1, ""string"": [""nature recessive heterogeneity unique majority neurological autosomal intellectual autism previous consistent e""]}, ""recessive"": {""freq"": 1, ""string"": [""neuronal exome candidate neurodevelopmental asd nature recessive heterogeneity unique majority neurological a""]}, ""genetic"": {""freq"": 1, ""string"": []}, ""heterogeneity"": {""freq"": 1, ""string"": [""exome candidate neurodevelopmental asd nature recessive heterogeneity unique majority neurological autosomal i""]}}",{},{},{},{}
20,20,20,10.3390/metabo9040076,31003499.0,biological tool new studied difference transcriptomics platform document researcher increasingly molecular due auckland conference traditional zealand session australian however life recent integrating variety perspective inherent protein integrated science envisage integration data question term ultimately full peer multi member software genomics database anzmet many omics product technique method system holistic guide recommendation promise list challenge downstream along metabolite biology community answer field metabolomics routinely popular also multiple facet interaction study perform assist proteomics gene idea complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523452/,abstract,0,envisage auckland anzmet facet integrating perform answer australian zealand transcriptomics popular inherent conference proteomics holistic idea integrated assist omics routinely peer session ultimately document studied promise software downstream integration guide list traditional multi researcher platform genomics variety increasingly question member biology metabolomics perspective science community recommendation database product technique biological field interaction metabolite tool challenge multiple complex molecular recent life term difference new protein gene method data study,{},{},{},{},{},{}
21,21,21,10.1126/sciadv.1500137,26601224.0,major biochemical although accumulate supramolecular disorder later phenylalanine offer cytotoxic new death single amyloid form apoptotic determine several limited induce structure role protein fibril previously mouse model phenylketonuria biophysical peptide moreover pathological general phenomenon property antibody like metabolic entity human acid accumulation generation patient ultrastructures disease even assembly formation amino cell hallmark metabolite paradigm,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643800/,abstract,0,ultrastructures supramolecular cytotoxic biophysical accumulate apoptotic fibril induce hallmark phenomenon entity amyloid paradigm assembly antibody offer pathological peptide later formation accumulation death property limited generation structure previously determine general like biochemical mouse form metabolite major single amino role cell phenylketonuria new human model phenylalanine acid protein metabolic disorder patient disease,"{""phenylalanine"": {""freq"": 2, ""string"": [""role cell phenylketonuria new human model phenylalanine acid protein metabolic disorder p""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""biochemical mouse form metabolite major single amino role cell phenylketonuria new h""]}}",{},{}
22,22,22,10.1007/s11306-019-1531-4,31037385.0,implication hgd herein difference glutamate methodsmetabolite specifically concern derivative pyranylium significantly respectively section murine noradrenaline measurement homogentisic amine nitisinone drinking dopamine brain fold aku mouse distribution primary neurotransmitter metabolism objectivenitisinone tail tetrafluoroborate significant alter water conclusionsmonoamine imaging tfb tyrosine diphenyl model resultsion towards hypertyrosinaemia treatment msi intensity methoxytyramine sample mass fresh suggest serotonin comparison alkaptonuria analysis spectrometry tryptophan eighteen plasma balb tissue different study monoamine direct patient tyramine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488549/,abstract,1,tfb tetrafluoroborate resultsion pyranylium objectivenitisinone msi methodsmetabolite hgd diphenyl conclusionsmonoamine balb methoxytyramine hypertyrosinaemia tyramine noradrenaline aku homogentisic fresh tail nitisinone drinking amine alkaptonuria eighteen suggest derivative section glutamate murine monoamine alter intensity imaging tryptophan serotonin neurotransmitter water fold specifically distribution dopamine concern implication direct comparison tissue measurement spectrometry tyrosine mouse mass plasma primary brain respectively difference sample metabolism significantly model different significant treatment analysis patient study,{},{},{},"{""spectrometry"": {""freq"": 1, ""string"": [""concern implication direct comparison tissue measurement spectrometry tyrosine mouse mass plasma p""]}}",{},{}
23,23,24,10.1093/hmg/ddw091,27005423.0,implication covalent activity uridylyltransferase better new difference information present glucose site molecular due missense open bacterial gln majority concept well increase disease serf template lethal galactose understanding ternary homologues pharmacological monomer form dysfunction therapy role protein crystal tendency metal therefore ligation mutant structural uridylylation enzyme effect stability change design uridylylated ability potentially significant commonly although rate mutation phosphate per aggregation arg structure dimer model homodimer intermediate active revealing future galactosemia variant lack likely chaperone influence zbetter consequence classic interaction human zinc arrangement absence hgalt resolution complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081055/,abstract,1,zbetter uridylylation uridylylated hgalt uridylyltransferase ternary revealing homologues homodimer covalent gln tendency serf ligation galactosemia galactose arrangement lethal template intermediate phosphate dimer monomer metal zinc chaperone arg crystal aggregation bacterial resolution classic commonly stability missense absence pharmacological mutant open glucose concept structural majority active potentially consequence implication understanding site lack likely dysfunction structure influence ability design interaction better form enzyme change complex variant increase future molecular therapy information rate activity mutation role difference present new human model protein significant effect disease,{},{},{},{},{},{}
24,24,25,10.1210/jc.2016-1760,27466884.0,grs blood assessment tertile whether greater composition context among glucose weight risk differentially objective significantly respectively estimated homeostatic modulate evidence reduction strategy trait obesity previous disturbance improvement result effect data change design novel genetic metabolism score level seven main female measure sensitivity overall outcome intervention pound model expression calculate loss baseline susceptibility year diet hundred age variant obese homa resistance closely macronutrient regardless preventative trial conclusion lowest plasma overweight glycemic different interaction high regulating insulin dietary eleven patient highest participant gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052340/,abstract,1,grs pound tertile estimated preventative macronutrient homeostatic homa glycemic calculate modulate closely overweight regulating differentially regardless lowest obese disturbance susceptibility insulin resistance composition highest seven glucose trait baseline obesity previous female improvement weight sensitivity loss reduction context greater design main overall score interaction participant assessment measure objective plasma trial expression change strategy variant diet respectively intervention dietary novel evidence outcome conclusion metabolism significantly risk model blood different age gene year effect high genetic data level result patient,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},"{""diet"": {""freq"": 1, ""string"": [""plasma trial expression change strategy variant diet respectively intervention dietary novel e""]}}",{}
25,25,26,10.1002/wnan.1339,25707913.0,blood memory lead time specifically modification literature igg igm uncharged well circulation numerous flexible individual animal anti clinical protein feature polyethylene body report efficacy existence question immune immunity type nanoparticle untreated formation bind although rate independent short pre clearance produce drug fully peg many approach immunological model therapeutic polymer potential antibody system response nevertheless rodent incidence address cell robust hydrophilic primarily typically prevalence order healthy mechanism research widely trial induction group study human predominantly complication highly presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515207/,abstract,1,uncharged nanoparticle igm hydrophilic immunological rodent igg flexible circulation clearance polymer polyethylene peg immunity induction existence bind predominantly produce antibody primarily fully untreated modification typically numerous immune complication specifically robust memory formation question anti widely independent address pre incidence short efficacy animal feature lead presence highly prevalence order literature body healthy trial drug response therapeutic mechanism report rate cell approach individual time human model blood type research potential protein group clinical study,{},{},{},{},{},{}
26,26,28,10.1037/neu0000336,28240926.0,relationship early time across visual present adult sustained due variation coordination chemical average testing control accumulation varied objective disease pku phe executive adulthood phenylalanine childhood unique visuomotor health protein brain task result metabolic attention question type level use inability vantage current stable outcome point phenylketonuria method bio predictor disruption development free test important associated diet best stronger strict age still adolescent function cognitive impairment impact monitor importance also different domain right acid dietary even amino performance show number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331922/,abstract,1,vantage visuomotor bio sustained inability coordination stronger disruption monitor strict varied visual right adulthood predictor executive stable chemical question adolescent task unique accumulation domain average associated best childhood impairment attention variation point free importance relationship performance testing cognitive phe objective brain adult use diet impact dietary current pku amino outcome important function phenylketonuria number present test time early phenylalanine control type acid different protein age development metabolic health method level result disease,"{""phenylalanine"": {""freq"": 2, ""string"": [""phenylketonuria number present test time early phenylalanine control type acid different p""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""use diet impact dietary current pku amino outcome important function phenylketonuria n""]}}","{""diet"": {""freq"": 1, ""string"": [""cognitive phe objective brain adult use diet impact dietary current pku a""]}}",{}
27,27,29,10.1186/s12915-017-0469-0,29325558.0,experimental biological relationship hierarchical factor pathway unrelated light literature common annotation share connectivity source regulatory concept well finally disease remain material player extensive transcriptional confident knowledge supplementary recent poorly combinatorial user role protein great chip six link attention data computational focused design experiment backgroundtranscription yet functional seq phenotype diversity drug capability discovery approach regulation conclusionour target organization unknown online article guide response key electronic network systematic tfs materialthe specificity version mendelian wide observe regulator two complementary apparently function upstream dna available also study pleiotropic human pharmacogenetic even gene shedding show number resultwe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795274/,abstract,5,remain backgroundtranscription tfs shedding resultwe player pharmacogenetic confident combinatorial observe upstream pleiotropic connectivity seq focused apparently annotation hierarchical conclusionour chip mendelian complementary capability share unrelated diversity transcriptional computational regulator guide poorly experiment light extensive link organization great discovery concept experimental network systematic specificity unknown regulatory regulation finally dna source attention materialthe biological wide design functional phenotype relationship knowledge target literature supplementary user drug version key response electronic online pathway recent material article role common function approach number available human factor protein gene data disease study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""drug version key response electronic online pathway recent material article role c""]}}",{},{},{}
28,28,30,,30854516.0,implication specific slds assessment blood cross memory early boy behavioral student despite site dyx dcdc without molecular silent saliva neuroimaging marker word brain candidate science instruction syntax base language oral genetic learning rate three one handwriting dyslexia phenotype current comprehension aural disability alphabet impaired association best dysgraphia construction sample within two allele mostly application girl analysis research reading translation hallmark grade different practice small gene sentence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407889/,abstract,3,dyx dcdc aural alphabet slds sentence dysgraphia handwriting syntax silent dyslexia comprehension instruction reading neuroimaging construction saliva hallmark learning student grade girl base impaired boy language translation candidate memory word oral behavioral science allele best implication site marker cross disability practice despite phenotype small assessment application brain association molecular rate current sample early specific blood research different gene genetic analysis,"{""behavioral"": {""freq"": 1, ""string"": [""language translation candidate memory word oral behavioral science allele best implication s""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
29,29,31,10.1590/1984-0462/;2018;36;2;00010,29412435.0,level rare inheritance scalp case immediately age rapid recessive brownish scarce boy hair since knee normal progressive autosomal infection description prevent acrodermatitis range attempt comment symmetrical diarrhea intermittent day improvement symptom yellowish foot report fever supplementation face hand six serum old lesion erythematous mcg zinc important oral thin objective disease month complication properly recurrent,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038791/,abstract,0,yellowish scalp erythematous brownish acrodermatitis knee mcg foot symmetrical hair properly comment scarce intermittent fever diarrhea description attempt immediately zinc recurrent lesion hand inheritance face boy progressive complication recessive oral infection prevent autosomal supplementation improvement serum old rapid symptom month normal objective day range report rare important case age level disease,"{""hair"": {""freq"": 1, ""string"": [""brownish acrodermatitis knee mcg foot symmetrical hair properly comment scarce intermittent f""]}}","{""inheritance"": {""freq"": 1, ""string"": [""attempt immediately zinc recurrent lesion hand inheritance face boy progressive complication r""]}, ""autosomal"": {""freq"": 1, ""string"": [""progressive complication recessive oral infection prevent autosomal supplementation improvement serum old r""]}, ""recessive"": {""freq"": 1, ""string"": [""hand inheritance face boy progressive complication recessive oral infection prevent autosomal s""]}}",{},{},{},{}
30,30,32,10.4103/0971-5916.171281,26658589.0,interpretation lower oxidative throughout liquid five condition due control glycine objective significantly sepsis phenylalanine life higher arginine polycystic histidine result like metabolic situation proline sixty level significant stress case derangement normal ovary syndrome tyrosine woman lysine reverse method alanine ass alteration isoleucine phase finding altered age along cystine background conclusion plasma high study acid similar methionine amino performance number chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743341/,abstract,1,sepsis polycystic ovary cystine derangement proline histidine lysine glycine reverse methionine alanine isoleucine altered arginine situation interpretation oxidative liquid alteration chromatography phase woman stress syndrome tyrosine ass like performance finding similar background normal objective plasma lower life amino conclusion higher condition number case significantly phenylalanine control acid age significant metabolic high method level result study,"{""phenylalanine"": {""freq"": 2, ""string"": [""conclusion higher condition number case significantly phenylalanine control acid age significant m""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""background normal objective plasma lower life amino conclusion higher condition number c""]}}",{},{}
31,31,33,10.1590/0104-1169.0196.2613,26444180.0,experimental implication relationship self search ill among profile world chronically document cinahl physical source asthma effective way objective descriptor caregiver evidence life scielo independence questionnaire health ulm burden academic integrative environment borgatta result interview inventory design planning relieve non level multidisciplinary zarit bref montgomery instrument implementation child evaluation intervention review method mental social organization illness parent accordance predominance premier convenience team mother lilac electronic iii medline revealing sample along scale adolescent chronic quality available identify conclusion transversal extent complex nottingham,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623740/,abstract,2,ulm transversal premier nottingham montgomery borgatta zarit scielo revealing lilac descriptor bref asthma relieve independence predominance convenience accordance ill cinahl chronically integrative multidisciplinary academic inventory planning illness iii document team instrument medline caregiver interview extent organization identify burden adolescent mother world experimental search way mental profile environment implication implementation source physical questionnaire self chronic evaluation social parent design scale relationship objective complex electronic quality effective intervention life evidence conclusion non sample available review child health method level result,"{""social"": {""freq"": 1, ""string"": [""source physical questionnaire self chronic evaluation social parent design scale relationship o""]}}",{},{},{},{},{}
32,32,34,10.1155/2018/2178346,30034865.0,implication disorder hour information time adult laboratory aged frequency ireland deal number month survey pku excellent phe weekly phenylalanine family evidence compliance portal improvement message result effectiveness metabolic effect good dietitian phone term level service use communication text centre department implementation child mobile review ass development via target national technology system web team year within two dietetic collaboration order pilot ncimd influence approximately quality currently either analysis study defero dietary patient ict successful financial demographic initiative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035849/,abstract,6,ncimd ireland ict defero portal weekly deal dietetic phone message mobile financial dietitian department collaboration team excellent web pilot initiative demographic centre compliance hour communication successful approximately text effectiveness good service aged implication implementation improvement survey national influence currently frequency laboratory ass technology order target month phe quality adult use family dietary information evidence pku term number time phenylalanine review child development metabolic year effect level disorder analysis result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""information evidence pku term number time phenylalanine review child development metabolic y""]}}",{},{},{},{},{}
33,33,35,10.5223/pghn.2018.21.3.155,29992114.0,chain milk korea lactose energy appropriate standard formula enriched cow protein currently review special infant indication error preterm inborn free soy medium hydrolysate acid phosphorus triglyceride type amino low metabolism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037801/,abstract,0,hydrolysate soy lactose cow phosphorus korea enriched triglyceride preterm formula indication milk special medium energy appropriate free chain currently standard inborn infant error amino low metabolism type review acid protein,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""chain currently standard inborn infant error amino low metabolism type review a""]}}",{},{}
34,34,36,10.1016/j.socscimed.2016.02.009,26950393.0,major male implication cross record sectional literally factor among examine behavioral attainment riskier attributable light five state risk fact race smoking formal survey status properly sociodemographic however assume subject later life much childhood trait poorly form obesity analytic multiplicatively nature respondent health logic result data cause term combination expectation mortality empirically educational four variable death certain conclude additivity multiplicative reflection socio model chance deadly identification sex iii valuable argue educated process generally public sample two obese typically survival relation additive estimate especially circumstance statistical birth act paper also multiple general group december interaction vulnerable black dangerous individual demographic nhanes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599176/,abstract,0,riskier multiplicatively literally deadly nhanes multiplicative logic educated assume additivity empirically dangerous attainment sociodemographic properly formal analytic reflection circumstance black vulnerable socio expectation race smoking conclude chance attributable additive argue fact obese iii december respondent demographic poorly act valuable educational light survival sex examine typically generally record later nature relation certain trait obesity behavioral statistical death sectional estimate mortality implication childhood variable survey cross combination especially identification general male paper public birth status interaction process form state subject major multiple cause life term sample individual risk model factor health group data result,"{""behavioral"": {""freq"": 1, ""string"": [""later nature relation certain trait obesity behavioral statistical death sectional estimate m""]}}",{},{},{},{},{}
35,35,37,10.3389/fnana.2015.00049,26106302.0,confocal various glial whether class early compact positively adult oligodendrocyte central ron additional characterization common express classically extensive understanding gfap marker form encapsulate observed arise feature double misidentification opc image astrocyte never lineage data selective first node rat low level significant akin optic gold pre wholly apparent immuno population approach ranvier degree axon day post labeling expression antibody myelin important nerve ultrastructural soma filament cell fixation process robust protocol within reveal orthogonal insufficiently ensheathment definitive fashion natal function criterion previously precursor also classic opcs study extent distinct reconstruction individual presence stack,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460730/,abstract,1,wholly ultrastructural stack ron ranvier opcs opc misidentification insufficiently immuno ensheathment encapsulate classically soma reconstruction labeling filament akin glial gfap compact orthogonal optic oligodendrocyte lineage fixation node natal confocal axon astrocyte express arise fashion nerve definitive myelin image gold apparent reveal positively antibody characterization class selective degree extensive classic extent distinct double robust precursor rat protocol post pre observed central understanding feature marker criterion presence previously additional various process form day expression adult important common cell function low approach individual early population significant data level study,{},{},{},{},{},{}
36,36,38,10.1016/j.ymgme.2016.07.004,27650066.0,specific cross relationship sporadic single discus affect acetaldehyde essential reaction endogenously toxin genotoxic disulfiram risk substitution well repair hematopoietic family subcellular marrow east exogenously fanconi particular anemia substrate genotype mitochondrion result link like recently change cause ability genetic metabolism isoenzyme rapid cellular dehydrogenase member interrelationship progression failure syndrome damage review maintenance unexpected compartment reactive expression thereby people polymorphism directly cell specificity downstream hsc million biology function dna stem ethanol consumption aldehyde different pattern namely aldh acid deficiency asian amino injury aplastic localization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082284/,abstract,2,interrelationship hematopoietic genotoxic disulfiram aplastic acetaldehyde isoenzyme hsc fanconi exogenously subcellular endogenously aldehyde unexpected aldh localization ethanol anemia marrow toxin repair mitochondrion sporadic compartment east asian reactive substitution maintenance stem downstream injury substrate million dehydrogenase link failure progression damage consumption people member biology affect polymorphism cellular genotype directly specificity reaction dna particular pattern recently cross rapid syndrome essential ability like relationship discus expression change cause single deficiency family amino cell function metabolism risk specific review acid different genetic result,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""amino"": {""freq"": 1, ""string"": [""expression change cause single deficiency family amino cell function metabolism risk s""]}}",{},{}
37,37,39,10.1038/ejhg.2016.129,27703146.0,tool benign fundamental context proxy pathogenicity accurate view genetics missense source number classical perhaps machine way disease prioritization medical precludes however consequent protein unfortunate replacement feature particular structural error putatively large good specie generation type functional orthologous filtering wild least evolutionary essentiality prediction evaluation exclusion residue approach degree ass bioinformatic propose potential disproportionately important reporting constitute conservation challenge generally hence variant allele likely intuitive demonstrate metric next currently impact natural alternative available importance also inappropriate consequence acid human sequencing mammalian amino performance presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5159764/,abstract,0,unfortunate putatively precludes orthologous filtering essentiality inappropriate disproportionately constitute conservation bioinformatic prioritization intuitive consequent pathogenicity evolutionary proxy machine metric benign reporting exclusion mammalian residue fundamental replacement specie degree accurate prediction propose missense view generally classical demonstrate wild structural alternative natural allele way good consequence particular source feature genetics likely generation context presence sequencing evaluation currently ass importance functional performance tool challenge variant error medical large impact amino important approach number available human type acid potential protein disease,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""challenge variant error medical large impact amino important approach number available h""]}}",{},{}
38,38,40,10.1016/j.ymgme.2017.02.011,28283349.0,male disorder blood self abnormality single early ammonia abnormal demonstrates inflammation pathology hemizygous old codon experience urinary virus month relevant life evidence recent heterozygous threatening eventual therapy clinically brain mouse ureagenesis elevation fibrosis knockout ornithine otc metabolic term aav long untreated level significant het administration mutation female death per acute dose failure prevent orotic damage liver development transcarbamylase treatment urea coma age deficient two complementary irreversible chronic cognitive impairment adeno also consequence cycle study human acid cirrhosis vector deficiency patient null gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423267/,abstract,1,ureagenesis threatening otc orotic het hemizygous coma codon transcarbamylase eventual cirrhosis ornithine null aav adeno knockout demonstrates irreversible complementary elevation ammonia heterozygous urea vector fibrosis untreated inflammation virus pathology urinary failure deficient damage cycle abnormal dose prevent acute death clinically administration experience consequence female old abnormality liver impairment self chronic relevant male mouse cognitive month long brain single recent deficiency therapy life evidence mutation term human early blood acid age significant development metabolic gene level disorder treatment patient study,{},"{""heterozygous"": {""freq"": 1, ""string"": [""knockout demonstrates irreversible complementary elevation ammonia heterozygous urea vector fibrosis untreated i""]}}",{},{},{},{}
39,39,41,10.1093/cdn/nzz082,31414073.0,line phenotypic significant animal cellular rna better short seq step application transcriptomics organism nutrition lastly advanced intervention nutrient transcriptomes approach principal research science view monitor history also state expression potential nutritional technology different investigate tissue interaction effect holistic study bottom simultaneously article principle nutrigenomics dietary response agricultural novel thorough gene briefly intracellular ultimately area,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686084/,abstract,1,transcriptomes agricultural transcriptomics lastly seq nutrigenomics briefly thorough holistic intracellular principal monitor simultaneously ultimately advanced organism principle rna view phenotypic line nutrient cellular nutrition science step history short nutritional animal investigate tissue technology interaction better area application state expression response intervention dietary novel article approach research potential different significant gene effect study,{},{},{},{},{},{}
40,40,42,10.3390/genes7020006,26805889.0,inheritance worldwide past factor pathway congenital difficult defect summarizes increasingly need genetics facilitate number inter transcription decade much screening resolve chds role developmental mouse usually complete mutant chd straightforward attention effect date fraction genetic non functional mutation nkx etiology able review model development target expression functionally dysmorphogenesis manifestation morbid complex downstream two continuously anomaly picture approximately heart analysis research firmly biggest syndromic multiple intricate different pattern study cardiac elucidate gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773750/,abstract,1,straightforward firmly dysmorphogenesis nkx morbid intricate biggest chds picture syndromic resolve summarizes elucidate functionally continuously anomaly inter inheritance chd usually downstream cardiac fraction facilitate worldwide manifestation transcription complete increasingly able etiology mutant past decade approximately date difficult heart pattern genetics attention developmental defect congenital functional need target mouse screening expression multiple complex pathway mutation non role number model factor research review different development gene effect genetic analysis study,{},"{""inheritance"": {""freq"": 1, ""string"": [""summarizes elucidate functionally continuously anomaly inter inheritance chd usually downstream cardiac f""]}, ""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""target mouse screening expression multiple complex pathway mutation non role number m""]}}","{""screening"": {""freq"": 1, ""string"": [""defect congenital functional need target mouse screening expression multiple complex pathway m""]}}",{},{}
41,41,43,10.1371/journal.pone.0143833,26624009.0,disorder blood backgroundphenylketonuria composition despite restriction without objectiveas moreover severe suggested supplementation lnaa investigate neurocognitive principle control concept enu objective significantly pku respectively optimized biochemical account monoaminergic however phenylalanine norepinephrine strategy dopamine dysfunction clinical protein brain disturbance mouse neurotransmitter result six effect large data first type relieve non methodsc suboptimal three wild neutral normal proof dose provide outcome regard week isonitrogenic resultsin thereby conclusionsthis concentration treatment valuable regimen diet still application serotonin reduced mechanism alternative pah high study acid dietary neuropsychological deficiency patient restricted amino show isocaloric,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666635/,abstract,0,objectiveas methodsc isonitrogenic optimized monoaminergic isocaloric relieve lnaa suggested norepinephrine enu restricted suboptimal regimen proof backgroundphenylketonuria regard neurocognitive resultsin conclusionsthis neutral neuropsychological disturbance valuable principle serotonin neurotransmitter composition wild reduced restriction dopamine concept account dose alternative supplementation pah dysfunction investigate despite provide week biochemical mouse severe normal application objective strategy large brain deficiency mechanism diet respectively dietary concentration pku amino outcome non significantly phenylalanine control blood type acid protein effect high data disorder treatment clinical result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""concentration pku amino outcome non significantly phenylalanine control blood type acid p""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""mechanism diet respectively dietary concentration pku amino outcome non significantly phenylalanine c""]}}","{""diet"": {""freq"": 1, ""string"": [""objective strategy large brain deficiency mechanism diet respectively dietary concentration pku a""]}}",{}
42,42,44,10.1097/YPG.0000000000000112,26565519.0,attendee major congress kluwer session manuscript society one new discus place wolters world psychiatric denmark october field student notable health rapporteur genetics report copenhagen postdoctoral psychiatr presentation latest copyright right topic oral conference genet participant inc total international,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519121/,abstract,2,wolters rapporteur psychiatr postdoctoral kluwer copyright attendee genet copenhagen congress manuscript notable denmark latest conference october session student topic place right society psychiatric presentation oral world international genetics discus field participant major report total new health,"{""psychiatric"": {""freq"": 1, ""string"": [""session student topic place right society psychiatric presentation oral world international g""]}}",{},{},{},{},{}
43,43,45,10.3389/fpsyg.2018.00703,29896137.0,major memory germinoma tertiary duration alertness astrocytoma germ unrelated median aged central condition pilocystic capacity deficit control evaluate objective month poorer lumpur executive childhood visuomotor ependymoma amsterdam range brain particular task result diagnosis attention effect stability late inhibition period significant case seven flexibility main least measure referral toxic processing fourteen prevent outcome method development system remission kuala treatment impaired response important year cell complex age protocol survivor healthy nervous irradiation medulloblastoma speed cognitive malaysia longer program consequence conclusion suprasellar study pineocytoma eleven neuropsychological center tumor accuracy performance statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986920/,abstract,3,suprasellar remission pineocytoma pilocystic lumpur kuala germinoma ependymoma astrocytoma alertness medulloblastoma malaysia visuomotor germ amsterdam survivor irradiation fourteen poorer flexibility tertiary speed referral unrelated longer processing impaired neuropsychological duration toxic tumor nervous executive stability capacity inhibition statistically memory late seven protocol task accuracy prevent center evaluate median consequence aged particular central childhood deficit attention period main performance cognitive measure month healthy objective program major range complex response brain outcome conclusion condition important cell case control diagnosis age significant development year effect method treatment result study,{},{},{},{},{},{}
44,44,46,10.1371/journal.pone.0211048,30668579.0,specific exon leu among accomplished frequency pro due severe responder common gln classical hydroxylase pku numerous phenylalanine chromosome probands russian therapy ligation genotype data date furthermore useful non detection case rate mutation pathogenic phenotype arg prediction sensitivity phenylketonuria potential technology russia frequent boundary treatment response multiplex probe exact amplification variant allele custom responsible dependent deletion analysis pah del cohort high study trp deficiency cofactor patient gene sensitive treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342299/,abstract,3,russian leu russia accomplished gln probands ligation del custom boundary responder exact trp multiplex arg amplification probe chromosome pro deletion prediction responsible numerous exon classical treat frequent cofactor sensitive pathogenic genotype date useful allele dependent sensitivity pah furthermore frequency cohort hydroxylase technology phenotype detection severe variant response deficiency therapy rate mutation pku non common phenylketonuria case phenylalanine specific potential gene high data treatment analysis patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""mutation pku non common phenylketonuria case phenylalanine specific potential gene high d""]}}",{},{},"{""detection"": {""freq"": 1, ""string"": [""furthermore frequency cohort hydroxylase technology phenotype detection severe variant response deficiency t""]}}",{},{}
45,45,47,10.1111/bcp.13886,30720885.0,blood cochrane difference rct profile time present author bias aimsthe due wmd risk significantly respectively phe however phenylalanine interval event reduction dihydrochloride mol improvement efficacy data decrease low level clinicaltrials significant confidence short independently database inclusion phenylketonuria safety concentration tolerance conclusionssapropterin resultsfour library methodsthe two collaboration sapropterin embase analysis criterion adverse benefit aim trial revman group high study meta dietary patient acceptable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475685/,abstract,3,aimsthe wmd revman conclusionssapropterin resultsfour rct dihydrochloride library cochrane collaboration sapropterin embase independently tolerance clinicaltrials bias acceptable methodsthe author meta confidence safety mol event interval inclusion decrease adverse profile short improvement efficacy reduction criterion database benefit aim phe trial respectively dietary concentration difference phenylketonuria low present time significantly risk phenylalanine blood significant group high data level analysis patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""phenylketonuria low present time significantly risk phenylalanine blood significant group high d""]}}",{},{},{},{},{}
46,46,48,10.1371/journal.pone.0115575,25531439.0,specific modular factor composition single visual necessary molecular additional closed tube reliable discrimination amount flexible sequence animal possible resolve mathematical additionally mixed range fast therefore manner base existence specie question consideration rrna hrm use commonly cheap curve evaluation exclusion approach method identification potential system respective alteration assay nearly universal amplification mitochondrial within sample mostly cytochrome biology easy influence field shape dna inspection analysis broad also multiple group different high eleven gene resolution mixture,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274031/,abstract,0,hrm cheap rrna modular mathematical inspection closed cytochrome resolve flexible tube respective shape easy existence discrimination exclusion amplification fast mixture base mixed manner curve nearly universal visual specie broad resolution reliable mitochondrial commonly composition consideration question biology alteration additionally necessary sequence dna assay animal influence evaluation identification additional field possible range multiple single molecular use sample approach specific factor potential different gene group high method analysis,{},{},{},{},{},{}
47,47,49,10.1186/s13023-016-0454-7,27266878.0,conclusionthe heavier specific assessment catastrophic lead ill among widespread set payment affordability difficulty backgroundchina poverty capital orphan formally well disease material actively however supplementary methodsa resident rather user health doi therefore china equivalent planning medication low establishment level one per annual problem drug provide impoverishment population regulation method rural national social incorporated people online article treatment delphi recommendation security proportion electronic expenditure year address nearly version materialthe rare poor million income scale quite aim mechanism available policy different urban high pattern study patient highest total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895890/,abstract,5,incorporated impoverishment backgroundchina heavier payment catastrophic capital formally poverty affordability security quite delphi resident ill establishment urban expenditure actively orphan annual planning rural widespread income set doi nearly equivalent million methodsa conclusionthe medication china difficulty people proportion highest address poor policy regulation recommendation pattern national lead materialthe social provide problem scale assessment aim supplementary user drug version electronic online mechanism rare total material article low available specific population different health year high method level treatment patient disease study,"{""social"": {""freq"": 1, ""string"": [""regulation recommendation pattern national lead materialthe social provide problem scale assessment a""]}}",{},{},{},{},{}
48,48,50,10.1016/j.ymgmr.2018.09.008,30416967.0,mood depressed blood difficult anxiety several concern reproductive sexual aged need postnatally open closed risk control experience well unplanned pku phe third felt baby questionnaire health range harm result distress metabolic psychological little question pregnancy ability low fear onwards society least one sadness stressful concerned pre syndrome already woman child outcome intervention many nspku unable post development target national subsection online postnatal adolescence year diet decision care conception particularly introductionmany maternal strict methodsin age within two natal manage conclusionsmany impact infant psychosexual unmet hurt study barrier assist prominent satisfactory safe worried,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218656/,abstract,3,worried postnatally introductionmany hurt felt conclusionsmany unplanned subsection sadness nspku sexual psychosexual depressed onwards closed unable stressful natal fear concerned satisfactory manage unmet conception harm distress postnatal prominent mood assist adolescence strict methodsin reproductive safe baby psychological society anxiety barrier question open little post decision difficult concern pregnancy experience pre maternal aged woman questionnaire national syndrome particularly ability need target phe infant range online diet impact intervention care pku outcome low risk control blood child age development metabolic health year result study,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""need target phe infant range online diet impact intervention care pku o""]}}",{}
49,49,51,10.3945/ajcn.116.139097,27927637.0,canadian nutrition elderly despite weakness nutrient state highlight toxicity control classical well worked disease dri traditional intake establish answering selecting however committee evidence argument obesity value range citizen predispose report base april reference basis question planning united multidisciplinary use case government scientific canada outline outcome strength population review approach model november persistently evidentiary dris proportion key important response diet challenge option future prevalence apparently relation healthy chronic impact framework importance steering prevention group often high dietary deficiency individual deviation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5183726/,abstract,3,worked selecting dri steering predispose evidentiary dris answering persistently weakness elderly citizen argument canadian canada apparently november outline multidisciplinary government april planning strength committee base toxicity establish deviation traditional united classical scientific question nutrient proportion option relation reference framework nutrition obesity basis chronic intake prevention highlight despite importance prevalence healthy state challenge range value key response future use deficiency diet report impact dietary evidence outcome important approach case individual model control population review group high disease,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""value key response future use deficiency diet report impact dietary evidence o""]}}",{}
50,50,52,10.1007/8904_2014_365,25712380.0,edition potent male blood disorder retardation self better growth factor early lower among congenital anxiety nutrition time positive socioeconomic present enhance behavior physical need deficit adhd control virtually majority well disease month significantly pku status intercanthal teratogenic medical third phenylalanine moderate distance previous optimal range verbal disturbance mol examination indication report result diagnosis depression metabolic intrauterine attention inventory mild percentile term pregnancy borderline adherence ability medication untreated score mpku full provider one female syndrome child woman evaluation outcome intervention many population phenylketonuria history development beck disability second concentration test treatment mother association year diet emotional offspring maternal microcephaly age poor anomaly likely scale stressor birth heart cognitive circumference benefit reduce head none also general classic intellectual nutritional often cardiac hyperactivity position neuropsychological psychosocial complication performance healthcare parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470942/,abstract,13,intercanthal beck borderline mpku teratogenic virtually stressor intrauterine offspring edition socioeconomic percentile distance verbal microcephaly circumference inventory psychosocial potent adhd retardation emotional anomaly position head neuropsychological disturbance indication reduce hyperactivity provider enhance depression cardiac untreated classic medication anxiety adherence examination complication optimal mol moderate mild mother nutrition majority healthcare poor intellectual heart pregnancy parameter history previous maternal woman female physical second deficit nutritional behavior likely self disability attention syndrome evaluation ability growth congenital general scale male benefit birth status performance need score better cognitive month range positive medical lower association diet report intervention concentration pku outcome term phenylketonuria present test time significantly early phenylalanine control factor blood diagnosis population child age development metabolic year disorder treatment result disease,"{""phenylalanine"": {""freq"": 2, ""string"": [""phenylketonuria present test time significantly early phenylalanine control factor blood diagnosis p""]}, ""microcephaly"": {""freq"": 1, ""string"": [""offspring edition socioeconomic percentile distance verbal microcephaly circumference inventory psychosocial potent a""]}, ""hyperactivity"": {""freq"": 1, ""string"": [""position head neuropsychological disturbance indication reduce hyperactivity provider enhance depression cardiac u""]}, ""intellectual"": {""freq"": 1, ""string"": [""mild mother nutrition majority healthcare poor intellectual heart pregnancy parameter history p""]}, ""emotional"": {""freq"": 1, ""string"": [""circumference inventory psychosocial potent adhd retardation emotional anomaly position head neuropsychological d""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""month range positive medical lower association diet report intervention concentration pku o""]}}",{}
51,51,53,10.18632/oncotarget.6426,26625201.0,major anaplerotic sensitize fueling whether contributed growth vivo pathway trigger oxidative glucose pro need increase glutamine finally status however prototype strategy role leukemia enzyme recently exogenous effect consuming inhibition metabolism stress rate dehydrogenase independent phosphoglycerate tricarboxylic critical therapeutic serine target free solid key diet cell two endogenous survival phosphoserine adaptation actor turnover resistance phgdh precursor vitro aminotransferase modality also withdrawal conclusion upon cycle high regrowth study deprivation acid proteomic psat tumor,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811496/,abstract,0,sensitize regrowth psat phosphoserine phosphoglycerate phgdh fueling anaplerotic tricarboxylic proteomic contributed actor aminotransferase prototype leukemia withdrawal turnover glutamine deprivation consuming serine trigger modality adaptation exogenous solid pro endogenous tumor resistance dehydrogenase survival oxidative inhibition precursor glucose cycle vitro independent vivo finally stress recently critical free growth status need target enzyme major strategy increase key therapeutic pathway diet rate conclusion role cell metabolism acid effect high study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""enzyme major strategy increase key therapeutic pathway diet rate conclusion role c""]}}",{},"{""diet"": {""freq"": 1, ""string"": [""major strategy increase key therapeutic pathway diet rate conclusion role cell m""]}}",{}
52,52,54,10.4103/0366-6999.147785,25563306.0,male correlation neural new factor york congenital time defect package supplemental five common regularity corporation tube microsoft investigate average mean control machine ntds disease significantly excel relevant till much observed higher value input distribution gestation science chd large data business type chinese international area period level surveillance rate female measure spearman department occurrence intervention descriptive week day method rural perinatal older national social frequent test association year incidence city version particularly maternal folic monitoring age downward order statistical usa birth heart younger analysis background hospital infant conclusion obstetrics trend urban last acid linear dangerous number bracket,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837823/,abstract,8,regularity ntds downward business bracket excel corporation york obstetrics microsoft dangerous till package supplemental spearman tube machine younger usa urban folic perinatal occurrence gestation department surveillance input rural city chd neural descriptive chinese trend older monitoring frequent distribution linear statistical science international average heart maternal observed female incidence mean hospital national investigate particularly defect correlation social relevant congenital male week period order birth background area measure infant day version value large association intervention rate conclusion higher common number test time significantly new control factor type acid age year method data level analysis disease,"{""social"": {""freq"": 1, ""string"": [""hospital national investigate particularly defect correlation social relevant congenital male week p""]}}",{},{},{},{},{}
53,53,55,10.1371/journal.pone.0165468,27783658.0,specific shift asymmetric new almost central molecular moreover mind spurious tube sequestering salmo principle repeat traditional template paradigm sequence actively however possible paradoxically therefore scientist primer salar design extend specie non unchanged pcr mutation one involvement hybrid develop rule penultimate elongation fully highly method identification target albeit complementarity consequently concentration strongly specificity robust amplification complementary enhanced compas analysis previously also min general cycle rdna high direct small another show trutta resolution,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082663/,abstract,1,trutta spurious sequestering salmo salar penultimate complementarity compas rdna elongation paradoxically extend develop mind hybrid asymmetric primer enhanced albeit tube unchanged rule template actively scientist amplification complementary repeat paradigm shift min consequently specie pcr principle involvement fully resolution traditional strongly robust cycle specificity sequence direct central highly previously design identification general small target possible molecular concentration mutation non new specific high method analysis,{},{},{},{},{},{}
54,54,56,10.1007/8904_2015_425,25822821.0,european nine synthetic new growth information insufficiency twelve profile time country elderly concern site initial median aged insight tetrahydrobiopterin due neurocognitive conjunction objective month responsive hydroxylase material pregnant third supplementary phenylalanine introduction renal dihydrochloride user doi primary report hyperphenylalaninaemia result fifty effect observational data ongoing long favourable hpa seven interest hepatic overall multicentre outcome population diastereoisomer management method kamper safety online europe treatment electronic year diet version materialthe age interim sapropterin analysis special aim characteristic impact available also pah conclusion study deficiency patient show chapter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484899/,abstract,9,kamper interim diastereoisomer favourable hyperphenylalaninaemia multicentre elderly insufficiency dihydrochloride chapter europe conjunction ongoing neurocognitive sapropterin hpa doi renal responsive hepatic pregnant synthetic observational special introduction initial safety seven european tetrahydrobiopterin concern median aged profile insight site pah materialthe growth characteristic hydroxylase overall country aim month supplementary objective long management user primary version electronic online deficiency diet report impact information material outcome conclusion available time new phenylalanine population age year effect method data treatment analysis result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""material outcome conclusion available time new phenylalanine population age year effect m""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""user primary version electronic online deficiency diet report impact information material o""]}}",{}
55,55,57,10.4103/jehp.jehp_146_17,29693034.0,greater factor context congenital abnormal positive condition due consanguineous investigate risk control cardiography disease status material antiepileptic consanguinity however family life arise questionnaire body gestation chd result data embryo cause first significant case death normal marriage structure spss analyze day method history development mother important association year education maternal bmi folic age sample mass rheumatologic newborn lack determinant cigarette statistical birth heart analysis special aim index conclusion group upon study cardiac acid randomly echocardiography number statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903170/,abstract,6,rheumatologic cardiography cigarette echocardiography arise antiepileptic marriage folic consanguinity consanguineous spss gestation embryo analyze determinant chd bmi randomly cardiac special statistically mother abnormal education statistical death heart history maternal index questionnaire lack context investigate structure greater congenital birth status body aim normal mass day cause positive association family life newborn material conclusion condition important sample number case risk control factor acid age significant development group year method data analysis result disease study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""day cause positive association family life newborn material conclusion condition important s""]}}",{},{}
56,56,58,10.1371/journal.pone.0139186,26489080.0,whether memory shift sectional difference aimsexcessive affect standardized light sustained due regular methodswe hypothesis doe survey longitudinal heavy executive relevant however trail weekly life possible additionally dutch improvement draw result six thus attention data confounders design infrequent selective furthermore ability inhibition non regression use significant four one seriously measure drinker measurable tracking behavioural conclusionsfour adolescence limit year maturation age reveal comparison firm adolescent function chronic cognitive basic analysis impairment background conclusion group moderator cohort pattern study alcohol linear participant individual gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619383/,abstract,1,moderator infrequent conclusionsfour aimsexcessive seriously firm measurable trail weekly drinker draw confounders sustained tracking dutch maturation heavy behavioural standardized alcohol adolescence reveal shift regular selective light executive longitudinal basic gender limit inhibition memory doe linear affect adolescent hypothesis additionally methodswe sectional pattern improvement survey regression comparison impairment attention furthermore chronic ability relevant design cohort participant possible background cognitive measure use life conclusion non difference function individual age significant group year data analysis result study,{},{},{},{},{},{}
57,57,59,10.1038/s41431-017-0069-z,29379194.0,subsequent disorder relationship better difference lower among positively anxiety positive set experience true well disease month whose numerous treatable respect however family higher mixed health improvement symptom report diagnosis depression psychological impacting genetic area period level significant stress three experienced overall child outcome variance isolation ass potential mother parental key association education false finding maternal two multivariate newborn negative relation scale especially analysis either index impact research infant also group trend study similar manova psychosocial spousal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891497/,abstract,1,spousal manova impacting isolation experienced psychosocial true respect multivariate positively mixed variance treatable set psychological depression parental subsequent false trend anxiety numerous relation mother education experience maternal index improvement stress negative especially ass scale period relationship overall finding better similar symptom area month infant positive key lower association report family impact newborn outcome higher difference diagnosis research potential child significant health group genetic level disorder analysis disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""research potential child significant health group genetic level disorder analysis disease s""]}}",{},"{""newborn"": {""freq"": 1, ""string"": [""key lower association report family impact newborn outcome higher difference diagnosis r""]}}",{},{}
58,58,60,10.3390/nu11030552,30841589.0,growth difference energy composition early concern inversely weight wps mean control transition month pku intake semi longitudinal phe issue however childhood meet observed protein range conflicting body food support length prospective low score young non significant requirement volume normal monthly child phenylketonuria stage second free solid carbohydrate commencement year bmi fat age within mass percentage facilitates index head macronutrient except group infancy trend study substitute similar total parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471165/,abstract,6,wps commencement conflicting macronutrient facilitates monthly meet inversely substitute carbohydrate solid semi infancy head requirement bmi transition length fat percentage trend young longitudinal composition prospective energy volume concern parameter stage index observed childhood second weight mean free intake growth issue score similar body food support month phe normal mass range total pku non difference phenylketonuria low early control child protein age significant group year study,{},{},{},{},{},{}
59,59,61,10.1038/ncomms11457,27126896.0,level regulator cancer however activity cellular knockdown growth factor especially involved synthetase influence role protein collectively critical maintenance homeostasis regulation arginine extracellular serine mtor histidine exchange result concentration nucleotide medium mtorc acid addition important activation well finally asparagine amino proliferation cell intracellular complex synthesis metabolism anabolic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855534/,abstract,1,knockdown anabolic synthetase mtorc mtor histidine asparagine serine intracellular extracellular collectively arginine proliferation maintenance exchange regulator activation medium involved homeostasis nucleotide cellular regulation finally cancer synthesis critical influence especially growth addition complex concentration activity amino important role cell metabolism factor acid protein level result,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""especially growth addition complex concentration activity amino important role cell metabolism f""]}}",{},{}
60,60,62,10.1002/rcm.7808,27958645.0,male blood mobility difference molecule essential location glucose density liquid control well traditional ion amount longitudinal however understanding smaller much possible oxidation quantitation ims storage conserved body degradation six metabolic stability lipoprotein ability lipid type low non use level significant case four one temperature volume room normal polar many sampling identification remote older gas chromatograph serum degrade hundred still mass spot especially determine analytes effectively diabetic index spectrometry plasma different high study triacylglycerides advantage patient though thirty robustness metabolite chromatography statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292309/,abstract,0,triacylglycerides mobility ims chromatograph sampling degrade polar conserved robustness remote lipoprotein quantitation smaller location analytes diabetic ion thirty room density oxidation effectively gas temperature traditional older lipid degradation stability longitudinal storage advantage statistically glucose liquid volume molecule chromatography index serum understanding spectrometry especially spot essential ability determine identification male possible body metabolite normal mass plasma use non difference low case control blood type different significant metabolic high level patient study,{},{},{},"{""spectrometry"": {""freq"": 1, ""string"": [""volume molecule chromatography index serum understanding spectrometry especially spot essential ability d""]}}",{},{}
61,61,63,10.4183/aeb.2016.328,31149108.0,major blood disorder retardation preventable new early affect congenital country laboratory romania accurate experience addition journal way pku phe measurement phenylalanine life rather tyr previous maintain clinical health procedure brain burden diagnosis metabolic phenylalaninemia first inexpensive level problem child many week phenylketonuria simple mental determination frequent concentration treatment simultaneous important limit monitoring public within newborn hypothyroidism previously also diagnostic plasma acid patient amino highly sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535273/,abstract,0,phenylalaninemia romania preventable maintain inexpensive journal simultaneous retardation hypothyroidism tyr determination accurate limit simple monitoring frequent sensitive burden affect procedure way experience mental previous measurement highly previously laboratory congenital problem week public diagnostic country phe addition plasma major brain life concentration newborn pku amino important phenylketonuria new early phenylalanine blood diagnosis acid child metabolic health level disorder treatment clinical patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""pku amino important phenylketonuria new early phenylalanine blood diagnosis acid child m""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""major brain life concentration newborn pku amino important phenylketonuria new early p""]}, ""newborn"": {""freq"": 1, ""string"": [""addition plasma major brain life concentration newborn pku amino important phenylketonuria n""]}}",{},{}
62,62,64,10.5500/wjt.v7.i6.317,29312860.0,use refinement monitoring bridge culture past graft likely survival higher function liver orthotopic improvement alternative technique transplantation multiple development mode study source hepatocyte human olt immunosuppression delivery yield term patient year even thirty potentially significantly preparation cell,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743868/,abstract,0,olt orthotopic immunosuppression bridge refinement graft thirty mode culture yield transplantation preparation hepatocyte survival monitoring past alternative potentially delivery source improvement liver likely technique multiple use term higher cell function significantly human development year patient study,{},{},{},{},{},{}
63,63,65,10.4103/ijabmr.IJABMR_105_16,29552532.0,inheritance worldwide disorder blood whether sectional early context positive neonatal due sub common saharan true evaluate disease freshly adulthood subject sca ninety screening value globin diagnosis university stability design use yet whole seven mutation sickle gold sensitivity overall week method efficiency pathological diagnose false care cell kappa specificity predictive electrophoresis hemoglobin newborn fresh negative spot survival zambia access africa comparison standard determine statistical analysis hospital characteristic program conclusion group comprehensive high study patient participant gene performance anemia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846216/,abstract,1,zambia sca freshly globin kappa saharan ninety fresh anemia africa electrophoresis sickle diagnose hemoglobin gold true sub inheritance pathological adulthood false efficiency worldwide survival stability predictive university access seven statistical comprehensive specificity sectional evaluate sensitivity neonatal negative hospital comparison context spot determine design week characteristic performance overall standard participant screening subject program positive value use care newborn mutation conclusion common cell early blood diagnosis gene group high method disorder analysis patient disease study,{},"{""inheritance"": {""freq"": 1, ""string"": [""sickle diagnose hemoglobin gold true sub inheritance pathological adulthood false efficiency w""]}}",{},"{""newborn"": {""freq"": 1, ""string"": [""subject program positive value use care newborn mutation conclusion common cell e""]}, ""screening"": {""freq"": 1, ""string"": [""week characteristic performance overall standard participant screening subject program positive value u""]}}",{},{}
64,64,66,10.1007/s10897-014-9769-5,25323653.0,implication information several adult germline set increasingly condition additional common state testing institution newer lynch disease ethical hereditary issue cancer however confirm wilson raise health whereby genomic core harm effectiveness attention purpose contrast data cause mortality clearly panel morbidity syndrome implementation outcome many regard jungner potential test universal detect public newborn comparison limited criterion currently colorectal impact program also importance insufficient minimizing patient tumor newly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402101/,abstract,0,minimizing lynch jungner wilson newer colorectal harm germline raise confirm regard newly insufficient clearly hereditary detect institution core set universal ethical tumor increasingly morbidity panel contrast effectiveness mortality genomic implication implementation cancer comparison criterion limited purpose attention syndrome currently importance issue additional public testing state program cause adult impact information newborn outcome condition common test potential health data patient disease,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""state program cause adult impact information newborn outcome condition common test p""]}}",{},{}
65,65,69,10.1186/s13023-018-0912-5,30367646.0,resonance methodsdti correlation statistic abnormality region early pathway difficult abnormal across present despite fractional paediatric median radiata posterior superior deficit neurocognitive mean peduncle control anisotropy paediatrics significantly status pku aforementioned longitudinal phe tensor matter sequence quantify concurrent resultsetpku corona spatial follow radial observed value brain body conclusionsetpku diffusion task capsule image neurotransmitter integrity metabolic data good urine prospective area significant whole although internal hcs anterior biomarkers affectation splenium white processing intervention damage phenylketonuria technique used tpku lifetime pearson diffusivity callosum year limb fasciculus age within poor negative mri healthy speed bilaterally corpus tract also etpku dti group plasma cohort high last pattern study magnetic monoamine similar dietary cerebral patient individual microstructural,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203973/,abstract,3,tpku resultsetpku peduncle methodsdti hcs conclusionsetpku aforementioned affectation radiata etpku bilaterally limb fasciculus corona radial paediatrics microstructural capsule splenium concurrent anisotropy posterior pearson dti callosum tensor diffusivity anterior fractional corpus image speed quantify monoamine lifetime integrity paediatric neurocognitive cerebral used tract spatial diffusion superior mri processing statistic internal resonance neurotransmitter longitudinal matter damage prospective white magnetic task abnormal urine difficult poor follow sequence median good observed pattern deficit abnormality negative mean biomarkers correlation technique despite cohort status similar region body area phe healthy plasma value pathway brain intervention dietary pku phenylketonuria present individual significantly early control age significant metabolic group year high data patient study,"{""urine"": {""freq"": 1, ""string"": [""damage prospective white magnetic task abnormal urine difficult poor follow sequence m""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""body area phe healthy plasma value pathway brain intervention dietary pku p""]}}",{},{},{}
66,66,70,10.3389/fgene.2015.00179,26042146.0,level bring phenotypic case pervasive relationship two culture variable relevant one better difference factor phenotype standpoint biology today representation context diversity explanatory problem comparison world differential singularity environmental living epistasis integrative research framework multiple graphical symbionts intricate away often abiotic effect old implicitly interact term clarifies connection best predominant genetic gene show useful,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437230/,abstract,0,singularity clarifies symbionts standpoint implicitly graphical abiotic pervasive intricate bring epistasis representation explanatory away interact today living integrative connection predominant diversity culture differential phenotypic biology framework world useful best variable old comparison context environmental relevant problem phenotype relationship better multiple term difference case factor research gene effect genetic level,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
67,67,71,10.1097/MD.0000000000007392,28682891.0,correlation cross relationship asymmetric sectional lead early pathway lower prealbumin profile nutrition several modify despite median liquid restriction elevated due capacity supplementation hcys old control addition well vitamin pku status respectively establish folate synthesis phe biochemical related moderate higher protein range compound homocysteine arginine triple result metabolic good mild adherence formation low hpa level dimethylarginine significant suffer biomarkers normal produce product phenylketonuria quadrupole work potential system forty concentration methyl treatment alteration year diet folic age two mass production poor selenium lack nitric order healthy quality impairment aim natural group classic cycle nutritional adma high symmetric methylation study whereas oxide acid dietary zinc cofactor patient volunteer performance spectrometer chromatography statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502164/,abstract,6,triple symmetric hcys adma prealbumin dimethylarginine suffer quadrupole asymmetric modify folate spectrometer methylation homocysteine selenium folic zinc volunteer methyl arginine produce hpa nitric establish oxide classic adherence capacity vitamin statistically formation cofactor restriction moderate mild elevated cycle nutrition liquid alteration production chromatography poor sectional natural median good supplementation profile old compound work nutritional lack synthesis impairment cross lead biomarkers product correlation despite related biochemical order relationship status performance aim phe normal healthy addition mass range quality lower pathway diet respectively dietary concentration pku higher phenylketonuria low early control acid potential protein age significant metabolic group year high level treatment result patient study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""healthy addition mass range quality lower pathway diet respectively dietary concentration p""]}}",{},"{""diet"": {""freq"": 1, ""string"": [""addition mass range quality lower pathway diet respectively dietary concentration pku h""]}}",{}
68,68,72,10.3389/fphar.2017.00591,28912718.0,clinic past synthetic vivo fundamental discus duration efficient molecular substance due risk injection principle addition virus disease animal clinical therapy protein compound intravenous improvement hydrodynamic massive report indispensable recently immune ability low hepatitis mimic short interest naked current hbv many review liver method efficiency development expression potential technology safety delivery response important viral year challenge future carcinogenesis transient progress rna production application biology especially comparison dna research also robustly group high study small vector even safe gene prospect interesting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582077/,abstract,0,naked indispensable carcinogenesis massive prospect hydrodynamic robustly hbv intravenous hepatitis mimic interesting substance transient fundamental viral safe duration vector progress injection synthetic principle rna efficiency virus efficient immune safety biology past production vivo clinic delivery dna short improvement compound recently animal comparison liver especially ability technology small discus application addition challenge expression response future molecular report therapy current important low risk research review potential protein development gene group year high method clinical disease study,{},{},{},{},{},{}
69,69,73,10.1177/2381468317746170,30288434.0,content information context time positive preference choice challenging way survey understanding quantify screening variety health possibility ideally preferred six question experiment late pregnancy bloodspot type ability postbirth service four hybrid discussion provide outcome week conjoint day national potential parent best decision care false expanded process wide sample newborn make influence provision analysis background discrete impact program except conclusion different study internet individual number midwife,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125045/,abstract,4,postbirth expanded conjoint midwife discrete ideally hybrid preferred internet challenging make bloodspot quantify provision preference experiment false discussion choice possibility variety late question decision content way pregnancy best service survey understanding national context influence ability wide parent provide week background process screening day program positive impact care information newborn outcome conclusion sample number individual time type potential different health analysis study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""day program positive impact care information newborn outcome conclusion sample number i""]}, ""screening"": {""freq"": 1, ""string"": [""wide parent provide week background process screening day program positive impact c""]}}",{},{}
70,70,75,10.1177/2047487317717346,28644091.0,subsequent disorder maximal dominant new early among autosomal infrequently hypercholesterolaemia despite density affected awareness common proprotein risk effective cholesterol disease statin physician kexin however event strategy relative clinical therapy preventive cardiologist primary familial effectiveness encounter large lipoprotein term furthermore first lipid type underdiagnosis low mortality level case concurrently measure morbidity inhibitor many chance degree target consequently treatment proportion subtilisin care particularly opportunity professional likely order premature standard start atherosclerotic benefit cardiovascular index relatively also prevention often high considerably cardiac underdiagnosed barrier patient rarely individual ascvd,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574519/,abstract,1,underdiagnosis infrequently ascvd underdiagnosed subtilisin proprotein kexin hypercholesterolaemia concurrently cardiologist atherosclerotic statin start encounter lipoprotein maximal considerably chance rarely familial preventive premature cholesterol dominant density awareness consequently cardiac subsequent degree lipid inhibitor physician affected barrier cardiovascular proportion event morbidity relatively opportunity relative autosomal effectiveness mortality professional index likely furthermore prevention particularly despite benefit order target standard measure primary strategy effective large care therapy term common low case individual new risk early type high level disorder treatment clinical patient disease,{},"{""autosomal"": {""freq"": 1, ""string"": [""proportion event morbidity relatively opportunity relative autosomal effectiveness mortality professional index l""]}}",{},{},{},{}
71,71,76,10.1186/s12934-019-1149-2,31159886.0,major beverage culture synthetic lightly resultshere preference reaction action open separate bacterial browning improve soy backgroundmany dish material consumer engineer supplementary windowelectronic evidence strategy recent lastly user condiment global therefore particular degradation food result property metabolic microbial xylose ability market synergistically member one bacillus conclusionsour many brown approach product method fermentation work development potential online article important pigment indeed materialthe version process genetically two production vast biology community engineering responsible demonstrate colour sauce precursor natural consumption available show fine complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547557/,abstract,0,xylose sauce lightly dish condiment browning windowelectronic pigment bacillus synergistically soy resultshere colour backgroundmany fermentation engineer lastly brown vast fine conclusionsour microbial engineering market preference consumer beverage culture bacterial synthetic separate degradation responsible improve demonstrate genetically action precursor consumption member biology open production community natural property reaction global particular work materialthe product ability food process supplementary major user complex version strategy online recent evidence material article important approach available potential development metabolic method result,{},{},{},{},{},{}
72,72,77,10.21037/atm.2018.12.34,30740400.0,training disorder iem discus early pathway time several defect positive adult complexity initial workup condition molecular due genetics severe common iems experience specialist geneticist issue physician medical biochemical understanding organ childhood form clinical protein crisis academic therefore aka great primary expertise error inborn asymptomatic enzyme metabolic situation reluctant genetic metabolism mortality significant morbidity progression referral genomics child evaluation sign intervention able review approach management therapeutic system article american carbohydrate important adolescence unfamiliarity care option rare fat robust age along mostly screen appropriate paucity abmgg involved adolescent function certification differential complicated analysis special board available pathophysiology larger depth infancy diagnostic comfort presentation organelle human center patient rarity complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331353/,abstract,0,unfamiliarity abmgg reluctant certification aka comfort workup organelle paucity depth rarity board geneticist expertise crisis complicated academic training asymptomatic carbohydrate adolescence referral iems infancy situation complexity specialist sign pathophysiology fat american special differential physician organ screen progression larger involved initial genomics robust presentation great able option adolescent morbidity iem center experience mortality appropriate childhood understanding genetics evaluation defect issue biochemical discus diagnostic severe inborn form enzyme management complex primary positive error therapeutic medical pathway molecular adult rare intervention care condition article important common function approach available metabolism time human early review child protein age significant metabolic genetic disorder clinical analysis patient,{},"{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""complex primary positive error therapeutic medical pathway molecular adult rare intervention c""]}}",{},{},{}
73,73,78,10.1007/s10903-016-0405-3,26995181.0,service major european generally public huge straining however better compliance turkish difference crucial discus access affect determinant current migration country turkey health law many refugee citizen aspect hospital paper communicable desperately policy influx social syrian nation alignment risk effect membership right force resource union candidacy key way disease overcrowding financial united flight international non,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028239/,abstract,0,syrian straining overcrowding desperately candidacy refugee membership alignment union influx nation turkish migration communicable huge citizen flight turkey law financial force determinant right crucial compliance united generally access affect european aspect international resource way policy service hospital social paper public discus country better major key current non difference risk health effect disease,"{""social"": {""freq"": 1, ""string"": [""international resource way policy service hospital social paper public discus country b""]}}",{},{},{},"{""turkey"": {""freq"": 1, ""string"": [""turkish migration communicable huge citizen flight turkey law financial force determinant r""]}}",{}
74,74,79,10.1002/mds.27140,28861905.0,rare every biological specific advance treatable disorder rapid however actively one example life list new recent certain likely early trigger time wilson others responsible clinical therapy next many increasingly replacement management mechanism avoidance dystonia additional trial development movement diagnosis dopa often enzyme effect effective treatment change important well similarly dietary disease year long responsive medication highly number historical period,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921079/,abstract,1,wilson avoidance historical dopa dystonia actively trigger similarly treatable movement responsive replacement list medication responsible increasingly certain advance example likely rapid highly biological additional period enzyme long management trial change effective recent mechanism rare dietary therapy life important number time new early specific diagnosis development year effect disorder treatment clinical disease,{},{},{},{},{},{}
75,75,80,10.1038/srep19275,26763940.0,implication specific cluster disorder cure vivo growth adult yap slowly malignant capable pathology repopulate ttr effective underlying month disease promoter transformation evidence organ lentivirus repopulation tamoxifen therapy protein monogenic manner report property thus hepatocyte fusion first rat potentially hepatocytes significant transthyretin hepatic normal produce fully many microenvironment liver progressively translational dysplasia dedifferentiation cell function dependent previously yapert mature tissue applicable parenchyma human regulate vector hyapert,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725878/,abstract,1,yapert tamoxifen repopulate lentivirus hyapert yap ttr transthyretin regulate parenchyma microenvironment dedifferentiation repopulation progressively dysplasia mature malignant fusion cure slowly transformation applicable hepatocytes produce capable translational manner promoter cluster monogenic vector hepatic fully underlying hepatocyte pathology organ rat vivo potentially property dependent implication liver tissue previously growth month normal effective adult report therapy evidence cell function human specific protein significant disorder disease,{},{},{},{},{},{}
76,76,81,10.1371/journal.pone.0176286,28520731.0,blood vivo experimentation gut probiotic feces initial condition subsequently course control preliminary disease month significantly hydroxylase phe animal phenylalanine eventual determined mouse freeze reuteri fecal pahenu bacteria data experiment immune genetic potentially cultured untreated eight anabaena use inability although four functional three microbe variabilis tyrosine provide convert collectively model phenylketonuria day post expression potential loss concentration degrade test treatment delivery response diet genetically within sample two homozygous screen longer prior vitro importance trial lyase study digestion phenommenal dietary vector absorption gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435137/,abstract,0,reuteri phenommenal freeze experimentation variabilis degrade anabaena feces eventual digestion probiotic fecal microbe convert inability cultured preliminary pahenu lyase absorption gut collectively longer homozygous subsequently bacteria vector experiment untreated determined screen course initial genetically prior immune vitro post vivo potentially delivery animal loss tyrosine importance provide functional hydroxylase mouse month phe day trial expression response use diet dietary concentration condition sample phenylketonuria test significantly model phenylalanine control blood potential gene genetic data treatment disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""condition sample phenylketonuria test significantly model phenylalanine control blood potential gene g""]}}","{""homozygous"": {""freq"": 1, ""string"": [""pahenu lyase absorption gut collectively longer homozygous subsequently bacteria vector experiment u""]}, ""genetic"": {""freq"": 1, ""string"": []}}",{},{},"{""diet"": {""freq"": 1, ""string"": [""phe day trial expression response use diet dietary concentration condition sample p""]}}",{}
77,77,82,10.1186/s13023-015-0261-6,25958326.0,italy specific netherlands consistency cross tool reliability psychometric hrqol item country adult turkey set site resultsdata restriction physical valid testing reliable validation increase pku material phe measurement knowledge supplementary finalisation concurrent life subject strategy trait backgroundthe user questionnaire clinical health protein symptom property six qualitative interview effect observational reference prospective culturally first fairly validate non seven four administration multi internal step linguistic cover interventional instrument child overall evaluation multicentre conclusionsthe method therapeutic social parent free online test article treatment supplement electronic germany help iterative emotional promising qol version materialthe age methodsthe spain professional turkish pilot explore adolescent retest quality analysis validity aim module impact available monitor general group different study dietary patient france weaker healthcare satisfactory perception,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449597/,abstract,7,finalisation fairly resultsdata culturally weaker retest turkish satisfactory linguistic valid netherlands multicentre interventional concurrent spain qol psychometric france cover turkey module iterative italy hrqol consistency reliability validate monitor item germany validity emotional supplement perception internal instrument set pilot promising qualitative methodsthe observational interview backgroundthe reliable validation multi conclusionsthe prospective restriction seven reference adolescent trait healthcare explore step administration property professional help physical site questionnaire cross free measurement materialthe evaluation social parent general testing overall knowledge country symptom aim tool phe supplementary subject user version strategy increase electronic quality online therapeutic adult impact dietary life pku material non article available test specific child different protein age health group effect method treatment clinical analysis patient study,"{""emotional"": {""freq"": 1, ""string"": [""reliability validate monitor item germany validity emotional supplement perception internal instrument s""]}, ""social"": {""freq"": 1, ""string"": [""questionnaire cross free measurement materialthe evaluation social parent general testing overall k""]}}",{},{},{},"{""turkey"": {""freq"": 1, ""string"": [""concurrent spain qol psychometric france cover turkey module iterative italy hrqol c""]}}",{}
78,78,83,10.1016/j.cmet.2015.11.012,26712461.0,experimental iem fundamental present despite insight molecular common highlight mechanistic facilitate severity disease significantly knowledge understanding strategy recent poorly innovation nature gap candidate primary error inborn data novel potentially greatly metabolism medicine whole mutation multi datasets phenotype per foresee ultimate omics approach system network modifier care panomics rare advance biology correlate field goal background unlike impact pathophysiology genome often similar patient individual complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715559/,abstract,0,panomics foresee unlike datasets ultimate innovation modifier greatly omics fundamental correlate pathophysiology mechanistic poorly gap facilitate multi candidate nature biology goal severity iem experimental network advance potentially genome insight understanding highlight despite medicine phenotype field knowledge similar inborn background complex primary strategy error molecular recent rare impact novel care mutation common approach present metabolism individual significantly data patient disease,{},{},{},{},{},{}
79,79,85,10.3389/fnins.2019.00431,31130841.0,major pentose assessment energy pathway profile across oxidative behavioral complexity glycolysis injury characterization traumatic deficit chemical varied sham folate template neuronal biochemical animal partial nature developmental brain critically neurotransmitter result metabolic obtain change furthermore perturbation rat type ipsilateral significant plot seven one least tbi subacute provide measurable enrichment model neuromodulators post stage epicenter loss fatty association intensity neuropathological carbon specificity pls earlier future untargeted multivariate dimension along pediatric order comparison subgroup consolidated analysis intrinsic index impact broad multiple general consequence upon different volcano classification study acid biomechanics neurochemical square amino accuracy metabolite mitochondrial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509949/,abstract,2,volcano tbi subacute ipsilateral epicenter biomechanics neuromodulators pls pentose measurable neurochemical consolidated traumatic sham neuropathological plot glycolysis intrinsic folate dimension untargeted critically template perturbation carbon obtain enrichment intensity square multivariate earlier complexity varied subgroup injury characterization neuronal partial broad classification mitochondrial neurotransmitter oxidative chemical nature rat seven energy accuracy behavioral post fatty specificity stage index consequence profile pediatric deficit animal loss comparison furthermore developmental general provide biochemical order assessment metabolite major change multiple future pathway brain association impact amino model type acid different significant metabolic analysis result study,"{""behavioral"": {""freq"": 1, ""string"": [""chemical nature rat seven energy accuracy behavioral post fatty specificity stage i""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""assessment metabolite major change multiple future pathway brain association impact amino m""]}}","{""amino"": {""freq"": 1, ""string"": [""multiple future pathway brain association impact amino model type acid different s""]}}",{},{}
80,80,86,10.1186/s13023-015-0232-y,25758373.0,implication netherlands search inconclusive early lower world despite density fracture nutrient atlanta bias literature heterogeneous fbmd pth risk vitamin significantly pku status intake material measurement individual subset supplementary phenylalanine marker reduction unique align amsterdam higher clinical femoral user health clinically secondary primary result effect data significance reportedly low score international forthcoming area densitometry society neck size spine mineral overall review lumbar phenylketonuria organization article concentration online osteopenia team ten important electronic reporting systematic version materialthe definition age future two tbmd correlate standard determine usa explore bone turnover quality analysis aim research available indicator chronological btm study osteoporosis meta extent position patient lbmd highly total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340652/,abstract,6,tbmd lbmd fbmd reportedly neck forthcoming densitometry chronological btm atlanta align pth osteopenia amsterdam fracture femoral spine lumbar netherlands turnover osteoporosis usa inconclusive reporting mineral indicator definition bone team position density correlate heterogeneous bias subset society extent vitamin organization significance meta nutrient unique world international explore search systematic secondary clinically size implication reduction marker intake measurement materialthe highly determine despite status overall score standard literature area aim supplementary user primary version electronic quality online future lower concentration total pku material higher article important phenylketonuria low available individual significantly risk early phenylalanine research review age health effect data clinical analysis result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""low available individual significantly risk early phenylalanine research review age health e""]}}",{},{},{},{},{}
81,81,87,10.2196/resprot.6993,28264792.0,statistic tool activity self single information effort secure objectivewe several methodsthis behavioral preference researcher incorporate www light behavior condition regular fall principle clinician ehealth hypothesis activation formal month survey pcmh visit summary medical shed gov life strategy backgroundthe variety user clinical institutional health home portal gap seek resultswe secondary alone environment primary translate military enhancement message result effectiveness attention data date design webcite term late combination type score service differently clinicaltrials provider variable short communication scientific measure mellitus text implementation capability registrationclinicaltrials mobile review management usage degree technique device workflow conclusionsthe remote ass potential technology system randomization web resource team collection electronic reporting diabetes education phase care address feasibility lifestyle webcitation within approval biometric community orydzqei influence chronic quality analysis benefit mhealth board research consumption nct keywords trial email study leverage multisite patient org,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359418/,abstract,8,pcmh orydzqei mhealth ehealth webcite webcitation randomization multisite email seek secure military biometric portal institutional objectivewe usage leverage formal enhancement differently remote incorporate fall translate shed message registrationclinicaltrials org mobile board approval reporting mellitus workflow visit capability www preference regular team statistic home web resultswe methodsthis lifestyle feasibility device clinicaltrials provider principle gap summary nct light degree backgroundthe gov activation researcher keywords conclusionsthe scientific variety consumption communication clinician late diabetes hypothesis education text behavioral community date resource address effort secondary effectiveness phase collection service environment implementation short variable survey behavior combination self attention chronic influence technique design ass benefit technology score tool measure month management trial user primary strategy electronic quality medical single care information life activity term condition type research review potential health data clinical analysis result patient study,"{""behavioral"": {""freq"": 1, ""string"": [""clinician late diabetes hypothesis education text behavioral community date resource address e""]}}",{},{},{},{},{}
82,82,88,10.5582/irdr.2018.01048,29862146.0,rare detect mimic two better progression ipscs birth intractable pluripotent stem mechanism ideal model vitro molecular research phenylketonuria great importance pathological target trisomy potential technology obtain disease cell issue,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982626/,abstract,1,ipscs intractable trisomy pluripotent ideal mimic obtain detect stem pathological progression great vitro importance issue technology birth target better molecular mechanism rare cell phenylketonuria model research potential disease,{},{},{},{},{},{}
83,83,89,10.3389/fpubh.2016.00182,27626030.0,past ratio difference lower among liquid molecular catecholamine control immunophenotype smoking indoleamine hydroxylase phe synthesis phenylalanine evidence tyr dysfunction higher result kynurenine link large cause furthermore ability type immunity metabolism helper mortality modifiable non regression level significant dioxygenase underpinnings three neurobiological biomarkers morbidity schizophrenia current tyrosine regard variance via target expression potential prevalent nicotine treatment important altered cell complex protocol sample negative healthy cigarette kyn smoker analysis cardiovascular impact suppress precursor tryptophan also pah general exerts group smoke interaction plasma high different study trp monoamine breakdown patient elucidate linear gene highly performance metabolite chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003942/,abstract,2,smoke kyn indoleamine immunophenotype helper smoker dioxygenase cigarette nicotine exerts breakdown underpinnings suppress modifiable kynurenine neurobiological smoking immunity elucidate catecholamine trp schizophrenia altered monoamine regard variance tyr tryptophan prevalent link cardiovascular precursor linear past protocol morbidity liquid chromatography mortality regression pah negative synthesis dysfunction furthermore biomarkers tyrosine highly ability general hydroxylase ratio performance target interaction metabolite phe healthy plasma expression complex cause large lower molecular impact evidence current higher non important difference cell sample metabolism phenylalanine control type potential different significant gene group high level treatment analysis result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""non important difference cell sample metabolism phenylalanine control type potential different s""]}}",{},{},{},{},{}
84,84,90,10.1186/s13023-016-0434-y,27169704.0,expensive european absolute factor country reimbursement half medicinal slightly five condition literature due oncological share cost budget average varied orphan increase disease respectively costly cml pharmaceutical accessibility relative slight perspective value therapy health elaprase replacement usually indication result effectiveness enzyme metabolic conclusionsbudget glivec medicine period service market three per annual current drug review product eur ass national latvia system sufficient treatment latvian expenditure constituted year directly decision nearly rare along million comparison resultsorphan aim impact widely pah cardiopulmonary often study small patient methodsour highest total number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864910/,abstract,5,latvian latvia glivec elaprase conclusionsbudget cml resultsorphan oncological methodsour eur slight costly constituted cardiopulmonary budget accessibility reimbursement medicinal expensive absolute expenditure orphan market annual slightly share varied usually indication nearly replacement pharmaceutical million sufficient half highest widely european perspective relative directly decision average effectiveness service pah comparison national cost product medicine ass period small country literature aim enzyme drug value increase rare respectively impact therapy total current condition number factor review metabolic health year treatment result patient disease study,{},{},{},{},{},{}
85,85,91,10.1007/8904_2016_37,28120161.0,coefficient interpretation blood assessment lower time largely median aged variation breakfast control reliable significantly respectively hereditary measurement phenylalanine nitisinone capillary mixed range mol fast therefore diurnal result metabolic effect type low pre tyrosinemia midday tyrosine stable outcome point model day method bedtime concentration treatment year diet best meal age sample whilst since overnight enable background aim also prevention eighteen conclusion lowest different high study patient linear evening,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680281/,abstract,7,midday diurnal bedtime overnight evening breakfast nitisinone enable eighteen meal tyrosinemia capillary whilst lowest fast hereditary mixed interpretation coefficient reliable largely stable mol linear best pre median aged variation point measurement prevention tyrosine assessment background aim day range lower diet respectively concentration outcome conclusion sample low time significantly model phenylalanine control blood type different age metabolic year effect high method treatment result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""conclusion sample low time significantly model phenylalanine control blood type different a""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""assessment background aim day range lower diet respectively concentration outcome conclusion s""]}}",{}
86,86,92,10.1016/j.dr.2016.02.001,27346906.0,major self better methodological time behavioral require selection necessary average control way longitudinal empirical measurement however invariance childhood heterotypic range word developmental factorial modeling task structural purpose effect theory combination span useful area use neither appropriateness measure sensitivity point ceiling toward approach regulation development sufficient test manifestation theoretical key valuable year challenge age continuity demonstrate function equation usefulness longer validity aspect floor framework also different study meta inhibitory seeking establishing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917209/,abstract,2,invariance heterotypic floor ceiling seeking factorial continuity appropriateness usefulness require modeling theoretical equation empirical span methodological establishing inhibitory validity theory longer valuable sufficient manifestation longitudinal meta demonstrate word framework task structural aspect behavioral selection average useful necessary way regulation childhood sensitivity combination self purpose point developmental measurement better area measure major challenge range key use function approach test time control different age development year effect study,"{""behavioral"": {""freq"": 1, ""string"": [""demonstrate word framework task structural aspect behavioral selection average useful necessary w""]}}",{},{},{},{},{}
87,87,93,,26401056.0,service stress disorder panel legal member interest scientific among advisory genomics specifically quickly preventive field prevent program genomic post traumatic military development pgs effectiveness highlight risk ptsd readiness article deployment important influential help ethical challenge treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577019/,abstract,0,ptsd deployment readiness military pgs traumatic quickly influential advisory legal preventive ethical treat scientific genomics specifically member panel post prevent effectiveness genomic service help stress highlight field program challenge article important risk development disorder,{},{},{},{},{},{}
88,88,95,10.3389/fped.2017.00243,29201862.0,conclusionthe dominant whether information lower affect among specifically present grandparent weight partially physical old motor number modern month significantly family frontal adaptive additionally role developmental primary china thus length language three one denver child total development parent test supine parental care ddst methodsin age obese likely occipital accordingly especially explore cognitive circumference objectivean cognitively pas general policy group lowest different often interaction domain study babysitter fine caregiver,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696336/,abstract,0,ddst babysitter supine objectivean grandparent denver cognitively pas occipital fine frontal modern circumference lowest obese methodsin accordingly dominant adaptive partially length caregiver conclusionthe parental language china specifically affect motor additionally explore domain policy physical old weight likely developmental especially parent general interaction cognitive month primary lower family care information total role number present test significantly child different age development group study,{},{},{},{},{},{}
89,89,96,10.1016/j.ymgmr.2017.10.004,29085781.0,adversely metopic blood delay biometry morning growth content gain essential cephalic neonatal throughout median weight partially additional morphologic old control severity classical backgroundin well month pku glycomacropeptide intake phe trimester phenylalanine partial adequate uterus previous protein bitemporal mol equivalent metabolic length intrauterine data percentile miscarriage pregnancy fetal first consideration prominence period mpku use case although gmp mutation female pre normal craniofacial aversion syndrome evaluation unlikely week phenylketonuria day history development bicornuate conclusionsthis free concentration suture dimorphism reporting year father conception near maternal age newborn poor lifelong portuguese sickness reduced circumference impact alternative infant head also part last substitute acid objectiveto reporta amino variability total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650649/,abstract,8,uterus suture sickness reporta prominence metopic bitemporal biometry bicornuate morphologic dimorphism cephalic miscarriage craniofacial aversion portuguese mpku father unlikely adversely morning intrauterine conception trimester percentile reporting substitute gmp circumference backgroundin lifelong conclusionsthis head near glycomacropeptide gain partially equivalent objectiveto length partial adequate variability fetal classical consideration reduced delay mol severity alternative poor content pregnancy pre median history previous maternal female old weight neonatal free intake syndrome evaluation essential growth week additional period month phe infant normal day use impact concentration total newborn mutation pku amino phenylketonuria case phenylalanine control blood acid protein age development metabolic year data,"{""phenylalanine"": {""freq"": 2, ""string"": [""newborn mutation pku amino phenylketonuria case phenylalanine control blood acid protein a""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""impact concentration total newborn mutation pku amino phenylketonuria case phenylalanine control b""]}, ""newborn"": {""freq"": 1, ""string"": [""normal day use impact concentration total newborn mutation pku amino phenylketonuria c""]}}",{},{}
90,90,97,10.1136/jmedgenet-2015-103342,26831755.0,european disorder chain notion respiratory reconsideration versa growth greater pathway cystic positively time positive partially physical serpina frequency capacity common increase disease vice merit relevant however partial form expiratory clinically top acyl fibrosis protease recently effect disadvantageous multicohort versus novel hmga south potentially inhibition score level although four dehydrogenase short measure resultsfindings phenotype volume cftr inhibitor strong vital capability child evaluation already around collectively elastase approach balanced management phenylketonuria backgroundseveral conclusionsthe attenuates therapeutic invite older development potential second conceivably polymorphism association care nearly blockade mendelian rare methodsin future snp variant allele adjustment mostly negative north recessive acadm correlate poly function chronic pulmonary height obstructive cognitive benefit lung also pah high part alpha medium study antitrypsin deficiency patient optimum agent gene individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819619/,abstract,2,serpina resultsfindings multicohort invite hmga elastase disadvantageous conceivably balanced backgroundseveral attenuates reconsideration protease obstructive expiratory antitrypsin acadm vice versa poly merit optimum blockade cftr notion adjustment pulmonary north mendelian acyl south respiratory lung vital height collectively capability methodsin cystic positively correlate partially nearly fibrosis snp alpha partial dehydrogenase older inhibitor versus medium capacity conclusionsthe inhibition agent strong recessive polymorphism european volume clinically potentially allele short physical second recently pah negative chronic chain evaluation greater frequency relevant growth benefit phenotype score form cognitive measure management positive variant increase therapeutic future pathway association deficiency rare novel care common function phenylketonuria approach individual time potential child development gene effect high level disorder patient disease study,{},"{""recessive"": {""freq"": 1, ""string"": [""medium capacity conclusionsthe inhibition agent strong recessive polymorphism european volume clinically p""]}}","{""pathway"": {""freq"": 1, ""string"": [""management positive variant increase therapeutic future pathway association deficiency rare novel c""]}}",{},{},{}
91,91,98,10.12659/MSM.909146,30375370.0,intellectually backgroundphenylketonuria almost difference early behavioral behavior deficit adhd control pku hydroxylase material aps initiation phenylalanine checklist compliance cognition higher therapy error inborn result attention metabolism untreated score low non significant although mutation resultsthere conclusionsour normal problem complaint syndrome child cbcl phenylketonuria externalizing dsm development disability parent treatment emotional subsample methodsthe negative adherent prevalence scale adolescent cognitive analysis impact importance also pah intellectual different study considerably hyperactivity dietary neuropsychological deficiency patient exception gene mesh total presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354646/,abstract,1,subsample externalizing cbcl aps adherent intellectually checklist dsm mesh complaint conclusionsour considerably resultsthere exception initiation backgroundphenylketonuria cognition adhd emotional neuropsychological hyperactivity methodsthe compliance untreated adolescent behavioral intellectual deficit pah negative behavior disability attention presence syndrome parent importance problem scale prevalence hydroxylase score inborn cognitive normal error deficiency impact dietary therapy total mutation pku material higher non difference phenylketonuria low metabolism early phenylalanine control child different significant development gene treatment analysis result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""non difference phenylketonuria low metabolism early phenylalanine control child different significant d""]}, ""hyperactivity"": {""freq"": 1, ""string"": [""initiation backgroundphenylketonuria cognition adhd emotional neuropsychological hyperactivity methodsthe compliance untreated adolescent b""]}, ""intellectual"": {""freq"": 1, ""string"": [""hyperactivity methodsthe compliance untreated adolescent behavioral intellectual deficit pah negative behavior d""]}, ""behavioral"": {""freq"": 1, ""string"": [""neuropsychological hyperactivity methodsthe compliance untreated adolescent behavioral intellectual deficit pah negative b""]}, ""emotional"": {""freq"": 1, ""string"": [""resultsthere exception initiation backgroundphenylketonuria cognition adhd emotional neuropsychological hyperactivity methodsthe compliance u""]}}",{},{},{},{},{}
92,92,99,10.1007/s10545-017-0053-3,28567541.0,summarise disorder tool encoding haemophilia single factor present careful efficient sustained severe pioneering risk injection virus disease paediatrics decade subset dozen recent clinical therapy focus monogenic candidate improvement therefore indication metabolic large term routine aav ongoing long genetic clearly update current systemic provide outcome many review liver comment milestone development potential technology treatment ten delivery care challenge option indeed near cdna urgent application likely scale especially demonstrate field analysis adeno benefit aim translation relatively trial different last rapidly human vector gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500673/,abstract,0,pioneering haemophilia summarise dozen paediatrics urgent sustained comment cdna careful aav milestone adeno update ongoing rapidly clearly encoding near indication monogenic vector injection subset systemic routine virus translation candidate efficient demonstrate option relatively decade delivery improvement focus liver likely especially provide scale benefit technology field severe aim tool application long trial challenge large single recent care therapy current outcome term present human risk factor review potential different development metabolic gene genetic disorder treatment clinical analysis disease,{},"{""genetic"": {""freq"": 1, ""string"": [""review potential different development metabolic gene genetic disorder treatment clinical analysis d""]}}",{},{},{},{}
93,93,100,10.3389/fgene.2015.00251,26300908.0,better handy discus information difficult time despite platform increasingly genetics common share locus way disease understanding blurred strategy trait recent form role monogenic candidate conventional positional familial result like large overlap genetic type significant functional one scientific phenotype exponentially approach identification boundary intermediate diabetes similarity rare linkage advance variant biology determinant especially impact multiple different technological understand gene complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528293/,abstract,1,handy blurred exponentially positional understand boundary overlap intermediate familial technological similarity linkage share determinant monogenic conventional locus candidate scientific platform increasingly biology diabetes trait difficult advance way understanding genetics especially despite identification functional like phenotype discus better form multiple complex strategy variant large recent rare impact information role common approach time type different significant gene genetic result disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
94,94,101,10.1186/s12993-015-0056-x,25871636.0,specific disorder antineuronal autism trigger positive conclusionsserum inflammation aged infiltration percent control addition backgroundin significantly epithelial recruit however possible higher role health play brain peptide autoimmune thus data first formation elisa level significant ena pathogenic child therapeutic inducing expression antibody serum methodsserum test response association year cell antagonist inflammatory positivity relation healthy caution neutrophil mechanism research chemokine also autistic auto resultsserum patient complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375929/,abstract,2,methodsserum inducing ena conclusionsserum antineuronal resultsserum positivity auto chemokine neutrophil infiltration caution recruit autoimmune elisa antagonist autistic epithelial trigger percent backgroundin antibody peptide inflammation formation pathogenic relation inflammatory play autism aged serum possible healthy addition expression complex positive response therapeutic brain association mechanism higher role cell test significantly specific control research child significant health year data level disorder patient,{},{},{},{},{},{}
95,95,102,10.1016/j.neubiorev.2016.07.031,27484869.0,implication experimental past sensory lead information explain several visual adult attempt unfortunately common state hypothesis majority underlying issue relevant evidence higher decline input degradation error sufficiently contrast cause non necessity neurobiological signal retinal correlational processing perceptual older association process age degeneration load order relation especially manipulation younger cognitive analysis either mechanism study turn deprivation though even performance perception,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030166/,abstract,0,perceptual correlational manipulation neurobiological necessity younger sufficiently sensory retinal deprivation unfortunately explain attempt turn decline degeneration load input processing perception visual underlying older degradation signal relation past hypothesis majority experimental contrast implication lead especially relevant issue order performance process cognitive state cause error association adult mechanism information evidence higher non common age analysis study,{},{},{},{},{},{}
96,96,103,10.1002/mgg3.915,31392824.0,specific disorder chain decompensation etfb resultsexome congenital glutaric present synthase without organic additional supplementation state methodswe urinary month disease biochemical treatable however life milder conclusionnewborn oxidation heterozygous form clinical attrs coa protein compound acylcarnitine normalized acyl backgroundmultiple asymptomatic diagnosis like recently metabolic effect detectable term first type riboflavin suggestive ultimately case fad full panel dehydrogenase phenotype text arg transporter unrevealing entrez etfa treatment madd fatty year western rare mitochondrial cys variant newborn screen analysis aciduria infant also blot plasma presentation nucleotide medium flad acid sequencing deficiency patient even gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732309/,abstract,1,unrevealing riboflavin resultsexome normalized madd flad etfb etfa conclusionnewborn backgroundmultiple fad cys entrez glutaric decompensation acylcarnitine suggestive milder blot detectable aciduria arg acyl attrs asymptomatic heterozygous ultimately treatable western oxidation transporter coa synthase dehydrogenase mitochondrial medium urinary screen organic presentation nucleotide panel text fatty methodswe supplementation compound recently chain sequencing congenital like additional biochemical phenotype form month infant state plasma variant deficiency rare life newborn term present case specific type diagnosis acid protein metabolic gene year effect disorder treatment clinical analysis patient disease,{},"{""heterozygous"": {""freq"": 1, ""string"": [""detectable aciduria arg acyl attrs asymptomatic heterozygous ultimately treatable western oxidation t""]}}",{},"{""newborn"": {""freq"": 1, ""string"": [""normalized madd flad etfb etfa conclusionnewborn backgroundmultiple fad cys entrez g"", ""state plasma variant deficiency rare life newborn term present case specific t""]}}",{},{}
97,97,104,10.1007/s12265-015-9630-8,25971844.0,various whether abnormality new fundamental context exert among mechanical frontier time insight rotatory action shear molecular due vascular mechanistic risk epigenetic course endothelial disease survey pluridisciplinary unappreciated paradigm medical knowledge cardiomyocytes relevant homeostatic organ perspective role law ventricular fluid cytoskeleton hydrodynamic geometry environment analogous primary structural fibroblast support link effect computational myocardial genetic remodeling significant diastolic functional variable myocardium phenotype dynamic others modulation morphological nucleoskeleton mechanotransduction endocardium reverse regulation work translational albeit expression attendant vortex important help finding cell still within reveal likely biology explore influence adaptation function heart goal environmental benefit torque mechanism cardiovascular murray flow research cytomechanics matrix modality extracellular interaction pattern cardiac adaptability arrangement squeeze contemporary discipline gene intrinsic versatile,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519381/,abstract,0,vortex unappreciated torque squeeze shear rotatory pluridisciplinary nucleoskeleton murray mechanotransduction geometry frontier endocardium cytomechanics cardiomyocytes adaptability remodeling myocardium attendant myocardial modulation mechanical homeostatic cytoskeleton analogous contemporary ventricular morphological diastolic versatile hydrodynamic exert albeit intrinsic arrangement law extracellular discipline reverse modality adaptation fibroblast epigenetic endothelial reveal paradigm vascular matrix fundamental translational flow computational mechanistic cardiac fluid link dynamic organ course cardiovascular action biology goal structural perspective explore heart regulation help environment insight pattern variable survey abnormality work likely context environmental influence relevant functional benefit phenotype knowledge finding interaction various support expression primary medical molecular mechanism important role cell function time new risk research significant gene effect genetic disease,{},"{""genetic"": {""freq"": 1, ""string"": [""discipline reverse modality adaptation fibroblast epigenetic endothelial reveal paradigm vascular m""]}}",{},{},{},{}
98,98,105,10.17245/jdapm.2019.19.4.191,31501777.0,male disorder record extremely content duration analgesic serious five condition physical need due literature common anesthetic mean disease respectively medical anesthesiologist conclusioncomplications clinical health therefore secondary retrospectively good data backgroundpatients comfortable type score mallampati story period level society female anesthesia communication sedation problem syndrome humanistic approach simple disability american treatment year care age methodsthe precaution resultsamong likely appropriate standard psychiatric perioperative complicated special aim min general group classification study dental patient agent successful complication demographic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726890/,abstract,1,precaution mallampati conclusioncomplications comfortable anesthetic anesthesiologist anesthesia humanistic story perioperative backgroundpatients sedation analgesic resultsamong dental retrospectively complicated extremely min demographic duration american methodsthe classification special society psychiatric record simple complication communication agent successful secondary content good appropriate female physical mean likely disability syndrome general problem male period need score standard literature aim medical respectively care condition common approach type age health group year data level disorder treatment clinical patient disease study,"{""psychiatric"": {""freq"": 1, ""string"": [""duration american methodsthe classification special society psychiatric record simple complication communication a""]}}",{},{},{},{},{}
99,99,106,10.2147/IJN.S88465,26347351.0,microbeads various fluorescence preferentially nucleic quantum polydimethylsiloxane dopamine dot strong cation adenosine protein dna biomolecule photoluminescence bead frequently heterogeneous support chip coordination detection interaction study microfluidic solid functionalized acid qds inp type intensity probe presence biomolecules,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554435/,abstract,0,qds polydimethylsiloxane photoluminescence microbeads inp functionalized bead quantum biomolecules biomolecule adenosine cation dot preferentially microfluidic nucleic chip coordination fluorescence probe intensity solid heterogeneous strong dopamine frequently dna presence interaction detection various support type acid protein study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""strong dopamine frequently dna presence interaction detection various support type acid p""]}}",{},{}
100,100,107,10.1016/j.clinbiochem.2016.06.002,27288551.0,correlation specific interpretation assessment shift prospectively pathway time several without verification retention preferable threonine glomerular transition month ion peak commercial partial renal range focus histidine analytical result integration good overlap run interference proline non transplant although rate least signal interest whenever independently sensitivity discovery method post serine loss baseline substantial methyl impaired response assay inconsistency false negative discrepancy function analysis background metabolomics also aspartate conclusion detector plasma filtration different pattern acid patient discriminant linear square amino kidney statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047903/,abstract,2,preferable detector verification discrepancy threonine glomerular filtration discriminant proline interference histidine aspartate run overlap commercial inconsistency transplant serine retention peak prospectively ion methyl shift square impaired kidney interpretation independently renal integration transition partial false substantial signal analytical statistically linear discovery metabolomics baseline post good pattern assay sensitivity focus negative loss correlation assessment background month plasma range response pathway rate amino conclusion non function time specific acid different method analysis result patient,{},{},"{""pathway"": {""freq"": 1, ""string"": [""assessment background month plasma range response pathway rate amino conclusion non f""]}}","{""amino"": {""freq"": 1, ""string"": [""month plasma range response pathway rate amino conclusion non function time s""]}}",{},{}
101,101,108,10.1007/s12687-018-0386-0,30284187.0,implication self better satisfied factor affect world cinahl reproductive programme condition thematic improve facilitate risk effective experience journal disease educate material ascertain knowledge relevant however family life evidence supplementary user improvement integrative report narrative result six create pregnancy genetic planning service significant theme peer one main sickle scientific produce database woman many review inclusion approach management method partner people prevalent participation online article psychinfo treatment person electronic best medline decision care cell education version age two professional make explore influence quality criterion paper research available trust healthcare,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435764/,abstract,2,psychinfo educate create satisfied thematic narrative ascertain trust make sickle journal cinahl partner integrative planning peer participation produce person reproductive medline theme programme prevalent facilitate improve scientific people affect world healthcare education inclusion explore decision pregnancy experience best service professional woman implication improvement criterion self influence database relevant paper main knowledge better supplementary management user version electronic quality online effective report family care life evidence material condition article cell approach available risk factor research review age significant genetic method treatment result disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
102,102,109,10.1038/s41525-017-0037-0,29263844.0,correlation relationship better information gain across necessary serious condition variation penetrance risk testing effective well disease costly presence individual however evidence reduction clinical role health play focus secondary genomic primary genotype support certainty effect date little term investment medicine area certain phenotype genomics strong economic outcome population approach management identification potential prevalent behavioural guide success treatment important net greatest incidence decision near application healthy currently priority available translation prevention practice high sequencing highly complex acceptable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698310/,abstract,0,penetrance costly certainty investment greatest net behavioural priority near gain guide acceptable prevalent success translation genomics economic strong little certain play genotype decision date secondary necessary genomic incidence focus reduction variation presence sequencing prevention practice highly currently correlation medicine identification phenotype relationship testing better area support healthy application management complex primary effective information evidence outcome term condition important role approach available individual risk population potential health effect high treatment clinical disease,{},{},{},{},{},{}
103,103,110,10.3390/foods7100166,30304801.0,positively positive isoelectric surface without weight molecular ultrafiltration addition increase close glycomacropeptide membrane smaller brush observed protein tolerant fold cheese report thus fraction similarly first pure use selectivity water gmp three one biguanide fractionation strong produce unmodified point conductivity polymer stage system salt bovine directly examined dairy mwco kda alternative attractive dilution study whey chromatographically rectification charge somewhat cleanly chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210718/,abstract,2,ultrafiltration tolerant rectification mwco fractionation conductivity cleanly chromatographically biguanide somewhat isoelectric examined brush cheese unmodified pure dilution salt kda bovine selectivity whey charge attractive polymer dairy smaller gmp similarly produce positively surface glycomacropeptide close membrane fraction water fold strong directly alternative chromatography stage observed weight point addition positive increase molecular use report protein study,{},{},{},{},{},{}
104,104,111,10.1007/s13311-015-0368-4,26169295.0,interestingly activity viability new context abnormal positive carrying affected efficient enzymatic codon control accumulation concept well disease termination responsive material ptc line supplementary strategy user therapy protein compound word ptcs doi fibroblast result nonsense effect genetic useful level mutation prediction proof drug silico therapeutic efficiency frequently localized expression potential online article treatment lysosomal response electronic key cell version materialthe evaluated screen order premature accordingly effectively authorized antibiotic aim mechanism available decay also conclusion different mrna study gentamicin patient agent metabolite localization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604176/,abstract,2,gentamicin evaluated ptcs ptc decay codon localized viability localization carrying termination nonsense silico antibiotic proof lysosomal fibroblast interestingly premature accordingly mrna authorized enzymatic doi responsive effectively efficiency prediction affected screen efficient line agent word concept accumulation abnormal frequently useful compound context materialthe order aim metabolite supplementary user expression positive drug version strategy key response electronic online therapeutic mechanism therapy activity mutation material conclusion article cell available new control potential different protein effect genetic level treatment result patient disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""new control potential different protein effect genetic level treatment result patient d""]}}",{},{},{},{}
105,105,112,10.1111/cts.12528,29194983.0,genetically strain cfu microbiome unit subject daily pharmacology new dos colony single cynomolgus healthy clearance time higher clinical cessation ecn median longer week kinetics day therapeutic also methodology support development fecal exposure concentration study human similar nissle oral evaluate coli volunteer quantitative medicine monkey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866967/,abstract,10,nissle ecn cynomolgus colony cfu monkey kinetics cessation fecal coli pharmacology clearance strain volunteer microbiome longer dos unit methodology genetically oral daily evaluate median quantitative exposure medicine week similar support healthy subject day therapeutic single concentration higher time new human development clinical study,{},{},{},{},{},{}
106,106,113,10.1371/journal.pone.0173269,28282402.0,activity neurotoxic ratio lower ammonia positive modify surface elevated immunogenicity titer due trans enzymatic injection addition subcutaneous disease pku hydroxylase issue phe animal however weekly ravpal clinical therapy protein replacement double mouse candidate polyethylene particular mutant result pahenu enzyme efficacy metabolic effect cyanobacteria stability specie decrease first genetic obstacle low anabaena recombinant level full three pegylation variabilis drug evaluation peg many critical model phenylketonuria excipients therapeutic ass yeast development expression potential mode loss treatment pal delivery phase cinnamate option version avpal cys production poor favorable currently alternative trial pah multiple upon ser lyase btbr patient pharmacodynamic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345807/,abstract,1,ravpal cyanobacteria avpal excipients cinnamate variabilis ser pegylation anabaena neurotoxic cys weekly titer pharmacodynamic modify btbr yeast subcutaneous immunogenicity polyethylene peg pal obstacle pahenu trans lyase favorable ammonia recombinant surface mode enzymatic replacement injection specie stability candidate double option mutant elevated production alternative poor phase delivery decrease particular efficacy animal pah loss critical evaluation currently ass issue hydroxylase ratio mouse enzyme phe addition trial expression multiple positive drug version therapeutic lower therapy activity pku phenylketonuria low model potential protein development metabolic effect genetic level treatment clinical result patient disease,{},"{""genetic"": {""freq"": 1, ""string"": [""model potential protein development metabolic effect genetic level treatment clinical result p""]}}",{},{},{},{}
107,107,114,10.1186/s12934-018-0996-6,30241531.0,culture flask encoding proteinogenic pathway organism synthase tkt biosynthesis titer together additional aromatic source finally tkta material suitable grafting supplementary phenylalanine backgroundthe supply user value fermenter nature venezuelae corynebacterium cultivation metabolic glutamicum copy far formation chromosomal non arofbl deoxyprephenate chassis lab deoxychorismate dehydrogenase main shake approach product model papb mutase plasmid producer chloramphenicol tyrr expression streptomyces online article glpx electronic papa batch carbon cell version genetically strain flux glycerol minimal production application papc pabab field deletion precursor available resultsescherichia broad high conclusionhere medium acid yield escherichia highest amino gene show,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148955/,abstract,3,venezuelae tkta tkt streptomyces shake resultsescherichia proteinogenic papc papb papa pabab grafting glutamicum glpx flask fermenter deoxyprephenate deoxychorismate corynebacterium chloramphenicol chassis arofbl tyrr producer cultivation conclusionhere glycerol titer flux batch mutase escherichia plasmid supply carbon chromosomal strain copy lab encoding organism minimal culture yield aromatic biosynthesis synthase broad far dehydrogenase backgroundthe deletion medium suitable genetically precursor nature formation highest production finally source product additional main field supplementary application user expression version value electronic online pathway material amino non article cell approach available model phenylalanine acid metabolic gene high,"{""phenylalanine"": {""freq"": 2, ""string"": []}}",{},"{""pathway"": {""freq"": 1, ""string"": [""user expression version value electronic online pathway material amino non article c""]}}","{""amino"": {""freq"": 1, ""string"": [""version value electronic online pathway material amino non article cell approach a""]}}",{},{}
108,108,115,10.1007/8904_2018_92,29478217.0,cross sectional growth difference single concern nutrient restriction supplementation investigate control month significantly shorter phenylalanine family reduction protein usually low score period mandatory significant neither normal current prevent phenylketonuria older target parent year diet age protocol within pediatric order postpubertal healthy standard sibling influence height cognitive impairment aim paper leeway group practice study whereas acid dietary puberty center patient prepubertal amino caregiver statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323026/,abstract,0,prepubertal postpubertal leeway puberty shorter sibling mandatory height usually caregiver older statistically nutrient restriction protocol prevent concern sectional center supplementation pediatric reduction impairment cross investigate influence practice growth parent paper period order score target standard cognitive aim month normal healthy single diet family dietary current amino difference phenylketonuria low significantly phenylalanine control acid protein age significant group year patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""current amino difference phenylketonuria low significantly phenylalanine control acid protein age s""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""healthy single diet family dietary current amino difference phenylketonuria low significantly p""]}}","{""diet"": {""freq"": 1, ""string"": [""cognitive aim month normal healthy single diet family dietary current amino d""]}}",{}
109,109,116,10.1016/j.dr.2019.100866,31417205.0,implication rise memory neural region early throughout highlight connectivity investigate control well finally biochemical third decade executive element childhood recent value brain structural substrate large change question first long area underpinnings pfc review technique development technology second prefrontal address anatomical advance future alongside separable order answer explore function field research importance cortex general infancy last study distinct inhibitory number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686207/,abstract,0,separable pfc answer anatomical underpinnings connectivity rise alongside prefrontal inhibitory cortex infancy neural substrate element executive distinct memory question decade structural explore advance address finally implication childhood second investigate highlight technique importance general biochemical technology order field region area long change value large future brain recent function number early control research review development study,{},{},{},{},{},{}
110,110,117,10.3389/fimmu.2018.02756,30564228.0,specific disorder blood lead difference srm early agammaglobulinemia signature congenital adult laboratory despite reaction pidds due severe fact proteolytically control effective linearity btk majority scid evaluate disease doe objective inter respectively pidd intra relevant concurrent life reduction unaffected optimal clinical protein primary peptide curative possibility copper comprise wasp result purpose large absent stability detectable quantification immune selective assurance capture xla use level significant case one biomarkers normal proteotypic syndrome outcome able population approach enrichment fmol method potential antibody combined concentration simultaneously treatment precision response immunoaffinity multiplex promise assay immunodeficiency monitoring sample wiskott mass newborn lack spot scale comparison determine analytes quality analysis background concordance distinguished spectrometry available multiple ranged conclusion group reliably high aldrich proteomic patient atp accurately another precisely sensitive statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288356/,abstract,8,wiskott wasp srm proteotypic proteolytically pidds pidd immunoaffinity fmol aldrich xla btk agammaglobulinemia proteomic linearity distinguished copper precisely comprise assurance scid ranged unaffected curative concurrent combined atp immunodeficiency absent reliably multiplex detectable concordance signature intra analytes enrichment fact accurately simultaneously capture inter promise antibody quantification peptide selective stability precision possibility monitoring immune statistically optimal able sensitive doe majority evaluate reaction assay comparison reduction lack lead purpose spectrometry biomarkers syndrome spot relevant determine despite laboratory congenital scale severe background normal objective mass multiple primary response quality effective large adult use respectively life concentration newborn outcome conclusion difference sample approach case available early specific control blood population potential protein significant group high method level disorder treatment clinical analysis result patient disease,{},{},{},"{""spectrometry"": {""freq"": 1, ""string"": [""assay comparison reduction lack lead purpose spectrometry biomarkers syndrome spot relevant d""]}, ""newborn"": {""freq"": 1, ""string"": [""large adult use respectively life concentration newborn outcome conclusion difference sample a""]}}",{},{}
111,111,118,10.1017/S0954579416000717,27739393.0,epidemiologic psychopathologists biological disorder rise studied factor among effort present nimh condition molecular literature risk institute way understanding applied health developmental focus core report recently large data question long genetic level use rate comorbid etiology discussion occurrence population review comorbidity approach method mental causal development national aggregate overview rdoc variant uniquely psychiatric criterion analysis currently research framework multiple different high pattern domain study individual initiative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079621/,abstract,0,rdoc psychopathologists nimh rise applied uniquely comorbidity comorbid epidemiologic institute occurrence aggregate studied core causal initiative discussion psychiatric overview question etiology framework domain effort way mental pattern understanding recently focus criterion national developmental currently biological literature long multiple variant large molecular use report rate condition approach present individual risk factor research population review different development health high genetic method data level disorder analysis study,"{""psychiatric"": {""freq"": 1, ""string"": [""aggregate studied core causal initiative discussion psychiatric overview question etiology framework d""]}}","{""genetic"": {""freq"": 1, ""string"": [""population review different development health high genetic method data level disorder a""]}}",{},{},{},{}
112,112,119,10.3390/ijerph15112367,30373129.0,implication specific cross nursing sectional lead among promotion student concern throughout necessary programme action deal cost risk intentional well disease nonprobabilistic issue relevant life quantitative health improvement probability qualitative situation existence interview data design educational significant nurse centre problem vital child teacher method school nevertheless appropriately incorporation sequential phase care option urgent percentage professional pilot explanatory quite quality background benefit prevention conclusion often high study complication show urgency total presence perception,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266904/,abstract,2,nonprobabilistic intentional urgency teacher explanatory deal urgent sequential nursing nurse quite promotion appropriately incorporation existence probability vital student perception situation school pilot programme centre qualitative percentage educational interview complication action option concern sectional necessary phase professional implication quantitative improvement cross lead cost presence prevention relevant design problem benefit issue background quality care life total conclusion risk specific child significant health high method data disease study,{},{},{},{},{},{}
113,113,120,10.1016/j.pharmthera.2017.02.036,28213088.0,major phenotypic disorder example everyday ratio almost factor composition single early explain uncertainty positive largely reaction insight slowly together pharmacoeconomics due severe variation cost multifactorial penetrance pgx epigenetic number justification innumerable underlying elusive resemble contribute numerous utility relevant however impossible event quantitative trait recent idiosyncratic clinical therapy monogenic pharmacogenomics genotype thus oligogenic effect large basis fraction prospective genetic incomplete medicine detection use although rate three mutation variable prediction drug overall ultimate outcome highly variance simple coding substantial pharmacokinetic test response association false discover predictive mendelian component wide rare future variant mostly typically limited category adrs environmental benefit relatively plus optimize cohort high study small power predominantly foreseeable pharmacodynamic variability gene individual rarity successful complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653378/,abstract,0,resemble pharmacoeconomics pgx foreseeable adrs innumerable impossible idiosyncratic penetrance oligogenic justification pharmacogenomics everyday pharmacodynamic incomplete elusive ultimate discover slowly multifactorial rarity pharmacokinetic optimize explain coding uncertainty mendelian epigenetic power predominantly plus variance monogenic contribute underlying fraction false largely substantial prediction typically numerous variability predictive phenotypic composition prospective simple category successful event trait relatively utility genotype reaction component basis insight quantitative variable example limited cost variation environmental highly relevant wide medicine cohort benefit ratio small overall detection severe major complex positive drug variant response large future single association recent use rare therapy rate mutation outcome number test individual early factor gene effect high genetic disorder clinical study,{},"{""genetic"": {""freq"": 1, ""string"": [""optimize explain coding uncertainty mendelian epigenetic power predominantly plus variance m""]}}",{},"{""detection"": {""freq"": 1, ""string"": [""medicine cohort benefit ratio small overall detection severe major complex positive d""]}}",{},{}
114,114,121,10.1523/ENEURO.0031-19.2019,31040160.0,importantly physiological improved oxidative binding cardioprotection glucose interesting cleavage insulinotropic homeostasis molecular trisomy deficit morphology neurodegenerative effective increase disease potentiation plasticity neuronal reduction recent chromosome form therapy mouse peptide report property thus like effect incretin tsdn conversely immature receptor term long neuroprotection low young stress alter administration functional one spine systemic syndrome failure product model affinity therapeutic work alzheimer dendritic potential disability glucagon prevalent sex tolerance alteration treatment hormone finding ameliorates lack inactive chronic cognitive impairment currently previously either natural available also secretion historically intellectual mature glp insulin human hippocampus maintains metabolite mitochondrial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520642/,abstract,1,tsdn maintains cardioprotection ameliorates potentiation neuroprotection incretin insulinotropic inactive glp cleavage trisomy immature spine mature glucagon dendritic conversely plasticity binding improved interesting secretion historically morphology hippocampus alter affinity chromosome importantly alzheimer tolerance neurodegenerative insulin prevalent neuronal peptide systemic sex mitochondrial young oxidative failure physiological hormone homeostasis receptor glucose alteration intellectual natural administration property stress deficit work reduction lack impairment disability chronic syndrome product currently previously functional like finding mouse form cognitive metabolite long increase therapeutic effective molecular recent report therapy term low available human model potential effect treatment disease,"{""intellectual"": {""freq"": 1, ""string"": [""physiological hormone homeostasis receptor glucose alteration intellectual natural administration property stress d""]}}",{},{},{},{},{}
115,115,122,10.1002/mrm.26034,26536382.0,unrealistic synthetic estimation vivo single profile time parametric present algorithm substantially common continuous reliable increase acquisition spectrum sequence however smaller inhomogeneity range brain distribution ideal complete error relaxometry base forward fraction experiment echo novel exponential long cpmg validate non mapping whole water multi variable least short imaging resultsusing compensate volume curve slice approach model projection technique conclusionsthe method myelin mwf methodwe negative phantom estimate mri scale numerically equation speed purposet framework optimization coverage limitation minute square accuracy physically resolution mixture,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854813/,abstract,3,resultsusing purposet numerically inhomogeneity cpmg relaxometry projection phantom exponential compensate unrealistic slice echo physically parametric methodwe mwf equation optimization ideal smaller myelin mapping acquisition substantially speed minute validate forward estimation mri coverage square mixture base imaging curve algorithm continuous synthetic experiment resolution fraction reliable multi conclusionsthe water complete distribution limitation framework volume accuracy vivo estimate sequence profile short variable negative technique scale spectrum long range increase error brain single novel non common approach present time model method,{},{},{},{},{},{}
116,116,124,10.1016/j.ymgmr.2017.04.006,28491816.0,logistic evolves blood activity clinic outpatient early progressive time autosomal retrospective resultsa severe percent continuous average risk mean number increase month significantly hydroxylase neurological visit longitudinal phe phenylalanine life childhood follow higher value preventive range mol diagnosis data adherence first methodologythis metabolism low eight sixty regression variable child sign intervention analyze second concentration treatment ten proportion adolescence greatest year diet age sample newborn conclusiontreatment recessive birth cognitive impairment analysis introductionphenylketonuria also group infancy high study deficiency discontinuation individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412103/,abstract,9,methodologythis evolves discontinuation conclusiontreatment introductionphenylketonuria greatest outpatient visit analyze percent adolescence preventive retrospective resultsa infancy sign progressive logistic continuous adherence longitudinal proportion mol recessive average neurological autosomal clinic follow childhood variable second regression mean impairment hydroxylase birth severe cognitive month phe range value increase deficiency diet intervention life concentration newborn activity higher sample low number metabolism individual time significantly risk early phenylalanine blood diagnosis child age group year high data treatment analysis study,"{""phenylalanine"": {""freq"": 2, ""string"": [""metabolism individual time significantly risk early phenylalanine blood diagnosis child age g""]}, ""neurological"": {""freq"": 1, ""string"": [""adherence longitudinal proportion mol recessive average neurological autosomal clinic follow childhood v""]}}","{""autosomal"": {""freq"": 1, ""string"": [""longitudinal proportion mol recessive average neurological autosomal clinic follow childhood variable s""]}, ""recessive"": {""freq"": 1, ""string"": [""logistic continuous adherence longitudinal proportion mol recessive average neurological autosomal clinic f""]}}",{},"{""newborn"": {""freq"": 1, ""string"": [""increase deficiency diet intervention life concentration newborn activity higher sample low n""]}}","{""diet"": {""freq"": 1, ""string"": [""month phe range value increase deficiency diet intervention life concentration newborn a""]}}",{}
117,117,125,10.1186/s12884-018-1674-8,29422013.0,logistic biological birthweight backgroundroutine investigation new growth difference lower rigorous examine molecule profile tide formula acetate neonatal prenatal site www restriction weight molecular fit need trimethylamine highlight risk methodswe control urinary well objective material gestational pregnant third related trimester supplementary langue recent possible relative courbes previous user nov health clinically resultswe morpho php environment result metabolic large data urine percentile pregnancy fetal first potentially low regression area significant case four multi fgr biomarkers parity conclusionsfirst current tyrosine provide woman population model ass development nmr second concentration online article sex collection proportion electronic net association year http inconsistency care audipog version maternal predictive bmi materialthe age earlier sample within multivariate reveal custom rank spectroscopy conditional relation estimate healthy birth exploratory height formate analysis previously research available infant obstetrics comprehensive cohort study internet similar center individual metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806311/,abstract,5,tide php nov morpho langue fgr courbes conclusionsfirst birthweight backgroundroutine audipog formate obstetrics acetate trimethylamine rank http rigorous parity internet custom conditional trimester percentile inconsistency fit exploratory net nmr height www reveal multivariate spectroscopy earlier formula resultswe bmi logistic gestational pregnant sex prenatal multi examine urinary predictive fetal restriction proportion relation molecule relative comprehensive urine methodswe estimate clinically potentially center pregnancy investigation collection previous maternal woman profile environment second regression site weight neonatal biomarkers materialthe tyrosine previously highlight biological growth ass provide related cohort birth need similar possible area metabolite infant supplementary healthy objective user version electronic online large lower association molecular recent care concentration current material article difference sample low case available individual new risk model control research population age significant development metabolic health year data analysis result study,"{""urine"": {""freq"": 1, ""string"": [""restriction proportion relation molecule relative comprehensive urine methodswe estimate clinically potentially c""]}}",{},{},{},{},{}
118,118,126,10.3390/cancers11050675,31096630.0,cancer functional simply clinic challenge interest unique discus pathway diversity redox essential several function macromolecule therapy already role clinical protein researcher modification currently either biosynthesis precursor great substrate trial post translational development system metabolic diverse non epigenetic acid antioxidant important providing status far beyond tumor amino metabolism synthesis numerous,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562791/,abstract,3,providing macromolecule simply redox epigenetic antioxidant diversity translational substrate biosynthesis tumor far modification researcher numerous diverse precursor great unique post clinic cancer synthesis currently essential functional discus status trial challenge pathway therapy amino non important role function metabolism acid protein development metabolic clinical,{},{},"{""pathway"": {""freq"": 1, ""string"": [""essential functional discus status trial challenge pathway therapy amino non important r""]}}","{""amino"": {""freq"": 1, ""string"": [""discus status trial challenge pathway therapy amino non important role function m""]}}",{},{}
119,119,127,10.1007/s10545-016-9918-0,26914933.0,mood specific retardation self whether difference greater early among specifically adult throughout five tetrahydrobiopterin resultspku difficulty control pku phe poorer respect phenylalanine life childhood recent methodsninety task negatively objectiveearly reportedly ability non level conclusionpku measure problem current outcome many variance phenylketonuria day mental evident social lifetime skill parent computerized treatment association adolescence year pencil age still multivariate estimate healthy comparison adolescent influence quality cognitive analysis paper regardless general group high study patient show performance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851698/,abstract,6,resultspku pencil objectiveearly methodsninety reportedly conclusionpku computerized poorer mood lifetime regardless retardation adolescence respect multivariate evident variance negatively skill specifically difficulty adolescent task tetrahydrobiopterin estimate mental childhood comparison self influence greater social ability parent general problem paper performance cognitive measure phe healthy day quality association adult recent life current pku outcome non difference phenylketonuria early phenylalanine specific control age group year high level treatment analysis patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""pku outcome non difference phenylketonuria early phenylalanine specific control age group y""]}, ""social"": {""freq"": 1, ""string"": [""mental childhood comparison self influence greater social ability parent general problem p""]}}",{},{},{},{},{}
120,120,128,10.3390/nu9040366,28383492.0,infectious rare sequence every implication yet use still tool life whether daily completion pharmacology professional requirement information dietetics genomics nutrition nutrigenetics clinical already health path nutrient analysis research project science oncology need framework genetics translate genome keywords variation nutritional conclusively practice interaction part article build study human deeply piece important guideline routine disease best genetic far care gene individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409705/,abstract,0,conclusively piece dietetics nutrigenetics oncology deeply completion translate pharmacology build path requirement infectious project far routine keywords genomics nutrient guideline framework nutrition daily science best sequence professional genome implication nutritional genetics variation practice need interaction tool use rare care information life article important individual human research health gene genetic clinical analysis disease study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
121,121,129,10.24911/SJP.2018.1.3,30166758.0,pathogenesis disorder availability clinic iem hyperglycaemic lead energy discus early among molecule congenital specifically present gland organic substance heterogeneous common ketothiolase accumulation finally cystinosis responsive hereditary synthesis emergency however megaloblastic scenario clinical ruining feature error inborn diagnosis aceruloplasminemia type metabolism methylmalonic detection hemochromatosis three one phenotype department toxic normal synthetase structure syndrome child review approach ready functionality hormone diabetes help ketoacidosis acidemia unclear propionic holocarboxylase differential rogers anaemia mechanism group diagnostic different endocrine deficiency glycosylation complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113785/,abstract,0,ruining rogers hyperglycaemic holocarboxylase cystinosis aceruloplasminemia megaloblastic ketothiolase ketoacidosis hemochromatosis synthetase anaemia glycosylation endocrine ready emergency functionality scenario gland propionic substance methylmalonic department acidemia hereditary heterogeneous responsive toxic pathogenesis differential organic hormone specifically unclear availability energy diabetes iem accumulation molecule clinic finally help feature synthesis lead structure syndrome congenital phenotype discus diagnostic detection inborn normal complex error deficiency mechanism common approach present metabolism early type diagnosis review child different group disorder clinical,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""structure syndrome congenital phenotype discus diagnostic detection inborn normal complex error d""]}}",{},{}
122,122,130,10.1016/j.jconrel.2016.06.040,27369864.0,various blood importantly better time specifically several despite modification surface immunogenicity literature highlight increase circulation presence animal anti clinical nature protein polyethylene hydrodynamic body report efficacy existence effect immune immunity detection bind market size pegylation pre drug epitope peg recognize conjugation critical technique therapeutic polymer method antibody system technology loss success treatment ten reduces adverse also different study beyond number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747248/,abstract,0,recognize epitope conjugation pegylation hydrodynamic circulation immunogenicity polymer polyethylene peg immunity existence bind market reduces importantly antibody surface success modification immune specifically nature anti pre size adverse efficacy animal loss critical presence highlight technique despite technology better literature detection various body drug increase therapeutic report number time blood different protein effect method treatment clinical study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""highlight technique despite technology better literature detection various body drug increase t""]}}",{},{}
123,123,131,10.3389/fpsyt.2019.00561,,mood disorder activity new improved anxiety across behavioral adult neonatal lifespan increasingly due common continuous heel risk institution control clinician attentional well pku hydroxylase synthesis noradrenaline advent adulthood however phenylalanine screening hold dopamine optimal therapy health protein brain disturbance restrictive particular result diagnosis enzyme effect good data little term long metabolism untreated level significant functioning although full mutation normal outcome population management phenylketonuria markedly mental development illness unknown guide alteration treatment myelin recommendation diet promise grossly particularly alongside hyperphenylalaninemia lifelong serotonin recessive birth function psychiatric cognitive impairment relatively pah intellectual optimize pegvaliase dietary cerebral patient prick even gene individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748028/,abstract,0,grossly attentional noradrenaline pegvaliase hold restrictive heel alongside prick optimize lifespan improved advent myelin mood functioning cerebral lifelong illness promise institution disturbance markedly guide continuous adulthood untreated serotonin psychiatric anxiety hyperphenylalaninemia increasingly clinician optimal little recessive dopamine relatively alteration behavioral intellectual unknown mental good recommendation particular pah neonatal synthesis impairment particularly hydroxylase birth cognitive enzyme normal screening long management brain adult diet dietary therapy activity mutation pku outcome term common function phenylketonuria metabolism individual new risk phenylalanine control diagnosis population protein significant development health gene effect data level disorder treatment result patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""function phenylketonuria metabolism individual new risk phenylalanine control diagnosis population protein s""]}, ""intellectual"": {""freq"": 1, ""string"": [""little recessive dopamine relatively alteration behavioral intellectual unknown mental good recommendation p""]}, ""behavioral"": {""freq"": 1, ""string"": [""optimal little recessive dopamine relatively alteration behavioral intellectual unknown mental good r""]}, ""psychiatric"": {""freq"": 1, ""string"": [""markedly guide continuous adulthood untreated serotonin psychiatric anxiety hyperphenylalaninemia increasingly clinician o""]}}","{""recessive"": {""freq"": 1, ""string"": [""anxiety hyperphenylalaninemia increasingly clinician optimal little recessive dopamine relatively alteration behavioral i""]}}",{},"{""screening"": {""freq"": 1, ""string"": [""particularly hydroxylase birth cognitive enzyme normal screening long management brain adult d""]}}","{""diet"": {""freq"": 1, ""string"": [""normal screening long management brain adult diet dietary therapy activity mutation p""]}}",{}
124,124,132,10.1530/EJE-17-0107,28694389.0,italy implication various worldwide blood congenital present author neonatal need severe neurocognitive effective well typical establish section issue however evidence life baby argument optimal value developmental guarantee cutoff examination primary stimulating debate recently mild good focused level whole one economic outline outcome population review iodine development thyroid article test association year tsh care consensus newborn opportunity prevalence access hypothyroidism cognitive quality benefit paper program also extent deficiency optimum australia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763485/,abstract,0,guarantee optimum argument focused iodine cutoff stimulating italy tsh outline australia section debate neurocognitive thyroid typical hypothyroidism establish baby consensus author worldwide extent access examination economic optimal mild opportunity good implication recently neonatal developmental congenital benefit prevalence paper issue need severe various cognitive program primary value quality effective association deficiency care life newborn evidence outcome article present test blood population review development year level,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""quality effective association deficiency care life newborn evidence outcome article present t""]}}",{},{}
125,125,133,10.4103/0253-7613.165186,26600635.0,pregnant decide inability emphasize relevant related legal evidence challenge teratogenicity protection ill indian psychopharmacoteratophobia drug woman health prescribing word provision thalidomide consumer review psychotropic causality avoidance available mentally physician tragedy indication due mental phenomenon helpful face locus illness deprivation treatment majority guideline key patient pregnancy fetal best accurately decision medicine ethical pitfall address anticipation malformation issue strict doctor,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621667/,abstract,0,tragedy thalidomide psychopharmacoteratophobia prescribing psychotropic mentally decide indian pitfall anticipation teratogenicity causality avoidance emphasize doctor inability helpful deprivation ill protection accurately phenomenon legal strict malformation illness provision consumer face indication pregnant locus ethical physician fetal word guideline majority decision address pregnancy best mental woman relevant medicine related issue challenge drug key evidence available review health treatment patient,{},{},{},{},{},{}
126,126,134,10.1177/1177392819857089,31258325.0,blood search dos information ammonia selection restriction additional trans mainstay source injection substitution dossier objective pku synthesis however phenylalanine gov subject event pharmacokinetics pharmacology strategy place therapy mol food cinnamic efficacy enzyme data language term combination first extraction english level clinicaltrials administration drug relevance convert review product management phenylketonuria therapeutic september safety article concentration manufacturer pal viable medline option approximately reduced adverse reduce conclusion historically lyase study pegvaliase human acid dietary patient,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589953/,abstract,0,dossier cinnamic manufacturer viable pegvaliase mainstay pharmacology pharmacokinetics convert pal english september trans historically lyase substitution ammonia dos medline extraction reduce place clinicaltrials relevance injection language gov reduced safety restriction option mol event approximately selection search administration adverse source efficacy synthesis combination product additional food enzyme objective subject management drug strategy therapeutic dietary therapy information concentration pku conclusion term article phenylketonuria human phenylalanine blood review acid data level patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""pku conclusion term article phenylketonuria human phenylalanine blood review acid data l""]}}",{},{},{},{},{}
127,127,135,10.1007/8904_2018_131,30242630.0,male specific disorder nine ixc gsd glycogen sectional lower thirteen preference median rest restriction behavior together smell difficulty tube taste myofunctional disease objective significantly material intake mouth geneticist issue whose medical ascertain stick supplementary family semisolid ixa user questionnaire storage swallowing range fluid olfactory orofacial error food inborn result diagnosis six oronasal dietitian amiofe prospective selective mealtime type metabolism eight score stress four administration hepatic cornstarch strip evaluation simple method unknown online fds test treatment carbohydrate electronic year version materialthe age flavour prevalence authorized sniffin facial available conclusion omds high feeding study anthropometry sour dietary patient twenty performance chapter perception,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336547/,abstract,2,swallowing strip sour sniffin semisolid oronasal omds myofunctional ixc ixa gsd flavour fds cornstarch amiofe smell orofacial olfactory mouth mealtime glycogen stick anthropometry rest thirteen ascertain taste tube geneticist facial dietitian chapter feeding carbohydrate preference perception authorized hepatic fluid selective prospective storage simple difficulty restriction sectional unknown administration median stress questionnaire behavior intake materialthe evaluation male prevalence issue performance score inborn food supplementary objective user range version electronic error online medical lower family dietary material conclusion available metabolism test significantly specific type diagnosis age year high method disorder treatment result patient disease study,{},{},{},{},{},{}
128,128,136,10.1186/s13065-019-0539-1,31384769.0,coefficient epidemiologic correlation assessment disorder reliability greater single instead methodsthis throughout liquid ease due separate common intraclass testing onto agreement excellent material measurement supplementary clinical user secondary comparable primary equivalent result large creatinine observational good icc urine prospective tandem useful progesterone four menstrual derivatized surrogate woman population estradiol day method gas serum concentration online article collection electronic hormone filter assay care version materialthe sample resultsthe mass spot ria comparison radioimmunoassay analysis prior paper research spectrometry available also cycle backgroundmeasuring pattern study similar patient men metabolite chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661742/,abstract,0,ria estradiol derivatized backgroundmeasuring icc radioimmunoassay progesterone menstrual intraclass surrogate epidemiologic creatinine agreement ease men instead reliability filter excellent methodsthis equivalent coefficient gas comparable observational separate hormone prospective resultsthe prior tandem cycle liquid urine chromatography useful secondary good collection woman pattern serum assay comparison measurement spectrometry materialthe spot greater correlation paper testing similar assessment metabolite supplementary mass day user primary version electronic online large single care concentration material article common sample available research population method disorder clinical analysis result patient study,"{""urine"": {""freq"": 1, ""string"": [""prospective resultsthe prior tandem cycle liquid urine chromatography useful secondary good c""]}}",{},{},"{""tandem"": {""freq"": 1, ""string"": [""observational separate hormone prospective resultsthe prior tandem cycle liquid urine chromatography u""]}, ""spectrometry"": {""freq"": 1, ""string"": [""woman pattern serum assay comparison measurement spectrometry materialthe spot greater correlation p""]}}",{},{}
129,129,137,10.1111/pcmr.12413,26300548.0,experimental various assessment search pathway effort widespread synonymous mirna splicing conspicuous highlight clear obvious substitution well disease oncogenesis prioritization numerous sequence knowledge cancer however evidence event recent driver role protein tcga focus contribution result large stability copy atlas somatically international detection alter functional mutation translocation main progression genomics discovery recognition somatic many review regulation identification causal via expression potential functionally collaborative nevertheless process rare advance variant accumulating lack mechanistically icgc involved function field goal impact research inception translation mutational consequence different consortium mrna study nucleotide technological sequencing acid direct connection absence tumor amino gene tumorigenic converge number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834044/,abstract,0,tumorigenic somatically icgc converge tcga oncogenesis conspicuous atlas accumulating translocation mirna prioritization inception mechanistically collaborative synonymous somatic obvious splicing driver mutational consortium functionally connection copy alter technological substitution widespread mrna causal recognition tumor clear translation stability numerous progression contribution absence involved genomics nucleotide goal event discovery experimental international search advance effort sequence regulation consequence direct cancer focus lack sequencing highlight identification functional main field knowledge detection various assessment process expression variant large pathway recent rare impact evidence mutation amino role function number research review acid potential different protein gene result disease study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""various assessment process expression variant large pathway recent rare impact evidence m""]}}","{""detection"": {""freq"": 1, ""string"": [""highlight identification functional main field knowledge detection various assessment process expression v""]}, ""amino"": {""freq"": 1, ""string"": [""pathway recent rare impact evidence mutation amino role function number research r""]}}",{},{}
130,130,139,10.1186/s12920-017-0247-4,28222731.0,conclusionthe benign alliance early present laboratory concern paediatric serious condition onset need ethic regulatory clinician addition disease ethical issue utility family backgroundthe possible today distinguish resolve clinical storage health global secondary task genomic scientist effectiveness data basis ability eight use whole interest genomics current implementation child many population exome technology team recommendation best decision wide detect consensus methodsthe variant newborn opportunity appropriate ownership program genome policy group jurisdiction disclosure sequencing maker incidental resultsbefore gene treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320805/,abstract,0,resultsbefore ownership alliance disclosure incidental jurisdiction resolve distinguish benign today maker scientist ethic paediatric detect team consensus ethical methodsthe conclusionthe backgroundthe exome storage treat genomics clinician task utility opportunity decision concern secondary effectiveness policy regulatory best appropriate global genomic basis recommendation genome implementation onset sequencing ability wide laboratory issue technology need possible addition program variant use family newborn current condition present early population child health gene group data clinical disease,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""possible addition program variant use family newborn current condition present early p""]}}",{},{}
131,131,140,10.1093/nar/gku1004,25378312.0,considerable epidemiologist information specifically chronically www substantially totality realization detailed substance common chemical toxin toxicity number well disease spectrum issue extensive sequence manuscript recent exposome align workplace compound home complete food scientist air property effect large data biofluids reference complement first capture ultimately water one interest death update referential toxic normal description database release many taxonomy toxicologist informative target expression nmr exposure concentration latest resource collection directly nearly conception version threshold along ontology acutely originally environmental previously mechanism closely genome nar often interaction human indirectly gene injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383875/,abstract,3,workplace toxicologist referential totality nar epidemiologist align taxonomy originally biofluids realization indirectly exposome informative air manuscript conception closely acutely toxin ontology latest chronically description scientist threshold substantially complement update substance release nmr www capture ultimately detailed toxicity home nearly injury toxic extensive considerable water chemical complete specifically reference directly resource death property sequence collection genome compound exposure environmental database previously issue spectrum target interaction food normal expression version large recent mechanism information concentration common number human gene effect data disease,{},{},{},{},{},{}
132,132,141,10.1145/2767007,26640318.0,major various implication countermeasure notably availability relationship threat essential present biomedical characterizing moreover state likelihood testing well increase specialist disease survey computer consumer medical knowledge family strategy trait possible sometimes feature move environment science genomic genotype belief report support scientist thus attention data forward design systematization forensics inexpensively medicine art service revelation rapid certain pace genomics problem enumeration capability personal erroneous review identification potential technology attack collection association address challenge revolution public company application community limited addressed goal field advanced dna dedicated privacy analysis benefit paper profit available framework crossroad policy internet direct highly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666540/,abstract,0,systematization erroneous enumeration crossroad countermeasure revelation inexpensively characterizing addressed profit belief forensics attack pace revolution likelihood company internet dedicated threat privacy art scientist personal computer notably biomedical forward capability consumer advanced specialist genomics availability goal framework certain trait genotype science community address policy collection genomic service dna environment implication direct survey feature rapid limited attention highly essential medicine design identification problem benefit paper public technology relationship field testing knowledge possible various support application state major challenge strategy increase medical association report family present available review potential data analysis disease,{},{},{},{},{},{}
133,133,142,10.1016/j.ymgmr.2017.04.001,28920014.0,level disorder iem growth factor dysfunction higher elevated without secondary primary fibroblast error inborn plasma biomarker study patient metabolism fgf mitochondrial elisa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586549/,abstract,0,fgf elisa fibroblast biomarker mitochondrial elevated iem secondary dysfunction growth inborn plasma primary error higher metabolism factor level disorder patient study,{},{},{},{},{},{}
134,134,144,10.1177/1933719116660843,27470150.0,male cross chain sectional early gain profile essential largely labor neonatal weight affected fetus pair admission risk source umbilical neurological gestational section trimester lcpufas supply higher health body science transport university effect negatively little term pregnancy fetal first long type low level female placenta proper outcome hypertension development gas oregon forty sex delivery spectrophotometry fatty offspring cord maternal thickness reduces mass poor lcpufa determine uncomplicated placental cesarean cardiovascular thinner upon plasma high study acid complication chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933200/,abstract,0,thinner oregon lcpufas lcpufa spectrophotometry cesarean uncomplicated placenta umbilical placental thickness labor trimester offspring supply cord hypertension fetus admission section pair proper reduces negatively gain transport gestational gas sex largely affected fetal university cardiovascular complication little science fatty neurological chromatography poor sectional pregnancy delivery maternal profile female source weight neonatal cross chain essential determine male body mass long plasma outcome term higher low risk early type acid development health effect high level study,"{""neurological"": {""freq"": 1, ""string"": [""university cardiovascular complication little science fatty neurological chromatography poor sectional pregnancy d""]}}",{},{},{},{},{}
135,135,145,10.1002/brb3.971,29761020.0,male activity daily youth versa factor kefs among focal boy brief behavioral present psychopathology aged behavior frequency difficulty deficit probably varied vice measurement sdq executive life latter resultsparent conclusionsa screening rating dysfunction higher questionnaire strongest symptom inventory furthermore ability genetic score capture independent centre problem strong norway child strength regulation predictor pathological national parent mode epilepsy test important association year umbrella consecutive age objectivesexecutive methodsthe along explore influence function psychiatric girl cognitive aspect index group different cohort study patient underwent gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943753/,abstract,1,umbrella sdq resultsparent objectivesexecutive kefs vice versa focal strongest psychopathology youth norway probably conclusionsa consecutive inventory underwent strength epilepsy brief rating capture girl mode boy varied pathological centre methodsthe predictor psychiatric executive gender difficulty strong daily aspect behavioral independent explore regulation index aged deficit questionnaire behavior dysfunction national furthermore measurement influence frequency ability parent problem male cohort score symptom cognitive screening association life activity higher important function present test factor child different age group year genetic patient study,"{""behavioral"": {""freq"": 1, ""string"": [""executive gender difficulty strong daily aspect behavioral independent explore regulation index a""]}, ""psychiatric"": {""freq"": 1, ""string"": [""boy varied pathological centre methodsthe predictor psychiatric executive gender difficulty strong d""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""screening"": {""freq"": 1, ""string"": [""problem male cohort score symptom cognitive screening association life activity higher i""]}}",{},{}
136,136,146,10.3389/fped.2018.00092,29721487.0,major specific past importantly daily lead ill complexity increasingly easily action fit deficit abstract control effective well increase doe solution neuronal individual knowledge executive account life pharmacological clinical health home focus academic secondary primary sufficiently oscillation novel ability incredible medicine use rate one seriously individually possibly current child intervention population approach management plan social success treatment important year argue challenge predictive pediatric relation easy function residual individualized quality cognitive aspect mechanism widely different direct refers powerful rarely highly complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915456/,abstract,0,refers incredible seriously oscillation individualized sufficiently ill fit easy easily rarely abstract individually argue academic possibly importantly residual home complexity powerful plan neuronal success executive solution predictive pharmacological action increasingly doe widely relation past daily aspect account secondary pediatric direct deficit focus lead highly social ability medicine knowledge cognitive management major challenge complex primary increase quality effective use mechanism intervention novel rate life current important function approach individual specific control population child different health year treatment clinical,"{""social"": {""freq"": 1, ""string"": [""pediatric direct deficit focus lead highly social ability medicine knowledge cognitive m""]}}",{},{},{},{},{}
137,137,147,10.1146/annurev-nutr-071816-064717,28715990.0,various specific example importantly physiological factor single discus profile nutrition behavioral algorithm complexity biomedical researcher necessary nutrient respond characterization supplementation risk biomarker addition true way finally extension essentially add issue utility biochemical era however subject pharmaceutical strategy unique objectively possible mitigation clinical health particular favorably great analytical integration data novel genetic consider area use interest compelling current implementation intervention many review motivation method ass translational development exposure technology precision appropriately assay probe motivate complex future breakthrough pharmacotherapies likely intuitive appropriate trivial individualized vetting accommodate intensive research posse also trial multiple prevention nutritional often study technological leverage contemporary limitation individual number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383767/,abstract,0,vetting trivial motivate mitigation pharmacotherapies objectively favorably add accommodate consider intuitive contemporary compelling leverage respond individualized essentially breakthrough motivation posse extension appropriately biomedical intensive technological probe true era importantly translational complexity integration algorithm pharmaceutical characterization biomarker researcher precision physiological analytical great nutrient limitation utility unique nutrition behavioral necessary way appropriate finally supplementation profile particular implementation nutritional assay example exposure likely prevention ass issue biochemical technology discus possible various area addition subject trial multiple complex strategy future single use intervention novel current number individual risk specific factor research review development health genetic method data clinical study,"{""behavioral"": {""freq"": 1, ""string"": [""great nutrient limitation utility unique nutrition behavioral necessary way appropriate finally s""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
138,138,148,10.7150/thno.19410,28839457.0,significant specific future tool mass challenge recent likely discus information possible fulfill ambient technical time perspective clinical ionization capability field point path analysis review real spectrometry molecular biomedicine therapeutic emphasis diagnostics also development potential diagnosis system tissue forward well powerful combination disease even solution highly spectrometer medical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566099/,abstract,0,biomedicine fulfill ionization ambient spectrometer path forward capability emphasis diagnostics powerful technical real solution perspective likely combination point tissue spectrometry highly discus field possible tool mass challenge therapeutic medical future molecular recent information time specific diagnosis review potential significant development clinical analysis disease,{},{},{},"{""spectrometry"": {""freq"": 1, ""string"": [""solution perspective likely combination point tissue spectrometry highly discus field possible t""]}}",{},{}
139,139,149,10.1002/jps.24505,26010239.0,conclusionthe immediate search class new exhibit intestinal half nineteen kinetics molecular literature common resultstwenty bddcs purposeto engine carvedilol issue third flip however life pharmacokinetics liable dosage form dihydrochloride substrate rabbit data oral explained rat consideration monkey three one short flop horse transporter drug release terminal solubility via second pharmacokinetic displaying two meclofenamic sapropterin elimination nominally characteristic larger classification entity internet human acid predominantly mammal absorption exception number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536115/,abstract,5,nominally meclofenamic liable horse engine displaying carvedilol bddcs nineteen explained rabbit flop flip solubility monkey kinetics resultstwenty purposeto internet mammal dihydrochloride pharmacokinetics pharmacokinetic immediate dosage terminal intestinal exception elimination absorption release entity sapropterin predominantly exhibit transporter substrate conclusionthe class classification half larger consideration rat oral search short second characteristic issue literature form drug molecular life common number new human acid data,{},{},{},{},{},{}
140,140,150,10.4103/jehp.jehp_152_14,28546969.0,provincial schedule worldwide immediate disorder retardation daily preventable better information registration among congenital time several laboratory location weakness without verification province action common cost improve recipient risk increase disease pku heavy satisfaction however follow place previous user eparchy health programming input feature therefore output improvement possibility error isfahan effectiveness diagnosis qualitative effect data reference server cause design equipment ability service level case lab moment three society main software end problem current implementation database many management phenylketonuria chance method mental efficiency sql development stage national system web online resource treatment delphi precision electronic net network help care process sample two newborn along scale timely hypothyroidism instantly goal precise quality analysis background program research infant monitor importance also consequence conclusion comprehensive different study human center charge limitation performance accuracy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433631/,abstract,1,sql provincial instantly eparchy verification server moment isfahan satisfaction weakness schedule recipient preventable equipment delphi charge programming heavy immediate chance net location output timely monitor lab retardation registration input province software precise web hypothyroidism place qualitative efficiency society worldwide improve precision possibility action end limitation reference goal daily accuracy network comprehensive resource effectiveness center follow stage mental previous service consequence help implementation improvement feature national cost database ability laboratory congenital design importance problem scale main performance better background process infant management program user cause increase electronic error quality online care information newborn current pku conclusion common sample phenylketonuria case time human risk diagnosis research different development health effect method data level disorder treatment analysis disease study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""electronic error quality online care information newborn current pku conclusion common s""]}}",{},{}
141,141,151,10.1371/journal.pbio.2000862,28441450.0,potent specific elicit seem factor single gut essential across behavioral lifespan reproductive nutrient behavior titer action choice due buffer true animal however life trait poorly pomorum health protein chemically output food bacteria eaas thus melanogaster effect consume change specie furthermore microbiome critical history yeast reproduction sufficient eaa rich important diet decision surprisingly modulators particularly determinant commensal appetite influence acetobacter shape act mechanism different interaction right deprivation acid dietary absence amino presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404834/,abstract,0,pomorum eaas eaa acetobacter modulators elicit commensal melanogaster chemically titer surprisingly reproduction consume buffer appetite yeast deprivation lifespan shape output gut potent true microbiome determinant reproductive rich bacteria poorly right specie act sufficient choice absence action nutrient trait behavioral decision history animal behavior critical presence furthermore influence particularly essential interaction food change single mechanism diet dietary life amino important specific factor acid different protein health effect,"{""behavioral"": {""freq"": 1, ""string"": [""sufficient choice absence action nutrient trait behavioral decision history animal behavior c""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""change single mechanism diet dietary life amino important specific factor acid d""]}}","{""diet"": {""freq"": 1, ""string"": [""essential interaction food change single mechanism diet dietary life amino important s""]}}",{}
142,142,152,10.3390/cancers10030067,29518918.0,major assessment clinic benign factor early effort several careful cooperation initial accurate molecular additional need share cost risk biomarker inadequate control effective regulatory validation disease uncertain pancreatic medical utility third cancer however beneficial much strategy recent clinical protein define move candidate therefore ideally large data forward generation combination first investment greatly consideration detection use mitigate commonly safely mutation panel independent imaging confront biomarkers failure sensitivity hurdle concomitant method describe history translational development stage technology second interdisciplinary reproducible test promising challenge specificity wide overcome sample within two progress entrepreneurial likely pdac community comparison organizational approximately advanced next validated dna analysis optimization head translation trial cohort high adenocarcinoma meta patient ductal highly moonshot number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876642/,abstract,0,moonshot entrepreneurial pdac confront organizational mitigate adenocarcinoma safely overcome ideally ductal interdisciplinary hurdle reproducible investment pancreatic concomitant cooperation optimization careful benign uncertain greatly define inadequate forward validated share advanced head translational imaging promising progress biomarker accurate validation commonly translation failure beneficial candidate meta consideration initial utility panel approximately independent community effort clinic specificity stage regulatory history dna second cancer sensitivity comparison likely generation combination cost biomarkers highly wide cohort additional technology need detection assessment trial major challenge strategy effective medical large molecular recent use mutation sample number test risk early control factor protein development high method data clinical analysis patient disease,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""highly wide cohort additional technology need detection assessment trial major challenge s""]}}",{},{}
143,143,153,10.1016/j.ymgme.2015.08.003,26293295.0,operation difference single among congenital positive laboratory algorithm probable presumably modification without condition race experience objective medical biochemical however life higher primary retrospectively diagnosis data versus routine first detection level significant case rate panel ethnicity one certain current convert day method predictor potential second loss treatment reflects particularly two multivariate newborn typically screen likely hypothyroidism analysis currently characteristic program consequence practice presentation study undergo performance individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640971/,abstract,1,reflects undergo presumably race probable convert retrospectively operation ethnicity multivariate hypothyroidism algorithm routine predictor modification versus typically screen presentation certain panel experience consequence second loss likely practice particularly currently laboratory congenital characteristic biochemical performance detection objective day program primary positive medical single rate life newborn current higher condition difference case individual diagnosis potential significant method data level treatment analysis study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""currently laboratory congenital characteristic biochemical performance detection objective day program primary p""]}, ""newborn"": {""freq"": 1, ""string"": [""primary positive medical single rate life newborn current higher condition difference c""]}}",{},{}
144,144,154,10.1104/pp.17.01608,29196539.0,major chain activity greater conformation pathway phenylpropanoid among ammonia dicotyledonous time several site preference reaction tal without molecular together additional trans monocotyledonous craft prosthetic thermodynamic display disease methylidene coumaric flexible dictated phenylalanine unique strategic distance imidazole crystal mutant substrate histidine property enzyme inner conferring basis bioenergy first formation plant isozymes recombinant significant three catalytic one deamination biomass side structure tyrosine gly residue critical approach via pal docking bicolor cinnamate friedel specificity nonoxidative production engineering enhanced elimination resistance quality kinetic analysis either mutagenesis mechanism also sbpal general group ala ser nutritional lyase domain acid sorghum loop conversion,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813539/,abstract,0,tal sorghum sbpal prosthetic nonoxidative monocotyledonous isozymes imidazole friedel dictated dicotyledonous craft coumaric bicolor thermodynamic phenylpropanoid methylidene conferring cinnamate bioenergy ser gly deamination docking strategic mutagenesis biomass inner histidine enhanced ala kinetic flexible loop distance conformation pal engineering elimination trans display lyase plant crystal conversion ammonia residue recombinant preference catalytic substrate resistance formation mutant unique production domain specificity property reaction basis site nutritional critical structure chain tyrosine greater general additional enzyme major quality pathway molecular mechanism activity approach time phenylalanine acid significant group analysis disease,"{""phenylalanine"": {""freq"": 2, ""string"": [""pathway molecular mechanism activity approach time phenylalanine acid significant group analysis d""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""greater general additional enzyme major quality pathway molecular mechanism activity approach t""]}}",{},{},{}
145,145,155,10.1186/s13023-016-0472-5,27356512.0,male disorder memory difference lower duration profile defect unrelated affected five due heterogeneous measuring investigate neurocognitive mean testing control backgroundhereditary poorer account executive accumulate however strategy recent conclusionsdespite cognition amsterdam dysfunction clinical range focus ntbc therefore task result diagnosis enzyme metabolic data resultsht negatively type inhibition score clearly significant flexibility female nitro fumarylacetoacetate tyrosinemia toxic problem fourteen recognition liver product identification social face sufficient consequently unknown treatment trifluoromethylbenoyl year diet rare age monitoring within pathophysiological reveal hydrolase mostly emotion healthy cyclohexanedione function cognitive facial analysis impairment mechanism methodsneurocognitive research group different domain study heterogeneity dietary neuropsychological patient participant show kidney gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928338/,abstract,3,resultsht methodsneurocognitive backgroundhereditary trifluoromethylbenoyl ntbc conclusionsdespite amsterdam nitro emotion cyclohexanedione measuring hydrolase fumarylacetoacetate accumulate fourteen tyrosinemia facial poorer flexibility pathophysiological neurocognitive cognition reveal clearly unrelated face recognition neuropsychological negatively kidney heterogeneous duration toxic consequently sufficient executive affected gender inhibition monitoring memory heterogeneity task account domain unknown profile female focus mean liver impairment dysfunction investigate product defect social identification problem male testing score participant cognitive enzyme healthy range strategy lower recent mechanism diet rare dietary difference function control type diagnosis research different age significant metabolic group year data disorder treatment clinical analysis result patient study,"{""social"": {""freq"": 1, ""string"": [""liver impairment dysfunction investigate product defect social identification problem male testing s""]}}","{""heterogeneity"": {""freq"": 1, ""string"": [""executive affected gender inhibition monitoring memory heterogeneity task account domain unknown p""]}}",{},{},"{""diet"": {""freq"": 1, ""string"": [""healthy range strategy lower recent mechanism diet rare dietary difference function c""]}}",{}
146,146,156,10.3390/molecules23061273,29861432.0,yet confocal significant experimental specific tool however incubation self cellular cytotoxic production metabolite reduction pre amyloid form proof specifically dynamic structure tyrosine provide fibril immunogenicity model microscopy molecular together cytotoxicity research immunostaining describe used antibody system towards like presentation study contrast toxicity acid fibrillary neuroblastoma immune finally furthermore assembly demonstration amino cultured cell intracellular presence non,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100058/,abstract,0,neuroblastoma immunostaining fibrillary incubation cytotoxic confocal cytotoxicity microscopy fibril immunogenicity demonstration intracellular cultured proof amyloid used assembly toxicity antibody dynamic immune specifically presentation cellular experimental production contrast pre finally reduction self presence furthermore structure tyrosine provide like form metabolite tool molecular amino non cell model specific research acid significant study,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""provide like form metabolite tool molecular amino non cell model specific r""]}}",{},{}
147,147,157,,29896075.0,augment sweetener commonly compliance mellitus pediatric ill content information measure among especially acute variety drug cariogenic child chronically palatability concern chronic health review product condition natural consumption widely literature caries prevention artificial thereby sweetness potential facilitate erosion sugar dentist dental oral increased diabetes medication,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969777/,abstract,0,erosion dentist sweetness cariogenic caries increased augment palatability dental sweetener ill chronically artificial mellitus sugar compliance facilitate medication commonly variety consumption widely diabetes oral acute concern natural content pediatric chronic prevention especially product literature measure drug information condition review potential child health,{},{},{},{},{},{}
148,148,158,10.1126/science.aal4043,29590070.0,rare transplant case individual augment interpretation subset record evidence variant organ single phenotype independently clinical subpopulation health phers consistent outcome initial feature approach five severe multiple score share common often risk pattern study ehr cause validation electronic distinct association disease patient genetic potentially aggregate mendelian,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959723/,abstract,2,phers ehr subpopulation augment transplant mendelian aggregate share interpretation independently subset validation organ record distinct initial potentially pattern consistent feature phenotype score severe multiple cause variant electronic single association rare evidence outcome common approach case individual risk health genetic clinical patient disease study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
149,149,159,10.7717/peerj.7309,31404401.0,biological specific huge new single pathway among affect gain set platform mirna reaction publicly insight light together molecular action resultsa download sub pair annotation regulatory validation disease demonstration amount whose shed sequence related cancer methodsdata recent possible form anti user value protein ncu edu store large data cause late novel type service use construct mirnas suppression transduction three cellular one comorbid signal possibly inhibitor drug failure database many comorbidity product alzheimer potential backgroundmicrorna mode web participation mirdrn association network diabetes http phase discover hundred process downstream public visualize proceed ontology explore currently colorectal available also trial multiple interaction often part bace study regulating human rsps tumor gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688598/,abstract,7,rsps ncu mirdrn edu download backgroundmicrorna bace proceed visualize mirnas mirna publicly methodsdata http construct store colorectal huge shed discover ontology demonstration comorbidity comorbid annotation transduction suppression regulating pair possibly participation resultsa sub mode gain web set downstream alzheimer tumor light inhibitor validation failure signal platform action late anti affect diabetes cellular network explore phase regulatory sequence reaction service insight cancer database product currently biological related public interaction possible process form trial user multiple cause drug value large pathway single association molecular recent use novel available new human specific type potential protein gene data disease study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""user multiple cause drug value large pathway single association molecular recent u""]}}",{},{},{}
150,150,160,10.1186/s12859-018-2409-6,30326846.0,exon relationship reliability conclusionswe new ratio centric visual laboratory algorithm median increasingly build devicnv finally cnv material visualization supplementary interval screening observed cbs assign user clinical value pragmatic resultswe candidate genomic diagnosis data obtain computational copy generation novel ability score capture bootstrapping regression detection level use plot confidence cnvs signal sensitivity strength model method binary propose online article test electronic systematic probe materialthe version every sample within variant newborn intuitive estimate since next inspection segmentation available also circular diagnostic sequencing linear gene individual number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192323/,abstract,0,segmentation devicnv bootstrapping cbs assign visualization pragmatic circular inspection centric intuitive cnv cnvs plot binary build obtain conclusionswe reliability copy probe strength capture computational resultswe algorithm visual propose exon candidate confidence signal increasingly linear interval systematic estimate median genomic finally observed regression sensitivity generation sequencing materialthe ability laboratory ratio relationship score diagnostic detection supplementary screening user version value variant electronic online use novel newborn material article sample number available test individual new model diagnosis gene method data level clinical,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""ability laboratory ratio relationship score diagnostic detection supplementary screening user version v""]}, ""newborn"": {""freq"": 1, ""string"": [""value variant electronic online use novel newborn material article sample number a""]}, ""screening"": {""freq"": 1, ""string"": [""ratio relationship score diagnostic detection supplementary screening user version value variant e""]}}",{},{}
151,151,161,10.1038/ejhg.2016.55,27302842.0,canadian satisfied content information consent province highlight recollection experience account relevant understanding evidence excepting health respondent improvement interview data little routine bloodspot long area theme although three provider variable child descriptive method constant parent parental decision care informed process two newborn professional lack timing comparison birth influence provision research importance jurisdiction practice interaction part similar patient prick depicts midwife,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110054/,abstract,0,recollection excepting midwife depicts satisfied jurisdiction informed timing canadian bloodspot prick constant consent provision respondent province theme descriptive provider parental routine interview little account decision content experience professional improvement variable understanding comparison lack influence practice highlight relevant parent importance birth interaction similar process area long care information newborn evidence research child health method data patient,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""similar process area long care information newborn evidence research child health m""]}}",{},{}
152,152,162,10.1002/ajmg.c.31653,30253036.0,specific clinic discus generalizable country adult half condition coordination probably institution experience number transition multisystemic medical presence adulthood childhood follow clinical always nature support service multidisciplinary although sclerosis least rule review model feasible tsc propose system disability accordance article manifestation resource team best education care address age pediatric likely continuity chronic dependent complicated program available regardless general intellectual different high patient tuberous variability healthcare individual complex establishing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635672/,abstract,0,multisystemic tuberous generalizable tsc continuity probably accordance rule establishing coordination sclerosis multidisciplinary complicated regardless team institution transition feasible adulthood half propose manifestation variability nature healthcare education resource address clinic intellectual follow experience best service dependent pediatric childhood likely disability presence chronic general discus country support program complex medical adult care condition article number available individual model specific review different age high clinical patient,"{""intellectual"": {""freq"": 1, ""string"": [""nature healthcare education resource address clinic intellectual follow experience best service d""]}}",{},{},{},{},{}
153,153,163,10.3390/ijerph16091638,31083436.0,hemoglobinopathy homozygote case endemic worldwide public cross life maranh hardy one newborn north sectional new sickle trait region strategy prevalence phenotype spatial delimit creation problem higher area health neonatal quality anaemia analysis distribution weinberg action frequency common state social improve analyse study test data capital important savanna temporal transition greatest disease respectively cell number amazon brazil,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540180/,abstract,1,weinberg savanna maranh hardy delimit amazon capital hemoglobinopathy homozygote anaemia endemic temporal greatest creation sickle north analyse spatial brazil transition worldwide improve action distribution trait sectional neonatal cross social frequency problem prevalence public phenotype region area state strategy quality respectively life newborn higher important common cell number case test new health data analysis disease study,"{""social"": {""freq"": 1, ""string"": [""action distribution trait sectional neonatal cross social frequency problem prevalence public p""]}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""area state strategy quality respectively life newborn higher important common cell n""]}}",{},{}
154,154,164,10.1097/MD.0000000000000313,25526483.0,correlation statistic esrd region almost hemodialysis difference factor lower duration bilateral laboratory fractional posterior superior left investigate risk control radiation disease anisotropy longitudinal tensor matter corona moderate spatial renal cognition dysfunction value institutional brain diffusion dialysis integrity creatinine data obtain change prospective edema level cingulum imaging end complaint diffuse map white eighty review approach disruption stage serum diffusivity test sex alteration urea association fasciculus hipaa age interstitial healthy function cognitive board corpus tract also dti group study right neuropsychological patient thalamic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603090/,abstract,2,hipaa esrd cingulum hemodialysis dialysis thalamic edema interstitial institutional fasciculus corona left diffuse radiation eighty complaint anisotropy posterior dti creatinine tensor diffusivity board fractional corpus obtain bilateral map integrity disruption cognition tract spatial diffusion superior urea statistic neuropsychological imaging renal duration right sex longitudinal matter prospective end moderate white alteration stage serum dysfunction investigate correlation laboratory region cognitive healthy change value lower brain association difference function approach test risk control factor review age group data level patient disease study,{},{},{},{},{},{}
155,155,165,10.1186/s12888-015-0616-5,26432691.0,disorder blood investigation factor ill abnormal psychopathology battery hospitalization psychosis stimulation risk old control hypothesis display saliva well danish disease status material contribute climate register spectrum equal family neuromotor neurodevelopmental perspective health decline home attachment symptom environment support like psychological data ongoing genetic level aug main measure problem instrument database child outcome somatic population participate degree method mental development via social illness behaviour parent behavioural relational collection proportion year emotional bipolar genetically entirely january neurocognition healthy birth influence psychiatric analysis environmental either aim style larger also backgroundsevere designwe group comprehensive interaction cohort representativity successfully extent discussiondata participant complication gene schizophrenia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592560/,abstract,7,style representativity discussiondata backgroundsevere aug neurocognition designwe attachment neuromotor entirely bipolar relational danish climate psychosis psychopathology somatic hospitalization battery saliva register participate ill schizophrenia equal decline display behavioural ongoing stimulation illness emotional behaviour instrument home january psychological contribute successfully degree psychiatric extent larger neurodevelopmental genetically complication proportion hypothesis abnormal perspective comprehensive mental investigation collection environment old environmental influence database social parent problem cohort like main birth status spectrum interaction participant symptom support aim measure healthy family material outcome risk control factor blood population child development health gene group year genetic method data level disorder analysis disease,"{""emotional"": {""freq"": 1, ""string"": [""decline display behavioural ongoing stimulation illness emotional behaviour instrument home january p""]}, ""social"": {""freq"": 1, ""string"": [""collection environment old environmental influence database social parent problem cohort like m""]}, ""psychiatric"": {""freq"": 1, ""string"": [""home january psychological contribute successfully degree psychiatric extent larger neurodevelopmental genetically c""]}}","{""genetic"": {""freq"": 1, ""string"": [""child development health gene group year genetic method data level disorder a""]}}",{},{},{},{}
156,156,166,10.1007/s40472-015-0059-4,26317066.0,experimental immediate availability cellular organ discus appropriate end acute standard current limited failure therapy chronic half review liver orthotopic benefit improvement technique research due transplantation unfortunately general stage century metabolic last course effective olt treatment immunosuppression surgical finite patient disease limit care option number donor medical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547556/,abstract,0,olt finite orthotopic immunosuppression unfortunately immediate century surgical donor transplantation half organ failure course limit end option availability cellular experimental acute stage appropriate improvement liver limited chronic technique general benefit discus standard effective medical care therapy current number research review metabolic treatment patient disease,{},{},{},{},{},{}
157,157,167,10.1002/jmd2.12019,31240157.0,disorder greater time ward brief despite temple median due admission highlight multifactorial average admit inpatient increase evaluate month doe pku respectively issue phe however phenylalanine street home input mol environment six university metabolic fifty basis change decrease term long metabolism period level multidisciplinary significant pre acute centre current child point irish phenylketonuria reason day post national team year discharge incidence care replicate age within january likely circumstance currently intensive hospital prior impact multiple december practice often study patient accurately consistently,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498819/,abstract,4,ward temple admit street replicate irish inpatient discharge circumstance multifactorial admission multidisciplinary intensive accurately consistently brief input december team reason home january centre university prior doe mol post average acute evaluate pre median basis decrease environment incidence hospital likely national point practice greater currently highlight despite issue period month phe long day change multiple increase respectively impact care current pku term phenylketonuria metabolism time phenylalanine child age significant metabolic year level disorder patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""current pku term phenylketonuria metabolism time phenylalanine child age significant metabolic y""]}}",{},{},{},{},{}
158,158,168,10.1021/acs.biochem.5b00616,26252467.0,resonance level fluorescence activity phenylalanine nuclear recent spectroscopy lower analogue norleucine propanol compound allosteric dimer able accompany model dimerization leucine structural also open separate support analytical result windowliver different effect domain study concentration magnetic phenyl allosterically regulatory acid extent methionine change activation phenylpropionate ultracentrifugation aminophenylalanine directly stabilize ability amino isoleucine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551101/,abstract,1,windowliver ultracentrifugation propanol norleucine aminophenylalanine allosterically accompany phenylpropionate stabilize phenyl dimerization analogue methionine dimer allosteric isoleucine fluorescence leucine spectroscopy resonance separate activation extent nuclear analytical able open magnetic structural directly domain regulatory compound ability support change lower recent concentration activity amino model phenylalanine acid different effect level result study,"{""phenylalanine"": {""freq"": 2, ""string"": [""windowliver ultracentrifugation propanol norleucine aminophenylalanine allosterically accompany phenylpropionate stabilize p"", ""lower recent concentration activity amino model phenylalanine acid different effect level r""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""support change lower recent concentration activity amino model phenylalanine acid different e""]}}",{},{}
159,159,169,10.1021/acs.biochem.5b00189,25856502.0,specific disorder tool assessment physiological new factor information molecule pathogenicity medically light accurate host open separate variation mechanistic risk biochemist windowwhole status actionable biophysicist strategy latter sometimes preventive protein science genomic stability basis genetic inexpensive medicine rational alter rapid pathogenic dynamic current structure personal many review diagnose potential treatment precision help care challenge overview linkage rna causative opportunity accordingly genome consequence interaction often human sequencing even newly individual number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415889/,abstract,0,windowwhole biophysicist biochemist rational pathogenicity medically actionable inexpensive diagnose personal alter host newly linkage causative preventive accordingly mechanistic rna light separate accurate dynamic stability precision physiological overview pathogenic open opportunity molecule science genomic basis genome consequence help rapid variation structure sequencing medicine status interaction assessment tool challenge strategy care information current number individual new human risk specific factor review potential protein genetic disorder treatment,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
160,160,170,10.1038/s41598-018-37542-2,30692599.0,coenzyme blood iem lower adult liquid advisable average control conclusi neurogenetic evaluate disease month significantly neurological status possible dysfunction value range protein possibility retrospectively error inborn diagnosis large genetic metabolism low young detection period significant suboptimal chi electrochemical prevent anova reverse phenylketonuric ultraviolet concentration test important association year diet phase mucopolysaccharidoses age monitoring percentage pediatric healthy especially coq chronic classified cardiovascular bonferroni also group classic plasma different cohort high study patient correction square participant individual total performance chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349877/,abstract,6,ultraviolet phenylketonuric conclusi coq mucopolysaccharidoses advisable neurogenetic electrochemical bonferroni anova coenzyme suboptimal retrospectively chi reverse classified square correction percentage classic young possibility monitoring cardiovascular iem liquid average prevent neurological chromatography phase evaluate pediatric dysfunction chronic especially cohort period status performance participant detection possible inborn month healthy plasma range value error large lower association adult diet concentration total important low metabolism test individual significantly control blood diagnosis different protein age significant group year high genetic patient disease study,"{""neurological"": {""freq"": 1, ""string"": [""monitoring cardiovascular iem liquid average prevent neurological chromatography phase evaluate pediatric d""]}}","{""genetic"": {""freq"": 1, ""string"": [""phenylketonuric conclusi coq mucopolysaccharidoses advisable neurogenetic electrochemical bonferroni anova coenzyme s""]}}",{},"{""detection"": {""freq"": 1, ""string"": [""especially cohort period status performance participant detection possible inborn month healthy p""]}}","{""diet"": {""freq"": 1, ""string"": [""value error large lower association adult diet concentration total important low m""]}}",{}
161,161,171,10.1371/journal.pone.0167433,27941974.0,transplant blood two reduction pediatric spot hemato per especially instead renal depend involved perspective drug child societal home population saving hospital alternative therapeutic attractive conventional oncology cost productivity loss purpose study nephrology number versus patient healthcare total caregiver,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152813/,abstract,0,saving productivity nephrology hemato depend oncology attractive societal transplant instead home renal conventional caregiver versus involved healthcare perspective alternative pediatric loss hospital reduction purpose cost especially spot drug therapeutic total number blood population child patient study,{},{},{},{},{},{}
162,162,172,10.1007/s13205-016-0485-8,28330246.0,various microorganism worldwide domestic activity energy discus widespread technical time present vinegar without ease due phenolic capable open separate common chemical cost highlight eco bread status biochemical bioconversion animal amine pharmaceutical compound input degradation food graphical century effectiveness enzyme etc microbial stability basis friendly ingredient plant low medicine use market catalytic involvement interest scientific toxic nitrile current produce processing nontoxic review product window via potential industrial waste production application wine either characteristic optimization keywords abstractbiocatalytic rapidly conversion industry agriculture,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991975/,abstract,0,wine nontoxic nitrile eco bioconversion abstractbiocatalytic vinegar graphical phenolic ingredient friendly domestic bread agriculture waste amine microorganism industrial optimization ease window century microbial market plant conversion rapidly input catalytic widespread produce industry processing capable technical toxic pharmaceutical involvement separate degradation worldwide stability keywords chemical scientific open energy production effectiveness basis compound animal cost product highlight medicine characteristic biochemical discus status various food enzyme application use activity current common low present time review potential,{},{},{},{},{},{}
163,163,173,10.1089/jwh.2015.5552,26447836.0,service suboptimal receipt public provider evidence opportunity professional death certain today among promotion variety clinical adult preventive woman health act critical gap affordable awareness available primary pocket prevention plan state cost highlight disability article american data delivery important nevertheless increase insurance care,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643365/,abstract,0,receipt pocket affordable promotion insurance suboptimal today preventive awareness plan provider american act gap variety certain opportunity death delivery service professional woman disability critical cost prevention highlight public state primary increase adult care evidence article important available health data clinical,{},{},{},{},{},{}
164,164,174,10.1016/j.neuroimage.2016.08.047,27561713.0,specific relationship notion quadratic difference content among difficult proxy across adult fractional throughout unrelated gradual evidenced common varied anisotropy tensor matter adulthood however cannot postmortem radial observed relaxation consistent usually diffusion result six spin contrast data date fraction late novel echo furthermore middle young use water multi short imaging splenium white mortem method frequently ass diffusivity myelin association year component age within sample mwf subcortical healthy demonstrate magnitude index tract dti pattern study accord null linear myelination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124541/,abstract,0,evidenced accord subcortical spin postmortem quadratic mortem gradual echo relaxation radial mwf splenium proxy anisotropy null myelination dti tensor diffusivity notion magnitude fractional myelin tract diffusion unrelated middle imaging varied usually adulthood fraction young multi matter water demonstrate late white linear frequently date contrast difficult content component index observed short pattern consistent furthermore ass relationship healthy association adult use novel difference common sample specific age year method data result study,{},{},{},{},{},{}
165,165,175,10.3390/metabo9010012,30641898.0,metabolome interpretation blood iem vus probable need view annotation evaluate disease status pipeline peak summary quantitative clinical value consistent programming nonselective complete error inborn diagnosis metabolic language significance genetic metabolism score non case whole hrms per correctly infusion method correct exome unknown test investigator sample isomer mass variant spot throughput analysis wherein metabolomics spectrometry diagnostics comprehensive plasma different high sequencing direct patient resolution metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359237/,abstract,6,nonselective vus isomer hrms pipeline investigator infusion programming probable correctly annotation metabolome peak throughput diagnostics interpretation correct summary resolution language exome view significance complete metabolomics iem comprehensive unknown evaluate direct quantitative consistent sequencing spectrometry spot status need score inborn metabolite mass plasma value variant error non sample case metabolism test blood diagnosis different metabolic high genetic method clinical analysis patient disease,{},"{""genetic"": {""freq"": 1, ""string"": [""test blood diagnosis different metabolic high genetic method clinical analysis patient d""]}}",{},"{""spectrometry"": {""freq"": 1, ""string"": [""unknown evaluate direct quantitative consistent sequencing spectrometry spot status need score i""]}}",{},{}
166,166,176,10.3390/nu11040832,31013738.0,macronutrients significant fat record lack childhood energy difference growth early scale comparison normal current provide questionnaire child health concern height anthropometrics density median protein weight therefore body day due macronutrient vegan kcal vegetarian ancova group average omnivorous study large online sugar whereas fiber carbohydrate dietary well germany year diet highest intake amount lifestyle,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521189/,abstract,1,vegetarian omnivorous vegan anthropometrics macronutrients ancova macronutrient kcal fiber germany height carbohydrate sugar density lifestyle fat record highest energy average concern median childhood weight questionnaire comparison lack intake growth provide scale body normal day online large diet dietary current difference early child protein significant health group year study,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""scale body normal day online large diet dietary current difference early c""]}}",{}
167,167,177,10.5812/ircmj.21633,27175306.0,case exon mutation phenylalanine introduction early autosomal differential deletion phenylketonuria error missense pah report inborn classic del conclusion diagnosis parent presentation large treatment small patient asian help first hydroxylase genetic finding metabolism gene even detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862320/,abstract,1,del asian differential deletion classic missense introduction exon presentation autosomal help pah parent hydroxylase small finding detection inborn error large report mutation conclusion phenylketonuria case metabolism early phenylalanine diagnosis gene genetic treatment patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""mutation conclusion phenylketonuria case metabolism early phenylalanine diagnosis gene genetic treatment p""]}}","{""autosomal"": {""freq"": 1, ""string"": [""deletion classic missense introduction exon presentation autosomal help pah parent hydroxylase s""]}, ""genetic"": {""freq"": 1, ""string"": []}}",{},"{""detection"": {""freq"": 1, ""string"": [""help pah parent hydroxylase small finding detection inborn error large report m""]}}",{},{}
168,168,178,10.1016/j.socscimed.2016.07.036,27526258.0,implication disorder self hierarchical early examine behavioral manipulated consent fractional preference serious action state facilitate methodswe control objectivesnearly survey treatable evidence normative recent baby expectant screening relative strongest mixed outreach range procedure resultswe feature factorial result diagnosis recently psychological call experiment united regression level mandatory construct format wider variance model predictor national parent participation online substantial treatment parental important education decision option attitude rare newborn permission intention conducted birth influence analysis background mechanism impact voluntary framework program importance conclusionprogram cohort,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023483/,abstract,0,permission objectivesnearly manipulated conclusionprogram outreach factorial expectant strongest voluntary construct normative wider intention format hierarchical mandatory fractional conducted attitude consent participation preference mixed variance treatable resultswe baby psychological parental experiment predictor facilitate substantial examine united action option framework education procedure behavioral relative decision methodswe implication survey regression recently feature national self influence parent importance cohort birth background screening state program range online recent mechanism rare impact newborn evidence important model early control diagnosis level disorder treatment analysis result,"{""behavioral"": {""freq"": 1, ""string"": [""united action option framework education procedure behavioral relative decision methodswe implication s""]}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""range online recent mechanism rare impact newborn evidence important model early c""]}, ""screening"": {""freq"": 1, ""string"": [""influence parent importance cohort birth background screening state program range online r""]}}",{},{}
169,169,179,10.1126/scitranslmed.aaf3838,27464750.0,trifluoromethylbenzyol immunohistochemistry disorder vivo reporter fah lentiviral onset severe recipient control addition hypothesis noninvasive disease promoter hereditary autologous animal partial repopulation clinical therapy range portal sodium ntbc complete fibrosis protective metabolic large hepatocyte date expansion tomography selective type genetic metabolism hepatocytes porter exploration level use transplant globulin one nitro fumarylacetoacetate pig emission tyrosinemia normal drug succinylacetone tyrosine provide liver model infusion isolation therapeutic sym correct cell near thyroxine deficient within hydrolase vein cyclohexanedione characteristic transplantation collagenase study digestion advantage small vector positron correction successful gene proliferation resection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477771/,abstract,1,trifluoromethylbenzyol sym porter collagenase autologous resection ntbc globulin thyroxine succinylacetone repopulation pig fah vein portal nitro lentiviral immunohistochemistry cyclohexanedione isolation hydrolase fumarylacetoacetate digestion recipient exploration positron infusion noninvasive tyrosinemia transplant reporter protective tomography sodium emission proliferation hereditary hepatocytes expansion correction near promoter transplantation vector fibrosis correct partial selective hepatocyte deficient complete advantage successful hypothesis vivo date animal liver onset tyrosine provide characteristic small severe normal addition range drug therapeutic large use therapy cell metabolism model control type metabolic gene genetic level disorder clinical disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""metabolism model control type metabolic gene genetic level disorder clinical disease s""]}}",{},{},{},{}
170,170,180,10.1016/j.kint.2016.09.032,27927599.0,experimental activity daily early targeting action pathology ace injection control effective glomerular lesion urinary well increase circulation significantly minicircle murine renin however rather profound form renal clinical nephropathy protein blocker angiotensin fold mouse circulatory therefore degradation result hyperfiltration thus effect cleaves change expansion term long ability formation untreated recombinant non emphasize rate size acute combat approach week markedly augmentation mesangial system serum ameliorate streptozotocin treatment delivery diabetes finding load albuminuria enhanced dna diabetic prior characteristic importance also induction group plasma different filtration cellularity extent similar intraperitoneal monocarboxypeptidase kidney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429993/,abstract,2,monocarboxypeptidase mesangial hyperfiltration combat cleaves cellularity streptozotocin albuminuria targeting renin nephropathy minicircle circulatory augmentation glomerular ace intraperitoneal filtration blocker angiotensin enhanced emphasize circulation induction ameliorate murine lesion diabetic load profound recombinant expansion markedly kidney renal injection untreated degradation pathology urinary extent fold prior action formation diabetes daily experimental acute delivery size dna serum ability importance week characteristic finding similar mouse form long plasma change increase effective rate activity term non approach significantly early control different protein group effect treatment clinical result,{},{},{},{},{},{}
171,171,181,10.1093/cdn/nzy077,30820487.0,interpretation consistency example noncommunicable studied factor nutrition across demonstrates present nutrient need moreover difficulty state fall risk varied avoid disease survey intake issue manuscript quintiles driver health nutritionally improvement sodium body primary food debate link thus nova data little united clearly four facilitated advice ultra canada others many scholarly emphasis national kingdom salt diet list brazil definition fat public within mass relation since category quality meaningful either index paper inception consumption widely policy group classification sugar considerably fiber constructive france total applies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389637/,abstract,1,nova noncommunicable facilitated constructive quintiles applies scholarly nutritionally inception salt manuscript fiber fall kingdom driver france canada ultra considerably avoid consistency advice demonstrates meaningful debate sodium clearly sugar definition brazil emphasis studied varied interpretation fat list classification link united category consumption difficulty nutrient little widely relation nutrition policy index improvement survey example national intake paper issue public need body food state mass primary quality diet total present risk factor health group data disease,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""body food state mass primary quality diet total present risk factor h""]}}",{}
172,172,182,10.1016/j.ymgmr.2015.03.009,26120559.0,investigation physiological lead maib demethylation partially characterization additional partitioning resultsmaib toxicity accumulation phe whose quantify higher compound brain fold determined mouse distribution npaa support pahenu aib data similarly approximate tolerability npaas non use conclusionsour aminoisobutyrate preclinical block liver toward day serum methodscontrol safety pharmacokinetic methyl test concentration treatment collection comparison approximately analysis matrix objectiveinitial trend study acid intraperitoneal accretion amino preparation parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478616/,abstract,5,resultsmaib partitioning objectiveinitial npaas npaa methodscontrol maib demethylation approximate aminoisobutyrate aib accretion tolerability intraperitoneal conclusionsour pharmacokinetic pahenu quantify preclinical methyl similarly block toxicity matrix partially preparation characterization trend determined physiological fold distribution safety accumulation approximately parameter investigation collection serum compound comparison liver lead additional mouse support phe day brain use concentration amino higher non test acid data treatment analysis study,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""support phe day brain use concentration amino higher non test acid d""]}}",{},{}
173,173,183,10.1186/s12859-016-1272-6,27770783.0,amplicons tool chain algorithm present biomedical reaction accurate verification parallel common variation polymerase machine cnv material however supplementary higher clinical user resultswe fast structural massive duplication large data copy novel genetic type detection pcr cnvs short step certain size structure sensitivity approach enrichment technique method identification online article electronic backgroundmultiplex challenge version specificity protocol still sample variant germinal authorized deletion paper research available widely diagnostics larger often high applicable cohort conclusionwe study limitation performance resolution number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075217/,abstract,0,backgroundmultiplex amplicons germinal conclusionwe verification cnv massive cnvs duplication machine applicable enrichment copy biomedical polymerase fast diagnostics authorized resultswe algorithm parallel pcr resolution deletion accurate larger limitation widely protocol certain structural specificity step reaction size short sensitivity variation structure chain technique identification cohort paper performance detection tool supplementary challenge user version variant electronic online large novel material higher article common sample approach number present available type research high genetic method data clinical study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""detection"": {""freq"": 1, ""string"": [""chain technique identification cohort paper performance detection tool supplementary challenge user v""]}}",{},{}
174,174,184,10.1007/8904_2017_11,28247338.0,registry major european specific consistency disorder assessment reliability self psychometric iem exhibit hrqol item proxy acidurias psychometrically organic choice neurocognitive elaboration disease excellent ucd material related supplementary life introduction user questionnaire clinical health generic focus crisis burden project error sound inborn result property metabolic interview metabqol date basis language question term intoxication first type medication metabolism exploration eight score adhere internal step discussion instrument child descriptives population method towards parent online solid urea electronic network year diet promising version strict german convergent imd estimate scale adolescent subjective quality cognitive impairment validity characteristic impact research available translation larger group cycle practice part study patient twenty participant total chapter acceptable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740049/,abstract,8,metabqol descriptives psychometrically elaboration ucd convergent sound adhere exploration proxy intoxication german subjective acidurias psychometric hrqol consistency generic crisis chapter imd reliability item neurocognitive validity strict solid registry exhibit urea internal instrument excellent promising acceptable project interview discussion language medication translation introduction choice larger organic question burden adolescent european iem cycle network date estimate step property basis questionnaire focus impairment self practice parent scale related characteristic score participant assessment inborn cognitive supplementary major user version electronic error quality online diet impact life total material term available metabolism specific type research population child metabolic health group year method disorder clinical result patient disease study,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""user version electronic error quality online diet impact life total material t""]}}",{}
175,175,185,10.1016/j.ymgmr.2016.08.006,27570738.0,level hitherto blood hyperlasia fluorimetric poor cah pregnanetriolone controversy congenital standard time hydroxyprogesterone economic neonatal economical reaction without product object method primary determination efficiency superior discriminate infant propose diagnostic system adrenal phosphoric acid classical urinary ability ohp recurrent,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992010/,abstract,0,pregnanetriolone phosphoric hyperlasia hitherto ohp hydroxyprogesterone fluorimetric controversy cah discriminate economical object adrenal recurrent superior efficiency determination urinary propose classical economic poor reaction neonatal product ability congenital diagnostic standard infant primary time blood acid method level,{},{},{},{},{},{}
176,176,186,10.1038/srep26952,27246267.0,nanoparticles cluster almost molecule resonant liquid surface molecular pressure need sers chemical optical microfluidic radiation solution phe bsa circuit phenylalanine strategy protein chemically albumin fast metal report methodology contactless sensor raman integration scheme novel formation lysozyme non implement detection neutral biomarkers hot gold volume aggregation nanorods technique via target potential serum free bovine active exploit limit sample locally efficiently spot order easy induce magnitude currently push embed namely acid small biomolecular amino presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887892/,abstract,0,nanorods lysozyme embed contactless biomolecular resonant sers raman push bsa exploit chemically scheme nanoparticles microfluidic locally hot radiation bovine optical implement albumin induce sensor magnitude easy circuit metal efficiently gold fast aggregation neutral surface cluster integration pressure solution methodology limit chemical formation liquid volume active molecule serum presence free biomarkers spot currently technique order small need target detection phe strategy molecular report novel amino non sample phenylalanine acid potential protein,"{""phenylalanine"": {""freq"": 2, ""string"": []}}",{},{},"{""detection"": {""freq"": 1, ""string"": [""currently technique order small need target detection phe strategy molecular report n""]}, ""amino"": {""freq"": 1, ""string"": [""detection phe strategy molecular report novel amino non sample phenylalanine acid p""]}}",{},{}
177,177,187,10.7189/jogh.08.021102,30479748.0,worldwide disorder iem search class region early pathway effort defect country laboratory selection conclusionsiem awareness communicable literature heterogeneous separate capacity geographical correlating methodswe modelling significantly consanguinity resultant knowledge cumulative interval childhood screening lmics higher pooled regional focus burden global error globally diagnosis metabolic effect good data date cause middle metabolism low mortality non area level yet significant case confidence although rate death morbidity per individually notable child eastern outcome intervention review mediterranean management accounting tackle intermediate parental proportion year incidence finding systematic fatality particularly split backgroundinborn rare prevalence estimate income community birth minimum analysis criterion currently also policy group often high study meta random highest,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237105/,abstract,9,conclusionsiem tackle pooled correlating split lmics fatality modelling mediterranean communicable backgroundinborn resultant notable geographical eastern globally accounting intermediate minimum consanguinity cumulative individually regional income random middle heterogeneous awareness class parental separate worldwide capacity meta confidence burden proportion highest morbidity interval iem selection community date search methodswe effort death systematic estimate policy mortality good global incidence childhood focus criterion particularly defect currently laboratory prevalence birth knowledge country finding region literature area screening management cause error pathway rare intervention rate outcome higher non low case metabolism significantly early diagnosis review child significant metabolic group year effect high data level disorder analysis study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""literature area screening management cause error pathway rare intervention rate outcome h""]}}","{""screening"": {""freq"": 1, ""string"": [""knowledge country finding region literature area screening management cause error pathway r""]}}",{},{}
178,178,188,10.3390/s19081917,31018573.0,infectious use component lab respect within transduction least along deep poct recent portable lower income lmics specifically country electrochemical structure value clinical mobile point review analytics overview device communicable method diagnostics methodology development chip connectivity potential system trend applicable ldcs testing data microfluidic phone machine important term patient novel disease photonic hardware middle care non,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515310/,abstract,0,poct ldcs hardware analytics photonic lmics portable microfluidic electrochemical connectivity communicable phone machine mobile chip transduction deep applicable lab respect diagnostics income middle infectious device trend overview methodology specifically component structure point testing country value lower recent use novel care term non important review potential development method data clinical patient disease,{},{},{},{},{},{}
179,179,189,10.12659/MSM.900257,28031551.0,logistic male statistic assessment thimerosal disorder pervasive past autism ratio early rigorous among examine odds risk mean control hypothesis disease significantly material spectrum infectious methodsa event reduction childhood recent academy health vaccination compound effect data date term late long mortality regression service significant case asd independent female morbidity database child vaccine population vaers ethylmercury development exposure system conclusionsthis american test sex recommendation associated year phase public future two mercury aap birth backgroundthis adverse analysis program reduce keywords also phenomenon autistic study similar resultsanalysis mesh,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5218387/,abstract,2,vaers thimerosal ethylmercury aap vaccination resultsanalysis pervasive mercury backgroundthis academy vaccine rigorous mesh autistic phenomenon conclusionsthis odds statistic infectious reduce logistic american methodsa sex examine keywords asd late past event morbidity hypothesis independent date associated phase autism mortality service recommendation adverse female childhood regression compound mean reduction exposure database male ratio public birth spectrum similar assessment long program future recent material term case test significantly risk early control population child significant development health year effect data disorder analysis disease study,{},{},{},{},{},{}
180,180,191,10.12659/MSM.911711,30612134.0,pain hour greater difference rescue analgesic visual backgroundnsaids median pressure additional common average pgf well proxicam material respectively emergency suitable intramuscular analogue observed verbal fluid double sodium symptom primary result effect dysmenorrhea decrease medication score period level service mann whitney administration menstrual end overall inclusion method efficiency baseline test treatment uterine numeric piroxicam conclusionsat resultsthe methodsthe scale standard either hospital aim keywords min group diclofenac study alpha blind patient agent mesh deviation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330839/,abstract,13,proxicam piroxicam pgf dysmenorrhea diclofenac conclusionsat backgroundnsaids numeric uterine menstrual intramuscular whitney analgesic mann mesh analogue emergency rescue verbal sodium pain min blind visual deviation alpha pressure methodsthe fluid efficiency hour medication suitable keywords double resultsthe end agent baseline inclusion average administration median service decrease observed hospital greater scale additional period overall score standard symptom aim primary respectively material difference common test group effect method level treatment result patient study,{},{},{},{},{},{}
181,181,192,10.1089/hum.2016.011,26986823.0,palindromic expensive specific chain single time laboratory labor germline reaction restriction without five cycling molecular open cost locus negate nuclease source effective polymerase repeat solution doe activator line sequence commercial transcription sanger animal understanding quantitative proprietary fluorescent scoring protein reagent therefore mutant genomic customization genotype simpler primer like length effect crispr qpcr generation genetic perturbation score completely effector pcr fluorescence although necessity rapid rate one short interest step phenotype hot pace current processing talens morphological point week model reverse method post system rflp polymorphism key limit assay cell probe version customizable universal component threshold strain still protocol accelerated allele unless biology standard quenchers regularly intensive either concordance reading classic tested cycle optimize often different clustered thermal sequencing house asq distinct gene individual fragment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931339/,abstract,1,quenchers negate cycling customization clustered talens simpler proprietary customizable asq unless house reagent palindromic rflp regularly pace nuclease hot thermal tested scoring qpcr morphological accelerated reading primer labor fluorescent necessity fragment commercial germline expensive effector activator perturbation optimize reverse crispr concordance threshold strain fluorescence polymerase intensive sanger probe repeat processing completely universal length locus pcr classic solution transcription distinct limit line doe restriction mutant biology open protocol polymorphism cycle post genotype step allele sequence reaction genomic component quantitative source short understanding assay animal rapid generation cost point chain sequencing laboratory week like phenotype score standard version key effective single molecular rate current cell individual time model specific different protein gene effect genetic method,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
182,182,193,10.3390/ijerph15061196,29880727.0,correlation milk growth energy gain warrant interquartile median weight accurate due preterm difficulty inadequate number determines intake gestational underfed life moderate meet ninety protein range clinically gestation report result observational change versus feed first level rate requirement current confirmation week day frequently fortification recommendation association iqr age two negative breast birth exploratory analysis infant trial study human direct,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025124/,abstract,5,underfed determines interquartile fortification ninety iqr meet feed warrant exploratory confirmation inadequate gestation breast preterm gain requirement milk gestational observational accurate versus difficulty moderate energy frequently clinically median recommendation direct weight negative intake correlation growth week birth infant day trial change range association report rate life current number human protein age level analysis result study,{},{},{},{},{},{}
183,183,194,10.1007/s12687-016-0279-z,27586542.0,use disorder within availability consideration discourse subject member better one certain likely improved northwestern stakeholder biobank comparison scenario terminology nuance outcome intervention benefit impact chance infant describe importance university high testing varied describing term versus perceive survey amongst type participant inter opinion option version,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138165/,abstract,2,perceive nuance northwestern describing discourse biobank terminology scenario improved chance stakeholder opinion inter varied versus university consideration member option availability certain survey comparison likely importance benefit testing better participant infant subject version use impact intervention outcome term type high disorder,{},{},{},{},{},{}
184,184,196,10.1155/2016/2453027,27313877.0,nutritive allowance daily ratio difference formula laboratory palatability median restriction zero common artificial percent toxicity significantly pku intake respectively phe phenylalanine partial form value therapy protein replacement mol result recently effect data versus combination use level significant gmp side tyrosine child phenylketonuria method work alanine phenyl treatment ten rich interquartiles regimen diet phase feasibility two aim natural conclusion different aaf study whey dietary caseinoglycomacropeptide patient amino satisfactory,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904101/,abstract,4,interquartiles caseinoglycomacropeptide aaf phenyl allowance zero satisfactory palatability nutritive whey artificial alanine regimen gmp percent toxicity rich formula feasibility replacement partial versus restriction mol daily natural phase median work recently combination intake tyrosine laboratory ratio form aim phe value use diet respectively dietary therapy pku amino conclusion difference common phenylketonuria significantly phenylalanine child different protein significant effect method data level treatment result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""amino conclusion difference common phenylketonuria significantly phenylalanine child different protein significant e""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""use diet respectively dietary therapy pku amino conclusion difference common phenylketonuria s""]}}","{""diet"": {""freq"": 1, ""string"": [""ratio form aim phe value use diet respectively dietary therapy pku a""]}}",{}
185,185,197,10.1371/journal.pgen.1006864,29069077.0,biological phenotypic disorder autism memory kmt single mbd present set site five molecular additional common highlight addition majority ehmt respectively plasticity promoter spectrum neuronal transcriptional related however trithorax family haploinsufficiency mainly clinical overlapping role fly protein feature body mutant chip indirect data overlap novo basis term novel arc significant four mutation asd variable short seq syndrome enrichment target synaptic system disability loss key network delineates nearly drosophila neuropathology methyltransferase process regulator variant ortholog reinforces ontology involved trr function nervous identical facial characteristic head mushroom also larger group intellectual euchromatin cohort histone kleefstra smarcb similar direct misregulated patient elucidate null convergence gene individual show,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656305/,abstract,4,trr trithorax smarcb ortholog misregulated mbd kleefstra euchromatin ehmt kmt arc overlapping mushroom methyltransferase haploinsufficiency delineates convergence reinforces neuropathology fly histone seq null identical plasticity overlap ontology drosophila indirect elucidate chip synaptic facial enrichment novo head transcriptional set regulator promoter nearly neuronal nervous larger phenotypic involved asd memory mainly mutant majority network intellectual autism basis direct short variable site loss feature disability syndrome highlight biological related cohort characteristic additional spectrum target similar body process addition variant key single molecular family respectively novel mutation term role common function present individual protein significant gene group data disorder clinical patient,"{""intellectual"": {""freq"": 1, ""string"": [""asd memory mainly mutant majority network intellectual autism basis direct short v""]}}",{},{},{},{},{}
186,186,198,10.1126/sciadv.aaq0266,29795781.0,presence various experimental inertness however much new moderate proceed biomass ether especially acetate rhcl substituents effectively compound many cleavage carbonylation reaction cleave mechanism efficient bond method moreover also aromatic abundantly different high attention methyl study lignin theoretical yield route important activation valuable synthesize synthesis assist conversion combination libf aryl challenge interesting transformation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959316/,abstract,0,substituents rhcl lignin libf inertness ether cleave carbonylation proceed aryl acetate abundantly synthesize cleavage bond biomass theoretical route transformation interesting assist methyl conversion yield aromatic effectively valuable activation efficient moderate experimental reaction compound synthesis combination attention presence especially various challenge mechanism important new different high method study,{},{},{},{},{},{}
187,187,199,10.1007/s10545-018-0153-8,29460030.0,disorder activity semialdehyde encoding largely analog elevated central action characterization elucidation mechanistic improve nsc accumulation concept neuromodulatory status murine neuronal succinic utility animal relevant channel latter recent gamma clinical therapy brain replacement gabaa mouse putative output outlook property enzyme attention effect unusual immature receptor term rapamycin novel long metabolism dehydrogenase ssadh ssadhd ghb update autophagy inhibitor proof drug excitatory hydroxybutyric model therapeutic mtor target expression potential system therapeutically cell antagonist option rare application regulated nervous advanced stem analysis vitro gaba research trial aldehyde study aldh acid deficiency agent inhibitory chloride gene prospect toxicological,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041169/,abstract,0,ssadhd ssadh ghb succinic semialdehyde neuromodulatory hydroxybutyric gamma gabaa unusual toxicological rapamycin outlook nsc autophagy aldehyde therapeutically excitatory aldh immature elucidation mtor chloride analog prospect gaba regulated antagonist channel proof update output murine inhibitory putative encoding advanced stem mechanistic replacement characterization neuronal dehydrogenase inhibitor nervous largely improve action agent receptor option elevated concept utility accumulation vitro property central animal attention relevant status target mouse enzyme application long trial expression drug therapeutic brain recent deficiency rare novel therapy activity term cell metabolism model research acid potential gene effect disorder clinical analysis study,{},{},{},{},{},{}
188,188,200,10.3390/nu11050995,31052331.0,blood assessment daily almost time median aged additional mean source classical pasta well increase bread month significantly intake phe third animal phenylalanine interval previous maintain fish protein mol burden potato minimise food equivalent six mild routine hpa low plant level unchanged variable periodic able product phenylketonuria day meat target national baseline free tolerance treatment important calculated year diet challenge systematic dairy age still within two hyperphenylalaninemia order whilst portuguese systematically optimise natural upper classic anthropometry substitute patient twenty rarely highly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566391/,abstract,15,pasta optimise potato portuguese periodic bread anthropometry minimise maintain upper unchanged meat dairy whilst fish rarely calculated substitute plant systematically hpa equivalent tolerance routine classic hyperphenylalaninemia classical able burden mol mild interval baseline daily systematic natural median previous aged source variable animal mean national free intake product highly additional order target assessment food month phe day challenge increase diet important phenylketonuria low time significantly phenylalanine blood protein age year level treatment patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""diet important phenylketonuria low time significantly phenylalanine blood protein age year l""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""food month phe day challenge increase diet important phenylketonuria low time s""]}, ""fish"": {""freq"": 1, ""string"": [""maintain upper unchanged meat dairy whilst fish rarely calculated substitute plant s""]}}",{}
189,189,201,10.1007/s00787-017-1020-0,28674760.0,major disorder assessment autism search widespread adult present standardized algorithm psycinfo set initial literature due subsequently deficit adhd eligible control reliable well disease spectrum issue medical infectious actively relevant however broader mainly clinical additionally developmental focus raters autoimmune attention integration data routine furthermore psychiatry gastrointestinal case asd independently neurobehavioral infection child database exclusion evaluation somatic formulate population review comorbidity inclusion work system article manifestation treatment recommendation association address systematic overview future two occur lack prevalence unclear adolescent nervous psychiatric validated quality criterion aware cardiovascular paper keywords general group often study vulnerable hyperactivity patient thorough show mesh promote,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591355/,abstract,3,raters neurobehavioral psycinfo psychiatry promote formulate somatic mesh autoimmune vulnerable thorough comorbidity occur aware actively exclusion broader eligible standardized adhd gastrointestinal validated widespread set infectious independently subsequently integration hyperactivity algorithm routine reliable psychiatric nervous manifestation keywords overview initial cardiovascular asd unclear mainly adolescent infection additionally inclusion search address systematic autism recommendation deficit work focus lack criterion attention furthermore developmental database evaluation relevant general prevalence paper issue spectrum literature assessment major quality medical future association adult article present case control population review child group data disorder treatment clinical patient disease study,"{""hyperactivity"": {""freq"": 1, ""string"": [""widespread set infectious independently subsequently integration hyperactivity algorithm routine reliable psychiatric n""]}, ""psychiatric"": {""freq"": 1, ""string"": [""subsequently integration hyperactivity algorithm routine reliable psychiatric nervous manifestation keywords overview i""]}}",{},{},{},{},{}
190,190,202,10.3390/cancers11010086,30646549.0,specific blood beckwith difference across several laboratory occasional measuring cost risk testing control increase month traditional disease longitudinal spectrum measurement utility cancer family marker bwsp compliance screening overlapped clinical health range consistent burden draw error result overlap fourth novel hepatoblastoma three independent biomarkers child liver management technique method thereby frequent concentration simultaneous help birthday wide every age within two fetoprotein spot standard invasive chronic currently background alternative reduce also conclusion plasma alpha wiedemann patient tumor show,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356556/,abstract,3,wiedemann hepatoblastoma bwsp birthday beckwith occasional fetoprotein overlapped fourth measuring draw overlap simultaneous reduce invasive alpha tumor compliance traditional longitudinal frequent burden utility independent alternative help consistent cancer marker liver cost chronic measurement biomarkers spot currently technique wide laboratory testing spectrum standard background month screening plasma management range increase error family novel concentration conclusion difference risk specific control blood child age health method clinical result patient disease,{},{},{},"{""screening"": {""freq"": 1, ""string"": [""laboratory testing spectrum standard background month screening plasma management range increase e""]}}",{},{}
191,191,203,10.3389/fnins.2018.00854,30519158.0,coefficient correlation tool better vivo region content time deeper across site bias variation gradient neurodegenerative agreement underlying disease genu matter measurement sequence understanding quantify vendor quantitative relaxation clinical philip regional clinically brain altman global therefore multicomponent support spin intersite good fraction use water multi sclerosis interest splenium progression strong white overall grase feasible pathological pearson reproducible myelin callosum valuable finding scan process two mwf siemens application estimate healthy metric reproducibility scanner analysis corpus trial multiple min different study magnetic human multisite small participant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258882/,abstract,3,vendor siemens philip intersite grase spin multisite multicomponent genu relaxation scanner reproducible mwf gradient altman splenium scan pearson deeper callosum agreement metric corpus myelin sclerosis quantify reproducibility regional min pathological coefficient bias neurodegenerative feasible valuable underlying fraction multi progression matter water strong white magnetic vivo estimate clinically content sequence good global quantitative understanding site variation measurement correlation small overall finding better region participant process support tool healthy application trial multiple brain use time human different clinical analysis disease study,{},{},{},{},{},{}
192,192,204,10.1007/8904_2018_105,29675588.0,implication cross resilience sectional difference factor anxious condition onset difficulty diverse experience pku longitudinal dependency questionnaire clinical protein generic developmental support distress metabolic psychological strictly low eight regression use significant measure problem child intervention population variance phenylketonuria social disability parent behaviour treatment parental diet finding care particularly future sample comparison responsible adolescent analysis aim impact research also larger multiple identify general group intellectual study distinct thirty statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122051/,abstract,1,anxious strictly dependency resilience distress generic thirty behaviour variance psychological parental responsible longitudinal larger identify distinct diverse statistically difficulty adolescent sectional intellectual experience implication regression questionnaire comparison cross onset disability developmental particularly social parent general problem finding support aim measure multiple future use diet impact intervention care pku condition difference sample phenylketonuria low factor research population child protein significant metabolic group treatment clinical analysis study,"{""intellectual"": {""freq"": 1, ""string"": [""distinct diverse statistically difficulty adolescent sectional intellectual experience implication regression questionnaire c""]}, ""social"": {""freq"": 1, ""string"": [""comparison cross onset disability developmental particularly social parent general problem finding s""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""support aim measure multiple future use diet impact intervention care pku c""]}}",{}
193,193,205,10.1016/j.trac.2016.04.009,28042191.0,decade future two mass ambien poc possible ambient current user ionization field advanced site point analysis review integrated impact spectrometry technique complete emphasis expert diagnostics miniature report development analytical potential system last integration miniaturization solution significantly status care challenge spectrometer non,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193165/,abstract,0,ambien miniature miniaturization poc ionization ambient spectrometer integrated emphasis diagnostics advanced integration solution expert complete analytical decade site point spectrometry technique status field possible mass challenge user future report impact care current non significantly review potential development analysis,{},{},{},"{""spectrometry"": {""freq"": 1, ""string"": [""expert complete analytical decade site point spectrometry technique status field possible m""]}}",{},{}
194,194,207,10.1177/2333794X17690314,28255576.0,cochrane psychometric search greater early anxiety despite psycinfo cinahl behavior central condition psychometrically physical substance handful facilitate risk related family evidence previous clinical clinically support depression language term long english use four problem format instrument database child intervention population review ltpcs via potential forty article medline list systematic universal adolescent embase criterion validity available multiple identify comprehensive limitation psychosocial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315369/,abstract,2,ltpcs handful psychometrically psycinfo format psychometric english cinahl substance cochrane psychosocial validity embase instrument medline universal depression list language facilitate anxiety identify limitation adolescent comprehensive search systematic clinically previous central physical behavior criterion database greater despite problem related support long multiple use family intervention evidence term condition article available risk early population review potential child clinical,{},{},{},{},{},{}
195,195,209,10.1007/s10545-017-0124-5,29318410.0,chain iem new pathway defect need underlies iems finally disease clinical storage coa focus outlook acyl error inborn enzyme metabolic reprograms type metabolism methylmalonic isotope dehydrogenase derangement phenotype stable review model phenylketonuria development technology system urea best altered wide hence flux deficient hydroxyglutaric progress estimate scale propionic residual suited analysis aciduria consequence conclusion cycle different study medium deficiency patient steady look metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959979/,abstract,0,reprograms hydroxyglutaric underlies outlook suited steady look flux derangement isotope aciduria propionic altered acyl methylmalonic iems urea residual coa progress dehydrogenase medium deficient stable storage iem cycle estimate best finally consequence focus chain defect wide scale technology phenotype need inborn metabolite enzyme error pathway deficiency conclusion phenylketonuria metabolism new model type review different development metabolic clinical analysis patient disease study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""phenotype need inborn metabolite enzyme error pathway deficiency conclusion phenylketonuria metabolism n""]}}",{},{},{}
196,196,210,10.1007/8904_2016_564,27295194.0,specific disorder chain nine ratio profile without easily biochemical subject marker definite suspicion value clinical acylcarnitine mol alone sum error inborn result diagnosis reference combination long metabolism low whole curve palmitoyltransferase normal sensitivity population method free concentration auc test receiver specificity operating acylcarnitines age deficient sample two lack dependent analysis either background characteristic roc conclusion lowest cycle plasma diagnostic high study deficiency patient molar highest carnitine cpt sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362552/,abstract,1,palmitoyltransferase cpt molar suspicion definite acylcarnitine sum roc easily carnitine auc operating acylcarnitines receiver lowest curve deficient sensitive mol highest reference cycle specificity dependent profile sensitivity marker lack combination free chain characteristic biochemical ratio diagnostic inborn background normal subject long plasma value error deficiency concentration conclusion sample low metabolism test specific diagnosis population age high method disorder clinical analysis result patient study,{},{},{},{},{},{}
197,197,211,10.4103/ijmr.IJMR_1738_18,30666988.0,epidemiological tool importantly micronutrient hierarchical fundamental factor difference information context nutrition set nutrient condition molecular mechanistic principle nutrigenomics concept transition disease traditional intake synthesis numerous offer concurrent modulate nutrigenomic unique health protein word environment food metabolic data undernutrition genetic metabolism although biomarkers phenotype problem syndrome provide discovery collectively intervention population review toward expression potential polymorphism alteration collection recommendation key network association directly component public rna opportunity metabolite application relation healthy fingerprint subgroup setting function dna quality flow research quantity importance also multiple nutritional comprehensive study similar dietary advantage indirectly absorption complication variability individual complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366269/,abstract,0,undernutrition nutrigenomic fingerprint indirectly setting modulate concurrent nutrigenomics hierarchical micronutrient absorption quantity collectively importantly fundamental epidemiological offer flow subgroup set mechanistic transition principle rna traditional numerous variability complication advantage word nutrient relation discovery polymorphism concept unique nutrition alteration opportunity network directly comprehensive collection component recommendation dna environment nutritional synthesis context intake biomarkers syndrome importance provide problem public phenotype similar food metabolite tool healthy application expression multiple complex key quality association molecular intervention dietary information condition difference function metabolism individual factor research population review potential protein metabolic health genetic data disease study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
198,198,212,10.1073/pnas.1501798112,26195738.0,inheritance biological abnormality lead organism proposal millennium present selection germ enhance slowly experience modern increase disease mankind hereditary line cannot cumulative organ possible eminent therapy causation health environment possibility decrease generation cultural genetic transmission mortality fertility healing although heredity feasible therapeutic endowment accomplish mode evolution nevertheless nerve technically intensity incidence care cell feasibility augment future two enhanced adaptation differential benefit natural ailment transplantation genome often last human gene individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517218/,abstract,0,mankind heredity endowment eminent technically millennium healing ailment accomplish germ proposal fertility causation augment enhanced slowly nerve modern cultural cumulative adaptation intensity transmission hereditary inheritance evolution mode organism transplantation feasibility feasible enhance differential organ possibility line selection natural experience mortality genome decrease environment incidence abnormality lead generation biological benefit possible increase therapeutic future care therapy cell present individual human health gene genetic disease,{},"{""inheritance"": {""freq"": 1, ""string"": [""cultural cumulative adaptation intensity transmission hereditary inheritance evolution mode organism transplantation f""]}, ""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
199,199,213,10.1093/hmg/ddw071,26965164.0,sided biological architecture new region ratio single congenital ctsk defect imequation attributable www insight odds common variation locus imputed control lesion addition myh disease mathvariant math subset family evidence disequilibrium chromosome previous role consistent nominal candidate mrow msubsup lsls genetic transmission mortality suggestive mapping significant case seven scroll morbidity normal provide discovery development mir potential combined replication substantial polymorphism association assertion address wide threshold overflow variant snp birth heritability heart analysis relatively mathml upon group lowest cohort high study nucleotide cardiac meta mml org moderately gene complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081047/,abstract,7,sided scroll overflow myh msubsup mrow mml mathvariant mathml math lsls imputed imequation ctsk disequilibrium assertion moderately nominal mir suggestive combined architecture org heritability replication mapping attributable threshold lesion lowest chromosome transmission www odds snp locus subset cardiac substantial candidate meta seven nucleotide discovery polymorphism morbidity relatively address heart mortality previous insight consistent variation defect biological wide congenital provide cohort ratio birth region normal addition complex variant single association family evidence role common case new control potential significant development gene group high genetic analysis disease study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
200,200,214,10.3791/54683,27842357.0,correlation assessment activity whether mxa precipitation without choice capacity state endogenously artificial enzymatic interferon virus thiol membrane issue line suitable however protection form higher protein gtpase mutant debate like dynamin fraction furthermore combination formation non cysteine effector cellular step crucial oligomeric aggregation structure proper many residue critical simple ass prerequisite free respective gel associated western cell interface particularly electrophoresis protocol ectopically irreversible order function polyacrylamide analysis broad exerts group blot interaction oligomerization human direct iodoacetamide antiviral page cytoplasmic another complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226139/,abstract,0,precipitation polyacrylamide mxa iodoacetamide ectopically dynamin cytoplasmic thiol gtpase oligomerization interferon endogenously exerts oligomeric page prerequisite antiviral respective electrophoresis blot gel effector cysteine artificial protection irreversible debate interface proper residue aggregation membrane enzymatic western crucial broad fraction virus choice capacity suitable simple line formation mutant protocol cellular associated step direct combination critical furthermore structure free particularly correlation ass like issue order interaction assessment form state complex activity higher non cell function human protein group analysis,{},{},{},{},{},{}
201,201,215,10.3389/fpsyg.2017.02004,29184527.0,level functioning age four understanding later asd autism whether typically prevalence rating follow affect positively behavioral child verbal intervention hfa degree symptom importance consequence often high attention baseline parent study ebp test whereas furthermore year significantly thirty participant emotional amount struggle,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694568/,abstract,2,hfa ebp struggle verbal functioning thirty rating emotional positively degree typically asd later affect baseline behavioral follow autism consequence understanding attention furthermore parent importance prevalence participant symptom intervention test significantly child age year high level study,"{""behavioral"": {""freq"": 1, ""string"": [""degree typically asd later affect baseline behavioral follow autism consequence understanding a""]}, ""emotional"": {""freq"": 1, ""string"": [""ebp struggle verbal functioning thirty rating emotional positively degree typically asd l""]}}",{},{},{},{},{}
202,202,216,10.5582/irdr.2018.01032,29862149.0,male tool cluster ipsc ucs examine time positive pathology old oct disease pku epithelial typical establish promoter line suitable marker verified bisulphite sox pluripotent pluripotency real body embryoid metabolic integration urine alkaline decrease genetic formation useful pcr biomarkers alp uipscs klf phenylketonuria nanog correct expression free phosphatase year assay cell rare two efficiently order differentiation stem cytometry characteristic flow research also methylation episomal sequencing isolated vector patient gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982629/,abstract,0,uipscs ucs sox nanog klf episomal embryoid bisulphite pluripotency oct ipsc alp alkaline verified phosphatase pluripotent cytometry methylation epithelial isolated efficiently typical flow stem promoter establish cluster integration vector correct pcr differentiation real pathology examine suitable line formation urine useful decrease old assay marker free sequencing biomarkers male characteristic order body tool expression positive rare pku cell phenylketonuria time research metabolic gene year genetic patient disease,"{""urine"": {""freq"": 1, ""string"": [""real pathology examine suitable line formation urine useful decrease old assay m""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
203,203,217,10.1007/s10875-017-0455-x,29116556.0,worldwide discus early improved krec country serious including without additional employed severe heterogeneous effective scid origin objective disease significantly month fatal recombining circle utility life strategy form therapy excision role range protein primary error methodology inborn asymptomatic diagnosis sequela pid receptor generation first immunity whole one current prevent outcome intervention many population uniformly identification potential technology evolution treatment assay cell trec kappa immunodeficiency future within wgs newborn definitive lymphopenia next analysis program available infant also genome group sequencing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742602/,abstract,0,recombining uniformly pid lymphopenia krec kappa including trec employed wgs fatal excision scid circle immunodeficiency sequela immunity improved definitive asymptomatic evolution heterogeneous origin worldwide methodology receptor utility prevent genome assay generation sequencing identification additional technology discus country severe inborn form month infant objective program range primary strategy error effective future intervention therapy life newborn current outcome role cell available significantly early diagnosis population potential protein group treatment analysis disease,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""error effective future intervention therapy life newborn current outcome role cell a""]}}",{},{}
204,204,218,10.3390/ijms20061385,30893889.0,various biological specific tool clinic example derail investigation momentum exhibit effort signature prognostic present despite necessary actual need superior evasion biomarker addition essentially utility biochemical decade cancer however pharmacological quantitative unique migration clinical clinically disturbance global metabolic purpose investigates ability metabolism reasonable rapid measure current drug outline review window therapeutic leave target technology important cell two endogenous opportunity apoptotic normally path mechanism characteristic metabolomics translation array diagnostic last tumor proliferation metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471292/,abstract,0,derail momentum leave investigates evasion normally reasonable migration prognostic essentially apoptotic actual window array signature outline path superior proliferation exhibit disturbance endogenous tumor biomarker translation pharmacological metabolomics decade utility unique opportunity effort clinic clinically necessary investigation global quantitative cancer example rapid purpose biological ability despite characteristic biochemical technology need diagnostic target various metabolite tool measure addition drug therapeutic mechanism current important cell present metabolism specific review metabolic clinical,{},{},{},{},{},{}
205,205,219,10.1097/MD.0000000000005219,27858868.0,factor early lower prematurity exhibit adult interquartile neonatal median liquid serious septic onset preterm common control well glycine disease significantly gestational sepsis supplementary value range neonate mol therefore primary result contrast data reference eos term furthermore first predominant suffering regression panel hrms independent biomarkers abundant serum concentration inflammatory age future within multivariate mass bile premature healthy standard determine analysis impact spectrometry infant hplc group high study chromatography acid performance resolution iqr parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591116/,abstract,1,eos septic hrms sepsis interquartile suffering iqr prematurity bile glycine abundant predominant hplc premature exhibit neonate multivariate preterm gestational resolution mol reference panel liquid inflammatory independent contrast chromatography parameter median serum regression neonatal onset furthermore spectrometry biomarkers determine performance standard infant supplementary healthy mass range primary value future lower adult impact concentration term common significantly early control factor acid age group high data analysis result disease study,{},{},{},"{""spectrometry"": {""freq"": 1, ""string"": [""median serum regression neonatal onset furthermore spectrometry biomarkers determine performance standard i""]}}",{},{}
206,206,220,10.1186/s12907-015-0013-5,26157353.0,coefficient registry inside correlation blood cross whether turbidimetric new lower time venous adult vendbs median finger subsequently variation hba triplicate agreement validation close objective traditional infirm respectively enough measurement zealand intra interval backgroundthe capillary proprietary observed punctured value clinical clinically duplicate altman acceptably comparable envelope instruction result resultseleven situation type inhibition low useful immunoassay area regression use level plot whole seven four mellitus gold narrow temperature glycated room prediction proper fourteen comparative breathable living model conclusionsthe day rural remote ass people actrn collection piece bland calculated filter diabetes limit particularly sample poor haemoglobin spot standard equation precise analysis venipuncture matrix paper alternative available methodsvenous trial except capdbs high study house patient linear participant registrationaustralian acceptable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495815/,abstract,6,vendbs turbidimetric triplicate registrationaustralian punctured methodsvenous infirm glycated duplicate capdbs breathable acceptably resultseleven proprietary piece narrow immunoassay envelope actrn house venipuncture hba haemoglobin bland zealand instruction inside altman remote plot fourteen equation finger agreement venous capillary mellitus living intra comparative calculated gold room registry proper rural matrix filter situation precise close subsequently coefficient acceptable temperature comparable backgroundthe traditional validation prediction conclusionsthe limit inhibition people seven linear diabetes interval alternative useful poor clinically median collection observed regression cross variation measurement particularly spot correlation ass paper standard participant area objective day trial value lower adult use respectively sample low available time new model blood type high level clinical analysis result patient study,{},{},{},{},{},{}
207,207,221,,26604868.0,staff major confidence unit minot friendship boston dedication whose love lifelong harvard medical peabody mentorship clinical hmu laboratory achievement despite intense dedicated many thorndike wei trainee either teacher hospital constantly leadership program research associate camaraderie also development result memorial loss residency experience clinician happiness way mentor soma george patient teaching care city founder physician graduate,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654193/,abstract,0,wei thorndike residency minot mentorship mentor memorial love leadership hmu harvard happiness george dedication camaraderie boston trainee soma peabody graduate friendship constantly teacher intense teaching associate dedicated staff founder achievement lifelong city unit physician confidence clinician way experience loss hospital despite laboratory program major medical care research development clinical result patient,{},{},{},{},{},{}
208,208,222,10.5127/pr.038315,28337341.0,genetically age future although understanding smaller primarily childhood typically factor crucial discus context problem aetiology sibling explore adolescent present psychiatric stable chronic role across wider developmental psychopathology analysis review maintenance adoption environmental therefore research widely literature also development twin study behavioural data stability change majority recommendation adolescence year genetic emotional systematic longitudinal examined predictive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360234/,abstract,6,examined psychopathology aetiology wider adoption twin sibling smaller behavioural adolescence emotional maintenance crucial primarily psychiatric typically stability longitudinal predictive stable genetically widely adolescent majority explore systematic recommendation childhood understanding context environmental chronic developmental problem discus literature change future role present factor research review age development year genetic data analysis study,"{""emotional"": {""freq"": 1, ""string"": [""adoption twin sibling smaller behavioural adolescence emotional maintenance crucial primarily psychiatric t""]}, ""psychiatric"": {""freq"": 1, ""string"": [""behavioural adolescence emotional maintenance crucial primarily psychiatric typically stability longitudinal predictive s""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
209,209,223,10.1155/2019/6908716,30755770.0,wide stress antidiabetic availability provider popularity antimicrobial better greater among pharmaceutically dynamic variety several anticancer value nature health acceptance document gastroprotective formulate medicinal review product mechanism herb action day posse physical emphasis due therapeutic food booster chemical people nutritional improve nowadays etc well supplement nutraceuticals increase longevity immunity healthcare challenge option medicine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348880/,abstract,0,pharmaceutically herb gastroprotective booster popularity nutraceuticals antidiabetic nowadays anticancer longevity formulate antimicrobial posse medicinal acceptance immunity supplement emphasis document provider dynamic improve chemical action variety nature people option availability healthcare physical stress nutritional product greater wide medicine better food day challenge value increase therapeutic mechanism review health,{},{},{},{},{},{}
210,210,225,10.1080/14737159.2018.1495076,30004274.0,specific disorder blood past lsd search compact present author neonatal platform condition literature fda expert state risk enzymatic biomarker testing preliminary underlying add disease unit subject introduction microfluidics fulfillment storage value health trace reagent bedside principal dmf symptom food result metabolic recently genetic inexpensive united area period four administration panel volume current drug vital highly review toward sourced device method conduct development technology test ten seeker lysosomal digital year promise assay care public commentary newborn application screen appropriate apparently healthy metric throughput intensive benefit program infant also high applicable perform small center successful electrowetting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481615/,abstract,0,sourced seeker fulfillment electrowetting dmf microfluidics commentary lsd compact bedside add reagent perform digital trace fda apparently inexpensive metric principal preliminary conduct applicable lysosomal throughput intensive vital promise enzymatic device unit author underlying biomarker united introduction screen expert storage platform successful past panel volume search center administration appropriate recently assay neonatal highly benefit period public technology small testing literature food symptom area infant healthy application state subject program drug value care newborn current condition present test risk specific blood review development metabolic health year high genetic method disorder result disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""newborn"": {""freq"": 1, ""string"": [""state subject program drug value care newborn current condition present test r""]}}",{},{}
211,211,227,10.1155/2018/2593745,30065914.0,major dht availability example herein new discus elevated literature parallel severe moreover artificial implant source number increase excellent amount however organ strategy meet supply clinical therapy recovery word report ideally hepatocyte hepatocytes mortality dlt rate functional acute problem failure syndrome review liver living method therapeutic shortage sufficient treatment key biochemically medline promising list challenge cell donor wide aiming slt definitive stem currently criterion background alternative available reduce transplantation conclusion patient limitation domino injury alf ldl treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051327/,abstract,2,slt domino dlt dht alf aiming implant ideally biochemically shortage meet ldl supply definitive artificial living hepatocytes recovery donor excellent stem medline reduce injury transplantation promising parallel list sufficient hepatocyte organ failure treat word availability limitation elevated alternative acute mortality source example criterion liver syndrome currently wide problem functional discus literature severe background major challenge strategy increase key therapeutic report therapy rate conclusion cell number available new review method treatment clinical patient,{},{},{},{},{},{}
212,212,228,10.1007/s13197-015-1894-0,26884639.0,biological antimicrobial milk technical gut essential present nutrient insight render apart physiology radiation antioxidant formulation well exercise disease excellent demand invigoration cancer desirable pharmaceutical insecurity obesity value role health protein range recovery suitability improvement peptide food utilization metabolic nourishment branched enormous protect functional replacer emulsifier hurdle residue edible review product phenylketonuria hypertension detrimental potential rich waste supplement valuable diabetes component wide augment fat dairy future advancement application scope packaging validated resistance worth nutraceutical benefit immunoglobulin cardiovascular array bioactive whey skin acid dietary industry amino complication highly total injury sector,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744604/,abstract,1,replacer nourishment invigoration insecurity emulsifier edible worth nutraceutical packaging detrimental suitability sector render protect waste hurdle enormous radiation augment desirable antimicrobial whey utilization immunoglobulin dairy branched apart bioactive hypertension array scope exercise gut demand advancement formulation antioxidant validated residue supplement recovery physiology industry skin rich excellent injury technical milk pharmaceutical fat resistance valuable peptide cardiovascular complication nutrient diabetes obesity component insight improvement cancer product highly essential biological wide functional benefit food application range value future dietary total amino role phenylketonuria present review acid potential protein metabolic health disease,"{""skin"": {""freq"": 1, ""string"": [""validated residue supplement recovery physiology industry skin rich excellent injury technical m""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""application range value future dietary total amino role phenylketonuria present review a""]}}",{},{}
213,213,229,10.3390/jintelligence6010006,31162433.0,various thoroughly gain time without due number knowledge plateau interval reduction moderate analytic focus task primary result multilevel thus effect ability score area significant although four administration one rts measure size outcome simple mental regarding test response best age sample sizable mostly estimate retest speed cognitive analysis research larger often high study heterogeneity whereas meta total complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480749/,abstract,3,rts regarding sizable plateau thoroughly retest multilevel analytic speed gain larger meta simple moderate heterogeneity task interval estimate administration best mental size focus reduction ability knowledge score various cognitive area measure complex primary response total outcome sample number test time research age significant effect high analysis result study,{},"{""heterogeneity"": {""freq"": 1, ""string"": [""speed gain larger meta simple moderate heterogeneity task interval estimate administration b""]}}",{},{},{},{}
214,214,230,10.1186/s12887-015-0332-9,25884714.0,subsequent clinic self hour difference thirteen difficult boy time socioeconomic median aged weight retention severe risk eligible well month status numerous tcoct family interval reduction childhood place obesity health inconsistent body tanner report methodspatients percentile investment score period use resultsthree rate one pubertal independent advice morbidity per referral implementation structure exclusion intervention march inclusion degree conclusionsthe plan stage parent baseline sex treatment parental year care hundred systematic bmi age protocol two mass professional collaboration acceptable standard chronic girl height dependent reduced criterion index characteristic study dropout patient modest february deviation gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363201/,abstract,6,tcoct tanner methodspatients dropout resultsthree pubertal thirteen investment march february socioeconomic percentile modest inconsistent retention advice exclusion eligible height collaboration referral girl boy bmi place plan deviation acceptable parental subsequent degree hour sex numerous gender conclusionsthe reduced protocol morbidity interval baseline obesity independent inclusion difficult clinic systematic stage median professional index aged dependent implementation childhood weight reduction criterion self chronic structure parent characteristic period status score standard severe body month mass use report family intervention care rate difference time risk age health year treatment patient study,{},{},{},{},{},{}
215,215,231,10.2478/jomb-2014-0040,28356819.0,explicit blood disorder difference information across country several consent refuse pressure detailed globe variation partly way disease survey opinion issue treatable executive however comply subject quantitative compliance screening broadly wilson storage health range legislation comparable great thus large data specimen guideline term potentially area level soon mutation economic regard degree jungner development potential technology system consequently parent ten parental care option detect definition generally public protocol sample newborn metabolite spot scope residual embedded dna provision criterion analysis widely genome general policy disposal practice part medium extent even number acceptable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922336/,abstract,0,embedded refuse jungner globe explicit wilson comply disposal soon legislation scope partly broadly regard consent specimen opinion provision detect definition detailed residual treatable consequently acceptable pressure comparable parental compliance degree medium executive extent generally storage economic great option widely protocol guideline potentially way policy genome dna quantitative survey criterion variation practice spot parent general issue public technology country area metabolite screening subject range large care information newborn mutation term difference sample number blood potential development health data level disorder analysis disease,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""screening subject range large care information newborn mutation term difference sample n""]}, ""screening"": {""freq"": 1, ""string"": [""issue public technology country area metabolite screening subject range large care i""]}}",{},{}
216,216,232,10.5702/massspectrometry.S0060,28337399.0,operation sample rapid mass simplicity almost application atmospheric ambient since clinical ionization site pretreatment many surface analysis review approach real spectrometry electrospray pressure technique widely due zero development cost highlight desorption directly low,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359754/,abstract,0,desorption atmospheric simplicity pretreatment electrospray zero ionization ambient operation surface pressure real widely directly site rapid cost spectrometry highlight technique application mass sample low approach review development clinical analysis,{},{},{},"{""spectrometry"": {""freq"": 1, ""string"": [""real widely directly site rapid cost spectrometry highlight technique application mass s""]}}",{},{}
217,217,233,10.3389/fnins.2016.00192,27242398.0,biological balance specific disorder autism abnormality architecture region semialdehyde energy subunit hyperexcitablity glutamate defect angelman elevated parallel risk fragile disrupts increase vitamin minicolumn spectrum heavy succinic medical circuit manuscript seizure reduction dysfunction brain feature gabaa metal neuropil elevation result thus metabolic immune genetic inhibition metabolism asd dehydrogenase interneuron mineral syndrome excitatory many review mortem neurotransmission phenylketonuria post expression exposure epilepsy excitation urea neuropathological finding elevate mitochondrial two aminobutyric pyridoxine prevalence peripheral function mglur dependent reduced gaba reduce cortex rett minicolumns cycle high turn acid similar deficiency inhibitory individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861974/,abstract,0,neuropil minicolumns minicolumn mglur interneuron hyperexcitablity angelman succinic semialdehyde gabaa mortem disrupts rett excitatory excitation elevate aminobutyric neuropathological pyridoxine manuscript gaba fragile neurotransmission heavy architecture subunit circuit turn mineral metal glutamate balance inhibitory elevation epilepsy cortex urea reduce peripheral parallel dehydrogenase seizure mitochondrial vitamin inhibition asd reduced immune energy elevated cycle post autism dependent abnormality feature reduction exposure dysfunction syndrome defect biological prevalence spectrum finding similar region expression increase medical brain deficiency function phenylketonuria metabolism individual risk specific review acid metabolic high genetic disorder result,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
218,218,234,10.1155/2019/1905416,31198782.0,logistic major relationship chain factor early congenital forecast defect hydroxybenzeneacetic fetus substance aromatic risk control urinary objective propanedioic respectively pca whose teratogenic third trimester relevant ranking subject vip marker partial logistics chds pairwise principal separated possibility sum chd result metabolic urine design pregnancy uric ability genetic metabolism score regression clearly significant case mann whitney rate least short biomarkers software graph external woman fully intervention population model method potential gas chromatograph second test multifactor simca treatment researching trimethylsilyloxy fatty wilcoxon maternal component sample two mass reveal teratogenicity orthogonal rank healthy especially hydracrylic heart opls analysis environmental background valeric mechanism metabolomics research infant foundation prevention conclusion group high acid advantage discriminant square amino spectrometer parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526572/,abstract,2,vip valeric trimethylsilyloxy simca researching ranking propanedioic opls multifactor hydroxybenzeneacetic hydracrylic forecast pca chromatograph pairwise wilcoxon orthogonal logistics graph chds whitney teratogenicity teratogenic rank discriminant mann uric separated trimester spectrometer sum principal fetus external substance reveal clearly square chd software foundation aromatic logistic gas partial fully urinary possibility advantage metabolomics fatty urine heart pregnancy parameter component maternal woman short second regression marker environmental chain prevention especially biomarkers defect ability relevant congenital design relationship score background infant healthy objective mass subject major mechanism respectively intervention rate amino conclusion sample case metabolism test risk model early control factor research population acid potential significant metabolic group high genetic method treatment analysis result,"{""urine"": {""freq"": 1, ""string"": [""fully urinary possibility advantage metabolomics fatty urine heart pregnancy parameter component m""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""amino"": {""freq"": 1, ""string"": [""subject major mechanism respectively intervention rate amino conclusion sample case metabolism t""]}}",{},{}
219,219,235,10.5935/1518-0557.20180044,29975498.0,methodssmall immediately biochemical sample ldh sulfhydryl culture dehydrogenase viability hour conclusionswe content size oxidant cryopreservation redox anti ovarian defense present lactate release protein resultsno fragmented rewarmed quality putative metal glutathione method vitrification post methodology potential radical trap tissue study large data bovine chamber specimen gsh antioxidant term effective furthermore objectivethe cultured safe human total parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106625/,abstract,1,rewarmed methodssmall ldh fragmented vitrification sulfhydryl cryopreservation trap resultsno gsh viability oxidant chamber bovine defense redox glutathione radical ovarian objectivethe lactate cultured metal immediately conclusionswe release specimen antioxidant putative safe culture dehydrogenase hour methodology anti post content parameter size furthermore tissue biochemical quality effective large total term sample present human potential protein method data study,{},{},{},{},{},{}
220,220,237,10.1016/j.jpeds.2018.03.032,29661562.0,logistic counseling record past better extremely intraventricular information early final strengthens profile nutrition neonatal weight conclusionsuse risk control evaluate significantly gestational physician designthis certificate clinical gestation metabolic live data furthermore tpn mortality singleton area regression use case variable death refine curve strong able inclusion week ivh model day via abbreviation auc postnatal mother association network receiver discharge operating age hemorrhage within resultsthe newborn survival premature explanatory birth category hospital characteristic stepwise metabolomics research available infant multiple nrn roc california pattern study objectiveto inform performance total parenteral metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016556/,abstract,12,tpn strengthens nrn ivh intraventricular conclusionsuse california refine designthis certificate hemorrhage explanatory discharge stepwise parenteral counseling singleton roc auc postnatal operating live gestation receiver final extremely abbreviation premature curve objectiveto inform logistic gestational survival physician record resultsthe category able strong past mother metabolomics nutrition network inclusion death evaluate mortality profile pattern variable regression weight neonatal hospital furthermore week characteristic birth performance better area metabolite infant day multiple association use information total newborn case available significantly risk model early control research age metabolic data clinical study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""day multiple association use information total newborn case available significantly risk m""]}}",{},{}
221,221,238,10.1016/j.ymgmr.2019.100498,31384561.0,disorder blood delta sole better neurotoxic factor early exhibit median slightly neuropsychologist mean testing control accumulation classical evaluate pku longitudinal phe treatable phenylalanine life moderate observed achievement range verbal modeling metabolic subscales data change long type metabolism regression level suboptimal significant normal child evaluation outcome socio phenylketonuria determination parent second test school network year diet age sample two multivariate continuously professional category influence quality cognitive analysis environmental etpku conclusion study patient though underwent performance total number statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664159/,abstract,1,delta neuropsychologist etpku subscales neurotoxic sole modeling socio suboptimal achievement verbal continuously underwent slightly exhibit multivariate treatable school determination longitudinal classical category statistically moderate accumulation network evaluate median professional observed second regression mean environmental influence evaluation parent performance testing better cognitive phe normal long change range quality diet life total pku outcome conclusion sample phenylketonuria number metabolism test early phenylalanine control factor blood type child age significant metabolic year data level disorder analysis patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""sample phenylketonuria number metabolism test early phenylalanine control factor blood type c""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""phe normal long change range quality diet life total pku outcome c""]}}",{}
222,222,239,10.3389/fnins.2017.00743,29367843.0,various disorder sporadic encoding factor pathway parkinsonism several homeostasis condition molecular common facilitate risk neurodegenerative underlying disease uncertain neuronal successively knowledge decade however family evidence previous clinical protein particular familial attention effect basis initiate combination genetic cellular death current failure many review modulatory alzheimer integratory second similarity neuropathological argue cell devastating still two likely chaperone since function precise parkinson environmental aberrant hsp gene mitochondrial versatile,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767785/,abstract,1,successively modulatory integratory hsp parkinsonism devastating aberrant neuropathological initiate versatile sporadic parkinson uncertain familial chaperone argue similarity encoding precise alzheimer neurodegenerative neuronal underlying facilitate mitochondrial failure homeostasis decade cellular death previous basis particular second likely combination attention environmental knowledge various pathway molecular family evidence current condition common cell function risk factor review protein gene effect genetic disorder clinical disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""likely combination attention environmental knowledge various pathway molecular family evidence current c""]}}",{},{},{}
223,223,240,10.1111/bph.13354,26650445.0,major tool record greater content information time nomenclature www knowledgebase detailed view open facilitate survive conjunction material ion summary bph related channel pharmacological pharmacology previous protein consolidates guidance doi property link data reference receptor late official eight website com full catalytic one nuclear update transporter format others drug database wiley point suggestion concise permanent guidetopharmacology separately target voltage landscape guide key hormone detail best onlinelibrary iuphar version overview alongside appropriate access order comparison previously constantly citable available grac plus classification human org contemporary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718211/,abstract,1,grac consolidates survive onlinelibrary iuphar guidetopharmacology citable bph knowledgebase concise nomenclature constantly com wiley contemporary voltage website format separately pharmacology official alongside suggestion org permanent channel landscape update conjunction ion guidance www catalytic detailed plus doi transporter guide classification summary facilitate link view record nuclear hormone pharmacological overview access late receptor open reference content property best appropriate previous comparison point database greater previously related order target tool major drug version key information material available time human protein data,{},{},{},{},{},{}
224,224,241,10.1038/ijo.2017.164,28792489.0,agonist physiological vivo greater exert stc gut glucose chronically weight homeostasis anorectic aromatic objective intake phe utility intra however phenylalanine evidence pharmacological obesity role protein mouse body peptide primary food result like effect data hpds oral ileal rat macronutrients gastrointestinal administration release provide regulation method therapeutic work via system glucagon loss tolerance treatment rich hormone diabetes diet rodent cell blockade exact obese casr unclear determine appetite acutely sensing mechanism ghrelin vitro tract also conclusion plasma high satiety glp insulin acid human digestion amino calcium,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678004/,abstract,0,stc ileal hpds casr anorectic sensing macronutrients glp ghrelin agonist digestion blockade glucagon rodent exert appetite acutely satiety exact chronically intra release gut calcium obese gastrointestinal tract rich tolerance aromatic insulin peptide physiological hormone homeostasis pharmacological unclear rat diabetes glucose oral utility obesity vitro vivo administration regulation work weight loss intake greater determine provide like mouse body food phe objective plasma primary therapeutic mechanism diet evidence amino conclusion role cell human phenylalanine acid protein effect high method data treatment result,"{""phenylalanine"": {""freq"": 2, ""string"": [""evidence amino conclusion role cell human phenylalanine acid protein effect high m""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""plasma primary therapeutic mechanism diet evidence amino conclusion role cell human p""]}}","{""diet"": {""freq"": 1, ""string"": [""phe objective plasma primary therapeutic mechanism diet evidence amino conclusion role c""]}}",{}
225,225,242,10.1038/s41598-019-49685-x,31506554.0,tool disorder iem absolute lead physiological single information congenital abnormal time country adult set efficient onset iems homogeneous trimethylamine trimethylaminuria number accumulation disease enough amount subject marker verified range neonate probability error basque inborn thus metabolic existence large psychological urine quantification late term demise metabolism non detection one toxic normal child population identification nmr potential concentration substantial strongly accessible adequately sequel predictive rare sample newborn spectroscopy irreversible healthy function invasive analysis metabolomics routinely episode diagnostic high ketosis powerful even derive absence another individual readily metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736868/,abstract,3,sequel demise basque trimethylaminuria ketosis verified trimethylamine homogeneous derive adequately absolute existence readily probability episode routinely nmr irreversible accessible iems neonate spectroscopy quantification set powerful invasive toxic psychological substantial strongly predictive absence physiological efficient late metabolomics iem accumulation abnormal urine marker lead onset congenital identification diagnostic country detection inborn metabolite tool normal healthy subject range error large single adult rare information concentration newborn term non function sample number metabolism individual time population potential child metabolic high disorder analysis disease,"{""urine"": {""freq"": 1, ""string"": [""efficient late metabolomics iem accumulation abnormal urine marker lead onset congenital i""]}}",{},{},"{""detection"": {""freq"": 1, ""string"": [""lead onset congenital identification diagnostic country detection inborn metabolite tool normal h""]}, ""newborn"": {""freq"": 1, ""string"": [""large single adult rare information concentration newborn term non function sample n""]}}",{},{}
226,226,243,10.1111/acer.13152,27419377.0,repeatedly beverage self whether lead methodsparticipants dos greater energy laboratory investigate risk soft increase amount consumer heavy session animal subject evidence possible rating variety questionnaire mixed consistent double alone caffeine result property backgroundconsumption purpose design versus combination administration drinker placebo dose drug breath day episodic social conclusionsthis test drink binge finding desire within likely subjective vodka consumption mixer high study alcohol blind rewarding beyond participant gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390898/,abstract,3,rewarding mixer episodic backgroundconsumption vodka methodsparticipants caffeine binge desire soft repeatedly drinker breath subjective heavy drink alcohol session rating dos consumer conclusionsthis beverage mixed blind placebo versus gender double variety consumption energy dose administration property consistent animal questionnaire likely lead combination self purpose investigate greater social laboratory design finding participant possible subject day drug increase evidence test risk high result study,"{""breath"": {""freq"": 1, ""string"": [""caffeine binge desire soft repeatedly drinker breath subjective heavy drink alcohol s""]}, ""social"": {""freq"": 1, ""string"": [""lead combination self purpose investigate greater social laboratory design finding participant p""]}}",{},{},{},{},{}
227,227,244,10.1007/8904_2016_572,27246466.0,biological blood availability ptps activity nationwide progressive time dihydropteridine essential laboratory present deterioration necessary liquid synthase tetrahydrobiopterin condition severe missense institute dhpr addition urinary disease hydroxylase pku measurement carbinolamine phenylalanine form pcd clinically mol reductase tetrahydropterin result diagnosis reference cause cyclohydrolase novel first hpa level case biopterin mutation implementation pyruvoyl phenylketonuria pasteur national test neopterin spectrophotometry care gtpch deficient two transient iran biochemistry newborn hyperphenylalaninemia pterin neurologic differential deletion kinetic previously benefit program gtp pah biomdb plasma different high study deficiency patient performance chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355377/,abstract,8,pasteur biomdb spectrophotometry neopterin carbinolamine ptps pcd tetrahydropterin pyruvoyl gtpch dhpr pterin nationwide dihydropteridine deterioration kinetic biopterin biochemistry reductase neurologic institute cyclohydrolase gtp transient hpa progressive iran synthase differential deletion urinary missense deficient hyperphenylalaninemia mol availability reference liquid tetrahydrobiopterin chromatography clinically necessary implementation pah national measurement previously essential biological laboratory benefit hydroxylase performance severe form addition plasma program cause deficiency novel care newborn activity mutation pku condition phenylketonuria present case test time phenylalanine blood diagnosis different high level result patient disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""condition phenylketonuria present case test time phenylalanine blood diagnosis different high l""]}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""plasma program cause deficiency novel care newborn activity mutation pku condition p""]}}",{},{}
228,228,245,10.3390/nu9050489,28498348.0,modify nutrient condition unfortunately derivative trimethylamine toxin fruit risk accumulation caramboxin disease physician microbiota evidence star indoxyl result bacteria effect potentially use level phosphatidylcholine ckd death alike toxic tmao others processing outcome choline indole causal development maneuver supplement association diet process component future acetic uremic chronic aware cresyl precursor cardiovascular tryptophan also nutritional oxide acid dietary patient absorption counter carnitine number kidney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452219/,abstract,0,star maneuver indoxyl cresyl ckd caramboxin counter uremic tmao phosphatidylcholine indole alike trimethylamine acetic modify choline toxin unfortunately aware carnitine fruit derivative absorption microbiota supplement processing causal kidney bacteria oxide toxic tryptophan physician cardiovascular precursor nutrient accumulation death potentially component nutritional chronic process future association use diet dietary evidence outcome condition number risk acid development effect level result patient disease,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""nutritional chronic process future association use diet dietary evidence outcome condition n""]}}",{}
229,229,246,10.1186/s13023-016-0392-4,26920579.0,methodstwo availability daily responsibility information tertiary take platform median increasingly equates affordability cost average usd course control orphan funding disease survey material respectively joint backgroundorphan medical however supplementary price resident recent caput enterprise user generic expense china data middle low chinese international level homoharringtonine seven market three government periodic measure per drug economic provide prevent suggestion model private conclusionsthe day rural diagnose japan system dispensary online article treatment electronic calculated net year materialthe overview rare component incentive public within efficiently access income comparison approximately resultsorphan basic hospital aim available reduce unaffordable also pocket except policy urban high study whereas extent maker patient insurance healthcare treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769558/,abstract,8,unaffordable homoharringtonine equates enterprise dispensary backgroundorphan resultsorphan methodstwo price periodic incentive caput usd pocket expense affordability responsibility funding resident joint japan insurance suggestion diagnose urban private maker generic net efficiently calculated tertiary orphan market government rural income middle reduce chinese extent china basic course conclusionsthe overview access treat platform increasingly economic availability seven daily healthcare approximately international average prevent policy median component survey hospital comparison cost materialthe provide public aim measure supplementary day user drug electronic online medical recent rare respectively information material article low available model control year high data level treatment patient disease study,{},{},{},{},{},{}
230,230,247,10.1038/s41598-018-29769-w,30054539.0,resonance quick measurement suitable naoh homogentisic mass acetic nuclear accelerated hypochlorite absorbance spectroscopy order oxidant oxidation easy screening hga alkaptonuric strong hydroxide time sensitivity present sensitively alkalization alkaptonuria reaction liquid brown spectrometric bqa alkali characteristic sodium spectrometry method due tof nmr diagnosis recently naocl study dark magnetic urine acid addition patient benzoquinone solution absorption flight spectrometer useful spectrum chromatography peak detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063975/,abstract,2,sensitively naocl hypochlorite hydroxide hga bqa benzoquinone alkaptonuric alkalization alkali absorbance naoh dark acetic oxidant homogentisic tof spectrometric brown accelerated quick alkaptonuria flight spectrometer easy peak absorption nmr sodium spectroscopy oxidation resonance suitable solution nuclear strong magnetic liquid urine chromatography useful reaction recently sensitivity measurement spectrometry characteristic order spectrum detection screening addition mass present time diagnosis acid method patient study,"{""urine"": {""freq"": 1, ""string"": [""suitable solution nuclear strong magnetic liquid urine chromatography useful reaction recently s""]}}",{},{},"{""detection"": {""freq"": 1, ""string"": [""sensitivity measurement spectrometry characteristic order spectrum detection screening addition mass present t""]}, ""spectrometry"": {""freq"": 1, ""string"": [""chromatography useful reaction recently sensitivity measurement spectrometry characteristic order spectrum detection s""]}, ""screening"": {""freq"": 1, ""string"": [""measurement spectrometry characteristic order spectrum detection screening addition mass present time d""]}}",{},{}
231,231,248,10.1016/j.toxrep.2015.11.009,26722641.0,experimental new cat cooperation workable behavior common chemical archival practical control dog concept disease primate longitudinal spectrum paradigm suitable sequence knowledge animal prototype cumulative quantitative repository exposome health affordable global burden body science support result integration data pet household complement marmoset theory sustain investment genetic international non hrm surveillance biologic short step scientific external prediction structure provide outcome point naturally inclusion approach toward analyze geography model management simple development exposure system article success response important network systematic refreshingly predictive universal component definition monitoring advance sample dauntingly opportunity complementary connects healthy space analysis adverse environmental salient partition metabolomics routinely available research broad relatively also multiple foundation upon high study successfully human sequencing resolution complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692045/,abstract,0,workable sustain refreshingly partition dauntingly connects archival repository geography cat salient marmoset hrm dog prototype pet exposome biologic primate investment household naturally cooperation affordable space external cumulative complement analyze routinely complementary theory surveillance paradigm definition foundation universal integration successfully practical broad success resolution prediction longitudinal suitable predictive chemical simple monitoring scientific burden metabolomics concept relatively experimental opportunity network science international inclusion advance systematic step sequence global component adverse quantitative short animal behavior exposure environmental structure point sequencing provide knowledge spectrum body support healthy management multiple complex response outcome non article important common sample approach available new human model control research development health high genetic data analysis result disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""model control research development health high genetic data analysis result disease s""]}}",{},{},{},{}
232,232,250,10.2147/DNND.S143989,30050383.0,implication erythrocyte lateral blood disorder relationship activity tool assessment memory among bradykinesia time condition molecular variation neurodegenerative motor control spta disease membrane neuronal quantitative reduction recent observed neurodegeneration dementia dysfunction clinical role protein real particular speculate ataxia movement thus integrity like nka furthermore significant pcr sclerosis current many highlighted pathological expression detail western cell sample amyotrophic spectrin function culminating impairment parkinson blot study similar atpase patient,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053092/,abstract,0,spta spectrin nka culminating bradykinesia amyotrophic speculate atpase ataxia neurodegeneration lateral highlighted dementia erythrocyte blot parkinson sclerosis integrity pathological membrane western movement neurodegenerative neuronal pcr real memory motor particular observed implication quantitative reduction impairment dysfunction variation furthermore like relationship similar assessment tool expression molecular recent activity current condition role cell function sample time control blood protein significant disorder clinical patient disease study,{},{},{},{},{},{}
233,233,252,10.1098/rstb.2017.0229,29786563.0,various eliminates disorder availability defect native need effective well disease issue however possible designer clinical therapy achievement replacement possibility like metabolic hepatocyte specie furthermore combination type far hepatocytes theme whole case lab engraft hepatic end preclinical provide fully organoids liver target stage people potential futuristic shortage article treatment limit cell option donor near overview future application standard function stem alternative transplantation different tissue biomaterial part parenchyma human limitation safe gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974451/,abstract,0,futuristic engraft biomaterial parenchyma organoids eliminates designer shortage achievement native preclinical lab hepatocytes donor near stem safe theme transplantation hepatic replacement specie fully far hepatocyte overview limit possibility end people option availability limitation alternative stage liver combination furthermore tissue defect provide like issue need target standard possible various application effective future therapy article cell function case human type potential different metabolic gene disorder treatment clinical disease,{},{},{},{},{},{}
234,234,253,10.1002/prot.24605,24833420.0,redundant significant lab alter cross within evidence example estrogen pharmaceutical likely local inhibitor molecule drug structure clinical database soluble protein site phosphorylation currently pdb framework eukaryotic available frequency bank method frequently multiple target phosphositeplus propose highlight efficacy interaction effect study alpha data fraction small little well mammalian receptor affinity near non,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233198/,abstract,1,pdb phosphositeplus eukaryotic redundant bank estrogen soluble phosphorylation alter affinity lab mammalian near pharmaceutical alpha fraction inhibitor propose local receptor little framework frequently molecule site efficacy example likely cross structure database currently highlight frequency small target interaction multiple drug evidence non available protein significant effect method data clinical study,{},{},{},{},{},{}
235,235,254,10.1038/s41598-017-06462-y,28754886.0,specific assessment two mutation whether one least percentage definite lower examine determine essential positive higher sensitivity value overall loading compound responsiveness ppv initial approach concordance cutoff characteristic molecular characterization obviate sum genotype pah responder result diagnostic thus test predictive good data chinese extent response deficiency patient null specificity status genetic responsive assay accuracy consistently option presence non,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533732/,abstract,2,obviate ppv definite null cutoff sum responsiveness responder loading concordance consistently responsive characterization percentage chinese examine extent predictive initial option accuracy genotype specificity good compound assay sensitivity pah presence essential determine characteristic status overall diagnostic assessment positive value response lower molecular deficiency mutation higher non approach test specific genetic data result patient,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
236,236,255,10.1016/j.cub.2016.06.061,27498566.0,level male curb specific related animal suppression activity subject neuron amine female wild suggest neuromodulator biogenic profound conclude dopamine inferior enigmatic influence role fly preference brain behavior impact drive neuromodulators mutant tyrr elevation slope artificial fruit tyrrgal melanogaster loss effect hyperactivation large high control collection courtship receptor increase neuromodulatory inhibitory type tyramine absence drosophila complex serf whose,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021585/,abstract,0,tyrrgal neuromodulator hyperactivation curb courtship tyrr neuromodulatory neuromodulators enigmatic tyramine slope inferior melanogaster fly biogenic serf drive amine drosophila conclude suppression suggest artificial fruit neuron profound inhibitory elevation preference absence wild receptor mutant dopamine collection female animal loss behavior influence related male subject complex increase large brain impact activity role specific control type effect high level,{},{},{},{},{},{}
237,237,256,10.1371/journal.pone.0175686,28426698.0,disorder blood chemistry class molecule glutamate across present malawian liquid central condition malaria due moreover highlight mechanistic physiology differentially glutamine disease significantly recurrent biochemical seizure later poorly form observed role compound fold global arginine report result basis change maximize lipid tandem mortality detection level dimethylarginine convalescence significant rate kynurenate ultra etiology abundant infection child many plasmodium day identification gas system concentration alteration coma library sample hemoglobin mass fdr survival falciparum explore neurologic function nervous analysis encephalopathy metabolomics spectrometry impact broad pathophysiology also arachidonic fever bioactive decreased comatose comprehensive plasma often high kyurenate acid small cerebral patient thirty amino performance accuracy total metabolite chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398544/,abstract,2,kyurenate kynurenate convalescence maximize malawian dimethylarginine comatose fdr falciparum decreased coma plasmodium malaria arachidonic fever glutamine ultra encephalopathy chemistry bioactive neurologic hemoglobin abundant library glutamate recurrent differentially thirty cerebral arginine physiology pathophysiology mechanistic poorly gas class broad seizure lipid survival nervous fold later etiology tandem metabolomics liquid infection alteration accuracy molecule explore comprehensive chromatography mortality global basis observed central compound spectrometry highlight identification biochemical small performance detection form metabolite mass plasma day change report impact rate concentration total amino condition role function sample present significantly blood acid child significant high level disorder analysis result patient disease,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""spectrometry highlight identification biochemical small performance detection form metabolite mass plasma d""]}, ""amino"": {""freq"": 1, ""string"": [""change report impact rate concentration total amino condition role function sample p""]}, ""tandem"": {""freq"": 1, ""string"": [""lipid survival nervous fold later etiology tandem metabolomics liquid infection alteration a""]}, ""spectrometry"": {""freq"": 1, ""string"": [""mortality global basis observed central compound spectrometry highlight identification biochemical small p""]}}",{},{}
238,238,257,10.3390/nu10050634,29772833.0,rate however mass milk growth fortifier single difference per content centre standard breast time higher despite protein outcome circumference weight week aim characteristic body gestation day infant ebm primary head trial ass preterm group high length effect study baseline human similar proportion increase hmf doe intake entry,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986513/,abstract,4,hmf fortifier ebm entry gestation circumference breast head preterm milk length centre doe proportion baseline content weight intake growth despite ass week characteristic standard similar body aim infant mass day trial primary increase single rate outcome higher difference time human protein group effect high study,{},{},{},{},{},{}
239,239,258,10.3389/fimmu.2018.02691,30515168.0,tregs inquiry collagen ifn pathway probiotic express diseased source regulatory severity increase disease respectively joint family unique protection ccr anti role play fold mouse bregs autoimmune property thus receptor oral recombinant cia administration progression cytokine therapeutic arthritis development influx potential treatment incidence therapeutically cell feasibility inflammatory dairy strain lactococcus production order pivotal function effectively responsible dedicated act foxp neutrophil previously benefit suppress relatively larger induction study abruptly newly show,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255909/,abstract,0,lactococcus foxp cia ccr bregs abruptly tregs inquiry diseased ifn therapeutically neutrophil influx collagen arthritis suppress pivotal probiotic express dedicated autoimmune joint dairy induction strain protection newly cytokine recombinant feasibility effectively act responsible progression larger fold anti receptor severity relatively oral unique inflammatory production play administration regulatory property incidence source previously benefit order mouse increase therapeutic pathway family respectively role cell function potential development treatment disease study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""previously benefit order mouse increase therapeutic pathway family respectively role cell f""]}}",{},{},{}
240,240,259,10.1016/j.rppede.2016.05.001,26979103.0,neural discus intestinal enterocolitis congenital nutrition segment ileum condition due severe difficulty old course motor remains objective disease month presence reduction possible form hirschsprung clinical obstruction hypovolemic examination diagnosis malnutrition postoperative colonic numerical case functional physiopathological morbidity description remnant comment management permanent differentiate enteral plausible shock alteration ganglionic associated proximal cell plexus two pathogenetic interstitial function aganglionic dependent reduced mechanism bowel characteristic infant episode classic aganglionosis dysmotility surgical patient connection total parenteral number resection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5178128/,abstract,1,remnant physiopathological hypovolemic ganglionic enterocolitis colonic aganglionic resection plexus obstruction ileum hirschsprung aganglionosis postoperative pathogenetic numerical dysmotility shock malnutrition interstitial enteral differentiate comment remains parenteral segment proximal plausible permanent description intestinal connection bowel episode surgical neural classic course reduced examination difficulty motor morbidity nutrition alteration associated dependent old reduction presence congenital functional characteristic discus severe possible form month infant objective management mechanism total condition cell function number case diagnosis clinical patient disease,{},{},{},{},{},{}
241,241,260,10.1186/s12881-016-0300-8,27176039.0,specific early autosomal methodsthis neonatal reproductive molecular heterogeneous uridyltransferase motor classical well disease material jaundice spectrum galactose supplementary introduction possible dysfunction user clinical doi galt error inborn diagnosis six enzyme effect date late novel type metabolism seven intolerance backgroundclassical mutation main one certain standpoint duarte failure population review liver conclusionsthis online test article treatment electronic hundred version materialthe brazil resultsthe galactosemia variant typically brazilian recessive reinforces routinely available program importance also del different high study dietary deficiency patient complication gene individual depicts miscegenation founder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866286/,abstract,2,uridyltransferase miscegenation duarte backgroundclassical standpoint galt depicts reinforces jaundice intolerance del galactosemia galactose founder brazilian routinely brazil conclusionsthis reproductive heterogeneous doi methodsthis typically introduction failure classical resultsthe complication late seven recessive motor certain date autosomal neonatal liver dysfunction materialthe importance main spectrum possible inborn enzyme supplementary program user version variant electronic error online molecular deficiency dietary novel mutation material article available metabolism test individual early specific type diagnosis population review different gene effect high treatment clinical patient disease study,{},"{""autosomal"": {""freq"": 1, ""string"": [""late seven recessive motor certain date autosomal neonatal liver dysfunction materialthe i""]}, ""recessive"": {""freq"": 1, ""string"": [""failure classical resultsthe complication late seven recessive motor certain date autosomal n""]}}",{},{},{},{}
242,242,261,10.1186/s13023-018-0890-7,30157945.0,disorder example better search backgroundphenylketonuria difference early behavioral present selection researcher necessary additional literature due severe classical doe pku neurological material escape however seizure phenylalanine supplementary dysfunction user brain disturbance mol symptom result diagnosis nowadays contrast data psychological reference symptomatology genetic untreated extraction case although full least independent pubmed sense normal methodsto outcome damage review inclusion unexpected identification resultsin september disability concentration article online treatment electronic year finding list version materialthe age within two favorable conducted picture embase obligatory authorized start criterion analysis available also intellectual plasma often high study successfully patient rarely total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116368/,abstract,4,obligatory escape unexpected symptomatology nowadays methodsto start sense pubmed picture conducted september rarely favorable backgroundphenylketonuria resultsin embase disturbance authorized extraction psychological list successfully untreated seizure researcher damage classical doe mol reference behavioral independent selection inclusion contrast search neurological intellectual necessary example criterion dysfunction disability materialthe identification additional finding better literature severe symptom supplementary normal plasma user version electronic online brain concentration total pku material outcome article difference present case available early phenylalanine diagnosis review age year high genetic data disorder treatment analysis result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""article difference present case available early phenylalanine diagnosis review age year h""]}, ""neurological"": {""freq"": 1, ""string"": [""behavioral independent selection inclusion contrast search neurological intellectual necessary example criterion d""]}, ""intellectual"": {""freq"": 1, ""string"": [""independent selection inclusion contrast search neurological intellectual necessary example criterion dysfunction d""]}, ""behavioral"": {""freq"": 1, ""string"": [""researcher damage classical doe mol reference behavioral independent selection inclusion contrast s""]}}","{""genetic"": {""freq"": 1, ""string"": [""phenylalanine diagnosis review age year high genetic data disorder treatment analysis r""]}}",{},{},{},{}
243,243,262,10.1055/a-0624-2266,30083580.0,male multicenter new affect acceptance ottawa parallel colonoscopy ascorbic effective solution respectively related event compliance observer adequate observed citrate clinical equivalence primary equivalent equally distress clensia mild reference visibility strictly term pmf tolerability low level full rate per end volume dose peg point product method moviprep safety mucosal regimen year phase randomized split age protocol asc scale quality inspection analysis adverse background aim bowel simethicone also trial conclusion group high study acid blind patient safe evening highly successful preparation acceptable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070370/,abstract,11,visibility simethicone pmf moviprep clensia observer equivalence asc split ottawa mucosal evening tolerability strictly multicenter inspection citrate ascorbic colonoscopy equally distress acceptance peg bowel regimen randomized safe equivalent preparation blind acceptable parallel compliance adequate solution end safety affect successful reference mild event protocol volume dose phase adverse observed point product highly scale related male background aim trial primary quality effective respectively rate conclusion term low new acid age group year high method level clinical analysis patient study,{},{},{},{},{},{}
244,244,263,10.1136/bcr-2015-211106,26670891.0,consensus nephromegaly however survival early timing insufficiency aggressive centre bilateral nutrition renal optimal autosomal present clinical nephrectomy therapy pulmonary neonatal role complicated replacement management condition infant expertise polycystic severe massive minimise report supportive following dialysis arpkd peritoneal experience mortality patient disease month decision challenge complex kidney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680283/,abstract,1,peritoneal nephromegaly nephrectomy arpkd following dialysis polycystic minimise aggressive supportive massive timing insufficiency expertise bilateral pulmonary complicated kidney renal consensus replacement centre survival optimal nutrition decision autosomal experience mortality neonatal severe month infant management challenge complex report therapy condition role present early clinical patient disease,{},"{""autosomal"": {""freq"": 1, ""string"": [""replacement centre survival optimal nutrition decision autosomal experience mortality neonatal severe m""]}}",{},{},{},{}
245,245,264,10.1093/ije/dyy274,30544190.0,intelligence geoffrey inequality new difference lower context nutrition country socioeconomic despite increasingly fit view artificial gradient practical way disease status intake ignores latter recent obesity undesirable perspective clinical additionally preventive health distribution alone environment effect large epidemic cause guideline theory novel cultural expectation level case one interest advice size smartphone current economic intervention population unlikely approach social disproportionately plausible treatment obesogenic finding address incidence public application likely income scale caution political limited actor impact reduce also prevention group socially high right dietary small deliver thanks individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469305/,abstract,0,obesogenic ignores geoffrey undesirable deliver thanks actor political disproportionately caution unlikely socially smartphone inequality gradient epidemic expectation plausible socioeconomic cultural fit artificial advice intelligence theory preventive income reduce right practical view increasingly economic distribution guideline nutrition obesity additionally perspective address way size environment incidence likely limited context intake prevention social despite scale public small status country finding application cause large lower recent impact intervention dietary novel current difference approach case individual new population health group effect high level treatment clinical disease,"{""social"": {""freq"": 1, ""string"": [""incidence likely limited context intake prevention social despite scale public small s""]}}",{},{},{},{},{}
246,246,265,10.1111/cts.12590,30369069.0,logistic confidence age subset relationship two phenylalanine one newborn interval ratio screening curve profile several across function area tyrosine consistent grouping without odds characteristic leucine infant also ass stimulating group ornithine forty metabolic pattern auc thyroid testing study whereas hyperbilirubinemia hormone strongly objective receiver tsh thirty isoleucine gestational metabolite kernicterus regression operating,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342241/,abstract,0,kernicterus grouping hyperbilirubinemia ornithine stimulating tsh auc operating isoleucine receiver leucine thirty thyroid odds curve logistic gestational subset strongly hormone confidence interval profile pattern consistent regression tyrosine ass characteristic ratio relationship testing area metabolite infant screening objective newborn function phenylalanine age metabolic group study,"{""phenylalanine"": {""freq"": 2, ""string"": []}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""testing area metabolite infant screening objective newborn function phenylalanine age metabolic g""]}, ""screening"": {""freq"": 1, ""string"": [""ratio relationship testing area metabolite infant screening objective newborn function phenylalanine a""]}}",{},{}
247,247,266,10.1038/npp.2014.214,25249059.0,inhibits availability activity radiotracer dos difference patch presumably elevated mao addition formulation disease significantly deprenyl however equal subject evidence dopamine higher range zydis brain conventional indirect result antidepressant reach significance tomography selective oral first inhibition level selectivity although three zelapar size inhibitor emission transporter dose amphetamine day emsam clorgyline dat target system oxidase treatment sample irreversible healthy transdermal parkinson buccal currently also group plasma high study orally monoamine human direct small positron men metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289953/,abstract,6,zydis zelapar transdermal patch mao emsam deprenyl clorgyline buccal radiotracer amphetamine dat inhibits antidepressant presumably selectivity positron oxidase orally parkinson indirect reach men equal monoamine irreversible tomography emission formulation dos transporter conventional selective inhibitor significance inhibition availability elevated dopamine oral dose size direct currently small target metabolite healthy addition subject plasma day range brain activity evidence higher difference sample significantly human group high level treatment result disease study,{},{},{},{},{},{}
248,248,267,10.1016/j.ymgme.2017.06.005,28645531.0,entire relationship bulk neurotoxic among defect present despite throughout native without additional view severe missense common state encode accumulation concept disease pku hydroxylase neurological perturb phe catalytically phenylalanine pharmacological restore dysregulation defective therapy protein error genotype inborn thus stability design hpa metabolism non level mutation phenotype refine others structure discovery intervention damage point phenylketonuria permanent therapeutic work dead concentration success architecturally help alternate variant opportunity hyperphenylalaninemia healthy chaperone function departs pah foundation often equilibrium acid human truncation dietary distinct inhibitory amino individual preventing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549558/,abstract,1,perturb departs dead architecturally truncation encode refine preventing catalytically bulk alternate restore neurotoxic dysregulation defective equilibrium permanent native chaperone inhibitory entire hpa foundation success stability missense view hyperphenylalaninemia distinct damage pharmacological discovery concept accumulation opportunity genotype neurological help work pah structure point defect despite design hydroxylase additional phenotype relationship severe inborn phe healthy state variant error therapeutic intervention dietary therapy concentration mutation pku amino non common function phenylketonuria present metabolism individual human phenylalanine acid protein level disease,"{""phenylalanine"": {""freq"": 2, ""string"": []}, ""neurological"": {""freq"": 1, ""string"": [""pharmacological discovery concept accumulation opportunity genotype neurological help work pah structure p""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""intervention dietary therapy concentration mutation pku amino non common function phenylketonuria p""]}}",{},{}
249,249,268,10.3390/ijms20092115,31035684.0,various specific disorder blood chain relationship tool autism new trigger oxidative probiotic homeostasis moreover bacterial tight unbalanced well origin establish spectrum microbiota phenylalanine dysbiosis strategy possible observed dysfunction value health compound brain focus amygdala cerebellum integrative body symptom structural represent link effect change cause perturbation metabolism junction level gastrointestinal yet stress although asd short biomarkers problem abundant side child point many therapeutic people potential scfas indoles free alteration response fatty altered cell particularly production mostly mechanism paper research consumption also leakage diagnostic autistic acid barrier leaky patient hippocampus individual metabolite mitochondrial explains,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539237/,abstract,0,unbalanced leaky leakage indoles dysbiosis junction scfas represent explains cerebellum tight probiotic amygdala perturbation autistic abundant trigger integrative altered hippocampus microbiota gastrointestinal establish bacterial origin mitochondrial link oxidative barrier homeostasis asd consumption people structural alteration production fatty autism observed short stress compound focus dysfunction point free chain biomarkers particularly problem paper relationship spectrum diagnostic possible various body symptom metabolite tool change cause strategy value response therapeutic brain mechanism cell metabolism individual new phenylalanine specific blood research acid potential child health effect level disorder patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""brain mechanism cell metabolism individual new phenylalanine specific blood research acid p""]}}",{},{},{},{},{}
250,250,269,10.1002/2211-5463.12175,28174686.0,phenylalanine catalytic pepxa mbp physiological form monomeric aggregation compatible structure srep soluble protein site conformationally allosteric crystal metastable hpah dimer act fold structurally mutant pah homodimeric state potential dimeric domain study concentration patel regulatory human addition arrangement fusion mammalian hydroxylase inhibited rep stereospecifically low sci phe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292662/,abstract,0,stereospecifically srep sci rep pepxa patel metastable mbp hpah monomeric inhibited homodimeric conformationally dimeric structurally compatible fusion arrangement soluble dimer allosteric crystal mammalian catalytic aggregation act physiological fold mutant domain regulatory site pah structure hydroxylase form phe addition state concentration low human phenylalanine potential protein study,"{""phenylalanine"": {""freq"": 2, ""string"": []}}",{},{},{},{},{}
251,251,270,10.1002/btm2.10090,30065971.0,overcome soon respect decade talent future market two past subject challenge one approval meet order end bioengineers technical time current others failure clinical therapy release provide field hurdle able review manufacturing research particular translation primary literature fda also additional state social practice august biotechnology article success practical vector viral year first status help gene overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063870/,abstract,0,talent manufacturing bioengineers overcome hurdle soon meet biotechnology august fda approval market release respect viral technical vector practical success translation failure overview end able past decade particular help practice social provide additional order status field literature state subject challenge primary future therapy current article time research review gene year clinical,"{""social"": {""freq"": 1, ""string"": [""able past decade particular help practice social provide additional order status f""]}}",{},{},{},{},{}
252,252,271,10.1253/circj.CJ-15-0064,25746522.0,stress pathogenesis still diastolic least poor observation new lead crucial form oxidative dysfunction failure clinical largely heart despite role play systolic review disappointing therapeutic emphasis diagnostics trial pathology general potential diagnosis different ejection treatment fraction concept experiment patient disease successful epidemiology number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861951/,abstract,0,ejection disappointing diastolic systolic epidemiology emphasis diagnostics observation pathogenesis crucial experiment fraction pathology largely oxidative failure successful concept play poor heart stress dysfunction lead despite general form trial therapeutic role number new diagnosis review potential different treatment clinical patient disease,{},{},{},{},{},{}
253,253,272,10.3390/molecules21050609,27171069.0,process excess selenoprotein element within cancer one micronutrient much selenium protection recent difference content organism problem slight carefully defense proper occurrence gland trace necessary reproductive increasingly mechanism metal regulation therefore detoxification method also supplementation group property system different thyroid study large success anticarcinogenic antioxidant well immune deficiency solution year cell amount cautiously number synthesis heavy area,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274134/,abstract,0,anticarcinogenic selenoprotein cautiously slight detoxification defense trace heavy carefully selenium gland metal excess occurrence micronutrient protection antioxidant proper thyroid reproductive organism success element solution immune increasingly necessary content property regulation supplementation cancer synthesis problem process area large recent deficiency mechanism difference cell number different group year method study,{},{},{},{},{},{}
254,254,273,10.1186/s12874-016-0220-5,27639560.0,ileus registry coefficient whether growth factor early lower cystic time methodsthis deterioration promotes five onset fit resultsapplication meconium apart risk addition significantly material supplementary interval childhood recent screening user cox doi symptom methodology support fibrosis diagnosis recently effect data aeruginosa although rate problem dynamic infection child sign pseudomonas model conclusionsthe online article treatment electronic year finding care version backgroundpersistent ppa age two newborn survival unclear function analysis benefit framework available lung foundation nutritional cohort last study extent patient interesting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027124/,abstract,5,resultsapplication pseudomonas meconium ileus cox backgroundpersistent aeruginosa ppa promotes deterioration apart fit interesting lung registry cystic foundation doi sign methodsthis coefficient fibrosis survival dynamic extent conclusionsthe methodology unclear framework interval infection childhood recently nutritional onset growth problem cohort benefit finding symptom support supplementary screening addition user version electronic online lower recent care rate newborn material article function available time significantly risk model early factor diagnosis child age year effect data treatment analysis patient study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""electronic online lower recent care rate newborn material article function available t""]}, ""screening"": {""freq"": 1, ""string"": [""cohort benefit finding symptom support supplementary screening addition user version electronic o""]}}",{},{}
255,255,274,10.1155/2018/4806534,29511682.0,sweetener widespread world author incorporate without judiciously potassium state risk well objective intake stevia consumer scielo childhood form saccharin obesity health searcher food sweetness calorie aspartame type art english use acesulfame scientific imperative individually overall provide child around population product scopus plan sufficient article diet age earlier professional additive cyclamate portuguese subgroup noncaloric become benefit aim alternative consumption keywords prevention group different study spanish dietary sucralose show,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817296/,abstract,0,searcher noncaloric judiciously sucralose scielo cyclamate sweetness stevia spanish saccharin acesulfame portuguese potassium scopus incorporate imperative aspartame calorie sweetener english art additive individually widespread consumer earlier subgroup plan author sufficient keywords scientific consumption world obesity alternative professional childhood intake prevention product provide benefit overall food form aim objective state use diet dietary article risk type population child different age health group study,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""food form aim objective state use diet dietary article risk type p""]}, ""aspartame"": {""freq"": 1, ""string"": [""acesulfame portuguese potassium scopus incorporate imperative aspartame calorie sweetener english art a""]}}",{}
256,256,275,10.1038/gim.2016.198,28079899.0,information unpredictable autosomal adult prenatal preference serious condition onset additional pair watch testing rorc simplifies clinician publication preconception genet respect committee life evidence possible range therefore genomic result purpose mild date thousand type genetic span use one communication elect categorized exclusion taxonomy inclusion method online test help finding list generally january recessive limited category criterion previously framework keywords conclusion group disclosure sequencing patient categorization gene return,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509491/,abstract,8,watch rorc elect unpredictable simplifies genet categorized disclosure taxonomy categorization return preconception span exclusion pair committee thousand preference respect january list publication prenatal keywords generally category communication clinician recessive mild framework inclusion date autosomal genomic help criterion limited purpose onset sequencing previously additional testing finding possible range online adult use information life evidence conclusion condition test type gene group genetic method result patient,{},"{""autosomal"": {""freq"": 1, ""string"": [""clinician recessive mild framework inclusion date autosomal genomic help criterion limited p""]}, ""recessive"": {""freq"": 1, ""string"": [""prenatal keywords generally category communication clinician recessive mild framework inclusion date a""]}, ""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
257,257,276,10.1371/journal.pgen.1008145,31120900.0,potent monocyte pla lactic new vivo energy hcar trigger homeostasis condition molecular host bacterial toxin physiology source unravel hypothesis activation well disease measurement interplay microbiota third however beneficial understanding modulate evidence pharmacological anti permanently migration transiently extensively role health protein phenyllactic manner primary food report analytical bacteria metabolic effect hominid urine advantageous fermented receptor immune combination intestine level pertussis lab sauerkraut functional member crucial evolutionary provide discovery method system evolution plausible pharmacokinetic concentration alimentary assay hca still regulator two hydroxycarboxylic limited demonstrate consolidated function dependent analysis genome plasma different interaction high physiologically human acid dietary mammal highly metabolite sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532841/,abstract,0,sauerkraut phenyllactic pertussis hydroxycarboxylic hominid hcar fermented pla permanently alimentary monocyte hca transiently lactic consolidated advantageous migration evolutionary unravel physiologically modulate mammal toxin plausible intestine interplay pharmacokinetic trigger extensively lab host potent microbiota physiology evolution manner regulator bacterial bacteria crucial activation beneficial homeostasis pharmacological demonstrate immune analytical sensitive member anti receptor energy discovery hypothesis vivo urine genome dependent source understanding assay limited combination measurement highly provide functional interaction food metabolite plasma primary molecular report dietary concentration evidence condition role function new human acid different protein metabolic health effect high method level analysis disease,"{""urine"": {""freq"": 1, ""string"": [""anti receptor energy discovery hypothesis vivo urine genome dependent source understanding a""]}}",{},{},{},{},{}
258,258,277,10.1186/s41687-019-0106-5,30847606.0,logistic specific netherlands delay youth difference single lower among item adult bias behavior substance severe preterm course transition significantly gestational autonomy trajectory adulthood later life backgroundthe conclusionsa questionnaire achievement respondent developmental project great support colq effect first exploration score young non regression level antisocial use biased peer size girlfriend problem others population variance milestone development social online test gambling school response year age resultsthe adjustment scale analysis teenage benefit infant relatively psychosexual importance general group different cohort often study vulnerable boyfriend small psychosocial show individual total gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405782/,abstract,3,girlfriend gambling boyfriend antisocial teenage colq biased psychosexual autonomy youth exploration netherlands vulnerable conclusionsa milestone achievement trajectory adjustment substance item psychosocial peer respondent variance preterm school bias transition logistic gestational adulthood project backgroundthe young gender course resultsthe later delay great relatively size regression questionnaire behavior developmental social importance general problem scale cohort benefit small score severe support infant response online lower single adult use life total non difference test individual significantly specific population different age development group year effect level analysis study,"{""social"": {""freq"": 1, ""string"": [""girlfriend gambling boyfriend antisocial teenage colq biased psychosexual a"", ""achievement trajectory adjustment substance item psychosocial peer respondent variance preterm s"", ""relatively size regression questionnaire behavior developmental social importance general problem scale c""]}}",{},{},{},{},{}
259,259,279,10.5152/TurkPediatriArs.2016.3759,28123333.0,inheritance male conclusionthe disorder activity abnormality early positive autosomal country world methodsthis present elevated retrospective molecular common admission consanguineous evaluate disease material jaundice sepsis galactose cannot family screening charcteristics clinical developmental brain mol aimgalactosemia diagnosis enzyme absent cause tongue first genetic anywhere beutler metabolism period case four mutation three one main female phosphate denver marriage moleculer liver reason day frequently history hypoglycemia development stage national frequent resultsnine test carbohydrate else earlier galactosemia january recessive cataract order cumulates neurologic lens hospital characteristic program infant classic study skin deficiency patient uridylytransferase kidney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242248/,abstract,8,uridylytransferase tongue resultsnine moleculer cumulates charcteristics beutler aimgalactosemia denver lens hypoglycemia sepsis jaundice cataract galactosemia galactose absent phosphate neurologic marriage consanguineous admission carbohydrate retrospective inheritance skin reason earlier kidney methodsthis january conclusionthe classic frequent mol recessive elevated world frequently autosomal evaluate stage history female abnormality hospital liver national developmental male characteristic period main order country enzyme infant screening day program cause positive brain molecular deficiency family activity mutation material common present case metabolism test early diagnosis development genetic disorder clinical patient disease study,"{""skin"": {""freq"": 1, ""string"": [""marriage consanguineous admission carbohydrate retrospective inheritance skin reason earlier kidney methodsthis j""]}}","{""inheritance"": {""freq"": 1, ""string"": [""neurologic marriage consanguineous admission carbohydrate retrospective inheritance skin reason earlier kidney m""]}, ""autosomal"": {""freq"": 1, ""string"": [""frequent mol recessive elevated world frequently autosomal evaluate stage history female a""]}, ""recessive"": {""freq"": 1, ""string"": [""methodsthis january conclusionthe classic frequent mol recessive elevated world frequently autosomal e""]}, ""genetic"": {""freq"": 1, ""string"": [""case metabolism test early diagnosis development genetic disorder clinical patient disease s""]}}",{},"{""screening"": {""freq"": 1, ""string"": [""period main order country enzyme infant screening day program cause positive b""]}}",{},{}
260,260,280,10.3390/ijns4020016,29862374.0,implication disorder new describes across positive condition onset expert variation state specialist disease uniform screening follow clinical health consistent regional clinically burden identifies core report diagnosis link long united service use level significant case surveillance panel short death morbidity phenotype local prevent tracking approach confirmatory secretary identification determination development plan national iterative process rare consensus definition public designation along screen irreversible prevalence birth precursor program infant group diagnostic human categorization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978752/,abstract,0,designation secretary describes categorization tracking uniform identifies iterative confirmatory irreversible regional surveillance definition core specialist plan consensus determination link united screen expert local precursor burden morbidity panel prevent death clinically follow service implication short consistent national onset variation identification prevalence public phenotype birth diagnostic process infant screening state long program positive use report rare condition approach case new human diagnosis significant development health group level disorder clinical disease,{},{},{},"{""screening"": {""freq"": 1, ""string"": [""public phenotype birth diagnostic process infant screening state long program positive u""]}}",{},{}
261,261,281,10.1038/gim.2014.209,25674778.0,conclusionthe purposemany blood irt nine better region among cystic positive algorithm laboratory ppv five retrospective additional validation disease traditional sweat screening value consistent transmembrane project retrospectively fibrosis result prospective generation immunoreactive validate panel mutation one normal sensitivity correctly method ass technology test concordant methodsan assay feasibility specificity predictive regulator sample resultsthe two variant newborn spot screen next dna analysis infant foundation high study successfully isolated distinct,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802962/,abstract,6,purposemany irt immunoreactive ppv concordant methodsan sweat transmembrane correctly retrospectively isolated validate retrospective cystic foundation regulator feasibility algorithm fibrosis successfully conclusionthe project traditional validation screen predictive distinct prospective resultsthe panel specificity dna consistent assay sensitivity generation spot laboratory ass additional technology better region infant normal screening positive value variant newborn mutation sample test blood high method analysis result disease study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""infant normal screening positive value variant newborn mutation sample test blood h""]}, ""screening"": {""freq"": 1, ""string"": [""additional technology better region infant normal screening positive value variant newborn m""]}}",{},{}
262,262,282,10.1038/cr.2015.84,26169608.0,fibrogenesis interestingly lead factor early pathway duct positive homeostasis moreover dmn repressed activation elusive disease significantly promoter transcriptional transcription crosstalk circuit beneficial participates hepatocellular previous alleviates anti role play ligation primary report stellate fibrosis stat effect contrast hepatocyte rat inhibition hepatocytes significant dimethylnitrosamine jak nuclear involvement hepatic progression shp feedback damage intervention critical liver maintenance model markedly via mir expression hscs phosphatase impaired treatment key active hnf directly carcinoma deregulation cell bdl inflammatory bile fibrotic repression facilitates demonstrate function chronic either domain study human loop inhibitory,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528057/,abstract,0,stellate shp hscs fibrotic fibrogenesis duct dmn dimethylnitrosamine bdl alleviates repressed participates jak deregulation stat crosstalk repression phosphatase hepatocellular facilitates elusive ligation carcinoma mir feedback bile loop circuit inhibitory interestingly maintenance hepatocytes impaired hnf transcriptional promoter markedly hepatic fibrosis involvement hepatocyte activation beneficial progression transcription nuclear homeostasis damage inhibition demonstrate rat anti inflammatory active play directly domain contrast previous liver lead critical chronic expression primary positive key pathway report intervention role cell function significantly human model early factor significant effect treatment disease study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""critical chronic expression primary positive key pathway report intervention role cell f""]}}",{},{},{}
263,263,283,10.1186/1471-2458-14-1243,25471331.0,coefficient male mood specific disorder assessment past better backgroundphenylketonuria pedsqltm lower among criticality adult present student resultsglobal detailed multivariable due investigate risk classical covariates disease significantly pku status phe medical however life interval conclusionsboth compliance previous relaxation higher questionnaire therapy respondent range global unemployed bdi error inborn result length observational mild tad furthermore long type metabolism score regression level educational confidence normal current instrument intervention able model method predictor baseline sex tolerance treatment whoqol regimen diet education detect strain age within advance pediatric lifelong achieve category effectively psychiatric chronic quality employment avoidance also upon cohort study acid patient linear amino,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265392/,abstract,1,unemployed tad resultsglobal criticality whoqol pedsqltm multivariable employment conclusionsboth covariates bdi relaxation avoidance regimen mood strain backgroundphenylketonuria achieve lifelong student detect respondent detailed instrument coefficient tolerance length effectively observational educational compliance predictor sex psychiatric classical confidence category able linear past mild interval baseline education advance previous global pediatric regression questionnaire investigate furthermore chronic male cohort status score better assessment inborn phe normal long range error quality medical lower adult diet intervention therapy life current pku amino higher present metabolism significantly risk model specific type acid age method level disorder treatment result patient disease study,"{""psychiatric"": {""freq"": 1, ""string"": [""effectively observational educational compliance predictor sex psychiatric classical confidence category able l""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""diet intervention therapy life current pku amino higher present metabolism significantly r""]}}","{""diet"": {""freq"": 1, ""string"": [""range error quality medical lower adult diet intervention therapy life current p""]}}",{}
264,264,284,10.3390/genes9030136,29494564.0,inject among despite exclude efficient condition molecular homogeneous transfer injection effective dog close disease solution primate establish murine poorer animal organ strategy compatible clinical protein procedure hydrodynamic symptom hydrofection manner translate possibility rabbit adapt result mid effect large data crispr rat mediate level use construct rapid one revert interest size gold volume pig standardization side drug prevent evaluation sign able approach hamster model therapeutic work catheterization target expression potential vasculature edit hemodynamic delivery directly make order standard reduce translation group classic different tissue human surgical distinct safe gene pathologic parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867857/,abstract,0,revert inject hydrofection exclude edit catheterization rabbit pig hemodynamic hamster dog vasculature homogeneous mid construct adapt standardization primate hydrodynamic compatible translate pathologic make mediate crispr poorer gold surgical murine transfer manner close safe establish sign reduce injection classic translation organ solution efficient distinct possibility rat able volume procedure directly prevent parameter delivery size work animal rapid tissue evaluation despite order target standard symptom expression drug strategy therapeutic effective large molecular use condition approach human model potential different protein gene group effect data level clinical result disease,{},{},{},{},{},{}
265,265,285,10.1001/jamaophthalmol.2014.6115,25675413.0,splice blood chain exon dominant single participantscase abnormal autosomal site reaction restriction splicing accurate molecular pair common locus august testing control polymerase repeat origin disease retina netgene sequence transcription family marker unspecified capillary possible screening place clinical health protein southwest consistent haplotype science macular message result diagnosis university enzyme effect illegitimate design cause texas genetic tandem mutation variable main short ancestor conformational strand retinal etiology independently prediction digest white suggesting outcome highly pigmentosa product management therapeutic slow target potential frequent dystrophy polymorphism gel cell option donor measuresresults alternate transcript rare electrophoresis future within degeneration resultsthe variant iowa prph january likely prevalence peripheral determine approximately mechanism priority program also kilobase foundation conclusion polymorphic retinitis cycle high pattern study nucleotide objectiveto bidirectional assist center correction relevancethe participant gene individual founder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449732/,abstract,8,texas southwest relevancethe prph participantscase netgene measuresresults kilobase iowa illegitimate unspecified suggesting digest ancestor macular bidirectional alternate strand retinitis retina pigmentosa splice polymorphic dystrophy splicing message august transcript electrophoresis slow retinal gel conformational founder capillary degeneration assist polymerase pair haplotype repeat donor dominant priority correction foundation independently place peripheral origin objectiveto january locus accurate prediction exon university transcription resultsthe frequent etiology restriction option white nucleotide tandem polymorphism cycle abnormal approximately science autosomal center sequence reaction short pattern consistent variable site marker likely chain product highly determine design prevalence main testing target participant possible enzyme screening management program cause variant therapeutic future single molecular mechanism rare family mutation outcome conclusion common cell individual control blood diagnosis potential protein health gene effect high genetic clinical result disease study,{},"{""autosomal"": {""freq"": 1, ""string"": [""tandem polymorphism cycle abnormal approximately science autosomal center sequence reaction short p""]}, ""genetic"": {""freq"": 1, ""string"": []}}",{},"{""tandem"": {""freq"": 1, ""string"": [""frequent etiology restriction option white nucleotide tandem polymorphism cycle abnormal approximately s""]}, ""screening"": {""freq"": 1, ""string"": [""main testing target participant possible enzyme screening management program cause variant t""]}}",{},{}
266,266,286,10.1186/s12881-018-0635-4,29996803.0,disorder exon bioinformatics abnormal several autosomal defect pathogenicity homology deleterious bond pro moreover missense polyphen enzymatic modelling swissmodel brother mutationtaster material respectively synthesis sanger biochemical however later family supplementary provean partial screening confirm follow mainly user clinical coa protein crystal replacement feature instability academic complete mutant china mut transport enzyme cblb good mild generation novel furthermore epimerase type genetic sift chinese functional panel mutation ethnicity wild three dimensional proband software phenotype cbld structure subtype residue conclusionsthe mutase han older target via exome loss online article manifestation treatment electronic acidemia adenosyl version materialthe rare detect mmaa resultsthe methodsthe two variant causative newborn poor homozygous recessive intramolecular influence function elder younger next validated analysis characteristic available cobalamin relatively ala different study whereas hydrogen human backgroundmethylmalonic position deficiency cofactor gene performance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042273/,abstract,2,swissmodel provean mutationtaster mmaa intramolecular epimerase elder cbld cblb backgroundmethylmalonic adenosyl sift brother polyphen instability bond subtype proband mut modelling homology cobalamin pathogenicity mutase hydrogen ala han younger ethnicity deleterious bioinformatics confirm academic crystal sanger dimensional causative validated acidemia residue pro detect position software homozygous enzymatic transport replacement coa partial methodsthe chinese older exome missense manifestation exon china conclusionsthe wild resultsthe later complete cofactor mainly mutant recessive mild relatively panel abnormal autosomal poor follow good loss feature synthesis generation furthermore structure influence materialthe defect functional characteristic biochemical phenotype performance target enzyme supplementary screening user version variant electronic online deficiency rare family respectively novel newborn mutation material article function available human type different protein gene genetic disorder treatment clinical analysis study,{},"{""autosomal"": {""freq"": 1, ""string"": [""mutant recessive mild relatively panel abnormal autosomal poor follow good loss f""]}, ""recessive"": {""freq"": 1, ""string"": [""resultsthe later complete cofactor mainly mutant recessive mild relatively panel abnormal a""]}, ""homozygous"": {""freq"": 1, ""string"": [""acidemia residue pro detect position software homozygous enzymatic transport replacement coa p""]}, ""genetic"": {""freq"": 1, ""string"": [""available human type different protein gene genetic disorder treatment clinical analysis s""]}}",{},"{""newborn"": {""freq"": 1, ""string"": [""online deficiency rare family respectively novel newborn mutation material article function a""]}, ""screening"": {""freq"": 1, ""string"": [""biochemical phenotype performance target enzyme supplementary screening user version variant electronic o""]}}",{},{}
267,267,287,,30008556.0,service court although within four two allocation example desirable community rule health range approach remedy matrix widely broad also compartment general practice right varies substantive response procedural individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039723/,abstract,0,substantive remedy procedural court varies desirable allocation rule compartment matrix right broad widely community service example practice general range response approach individual health,{},{},{},{},{},{}
268,268,288,10.1098/rspb.2016.2759,28228517.0,caloric balance delay importantly energy lower maximum positive world liquid capacity reward cost trade relevant possible higher value distribution real probability task support result monetary decrease furthermore water rate crucial prediction block many model potential theoretical drink temporal decision future opportunity survival conditional quitting persistence estimate determinant analysis previously either alternative high physiologically study randomly participant individual dieting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5326537/,abstract,1,quitting dieting monetary caloric trade physiologically persistence theoretical temporal conditional drink reward maximum probability balance determinant block importantly randomly crucial survival real prediction capacity water delay distribution energy task liquid world opportunity alternative decision estimate decrease cost furthermore previously relevant participant possible support positive value future lower rate higher individual model potential high analysis result study,{},{},{},{},{},{}
269,269,289,10.1016/j.ymgmr.2015.10.003,28649544.0,immediately blood chain conclusionsacute respiratory ratio early lower profile formula several dioxide stay glucose density necessary aged prevents slightly central basal physical severe methodsfive capacity state breakfast control backgroundin well cholesterol increased exercise disease evaluate pku phe peak session however later phenylalanine poorly follow tyr obesity rer higher value brain therefore body result metabolic effect besides cause lipoprotein term late long lipid low non level significant functioning moment four rate one least individually acute tyrosine lactate outcome week consumptionkeywords phenylketonuria mental abbreviation thereby vco unknown concentration sex treatment response year diet intensity ctl carbon component age sample aerobic mass production hormonal unclear peripheral adaptation bone hdl aspect index natural consumption resultsphenylketonuria bmr regardless oxygen also min exchange plasma optimize high applicable study acid similar dietary small patient participant amino total number parameter ldl,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471389/,abstract,3,vco resultsphenylketonuria rer ctl consumptionkeywords conclusionsacute bmr methodsfive hormonal aerobic dioxide breakfast moment stay increased hdl lipoprotein ldl lactate prevents optimize carbon basal peak immediately applicable individually functioning exercise respiratory oxygen adaptation regardless intensity abbreviation session backgroundin slightly cholesterol min exchange bone formula density peripheral poorly tyr lipid sex capacity later consumption unclear late glucose aspect obesity production acute unknown necessary natural parameter follow evaluate mental component index aged profile central physical chain tyrosine week ratio small similar participant severe body phe state mass long plasma cause value response lower brain diet dietary rate concentration total pku amino outcome term higher non sample phenylketonuria low number early phenylalanine control blood acid age significant metabolic year effect high level treatment result patient disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""non sample phenylketonuria low number early phenylalanine control blood acid age s""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""diet dietary rate concentration total pku amino outcome term higher non s""]}}","{""diet"": {""freq"": 1, ""string"": [""plasma cause value response lower brain diet dietary rate concentration total p""]}}",{}
270,270,290,10.3390/nu10091301,30223443.0,mood culture daily new growth discus difficult time preference half behavior difficulty finally related subject health underlie food century recently psychological deeply ingredient period rapid humanitarian one signal certain problem many review product reason meat people potential system second habit criticism rich diet western attitude production poor hormonal nervous environmental aim paper consumption also consequence phenomenon nutritional often limitation wealth highly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165406/,abstract,0,humanitarian hormonal criticism wealth underlie ingredient deeply meat habit century mood attitude phenomenon preference reason rich western culture psychological nervous half signal consumption difficulty people limitation certain daily production difficult poor finally consequence second recently nutritional behavior rapid environmental product highly growth problem related paper period discus food aim subject diet time new review potential health,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""paper period discus food aim subject diet time new review potential h""]}}",{}
271,271,291,10.1371/journal.pone.0165122,27906972.0,major conclusionthe prescription relationship absolute prospectively ratio difference information congenital defect largely findingsthree reuptake modification odds together additional utero severe left risk holding quarter preconception status ssri however interval timeframes denmark teratogenesis health consistent putative composite chd result diagnosis depression data significance lmp selective pregnancy first controversial regression period unchanged significant confidence one menstrual inhibitor norway dose side economic database outcome population socio day method separately causal exposure guide wale delivery foetus response electronic association regimen year care eurocat particularly public teratogenicity anomaly serotonin prevalence statistical heart analysis adverse either available importance also high last funen augments meta small healthcare statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131901/,abstract,3,wale timeframes teratogenesis ssri lmp holding funen findingsthree augments reuptake quarter eurocat foetus menstrual composite teratogenicity left norway prescription socio denmark separately preconception utero unchanged absolute controversial regimen prospectively putative anomaly chd odds causal guide depression conclusionthe selective modification serotonin inhibitor largely significance meta confidence statistically economic interval healthcare dose statistical heart pregnancy delivery adverse consistent regression exposure database particularly defect congenital importance prevalence additional period ratio public small relationship status severe day major response electronic association care information outcome difference available risk diagnosis population significant health year high method data analysis result,{},{},{},{},{},{}
272,272,292,10.1186/s13023-019-1165-7,31429789.0,major correlation mainland outpatient factor information tertiary among stay reimbursement statement province common cost investigate institution effective backgroundrare well inpatient disease material visit whose medical era however supplementary user health safeguard affordable burden expertise china support result utilization resultsmedical situation methodsfrom length effect type eight chinese medicine level service rate one conclusionshealthcare economic database population geography yuan national social minority system technology online demography article treatment precision security electronic expenditure accessible challenge version materialthe doctor rare monitoring still million limited authorized analysis basic hospital available coverage general policy group diagnostic different high study patient ttc insurance highest healthcare total demographic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700821/,abstract,3,yuan ttc demography conclusionshealthcare resultsmedical geography methodsfrom inpatient mainland backgroundrare stay safeguard security doctor affordable reimbursement minority utilization statement insurance outpatient expertise expenditure tertiary visit accessible era coverage province institution situation authorized demographic length million chinese china basic precision monitoring economic burden highest healthcare policy service hospital national limited cost investigate database materialthe correlation social medicine general technology diagnostic support supplementary major challenge user version electronic online effective medical rare information rate total material article common available factor type population different health group effect high level treatment analysis result patient disease study,"{""social"": {""freq"": 1, ""string"": [""limited cost investigate database materialthe correlation social medicine general technology diagnostic s""]}}",{},{},{},{},{}
273,273,293,10.1373/clinchem.2014.237164,26467505.0,various biological immediately chemistry example new information early lower ambient molecule brief site reaction chemical state cost diverse testing number significantly instrumentation measurement decade poc pharmaceutical quantitative contentambient eliminate variety user clinical protein primary food analytical exogenous biofluids friendly quantification forensics miniaturization rapid volume current drug implementation unmodified point minimize review motivation approach spray technique backgroundone miniature development stage technology driving summaryambient hormone promise decision care interface overview complex monitoring sample mass endogenous opportunity suite application appropriate especially analytes ago ionization field quality analysis background paper spectrometry translation diagnostics conveniently upon practice direct small patient healthcare preparation spectrometer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367930/,abstract,0,summaryambient spray conveniently contentambient backgroundone miniature instrumentation eliminate driving miniaturization unmodified friendly forensics biofluids poc suite minimize ionization motivation ambient spectrometer chemistry ago immediately analytes interface exogenous brief diagnostics promise quantification preparation endogenous pharmaceutical translation hormone overview chemical monitoring diverse analytical variety decade volume healthcare opportunity molecule decision stage appropriate reaction direct quantitative implementation site example rapid cost point measurement spectrometry especially practice technique biological paper technology small field testing various food background application state mass user complex primary drug quality lower care information current sample approach number significantly new early review protein development clinical analysis patient,{},{},{},"{""spectrometry"": {""freq"": 1, ""string"": [""site example rapid cost point measurement spectrometry especially practice technique biological p""]}}",{},{}
274,274,294,10.1111/jnc.14311,29364507.0,male specific disorder activity dominant greater factor region autosomal mean old control neurogenetic month significantly unlabeled calculation synthesis initiation account quantitative haploinsufficiency higher value role protein regional consistent brain mouse leucine tracer rcps degradation effect mtorc fraction rate mutation three sclerosis regulation method tsc target ribosomal people unexpectedly awake pool autoradiographic estimate reduced either previously precursor translation plasma tissue biogenesis regulating acid breakdown cerebral mammalian tuberous amino freely complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6576257/,abstract,4,ribosomal autoradiographic unlabeled tuberous rcps biogenesis unexpectedly tsc tracer haploinsufficiency awake neurogenetic mtorc breakdown freely pool regulating sclerosis initiation calculation leucine regional cerebral mammalian dominant fraction degradation translation reduced precursor people account autosomal estimate regulation quantitative consistent old mean synthesis tissue greater previously male target mouse region month plasma complex value brain rate activity mutation amino higher role significantly specific control factor acid protein effect method disorder,{},"{""autosomal"": {""freq"": 1, ""string"": [""degradation translation reduced precursor people account autosomal estimate regulation quantitative consistent o""]}}",{},"{""amino"": {""freq"": 1, ""string"": [""complex value brain rate activity mutation amino higher role significantly specific c""]}}",{},{}
275,275,295,10.1542/peds.2015-3731D,26729704.0,refinement whether new examine technical time consent concern increasingly opportune genetics state number geneticist knowledge relevant understanding screening select role health range procedure secondary primary revisit contemplate result expansion question procedural official united area whole underpinnings panel cheaper current unprecedented cusp regulation contemplating article detail year nearly option public within legal wgs newborn statute million screen explore criterion benefit easier program routinely framework genome constitutional human sequencing complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939764/,abstract,2,contemplating contemplate constitutional statute revisit opportune cusp cheaper procedural wgs underpinnings easier unprecedented refinement official select geneticist routinely consent legal expansion nearly technical million examine united screen increasingly question option framework panel procedure explore concern secondary regulation genome understanding genetics criterion sequencing relevant benefit public knowledge area screening state program range complex primary newborn current article role number time new human health year result,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""screening state program range complex primary newborn current article role number t""]}, ""screening"": {""freq"": 1, ""string"": [""sequencing relevant benefit public knowledge area screening state program range complex p""]}}",{},{}
276,276,296,10.12669/pjms.342.14066,29805412.0,monosyllabic investigation difference profile without diagnosed battery polysyllabic due throat snhl stimulation statistically effective evaluate objective sensorineural month respectively quick respect unit profound speech value word implantation university mtp inner auditory ear score medicine significant rate variable department october child evaluation gaziantep method development trochee nose loss subsection test preoperative treatment response electrode two faculty advancement progress anomaly function conclusion group december prelingual study whereas similar postoperatively patient underwent performance total presence cochlear,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954383/,abstract,15,trochee throat snhl postoperatively polysyllabic mtp monosyllabic gaziantep subsection preoperative prelingual nose faculty diagnosed sensorineural cochlear ear implantation inner electrode quick auditory speech battery october underwent profound department advancement stimulation anomaly december respect unit progress university statistically word evaluate investigation profile variable loss presence evaluation medicine performance score similar month objective value response effective respectively rate total conclusion difference function test child significant development group method treatment patient study,{},{},{},{},{},{}
277,277,297,10.1155/2019/5483946,31223625.0,oil fat related regulator degeneration red hepatic vivo aggravated pathway inhibitor time oxidative steatosis function downregulation phosphorylation liver glycolipid mouse mechanism vitro model socs reverse regulation method also immunofluorescence induction anabolism expression blot nsc stat effect free study regulating hepatocyte insulin acid ffa gradually breakdown treatment negatively activation qpcr fatty hnf signaling lipid western metabolism hepatocytes cell,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541945/,abstract,1,socs immunofluorescence glycolipid ffa anabolism aggravated steatosis stat nsc downregulation breakdown qpcr oil red blot gradually reverse phosphorylation regulating induction degeneration signaling hepatocytes hnf negatively regulator western insulin hepatic fat hepatocyte lipid inhibitor activation oxidative vitro vivo fatty regulation liver free related mouse expression pathway mechanism cell function metabolism time model acid effect method treatment study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""regulation liver free related mouse expression pathway mechanism cell function metabolism t""]}}",{},{},{}
278,278,298,10.3390/ijns1020069,28868497.0,marginally individual blood sample variable newborn cdc spot certain possible screening per volume diameter uncontrollable time range quality characteristic impact program rbc physical used prevention nsqap inevitably serum outside study test logarithmically hematocrit patient disease year though absorption assurance total punch acceptable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580822/,abstract,1,uncontrollable logarithmically nsqap rbc punch inevitably cdc marginally hematocrit diameter assurance outside absorption used acceptable certain volume physical variable serum prevention spot characteristic possible screening program range quality impact total newborn sample test individual time blood year patient disease study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""screening program range quality impact total newborn sample test individual time b""]}, ""screening"": {""freq"": 1, ""string"": [""variable serum prevention spot characteristic possible screening program range quality impact t""]}}",{},{}
279,279,299,10.7150/thno.19061,28382168.0,major nanoparticles self lectin vivo factor reticuloendothelial innate present modification surface efficient evasion accumulation sialic phagocytic cancer marker strategy clinical protein acetylneuraminic therefore like effect immune aunps ability significant neu cellular one siglec gold critical development via system towards serum delivery nanotechnology response active promising challenge advance regulator accordingly reduced immunoglobulin vitro translation also diagnostic different interaction acid tumor prospect,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381258/,abstract,0,siglec reticuloendothelial phagocytic lectin aunps neu acetylneuraminic sialic evasion nanotechnology nanoparticles prospect innate immunoglobulin gold accordingly surface regulator promising tumor modification translation efficient reduced immune cellular accumulation active vitro vivo advance delivery serum cancer marker self critical ability like diagnostic interaction major challenge strategy response present factor acid different protein significant development effect clinical,{},{},{},{},{},{}
280,280,300,10.1155/2017/7460780,29375198.0,experimental twofold new difference lower time crevicular bleeding selection surface gingivitis hygiene fact control accumulation evaluate material register periodontal brightness however higher clinical nature health fluid double plaque support effectiveness effect prospective use proanthocyanidins oligomeric divided silness day method tooth response randomized inflammatory gingiva complementary gingival since determine criterion aim index also trial conclusion group nutritional tissue study blind dental patient,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742508/,abstract,4,twofold tooth silness proanthocyanidins gingival gingiva crevicular brightness bleeding periodontal hygiene gingivitis plaque oligomeric divided dental register fact complementary randomized surface blind fluid prospective double nature accumulation inflammatory experimental selection effectiveness evaluate index nutritional criterion tissue determine support aim day trial response lower use material conclusion higher difference time new control health group effect method clinical patient study,{},{},{},{},{},{}
281,281,301,10.2147/OTT.S99099,27217771.0,blood tool clinic example iem benign ratio early cancerous among item several cont pro biomarker effective disease traditional significantly material abovementioned cancer marker strategy remarkably quantitation protein error inborn result diagnosis six purpose finished quantification tandem metabolism regression detection commonly four measure orn arg sensitivity proper discovery technique methodstwenty cit assistance forty serum help promising specificity acylcarnitines mass complementary spot objectivenewborn pilot healthy explore differential analysis spectrometry lung also group trend study acid patient minute volunteer conclusionthis tumor amino metabolite parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853144/,abstract,6,objectivenewborn cont cit abovementioned orn methodstwenty finished cancerous assistance quantitation conclusionthis benign remarkably acylcarnitines minute arg volunteer item complementary lung proper pro quantification pilot promising tumor trend traditional differential biomarker commonly discovery tandem iem explore clinic specificity parameter help serum regression cancer sensitivity example marker purpose spectrometry spot technique ratio detection inborn metabolite tool measure healthy mass strategy error effective material amino metabolism significantly early blood diagnosis acid protein group analysis result patient disease study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""marker purpose spectrometry spot technique ratio detection inborn metabolite tool measure h""]}, ""amino"": {""freq"": 1, ""string"": [""healthy mass strategy error effective material amino metabolism significantly early blood d""]}, ""tandem"": {""freq"": 1, ""string"": [""trend traditional differential biomarker commonly discovery tandem iem explore clinic specificity p""]}, ""spectrometry"": {""freq"": 1, ""string"": [""regression cancer sensitivity example marker purpose spectrometry spot technique ratio detection i""]}}",{},{}
282,282,302,10.1186/s13023-018-0893-4,30165883.0,relationship cochrane memory better search micronutrient ratio early fluctuation across several adult despite selection psycinfo vigilance careful throughout elevated prevents severe heterogeneous deficit homogeneous continuous resultstwenty motor publication well vitamin inter pku neurological material phe intra executive supplementary phenylalanine life methodsa variety user nature focus science report attention large observational term furthermore long level use peer measure sensitivity tyrosine child outcome multicentre collectively highly review inclusion management phenylketonuria backgroundeven scopus development national skill web online article test electronic association conclusionsto medline inconsistency finding systematic materialthe overview version still future two unclear embase function influence sciencedirect cognitive impairment benefit awpku research ovid available nutritional often domain study successfully whereas dietary though variability performance consistently,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117942/,abstract,1,sciencedirect backgroundeven awpku vigilance conclusionsto psycinfo ovid homogeneous resultstwenty scopus multicentre fluctuation prevents inconsistency careful intra micronutrient cochrane peer consistently collectively inter embase web medline heterogeneous skill continuous successfully methodsa publication observational executive vitamin variability overview variety nature memory unclear motor elevated selection science inclusion domain search neurological systematic deficit nutritional sensitivity focus impairment national attention furthermore influence materialthe tyrosine highly despite benefit ratio relationship performance finding better severe cognitive measure phe supplementary long management user version electronic online large future association adult use report dietary life pku material outcome term article function phenylketonuria available test early phenylalanine research review child development level study,"{""phenylalanine"": {""freq"": 2, ""string"": [""article function phenylketonuria available test early phenylalanine research review child development l""]}, ""neurological"": {""freq"": 1, ""string"": [""elevated selection science inclusion domain search neurological systematic deficit nutritional sensitivity f""]}}",{},{},{},{},{}
283,283,303,10.1128/MCB.00371-15,26124279.0,major male exon activity new vivo rescue ola defect document identity light missense open capacity destabilization xeroderma polymerase hypothesis embryonic testis amount murine synthesis catalytically reversible proteasome related animal family form protein polyclonal mouse therefore mutant fibroblast nonsense knockout length data novo isoform fraction similarly furthermore velcade ability type genetic inhibition completely case although full functional mutation wild phenotype drug sensitivity fully collectively translesion antibody replication substantial iota pol treatment active pigmentosum challenge terminus frame cdna deficient xpv two mass variant function irradiation turnover dna analysis spectrometry also otherwise small patient gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525304/,abstract,4,xpv xeroderma velcade translesion testis polyclonal pigmentosum ola iota pol destabilization catalytically proteasome isoform irradiation terminus frame cdna turnover identity nonsense rescue reversible replication knockout murine polymerase fibroblast embryonic novo collectively similarly document antibody completely length fully light fraction substantial missense exon deficient capacity inhibition wild mutant open hypothesis active vivo dna animal sensitivity synthesis furthermore spectrometry defect ability related male functional phenotype small mouse form mass major challenge drug variant family activity mutation function case new type protein gene genetic data treatment analysis patient,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""spectrometry"": {""freq"": 1, ""string"": [""vivo dna animal sensitivity synthesis furthermore spectrometry defect ability related male f""]}}",{},{}
284,284,304,10.4103/0366-6999.181955,27174328.0,logistic cross past better inconclusive sectional hierarchical chaid factor information representative pathway among early subdistrict avenue anemic metropolis aged native prompt together risk well month status decade resident recent mainly higher health range practitioner great china multilevel large besides fourth pregnancy first useful regression area detection educational three automatic breastfeeding chi curve tree overall population living model rural method predictor parent receiver year decision care city maternal predictive operating complex squared january prevalence especially determine downtown explore subgroup carefully exclusive meaningful analysis basic background characteristic stepwise beijing available infant also larger conclusion december different interaction classification study heterogeneity accuracy performance caregiver anemia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878165/,abstract,3,subdistrict metropolis downtown chaid breastfeeding squared automatic anemic beijing fourth exclusive multilevel avenue anemia stepwise tree resident inconclusive hierarchical carefully prompt chi practitioner operating living native receiver meaningful representative rural december city subgroup curve january logistic caregiver educational classification predictor china basic predictive larger great mainly past heterogeneity decade accuracy explore decision useful sectional pregnancy maternal aged regression cross especially determine parent characteristic prevalence status performance overall interaction better detection background area month infant range complex large pathway recent care information conclusion higher available risk model early factor population different health year method analysis study,{},"{""heterogeneity"": {""freq"": 1, ""string"": [""basic predictive larger great mainly past heterogeneity decade accuracy explore decision u""]}}","{""pathway"": {""freq"": 1, ""string"": [""area month infant range complex large pathway recent care information conclusion h""]}}","{""detection"": {""freq"": 1, ""string"": [""prevalence status performance overall interaction better detection background area month infant r""]}}",{},{}
285,285,305,10.1016/j.ymgmr.2015.08.001,26937416.0,significant biochemical executive although worse relationship phenylalanine still independent continuously ratio difference measure early dopamine previous sibling adolescent function tyrosine influence child consistent analysis impairment slightly phenylketonuria research evident abbreviation group result exposure high metabolic study control well term long pku functionkeywords poorer non,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750585/,abstract,0,functionkeywords worse sibling poorer continuously abbreviation slightly evident executive dopamine adolescent independent previous consistent exposure impairment influence tyrosine biochemical ratio relationship measure long pku term non difference function phenylketonuria early phenylalanine control research child significant metabolic group high analysis result study,"{""phenylalanine"": {""freq"": 2, ""string"": [""term non difference function phenylketonuria early phenylalanine control research child significant m""]}}",{},{},{},{},{}
286,286,306,10.1186/s12864-015-1261-6,25765049.0,biological phenotypic specific relationship mismatch molecule pfcrt demonstrates insight action state highlight progeny regulatory topological clone well material repair paradigm transcriptional utility parasite supplementary family quantitative strategy trait backgroundthe possible anti driver user divergent protein consistent doi identifies phenotypically particular analytical effect data resistant computational divergence genetic metabolism validate recombinant mapping case lab confidence functional mutation cqs independent step datasets inhibitor transporter drug provide intervention population approach regulation drive work mediator expression potential mode evolution qtl conclusionsthis online article key electronic network allelic materialthe version regulator hemoglobin variant resultsto malarial chemotherapeutic function series differential acetylation resistance analysis chloroquine background framework available different interaction high histone leverage small distinct agent cqr gene readily sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352545/,abstract,3,resultsto pfcrt parasite malarial cqs cqr clone chloroquine topological qtl divergence chemotherapeutic acetylation phenotypically mismatch progeny divergent datasets leverage drive histone driver resistant repair mediator identifies allelic hemoglobin mapping readily demonstrates validate lab paradigm recombinant evolution conclusionsthis series transcriptional mode computational regulator doi transporter resistance backgroundthe inhibitor differential phenotypic distinct confidence analytical action agent sensitive anti framework trait utility network molecule independent step regulatory regulation particular insight quantitative consistent work materialthe highlight biological provide functional small relationship interaction possible background supplementary state user expression drug version strategy variant key electronic online family intervention mutation material article function approach case available metabolism specific population potential different protein gene effect high genetic data analysis,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
287,287,307,10.4103/jehp.jehp_154_15,28852656.0,counseling statistic cross sectional factor among present researcher five condition due percent risk disease preconception material issue checklist indication isfahan result data pregnancy forensics fetal genetic medicine abortion independent chi problem eighty october spss intervention march descriptive applicant therapeutic method test convenience care version maternal iran along elimination background research conclusion study center even square participant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561683/,abstract,3,applicant checklist isfahan forensics eighty convenience abortion counseling preconception march october chi elimination spss percent square statistic indication descriptive iran researcher fetal independent sectional center pregnancy maternal cross medicine problem issue participant background version therapeutic intervention care material conclusion condition present test risk factor research genetic method data result disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""condition present test risk factor research genetic method data result disease s""]}}",{},{},{},{}
288,288,308,10.1002/jmd2.12042,31392115.0,metabolome male difference pathway redox time several largely algorithm benjamini liquid accurate retention frequency state control number agilent evaluate month raw xanthine homogentisic intermediary nitisinone backgroundthe therapy feature fold aku infinity metabolic data significance change conclusionsevaluation metabolism flight extraction significant rate ppm measure centre log tyrosine wider database discovery window quadrupole abundance work national citric system serum unknown theoretical analyzed treatment batch year false cell hypertyrosinemia resultseight age sample mass adjustment statistical alkaptonuria quality analysis previously impact spectrometry tryptophan consequence group cycle entity acid synopsisnitisinone patient minute beyond variability metabolite chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606987/,abstract,10,synopsisnitisinone infinity hypertyrosinemia conclusionsevaluation citric benjamini agilent xanthine resultseight ppm intermediary analyzed aku homogentisic batch quadrupole raw nitisinone alkaptonuria wider theoretical redox log flight metabolome window retention adjustment minute entity abundance extraction algorithm centre tryptophan false backgroundthe accurate largely variability significance fold discovery cycle liquid statistical chromatography unknown evaluate consequence serum work feature national spectrometry database tyrosine previously frequency male metabolite measure month state mass change quality pathway impact therapy rate difference cell sample number metabolism time control acid age significant metabolic group year data treatment analysis patient,{},{},"{""pathway"": {""freq"": 1, ""string"": [""measure month state mass change quality pathway impact therapy rate difference c""]}}","{""spectrometry"": {""freq"": 1, ""string"": [""evaluate consequence serum work feature national spectrometry database tyrosine previously frequency m""]}}",{},{}
289,289,309,10.1038/srep31463,27528366.0,level rare sequence significant whole related disorder relationship four two catalytic variant quantitative much region trait moderate phenotype peripheral correlate involved synonymous demonstrate location site population analysis deleterious five frequency structural larger also result enzyme cohort metabolic effect domain study contrast data susceptibility regulatory human change association disease first demonstration individuality individual metabolite near non,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985752/,abstract,1,individuality synonymous demonstration location deleterious catalytic near correlate peripheral susceptibility larger involved demonstrate moderate trait structural domain contrast regulatory sequence quantitative site frequency related cohort phenotype relationship region metabolite enzyme change variant association rare non individual human population significant metabolic effect data level disorder analysis result disease study,{},{},{},{},{},{}
290,290,310,10.1038/srep39854,28079055.0,ptps schleiferi content intestinal congenital adult present synthase tetrahydrobiopterin microbacterium source regulatory control number increase flora material hypothesize microbiota chemostat hph mouse body fecal bacteria exogenous equolifaciens specie cyclohydrolase generation type although biopterin wild actinobacteria least certain comparatively translational phylum aldercreutzia important finding age deficient two newborn hyperphenylalaninemia since manipulation goal gtp conclusion tissue mrna human cofactor deficiency individual total presence indicative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5227711/,abstract,0,schleiferi microbacterium flora equolifaciens chemostat aldercreutzia actinobacteria comparatively ptps phylum hypothesize hph fecal manipulation biopterin indicative cyclohydrolase intestinal gtp exogenous microbiota mrna translational bacteria synthase specie deficient hyperphenylalaninemia wild cofactor goal certain tetrahydrobiopterin content regulatory source generation presence tissue congenital finding mouse body increase adult deficiency total newborn material conclusion important number present individual human control type age,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""mouse body increase adult deficiency total newborn material conclusion important number p""]}}",{},{}
291,291,311,10.6515/ACS20140310B,27122842.0,single congenital mirna molecular risk regulatory control evaluate disease significantly transcriptional element family role play genotype chd result epidemiology chinese non case mirnas functional ethnicity micrornas population model method post tof development mir susceptibility polymorphism finding tetralogy future two endogenous snp rna recessive heart act background aim impact keywords larger conclusion group cohort study nucleotide small patient fallot gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804909/,abstract,2,micrornas mirnas mirna tetralogy fallot tof mir ethnicity epidemiology chd transcriptional endogenous susceptibility snp act rna chinese element larger keywords recessive nucleotide polymorphism post play genotype heart evaluate regulatory congenital functional cohort small finding background aim future single molecular family impact conclusion non role case significantly risk model control population development gene group method result patient disease study,{},"{""recessive"": {""freq"": 1, ""string"": [""act rna chinese element larger keywords recessive nucleotide polymorphism post play g""]}}",{},{},{},{}
292,292,312,10.1038/s41598-018-37485-8,30696889.0,culture synthetic encoding factor profile adult tubule differentiated efficient gata condition additional subsequently transfections sall disease transcription distal possible renal podocytes therapy pluripotent replacement global report six like pitx first ascl nephron rapid dimensional pretubular end inephlos hpscs lhx organoids model day efficiency progenitor stage expression second derivation hnf similarity proximal aggregate cell consecutive within two application differentiation emx stem pax vitro widely tissue mrna human tfap another gene kidney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351687/,abstract,3,tfap sall pretubular podocytes pitx pax nephron lhx inephlos hpscs gata emx derivation ascl transfections organoids differentiated progenitor tubule pluripotent distal proximal consecutive similarity dimensional aggregate encoding mrna hnf stem kidney subsequently renal culture replacement differentiation synthetic efficiency transcription efficient end widely vitro stage global profile second rapid tissue like additional possible application day expression adult report therapy condition cell human model factor gene disease,{},{},{},{},{},{}
293,293,313,10.1016/j.btre.2019.e00370,31516850.0,resonance activity antimicrobial phenol vegetable class lead oxidative biosynthesis phenolic sub variation fruit radical risk source addition tremendous antioxidant well disease significantly ubiquitously cancer evidence donation anti health compound quenching particular contribution result property protective like effect etc furthermore atom intestine plant metabolism epidemiology stress main anticancer structure drug vital occurrence discovery many moiety via potential effortlessly mode rich detail diet component inflammatory reduces mutagenic viz electron benefit mechanism cardiovascular posse oxygen also group human acid position dietary singlet number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734135/,abstract,0,viz singlet quenching phenol mutagenic effortlessly donation atom ubiquitously phenolic moiety anticancer tremendous antimicrobial vegetable radical posse intestine electron protective fruit occurrence plant oxygen vital epidemiology antioxidant reduces sub position rich mode biosynthesis class resonance oxidative contribution cardiovascular anti discovery inflammatory property component particular source stress compound cancer lead variation furthermore structure benefit like main addition drug mechanism diet dietary activity evidence number metabolism significantly human risk acid potential health group effect result disease,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""benefit like main addition drug mechanism diet dietary activity evidence number m""]}}",{}
294,294,314,10.3892/ol.2015.3959,26870252.0,line genetically sanger fluorescence future hybridization lymphoblastic carcinogenesis progress immunocytochemistry situ order acute since several drug present anticancer subpopulation advanced leukemia insight therefore technique research examination aid massive parallel result different evolution purpose study heterogeneity testing addition rpmi furthermore traditional genetic thorough address uncommon cell typical issue,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726987/,abstract,0,uncommon rpmi immunocytochemistry lymphoblastic subpopulation leukemia carcinogenesis anticancer massive thorough situ hybridization fluorescence aid sanger evolution advanced typical progress parallel traditional line genetically examination heterogeneity address acute insight purpose furthermore technique issue order testing addition drug future cell present research different genetic result study,{},"{""genetic"": {""freq"": 1, ""string"": []}, ""heterogeneity"": {""freq"": 1, ""string"": [""progress parallel traditional line genetically examination heterogeneity address acute insight purpose f""]}}",{},{},{},{}
295,295,315,10.1007/s00213-017-4680-z,28710519.0,experimental interestingly self memory whether information visual present enhance battery condition significantly objectivesto however reduction spatial inattention digit clinical gap particular task enhancement occasion attention effect contrast gum forward conclusionsgiven rat span useful non use letter significant rapid three main measure placebo dose strong back reverse concomitant ost nicotine concentration baseline rvip methodsthirty association similarity rodent rationaleamongst address robust generally load limited odor smoker dependent cognitive either alternative study human sequencing generalizes participant resultsnicotine performance accuracy number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772879/,abstract,0,rvip resultsnicotine rationaleamongst ost generalizes conclusionsgiven odor smoker occasion methodsthirty inattention gum digit nicotine enhancement rodent letter concomitant battery span objectivesto reverse load forward similarity interestingly spatial visual placebo enhance gap generally robust memory rat strong task baseline experimental dose accuracy alternative contrast address useful dependent particular reduction rapid limited self attention sequencing main performance participant cognitive measure association use information concentration condition non number present significantly human significant effect clinical study,{},{},{},{},{},{}
296,296,316,10.1007/s11682-016-9641-3,27796732.0,correlation memory whether abnormality region specifically behavioral fractional throughout superior pathology deficit valid investigate biomarker control radiation neurofibromatosis anisotropy longitudinal matter executive radial observed range verbal brain axial task integrity basis ability type significant commonly whole sixteen least anterior measure phenotype local white damage bundle pathological atr diffusivity strongly associated fasciculus future working estimate mri healthy adolescent function metric cognitive analysis aspect aim tract available also dti slf different study patient inhibitory thalamic performance microstructural,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707233/,abstract,3,slf bundle atr thalamic neurofibromatosis fasciculus axial working radial microstructural sixteen radiation valid anisotropy dti metric diffusivity anterior fractional verbal integrity inhibitory tract superior mri pathological biomarker pathology executive commonly longitudinal strongly matter damage local specifically memory white adolescent task aspect behavioral estimate associated basis observed deficit abnormality investigate correlation ability phenotype performance region cognitive aim measure healthy range future brain function available control type different significant analysis patient study,"{""behavioral"": {""freq"": 1, ""string"": [""specifically memory white adolescent task aspect behavioral estimate associated basis observed d""]}}",{},{},{},{},{}
297,297,317,10.1097/MD.0000000000011397,29995784.0,fev region insufficiency cystic duration adult prognostic present asp affected frequency pancreatitis common prognosis mean testing old pancreatic recurrent whose biochemical account adulthood cannot childhood screening follow val clinical expiratory feature symptom transmembrane fibrosis diagnosis six mild first genetic low period case although mutation involvement volume cftr child fully population inclusion expression evolution year age regulator newborn order function pulmonary previously program lung also tested group last study patient gene conductance spirometric,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076148/,abstract,4,spirometric pancreatitis fev expiratory val asp conductance tested cftr prognostic pancreatic transmembrane insufficiency pulmonary recurrent lung prognosis evolution cystic regulator duration fibrosis adulthood involvement fully affected mild account volume inclusion follow childhood old mean feature previously frequency period biochemical order testing region symptom screening program expression adult newborn mutation common function low present case diagnosis population child age gene group year genetic clinical patient study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""newborn"": {""freq"": 1, ""string"": [""region symptom screening program expression adult newborn mutation common function low p""]}, ""screening"": {""freq"": 1, ""string"": [""period biochemical order testing region symptom screening program expression adult newborn m""]}}",{},{}
298,298,318,10.1371/journal.pone.0150872,26974654.0,major implication depressed disorder investigation specifically positive adult condition superior mind state drd control preliminary ninety form dopamine cognition clinical task result depression six contrast valence basis receptor theory term ability genetic long young non neurobiological short etiology catechol current transporter others model reason mental dat social skill methyl mentalistic decoding polymorphism association universal carrier homozygote sample homozygous allele negative serotonin decode cognitive impairment eye reading comt depressive transferase group study human accuracy gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790964/,abstract,1,valence mentalistic decoding catechol transferase decode comt depressed dat ninety mind homozygote drd reading depressive neurobiological preliminary eye methyl cognition theory superior reason homozygous skill universal transporter depression serotonin young specifically etiology receptor dopamine polymorphism carrier task accuracy contrast allele mental investigation basis implication short negative impairment social ability form cognitive state long major positive association adult current term condition non sample human model control gene group genetic disorder clinical result study,"{""social"": {""freq"": 1, ""string"": [""investigation basis implication short negative impairment social ability form cognitive state l""]}}","{""homozygous"": {""freq"": 1, ""string"": [""eye methyl cognition theory superior reason homozygous skill universal transporter depression s""]}, ""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
299,299,319,10.3889/oamjms.2018.336,30455769.0,major various suitable inhibits specific hence streptococci availability past search interest growth form scenario present cariogenic role concern review background therefore consumption available method widely day plaque caries prevention bacterial share result bacteria conclusion etiologic comprehensive xylitol article sugar safety substitute dental well decrease association oral disease agent palatable mutans adherence safe profession formation presence streptococcus period,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236052/,abstract,0,streptococci mutans xylitol profession plaque etiologic cariogenic streptococcus palatable inhibits caries dental scenario substitute share sugar safe bacterial bacteria adherence suitable formation consumption agent safety availability widely past oral comprehensive search concern decrease presence prevention growth period various background form day major association conclusion article role present available specific review method result disease,{},{},{},{},{},{}
300,300,321,10.3389/fgene.2018.00122,29731766.0,nine region early country prenatal efficient severe suggested iems cblc increase jining hydroxylase respectively phenylalanine family top neonate presymptomatic therefore primary error china inborn diagnosis sequela solute cause predominant tandem type genetic metabolism methylmalonic area case mutation member death overall critical approach permanent phenylketonuria work mmachc treatment incidence acidemia dramatically carrier mass newborn healthy determine aciduria characteristic spectrometry cobalamin coverage pah different high homocystinuria deficiency thirty gene carnitine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920142/,abstract,5,mmachc jining presymptomatic cblc solute cobalamin homocystinuria suggested sequela permanent dramatically carnitine aciduria predominant methylmalonic thirty iems acidemia coverage neonate prenatal china efficient member tandem carrier death incidence work pah critical spectrometry determine characteristic hydroxylase overall country region severe inborn area healthy mass primary cause increase error deficiency family respectively newborn mutation phenylketonuria approach case metabolism early phenylalanine type diagnosis different gene high genetic treatment,"{""phenylalanine"": {""freq"": 2, ""string"": [""mutation phenylketonuria approach case metabolism early phenylalanine type diagnosis different gene h""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""tandem"": {""freq"": 1, ""string"": [""coverage neonate prenatal china efficient member tandem carrier death incidence work p""]}, ""spectrometry"": {""freq"": 1, ""string"": [""carrier death incidence work pah critical spectrometry determine characteristic hydroxylase overall c""]}, ""newborn"": {""freq"": 1, ""string"": [""cause increase error deficiency family respectively newborn mutation phenylketonuria approach case m""]}}",{},{}
301,301,322,10.1021/acs.analchem.7b01358,28782931.0,blood delay disorder activity lead early lower positive plp adult prompt severe open separate supplementation prognosis control well vitamin month fatal neurological ine pyridoxal suitable however incubation seizure dysfunction clinical developmental feature therefore diagnosis arena enzyme pyridox potentially level seven rapid phosphate pnpo normal child outcome fully day simple method development epileptic oxidase concentration treatment year false robust sample deficient two negative spot pyridoxine reliant omim validated hospital encephalopathy translation min upon group diagnostic high pnp windowwe deficiency patient,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588098/,abstract,4,windowwe pyridox pnp plp ine reliant pyridoxal pnpo incubation arena fatal pyridoxine epileptic oxidase omim encephalopathy prompt phosphate validated prognosis min fully false separate seizure translation deficient vitamin suitable simple delay robust seven open neurological potentially supplementation negative hospital feature dysfunction rapid lead developmental spot diagnostic severe enzyme month normal day positive lower adult deficiency concentration activity outcome sample early control blood diagnosis child development group year high method level disorder treatment clinical patient,"{""neurological"": {""freq"": 1, ""string"": [""suitable simple delay robust seven open neurological potentially supplementation negative hospital f""]}}",{},{},{},{},{}
302,302,323,10.1155/2017/8570469,29270317.0,various heavier nine growth difference time adult set weight retrospective hcu mainstay control intake clinical higher protein body diagnosis metabolic effect dietitian late genetic low international level rate three one point population review irish intermittently treatment association diet year bmi age mass newborn poor cystine pyridoxine nonresponsive standard height index general group lowest homocystinuria methionine taller patient deviation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705888/,abstract,4,taller nonresponsive intermittently heavier hcu irish cystine homocystinuria pyridoxine mainstay methionine dietitian lowest height retrospective set bmi deviation late international poor index weight point intake growth general standard various body mass association adult diet rate newborn higher difference low time control diagnosis population review protein age metabolic group year effect genetic level treatment clinical patient,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""newborn"": {""freq"": 1, ""string"": [""body mass association adult diet rate newborn higher difference low time c""]}}","{""diet"": {""freq"": 1, ""string"": [""standard various body mass association adult diet rate newborn higher difference l""]}}",{}
303,303,324,10.1007/8904_2017_75,29170929.0,cross ffmdeut assessment clinic sectional outpatient difference composition portable median tbwbia bias deuterium due improve portability pku status tbw ffm measurement range altman ffmbia body occasion result non significant water sixteen bodystat per child approach phenylketonuria method free test bland year predictive fat age protocol mass space standard adolescent equation invasive bioelectrical criterion analysis bia monitor conclusion quadscan dilution nutritional proportional reliably tbwdeut study impedance patient highly total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226404/,abstract,2,tbwdeut tbwbia tbw quadscan portability ffmdeut ffmbia ffm bodystat impedance deuterium bioelectrical bia proportional occasion portable dilution bland sixteen altman equation space reliably outpatient monitor bias invasive fat improve predictive composition water adolescent protocol clinic sectional median nutritional criterion cross free measurement highly status standard body assessment mass range total pku conclusion non difference phenylketonuria approach test child age significant year method analysis result patient study,{},{},{},{},{},{}
304,304,325,10.3390/nu7125517,26633479.0,phalanx activity tertile lead difference factor lower laboratory amplitude nutrient deleterious aged weight physical compare investigate control vitamin intake antiepileptic respectively quantitative adequate therapy health sound effect confounders low significant conclude child valproate potential epileptic test sex treatment greatest year particularly age mass adjustment pediatric anticonvulsant healthy bone chronic dependent height speed counteract qus none group classification ultrasound deficiency patient participant demographic calcium,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690069/,abstract,2,qus anticonvulsant tertile phalanx valproate sound counteract confounders amplitude compare antiepileptic epileptic greatest conclude adjustment ultrasound speed deleterious calcium height bone demographic classification adequate sex vitamin nutrient aged dependent pediatric quantitative physical weight lead investigate chronic intake particularly laboratory participant healthy mass lower deficiency respectively therapy activity difference low test control factor potential child age significant health group year effect treatment patient,{},{},{},{},{},{}
305,305,326,10.1007/s12291-016-0613-6,28811691.0,balance correlation disorder assessment hormonally present laboratory common control antioxidant evaluate disease significantly measurement hematological subject marker possible irregular mainly higher value feature examination polycystic indirect result like effect decrease level significant case one menstrual oxidant progression normal ovarian ovary drug syndrome many method prooxidant potential serum concentration treatment colorimetric regimen spironolactone healthy effectively imbalance infertility available also cycle study patient pcos individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539008/,abstract,2,spironolactone prooxidant pcos hormonally colorimetric irregular polycystic ovary menstrual oxidant hematological infertility imbalance ovarian indirect regimen balance antioxidant effectively progression examination mainly cycle evaluate decrease serum feature marker measurement syndrome correlation laboratory like possible assessment normal healthy subject drug value concentration higher common present case available individual significantly control potential significant effect method level disorder treatment result patient disease study,{},{},{},{},{},{}
306,306,327,10.3892/etm.2016.4007,28352331.0,resonance abnormality early bilateral abnormal glutaric present central onset uighur organic basal literature prognosis investigate urinary disease infectious matter biochemical relevant glutaryl heterozygous clinical coa asymptomatic diagnosis large data besides late genetic type gcdh ganglion case mutation dehydrogenase one signal cranial white correct headache system test treatment temporal key lobe degeneration two primarily propionic cyst nervous analysis aciduria characteristic intermittent study magnetic acid patient highly arachnoid number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348702/,abstract,0,uighur arachnoid glutaryl gcdh lobe cranial cyst glutaric ganglion intermittent headache temporal basal aciduria bilateral propionic degeneration asymptomatic heterozygous prognosis infectious correct coa resonance primarily dehydrogenase nervous urinary organic matter signal late white magnetic abnormal central abnormality onset investigate highly relevant characteristic biochemical literature key large mutation number present case test early type diagnosis acid genetic data treatment clinical analysis patient disease study,{},"{""heterozygous"": {""freq"": 1, ""string"": [""basal aciduria bilateral propionic degeneration asymptomatic heterozygous prognosis infectious correct coa r""]}, ""genetic"": {""freq"": 1, ""string"": [""case test early type diagnosis acid genetic data treatment clinical analysis p""]}}",{},{},{},{}
307,307,328,10.1371/journal.pone.0183509,28863139.0,resonance marginally striatal abnormality neural striatum encoding difference ventral time several adult genus increasingly bifidobacterium reward bacterial deficit adhd methodswe control hypothesis well increase significantly resultsfor taxon synthesis subset phenylalanine axis marker neurodevelopmental relative dopamine health nominal brain result diagnosis enzyme attention effect microbial first intestine rrna significant case microbiome functional one independent fmri conclusionsour etiology processing cyclohexadienyl approach neurotransmission abundance describe neuro functionality via albeit potential dehydratase driven undiagnosed response circuitry age relation pilot enhanced adolescent function impact precursor makeup hallmark study magnetic human sequencing hyperactivity backgroundmicroorganisms participant gene show anticipation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581161/,abstract,3,taxon cyclohexadienyl bifidobacterium backgroundmicroorganisms driven undiagnosed resultsfor makeup genus dehydratase ventral rrna neuro marginally fmri anticipation striatal nominal enhanced circuitry albeit striatum conclusionsour neurotransmission intestine functionality reward axis hallmark microbial adhd microbiome abundance encoding processing pilot neural bacterial hyperactivity subset resonance neurodevelopmental precursor increasingly etiology relation dopamine adolescent magnetic hypothesis independent relative methodswe deficit abnormality marker synthesis attention sequencing functional participant enzyme increase response brain adult impact difference function approach case time significantly human phenylalanine control diagnosis potential age significant health gene effect result study,"{""phenylalanine"": {""freq"": 2, ""string"": [""function approach case time significantly human phenylalanine control diagnosis potential age s""]}, ""hyperactivity"": {""freq"": 1, ""string"": [""abundance encoding processing pilot neural bacterial hyperactivity subset resonance neurodevelopmental precursor i""]}}",{},{},{},{},{}
308,308,329,10.1186/s13023-016-0510-3,27629047.0,registry disorder strategist lsd iem new tertiary molecule country resultsover riyadh retrospective molecular organic common iems addition concept disease medical biochemical however sphingolipidosis strategic previous storage health distribution error saudi inborn result diagnosis large term novel long type metabolism period rate mutation king individually department child urge collectively technique method conclusionour national school lysosomal year incidence care acidemia city backgroundinborn carrier rare pediatric determine birth previously constantly program available prevention arabia high study human small center patient total number abdulaziz,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024448/,abstract,6,urge strategist sphingolipidosis abdulaziz riyadh resultsover king lsd constantly arabia strategic saudi backgroundinborn conclusionour tertiary lysosomal individually department collectively registry iems acidemia retrospective city school organic storage distribution concept carrier iem molecule center previous pediatric incidence national prevention previously technique determine period biochemical birth small country inborn addition long program error medical large molecular rare novel care rate total mutation term common number available metabolism new human type diagnosis child health year high method disorder result patient disease study,{},{},{},{},{},{}
309,309,330,10.1093/hmg/ddv309,26246501.0,inheritance cluster unbiased dominant whether new region difference difficult autosomal condition missense interpret testing control disease sequence maf form role causation protein result large removal permutation novel non significant mutation etiology uniformly approach method mode loss localize key invariably associated wilcoxon rare within sample variant reveal along recessive explore function either previously general clustering pattern domain study whereas extent position random even prominent gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354780/,abstract,0,localize clustering permutation invariably uniformly unbiased maf wilcoxon removal causation interpret prominent reveal inheritance dominant position random mode cluster missense extent etiology recessive explore domain difficult autosomal associated sequence pattern loss previously general testing region form variant key large rare novel mutation condition non role difference function sample approach new control protein significant gene method result disease study,{},"{""inheritance"": {""freq"": 1, ""string"": [""wilcoxon removal causation interpret prominent reveal inheritance dominant position random mode c""]}, ""autosomal"": {""freq"": 1, ""string"": [""extent etiology recessive explore domain difficult autosomal associated sequence pattern loss p""]}, ""recessive"": {""freq"": 1, ""string"": [""random mode cluster missense extent etiology recessive explore domain difficult autosomal a""]}}",{},{},{},{}
310,310,331,10.1016/j.sbi.2017.10.008,29080468.0,transcriptional empirical transduction signal idp physiological application recent polarizable role field protein many increasingly regulation improvement modeling benchmark also simulation force important intrinsically biophysics accuracy computer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826789/,abstract,0,polarizable biophysics intrinsically idp benchmark modeling empirical transduction computer force simulation transcriptional physiological signal increasingly accuracy regulation improvement field application recent important role protein,{},{},{},{},{},{}
311,311,332,10.1152/ajpgi.00211.2015,26251473.0,chain content lower acetate genus inflammation characterizing pro galactosamine propionate interferon disease objective significantly glycomacropeptide glycophosphopeptide pku ion summary sialic extensive galactose microbiota beneficial reduction proteobacteria obesity mouse putative firmicutes food fecal pahenu property microbial casein immune type extraction desulfovibrio functional gmp wild short cytokine population butyrate management phenylketonuria bio via gas ibd concentration response fatty diet assay plex cell inflammatory cecal percentage primarily application pgm isoenergetic dependent reduced dna analysis splenocyte cytometry bowel index flow bacteroidetes torrent scfa nutritional plasma acid sequencing prebiotic amino glycosylation chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593820/,abstract,1,splenocyte scfa proteobacteria plex isoenergetic glycophosphopeptide galactosamine desulfovibrio cecal torrent characterizing butyrate sialic interferon ibd genus bacteroidetes acetate propionate pgm firmicutes bio glycosylation fecal cytometry prebiotic galactose casein pahenu microbial bowel gmp ion cytokine microbiota putative pro glycomacropeptide flow extraction percentage gas primarily summary inflammation extensive beneficial wild reduced immune obesity inflammatory fatty chromatography content property index dna dependent short nutritional assay reduction chain sequencing functional mouse food application objective plasma management response lower diet concentration pku amino cell phenylketonuria significantly type population acid analysis disease,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""management response lower diet concentration pku amino cell phenylketonuria significantly type p""]}}","{""diet"": {""freq"": 1, ""string"": [""application objective plasma management response lower diet concentration pku amino cell p""]}}",{}
312,312,333,10.1186/s12881-018-0731-5,30612563.0,heterozygote chain nine dominant backgroundtandem iem methioninemia positive glutaric autosomal initial bloodspots retrospective pear fluorometric cost testing effective clinician validation true evaluate pku hydroxylase material utility biochemical relevant supplementary phenylalanine methodsa misinterpretation heterozygous citrullinemia user clinical value coa compound genomic acyl error inborn diagnosis metabolic data prospective novel type potentially metabolism eight methylmalonic pcr case rapid mutation dehydrogenase one short pathogenic isobutyryl correctly phenylketonuria conclusionsthe simple method resultsin exome second online article test electronic assay false version materialthe predictive carrier original amplification sample two mass newborn negative tier authorized dna currently analysis spectrometry program available pah different study acid sequencing assist deficiency accurately gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322297/,abstract,13,misinterpretation methioninemia isobutyryl backgroundtandem pear heterozygote fluorometric bloodspots citrullinemia tier glutaric correctly assist original amplification acyl methylmalonic accurately true heterozygous retrospective resultsin dominant authorized coa pcr methodsa false dehydrogenase validation exome predictive conclusionsthe prospective simple initial clinician pathogenic carrier iem utility autosomal potentially evaluate genomic dna short second compound assay pah negative rapid cost chain sequencing spectrometry materialthe currently relevant hydroxylase biochemical testing inborn supplementary mass program user positive version value electronic error online effective deficiency novel newborn mutation pku material article sample phenylketonuria case available metabolism test phenylalanine type diagnosis acid different metabolic gene method data clinical analysis study,"{""phenylalanine"": {""freq"": 2, ""string"": [""sample phenylketonuria case available metabolism test phenylalanine type diagnosis acid different m""]}}","{""autosomal"": {""freq"": 1, ""string"": [""initial clinician pathogenic carrier iem utility autosomal potentially evaluate genomic dna s""]}, ""heterozygous"": {""freq"": 1, ""string"": [""original amplification acyl methylmalonic accurately true heterozygous retrospective resultsin dominant authorized c""]}}",{},"{""spectrometry"": {""freq"": 1, ""string"": [""pah negative rapid cost chain sequencing spectrometry materialthe currently relevant hydroxylase b""]}, ""newborn"": {""freq"": 1, ""string"": [""electronic error online effective deficiency novel newborn mutation pku material article s""]}, ""fluorometric"": {""freq"": 1, ""string"": [""misinterpretation methioninemia isobutyryl backgroundtandem pear heterozygote fluorometric bloodspots citrullinemia tier glutaric c""]}}",{},{}
313,313,335,10.1371/journal.pone.0179314,28614374.0,biological specific cross relationship neighborhood better difference single dataset gain across algorithm selection savs predsav variation gradient sav reliable validation well disease significantly sequence relevant understanding incorporating range feature gtb structural result diagnosis property computational optimally experiment novel furthermore potentially validate score neutral independent step certain tree prediction capability overall point approach informative method propose auc test association promising specificity wide two variant likely especially competitive effectively explore function mechanism natural benchmark prevention acid advantage amino individual performance show return,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470696/,abstract,0,savs sav predsav incorporating gtb neighborhood benchmark optimally competitive informative gradient tree return dataset auc validate capability neutral gain computational algorithm promising effectively experiment reliable validation prediction propose advantage certain structural independent selection explore specificity step potentially natural property sequence understanding feature likely cross variation furthermore point prevention especially biological relevant wide relationship performance overall score better range variant single association mechanism novel amino difference function approach test individual significantly specific diagnosis acid method result disease,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""range variant single association mechanism novel amino difference function approach test i""]}}",{},{}
314,314,336,10.1016/j.csbj.2018.01.002,30275935.0,commonly pcr beneficial mutation whether disadvantage strategy application prediction beside clinical algorithm goal protein site basic review approach mutagenesis foldx accurate efficient silico research technique physical widely highlighted error prone target immobilization different like attention stability industrial advantage important well question random stabilize,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158775/,abstract,0,foldx immobilization stabilize mutagenesis highlighted disadvantage prone industrial silico random algorithm pcr accurate prediction commonly stability beneficial basic efficient advantage question widely goal physical site attention technique like target application strategy error mutation important approach research review different protein clinical,{},{},{},{},{},{}
315,315,337,10.1186/s12881-017-0464-x,28915855.0,pathway unrelated restriction biosynthesis tetrahydrobiopterin molecular investigate effective supported pku hydroxylase synthesis however phenylalanine definite mutant neurotransmitter thai diagnosis thus generation novel genetic hpa eight use four mutation three main one backgroundhyperphenylalaninemia proper prevent intervention many approach management phenylketonuria technique disability alteration treatment two methodwe allele hyperphenylalaninemia irreversible appropriate involved next classified either alternative also pah intellectual study successfully dietary deficiency patient cofactor conclusionthis gene resultwe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602921/,abstract,0,supported backgroundhyperphenylalaninemia resultwe thai methodwe definite conclusionthis irreversible classified proper unrelated hpa biosynthesis successfully neurotransmitter involved hyperphenylalaninemia cofactor restriction mutant tetrahydrobiopterin alteration alternative prevent intellectual allele appropriate pah synthesis generation disability investigate technique hydroxylase main management effective pathway molecular use deficiency intervention dietary novel mutation pku phenylketonuria approach phenylalanine diagnosis gene genetic treatment patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""dietary novel mutation pku phenylketonuria approach phenylalanine diagnosis gene genetic treatment p""]}, ""intellectual"": {""freq"": 1, ""string"": [""restriction mutant tetrahydrobiopterin alteration alternative prevent intellectual allele appropriate pah synthesis g""]}}","{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""investigate technique hydroxylase main management effective pathway molecular use deficiency intervention d""]}}",{},{},{}
316,316,338,10.1016/j.sbi.2015.07.004,26241318.0,two phenylalanine catalytic monomer form subunit regulated homotetramers structure tyrosine stable hydroxylases divergent consistent undergoes dimer act allosteric site mechanism tryptophan core homologous aromatic property catecholamine enzyme domain equilibrium regulatory acid similar stabilizing active solution hydroxylase amino establishes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688188/,abstract,0,stabilizing homotetramers undergoes hydroxylases establishes divergent homologous regulated equilibrium catecholamine subunit dimer allosteric monomer catalytic core aromatic tryptophan act solution stable active domain regulatory property consistent site structure tyrosine hydroxylase similar form enzyme mechanism amino phenylalanine acid,"{""phenylalanine"": {""freq"": 2, ""string"": []}}",{},{},"{""amino"": {""freq"": 1, ""string"": []}}",{},{}
317,317,339,10.1186/s13023-018-0953-9,30486833.0,specific tool assessment pedsql self example among creation hrqol proxy adult incites condition due heterogeneous severe backgroundhealth multidimensional effective reliable validation evaluate disease responsive material respectively numerous measurement relevant however supplementary life methodsa observer user clinical therapy additionally generic critically obsroms methodology result metabolic resultsof observational mild data change design furthermore score conclusionshrqol main completion measure phenotype interventional implementation instrument relevance evaluation outcome recognition population review approach informative method frequently development social consequently article online electronic nevertheless care imds particularly version still drawback mostly application pediatric objectiveswe especially malley authorized field quality research available arksey importance multiple identify group often study patient prom limitation rarity successful total caregiver,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263554/,abstract,3,obsroms malley incites conclusionshrqol arksey prom observer backgroundhealth multidimensional drawback pedsql objectiveswe imds informative proxy interventional completion creation hrqol critically rarity generic resultsof recognition instrument authorized heterogeneous responsive relevance consequently caregiver methodsa observational reliable validation numerous identify methodology limitation successful mild frequently additionally evaluate pediatric implementation example self furthermore measurement especially particularly evaluation social relevant design importance main phenotype field score severe assessment tool measure supplementary application user change multiple version electronic quality online effective adult respectively care therapy life total material outcome condition article approach available specific research population review development metabolic group method data clinical result patient disease study,"{""social"": {""freq"": 1, ""string"": [""self furthermore measurement especially particularly evaluation social relevant design importance main p""]}}",{},{},{},{},{}
318,318,340,10.1371/journal.pone.0134782,26258410.0,considerable epidemiological whether lys iem lead ratio syrup baht early context mma conclusionat several neonatal serious programme qaly cost effective disease pku icer issue utility incur ascertain however life possible screening carboxylase dollar clinical iva health expense error thai effectiveness result six urine incremental term late long genetic tandem favourable metabolism international methylmalonic detection significant rapid parity per tree problem current implementation child outcome ceiling model phenylketonuria qalys potential mcd resource simultaneous treatment strongly year decision address incidence maple markov process rare backgroundinborn threshold resultsthe mass newborn isovaleric million order estimate propionic comparison thb determine limited approximately magnitude msud quality analysis benefit impact spectrometry also methoda multiple group practice presentation study power deficiency patient complication budget,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530882/,abstract,2,thb qalys qaly methoda mcd lys iva incur icer dollar conclusionat baht incremental ceiling thai markov isovaleric favourable expense budget parity msud mma ascertain carboxylase backgroundinborn tree maple magnitude syrup threshold simultaneous propionic methylmalonic power epidemiological programme million considerable strongly resultsthe complication presentation late tandem iem utility approximately international decision urine resource address estimate effectiveness incidence implementation neonatal comparison rapid limited lead cost context spectrometry practice determine problem benefit issue ratio order detection possible process screening mass long multiple error quality effective deficiency rare impact life newborn current pku outcome term phenylketonuria metabolism model early potential child significant health group year genetic treatment clinical analysis result patient disease study,"{""urine"": {""freq"": 1, ""string"": [""tandem iem utility approximately international decision urine resource address estimate effectiveness i""]}}","{""genetic"": {""freq"": 1, ""string"": [""potential child significant health group year genetic treatment clinical analysis result p""]}}",{},"{""detection"": {""freq"": 1, ""string"": [""determine problem benefit issue ratio order detection possible process screening mass l""]}, ""tandem"": {""freq"": 1, ""string"": [""considerable strongly resultsthe complication presentation late tandem iem utility approximately international d""]}, ""spectrometry"": {""freq"": 1, ""string"": [""comparison rapid limited lead cost context spectrometry practice determine problem benefit i""]}, ""newborn"": {""freq"": 1, ""string"": [""quality effective deficiency rare impact life newborn current pku outcome term p""]}, ""screening"": {""freq"": 1, ""string"": [""issue ratio order detection possible process screening mass long multiple error q""]}}",{},{}
319,319,341,,25767534.0,immediately decompensation instance lethargy growth discus early respond onset view severe common catabolic well objective disease neurological fatal antiepileptic neuroimaging seizure interval neurodevelopmental clinical additionally word invaluable crisis neurologist symptom favorably result metabolic untreated regression detection fare acute normal consciousness drug child prevent sign intervention approach milestone development insult loss manifestation treatment important key vomiting finding near dramatically neurometabolic catabolism newborn poor mostly pediatric paper infant regardless electroencephalography group often presentation refractory patient prominent number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322494/,abstract,0,lethargy consciousness neurologist fare insult favorably invaluable fatal electroencephalography catabolism vomiting refractory catabolic respond neurometabolic neuroimaging instance decompensation antiepileptic milestone dramatically immediately crisis prominent regardless near sign untreated seizure manifestation view neurodevelopmental presentation word interval additionally prevent neurological acute poor pediatric regression loss onset growth paper discus finding detection severe symptom infant normal objective drug key intervention newborn important common approach number early child development metabolic group treatment clinical result patient disease,"{""neurological"": {""freq"": 1, ""string"": [""neurodevelopmental presentation word interval additionally prevent neurological acute poor pediatric regression l""]}}",{},{},"{""detection"": {""freq"": 1, ""string"": [""loss onset growth paper discus finding detection severe symptom infant normal o""]}, ""newborn"": {""freq"": 1, ""string"": [""infant normal objective drug key intervention newborn important common approach number e""]}}",{},{}
320,320,342,10.1016/j.molmet.2019.08.010,,various biological blood conclusionswe almost difference factor pathway across standardized liquid insight multivariable compare deal comparability number well disease pipeline transformation numerous confounder account however quantify understanding observed clinical strongest uni distribution comparable primary methodology analytical metabolic effect large data quantification novel far tandem completely regression level significant necessity three panel one least biomarkers size haematocrit normal current proper relevance comprehensively fully approach enrichment variance regulation method identification prerequisite simulation sex key hormone association network reticulocyte batch steroid best lifestyle process resultsinverse acylcarnitines age mass application waist preprocessing limited hip goal analysis environmental aim characteristic impact outlier spectrometry translation comprehensive cohort study heterogeneity human acid linear amino total metabolite chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734104/,abstract,3,reticulocyte resultsinverse preprocessing outlier haematocrit confounder uni multivariable comparability hip waist strongest deal batch prerequisite compare steroid pipeline necessity comprehensively transformation quantify conclusionswe acylcarnitines enrichment standardized simulation proper variance quantification completely lifestyle relevance comparable fully far sex translation numerous hormone methodology analytical distribution linear heterogeneity goal tandem panel liquid account network comprehensive chromatography best size regulation observed insight regression understanding limited environmental spectrometry biomarkers biological identification cohort characteristic various process aim metabolite normal application mass primary key large pathway association impact novel total current amino difference approach number human factor blood acid age significant metabolic effect method data level clinical analysis disease study,{},"{""heterogeneity"": {""freq"": 1, ""string"": [""numerous hormone methodology analytical distribution linear heterogeneity goal tandem panel liquid a""]}}","{""pathway"": {""freq"": 1, ""string"": [""normal application mass primary key large pathway association impact novel total c""]}}","{""amino"": {""freq"": 1, ""string"": [""pathway association impact novel total current amino difference approach number human f""]}, ""tandem"": {""freq"": 1, ""string"": [""methodology analytical distribution linear heterogeneity goal tandem panel liquid account network c""]}, ""spectrometry"": {""freq"": 1, ""string"": [""observed insight regression understanding limited environmental spectrometry biomarkers biological identification cohort c""]}}",{},{}
321,321,343,10.1515/jomb-2017-0052,30598633.0,hematologic balance correlation disorder new studied factor congenital oxidative present probable due supplementation risk control significantly status platelet mato hematological biochemical however subject marker anti higher value logical conclusionsalthough recently attention effect data pab change cause methodsblood count low use level significant stress oxidant spss many markedly pathological prooxidant potential lym serum thyroid free concentration treatment association tsh version thyroxine sample two selenium paucity healthy determine hypothyroidism index plt also lymphocyte group different high study direct resultsserum backgroundthere patient statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298467/,abstract,3,plt pab mato lym resultsserum prooxidant methodsblood thyroxine platelet hematologic backgroundthere logical oxidant lymphocyte hematological count conclusionsalthough paucity probable selenium tsh spss balance thyroid studied pathological markedly hypothyroidism oxidative statistically anti index supplementation direct stress serum recently marker attention free correlation determine congenital biochemical status healthy subject change cause version value association use concentration higher sample low present significantly new risk control factor potential different significant group effect high data level disorder treatment patient study,{},{},{},{},{},{}
322,322,344,10.1371/journal.pcbi.1004454,26317529.0,cluster glycogenolysis activity investigation class hierarchical early pathway maximum signature glucose glycolysis behavior central coincide sustained physical characterization biomarker physiology regulatory hypothesis concept exercise objective disease longitudinal template knowledge polynomial stick marker moderate form oxidation quantitation mathematical value fold candidate metabolic data change significance late sid perturbation tandem metabolism isotope mfc dynamic external strong stable ergometry approach work identification alanine used predictor potential concentration response fitting fatty finding mfcs pharmacodynamics acylcarnitines within mass statistical function shape kinetic analysis basic mechanism characteristic metabolomics spectrometry group cycle dilution different cohort acetylcarnitine classification pattern high study sugar human acid similar yield hockey highest amino individual total metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552566/,abstract,3,polynomial mfcs mfc hockey glycogenolysis ergometry pharmacodynamics coincide acetylcarnitine sid fitting stick mathematical dilution sustained isotope glycolysis kinetic quantitation hierarchical template perturbation shape external signature maximum alanine acylcarnitines exercise used sugar physiology cluster oxidation yield characterization class classification predictor biomarker dynamic longitudinal basic candidate stable significance fold late strong moderate highest tandem metabolomics hypothesis glucose concept cycle statistical fatty regulatory investigation central physical pattern work behavior marker spectrometry identification cohort characteristic knowledge finding similar form metabolite objective mass change value response pathway mechanism concentration total activity amino function approach metabolism individual human early acid potential different metabolic group high data analysis disease study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""metabolite objective mass change value response pathway mechanism concentration total activity a""]}}","{""amino"": {""freq"": 1, ""string"": [""response pathway mechanism concentration total activity amino function approach metabolism individual h""]}, ""tandem"": {""freq"": 1, ""string"": [""significance fold late strong moderate highest tandem metabolomics hypothesis glucose concept c""]}, ""spectrometry"": {""freq"": 1, ""string"": [""central physical pattern work behavior marker spectrometry identification cohort characteristic knowledge f""]}}",{},{}
323,323,345,10.1002/14651858.CD012618,,biochemical protocol ass cochrane objective role people diet intervention regard lnaa tolerability outcome review neurocognitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478180/,abstract,0,tolerability lnaa regard cochrane neurocognitive people protocol ass biochemical objective diet intervention outcome role review,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": []}}",{}
324,324,346,10.1016/j.ymgmr.2018.06.007,30069431.0,daily factor formula time adult despite palatability intense half unsatisfactory awareness ease pressure due regular declaring source inadequate control clinician addition well disease month survey pku characterize measurement knowledge relevant phenylalanine life compliance transitional questionnaire therapy value protein mol italian complete examination metabolic psychological decrease adherence low level use cornerstone educational rate measure management phenylketonuria day progressively unable social habit treatment response important supplement adolescence diet care nearly process monitoring poor negative lack likely characteristic impact natural consumption inappropriate plasma high last acid periodical dietary center patient participant amino intrinsic perception,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066799/,abstract,1,unsatisfactory transitional declaring cornerstone periodical inappropriate unable progressively intense palatability italian intrinsic ease habit inadequate adolescence supplement regular perception formula awareness nearly psychological characterize pressure educational compliance half adherence monitoring examination complete consumption clinician mol daily poor natural center decrease source survey questionnaire negative lack likely measurement social relevant despite characteristic knowledge participant process measure month addition plasma management day value response adult use diet impact dietary care therapy rate life pku amino important phenylketonuria low time phenylalanine control factor acid protein metabolic high level treatment patient disease,"{""phenylalanine"": {""freq"": 2, ""string"": [""pku amino important phenylketonuria low time phenylalanine control factor acid protein m""]}, ""social"": {""freq"": 1, ""string"": [""survey questionnaire negative lack likely measurement social relevant despite characteristic knowledge p""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""dietary care therapy rate life pku amino important phenylketonuria low time p""]}}","{""diet"": {""freq"": 1, ""string"": [""management day value response adult use diet impact dietary care therapy r""]}}",{}
325,325,347,,26770561.0,male correlation blood relationship whether lead growth energy qdr content elderly density fracture manganese moreover significantly correlatively element subject vertebra osteoporotic interfere trace absorptiometry therefore body copper negatively bmd term level three dual mineral spss many maintenance lumbar development serum unknown concentration cadmium ray inductively year directly incidence age future iron mass osteopoenic selenium healthy carefully influence bone mechanism index beijing spectrometry group plasma study osteoporosis similar zinc epidemiologically total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694461/,abstract,6,vertebra qdr osteoporotic osteopoenic correlatively cadmium inductively epidemiologically manganese interfere copper beijing fracture bmd lumbar absorptiometry elderly trace osteoporosis iron dual carefully selenium ray mineral zinc spss maintenance bone negatively density element energy directly unknown content index incidence serum lead spectrometry influence correlation growth male relationship similar body healthy mass subject plasma future mechanism concentration total term significantly blood age development group year level study,{},{},{},"{""spectrometry"": {""freq"": 1, ""string"": [""unknown content index incidence serum lead spectrometry influence correlation growth male r""]}}",{},{}
326,326,348,10.3390/nu10070818,29941818.0,caloric sweetener european nursing beverage activity better extremely information context effort nutrition july world document weight programme statement physical literature expert mind glycaemic toothpaste source regulatory control publication addition way objective contribute organisation consumer issue line related evidence desirable reduction place broadly extensively role health endocrinology academic lncs body food globally result continued reference guideline calorie furthermore low medicine useful international use administration scientific sustainable current drug provide point population product management regulation plan albeit safety free recommendation key supplement diabetes diet education care option consensus robust public toxicology professional dietetics additive relation since goal authority aspect benefit alternative consumption lisbon also constituent general conclusion fewer nutritional comprehensive sugar substitute position dietary dental assist patient modest,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073242/,abstract,1,toothpaste lncs lisbon glycaemic continued constituent toxicology organisation dietetics caloric sustainable mind endocrinology authority nursing desirable albeit dental statement modest globally calorie sweetener july fewer additive substitute assist extensively broadly academic extremely sugar supplement document consumer beverage position place plan consensus programme contribute publication expert line scientific robust consumption safety option relation reference goal diabetes guideline european nutrition aspect world education international comprehensive alternative useful effort way administration regulatory regulation recommendation professional source physical nutritional weight reduction context furthermore point free product medicine general provide related benefit issue public better literature body food objective addition management drug key use diet dietary care information activity evidence current conclusion role low control population health result patient,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""objective addition management drug key use diet dietary care information activity e""]}}",{}
327,327,349,10.1016/j.neuroimage.2016.09.064,27729276.0,resonance conventionally estimation search observation new vivo region realistic content single improved exhibit among discus greater lower time algorithm cns substantially central accurate unfortunately pathology acquisition disease excellent respectively longitudinal pulse measurement however carlo partial previous relaxation clinically procedure brain therefore particular multicomponent result bayesian recently effect data absent change fraction combination long mapping whole water stochastic signal short interest transverse biomarkers volume depiction failure structure overall src approach model noise method determination system simulation towards simultaneous myelin important bmc fitting limit component within two mwf contraction permit estimate space demonstrate nervous analysis mcdespot upper also high study magnetic equilibrium human small modest derive performance show resolution number parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303643/,abstract,0,depiction bmc stochastic src realistic conventionally carlo noise mcdespot fitting contraction bayesian transverse multicomponent derive relaxation permit mwf absent upper space modest cns unfortunately equilibrium improved myelin mapping acquisition substantially simultaneous pulse estimation simulation exhibit excellent observation algorithm partial resonance resolution fraction determination accurate pathology nervous longitudinal failure water limit demonstrate signal magnetic volume procedure vivo search estimate clinically content parameter previous component particular central short recently combination structure measurement biomarkers greater small discus performance overall region long change lower brain single respectively important approach number time new human model effect high method data analysis result disease study,{},{},{},{},{},{}
328,328,350,10.1002/prca.201600103,28112871.0,experimental correlation blood prm across relevancealthough concern bias biomarker linearity apolipoprotein measurement moderate adequate possible raise clinical protein clinically replacement attention stability validate interference skyline significant develop temperature normal stable analyze method via serum concentration precision assay sample resultsthe hemoglobin provisionally precise analysis venipuncture relatively conclusion designwe purposeproteomic plasma high human linear volunteer accuracy individual total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501987/,abstract,3,skyline relevancealthough purposeproteomic provisionally prm designwe linearity apolipoprotein develop venipuncture interference hemoglobin raise analyze volunteer validate precise bias replacement temperature adequate biomarker stability stable precision resultsthe moderate linear relatively experimental accuracy concern clinically serum assay attention measurement correlation possible normal plasma concentration total conclusion sample individual human blood protein significant high method clinical analysis,{},{},{},{},{},{}
329,329,351,10.1007/s12687-016-0283-3,27796853.0,clinic cbetao abnormal liquid programme hbc accurate contamination pressure umbilical disease hereditary family compliance trait baby screening logistics clinically card genotype result thalassaemia cbeta fetal planning significant society sickle local economic syndrome week model helpful test resource collection sbeta year embark cell cord maternal robust age sample variant newborn haemoglobin guthrie prevalence persistence limited aim diagnostic high study patient confusion chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222757/,abstract,11,thalassaemia sbeta embark cbetao cbeta logistics hbc guthrie umbilical haemoglobin contamination confusion persistence sickle helpful cord card planning hereditary baby programme pressure compliance society accurate fetal local robust economic trait liquid abnormal genotype resource chromatography clinic clinically collection maternal limited syndrome week prevalence diagnostic aim screening variant family newborn cell sample test model age significant year high result patient disease study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""prevalence diagnostic aim screening variant family newborn cell sample test model a""]}, ""screening"": {""freq"": 1, ""string"": [""limited syndrome week prevalence diagnostic aim screening variant family newborn cell s""]}, ""guthrie"": {""freq"": 1, ""string"": [""sbeta embark cbetao cbeta logistics hbc guthrie umbilical haemoglobin contamination confusion p""]}}",{},{}
330,330,352,10.1038/gim.2017.61,28661487.0,worldwide mucopolysaccharide lower proficiency laboratory organic genetics highlight subtle testing majority cap pathologist medical college biochemical subset recent analytic higher clinical nature procedure error inborn analytical data interpretive resultssince metabolism necessity four one least genomics sensitivity conclusionus management accounting minority american test methodsan finding challenge acylcarnitines opportunity since underscore quality analysis program identify pattern acid participant amino performance satisfactory complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763156/,abstract,1,resultssince mucopolysaccharide conclusionus proficiency interpretive cap pathologist methodsan satisfactory analytic subtle necessity minority college accounting underscore acylcarnitines american subset worldwide identify organic genomics analytical nature majority procedure opportunity pattern sensitivity genetics highlight laboratory biochemical performance testing finding participant inborn management program challenge complex error quality medical lower recent amino higher metabolism test acid data clinical analysis,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""complex error quality medical lower recent amino higher metabolism test acid d""]}}",{},{}
331,331,353,,30245780.0,twice inheritance ural european mutation family load north kchr studied region ethnic difference size form among caucasus division diversity russian higher clinical population comparative analysis previously monogenic rural municipal people karachay group part russia nosological volga pool circassian republic patient center disease genetic respectively type city administrative hereditary cherkess,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6146169/,abstract,13,volga ural nosological municipal kchr circassian russian caucasus russia karachay cherkess administrative twice republic division pool ethnic comparative north load rural hereditary inheritance diversity city studied monogenic people european center size previously region form family respectively mutation higher difference type population group genetic clinical analysis patient disease,{},"{""inheritance"": {""freq"": 1, ""string"": [""ethnic comparative north load rural hereditary inheritance diversity city studied monogenic p""]}, ""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
332,332,354,10.1155/2017/6859820,29464117.0,record micronutrient energy profile despite nutrient without potassium due supplementation diverse inadequate status pku intake glycomacropeptide phe medical glytactin adequate observed optimal clinical restrictive sodium food result consume urine reference design metabolon combination crossover low surveillance gmp measure log week management choline phenylketonuria day method excessive diet inc folic generally analysis venipuncture background metabolomics research metabolomic conclusion plasma sugar acid similar dietary participant amino,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804357/,abstract,3,glytactin metabolon venipuncture potassium consume restrictive log choline folic inadequate gmp excessive micronutrient sodium metabolomic crossover surveillance sugar glycomacropeptide adequate generally record diverse optimal nutrient energy reference metabolomics urine supplementation profile observed combination intake despite design week status similar participant food background measure phe plasma management day medical diet dietary pku amino conclusion phenylketonuria low research acid method clinical analysis result,"{""urine"": {""freq"": 1, ""string"": [""diverse optimal nutrient energy reference metabolomics urine supplementation profile observed combination i""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""management day medical diet dietary pku amino conclusion phenylketonuria low research a""]}}","{""diet"": {""freq"": 1, ""string"": [""measure phe plasma management day medical diet dietary pku amino conclusion p""]}}",{}
333,333,355,10.1186/s13633-017-0051-0,29026407.0,disorder whether new pathway congenital world light affected central stringent additional need due moreover severe common risk physiology regulatory virtually underlying origin hypothalamic severely shed igsf decade however evidence much strategy neurodevelopmental recent optimal define conflicting primary obscure mild promptly combination ongoing genetic detection significant case gonadotropes apparent provide management identification development potential face disability thyroid treatment thyrotropes proportion incidence devastating rare variant newborn pituitary likely involved hypothyroidism function approximately benefit research infant multiple consequence intellectual study patient gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625825/,abstract,2,thyrotropes obscure igsf gonadotropes promptly conflicting stringent hypothalamic devastating virtually shed pituitary define severely apparent ongoing thyroid physiology face hypothyroidism origin underlying light affected involved neurodevelopmental optimal proportion mild decade world approximately intellectual regulatory consequence central incidence likely combination disability congenital identification provide benefit additional need detection severe infant management multiple primary strategy variant pathway recent rare newborn evidence common function case new risk research potential significant development gene genetic disorder treatment patient study,"{""intellectual"": {""freq"": 1, ""string"": [""optimal proportion mild decade world approximately intellectual regulatory consequence central incidence l""]}}","{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""infant management multiple primary strategy variant pathway recent rare newborn evidence c""]}}","{""detection"": {""freq"": 1, ""string"": [""congenital identification provide benefit additional need detection severe infant management multiple p""]}, ""newborn"": {""freq"": 1, ""string"": [""primary strategy variant pathway recent rare newborn evidence common function case n""]}}",{},{}
334,334,356,10.1016/j.bbamem.2016.03.028,27045077.0,implication specific activity class new growth essential across condition together fetus compartmental cost modelling transfer increase epithelium membrane syncytiotrophoblast however clinical protein feature principal therefore substrate result transport complement computational fetal mediate clearly certain transporter others fully accumulative approach model phenylketonuria work development system facilitative mother treatment net option specificity carrier flux two poor demonstrate function placental impairment transporting aim framework broad array exchange group plasma different study successfully human distinct amino individual transplacental,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884669/,abstract,0,transplacental syncytiotrophoblast compartmental transporting facilitative accumulative epithelium placental modelling flux mediate principal fetus array net complement transfer clearly exchange computational membrane transporter substrate transport successfully class broad fully fetal distinct demonstrate option mother framework certain carrier poor specificity implication work feature impairment cost essential growth aim plasma increase activity amino condition function phenylketonuria approach individual new human model specific different protein development group treatment clinical result study,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""essential growth aim plasma increase activity amino condition function phenylketonuria approach i""]}}",{},{}
335,335,357,10.1111/ahg.12177,27870113.0,cldn case specific family variant causative gjb santo region brazilian pathogenic remarkably recessive monte single among val etiology simplex screening probands autosomal consistent population analysis myo city haplotype feasible due group geographical different loss northeastern study heterogeneity person northeast genetic variability deafness gene extreme founder brazil,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127167/,abstract,5,santo northeastern gjb cldn myo monte simplex northeast deafness val probands extreme geographical founder remarkably brazilian haplotype causative brazil person city feasible variability etiology pathogenic recessive heterogeneity autosomal consistent loss region screening variant single family case specific population different gene group genetic analysis study,{},"{""autosomal"": {""freq"": 1, ""string"": [""feasible variability etiology pathogenic recessive heterogeneity autosomal consistent loss region screening v""]}, ""recessive"": {""freq"": 1, ""string"": [""person city feasible variability etiology pathogenic recessive heterogeneity autosomal consistent loss r""]}, ""genetic"": {""freq"": 1, ""string"": []}, ""heterogeneity"": {""freq"": 1, ""string"": [""city feasible variability etiology pathogenic recessive heterogeneity autosomal consistent loss region s""]}}",{},"{""screening"": {""freq"": 1, ""string"": [""recessive heterogeneity autosomal consistent loss region screening variant single family case s""]}}",{},{}
336,336,358,10.1016/j.bbagrm.2016.02.005,26855178.0,specific activity factor intestinal cdx caco pancreas site box well epithelial membrane line transcriptional transcription however role conventional chip property data hepatocyte decrease qpcr coordinated type intestine level mutation cellular member nuclear biosynthetic seq foxa sirna many liver enrichment regulation abundance target chromatin caudal response important hormone network diabetes hnf directly assay cell immunoprecipitation process wide biology depletion ontology function approximately analysis also multiple tissue interaction homeobox direct gene kidney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818657/,abstract,2,coordinated cdx caudal caco box homeobox foxa sirna pancreas immunoprecipitation qpcr biosynthetic chromatin seq ontology intestine depletion chip epithelial intestinal enrichment abundance hnf transcriptional membrane kidney conventional hepatocyte transcription nuclear hormone line member biology diabetes cellular approximately network directly property regulation decrease direct site assay liver tissue wide target interaction process multiple response activity mutation important role cell function specific factor type gene data level analysis,{},{},{},{},{},{}
337,337,359,10.3389/fonc.2018.00082,29629339.0,individual decade cancer rapid past death recent factor phenotype pathway among cancerous possible progression profile oxidative several drug adaptation elderly clinical present woman glycolysis necessary resistance neoplasm currently focus identification trial common development target tissue prevalent warburg effect study glycolytic glutaminolysis thyroid metabolic change ability tumor metabolism cell proliferation hallmark incidence finding promising,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876306/,abstract,0,warburg glutaminolysis neoplasm glycolytic cancerous glycolysis elderly hallmark adaptation thyroid proliferation promising prevalent tumor resistance oxidative progression past decade death necessary woman profile incidence cancer focus rapid tissue currently ability identification phenotype target finding possible trial change drug pathway recent common cell present metabolism individual factor development metabolic effect clinical study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""target finding possible trial change drug pathway recent common cell present m""]}}",{},{},{}
338,338,360,10.1126/scitranslmed.aad8166,27280686.0,specific disorder physiological selectively vivo factor fah hpd molecule specifically amenable carboxyethyl selection site mirna modification hairpin sub locus catabolic confers toxicity relevant however event select therapy protein albumin shrna mouse particular supra undergone enzyme protective expansion aav genetic obstacle low hepatocytes recombinant level dioxygenase recombination hydroxyphosphinyl transgene short phenylpyruvate fumarylacetoacetate inhibitor drug tyrosine stable many liver oxobutyrate therapeutic efficiency describe homologous expression system active engraftment therapeutically cell rna hydrolase order resistance universally background often applicable cehpoba human small vector gene highly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242329/,abstract,1,supra oxobutyrate hydroxyphosphinyl cehpoba carboxyethyl phenylpyruvate hpd confers undergone hairpin fah dioxygenase universally therapeutically mirna shrna hydrolase fumarylacetoacetate recombination homologous catabolic selectively engraftment transgene amenable albumin aav select obstacle protective applicable recombinant hepatocytes sub expansion toxicity vector locus resistance rna modification efficiency inhibitor stable physiological specifically event active molecule vivo selection particular short site liver tyrosine highly relevant order small mouse background enzyme expression drug therapeutic therapy cell low human specific factor protein gene genetic level disorder,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
339,339,361,10.1016/j.ymgmr.2015.07.002,26937412.0,blood micronutrient observation nutrition monotherapy throughout nutrient conclusionsbh tetrahydrobiopterin choice due investigate risk control classical cereal methodsretrospective drop vitamin significantly pku intake respectively sensitve phe initiation phenylalanine supply follow therapy range potato food metabolic good aimsbh change term regime long adjuvant period unchanged three one independent implementation adjust product phenylketonuria therapeutic keeping iodine meat abbreviation concentration tolerance habit treatment jeopardize year diet imbalanced education dairy age within iron two achieve quality analysis resultsphe background special aam acid dietary deficiency patient variability amino calcium sensitive mixture,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750587/,abstract,0,sensitve resultsphe jeopardize conclusionsbh aimsbh aam monotherapy keeping cereal regime potato methodsretrospective imbalanced adjust drop adjuvant iron iodine unchanged supply meat dairy habit initiation micronutrient achieve calcium abbreviation mixture tolerance observation special choice vitamin variability classical sensitive nutrient nutrition tetrahydrobiopterin education independent follow good implementation investigate intake product period food background phe long change range quality therapeutic deficiency diet respectively dietary therapy concentration pku amino term phenylketonuria significantly risk phenylalanine control blood acid age metabolic year treatment analysis patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""pku amino term phenylketonuria significantly risk phenylalanine control blood acid age m""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""diet respectively dietary therapy concentration pku amino term phenylketonuria significantly risk p""]}}","{""diet"": {""freq"": 1, ""string"": [""long change range quality therapeutic deficiency diet respectively dietary therapy concentration p""]}}",{}
340,340,362,10.1038/eye.2015.278,26821761.0,male keratitis simplex early aggressive visual author inflammation median onset together pkp severe bullosa clear mean melt purposeto rosacea close disease month note medical follow street marrow sometimes therapy range recovery secondary great ormond retrospectively structural acne movement hand length good cause immune herpes four functional three dystrophic one graft female recurrence anterior pre acute etiology child outcome damage corneal private therapeutic post ass chamber treatment response year phase keratoplasty consecutive resultsfour epidermolysis inflammatory age acuity urgent irreversible recessive achieve bone perforation conclusionpkp hospital eye operative transplantation ranged practice clarity last surgical patient underwent complication methodscase blepharokeratoconjunctivitis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108539/,abstract,4,rosacea pkp perforation ormond operative methodscase melt keratoplasty keratitis corneal conclusionpkp blepharokeratoconjunctivitis acne street herpes epidermolysis dystrophic bullosa simplex resultsfour note clarity acuity recurrence purposeto chamber aggressive urgent ranged graft marrow retrospectively anterior private consecutive surgical eye irreversible achieve underwent hand recovery bone close movement transplantation length visual author inflammation clear damage immune complication great etiology recessive structural inflammatory post acute secondary phase follow pre median good female mean hospital onset practice ass male functional severe month range cause response therapeutic medical therapy outcome early child age year treatment patient disease,{},"{""recessive"": {""freq"": 1, ""string"": [""clear damage immune complication great etiology recessive structural inflammatory post acute s""]}}",{},{},{},{}
341,341,363,10.1371/journal.pone.0176344,28445494.0,sociodemographic male third age account cross overestimate female sectional childhood factor likely prevalence appropriate adequate scale questionnaire adult perception child student height relevance intervention role recognition weight aim impact private district need identification pair prevention grade potential nutritional overweight thus misperception high online study underestimate data conversely treatment school mother silhouette elementary federal evaluate first status year successful show highly maternal non brazil,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405958/,abstract,2,silhouette overestimate misperception underestimate elementary district sociodemographic conversely federal private overweight pair height student grade brazil perception recognition school relevance adequate successful mother account sectional evaluate appropriate maternal female childhood nutritional weight questionnaire likely cross prevention highly identification scale male prevalence status need aim online adult impact intervention non role factor potential child age year high data treatment study,{},{},{},{},{},{}
342,342,364,10.3390/nu9080913,28829397.0,unbiased prescription activity example new factor discus effort among nutrition world avenue behavior physical need sub nutrigenomics well finally exercise solution disease establish microbiota account relevant deep recent obesity clinical health clinically disturbance science food scientist result nowadays metabolic novel type innovative implement level one main advice likewise implementation syndrome relevance intervention many population review approach management work development latest habit precision response promising challenge lifestyle advance professional application prevalence field meaningful basic analysis aspect cardiovascular metabolomics framework translation prevention group overwhelming nutritional comprehensive study successfully dietary individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579706/,abstract,1,overwhelming unbiased nowadays likewise avenue prescription implement nutrigenomics latest innovative habit deep advice scientist exercise meaningful microbiota sub disturbance establish lifestyle promising relevance successfully translation basic solution precision cardiovascular metabolomics framework nutrition aspect account world obesity science comprehensive advance effort clinically professional finally implementation physical work nutritional example behavior prevention syndrome relevant prevalence main discus need field food application management challenge response recent intervention dietary novel activity approach individual new factor type population review development metabolic health group level clinical analysis result disease study,{},{},{},{},{},{}
343,343,365,10.1007/s00431-015-2622-5,26350228.0,european blood clinic new region early among effort time across country adult neonatal document dietician throughout median five frequency need severe common open specialised separate percent risk survey pku material respectively phe initiation pregnant supplementary windowelectronic phenylalanine life possible screening dihydrochloride questionnaire user health inconsistent sequalae improvement minimise result diagnosis metabolic situation dietitian optimally long south potentially area period yet soon government main one per centre eastern woman outcome responsiveness approach management week phenylketonuria day southern target online article test europe treatment ten key care option version materialthe universal threshold every monitoring within newborn poor professional prevalence appropriate access birth sapropterin analysis optimise currently available upper widely conclusion diagnostic comprehensive practice different insufficient patient number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724370/,abstract,10,sequalae windowelectronic specialised optimise optimally minimise dietician soon dihydrochloride eastern upper responsiveness southern inconsistent dietitian threshold initiation europe government south percent insufficient sapropterin document situation universal centre pregnant separate monitoring access option open widely european comprehensive poor effort clinic potentially median appropriate professional woman improvement survey questionnaire neonatal practice materialthe currently frequency week prevalence period main birth need diagnostic country target region severe possible area phe supplementary screening long management day user version key online adult respectively care life newborn pku material outcome conclusion article common phenylketonuria approach number available test time new risk early phenylalanine blood diagnosis different metabolic health treatment analysis result patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""available test time new risk early phenylalanine blood diagnosis different metabolic h""]}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""key online adult respectively care life newborn pku material outcome conclusion a""]}, ""screening"": {""freq"": 1, ""string"": [""region severe possible area phe supplementary screening long management day user v""]}}",{},{}
344,344,366,10.1016/j.cmet.2017.12.006,29337136.0,use line experimental activity production biosynthetic introduction pathophysiologic growth vivo survival rescue evolutionary instead uptake maintain essential adaptation dependent protein enhance anaplerosis precursor xenograft index translation capable report severely variation extracellular result cycle sufficient asparaginase exogenous nucleotide medium utilize acid intermediate cytosolic increase glutamine mammalian asparagine exception tumor amino cell synthesis tca,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803449/,abstract,0,utilize asparaginase anaplerosis tca xenograft pathophysiologic cytosolic evolutionary biosynthetic asparagine maintain glutamine rescue intermediate extracellular exception uptake instead severely adaptation exogenous mammalian capable enhance tumor sufficient survival medium translation introduction line precursor nucleotide cycle experimental production vivo index dependent synthesis variation essential growth increase use report activity amino cell acid protein result,{},{},{},"{""amino"": {""freq"": 1, ""string"": []}}",{},{}
345,345,367,10.1155/2018/3458185,30410553.0,coenzyme pentose difference factor lower pathway profile molecule liquid biosynthesis recruitment action potassium investigate hyperuricemia injection addition discrimination biochemical phenylalanine protection allopurinol delineate granule mainly renal anti coa compound determined nitrogen purine result metabolic effect creatinine oral uric rat metabolism ultrahigh level significant seven ctg cytokine normal structure evaluation nodal model projection method acetyl serum test uracil interconversions urea reversed network inflammatory mass bile orthogonal primarily screen achieve gavage regulated function analysis mechanism spectrometry pantothenate secretion group study acid intraperitoneal hypoxanthine pyrimidine latent performance total metabolite chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206513/,abstract,0,uracil pyrimidine nodal interconversions hyperuricemia granule ctg allopurinol ultrahigh reversed projection pantothenate hypoxanthine gavage pentose delineate purine orthogonal potassium intraperitoneal uric latent regulated nitrogen coenzyme bile acetyl creatinine recruitment discrimination secretion protection achieve cytokine urea renal coa biosynthesis injection primarily determined screen action rat mainly anti seven oral liquid inflammatory network molecule chromatography profile serum compound investigate structure spectrometry evaluation biochemical performance metabolite normal addition mass lower pathway mechanism total difference function metabolism test model phenylalanine factor acid significant metabolic group effect method level analysis result study,"{""phenylalanine"": {""freq"": 2, ""string"": [""total difference function metabolism test model phenylalanine factor acid significant metabolic g""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""performance metabolite normal addition mass lower pathway mechanism total difference function m""]}}","{""spectrometry"": {""freq"": 1, ""string"": [""chromatography profile serum compound investigate structure spectrometry evaluation biochemical performance metabolite n""]}}",{},{}
346,346,368,10.1080/13648470.2017.1381230,29533091.0,judicialisation class context author concern increasingly state diversely way rareness disease neurological grapple account cancer relevant family subject recent clinical therapy health mobilisation legislation global particular ataxia arena attention degenerative genetic infrastructure differently case intersection local genomics dynamic relevance exclusion around inclusion product separately history participation agenda boundary limit care brazil rare public within two access community ethnographic complicated paper research prevention different necessarily right slippery loop patient prominent densely,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890301/,abstract,0,slippery rareness mobilisation judicialisation intersection diversely densely grapple ethnographic necessarily infrastructure degenerative ataxia arena differently legislation agenda boundary separately loop prominent exclusion complicated participation brazil right relevance class author dynamic limit access local genomics increasingly account inclusion community neurological concern way history global particular cancer context attention prevention product relevant paper public state subject recent rare family care therapy case research different health genetic clinical patient disease,"{""neurological"": {""freq"": 1, ""string"": [""local genomics increasingly account inclusion community neurological concern way history global p""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
347,347,369,10.1016/j.gendis.2015.02.008,30258868.0,various specific disorder relationship hypersusceptibility example lead region discus organism instead cystic enveloped defect selection tuberculosis rabies condition malaria pressure geographic well nonetheless virus disease tay infectious hemoglobinopathy endemic evidence adaptive invaluable hemogloginopathies curative niemann fibrosis result gravis large genetic case immunologic abortion although four serendipitous short cover mycotic hypersusceptibilities infection cholera hiv point review phenylketonuria face exposure treatment sachs cell option genetically two filovirus circumstance explore resistance adverse currently mechanism research available also reliably advantage agent glycosylation number myasthenia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150079/,abstract,0,tay serendipitous sachs rabies mycotic myasthenia immunologic hypersusceptibility hypersusceptibilities hemogloginopathies gravis filovirus enveloped tuberculosis cholera niemann invaluable hemoglobinopathy nonetheless malaria glycosylation abortion endemic curative circumstance geographic cover reliably hiv instead cystic adaptive face infectious organism fibrosis resistance pressure virus genetically advantage agent option infection selection explore adverse short example exposure lead point defect currently relationship discus region various large mechanism evidence condition cell phenylketonuria number case available specific research review genetic disorder treatment result disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
348,348,370,10.1016/j.conctc.2017.11.012,29696231.0,whether estimation investigation materially modestly across unconditional restriction choice additional zero hartung pose doe predefine whose presence sidik sparsity cannot event interval relative estimator differ range report analytical effect data level conditioning one least makambi assumption pre overall evaluation accounting method simulation behaviour mandel treatment strongly cell robust two typically comparison depend explore paul analysis jonkman trial practice different reliably study heterogeneity arm meta small performance number deviation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898531/,abstract,0,unconditional sparsity sidik predefine paul materially mandel makambi jonkman hartung modestly estimator conditioning depend zero pose differ accounting reliably arm assumption estimation simulation behaviour deviation typically choice strongly meta analytical robust doe restriction heterogeneity event interval relative explore pre investigation comparison presence practice evaluation additional small performance overall trial range report cell number different effect method data level treatment analysis study,{},"{""heterogeneity"": {""freq"": 1, ""string"": [""strongly meta analytical robust doe restriction heterogeneity event interval relative explore p""]}}",{},{},{},{}
349,349,371,10.5812/ijem.55451,29201074.0,specific worldwide conclusionsit tool methodspublications new region factor lower congenital time positive laboratory despite site cooperation recall molecular cut due suggested preterm vary risk control well status properly physician suitable family evidence marker baby screening range regional expense thyrotropin cutoff project great error result sequela effect psychological cultural assurance use level rate overall intervention point population review technique mental iodine development helpful social parent free test success collection delivery best tsh discharge false incidence challenge wide age protocol sample mass antiseptic contextneonatal hypothyroidism dependent quality criterion program reduce prevention conservative different high acquisitionin human deficiency even unnecessary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702453/,abstract,2,thyrotropin methodspublications contextneonatal antiseptic acquisitionin conservative conclusionsit recall expense assurance vary properly discharge unnecessary suggested cooperation iodine cutoff sequela helpful cut cultural tsh regional preterm hypothyroidism reduce baby psychological project success false worldwide physician suitable great protocol delivery best mental collection dependent incidence site marker criterion point free prevention technique social despite wide parent laboratory congenital status overall region tool screening mass program challenge range positive error quality lower molecular use deficiency family intervention rate evidence sample test time new human risk specific control factor population review different age development effect high level result,"{""social"": {""freq"": 1, ""string"": [""marker criterion point free prevention technique social despite wide parent laboratory c""]}}",{},{},"{""screening"": {""freq"": 1, ""string"": [""laboratory congenital status overall region tool screening mass program challenge range p""]}}",{},{}
350,350,372,10.1016/j.jmb.2016.02.032,26972339.0,correlation disorder cross chain region conformation lower congenital glucose site density glycolysis insight homeostasis central characterization missense highlight substitution proteolysis glycine disease establishes sequence recent gluconeogenesis dysfunction clinical storage role protein crystal diffraction biophysical complete examination arginine structural error inborn away enzyme effect change cause basis phosphoglucomutase first type metabolism medicine mutation multi cellular wild independent phosphate interdomain side contiguous structure sensitivity many switch loss boundary precision key active nearly interface particularly two occur variant along pgm rearrangement electron field domain study human acid deficiency loop conversion even amino glycosylation resolution,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802404/,abstract,3,rearrangement proteolysis phosphoglucomutase contiguous interdomain gluconeogenesis switch pgm establishes diffraction biophysical glycosylation away glycolysis boundary loop glycine conformation occur electron phosphate crystal interface substitution conversion arginine density nearly characterization resolution multi missense precision homeostasis wild storage examination complete glucose cellular structural active independent domain sequence basis insight central site sensitivity loss dysfunction cross structure chain particularly highlight correlation congenital medicine field region inborn enzyme change cause variant key error lower recent deficiency mutation amino role metabolism human type acid protein effect disorder clinical disease study,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""key error lower recent deficiency mutation amino role metabolism human type a""]}}",{},{}
351,351,374,10.1177/1535370216683837,28056555.0,operation blood tool abnormality anxiety positive cfdna ease physical parallel capacity beta risk build practical effective addition display atop true well close significantly respectively pregnant demand however family subject strategy partial amniocentesis statementchildren undesirable range protein burden secondary comparable primary result thus thousand decrease pregnancy fetal low eight singleton chinese chromosomal detection seven rate three one society side syndrome woman method mental efficiency disability free test treatment false hundred cell dramatically wide sample two reduces spot fetoprotein massively tier invasive dna analysis currently either chorionic impact none also diagnostic high study alpha human gonadotropin thirty tactic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367654/,abstract,1,tactic statementchildren chorionic cfdna atop amniocentesis undesirable gonadotropin fetoprotein massively tier singleton build ease dramatically operation display chromosomal beta thirty demand true thousand reduces close invasive pregnant parallel alpha practical partial comparable false efficiency chinese society anxiety capacity fetal burden seven secondary pregnancy mental woman dna decrease physical abnormality disability free syndrome spot currently wide diagnostic detection tool addition subject range primary positive strategy effective family respectively impact rate cell sample low test significantly human risk blood protein high method treatment analysis result study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""free syndrome spot currently wide diagnostic detection tool addition subject range p""]}}",{},{}
352,352,375,10.1007/s40258-015-0177-2,25995075.0,implication imperfect search nbsps information anxiety proxy time positive using cinahl programme five need resultsa cost majority objectivesto material synthesis account supplementary quantify methodsa evidence strategy backgroundthe screening user value narrative result hand base reference term bloodspot four three disutility conclusiona economic database evaluation outcome review quantifies november national technology parent online article resource parental electronic filter medline false list systematic version materialthe newborn suggest estimate limited embase provision currently impact available ovid otherwise part study extent healthcare total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751163/,abstract,1,quantifies nbsps imperfect disutility using ovid conclusiona narrative proxy bloodspot november objectivesto cinahl suggest quantify hand resultsa provision base filter embase medline programme list methodsa parental false backgroundthe anxiety extent economic reference majority account healthcare search resource systematic estimate implication synthesis national limited cost database materialthe evaluation currently parent technology need supplementary screening user positive version strategy value electronic online impact information total newborn evidence material outcome term article available time review result study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""value electronic online impact information total newborn evidence material outcome term a""]}, ""screening"": {""freq"": 1, ""string"": [""evaluation currently parent technology need supplementary screening user positive version strategy v""]}}",{},{}
353,353,376,10.1186/s13023-016-0483-2,27496147.0,mass newborn early recessive since autosomal country many phenylketonuria therefore spectrometry error inborn result continuous treatment macedonia selective pku tandem metabolism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975894/,abstract,1,macedonia continuous selective recessive tandem autosomal spectrometry country inborn mass error newborn pku phenylketonuria metabolism early treatment result,{},"{""autosomal"": {""freq"": 1, ""string"": [""macedonia continuous selective recessive tandem autosomal spectrometry country inborn mass e""]}, ""recessive"": {""freq"": 1, ""string"": [""macedonia continuous selective recessive tandem autosomal spectrometry country i""]}}",{},"{""tandem"": {""freq"": 1, ""string"": [""macedonia continuous selective recessive tandem autosomal spectrometry country inborn m""]}, ""spectrometry"": {""freq"": 1, ""string"": [""macedonia continuous selective recessive tandem autosomal spectrometry country inborn mass error n""]}, ""newborn"": {""freq"": 1, ""string"": [""autosomal spectrometry country inborn mass error newborn pku phenylketonuria metabolism early t""]}}",{},{}
354,354,378,10.1016/j.ymgmr.2018.07.008,30101073.0,european blood milk sectional region growth formula fluctuation across country practicality document necessary five together choice open admission geographical methodswe control varied backgroundin month survey pku intake amount phe phenylalanine largest mainly questionnaire health range focus report diagnosis metabolic guideline question little prospective term feed combination monkey level use pre centre eastern woman management week phenylketonuria technique day method southern sharply evident ass development target resultsninety abbreviation free europe diet western age still within titrating newborn imd professional discussionthis order standard breast birth influence longer hospital infant widely multiple different practice satiety feeding study whereas dietary disorderskeywords,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082991/,abstract,8,titrating resultsninety practicality disorderskeywords sharply monkey discussionthis feed fluctuation satiety geographical eastern southern largest admission imd europe feeding breast abbreviation backgroundin longer document evident formula varied western milk centre choice prospective question mainly open little widely guideline european methodswe sectional necessary pre professional woman survey questionnaire focus hospital combination free intake influence practice technique growth ass week order birth country target standard region month phe infant management day range multiple use diet report dietary newborn pku term phenylketonuria phenylalanine control blood diagnosis different age development metabolic health method level study,"{""phenylalanine"": {""freq"": 2, ""string"": [""report dietary newborn pku term phenylketonuria phenylalanine control blood diagnosis different a""]}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""range multiple use diet report dietary newborn pku term phenylketonuria phenylalanine c""]}}","{""diet"": {""freq"": 1, ""string"": [""infant management day range multiple use diet report dietary newborn pku t""]}}",{}
355,355,379,10.1159/000431250,26087778.0,logistic implication specific hispanic greater information lower cystic condition risk methodswe varied disease statin significantly summary graduate college knowledge however numeracy higher health range genomic report fibrosis result tailor question genetic type score non regression level ethnicity female white format drug overall personal comprehension phenylketonuria customer alzheimer ass older correct test response diabetes year education carrier age sample correlate resultsparticipants characteristic pgt high presentation highest participant accurately demographic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926310/,abstract,2,numeracy customer pgt graduate tailor statin resultsparticipants hispanic comprehension format college personal ethnicity accurately cystic correlate varied demographic alzheimer fibrosis correct logistic summary older presentation question highest white diabetes carrier education methodswe genomic female implication regression greater ass characteristic overall knowledge score participant range drug response lower report information higher condition non sample phenylketonuria test significantly risk specific type age health year high genetic level result disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
356,356,380,10.4274/jcrpe.3128,27353739.0,inheritance disorder blood early ulnar duration boy autosomal country laboratory rickets despite onset physical need due included common cyp pth consanguineous quadratum spasm turkmenistan brother vitamin month respectively measurement knowledge seizure radial renal anthropometric clinical attrs nephrocalcinosis examination recessively report diagnosis tetany radiological data metaphyses alkaline term novel first type pneumonia low level case mutation carpopedal calcitriol text normal marriage dose population hydroxyvitamin product entrez hypocalcemia wrist serum online phosphatase treatment limit carbonate mendelian rare homozygote vddr age still within homozygous healthy man dependent dna truncating available grade nutritional high dihydroxyvitamin nucleotide orally phosphorus ultrasound patient deficiency parathormone even calcium,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198011/,abstract,3,wrist vddr ulnar turkmenistan truncating tetany quadratum parathormone nephrocalcinosis metaphyses hypocalcemia dihydroxyvitamin carpopedal carbonate calcitriol rickets alkaline pth pneumonia man hydroxyvitamin brother spasm phosphatase recessively radiological radial phosphorus homozygote entrez cyp included orally marriage consanguineous anthropometric ultrasound mendelian attrs calcium grade inheritance boy homozygous renal duration seizure vitamin limit examination nucleotide dose text autosomal dna dependent physical serum nutritional onset measurement product despite laboratory need knowledge country month normal healthy online deficiency report rare respectively novel mutation term common low case available early blood type diagnosis population age high data level disorder treatment clinical patient,{},"{""inheritance"": {""freq"": 1, ""string"": [""anthropometric ultrasound mendelian attrs calcium grade inheritance boy homozygous renal duration s""]}, ""autosomal"": {""freq"": 1, ""string"": [""vitamin limit examination nucleotide dose text autosomal dna dependent physical serum n""]}, ""homozygous"": {""freq"": 1, ""string"": [""mendelian attrs calcium grade inheritance boy homozygous renal duration seizure vitamin l""]}}",{},{},{},{}
357,357,381,10.1007/s10545-016-9935-z,27099181.0,major derivatization hilic conclusionthe specific iem class single time defect liquid without retention backgroundamino derivative overcomes material supplementary methodsa quantitative strategy user compound procedure ideal leucine error report inborn column like qualitative consuming run acidopathies metabolism use separation rapid water problem current sensitivity ninhydrin correctly xevo method post mode amide baseline isomeric resultsexcellent online article electronic isoleucine version allo hydrophilic within mass drawback beh cation acquity analysis spectrometry available hplc min underivatized exchange plasma interaction applicable study acid patient amino sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987396/,abstract,5,xevo underivatized resultsexcellent overcomes isomeric hilic beh backgroundamino amide allo acquity acidopathies ninhydrin drawback cation column hydrophilic derivatization run correctly ideal consuming separation retention derivative applicable isoleucine leucine hplc min exchange mode qualitative methodsa conclusionthe class water sensitive iem baseline liquid procedure post quantitative compound sensitivity rapid spectrometry defect problem like interaction inborn supplementary mass plasma major user version strategy electronic error online single use report current material amino article available metabolism time specific acid method analysis patient study,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""resultsexcellent overcomes isomeric hilic beh backgroundamino amide allo acquity acidopathies n"", ""online single use report current material amino article available metabolism time s""]}, ""spectrometry"": {""freq"": 1, ""string"": [""procedure post quantitative compound sensitivity rapid spectrometry defect problem like interaction i""]}}",{},{}
358,358,382,10.3389/fphys.2019.01070,31481901.0,exciting erythrocyte specific blood clinic new vivo several couple biomedical lentiviral modification without native immunogenicity capable erythroid chemical toxin circulation membrane however organ perspective unconventional protein peptide transfection property removal expansion immature immune long useful innovative non use construct administration cellular red drug processing already approach competence biotinylation pathogen method therapeutic convenient expression antibody system tolerance delivery investigator active phase cell insertion peculiar carrier original company application survival differentiation actually crosslinking field vitro precursor research rbc upon mature entity advantage small bifunctional vector patient random agent another number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710399/,abstract,1,erythroid crosslinking biotinylation bifunctional unconventional peculiar rbc convenient actually lentiviral competence transfection removal immature construct mature couple company erythrocyte red investigator exciting circulation toxin immunogenicity pathogen innovative insertion native original biomedical entity expansion processing capable antibody random membrane tolerance vector differentiation peptide modification survival organ chemical immune advantage precursor agent carrier cellular perspective active vitro vivo useful clinic phase administration property delivery small field application long expression drug therapeutic use non cell approach number new specific blood research protein method patient,{},{},{},{},{},{}
359,359,383,10.1186/s13063-016-1261-0,26979433.0,activity selectively lower exert ifg present glucose effectivity supplementation control increase significantly related however beneficial subject marker gov interval clinical additionally double registered effect consuming sucrase design decrease term postprandial crossover type area level significant sucrose water one curve text normal dose hyperglycemia registrationclinicaltrials week backgroundprevious serum test drink prediabetes identifier response hyperglycemic conclusionxylose methodsthe january consumption nct also trial min resultsnormal group glycemic study insulin blind patient randomly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791768/,abstract,14,sucrase resultsnormal prediabetes ifg hyperglycemic effectivity conclusionxylose registered hyperglycemia backgroundprevious postprandial sucrose glycemic selectively exert identifier drink consuming registrationclinicaltrials crossover min curve randomly january insulin blind methodsthe nct gov beneficial water double consumption glucose interval dose additionally text supplementation decrease serum marker design related week area normal subject trial increase response lower activity term present test significantly control type significant group effect level clinical patient study,{},{},{},{},{},{}
360,360,384,10.1038/s41598-019-43892-2,31092881.0,thalassemia disorder single str selection prenatal probable contamination genetics common aneuploidy trisomy segregation well preliminary evaluate respectively subject marker quantitative chromosome arise value globin procedure blastomere haplotype implantation effectiveness diagnosis novel fetal genetic non detection pgd authenticity pcr case panel mutation one pnd pre end carried hapscreen method stage combined mix simultaneous multiplex valuable help cell kit maternal detect linkage sample allele hbb complicated analysis heterozygosity also pgs different otherwise high study arm successfully misdiagnosis direct perform complication paternity gene mlpa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520367/,abstract,9,paternity hbb hapscreen carried blastomere authenticity pgd globin segregation pnd mix misdiagnosis aneuploidy str pgs perform mlpa heterozygosity trisomy thalassemia implantation contamination kit arise combined probable preliminary multiplex arm simultaneous complicated haplotype linkage chromosome detect successfully pcr valuable prenatal fetal complication end panel procedure selection effectiveness allele evaluate stage pre maternal help direct quantitative marker genetics detection subject value single respectively novel mutation non common cell sample case diagnosis different gene high genetic method disorder analysis study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""detection"": {""freq"": 1, ""string"": [""maternal help direct quantitative marker genetics detection subject value single respectively n""]}}",{},{}
361,361,385,10.1038/gim.2015.107,26270766.0,adversely blood chain growth ratio hypomethioninemia content composition early lower oxidative defect www biosynthesis methodsdietary onset risk propionate cblc disease intake medical measurement biochemical however seizure gov registrationthis anthropometric impairs clinical attrs protein brain leucine body food diagnosis effect guideline term combination branched type conclusionspatients methylmalonic regression clinicaltrials methylcobalamin url text outcome history development influx concentration hyperhomocysteinemia imbalanced diet best adenosyl acidemia purposecobalamin devoid resultsprotein height circumference nct cobalamin head trial multiple iatrogenic plasma cohort high study acid methionine barrier dietary deficiency patient amino show parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752912/,abstract,1,resultsprotein purposecobalamin methylcobalamin methodsdietary hypomethioninemia url registrationthis hyperhomocysteinemia devoid conclusionspatients adenosyl imbalanced iatrogenic cblc propionate influx cobalamin adversely impairs branched methionine anthropometric circumference methylmalonic leucine attrs height www acidemia head clinicaltrials biosynthesis nct seizure gov oxidative barrier composition guideline text content parameter best history regression combination onset chain intake measurement defect growth cohort biochemical ratio body food plasma trial multiple medical lower brain deficiency diet dietary concentration amino outcome term risk early blood type diagnosis acid protein development effect high clinical patient disease study,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""lower brain deficiency diet dietary concentration amino outcome term risk early b""]}}","{""diet"": {""freq"": 1, ""string"": [""trial multiple medical lower brain deficiency diet dietary concentration amino outcome t""]}}",{}
362,362,386,10.1016/j.ymgmr.2014.11.003,27896128.0,cross activity better sectional gain boy country turkey adult aged discussionin weight madrid clear pku groningen munich subject childhood strategy porto obesity higher range body food data little score level rate female local centre birmingham overall child woman population resultsin copenhagen europe treatment important introductionin calculated year particularly excess methodsin age within mass percentage prevalence ankara girl brussels index closely general overweight different pattern study vulnerable similar patient individual number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121346/,abstract,4,porto madrid groningen birmingham munich discussionin copenhagen brussels ankara introductionin vulnerable closely turkey overweight excess calculated europe resultsin methodsin girl gain boy centre percentage clear local little obesity sectional index aged woman female pattern childhood weight cross particularly general prevalence overall score country better similar body food mass subject range strategy adult rate activity pku higher important number individual population child different age year data level treatment patient study,{},{},{},{},"{""turkey"": {""freq"": 1, ""string"": [""copenhagen brussels ankara introductionin vulnerable closely turkey overweight excess calculated europe r""]}}",{}
363,363,387,10.1016/j.conctc.2019.100375,31193565.0,various surgery backgroundpharmacokinetic blood whether lead microdialysis single factor information analgesic drks site necessary weight discussioninadequate pdcharacteristics tazobactam parallel open bacterial investigate soft methodswe effective well subcutaneous calculation register measurement relevant pharmacokinetics cefazolin possible dependence piperacillin obesity dependency clinical therapy fluid secondary body primary morbidly data metronidazole prospective regime furthermore mortality non area prophylaxis meropenem administration elective morbidity curve current infection drug population abdominal inclusion model development metamizole exposure concentration auc pharmacokinetic tigecycline regimen acetaminophen pharmacodynamics rare morbid german sample mass obese primarily mostly interstitial dependent antibiotic resistance perioperative criterion analysis eudract aim index keywords trial registrationeu group plasma different tissue study linezolid microdialysate center patient pharmacodynamic individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535681/,abstract,1,tigecycline tazobactam registrationeu piperacillin pdcharacteristics morbidly microdialysate metamizole meropenem linezolid drks discussioninadequate cefazolin backgroundpharmacokinetic prophylaxis pharmacodynamics metronidazole eudract acetaminophen regime perioperative morbid microdialysis elective soft interstitial pharmacodynamic dependency analgesic german dependence subcutaneous pharmacokinetics register pharmacokinetic abdominal surgery auc antibiotic regimen calculation obese curve bacterial parallel resistance primarily fluid keywords prospective open morbidity obesity infection inclusion methodswe secondary necessary center administration mortality index dependent site weight exposure criterion lead investigate furthermore tissue measurement relevant possible various body area aim mass plasma trial primary drug effective single rare therapy information concentration current non sample individual model factor blood population different development group data clinical analysis patient study,{},{},{},{},{},{}
364,364,389,10.1002/humu.22633,25125334.0,disorder tool activity thoroughly almost essential defect half thermostability thermolability characterization due missense stabilization bacterial chemical enzymatic misfolding propionate spectrum biochemical adenosylcobalamin however methylmalonyl dysfunction clinical therapy coa protein mutant structural substrate support mut enzyme thermolabile data stability change cause type exonic recombinant methylmalonic level mutation wild phenotype current population mutase development expression system guide impaired treatment response assay cell devastating future two catabolism ethnic order determine chaperone category influence function turnover aciduria mechanism vitro alternative available depth study cofactor patient categorization gene affinity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441004/,abstract,2,thermostability thermolability thermolabile adenosylcobalamin thoroughly misfolding exonic propionate methylmalonyl categorization stabilization mut devastating catabolism mutase turnover ethnic depth aciduria chaperone affinity methylmalonic recombinant impaired enzymatic bacterial substrate guide coa characterization half stability missense chemical wild category cofactor mutant structural vitro alternative assay dysfunction influence defect essential determine biochemical phenotype order spectrum support tool enzyme expression change cause response future mechanism therapy activity current mutation cell function available type population protein development gene data level disorder treatment clinical patient study,{},{},{},{},{},{}
365,365,390,10.1007/8904_2016_11,27677920.0,coefficient correlation specific nine memory abnormality region early lower anxiety adult researcher battery additional severe average mean traditional uncertain pku phe poorer matter executive however phenylalanine largest introduction moderate tyr higher brain mol structural result auditory low validate rho level direction parietal measure biomarkers white tyrosine pcg phenylketonuria method potential concentration test association adequately two spectroscopy pilot mri index gray ranged conclusion classic high cosy study magnetic neuropsychological gyrus pwm participant variability,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509554/,abstract,4,pwm pcg parietal cosy gray rho ranged gyrus adequately auditory battery uncertain poorer largest validate direction mri spectroscopy neuropsychological pilot coefficient tyr traditional classic executive anxiety researcher introduction variability matter memory mol moderate white magnetic structural average index abnormality mean biomarkers tyrosine correlation additional region participant severe measure phe lower brain association adult concentration pku conclusion higher phenylketonuria low test early phenylalanine specific potential high method level result study,"{""phenylalanine"": {""freq"": 2, ""string"": [""conclusion higher phenylketonuria low test early phenylalanine specific potential high method l""]}}",{},{},{},{},{}
366,366,392,10.1186/s12910-016-0137-x,27600117.0,implication biological relies availability mediafitness consent increasingly awareness literature ethic backgroundhealth regulatory well investigationscivil consumer jurisdictional discussionalthough related subversion subject protection broader hypothetical broadly scenario health guidance safeguard law anonymization secondary therefore particular debate sufficiently attention purpose existence data victim oversight unforeseen beneficent type genetic controversial non use protect reasonable tracker main concerned strong border database outline societal many population scholarly eventsdenial development biobanks social potential resource collection security lawsuitsidentification casualty address challenge informed entry public sample legal mass autocratic negative sensorsethical biometric apps limited testingsocial privacy paper research databasesclinical datadirect consequence comprehensive different cohort forensic study right insufficient human unintended arrangement though beyond individual regimesconclusionscurrent,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011895/,abstract,0,unforeseen testingsocial subversion sensorsethical relies regimesconclusionscurrent mediafitness lawsuitsidentification jurisdictional investigationscivil eventsdenial discussionalthough datadirect databasesclinical casualty beneficent autocratic apps anonymization victim unintended oversight forensic border backgroundhealth tracker scholarly biometric protect biobanks safeguard reasonable concerned security informed hypothetical entry privacy arrangement sufficiently societal scenario law outline existence controversial broader ethic broadly protection debate consent legal guidance insufficient consumer awareness right increasingly strong availability comprehensive resource address secondary regulatory collection consequence particular implication negative limited purpose attention database social biological related cohort paper main public literature mass subject challenge use non sample individual human type research population potential different development health genetic data study,"{""social"": {""freq"": 1, ""string"": [""unforeseen testingsocial subversion sensorsethical relies regimesconclusionscurrent m"", ""implication negative limited purpose attention database social biological related cohort paper m""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
367,367,393,10.1016/j.neurobiolaging.2016.10.006,27871051.0,striatal ratio difference single factor early lower among affect anxiety essential nigrostriatal odds onset investigate risk motor control disease csf worse executive subject marker synuclein dopamine higher clinical contribution genotype enzyme sequela effect strikingly cyclohydrolase novel genetic untreated functional neurobiological quells progression gch modifies guanosine development dat polymorphism year altered cell triphosphate carrier age earlier within future variant production allele unexplored influence function alters younger cognitive parkinson index also study newly initiative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5209269/,abstract,1,quells modifies synuclein nigrostriatal triphosphate guanosine dat alters unexplored strikingly striatal csf gch worse neurobiological younger sequela parkinson cyclohydrolase altered newly odds earlier initiative untreated executive anxiety progression contribution affect motor dopamine polymorphism carrier production genotype allele index marker onset investigate influence essential functional ratio cognitive enzyme subject variant future lower single novel higher difference cell function risk early control factor age development year effect genetic clinical disease study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
368,368,394,10.1016/j.nicl.2019.101916,31491833.0,resonance male implication disorder relationship difference single aged literature pathology mean control pku longitudinal phe tensor matter trajectory executive phenylalanine much compliance volumetric regional developmental brain gap body diffusion semiovale structural contrast date ability metabolism period three neurobiological imaging white structure outcome phenylketonuria disruption development plausible substantial diffusivity treatment callosum year finding address specificity neuropathology centrum age within typically recessive timing mri compromise influence cognitive analysis mechanism prior corpus research mediation gray consequence dti often magnetic acid dietary small mediated amino prominent individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627563/,abstract,2,mediated semiovale mediation centrum volumetric neuropathology gray compromise timing plausible neurobiological dti callosum tensor diffusivity corpus trajectory prominent disruption regional diffusion mri imaging resonance gap compliance pathology substantial executive typically longitudinal matter prior white recessive magnetic structural date contrast address specificity consequence aged implication mean structure developmental influence ability male period small relationship finding literature body cognitive phe brain single mechanism dietary pku amino outcome difference phenylketonuria metabolism individual phenylalanine control research acid age development year disorder treatment analysis,"{""phenylalanine"": {""freq"": 2, ""string"": [""amino outcome difference phenylketonuria metabolism individual phenylalanine control research acid age d""]}}","{""recessive"": {""freq"": 1, ""string"": [""executive typically longitudinal matter prior white recessive magnetic structural date contrast a""]}}",{},"{""amino"": {""freq"": 1, ""string"": [""phe brain single mechanism dietary pku amino outcome difference phenylketonuria metabolism i""]}}",{},{}
369,369,395,10.3390/nu11030529,30823463.0,breastmilk self anxiety formula complexity acceptance motor control formally month pku semi regurgitation amount longitudinal phe however phenylalanine subject family protein symptom environment comparable equivalent food support prospective mealtime low non spoon use gastrointestinal case normalise per volume progression normal spoonable monthly child phenylketonuria day development stage social skill behaviour second parent snack free solid gradually parental associated flatulence texture meal age negative comparison inclusivity special infant fewer practice pattern study substitute bottle complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470524/,abstract,4,texture spoon regurgitation normalise inclusivity flatulence breastmilk spoonable bottle snack mealtime formally monthly meal gradually acceptance fewer substitute gastrointestinal solid semi behaviour formula complexity skill equivalent comparable parental special anxiety longitudinal progression prospective motor volume associated stage environment pattern second negative comparison self free practice social parent food symptom support month phe infant normal subject day complex use family pku non phenylketonuria low case phenylalanine control child protein age development study,"{""phenylalanine"": {""freq"": 2, ""string"": [""family pku non phenylketonuria low case phenylalanine control child protein age d""]}, ""social"": {""freq"": 1, ""string"": [""second negative comparison self free practice social parent food symptom support m""]}}",{},{},{},{},{}
370,370,396,10.1038/s41598-017-01991-y,28536443.0,occipitofrontal nine context lower diameter positive prenatal unrelated accurate eligible true virus measurement pregnant presence higher value consistent therefore zika diagnosis pregnancy fetal full bpd text infection sensitivity database woman march inclusion ofd false predictive specificity threshold microcephaly two negative estimate biometric standard bibliographic circumference analysis criterion biparietal head group study meta ultrasound absence accuracy number deviation parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442132/,abstract,5,ofd bpd biparietal occipitofrontal bibliographic biometric zika diameter march microcephaly ultrasound threshold eligible circumference true unrelated head deviation pregnant false virus accurate prenatal predictive fetal absence meta infection accuracy text inclusion specificity estimate pregnancy parameter woman consistent sensitivity negative criterion context presence measurement database standard positive value lower higher number diagnosis group analysis study,"{""microcephaly"": {""freq"": 1, ""string"": [""occipitofrontal bibliographic biometric zika diameter march microcephaly ultrasound threshold eligible circumference t""]}}",{},{},{},{},{}
371,371,397,10.1016/j.ymgmr.2019.100466,30963029.0,disorder prescription delay better new examine instead researcher median choice open pharmacist experience backgroundin well aima month visit amount longitudinal methodsimd questionnaire storage protein inefficiency home burden conclusionsalthough whereby primary error food support effectiveness simpler metabolic recently observational dietitian date prospective question incorrect adequacy low period service customary receipt member one least local problem gluten overall product method resultsin system check safety free resource team treatment delivery diet care complex still two dietetic prescribe imd company likely access unclear limited inaccuracy special also multiple different pharmacy study patient stock total caregiver,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434332/,abstract,9,stock methodsimd inefficiency customary simpler receipt pharmacy pharmacist inaccuracy aima prescribe gluten check incorrect conclusionsalthough dietetic company adequacy prescription dietitian instead imd visit backgroundin resultsin team home caregiver observational special examine researcher longitudinal choice prospective storage access local delay unclear question member burden safety open date resource effectiveness experience delivery median service recently questionnaire likely limited free product problem period overall better food support month multiple complex primary error diet care total low new different protein metabolic method disorder treatment patient study,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""support month multiple complex primary error diet care total low new d""]}}",{}
372,372,398,10.1093/molbev/msw005,26764160.0,considerable interestingly specific almost fundamental difference representative information across several site unrelated publicly detailed frequency need pathology risk cardiomyopathy number disease medical third relevant cancer however opposite recent distinguish observed differ role real complete project genomic result like purpose effect large conferring server degenerative type whole babelomics one retinal local schizophrenia drug overall relevance highly population motivated catalog private alzheimer exome web dystrophy susceptibility polymorphism important association http list allelic mendelian rare variant allele prevalence scale healthy spv resistance adverse available correspondence also different trend study considerably sequencing similar position page variability individual complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839216/,abstract,2,spv babelomics correspondence conferring server motivated catalog degenerative publicly http cardiomyopathy page dystrophy opposite differ retinal distinguish considerably allelic private schizophrenia mendelian interestingly representative unrelated detailed position fundamental web alzheimer susceptibility relevance list resistance project trend real pathology exome considerable variability local complete polymorphism allele genomic adverse observed cancer site purpose sequencing highly frequency relevant scale like prevalence need overall similar healthy complex drug variant medical large association recent rare information important role difference number available individual risk specific type population different effect result disease study,{},{},{},{},{},{}
373,373,399,10.1093/ajcn/nqy348,31175810.0,major worldwide backgroundchild cochrane growth formula across inverse weight bias odds literature preterm supplementation abstract stratified investigate risk source publication well gestational animal cumulative unique childhood continent fill health protein science food length effect conclusionssupplementation resultsof data term pregnancy egger low score latin young regression plot full neither main measure trim text independently problem child outcome variance method people web article american caribbean test mother finding maternal library generally age public lack million limited birth embase height analysis aim index funnel infant also trial study heterogeneity anthropometry whereas meta small objectivethe participant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669064/,abstract,8,trim funnel caribbean backgroundchild egger continent conclusionssupplementation stratified latin anthropometry inverse plot objectivethe resultsof library cumulative abstract cochrane height odds embase variance preterm formula web independently bias length gestational million american publication worldwide young generally meta people heterogeneity mother unique text science pregnancy maternal index supplementation source childhood regression animal weight lack limited investigate growth problem main public birth small score finding participant literature food aim measure infant trial major outcome term article low test risk child protein age health effect method data analysis study,{},"{""heterogeneity"": {""freq"": 1, ""string"": [""publication worldwide young generally meta people heterogeneity mother unique text science p""]}}",{},{},{},{}
374,374,400,10.1007/s00726-014-1893-x,25526869.0,correlation disorder early essential positive nutrient together structurally common chemical aromatic correlating jacchus principle disease primate neurological phe knowledge lifecycle phenylalanine cumulative strategy exposome interfere callithrix health compound developmental feature structural termed result utilization microbial marmoset little specie genetic non level alter requirement structure database many development exposure concentration test similarity systematic excess endogenous negative lifelong ring adverse analysis environmental impact metabolomics also consequence nutritional plasma high vulnerable acid human similar dietary deficiency agent amino individual resolution metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329081/,abstract,3,termed jacchus callithrix lifecycle correlating marmoset interfere structurally exposome primate vulnerable ring utilization microbial excess cumulative alter similarity lifelong requirement endogenous aromatic specie principle resolution chemical agent nutrient little metabolomics structural neurological systematic consequence adverse compound nutritional negative feature exposure environmental structure developmental database correlation essential knowledge similar metabolite phe plasma positive strategy deficiency impact dietary concentration amino non common test individual human early phenylalanine acid development health high genetic level disorder analysis result disease,"{""phenylalanine"": {""freq"": 2, ""string"": [""non common test individual human early phenylalanine acid development health high g""]}, ""neurological"": {""freq"": 1, ""string"": [""chemical agent nutrient little metabolomics structural neurological systematic consequence adverse compound n""]}}","{""genetic"": {""freq"": 1, ""string"": [""early phenylalanine acid development health high genetic level disorder analysis result d""]}}",{},"{""amino"": {""freq"": 1, ""string"": [""positive strategy deficiency impact dietary concentration amino non common test individual h""]}}",{},{}
375,375,401,10.1007/8904_2014_368,25366392.0,exon handicap delay activity self boy present without due continuous motor nyhan disease recurrent spectrum overproduction lnd lesch extrapyramidal maladaptive milder nephrolithiasis injurious higher clinical developmental hyperuricaemia abolish hypotonia never message result enzyme metabolic gout uric low significant case mutation one involvement phenotype fully sign degree phosphoribosyltransferase associate urate disability behaviour key rare generally age permit variant guanine lack residual cognitive deletion analysis currently classic intellectual acid hypoxanthine hprt deficiency patient pyramidal though null gene injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361920/,abstract,1,urate phosphoribosyltransferase nephrolithiasis lnd hyperuricaemia hprt gout nyhan maladaptive lesch hypoxanthine handicap overproduction injurious extrapyramidal abolish guanine pyramidal permit associate uric hypotonia null milder message recurrent behaviour residual boy sign injury continuous involvement fully degree deletion classic exon generally delay motor intellectual lack self disability developmental currently phenotype spectrum cognitive enzyme variant key deficiency rare activity mutation higher low present case acid age significant metabolic gene clinical analysis result patient disease,"{""intellectual"": {""freq"": 1, ""string"": [""deletion classic exon generally delay motor intellectual lack self disability developmental c""]}}",{},{},{},{},{}
376,376,402,10.3389/fphys.2019.00467,31133865.0,male exon new encoding single fructose affect amelioration several autosomal defect algorithm glucose despite reaction glycolysis attributable insight molecular severe common neuromuscular admission locus severity origin doe disease neurological kinase reversible hematological family largest isomerase interval erythro trait moderate chromosome sometimes clinical always italian conserved symptom spherocytic great report pyruvate never result six enzyme hgmd far eight non case four mutation variable female phosphate step pathogenic database residue disability second enzymopathy year isomerization gpi rare splenectomy age deficient causative recessive hemolytic series chronic dependent impairment aspect characteristic none also intellectual different dimeric study heterogeneity deficiency patient anaerobic gene highly anemia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514191/,abstract,9,splenectomy spherocytic isomerization hgmd hemolytic gpi enzymopathy anaerobic isomerase erythro amelioration dimeric neuromuscular fructose conserved hematological anemia italian glycolysis pyruvate kinase reversible phosphate largest attributable admission chromosome causative residue encoding series origin algorithm locus far exon deficient great doe pathogenic moderate affect recessive heterogeneity glucose trait severity interval aspect neurological autosomal intellectual step reaction dependent female insight variable second impairment disability chronic database highly defect despite male characteristic severe symptom enzyme single molecular deficiency report rare family mutation non common case new different age gene year clinical result patient disease study,"{""neurological"": {""freq"": 1, ""string"": [""heterogeneity glucose trait severity interval aspect neurological autosomal intellectual step reaction d""]}, ""intellectual"": {""freq"": 1, ""string"": [""trait severity interval aspect neurological autosomal intellectual step reaction dependent female i""]}}","{""autosomal"": {""freq"": 1, ""string"": [""glucose trait severity interval aspect neurological autosomal intellectual step reaction dependent f""]}, ""recessive"": {""freq"": 1, ""string"": [""deficient great doe pathogenic moderate affect recessive heterogeneity glucose trait severity i""]}, ""heterogeneity"": {""freq"": 1, ""string"": [""great doe pathogenic moderate affect recessive heterogeneity glucose trait severity interval a""]}}",{},{},{},{}
377,377,403,10.1093/glycob/cwx070,29044377.0,self threat glycol investigation better dos molecule time site biosynthesis glca immunogenicity postmodification xenograft analogy encapsulation mononuclear formulation hep circulation disease escape camouflage computer characterize utility cancer however life strategy anti prolongs sometimes mouse polyethylene heparosan capsule effectiveness bacteria thus efficacy effect immune lipid potentially rat useful detection certain clearance grain dynamic deposition drug side infection scattering outcome population model liposome hypersensitivity target system free coated test phagocyte delivery response doxorubicin insertion glcnac heparin hydrophilic chemotherapeutic passively healthy especially vehicle poisoning breast quality precursor natural alternative also extracellular multiple foreign tissue study human constrain small liposomal patient mammal agent tumor,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881748/,abstract,0,prolongs postmodification phagocyte passively liposomal heparosan glcnac glca doxorubicin constrain coated camouflage analogy poisoning liposome hep grain deposition chemotherapeutic xenograft scattering heparin foreign escape encapsulation glycol mononuclear hydrophilic hypersensitivity capsule vehicle threat mammal circulation immunogenicity clearance polyethylene extracellular insertion computer breast formulation dos bacteria characterize biosynthesis tumor lipid dynamic immune precursor agent rat anti certain utility infection molecule alternative useful effectiveness potentially natural delivery investigation cancer site efficacy self free tissue especially small target better mouse detection healthy multiple drug strategy response quality life outcome test time human model population effect patient disease study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""tissue especially small target better mouse detection healthy multiple drug strategy r""]}}",{},{}
378,378,404,10.1002/cmmi.1711,27596704.0,various experimental specific demyelination new vivo content greater visible essential light microscopy optical luxol reliable section synthesis matter visualization remyelination value compound clinically brain feature fast mouse structural image result property contrast cause validate histological use detection relaxivity emission gdiii white drug block structure technique method texaphyrins development multimodal myelin probe near specificity visualize orthogonal application demonstrate blue stain study magnetic agent accurately absorption complex enables,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5247309/,abstract,0,texaphyrins stain remyelination relaxivity luxol gdiii multimodal visualize visualization orthogonal demyelination blue optical histological visible microscopy enables myelin image section absorption validate accurately probe fast emission block near light reliable matter demonstrate agent white magnetic structural experimental vivo contrast specificity clinically content property compound feature synthesis structure greater technique essential mouse detection various application complex cause drug value brain use new specific development method result study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""synthesis structure greater technique essential mouse detection various application complex cause d""]}}",{},{}
379,379,405,10.1186/s13023-018-0911-6,30268140.0,european early world restriction partially tetrahydrobiopterin additional subsequently expert interpret algorithmic experience effective pku responsive material opinion line biochemical however supplementary strategy optimal dihydrochloride user range guidance real alone particular expertise diagnosis complement guideline term pharmacotherapy long resultsour measure cover format overall provide outcome responsiveness many management phenylketonuria therapeutic ass online article test treatment important electronic serve year diet care option particularly version age newborn approval appropriate accordingly usa sapropterin birth loading individualized previously aspect aim backgroundtreatment available monitor also union advantage dietary patient,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162894/,abstract,1,backgroundtreatment algorithmic pharmacotherapy union serve resultsour individualized interpret format dihydrochloride cover usa responsiveness loading approval expertise complement monitor opinion guidance sapropterin accordingly partially subsequently responsive real expert line advantage optimal restriction option guideline european aspect world tetrahydrobiopterin experience appropriate particular particularly previously ass provide additional biochemical birth overall aim measure supplementary long management user range version strategy electronic online therapeutic effective diet dietary care newborn pku material outcome term article important phenylketonuria available test early diagnosis age year treatment patient,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""online therapeutic effective diet dietary care newborn pku material outcome term a""]}}","{""diet"": {""freq"": 1, ""string"": [""version strategy electronic online therapeutic effective diet dietary care newborn pku m""]}}",{}
380,380,406,10.1093/aje/kwx227,28978193.0,tool assessment new additional need genetics annotation highlight institute conjunction disease issue respect cancer workshop recent health improvement environment science analytical recently large data design generation consideration theme functional society measure annual current october discovery outcome many population omics critical approach method national exposure american meeting year incorporation challenge particularly opportunity scale continual statistical field next environmental paper research interaction study human sequencing participant gene complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5860428/,abstract,0,continual workshop annotation meeting incorporation october institute omics conjunction annual respect theme american society consideration analytical discovery opportunity statistical science environment improvement cancer recently genetics exposure national generation critical environmental sequencing particularly highlight design scale functional paper issue additional need field interaction participant assessment tool measure challenge complex large recent current outcome approach new human research population health gene year method data disease study,{},{},{},{},{},{}
381,381,407,10.1016/j.jnutbio.2016.09.002,27764725.0,immediately glycemia difference early maximum time mmol glucose inhibit insulinotropic together vascular fruit polyphenols glycoside control cmax significantly pulse polyphenolic gov dvp relative clinical attrs health double arterial peptide equivalent food like metabolic effect incretin postmenopausal term similarly postprandial crossover type low incretins non area clinicaltrials concentrationkeywords roughly isoprostane placebo volume text dose woman blackcurrants stiffness inclusion reflection blackcurrant con abbreviation glucagon baseline concentration intermediate treatment carbohydrate rich response digital fatty year aob berry meal age determine function cardio dependent benefit aim index consumption nct trial secretion min polypeptide tag plasma high sugar medium glp triacylglycerol nefa insulin acid blind men total gip,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5170886/,abstract,5,triacylglycerol polyphenols polyphenolic isoprostane glycoside gip dvp concentrationkeywords blackcurrants blackcurrant berry aob postmenopausal nefa incretins incretin glycemia cmax tag roughly mmol insulinotropic glp postprandial polypeptide cardio stiffness digital arterial glucagon reflection inhibit meal intermediate men maximum immediately fruit secretion pulse attrs abbreviation crossover carbohydrate sugar similarly vascular min rich equivalent clinicaltrials insulin blind placebo peptide nct gov medium double consumption glucose baseline volume dose text relative inclusion fatty index woman dependent determine benefit like food area aim plasma trial response concentration total term non difference function low time significantly early control type acid age metabolic health year effect high treatment clinical,{},{},{},{},{},{}
382,382,408,10.1186/s13023-019-1153-y,31331350.0,major conclusionthe disorder backgroundphenylketonuria growth ratio difference among methodsthis adult contains throughout reaction without aged retrospective severe ingef common chemical colitis beta requisite risk asthma control disease significantly hydroxylase material gastroenteritis atc numerous infectious maintained renin supplementary seizure phenylalanine life interval antirheumatic introduction unspecified poorly possible screening anti clinical value higher user blocker angiotensin replacement burden diagnosis enzyme giddiness medication significant soon commonly confidence stress mellitus ischemic comorbidities systemic database overall damage antibacterial population management therapeutic unexpected ass via illness online article electronic angewandte germany diabetes year version exact microcephaly anatomical inflammatory age hence deficient within berlin resultsthe newborn continuously dizziness adjustment million irreversible prevalence sapropterin approximately heart chronic authorized impairment analysis aim research available depressive pah general group intellectual cohort matching study acid direct deficiency patient agent healthcare gender statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647060/,abstract,6,ingef giddiness gastroenteritis atc antirheumatic antibacterial angewandte unspecified requisite dizziness colitis renin matching ischemic berlin asthma unexpected maintained anatomical blocker angiotensin soon depressive comorbidities exact contains microcephaly mellitus adjustment continuously beta backgroundphenylketonuria irreversible germany illness sapropterin retrospective authorized infectious methodsthis poorly replacement million conclusionthe systemic seizure medication commonly numerous introduction deficient gender damage chemical resultsthe confidence statistically agent burden anti diabetes interval inflammatory healthcare approximately intellectual heart reaction aged direct stress pah impairment chronic database growth ass general cohort prevalence hydroxylase ratio overall severe possible aim enzyme supplementary screening management major user version value electronic online therapeutic adult deficiency life newborn material higher article difference common available significantly risk phenylalanine control diagnosis research population acid age significant group year disorder clinical analysis patient disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""article difference common available significantly risk phenylalanine control diagnosis research population a""]}, ""microcephaly"": {""freq"": 1, ""string"": [""angiotensin soon depressive comorbidities exact contains microcephaly mellitus adjustment continuously beta b""]}, ""intellectual"": {""freq"": 1, ""string"": [""anti diabetes interval inflammatory healthcare approximately intellectual heart reaction aged direct s""]}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""electronic online therapeutic adult deficiency life newborn material higher article difference c""]}, ""screening"": {""freq"": 1, ""string"": [""overall severe possible aim enzyme supplementary screening management major user version v""]}}",{},{}
383,383,409,10.1016/j.gendis.2016.11.004,30258912.0,major european disorder exon observation among slovak autosomal defect unrelated necessary central molecular frequency missense common origin pku hydroxylase slovenian subset later phenylalanine evidence relative previous italian determined improvement mutant diagnosis metabolic existence large cause ukraine first detection pcr mutation one population polish management phenylketonuria frequent simultaneous important finding amplification czech allele negative recessive demonstrate dna deletion analysis previously also pah del study predominantly deficiency patient slavic descent ukrainian gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136599/,abstract,2,ukrainian ukraine slavic polish slovenian descent slovak czech italian del existence simultaneous amplification unrelated predominantly origin observation subset pcr determined deletion missense exon demonstrate later frequent mutant recessive european relative autosomal necessary allele previous dna central improvement pah negative defect previously frequency hydroxylase finding detection management major cause large molecular deficiency evidence mutation pku important common phenylketonuria phenylalanine diagnosis population metabolic gene disorder analysis patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""evidence mutation pku important common phenylketonuria phenylalanine diagnosis population metabolic gene d""]}}","{""autosomal"": {""freq"": 1, ""string"": [""later frequent mutant recessive european relative autosomal necessary allele previous dna c""]}, ""recessive"": {""freq"": 1, ""string"": [""missense exon demonstrate later frequent mutant recessive european relative autosomal necessary a""]}}",{},"{""detection"": {""freq"": 1, ""string"": [""negative defect previously frequency hydroxylase finding detection management major cause large m""]}}",{},{}
384,384,410,10.1042/EBC20170054,30509933.0,exciting rare biochemical microorganism cancer biochemistry pharmacology reader new scope form biology pathway discussion problem current give nutrition since remit role health range many commonality procedure insight liver global aspect attempt closely readily technique method coverage also alzheimer pathology common development highlight comprehensive consequently article physiology source cause key detail diabetes disease accessible survey succinct beyond cell atherosclerosis fascinating,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279435/,abstract,0,remit fascinating commonality succinct atherosclerosis reader exciting closely pharmacology microorganism biochemistry attempt scope readily accessible coverage physiology alzheimer consequently discussion pathology biology diabetes nutrition aspect procedure comprehensive global insight source survey cancer liver highlight technique problem biochemical form range cause key pathway rare current article role common cell new development health method disease,{},{},"{""pathway"": {""freq"": 1, ""string"": [""problem biochemical form range cause key pathway rare current article role c""]}}",{},{},{}
385,385,411,10.1016/j.vph.2015.08.009,26276526.0,specific hour vivo factor context essential inflammation septic biosynthesis partially condition tetrahydrobiopterin severe vasoconstriction vascular lipopolysaccharide control endothelial increase significantly lipopolysaccharidekeywords enos overproduction evidence broader dysfunction role phenylephrine mouse contribution hypotension aortic data novel type level significant saline wild independent endotoxaemia gch systemic provide therapeutic mediator endothelium target abbreviation vasculature loss shock vasodilatations artery treatment impaired response key directly challenge cell isometric deficient upregulation aorta production nitric unclear determine fltie ring cre heart dependent reduced gtp lung also mesenteric study oxide direct tension patient even,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746318/,abstract,1,vasodilatations vasoconstriction phenylephrine mesenteric lipopolysaccharidekeywords isometric fltie endotoxaemia septic lipopolysaccharide hypotension overproduction vasculature tension shock saline cre aorta enos endothelium upregulation gch ring mediator artery aortic gtp broader lung abbreviation endothelial vascular impaired nitric partially oxide biosynthesis systemic inflammation hour deficient contribution wild reduced unclear tetrahydrobiopterin production independent vivo directly heart dependent direct loss dysfunction context essential determine provide target mouse severe challenge increase key response therapeutic novel evidence condition role cell significantly specific control factor type significant data level treatment patient study,{},{},{},{},{},{}
386,386,412,10.1371/journal.pone.0150289,26954501.0,interpretation memory class difference information context across adult increasingly efficient interpret difficulty clear metaphor old experience objective significantly individual knowledge executive however strategy latter verbal developmental contribution task result semantic effect novel first inhibition low young level clearly case three variable main one processing comprehension inclusion evident predictor development analyse analogical relational reasoning year age two progress working updating involved function cognitive either special reading relatively none importance group different high whereas restricted absence participant performance highly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783029/,abstract,4,metaphor analogical semantic reasoning updating relational working comprehension reading interpret restricted verbal analyse clearly processing evident interpretation progress class predictor clear special young executive contribution absence involved efficient inhibition memory increasingly difficulty task relatively inclusion experience variable old context developmental highly importance main performance knowledge participant cognitive objective strategy adult novel information difference function low case individual significantly different age development group year effect high level result,{},{},{},{},{},{}
387,387,413,10.1186/s12887-019-1590-8,31288776.0,netherlands blood example new factor information early positive several consent neonatal developing insight condition easily retention need contributes conclusionswhile survey material pregnant account relevant supplementary subject methodsa adequate screening speaking perspective user always mixed safeguard focus dutch identifies secondary therefore debate internationally interview design ndbs bloodspot type use clearly one least involvement communication discussion current implementation overall woman child intervention damage minimize population par week regulation feasible method partner potential system prerequisite parent online article guide topic parental electronic active accessible year decision challenge option version materialthe public updating spot backgroundneonatal irreversible authorized actor privacy longer aim research available depth policy group comprehensive different study participant individual perception,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615086/,abstract,1,speaking conclusionswhile ndbs backgroundneonatal par developing actor updating safeguard internationally minimize prerequisite netherlands dutch privacy identifies bloodspot depth retention partner easily contributes irreversible debate consent accessible clearly longer topic perception mixed authorized guide feasible pregnant methodsa parental involvement interview discussion adequate damage communication option account perspective active comprehensive decision secondary policy regulation woman insight implementation survey focus example neonatal materialthe spot relevant parent design week public need overall participant aim supplementary screening subject challenge user positive version electronic online use intervention information current material condition article available individual new early factor blood type research population potential child different group year method study,{},{},{},"{""screening"": {""freq"": 1, ""string"": [""public need overall participant aim supplementary screening subject challenge user positive v""]}}",{},{}
388,388,414,10.1074/jbc.M115.670646,26292219.0,specific cluster activity dominant factor pathway reporter cystic binding site host control mesenchymal increased transition disease pkhd epithelial promoter transcriptional transcription microarray evolutionarily family organ sirnas pkd renal previous encodes mouse whereby mutant luciferase ttll chip hepatocyte generation novel long inhibition bind level pcr mirnas mutation member nuclear seq produce micrornas mir target expression chromatin overexpression active hnf directly assay lncrna cell immunoprecipitation within two rna negative regulated cyst next upstream analysis tissue study gene kidney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598991/,abstract,1,ttll sirnas pkhd pkd micrornas lncrna evolutionarily mirnas mesenchymal upstream luciferase increased immunoprecipitation cyst overexpression mir chromatin seq regulated microarray binding encodes reporter chip epithelial bind host produce dominant cystic hnf transcriptional promoter kidney cluster renal transition pcr rna hepatocyte organ transcription nuclear inhibition member mutant active directly previous site assay negative generation tissue target mouse long expression pathway family novel activity mutation cell specific control factor gene level analysis disease study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""generation tissue target mouse long expression pathway family novel activity mutation c""]}}",{},{},{}
389,389,415,10.1186/s13052-016-0311-2,27871331.0,sporadic ratio greater single dars among congenital mar msc defect odds common risk control number significantly respectively hypothesize account iars interval poorly trna form additionally resultswe fold kars therefore chd effect aminoacyl potentially eight chinese nonenzymatic non rars significant case confidence vsd four three functional etiology dose subtype population multisynthetase susceptibility polymorphism component methodsin within snp variant allele synthetases influence ptrend heart backgroundventricular different nucleotide study isolated patient septal gene individual complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117545/,abstract,5,vsd synthetases rars ptrend mar kars iars dars backgroundventricular nonenzymatic multisynthetase septal msc hypothesize aminoacyl trna subtype sporadic isolated methodsin chd odds resultswe susceptibility poorly snp chinese fold confidence etiology nucleotide polymorphism interval account dose additionally potentially heart allele component influence greater defect congenital functional ratio form complex variant single respectively non common number case individual significantly risk control population different significant gene effect patient study,{},{},{},{},{},{}
390,390,416,10.1093/jn/nxx039,29490096.0,blood greater early lower profile adult despite inflammation www biosynthesis due supplementation trimethylamine bacterial risk methodswe resultsrbc control classical docosahexaenoic urinary excretion significantly glycomacropeptide intake membrane phe medical animal subset phenylalanine gov milder higher clinical attrs protein degradation food bacteria conclusionssupplementation urine eicosapentaenoic term metabolon combination lipid crossover type metabolism low clinicaltrials red text tmao many phenylketonuria combined concentration bioavailability fatty diet intensity cell devoid sample carnitine variant percentage adolescent cognitive impairment analysis dha metabolomics nct backgroundindividuals trial group plasma different part whereas oxide acid objectiveto similar prebiotic participant amino total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251508/,abstract,4,resultsrbc eicosapentaenoic devoid conclusionssupplementation tmao metabolon backgroundindividuals trimethylamine prebiotic red milder docosahexaenoic combined dha bioavailability carnitine excretion attrs intensity crossover www glycomacropeptide membrane bacterial bacteria objectiveto clinicaltrials oxide biosynthesis percentage subset nct inflammation lipid gov degradation urinary classical adolescent metabolomics text fatty urine methodswe supplementation profile animal impairment combination intake greater despite similar participant food cognitive phe plasma trial variant medical lower adult diet concentration total amino term higher cell sample phenylketonuria low metabolism significantly risk early phenylalanine control blood type acid different protein group clinical analysis,"{""urine"": {""freq"": 1, ""string"": [""urinary classical adolescent metabolomics text fatty urine methodswe supplementation profile animal i""]}, ""phenylalanine"": {""freq"": 2, ""string"": [""phenylketonuria low metabolism significantly risk early phenylalanine control blood type acid d""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""medical lower adult diet concentration total amino term higher cell sample p""]}}","{""diet"": {""freq"": 1, ""string"": [""plasma trial variant medical lower adult diet concentration total amino term h""]}}",{}
391,391,417,10.3978/j.issn.2224-4336.2015.10.07,26835392.0,major milk early glycomacropeptides formula autosomal palatability attempt due left continuous lnaa substitution vitamin pku hydroxylase issue medical executive phenylalanine life compliance recent poorly possible clinical therapy feature replacement commences error food inborn diagnosis large data fraction first metabolism untreated low adhere suboptimal soon although gmp main neutral hepatic current outcome review week phenylketonuria potential disability bovine treatment diet year advance future within recessive especially quality cognitive pah yielded intellectual nutritional whey acid dietary supplemented deficiency patient amino successful gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728993/,abstract,0,glycomacropeptides commences yielded adhere left lnaa bovine soon palatability whey supplemented suboptimal attempt gmp substitution neutral formula milk poorly hepatic replacement continuous compliance untreated fraction executive vitamin successful recessive autosomal advance intellectual nutritional pah feature disability especially week issue hydroxylase main possible inborn food cognitive major error quality medical large future recent deficiency diet dietary therapy life current pku amino outcome phenylketonuria low metabolism early phenylalanine diagnosis review acid potential gene year data treatment clinical patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""amino outcome phenylketonuria low metabolism early phenylalanine diagnosis review acid potential g""]}, ""intellectual"": {""freq"": 1, ""string"": [""executive vitamin successful recessive autosomal advance intellectual nutritional pah feature disability e""]}}","{""autosomal"": {""freq"": 1, ""string"": [""untreated fraction executive vitamin successful recessive autosomal advance intellectual nutritional pah f""]}, ""recessive"": {""freq"": 1, ""string"": [""compliance untreated fraction executive vitamin successful recessive autosomal advance intellectual nutritional p""]}}",{},"{""amino"": {""freq"": 1, ""string"": [""diet dietary therapy life current pku amino outcome phenylketonuria low metabolism e""]}}","{""diet"": {""freq"": 1, ""string"": [""quality medical large future recent deficiency diet dietary therapy life current p""]}}",{}
392,392,418,10.1038/srep06941,25373594.0,potent experimental tool relationship chain activity investigation new abnormal present slowly molecular due supplementation proliferate severity accumulation well disease pku amount heavy presence biochemical phenylalanine observed higher range protein clinically symptom result metabolic mtorc cause novel rapamycin lat level although cellular valine transporter sensitivity terminal approach model phenylketonuria therapeutic target expression excessive cell within lack effectively responsible explore analysis vitro adapter acid mammalian amino proliferation show complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221789/,abstract,0,proliferate adapter rapamycin mtorc lat valine slowly heavy terminal excessive potent mammalian proliferation transporter effectively responsible severity cellular accumulation abnormal experimental vitro explore clinically investigation supplementation observed sensitivity lack presence chain biochemical relationship target symptom tool expression range complex cause therapeutic molecular novel activity pku amino higher cell phenylketonuria approach present new model phenylalanine acid protein metabolic level analysis result disease,"{""phenylalanine"": {""freq"": 2, ""string"": [""cell phenylketonuria approach present new model phenylalanine acid protein metabolic level a""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""cause therapeutic molecular novel activity pku amino higher cell phenylketonuria approach p""]}}",{},{}
393,393,419,10.1007/s10815-016-0714-4,27116010.0,major european discussionbabies whether difference single congenital time couple cleavage reproductive weight resultsa common mean transfer control methodsretrospective increase significantly gestational medical denominator however baby higher clinical ectopic diagnosis data embryo triplet pregnancy versus fetal art infertile period significant abortion surveillance rate overall provide outcome population comparative perinatal stage twin technology purposethe treatment delivery incidence conception eurocat age within two fresh suggest anomaly spontaneous ivf analysis infertility spontaneously group cycle comprehensive different classification study patient total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889486/,abstract,8,triplet discussionbabies infertile eurocat ectopic denominator purposethe methodsretrospective spontaneously ivf cleavage fresh infertility couple abortion spontaneous conception twin art suggest comparative perinatal embryo transfer surveillance anomaly resultsa reproductive baby gestational classification versus fetal european cycle comprehensive pregnancy stage delivery incidence weight mean congenital provide period technology overall major increase medical single rate total outcome higher difference common time significantly control diagnosis population different age significant group data treatment clinical analysis patient study,{},{},{},{},{},{}
394,394,420,10.1093/jn/nxx031,29546296.0,intelligence assessment logarithm region ratio difference duration across visual behavioral world without bias pdi preterm supplementation abstract stratified methodswe race publication angle later resolution seafood nonsignificant childhood latter higher conclusionsn mixed psychomotor developmental global result link effect bayley data term egger quotient backgroundepidemiologic score regression period significant although full main measure placebo text independently child outcome intervention mental development potential article mother pufa fatty education finding randomized maternal age acuity electrophysiological epa scale subgroup minimum systematically quality cognitive analysis index dha consumption infant also trial conclusion fewer different trend interaction study arm heterogeneity mdi acid meta random participant show logmar statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251555/,abstract,9,seafood logmar conclusionsn backgroundepidemiologic pdi logarithm epa electrophysiological egger nonsignificant mdi acuity stratified pufa quotient bayley angle psychomotor race dha minimum arm fewer abstract intelligence randomized systematically mixed random preterm subgroup independently duration bias visual placebo publication resolution trend link meta later statistically consumption heterogeneity mother world education text behavioral fatty methodswe mental global maternal index supplementation childhood regression developmental scale period main ratio score finding interaction region participant assessment cognitive measure infant trial quality intervention outcome conclusion term higher article difference acid potential child different age significant development effect data analysis result study,"{""behavioral"": {""freq"": 1, ""string"": [""consumption heterogeneity mother world education text behavioral fatty methodswe mental global m""]}}","{""heterogeneity"": {""freq"": 1, ""string"": [""trend link meta later statistically consumption heterogeneity mother world education text b""]}}",{},{},{},{}
395,395,422,10.1186/s13063-017-2306-8,29246188.0,resonance pathogenesis amoxicillin assessment blood pain better difference rct time present comparing lbp cost investigate course examines month material supplementary gov possible follow marrow previous discussionto user questionnaire clinical herniation protein double effectiveness six effect term disc genetic type low score period level three roland least biomarkers measure placebo refine text norway registrationclinicaltrials vertebral back lumbar inclusion november designa day method mediator expression characterise disability baseline online article treatment security electronic year help materialthe version inflammatory within two sample appropriate mri intention standard authorized bone chronic antibiotic analysis backgrounda hospital aim impact available nct also trial group different high study orally magnetic similar patient variability gene morris total modic deviation treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732434/,abstract,8,vertebral roland morris modic lbp herniation amoxicillin discussionto refine examines disc characterise comparing backgrounda rct designa security norway lumbar marrow intention orally mediator november registrationclinicaltrials antibiotic mri pain bone authorized placebo pathogenesis deviation resonance nct gov variability course double treat magnetic baseline inflammatory text inclusion effectiveness follow appropriate previous help questionnaire hospital disability cost investigate chronic biomarkers materialthe period score standard better similar possible assessment aim measure month supplementary day trial user expression version electronic online impact total material term article difference sample low present available time blood type different protein gene group year effect high genetic method level treatment clinical analysis patient study,{},"{""genetic"": {""freq"": 1, ""string"": [""protein gene group year effect high genetic method level treatment clinical a""]}}",{},{},{},{}
396,396,423,10.1155/2014/850312,25548592.0,entire various cochrane search new early positive using throughout synthase central tetrahydrobiopterin literature supplementation vascular control endothelial disease significantly initiation strategy dysfunction improvement result effect novel vasculopathy low level significant three one established placebo progression dose database fourteen prevent outcome review approach method therapeutic hypertension augmentation stage article artery ten electronic medline endogenous january nitric embase hypercholesterolemia background diabetic cardiovascular trial conclusion group different coronary high study oxide cofactor patient agent even total atherosclerosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273464/,abstract,1,vasculopathy hypercholesterolemia using established augmentation coronary atherosclerosis fourteen artery hypertension initiation diabetic cochrane entire endothelial vascular embase nitric medline january endogenous oxide placebo synthase progression cardiovascular agent cofactor tetrahydrobiopterin dose search prevent stage supplementation central improvement dysfunction database literature various background trial positive strategy electronic therapeutic novel total outcome conclusion article low approach significantly new early control review different significant group effect high method level result patient disease study,{},{},{},{},{},{}
397,397,424,10.1371/journal.ppat.1004667,25764397.0,availability activity african ratio recycling factor lower oxidative adult mmol median synthase tetrahydrobiopterin together severe fall control severity urinary increase disease hydroxylase sepsis icam phenylalanine subject possible enzymatically therapy role mol primary creatinine conversely decrease potentially reactivity non stress biopterin three catalytic uncouples child overall nadph dihydrobiopterin back oscillates unstable msm oxidase impaired bioavailability association perfusion iqr superoxide adjunctive production nitric pterin healthy falciparum microvascular lowest plasma insufficient oxide acid deficiency asian moderately amino metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357386/,abstract,0,uncouples oscillates icam enzymatically adjunctive recycling reactivity msm perfusion mmol falciparum unstable sepsis nadph microvascular pterin moderately dihydrobiopterin iqr fall conversely biopterin oxidase creatinine bioavailability african asian superoxide lowest insufficient catalytic impaired nitric oxide synthase urinary oxidative mol availability severity tetrahydrobiopterin production potentially median decrease stress hydroxylase ratio overall severe possible metabolite healthy subject plasma primary increase lower association adult deficiency therapy activity amino non role phenylalanine control factor acid child disease,"{""phenylalanine"": {""freq"": 2, ""string"": [""deficiency therapy activity amino non role phenylalanine control factor acid child d""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""lower association adult deficiency therapy activity amino non role phenylalanine control f""]}}",{},{}
398,398,426,10.1038/gim.2017.167,29693650.0,disorder three two isotope production pharmacokinetics dos conjugate per lower healthy purposebenzoate dose combinatorial drug higher therapy stable conjugation comparative without nitrogen day widely superior due napb trial efficiency disposal result cycle potential efficacy usd methodswe effect study phenylbutyrate arm whereas effective treatment urea similar dietary decrease excretion combination significantly crossover volunteer medication bsa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924481/,abstract,0,purposebenzoate napb phenylbutyrate conjugation conjugate combinatorial bsa usd isotope disposal nitrogen pharmacokinetics arm comparative volunteer excretion crossover superior dos urea efficiency medication stable widely cycle dose production methodswe decrease efficacy combination similar healthy day trial drug effective lower dietary therapy higher significantly potential effect disorder treatment result study,{},{},{},{},{},{}
399,399,427,10.1007/8904_2017_85,29288420.0,exon studied factor information autosomal restriction missense prognosis majority disease objective pku hydroxylase characterize medical phenylalanine subject chromosome possible heterozygous val value compound biallelic genotype result length date case mutation one main pathogenic phenotype population management phenylketonuria technique method frequent polymorphism allele accordingly omim chilean pah conclusion del classic nutritional different sequencing patient gene fragment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226402/,abstract,7,chilean val biallelic del omim fragment chromosome heterozygous accordingly prognosis studied length characterize classic missense exon frequent restriction pathogenic polymorphism majority genotype date autosomal allele compound nutritional pah sequencing technique hydroxylase main phenotype possible objective subject management value medical information mutation pku conclusion phenylketonuria case phenylalanine factor population different gene method result patient disease,"{""phenylalanine"": {""freq"": 2, ""string"": [""information mutation pku conclusion phenylketonuria case phenylalanine factor population different gene m""]}}","{""autosomal"": {""freq"": 1, ""string"": [""restriction pathogenic polymorphism majority genotype date autosomal allele compound nutritional pah s""]}, ""heterozygous"": {""freq"": 1, ""string"": [""val biallelic del omim fragment chromosome heterozygous accordingly prognosis studied length c""]}}",{},{},{},{}
400,400,428,10.1007/8904_2016_545,26983835.0,major specific disorder iem new syrup content information hrqol essential acidurias paediatric increasingly restriction organic physical expert constraint well disease issue account relevant life introduction cognition perspective questionnaire health generic focus burden error stigmatisation support inborn austria diagnosis qualitative metabolic interview effect urine term intoxication first long type metabolism young significant four three switzerland discussion centre fourteen outcome method mental older development social consequently parent topic resource treatment urea delivery important germany year emotional care maple transcript fatigue age progress dimension appropriate survivor category quality meaningful analysis group cycle whereas dietary patient psychosocial individual number parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388637/,abstract,3,switzerland stigmatisation survivor fatigue constraint austria intoxication dimension acidurias transcript fourteen hrqol maple generic syrup paediatric meaningful psychosocial germany cognition emotional topic urea consequently centre qualitative progress interview discussion older young introduction organic expert category increasingly burden restriction iem cycle account perspective urine resource content parameter delivery mental appropriate physical questionnaire focus social essential relevant parent issue inborn support long major error quality dietary care information life outcome term important number metabolism individual new specific type diagnosis age significant development metabolic health group year effect method disorder treatment analysis patient disease,"{""urine"": {""freq"": 1, ""string"": [""burden restriction iem cycle account perspective urine resource content parameter delivery m""]}, ""emotional"": {""freq"": 1, ""string"": [""syrup paediatric meaningful psychosocial germany cognition emotional topic urea consequently centre q""]}, ""social"": {""freq"": 1, ""string"": [""maple generic syrup paediatric meaningful psychosocial germany cognition emotional topic u"", ""delivery mental appropriate physical questionnaire focus social essential relevant parent issue i""]}}",{},{},{},{},{}
401,401,429,10.1038/srep15769,26503515.0,various counseling disorder exon mainland region difference among time several autosomal frequency cost race effective finally pku hydroxylase spectrum offer phenylalanine adjacent screening mainly additionally china report thus generation furthermore novel genetic metabolism chinese significant mutation ethnicity northern proof database population phenylketonuria southern differs incidence reduces appropriate recessive facilitates next intronic provision pah mutational different high study sequencing deficiency patient gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621502/,abstract,7,mainland intronic differs adjacent facilitates counseling race mutational southern northern ethnicity proof reduces provision offer chinese exon china mainly recessive additionally autosomal appropriate finally incidence pah generation cost furthermore sequencing database frequency hydroxylase spectrum region various screening effective deficiency report novel mutation pku difference phenylketonuria metabolism time phenylalanine population different significant gene high genetic disorder patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""mutation pku difference phenylketonuria metabolism time phenylalanine population different significant gene h""]}}","{""autosomal"": {""freq"": 1, ""string"": [""chinese exon china mainly recessive additionally autosomal appropriate finally incidence pah g""]}, ""recessive"": {""freq"": 1, ""string"": [""provision offer chinese exon china mainly recessive additionally autosomal appropriate finally i""]}, ""genetic"": {""freq"": 1, ""string"": []}}",{},"{""screening"": {""freq"": 1, ""string"": [""database frequency hydroxylase spectrum region various screening effective deficiency report novel m""]}}",{},{}
402,402,430,10.1038/ejhg.2014.289,25626707.0,entire refinement european preventable herein early context time author present platform paediatric publicly necessary programme statement condition genetics cost ethic risk clinician well objective phg organisation issue sequence advent shortly treatable relevant committee childhood accessibility clinical law primary scientist predict data decrease expectation consideration international period service whole society wider population approach identification lifetime exome potential technology guide treatment recommendation important help address public variant newborn professional birth throughput analysis research available genome foundation policy high namely human sequencing maker patient inform gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795188/,abstract,0,phg organisation shortly publicly refinement predict preventable accessibility wider expectation statement law maker advent scientist throughput lifetime ethic paediatric entire committee foundation treatable guide programme inform author society exome consideration platform clinician european international address necessary policy sequence service recommendation professional genome decrease help childhood genetics cost context sequencing relevant identification issue period public technology birth objective primary variant newborn condition important approach present available time human risk early research population potential gene high data treatment clinical analysis patient,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""public technology birth objective primary variant newborn condition important approach present a""]}}",{},{}
403,403,431,10.1016/j.cca.2016.03.014,27016455.0,blood maximal new factor time glucose neonatal insight bias utero vary risk average hba purposegestational reliable evaluate disease significantly gestational establish measurement optimal value result metabolic stability specimen sixty level measure population day feasible method ass potential exposure test conclusionsmeasurement collection theoretically assay within sample hemoglobin minimal newborn suggest application spot estimate elution standard influence reproducibility analysis characteristic infant trial study human statewide resultsanalysis minute glycosylation deviation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875889/,abstract,3,purposegestational conclusionsmeasurement theoretically statewide resultsanalysis hba vary glycosylation elution maximal utero suggest hemoglobin reproducibility minute specimen establish minimal bias feasible gestational deviation reliable stability optimal glucose average estimate evaluate collection insight assay neonatal exposure measurement influence spot ass characteristic standard measure infant application day trial value newborn sample test time significantly new human risk factor blood population potential metabolic method level analysis result disease study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""measure infant application day trial value newborn sample test time significantly n""]}}",{},{}
404,404,432,10.1016/j.ymgme.2016.05.017,27268406.0,disorder assessment example lead growth early congenital widespread across condition onset state continuous clear diverse source publication well disease pku element however manuscript committee uniform reduction rusp applied health consistent developmental achdnc improvement symptom data term long standardize mortality useful service panel sickle measure child outcome intervention approach phenylketonuria secretary development potential system success heritable cell public within two newborn application order advisory function goal prior framework program different human extent,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970906/,abstract,0,achdnc standardize rusp secretary manuscript applied uniform sickle heritable advisory committee widespread continuous publication success clear element extent diverse prior goal framework panel useful mortality service source improvement consistent example reduction lead onset developmental growth congenital public order assessment symptom measure application state long program intervention newborn pku outcome term condition cell function phenylketonuria approach human early potential child different development health data disorder disease,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""measure application state long program intervention newborn pku outcome term condition c""]}}",{},{}
405,405,433,10.1146/annurev-pathol-012615-044152,26907531.0,level exciting inflammatory genetically individual advance underpinnings understanding microbiome main allele fundamental time interrogate function clinical relevance goal role field shape play able currently model bowel vitro priority environment translate also genetics development technology locus ibd part high interaction functionally large test study susceptibility hypothesis patient novel disease genetic susceptible improve care gene challenge complex revolution ultimately,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961083/,abstract,0,interrogate ibd underpinnings revolution susceptible translate exciting shape functionally bowel microbiome ultimately priority fundamental susceptibility relevance locus improve genetically able goal hypothesis inflammatory vitro play advance allele environment understanding genetics currently main technology field interaction challenge complex large novel care role function test individual time model development gene high genetic level clinical patient disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""individual time model development gene high genetic level clinical patient disease s""]}}",{},{},{},{}
406,406,434,10.1124/jpet.115.226365,26427720.0,mva activity region content factor information sulfotransferase reporter several mevalonate synthase basal pair race accumulation cholesterol activation cytosolic squalene respectively promoter synthesis transcriptional sequence transcription element however distal methylglutaryl mediating coa sult role play fold reductase primary enzyme base effect hepatocyte cause rat cultured hepatocytes rapid mutation postsqualene nuclear biosynthetic isoprenoids inhibitor collectively generate liver product regulation localized expression intermediate treatment important overexpression strongly longest hnf nonsterol proximal squalestatin finding amplification stomach cdna production epoxidase pravastatin demonstrate influence upstream deletion analysis mechanism mrna whereas metabolite kidney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658488/,abstract,2,sult sulfotransferase squalestatin squalene pravastatin postsqualene nonsterol mva mevalonate methylglutaryl longest isoprenoids epoxidase stomach mediating upstream localized generate cytosolic distal cdna biosynthetic overexpression race proximal reporter intermediate cultured basal reductase amplification pair collectively hepatocytes cholesterol base mrna hnf transcriptional promoter kidney coa synthase hepatocyte inhibitor deletion activation element strongly transcription nuclear fold demonstrate rat accumulation production play content sequence regulation synthesis liver rapid influence product finding region metabolite enzyme expression primary cause mechanism respectively information activity mutation important role factor effect treatment analysis,{},{},{},{},{},{}
407,407,435,10.1186/s13063-018-2686-4,29950170.0,various disorder assessment clinic allocation whether information rigorous technical time july consent concern prenatal reaction five condition additional interactive challenging devise control well traditional material ethical amount supplementary gov actionable childhood recent screening priori user clinical regret questionnaire role secondary primary possibility result large data term generation routine novel genetic type designparticipants non pre precedent discussionnc text current sensitivity child outcome registrationclinicaltrials approach aid method exome parent second interdisciplinary online simultaneously article parental rich electronic best phase decision care randomized option version materialthe universal categorize age future newborn pediatric make healthy standard metric goal next symptomatically framework research nct available trial policy plus practice cohort study arm nexus inform limitation participant highly number treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022715/,abstract,2,symptomatically regret precedent discussionnc devise designparticipants categorize nexus priori interdisciplinary rigorous challenging allocation actionable make interactive registrationclinicaltrials metric arm july aid consent simultaneously randomized plus rich universal technical inform ethical parental routine nct traditional gov prenatal exome possibility treat option limitation goal framework text decision concern clinic secondary policy phase best pre reaction pediatric childhood second sensitivity questionnaire generation practice materialthe highly parent cohort additional standard participant various assessment supplementary healthy screening trial user primary version electronic online large future recent novel care information newborn current material outcome term condition non article role approach number available time control type research child age genetic method data disorder clinical result study,{},"{""genetic"": {""freq"": 1, ""string"": [""time control type research child age genetic method data disorder clinical r""]}}",{},"{""newborn"": {""freq"": 1, ""string"": [""large future recent novel care information newborn current material outcome term c""]}, ""screening"": {""freq"": 1, ""string"": [""standard participant various assessment supplementary healthy screening trial user primary version e""]}}",{},{}
408,408,436,10.1136/bmjpo-2017-000105,29637134.0,european worldwide african region lower country neonatal selection restriction without severe common southeast objectivedetermine clear significantly respectively jaundice related marker evidence higher clinical pooled health brain burden global sourcespubmed result contextto effect resultsof data language late middle low regression significant one least compelling death per bilirubin acute problem pacific database eastern outcome damage population mediterranean management model scopus disability article extractionstratification associated incidence western kernicterus poor snj irreversible estimate income survivor especially africa birth previously encephalopathy infant exchange america high study meta asian random highest conclusionslimited establishing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862199/,abstract,9,sourcespubmed snj objectivedetermine extractionstratification contextto conclusionslimited pooled kernicterus pacific survivor southeast mediterranean jaundice compelling bilirubin scopus africa eastern establishing encephalopathy america african resultsof asian irreversible exchange income random middle western clear language worldwide damage meta late burden restriction highest european selection acute poor death estimate associated global incidence regression neonatal marker disability especially database previously problem related birth country region severe infant management lower brain respectively evidence outcome higher article common low significantly model population significant health effect high data clinical result study,{},{},{},{},{},{}
409,409,437,10.1371/journal.pone.0155776,27183228.0,metabolome male various phenotypic major specific relationship whether among examine gain glucose document weight variation biomarker old well discrimination animal however much partial distinguish tyr obesity value feature mouse body result thus metabolic change lipid metabolism low period level separation case least female orn phenotype syndrome sensitivity outcome able week model evident development univariate tolerance fatty diet predictive complex acylcarnitines fat sample multivariate bwg statistical limited explore homa resistance analysis either aim characteristic also propensity general group plasma high feeding study namely insulin acid human advantage square amino weaker metabolite gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868278/,abstract,1,bwg orn weaker homa univariate propensity distinguish separation metabolome discrimination acylcarnitines feeding square multivariate document evident gain tolerance insulin fat tyr resistance partial lipid biomarker examine predictive gender phenotypic advantage able glucose obesity statistical fatty explore female old animal weight sensitivity feature limited variation syndrome general male week characteristic period phenotype relationship mouse various body aim metabolite plasma major change complex value diet amino outcome sample low case metabolism human model specific acid development metabolic group high level analysis result study,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""plasma major change complex value diet amino outcome sample low case m""]}}","{""diet"": {""freq"": 1, ""string"": [""metabolite plasma major change complex value diet amino outcome sample low c""]}}",{}
410,410,438,10.1371/journal.pone.0126067,25950434.0,efficacious subsequent schedule picosulfate glycol harefield better morning positively attributable pdr magnesium adenoma colonoscopy afternoon lesion solution significantly respectively twice colonoscopist cancer gov event endpoint mainly higher citrate clinical attrs sodium polyethylene symptom primary resultsof mild good term versus ability type low mortality detection methodsdiagnostic napic rate surveillance multi administration per volume label text side overall registrationclinicaltrials many abdominal day thereby tolerance treatment investigator proportion polyp phase two likely asc scale mgcit quality adverse emergent colorectal bowel nct trial prevention flat group plus objectivesefficacy different ascorbate study right polypoid center patient evening preparation successful number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423835/,abstract,4,polypoid pdr objectivesefficacy napic mgcit methodsdiagnostic harefield flat colonoscopist polyp picosulfate asc afternoon evening glycol citrate ascorbate adenoma twice colonoscopy schedule efficacious colorectal morning emergent investigator magnesium label endpoint registrationclinicaltrials polyethylene abdominal resultsof bowel attributable lesion attrs sodium surveillance positively plus tolerance preparation right subsequent nct gov versus multi solution mainly proportion successful mild event volume text center phase administration mortality good adverse cancer likely prevention ability scale overall better detection symptom day trial primary quality respectively rate term higher low number significantly type different group treatment clinical patient study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""likely prevention ability scale overall better detection symptom day trial primary q""]}}",{},{}
411,411,439,,30279718.0,tehran delay respiratory lead factor lower neonatal vali necessary aged brainstem hospitalization risk control effective acquisition month unit abr quantitative screening speech therapy word neonate icterus phototherapy support distress neurology auditory score detection period significant case rehabilitation one rds office syndrome prevent nicu history development older system disability loss test important response key associated care asr methodsin age resultsthe mildly iran pediatric prevalence intensive hospital study patient moderately apgar,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160623/,abstract,2,vali phototherapy nicu icterus asr abr rds brainstem apgar rehabilitation moderately mildly tehran office neurology hospitalization auditory speech distress acquisition respiratory intensive methodsin neonate unit iran older resultsthe delay word prevent associated necessary history aged pediatric quantitative neonatal loss hospital lead disability syndrome prevalence period score detection support month screening key response effective lower care therapy important case test risk control factor age significant development patient study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""lead disability syndrome prevalence period score detection support month screening key r""]}, ""screening"": {""freq"": 1, ""string"": [""prevalence period score detection support month screening key response effective lower c""]}}",{},{}
412,412,440,10.1038/srep33087,27667715.0,major specific importantly extremely growth glycemia factor single islet synonymous onset molecular moreover genetics locus control severity disease significantly transcription relevant chromosome form remarkably defective mouse monogenic result fasting mody type genetic completely young non use mutation variable mellitus moda model identification prone via suppressor prevalent postnatal association hnf carry cba modifier finding scan wide strain still snp mechanistically since analysis background mechanism diabetic suppress secretion genome alpha study insulin human syntenic deficiency patient powerful even absence gene show maturity sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036084/,abstract,4,syntenic moda cba carry glycemia fasting maturity suppress mody islet suppressor mechanistically synonymous scan prone defective modifier remarkably postnatal mellitus secretion strain diabetic extremely chromosome importantly hnf powerful completely monogenic insulin snp prevalent locus alpha young absence transcription sensitive severity genome variable genetics onset relevant growth wide identification finding mouse background form major single association molecular use deficiency mechanism mutation non significantly human model specific control factor type gene genetic analysis result patient disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""model specific control factor type gene genetic analysis result patient disease s""]}}",{},{},{},{}
413,413,441,10.3390/ijms18102049,28946642.0,male specific bioinformatics whether information present molecular choice missense severe common polyphen manifest facilitate fabry principle disease physician sequence uniprot pharmacological reader hypothetical therapy nature protein symptom genotype result diagnosis data reference term genetic inexpensive exonic tutorial mutation certain phenotype database confirmation approach simple method therapeutic work ass exome web challenge option rare application browser chaperone field analysis blastx background genome conclusion human similar patient rarely,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666731/,abstract,0,uniprot tutorial browser blastx exonic polyphen manifest hypothetical reader fabry inexpensive rarely confirmation bioinformatics chaperone web principle facilitate physician exome missense choice pharmacological simple nature option reference certain genotype sequence genome work database ass male phenotype field similar severe background symptom application challenge therapeutic molecular rare therapy information mutation conclusion term common approach present human specific diagnosis protein genetic method data analysis result patient disease,{},"{""genetic"": {""freq"": 1, ""string"": [""approach present human specific diagnosis protein genetic method data analysis result p""]}}",{},{},{},{}
414,414,443,10.1007/s12070-018-1386-4,30211093.0,various delay hearing maharashtra abnormality factor early across country world lesser neonatal populated weight need risk pune well respectively life evidence organ baby speech clinical neonate live april language prospective taluka low young non area detection level rehabilitation one sense per normal craniofacial overall child around intervention population chance rural identification development second loss important hyperbilirubinemia nearly fifth universal find earlier india prevalence birth man quality impairment often high study center deafness total number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127065/,abstract,7,taluka pune populated maharashtra man deafness craniofacial rehabilitation hyperbilirubinemia fifth sense lesser speech india hearing chance live april rural neonate earlier nearly baby universal language young organ prospective delay world center second abnormality weight neonatal loss impairment identification prevalence birth need overall country detection various area normal quality respectively intervention life total evidence non important low number risk early factor population child development high level clinical study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""identification prevalence birth need overall country detection various area normal quality r""]}}",{},{}
415,415,444,10.3390/diseases3040325,28943628.0,subsequent tool new factor trigger creation necessary inhibit efficient onset molecular literature due neoplastic pathology common ineffective epigenetic origin essentially epithelial restoration transformation extensive transcription cancer family strategy recent mainly hepatocellular allow therapy protein particular report fibrosis diagnosis data hepatocyte late type genetic hepatocytes member pre progression current infection hbv able liver hcv therapeutic development hcc suppressor expression frequent treatment simultaneous delivery alteration response hnf carcinoma cell still survival differentiation chronic stem precursor induction multiple different often heterogeneity master cirrhosis patient letf tumor antitumor gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548255/,abstract,0,letf hcc antitumor neoplastic ineffective hcv master hepatocellular cirrhosis allow suppressor restoration carcinoma inhibit essentially hbv creation transformation epithelial trigger induction simultaneous epigenetic hepatocytes hnf stem origin fibrosis tumor differentiation subsequent hepatocyte extensive survival pathology progression transcription efficient precursor frequent late able member mainly heterogeneity infection alteration necessary delivery pre particular cancer liver onset chronic literature tool expression multiple strategy response therapeutic molecular recent report family therapy current common cell new factor type diagnosis different protein development gene genetic data treatment patient,{},"{""genetic"": {""freq"": 1, ""string"": [""transformation epithelial trigger induction simultaneous epigenetic hepatocytes hnf stem origin f""]}, ""heterogeneity"": {""freq"": 1, ""string"": [""precursor frequent late able member mainly heterogeneity infection alteration necessary delivery p""]}}",{},{},{},{}
416,416,445,10.4103/ijpvm.IJPVM_24_17,29184644.0,major epidemiological disorder difference factor boy neonatal liquid retrospective actual severe consanguineous varies mazandaran severity addition disease pku iranian biochemical phenylalanine family screening real nonclassic report familial result metabolic purpose mild cause hpa elisa level significant case although rate phenotype marriage descriptive phenylketonuria confirmatory technique method history incidence particularly definitely iran suspicious newborn hyperphenylalaninemia prevalence girl background program conclusion classic group different high pattern study patient performance chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686926/,abstract,4,suspicious nonclassic definitely mazandaran varies elisa actual marriage iranian familial consanguineous confirmatory retrospective girl hpa epidemiological boy descriptive iran classic real hyperphenylalaninemia mild severity liquid chromatography history incidence pattern neonatal purpose particularly technique prevalence biochemical phenotype performance severe background screening addition program major cause report family rate newborn pku conclusion difference phenylketonuria case phenylalanine factor different significant metabolic group high method level disorder result patient disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""newborn pku conclusion difference phenylketonuria case phenylalanine factor different significant metabolic g""]}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""program major cause report family rate newborn pku conclusion difference phenylketonuria c""]}, ""screening"": {""freq"": 1, ""string"": [""prevalence biochemical phenotype performance severe background screening addition program major cause r""]}}",{},{}
417,417,446,10.1007/s11154-018-9455-2,30198059.0,various biological disorder better preventable greater discus affect essential adult neonatal enhance insight awareness condition literature common practical clinician experience well transition paediatrics amongst contraindicated lethal knowledge adulthood relevant family screening mainly clinical preventive range gap error inborn emptive diagnosis metabolic symptomatic unanswered cause question pregnancy type potentially metabolism mortality medicine capture establishment significant stress member step pre specialty morbidity individually foetal normal current outcome many review management identification translational mother foetus adolescence appropriately maternal rare wide newborn imd collective survival prevalence especially puerperium manage adaptation parturition systematically currently previously aim impact unrecognized program research presentation successful number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208575/,abstract,0,unrecognized unanswered puerperium parturition emptive contraindicated foetus foetal paediatrics specialty manage preventable lethal collective appropriately establishment imd individually adaptation adolescence preventive capture systematically symptomatic translational awareness transition enhance adulthood practical gap survival presentation clinician question member mainly affect successful mother morbidity step potentially pregnancy experience pre mortality maternal insight stress neonatal especially greater currently previously essential biological relevant wide medicine identification prevalence discus knowledge better literature various inborn aim normal screening management program range cause error adult rare family impact newborn current outcome condition common number metabolism type diagnosis research review significant metabolic disorder clinical,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""cause error adult rare family impact newborn current outcome condition common n""]}, ""screening"": {""freq"": 1, ""string"": [""better literature various inborn aim normal screening management program range cause e""]}}",{},{}
418,418,447,10.1089/rej.2014.1581,25298234.0,assessment activity growth factor pathway organism maximum oxidative guentheri foxo nutrient enhance aged onset molecular together action view accumulation concept extension intrusion epithelium respectively synthesis nothobranchius modulate cumulative life marker reduction poorly oxidation anti variety fish protein galactosidase glutathione dismutase catalase like specie decrease late first lipid span peroxidase non histological level one oxidant temperature annual lipofuscin retard damage intervention able phosphorylation liver peroxidation product week simple reactive via system second senescence signaling finding process downstream regulator prolong superoxide two gal approximately mechanism igf oxygen also comprehensive different insulin synergistic muscle show sirt,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270139/,abstract,2,sirt retard nothobranchius lipofuscin intrusion guentheri gal foxo peroxidation peroxidase galactosidase catalase prolong senescence igf epithelium dismutase synergistic oxidant modulate histological glutathione extension span phosphorylation fish maximum cumulative superoxide oxygen muscle annual signaling reactive regulator downstream oxidation organism poorly insulin enhance temperature specie lipid oxidative view damage simple action variety late able nutrient anti concept accumulation approximately comprehensive aged decrease second reduction marker synthesis liver onset product growth week like finding assessment process pathway molecular mechanism respectively intervention life activity non factor different protein level,{},{},"{""pathway"": {""freq"": 1, ""string"": [""growth week like finding assessment process pathway molecular mechanism respectively intervention l""]}}",{},"{""fish"": {""freq"": 1, ""string"": [""modulate histological glutathione extension span phosphorylation fish maximum cumulative superoxide oxygen m""]}}",{}
419,419,448,,31089344.0,coefficient expensive electrochemistry blood thf new economy time ease condition molecular offering rod enzymatic ion potentiometric compatibility measurement decade phenylalanine lacking range word mip metal report result sensor base good basis selective first detection use selectivity sensitivity mips method polymer determination constant conduct nernstian potential towards serum concentration plasticizer response key limit similarity assay electrode construction sec polyvinyl routinely hplc molecularly different sensitive graphite successfully chloride amino number mixture,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487406/,abstract,3,rod potentiometric polyvinyl nernstian mips graphite electrochemistry thf sec plasticizer mip compatibility molecularly lacking economy electrode chloride selectivity offering construction polymer expensive sensor ease constant metal conduct routinely ion similarity hplc mixture base enzymatic coefficient successfully selective determination limit word sensitive decade good basis serum assay sensitivity measurement detection range key response molecular use report concentration amino condition number time new phenylalanine blood potential different method result,"{""phenylalanine"": {""freq"": 2, ""string"": [""concentration amino condition number time new phenylalanine blood potential different method r""]}}",{},{},"{""detection"": {""freq"": 1, ""string"": [""good basis serum assay sensitivity measurement detection range key response molecular u""]}, ""amino"": {""freq"": 1, ""string"": [""key response molecular use report concentration amino condition number time new p""]}}",{},{}
420,420,449,10.1111/cts.12537,29383836.0,specific knowledge although quantitate prescribe glycol event apa specialty especially community anti several drug overall respondent peg adverse light critical antidrug inclusion awareness aware affected polyethylene critically research therapeutic need ass sizeable general via potential antibody efficacy otherwise recently safety transfer topic clinician extent fraction response patient finally potentially education physician,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866984/,abstract,0,sizeable apa antidrug quantitate prescribe glycol specialty critically polyethylene peg aware transfer topic respondent antibody awareness light fraction physician extent affected clinician anti safety event education inclusion community potentially finally adverse recently efficacy critical especially ass general need overall knowledge drug response therapeutic specific research potential patient,{},{},{},{},{},{}
421,421,450,10.3390/nu11071650,31330987.0,disorder pedsql ratio factor among glucose aged affected physical frequency pedsqol average well disease survey neurological element seizure subject life introduction perspective questionnaire clinical administrable health range generic double global determined comparable core movement result diagnosis inventory glut long type score consideration ketogenic significant functioning variable crucial gold transporter syndrome stable postal child method social epileptic parent disability treatment school year diet emotional rare genetically sample pediatric relation scale standard since influence exploratory chronic quality background concordance research keywords conclusion intellectual cohort study auto deficiency patient center presence perception,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682968/,abstract,4,postal pedsqol glut administrable ketogenic auto pedsql epileptic exploratory generic concordance gold functioning inventory emotional perception core school movement transporter crucial comparable seizure determined element introduction affected keywords stable double consideration genetically relation glucose perspective average neurological intellectual center global aged pediatric physical variable survey questionnaire disability presence chronic influence syndrome social frequency parent scale cohort ratio score standard background subject long range quality deficiency diet rare life conclusion sample factor type diagnosis research child significant health year method disorder treatment clinical result patient disease study,"{""neurological"": {""freq"": 1, ""string"": [""consideration genetically relation glucose perspective average neurological intellectual center global aged p""]}, ""intellectual"": {""freq"": 1, ""string"": [""genetically relation glucose perspective average neurological intellectual center global aged pediatric p""]}, ""emotional"": {""freq"": 1, ""string"": [""exploratory generic concordance gold functioning inventory emotional perception core school movement t""]}, ""social"": {""freq"": 1, ""string"": [""questionnaire disability presence chronic influence syndrome social frequency parent scale cohort r""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""background subject long range quality deficiency diet rare life conclusion sample f""]}}",{}
422,422,451,10.3390/ijms19041024,29596327.0,ptps encoding pathway defect synthase biosynthesis tetrahydrobiopterin substance supplementation dopa display pku hydroxylase alc phe synthesis lethal related animal phenylalanine tyr dopamine defective hydroxypyrimidine feature tetrahydropterin body mutant positional error report substrate inborn color enzyme like metabolic first type metabolism detection dahp mutation wild imply phenotype normal drug block tyrosine silkworm evaluation phenylketonuria model expression propose treatment key similarity deficient diamino application effectively responsible pale head pah eventually high lethality human gene individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979516/,abstract,0,pale imply hydroxypyrimidine diamino dahp alc silkworm lethality ptps positional tetrahydropterin eventually lethal dopa defective color display substance similarity block encoding head substrate effectively biosynthesis tyr synthase responsible propose deficient wild mutant dopamine tetrahydrobiopterin supplementation animal pah feature synthesis tyrosine evaluation defect related like hydroxylase phenotype detection body inborn enzyme phe normal application expression drug key error pathway report mutation pku phenylketonuria metabolism individual human model phenylalanine type metabolic gene high treatment,"{""phenylalanine"": {""freq"": 2, ""string"": [""pku phenylketonuria metabolism individual human model phenylalanine type metabolic gene high t""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""normal application expression drug key error pathway report mutation pku phenylketonuria m""]}}","{""detection"": {""freq"": 1, ""string"": [""evaluation defect related like hydroxylase phenotype detection body inborn enzyme phe n""]}}",{},{}
423,423,452,10.5812/ijp.3033,26635939.0,edition intelligence intellectually difference early effective increase objective pku hydroxylase status historical medical phenylalanine screening observed questionnaire value developmental brain phenylkeonuria primary error diagnosis enzyme metabolic hpa score level educational significant case necessity measure toxic normal child population inclusion method ass older national stage test treatment year age two wppi hyperphenylalaninemia order scale healthy wechsler comparison younger criterion background program conclusion group intellectual cohort study asq preschool deficiency patient even performance show,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662839/,abstract,4,wppi phenylkeonuria asq wechsler intellectually preschool necessity historical edition younger intelligence hpa toxic educational older hyperphenylalaninemia inclusion intellectual stage observed questionnaire comparison criterion national developmental ass scale cohort hydroxylase order status performance score background enzyme measure normal healthy screening objective program primary value increase error effective medical brain deficiency pku conclusion difference case test early phenylalanine diagnosis population child age significant metabolic group year method level treatment patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""pku conclusion difference case test early phenylalanine diagnosis population child age s""]}, ""intellectual"": {""freq"": 1, ""string"": [""hpa toxic educational older hyperphenylalaninemia inclusion intellectual stage observed questionnaire comparison c""]}}",{},{},"{""screening"": {""freq"": 1, ""string"": [""score background enzyme measure normal healthy screening objective program primary value i""]}}",{},{}
424,424,453,10.1186/s13023-017-0684-3,28724394.0,registry disorder tool relationship clinic self past backgroundnewborn better syrup information profile recruitment condition interactive highlight clinician addition hypothesis disease objective month pku material traditional consumer knowledge connect family life evidence tyr clinical outreach health respondent distribution complete symptom contribution support emory diagnosis university like metabolic data urine question term generation ability long appointment medicine panel one least tyrosinemia current outcome feedback grassroots tracking week phenylketonuria recipe work resultsin september development organization system towards parent web online latest test resource treatment dxa meeting year education care scan maple rare age future newborn professional stakeholder bone msud refined quality paper research trial practice trend presentation study skin direct understand barrier patient inform industry participant individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517813/,abstract,16,recipe grassroots emory refined outreach connect appointment dxa backgroundnewborn understand msud tracking feedback scan latest interactive meeting tyrosinemia maple recruitment syrup september stakeholder registry resultsin respondent industry consumer bone skin web inform tyr trend traditional organization contribution barrier university complete presentation clinician question distribution past hypothesis panel education urine resource clinic professional profile direct work generation self practice highlight ability parent medicine week like paper relationship knowledge better participant symptom support tool month objective addition long trial quality online future rare family care information life newborn evidence current pku material outcome term condition phenylketonuria test individual diagnosis research age development metabolic health year data disorder treatment clinical patient disease study,"{""skin"": {""freq"": 1, ""string"": [""registry resultsin respondent industry consumer bone skin web inform tyr trend t""]}, ""urine"": {""freq"": 1, ""string"": [""question distribution past hypothesis panel education urine resource clinic professional profile d""]}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""refined outreach connect appointment dxa backgroundnewborn understand msud tracking feedback s"", ""future rare family care information life newborn evidence current pku material o""]}}",{},{}
425,425,454,10.1016/j.ymgmr.2016.01.001,27014575.0,iec major contributor blood resultsblood difference factor lower analyzer instead spotkeywords venous across due measuring improve investigate mean control objective significantly pku hydroxylase ion phe phenylalanine subject conclusionuse compliance capillary screening calibration tyr mol altman designthree methodology analytical large tandem low level four measure current tyrosine aaa adjust management phenylketonuria technique method frequently abbreviation concentration simultaneously bland filter year diet education introductionmetabolic age protocol sample mass newborn sem along spot appropriate discrepancy analysis either paper spectrometry optimization monitor larger pah exchange plasma objectiveour acid yield patient variability accuracy individual amino chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789345/,abstract,7,spotkeywords resultsblood iec designthree conclusionuse sem objectiveour introductionmetabolic discrepancy adjust calibration measuring bland analyzer aaa contributor altman optimization venous capillary instead monitor ion abbreviation simultaneously exchange filter yield tyr compliance improve variability larger methodology analytical mol tandem protocol frequently education accuracy chromatography appropriate pah mean investigate spectrometry tyrosine spot technique paper hydroxylase measure phe screening objective mass subject plasma management major large lower diet concentration newborn current pku amino difference sample phenylketonuria low individual significantly phenylalanine control factor blood acid age year method level analysis patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""difference sample phenylketonuria low individual significantly phenylalanine control factor blood acid a""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""lower diet concentration newborn current pku amino difference sample phenylketonuria low i""]}, ""tandem"": {""freq"": 1, ""string"": [""improve variability larger methodology analytical mol tandem protocol frequently education accuracy c""]}, ""spectrometry"": {""freq"": 1, ""string"": [""accuracy chromatography appropriate pah mean investigate spectrometry tyrosine spot technique paper h""]}, ""newborn"": {""freq"": 1, ""string"": [""management major large lower diet concentration newborn current pku amino difference s""]}, ""screening"": {""freq"": 1, ""string"": [""spot technique paper hydroxylase measure phe screening objective mass subject plasma m""]}}","{""diet"": {""freq"": 1, ""string"": [""subject plasma management major large lower diet concentration newborn current pku a""]}}",{}
426,426,455,10.1155/2017/7478523,29441149.0,major experimental various disorder hyperlipidaemia observation plenty essential necessary action molecular need supplementation toxicity antioxidant disease amount xanthine knowledge element beneficial recent clinical role health protein trace body food indispensable metabolic significance metabolism although water dehydrogenase one direction mineral normal dose naturally review management phenylketonuria day via target supplement network diabetes arteriosclerosis every hyperglycaemia advance future selenium hyperphenylalaninemia chronic benefit mechanism also nutritional interaction study human dietary deficiency soil,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758946/,abstract,0,plenty hyperlipidaemia hyperglycaemia arteriosclerosis xanthine soil indispensable trace naturally selenium mineral direction antioxidant supplement toxicity observation dehydrogenase element beneficial hyperphenylalaninemia water significance action diabetes experimental dose network advance necessary supplementation nutritional chronic essential benefit need knowledge target interaction various body food normal management day major future molecular recent deficiency mechanism dietary role phenylketonuria metabolism human review protein metabolic health disorder clinical disease study,{},{},{},{},{},{}
427,427,456,10.1021/bi500734h,25295853.0,various chain sole molecule essential defect site productive together bond molecular stabilization separate state aromatic coordination contributes transition respectively titration orientation however phenylalanine ground much form relative aaahs chromobacterium value role play crystal acidic fold metal windowthe mutant heme equivalent result thus data change decrease type extrapolation mediate non sphere case significant itc biopterin water three catalytic wild asn size possibly dynamic side structure hydroxylation prevent mask point many residue polarity calorimetry fine via simulation second loss substantial cpah important key active triad kcat nearly complex within iron two isothermal reveal deformable likely pterin determine facial analysis criterion arrival also pah violaceum ala interaction high domain carboxylate study hydrogen acid direct position cofactor charge even uncoupled retained amino resolution affinity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222540/,abstract,1,violaceum triad heme deformable cpah chromobacterium arrival aaahs sphere retained productive orientation mask kcat itc hydroxylation extrapolation carboxylate windowthe uncoupled isothermal asn titration polarity ground calorimetry bond stabilization sole pterin hydrogen acidic ala fine charge biopterin iron mediate facial contributes metal coordination affinity crystal possibly simulation reveal residue catalytic position nearly equivalent aromatic transition resolution separate substantial dynamic water fold wild cofactor mutant active play molecule relative domain prevent size decrease direct second site pah loss criterion likely structure point chain defect essential determine interaction various form state change complex value key molecular respectively amino non important role case phenylalanine type acid significant high data analysis result study,"{""phenylalanine"": {""freq"": 2, ""string"": [""respectively amino non important role case phenylalanine type acid significant high d""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""change complex value key molecular respectively amino non important role case p""]}}",{},{}
428,428,457,10.1371/journal.pone.0135930,26291823.0,prospectively purposesince difference early lower profile restriction omega deficit risk conclusionsfish control cholesterol activation doe pku platelet intake phenylalanine marker higher fish value protein cytometric sum never significant surrogate stiffness phenylketonuria determination free analyse concentration triglyceride fatty diet cimt thickness methodsin intima lifelong correlate healthy carotid induce chronic atherosclerotic hdl background index bilaterally natural flow group study medium right acid ultrasound patient resultsdespite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546235/,abstract,2,resultsdespite purposesince intima cytometric conclusionsfish cimt carotid bilaterally atherosclerotic platelet omega stiffness thickness hdl triglyceride surrogate sum induce fish ultrasound prospectively analyse lifelong methodsin cholesterol flow correlate right determination activation medium doe restriction fatty natural index profile deficit marker chronic free intake background healthy value lower diet concentration pku higher difference phenylketonuria risk early phenylalanine control acid protein significant group patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""pku higher difference phenylketonuria risk early phenylalanine control acid protein significant g""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""free intake background healthy value lower diet concentration pku higher difference p""]}, ""fish"": {""freq"": 1, ""string"": [""resultsdespite purposesince intima cytometric conclusionsfish cimt carotid bilaterally atherosclerotic p"", ""thickness hdl triglyceride surrogate sum induce fish ultrasound prospectively analyse lifelong m""]}}",{}
429,429,458,10.1098/rsob.170229,29367352.0,various correlation specific disorder notion observation new discus among effort quinolinic insight condition malignant due view moreover state mechanistic diverse neurodegenerative accumulation hypothesis well disease elusive paradigm tumour offer cancer however possible form fill observed neurodegeneration protein homocysteine gap error inborn oncometabolites like metabolic ability type genetic metabolism formation level aggregation aetiology abundant structure provide occurrence many therapeutic alzheimer development malady suppressor potential towards loss alteration still fresh amyloid aetiological function abnormally high human acid similar patient metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795054/,abstract,0,oncometabolites quinolinic malady aetiological abnormally tumour neurodegeneration fresh elusive suppressor malignant aetiology homocysteine notion abundant occurrence amyloid paradigm aggregation offer alzheimer observation mechanistic neurodegenerative gap view diverse formation hypothesis accumulation alteration effort observed insight cancer loss structure correlation ability provide like discus similar possible various inborn form metabolite state error therapeutic condition function metabolism new human specific type acid potential protein development metabolic high genetic level disorder patient disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
430,430,459,10.1038/ejcn.2016.166,27623981.0,blood activity clinic investigation new lower formula autosomal throughout without choice improve percent control well objective disease pku hydroxylase excellent phe suitable lutein phenylalanine subject life compliance biotin decline nutritionally nitrogen restrictive complete result phelnaa fifty purpose large decrease adherence long low eight level significant neutral week phenylketonuria lowering method older illness concentration baseline test treatment help deficient continuously additive loading background dha conclusion nutritional get study acid dietary patient amino,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222990/,abstract,2,phelnaa lowering lutein nutritionally biotin restrictive nitrogen loading dha decline additive continuously percent illness neutral formula excellent compliance older adherence improve deficient choice suitable complete baseline autosomal clinic investigation decrease help nutritional purpose week hydroxylase background phe objective subject long large lower dietary life concentration activity pku amino conclusion phenylketonuria low test new phenylalanine control blood acid significant method level treatment result patient disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""amino conclusion phenylketonuria low test new phenylalanine control blood acid significant m""]}}","{""autosomal"": {""freq"": 1, ""string"": [""improve deficient choice suitable complete baseline autosomal clinic investigation decrease help n""]}}",{},"{""amino"": {""freq"": 1, ""string"": [""lower dietary life concentration activity pku amino conclusion phenylketonuria low test n""]}}",{},{}
431,431,460,10.2147/PHMT.S85717,29388597.0,asds disorder activity pain self autism greater factor pathway intestinal anxiety time gut concern inflammation necessary restriction neuroinflammation without behavior due wheat deficit constipation risk neurodegenerative practical unexplained concept well way persistent disease contribute spectrum endophenotype medical related understanding axis dysregulation neurodevelopmental recent possible allergy mainly autoimmunity cognition dysfunction clinical brain disturbance sleep determined diarrhea symptom possibility indication core food diagnosis multilevel metabolic situation immune alert furthermore experiment ability genetic potentially long repetitive non use gastrointestinal protect stress microbiome functional asd interest communication certain possibly gluten comorbidities current sensitivity syndrome child nonverbal permeability many vulnerability abdominal comorbidity approach hypersensitivity social propose thereby alimentary celiac mucosal alteration treatment commencement recommendation aggression reflux help cell systematic gastroesophageal component genetically pathophysiological visceral professional pathogenetic function contributing currently agitation discomfort mechanism immunoglobulin tract motility research also general upon different interaction dysmotility pattern study deprivation dietary patient individual injury unnecessary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683266/,abstract,0,wheat celiac autoimmunity agitation neuroinflammation gastroesophageal discomfort constipation commencement alimentary permeability pathogenetic nonverbal mucosal motility gluten endophenotype dysmotility visceral reflux protect allergy alert aggression unexplained multilevel hypersensitivity dysregulation contributing asds unnecessary persistent diarrhea repetitive comorbidity vulnerability immunoglobulin deprivation comorbidities axis abdominal intestinal pathophysiological sleep gut possibly cognition microbiome gastrointestinal tract pain core situation disturbance indication injury neurodegenerative contribute practical experiment inflammation determined anxiety propose possibility neurodevelopmental genetically asd immune communication mainly restriction concept certain alteration concern systematic potentially necessary way autism component recommendation professional help pattern stress deficit understanding sensitivity behavior dysfunction self furthermore syndrome greater currently social ability general related functional spectrum interaction possible food symptom long medical pathway brain recent use mechanism dietary activity current non cell function approach individual time risk factor diagnosis research child different metabolic genetic disorder treatment clinical patient disease study,"{""social"": {""freq"": 1, ""string"": [""dysfunction self furthermore syndrome greater currently social ability general related functional s""]}}","{""genetic"": {""freq"": 1, ""string"": [""discomfort constipation commencement alimentary permeability pathogenetic nonverbal mucosal motility gluten e"", ""factor diagnosis research child different metabolic genetic disorder treatment clinical patient d""]}}","{""pathway"": {""freq"": 1, ""string"": [""interaction possible food symptom long medical pathway brain recent use mechanism d""]}}",{},{},{}
432,432,461,10.1371/journal.pgen.1007360,29684050.0,splice notably specific exon region hnrnpa site slightly efficient due common regulatory canonical determines well close disease pku hydroxylase element intron phenylalanine weak strategy snrnp report result thus recently effect basis novel metabolism exonic non functional mutation one motif pathogenic snrna inhibitor provide point phenylketonuria concomitant regulation therapeutic work disruption development correct minigene system consequently stimulatory important overexpression assay definition downstream variant rna intronic deletion mechanism natural pah different study vulnerable acid patient disrupt amino gene show,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933811/,abstract,7,stimulatory snrnp snrna minigene hnrnpa disrupt determines exonic intronic splice intron canonical weak overexpression concomitant vulnerable motif notably disruption slightly definition close downstream correct consequently rna inhibitor deletion element exon efficient pathogenic natural regulatory basis regulation work site recently assay pah point provide functional hydroxylase region strategy variant therapeutic mechanism report novel mutation pku amino non important common phenylketonuria metabolism phenylalanine specific acid different development gene effect result patient disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""amino non important common phenylketonuria metabolism phenylalanine specific acid different development g""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""therapeutic mechanism report novel mutation pku amino non important common phenylketonuria m""]}}",{},{}
433,433,462,10.1002/ajmg.a.37477,26792268.0,predictability correlation consistency whether proposed difference unpredictable several autosomal across adult lifespan serious five condition onset expert mean practical severity number survey preconception significantly medical empirical however ever subject evidence screening fill want rating simplify feature logical distinction result like large mild little genetic although rate one problem implementation woman discovery outcome taxonomy method attribute ass judgment via key aggregated year decision carrier advance opportunity efficiently category usable classified validity genome last study sequencing patient controllability participant gene total perception,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824299/,abstract,4,simplify proposed controllability aggregated want usable unpredictable predictability distinction attribute taxonomy logical judgment preconception empirical lifespan consistency efficiently classified validity rating perception practical expert category little mild discovery carrier severity opportunity decision autosomal advance genome woman implementation survey mean feature onset sequencing correlation ass problem like participant screening subject key medical large adult rate total evidence outcome condition difference number significantly gene year genetic method result patient study,{},"{""autosomal"": {""freq"": 1, ""string"": [""mild discovery carrier severity opportunity decision autosomal advance genome woman implementation s""]}, ""genetic"": {""freq"": 1, ""string"": []}}",{},"{""screening"": {""freq"": 1, ""string"": [""sequencing correlation ass problem like participant screening subject key medical large a""]}}",{},{}
434,434,464,10.1371/journal.pone.0204417,30379944.0,importantly investigation greater factor information context specifically concern researcher bias aside literature view abstract conflate risk testing control addition varied well opinion issue medical commercial willingness knowledge however understanding much hypothetical poorly sociocultural perspective clinical respondent gap real worry genomic riddled attention data good obtain force question term little genetic ultimately case three government yes confidentiality concerned genomics independently already many review critical participate frequently people social trustworthy web relational collection investigator insurer security medline decision care systematic sociological public future professional circumstance picture explore bibliographic influence privacy criterion salient research widely also general identify practice often medium entity human patient employer participant individual complex perception willing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209148/,abstract,1,trustworthy sociological sociocultural riddled insurer employer conflate yes worry confidentiality bibliographic willingness salient aside relational concerned willing security picture hypothetical circumstance privacy investigator commercial participate obtain force abstract government opinion entity ultimately respondent perception importantly web varied medline independently bias poorly gap real medium researcher view identify genomics specifically question people little widely frequently perspective explore decision concern systematic investigation good collection genomic professional understanding criterion critical context attention influence practice greater social general issue public testing knowledge participant literature addition complex medical future care information term case individual human risk control factor research review genetic data clinical patient,"{""social"": {""freq"": 1, ""string"": [""critical context attention influence practice greater social general issue public testing k""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
435,435,465,10.1186/s12986-017-0207-1,28824701.0,correlation relationship self whether daily unassisted content among effort ashamed selection paediatric aged perpetuating fact affirmatively well doe pku teaching intake material establish phe individual knowledge comply supplementary family independence compliance backgroundthe wish follow observed select user questionnaire therapy consistent doi great food report effect data good basis question term adherence long resultsour reliance educational necessity four three child regard product phenylketonuria conclusionour behaviour parent online article treatment recommendation electronic associated diet teach care attitude materialthe version age methodsthe permit negative likely helplessness minimum responsible approximately aim impact counteract available regardless importance also group different study direct dietary patient preparation consistently,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559804/,abstract,3,unassisted perpetuating helplessness ashamed affirmatively teach wish reliance independence counteract comply teaching permit resultsour necessity conclusionour select minimum attitude regard paediatric fact regardless consistently behaviour establish doi preparation methodsthe educational compliance backgroundthe adherence responsible great question doe daily approximately selection effort associated content follow good basis recommendation aged observed direct consistent questionnaire negative likely self intake materialthe product correlation parent importance relationship knowledge food aim phe supplementary long user version electronic online diet report family impact dietary care therapy pku material term article phenylketonuria available individual child different age group effect data treatment patient study,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""supplementary long user version electronic online diet report family impact dietary c""]}}",{}
436,436,466,10.1038/srep39082,27966633.0,implication biological tool activity congenital five detailed literature due moreover cyp addition survey hydroxylase exclusively extensive sequence account subset applied protein putative mutant structural hyperplasia effect stability novel case functional mutation pathogenic phenotype prediction structure approach model work bioinformatic propose plausible emerge assay initially deficient two snp variant cah residual classified analysis either concordance vitro impact available adrenal high cohort synergy deficiency patient gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155424/,abstract,0,synergy emerge cah bioinformatic cyp hyperplasia exclusively applied plausible adrenal concordance initially classified putative detailed residual snp subset extensive prediction stability propose deficient pathogenic mutant structural account vitro sequence implication survey work assay structure biological congenital functional cohort hydroxylase phenotype literature tool addition variant deficiency impact novel activity mutation approach case available model protein gene effect high analysis patient,{},{},{},{},{},{}
437,437,467,10.1186/s13023-015-0294-x,26084935.0,italy specific netherlands assessment blood abnormality greater lower affect anxiety hrqol item across turkey adult resultsdata aged restriction tetrahydrobiopterin mean old practical according severity survey pku status intake material phe medical related supplementary family life methodsa subject pharmacological moderate backgroundthe form user questionnaire hoc therapy value health protein generic comparable large data mild observational inventory reference good prospective pregnancy adherence score innovative international young non level guilt one least short measure interventional child overall multicentre outcome population management post parent free online article treatment investigator electronic germany year diet emotional qol version strict age spain poor primarily negative pediatric conclusionpatients subgroup adolescent exploratory quality cognitive analysis aim impact available also general group different domain study acid dietary patient france highest amino newly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542123/,abstract,7,conclusionpatients according resultsdata guilt hoc netherlands multicentre interventional spain qol investigator france turkey italy hrqol exploratory innovative generic item inventory newly germany strict emotional subgroup practical methodsa comparable primarily observational backgroundthe young anxiety adherence prospective pharmacological restriction moderate highest affect reference mild adolescent severity tetrahydrobiopterin post international domain poor pregnancy good aged pediatric short survey old abnormality questionnaire negative mean free intake greater parent general related status overall score assessment form cognitive aim measure phe supplementary subject management user version value electronic quality online medical large lower adult diet family impact dietary therapy life pku material amino outcome non article available specific blood population acid child different protein age health group year data level treatment analysis patient study,"{""emotional"": {""freq"": 1, ""string"": [""generic item inventory newly germany strict emotional subgroup practical methodsa comparable p""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""impact dietary therapy life pku material amino outcome non article available s""]}}","{""diet"": {""freq"": 1, ""string"": [""quality online medical large lower adult diet family impact dietary therapy l""]}, ""turkey"": {""freq"": 1, ""string"": [""multicentre interventional spain qol investigator france turkey italy hrqol exploratory innovative g""]}}",{}
438,438,468,10.4137/CMPed.S33086,27279759.0,major universal worldwide however panel newborn death likely morbidity early screening congenital timely time country birth higher several heart outcome intervention many necessary adverse critical gap without hospital review criterion inclusion infant trial state share diagnosis likelihood diagnostic study large data resource cause disease significantly even discharge help objective low united oximetry show cchd pulse,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892233/,abstract,0,cchd oximetry likelihood discharge pulse timely share universal gap worldwide united morbidity panel inclusion resource death necessary heart adverse help hospital criterion likely critical congenital birth diagnostic country infant screening objective state trial major cause large intervention newborn outcome higher low time significantly early diagnosis review data disease study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""state trial major cause large intervention newborn outcome higher low time s""]}, ""screening"": {""freq"": 1, ""string"": [""critical congenital birth diagnostic country infant screening objective state trial major c""]}}",{},{}
439,439,469,10.1111/eva.12846,31548853.0,relationship activity discus cancerous uncovering epistasis molecular parallel capable genetics mechanistic way synthesis empirical deep recent possible variety scoring fitness distribution genotype enzyme recently base effect data besides basis ability potentially medicine mutation cellular direction phenotype map population review model pathogen development antibody behaviour towards directly assay cell revolution predictive library advance future along application biology massively goal mutational comprehensive trend technological direct industry even,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752143/,abstract,0,uncovering fitness cancerous massively epistasis scoring revolution mutational empirical pathogen deep library map technological direction behaviour industry base capable antibody mechanistic parallel trend predictive variety distribution biology goal cellular genotype directly comprehensive advance potentially way basis direct recently assay genetics synthesis ability medicine phenotype relationship discus possible enzyme application future molecular recent activity mutation cell model population review development effect data,{},{},{},{},{},{}
440,440,470,,25429178.0,derivatization cross blood thf better former intestinal sulfoxide present without five molecular solvent toluene moreover capacity enzymatic control addition synthesization increase significantly polymerization template phe dimethacrylate phenylalanine reduction monomer eisf anti mip fluid body methacrylic porogenic result property data good selective esif linker adsorption selectivity water functional maa nip dmso egdma drug structure soluble morphological chloroform phenylketonuria method polymer system serum concentration dimethyl treatment delivery finding acetonitrile tetrahydrofuran application order comparison ethylene background aim synthesized keywords hplc conclusion group molecularly different study successfully acid human highest amino preparation presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242990/,abstract,1,toluene tetrahydrofuran synthesization sulfoxide porogenic polymerization nip methacrylic maa linker esif eisf egdma dmso dimethyl dimethacrylate chloroform thf synthesized mip ethylene adsorption acetonitrile molecularly derivatization solvent morphological selectivity polymer template soluble monomer intestinal hplc enzymatic preparation successfully fluid selective capacity keywords water anti highest property delivery good serum comparison reduction cross presence structure functional order finding better body background aim phe application addition drug increase molecular concentration amino conclusion phenylketonuria present significantly human phenylalanine control blood acid different group method data treatment result study,"{""phenylalanine"": {""freq"": 2, ""string"": [""amino conclusion phenylketonuria present significantly human phenylalanine control blood acid different g""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""application addition drug increase molecular concentration amino conclusion phenylketonuria present significantly h""]}}",{},{}
441,441,471,10.1186/s12993-014-0048-2,25757041.0,level inflammatory linoleic relationship however whether percentage ratio pathogenic relation healthy molecule problem anti backgroundgastrointestinal child role pufas inflammation initial invesigate previously methodsplasma elevated without dha frequency arachidonic report common result hand autistic plasma investigate serum linolenic study mere manifestation docosahexaenoic addition deficiency fatty patient association first significantly respectively conclusionsreduced carnitine alphalinolenic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332725/,abstract,2,methodsplasma mere invesigate backgroundgastrointestinal alphalinolenic conclusionsreduced pufas linolenic linoleic arachidonic docosahexaenoic dha autistic carnitine hand percentage inflammation manifestation initial anti pathogenic relation elevated inflammatory molecule fatty serum investigate previously frequency problem ratio relationship healthy addition plasma association deficiency report respectively role common significantly child level result patient study,{},{},{},{},{},{}
442,442,472,10.3109/08039488.2015.1042519,25971862.0,biological disorder autism example factor early pathway among several world psychoeducational researcher programme five onset physical heterogeneous deficit adhd proposition risk institution essence finally disease briefly extreme spectrum infectious knowledge family rather neurodevelopmental relative clinical range home brain cytoskeleton examination synapse stimulating link metabolic attention foster symptomatic data cause immune combination first genetic medication metabolism formation useful use three asd main dimensional pre diversity toxic rule dynamic others syndrome child intervention population review degree perinatal social chromatin disability towards postnatal trauma treatment school detail year age progress community category function field environmental research translation broad intellectual nutritional diagnostic interaction often inclusive deprivation human hyperactivity patient exception participant individual initiative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776682/,abstract,1,psychoeducational proposition trauma inclusive foster essence cytoskeleton synapse extreme chromatin briefly stimulating rule deprivation postnatal exception perinatal dimensional adhd diversity symptomatic institution home infectious heterogeneous school initiative hyperactivity programme toxic progress broad degree medication link dynamic translation researcher neurodevelopmental category asd immune examination formation world relative community useful intellectual autism pre finally physical deficit nutritional example combination onset disability attention environmental syndrome social biological main field knowledge spectrum diagnostic interaction participant range cause pathway brain use family intervention function metabolism individual human risk early factor research population review child age metabolic year genetic data disorder treatment clinical patient disease,"{""hyperactivity"": {""freq"": 1, ""string"": [""institution home infectious heterogeneous school initiative hyperactivity programme toxic progress broad d""]}, ""intellectual"": {""freq"": 1, ""string"": [""examination formation world relative community useful intellectual autism pre finally physical d""]}, ""social"": {""freq"": 1, ""string"": [""combination onset disability attention environmental syndrome social biological main field knowledge s""]}}","{""genetic"": {""freq"": 1, ""string"": [""population review child age metabolic year genetic data disorder treatment clinical p""]}}","{""pathway"": {""freq"": 1, ""string"": [""spectrum diagnostic interaction participant range cause pathway brain use family intervention f""]}}",{},{},{}
443,443,473,10.1371/journal.pgen.1006382,27760139.0,sunlight worldwide example whether several positive across selection frequency variation locus investigate diverse differentially regulatory radiation classical significantly quantitative trait recent solar genomic result data thousand eqtls first genetic slc non level rassf variable seq local experienced pigmentation population regulation expression exposure evolution epidermal response key serve transcript sample rna variant allele correlate differentiation influence adaptation magnitude dependent analysis environmental impact eqtl interaction study skin human gene individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070784/,abstract,2,solar rassf eqtls sunlight slc eqtl epidermal pigmentation serve radiation seq transcript experienced magnitude differentially adaptation thousand evolution skin correlate locus differentiation rna worldwide classical diverse local trait selection allele regulatory genomic regulation dependent quantitative variable example exposure variation investigate environmental influence frequency interaction expression positive variant key response recent impact non sample individual significantly human population gene genetic data level analysis result study,"{""skin"": {""freq"": 1, ""string"": [""experienced magnitude differentially adaptation thousand evolution skin correlate locus differentiation rna w""]}}","{""genetic"": {""freq"": 1, ""string"": [""sample individual significantly human population gene genetic data level analysis result s""]}}",{},{},{},{}
444,444,474,10.1080/21688370.2015.1078432,26716073.0,wide genetically biological effector microorganism roundworm discus pathway mainly invertebrate infection innate field naturally review fungal model neurobiology tractable epidermis pathogen particular host parallel infect fungi development upon bacteria interaction diverse epidermal successfully infected response way immune virus feed nematode mammal developed immunity signaling wounding,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681281/,abstract,1,wounding roundworm infect nematode fungi epidermis tractable neurobiology infected epidermal invertebrate fungal developed feed naturally mammal innate microorganism effector pathogen immunity host signaling bacteria parallel successfully virus genetically diverse immune mainly infection way particular biological wide discus field interaction response pathway model review development,{},{},"{""pathway"": {""freq"": 1, ""string"": []}}",{},{},{}
445,445,475,10.4103/abr.abr_131_17,30050886.0,coefficient logistic correlation tool relationship chain among location density reaction modification due common polymerase cholesterol disease iranian material beneficial obesity higher role body mutant genomic autoimmune result metabolic effect lipoprotein immunity type metabolism low regression hrm fad rate mutation variable one syndrome prevent population method mediator prone development polymorphism important key triglyceride fatty association decision lifestyle mass allele dyslipidemia dna background diabetic precursor impact index also arachidonic conclusion high study acid patient participant gene total resolution,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036782/,abstract,6,dyslipidemia hrm fad arachidonic triglyceride lipoprotein autoimmune prone mediator immunity location iranian diabetic polymerase cholesterol density coefficient lifestyle logistic resolution modification beneficial precursor mutant polymorphism obesity fatty decision prevent allele reaction genomic index dna variable regression chain syndrome correlation relationship participant body background tool mass key association impact rate total mutation material conclusion higher important role common low metabolism type population acid development metabolic gene effect high method result patient disease study,{},{},{},{},{},{}
446,446,476,10.1002/chem.201700793,28401991.0,component smallest supramolecular water phenylalanine self crystalline multi fibre herein interest gelation difference single composition form additive gain molecule dynamic structure restrict insight approach model mechanism flow technique particular due identification state nmr analytical property exchange high microscopic free study saturation solid transfer equilibrium date magic pxrd gelator experiment network gel solution material resolution interface angle,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575562/,abstract,0,restrict pxrd magic gelator gelation smallest microscopic crystalline saturation fibre supramolecular angle gel equilibrium additive nmr transfer interface solid exchange gain flow experiment resolution multi dynamic solution composition water analytical network molecule date property component particular insight self structure free technique identification form state single mechanism material difference approach model phenylalanine high study,"{""phenylalanine"": {""freq"": 2, ""string"": []}}",{},{},{},{},{}
447,447,477,10.1007/s11306-016-1022-9,28775675.0,chemistry across defect glucose proteotoxicity five due common catecholamine methodswe significantly pancreatic phenylalanine marker norepinephrine reduction unique recent dopamine dysfunction role protein brain metabolic effect contrast decrease type amylin rat metabolism mortality non level significant four multi death morbidity systemic tyrosine liver lysine model hyperamylinemia alanine serine compartment system amyloidogenic oligomers aggregate cell resultsfour cytotoxic epinephrine hypersecretion uniquely heart analysis introductionchronic diabetic mechanism metabolomics precursor multiple implicate consequence plasma different tissue cardiac acid human deficiency beyond amino metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538143/,abstract,3,proteotoxicity introductionchronic implicate hypersecretion hyperamylinemia oligomers amylin resultsfour epinephrine amyloidogenic cytotoxic pancreatic norepinephrine uniquely lysine chemistry serine compartment catecholamine alanine diabetic aggregate cardiac systemic multi precursor rat dopamine morbidity metabolomics glucose unique contrast methodswe death heart mortality consequence decrease reduction marker liver dysfunction tissue tyrosine defect metabolite plasma multiple brain recent deficiency mechanism amino non role common cell metabolism significantly human model phenylalanine type acid different protein significant metabolic effect level analysis,"{""phenylalanine"": {""freq"": 2, ""string"": [""common cell metabolism significantly human model phenylalanine type acid different protein s""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""plasma multiple brain recent deficiency mechanism amino non role common cell m""]}}",{},{}
448,448,478,10.1155/2017/6935402,28265582.0,experimental hapten dominant content dermatitis country present reaction pruritus recruitment action together hydrolysis common investigate immunomodulatory lesion severity addition dinitrochlorobenzene effective ige disease significantly glycomacropeptide murine whose remarkably anti therapy mast feature eosinophil atopic peptide hyperplasia like effect besides casein epicutaneous decrease immune rat edema level significant administration gmp one cytokine histopathological chymosin management expression potential serum evokes response intensity incidence cell dncb process inflammatory dairy production application immunoglobulin alternative induction prevention bioactive study skin prebiotic inhibitory total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318634/,abstract,0,mast hapten evokes epicutaneous eosinophil dncb dinitrochlorobenzene chymosin pruritus immunomodulatory ige histopathological edema hydrolysis dermatitis atopic prebiotic hyperplasia casein immunoglobulin dairy bioactive remarkably recruitment induction gmp murine lesion intensity inhibitory cytokine dominant skin glycomacropeptide peptide immune action rat anti severity inflammatory experimental production alternative content administration reaction decrease incidence serum feature investigate prevention like country process application addition management expression response effective therapy total common cell present significantly potential significant effect level disease study,"{""skin"": {""freq"": 1, ""string"": [""murine lesion intensity inhibitory cytokine dominant skin glycomacropeptide peptide immune action r""]}}",{},{},{},{},{}
449,449,479,10.1186/s12880-019-0314-8,30683072.0,resonance factor methodsmri congenital abnormal present accurate efficient fetus investigate effective well disease significantly pregnant however chromosome form alone environment effectiveness diagnosis aortic fetal genetic resultsour deformity fluorescence hybridization external current structure sensitivity woman comparative analyze method stenosis maternal specificity protocol two suggest situ backgroundfetal mri healthy effectively heart pulmonary analysis either conclusionin aim also genome conclusion diagnostic study magnetic gene accuracy total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347844/,abstract,4,stenosis methodsmri backgroundfetal deformity conclusionin resultsour aortic situ suggest hybridization fetus external comparative pulmonary fluorescence analyze chromosome mri effectively pregnant resonance accurate fetal efficient protocol magnetic abnormal accuracy specificity effectiveness heart maternal genome woman environment sensitivity investigate structure congenital diagnostic form aim healthy effective total current conclusion present significantly factor diagnosis gene genetic method analysis disease study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
450,450,480,10.1155/2019/3460902,30723736.0,specific blood chain nine reliability offs positive defect demonstrates liquid accurate cut iems reliable urinary evaluate quantifying quantitation uptake citrullinemia value coa clinically error card inborn diagnosis metabolic specimen tandem type metabolism validate methylmalonic establishment case seven dehydrogenase confirmation total divided phenylketonuria day method gas system second test bangladesh year acidemia acylcarnitines age carnitine two mass newborn isovaleric along negative spot healthy determine tier analytes mcad analysis spectrometry available also conclusion group different study namely medium acid predominantly deficiency patient participant amino presence chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339774/,abstract,11,quantifying offs bangladesh mcad isovaleric citrullinemia divided tier quantitation cut establishment carnitine confirmation analytes uptake demonstrates acylcarnitines reliability card validate methylmalonic specimen iems acidemia predominantly coa gas dehydrogenase reliable accurate medium urinary seven tandem liquid chromatography clinically evaluate second negative presence chain spectrometry spot defect determine participant inborn healthy mass day positive value error deficiency total newborn amino conclusion phenylketonuria case available metabolism test specific blood type diagnosis acid different age metabolic group year method analysis patient study,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""positive value error deficiency total newborn amino conclusion phenylketonuria case available m""]}, ""tandem"": {""freq"": 1, ""string"": [""dehydrogenase reliable accurate medium urinary seven tandem liquid chromatography clinically evaluate s""]}, ""spectrometry"": {""freq"": 1, ""string"": [""clinically evaluate second negative presence chain spectrometry spot defect determine participant i""]}, ""newborn"": {""freq"": 1, ""string"": [""day positive value error deficiency total newborn amino conclusion phenylketonuria case a""]}}",{},{}
451,451,481,10.1212/CPJ.0000000000000266,29443118.0,process biochemical future disorder internal new summary recent discus screening especially present adult laboratory therapy field next speed subspecialty recognition workup review insight mechanism technique molecular emphasis importance error cautiously diagnostic metabolic neurology purpose pattern attention sequencing yield basis patient generation increase furthermore underlying disease novel genetic care deepen challenge briefly medicine gene issue transition neurometabolic metabolism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727707/,abstract,0,subspecialty deepen cautiously workup neurometabolic neurology briefly speed emphasis recognition internal yield transition underlying summary basis insight pattern generation purpose attention furthermore sequencing especially technique laboratory medicine importance issue biochemical discus field diagnostic process screening challenge increase error future molecular adult recent mechanism novel care therapy present metabolism new review metabolic gene genetic disorder patient disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""screening"": {""freq"": 1, ""string"": [""issue biochemical discus field diagnostic process screening challenge increase error future m""]}}",{},{}
452,452,482,,26776175.0,relationship activity example better new encoding maximization factor pathway context signature across present algorithm biomedical molecular chemical state diverse outside well way underlying disease line employ higher clinical pairwise feature probability genomic large contrast data basis design thousand novel far art non area use although multi curve current prediction drug structure able approach model classifies propose system loss relational manifestation multiplex similarity cell jointly predictive differentiable superiority negative collective estimate scale category analysis alternative correspondence roc interaction classification domain entity leverage latent connection successful performance complex bear,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4719585/,abstract,0,maximization differentiable classifies superiority correspondence bear pairwise relational jointly employ leverage latent collective outside art roc multiplex signature connection probability biomedical similarity entity thousand encoding curve algorithm far classification underlying prediction multi propose manifestation predictive chemical line diverse category able successful alternative domain contrast estimate way genomic basis example negative loss feature context structure design scale relationship performance interaction better area state complex drug large pathway molecular use novel activity current higher non cell approach present new model factor data clinical analysis disease,{},{},"{""pathway"": {""freq"": 1, ""string"": [""better area state complex drug large pathway molecular use novel activity c""]}}",{},{},{}
453,453,483,10.18632/aging.100902,26922388.0,specific ratio phosphatidylcholines reticulum eif pathway several inversely affected supplementation risk finally vitamin disease gulo significantly intake amount measurement endoplasmic animal phenylalanine marker life drinking overlapped mouse arginine enzyme metabolic specie type untreated span level suboptimal stress water wild hepatic cytokine normal tyrosine liver lysine gulonolactone ire modulates serum unknown oxidase response exact still mass chronic spectrometry also upon different ascorbate study dietary supplemented longevity metabolite return,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833140/,abstract,1,phosphatidylcholines gulonolactone gulo ire eif modulates overlapped ascorbate reticulum longevity endoplasmic inversely drinking return supplemented oxidase span lysine suboptimal exact cytokine arginine hepatic specie untreated affected vitamin water wild unknown finally supplementation stress serum animal marker liver chronic intake measurement spectrometry tyrosine ratio mouse metabolite enzyme normal mass response pathway dietary life significantly risk phenylalanine specific type different metabolic level disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""response pathway dietary life significantly risk phenylalanine specific type different metabolic l""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""mouse metabolite enzyme normal mass response pathway dietary life significantly risk p""]}}","{""spectrometry"": {""freq"": 1, ""string"": [""animal marker liver chronic intake measurement spectrometry tyrosine ratio mouse metabolite e""]}}",{},{}
454,454,484,10.1007/s10545-016-9979-0,27778219.0,disorder abnormality lead pathway present adult synthase serious affected respond literature unfortunately difficulty beta catabolic testing accumulation specialist disease severely synthesis whose thromboembolism evidence childhood cbs clinical homocysteine feature mol usually diagnosis contrast learning level lentis current responsiveness many betaine unlikely review management cystathionine recommend article concentration fluctuate impaired treatment standardise recommendation strongly nevertheless diet systematic rare generally mildly poor likely pyridoxine quality plasma different often skeletal high methionine deficiency patient complication total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203861/,abstract,2,thromboembolism standardise lentis fluctuate cbs betaine cystathionine recommend unlikely mildly catabolic respond pyridoxine homocysteine responsiveness unfortunately skeletal methionine learning severely beta impaired usually specialist synthase affected strongly generally complication difficulty mol accumulation contrast poor systematic recommendation childhood abnormality feature synthesis likely lead testing literature plasma management quality pathway adult deficiency diet rare concentration total evidence current article present diagnosis review different high level disorder treatment clinical patient disease,{},{},"{""pathway"": {""freq"": 1, ""string"": [""lead testing literature plasma management quality pathway adult deficiency diet rare c""]}}",{},"{""diet"": {""freq"": 1, ""string"": [""plasma management quality pathway adult deficiency diet rare concentration total evidence c""]}}",{}
455,455,485,10.1111/biom.12735,28653391.0,various correlation statistic single affect across without additional need genetics common appealing mean summary trait value mixed procedure global error large data computational genetic type lipid level differently rate phenotype analytically variance accounting model method correct simulation test arbitrary association jointly wide component original robust practically variant access scale since analysis matrix paper genome multiple often consortium study advantage gwass power powerful linear show individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743780/,abstract,0,gwass appealing analytically practically arbitrary jointly differently accounting consortium original simulation power mixed matrix variance statistic computational powerful correct summary lipid access advantage robust linear affect trait procedure global component genome mean genetics correlation wide scale paper additional phenotype need various multiple value variant error large single association rate common test individual model type genetic method data level analysis study,{},"{""genetic"": {""freq"": 1, ""string"": [""rate common test individual model type genetic method data level analysis s""]}}",{},{},{},{}
456,456,486,10.1002/ajmg.a.37011,25728503.0,intelligence investigation estimation factor information early time country present author selection bias recall liveborns due genetics likelihood unexplained journal medical extensive related childhood determined possibility diagnosis large cause genetic middle south case although variable short etiology overall child wiley many population inclusion management identification development thereby disability american test inc city brazil age poor prevalence appropriate income birth approximately environmental intellectual different cohort part study periodical even performance number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863139/,abstract,6,liveborns periodical recall wiley unexplained likelihood journal south intelligence estimation brazil city income middle bias american author extensive determined possibility etiology approximately selection inclusion poor intellectual investigation appropriate short childhood variable genetics disability environmental identification related cohort prevalence birth performance overall country management cause medical large information number present case test time early factor diagnosis population child different age development genetic study,"{""intellectual"": {""freq"": 1, ""string"": [""possibility etiology approximately selection inclusion poor intellectual investigation appropriate short childhood v""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
457,457,487,10.1093/database/bay144,30689844.0,major biological oxidoreductase activity herein unchecked commission positive across researcher www expert annotation bioinformaticians flybase origin significantly numerous related however isomerase inference improvement genomic error enzyme melanogaster data date term similarly type incorrect four functional catalytic one database wider review workflow work lyases potential resource manually curator false drosophila computationally within negative unclear ontology congruent usefulness systematically quality either impact routinely available coverage multiple conclusion group different often direct org absence gene number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343044/,abstract,0,lyases flybase curator computationally bioinformaticians unchecked manually isomerase oxidoreductase congruent usefulness melanogaster inference incorrect commission wider ontology drosophila annotation org workflow routinely www similarly coverage catalytic systematically origin false researcher numerous absence expert unclear date resource genomic direct improvement work negative database biological related functional enzyme major multiple positive error quality impact activity conclusion term number available significantly type review potential different gene group data,{},{},{},{},{},{}
458,458,488,10.1186/s12887-015-0479-4,26475713.0,assessment conclusionswe factor methodological difficult essential neonatal weakness contains programme weight statement condition literature subsequently state risk toxicity experience material confounding consanguinity explanation knowledge unit toxoplasmosis family methodsa evidence supplementary weak moderate possible follow user clinical questionnaire health doi grand effect contrast belgium auditory basis hospitalisation low score level case three panel one step scientific update foetal bilirubin current belgian infection syndrome sensitivity drug implementation evaluation strength review approach management resultscongenital method history development face system parent accordance loss online syphilis article treatment delphi recommendation electronic finding care version materialthe process consensus two newborn accordingly birth function next unidentified quality intensive round available also grade high study alcohol cytomegalovirus even hyperbilirubinaemia individual malformation ototoxic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609128/,abstract,0,syphilis resultscongenital ototoxic hyperbilirubinaemia grand toxoplasmosis hospitalisation confounding belgian unidentified round foetal cytomegalovirus belgium weakness explanation bilirubin weak delphi auditory accordance statement methodological contains consanguinity conclusionswe update intensive alcohol strength malformation grade accordingly toxicity face doi subsequently consensus programme unit methodsa scientific moderate panel infection contrast difficult step follow experience history basis recommendation implementation weight sensitivity questionnaire neonatal loss syndrome materialthe evaluation essential parent birth knowledge score finding literature possible assessment process supplementary state management user drug version electronic quality online family care newborn evidence current material condition article function low approach case available individual risk factor review development health effect high method level treatment clinical study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""version electronic quality online family care newborn evidence current material condition a""]}}",{},{}
459,459,490,10.3389/fmicb.2019.01581,31379769.0,experimental adversely interestingly chain viability growth greater trigger among subunit pathway glutamate persister innate evasive pathogenicity treacherous insight behavior together moreover macrophage shuttle bacterial evasion state highlight catabolic physiology differentially route conjunction significantly epithelial respectively murine transcriptional presence phenylalanine strategy trait pleural observed hap additionally role adaptable fluid fold global degradation pyruvate utilization metabolic existence chemotactic data immune pneumonia metabolism formation pathoadaptabililty dehydrogenase one signal independent short pathogenic phenylpyruvate phenotype overall provide convert chemotaxis approach degree pathogen expression pyr versatility acinetobacter intermediate response key fatty assay cell process upregulation virulence persistence differential dependent reduced undergoes antibiotic resistance analysis environmental hospital neutrophil transcriptomic impact alternative posse cytotoxicity also baumannii study human acid phenylacetic gene complex styrene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650585/,abstract,0,versatility treacherous styrene shuttle pyr pleural phenylacetic persister pathoadaptabililty hap evasive chemotaxis chemotactic baumannii acinetobacter phenylpyruvate adaptable virulence undergoes pneumonia evasion neutrophil viability transcriptomic adversely pathogenicity cytotoxicity catabolic upregulation persistence route pyruvate macrophage innate posse convert utilization pathogen intermediate subunit epithelial antibiotic trigger existence glutamate murine conjunction differentially interestingly physiology transcriptional bacterial resistance fluid dehydrogenase degree differential degradation fold signal reduced immune formation pathogenic trait experimental additionally independent fatty alternative global dependent observed insight short assay hospital behavior presence environmental chain greater highlight growth provide phenotype overall process state expression complex strategy key response pathway respectively impact role cell approach metabolism significantly human phenylalanine acid metabolic gene data analysis study,"{""phenylalanine"": {""freq"": 2, ""string"": [""role cell approach metabolism significantly human phenylalanine acid metabolic gene data a""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""state expression complex strategy key response pathway respectively impact role cell a""]}}",{},{},{}
460,460,491,10.5152/eurasianjmed.2015.0267,27551178.0,blood agonist shine activity pain memory new greater factor affect binding gland pressure detoxification due pathology vascular seasonal physiology effective antioxidant orphan bird increase antinociceptive amphibian ramelteon retinoid membrane transcription era circadin neuroprotective antineophobic gpr anti prize secreted fish role protein sleep reductase contribution scientist enzyme tasimelteon attention effect antidepressant clock decrease receptor osteoblast type medicine level bind four pubertal nuclear interest retinal anxiolytic night ovarian side drug nobel review day calmoduline development quinone melatonin hormone promising cell intracellular inflammatory rzr future turkish locomotor differentiation adaptation closely mechanism agomelatine conclusion cycle plasma regulating nucleus tik pineal tumor gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970552/,abstract,1,tik tasimelteon shine seasonal rzr retinoid ramelteon prize pineal osteoblast nobel neuroprotective circadin calmoduline antinociceptive antineophobic amphibian agomelatine gpr clock anxiolytic locomotor bird secreted quinone detoxification antidepressant agonist pubertal night turkish melatonin nucleus closely ovarian binding retinal intracellular reductase gland fish scientist regulating bind orphan sleep adaptation era antioxidant vascular physiology pain membrane promising tumor pressure differentiation pathology contribution transcription nuclear hormone memory anti receptor affect cycle inflammatory decrease attention greater medicine enzyme plasma day drug increase effective future mechanism activity conclusion role cell new factor blood type review protein development gene effect level,{},{},{},{},"{""fish"": {""freq"": 1, ""string"": [""ovarian binding retinal intracellular reductase gland fish scientist regulating bind orphan s""]}}",{}
461,461,492,10.3390/nu11030591,30862081.0,male experimental biological blood lower exert gain gut essential laboratory neomycin separate bacterial contributes dawley sprague mean control increase solution significantly evidence smaller recent higher protein output body contribution bacteria effect contrast change decrease rat tap significant water three product stool indole potential serum free concentration rich iii diet propionic vehicle standard series antibiotic tryptophan group plasma high study acid amino total metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471155/,abstract,0,tap neomycin indole sprague dawley stool vehicle exert smaller contributes antibiotic propionic output gut iii series rich gain bacterial bacteria tryptophan separate solution contribution water rat experimental contrast decrease serum mean free product essential biological laboratory male standard body metabolite plasma change increase lower recent diet concentration total evidence amino higher significantly control blood acid potential protein significant group effect high study,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""lower recent diet concentration total evidence amino higher significantly control blood a""]}}","{""diet"": {""freq"": 1, ""string"": [""metabolite plasma change increase lower recent diet concentration total evidence amino h""]}}",{}
462,462,493,10.1016/j.pediatrneurol.2017.06.010,28844798.0,schedule disorder tool multicenter autism observation early ado behavior need cut risk backgroundtuberous objective month significantly higher clinical developmental primary predict aosi observational prospective similarly ability genetic score useful non asd adi sclerosis measure biomarkers child mullen intervention conclusionsthe tsc predictor network tacern specificity detect age prevalence scale determine excellence classified research infant group diagnostic methodschildren high study center resultsanalysis total complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610103/,abstract,12,tacern mullen backgroundtuberous aosi ado adi tsc resultsanalysis methodschildren multicenter excellence schedule predict cut sclerosis classified similarly detect observation observational predictor conclusionsthe prospective asd network useful specificity center autism behavior developmental biomarkers ability determine scale prevalence need score diagnostic tool measure month infant objective complex primary intervention total higher non significantly risk early research child age group high genetic disorder clinical study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
463,463,494,,25550961.0,exon chain tool region single conformation time prognostic reaction frequency common investigate polymerase hydroxylase pku promoter spectrum intron phenylalanine additionally china diagnosis flanking novel furthermore combination first type genetic area detection pcr case four rate mutation sixteen strand local database evaluation phenylketonuria potential minority prevalent polymorphism valuable serve construction allele north screen dna analysis distinctive sscp pah different sequencing direct similar patient another xinjiang gene individual promote,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276219/,abstract,4,xinjiang sscp flanking distinctive strand sixteen serve promote intron prognostic construction minority conformation north polymerase promoter prevalent pcr valuable exon china screen local polymorphism additionally allele reaction dna direct pah combination investigate furthermore chain sequencing database evaluation frequency hydroxylase spectrum similar region detection area tool single novel rate mutation pku common phenylketonuria case individual time phenylalanine type diagnosis potential different gene genetic analysis patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""pku common phenylketonuria case individual time phenylalanine type diagnosis potential different g""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""detection"": {""freq"": 1, ""string"": [""evaluation frequency hydroxylase spectrum similar region detection area tool single novel r""]}}",{},{}
464,464,495,10.1038/srep39732,28054562.0,experimental biological growth vivo specifically eukaryote fda regulatory effective remains chemoresistance disease xenografted pancreatic screening migration prof protein compound mouse candidate possibility besides completely multifunctional idp nupr drug discovery technique partner development target simulation prevalent active intrinsically fuzzy constitute signaling senescence cell interface fifteen mimicking pdac function arrest natural upon often interaction study adenocarcinoma human intact deficiency ductal tumor,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5213423/,abstract,1,xenografted nupr eukaryote prof pdac multifunctional mimicking fuzzy chemoresistance intrinsically idp arrest adenocarcinoma senescence ductal constitute migration remains pancreatic intact fda partner signaling interface simulation completely prevalent tumor candidate possibility specifically discovery experimental active vivo natural regulatory compound technique biological growth target interaction mouse screening drug effective deficiency cell function human protein development disease study,{},{},{},"{""screening"": {""freq"": 1, ""string"": [""technique biological growth target interaction mouse screening drug effective deficiency cell f""]}}",{},{}
465,465,497,10.1016/j.ymgmr.2015.10.004,28649543.0,disorder hpd hydroxyphenyl autosomal www elevated missense derivative orpha old accumulation urinary excretion doe recurrent neuronal phenylalanine rather trait form tyr clinical value fluid feature mol body symptom massive error report pyruvate never inborn proteinuria metabolic mild urine basis change type far metabolism level case dioxygenase mutation variable least etiology tyrosinemia normal tyrosine damage mental development unknown frequent concentration net year diet directly rare genetically cys homozygous recessive since girl high patient gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471395/,abstract,5,proteinuria orpha hpd hydroxyphenyl dioxygenase cys massive pyruvate tyrosinemia net derivative recurrent excretion www girl homozygous tyr neuronal fluid far urinary missense damage genetically frequent etiology doe mol recessive mild elevated trait accumulation directly urine autosomal unknown mental basis variable old feature tyrosine body inborn symptom form normal change value error diet report rare concentration mutation case metabolism phenylalanine type development metabolic gene year high level disorder clinical patient,"{""urine"": {""freq"": 1, ""string"": [""recessive mild elevated trait accumulation directly urine autosomal unknown mental basis v""]}, ""phenylalanine"": {""freq"": 2, ""string"": [""report rare concentration mutation case metabolism phenylalanine type development metabolic gene y""]}}","{""autosomal"": {""freq"": 1, ""string"": [""mild elevated trait accumulation directly urine autosomal unknown mental basis variable o""]}, ""recessive"": {""freq"": 1, ""string"": [""damage genetically frequent etiology doe mol recessive mild elevated trait accumulation d""]}, ""homozygous"": {""freq"": 1, ""string"": [""net derivative recurrent excretion www girl homozygous tyr neuronal fluid far u""]}}",{},{},"{""diet"": {""freq"": 1, ""string"": [""symptom form normal change value error diet report rare concentration mutation c""]}}",{}
466,466,498,10.1186/s13023-019-1188-0,31492166.0,blood abnormality factor early oxidative venous adult pressure need vascular marked risk resultstwenty control endothelial accumulation cholesterol occlusion velocity traditional significantly pku characterize pulse measurement biochemical marker reduction dysfunction higher clinical femoral protein demonstrating malondialdehyde body examination purpose data significance backgroundpatients non level yet stress three rate phenotype ischemic plethysmography stiffness systolic phenylketonuria post reactive subfraction conclusionsthis serum unknown wave inflammatory age mass amyloid healthy carotid function invasive heart hdl cardiovascular index flow multiple plasma high study whereas dietary patient total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731621/,abstract,1,subfraction occlusion malondialdehyde plethysmography carotid ischemic backgroundpatients velocity femoral stiffness resultstwenty hdl wave systolic marked venous pulse reactive demonstrating endothelial amyloid cholesterol vascular conclusionsthis flow invasive characterize pressure traditional oxidative significance cardiovascular examination accumulation inflammatory post unknown heart index stress serum abnormality reduction marker dysfunction purpose measurement biochemical phenotype need body healthy mass plasma multiple adult dietary rate total pku higher non function phenylketonuria significantly risk early control factor blood protein age high data level clinical patient study,{},{},{},{},{},{}
467,467,499,10.1371/journal.pone.0121082,25793983.0,immunohistochemistry experimental specific conclusionthese observation apoptosis factor lower pancreas homeostasis molecular methodsusing well significantly pancreatic backgroundhnf line sequence transcription cancer however evidence adjacent possible higher role protein result recently hepatocyte significance selective eight non level pcr transduction functional three rate nuclear normal provide sirna phosphorylation method mtor target expression suppressor susceptibility association hnf carcinoma phase western assay cell wide downstream sample carcinogenesis two akt unclear differentiation analysis cytometry mechanism impact flow genome blot cycle tissue mrna study alpha adenocarcinoma patient mammalian atp ductal tumor gene proliferation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368635/,abstract,1,methodsusing backgroundhnf akt adenocarcinoma sirna pancreas immunohistochemistry ductal adjacent conclusionthese carcinogenesis suppressor mtor cytometry carcinoma pancreatic atp blot apoptosis transduction phosphorylation mammalian proliferation mrna hnf flow downstream western observation susceptibility alpha tumor pcr differentiation selective hepatocyte transcription nuclear homeostasis significance line unclear cycle experimental phase sequence genome cancer recently assay tissue wide provide functional target possible normal expression lower association molecular mechanism impact rate evidence higher non role cell sample significantly specific factor protein gene method level analysis result patient study,{},{},{},{},{},{}
468,468,500,10.1074/jbc.H118.006676,30578407.0,crystallography regulator however phenylalanine step conformational pathway unclear scale positive explore motion selection protein site allosteric impairment critical determined mechanism phenylketonuria also catabolic enzyme simulation large human regulatory activation hydroxylase gating,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314130/,abstract,0,gating crystallography motion catabolic conformational allosteric simulation regulator determined activation unclear selection explore step regulatory site impairment critical scale hydroxylase enzyme positive large pathway mechanism phenylketonuria human phenylalanine protein,"{""phenylalanine"": {""freq"": 2, ""string"": []}}",{},"{""pathway"": {""freq"": 1, ""string"": [""critical scale hydroxylase enzyme positive large pathway mechanism phenylketonuria human phenylalanine p""]}}",{},{},{}
469,469,501,10.3390/genes10050387,31117296.0,disorder observation discus cystic molecule autosomal need highlight effective addition concept well way disease significantly exclusively animal however rather strategy clinical therapy monogenic fibrosis base effect date term long genetic clearly yet mutation one least cftr stabilise proof already many able machinery approach model therapeutic development correct target potential towards pave delivery precision key engraftment cell option cdna variant breakthrough recessive function reality available lung trial genome study small patient successful gene number treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562706/,abstract,1,stabilise machinery pave reality cftr cdna engraftment breakthrough exclusively proof lung clearly cystic base monogenic observation fibrosis correct precision treat able option successful recessive concept molecule date autosomal way delivery genome animal highlight small discus need target addition long trial strategy variant key therapeutic effective therapy mutation term cell function approach number available significantly model potential development gene effect genetic disorder clinical patient disease study,{},"{""autosomal"": {""freq"": 1, ""string"": [""option successful recessive concept molecule date autosomal way delivery genome animal h""]}, ""recessive"": {""freq"": 1, ""string"": [""correct precision treat able option successful recessive concept molecule date autosomal w""]}, ""genetic"": {""freq"": 1, ""string"": [""significantly model potential development gene effect genetic disorder clinical patient disease s""]}}",{},{},{},{}
470,470,502,10.1517/21678707.2015.1039511,27668135.0,specific availability discus information opinioncurrently molecule researcher insight expert highlight virus disease introductionan decade dozen gov clinical therapy conventional bottleneck immune generation aav ability area detection use clinicaltrials one pre current preclinical review model therapeutic emphasis translational development expression coveredin tropism safety american edge viral associated phase option rare overcome future within two advancement variant application million scope biology shape adeno benefit paper research available broad trial array tissue last study small vector limitation gene number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034874/,abstract,1,tropism opinioncurrently introductionan coveredin edge bottleneck overcome dozen aav adeno shape array scope preclinical advancement emphasis viral translational conventional clinicaltrials vector million american broad virus gov researcher expert immune safety option biology availability limitation decade molecule associated phase pre insight generation tissue highlight ability benefit paper small discus detection area application trial expression variant therapeutic future use rare therapy information current number available model specific research review development gene clinical disease study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""highlight ability benefit paper small discus detection area application trial expression v""]}}",{},{}
471,471,503,10.1097/MD.0000000000010424,29702991.0,rare hemorrhage related oblongata female extremely neurodevelopmental form premature early medulla birth neonatal concern outcome intervention condition levetiracetam week valproate closely prompt onset sodium gestation day infant identification aware report immaturity hospitalization dysplasia diagnosis hydrocephalus epilepsy rationale symptomatic manifestation treatment lesson clinician cause intracranial patient potentially subependymal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944545/,abstract,2,subependymal oblongata levetiracetam hydrocephalus medulla immaturity intracranial valproate hemorrhage dysplasia hospitalization closely prompt aware rationale lesson gestation sodium extremely epilepsy premature symptomatic manifestation neurodevelopmental clinician concern potentially female neonatal onset identification related week birth form infant day cause report rare intervention outcome condition early diagnosis treatment patient,{},{},{},{},{},{}
472,472,504,10.5455/msm.2018.30.297-303,30936797.0,federation availability huge better new difference lower country reimbursement document without awareness due cost fbih orphan disease objective significantly respectively herzegovina ground much introduction price bosnia legislation bih result situation payer orphanet republic official genetic medication obstacle low medicine international four current drug lot evaluation fund toward method organization important active thou assuring list rare still within access order since srpska field goal criterion special aim research available program diagnostics consequence policy conclusion diagnostic high domain right study entity insufficient maker patient engagement even number initiative treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377930/,abstract,2,thou srpska federation fbih bih assuring orphanet lot herzegovina fund bosnia price payer ground republic legislation huge reimbursement official engagement obstacle maker orphan entity insufficient document diagnostics situation awareness initiative right list special medication introduction organization access treat availability goal active international domain policy consequence criterion cost evaluation medicine order field diagnostic country better aim objective program drug lower rare respectively current conclusion important difference low number available significantly new research high genetic method result patient disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""number available significantly new research high genetic method result patient disease s""]}}",{},{},{},{}
473,473,505,10.1053/j.semperi.2015.09.010,26499764.0,interpretation new discus information time across present concern molecular genetics testing discrimination utility shortly life quickly clinical complete possibility conceptual large data expansion term generation first ability far potentially genetic tandem span whole rapid panel volume implementation capability exome towards evolution year best iterative challenge conception cytogenetics advance continuously unclear birth reality field next path privacy karyotype consequence practice last technological human sequencing gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644676/,abstract,0,cytogenetics karyotype shortly reality conceptual quickly privacy conception span iterative discrimination continuously path technological capability expansion evolution interpretation far exome possibility complete unclear tandem utility panel volume advance concern potentially best consequence implementation genetics rapid generation sequencing practice ability birth discus field testing challenge large molecular information life term present time new human gene year genetic data clinical,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""tandem"": {""freq"": 1, ""string"": [""interpretation far exome possibility complete unclear tandem utility panel volume advance c""]}}",{},{}
474,474,506,10.1542/peds.2015-4256,27464676.0,epidemiologic alcoholism specific disorder new among defect author present behavioral prenatal cadre accurate lip literature view dysmorphology institute practical clinician specifying conjunction conference spectrum related neurodevelopmental partial clinical scoring developmental expertise report diagnosis neurology effect purpose large abuse philtrum guideline call fetal psychology epidemiology medicine area educational pediatrics rockville standardization office current neurobehavioral white syndrome child evaluation population review degree national potential exposure disability system guide collaborative investigator meeting specificity definition collaboration prevalence category birth field continuum precise adverse criterion prenatally research infant diagnostics diagnostic comprehensive clarity study alcohol fasd thorough initiative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960726/,abstract,1,specifying rockville philtrum dysmorphology cadre fasd alcoholism psychology prenatally neurobehavioral clarity pediatrics abuse lip standardization scoring continuum collaborative office neurology investigator thorough conference meeting epidemiologic institute expertise conjunction alcohol epidemiology collaboration definition diagnostics precise initiative guide practical partial educational author degree accurate prenatal view fetal neurodevelopmental category clinician white guideline behavioral comprehensive specificity adverse exposure criterion national purpose disability developmental syndrome evaluation defect medicine related prevalence birth field spectrum diagnostic literature area infant large report current present new specific diagnosis research population review potential child effect disorder clinical study,"{""behavioral"": {""freq"": 1, ""string"": [""cadre fasd alcoholism psychology prenatally neurobehavioral clarity pediatrics abuse lip s"", ""fetal neurodevelopmental category clinician white guideline behavioral comprehensive specificity adverse exposure c""]}}",{},{},{},{},{}
475,475,509,10.3390/jpm8020016,29710874.0,specific blood investigation african single factor cau caucasian pressure additional moreover variation locus control respectively prove whose respect however subject trait role health candidate improvement integrative project large data combination genetic medicine level use provider one measure lenoir outcome responsiveness intervention population systolic variance management regulation rural associate hypertension identification expression baseline american test success polymorphism treatment padi recommendation response iii association help year finding decision wide genetically age sbp within future two snp ancestral healthy determine heart goal precise analysis either cardiovascular also identify conclusion group practice interaction part applicable different nucleotide study patient gene individual complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023309/,abstract,4,sbp padi lenoir cau ancestral prove associate systolic responsiveness caucasian hypertension african integrative applicable rural iii respect variance precise provider snp locus american pressure project success identify candidate genetically cardiovascular nucleotide goal polymorphism trait baseline decision heart investigation regulation recommendation help improvement combination variation practice determine wide medicine identification additional finding interaction measure healthy subject management expression complex response large future single association use respectively intervention outcome conclusion role test individual specific control factor blood population different age health gene group year genetic data level treatment analysis patient study,{},"{""genetic"": {""freq"": 1, ""string"": [""different age health gene group year genetic data level treatment analysis p""]}}",{},{},{},{}
476,476,510,10.1186/s40064-015-1309-8,26413448.0,pcr exon sixteen rate mutation phenylalanine two iran region hyperphenylalaninemia information autosomal present site delc population product splicing phenylketonuria distribution province zanjan characterization frequency identification pah result locus different high study heterogeneity direct patient disease qazvin pku hydroxylase iranian gene promoter detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579200/,abstract,2,zanjan delc qazvin sixteen splicing iranian province promoter characterization locus iran pcr exon hyperphenylalaninemia distribution heterogeneity autosomal direct site pah product frequency identification hydroxylase region detection information rate mutation pku phenylketonuria present phenylalanine population different gene high result patient disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""information rate mutation pku phenylketonuria present phenylalanine population different gene high r""]}}","{""autosomal"": {""freq"": 1, ""string"": [""iran pcr exon hyperphenylalaninemia distribution heterogeneity autosomal direct site pah product f""]}, ""heterogeneity"": {""freq"": 1, ""string"": [""locus iran pcr exon hyperphenylalaninemia distribution heterogeneity autosomal direct site pah p""]}}",{},"{""detection"": {""freq"": 1, ""string"": [""pah product frequency identification hydroxylase region detection information rate mutation pku p""]}}",{},{}
477,477,511,10.1007/8904_2015_512,26589311.0,disorder chain nine activity premarital iem region among glutaric amenable undetectable affected halt consanguineous methylcrotonyl disease family biotinidase resident screening glycinuria methylmalonyl coa clinically btd acyl error report inborn thus type metabolism eight period significant mutation dehydrogenase one marriage fourteen phenylketonuria mutase national frequent uae associated incidence hundred homozygous prevalence argininosuccinic analysis universally aciduria program relatively except comprehensive high study medium entity somalian distinct deficiency patient twenty,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059198/,abstract,8,somalian premarital halt glycinuria uae methylcrotonyl undetectable btd argininosuccinic universally methylmalonyl mutase glutaric biotinidase resident fourteen amenable marriage aciduria consanguineous acyl entity homozygous coa dehydrogenase medium affected distinct frequent relatively iem comprehensive clinically associated incidence national chain prevalence period region inborn screening program error deficiency report family activity mutation phenylketonuria metabolism type significant high disorder analysis patient disease study,{},"{""homozygous"": {""freq"": 1, ""string"": [""amenable marriage aciduria consanguineous acyl entity homozygous coa dehydrogenase medium affected d""]}}",{},"{""screening"": {""freq"": 1, ""string"": [""national chain prevalence period region inborn screening program error deficiency report f""]}}",{},{}
478,478,512,10.1073/pnas.1809045115,30322941.0,astaxanthin immediate class trigger improved nutrient bacterial state supplementation favor risk antioxidant vitamin disease lutein cryptoxanthin evidence much consequent role health protein compound putative zeaxanthin result enzyme insidious carotene term versus triage theory long plant one dual essentiality queuine damage many fungal elsewhere propose reproduction carotenoid marine prevalent quinone associated diet pyrroloquinoline two acceleration survival conditional appropriate premature function lycopene ergothioneine chronic classified impairment mechanism pqq reduce also deficiency cofactor longevity modest highly metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205492/,abstract,1,zeaxanthin triage queuine pyrroloquinoline pqq lycopene cryptoxanthin astaxanthin marine lutein insidious essentiality ergothioneine carotene acceleration carotenoid quinone fungal consequent longevity reproduction favor conditional dual modest immediate improved trigger plant classified theory antioxidant putative premature reduce bacterial prevalent class versus survival propose vitamin damage cofactor nutrient associated appropriate supplementation compound impairment chronic highly metabolite enzyme state long deficiency mechanism diet evidence term role function risk protein health result disease,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""metabolite enzyme state long deficiency mechanism diet evidence term role function r""]}}",{}
479,479,513,10.1186/s13023-016-0508-x,27612877.0,correlation cross relationship blood better inconclusive sectional quadratic apob factor lower profile several inverse density median pressure ethic contributes risk methodswe addition cholesterol apolipoprotein disease vitamin pku material phe measurement biochemical however phenylalanine committee supplementary weak protection backgroundthe strategy atherogenesis registrationresearch anthropometric higher clinical user protein homocysteine restrictive retrospectively food hyperphenylalaninaemia hscrp result contrast data good lipoprotein adherence lipid type hpa low useful level diastolic atherogenic phenotype annual sensitivity multicentre outcome systolic phenylketonuria conclusionour september reactive free concentration online article tolerance lugo treatment resultsplasma triglyceride electronic diet version materialthe santiago age obese order hdl apoa cardiovascular natural available reduce thcy trial group optimize high plasma overweight study acid direct methionine dietary patient linear restricted amino total parameter ldl,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016957/,abstract,5,santiago resultsplasma registrationresearch lugo hscrp atherogenic apob apoa thcy atherogenesis quadratic apolipoprotein hyperphenylalaninaemia inverse hdl diastolic weak triglyceride systolic multicentre lipoprotein restrictive ldl restricted homocysteine inconclusive conclusionour retrospectively optimize overweight methionine contributes september anthropometric ethic protection annual reactive obese committee cholesterol hpa density reduce tolerance pressure backgroundthe lipid adherence vitamin cardiovascular linear contrast useful methodswe sectional natural parameter median good profile direct sensitivity cross free measurement materialthe correlation biochemical phenotype order relationship better food phe supplementary addition plasma trial user version strategy electronic online lower diet dietary concentration total pku material amino outcome higher article phenylketonuria low available risk phenylalanine factor blood type acid protein age group high data level treatment clinical result patient disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""higher article phenylketonuria low available risk phenylalanine factor blood type acid p""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""diet dietary concentration total pku material amino outcome higher article phenylketonuria l""]}}","{""diet"": {""freq"": 1, ""string"": [""user version strategy electronic online lower diet dietary concentration total pku m""]}}",{}
480,480,514,10.1186/s13023-015-0375-x,26666653.0,exon hour new almost among difficult french several present location molecular literature missense highlight classical hydroxylase responsive material exclusively however cannot phenylalanine methodsa supplementary strategy milder user doi therapeutical ligation genotype enzyme certainty mild cause kind combination first type necessity mutation one phenotype prediction others population phenylketonuria resultsoverall conclusionsthis online simultaneously test article important multiplex response electronic probe stronger particularly version amplification allele negative hyperphenylalaninemia unless comparison sapropterin loading analysis available pah identify general polymorphic different study cofactor patient though even backgroundmutations gene highly total newly number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024853/,abstract,7,therapeutical resultsoverall french backgroundmutations unless certainty polymorphic ligation milder exclusively necessity loading kind multiplex location stronger amplification probe newly simultaneously sapropterin conclusionsthis doi responsive methodsa hour prediction missense exon identify hyperphenylalaninemia classical cofactor mild genotype difficult allele pah negative comparison combination particularly highly highlight general hydroxylase phenotype literature enzyme supplementary user cause version strategy response electronic online molecular total mutation material article important phenylketonuria number present available test new phenylalanine type population different gene analysis patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""phenylketonuria number present available test new phenylalanine type population different gene a""]}}",{},{},{},{},{}
481,481,515,10.1155/2015/182107,26436087.0,potent complex biological robust process monitoring future tool progress cellular challenge unique growth recent application discus reporter current engineering analytes field consistent surface review environmental global degree research environment polymer patterning diagnostics capacity target via cost highlight immobilization technology molecularly different result high attention diverse live microbial study data convenience solid detectable basis novel disease ability incorporation genetic promise low cell prospect readily,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576000/,abstract,0,patterning immobilization molecularly convenience prospect polymer incorporation reporter detectable microbial live engineering analytes readily potent solid diagnostics promise surface progress degree capacity monitoring diverse robust cellular unique global basis environment consistent cost attention environmental highlight biological ability growth technology discus field target process tool application challenge complex future recent novel current cell low research review different high genetic data result disease study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
482,482,516,10.1007/8904_2016_539,26936850.0,whether information intestinal mine dataset concern supplemental restriction elevated organic common iems supplementation marked diverse average month quantitative recent circumvention clinical therapy fold error elevation inborn bacteria efficacy effect data metronidazole term oral long lasting metabolism level suppression microbe metabolized tmao collectively population day meat safety free supplement diet acidemia production determine chronic precursor metabolomic plasma part high study oxide dietary patient conversion individual carnitine atherosclerosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110437/,abstract,1,lasting circumvention metronidazole metabolized tmao atherosclerosis supplemental microbe marked dataset meat suppression carnitine intestinal elevation metabolomic conversion collectively iems acidemia supplement bacteria oxide organic fold diverse precursor safety restriction elevated oral production average concern supplementation quantitative efficacy chronic free determine inborn month long plasma day error recent diet dietary therapy information term common metabolism individual population effect high data level clinical patient study,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""month long plasma day error recent diet dietary therapy information term c""]}}",{}
483,483,517,10.1002/elps.201500011,25959062.0,metabolome subsequent chain milk class new single composition energy factor profile platform molecular capable source well month neurological characterize extensive utility health compound focus multicomponent analytical metabolic change first area gastrointestinal short profiled ultra dynamic comprehensively approach immunological abundance method used lactation development nmr baseline reproducible fucose important fatty detail greatest phase maternal volatile downstream sample profiling metabolite spectroscopy relation uniquely breast reproducibility analysis environmental characteristic impact triacylglycerols multiplatform coverage hplc multiple consequence seventy study whereas human acid dietary amino performance individual total number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744768/,abstract,2,triacylglycerols profiled multiplatform lactation fucose profiling multicomponent seventy volatile reproducible immunological uniquely greatest ultra comprehensively metabolome reproducibility nmr hplc breast gastrointestinal used coverage abundance spectroscopy capable downstream milk characterize class subsequent extensive dynamic composition platform analytical energy relation baseline utility fatty neurological phase maternal consequence profile source short compound focus environmental chain characteristic performance area metabolite month change multiple single molecular impact dietary total amino important sample approach number individual new human factor acid development metabolic health method analysis study,"{""neurological"": {""freq"": 1, ""string"": [""analytical energy relation baseline utility fatty neurological phase maternal consequence profile s""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""multiple single molecular impact dietary total amino important sample approach number i""]}}",{},{}
484,484,518,10.1186/s12889-017-4805-7,29017527.0,subsequent early among time across behavioral projecting behavior due state cost unemployment methodswe conclusionseffective poverty horizon increase disease expectancy however family life childhood obesity achievement health programming latino academic enhancement effectiveness sequela save abuse elementary term long resultsparentcorps three assumption pre per problem drug sensitivity child outcome intervention model development backgroundparentcorps lifetime potential system unknown substantial school parentcorps diabetes year education nearly markov robust opportunity primarily standard adjusted quality analysis kindergarten longer benefit impact program except prevention interaction urban high domain yield black judiciary small center graduation individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635549/,abstract,0,unemployment save resultsparentcorps projecting parentcorps judiciary graduation conclusionseffective backgroundparentcorps latino kindergarten elementary markov adjusted abuse poverty horizon enhancement expectancy black programming sequela achievement urban assumption lifetime academic longer school nearly yield primarily subsequent substantial robust diabetes obesity education opportunity behavioral domain methodswe effectiveness unknown center pre childhood sensitivity behavior cost prevention problem benefit small standard interaction state long program drug increase quality family impact intervention life outcome term individual time model early potential child development health year high analysis disease,"{""behavioral"": {""freq"": 1, ""string"": [""substantial robust diabetes obesity education opportunity behavioral domain methodswe effectiveness unknown c""]}}",{},{},{},{},{}
485,485,519,10.1093/jpepsy/jsx138,29096013.0,implication empirical individual refinement resultsreviews exciting future within sample rate assessment family tool evidence opportunity pediatric application factor nonadherence community since current implementation clinical present health mobile intervention review integrative research framework literature development system nonmodifiable technology risk free study gfd domain agenda methodstopical objectiveto novel adherence diet promising modifiable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658851/,abstract,2,resultsreviews nonmodifiable nonadherence methodstopical gfd modifiable refinement agenda exciting empirical mobile integrative objectiveto promising adherence framework opportunity community domain pediatric implication implementation free technology literature assessment tool application future diet family intervention novel rate evidence current sample present individual risk factor research review development health clinical study,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""technology literature assessment tool application future diet family intervention novel rate e""]}}",{}
486,486,520,10.1016/j.ymgmr.2017.09.003,29021962.0,consensus significant functioning age still blood within three phenylalanine life childhood difference early standard time country higher always positive child neonatal range psychomotor cognitive mol deviation index pdi impact method mental importance development target conclusion group result lowest different metabolic concentration mdi control motor treatment school term center patient preschool month year first long pku show score phe period,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633247/,abstract,12,pdi mdi preschool psychomotor functioning lowest school consensus deviation mol motor center mental index childhood neonatal importance period score country target standard cognitive month phe long range positive impact life concentration pku conclusion term higher difference time early phenylalanine control blood child different age significant development metabolic group year method treatment result patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""conclusion term higher difference time early phenylalanine control blood child different a""]}}",{},{},{},{},{}
487,487,521,10.2147/IJN.S79480,25834436.0,activity lead biophysically molecule despite inhibit five condition potency difficulty effective increase solution significantly excellent activator third internalization pharmacological strategy protein compound allosteric procedure fold secondary primary result protease thus efficacy novel potentially metabolism low hepatitis obstacle completely three cellular remarkable confront inhibitor problem apparent discovery able cyclodextrin target replication free concentration viral assay challenge intracellular cell carrier two order chaperone fashion vitro bioactive different often interaction complexed antiviral even performance show complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371900/,abstract,2,potency internalization complexed biophysically protease cyclodextrin confront remarkable inhibit antiviral fashion activator obstacle intracellular hepatitis bioactive allosteric replication chaperone apparent viral excellent completely inhibitor solution pharmacological fold difficulty able discovery carrier cellular procedure vitro molecule secondary potentially compound efficacy assay lead free despite problem order performance target interaction challenge complex primary strategy increase effective novel concentration activity condition cell low metabolism significantly different protein result,{},{},{},{},{},{}
488,488,522,10.17712/nsj.2015.4.20150319,26492114.0,logistic cross disorder self sectional factor ill among anxiety july turkey chronically state supportive investigate risk control classical objective significantly pku subset trait higher questionnaire bdi dokuz report depression university existence inventory metabolism low score regression level service educational case independent division local child erzurum phenylketonuria method ass beck parent mother parental eylul pediatric january order healthy ankara analysis hospital research depressive conclusion group study kkale patient,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727619/,abstract,2,kkale eylul erzurum dokuz beck ankara bdi supportive division depressive turkey ill chronically july existence inventory january logistic depression subset parental educational anxiety university classical local mother trait independent sectional service pediatric regression questionnaire hospital cross self investigate parent ass order score healthy objective state report pku conclusion higher phenylketonuria low case metabolism significantly risk control factor research child group method level disorder analysis patient study,{},{},{},{},"{""turkey"": {""freq"": 1, ""string"": [""beck ankara bdi supportive division depressive turkey ill chronically july existence i""]}}",{}
489,489,524,10.1007/s13142-015-0355-7,27012252.0,use threshold implication nontrivial disorder however example one shift opposite trait difference factor accordingly differ perspective discussed goal biomedical recovery intervention coequal resistance focus substantiate aspect mechanism research choice distinction method substance need also translation prevention elevation potential result liability diagnostic thus practice risk effect article translates protective treatment concept latent increase elevate show medical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807197/,abstract,0,substantiate nontrivial coequal translates liability discussed distinction elevate opposite latent differ protective threshold substance biomedical elevation shift accordingly recovery resistance translation choice goal concept trait aspect perspective implication focus example prevention practice need diagnostic increase medical use mechanism intervention article difference risk factor research potential effect method disorder treatment result,{},{},{},{},{},{}
490,490,525,10.1371/journal.pone.0139934,26545209.0,phenotypic correlation relationship information positive essential site pyrethroids necessary five actual frequency nonsynonymous effective revealed pirimiphos status respectively rcv however korea quantitative moderate bioassay adaptive choosing alone fenpropathrin cultivation data resistant basis urticae mite tetranychus vial type genetic dimethoate useful area detection level use rapid mutation current seriousness abamectin evaluation point population management method contact target potential methyl test organophosphate nevertheless limit particularly allele etoxazole application genotypic appropriate residual field resistance analysis basic background chlorpyrifos indicator multiple monocrotophos general applicable high direct estimating,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636269/,abstract,2,vial urticae tetranychus seriousness rcv pyrethroids pirimiphos organophosphate monocrotophos mite fenpropathrin etoxazole dimethoate choosing chlorpyrifos abamectin nonsynonymous estimating cultivation revealed bioassay korea genotypic resistant actual contact applicable methyl indicator adaptive residual resistance basic phenotypic limit moderate useful necessary allele appropriate basis direct quantitative site rapid point particularly evaluation correlation frequency essential general relationship status field target detection background area application management multiple positive effective use respectively information current mutation test type population potential high genetic method data level analysis,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""detection"": {""freq"": 1, ""string"": [""essential general relationship status field target detection background area application management m""]}}",{},{}
491,491,526,10.3389/fendo.2018.00497,30197627.0,resonance disorder blood agonist activity hmr growth diameter progressive bilateral gait gland deterioration leukoencephalopathy slightly central subsequently metachromatic stimulation motor accumulation month disease hypothalamic longitudinal peak extensive matter biochemical axis reduction heterozygous sulfatides compound psychomotor brain disturbance precocious report diagnosis enzyme thus metabolic good leucodystrophy resistant language change far genetic arylsulfatase rapid mutation signal female pubertal involvement normal mld white drug lactate child choline development acetyl thelarche system skill loss epilepsy frequent test treatment lysosomal uterine response hormone association essay network year rare complex age pituitary spectroscopy nervous function cognitive analysis aspartate conclusion pelvic regulating magnetic rapidly puberty small proposita ultrasound patient gonadotropin gene presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117375/,abstract,3,thelarche sulfatides proposita precocious leucodystrophy hmr pelvic mld metachromatic gonadotropin gait arylsulfatase uterine puberty leukoencephalopathy essay agonist pubertal hypothalamic diameter deterioration aspartate psychomotor pituitary choline resistant lactate acetyl axis gland regulating peak bilateral ultrasound lysosomal epilepsy stimulation slightly rapidly heterozygous spectroscopy disturbance subsequently skill progressive resonance involvement far language extensive nervous longitudinal matter hormone signal frequent white motor magnetic accumulation network good female central compound loss reduction rapid presence growth biochemical small cognitive enzyme month normal change complex drug response brain association report rare activity mutation conclusion function test blood diagnosis child age development metabolic gene year genetic disorder treatment analysis patient disease,{},"{""heterozygous"": {""freq"": 1, ""string"": [""ultrasound lysosomal epilepsy stimulation slightly rapidly heterozygous spectroscopy disturbance subsequently skill p""]}, ""genetic"": {""freq"": 1, ""string"": [""child age development metabolic gene year genetic disorder treatment analysis patient d""]}}",{},{},{},{}
492,492,527,10.1371/journal.pone.0178815,28582452.0,correlation phenotypic investigation sectional region factor lower explain glucose inflammation rest substantially common mexico share acidity severity respectively family subject marker resident questionnaire value protein disturbance sleep determined symptom body request metabolic oligogenic routine genetic mexican score methodscross significant mellitus software phenotype complaint syndrome woman abdominal variance determination reactive susceptibility diabetes conclusiongenetic year sequential city component linkage age mass order estimate correlate gerd heritability analysis aim index identify plasma practice study objectivethe gene total statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459455/,abstract,2,gerd conclusiongenetic mexican acidity oligogenic mexico methodscross rest request sequential complaint resident objectivethe heritability explain abdominal mellitus substantially sleep reactive linkage share city variance software disturbance correlate susceptibility routine inflammation determination determined identify phenotypic statistically diabetes glucose severity sectional estimate investigation component index woman questionnaire marker syndrome practice correlation phenotype order score region body symptom aim mass subject plasma value lower family respectively total common factor protein age significant metabolic gene year genetic analysis study,{},"{""genetic"": {""freq"": 1, ""string"": [""gerd conclusiongenetic mexican acidity oligogenic mexico m""]}}",{},{},{},{}
493,493,528,10.1371/journal.pntd.0006913,30418973.0,subsequent blood preventable new region duration essential attributable sexual due risk disease objective atl htlv pregnant however findingsin mainly mtct east impairs principal therefore result annually antenatal live data methodologyto south transmission mortality period case rate utmost government variable least advice morbidity infection child woman regionally significancea contact development via backgroundbrazil mother treatment year brazil every north lack ham prevalence tsp limited birth intercourse routinely infant importance also prevention policy conclusion nationally high pattern feeding individual number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261628/,abstract,0,significancea mtct methodologyto intercourse ham findingsin backgroundbrazil tsp htlv atl utmost sexual regionally impairs annually preventable nationally antenatal contact principal east advice live attributable north government south routinely feeding transmission brazil duration pregnant subsequent mainly mother morbidity infection policy mortality woman pattern variable lack limited prevention essential importance prevalence period birth region infant objective rate conclusion number case individual new risk blood child development year high data treatment result disease,{},{},{},{},{},{}
494,494,529,10.1093/shm/hkw127,29670320.0,universal scandinavia educational specific disorder rate notion superficial india much rather region recent difference methodological profound imperfection factor place local problem time essential across pronouncement author country canada strengthen mask population global product distribution paper actual due globe political china variation phenomenon deficit adhd corner different attention study behavioural human hyperactivity true concept late cultural arguing argue emergence historical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903618/,abstract,0,scandinavia pronouncement imperfection corner arguing superficial mask globe political strengthen india historical canada methodological cultural actual emergence notion behavioural argue profound phenomenon adhd true place universal hyperactivity educational author china local late distribution concept global deficit attention variation product essential problem paper country region recent rate difference time human specific factor population different disorder study,"{""hyperactivity"": {""freq"": 1, ""string"": [""profound phenomenon adhd true place universal hyperactivity educational author china local l""]}}",{},{},{},{},{}
495,495,530,10.3390/nu10101453,30301251.0,correlation specific consistency tool self psychometric prospectively factor item hrqol median restriction physical literature minnesota validation bird inter excellent related quantify life vitality reduction perspective questionnaire health burden determined global candidate sodium report property good low score acceptability useful non rho rate internal develop failure overall intervention management mlhf method mental ass via social organization response diet help leisure convergent scale conducted exploratory heart quality analysis validity background aim impact conclusion optimize domain study alpha dietary patient iqr pleasure,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213449/,abstract,3,vitality pleasure mlhf leisure minnesota convergent bird develop rho iqr psychometric hrqol optimize exploratory consistency acceptability conducted quantify prospectively item sodium validity inter internal excellent alpha determined validation failure organization candidate burden restriction perspective domain useful heart property mental median good global help physical questionnaire reduction self correlation social ass scale related overall score literature background aim tool management response quality diet report impact intervention dietary rate life conclusion non low specific factor health method analysis patient study,"{""social"": {""freq"": 1, ""string"": [""help physical questionnaire reduction self correlation social ass scale related overall s""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""background aim tool management response quality diet report impact intervention dietary r""]}}",{}
496,496,531,10.3389/fpsyg.2018.00083,29515472.0,disorder structured infantsdiffer factor early context examine specifically five interactive preterm hospitalization risk control velocity month significantly typical descriptor longitudinal trajectory preverbal atypical spatial developmental principal west video environment support movement result hand curvature observational data visually four three one kinematics orality communication assumption syndrome motion intervention object development stage mother person finding age acceleration typically birth shape either environmental infant importance discriminate prevention different cohort pattern study extent,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826068/,abstract,8,preverbal orality kinematics infantsdiffer curvature visually video descriptor acceleration velocity motion discriminate structured atypical object hospitalization west interactive shape principal trajectory assumption spatial hand person typical preterm movement observational examine typically longitudinal extent specifically communication mother stage environment pattern context environmental developmental prevention syndrome importance cohort birth finding support month infant intervention significantly risk early control factor different age development data disorder result study,{},{},{},{},{},{}
497,497,532,10.1002/0471142905.hg0615s88,26724722.0,biological whole downstream tool rapid unit functional within variant assumption information elaborate estimate context prioritizing assign present function approach impact technique available progressively genomic assigning genome foundation consequence general annotation exome potential different philosophy study nucleotide practical human sequencing significance concept important computational change increase disease genetic type gene highlighting overview annotating,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722816/,abstract,0,assigning philosophy assign annotating progressively prioritizing highlighting elaborate annotation assumption foundation computational downstream unit practical exome significance overview nucleotide concept estimate genomic genome consequence rapid context sequencing technique biological general functional tool change variant increase impact information important function approach present available human type potential different gene genetic disease study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
498,498,533,10.1590/1678-7757-2017-0186,30020349.0,assessment activity observation difference greater representative peabody socioeconomic author student anamnesis without behavior pair preterm difficulty risk well objective month status neurological material semi questionnaire receptive reflect macarthur prematurely narrative result sequela attention inventory term expressive type low level educational significant peer vocabulary linguistic child abfw dialogic teacher private method ass development skill loss test sex mother school age public two legal premature comparison picture category communicative importance chronological conclusion group part study preschool highest participant performance injury statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089568/,abstract,3,vocabulary receptive macarthur dialogic abfw reflect peabody expressive chronological anamnesis prematurely communicative teacher preschool narrative picture linguistic socioeconomic sequela private pair inventory peer legal representative student semi premature preterm skill school injury observation educational author sex category statistically difficulty highest mother neurological questionnaire loss comparison behavior attention greater ass importance public status performance participant assessment month objective activity material conclusion term difference low test risk type child age significant development group method level result study,"{""neurological"": {""freq"": 1, ""string"": [""sex category statistically difficulty highest mother neurological questionnaire loss comparison behavior a""]}}",{},{},{},{},{}
499,499,534,10.1186/s12907-016-0035-7,27499701.0,blood chain whether sectional ratio difference lower among parametric essential despite necessary liquid median aged wallis physical pathology omega supplementation august methodswe old docosahexaenoic dpa antioxidant well significantly respectively documentation ara oil backgroundomega interval zimbabwean higher fish range pufas peri reference eicosapentaenoic late pregnancy long non level whole sixteen kruskal docosapentaenoic child hiv intervention vulnerability elsewhere method mental identification development gas unknown fortification test algae mother rich pufa fatty filter year help incorporation diet particularly inflammatory age locally epa apparently healthy determine statistical girl benefit prior dha paper program arachidonic prevention conclusionsin group cohort urban high study acid dietary hydroxytoluene optimum foodstuff participant show chromatography gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974798/,abstract,12,zimbabwean wallis kruskal hydroxytoluene dpa docosapentaenoic backgroundomega ara algae foodstuff epa eicosapentaenoic documentation pufas peri omega pufa parametric fortification conclusionsin optimum locally sixteen oil arachidonic docosahexaenoic august apparently vulnerability incorporation dha hiv urban fish antioxidant girl filter rich gas pathology gender prior late reference mother interval liquid inflammatory statistical fatty chromatography methodswe sectional unknown necessary pregnancy mental median aged supplementation help physical old chain prevention particularly essential determine despite identification cohort benefit paper ratio participant healthy long program range lower diet respectively intervention dietary higher non difference test significantly blood acid child age development group year high method level study,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""participant healthy long program range lower diet respectively intervention dietary higher n""]}, ""fish"": {""freq"": 1, ""string"": [""apparently vulnerability incorporation dha hiv urban fish antioxidant girl filter rich g""]}}",{}
500,500,535,10.3390/ijms18050941,28468253.0,disorder activity autism pathway among affected adhesion molecular frequency moreover altogether common pathology plasmatic addition well enu disease pku hydroxylase neurological plasticity spectrum neuronal animal phenylalanine evidence higher protein mouse synapse result pahenu metabolic data neuroligin first genetic type inhibition transmission area level significant functional variable wild excitatory point pfc toward neurotransmission model phenylketonuria post development potential synaptic organization excitation alteration prefrontal association cell component downstream pathophysiological within along hyperphenylalaninemia comparison cognitive imbalance impairment mechanism cortex cortical study btbr deficiency excitability inhibitory show intrinsic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454854/,abstract,0,plasmatic neuroligin pfc excitability adhesion excitatory excitation synapse altogether intrinsic imbalance enu cortical btbr plasticity neurotransmission prefrontal synaptic pahenu pathophysiological inhibitory transmission cortex downstream neuronal pathology affected organization hyperphenylalaninemia inhibition wild alteration post neurological autism component variable animal comparison impairment point frequency functional hydroxylase spectrum mouse cognitive area addition pathway association molecular deficiency mechanism activity evidence pku higher common cell phenylketonuria model phenylalanine type potential protein significant development metabolic genetic data level disorder result disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""pku higher common cell phenylketonuria model phenylalanine type potential protein significant d""]}, ""neurological"": {""freq"": 1, ""string"": [""organization hyperphenylalaninemia inhibition wild alteration post neurological autism component variable animal c""]}}","{""genetic"": {""freq"": 1, ""string"": [""type potential protein significant development metabolic genetic data level disorder result d""]}}","{""pathway"": {""freq"": 1, ""string"": [""hydroxylase spectrum mouse cognitive area addition pathway association molecular deficiency mechanism a""]}}",{},{},{}
501,501,536,10.3390/healthcare3041133,26702401.0,specific past example difference information representative early cystic unscreened without statement condition everything frequency hospitalization common overstated cost influential quantifying life event scenario sometimes value health comparable request fibrosis effectiveness diagnosis qualitative data numerical detection level significant one problem economic child evaluation outcome population review phenylketonuria identification judgment treatment else decision public two newborn lack estimate accordingly analysis either benefit paper program also group historically cohort different maker,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686149/,abstract,0,unscreened overstated quantifying numerical request judgment influential hospitalization statement scenario maker historically representative accordingly cystic fibrosis qualitative comparable economic past event decision estimate effectiveness example lack cost evaluation frequency identification problem cohort benefit paper public detection program value information life newborn outcome condition difference common phenylketonuria early specific diagnosis population review child different significant health group data level treatment analysis,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""identification problem cohort benefit paper public detection program value information life n""]}, ""newborn"": {""freq"": 1, ""string"": [""public detection program value information life newborn outcome condition difference common p""]}}",{},{}
502,502,537,10.1007/8904_2014_386,25614310.0,level hypothesize case inactivity activity phenylalanine levodopa reduction lead depletion tyr dopamine parkinsonism influence clinical tyrosine therapy convert woman sign brain phenylketonuria symptom particularly due report parkinsonian diagnosis intellectual enzyme disability old regulatory negatively response well key deficiency synthesis patient late modest year alert pku hydroxylase agent transmission phe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375126/,abstract,0,parkinsonian levodopa inactivity hypothesize alert parkinsonism convert modest depletion transmission negatively sign tyr agent late dopamine intellectual regulatory woman old reduction synthesis lead disability influence particularly tyrosine hydroxylase symptom enzyme phe key response brain deficiency report therapy activity pku phenylketonuria case phenylalanine diagnosis year level clinical patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""report therapy activity pku phenylketonuria case phenylalanine diagnosis year level clinical p""]}, ""intellectual"": {""freq"": 1, ""string"": [""negatively sign tyr agent late dopamine intellectual regulatory woman old reduction s""]}}",{},{},{},{},{}
503,503,538,10.3390/jpm9020029,31137623.0,training advise pcp better factor gain awareness genetics common percent risk testing concept disease consumer summary physician knowledge however family andme role health respondent play primary genomic result ability genetic medicine sixty level service confidence provider three interest genomics personal participate dtc towards baseline test precision important key limit care attitude two lack ancestry prior board pgt seventy comfort practice study direct patient total perception,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617198/,abstract,2,andme pgt dtc advise pcp comfort seventy ancestry participate board personal attitude training percent respondent consumer perception gain awareness provider summary physician precision limit confidence prior genomics concept baseline play genomic service direct lack genetics practice ability medicine testing knowledge better primary key family care total important role common test risk factor health genetic level result patient disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""role common test risk factor health genetic level result patient disease s""]}}",{},{},{},{}
504,504,539,10.5339/qmj.2015.3,26535171.0,logistic various immediate disorder cross sectional among anxiety socioeconomic stay despite common risk old number well objective status respectively family introduction higher value symptom saudi result depression large psychological term long low stress rate three one least measure population model method older test year education finding version age multivariate prevalence income scale relation determine psychiatric approximately arabic das hospital research conclusion high study patient show caregiver,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614325/,abstract,5,arabic das stay saudi socioeconomic immediate multivariate income psychological logistic depression caregiver older psychiatric anxiety introduction relation education approximately sectional stress old hospital cross determine despite scale prevalence status finding various symptom measure objective long version value large family respectively rate conclusion term higher common low number test risk model research population age year high method disorder result patient study,"{""psychiatric"": {""freq"": 1, ""string"": [""income psychological logistic depression caregiver older psychiatric anxiety introduction relation education a""]}}",{},{},{},{},{}
505,505,540,10.1186/s13023-018-0985-1,30665446.0,bioinformatics iem new single sufferer information positively difficult five condition iems common likelihood biomarker backgroundrare experience effective way disease material pitfall emergence serf medical sanger supplementary family life urd profound user clinical oxysterols usually secondary primary error niemann inborn six data pick date basis design prospective generation chart mining type planning metabolism genetic eight non case four categorised panel surveillance one ultra biobank notoriously many review approach method exome execution online unsuccessful article guide recommendation key electronic best year conclusionshistorically systematic challenge version rare detect protocol alongside two newborn opportunity screen scale series chronic next analysis benefit impact available larger general group diagnostic comprehensive practice often part cohort last study misdiagnosis small patient twenty illustrate successful gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341610/,abstract,0,urd sufferer conclusionshistorically pick oxysterols notoriously illustrate execution categorised unsuccessful misdiagnosis pitfall niemann mining backgroundrare serf likelihood chart biobank alongside ultra emergence bioinformatics sanger profound planning surveillance iems detect series positively usually guide biomarker exome screen larger prospective successful protocol iem panel opportunity comprehensive date difficult systematic secondary way experience best basis recommendation generation chronic practice design general scale cohort benefit small diagnostic inborn supplementary challenge user primary version key electronic error online effective medical single rare family impact information life newborn material condition non article common approach case available metabolism new type review gene group year genetic method data clinical analysis patient disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""new type review gene group year genetic method data clinical analysis p""]}}",{},"{""newborn"": {""freq"": 1, ""string"": [""single rare family impact information life newborn material condition non article c""]}}",{},{}
506,506,541,10.1016/j.cobme.2018.09.003,31011691.0,present selection site researcher ease efficient moreover highlight harsh route traditional material however strategy compliance unique recent therapy vaccination acidic environment layer transfection enzyme mucus design oral immunity non gastrointestinal case administration variable transgene interest local lends systemic outcome transit able review approach therapeutic efficiency development via system towards mucosal delivery important viral promising challenge overview still advancement production application invasive dna unlike tract high orally barrier distinct patient successful gene parenteral,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474414/,abstract,0,mucus lends harsh transit vaccination mucosal unlike transfection acidic parenteral route transgene orally immunity ease layer advancement gastrointestinal tract viral promising invasive compliance systemic efficiency traditional researcher barrier efficient distinct overview local able successful oral unique production selection administration delivery dna environment variable site highlight design enzyme application challenge strategy therapeutic recent therapy material outcome non important approach present case review development gene high patient,{},{},{},{},{},{}
507,507,542,10.3390/molecules24071358,30959894.0,repeatability significant sample chromatographic prototype automatic lead new printer application reduction possible comparison manual time additionally mobile deposited sfpe procedure path analysis chromatogram mechanism paper device layer solvent plate development movement result classic adsorbent pipette onto front classical position run equipment phase semi extraction preparation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480151/,abstract,0,sfpe printer pipette deposited adsorbent automatic repeatability chromatogram prototype plate chromatographic solvent equipment run manual mobile layer path semi position extraction movement preparation device classic classical additionally procedure phase comparison reduction lead paper possible application mechanism sample time new significant development analysis result,{},{},{},{},{},{}
508,508,543,10.4062/biomolther.2016.061,27133257.0,various phenotypic disorder cluster autism abnormality factor pathway difficult behavior molecular common mechanistic highlight diverse neurophenotypic epigenetic lesion well finally underlying establish spectrum utility advent animal seizure ground sensorimotor neurodevelopmental broader clinical unify restrictive symptom contribution core result theory genetic potentially repetitive neurophysiological asd one neurobiological communication measure henceforth etiology comorbidities preclinical relevance critical review approach model translational ass summarize social test manifestation overwhelmingly neuropathological rodent paramount exact stratification scale comparison determine subgroup impairment environmental benefit mechanism research pathophysiology autistic often heterogeneity hyperactivity elucidate,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859786/,abstract,0,unify overwhelmingly neurophysiological neurophenotypic henceforth sensorimotor paramount stratification ground neuropathological rodent summarize restrictive repetitive neurobiological comorbidities exact elucidate autistic advent broader preclinical lesion epigenetic theory core translational subgroup establish cluster pathophysiology mechanistic hyperactivity relevance underlying seizure manifestation contribution phenotypic neurodevelopmental diverse asd communication etiology heterogeneity utility difficult potentially autism finally abnormality animal comparison behavior impairment critical environmental highlight social determine ass scale benefit spectrum various symptom measure pathway molecular mechanism common approach test model factor research review genetic disorder clinical result,"{""hyperactivity"": {""freq"": 1, ""string"": [""translational subgroup establish cluster pathophysiology mechanistic hyperactivity relevance underlying seizure manifestation c""]}, ""social"": {""freq"": 1, ""string"": [""comparison behavior impairment critical environmental highlight social determine ass scale benefit s""]}}","{""genetic"": {""freq"": 1, ""string"": [""autistic advent broader preclinical lesion epigenetic theory core translational subgroup e""]}, ""heterogeneity"": {""freq"": 1, ""string"": [""phenotypic neurodevelopmental diverse asd communication etiology heterogeneity utility difficult potentially autism f""]}}","{""pathway"": {""freq"": 1, ""string"": [""scale benefit spectrum various symptom measure pathway molecular mechanism common approach t""]}}",{},{},{}
509,509,544,10.1007/8904_2017_16,28293905.0,various pathogenesis disorder blood relationship new redox oxidative several contains homeostasis organic highlight addition antioxidant urinary evaluate vitamin significantly neurological status material biochemical element adulthood supplementary phenylalanine specify observed defense user role disturbance global restrictive glutathione result specie phenylalaninemia decrease experiment glutaredoxins first peroxidase useful level significant stress isoforms white management phenylketonuria method therapeutic ass reactive expression concentration online recommendation electronic association diet cell version materialthe age superoxide rna hyperphenylalaninemia relation especially comparison dismutases background available oxygen also trial conclusion plasma cohort study acid oligo patient amino gene chapter parameter gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740050/,abstract,4,specify oligo glutaredoxins dismutases phenylalaninemia peroxidase isoforms defense restrictive redox glutathione contains chapter superoxide oxygen reactive antioxidant disturbance pathogenesis adulthood specie experiment rna element urinary oxidative vitamin gender organic hyperphenylalaninemia homeostasis white relation neurological useful parameter evaluate global recommendation decrease observed stress comparison especially materialthe highlight ass cohort biochemical relationship status various background supplementary addition plasma management trial user expression version electronic online therapeutic association diet concentration material amino conclusion role cell phenylketonuria available significantly new phenylalanine blood acid age significant gene method level disorder result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""role cell phenylketonuria available significantly new phenylalanine blood acid age significant g""]}, ""neurological"": {""freq"": 1, ""string"": [""gender organic hyperphenylalaninemia homeostasis white relation neurological useful parameter evaluate global r""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""online therapeutic association diet concentration material amino conclusion role cell phenylketonuria a""]}}","{""diet"": {""freq"": 1, ""string"": [""expression version electronic online therapeutic association diet concentration material amino conclusion r""]}}",{}
510,510,545,,28316693.0,region ratio greater factor congenital formula several defect revision weakness cooperation attributable odds five severe risk control hole finally evaluate disease material amount calculation hereditary levin dic obesity higher range portion result like data mild fraction cause kind pregnancy ascribable sixty international use case although rate multivitamin one measure problem current outcome flaw population par echocardiography sampling method history shortage sex chamber danger association greatest associated hundred maternal stillbirth iran newborn lack prevalence community involved birth influence heart basic background hospital prior impact priority research natural keywords conclusion overweight different part classification insufficient cardiac yazd small deficiency random highest weaker performance total malformation parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348960/,abstract,4,yazd levin dic ascribable stillbirth hole flaw weaker sampling revision par multivitamin danger portion chamber weakness shortage echocardiography cooperation greatest kind overweight attributable calculation malformation insufficient hereditary priority odds random formula iran cardiac classification fraction sex basic keywords involved prior highest mild obesity international community associated natural heart pregnancy parameter evaluate history maternal finally hospital lack influence greater defect congenital problem like prevalence ratio birth small performance region severe background measure range cause association use deficiency impact rate total newborn current material outcome conclusion higher case risk control factor research population different method data result disease,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""association use deficiency impact rate total newborn current material outcome conclusion h""]}}",{},{}
511,511,546,10.1007/s13205-016-0586-4,28391479.0,infectious commodity significant sphere microorganism biotransformation animal life production metabolite primarily almost sustainable proved nutrition value largely capability additionally role compound play product biopharmaceutical natural secondary organic reduce contribution primary due development veterinary inevitably nutritional thus tissue source whereas human acid alcohol industrial well supplement increase vitamin disease industry agriculture expectancy plant healthcare enormous number amino extraction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385174/,abstract,0,veterinary proved commodity sphere biotransformation biopharmaceutical inevitably sustainable agriculture enormous expectancy microorganism industrial plant alcohol capability supplement industry infectious extraction reduce primarily largely vitamin contribution organic nutrition healthcare additionally production play secondary natural source compound nutritional animal tissue product metabolite primary value increase life amino role number human acid significant development disease,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""product metabolite primary value increase life amino role number human acid s""]}}",{},{}
512,512,547,10.1016/j.ymgmr.2017.01.013,28271047.0,level matter intelligence subsequent biochemical although subset disorder multi phenylalanine reduces neural unexplored dimensional difference greater genotypic delineate end healthy white sapropterin largely across underscore point cognitive prior phenylketonuria characteristic research additional need importance responder lifetime integrity control treatment addition response pku variability individual phe poorer non,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323508/,abstract,3,delineate unexplored genotypic responder underscore poorer lifetime integrity intelligence dimensional sapropterin reduces neural subset subsequent largely multi variability matter prior end white point greater importance characteristic additional biochemical need cognitive phe healthy addition response pku non difference phenylketonuria individual phenylalanine control research level disorder treatment,"{""phenylalanine"": {""freq"": 2, ""string"": [""response pku non difference phenylketonuria individual phenylalanine control research level disorder t""]}}",{},{},{},{},{}
513,513,548,10.1186/s12859-016-1286-0,27760515.0,tool rmsd chain activity whether conclusionswe instead several algorithm package deleterious including moreover capable polyphen beta ibrahimtanyalcin hydroxylase material sequence renin supplementary phenylalanine biotinidase experimentally mathematical user value coa protein resultswe btd acyl result enzyme root effect sphingomyelin perl sift score com ren level mutation dehydrogenase per prediction residue model smpd online article electronic http version materialthe commercially custom tubb tubulin acadm manual residual authorized available multiple pah backgroundpredict medium square phosphodiesterase gene deviation modict,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070100/,abstract,1,tubulin tubb sphingomyelin smpd rmsd ren phosphodiesterase perl modict ibrahimtanyalcin backgroundpredict acadm sift root renin including btd polyphen mathematical com http commercially experimentally biotinidase package custom manual instead deleterious conclusionswe beta acyl residue square capable residual authorized resultswe algorithm deviation coa dehydrogenase medium prediction sequence pah chain materialthe hydroxylase score tool enzyme supplementary user multiple version value electronic online activity mutation material article available model phenylalanine protein gene effect level result,"{""phenylalanine"": {""freq"": 2, ""string"": [""activity mutation material article available model phenylalanine protein gene effect level r""]}}",{},{},{},{},{}
514,514,549,10.3389/fgene.2014.00357,25368629.0,major correlation repeatedly specific estimation single factor among time underlies testing covariates evaluate disease longitudinal account workshop subject quantitative trait mixed focus contribution hand situation effect data design first genetic type count validate separation step many model analyze method propose binary simulation second simultaneously test simultaneous important association wide complex within variant efficiently conducted influence heart analysis paper also genome multiple different often flexibly pleiotropic random gene performance fhs interesting enables,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202779/,abstract,0,flexibly fhs underlies covariates repeatedly pleiotropic count workshop binary enables separation conducted interesting efficiently simultaneous analyze validate estimation simultaneously simulation hand mixed situation random propose longitudinal contribution trait account step heart evaluate genome quantitative second focus influence correlation wide design paper performance testing subject major multiple complex variant single association important test time model specific factor type different gene effect genetic method data analysis disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
515,515,550,10.1186/s12913-018-2878-3,29378570.0,subsequent specific assessment hearing backgroundnewborn conclusionswe region difference greater early lower among context time methodsthis flanders initial median accurate expert common regular billing facilitate statistically month decade however later higher totally regional fold never implantation result belgium data decrease period significant pronounced main one annual belgian implementation child database evaluation outcome intervention population descriptive milestone aid frequently ass resultsin wallonia evolution delivery proportion care age earlier two newborn typically audiological birth approximately brussels program also except cohort trend part study another healthcare cochlear,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789748/,abstract,4,wallonia flanders billing audiological totally brussels belgian pronounced cochlear backgroundnewborn implantation belgium hearing milestone conclusionswe aid annual regional resultsin regular evolution earlier methodsthis descriptive subsequent trend facilitate accurate typically fold expert initial later statistically proportion decade healthcare frequently approximately delivery median decrease implementation context database evaluation greater ass cohort period main birth region assessment month program lower intervention care newborn outcome higher difference common time early specific population child age significant data result study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""totally brussels belgian pronounced cochlear backgroundnewborn implantation belgium hearing milestone c"", ""assessment month program lower intervention care newborn outcome higher difference common t""]}}",{},{}
516,516,551,10.1080/10810730.2014.999895,25806781.0,specific public tool emphasize issue evidence variant new pharmaceutical screening examine tailoring since current influence preventive vaccine concern site outcome population analysis tendency focus approach benefit news explosion print technique research popular host possibility coverage report capacity prevention development cost highlight potential often risk article medium internet treatment combination solution genetic textual individual ethical perception addiction medical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451206/,abstract,1,textual tailoring print explosion addiction news vaccine tendency internet popular emphasize host preventive coverage perception pharmaceutical ethical medium examine capacity solution possibility concern site focus combination cost prevention influence highlight technique benefit issue public tool screening variant medical report evidence current outcome article approach individual new risk specific research population potential development genetic treatment analysis,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""screening"": {""freq"": 1, ""string"": [""highlight technique benefit issue public tool screening variant medical report evidence c""]}}",{},{}
517,517,552,10.12669/pjms.343.14564,30034445.0,level presence significant correlation case two cholestasis family difference information mma bilirubin centre conducted turkey health homocysteine total without background therefore program infant method history common indirect conclusion group plasma file june serum part percent study data acid phenomenon ministry direct similar hyperbilirubinemia deficiency term association vitamin objective folate demographic prove methylmalonic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041549/,abstract,4,file cholestasis prove hyperbilirubinemia mma bilirubin ministry folate homocysteine turkey indirect conducted methylmalonic phenomenon percent june demographic centre vitamin history direct serum presence correlation similar background infant objective plasma program association deficiency family information total conclusion term difference common case acid significant health group method data level study,{},{},{},{},"{""turkey"": {""freq"": 1, ""string"": [""hyperbilirubinemia mma bilirubin ministry folate homocysteine turkey indirect conducted methylmalonic phenomenon p""]}}",{}
518,518,553,10.1016/j.ymgmr.2016.10.008,27830119.0,methodstwo specific disorder delay blood nine retardation tyrosiluria handicap iem studied single early pathway congenital formula abnormal essential defect restriction discussionin citrin organic due suggested accumulation urinary synthesize excretion pku neurological respectively medical seizure arise dysfunction clinical compound psychomotor clinically developmental spectrometric resultsone hypotonia hypoketotic substrate error report pyruvate elevation inborn result metabolic cause first genetic metabolism non methylmalonic significant case three mutation one phenyllactate problem toxic normal mongolia mongolian block lactate child phenylacetate liver product management phenylketonuria gas unknown treatment dicarboxylic incidence hundred backgroundinborn rare acylcarnitines genetically glycerol mass newborn specialized pilot hypothyroidism function analysis either aciduria previously pah prevention conclusion study acid dietary ketosis deficiency patient twenty thirty amino gene metabolite chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094263/,abstract,9,tyrosiluria phenyllactate phenylacetate mongolian mongolia hypoketotic dicarboxylic ketosis handicap discussionin citrin methodstwo glycerol synthesize resultsone spectrometric hypotonia backgroundinborn arise suggested specialized pyruvate psychomotor lactate aciduria acylcarnitines methylmalonic excretion thirty elevation retardation block studied formula hypothyroidism pilot substrate toxic gas seizure urinary organic genetically delay restriction iem accumulation abnormal neurological chromatography clinically unknown incidence compound pah liver dysfunction developmental prevention product defect previously essential congenital problem inborn metabolite normal mass management cause error medical pathway single deficiency report rare respectively dietary newborn mutation pku amino conclusion non function phenylketonuria case metabolism early specific blood acid child significant metabolic gene genetic disorder treatment clinical analysis result patient study,"{""neurological"": {""freq"": 1, ""string"": [""genetically delay restriction iem accumulation abnormal neurological chromatography clinically unknown incidence c""]}}","{""genetic"": {""freq"": 1, ""string"": [""blood acid child significant metabolic gene genetic disorder treatment clinical analysis r""]}}","{""pathway"": {""freq"": 1, ""string"": [""normal mass management cause error medical pathway single deficiency report rare r""]}}","{""amino"": {""freq"": 1, ""string"": [""rare respectively dietary newborn mutation pku amino conclusion non function phenylketonuria c""]}, ""newborn"": {""freq"": 1, ""string"": [""single deficiency report rare respectively dietary newborn mutation pku amino conclusion n""]}}",{},{}
519,519,554,10.1093/hmg/ddv502,26662796.0,phenotypic inquiry causing new apoptosis factor reticulum organism across demonstrates present avenue increasingly need variation diverse testing disease extensive utility endoplasmic quantitative recent profound allow therapy role range top candidate expressivity effect reference genetic stress functional mutation panel wild variable pathogenic retinal phenotype rnai provide outcome pigmentosa model development driving test collection association modifier drosophila wide genetically strain degeneration advancement reveal order biology quite influence function environmental previously background mechanism priority broad genome retinitis high study human variability gene individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743685/,abstract,2,rnai expressivity causing inquiry driving retinitis pigmentosa allow reticulum endoplasmic avenue quite drosophila retinal apoptosis modifier demonstrates degeneration strain profound advancement reveal priority organism broad extensive variability candidate phenotypic wild genetically diverse increasingly pathogenic biology reference utility panel collection genome quantitative stress variable variation environmental influence previously wide provide functional phenotype order need testing background range association recent mechanism therapy mutation outcome role function present test individual new human model factor development gene effect high genetic disease study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
520,520,555,10.5152/TurkPediatriArs.2018.01813,31236026.0,age two evidence along complementary appropriate community strong economic world health many environmental benefit research infant food potential organization mother well month year beyond exclusively,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568295/,abstract,1,exclusively complementary organization economic strong mother world community appropriate environmental benefit food month infant evidence research potential age health year,{},{},{},{},{},{}
521,521,556,10.1186/s13073-015-0156-0,25810764.0,extraordinary individual find within blood immunologist new recent diversity present health approach impact degree contribution familiar capacity development twin wellbeing highlight system necessitating pattern study heterogeneity immune long restricted grapple heritable cell non astonishing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373126/,abstract,0,necessitating immunologist familiar astonishing wellbeing grapple extraordinary restricted twin heritable diversity degree capacity contribution immune heterogeneity pattern highlight long recent impact non cell approach present individual new blood development health study,{},"{""heterogeneity"": {""freq"": 1, ""string"": [""heritable diversity degree capacity contribution immune heterogeneity pattern highlight long recent i""]}}",{},{},{},{}
522,522,557,10.1038/ncomms7393,25744659.0,reversible level depressed impair superoxide however secondarily animal organ much lead observation vivo requirement phenotype partial lower depletion irreversible observed acutely present function vital electron heart dysfunction lifespan act gradual aged global biosynthesis mouse partially model interrupted due severe severely development mitochondrion upon transport loss fact ubiquinone aging addition antioxidant rich generation strongly degenerative disease doe even restoration membrane mitochondrial characterize,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715896/,abstract,0,ubiquinone interrupted aging secondarily gradual depressed degenerative restoration impair acutely mitochondrion depletion reversible lifespan electron superoxide severely irreversible fact vital antioxidant rich requirement partially membrane observation transport characterize biosynthesis partial act mitochondrial organ strongly doe vivo heart global aged observed animal loss dysfunction lead generation phenotype mouse severe addition lower function present model development level disease,{},{},{},{},{},{}
523,523,558,10.4081/pr.2017.7045,29285339.0,informatic disorder chain record decompensation hour context parenteral prematurity nutrition positive prompt need subsequently severe contraindicated extreme medical resultant however seizure expectant screening coa word hyperammonemia symptom acyl error report support inborn result six thus metabolic feed metabolism case lab seven dehydrogenase death representation ingestion intervention review management day history hypoglycemia moderation enteral test key electronic triglyceride coma diet care challenge rare sample within newborn premature standard birth analytes mcad advanced special natural infant nutritional diagnostic medium vulnerable deficiency patient pathologic enables,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733391/,abstract,1,informatic contraindicated moderation hypoglycemia expectant coma mcad hyperammonemia enteral representation extreme triglyceride prematurity parenteral ingestion feed decompensation vulnerable resultant pathologic enables prompt analytes acyl lab premature advanced subsequently coa dehydrogenase special seizure hour medium record word seven nutrition death natural history nutritional context chain birth need diagnostic standard severe inborn symptom support infant screening management day challenge positive key electronic error medical deficiency diet report rare intervention care newborn sample case metabolism test review metabolic disorder result patient,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""deficiency diet report rare intervention care newborn sample case metabolism test r""]}, ""screening"": {""freq"": 1, ""string"": [""standard severe inborn symptom support infant screening management day challenge positive k""]}}","{""diet"": {""freq"": 1, ""string"": [""positive key electronic error medical deficiency diet report rare intervention care n""]}}",{}
524,524,559,10.2147/NDT.S176198,30323604.0,various egypt intelligence delay disorder retardation clinic psychometric autism abnormality backgroundphenylketonuria early analyzer duration abnormal present laboratory neonatal initial province deficit neuropsychiatric average motor survey pku significantly matter super phenylalanine methodsa binet childhood moderate screening rating mainly suspicion objectivesthe clinical therapy verbal clinically developmental brain global probability error inborn result university neurology attention mild language prospective late tomography quotient metabolism untreated period level significant case conclusionpku variable one imaging stanford white overall child evaluation outcome intervention confirmation management mental predictor frequent ten important commonest hundred rare sohag dietetic poor adjustment pediatric hyperphenylalaninemia scale hospital available upper electroencephalography classic plasma cohort pattern presentation study magnetic acid hyperactivity dietary neuropsychological patient atrophy exception moderately amino,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179721/,abstract,4,stanford sohag egypt binet super objectivesthe conclusionpku commonest moderately electroencephalography atrophy analyzer suspicion quotient dietetic neurology psychometric upper verbal exception confirmation adjustment probability neuropsychiatric backgroundphenylketonuria intelligence tomography retardation rating province neuropsychological imaging hyperactivity duration methodsa untreated predictor language classic university matter hyperphenylalaninemia prospective initial delay presentation frequent late mainly moderate white motor mild magnetic abnormal average poor clinic clinically autism mental global pediatric pattern childhood variable survey deficit abnormality neonatal hospital attention developmental evaluation laboratory scale cohort period overall various inborn screening plasma management error brain rare intervention dietary therapy pku amino outcome important present case available metabolism significantly early phenylalanine acid child significant level disorder clinical result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""present case available metabolism significantly early phenylalanine acid child significant level d""]}, ""hyperactivity"": {""freq"": 1, ""string"": [""tomography retardation rating province neuropsychological imaging hyperactivity duration methodsa untreated predictor l""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""brain rare intervention dietary therapy pku amino outcome important present case a""]}, ""screening"": {""freq"": 1, ""string"": [""scale cohort period overall various inborn screening plasma management error brain r""]}}",{},{}
525,525,561,10.1111/jcmm.13982,30450693.0,entire bioinformatics tool milk herein region early znt world neonatal deleterious together frequency conspicuous missense highlight diverse exac increase exclusively however health inactivating equally harboured transport diagnosis genetic slc tnzd yet rate mutation ethnicity least breastfed mcf prediction transporter database population markedly functionality potential organization consequently loss unknown assay cell transient two newborn allele estimate healthy breast function exclusive impact infant importance secretion prevention general high human zinc lof deficiency individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349188/,abstract,8,tnzd lof inactivating harboured exac breastfed znt slc mcf conspicuous exclusive equally exclusively functionality ethnicity secretion deleterious bioinformatics zinc entire breast transient markedly transporter milk transport consequently prediction missense organization diverse world estimate unknown allele assay neonatal loss prevention database highlight frequency importance general region tool infant healthy increase deficiency impact rate newborn mutation cell function individual human early diagnosis population potential health high genetic,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""newborn"": {""freq"": 1, ""string"": [""infant healthy increase deficiency impact rate newborn mutation cell function individual h""]}}",{},{}
526,526,563,10.1016/j.omtn.2018.07.005,30092403.0,potent activity encoding reporter lentiviral gfp pressure injection transfer effective majority way virus section stomatitis summary uptake vesicular higher demonstrating bioluminescence fold mouse hydrodynamic conventional efficacy scheme low hepatocytes tail transduction rate naked volume liver plasmid targeted target pave delivery readout strongly viral finding specificity vsv glycoprotein vein typically fashion demonstrate intrahepatic dna analysis routinely also high study direct vector gene number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083003/,abstract,0,vsv vesicular bioluminescence targeted stomatitis intrahepatic gfp pave naked vein readout lentiviral glycoprotein scheme tail hydrodynamic fashion plasmid reporter transduction uptake section routinely transfer potent demonstrating hepatocytes encoding viral conventional vector injection pressure summary virus typically strongly fold demonstrate majority volume specificity way delivery dna direct efficacy liver target finding mouse effective rate activity higher low number gene high analysis study,{},{},{},{},{},{}
527,527,564,10.3390/metabo4041007,25375236.0,activity new effort difficult progressive ammonia defect despite literature due moreover capable aromatic neurocognitive addition subcutaneous disease pku glycomacropeptide hydroxylase amount phenylalanine strategy clinical therapy brain feature food metabolic recently large decrease oral adherence first phenylanine administration neutral underway current prevent review tetrahydropterina approach phenylketonuria summarize treatment diet near entry future residual aim also trial lyase acid human dietary cofactor palatable amino gene presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279156/,abstract,0,tetrahydropterina phenylanine underway palatable entry summarize subcutaneous lyase neurocognitive ammonia neutral capable residual near glycomacropeptide progressive aromatic adherence cofactor oral prevent difficult effort administration decrease recently feature presence defect despite hydroxylase literature food aim addition trial strategy large future brain diet dietary therapy activity current pku amino phenylketonuria approach new human phenylalanine review acid metabolic gene treatment clinical disease,"{""phenylalanine"": {""freq"": 2, ""string"": [""pku amino phenylketonuria approach new human phenylalanine review acid metabolic gene t""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""diet dietary therapy activity current pku amino phenylketonuria approach new human p""]}}","{""diet"": {""freq"": 1, ""string"": [""addition trial strategy large future brain diet dietary therapy activity current p""]}}",{}
528,528,565,10.1016/j.trsl.2016.11.002,27893987.0,epidemiologist example better single discus information surmountable specifically accomplished researcher minded insight realization open improve facilitate publication impede disease confines doe typical apply issue knowledge relevant evidence priori optimal achievement role health causation institutional play uni disciplinary primary transdisciplinary like novel useful although really one communication hard overall point many review approach work translational ass plan propose prerequisite important key help decision address process frame advance protocol within progress pressing achieve conversation effectively goal benefit research exchange human barrier rigid look discipline complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362296/,abstract,0,transdisciplinary surmountable really pressing minded impede confines apply uni epidemiologist rigid priori disciplinary accomplished look institutional conversation realization frame causation prerequisite hard discipline achievement achieve exchange typical translational plan effectively progress publication facilitate researcher propose improve barrier specifically communication optimal doe open goal protocol play decision advance address useful help insight work example point relevant ass benefit like issue discus overall knowledge better process complex primary key single novel information evidence important role approach human research review health disease,{},{},{},{},{},{}
529,529,566,,27375759.0,male specific tehran aminoacidopathy disorder delay assessment mofid class progressive objectivewe abnormal positive without organic view sub percent investigate average month disease peroxizomal material exam consanguinity para myoclonic treatable seizure family oxidation relative clinical storage word developmental brain neurologist metabolic neurology term genetic type lipid regression lab seven one referral department marriage eighty overall child inclusion milestone neuro history resultsoverall parent epilepsy test manifestation urea important key eukodystrophy acidemia neurometabolic age methodsthe iran along pediatric neurologic classified criterion conclusionin hospital cycle diagnostic different pattern study similar patient,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928619/,abstract,7,peroxizomal eukodystrophy aminoacidopathy resultsoverall para neurologist myoclonic mofid neuro objectivewe conclusionin tehran eighty neurometabolic neurology exam milestone neurologic marriage consanguinity lab percent department classified epilepsy referral acidemia sub urea treatable oxidation progressive iran methodsthe class seizure lipid manifestation view organic storage delay word seven cycle abnormal relative inclusion average history pediatric pattern regression hospital criterion investigate developmental parent male overall diagnostic similar assessment month positive key brain family material term important test specific type child different age metabolic genetic disorder clinical patient disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""specific type child different age metabolic genetic disorder clinical patient disease s""]}}",{},{},{},{}
530,530,567,10.1016/j.ymgme.2017.04.003,28400091.0,greater pathway intestinal affect gut quinolinic methodssubjects concern due catecholamine classical origin objective significantly pku glycomacropeptide phe medical microbiota subject tyr dopamine higher health compound degradation neurotransmitter food kynurenine bioavailable urine change metabolon crossover metabolism low sulfate level microbiome gmp microbe ingestion week conclusionsthe day frequently via concentration test diet inc sample variant serotonin resultsintake analysis backgrounddeficiencies metabolomics research quantity larger metabolomic plasma different part sulfatoxymelatonin study trp monoamine acid neuropsychological prebiotic amino performance individual metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484416/,abstract,1,resultsintake methodssubjects backgrounddeficiencies quinolinic bioavailable sulfatoxymelatonin sulfate metabolon kynurenine prebiotic ingestion microbe catecholamine trp intestinal gmp monoamine gut quantity microbiota microbiome metabolomic crossover neuropsychological glycomacropeptide origin tyr serotonin degradation neurotransmitter larger conclusionsthe classical affect dopamine metabolomics frequently urine concern compound greater week performance food metabolite phe objective subject plasma day change variant medical pathway diet concentration pku amino higher sample low metabolism test individual significantly research acid different health level analysis study,"{""urine"": {""freq"": 1, ""string"": [""conclusionsthe classical affect dopamine metabolomics frequently urine concern compound greater week p""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""subject plasma day change variant medical pathway diet concentration pku amino h""]}}","{""amino"": {""freq"": 1, ""string"": [""variant medical pathway diet concentration pku amino higher sample low metabolism t""]}}","{""diet"": {""freq"": 1, ""string"": [""plasma day change variant medical pathway diet concentration pku amino higher s""]}}",{}
531,531,568,10.1016/j.ymgmr.2017.04.002,28487825.0,subsequent blood lead ratio factor difficult time methodsthis reaction inherently without additional subsequently cost reliable well way increase doe material amount insignificant however reduction consistent beadchip input focus secondary project primary structural genotype aimthe thus data change detection whole alter rate replig size volume temperature log produce overall noise expenditure kit studio wide robust amplification protocol sample resultsthe snp variant spot order psycharray reduced discussionwhole suited dna quality aim optimization regardless also array introduces number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408502/,abstract,0,studio replig psycharray insignificant discussionwhole introduces inherently beadchip noise aimthe suited kit log optimization expenditure array amplification alter regardless input produce subsequently methodsthis snp temperature project subsequent reliable resultsthe reduced robust doe protocol structural volume genotype difficult secondary way reaction size dna consistent focus reduction lead cost spot wide additional ratio order overall detection aim change primary variant increase quality rate material sample number time factor blood data,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""spot wide additional ratio order overall detection aim change primary variant i""]}}",{},{}
532,532,569,10.1016/j.ntt.2016.08.002,27545092.0,major specific sac assessment self memory striatum asymmetric lead organism location light central capacity outside route avoid way conjunction escape animal wall distal rather encodes extensively home cincinnati brain integrated environment task error food cul movement base purpose entorhinal dark advantageous reach specie procedural ability type rat learning water internal one cue end structure review elsewhere approach method cwm system opening test danger best proximal navigational two along survival order especially egocentric goal path wherein paper multiple allocentric cortex dorsal different maze whereas navigation human mammal hippocampus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056837/,abstract,0,navigational navigation entorhinal egocentric cwm cincinnati allocentric wall sac opening maze dark cul escape dorsal danger procedural cue advantageous distal asymmetric striatum route mammal proximal outside encodes avoid reach integrated location learning path hippocampus extensively conjunction cortex base internal home organism movement specie light survival capacity water memory end rat goal task way best environment central animal lead self purpose structure especially ability paper order assessment food major multiple error brain approach test human specific type review different method,{},{},{},{},{},{}
533,533,570,10.1186/s11689-018-9228-y,29587625.0,implication experimental considerable disorder delay autism neural caudate greater single mesocorticolimbic examine bilateral condition superior pole reward intranasal connectivity activation well increase finally material orbital frontostriatal spectrum paradigm cingulate session supplementary backgroundintranasal nonsocial relative dopamine frontal user clinical additionally brain double output task thus effect alternatively date change versus novel significant functioning although functional administration asd resultscentral one interest communication anterior placebo fmri observable preclinical dose ofc child outcome conclusionsthe oxytocin therapeutic ass modulates social potential system ameliorate online article treatment stimulus response electronic year finding address salience scan materialthe version process incentive methodsin age generally two primarily plc adolescent analysis acc impairment impact research available relatively trial cortex group interaction study right blind nucleus nacc connection agent participant individual anticipation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870086/,abstract,1,salience resultscentral pole plc orbital observable nonsocial intranasal frontostriatal backgroundintranasal acc oxytocin ofc nacc mesocorticolimbic cingulate modulates caudate incentive fmri anticipation connectivity alternatively scan nucleus frontal stimulus reward anterior connection bilateral ameliorate preclinical output functioning session cortex paradigm superior methodsin neural blind right placebo primarily activation versus examine considerable generally conclusionsthe double asd delay communication agent dopamine adolescent task relatively experimental dose additionally relative date address administration autism finally implication impairment materialthe greater social ass functional spectrum finding interaction participant process supplementary trial user change version increase response electronic online therapeutic brain single impact novel material outcome condition article available individual research potential child age significant group year effect disorder treatment clinical analysis study,"{""social"": {""freq"": 1, ""string"": [""resultscentral pole plc orbital observable nonsocial intranasal frontostriatal backgroundintranasal acc o"", ""autism finally implication impairment materialthe greater social ass functional spectrum finding i""]}}",{},{},{},{},{}
534,534,571,10.1093/jamia/ocv065,26142422.0,major record greater content information among effort laboratory location medically need interpret institute source institution clinician display objective note survey material medical enters actionable rather optimal clinical multiphase health ehrs improvement genomic support result data ehr optimally ability genetic type area use implement main representation discussion genomics critical method nih national system substantial interoperable recommendation electronic iterative decision address care process augment envision order determinant determine effectively exploratory dependent currently mechanism priority research flow importance multiple conclusion upon group different heterogeneity sequencing barrier patient highest consistently,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009914/,abstract,1,multiphase interoperable ehrs envision ehr note enters optimally representation nih augment medically implement interpret actionable iterative exploratory institute location display consistently determinant priority institution flow effectively discussion substantial barrier record genomics clinician optimal highest heterogeneity decision address effort content genomic recommendation dependent source improvement survey national critical sequencing greater currently ability determine laboratory importance main order need process area support objective major multiple electronic medical use mechanism care information material conclusion type research different health group genetic method data clinical result patient,{},"{""genetic"": {""freq"": 1, ""string"": [""conclusion type research different health group genetic method data clinical result p""]}, ""heterogeneity"": {""freq"": 1, ""string"": [""barrier record genomics clinician optimal highest heterogeneity decision address effort content g""]}}",{},{},{},{}
535,535,572,10.1002/jcsm.12419,30868736.0,major male balance surgery disorder biopsy vivo mole lower among lateralis pancreas fractional throughout continuous mean cent respectively pancreatic synthesis tumour animal cancer phenylalanine organ backgroundliving higher protein procedure fold therefore body resultsfive effect change metabolism eight whole rate three female per tyrosine absorptive vastus liver enrichment infusion post ass pool strongly year incorporation excess methodsin age sample pancreaticoduodenectomy healthy ring prior cachexia precursor impact plasma tissue skeletal study human breakdown surgical patient muscle fine conclusionsliver,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6596396/,abstract,2,vastus pancreaticoduodenectomy mole lateralis conclusionsliver cachexia backgroundliving resultsfive tumour pancreas cent breakdown absorptive pancreatic ring pool infusion fine biopsy incorporation skeletal surgery fractional excess surgical enrichment balance muscle methodsin continuous organ strongly fold prior precursor procedure post vivo female cancer animal mean synthesis liver tissue tyrosine ass male body healthy plasma major change lower respectively impact rate higher sample metabolism human phenylalanine protein age year effect disorder patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""impact rate higher sample metabolism human phenylalanine protein age year effect d""]}}",{},{},{},{},{}
536,536,573,10.1007/978-1-4939-6506-9_1,27830542.0,transplant significant demand whole advance experimental disorder cure organ introduction pediatric supply end acute technical select since several perspective failure clinical involved child despite field focus liver approach orthotopic special outweighs alternative infant transplantation also trial stage international historically metabolic hepatocyte human majority center patient disease far chapter donor,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125821/,abstract,0,outweighs orthotopic cure supply transplant select chapter historically demand donor transplantation technical far hepatocyte special organ introduction failure involved end majority experimental perspective international alternative advance acute center stage pediatric focus liver despite field infant trial approach human child significant metabolic disorder clinical patient disease,{},{},{},{},{},{}
537,537,574,,29114196.0,knowledge advance disorder rapid phenylalanine one way strategy recent discus recessive pertaining among regeneration early several autosomal laboratory neonatal protein collectively many focus biosynthesis phenylketonuria tetrahydrobiopterin improvement therapeutic relatively literature error pah common enhancement inborn diagnosis diagnostic technology enzyme metabolic recently data treatment well deficiency cofactor patient disease objective pku responsive hydroxylase metabolism systematic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669513/,abstract,0,pertaining enhancement regeneration collectively responsive biosynthesis cofactor recessive relatively tetrahydrobiopterin autosomal advance systematic way improvement recently focus pah neonatal rapid laboratory hydroxylase technology discus knowledge diagnostic literature inborn enzyme objective strategy error therapeutic recent deficiency pku common phenylketonuria metabolism early phenylalanine diagnosis protein metabolic data disorder treatment patient disease,"{""phenylalanine"": {""freq"": 2, ""string"": [""deficiency pku common phenylketonuria metabolism early phenylalanine diagnosis protein metabolic data d""]}}","{""autosomal"": {""freq"": 1, ""string"": [""responsive biosynthesis cofactor recessive relatively tetrahydrobiopterin autosomal advance systematic way improvement r""]}, ""recessive"": {""freq"": 1, ""string"": [""enhancement regeneration collectively responsive biosynthesis cofactor recessive relatively tetrahydrobiopterin autosomal advance s""]}}",{},{},{},{}
538,538,576,10.1021/jacs.5b09536,26700445.0,experimental cross mobility among collision essential barrel microscopy kinetics sheet common addition hypothesis glycine increase disease ion section membrane neuronal adopt however form seminal cylindrins neuropathogenetic protein fast peptide integrity force computational combination perturbation type tail significant rapid hexamers death size oligomeric toxic aggregation dynamic structure terminal sized therapeutic alzheimer potential test oligomers treatment proportion challenge atomic two mass amyloid order determine cylindrin electron identical spectrometry head also larger plasma different equilibrium similar agent show injury fragment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741107/,abstract,0,neuropathogenetic cylindrins cylindrin collision barrel oligomers mobility hexamers sheet seminal adopt kinetics atomic sized oligomeric tail microscopy identical fragment glycine perturbation equilibrium electron terminal section force integrity ion fast amyloid aggregation head computational membrane injury alzheimer toxic neuronal peptide dynamic larger agent proportion hypothesis experimental death size cross rapid combination structure spectrometry essential determine order similar form addition mass plasma challenge increase therapeutic common test type potential different protein significant treatment disease,{},{},{},"{""spectrometry"": {""freq"": 1, ""string"": [""death size cross rapid combination structure spectrometry essential determine order similar f""]}}",{},{}
539,539,578,10.3399/bjgp17X693461,29061717.0,conclusionthe specific record search difficult positive choice physical additional need difficulty testing eligible register quick however settingan moderate follow backgroundpeople health west therefore symptom improvement primary support large observational mild run design validate learning service use functional code methodread referral problem others population review descriptive method mental identification target people disability test danger team viable proportion adequately false care aimto harder poor complementary revalidation likely field unidentified refined worker currently previously resultsdiagnostic also general tested practice often unrecognised study yorkshire small healthcare individual number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697554/,abstract,0,yorkshire unrecognised settingan revalidation resultsdiagnostic methodread harder backgroundpeople unidentified refined danger worker viable tested quick adequately run aimto west code register learning eligible validate complementary referral team descriptive conclusionthe observational false choice record difficulty people proportion moderate mild healthcare search difficult poor follow mental service physical improvement likely disability practice currently previously design identification general problem functional additional small need field testing target symptom support primary positive large use care number test individual specific population review health method study,{},{},{},{},{},{}
540,540,579,10.3390/molecules22010105,28075340.0,specific disorder instance physiological lead selectively herein factor transcriptomics pathway affect molecule nutrition elderly nutrient increasingly molecular action capable neoplastic state multifactorial investigate risk nutrigenomics well disease status expectancy knowledge relevant beneficial life unique strategy clinical health procedure body stimulating result chemopreventive metabolic exogenous effect reviewed expansion genetic epidemiology art main progression strength outcome population omics therapeutic pathological development technology exposure diet systematic lifestyle near influenced process component future explore field analysis environmental cardiovascular mechanism metabolomics research bioactive diagnostic interaction substantive human dietary proteomics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155887/,abstract,0,reviewed influenced chemopreventive neoplastic substantive transcriptomics selectively instance expectancy elderly nutrigenomics multifactorial stimulating proteomics bioactive art omics exogenous strength epidemiology expansion capable near pathological lifestyle beneficial progression physiological cardiovascular action increasingly nutrient affect metabolomics unique nutrition procedure molecule explore systematic component exposure lead investigate environmental relevant main technology status field knowledge diagnostic interaction body process state strategy therapeutic future pathway molecular mechanism diet dietary life outcome human risk specific factor research population development metabolic health effect genetic disorder clinical analysis result disease,{},"{""genetic"": {""freq"": 1, ""string"": [""research population development metabolic health effect genetic disorder clinical analysis result d""]}}","{""pathway"": {""freq"": 1, ""string"": [""body process state strategy therapeutic future pathway molecular mechanism diet dietary l""]}}",{},"{""diet"": {""freq"": 1, ""string"": [""strategy therapeutic future pathway molecular mechanism diet dietary life outcome human r""]}}",{}
541,541,580,10.1136/bmjdrc-2015-000161,26977306.0,biological correlation specific worldwide domestic culture self region among proxy urbanization country selection geographic gross state old practical resultsworldwide increase disease solution significantly respectively objectiveprevalence life partial caput obesity globally data design cause methodscountry type epidemiology ecological rate independent per spearman economic spss exponentially population product pearson test association diabetes year conclusionsreduced ibs gdp generally newborn prevalence estimate birth analysis background index natural research consumption also different sugar study longevity categorization speci total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780042/,abstract,3,speci resultsworldwide objectiveprevalence methodscountry ecological urbanization ibs exponentially conclusionsreduced gdp domestic categorization caput longevity gross proxy spearman pearson geographic globally spss epidemiology sugar culture practical partial worldwide solution generally economic consumption diabetes obesity independent selection estimate natural index old self product correlation biological design prevalence birth country region background state cause increase association respectively rate life total newborn test significantly specific type research population different year data analysis disease study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""increase association respectively rate life total newborn test significantly specific type r""]}}",{},{}
542,542,581,10.1002/pro.2971,27327045.0,correlation specific although still relationship two family new studied encoding scop conundrum information graph space molecule comparison dataset structure extensively database comprehensively protein recognition site many interesting hidden mechanism abundance method relatively ligand chemical homologous result different interaction mode high dissimilar landscape effective treatment similar addition computational small well novel similarity long evolutionally distant complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338237/,abstract,1,scop hidden evolutionally dissimilar conundrum distant graph homologous ligand dataset space comprehensively interesting landscape extensively similarity abundance encoding studied recognition mode computational chemical relatively molecule site comparison structure database correlation small relationship interaction similar addition long complex effective mechanism family novel information new specific different protein high method treatment result,{},{},{},{},{},{}
543,543,582,10.1007/s00401-017-1739-1,28638987.0,resonance specific disorder blood example progressive time defect microgliopathies prenatal oligodendrocyte central onset molecular due pathology fall physiology course axonopathies vessel tremendous increase underlying disease fatal leukodystrophies matter interplay knowledge decade impair account life rather strategy possible clinical nature primary structural curative astrocyte static behind generation selective degenerative novel astrocytopathies mutation cellular one involvement imaging microglia crucial vacuolization white recognition many approach axon propose system treatment myelin senescence dramatically neuropathology component genetically complex age mostly category vasculopathies nervous function next mechanism also diagnostic often classification last pattern magnetic sequencing even gene leuko number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563342/,abstract,0,vasculopathies vacuolization microgliopathies leuko axonopathies astrocytopathies microglia static leukodystrophies senescence oligodendrocyte degenerative neuropathology fatal axon astrocyte impair vessel tremendous fall curative interplay dramatically myelin physiology recognition imaging progressive crucial resonance involvement classification underlying selective pathology nervous prenatal propose course matter genetically category nature white magnetic decade cellular structural account component central pattern example generation onset sequencing defect knowledge diagnostic possible complex primary strategy increase molecular mechanism novel life mutation function approach number time specific blood age gene disorder treatment clinical disease,{},{},{},{},{},{}
544,544,583,10.3390/metabo9060117,31216675.0,epidemiologic measurement implication various linkage sample biospecimen multi challenge investigation single discus phenotype timing context across arise selection strength omic population critical review technique study source data integration principle human collection design limitation type consideration controversial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630728/,abstract,0,biospecimen omic arise timing epidemiologic controversial linkage strength integration principle multi consideration limitation selection investigation collection implication source critical context measurement technique design phenotype discus various challenge single sample human type population review data study,{},{},{},{},{},{}
545,545,584,10.1194/jlr.M052969,25652089.0,whether observation vivo factor content affect examine positive demonstrates hepg site altogether proprotein ldlr cholesterol increase significantly promoter kexin transcription however normolipidemic reduction consequent shhnf protein consistent fold shrna mouse primary effect change receptor furthermore type cultured bind level significant one nuclear hepatic knockdown normal infection liver concomitant abundance markedly expression serum unknown concentration hnf diet subtilisin cell regulator obligatory reduced circulating impact adenoviral tissue mrna study convertase modest gene ldl,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373738/,abstract,1,shhnf normolipidemic convertase subtilisin proprotein ldlr knockdown kexin circulating adenoviral obligatory hepg shrna consequent concomitant altogether ldl modest cultured bind demonstrates cholesterol abundance mrna hnf regulator promoter markedly observation hepatic examine transcription nuclear fold reduced receptor affect infection vivo unknown content consistent serum site reduction liver furthermore tissue mouse normal expression change primary positive increase diet impact concentration cell significantly factor type protein significant gene effect level study,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""normal expression change primary positive increase diet impact concentration cell significantly f""]}}",{}
546,546,585,10.1152/physrev.00029.2016,29442594.0,exciting clinic class vivo reticulum conformation energy molecule several defect native molecular literature due pathology chemical misfolding control disease neurological membrane synthesis numerous line endoplasmic proteasome animal however pharmacological dysfunction eventual clinical protein compound mutant degradation substrate enzyme receptor genetic ubiquitin area bind mutation cellular conformational per autophagy soluble comprehensively many review model therapeutic summarize prone misrouted ligand correct expression potential pharmacoperones system ameliorate promising aggregate cell specificity transgenic lack especially since limited function quality either modulating vitro mechanism research also trial intricate high study small barrier correction another gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966717/,abstract,0,pharmacoperones misrouted ubiquitin modulating misfolding intricate autophagy proteasome eventual reticulum endoplasmic transgenic summarize exciting prone ligand conformational conformation comprehensively soluble bind native ameliorate aggregate correction membrane substrate promising correct class degradation pathology numerous barrier pharmacological chemical line receptor mutant energy cellular vitro molecule vivo neurological clinic specificity compound animal lack synthesis dysfunction limited especially defect small literature area enzyme trial expression quality therapeutic molecular mechanism mutation cell function model control research review potential protein gene high genetic clinical disease study,"{""neurological"": {""freq"": 1, ""string"": [""mutant energy cellular vitro molecule vivo neurological clinic specificity compound animal l""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
547,547,586,10.1136/archdischild-2016-312156,28600385.0,hour congenital carrying laboratory probable median initial elevated programme need repeat close objectivesto however subject definite strategy capillary possible screening range notification request elevation resultsof methodsreferrals first favourable transmission use onwards seven block day second thyroid treatment hormone electronic reporting year tsh particularly age sample newborn standard determine hypothyroidism scottish infant inclusive consistently performance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739820/,abstract,20,notification methodsreferrals inclusive scottish onwards favourable request carrying definite probable objectivesto capillary tsh resultsof reporting elevation transmission consistently repeat thyroid block close hypothyroidism programme hour hormone initial seven elevated median second particularly determine laboratory congenital performance need standard possible infant screening subject day range strategy electronic use newborn sample age year treatment,{},{},{},"{""newborn"": {""freq"": 1, ""string"": []}, ""screening"": {""freq"": 1, ""string"": [""congenital performance need standard possible infant screening subject day range strategy e""]}}",{},{}
548,548,587,10.1155/2016/6053295,28058133.0,biological blood chromatographic shaker new single coumachlor present reaction liquid onto validation transition ion intra incubation protein range recovery fluid card result quantification novel oral disc tandem rat extraction eight useful anticoagulant separation water internal one drug whatman method development sufficient pharmacokinetic precision cooh acetonitrile sample within mass negative spot standard influence approximately interday analysis warfarin paper spectrometry research saver hplc multiple plasma high small hematocrit dry variability performance accuracy chromatography preclude mixture,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5183798/,abstract,10,shaker preclude coumachlor cooh anticoagulant warfarin saver interday disc acetonitrile incubation whatman hematocrit chromatographic dry separation pharmacokinetic intra card ion hplc recovery mixture quantification internal extraction transition fluid sufficient validation variability precision water rat tandem oral liquid approximately accuracy chromatography useful reaction negative spectrometry influence spot biological paper small performance standard mass plasma range multiple drug single novel sample present new blood research protein development high method analysis result,{},{},{},"{""tandem"": {""freq"": 1, ""string"": [""sufficient validation variability precision water rat tandem oral liquid approximately accuracy c""]}, ""spectrometry"": {""freq"": 1, ""string"": [""approximately accuracy chromatography useful reaction negative spectrometry influence spot biological paper s""]}}",{},{}
549,549,588,10.1212/WNL.0000000000003435,27956565.0,registry multicenter daily everyday class new amelioration july behavioral aged battery behavior deficit cohen well objective neurofibromatosis doe zealand australian executive gov lovastatin life interval event evidence clinical double secondary task primary error result efficacy attention effect term type score international learning clinicaltrials significant confidence placebo text child outcome population week method associate ass skill actrn baseline test treatment identifier year intention function quality cognitive analysis adverse subtest nct trial conclusion consortium part classification study visuospatial blind neuropsychological randomly cambridge total treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207004/,abstract,8,subtest lovastatin visuospatial cohen amelioration actrn neurofibromatosis multicenter everyday cambridge australian zealand associate intention identifier battery consortium learning july registry neuropsychological skill randomly clinicaltrials blind placebo class classification nct gov executive double confidence treat doe event task interval baseline daily text behavioral international secondary aged adverse deficit efficacy behavior attention ass week score cognitive objective trial primary error quality life total evidence outcome conclusion term function test new type population child significant year effect method treatment clinical analysis result study,"{""behavioral"": {""freq"": 1, ""string"": [""event task interval baseline daily text behavioral international secondary aged adverse d""]}}",{},{},{},{},{}
550,550,589,10.7860/JCDR/2017/28793.10632,29207797.0,specific immediate blood disorder autism iem better sensory neural ammonia acidurias five prompt frequency methodshospital common supplementation deficit prognosis amongst material respectively recurrent issue spectrum account largest extrapyramidal compliance neurodevelopmental follow carboxylase clinical therapy spite feature crisis gap conclusionoa error anion inborn movement diagnosis metabolic attention symptomatic resultsof urine term long metabolism case recurrence death morbidity child lactate outcome recognition spasticity management introductionorganic bicarbonate malonic methyl treatment proportion constituted year acidemia protocol two percentage india survival survivor propionic sick standard differential next complicated adverse analysis spectrometry multiple intellectual part presentation study subnormality hyperactivity deficiency cofactor even deafness aimto,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713819/,abstract,5,subnormality methodshospital malonic introductionorganic conclusionoa bicarbonate spasticity sick extrapyramidal deafness constituted survivor recurrence spite carboxylase anion aimto acidurias lactate india sensory prompt immediate resultsof largest crisis propionic complicated recurrent methyl ammonia acidemia prognosis symptomatic recognition neural movement hyperactivity percentage gap compliance differential survival neurodevelopmental presentation cofactor proportion protocol morbidity iem account urine death intellectual follow autism supplementation adverse deficit feature attention spectrometry frequency issue spectrum standard better inborn long management multiple error deficiency respectively therapy material outcome term common case metabolism specific blood diagnosis child metabolic year disorder treatment clinical analysis study,"{""urine"": {""freq"": 1, ""string"": [""cofactor proportion protocol morbidity iem account urine death intellectual follow autism s""]}, ""hyperactivity"": {""freq"": 1, ""string"": [""acidemia prognosis symptomatic recognition neural movement hyperactivity percentage gap compliance differential s""]}, ""intellectual"": {""freq"": 1, ""string"": [""protocol morbidity iem account urine death intellectual follow autism supplementation adverse d""]}}",{},{},"{""spectrometry"": {""freq"": 1, ""string"": [""autism supplementation adverse deficit feature attention spectrometry frequency issue spectrum standard b""]}}",{},{}
551,551,590,10.1080/87565641.2018.1438439,29432026.0,process trajectory age executive disorder however three phenylalanine unclear present child nature precise verbal cognitive developmental impairment fluency phenylketonuria task contribution dissociate group result interaction metabolic study data control year pku metabolism timepoints performance longitudinal hereditary period,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902806/,abstract,0,timepoints dissociate fluency verbal trajectory hereditary precise executive longitudinal contribution nature unclear task impairment developmental period performance interaction process cognitive pku phenylketonuria present metabolism phenylalanine control child age metabolic group year data disorder result study,"{""phenylalanine"": {""freq"": 2, ""string"": [""process cognitive pku phenylketonuria present metabolism phenylalanine control child age metabolic g""]}}",{},{},{},{},{}
552,552,591,10.1590/1984-0462/;2018;36;4;00001,29995139.0,resonance inheritance male factor eif progressive time autosomal present deterioration leukoencephalopathy symmetrical five additional codification admission state old control objective disease month mouth recurrent extreme hyper peak hereditary matter initiation worse unit seizure lvwm protein brain body symptom examination report somnolence diagnosis sleepy late genetic case dehydration rapid mutation one signal death pathogenic adipsy temperature diffuse white description child sign comment week day eukaryotic describe predominance alteration care rare primarily recessive sleepiness breast responsible chronic intensive aspect hospital infant translation fever episode tonsillitis comatose pattern magnetic dry gene individual complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322808/,abstract,1,tonsillitis sleepy lvwm codification adipsy somnolence eukaryotic eif dehydration comatose sleepiness mouth hyper symmetrical leukoencephalopathy predominance diffuse extreme comment dry deterioration worse fever description peak admission initiation episode recurrent intensive breast hereditary inheritance sign progressive unit temperature resonance primarily seizure translation responsible matter signal examination late pathogenic white recessive magnetic aspect alteration autosomal death pattern old hospital rapid chronic male week additional body symptom month infant objective state day complex brain report rare care mutation present case individual time control factor diagnosis child protein gene genetic disease,{},"{""inheritance"": {""freq"": 1, ""string"": [""initiation episode recurrent intensive breast hereditary inheritance sign progressive unit temperature r""]}, ""autosomal"": {""freq"": 1, ""string"": [""pathogenic white recessive magnetic aspect alteration autosomal death pattern old hospital r""]}, ""recessive"": {""freq"": 1, ""string"": [""matter signal examination late pathogenic white recessive magnetic aspect alteration autosomal d""]}, ""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
553,553,592,10.1146/annurev-bioeng-062117-121019,29528686.0,significant case microbiota advance bacteroides future lactic synthetic member bifidobacteria interest recent composition discus biology biotic community commensal nonresident several engineering perspective probiotic provide health many insight review condition indigenous therapeutic diagnostics bacteria potential technology purpose study human acid strongly directly probe number engineer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100750/,abstract,0,nonresident indigenous biotic bacteroides commensal bifidobacteria lactic engineer probiotic engineering probe microbiota diagnostics bacteria synthetic strongly composition member biology perspective directly community advance insight purpose provide technology discus therapeutic future recent condition number case human review acid potential significant health study,{},{},{},{},{},{}
554,554,593,10.2478/jomb-2014-0056,28356825.0,derivatization specific disorder tool ljubljana activity iem early pathway congenital isoelectric defect positive adult laboratory cooperation liquid organic frequency literature centralized fabry well close disease evaluate ion slovenian register measurement account pediatrician childhood screening error diagnosis university enzyme column metabolic symptomatic selective genetic tandem planning metabolism mortality significant although resultsthere death morbidity block child management technique method work post gas team proportion important fatty acidemia gaucher backgroundinborn rare methodsin mass newborn fluorimetric quite hospital spectrometry conclusionsin group exchange diagnostic study acid patient slovenia even exception complication amino glycosylation chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922335/,abstract,7,ljubljana slovenian isoelectric slovenia fluorimetric conclusionsin column centralized gaucher derivatization glycosylation pediatrician fabry backgroundinborn quite cooperation resultsthere register exception ion planning acidemia methodsin block exchange team symptomatic close gas selective university organic complication proportion tandem morbidity iem liquid account post fatty chromatography death evaluate mortality childhood work hospital measurement spectrometry defect technique frequency laboratory congenital diagnostic literature tool enzyme screening mass management positive error pathway adult rare newborn activity amino important metabolism early specific diagnosis acid child significant metabolic group genetic method disorder patient disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""diagnosis acid child significant metabolic group genetic method disorder patient disease s""]}}","{""pathway"": {""freq"": 1, ""string"": [""enzyme screening mass management positive error pathway adult rare newborn activity a""]}}","{""amino"": {""freq"": 1, ""string"": [""error pathway adult rare newborn activity amino important metabolism early specific d""]}, ""tandem"": {""freq"": 1, ""string"": [""gas selective university organic complication proportion tandem morbidity iem liquid account p""]}, ""spectrometry"": {""freq"": 1, ""string"": [""evaluate mortality childhood work hospital measurement spectrometry defect technique frequency laboratory c""]}, ""newborn"": {""freq"": 1, ""string"": [""management positive error pathway adult rare newborn activity amino important metabolism e""]}, ""screening"": {""freq"": 1, ""string"": [""laboratory congenital diagnostic literature tool enzyme screening mass management positive error p""]}}",{},{}
555,555,594,,30417173.0,potent disorder daily information early blum time laboratory chronically despite nutrient retention substance superior pro fda reward risk conjunction significantly gar characterize narcotic actively however later concurrent evidence much weak dosage compliance dependence seminal dopamine mesolimbic higher therapy nature thus like basis receptor term adherence first long combination genetic consideration score non rate panel relapse short naltrexone imperative block release provide outcome many vulnerability injectable management naloxone work identification neuro development sufficient treatment ten precision valuable oud circuitry antagonist genetically regulator allele opioid likely especially cocaine effectively longer research consumption relatively modality ntx also polymorphic high study alcohol regulate aud show gene addiction treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226033/,abstract,1,relapse oud opioid ntx narcotic naltrexone naloxone gar cocaine blum aud regulate injectable addiction seminal mesolimbic neuro polymorphic weak imperative dependence concurrent circuitry antagonist fda vulnerability reward chronically retention dosage actively substance conjunction release modality alcohol potent superior pro longer block regulator effectively characterize valuable compliance sufficient adherence precision consideration genetically treat later nature consumption nutrient receptor dopamine relatively panel daily allele basis short work likely combination especially despite laboratory identification provide like score long management therapy information rate evidence outcome term higher non time significantly risk early research development gene high genetic disorder treatment study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
556,556,595,,28540274.0,inheritance wide counseling case pcr tehran sequence mutation phenylalanine family iran female moderate leu recessive heterozygous department arg analysis phenylketonuria science genetics error pah inborn identify variation diagnosis university heterogeneity old substitution april acid sequencing patient novel pku hydroxylase iranian amino metabolism gene genetic allelic medical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439047/,abstract,0,leu tehran counseling allelic iranian arg april department substitution heterozygous inheritance iran pcr identify university moderate recessive heterogeneity science sequence female old pah genetics variation sequencing wide hydroxylase inborn error medical family novel mutation pku amino phenylketonuria case metabolism phenylalanine diagnosis acid gene genetic analysis patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""mutation pku amino phenylketonuria case metabolism phenylalanine diagnosis acid gene genetic a""]}}","{""inheritance"": {""freq"": 1, ""string"": [""iranian arg april department substitution heterozygous inheritance iran pcr identify university m""]}, ""recessive"": {""freq"": 1, ""string"": [""inheritance iran pcr identify university moderate recessive heterogeneity science sequence female o""]}, ""heterozygous"": {""freq"": 1, ""string"": [""allelic iranian arg april department substitution heterozygous inheritance iran pcr identify u""]}, ""genetic"": {""freq"": 1, ""string"": []}, ""heterogeneity"": {""freq"": 1, ""string"": [""iran pcr identify university moderate recessive heterogeneity science sequence female old p""]}}",{},"{""amino"": {""freq"": 1, ""string"": [""error medical family novel mutation pku amino phenylketonuria case metabolism phenylalanine d""]}}",{},{}
557,557,596,10.1016/j.yjmcc.2015.07.031,26254182.0,interestingly blood relationship activity preserving dos lower aneurysm attenuate oxidative nifedipine sustained pressure view sub vascular risk old endothelial effective pressor activation month note respectively enos lethal channel event unique eliminate uncouple hph blocker angiotensin mouse six protective recently effect aortic data oral novel type inhibition formation low completely smooth stress although rate imaging dose drug coupling aaa prevent nadph abdominal week model day hypertension via oxidase treatment bioavailability incidence cell superoxide two aorta production hyperphenylalaninemia unclear function either mechanism available also prevention group different high uncoupling rupture ultrasound patient muscle uncoupled highly calcium treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637219/,abstract,4,uncoupling uncouple rupture pressor aneurysm smooth preserving nifedipine eliminate uncoupled note attenuate nadph hph aorta enos blocker angiotensin aaa sustained coupling oxidase lethal bioavailability aortic abdominal hypertension channel protective ultrasound superoxide muscle calcium interestingly endothelial dos vascular sub imaging completely pressure activation oxidative view hyperphenylalaninemia inhibition treat formation unclear event oral unique dose production prevent incidence stress old recently prevention highly week relationship mouse month day drug effective lower mechanism respectively novel rate activity cell function low available risk model blood type different group effect high data treatment patient,{},{},{},{},{},{}
558,558,597,10.2147/JMDH.S91559,26937199.0,staff training assessment self new early item positive several behavioral neonatal additional relevancethis coordination highlight institution eligible well specialist month medical unit family life possible screening role health postpartum symptom project support harm result depression routine ongoing psychologist consideration ultimately multidisciplinary significant predictable administrator provider completion communication nurse referral implementation child critical review intervene day mental describe ass development mother recommendation response key care challenge process future conclusionseveral adjustment screen intensive resultsapproximately program research infant part study barrier coordinator objectivethe complication,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762650/,abstract,3,resultsapproximately relevancethis intervene conclusionseveral coordinator administrator psychologist predictable postpartum nurse completion staff objectivethe harm coordination adjustment multidisciplinary eligible training item intensive ongoing referral ultimately institution specialist provider depression unit project routine screen barrier consideration complication communication mother behavioral mental recommendation implementation neonatal self critical highlight ass additional possible assessment symptom process support month infant screening day program challenge positive key response medical future family care life role new early research review child significant development health result study,"{""behavioral"": {""freq"": 1, ""string"": [""screen barrier consideration complication communication mother behavioral mental recommendation implementation neonatal s""]}}",{},{},"{""screening"": {""freq"": 1, ""string"": [""assessment symptom process support month infant screening day program challenge positive k""]}}",{},{}
559,559,598,10.3390/genes10060459,31208052.0,disorder activity maximum affect hepg molecular together characterization pro genetics missense enzymatic obvious ile well disease significantly pku hydroxylase respectively phe severely however phenylalanine tyr clinical uncharacterized protein portion result enzyme like effect mild date significance novel combination first type hpa level yet seven functional mutation three wild asn prediction structure many phenylketonuria silico identification work functionality unknown substantial associated cell czech variant hyperphenylalaninemia chaperone function residual complicated vitro impact precursor pah ala ser often thr study namely similar predominantly patient null gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628251/,abstract,1,uncharacterized thr ile ser asn hepg portion czech obvious ala null functionality silico maximum complicated severely chaperone pro predominantly hpa residual enzymatic characterization tyr substantial prediction missense hyperphenylalaninemia significance wild precursor seven affect mild vitro date associated unknown work pah genetics combination structure identification functional like hydroxylase similar enzyme phe variant molecular respectively impact novel activity mutation pku cell function phenylketonuria significantly phenylalanine type protein gene effect level disorder clinical result patient disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""mutation pku cell function phenylketonuria significantly phenylalanine type protein gene effect l""]}}",{},{},{},{},{}
560,560,599,10.1007/s13353-017-0424-3,29344903.0,case transcription multisystem although disorder chain still mutation list nuclear respiratory vast mtdna trna subunit form especially depletion molecule essential dysfunction encodes function responsible fashion protein ndna point necessary deletion maintenance instability multicopy secondary together rrnas translation also multiple expression manifest replication turn number cause well accumulation nerve disease muscle predominant long incomplete gene cell complex mitochondrial mendelian,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799321/,abstract,3,rrnas ndna multicopy mtdna multisystem instability trna incomplete manifest vast fashion nerve encodes depletion subunit turn replication mendelian predominant respiratory muscle maintenance list deletion mitochondrial translation responsible transcription nuclear accumulation molecule secondary necessary dysfunction point chain especially essential form long expression multiple complex cause mutation cell function number case protein gene disorder disease,{},{},{},{},{},{}
561,561,600,10.3389/fpsyg.2018.02758,30778325.0,two evidence one sensory greater information representation independently dot map across visual shape brain unusually total integrated action available infant due possibility familiarization hemifield development infancy often topographic investigate interhemispheric domain study integration human equality experiment late month lateralized challenge stronger perception vision,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369161/,abstract,2,topographic hemifield familiarization unusually lateralized interhemispheric equality vision dot representation sensory shape integrated stronger map infancy perception independently integration visual experiment possibility action late domain investigate greater month infant challenge brain information total evidence available human development study,{},{},{},{},{},{}
562,562,602,10.1186/s12881-014-0120-7,25409741.0,major specific blood nine whether conclusionswe encoding studied factor single content inflammation five epistasis additional severe suggested common preterm investigate risk interleukin testing control glucocorticoid umbilical addition disease respectively material however interactively supplementary evidence moderate methodsgenes user role protein finland necrosis receptor furthermore genetic suggestive finnish significant case four one northern conclude canada backgroundbronchopulmonary population dysplasia replication online article susceptibility polymorphism important electronic association directly cord materialthe version within two snp hungary differentiation birth influence chronic analysis aim tnf available lung infant also immaturity multiple interaction study nucleotide correction tumor gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258941/,abstract,5,methodsgenes interactively glucocorticoid backgroundbronchopulmonary immaturity tnf necrosis interleukin hungary finnish finland epistasis umbilical dysplasia suggestive suggested canada cord conclude northern replication conclusionswe lung encoding studied correction preterm susceptibility snp tumor differentiation inflammation receptor moderate nucleotide polymorphism directly content investigate furthermore chronic influence materialthe additional birth testing interaction severe aim infant supplementary addition major user multiple version electronic online single association respectively evidence material article important role common case available risk specific control factor blood population protein significant gene genetic analysis disease study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
563,563,603,10.1155/2017/4231489,28804645.0,hemorrhage age full within three respect one newborn retcamiii factor retinal greater accordingly duration positively birth clinical section labor neonatal spontaneous advanced svd cesarean eye week degree examination method infant quantity vaginal development conclusion stage obstetric group result potential aggravation second protective risk purpose attention study conversely delivery proportion term intracranial parameter objective respectively incidence total maternal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540476/,abstract,6,svd retcamiii obstetric aggravation vaginal intracranial cesarean hemorrhage labor conversely spontaneous retinal protective section eye quantity accordingly respect advanced positively duration degree examination proportion parameter stage delivery maternal incidence second neonatal purpose attention greater week birth infant objective respectively total newborn conclusion term risk factor potential age development group method clinical result study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""week birth infant objective respectively total newborn conclusion term risk factor p""]}}",{},{}
564,564,604,10.3748/wjg.v21.i21.6427,26074681.0,disorder ipsc technical time several despite iheps efficient need trans partly well way disease solution embryonic issue suitable however latter inherent pluripotent procedure global comparable project fibroblast like hepatocyte scarcity generation hepatocytes empirically logically functional certain independently failure liver method unsuccessful important engraftment cell donor near protocol future poor disadvantage ipscs differentiation conversation goal systematically currently alternative relatively popular transplantation transplanted group different human direct isolated advantage surgical another highly initiative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458753/,abstract,0,iheps logically ipsc unsuccessful transplanted scarcity ipscs empirically conversation disadvantage pluripotent engraftment popular inherent partly isolated trans surgical fibroblast embryonic hepatocytes donor systematically near independently initiative transplantation technical differentiation comparable project hepatocyte failure suitable solution efficient advantage goal protocol certain relatively procedure alternative poor way global direct liver generation highly currently despite functional like issue need future important cell time human different group method disorder disease,{},{},{},{},{},{}
565,565,605,10.1136/bmjopen-2017-020944,29654045.0,immediately disorder assessment activity autism whether hour morning representative registration several present supplemental physical elicits parallel regular ethic eligible control effective publication urinary hong journal objective spectrum measurement however committee clinical disturbance sleep symptom core result effectiveness thus university effect creatinine actigraphic change design term first type medication enrolment use level commonly sustainability peer asd text log disseminationethical collect child intervention metabolise week method behavioural degrade melatonin treatment parental education care analysisall traditionally protocol sample two poor approval typically standard determine adjusted quality either research nct also trial introductionsleep group december kong sulfatoxymelatonin study human disturbed february randomly participant number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905756/,abstract,2,metabolise kong introductionsleep hong enrolment analysisall actigraphic disseminationethical collect sulfatoxymelatonin elicits disturbed degrade adjusted sustainability traditionally morning melatonin supplemental log february creatinine journal approval immediately ethic eligible behavioural sleep peer registration committee representative december regular core disturbance randomly parallel publication parental nct hour medication commonly urinary typically university asd protocol education text poor effectiveness autism physical measurement determine design week spectrum standard participant assessment symptom objective trial change quality effective use intervention care activity term sample number present human control type research child group effect method level disorder treatment clinical result study,{},{},{},{},{},{}
566,566,606,10.1016/j.ymgmr.2015.12.003,27014574.0,level seven age although activity phenylalanine conclusionsbrazilian resultsthere marker backgroundphenylketonuria difference composition comparison toxic anthropometric time value bioelectrical population disturbance feature bia eutrophic therefore body methodstwenty due regardless also older general group diagnosis nutritional bmi risk metabolic effect impedance control accumulation gender similar disturbed patient year diet pku hydroxylase status type low show brazilian phe parameter historical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789337/,abstract,2,eutrophic conclusionsbrazilian methodstwenty impedance bioelectrical bia disturbed historical resultsthere anthropometric brazilian backgroundphenylketonuria regardless disturbance bmi toxic older gender composition seven accumulation parameter nutritional feature comparison marker general hydroxylase status similar body phe value diet activity pku difference low time risk phenylalanine control type diagnosis population age metabolic group year effect level patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""activity pku difference low time risk phenylalanine control type diagnosis population a""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""hydroxylase status similar body phe value diet activity pku difference low t""]}}",{}
567,567,607,10.1016/j.ymgmr.2017.10.007,29124015.0,exhibited difference greater preference bitter objectivein choice frequency unfamiliar source taste pasta backgroundin extension bread significantly methodsmale phe phenylalanine resultsboth staple previous questionnaire additionally protein neophobic potato food observational potentially low fear non case although female fry neophobia child sweet behaviour parent snack free habit drink carbohydrate parental supplement habitual comparison limited influence consumption biscuit also general closer group high study acid amino artificially,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671408/,abstract,2,objectivein neophobic neophobia methodsmale fry artificially staple pasta bitter biscuit unfamiliar snack resultsboth potato closer sweet habitual exhibited bread fear taste extension drink habit carbohydrate backgroundin preference behaviour supplement parental observational choice consumption additionally potentially previous female source questionnaire comparison limited free influence greater frequency parent general food phe amino non difference low case significantly phenylalanine acid child protein group high study,"{""phenylalanine"": {""freq"": 2, ""string"": [""amino non difference low case significantly phenylalanine acid child protein group h""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""greater frequency parent general food phe amino non difference low case s""]}}",{},{}
568,568,608,10.1038/nrg.2016.162,28138143.0,rapid life community genomics across adult clinical pervade next health fully approach efficiency genome stage cost technology evolution data human barrier generation patient preconception care accuracy challenge medicine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517837/,abstract,0,pervade preconception evolution fully efficiency barrier genomics accuracy community stage genome rapid generation cost medicine technology challenge adult care life approach human health data clinical patient,{},{},{},{},{},{}
569,569,609,10.1007/s00216-017-0571-8,28815270.0,blood single composition profile time condition need fact number addition boost drop solution month significantly amount animal however strategy mainly volumetric storage divergent procedure integrated therefore analytical integration contrast stability question novel first extraction use significant water red step pre temperature room absorptive polar stable approach device workflow work concentration collection key best cell intracellular acetonitrile sample untargeted mass basic longer metabolomics spectrometry attractive also upon different study rapidly human highest metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694668/,abstract,3,boost acetonitrile polar drop divergent absorptive volumetric red attractive untargeted intracellular integrated workflow fact room rapidly longer extraction integration device temperature stability basic solution stable composition water storage analytical question mainly highest metabolomics procedure contrast step best pre collection profile work animal spectrometry need metabolite month addition mass strategy key single use novel concentration condition cell sample approach number time significantly human blood different significant study,{},{},{},"{""spectrometry"": {""freq"": 1, ""string"": [""best pre collection profile work animal spectrometry need metabolite month addition m""]}}",{},{}
570,570,610,10.3390/ijms20133371,31323994.0,palindromic subsequent specific availability microindels proximity region pathway brief finger frequency nuclease repeat activator repair template transcription decade event foremost higher feature double knock like crispr first plant non dsb zfn effector recombination main one short involvement strand end review object method target homologous system frequent accessible help insertion donor two along order magnitude regularly genome part last frameshift zinc gene number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651222/,abstract,0,zfn proximity microindels knock foremost dsb strand palindromic frameshift regularly nuclease recombination homologous object repair finger effector activator template magnitude crispr insertion zinc plant accessible brief repeat donor involvement subsequent transcription double frequent end availability event decade genome help short feature frequency like main order target region pathway higher non number specific review gene method,{},{},"{""pathway"": {""freq"": 1, ""string"": [""frequency like main order target region pathway higher non number specific r""]}}",{},{},{}
571,571,612,10.4103/0253-7176.203125,28515550.0,various implication disorder delay record iem almost factor tertiary time present laboratory half condition iems common risk significantly consanguinity medical understanding family much recent speech variety clinical developmental retrospectively error inborn result diagnosis purpose data language genetic metabolism period direction communication death child many population method identification history development manifestation ten detail year finding care complex future pediatric sibling impairment hospital research conclusion group study predominantly demographic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385742/,abstract,0,speech sibling retrospectively consanguinity tertiary direction iems predominantly demographic language half manifestation record delay variety communication iem death history pediatric implication understanding hospital impairment purpose developmental laboratory identification period finding various inborn complex error medical future recent family care conclusion condition common present metabolism time significantly risk factor diagnosis research population child development group year genetic method data disorder clinical result study,{},"{""genetic"": {""freq"": 1, ""string"": [""research population child development group year genetic method data disorder clinical r""]}}",{},{},{},{}
572,572,613,10.1093/jnci/djv125,25956173.0,specific luck statistic example observation early effort difficult across selection bad unavoidable state unwarranted disease pitfall issue cancer quantify fundamentally event rather recent arise role focus contribution error report result type incorrect united detection case rate three cellular division etiology log highly inferential suggestion chance lifetime replication incidence argue cell fatality traffic statistical underscore demonstrate dna stem unpreventable research importance prevention conclusion tissue often necessarily random analyst number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822527/,abstract,1,unwarranted unpreventable unavoidable luck fundamentally analyst traffic inferential fatality pitfall necessarily incorrect division bad arise log underscore suggestion chance replication quantify lifetime argue statistic random stem observation united contribution demonstrate etiology event cellular statistical selection difficult effort dna incidence cancer focus example tissue prevention highly importance issue detection state error recent report rate conclusion role cell number case early specific type research result disease,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""example tissue prevention highly importance issue detection state error recent report r""]}}",{},{}
573,573,614,10.1007/s12687-018-0389-x,30259298.0,implication commentator assessment responsibility generalizable several world concern insight detailed governmental expert moreover thematic improve institution swedish preconception semi ethical sweden respect knowledge however evidence profound harbored perspective questionnaire role health respondent subthemes procedure milieu therefore result qualitative interview effect term novel long interpretative international non use theme seven verbatim one implementation societal regard method via social organization technology ten directly process carrier policymakers public sample since political influence analysis aspect priority research program depth part readiness study inductive extent small engagement random economics participant healthcare,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435768/,abstract,0,inductive commentator verbatim swedish subthemes interpretative harbored governmental generalizable readiness economics political milieu thematic policymakers responsibility sweden preconception engagement societal depth regard profound semi respondent respect detailed priority institution random theme qualitative ethical interview improve extent organization expert seven carrier aspect world healthcare procedure perspective international directly concern insight implication implementation questionnaire influence social public technology small knowledge participant assessment process long program use novel evidence term non role sample research health effect method analysis result study,"{""social"": {""freq"": 1, ""string"": [""concern insight implication implementation questionnaire influence social public technology small knowledge p""]}}",{},{},{},{},{}
574,574,615,10.1080/21675511.2015.1128617,27141408.0,rare process utility experimental specific theme future understanding strategy recent broader discus etiology brain either mouse model characterization dystonia work backward dopa drd presentation symptomatic data forward treatment design generation disease responsive genetic issue,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838313/,abstract,0,backward drd dopa dystonia broader forward symptomatic theme responsive characterization presentation etiology utility experimental work understanding generation design issue discus mouse process strategy future brain recent rare model specific genetic data treatment disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
575,575,616,10.1089/acm.2015.0163,26654976.0,various asds disorder prescription autism sensory among southeastern ease frequency average injection effective well objective survey spectrum understanding quantify form rating variety user clinical therapy health result effectiveness efficacy large integration data casein question medication medicine multivitamin asd local label problem gluten child many population method frequently used organization parent participation online free methyl safety melatonin antifungal cam treatment proportion diet challenge option complementary mitigating setting try alternative research conclusion practice often patient highest,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739350/,abstract,1,mitigating cam antifungal try southeastern multivitamin gluten setting asds prescription melatonin label casein sensory ease quantify complementary methyl used rating participation integration injection medication organization asd local variety question safety proportion option highest frequently alternative average effectiveness autism survey understanding efficacy free practice frequency parent medicine problem spectrum various form objective challenge user online effective large diet therapy conclusion research population child health method data disorder treatment clinical result patient,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""objective challenge user online effective large diet therapy conclusion research population c""]}}",{}
576,576,617,10.1002/mgg3.315,29178638.0,conclusionthe specific disorder hemophilia single factor several across adult condition common highlight bullosa fabry methodswe risk experience disease medical knowledge however unique clinical storage health range diagnosis qualitative metabolic psychological nongenetic genetic theme four three one main experienced categorized point review living phenylketonuria social face system lysosomal myriad care systematic challenge epidermolysis specificity rare wide resultsthe lack order systematically shared impact paper research backgroundindividuals except consequence different practice study skin individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702559/,abstract,2,shared nongenetic hemophilia epidermolysis categorized bullosa backgroundindividuals myriad fabry experienced living lysosomal systematically skin face theme psychological qualitative conclusionthe storage resultsthe unique methodswe systematic specificity experience consequence lack point practice highlight social wide paper main order knowledge challenge range medical single adult rare impact care condition common phenylketonuria individual risk specific factor diagnosis research review different metabolic health genetic disorder clinical disease study,"{""skin"": {""freq"": 1, ""string"": [""myriad fabry experienced living lysosomal systematically skin face theme psychological qualitative c""]}, ""social"": {""freq"": 1, ""string"": [""experience consequence lack point practice highlight social wide paper main order k""]}}","{""genetic"": {""freq"": 1, ""string"": [""shared nongenetic hemophilia epidermolysis categorized bullosa b""]}}",{},{},{},{}
577,577,618,10.7171/jbt.18-2904-001,,reviewer athens member agu interest clive information usa readership tel board editorial fax uga highlight column ude recently necessarily article prince ave thgualsc forward publication mcg slaughter important association abrf opinion partnership useful mail summary medical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201863/,abstract,1,ude thgualsc tel slaughter readership prince partnership clive ave athens abrf uga fax editorial agu mcg necessarily column reviewer mail usa board forward opinion publication summary member useful recently highlight medical association information article important,{},{},{},{},{},{}
578,578,619,10.3389/fpsyg.2019.01622,31354597.0,biological contributor activity neural new difference discus context epigenetics innate world student despite set throughout modification enhance behavior condition genetics clear epigenetic concept well origin uncertain opinion plasticity flexible knowledge subject life organ form versatile variety word adaptable brain therefore particular contribution possibility support thus respectful alternatively term ability genetic formation educational one main neuroscience capability review regulation mental something development expression people thereby skill implicitly key associated education process genetically professional lifelong make inheritability especially function heritability goal act environmental aspect background relatively importance also conclusion practice high human connection gene idea enables,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635910/,abstract,0,respectful inheritability implicitly adaptable neuroscience alternatively contributor versatile epigenetics innate flexible plasticity make enables idea heritability uncertain connection opinion epigenetic capability lifelong student set skill neural origin enhance act educational modification clear organ contribution possibility genetically variety formation word people goal concept relatively aspect world education associated mental regulation professional particular behavior genetics context environmental especially practice biological ability despite importance main discus knowledge background process form support subject expression key brain life activity conclusion term condition difference function new human review development gene high genetic,{},"{""genetic"": {""freq"": 1, ""string"": [""idea heritability uncertain connection opinion epigenetic capability lifelong student set s""]}}",{},{},{},{}
579,579,620,10.1080/14686996.2019.1590126,31068982.0,carrier use suitable related actively future however substantively direction negative recent conjugate order context conclude block poly current explore drug anticancer clinical side present concern protein ethylene researcher light immunological insight immunogenicity characteristic therapeutic counterpart also polymeric propose potential system attention effect nanocarrier contrast micelle deeply little immune novel unresolved biopharmaceuticals issue toxicological,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493319/,abstract,0,substantively polymeric nanocarrier micelle biopharmaceuticals unresolved ethylene conjugate toxicological poly counterpart anticancer immunological deeply immunogenicity conclude actively direction block light researcher propose suitable immune little carrier explore contrast concern insight negative context attention related characteristic issue order drug therapeutic future recent use novel current present potential protein effect clinical,{},{},{},{},{},{}
580,580,621,10.1186/s12889-017-4755-0,28946866.0,cluster daily micronutrient prospectively registration early modestly anemic aged behavior province due zero methodswe course motor control eligible month survey village however life strategy compliance mnp follow value endline home developmental sachet mnps powder resultsone improvement primary translate china thereafter six effect april bayley absent change thousand first low eight score level significant isrctn developmentally child outcome intervention point assignment rural development target baseline fortification concentration treatment investigator ten address hundred backgroundanemia iron two hemoglobin scale statistical cognitive program infant cognitively trial multiple group shaanxi feeding study marginal power randomly freely caregiver anemia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613507/,abstract,5,mnps mnp marginal endline developmentally backgroundanemia shaanxi sachet modestly cognitively anemic isrctn resultsone fortification village powder freely assignment zero bayley anemia translate investigator iron absent hemoglobin prospectively micronutrient eligible april feeding registration thousand power rural province home cluster randomly caregiver compliance china course motor baseline daily statistical address methodswe follow aged improvement survey behavior point developmental scale score target cognitive month infant trial program change multiple primary strategy value intervention life concentration outcome low early control child significant development group effect level treatment study,{},{},{},{},{},{}
581,581,623,10.3389/fpubh.2017.00053,28377917.0,conclusionthe scanning specific assessment advise past search new information instead pertinent essential modification condition literature need highlight horizon significantly emergence issue account element committee methodsa hoc consistent support harm debate expansion furthermore unanimous bloodspot genetic consideration multidisciplinary level theme government independent advice implementation cessation vital evaluation review approach ass plan development technology article agenda wave nominate recommendation year decision particularly threshold robust monitoring resultsthe two continuously screen advisory explore criterion lens benefit program policy upon historically group cycle often different part transparent maker successful,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359248/,abstract,0,unanimous nominate advise pertinent lens transparent scanning hoc cessation horizon wave agenda bloodspot harm emergence advisory maker advice threshold multidisciplinary instead historically continuously government debate vital committee expansion theme plan methodsa conclusionthe modification element screen consideration resultsthe monitoring robust successful past cycle account independent explore decision search policy recommendation implementation consistent criterion furthermore particularly evaluation highlight essential ass benefit issue technology need literature assessment support program information condition article approach significantly new specific review different development group year genetic level,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
582,582,624,10.1038/srep37298,27905547.0,tool relationship better energy heat difficult congenital homology identity missense control severity well disease calculation quick account leber possible previous protein crystal genotype macular result effect data reference computational generation genetic perturbation useful level mutation phenotype curve map prediction structure database evaluation residue critical pigmentosa model silico free protherm association help amaurosis every age degeneration screen scale series next analysis previously program available ums propensity retinitis study sequencing similar developed show accuracy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131339/,abstract,2,ums protherm leber amaurosis macular retinitis pigmentosa developed homology quick propensity heat identity silico perturbation degeneration calculation map crystal residue series computational curve prediction missense screen energy reference severity account accuracy genotype difficult useful previous help generation critical structure free sequencing database evaluation previously congenital scale phenotype relationship better similar possible tool program association mutation available model control protein age effect genetic data level analysis result disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""available model control protein age effect genetic data level analysis result d""]}}",{},{},{},{}
583,583,625,10.1007/s10545-014-9802-8,25567501.0,registry disorder record investigation information early among mma prematurity largely prenatal condition literature due preterm risk progeny number majority well nonreassuring termination responsive status introductionwomen related trimester gov life cumulative observed optimal clinical cbla crisis hyperammonemia indication mut result distress diagnosis metabolic mild term pregnancy fetal first type non methylmalonic clinicaltrials case abortion rate one text child woman methodspregnancies population review approach management perinatal via unknown identifier delivery acidemia care maternal age advance unexplored pediatric clarify cesarean complicated basic adverse previously nct cobalamin trial episode often cohort study isolated small patient participant complication malformation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496322/,abstract,6,nonreassuring methodspregnancies introductionwomen cbla cesarean unexplored progeny hyperammonemia mut cobalamin mma abortion prematurity clarify termination trimester identifier distress isolated crisis episode cumulative complicated perinatal methylmalonic registry malformation acidemia preterm indication responsive clinicaltrials nct gov largely prenatal basic fetal record complication optimal mild majority text advance unknown pregnancy delivery investigation maternal woman adverse observed pediatric previously related cohort small status participant literature management trial care information rate life term condition non approach number case risk early type diagnosis population review child age metabolic disorder clinical result patient study,{},{},{},{},{},{}
584,584,626,10.3892/etm.2016.3167,27168772.0,oximetry shortly ductus disorder pulse exam anomalous death factor return prematurity relative congenital option current venous defect birth syndrome infection approximately heart pulmonary drug tricuspid echocardiogram review usually chance degree consumption technique infant great fetus physical utero method chd diagnosis different often risk artery repair truncus vessel surgical transposition increase close first fallot type genetic incidence total tetralogy maternal hypoplastic atresia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840484/,abstract,0,truncus tricuspid hypoplastic transposition echocardiogram ductus anomalous oximetry atresia tetralogy shortly fallot vessel prematurity exam return repair utero artery venous fetus chance pulse pulmonary surgical chd close usually degree consumption great option infection approximately relative death heart maternal incidence physical syndrome defect technique congenital birth infant drug increase total current risk factor type diagnosis review different genetic method disorder,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
585,585,627,,28883876.0,methodstwo tehran disorder delay relationship seizure mass mofid one iran resultstotally observation outpatient software early relation statistical positive prominently conclusionpositive clinical laboratory child spss evaluation word developmental meaningful review hospital milestone ver retrospective eeg spectrometry examination method history development group diagnosis metabolic presentation study radiological besides statistically important key infantile patient disease year material tandem objectiveneurometabolic demographic regression period,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582359/,abstract,2,ver resultstotally prominently objectiveneurometabolic conclusionpositive mofid methodstwo radiological tehran infantile eeg outpatient milestone spss meaningful retrospective software demographic observation iran seizure examination delay statistically presentation word relation tandem statistical history regression hospital developmental spectrometry evaluation laboratory period relationship mass positive key material important early diagnosis review child development metabolic group year method disorder clinical patient disease study,{},{},{},"{""tandem"": {""freq"": 1, ""string"": [""examination delay statistically presentation word relation tandem statistical history regression hospital d""]}, ""spectrometry"": {""freq"": 1, ""string"": [""tandem statistical history regression hospital developmental spectrometry evaluation laboratory period relationship m""]}}",{},{}
586,586,628,10.1007/s13205-017-0763-0,28597164.0,diaphorase considerable exhibited maximal activity diaphorases almost nad reaction weight molecular characterization moreover sphaericus ion respectively catalyzed reduction optimal value protein metal max property enzyme biosensor biotransfomation pad design quantification recombinant dehydrogenase bacillus communication temperature inhibitor stable describe used target expression potential test active flavin component dihydrolipoamide application monomeric kda influence dependent nadh vitro dld lipoamide conclusion diagnostic different acid escherichia amino gene metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465047/,abstract,6,sphaericus pad nadh lipoamide flavin dihydrolipoamide diaphorases diaphorase catalyzed biotransfomation nad monomeric max dld bacillus exhibited biosensor kda escherichia maximal metal ion used recombinant quantification characterization temperature dehydrogenase inhibitor considerable stable communication optimal active vitro property reaction component dependent weight reduction influence design diagnostic target metabolite enzyme application expression value molecular respectively activity amino conclusion test acid potential different protein gene,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""application expression value molecular respectively activity amino conclusion test acid potential d""]}}",{},{}
587,587,629,10.3390/ijerph13020225,26901212.0,seven blood sample rate hemoglobin largest subject variant newborn african sickle region confirm hbsc referral bahia africa twelve time country higher child demonstrating period rec liquid total ncavo hbc city program frequency coverage genotype state high forty purpose study data eleven proportion center colonization patient disease slave underwent care show cell brazilian baiano number performance chromatography brazil,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772245/,abstract,2,slave rec ncavo hbsc baiano bahia colonization hbc africa sickle hemoglobin african largest confirm brazilian underwent demonstrating referral coverage brazil city proportion seven liquid genotype chromatography center purpose frequency period performance country region state subject program variant care rate total newborn higher cell sample number time blood child high data patient disease study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""subject program variant care rate total newborn higher cell sample number t""]}}",{},{}
588,588,630,10.22074/ijfs.2019.5373,30291693.0,logistic major adversely relationship backgroundinfertility tertile growth greater factor lower item methodsthis reproductive enhance metaphase bad odds frequency employed common average increase significantly status embryonic material intake pregnant biochemical third conclusionnutrition interval today higher clinical questionnaire primary food fertilization isfahan good covariance unhealthy embryo prospective pregnancy adherence first fertility art infertile regression level educational significant confidence resultsthree rate one chi oocyte woman outcome variance anova chance technique second treatment year diet western challenge maternal age iran determinant healthy conducted quality analysis infertility quantity also ancova nutritional cohort high trend pattern last study dietary center square total number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186288/,abstract,1,metaphase covariance conclusionnutrition backgroundinfertility unhealthy infertile fertilization tertile resultsthree ancova isfahan employed adversely oocyte infertility fertility bad anova chi art today conducted chance embryo item embryonic quantity determinant square reproductive odds variance western methodsthis logistic enhance pregnant iran educational trend adherence prospective confidence interval average center pregnancy good maternal woman pattern second regression nutritional questionnaire intake greater technique frequency growth cohort biochemical relationship status food healthy major challenge primary increase quality lower diet dietary rate total material outcome higher common number significantly factor age significant year high level treatment clinical analysis study,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""major challenge primary increase quality lower diet dietary rate total material o""]}}",{}
589,589,631,10.1016/j.ymgmr.2018.01.004,30023287.0,male subsequent record difference energy composition greater early lower femur density www aged magnesium percent classical urinary excretion significantly glycomacropeptide pku intake phe medical related subset phenylalanine gov compliance renal higher clinical attrs protein absorptiometry fragility body food equivalent methodsfrom consume urine consuming negatively bmd term resultsmale long crossover type score low sulfate backgroundlow clinicaltrials gmp appendicular one female dual per spine mineral gram text normal week phenylketonuria day ray treatment dxa collection net diet scan fat mass variant percentage lifelong lean determine bone index nct trial skeletal trend acid objectiveto similar dietary conclusionsmales participant complication amino total calcium,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047464/,abstract,14,resultsmale conclusionsmales backgroundlow lean gram femur appendicular sulfate methodsfrom fragility dxa bmd spine absorptiometry consume scan magnesium dual consuming skeletal ray net mineral gmp excretion attrs percent calcium crossover www lifelong bone negatively glycomacropeptide density renal equivalent objectiveto clinicaltrials fat percentage subset compliance subsequent nct trend gov urinary record composition classical complication energy text urine collection index aged female intake greater determine related male week score similar participant body food phe normal mass long day trial variant medical lower diet dietary total pku amino term higher difference phenylketonuria low significantly early phenylalanine type acid protein treatment clinical,"{""urine"": {""freq"": 1, ""string"": [""record composition classical complication energy text urine collection index aged female i""]}, ""phenylalanine"": {""freq"": 2, ""string"": [""higher difference phenylketonuria low significantly early phenylalanine type acid protein treatment c""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""medical lower diet dietary total pku amino term higher difference phenylketonuria l""]}}","{""diet"": {""freq"": 1, ""string"": [""long day trial variant medical lower diet dietary total pku amino t""]}}",{}
590,590,632,10.1186/s13023-017-0696-z,28893311.0,disorder cross record availability better sectional single improved lower context early autosomal concern restriction without bias need admission abstract investigate risk methodswe effective journal month shorter fatal neurological material issue reviewer however later evidence life nitisinone beneficial subject weak unique moderate possible screening tyr renal dysfunction user clinical hoc health consistent resultswe crisis science primary result effect symptomatic title data observational term versus late first long type medication metabolism extraction applicability mortality detection transplant conclusionsthere seven full four rate three one pre size text independently outcome review liver backgroundtyrosinemia post september second supplementary web article online treatment electronic association reporting associated medline finding address systematic version rare earlier sample within two recessive timing limited embase reduced quality analysis either hospital prior impact available transplantation group fewer practice cohort high study acid dietary patient amino,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594482/,abstract,5,backgroundtyrosinemia title hoc conclusionsthere shorter fatal applicability reviewer weak nitisinone timing transplant journal improved september reporting fewer crisis admission abstract symptomatic embase earlier web resultswe medline independently extraction renal transplantation bias tyr observational versus medication beneficial record reduced prior later late restriction moderate availability seven recessive unique text post science neurological autosomal address methodswe concern systematic sectional associated pre mortality size consistent second hospital liver dysfunction cross limited context investigate practice cohort issue need finding better detection possible month supplementary screening subject long user primary version electronic quality online effective lower single association rare impact dietary rate life evidence material amino outcome term article sample available metabolism risk early type review acid health group effect high data disorder treatment clinical analysis result patient study,"{""neurological"": {""freq"": 1, ""string"": [""seven recessive unique text post science neurological autosomal address methodswe concern s""]}}","{""autosomal"": {""freq"": 1, ""string"": [""recessive unique text post science neurological autosomal address methodswe concern systematic s""]}, ""recessive"": {""freq"": 1, ""string"": [""later late restriction moderate availability seven recessive unique text post science n""]}}",{},"{""detection"": {""freq"": 1, ""string"": [""practice cohort issue need finding better detection possible month supplementary screening s""]}, ""amino"": {""freq"": 1, ""string"": [""impact dietary rate life evidence material amino outcome term article sample a""]}, ""screening"": {""freq"": 1, ""string"": [""finding better detection possible month supplementary screening subject long user primary v""]}}",{},{}
591,591,633,10.3389/fnbeh.2016.00102,27252633.0,disorder relationship activity self neural new region york mesocorticolimbic several juan largely adult present chronically site half without behavior irrespective bronx substance literature ricans reward state connectivity risk rico true contribute related mcls relative higher brain gap san south potentially young non level significant functional fmri suggesting vulnerability population coherence history potential minority system disproportionately alteration finding promoting particularly age within sample two mri sud reduced path analysis background puerto mechanism prior also consequence upon confer impulsivity part cohort high study nucleus nacc individual seeking,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879128/,abstract,1,sud rico ricans puerto mcls juan impulsivity coherence bronx suggesting promoting nacc mesocorticolimbic york seeking san confer irrespective fmri disproportionately connectivity nucleus minority vulnerability reward chronically substance path south true mri neural contribute gap largely young half reduced prior alteration relative potentially history consequence site behavior self particularly related functional cohort relationship finding region literature background state brain adult mechanism activity higher non sample present individual new risk population potential age significant high level disorder analysis study,{},{},{},{},{},{}
592,592,634,10.1007/s11904-018-0377-0,29380227.0,considerable immediate blood better new time present incorporate offering improve addition well findingsantiretroviral traditional offer cumulative pharmacological strategy objectively recent reviewin clinical antiretroviral real possibility efficacy recently purpose novel adherence long ultimately non period prophylaxis measure pre drug outcome hiv intervention review approach device informative proven method development exposure concentration treatment electronic care two spot summarynew research monitor also prevention optimize advantage highly hair,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876155/,abstract,0,reviewin proven findingsantiretroviral summarynew prophylaxis antiretroviral objectively hair informative offering incorporate optimize immediate hiv cumulative monitor ultimately offer device traditional real considerable adherence improve pharmacological possibility advantage pre recently efficacy exposure purpose prevention highly spot period better measure addition long drug strategy electronic recent intervention novel care concentration outcome non approach present time new blood research review development method treatment clinical,"{""hair"": {""freq"": 1, ""string"": [""proven findingsantiretroviral summarynew prophylaxis antiretroviral objectively hair informative offering incorporate optimize i""]}}",{},{},{},{},{}
593,593,635,10.1155/2016/7374316,27559481.0,derivatization milk absolute fphe without hydrolysis homotyrosine aromatic excellent material phe bsa offer phenylalanine microwave quantitative calibration tyr relative protein compound albumin powder peptide support like reference optionally quantification pure detection separation internal step gold tyrosine lod technique simple method determination propose serum solid bovine precision limit phase crm sample two fluorophenylalanine standard aaaa analysis tryptophan hplc htyr trp acid minute amino accuracy complex deviation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983383/,abstract,3,optionally microwave htyr homotyrosine fphe fluorophenylalanine aaaa crm lod bsa pure hydrolysis calibration powder derivatization bovine albumin separation absolute trp gold minute hplc solid quantification offer internal excellent milk aromatic deviation tyr tryptophan peptide determination propose precision limit simple reference accuracy relative step phase quantitative serum compound tyrosine technique like standard detection support phe complex material amino sample phenylalanine acid protein method analysis,"{""phenylalanine"": {""freq"": 2, ""string"": [""optionally microwave htyr homotyrosine fphe fluorophenylalanine aaaa crm lod bsa p""]}}",{},{},"{""detection"": {""freq"": 1, ""string"": [""serum compound tyrosine technique like standard detection support phe complex material a""]}, ""amino"": {""freq"": 1, ""string"": [""standard detection support phe complex material amino sample phenylalanine acid protein m""]}}",{},{}
594,594,636,10.1038/s41598-018-35092-1,30467356.0,major implication relationship physiological almost encoding representative affect unrelated deleterious increasingly partially capacity enzymatic disease exclusively however trait protein fitness tendency fast abolish genotype seemingly enzyme metabolic effect data obstacle level mapping case full mutation microbe phenotype biomass fully nadph population saccharomyces model degree currency development expression evolution polymorphism component production allele metabolite typically scale compromise influence function natural genome except multiple often pleiotropic escherichia atp coli gene show number cerevisiae,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250661/,abstract,0,saccharomyces cerevisiae fitness currency abolish nadph seemingly pleiotropic biomass tendency compromise coli escherichia microbe exclusively atp obstacle mapping deleterious fast representative unrelated evolution encoding partially enzymatic fully degree typically capacity physiological increasingly affect polymorphism trait production genotype natural allele component genome implication influence scale phenotype relationship metabolite enzyme major expression multiple mutation function number case model population protein development metabolic gene effect data level disease,{},{},{},{},{},{}
595,595,637,10.3892/mmr.2017.7801,29039604.0,pathogenesis pentose oxygenation pathway present stay platform elevated without insight severe uplc control effective increased hapc significantly typical polycythemia subject plateau strategy distance clinical value plain recovery microcirculation disturbance therefore environment result perturbed metabolic novel area level panel hypoxia provide outcome upregulated intervention model participate day method therapeutic target via potential concentration excessive rich year phase finding altitude metaboanalyst sample hemoglobin along qtof uniquely comparison explore differential classified mechanism erythrocytosis oxygen except group plasma tissue high study whereas direct patient total metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780001/,abstract,2,polycythemia oxygenation metaboanalyst hapc erythrocytosis altitude plateau uplc qtof perturbed pentose microcirculation upregulated plain stay increased hypoxia uniquely distance participate hemoglobin excessive oxygen classified recovery typical rich disturbance pathogenesis differential platform elevated panel explore phase environment insight direct comparison tissue provide target finding severe area metabolite subject plasma day strategy value therapeutic effective pathway mechanism intervention novel concentration total outcome sample present significantly model control potential metabolic group year high method level clinical result patient study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""plasma day strategy value therapeutic effective pathway mechanism intervention novel concentration t""]}}",{},{},{}
596,596,638,10.1093/ilar/ilu047,25541546.0,experimental specific unrealistic shift new fundamental factor instead positive biomedical researcher need embrace biomarker effective essence majority true concept justification validation essentially doe solution decade animal adopt however cannot attrition recent variety clinical health compound crisis psychologically methodology result thus anatomically complement design change experiment medicine empirically one measure problem current drug failure outcome incorrectly correctly able population review approach enrichment model reverse preponderance method translational prone thereby potential test false argue predictive library every public advocate two poor negative lack order reasonably basic analysis currently tragic aspect impact heterogenization research widely trial multiple different practice openly physiologically last philosophy human successful show highly sensitive treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342719/,abstract,0,psychologically openly incorrectly heterogenization embrace tragic preponderance philosophy anatomically unrealistic reasonably justification empirically attrition adopt essence advocate physiologically essentially prone correctly reverse crisis library instead complement enrichment biomedical argue true shift fundamental translational experiment false biomarker validation researcher failure basic solution predictive methodology treat variety able sensitive doe widely successful concept decade majority aspect experimental poor compound animal negative lack practice highly currently medicine design problem public order need measure trial change multiple positive drug effective recent impact current outcome approach test new human model specific factor research population review potential different health method clinical analysis result,{},{},{},{},{},{}
597,597,639,10.1007/8904_2016_544,27008193.0,disorder relationship chain assessment glycogen syrup early glutaric enhance programme well objective disease respectively family normative internalising questionnaire storage coa symptom acyl support result distress ornithine metabolic psychological data long type score methylmalonic level variable dehydrogenase referral child intervention management method therapeutic identification social transcarbamylase skill behaviour parent behavioural parental maple imd isovaleric propionic explore exploratory cognitive analysis aciduria impact conclusion high domain whereas deficiency,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388638/,abstract,0,internalising glycogen transcarbamylase isovaleric ornithine normative glutaric distress maple exploratory aciduria syrup propionic imd behavioural acyl methylmalonic referral behaviour skill programme psychological enhance coa parental dehydrogenase storage explore domain variable questionnaire chain social parent identification relationship score assessment symptom cognitive support objective long management therapeutic deficiency family respectively impact intervention conclusion early type child metabolic high method data level disorder analysis result disease,"{""social"": {""freq"": 1, ""string"": [""storage explore domain variable questionnaire chain social parent identification relationship score a""]}}",{},{},{},{},{}
598,598,640,10.1186/s13054-015-0999-1,26268570.0,individual statistic two operator rate least physiological extremely typically pre prevalence early per discus adequate curve statistical positive implementation present sensitivity value metric evaluation deterioration analysis either statement characteristic cutoff alternative day importance also behind number alert patient reasoning novel receiver performance score low useful argue predictive area,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535737/,abstract,0,operator reasoning alert deterioration cutoff statement metric argue receiver extremely statistic curve adequate typically predictive physiological statistical alternative useful pre implementation sensitivity evaluation importance characteristic prevalence discus performance score area day positive value novel rate low number present individual early analysis patient,{},{},{},{},{},{}
599,599,641,10.1590/1678-7757-2017-0500,29898180.0,daily better factor early lower icdas profile greene teeth evaluates caries bacterial continuous risk spp injection control saliva subcutaneous objective evaluate material nondiabetic perspective higher therapy health vermillion result bacteria diagnosis metabolic oral type sixty biofilm level rate imperative supragingival prevent evaluation infusion method development diabetes help unstimulated streptococcus pump load prevalence since individualized diabetic index flow program multiple prevention conclusion group study namely insulin lactobacillus dental patient salivary complication individual total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007967/,abstract,5,vermillion supragingival pump nondiabetic icdas greene evaluates unstimulated teeth spp biofilm lactobacillus streptococcus caries salivary individualized imperative infusion subcutaneous dental saliva diabetic load flow bacterial bacteria insulin injection continuous complication diabetes oral daily perspective prevent evaluate index profile help prevention evaluation prevalence better objective program multiple lower therapy rate total material conclusion higher individual risk early control factor type diagnosis development metabolic health group method level result patient study,{},{},{},{},{},{}
600,600,642,10.1021/acsinfecdis.6b00124,27641435.0,major erythrocyte availability blood investigation essential require synthase elevated malaria onset severe open separate supplementation continuous investigate biomarker urinary sepiapterin disease hydroxylase restoration synthesis characterize summary however phenylalanine oxidation brain minor mouse nitrite improvement symptom berghei arginine vasodilation effect aortic low whole citrulline infection systemic tyrosine prevent liver product plasmodium infusion anka endothelium compartment concentration limit aorta nitric depletion compromise dependent precursor plasma tissue windowtetrahydrobiopterin oxide human cofactor patient,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289270/,abstract,0,windowtetrahydrobiopterin nitrite berghei anka vasodilation plasmodium aorta endothelium restoration require malaria compromise citrulline erythrocyte infusion sepiapterin minor depletion aortic compartment arginine nitric oxidation oxide characterize continuous synthase systemic summary separate biomarker urinary limit precursor cofactor availability open elevated infection prevent investigation supplementation dependent improvement synthesis liver onset investigate tissue tyrosine product essential hydroxylase mouse severe symptom plasma major brain concentration low human phenylalanine blood effect patient disease,"{""phenylalanine"": {""freq"": 2, ""string"": []}}",{},{},{},{},{}
601,601,643,10.1093/nar/gku1267,25514926.0,rewire uniprotkb reliability new information early pathway dataset across site www modification knowledgebase molecular missense common improve source regulatory phospho disease succinylation spectrum ubiquityl cancer protein ptmvar tcga identifies ptms phosphosite data experiment non redundant phosphorlyation mutation cellular ubiquitylation syndrome assignment post translational acetyl ptmvars phosphositeplus methyl polymorphism intersect http hundred process downstream two mass variant psp order standard function acetylation analysis spectrometry available group interaction methylation mammalian org downloads,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383998/,abstract,14,uniprotkb ubiquityl succinylation rewire ptmvars ptmvar ptms psp phosphosite phosphorlyation intersect downloads ubiquitylation tcga phosphositeplus acetylation redundant phospho knowledgebase http assignment methylation identifies dataset acetyl org reliability methyl www mammalian translational downstream experiment modification missense improve polymorphism cellular post regulatory source cancer site spectrometry syndrome order spectrum standard interaction process mass variant pathway molecular information mutation non common function available new early protein group data analysis disease,{},{},"{""pathway"": {""freq"": 1, ""string"": [""spectrum standard interaction process mass variant pathway molecular information mutation non c""]}}","{""spectrometry"": {""freq"": 1, ""string"": [""cellular post regulatory source cancer site spectrometry syndrome order spectrum standard i""]}}",{},{}
602,602,644,10.1007/s10545-016-9923-3,27240455.0,example new region catalysis pathway molecule centric defect ssiem oppermann uncovered site five surveying chemical transsulfuration diverse principle activator spectrum matter biochemical recent symposium integrating therapy nature protein allosteric structural error inborn result away enzyme metabolic data stability design generation novel metabolism consideration three mutation catalytic multi update inhibitor strong drug structure outline discovery collaborator many approach work via yue stage loss article guide key active year technically cell overview wide advance setting function field next worker cobalamin group different interaction presentation domain study lesson small istanbul complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920855/,abstract,0,yue uncovered transsulfuration surveying oppermann istanbul collaborator technically symposium ssiem integrating catalysis centric worker cobalamin setting away activator allosteric outline lesson update catalytic guide principle inhibitor multi stability matter overview consideration chemical diverse presentation nature strong discovery structural active molecule domain advance stage work site example loss generation structure defect wide design biochemical small field spectrum interaction region inborn enzyme complex drug key error pathway recent novel therapy mutation article cell function approach metabolism new different protein metabolic group year data result study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""inborn enzyme complex drug key error pathway recent novel therapy mutation a""]}}",{},{},{}
603,603,645,10.4103/1817-1745.187640,27606023.0,resonance male leukodystrophy insufficiency progressive resulting mld word spasticity feature milestone diffusion report metachromatic old magnetic impaired key disease month rarely myelination arylsulfatase regression,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991155/,abstract,0,resulting mld metachromatic arylsulfatase spasticity leukodystrophy myelination insufficiency milestone rarely diffusion impaired progressive resonance word magnetic regression old feature male month key report disease,{},{},{},{},{},{}
604,604,646,10.7717/peerj.6518,30828498.0,claim fluorescence dye however spectrum phenylalanine lead opposite fibrillar amyloid form visible aggregation positive structure nature reaction fibril light thioflavin previously phenylketonuria condition cytotoxicity due work identification report multiple occasion property nanostructures optical part study data oligomerization overlap remains cause patient uncertain ability assay formation show emergence false phe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394350/,abstract,0,claim thioflavin fibrillar oligomerization occasion nanostructures dye cytotoxicity remains optical opposite visible fibril overlap emergence uncertain fluorescence amyloid aggregation light false nature formation property reaction work assay lead structure previously ability identification spectrum form phe multiple cause positive report condition phenylketonuria phenylalanine data patient study,"{""phenylalanine"": {""freq"": 2, ""string"": []}}",{},{},{},{},{}
605,605,647,10.3390/toxins11020077,30717092.0,significant mycotoxin biochemical volatile superoxide dairy milk production micro afb biomarkers difference composition macro organism pathway mainly risk cow aflatoxin fluid mda metabolomics research indicator post dismutase capacity eighteen result exposure plasma rumen serum dialdehyde effect concentration study test biofluids attention removal acid addition antioxidant important fatty malon significantly amino systematic total metabolism metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410036/,abstract,2,rumen mda malon dialdehyde aflatoxin afb mycotoxin macro micro cow dismutase biofluids removal volatile eighteen dairy superoxide indicator antioxidant organism milk fluid capacity composition mainly metabolomics production post fatty systematic serum exposure attention biomarkers biochemical metabolite addition plasma pathway concentration total amino important difference metabolism test significantly risk research acid significant effect result study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""attention biomarkers biochemical metabolite addition plasma pathway concentration total amino important d""]}}","{""amino"": {""freq"": 1, ""string"": [""metabolite addition plasma pathway concentration total amino important difference metabolism test s""]}}",{},{}
606,606,649,10.12669/pjms.335.13330,29142578.0,various tool blood better search factor information profile item glucose modification communicable due included effective addition concept disease issue relevant however till fel perspective user role play focus food thus like friendly term cultural adherence lipid consideration non level significant combating measure relevance review maintenance management development helpful people help diet list meal relation whilst effectively google quality paper ailment importance prevention exchange group plasma june different study dietary scholar reducing reoccurrences individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673747/,abstract,4,reoccurrences reducing fel combating ailment till scholar google friendly included communicable meal helpful cultural whilst item june maintenance exchange effectively relevance list modification lipid adherence consideration people relation glucose concept perspective play search profile help focus prevention relevant importance like paper issue better various food tool measure addition plasma management user quality effective diet dietary information term non role individual factor blood review different significant development group level disease study,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""addition plasma management user quality effective diet dietary information term non r""]}}",{}
607,607,650,10.1111/1751-7915.12778,28696008.0,potent inflammatory expensive infectious hence age disorder microbiome cancer locally life production situ sustainable healthy obesity cytokine technical achieve drug provide goal economical many currently global body multiple pathology autoimmune bacteria antibody enzyme metabolic human effective treatment delivery barrier well diabetes disease biologics medicine complex promote,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609241/,abstract,0,biologics sustainable locally promote economical autoimmune expensive situ achieve potent cytokine microbiome antibody infectious bacteria technical pathology barrier goal diabetes obesity inflammatory production delivery global cancer currently medicine provide body enzyme healthy multiple complex drug effective life human age metabolic disorder treatment disease,{},{},{},{},{},{}
608,608,651,10.1021/jacs.8b11882,30829477.0,chain synthetic self architecture difference visible several modification separate optical morphology well material spectrum chitin glycomaterials monomer form nature range manner peptide structural report property six length use fluorescence hexamers biomaterials polysaccharide aggregation cellulose dimer approach device method potential nanostructures excitation carbohydrate nanotechnology key systematic component oligosaccharide within application assemble dependent shape windowself natural broad emit foundation interaction yield distinct though even,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727349/,abstract,0,windowself oligosaccharide glycomaterials emit chitin cellulose assemble polysaccharide hexamers biomaterials nanotechnology nanostructures excitation optical visible architecture shape dimer monomer morphology fluorescence carbohydrate aggregation manner foundation yield device length broad synthetic peptide modification separate distinct nature structural systematic natural property component dependent self chain spectrum interaction form application range key use report material difference approach potential method,{},{},{},{},{},{}
609,609,652,10.1021/acscentsci.7b00299,28852705.0,clinic herein new lower early cystic positive platform inflammation unrelated light affected molecular organic characterization ambiguous open separate derivative bacterial ethylhexyl testing injection control orphan glutamine disease significantly arylesterase recurrent spectrum sweat however phthalic later life capillary unaffected screening pilocarpic ionic relative paraoxonase secreted compound nonspecific windowthe environment purine transmembrane report support multisegment fibrosis result asymptomatic diagnosis transport enzyme exogenous effect specimen complement first tandem formation medicine biofilm detection yet case mutation pilocarpine gold volume cftr progression independently infection polar child intervention confirmatory therapeutic work target exposure dipeptides unknown unexpectedly concentration test plasticizer impaired precision modifier universal carrier complex electrophoresis advance regulator sample two mass newborn screen standard throughput analysis environmental benefit mono mechanism program spectrometry infant lung pathophysiology secretion high lactonase pleiotropic acid human deficiency asparagine chloride amino gene conductance resolution metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571457/,abstract,2,pilocarpine pilocarpic phthalic paraoxonase multisegment mono lactonase ionic ethylhexyl arylesterase plasticizer dipeptides biofilm windowthe unexpectedly sweat secreted purine polar pleiotropic nonspecific conductance ambiguous chloride cftr unaffected asparagine transmembrane glutamine electrophoresis modifier capillary derivative confirmatory secretion orphan gold complement throughput recurrent specimen lung exogenous asymptomatic unrelated cystic impaired regulator independently bacterial universal pathophysiology fibrosis transport characterization injection resolution light inflammation separate affected screen progression precision organic platform later formation open tandem carrier volume infection relative advance clinic unknown environment compound work exposure environmental spectrometry medicine benefit testing spectrum target standard detection support metabolite enzyme infant screening mass program complex positive therapeutic lower molecular deficiency mechanism report intervention life concentration newborn mutation amino sample case test significantly new human early control diagnosis acid child gene effect high analysis result disease,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""medicine benefit testing spectrum target standard detection support metabolite enzyme infant s""]}, ""amino"": {""freq"": 1, ""string"": [""report intervention life concentration newborn mutation amino sample case test significantly n""]}, ""tandem"": {""freq"": 1, ""string"": [""precision organic platform later formation open tandem carrier volume infection relative a""]}, ""spectrometry"": {""freq"": 1, ""string"": [""unknown environment compound work exposure environmental spectrometry medicine benefit testing spectrum t""]}, ""newborn"": {""freq"": 1, ""string"": [""deficiency mechanism report intervention life concentration newborn mutation amino sample case t""]}, ""screening"": {""freq"": 1, ""string"": [""standard detection support metabolite enzyme infant screening mass program complex positive t""]}}",{},{}
610,610,653,10.1111/cdev.13057,29529358.0,age executive cross sample hemoglobin memory northern india sectional relation income widespread nutrition country function standardized child role additionally outcome path personal intervention analysis rural mental development social nutritional stimulation often concentration malnutrition motor language important bihar association inform month diet status middle significantly low score particularly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174960/,abstract,0,bihar malnutrition india northern hemoglobin personal path standardized stimulation rural widespread income middle inform language executive memory relation motor nutrition additionally sectional mental nutritional cross particularly social status score country month association diet intervention concentration outcome important role function sample low significantly child age development analysis,"{""social"": {""freq"": 1, ""string"": [""additionally sectional mental nutritional cross particularly social status score country month a""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""social status score country month association diet intervention concentration outcome important r""]}}",{}
611,611,654,10.1007/s12311-014-0610-3,25382714.0,resonance specific tool disorder sporadic autism abnormality better physiological early several developing characterization state source neurodegenerative severity disease briefly hereditary neuroimaging whose cannot much quantitative mainly dementia clinical developmental brain feature diffusion task structural comprise ataxia diagnosis thus qualitative symptomatic radiological data pet date immune voxel routine fetal radiotracers medicine although functional main nuclear involvement biomarkers progression current tractography surrogate sensitivity evaluation proton technique method differentiate ass helpful potential system consequently evolution execution article alteration spetc resting anatomical still application spectroscopy vast differentiation cerebellar subgroup reproducibility impairment aim available identify group diagnostic magnetic morphometry atrophy usual malformation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929983/,abstract,0,tractography spetc morphometry resting radiotracers execution cerebellar developing voxel proton ataxia anatomical radiological pet dementia comprise atrophy differentiate vast usual neuroimaging surrogate briefly sporadic helpful reproducibility malformation diffusion hereditary evolution symptomatic spectroscopy subgroup neurodegenerative consequently characterization qualitative differentiation resonance involvement routine progression identify fetal physiological nuclear immune mainly magnetic task severity structural alteration date autism quantitative source abnormality sensitivity feature impairment developmental biomarkers evaluation technique medicine ass functional main diagnostic better aim tool application state brain current article available early specific diagnosis potential group method data disorder clinical disease,{},{},{},{},{},{}
612,612,655,10.1155/2018/8565498,30305825.0,correlation specific cross assessment better sectional pedsqltm hemodialysis difference among positive mean control disease objective significantly respectively worse understanding life moderate renal therapy health generic burden report result inventory negatively score significant case spearman child outcome intervention highly management abo method stage parent treatment important care qol version pediatric healthy conducted quality either aspect background hospital module indicator modality transplantation conclusion group december domain study individual total statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165587/,abstract,7,abo pedsqltm hemodialysis worse spearman qol module generic conducted modality inventory indicator december negatively renal transplantation statistically burden moderate aspect domain sectional stage pediatric understanding mean hospital cross highly correlation parent score better assessment background healthy objective management positive version quality report respectively intervention care therapy life total outcome conclusion important difference case individual significantly specific control child significant health group method treatment result disease study,{},{},{},{},{},{}
613,613,656,10.1007/8904_2016_573,27344649.0,specific disorder relationship daily iem economically hypercatabolism factor anxiety essential medically need difficulty risk well disease caregiver demand adulthood life quantitative previous therapy additionally health developmental symptom error support inborn distress encounter qualitative metabolic large psychological metabolism english three japanese child population japan stage social parent school treatment adolescence diet qol particularly rare age future poor healthy statistical nervous subjective quality infant also group socially comprehensive high study even individual presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413451/,abstract,2,hypercatabolism economically socially encounter japanese medically subjective qol japan distress english demand adolescence school psychological qualitative caregiver adulthood nervous anxiety difficulty iem daily additionally statistical comprehensive poor stage previous quantitative presence developmental particularly social essential parent relationship need inborn symptom support infant healthy error quality large future diet rare therapy life metabolism individual risk specific factor population child age metabolic health group high disorder treatment disease study,"{""social"": {""freq"": 1, ""string"": [""stage previous quantitative presence developmental particularly social essential parent relationship need i""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""infant healthy error quality large future diet rare therapy life metabolism i""]}}",{}
614,614,657,10.2337/db14-0783,25024374.0,specific disorder hypoglucagonemic importantly better instead congenital islet despite glucose homeostasis central insensitive moreover control contribute counterregulation severely axis hyperinsulinemia role mouse hyperammonemia paradoxically contribution support result symptomatic hypoglycemic inhibition suppression mutation dehydrogenase signal independent acute child gdhh identification hypoglycemia via glucagon concentration tolerance impaired response appropriately surprisingly transgenic occur lack pharmacologic dependent perifused gtp clamp secretion plasma study insulin acid human similar gdh amino presence mitochondrial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237996/,abstract,0,perifused insensitive hypoglycemic hypoglucagonemic gdhh gdh counterregulation clamp pharmacologic hyperinsulinemia paradoxically hypoglycemia hyperammonemia surprisingly islet glucagon transgenic appropriately axis occur suppression gtp secretion instead severely symptomatic importantly impaired tolerance insulin contribute dehydrogenase mitochondrial contribution homeostasis inhibition signal glucose independent acute dependent central lack presence despite congenital identification better similar mouse support plasma response concentration mutation amino role human specific control acid child disorder result study,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""mouse support plasma response concentration mutation amino role human specific control a""]}}",{},{}
615,615,658,10.3390/jcm6070071,28753922.0,pathogenesis disorder energy oxidative adjunct condition together employed view highlight radical number antioxidant disease status accumulate evidence organ strategy dysfunction defense always clinical protein nitrogen secondary body primary result efficacy metabolic purpose specie generation lipid non detoxify yet stress case although cellular interest certain toxic current damage able review management therapeutic reactive free treatment unchallenged become dna impairment longer either oxygen importance consequence eventually direct patient successful metabolite mitochondrial parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532579/,abstract,0,unchallenged detoxify employed adjunct accumulate eventually defense nitrogen radical oxygen reactive antioxidant longer toxic pathogenesis specie lipid mitochondrial oxidative organ view damage able energy successful certain cellular secondary parameter consequence dna direct stress efficacy impairment dysfunction generation purpose free highlight importance status body metabolite management primary strategy therapeutic evidence current condition non number case review protein metabolic disorder treatment clinical result patient disease,{},{},{},{},{},{}
616,616,659,10.1016/j.nicl.2014.10.006,25379454.0,relationship region difference early positive adult present posterior psychosis subtle course genu matter however subject strategy frontal clinical additionally disturbance particular capsule integrity contrast fraction novel first area significant water internal signal anterior splenium volume local normal current white relevance ass american test fep naart myelin association year education age sample mwf north healthy reading bonferroni episode group pattern study correction volunteer individual myelination statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4218939/,abstract,2,naart fep genu psychosis mwf capsule bonferroni splenium reading posterior myelination subtle frontal anterior myelin north episode integrity volunteer correction internal disturbance relevance american fraction course matter water signal local statistically white volume education additionally contrast particular pattern ass relationship region area normal healthy subject positive strategy association adult novel current difference sample present test individual early age significant group year clinical study,{},{},{},{},{},{}
617,617,660,10.3389/fphys.2019.00360,31105574.0,neurovascular blood activity whether vivo ratio fluctuation time abnormal essential frequency interactive lnaas needed supplementation lnaa investigate clear well nvu disease pku hydroxylase phe characterize numerous unit cannot phenylalanine observed brain move propagate result metabolic effect large data change low level neutral normal current dynamic approach toward model phenylketonuria silico elucidates method therapeutic thereby concentration association physiologic cell neuron abnormally impairment alternative also pah intellectual plasma high study acid highest amino readily,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454150/,abstract,0,propagate nvu needed physiologic neurovascular lnaas elucidates abnormally lnaa fluctuation interactive silico readily neuron neutral characterize unit clear dynamic numerous highest abnormal vivo alternative intellectual supplementation observed pah impairment investigate frequency essential hydroxylase ratio phe normal plasma change therapeutic large brain association concentration activity current pku amino cell phenylketonuria low approach time model phenylalanine blood acid metabolic effect high method data level result disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""cell phenylketonuria low approach time model phenylalanine blood acid metabolic effect h""]}, ""intellectual"": {""freq"": 1, ""string"": [""dynamic numerous highest abnormal vivo alternative intellectual supplementation observed pah impairment i""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""brain association concentration activity current pku amino cell phenylketonuria low approach t""]}}",{},{}
618,618,661,10.1161/JAHA.116.003208,27001967.0,specific whether abnormality early pathway instead oxidative hypertrophic synthase condition tetrahydrobiopterin pressure macrophage supplementation infiltration morphology endothelial disease synthesis backgroundnitric however rather protection resultsmice mouse primary link enzyme protective exogenous effect aortic contrast myocardial cyclohydrolase novel type stress suppression administration cellular wild cardiomyocyte transverse cytokine normal coupling markedly method target overexpression cell replicate constriction genetically inflammatory pathophysiological superoxide nitric function heart chronic adverse previously mechanism unlike mgch gtp multiple prevention conclusion group oxide cardiac similar littermates overload cofactor underwent dominate,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943286/,abstract,1,resultsmice mgch hypertrophic dominate constriction backgroundnitric littermates replicate cardiomyocyte transverse overload myocardial infiltration unlike coupling overexpression macrophage aortic suppression cyclohydrolase protective gtp instead superoxide pathophysiological morphology protection underwent exogenous cytokine endothelial nitric markedly oxide synthase pressure cardiac link oxidative wild genetically cofactor cellular tetrahydrobiopterin inflammatory contrast heart administration supplementation adverse stress abnormality synthesis chronic prevention previously target similar mouse enzyme normal multiple primary pathway mechanism novel conclusion condition cell function early specific type group effect method disease,{},{},"{""pathway"": {""freq"": 1, ""string"": [""similar mouse enzyme normal multiple primary pathway mechanism novel conclusion condition c""]}}",{},{},{}
619,619,662,10.1371/journal.pone.0211935,30785927.0,major potent subsequent disorder herein greater energy conformation pathway among molecule progressive density site molecular basal moreover common derivative neurodegenerative addition disease phe strategy tyr broadly role decline protein compound play gap ache candidate metal enthalpy copper report support result property data receptor theory ability level bind moment functional one donepezil toxic dynamic strong drug ensemble unmodified residue lyp bank therapeutic alzheimer cholinergic slow ligand potential simulation parent free pharmacokinetic simultaneously lumo treatment important electronic active energie docking best future reveal forebrain cognitive analysis also homo sdd adme interaction acetylcholinesterase trp gibbs cerebral dft show affinity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382135/,abstract,0,sdd lyp lumo homo gibbs forebrain enthalpy energie dft cholinergic adme ache acetylcholinesterase ensemble donepezil copper bank unmodified moment docking ligand slow conformation pharmacokinetic basal trp metal derivative decline bind broadly affinity potent theory simultaneously simulation cerebral reveal residue density alzheimer progressive neurodegenerative toxic tyr gap subsequent dynamic candidate strong receptor energy active play molecule property best compound site free greater ability parent functional interaction cognitive support phe addition major drug strategy electronic therapeutic future pathway molecular report important role common potential protein data level disorder treatment analysis result disease,{},{},"{""pathway"": {""freq"": 1, ""string"": [""major drug strategy electronic therapeutic future pathway molecular report important role c""]}}",{},{},{}
620,620,663,10.3945/ajcn.116.135293,27413125.0,blood record greater early profile time across despite www enhance aged behavior frequency mean control classical increase objective traditional significantly glycomacropeptide intake amount phe medical individual executive phenylalanine subject gov rating higher clinical attrs protein contain mol separated symptom food equivalent result efficacy effect inventory term combination adherence crossover type low acceptability clinicaltrials gastrointestinal significant gmp text side stable provide prevent management phenylketonuria stage safety concentration free washout test treatment diet randomized option hunger variant primarily lifelong order function cognitive impairment background natural nct quantity trial ancova conclusion nutritional plasma different fewer acid similar intact small dietary neuropsychological random amino usual safe acceptable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962165/,abstract,11,washout hunger ancova contain usual separated intact acceptability fewer gmp inventory attrs randomized quantity gastrointestinal crossover www rating lifelong random neuropsychological glycomacropeptide safe equivalent clinicaltrials enhance acceptable primarily nct traditional gov executive adherence stable record classical safety option mol text prevent natural stage aged profile nutritional efficacy mean behavior impairment combination free intake greater frequency despite provide order small similar food background symptom cognitive phe objective subject plasma management trial variant increase medical diet dietary concentration amino conclusion term higher function phenylketonuria low test individual time significantly early phenylalanine control blood type acid different protein significant effect treatment clinical result,"{""phenylalanine"": {""freq"": 2, ""string"": [""low test individual time significantly early phenylalanine control blood type acid d""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""variant increase medical diet dietary concentration amino conclusion term higher function p""]}}","{""diet"": {""freq"": 1, ""string"": [""plasma management trial variant increase medical diet dietary concentration amino conclusion t""]}}",{}
621,621,664,10.1007/s13300-019-0633-3,31098941.0,inheritance case account age exon supplementary mutation dominant evidence nuclear investigation herein pediatric recent factor early heterozygous observed autosomal user clinical authorized article criterion usually available conventional frequently secretion report support glucokinase diagnosis beta diagnostic average frequent alpha online hepatocyte novo insulin substitution hypothesis version electronic patient mody diabetes year hnf genetic material gene individual maturity young materialthe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612332/,abstract,1,glucokinase maturity mody secretion beta substitution novo heterozygous inheritance dominant hnf authorized usually conventional insulin alpha hepatocyte young exon nuclear frequent diabetes hypothesis account frequently average autosomal investigation observed pediatric criterion materialthe diagnostic support supplementary user version electronic online recent report evidence mutation material article case available individual early factor diagnosis age gene year genetic clinical patient,{},"{""inheritance"": {""freq"": 1, ""string"": [""mody secretion beta substitution novo heterozygous inheritance dominant hnf authorized usually c""]}, ""autosomal"": {""freq"": 1, ""string"": [""frequent diabetes hypothesis account frequently average autosomal investigation observed pediatric criterion m""]}, ""heterozygous"": {""freq"": 1, ""string"": [""maturity mody secretion beta substitution novo heterozygous inheritance dominant hnf authorized u""]}, ""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
622,622,666,10.1155/2016/2152847,27872841.0,european domestic nine example bonasus milk class region growth single among autozygosity profile time visual selection investigate increase event recent chromosome distribution haplotype examination genomic genotype methodology result length focused specie decrease generation versus immune potentially metabolism area three bos one interest comparative informative identification meat parent polymorphism important address offspring conservation wide dairy within two snp permit homozygous percentage uninterrupted roh estimate ancient taurus function approximately identical quality homozygosity natural program bison genome group high pattern nucleotide human distinct gene number cattle,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107238/,abstract,1,taurus roh cattle bonasus bison autozygosity uninterrupted bos ancient homozygosity domestic conservation permit informative identical focused offspring meat dairy comparative haplotype chromosome homozygous milk length visual snp percentage specie class versus distinct methodology immune examination distribution nucleotide event polymorphism european approximately genotype selection address estimate potentially natural genomic genome decrease profile pattern example generation investigate growth wide parent identification region area program increase quality single recent important function number metabolism time human gene group high result,{},"{""homozygous"": {""freq"": 1, ""string"": [""offspring meat dairy comparative haplotype chromosome homozygous milk length visual snp p""]}}",{},{},{},{}
623,623,667,10.1038/s41467-018-06023-5,30224702.0,phenotypic seven cross mutation wild one architecture growth measure order exhibit map higher using many complicated analysis background epistasis mutant environment also multiple yeast result knockout locus fewer different interaction effect data progeny polymorphism interact cause distinct genetic type respectively individual gene characterize,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141565/,abstract,6,using progeny epistasis yeast interact architecture fewer knockout complicated map exhibit characterize locus phenotypic distinct wild mutant seven polymorphism environment cross growth order interaction background measure multiple cause respectively mutation higher individual type different gene effect genetic data analysis result,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
624,624,668,10.1186/s12916-016-0760-x,27989237.0,subsequent epidemiological conclusionsit tool threat investigation respiratory instead specifically central respond coronavirus severe separate contextual risk inadequate practical reliable begin virus disease traditional ethical infectious discussionthe third however evidence rather place quickly east clinical health bedside global usually improvement science support data epidemic call generation first middle planning useful significant three one step crucial pandemic acute centre problem office current infection syndrome suggestion review approach model day method second resource collection investigator security response network adequately decision care challenge influenza policymakers ebola generally public sample within demonstrate excellence field heart quality research framework matures study barrier deficiency patient inform discipline,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5165716/,abstract,0,pandemic matures influenza ebola coronavirus begin conclusionsit bedside excellence discussionthe contextual security policymakers epidemic respond office adequately threat quickly investigator suggestion discipline east instead inadequate respiratory planning epidemiological middle usually infectious place inform crucial centre ethical practical subsequent virus traditional separate reliable generally barrier demonstrate specifically framework infection network science decision resource acute useful step heart investigation collection global central improvement second generation syndrome problem public field severe support tool day challenge response quality deficiency care evidence current sample approach risk model research review significant health method data clinical patient disease study,{},{},{},{},{},{}
625,625,669,10.1097/MD.0000000000016188,31261556.0,correlation erythrocyte assessment activity pain urease ratio difference tertiary among positive laboratory romania helicobacter without nlr mean control noninvasive significantly establish marker anti higher value leukocyte examination histologic april iga prospective term inexpensive useful area significant case rapid rate infection child epigastric simple rural antibody loss frequent test pylorus year inflammatory find age pediatric gastritis january healthy especially statistical neutrophil hospital aim group histologically sedimentation study whereas patient though even pathologic presence parameter lymphocyte,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616319/,abstract,9,urease sedimentation pylorus nlr histologic helicobacter gastritis iga histologically epigastric romania leukocyte neutrophil lymphocyte erythrocyte pathologic noninvasive inexpensive tertiary april rural pain antibody establish january prospective simple examination frequent anti inflammatory infection statistical useful parameter pediatric mean loss hospital marker rapid presence especially correlation laboratory ratio assessment area aim healthy positive value rate activity term higher difference case test significantly control child age significant group year patient study,{},{},{},{},{},{}
626,626,670,10.1186/s12916-018-1020-z,29530020.0,edition intelligence biological blood chain record whether rct time sub coordination lamb investigate mean source old motor hole docosahexaenoic intercept increase raw material intake caregiver knowledge supplementary beneficial gov interval compliance cognition higher fish questionnaire clinical mixed user pufas brain lunch improvement primary beef purpose chicken effect urine change term mackerel first long type score significant conclusionsthere confidence three variable resultsthere main red pre text hpt norway child registrationclinicaltrials intervention peg point week wppsi model fin analyze kid post development meat backgroundmarine online article test resource important iii electronic fatty year randomized cell version exact meal methodsthe sample two scale wechsler standard function cognitive analysis kindergarten impact consumption nct available bergen trial group december study acid dietary preschool linear random randomly armed total fine hair deviation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848440/,abstract,6,wppsi mackerel lunch lamb intercept hpt fin bergen beef backgroundmarine armed kindergarten hole chicken wechsler pufas kid conclusionsthere rct preschool hair norway raw red fine docosahexaenoic meal edition meat resultsthere registrationclinicaltrials peg exact fish coordination analyze intelligence cognition randomized iii december sub mixed random randomly deviation caregiver methodsthe compliance nct gov beneficial record confidence consumption linear motor interval text post fatty urine resource pre source improvement variable old questionnaire mean purpose investigate point chain intake biological scale week main knowledge score standard cognitive supplementary long trial user change primary version increase electronic online brain impact intervention dietary total material term higher article important cell function sample available test time model blood type acid child significant development group year effect clinical analysis study,"{""urine"": {""freq"": 1, ""string"": [""linear motor interval text post fatty urine resource pre source improvement v""]}, ""hair"": {""freq"": 1, ""string"": [""wechsler pufas kid conclusionsthere rct preschool hair norway raw red fine d""]}}",{},{},{},"{""chicken"": {""freq"": 1, ""string"": [""bergen beef backgroundmarine armed kindergarten hole chicken wechsler pufas kid conclusionsthere r""]}, ""fish"": {""freq"": 1, ""string"": [""edition meat resultsthere registrationclinicaltrials peg exact fish coordination analyze intelligence cognition r""]}}",{}
627,627,671,10.1016/j.intell.2015.11.005,26912939.0,intelligence phenotypic cluster whether difference single across autosomal scotland deleterious biologically molecular together genetics common variation locus clear addition significantly line account quantitative trait range distribution effect large first ability genetic mining low non theme mutation one end text aetiology normal current schizophrenia arid polygenic around many population work disability second qtl test polymorphism association finding two simply variant recessive enriched cage height england cognitive analysis syndromic genome intellectual consortium nucleotide study randomly gene individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725222/,abstract,2,scotland qtl arid england mining cage simply enriched biologically aetiology syndromic polygenic consortium schizophrenia deleterious intelligence height cluster theme randomly locus clear phenotypic line end distribution recessive nucleotide polymorphism trait account text autosomal intellectual genome quantitative second work genetics disability variation ability finding cognitive normal addition range variant large single association molecular current mutation non difference common low test individual significantly population gene effect genetic analysis study,"{""intellectual"": {""freq"": 1, ""string"": [""nucleotide polymorphism trait account text autosomal intellectual genome quantitative second work g""]}}","{""autosomal"": {""freq"": 1, ""string"": [""recessive nucleotide polymorphism trait account text autosomal intellectual genome quantitative second w""]}, ""recessive"": {""freq"": 1, ""string"": [""locus clear phenotypic line end distribution recessive nucleotide polymorphism trait account t""]}, ""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
628,628,672,10.3390/metabo5010140,25738426.0,exciting various specific disorder tool new profile present organic chemical effective noninvasive disease status summary vocs organ much affliction recent distinguish clinical health range compound recovery output body diagnosis air sensor metabolic gaseous detectable aroma useful area detection rapid biomarkers overall point many breath review device technique bio development via potential technology nose treatment electronic promise care particularly wide complex volatile earlier advancement metabolite application effectively field suited analysis lung indicator diagnostics aberrant diagnostic different human yield faster patient individual presence sensitive mixture,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381294/,abstract,0,vocs gaseous affliction nose aroma suited bio aberrant volatile breath air exciting noninvasive distinguish sensor faster detectable output lung advancement indicator recovery mixture diagnostics promise earlier yield device effectively summary organ organic chemical sensitive useful profile compound rapid presence point biomarkers particularly technique wide technology status field overall diagnostic detection various body area metabolite tool application range complex electronic effective recent care present individual new human specific diagnosis review potential different development metabolic health disorder treatment clinical analysis patient disease,"{""breath"": {""freq"": 1, ""string"": [""nose aroma suited bio aberrant volatile breath air exciting noninvasive distinguish s""]}}",{},{},"{""detection"": {""freq"": 1, ""string"": [""wide technology status field overall diagnostic detection various body area metabolite t""]}}",{},{}
629,629,673,10.1016/j.ymgmr.2017.12.003,29326880.0,level significant correlation blood relationship phenylalanine childhood hyperphenylalaninemia measure lifelong anxiety problem teenager fluctuation adolescent standardized phenylketonuria reduce group probably metabolic concentration psychological control stability treatment severity term adherence long pku variability,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758931/,abstract,1,teenager probably fluctuation standardized lifelong reduce psychological anxiety adherence stability variability hyperphenylalaninemia adolescent severity childhood correlation problem relationship measure long concentration pku term phenylketonuria phenylalanine control blood significant metabolic group level treatment,"{""phenylalanine"": {""freq"": 2, ""string"": [""measure long concentration pku term phenylketonuria phenylalanine control blood significant metabolic g""]}}",{},{},{},{},{}
630,630,674,10.1080/14636778.2015.1033052,26217167.0,matter biological determinism public notion discourse one society scientific trait discus biology epigenetics conversation across influence actually health many population increasingly behavior mechanism fastest impact research framework science cut popular genetics belief support expression away practice often epigenetic contrast rapidly human extent language press genetic discipline prominent show deterministic received revolution area,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513352/,abstract,0,received press fastest deterministic determinism belief actually conversation revolution discourse away epigenetics popular cut discipline notion prominent epigenetic rapidly society language extent matter scientific increasingly biology framework trait science contrast behavior genetics influence practice biological public discus area support expression mechanism impact human research population health genetic,{},"{""genetic"": {""freq"": 1, ""string"": [""popular cut discipline notion prominent epigenetic rapidly society language extent m""]}}",{},{},{},{}
631,631,675,10.1038/nrd.2017.226,29217837.0,major specific past new single discus effort targeting heterogeneous interpret variation highlight underlying disease unimpressive pipeline utility decade however recent broader possible clinical analytical efficacy large forward cause first genetic medicine ultimately although three genomics current drug overall discovery review window development thereby potential success treatment precision phase advance earlier mechanistically precise enable mechanism part successfully excitement rapidly technological scepticism patient inform limitation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287751/,abstract,0,unimpressive excitement scepticism targeting mechanistically pipeline interpret enable window broader forward technological rapidly ultimately earlier precise heterogeneous inform successfully underlying success precision genomics analytical limitation past discovery decade utility advance effort phase efficacy variation highlight medicine discus overall possible major cause drug large single recent mechanism current new specific review potential development genetic treatment clinical patient disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
632,632,676,10.1053/j.ajkd.2016.08.029,27865566.0,specific cross beverage blood hour ratio outcomeschange growth factor single early lower duration adult median breakfast glomerular addition increase excretion disease significantly intake egfr bar confirm acr higher value albumin double fibroblast food result effect creatinine urine change period backgroundlittle rate short size end woman point intervention week product stage baseline sex collection diet commercially sample albuminuria additive chronic resultsmean interventionhigher background available consumption min filtration plasma study blind phosphorus patient men iqr kidney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5263092/,abstract,12,outcomeschange interventionhigher backgroundlittle acr albuminuria resultsmean egfr breakfast glomerular bar phosphorus filtration commercially iqr albumin creatinine men additive confirm excretion fibroblast min beverage kidney duration blind hour sex double end consumption baseline urine stage median collection size woman short cross chronic point intake product growth week period ratio food background addition plasma change value increase lower single adult diet intervention rate higher sample available significantly early specific factor blood effect result patient disease study,"{""urine"": {""freq"": 1, ""string"": [""hour sex double end consumption baseline urine stage median collection size w""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""change value increase lower single adult diet intervention rate higher sample a""]}}",{}
633,633,678,10.1371/journal.pgen.1006977,28873402.0,childbirth specific interestingly cross activity sectional factor single examine difficult socioeconomic modify unrelated caucasian physical frequency due locus risk smoking well status intake respectively amount deduce sleeping however weekly rather obesity previous strongest health double body environment alone effect data experiment genetic score regression significant female measure pace biobank fully highly many mental used causal characterise resource habit interact association hundred lifestyle bmi wide mass snp estimate ancestry analysis environmental mechanism index consumption also fto group interaction pattern study deprivation alcohol dietary gsbmi linear participant gene individual total usual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600404/,abstract,4,sleeping gsbmi childbirth fto deduce characterise strongest weekly pace biobank usual modify ancestry interact socioeconomic smoking deprivation caucasian habit alcohol interestingly used unrelated causal bmi lifestyle snp locus fully experiment examine double consumption linear obesity resource difficult sectional estimate mental previous index female environment physical pattern regression cross environmental intake highly frequency wide status score interaction participant body measure mass single association mechanism respectively dietary total activity individual risk specific factor significant health gene group effect genetic data analysis study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
634,634,679,10.1016/j.jmoldx.2015.11.005,26847993.0,lengthy specific blood exon single early cystic time positive across undetected publicly condition molecular due expert common cost testing effective turnaround cfseq validation disease sequence sanger relevant unique screening compendium value additionally complete genomic fibrosis thus data specimen design little generation novel genetic type detection significant integrates rapid mutation software sensitivity processing replace able management confirmatory day method impractical multiplex assay insertion consecutive predictive robust amplification sample variant newborn screen spot definitive poly throughput next dna deletion analysis previously concordance tract available relatively polymorphic comprehensive high study nucleotide sequencing accurately gene highly sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816703/,abstract,3,lengthy impractical compendium cfseq undetected turnaround replace poly integrates publicly polymorphic multiplex definitive concordance insertion consecutive confirmatory throughput amplification accurately specimen sanger tract cystic processing software fibrosis deletion validation exon screen predictive expert complete robust able sensitive little nucleotide relatively unique additionally comprehensive sequence genomic dna assay sensitivity rapid generation cost sequencing highly spot previously relevant design testing detection screening management day positive value variant effective single molecular novel newborn mutation condition common sample available time early specific blood type significant gene high genetic method data analysis disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""specific blood type significant gene high genetic method data analysis disease s""]}}",{},"{""detection"": {""freq"": 1, ""string"": [""highly spot previously relevant design testing detection screening management day positive v""]}, ""newborn"": {""freq"": 1, ""string"": [""value variant effective single molecular novel newborn mutation condition common sample a""]}, ""screening"": {""freq"": 1, ""string"": [""spot previously relevant design testing detection screening management day positive value v""]}}",{},{}
635,635,680,10.1186/s13023-018-0950-z,30606267.0,specific interpretation allocation elaborate final across adult british acceptance paediatric initial without statement choice clear practical majority backgroundin disease month pku calculation measurement phenylalanine questionnaire respondent protein health guidance food methodology methodologyin metabolic dietitian guideline adherence low controversial bimdg variable one society advice discussion label divided phenylketonuria conclusionsthe national free harmonise topic treatment delphi response diet phase initially maternal consensus definition resultsthe dietetic professional scale disparity facilitator systematically round aim multiple general exchange group different practice part dietary patient,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318866/,abstract,12,methodologyin harmonise facilitator bimdg british round divided disparity dietetic elaborate delphi allocation label statement acceptance advice initially dietitian controversial calculation paediatric final guidance backgroundin definition topic respondent exchange systematically interpretation consensus practical discussion clear society adherence choice conclusionsthe methodology resultsthe initial guideline majority phase professional maternal variable questionnaire national free measurement practice general scale food aim month multiple response adult diet dietary pku phenylketonuria low phenylalanine specific different protein metabolic health group treatment patient disease,"{""phenylalanine"": {""freq"": 2, ""string"": [""adult diet dietary pku phenylketonuria low phenylalanine specific different protein metabolic h""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""food aim month multiple response adult diet dietary pku phenylketonuria low p""]}}",{}
636,636,681,10.3389/fnins.2017.00248,28579939.0,specific activity lead discus early organism heat present adult lifespan throughout necessary synapsis without behavior efficient onset snare client break deficit neurodegenerative well preservation disease rme assembly neuronal axonal dnajs related synuclein presynaptic uncoating distance form maintain neurodegeneration endosomes role protein gtpase demonstrating brain conserved body endocytic lipofuscinosis synapse support familial endocytosis result link transport significance fourth long genetic reliance string cysteine bind four rate three mutation end local normal aggregation structure proper terminal clathrin prevent dnajc already review maintenance neurotransmission compartment proteostasis auxilin thereby synaptic system shock delivery nerve constitute preserve vesicle address cell aggregate terminus disaggregase process cognate hence hsc csp regeneration exo chaperone interacts congruent nervous cage imbalance parkinson exocytosis mechanism importance hsp interaction high domain alpha regulating organelle dnajas newly complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437171/,abstract,3,uncoating string snare rme proteostasis presynaptic lipofuscinosis exocytosis exo endosomes endocytosis endocytic dnajs dnajas disaggregase csp cognate clathrin auxilin synuclein hsc gtpase client axonal vesicle reliance preserve interacts congruent synapsis shock hsp fourth dnajc constitute conserved cage break terminus organelle neurodegeneration synapse preservation heat maintain imbalance regeneration neurotransmission nerve parkinson distance cysteine lifespan compartment synaptic terminal regulating familial bind chaperone newly demonstrating aggregate proper maintenance assembly aggregation organism neurodegenerative transport neuronal alpha nervous link efficient significance local end domain prevent address necessary delivery deficit behavior lead onset structure importance related discus interaction body process form support normal long complex brain adult mechanism rate activity mutation role cell present early specific review protein high genetic result disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
637,637,682,10.1016/j.mce.2016.08.029,27555292.0,major experimental biological epidemiologic cross unbiased activity mitigates investigation factor pathway congenital technical defect modify adult despite necessary insight implicates mechanistic risk physiology old principle exercise disease significantly decade relevant however quantitative intent clinical define seek mouse ideal therefore embryo reciprocal basis cause strikingly fetal genetic undefined mortality young formidable transplant mutation nkx main one oocyte map ovarian notoriously child hurdle intervention approach target via face polymorphism mother modifier incidence offspring maternal original strain age progress causative efficiently correlate determine serendipitously heart groundwork analysis background voluntary alternative broad also trial foundation prevention group interaction study human even gene individual total complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014674/,abstract,0,serendipitously mitigates undefined reciprocal notoriously nkx intent implicates formidable unbiased seek groundwork strikingly voluntary hurdle oocyte modify ovarian offspring ideal epidemiologic transplant modifier efficiently define strain original map exercise embryo causative physiology face foundation correlate technical mechanistic progress broad principle young fetal polymorphism mother decade experimental alternative necessary heart mortality investigation basis maternal insight quantitative incidence old cross prevention defect biological relevant determine despite congenital main target interaction mouse background trial major complex cause pathway adult intervention total activity mutation approach individual significantly human risk factor child age gene group genetic clinical analysis disease study,{},"{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""mouse background trial major complex cause pathway adult intervention total activity m""]}}",{},{},{}
638,638,683,10.1186/s12940-015-0049-0,26276052.0,immediately specific rmssd blood summer hour class ratio adult location inflammation microenvironmental organic pressure frequency diverse source smoking increase month material measurement roadway related supplementary marker methodsa unique endpoint profound user clinical mixed health conclusionssmall resultsminimal effect change design decrease crossover low diesel young non area rate three measure emission acute systemic population pollutant model backgroundprevious ass exposure hrv concentration online article electronic association carbon version materialthe inflammatory two along vast nitric traffic healthy pollution function heart adverse prior characteristic cardiovascular intermittent available lung array multiple cardiopulmonary group high study oxide human black small participant elemental variability air mixture,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537534/,abstract,2,roadway rmssd resultsminimal microenvironmental diesel conclusionssmall summer elemental backgroundprevious traffic hrv cardiopulmonary pollution pollutant air vast intermittent black endpoint smoking carbon array location immediately profound lung emission crossover mixture mixed nitric oxide pressure methodsa class systemic inflammation hour young variability organic diverse cardiovascular prior unique inflammatory acute heart decrease adverse source marker exposure measurement materialthe frequency design ass related characteristic ratio small participant area measure month supplementary healthy user change multiple version increase electronic online association adult rate concentration material non article function low available human model specific blood population health group effect high clinical study,{},{},{},{},{},{}
639,639,684,10.3389/fphar.2018.00951,30429786.0,blood inconclusive new registration lower several adult onset injury pro severe state favor regenerative immunomodulatory number isrct objective aes event anti higher clinical ischemia range top sofa double angiogenic secondary primary result annually thus protective effect cause prospective term epithelialization first medication mortality score art healing saes level significant erythropoietin graft one isrctn morbidity placebo per hypoxia outcome day therapeutic minority treatment germany care challenge option epo inflammatory every still protocol two reveal specialized million burn demonstrate influence cytoprotective obligatory reduced eudract analysis adverse transplantation trial receive group study skin blind faster center patient statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220439/,abstract,8,sofa saes receive isrct epo epithelialization cytoprotective burn immunomodulatory healing eudract erythropoietin obligatory isrctn ischemia angiogenic aes regenerative graft annually hypoxia favor specialized minority inconclusive faster art protective germany registration reveal pro skin injury transplantation blind placebo million medication prospective double demonstrate reduced statistically anti option event protocol morbidity inflammatory secondary center mortality adverse onset influence score severe objective state day trial challenge range primary cause therapeutic lower adult care outcome term higher number new blood significant group effect level treatment clinical analysis result patient study,"{""skin"": {""freq"": 1, ""string"": [""art protective germany registration reveal pro skin injury transplantation blind placebo m""]}}",{},{},{},{},{}
640,640,685,10.1021/jacs.6b01563,27145334.0,blood disorder activity lead factor present site elevated sax together state risk control regulatory activation way elusive solution hydroxylase demonstration angle titration phenylalanine extensively allosteric crystal dimerization structural substrate support movement result enzyme metabolic change first rat level commonly crystallography itc inability although catalytic independent step pre structure tyrosine model phenylketonuria method mental calorimetry tetramer disability ray active component isothermal catabolism pterin pheh dependent analysis allostery mechanism efa high domain stabilizes acid small mammalian conversion powerful amino complex chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896396/,abstract,0,stabilizes efa allostery tetramer pheh itc sax isothermal titration crystallography calorimetry pterin elusive dimerization catabolism angle demonstration inability ray allosteric extensively crystal conversion mammalian catalytic powerful movement substrate activation commonly solution rat elevated structural active independent domain chromatography step way regulatory pre mental component dependent site lead disability structure tyrosine hydroxylase small support enzyme state change complex mechanism activity amino phenylketonuria present risk model phenylalanine control factor blood acid metabolic high method level disorder analysis result,"{""phenylalanine"": {""freq"": 2, ""string"": [""activity amino phenylketonuria present risk model phenylalanine control factor blood acid m""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""enzyme state change complex mechanism activity amino phenylketonuria present risk model p""]}}",{},{}
641,641,686,10.3390/ijms17071167,27447622.0,biological considerable rise investigation iem factor early pathway molecule profile time molecular characterization difficulty principle disease biochemical related offer era however recent clinical procedure usually conventional error inborn diagnosis metabolic overlap genetic metabolism medicine level mandatory crucial diversity overall comprehensively review ass technology system holistic test treatment precision sequential incidence address rare application series omic basic environmental metabolomics group different successful individual metabolite explains,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964538/,abstract,1,omic explains sequential rise overlap holistic comprehensively mandatory era diversity series offer usually conventional crucial characterization principle considerable basic precision difficulty successful metabolomics iem procedure molecule address investigation profile incidence environmental biological medicine ass related biochemical technology overall inborn metabolite application error pathway molecular recent rare metabolism test individual time early factor diagnosis review different metabolic group genetic level treatment clinical disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""technology overall inborn metabolite application error pathway molecular recent rare metabolism t""]}}",{},{},{}
642,642,687,10.1038/tp.2017.106,28608853.0,pathogenesis specific tool assessment cross disorder new fundamental information effort world platform light view genetics subsequently source old classical newer concept disease paradigm medical extraordinary advent offer era connect rather trait today concerted clinical therapy disciplinary real integrative symptom genomic possibility translate diagnosis integrity computational generation type genetic medicine psychiatry level emphasize concurrently personalized current starting structure provide disentangle many approach method mental describe intricacy post propose potential technology system network challenge option sophisticated operating bring microarrays advance future within nascent opportunity application relation psychiatric field next currently background paper research regardless diagnostics general diagnostic practice entity sequencing rooted barrier patient beyond gene individual complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537634/,abstract,0,starting rooted intricacy personalized nascent extraordinary concurrently concerted microarrays disentangle disciplinary connect bring sophisticated psychiatry newer translate emphasize today advent operating integrative integrity regardless entity era paradigm diagnostics fundamental offer computational subsequently pathogenesis light real psychiatric propose view barrier classical possibility platform option relation concept trait world opportunity network post advance effort mental genomic source old genetics cross generation structure sequencing practice currently medicine general provide paper technology field diagnostic assessment background symptom tool application challenge complex medical future therapy information current approach individual new specific type diagnosis research potential gene genetic method level disorder clinical patient disease,"{""psychiatric"": {""freq"": 1, ""string"": [""offer computational subsequently pathogenesis light real psychiatric propose view barrier classical p""]}}","{""genetic"": {""freq"": 1, ""string"": [""specific type diagnosis research potential gene genetic method level disorder clinical p""]}}",{},{},{},{}
643,643,688,10.1172/JCI90327,28394260.0,correlation worldwide biopsy activity factor context positive glycolysis together frequency control effective finally disease respectively murine transcription cancer crosstalk ppar pharmacological observed tumorigenesis clinical role mouse putative lipogenesis thus metabolic phosphorylates hepatocyte epidemic atlas genetic inhibition malignancy suppression nuclear adipocyte hepatic preclinical steatosis liver model therapeutic target expression unknown hnf signaling therapeutically challenge regulator aerobic reveal akt differentiation adaptation protumoral interaction study heterogeneity master human highest identifying,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409083/,abstract,0,protumoral phosphorylates lipogenesis identifying adipocyte steatosis ppar atlas akt aerobic crosstalk tumorigenesis therapeutically master epidemic malignancy glycolysis biopsy suppression preclinical murine adaptation signaling reveal putative hnf regulator hepatic differentiation hepatocyte worldwide transcription nuclear pharmacological inhibition highest heterogeneity unknown finally observed cancer liver context correlation frequency target interaction mouse challenge expression positive therapeutic effective respectively activity role human model control factor metabolic genetic clinical disease study,{},"{""genetic"": {""freq"": 1, ""string"": []}, ""heterogeneity"": {""freq"": 1, ""string"": [""worldwide transcription nuclear pharmacological inhibition highest heterogeneity unknown finally observed cancer l""]}}",{},{},{},{}
644,644,689,10.1038/s41398-019-0477-7,31028242.0,dentate disorder whether herein oml specifically positive segment adult complexity density condition molecular pathology physiology differentially number addition well disease shorter plasticity whose neuronal neuroplasticity animal subject granular brain layer structural depression inner effect change little immature term medial remodeling stress dcx although suppression stressful outer tree dynamic neuroscience sublayer many doublecortin alzheimer neurogenesis dendritic compartment development stage neuroplastic contrary phase cell maturation neuron newborn demonstrate psychiatric chronic longer impact different precipitant study whereas distinct arbor hippocampus gyrus complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486609/,abstract,0,sublayer precipitant oml neuroplastic doublecortin dcx arbor outer remodeling neuroscience neuroplasticity granular dentate neurogenesis stressful shorter immature inner gyrus dendritic medial contrary tree segment maturation plasticity compartment suppression layer hippocampus neuron differentially longer physiology density complexity alzheimer depression neuronal psychiatric pathology dynamic distinct demonstrate specifically little structural phase stage stress animal chronic addition subject change complex positive brain molecular adult impact newborn term condition cell number different development effect disorder disease study,"{""psychiatric"": {""freq"": 1, ""string"": [""physiology density complexity alzheimer depression neuronal psychiatric pathology dynamic distinct demonstrate s""]}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""complex positive brain molecular adult impact newborn term condition cell number d""]}}",{},{}
645,645,690,10.1007/s11910-018-0890-y,30291526.0,resonance disorder tool findingsseveral lower time molecular supportive huntingtin neurodegenerative concept validation evaluate disease pipeline neuroimaging marker recent clinical therapy protein brain alone mutant primary structural support diagnosis efficacy like purpose change tomography combination potentially useful level alter biomarkers progression discussion emission huntington preclinical others sensitivity syndrome evaluation outcome review aid emphasis ass potential article treatment finding primarily order mri summarynew differentiation limited goal field either fluorodeoxyglucose reduce monitor trial diagnostic magnetic positron mhtt pharmacodynamic show,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182636/,abstract,0,mhtt huntingtin fluorodeoxyglucose summarynew findingsseveral huntington pharmacodynamic supportive neuroimaging positron pipeline preclinical alter aid monitor tomography emission mri emphasis reduce neurodegenerative differentiation resonance primarily discussion validation progression mutant goal magnetic concept structural useful potentially evaluate efficacy sensitivity marker limited combination purpose biomarkers syndrome evaluation ass like order field diagnostic finding support tool trial change primary lower brain molecular recent therapy outcome article time diagnosis review potential protein level disorder treatment clinical disease,{},{},{},{},{},{}
646,646,691,10.1016/j.ymgmr.2016.08.005,27595068.0,blood allowance daily milk ratio rda energy composition lower adult nutrient aged weight need magnesium improve classical addition urinary resumption well vitamin pku intake respectively phenylalanine evidence adequate possible relative biotin therapy protein symptom body environment equivalent food cause calorie low level microelements although hydroxyisovaleric requirement japanese problem normal rule evaluation review phenylketonuria day iodine development japan lifetime free concentration habit carbohydrate year diet fat excess age continuously selenium hyperphenylalaninemia make approximately natural nutritional high study substitute acid dietary zinc neuropsychological phosphorus patient psychosocial amino preparation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995528/,abstract,1,resumption microelements hydroxyisovaleric rda phosphorus allowance japanese biotin make magnesium japan iodine rule calorie selenium habit excess substitute continuously zinc lifetime psychosocial carbohydrate neuropsychological requirement equivalent preparation milk fat adequate urinary improve vitamin hyperphenylalaninemia composition classical nutrient energy daily approximately relative natural aged environment nutritional weight free intake evaluation problem ratio need possible body food symptom normal addition day cause lower adult diet respectively dietary therapy concentration evidence pku amino phenylketonuria low phenylalanine blood review acid protein age development year high level patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""concentration evidence pku amino phenylketonuria low phenylalanine blood review acid protein a""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""respectively dietary therapy concentration evidence pku amino phenylketonuria low phenylalanine blood r""]}}","{""diet"": {""freq"": 1, ""string"": [""normal addition day cause lower adult diet respectively dietary therapy concentration e""]}}",{}
647,647,692,10.1186/s13023-018-0858-7,29973227.0,lower ammonia profile adult site throughout reaction elevated immunogenicity open common neuropsychiatric neurocognitive mean injection severity extension persistent hydroxylase pku respectively intake material phe characterize supplementary phenylalanine subject gov event reduction moderate unaffected user clinical attrs protein mol symptom efficacy mild cause term ongoing long type investigational level clinicaltrials rate three methodspal one per label text dose stable registrationclinicaltrials population week phenylketonuria day erythema headache parent safety concentration baseline online article treatment person electronic associated year manageable phase version arthralgia backgrounddeficiency adjustment standard limited resultsmean meaningful adverse available nct trial plasma lyase june study pegvaliase conclusionspegvaliase similar agent participant show deviation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031112/,abstract,7,methodspal investigational conclusionspegvaliase backgrounddeficiency arthralgia erythema resultsmean manageable pegvaliase unaffected headache persistent label immunogenicity extension registrationclinicaltrials adjustment neuropsychiatric lyase meaningful attrs ongoing neurocognitive june ammonia person clinicaltrials deviation characterize injection nct gov stable agent safety mol moderate open mild event elevated severity baseline dose text associated phase reaction adverse profile site efficacy mean reduction limited intake parent week hydroxylase standard similar participant symptom phe supplementary subject long plasma day trial user cause version electronic online lower adult respectively rate concentration pku material term article common phenylketonuria available phenylalanine type population protein year level treatment clinical study,"{""phenylalanine"": {""freq"": 2, ""string"": [""material term article common phenylketonuria available phenylalanine type population protein year l""]}}",{},{},{},{},{}
648,648,694,10.1186/s12955-014-0151-y,25649344.0,rare disorder family classify among osteogenesis musculoskeletal child duchenne imperfecta aim impact literature summarize system achondroplasia substantial frequent muscular dystrophy genetic healthcare severely non medical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332447/,abstract,0,osteogenesis imperfecta achondroplasia duchenne musculoskeletal classify muscular dystrophy summarize severely substantial frequent healthcare literature aim medical rare family impact non child genetic disorder,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
649,649,695,10.1021/acs.analchem.5b00893,25955132.0,specific blood activity factor content time demonstrates initial substantially without need safer control appeal measurement intra quantitative protein spotted degradation card result store stability specimen resistant quantification inhibition use measure volume analyte format wet normalization bche product device method via adduct serum unknown collection nerve assay robust sample spot unspotted butyrylcholinesterase limited reduced analysis previously sarin matrix easier also decreased plasma ellman agent accurately variability total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517423/,abstract,0,unspotted spotted sarin ellman butyrylcholinesterase bche adduct wet safer appeal decreased normalization easier store format resistant nerve analyte intra substantially demonstrates card accurately specimen matrix quantification device degradation stability variability inhibition initial reduced robust agent volume unknown content collection quantitative serum assay limited measurement product spot previously need measure plasma use total activity sample time specific control factor blood protein method analysis result,{},{},{},{},{},{}
650,650,696,,30936770.0,treatable disorder within spectrum marker biochemistry iem new pediatric neurodevelopmental recent phenotype screening affect progressive molecule involved neurodegeneration defect neurologic nervous clinical present description chronic continuum many feature constantly onset intermittent neurodevelopment molecular technique paper also error frequently inborn general system comprehensive metabolic fact presentation frequent diverse antenatal neurodegenerative contrast considerably severity kind well small late disease far metabolism list complex particularly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436954/,abstract,0,constantly neurodegeneration neurodevelopment continuum intermittent biochemistry antenatal considerably kind neurologic description fact treatable progressive neurodegenerative list far nervous involved neurodevelopmental diverse presentation frequent late affect severity iem frequently molecule comprehensive contrast pediatric feature marker onset chronic particularly defect technique general paper phenotype small spectrum inborn screening complex error molecular recent present metabolism new metabolic disorder clinical disease,{},{},{},"{""screening"": {""freq"": 1, ""string"": [""general paper phenotype small spectrum inborn screening complex error molecular recent p""]}}",{},{}
651,651,697,10.1186/1477-7827-12-108,25420886.0,palindromic whether herein discus examine country germline reproductive modification efficient finger moreover regulatory repeat disease status primate embryonic material activator ethical issue transcription supplementary editing user clinical preventive doi integrated fertilization like crispr far genetic medicine international non effector although rapid short current considers zygote talens many feasible social potential technology online landscape article electronic address cell version materialthe still likely engineering setting authorized zfns regularly stem vitro available genome expected biotechnology human zinc mammalian even correction gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251934/,abstract,0,zygote expected zfns talens fertilization considers palindromic regularly setting primate editing biotechnology germline finger effector activator integrated crispr engineering landscape zinc embryonic repeat preventive mammalian reproductive correction authorized stem doi feasible ethical far modification examine transcription efficient vitro international address regulatory genome short likely rapid materialthe social medicine like issue technology discus status country supplementary user version electronic online current material non article cell available human potential gene genetic clinical disease,"{""social"": {""freq"": 1, ""string"": [""regulatory genome short likely rapid materialthe social medicine like issue technology d""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
652,652,698,10.1097/MD.0000000000009801,29465562.0,male disorder progressive disorientation visual concern onset manifest neuropsychiatric old lesion vitamin disease pku neurological folate mthfr adulthood phenylalanine childhood spatial follow irregular heterozygous dysfunction clinical protein homocysteinmia homocysteine disturbance improvement symptom diagnosis metabolic kind late period level case leukodystrophy synergistically mutation one short involvement normal outcome intervention many elsewhere phenylketonuria day system serum manifestation hyperhomocysteinemia year diet directly original homozygous along irreversible especially function nervous cobalamine cognitive impairment analysis pathophysiology head also pah infancy rationale similar lesson patient asian another gene resolution,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842012/,abstract,2,mthfr homocysteinmia disorientation cobalamine hyperhomocysteinemia synergistically irregular manifest leukodystrophy folate homocysteine kind rationale asian neuropsychiatric lesson original lesion irreversible spatial heterozygous infancy head disturbance homozygous progressive pathophysiology visual adulthood involvement resolution nervous manifestation vitamin late directly neurological concern follow short improvement childhood serum old pah impairment dysfunction onset especially male period similar symptom cognitive normal day diet intervention mutation pku outcome function phenylketonuria case phenylalanine diagnosis protein metabolic gene year level disorder clinical analysis patient disease,"{""phenylalanine"": {""freq"": 2, ""string"": [""mutation pku outcome function phenylketonuria case phenylalanine diagnosis protein metabolic gene y""]}, ""neurological"": {""freq"": 1, ""string"": [""resolution nervous manifestation vitamin late directly neurological concern follow short improvement c""]}}","{""homozygous"": {""freq"": 1, ""string"": [""irreversible spatial heterozygous infancy head disturbance homozygous progressive pathophysiology visual adulthood i""]}, ""heterozygous"": {""freq"": 1, ""string"": [""neuropsychiatric lesson original lesion irreversible spatial heterozygous infancy head disturbance homozygous p""]}}",{},{},"{""diet"": {""freq"": 1, ""string"": [""period similar symptom cognitive normal day diet intervention mutation pku outcome f""]}}",{}
653,653,699,10.1186/s12884-019-2278-7,30991967.0,elicit example search class new content information dce across country preference programme condition choice literature subsequently common investigate risk testing eligible backgroundmany logit pregnant demand trade offer methodsa baby screening differ driver commissioner respondent support narrative analytical diagnosis antenatal data design term experiment miscarriage conclusionthere worst commonly one certain database october woman relevance population review model aid method development potential participation europe treatment ten key electronic best incorporation systematic overview sophisticated earlier dces two newborn north professional conditional comparison standard systematically provision analysis discrete unborn popular identify america different study heterogeneity technological extent latent inform accuracy healthcare total australia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469127/,abstract,2,unborn logit dces dce commissioner elicit worst miscarriage discrete conclusionthere backgroundmany sophisticated trade narrative latent differ popular driver conditional antenatal incorporation october america australia north europe eligible aid technological demand participation provision preference respondent systematically earlier offer subsequently baby programme inform relevance pregnant methodsa class experiment commonly extent choice identify overview analytical heterogeneity certain healthcare accuracy search systematic content best professional woman example comparison investigate database design testing country standard literature support screening key electronic information total newborn term condition common new risk model diagnosis population review potential different development method data treatment analysis study,{},"{""heterogeneity"": {""freq"": 1, ""string"": [""commonly extent choice identify overview analytical heterogeneity certain healthcare accuracy search s""]}}",{},"{""newborn"": {""freq"": 1, ""string"": [""support screening key electronic information total newborn term condition common new r""]}, ""screening"": {""freq"": 1, ""string"": [""design testing country standard literature support screening key electronic information total n""]}}",{},{}
654,654,700,10.1186/s13073-014-0087-1,25473426.0,experimental bioinformatics fundamental discus information several across algorithm molecular genetics variation mechanistic polyphen source hypothesis validation disease sequence biochemical cannot possible confirm follow variety role play result change computational experiment novel sift use functional main interpreting phenotype gold current prioritizing review approach technique coding ass development important wide downstream variant million standard responsible goal currently widely also genome identify different study human inform limitation individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254438/,abstract,1,sift interpreting polyphen prioritizing coding gold bioinformatics confirm fundamental computational downstream mechanistic algorithm inform million experiment validation responsible identify variety limitation widely goal hypothesis experimental play follow sequence genome source genetics variation currently technique wide ass functional main biochemical phenotype discus standard possible change variant molecular use novel information current important role approach individual human review different development result disease study,{},{},{},{},{},{}
655,655,701,10.1186/s12887-019-1421-y,30736757.0,disorder cross record chain iem sectional studied region information time across country present attributable aged corresponding frequency literature iems aromatic ministry material characterize related supplementary sim backgroundthe sudden user health west error inborn metabolic live data date branched predominant south first icd metabolism mortality one least interest death code per resultsfrom population descriptive die system conclusionsthis unexpectedly online article carbohydrate electronic fatty associated year northeast version materialthe brazil age north prevalence birth series analysis available infant different study acid center amino brazilian number sudi,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367785/,abstract,11,sudi sim die icd unexpectedly sudden resultsfrom northeast corresponding ministry west code branched live attributable north predominant brazilian south carbohydrate iems brazil conclusionsthis studied series descriptive aromatic characterize backgroundthe record iem fatty date death sectional associated center mortality aged cross chain materialthe frequency related prevalence birth country region literature inborn infant supplementary user version electronic error online information material amino article number present available metabolism time population acid different age metabolic health year data disorder analysis study,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""version electronic error online information material amino article number present available m""]}}",{},{}
656,656,703,10.3389/fmolb.2018.00029,29682508.0,major biological quench anthranilate past antimicrobial pathway among phenylpropanoid organism gut several chorismate synthase biosynthesis host apart aromatic radical enzymatic addition well synthesis numerous name subset animal beneficial phenylalanine resident microflora variety integral role health protein compound coa brain secondary therefore primary structural degradation bacteria kynurenine enzyme metabolic novo obtain palette specie coloration type metabolism plant transmission mediate functional three signal biosynthetic microbe current others tyrosine aaa intervention machinery review tautomerase pathogen mutase polymer emphasis reactive via development target potential dehydratase important key iii hormone pigment herbicide delineates diet aryllactate catabolism harmful vast dopachrome involved responsible nervous shikimate antibiotic aspect aminotransferase posse tryptophan oxygen also general transferase interaction monoamine acid amino anabolic metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897657/,abstract,0,tautomerase shikimate quench palette dopachrome chorismate aryllactate anthranilate transferase pigment phenylpropanoid microflora machinery coloration anabolic herbicide delineates dehydratase harmful aminotransferase kynurenine catabolism aaa mutase integral biosynthetic vast antimicrobial microbe resident radical posse polymer mediate apart pathogen antibiotic obtain monoamine plant oxygen host gut reactive transmission novo iii emphasis enzymatic organism bacteria aromatic coa biosynthesis tryptophan synthase subset specie degradation nervous responsible numerous beneficial involved hormone signal variety past structural aspect secondary compound animal synthesis tyrosine biological general functional target interaction metabolite enzyme addition major primary key pathway brain diet intervention current amino important role metabolism phenylalanine type review acid potential protein development metabolic health,"{""phenylalanine"": {""freq"": 2, ""string"": [""intervention current amino important role metabolism phenylalanine type review acid potential p""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""metabolite enzyme addition major primary key pathway brain diet intervention current a""]}}","{""amino"": {""freq"": 1, ""string"": [""key pathway brain diet intervention current amino important role metabolism phenylalanine t""]}}","{""diet"": {""freq"": 1, ""string"": [""addition major primary key pathway brain diet intervention current amino important r""]}}",{}
657,657,704,10.1186/s13023-014-0159-8,25344299.0,considerable specific disorder assessment threat sparse iem syrup difference single methodological factor lower effort affect warrant hrqol present acidurias selection intense enhance central organic risk effective backgroundin well disease ucd medical reviewer decade however equal worse life pharmacological recent lacking tyr adaptive higher always health inconsistent consistent procedure crisis therefore error inborn resultseleven diagnosis sequela metabolic psychological data urine date term furthermore intoxication long type planning metabolism extraction consideration variable independent step measure tyrosinemia methodsrelevant others database evaluation outcome intervention population review inclusion approach social system consequently viewpoint behavioural article topic treatment urea maple strict overview norm still two progress dietetic adjustment mostly standard nervous psychiatric msud systematically quality cognitive criterion either research available keywords group cycle different study patient psychosocial cns caregiver,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219016/,abstract,1,resultseleven methodsrelevant viewpoint ucd norm lacking sparse intense reviewer msud dietetic intoxication worse warrant threat acidurias sequela methodological hrqol cns tyrosinemia maple inconsistent syrup equal crisis adjustment behavioural psychosocial planning backgroundin strict topic adaptive systematically urea extraction psychological enhance consequently tyr progress caregiver psychiatric nervous considerable keywords organic pharmacological overview consideration affect iem decade cycle procedure independent selection inclusion date urine effort step central consistent variable criterion furthermore database evaluation social standard assessment inborn cognitive measure long error quality effective medical lower single recent intervention life outcome term higher article difference approach present available metabolism risk specific factor type diagnosis research population review different metabolic health group data disorder treatment patient disease study,"{""urine"": {""freq"": 1, ""string"": [""cycle procedure independent selection inclusion date urine effort step central consistent v""]}, ""social"": {""freq"": 1, ""string"": [""syrup equal crisis adjustment behavioural psychosocial planning backgroundin strict topic a"", ""consistent variable criterion furthermore database evaluation social standard assessment inborn cognitive m""]}, ""psychiatric"": {""freq"": 1, ""string"": [""psychological enhance consequently tyr progress caregiver psychiatric nervous considerable keywords organic p""]}}",{},{},{},{},{}
658,658,705,10.1186/s12967-015-0720-9,26572608.0,specific activity better discus information context technical specifically country world author muslim frequency literature geographic testing experience well disease ethical opinion arab issue consanguinity relevant realize perspective focus project particular genomic contribution saudi debate diagnosis etc date guideline thousand genetic medicine ultimately area discussion implementation structure relevance population regulation accelerate roll national social qatar article treatment hundred sample legal professional gulf comparison series field analysis aspect aim impact also prevention general conclusion arabia islamic sequencing advantage,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647661/,abstract,1,realize qatar muslim islamic gulf roll arab accelerate arabia saudi geographic consanguinity debate opinion legal thousand ultimately series technical relevance ethical project author discussion contribution advantage specifically guideline aspect world perspective date experience genomic regulation professional particular implementation focus comparison national context structure sequencing prevention social frequency relevant medicine general issue discus field testing country better literature area aim impact information activity conclusion article sample specific diagnosis population genetic treatment analysis disease,"{""social"": {""freq"": 1, ""string"": [""comparison national context structure sequencing prevention social frequency relevant medicine general i""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
659,659,706,10.1007/s12264-017-0152-z,28667479.0,eliminates tool pain activity sensory physiological new vivo pathway molecule analgesic abnormal spr present concern selection caucasian attempt without causality tetrahydrobiopterin action genetics macrophage common state biomarker reliable finally sepiapterin inhibited synthesis nociceptive animal relevant reduction strategy trait poorly optimal clinical engage reductase mouse therefore haplotype neurotransmitter protective enzyme efficacy contrast data novo date design cause quantification cyclohydrolase novel genetic inhibition low completely pharmacologically rational use case rate one independent biomarkers obligate gch proof drug systemic relevance population approach back model therapeutic describe translational pathological development target potential safety success treatment response association heritable initially process genetically definition neuron production biology peripheral engineering function pharmacologic chronic either validity available reduce gtp also multiple plus cohort part high last study human similar yield altering power patient engagement treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799129/,abstract,2,altering pharmacologically pharmacologic nociceptive inhibited eliminates obligate spr rational engage analgesic causality gch macrophage sepiapterin engagement sensory heritable caucasian reductase cyclohydrolase attempt protective initially gtp engineering proof neuron haplotype validity novo power definition pain plus translational quantification pathological completely reduce yield peripheral poorly relevance systemic success reliable biomarker neurotransmitter physiological inhibition genetically treat action optimal safety biology trait abnormal tetrahydrobiopterin production molecule independent vivo selection date contrast concern finally efficacy animal reduction genetics synthesis chronic biomarkers relevant design cohort target similar mouse process tool enzyme state multiple cause drug strategy response therapeutic pathway association use novel rate activity common function low approach present case available new human model population potential development high genetic data treatment clinical patient study,{},"{""genetic"": {""freq"": 1, ""string"": [""human model population potential development high genetic data treatment clinical patient s""]}}","{""pathway"": {""freq"": 1, ""string"": [""multiple cause drug strategy response therapeutic pathway association use novel rate a""]}}",{},{},{}
660,660,707,10.1177/1178630217751906,29398918.0,epidemiologic original linkage relevant unit recent anthropogenic information environmentally place perspective relevance health segregate platform outcome contention aquatic environmental paper framework research environment literature watershed geospatial group article landscape data human stratify concept well valuable epidemiologically establishing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788116/,abstract,0,watershed geospatial environmentally aquatic anthropogenic stratify segregate epidemiologically contention establishing epidemiologic landscape original linkage place relevance unit valuable platform framework concept perspective environment environmental relevant paper literature recent information outcome article human research health group data,{},{},{},{},{},{}
661,661,708,10.1007/8904_2014_399,25732995.0,chain clinic single information lower essential positive adult laboratory despite site frequency omega supplementation risk mean control docosahexaenoic month pku status intake commercial linoleic subject rather recent higher questionnaire value error food inborn result guideline prospective long metabolism low level suboptimal one phenylketonuria method history recommend target sufficient fatty diet care predictive preformed age negative access limited background dha precursor conclusion ala high study alpha acid patient,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470952/,abstract,1,preformed omega recommend linoleic ala docosahexaenoic commercial dha suboptimal alpha sufficient predictive prospective access precursor guideline fatty clinic history supplementation site questionnaire negative mean limited chain intake frequency essential despite laboratory status target inborn food background month subject long positive value error lower single adult recent diet care information pku conclusion higher phenylketonuria low metabolism risk control acid age high method level result patient study,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""value error lower single adult recent diet care information pku conclusion h""]}}",{}
662,662,709,10.3390/bios9020065,31117262.0,biological subsequent threat reliability early country largely platform serious equipped pro due centralized continuous principle restructuring well underlying virus disease infectious strategy quickly perspective health protein economical global great analytical diagnosis stability facility change nano type low area detection omnipresent update biomarkers scarce current dynamic implementation comprehensively many review sized reason object rural method con malady target biosensors deployment resource treatment person limit care address challenge city specificity still public future application appropriate access paucity especially unquestionably limited classified analysis aspect module matrix impact conclusion diagnostic turn technological barrier distinct linear limitation urgency number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627152/,abstract,0,unquestionably restructuring omnipresent nano equipped deployment urgency malady centralized sized paucity biosensors scarce economical threat quickly object facility module comprehensively turn update reliability technological classified rural pro person city reason matrix infectious continuous principle underlying subsequent virus largely dynamic stability barrier distinct limit access platform analytical great linear limitation aspect perspective resource address specificity appropriate global implementation limited especially biomarkers biological public diagnostic country target detection area application challenge change strategy future impact care current conclusion low number early type diagnosis review protein health method treatment analysis disease,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""biomarkers biological public diagnostic country target detection area application challenge change s""]}}",{},{}
663,663,710,10.1681/ASN.2016050508,28739648.0,subsequent disorder activity factor early ifn aki tubule strengthen inflammation condition moreover infiltration partly morphology injection control significantly epithelial proliferator repair promoter peroxisome transcriptional transcription adulthood ppar renal overlapped coactivator dysfunction nephropathy role downregulation microcirculation endotoxin mouse link thus hepatocyte receptor inhibition pcr mutation nuclear signal local cytokine respiration via expression potential chromatin exposure frequent network hnf proximal assay altered cell immunoprecipitation inflammatory transient production pivotal function germinal reduced impairment analysis vitro tnf also extracellular biogenesis regulating patient proinflammatory mitochondrial kidney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661272/,abstract,0,endotoxin coactivator aki respiration proliferator proinflammatory ppar peroxisome germinal biogenesis tnf nephropathy microcirculation ifn downregulation overlapped infiltration tubule pivotal immunoprecipitation strengthen chromatin repair proximal extracellular epithelial regulating partly altered morphology cytokine transient hnf transcriptional promoter kidney renal injection adulthood pcr subsequent inflammation hepatocyte mitochondrial link transcription nuclear inhibition signal reduced local frequent receptor inflammatory network vitro production assay exposure impairment dysfunction mouse expression activity mutation condition role cell function significantly early control factor potential disorder analysis patient,{},{},{},{},{},{}
664,664,711,10.1016/j.cell.2016.05.071,27374330.0,beige blood disorder administration family endogenous independent likely energy heat pathway hydrolytic obesity secreted peptidase demonstrate function lastly glucose reaction brown dissipate mechanism vitro mouse reverse alternative homeostasis posse condensation acyl also mitochondrion chemical express enzyme enzymatic uncouplers adipocytes domain useful data thermogenic acid bidirectional versus fatty increase expenditure ucp directly node amino cell metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947008/,abstract,1,uncouplers ucp thermogenic hydrolytic dissipate condensation beige adipocytes peptidase bidirectional secreted node lastly express brown heat posse mitochondrion reverse expenditure acyl enzymatic endogenous versus homeostasis demonstrate chemical energy glucose obesity vitro independent fatty directly alternative domain useful administration reaction likely mouse metabolite enzyme increase pathway mechanism family amino cell function blood acid data disorder,{},{},"{""pathway"": {""freq"": 1, ""string"": [""reaction likely mouse metabolite enzyme increase pathway mechanism family amino cell f""]}}","{""amino"": {""freq"": 1, ""string"": [""metabolite enzyme increase pathway mechanism family amino cell function blood acid d""]}}",{},{}
665,665,712,10.4269/ajtmh.17-0889,29968557.0,blood reliability example accessory physiological laboratory condition literature cost source effective disease solution offer evidence logistics optimal storage health recovery procedure global determined conceptually card report analytical property data stability specimen type infrastructure use case surveillance interest pre hard analyte drug minimize population review feasible method efficiency development technology bioanalysis minimal newborn spot community standard determine field program importance also multiple limitation variability,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090344/,abstract,0,bioanalysis accessory conceptually logistics infrastructure minimize hard analyte reliability card specimen surveillance recovery offer minimal feasible efficiency determined stability variability solution physiological storage analytical optimal limitation procedure community property pre global source example cost spot determine laboratory importance technology field standard literature program multiple drug effective use report newborn evidence condition case blood type population review development health method data disease,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""program multiple drug effective use report newborn evidence condition case blood t""]}}",{},{}
666,666,713,10.3892/etm.2017.4167,28565794.0,derivatization repeatability disorder example spiked time present mmol neonatal platform citrin five retention ureidopropionase effective reliable preliminary disease material respectively semi peak biochemical possible screening relative clinical protein range recovery reagent blank locking result ornithine metabolic creatinine good urine considering thermally novel furthermore first type greatly area non rate silylation oximation temperature ketoacids room stable residue removed phenylketonuria technique method identification conduct pathological gas transcarbamylase second urea simultaneous rsd imds process volatile sample two cholestasis mass imd standard facilitates category intrahepatic analysis deviation spectrometry research synchronously aldehyde comprehensive study acid deficiency patient metabolite mitochondrial chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443173/,abstract,0,ureidopropionase thermally synchronously spiked silylation oximation locking ketoacids considering rsd removed intrahepatic citrin cholestasis blank repeatability mmol aldehyde transcarbamylase reagent imds facilitates derivatization volatile ornithine creatinine retention preliminary peak greatly conduct simultaneous imd room semi residue recovery urea pathological deviation gas temperature reliable mitochondrial stable category platform relative comprehensive urine chromatography good second example neonatal furthermore spectrometry technique identification biochemical standard possible process area metabolite screening mass range effective deficiency respectively novel rate material non sample phenylketonuria present time type research acid protein metabolic method disorder clinical analysis result patient disease study,"{""urine"": {""freq"": 1, ""string"": [""mitochondrial stable category platform relative comprehensive urine chromatography good second example n""]}}",{},{},"{""spectrometry"": {""freq"": 1, ""string"": [""chromatography good second example neonatal furthermore spectrometry technique identification biochemical standard p""]}, ""screening"": {""freq"": 1, ""string"": [""biochemical standard possible process area metabolite screening mass range effective deficiency r""]}}",{},{}
667,667,714,10.1038/s41431-018-0144-0,29703952.0,implication tool new final selection preference engages choice interactive capacity testing adviser exercise knowledge prototype fill user value clinical mixed health clarification programming gap video expertise genomic support result convey interview large design guideline usability enthusiastic learning use yet educational quiz step volume genomics critical aid method recommend development system towards online test guide delivery iterative myriad decision care feasibility process intuitive limited category cognitive aim framework multiple study sequencing patient incidental participant whiteboard acceptable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018661/,abstract,0,whiteboard quiz engages convey adviser video usability enthusiastic clarification recommend myriad incidental prototype intuitive programming interactive iterative expertise learning exercise aid final preference mixed guide feasibility acceptable gap educational interview choice capacity category genomics guideline framework volume selection decision step delivery genomic implication limited critical sequencing design testing knowledge participant process cognitive support aim tool user multiple value online large use care test new development health method clinical result patient study,{},{},{},{},{},{}
668,668,715,10.1007/8904_2014_360,25503300.0,male specific disorder assessment autism sparse lead factor information early affect time glutaric country neglect initial programme battery prompt severe deficit admission risk average motor executive family subject neurodevelopmental follow speech previous questionnaire therapy range developmental report diagnosis metabolic long type score detection four centre normal child stable outcome point many intervention history via skill behaviour test treatment parental year generally age reduces two within newborn poor appropriate correlate problematic effectively cognitive impairment aciduria previously hospital research regardless multiple comprehensive high neuropsychological patient participant fine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361926/,abstract,1,neglect problematic sparse glutaric fine speech battery prompt aciduria admission regardless reduces behaviour neuropsychological correlate skill programme effectively centre parental executive generally stable neurodevelopmental initial affect motor comprehensive average poor follow autism history appropriate previous deficit questionnaire hospital impairment lead point developmental previously male score country participant detection severe assessment cognitive normal subject long range multiple report family intervention therapy information newborn outcome test time risk early specific factor type diagnosis research child age metabolic year high disorder treatment patient,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""developmental previously male score country participant detection severe assessment cognitive normal s""]}, ""newborn"": {""freq"": 1, ""string"": [""multiple report family intervention therapy information newborn outcome test time risk e""]}}",{},{}
669,669,716,10.3892/etm.2017.5440,29434692.0,correlation specific whether region early among abnormal present author anisotrophy fractional oligodendrocyte characterization common preterm admission investigate risk mean motor increase significantly gestational tensor genu matter measurement however neurodevelopmental baby dysfunction value axial manner diffusion capsule result integrity bayley data late level internal imaging interest anterior splenium external white regionally outcome week predictor development dysplasia potential thyroid diffusivity test callosum iii year tsh limb age transient premature unclear hypothyroidism explore function adverse corpus infant group cohort study intact total myelination recruiting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772951/,abstract,5,recruiting anisotrophy regionally limb oligodendrocyte genu axial dysplasia capsule bayley splenium myelination intact callosum tensor diffusivity anterior tsh fractional external corpus admission integrity diffusion transient thyroid premature iii preterm manner internal imaging hypothyroidism baby gestational characterization author predictor matter neurodevelopmental unclear late white motor abnormal explore adverse mean dysfunction investigate measurement correlation cohort week region infant value increase total outcome common function present test significantly risk early specific potential age development group year data level result study,{},{},{},{},{},{}
670,670,717,10.1186/s13023-016-0410-6,27008844.0,male cross blood clinic investigation sectional satisfied outpatient difference single effort positively time adult throughout paediatric median retrospective sub specialised control experience well unplanned transition disease survey pku sociodemographic satisfaction respect however later life phenylalanine childhood follow questionnaire therapy range economical remained mol symptom comparable task error support diagnosis university metabolic data good pregnancy welfare long metabolism establishment period educational mann whitney three flzm independent female chi centre department current economic syndrome stable prevent evaluation outcome conclusionscontinuous population management phenylketonuria anova therapeutic contact social loss concentration test success treatment ten germany adolescence help year care maternal age still within newborn mostly splitting uninterrupted professional appropriate statistical limited methodsall influence quality analysis hospital characteristic importance general cohort last patient square successful satisfactory,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806494/,abstract,7,splitting remained flzm conclusionscontinuous welfare unplanned uninterrupted specialised methodsall satisfied whitney satisfaction sociodemographic satisfactory mann economical anova outpatient establishment contact chi paediatric germany department adolescence retrospective sub square respect positively transition centre comparable educational success university stable later economic mol successful task independent statistical prevent effort clinic sectional pregnancy follow experience median investigation good appropriate professional maternal help female childhood survey questionnaire loss hospital cross limited influence syndrome evaluation social importance general male cohort characteristic period symptom support long management range error quality therapeutic single adult care therapy life concentration newborn current pku outcome difference phenylketonuria metabolism test time phenylalanine control blood diagnosis population age metabolic year data treatment analysis patient disease,"{""phenylalanine"": {""freq"": 2, ""string"": [""outcome difference phenylketonuria metabolism test time phenylalanine control blood diagnosis population a""]}, ""social"": {""freq"": 1, ""string"": [""hospital cross limited influence syndrome evaluation social importance general male cohort c""]}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""single adult care therapy life concentration newborn current pku outcome difference p""]}}",{},{}
671,671,718,10.1186/s13628-018-0047-z,30473783.0,various counterion disorder self early dppe dppc site fibril initial surface implicated pressure epifluorescence instrumental assembly neurological material underneath membrane phe knowledge understanding however phenylalanine supplementary event intercalate monomer user value consistent particular environment primary monolayers metabolic conclusionsphe specie aphe formation area use mimic nonpolar saline phosphatidylcholine imaging nucleation outer phosphatidylethanolamine leaflet normal drive constant resultsin plausibly mode online phenyl article electronic docking intercalation phase assay nearly insertion version materialthe process two along amyloid determine ring backgroundpropensity authorized goal available monitor larger discriminate interaction aqueous study complex phospholipid parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237005/,abstract,8,underneath plausibly phosphatidylethanolamine nucleation nonpolar monolayers leaflet intercalation intercalate epifluorescence dppe counterion conclusionsphe backgroundpropensity aphe phospholipid outer implicated dppc aqueous phosphatidylcholine saline instrumental docking phenyl discriminate drive ring fibril mimic constant monomer insertion monitor amyloid resultsin assembly surface mode imaging authorized membrane nearly specie pressure larger initial formation goal event neurological phase parameter particular environment consistent understanding site assay self materialthe determine knowledge interaction various process area phe supplementary normal user complex primary version value electronic online use material article available early phenylalanine metabolic disorder study,"{""phenylalanine"": {""freq"": 2, ""string"": []}, ""neurological"": {""freq"": 1, ""string"": [""pressure larger initial formation goal event neurological phase parameter particular environment c""]}}",{},{},{},{},{}
672,672,719,10.1089/hum.2017.009,28293963.0,herein new genotoxicity insertional positive largely undetected serious without recall need risk toxicity disease solution murine animal however event retroviral possible clinical therapy extensively elevation result enzyme data aav proactive recombinant use case raavs emphasize death liver product model prudent potential success europe treatment delivery viral associated raav aggregate amid renaissance two transient occur especially field currently tragic adeno either mutagenesis adenoviral trial multiple except study human position small vector patient gene number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399742/,abstract,2,renaissance raavs prudent genotoxicity amid undetected tragic retroviral raav proactive insertional adenoviral recall mutagenesis emphasize aav occur adeno europe murine extensively elevation aggregate transient recombinant toxicity position viral vector success largely solution event death associated delivery animal liver especially product currently small need field possible enzyme trial multiple positive use therapy number case new human risk model potential gene data treatment clinical result patient disease study,{},{},{},{},{},{}
673,673,720,10.3389/fgene.2019.00552,31275354.0,various european specific worldwide new pathway among country increasingly five literature genetics cost testing specialist evaluate disease lynch consumer geneticist medical zealand demand trait recent ninety screening mainly role affordable citizen italian primary ideally effectiveness six efficacy integration genetic type english area period service brca specialty genomics prediction syndrome regionally intervention population review inclusion model method development system article test resource respective delivery electronic iii accessible year care address systematic within newborn along mostly professional collaboration application appropriate order pilot usa field classified provision criterion currently background research program available extra identify conclusion nationally different urban study direct patient redistribution prominent healthcare australia interested,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593087/,abstract,3,redistribution lynch brca regionally interested extra ideally ninety zealand specialty italian citizen nationally affordable respective usa english urban geneticist australia prominent demand classified accessible collaboration provision iii consumer specialist pilot integration worldwide prediction identify genomics increasingly mainly european trait healthcare inclusion resource address systematic effectiveness evaluate delivery appropriate service professional direct efficacy genetics criterion cost syndrome currently period order field testing country literature various background area application screening program primary electronic medical pathway recent intervention care newborn conclusion article role available test new model specific type research population review different development year genetic method patient disease study,{},"{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""application screening program primary electronic medical pathway recent intervention care newborn c""]}}","{""newborn"": {""freq"": 1, ""string"": [""electronic medical pathway recent intervention care newborn conclusion article role available t""]}, ""screening"": {""freq"": 1, ""string"": [""country literature various background area application screening program primary electronic medical p""]}}",{},{}
674,674,721,10.3389/fbioe.2015.00020,25767794.0,delay bench micro new transformative portable widespread technical time necessary due superior inadequate control effective way disease opinion hematological relevant however marker poc recent anti therapy clinical clinically top fast great drag behind pervasiveness analytical store like first medicine forthcoming yet commonly one local drug capability outcome point approach device technique therapeutic development technology epileptic latest treatment nanotechnology help care surprisingly promising predictive inertial monitoring still two advancement breakthrough lack application community field analysis intensive tdm preventative unmet practice glycemic cardiac technological patient show performance parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4341557/,abstract,0,tdm pervasiveness inertial drag transformative forthcoming micro bench preventative portable nanotechnology surprisingly poc hematological glycemic store breakthrough unmet epileptic latest inadequate intensive technological opinion fast advancement capability superior widespread technical device promising cardiac commonly predictive monitoring local delay analytical great anti community clinically necessary way parameter help marker lack point practice technique relevant medicine like technology performance field application drug therapeutic effective recent care therapy outcome approach time new control development treatment clinical analysis patient disease,{},{},{},{},{},{}
675,675,722,10.1016/j.psychres.2018.02.020,29471261.0,disorder relationship lower essential periphery tetrahydrobiopterin onset additional deficit psychosis hypothesis finally significantly synthesis spectrum subject schizoaffective dopamine encodes genotype diagnosis enzyme effect data versus first genetic medication level significant biopterin rate measure schizophrenia gch approach regulation expression potential illness polymorphism prefrontal associated sample allele primarily nitric serotonin peripheral psychiatric antipsychotic episode cortex group plasma study oxide cofactor patient linear total cns,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866784/,abstract,2,schizoaffective periphery antipsychotic psychosis gch biopterin encodes cns prefrontal schizophrenia episode cortex illness nitric peripheral oxide primarily serotonin versus psychiatric medication cofactor linear dopamine polymorphism hypothesis tetrahydrobiopterin genotype associated allele regulation finally deficit synthesis onset essential additional relationship spectrum enzyme measure subject plasma expression lower rate total sample approach significantly diagnosis potential significant group effect genetic data level disorder patient study,"{""psychiatric"": {""freq"": 1, ""string"": [""nitric peripheral oxide primarily serotonin versus psychiatric medication cofactor linear dopamine p""]}}","{""genetic"": {""freq"": 1, ""string"": [""significantly diagnosis potential significant group effect genetic data level disorder patient s""]}}",{},{},{},{}
676,676,723,10.4254/wjh.v7.i23.2482,26483870.0,blood chain abbott cobastaqman search instance thoroughly serological chemiluminescent immunosorbent among lower time reaction molecular abstract reliable saliva polymerase well virus respectively quantify marker quantitative renal quantitation cerumen real mutant result cobasampliprep enzyme etc data reference embryo predominant applicability hepatitis hepatocytes english detection qualitatively case commonly full text oocyte ovarian infection drug sensitivity database hbv seronegative many review technique method cholangiocarcinoma system article test year limit medline assay kit version specificity original monitoring sample parotid spot manual dna resistance clia available also conclusion plasma different tissue last study patient highly total sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606204/,abstract,2,seronegative parotid cobastaqman cobasampliprep cholangiocarcinoma chemiluminescent cerumen abbott serological qualitatively clia thoroughly immunosorbent applicability oocyte kit instance manual hbv quantitation ovarian saliva hepatitis english quantify abstract predominant original embryo polymerase hepatocytes medline renal resistance virus reliable real commonly limit monitoring sensitive mutant reference infection text search specificity reaction dna quantitative assay sensitivity marker chain tissue database highly spot technique detection enzyme plasma drug version lower molecular respectively total conclusion article sample case available test time blood review different year method data result patient study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""chain tissue database highly spot technique detection enzyme plasma drug version l""]}}",{},{}
677,677,724,10.1038/s41598-019-38874-3,30742005.0,male correlation blood chain ratio difference composition lower signature profile positively density hypercholesterolemic bacterial cholesterol objective respectively microbiota related subject opposite odoribacter relative higher value haemophilus particular negatively lipoprotein lipid metabolism short biomarkers size abundance nmr scfas behaviour triglyceride fatty isobutyric faecal normocholesterolemia bile isovaleric hdl analysis hplc group rdna high study acid sequencing anaeroplasma unfavourable volunteer show total parameter indicative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370822/,abstract,0,unfavourable normocholesterolemia isobutyric hypercholesterolemic haemophilus anaeroplasma rdna odoribacter faecal scfas isovaleric hdl triglyceride opposite lipoprotein indicative bile signature volunteer nmr hplc microbiota cholesterol behaviour abundance positively negatively density bacterial lipid composition relative fatty parameter size profile particular short chain sequencing biomarkers correlation related male ratio objective subject value lower respectively total higher difference metabolism blood acid group high analysis study,{},{},{},{},{},{}
678,678,725,10.1371/journal.pone.0201629,30063765.0,correlation blood whether hour conclusionswe new lower backgroundwith venous probable bias plastic regular apart cost tube effective reliable virus month visit introduction anti value altman therefore fibrosis result diagnosis six desiccator reach hepatitis sixty resultsanti significant one hard temperature progression log room elastography infection overall population hcv puncture feasible method determination gas antibody baseline concentration pearson test treatment bland consecutively heparin transient rna spot easy standard impermeable approximately chronic analysis alternative available also bag methodforty plasma direct antiviral patient mail statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067740/,abstract,1,resultsanti plastic methodforty impermeable elastography desiccator consecutively bag heparin hcv backgroundwith puncture bland altman mail antiviral pearson log hard tube probable apart venous reach hepatitis easy conclusionswe visit room transient regular antibody bias fibrosis feasible gas temperature rna determination virus reliable hour introduction progression statistically anti baseline infection approximately alternative direct cost chronic spot correlation overall standard month plasma value effective lower concentration available test new blood diagnosis population significant method treatment analysis result patient,{},{},{},{},{},{}
679,679,726,10.1186/s12929-016-0256-1,27084339.0,disorder blood exon dominant clinic new continues ldlrap discus early affect across autosomal hypercholesterolaemia concern elevated programme condition risk ldlr effective cholesterol disease significantly simon however family recent screening higher health dutch distribution whereby globally familial result effectiveness diagnosis effect alternatively data basis change genetic lipid case rate one member death referral prevent population important network year cascade dramatically rare universal public progress variant typically prevalence community systematically criterion currently index broome also different sequencing dcln patient gene atherosclerosis founder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833930/,abstract,2,simon ldlrap dcln continues broome ldlr hypercholesterolaemia alternatively atherosclerosis dutch cascade globally founder dramatically familial referral cholesterol dominant systematically universal programme progress lipid typically exon member distribution affect elevated network community prevent autosomal death concern clinic effectiveness basis index criterion sequencing currently prevalence public discus screening change variant effective recent rare family rate higher condition important case significantly new risk early blood diagnosis population different health gene year effect genetic data disorder result patient disease,{},"{""autosomal"": {""freq"": 1, ""string"": [""distribution affect elevated network community prevent autosomal death concern clinic effectiveness b""]}, ""genetic"": {""freq"": 1, ""string"": [""population different health gene year effect genetic data disorder result patient d""]}}",{},"{""screening"": {""freq"": 1, ""string"": [""criterion sequencing currently prevalence public discus screening change variant effective recent r""]}}",{},{}
680,680,728,10.3390/molecules21020149,26821009.0,marginally notably alendronate investigation time positive glucose vinegar liquid butyric without five physical highlight effective ovariectomized sham significantly respectively biochemical however phenylalanine rubus coreanus curative result efficacy effect postmenopausal rat low flight alen histological level prophylactic ultra dose model quadrupole regulation tof ovx gas potential hrv treatment mass lrv estrogen analysis natural spectrometry alternative tryptophan metabolomic prevention group plasma high pattern study osteoporosis similar dietary parameter performance lysophosphatidylcholines metabolite chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273122/,abstract,2,rubus ovx ovariectomized lysophosphatidylcholines lrv coreanus butyric alendronate alen vinegar postmenopausal prophylactic hrv marginally sham tof quadrupole histological estrogen curative osteoporosis flight ultra notably metabolomic tryptophan gas rat glucose liquid dose alternative chromatography natural parameter investigation regulation physical pattern efficacy spectrometry prevention highlight biochemical performance similar metabolite mass plasma positive effective respectively dietary low time significantly model phenylalanine potential group effect high level treatment analysis result study,"{""phenylalanine"": {""freq"": 2, ""string"": [""respectively dietary low time significantly model phenylalanine potential group effect high l""]}}",{},{},"{""spectrometry"": {""freq"": 1, ""string"": [""parameter investigation regulation physical pattern efficacy spectrometry prevention highlight biochemical performance s""]}}",{},{}
681,681,729,10.1038/ncomms14904,28383026.0,rare various employ utility although chain unit synthetic importantly one herein step moderate transformation propionic side extensively prepared series amenable product condition easily natural method peptide assistance report methodology derivative ligand aromatic group affording potential arylation carboxylate good acid direct phthaloylalanine yield important acetylglycine way furthermore reflux directly material amino aliphatic excellent synthesis non,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384235/,abstract,1,phthaloylalanine arylation aliphatic affording acetylglycine carboxylate reflux employ prepared assistance ligand amenable transformation easily derivative propionic extensively series importantly excellent yield aromatic unit synthetic peptide methodology moderate utility directly step natural way good direct synthesis furthermore chain product various report rare material amino condition non important acid potential group method,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""chain product various report rare material amino condition non important acid p""]}}",{},{}
682,682,730,10.1007/s12687-018-0376-2,30109643.0,implication disorder single present document grouping necessary programme without condition communicable frequency common source effective material empirical account supplementary family user health burden large data date genetic planning mortality non service level use rate assumption morbidity overall child collectively intervention population approach frequently disability online article proportion important electronic manageable year aggregate version materialthe rare age public collective estimate premature available policy maker gene demographic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167259/,abstract,1,grouping manageable communicable empirical collective maker assumption planning aggregate collectively premature document demographic programme burden proportion morbidity account frequently date estimate necessary policy mortality service implication source disability materialthe frequency public overall supplementary user version electronic online effective large single use rare family intervention rate material condition non article important common approach present available population child age health gene year genetic data level disorder,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
683,683,731,10.1186/s12913-014-0589-y,25406529.0,staff schedule better ratio wch time central actual corresponding compare capacity institution workload survey respectively amount medical however strategy east health west real china equitable annually situation data type chinese area service whole resultsthere child woman lot motivation conclusionsthe work national nation potential sufficient resource accessible norm universal consensus still professional make especially since quality coverage larger spends human backgroundto number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245722/,abstract,5,wch spends backgroundto workload norm lot corresponding equitable nation schedule annually compare staff motivation west make actual resultsthere east accessible coverage institution situation universal consensus sufficient chinese real china capacity larger conclusionsthe resource service professional woman central survey work national especially ratio better area strategy quality medical respectively number time human type potential child health data,{},{},{},{},{},{}
684,684,732,10.1007/s12687-014-0209-x,25564015.0,epidemiological teamwork information tertiary specifically several defect country present concern condition action genetics severe argentina risk finally transition objective firstly teratogenic medical line coordinate perspective health law focus global secondary primary basis cause term fetal middle genetic low mortality level service surveillance rehabilitation problem critical approach pollutant national organization treatment teratology network address challenge list particularly public mass professional income community birth authority tip environmental aware impact paper program infant importance prevention general conclusion different medium center,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356676/,abstract,0,tip teratology teamwork coordinate argentina rehabilitation pollutant teratogenic firstly authority law aware tertiary surveillance income epidemiological middle transition list medium organization fetal line action specifically perspective network community address concern secondary center mortality global basis service professional finally focus genetics national critical environmental prevention particularly defect importance general problem paper public birth country severe infant objective mass program challenge primary cause medical impact information conclusion term condition low approach present risk different health genetic level treatment,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
685,685,733,10.1002/14651858.CD012555.pub2,30246876.0,registry await assessment cochrane whether hour absolute search new ratio difference greater rescue thirteen lower duration metoclopramide uncertainty time nausea world adult author country freedom selection nauseous platform backgroundolanzapine preference aged adjunct without serious bias central frequency additional due expert likelihood probably risk methodswe effective experience severity addition analysiswe well emetogenic increase subcutaneous doe uncertain objectivesto issue criteriawe tumour nntb comparator cancer beneficial cannot gov evidence attrition event interval life reduction moderate form intramuscular prokinetic relative outcomesfour clinical therapy health intravenous antiemetic resultswe double secondary primary possibility methodology somnolence harm efficacy imprecision data palliative dexamethasone cause versus oral ongoing middle low eight international use clinicaltrials conclusionsthere confidence four administration main least one per placebo acute drug hec overall outcome provide point review injectable ass september older people illness safety solid treatment collection vomiting reporting year phase medline inconsistency finding list antagonist treatmentprimary fatigue randomised reduces breakthrough lack income unclear whilst comparison standard subgroup embase field quality adverse analysis antipsychotic benefit mec trial prevention olanzapine grade fewer different high classification domain study arm insufficient meta palliation comparisonsone patient chemotherapy limitation participant absence moderately chemoradiotherapy highly number perception treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513437/,abstract,36,treatmentprimary prokinetic palliation outcomesfour olanzapine nntb nauseous metoclopramide mec hec freedom emetogenic comparisonsone comparator chemoradiotherapy backgroundolanzapine await antiemetic analysiswe somnolence injectable dexamethasone criteriawe antipsychotic randomised palliative imprecision chemotherapy attrition tumour nausea intramuscular fatigue conclusionsthere adjunct moderately vomiting thirteen likelihood probably breakthrough antagonist subcutaneous intravenous rescue inconsistency harm objectivesto absolute whilst arm uncertain september reporting fewer uncertainty cochrane ongoing solid registry insufficient illness reduces preference grade perception income embase middle subgroup resultswe medline duration clinicaltrials bias placebo list classification author older hour gov versus beneficial absence methodology meta expert double possibility confidence treat platform unclear people doe safety moderate limitation event severity oral interval world selection relative international domain search acute methodswe secondary phase administration experience collection aged adverse central cancer efficacy comparison reduction lack point prevention highly greater frequency ass provide benefit issue additional main ratio field overall country standard finding participant assessment form addition trial primary cause drug increase quality effective lower adult use therapy life evidence outcome difference low number time new risk review different health year high data treatment clinical analysis patient study,{},{},{},{},{},{}
686,686,734,10.1208/s12248-015-9860-3,26857396.0,major blood relationship clinic example vivo information dataset across package merck initial without choice literature fda regulatory experience disease establish however subject quantitative pharmaceutical strategy clinical word input burden integrated suitability ema guideline decrease late concurrence interest agency implementation evaluation population descriptive method alzheimer bioanalytical target stage potential pharmacokinetic concentration test collection key phase initially feasibility sample application spot healthy logistical seamlessly analysis matrix vitro paper alternative program impact trial conclusion plasma study patient industry,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779096/,abstract,2,seamlessly merck ema concurrence logistical bioanalytical suitability package fda dataset agency pharmacokinetic integrated initially input industry matrix establish alzheimer feasibility descriptive pharmaceutical choice initial word late burden guideline vitro vivo alternative clinic phase stage regulatory experience collection decrease quantitative implementation example evaluation spot paper relationship target literature healthy application subject plasma trial program major strategy key impact information concentration conclusion sample test blood population potential method clinical analysis patient disease study,{},{},{},{},{},{}
687,687,735,10.3389/fcvm.2016.00019,27379245.0,disorder abnormality factor information early lower pathway gain congenital abnormal positive defect several malformation enhance light additional due genetics common variation ahead risk testing tremendous underlying cnv summary medical advent microarray offer however family neurodevelopmental recent chromosome variety perspective chds clinical role play global candidate genomic chd seemingly support diagnosis cardiology copy novel genetic incomplete potentially non significant cnvs provider one recurrence member crucial morbidity normal economic provide evaluation critical review management model identification slow development technology nevertheless address challenge lie advocate causative anomaly standard involved birth heart either benefit mechanism cardiovascular impact syndromic also multiple identify group historically fewer diagnostic cma part cardiac technological human yield patient limitation individual gene number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905945/,abstract,0,cma ahead chds cardiology advocate seemingly recurrence lie incomplete cnv cnvs tremendous syndromic microarray slow advent fewer historically copy technological chromosome causative malformation anomaly chd offer gain yield provider enhance crucial cardiac underlying summary light identify candidate involved neurodevelopmental cardiovascular variety economic member limitation morbidity abnormal perspective play address potentially heart global genomic abnormality genetics critical variation evaluation defect congenital identification provide benefit additional technology birth testing diagnostic standard support normal management challenge multiple positive medical lower pathway recent mechanism family impact novel information non role common number individual human risk model early factor diagnosis review significant development gene group genetic disorder clinical patient,{},"{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""management challenge multiple positive medical lower pathway recent mechanism family impact n""]}}",{},{},{}
688,688,736,10.1186/s13023-018-0839-x,29941009.0,considerable backgrounddespite availability assessment better micronutrient difference early lower essential complexity strengthen nutrient condition literature due magnesium sub control publication cholesterol vitamin significantly pku status intake material folate phe supplementary compliance adequate possible poorly optimal user nature role protein brain focus restrictive output particular resultsof data ongoing phospholipid non level suboptimal significant monitored compliant normal current review management choline conclusionsthe iodine development online article important key electronic fatty diet best systematic version entry folic rare iron continuously selenium healthy limited function authorized criterion analysis impact dha available nutritional practice study heterogeneity insufficient substitute meta acid dietary zinc neuropsychological deficiency patient inform show individual number calcium,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020171/,abstract,2,backgrounddespite phospholipid monitored compliant strengthen entry restrictive folate choline magnesium iron iodine dha suboptimal selenium resultsof folic substitute continuously zinc output micronutrient ongoing calcium insufficient cholesterol sub neuropsychological complexity authorized poorly inform publication compliance adequate considerable vitamin conclusionsthe meta nature optimal nutrient availability heterogeneity fatty systematic best particular nutritional focus criterion limited intake practice essential status better literature possible assessment phe supplementary normal healthy management user version key electronic online lower brain deficiency diet rare impact dietary current pku material condition non article important role difference function number available individual significantly early control review acid protein significant development data level analysis patient study,{},"{""heterogeneity"": {""freq"": 1, ""string"": [""conclusionsthe meta nature optimal nutrient availability heterogeneity fatty systematic best particular n""]}}",{},{},"{""diet"": {""freq"": 1, ""string"": [""key electronic online lower brain deficiency diet rare impact dietary current p""]}}",{}
689,689,737,10.1152/ajplung.00238.2016,27542807.0,major whether ratio greater rescue lower piglet chronically throughout synthase tetrahydrobiopterin condition additional catheter vascular control endothelial effective disease enos measurement summar animal evidence rather strategy monomer clinical higher prophylactically consistent mol diagnosis purpose oral cunningham untreated suffering hypoxic although least measure progression hypoxia biol current coupling dimer normoxic day hypertension dikalova development vasculature exposure ameliorate aschner hemodynamic artery treatment respir cell fike superoxide newborn production typically nitric kaplowitz sapropterin pulmonary chronic resistance previously infant episode cardiopulmonary part study oxide cofactor,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142125/,abstract,2,summar respir prophylactically normoxic kaplowitz fike dikalova cunningham biol aschner piglet catheter hemodynamic cardiopulmonary vasculature hypoxic suffering enos coupling hypoxia rescue artery chronically hypertension dimer monomer pulmonary episode ameliorate superoxide endothelial sapropterin vascular nitric oxide synthase resistance untreated typically progression cofactor mol oral tetrahydrobiopterin production consistent animal exposure purpose chronic measurement greater previously additional ratio measure infant day major strategy effective lower newborn evidence current higher condition cell control diagnosis development treatment clinical disease study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""infant day major strategy effective lower newborn evidence current higher condition c""]}}",{},{}
690,690,738,10.3389/fgene.2018.00087,29616079.0,biological neurotrophic growth encoding factor information pathway reproductive transducer central onset molecular annotation differentially regulatory activator transcription however understanding evidence observed additionally role play brain contribution link like question receptor term metabolism significant three pubertal signal hepatic pre polybromo release fully critical liver enrichment brahman work post development expression potential propose system important key hormone network signaling list tfs regulator sample estrogen regulated explore influence function differential metric analysis transcriptomic mechanism igf impact pbx homeobox insulin puberty gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869259/,abstract,3,polybromo pbx neurotrophic brahman tfs homeobox puberty transducer igf transcriptomic pubertal estrogen regulated annotation activator metric enrichment release differentially signaling encoding reproductive regulator insulin hepatic list fully differential link propose contribution transcription hormone signal question receptor additionally network post play explore regulatory pre observed central work understanding liver onset critical influence biological growth like expression key pathway brain molecular mechanism impact information evidence term important role function sample metabolism factor potential significant development gene analysis,{},{},"{""pathway"": {""freq"": 1, ""string"": [""influence biological growth like expression key pathway brain molecular mechanism impact i""]}}",{},{},{}
691,691,739,10.17113/ftb.54.03.16.4519,27956861.0,level hcl endemic gastric activity phenylalanine nacl two one production new fruticulosa possible purification temperature intestinal biotechnological ammonia serial bunge responsible juice therapy kda role protein word cyathobasis analysis fold approach product candidate phenylketonuria trans hplc food buffer cinnamic tris blot enzyme high potential concentration substitution acid pal treatment dietary similar key patient conversion optimum pku band respectively western,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5151209/,abstract,5,juice fruticulosa cyathobasis bunge tris nacl hcl band serial gastric cinnamic purification optimum biotechnological kda endemic buffer blot pal intestinal trans hplc substitution conversion ammonia western temperature responsible candidate fold word production product similar possible food enzyme key respectively dietary therapy concentration activity pku role phenylketonuria approach new phenylalanine acid potential protein high level treatment analysis patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""activity pku role phenylketonuria approach new phenylalanine acid potential protein high l""]}}",{},{},{},{},{}
692,692,740,10.1155/2017/1716701,28337245.0,disorder growth several enhance weight condition molecular common supplementation state threonine effective bird well glycine disease neurological animal cancer supplementary beneficial protection recent obesity role health focus sleep glutathione porphyrin purine report support sufficiently property metabolic effectual metabolism low haem proper many review liver choline simple serine important key creatine hydroxyproline diabetes interorgan inflammatory generally primarily function quality act cardiovascular precursor also prevention nonessential overwhelming different feeding acid human dietary mammal patient amino metabolite kidney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350494/,abstract,0,porphyrin haem effectual overwhelming nonessential interorgan hydroxyproline creatine bird threonine purine mammal glutathione choline sufficiently glycine serine sleep protection feeding proper kidney enhance act primarily beneficial generally simple cardiovascular precursor diabetes obesity inflammatory neurological property supplementation cancer animal weight focus liver prevention growth support metabolite supplementary state key quality effective molecular recent report dietary amino condition important role common function low metabolism human review acid different metabolic health disorder patient disease,"{""neurological"": {""freq"": 1, ""string"": [""simple cardiovascular precursor diabetes obesity inflammatory neurological property supplementation cancer animal w""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""quality effective molecular recent report dietary amino condition important role common f""]}}",{},{}
693,693,741,10.1172/jci.insight.121762,30046012.0,exhibited blood importantly memory reabsorbs pathway lower tubule reuptake deficit accumulation addition majority finally excretion pku phe related phenylalanine marker spatial renal uptake brain mouse body mutant neurotransmitter pahenu result effect antisense decrease novel intestine inhibition level inability neutral transporter abundant systemic provide approach model phenylketonuria efficiency free key proximal neuropathological cell transgenic excess working aminoacidopathies normally healthy oligonucleotides since responsible approximately disposal plasma otherwise high acid small absorption amino kidney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124451/,abstract,0,reabsorbs antisense reuptake oligonucleotides normally exhibited working tubule neuropathological disposal aminoacidopathies transgenic proximal intestine inability pahenu abundant excess uptake absorption excretion spatial neutral importantly kidney renal transporter systemic efficiency neurotransmitter responsible inhibition memory mutant majority accumulation approximately finally decrease deficit marker free provide related small mouse body phe healthy addition plasma key lower pathway brain novel pku amino cell phenylketonuria approach model phenylalanine blood acid effect high level result,"{""phenylalanine"": {""freq"": 2, ""string"": [""pku amino cell phenylketonuria approach model phenylalanine blood acid effect high l""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""phe healthy addition plasma key lower pathway brain novel pku amino c""]}}","{""amino"": {""freq"": 1, ""string"": [""key lower pathway brain novel pku amino cell phenylketonuria approach model p""]}}",{},{}
694,694,744,10.1016/j.atg.2015.02.003,26937350.0,tool new nutrition several interesting nutrient molecular need literature due genetics ethic physiology testing metanalysis nutrigenomics way disease however definite strategy possible obesity perspective protein move usually particular science great result effect ongoing investigates epidemiology eight medicine area use step certain current evolving many population determination expression towards polymorphism response association network diet still certainly access biology order limited influence currently research group different study heterogeneity patient though even thirty gene individual show number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745366/,abstract,0,metanalysis evolving investigates certainly definite nutrigenomics interesting ethic thirty ongoing epidemiology physiology usually determination access great nutrient biology heterogeneity polymorphism certain nutrition obesity perspective network science step way particular genetics limited influence currently medicine order need testing literature possible area tool expression strategy response association molecular use diet current number individual new research population different protein gene group effect result patient disease study,{},"{""heterogeneity"": {""freq"": 1, ""string"": [""usually determination access great nutrient biology heterogeneity polymorphism certain nutrition obesity p""]}}",{},{},"{""diet"": {""freq"": 1, ""string"": [""expression strategy response association molecular use diet current number individual new r""]}}",{}
695,695,745,10.21010/ajtcam.v14i4.15,28638875.0,male balance cross whether sensory region mechanical time brief platform avenue five actual physical open stimulation motor control unravel activation well way underlying beam month significantly material respectively session impair however beneficial subject form spatial relocation vibration brain mouse secondary body improvement task primary result recently attention effect little receptor novel selective first low whole although wbv cue step measure acute preclinical strength outcome recognition week day object method via test intensity age protocol notice custom vibrating chronic next either background mechanism impact research cortical conclusion pseudo skin human similar muscle minute performance show,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471459/,abstract,5,vibrating relocation wbv vibration pseudo notice beam mechanical cue impair avenue unravel custom object cortical sensory actual preclinical minute balance muscle intensity strength session brief stimulation spatial skin recognition underlying selective activation beneficial platform receptor open little motor protocol task acute secondary step way physical improvement recently cross attention chronic male week performance similar mouse region body background form measure month subject day primary brain mechanism respectively impact novel material outcome conclusion low test time significantly human control research age effect method result,"{""skin"": {""freq"": 1, ""string"": [""intensity strength session brief stimulation spatial skin recognition underlying selective activation b""]}}",{},{},{},{},{}
696,696,746,10.1007/8904_2015_468,26427993.0,pathogenesis carrying demonstrates common investigate refractive disease significantly compatible additionally axial mouse putative examination error recessively recently effect symptomatic cause emmetropic significant mutation one sco viet pathogenic elongation population tran model oxidase undiagnosed association myopia carrier sample ophthalmic variant homozygous screen cytochrome prevalence either heterozygosity infant general grade cohort high study human deficiency patient individual indicative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864719/,abstract,3,viet tran sco refractive ophthalmic emmetropic myopia elongation undiagnosed heterozygosity axial recessively cytochrome carrying compatible oxidase indicative demonstrates putative grade symptomatic homozygous pathogenesis screen examination pathogenic carrier additionally recently investigate general cohort prevalence mouse infant cause variant error association deficiency mutation common sample individual significantly human model population significant effect high patient disease study,{},"{""homozygous"": {""freq"": 1, ""string"": [""oxidase indicative demonstrates putative grade symptomatic homozygous pathogenesis screen examination pathogenic c""]}}",{},{},{},{}
697,697,747,10.3390/ijms19113597,30441827.0,major male biological bulk whether blockage vivo profile glucose malabsorption restriction homeostasis due bacterial evaluate disease significantly intra pharmacological recent lacking reabsorption screening obesity mixture health protein compound global mouse inefficient putative efficacy metabolic recently urine novel type intestine inhibition validate appearance level use rate administration neutral biomarkers curve inhibitor transporter abundant block provide sign approach indole fermentation gas potential tolerance diabetes receiver diet finding faecal sample gastric untargeted mass lack cresol kidney unclear propionic analysis vitro characteristic metabolomics spectrometry discriminate roc glucuronide plasma reliably study acid dietary absorption amino successful consistently metabolite chromatography treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274964/,abstract,1,reabsorption glucuronide cresol faecal blockage malabsorption inefficient indole gastric bulk lacking fermentation appearance discriminate intestine untargeted reliably roc abundant intra propionic absorption validate receiver consistently putative block mixture neutral kidney curve sign bacterial transporter tolerance gas inhibitor homeostasis pharmacological inhibition treat unclear restriction successful diabetes metabolomics glucose obesity vitro vivo urine chromatography evaluate administration global profile compound recently efficacy lack spectrometry biomarkers biological provide male characteristic finding mouse metabolite screening mass plasma major recent use diet dietary novel rate amino sample approach significantly type acid potential protein metabolic health level analysis disease study,"{""urine"": {""freq"": 1, ""string"": [""diabetes metabolomics glucose obesity vitro vivo urine chromatography evaluate administration global p""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""recent use diet dietary novel rate amino sample approach significantly type a""]}, ""spectrometry"": {""freq"": 1, ""string"": [""global profile compound recently efficacy lack spectrometry biomarkers biological provide male c""]}, ""screening"": {""freq"": 1, ""string"": [""provide male characteristic finding mouse metabolite screening mass plasma major recent u""]}}","{""diet"": {""freq"": 1, ""string"": [""screening mass plasma major recent use diet dietary novel rate amino s""]}}",{}
698,698,748,10.1371/journal.pone.0120191,25781028.0,disorder availability shift compulsive striatum factor behavioral inbred behavior condition moreover parallel compulsion risk methodswe hypothesis well finally material respectively interplay animal form confirm downregulates downregulation mouse environment food support like situation receptor dba genetic neuroadaptive low medial level alter suppression certain phenotype constitutive many motivated expression potential exposure manifestation response prefrontal western finding complex strain upregulation two circumstance determine influence induce function adverse environmental background cortex blot induces interaction pattern stressed resultsexposure palatable gene seeking,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363151/,abstract,0,stressed resultsexposure neuroadaptive inbred downregulates compulsion dba compulsive seeking motivated downregulation constitutive palatable induces upregulation medial circumstance striatum blot interplay induce prefrontal suppression strain confirm alter cortex shift situation western parallel manifestation receptor availability hypothesis certain behavioral methodswe finally adverse environment pattern animal behavior exposure environmental influence determine like phenotype finding interaction mouse food background form support expression complex response respectively material condition function low risk factor potential gene genetic level disorder,"{""behavioral"": {""freq"": 1, ""string"": [""parallel manifestation receptor availability hypothesis certain behavioral methodswe finally adverse environment p""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
699,699,749,10.1186/s13023-016-0458-3,27282290.0,training disorder inequality allowance activity region country five offering unfortunately percent doe disease medical third pay family subject latter adequate continental integral health procedure spite project defines error support inborn diagnosis thus metabolic attention large comprises reference personally thousand far genetic metabolism non area service main already many population private social system article treatment sus brazil component rare public still two dimension professional lack intention fashion effectively program research coverage general policy seventy comprehensive part small center patient insurance financial brazilian establishing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901491/,abstract,0,personally defines sus pay continental comprises seventy allowance spite integral inequality offering intention fashion dimension insurance establishing unfortunately financial private brazilian training percent thousand coverage brazil effectively project far adequate doe reference procedure comprehensive center policy component service professional lack attention social general main public small country region inborn area support subject program error medical large rare family activity non article metabolism diagnosis research population metabolic health genetic disorder treatment patient disease,"{""social"": {""freq"": 1, ""string"": [""policy component service professional lack attention social general main public small c""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
700,700,750,10.1371/journal.pone.0142887,26566276.0,european disorder channel however relationship asd autism snp family neural neurodevelopmental recent single size confirm unclear etiology twelve previous involved sample explore role population total central bonferroni additional trio han development group voltage risk study alpha nucleotide confers test polymorphism important association though first correction genetic finding gene chinese spectrum calcium,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643966/,abstract,4,confers voltage bonferroni trio han channel confirm calcium correction neural snp alpha chinese involved neurodevelopmental asd unclear etiology nucleotide polymorphism european explore autism previous size central additional relationship spectrum finding single association recent family total important role sample test risk population development gene group genetic disorder study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
701,701,751,10.1038/s41598-017-17315-z,29222521.0,correlation blood infantum new frozen ifn antigen ambient chemokines open stimulation onto control examines endemic subject marker allow storage protein procedure therefore possibility cxcl card asymptomatic transport leishmania detectable type prepared area three sla temperature cytokine strong infection soluble living determination work potential concentration resource bangladesh help tlp sample spain negative spot easy courier field ccl donovani chemokine saver plasma study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722824/,abstract,2,tlp sla leishmania infantum donovani cxcl courier chemokines antigen saver ccl ifn frozen examines chemokine bangladesh allow prepared endemic spain ambient soluble easy detectable living card cytokine asymptomatic stimulation transport temperature determination storage possibility strong open infection procedure resource help work negative marker spot correlation field area subject plasma concentration sample new control blood type potential protein study,{},{},{},{},{},{}
702,702,752,10.5582/irdr.2019.01068,31218157.0,rare availability however poor adjustment new recent accessibility catalogue context problematic annual speeding limited prioritizing drug perspective ordinary country evaluation outcome payment basic mechanism priority research project tilt china severe development policy national foreign affordability diagnosis thus like effect treatment important well patient pricing disease year insurance month shorter publishing chinese medicine number issue medical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557233/,abstract,1,tilt speeding publishing ordinary catalogue pricing payment foreign problematic shorter prioritizing affordability accessibility insurance adjustment annual priority project chinese china basic availability perspective poor policy national limited context evaluation medicine like issue country severe month drug medical recent mechanism rare outcome important number new diagnosis research development year effect treatment patient disease,{},{},{},{},{},{}
703,703,753,,26171360.0,schedule tehran assessment cross shahriar record sectional information technical widespread country cost risk usd month phonemethod section evidence form questionnaire health pram consistent home postpartum west project comparable result live telos data operational epidemic phone pregnancy seven surveillance rate periodic requirement problem economic implementation provide woman child outcome many model day simple method feasible via national system participation thyroid mother collection important valuable help incidence decision systematic city feasibility maternal component monitoring still within legal iran prevalence community determine birth background hospital conclusion different pattern study interviewer center random thirty volunteer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499089/,abstract,4,telos shahriar pram phonemethod operational interviewer periodic usd postpartum tehran schedule epidemic phone west live section volunteer thirty legal surveillance participation thyroid widespread city random home requirement technical feasibility feasible iran comparable valuable project record simple monitoring economic seven mother community decision systematic sectional center pregnancy collection component maternal woman help incidence implementation pattern consistent questionnaire hospital cross national cost determine provide problem prevalence birth country assessment background form month day information rate evidence outcome conclusion important risk model child different health method data result study,{},{},{},{},{},{}
704,704,755,10.1371/journal.pgen.1007557,30081392.0,bypass endoplasmic stress elongase disorder chain however elovl degeneration reduces activity baldspot death difference reticulum rescue pathway unclear across demonstrate role pigmentosa mechanism model ire cell stearate method induction variation supplementation target retinitis different tissue loss regulates human acid treatment perk number dietary important response finally fatty disease inter long genetic modifier gene individual drosophila promising characterize,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078684/,abstract,0,stearate perk elovl elongase baldspot regulates ire retinitis pigmentosa bypass reticulum endoplasmic drosophila rescue modifier induction degeneration reduces inter promising characterize demonstrate unclear fatty death finally supplementation stress loss variation chain tissue target long response pathway mechanism dietary activity important role difference cell number individual human model acid different gene genetic method disorder treatment disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""variation chain tissue target long response pathway mechanism dietary activity important r""]}}",{},{},{}
705,705,756,10.1177/1179547619831034,30814848.0,european exon better new encoding studied factor country onset need view highlight disease gestational extensive sanger relevant family atypical malta form clinical regional monogenic report never duplication diagnosis hepatocyte island mody combination first genetic type epidemiology young whole mutation three nuclear northern interest phenotype description population mediterranean exome diabetes hnf maltese father particularly rare lie within reported prevalence hotspot reinforces characterisation sibling responsible analysis either also mutational high frameshift heterogeneity gene maturity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383084/,abstract,1,maltese malta characterisation reported island hotspot reinforces maturity frameshift father mody mediterranean lie atypical duplication mutational sibling northern description sanger regional epidemiology encoding studied hnf monogenic gestational hepatocyte extensive young exome responsible exon view nuclear heterogeneity diabetes european combination onset particularly highlight relevant prevalence phenotype need country better form report rare family mutation new factor type diagnosis population gene high genetic clinical analysis disease,{},"{""genetic"": {""freq"": 1, ""string"": []}, ""heterogeneity"": {""freq"": 1, ""string"": [""young exome responsible exon view nuclear heterogeneity diabetes european combination onset p""]}}",{},{},{},{}
706,706,757,10.1007/s11136-016-1326-2,27245777.0,purposephenylketonuria discus difficult essential acceptance cooperation condition open pose disease pku friend medical family inferior questionnaire role courage support preferred integration data basis significance psychologist peer communication child therapeutic frequently conclusionour ass social towards parent team treatment challenge strict doctor find age still professional healthy comparison aim aware regardless importance also group different study barrier patient total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065618/,abstract,10,courage purposephenylketonuria friend psychologist inferior preferred pose doctor cooperation conclusionour acceptance aware regardless peer strict team integration barrier significance communication open frequently difficult basis professional questionnaire comparison social essential parent ass importance discus support aim healthy challenge therapeutic medical family total pku condition role child different age group data treatment patient disease study,"{""social"": {""freq"": 1, ""string"": [""frequently difficult basis professional questionnaire comparison social essential parent ass importance d""]}}",{},{},{},{},{}
707,707,758,10.1177/0022219417691048,28199175.0,specific slds whether memory difference phonological switching largely student additional average finally respectively form higher achievement word result syntax attention language basis oral explained regression level handwriting dyslexia measure linguistic text block variance model coding used predictor disability sequentially supervisory sequential nearly dysgraphia subword component every application uniquely cognitive impairment cascading orthographic translation grade group owl whereas spelling loop even beyond literacy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538955/,abstract,3,supervisory owl literacy cascading subword slds phonological explained dysgraphia switching spelling orthographic handwriting syntax sequentially dyslexia sequential linguistic uniquely loop coding achievement used student grade block variance nearly predictor language largely translation memory word oral text average component basis finally regression impairment disability attention additional form cognitive measure application respectively higher difference model specific group level result,{},{},{},{},{},{}
708,708,759,10.1371/journal.pone.0136602,26313643.0,presence every sequence strain two self shift spectroscopic monomer conformational factor conformation phenotype amyloid possible context current deeper structure spontaneous protein propagation fibril able feature modification previously either slightly analysis condition ethanol structurally infective literature report common thus different like study infrared data dimer acid unravel similar equilibrium important distinct prion disease type formation low amino number template,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551895/,abstract,0,spectroscopic prion infective propagation structurally infrared ethanol unravel spontaneous fibril deeper conformational conformation template equilibrium dimer monomer strain amyloid slightly shift modification distinct formation able sequence feature self context presence structure previously like phenotype similar literature possible report current amino condition important common low number factor type acid different protein data analysis disease study,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""phenotype similar literature possible report current amino condition important common low n""]}}",{},{}
709,709,760,10.1038/gim.2015.30,25741868.0,specific interpretation disorder past shift benign new describes single representative catalogue context amp laboratory complexity leveraging five molecular genetics expert moreover pathology segregation virtue epigenetic testing clinician acmg cap uncertain typical pathologist opinion geneticist paradigm medical director college sequence advent decade ever evidence exomes clinical guidance input report equivalent revisit result etc data significance computational guideline generation genetic type use functional panel pathogenic genomics population breadth describe technology american test recommendation association strongly challenge mendelian process variant primarily likely stakeholder standard category terminology next criterion analysis previously clia board genome group high classification rapidly sequencing revise gene workgroup,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544753/,abstract,1,workgroup virtue revise leveraging exomes director amp revisit clia catalogue cap breadth segregation pathologist describes acmg terminology college board benign geneticist advent uncertain mendelian stakeholder opinion epigenetic guidance representative rapidly paradigm input shift typical computational complexity interpretation equivalent american primarily classification pathology strongly significance expert category genomics clinician pathogenic past guideline decade panel sequence recommendation genome genetics criterion likely generation context sequencing previously laboratory functional technology testing standard process challenge variant medical single association molecular use report evidence test new specific type population gene group high genetic data disorder clinical analysis result,{},"{""genetic"": {""freq"": 1, ""string"": [""advent uncertain mendelian stakeholder opinion epigenetic guidance representative rapidly paradigm i"", ""specific type population gene group high genetic data disorder clinical analysis r""]}}",{},{},{},{}
710,710,761,10.1016/j.ymgmr.2019.100500,31453106.0,blood synthetic daily pathway molecule central tetrahydrobiopterin hiaa increase sepiapterin doe hydroxylase respectively csf subject homovanillic pharmaceutical dopamine clinically brain fluid fold neurotransmitter report sufficiently effect little genetic nmol low cerebrospinal level rate administration three one biomarkers pre placebo normal cnsa tyrosine notable overall already hydroxyindoleacetic dihydrobiopterin management day markedly post system baseline treatment person key within production serotonin apparently healthy hva nervous approximately precursor natural tryptophan larger trial plasma acid barrier cofactor deficiency volunteer preparation cns metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700519/,abstract,3,cnsa hydroxyindoleacetic hva homovanillic hiaa cerebrospinal dihydrobiopterin nmol csf notable sepiapterin apparently sufficiently cns volunteer person markedly preparation placebo pharmaceutical tryptophan synthetic fluid serotonin nervous neurotransmitter larger barrier fold precursor cofactor doe little dopamine baseline daily tetrahydrobiopterin approximately production post molecule clinically natural administration pre central biomarkers tyrosine hydroxylase overall metabolite normal healthy subject plasma management day trial increase key pathway brain deficiency report respectively rate low blood acid effect genetic level treatment,{},"{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""plasma management day trial increase key pathway brain deficiency report respectively r""]}}",{},{},{}
711,711,762,10.1007/978-1-4939-3271-9_30,26611604.0,rare suitable knowledge disorder availability animal three whether book example mellitus nervous therapy cns selection commonality brain review either amendable attempt adeno model central phenylketonuria degree secondary therapeutic primary heterogeneous comprise niemann development group highlight system like metabolic canavan prevalent large pick treatment vector finally virus diabetes disease aav genetic obstacle gene chapter pathomechanism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961359/,abstract,0,pathomechanism canavan amendable pick commonality book niemann comprise cns aav obstacle adeno attempt mellitus chapter heterogeneous vector prevalent degree virus nervous suitable availability diabetes selection secondary finally central animal example highlight like knowledge primary therapeutic large brain rare therapy phenylketonuria model review development metabolic gene group genetic disorder treatment disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
712,712,763,10.1080/20016689.2017.1381544,29081924.0,new pathway effort duration warrant reimbursement substantially additional due amendment parallel orphan funding well nonetheless medical introduction pharmaceutical innovation indication change poland establishment use appreciation flexibility market main direction ultra discussion label drug overall already vaccine many regulation device evident development stage landscape manufacturer excessive pricing draft decision list strict still two import likely access unclear category act currently criterion aspect mechanism impact research alignment high compassionate industry preparation budget,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645901/,abstract,0,compassionate amendment import pricing poland draft appreciation alignment vaccine manufacturer budget nonetheless warrant innovation funding reimbursement label ultra establishment flexibility substantially orphan market landscape excessive direction strict industry evident indication preparation duration device pharmaceutical parallel list act discussion introduction category access unclear aspect decision effort stage regulation criterion likely currently additional main overall change drug medical pathway use mechanism impact new research development high,{},{},"{""pathway"": {""freq"": 1, ""string"": [""additional main overall change drug medical pathway use mechanism impact new r""]}}",{},{},{}
713,713,766,10.1371/journal.pntd.0006196,29377882.0,specific tool blood culture venous serosurveillance separator titer condition igg igm control isotype findingsas concept pose eluate drop unsuitable highlighting vibriocidal storage range principal conventional card methodology result transport cholerae specimen iga cause change immune similarly strike south transmission useful elisa period use case functional death temperature polysaccharide current proof prioritizing cholera intervention population method determination potential antibody serum response filter year backgroundvibrio intensity assay challenge wide downstream sudan million spot logistical field spectrophotometric conclusionin paper plate also conclusion retained volunteer show,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805362/,abstract,1,vibriocidal sudan strike serosurveillance separator isotype findingsas eluate cholerae backgroundvibrio unsuitable spectrophotometric retained polysaccharide iga cholera logistical igm drop titer prioritizing plate conclusionin highlighting pose igg elisa venous principal proof card volunteer south specimen intensity transmission similarly filter antibody downstream culture conventional transport million temperature determination methodology storage immune concept useful death serum assay spot wide functional paper period field tool challenge change range cause response use intervention current conclusion condition case specific control blood population potential year method result,{},{},{},{},{},{}
714,714,767,10.21037/atm.2018.10.62,30740409.0,implication monitoring disorder assessment family iem pediatric behavioral clinical psychiatric role health review background benefit integrated model ibh emphasis error inborn highlight intellectual practice disability collaborate clinician specialist patient metabolism issue overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331357/,abstract,0,ibh collaborate integrated emphasis specialist psychiatric overview monitoring clinician iem behavioral intellectual pediatric implication disability practice highlight benefit issue assessment inborn background error family role metabolism model review health disorder clinical patient,"{""intellectual"": {""freq"": 1, ""string"": [""psychiatric overview monitoring clinician iem behavioral intellectual pediatric implication disability practice h""]}, ""behavioral"": {""freq"": 1, ""string"": [""specialist psychiatric overview monitoring clinician iem behavioral intellectual pediatric implication disability p""]}, ""psychiatric"": {""freq"": 1, ""string"": [""ibh collaborate integrated emphasis specialist psychiatric overview monitoring clinician iem b""]}}",{},{},{},{},{}
715,715,768,10.1016/j.ymgmr.2018.05.003,29946514.0,conclusionthe disorder chain record vietnam enbs difference among country several increasingly organic frequency moreover taiwan ketothiolase vary methylcrotonyl disease pku material spectrum however korea oxidation carboxylase citrullinemia additionally coa acyl china inborn result metabolic similarly selective furthermore south type methylmalonic yet rate dehydrogenase overall many phenylketonuria frequently via gas frequent respective fatty germany acidemia incidence imds particularly ppa mass newborn india imd resultsamong propionic determine mccd spectrometry popular different study medium methodsselective faods acid deficiency patient asian underwent amino chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014585/,abstract,1,methodsselective mccd faods vietnam taiwan ppa methylcrotonyl ketothiolase enbs citrullinemia korea imds vary resultsamong carboxylase popular respective india asian propionic imd acyl south methylmalonic underwent germany acidemia similarly oxidation coa gas conclusionthe selective dehydrogenase medium china record organic increasingly frequent frequently additionally fatty chromatography incidence furthermore chain spectrometry particularly frequency determine overall spectrum country inborn mass deficiency rate newborn pku material amino difference phenylketonuria type acid different metabolic disorder result patient disease study,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""mass deficiency rate newborn pku material amino difference phenylketonuria type acid d""]}, ""spectrometry"": {""freq"": 1, ""string"": [""additionally fatty chromatography incidence furthermore chain spectrometry particularly frequency determine overall s""]}, ""newborn"": {""freq"": 1, ""string"": [""spectrum country inborn mass deficiency rate newborn pku material amino difference p""]}}",{},{}
716,716,769,10.1016/j.cmet.2017.07.001,28768171.0,advance regulator availability however past growth transmit recent unexplored pathway variety protein input environmental review identification target mechanistic highlight sensor recently diverse master mtorc acid number ten question year help amino cell complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560103/,abstract,1,transmit unexplored mtorc master sensor input regulator mechanistic diverse variety question availability past advance help recently environmental highlight growth identification target complex pathway recent amino cell number review acid protein year,{},{},"{""pathway"": {""freq"": 1, ""string"": [""environmental highlight growth identification target complex pathway recent amino cell number r""]}}","{""amino"": {""freq"": 1, ""string"": [""growth identification target complex pathway recent amino cell number review acid p""]}}",{},{}
717,717,770,10.1007/s00213-015-4125-5,26576942.0,implication immediately blood relationship better single context reproduce across location glucose action difficulty display way significantly session evidence resultsglucose cognition higher impairs consistent play word improvement blank task draw mid level one ingestion placebo end conclusionsthe object hippocampal mode facilitative drink key methodsthirty finding particularly process robust heavily within load remembering manipulation rationalethere temporarily influence function dependent shape cognitive aim matrix impact group different objectivethis study successfully hippocampus participant successful performance sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710657/,abstract,7,temporarily resultsglucose remembering rationalethere reproduce heavily facilitative blank objectivethis methodsthirty mid hippocampal draw impairs manipulation ingestion object drink shape location immediately display hippocampus load cognition session matrix mode placebo successfully conclusionsthe action robust end word difficulty sensitive successful glucose task play way dependent implication improvement consistent context influence particularly relationship performance finding better participant process cognitive aim key single impact evidence higher function significantly blood different group level study,{},{},{},{},{},{}
718,718,772,10.3390/nu11071537,31284588.0,biological prisma chain cochrane neural inconclusive item visual adult bias common supplementation risk neurocognitive mean old motor effective docosahexaenoic pku status intake retina animal beneficial phenylalanine evidence cognition optimal value role protein brain error food methodology inborn preferred effect data guideline decrease long metabolism level database child review week phenylketonuria development scopus potential concentration free treatment wave rich pufa fatty limit diet year medline finding systematic latency age collaboration especially function analysis dha natural available trial arachidonic high study acid meta patient amino,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682937/,abstract,5,prisma retina pufa arachidonic wave scopus preferred latency docosahexaenoic inconclusive dha item cochrane neurocognitive cognition collaboration rich medline neural bias visual beneficial methodology meta limit optimal motor guideline fatty systematic natural supplementation decrease old animal mean free chain intake especially database biological week status finding inborn food long trial value error effective brain adult diet concentration evidence pku amino role common function phenylketonuria available metabolism risk phenylalanine review acid potential child protein age development year effect high data level treatment analysis patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""common function phenylketonuria available metabolism risk phenylalanine review acid potential child p""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""brain adult diet concentration evidence pku amino role common function phenylketonuria a""]}}","{""diet"": {""freq"": 1, ""string"": [""trial value error effective brain adult diet concentration evidence pku amino r""]}}",{}
719,719,773,10.1002/mgg3.160,26740942.0,disorder exon region fancd time positive molecular moreover variation testing fancf control number ion characterize suitable sanger quantitative marrow fancl clinical fanca fanconi output mutant diagnosis large characterized consuming copy generation novel genetic greatly ipgm mutation least size failure sensitivity evaluation point coding identification frequently technology system unknown intragenic false specificity rare sample two variant allele negative pgm complementation since involved bone next dna quality deletion analysis coverage also group high heterogeneity fancc sequencing gene complex anemia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694132/,abstract,1,ipgm intragenic fancl fancf fancd fancc fanca complementation fanconi characterized pgm anemia marrow consuming coding greatly output copy ion sanger coverage bone characterize false deletion failure exon suitable involved mutant heterogeneity frequently specificity unknown allele size dna quantitative sensitivity negative generation variation point sequencing evaluation identification technology testing region complex positive variant quality large molecular rare novel mutation sample number time control diagnosis gene group high genetic disorder clinical analysis,{},"{""genetic"": {""freq"": 1, ""string"": []}, ""heterogeneity"": {""freq"": 1, ""string"": [""deletion failure exon suitable involved mutant heterogeneity frequently specificity unknown allele s""]}}",{},{},{},{}
720,720,774,10.1016/j.ymgme.2014.12.434,25655951.0,specific disorder abnormality instance neuroim discus proposal present cns careful half central molecular glia ambiguous testing gle majority disease leukodystrophies spectrum extensive matter line decade however addison hold resolve clinical feature global result diagnosis generation combination adrenoleukodystrophy first genetic use case hypodontia leukodystrophy least white evaluation odyssey many approach workflow system pol recommendation iii gles promise unresolved nearly systematic dramatically process wide consensus lds mri definitive detailing minimum nervous next salient leukoencephalopathies broad also trial genome diagnostic often magnetic agnostic patient gene number initiative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390485/,abstract,0,odyssey neuroim lds hypodontia gles detailing agnostic adrenoleukodystrophy addison unresolved pol leukoencephalopathies glia gle salient leukodystrophies proposal ambiguous leukodystrophy hold resolve instance cns careful minimum dramatically definitive workflow mri iii promise nearly initiative consensus broad extensive nervous half matter line white magnetic decade majority systematic global recommendation genome central abnormality feature generation combination evaluation wide discus testing spectrum diagnostic process trial molecular use approach number present case specific diagnosis gene genetic disorder clinical result patient disease,{},"{""genetic"": {""freq"": 1, ""string"": [""number present case specific diagnosis gene genetic disorder clinical result patient d""]}}",{},{},{},{}
721,721,775,10.1007/s10354-015-0423-0,26819216.0,rare phenotypic specific considerable outpaces tool relationship however opportunity company pharmaceutical unique screening philanthropist since current symbiotic drug failure present therapy discovery researcher approach academic profit forefront therapeutic framework development target cost state diagnosis potential thus risk institute useful technological somewhat orphan vastly novel disease industry discover academia gene challenge medicine number art non,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963293/,abstract,2,symbiotic philanthropist outpaces somewhat forefront academia profit vastly company discover art institute orphan academic technological industry pharmaceutical considerable researcher failure phenotypic discovery framework unique opportunity useful cost medicine relationship target tool screening state challenge drug therapeutic rare novel therapy current non approach number present risk specific diagnosis potential development gene disease,{},{},{},"{""screening"": {""freq"": 1, ""string"": [""useful cost medicine relationship target tool screening state challenge drug therapeutic r""]}}",{},{}
722,722,776,10.1093/jlb/lsy014,30191066.0,propel information affect difficult algorithm selection reproductive together choice pressure capacity profoundly experience inequity autonomy amount numerous however ever trait tyranny raise health result tale diagnosis effect obtain embryo change combination ability genetic enormous ultimately cautionary provider compelling diversity specter child societal toward development social potential inevitably technology parent article test vexing nevertheless best decision challenge particularly predictive future two simply advancement variant professional vast make eugenics circumspection remedy preimplantation technological overload assist number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121058/,abstract,0,vexing tyranny tale specter propel circumspection profoundly inequity eugenics cautionary inevitably remedy overload autonomy simply preimplantation enormous compelling vast make societal obtain assist raise embryo technological advancement ultimately diversity reproductive algorithm provider pressure numerous choice capacity predictive affect trait selection decision difficult experience best professional combination particularly social ability parent technology challenge change variant future information article number test diagnosis potential child development health effect genetic result,"{""social"": {""freq"": 1, ""string"": [""difficult experience best professional combination particularly social ability parent technology challenge c""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
723,723,777,10.1038/s41431-018-0276-2,30287898.0,biological blood shift search new greater methodological information transparency final present consent initial insight literature ethic danish disease objective contribute knowledge actively however screening secondary therefore primary result metabolic purpose little ndbs area use hope three main one discussion biobank many population inclusion usage mental describe national illness article resource year finding future sample two newborn approval spot million estimate field criterion analysis paper program research also part study beyond,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336790/,abstract,1,ndbs transparency danish hope usage biobank methodological approval actively ethic consent final illness shift million contribute discussion initial little inclusion search resource secondary estimate mental insight criterion national purpose spot greater biological paper main field knowledge finding literature area screening objective program primary future use information newborn article sample present new blood research population metabolic year analysis result disease study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""objective program primary future use information newborn article sample present new b""]}, ""screening"": {""freq"": 1, ""string"": [""main field knowledge finding literature area screening objective program primary future u""]}}",{},{}
724,724,778,10.1186/s13023-016-0544-6,27906067.0,disorder activity pathophysiologic respiratory lead growth single early progressive spurt glycoconjugates prenatal condition physical common share substitution effective accumulation disease glycoasparagines embryonic neuronal biochemical animal macrocephalia histopathologic cognition adaptive clinical storage health protein fluid brain replacement mouse usually body symptom degradation recessively finland diagnosis enzyme change cause infantile far appearance completely recombinant cysteine detection non finnish case rapid mutation main death end infection structure sign population undegraded therapeutic aspartylglucosamine identification serine moiety development disruption allogenic skill disability treatment lysosomal key personality year cell carrier glycosylasparaginase age deficient protocol agu glycoprotein lifelong prevalence responsible stem homozygosity characteristic transplantation trial aspartylglucosaminuria intellectual tissue high nucleotide human deficiency patient correction gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134220/,abstract,1,undegraded spurt macrocephalia histopathologic glycosylasparaginase glycoconjugates glycoasparagines aspartylglucosaminuria aspartylglucosamine allogenic personality agu finnish homozygosity glycoprotein finland appearance recessively pathophysiologic moiety infantile cysteine serine lysosomal disruption respiratory embryonic cognition substitution share lifelong recombinant adaptive correction usually stem completely skill sign transplantation progressive replacement neuronal fluid far degradation prenatal responsible deficient storage end nucleotide protocol carrier accumulation infection death intellectual physical animal rapid lead disability structure tissue growth identification characteristic prevalence main biochemical mouse detection body symptom enzyme trial change cause key therapeutic effective brain single deficiency activity mutation condition non common cell case human early diagnosis population protein age development health gene year high disorder treatment clinical patient disease,"{""intellectual"": {""freq"": 1, ""string"": [""nucleotide protocol carrier accumulation infection death intellectual physical animal rapid lead d""]}}",{},{},"{""detection"": {""freq"": 1, ""string"": [""identification characteristic prevalence main biochemical mouse detection body symptom enzyme trial c""]}}",{},{}
725,725,779,10.1186/s12889-015-1983-z,26197779.0,resonance major metabolome disorder assessment almost factor early deeper adult elderly vigilance programme physical additional separate vascular inhabitant investigate august biomarker testing well disease objective leipzig visit extensive discussionthe life marker deep dysregulation backgroundthe allergy follow predisposition east questionnaire role range brain focus sleep particular examination primary core genotype depression recently metabolic interview kind first genetic designthe completely rate main imaging size retinal optic centre cover already eastern population november method baseline participation collection germany nerve year city lifestyle age degeneration biospecimen two prevalence civilization subgroup function heart cognitive impairment analysis research electroencephalography diagnostic cohort urban part study magnetic underwent randomly participant commence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509697/,abstract,4,leipzig civilization vigilance designthe commence biospecimen inhabitant predisposition optic discussionthe allergy electroencephalography dysregulation elderly deeper august nerve eastern cover retinal november metabolome kind urban east deep degeneration visit sleep underwent germany participation vascular city core imaging subgroup completely randomly lifestyle programme depression centre resonance interview backgroundthe separate extensive biomarker examination magnetic baseline genotype heart follow collection size particular physical recently questionnaire focus marker impairment investigate cohort prevalence additional main testing diagnostic participant assessment cognitive objective major range primary brain adult rate life role function early factor research population age metabolic year genetic method disorder analysis disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""factor research population age metabolic year genetic method disorder analysis disease s""]}}",{},{},{},{}
726,726,780,10.1186/s13229-016-0095-7,27354901.0,disorder whether investigation sensory region visual density amplitude variation translatable backgroundduplication continuous investigate control waveform noninvasive way status merit animal however quantitative dosage unaffected relative methodspattern dysfunction range developmental eeg symptom duplication result diminished effect resultsquantitative contrast language change cause copy useful chromosomal checkerboard neurobiological measure white processing child model conclusionsthe method development potential disability stimulus response net circuitry year directly promising probe electrode component latency age typically unclear correlate dependent deletion circumference impairment analysis mechanism broad head cortical intellectual high study successfully black reversal gene number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924305/,abstract,6,waveform translatable resultsquantitative methodspattern diminished backgroundduplication reversal checkerboard merit electrode amplitude unaffected circuitry black latency duplication cortical neurobiological stimulus sensory noninvasive eeg dosage net chromosomal copy circumference probe processing head density correlate promising visual continuous successfully broad language deletion typically conclusionsthe unclear white relative directly contrast useful intellectual way investigation component dependent quantitative animal impairment dysfunction disability variation investigate developmental status region symptom measure change range cause response mechanism number model control potential child age development gene year effect high method disorder analysis result study,"{""intellectual"": {""freq"": 1, ""string"": [""unclear white relative directly contrast useful intellectual way investigation component dependent q""]}}",{},{},{},{},{}
727,727,781,10.1097/MD.0000000000009322,29390507.0,blood relationship daily sectional greater lower positive present median weight central tonometry pressure pwv marked risk old control velocity increase pku phe pulse biochemical subject pharmacological atherogenesis higher clinical range tendency arterial body never bigger result property effect large aortic data percentile level compliant although biomarkers annual proper evaluation applanation stiffness phenylketonuria augmentation second artery tolerance treatment wave year diet inflammatory age percentage healthy sapropterin aix index cardiovascular research classic overweight practice study noninvasively patient show elastic parameter gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758209/,abstract,3,tonometry pwv elastic bigger applanation aix noninvasively atherogenesis augmentation velocity compliant stiffness arterial tendency wave marked percentile artery aortic overweight pulse annual proper sapropterin tolerance percentage pressure classic gender pharmacological cardiovascular daily inflammatory sectional parameter property median index central second old weight biomarkers practice evaluation greater biochemical relationship body phe healthy subject range positive increase large lower diet pku higher phenylketonuria present risk control blood research age year effect data level treatment clinical result patient study,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""subject range positive increase large lower diet pku higher phenylketonuria present r""]}}",{}
728,728,782,10.1155/2016/9485412,27123458.0,asds hydroxypropionic disorder autism information abnormal gut hydroxyphenyl hphpa presumably aged aromatic control urinary overgrown excretion spectrum measurement utility microbiota subject recent optimal higher clinical compound probability china support purpose oral hpa non regression area three biomarkers curve prediction strong sensitivity child highly hydroxyhippuric markedly mental used predictor potential illness concentration auc treatment receiver finding specificity two hha demonstrate subgroup analysis characteristic paper also metabolomic roc group diagnostic autistic high study acid similar patient vancomycin hydroxyphenylacetic metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829699/,abstract,2,vancomycin overgrown hydroxypropionic hydroxyhippuric hphpa hha hydroxyphenylacetic hydroxyphenyl presumably asds autistic roc auc probability receiver gut excretion microbiota metabolomic used illness hpa subgroup markedly curve aromatic predictor prediction urinary china demonstrate optimal strong oral utility abnormal specificity autism mental aged regression compound sensitivity purpose measurement biomarkers highly characteristic paper spectrum diagnostic finding similar area support metabolite subject recent information concentration higher non control acid potential child group high disorder treatment clinical analysis patient study,{},{},{},{},{},{}
729,729,783,10.1371/journal.pone.0159002,27391465.0,considerable exhibited activity search single difference dichlorobenzene site chemical substitution hypothesis well cytosolic isoenzymes significantly respectively methylidene threefold pepck trait value compound property hand effect decrease novel thienyl inhibition significant isoenzyme three one isoforms interest phenotype pig inhibitor apparent economic population work solubility methyl pyrazol strongly finding specificity library two carbohydrazide reinforces magnitude carboxykinase kinetic either gtp different pattern nucleotide whereas acid similar mercaptopicolinic vmax trifluoromethyl inhibitory amino,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938538/,abstract,3,trifluoromethyl thienyl pyrazol pepck mercaptopicolinic dichlorobenzene carboxykinase carbohydrazide vmax methylidene isoenzymes isoenzyme threefold pig solubility reinforces isoforms exhibited cytosolic kinetic magnitude gtp library apparent methyl inhibitory substitution hand inhibitor considerable strongly inhibition chemical economic nucleotide hypothesis trait search specificity property decrease pattern compound work site phenotype finding similar value single respectively novel activity amino difference significantly population acid different significant effect,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""similar value single respectively novel activity amino difference significantly population acid d""]}}",{},{}
730,730,784,10.3389/fmicb.2016.01736,27853455.0,expensive culture isolate mail biohazard ambient time laboratory liquid without condition easily moreover regular recipient control effective addition avoid virus preservation material quick sanger desirable container form value storage recovery reagent san minor whereby therefore real purified degradation card result inactivate thus supernatant obtain specimen equipment low llc worst pcr lab ultra nsw temperature room capability many week device whatman day method feasible simple target fortiusbio filter nevertheless cool cell rnasound threshold sample two minimal rna normally whilst packaging usa quality either special send paper alternative also rydalmere diego grade cycle different similar dry healthcare gene australia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5090134/,abstract,3,supernatant send rydalmere rnasound nsw inactivate fortiusbio cool biohazard llc isolate diego container worst san purified packaging reagent normally whatman recipient preservation quick mail equipment dry desirable ambient usa ultra minor expensive avoid whilst easily obtain australia threshold card lab specimen sanger room capability grade regular recovery filter minimal culture device feasible temperature pcr rna virus special degradation real storage simple cycle liquid healthcare alternative laboratory week paper target similar form addition day value quality effective material condition cell sample low time control different gene method result,{},{},{},{},{},{}
731,731,785,10.1002/advs.201800801,30479925.0,specific nanoparticles new vivo site encapsulation dds concept extension finally disease nanoreactors cancer much rather strategy basically biocatalytic nanofactories glaucoma feature therefore capsule effectiveness efficacy enzyme attention effect fabrication design decrease intoxication type lipid significant although current capsid drug side release provide approach simple therapeutic polymer development mesoporous reactor system neuropathic respective treatment delivery important viral help vesicle promising shortcoming overview carrier wide still silica application scope field also different hydrogel prodrug alcohol advantage conversion agent prospect,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247036/,abstract,0,silica reactor prodrug neuropathic nanoreactors nanofactories mesoporous glaucoma dds capsid basically biocatalytic vesicle shortcoming encapsulation hydrogel fabrication nanoparticles capsule prospect intoxication respective extension polymer scope release alcohol conversion viral promising lipid overview simple advantage agent concept carrier vivo effectiveness delivery finally decrease help cancer site efficacy feature attention wide design provide field enzyme application drug strategy therapeutic current important approach new specific type different significant development effect treatment disease,{},{},{},{},{},{}
732,732,786,10.1124/jpet.114.221572,25550200.0,potent activity sulfathiazole redox spr reaction presumably inhibit biosynthesis tetrahydrobiopterin molecular chemical aromatic catecholamine radical toxicity sepiapterin bipyridinium generates homovanillic reduction dopamine menadione anti higher alkylglycerol reductase neurotransmitter enzyme effect data specie ability inhibition metabolism recombinant rapid one sulfapyridine inhibitor sulfonamide drug mediates critical markedly reactive via target noncompetitive quinone concentration ameliorate dihydroxyphenylacetic active herbicide cell inflammatory production phenanthrenequinone diquat nitric untoward electron sulfasalazine dependent reduced hydroxylases mechanism precursor chlorpropamide oxygen also sulfamethoxazole oxide monoamine acid human distinct cofactor amino metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352594/,abstract,0,sulfonamide sulfathiazole sulfasalazine sulfapyridine sulfamethoxazole phenanthrenequinone noncompetitive menadione diquat chlorpropamide bipyridinium untoward mediates generates dihydroxyphenylacetic herbicide alkylglycerol spr quinone hydroxylases homovanillic presumably inhibit redox sepiapterin radical electron catecholamine reductase ameliorate monoamine oxygen reactive potent recombinant toxicity nitric markedly aromatic oxide biosynthesis specie inhibitor neurotransmitter distinct inhibition chemical reduced precursor cofactor anti dopamine tetrahydrobiopterin inflammatory active production reaction dependent reduction rapid critical ability target metabolite enzyme drug molecular mechanism concentration activity amino higher cell metabolism human acid effect data,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""enzyme drug molecular mechanism concentration activity amino higher cell metabolism human a""]}}",{},{}
733,733,787,10.1371/journal.pone.0201489,30067850.0,various region growth among caucasus widespread country world frequency due parallel common locus varies repeat origin disease hydroxylase pku tradition phenylalanine disequilibrium monoethnic unique titular haplotype geographically republic generation culturally genetic tandem extragenic mutation short pathogenic marriage arg population phenylketonuria nation russia year incidence cherkess carrier linkage age variant newborn allele ethnic prevalence healthy ago ethnos analysis pah phenomenon group karachay different isolated patient highest variability gene individual founder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070269/,abstract,1,titular monoethnic extragenic ethnos tradition culturally caucasus russia karachay geographically cherkess disequilibrium varies nation republic ethnic founder marriage ago isolated arg haplotype phenomenon linkage repeat widespread origin parallel locus variability pathogenic highest tandem carrier unique world allele incidence short pah generation frequency growth prevalence hydroxylase country region various healthy variant newborn mutation pku common phenylketonuria individual phenylalanine population different age gene group year genetic analysis patient disease,"{""phenylalanine"": {""freq"": 2, ""string"": [""newborn mutation pku common phenylketonuria individual phenylalanine population different age gene g""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""tandem"": {""freq"": 1, ""string"": [""origin parallel locus variability pathogenic highest tandem carrier unique world allele i""]}, ""newborn"": {""freq"": 1, ""string"": [""hydroxylase country region various healthy variant newborn mutation pku common phenylketonuria i""]}}",{},{}
734,734,790,10.1007/8904_2017_86,29380259.0,reanalysis delay disorder daily early improved boy analog despite gait due marked old revealed exercise responsive pipeline initiation later phenylalanine life extrapyramidal reduction partial dihydrochloride additionally biallelic developmental improvement report movement diagnosis recently strikingly hpa level case mutation dnajc outcome normalization day persistently exome tolerance treatment year age homozygous hyperphenylalaninemia favorable standard sapropterin advanced deletion analysis background benefit conclusion upon plasma deficiency patient even,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226397/,abstract,1,reanalysis gait revealed extrapyramidal strikingly persistently dnajc biallelic normalization analog pipeline dihydrochloride marked improved initiation favorable exercise sapropterin advanced hpa boy homozygous movement tolerance responsive partial deletion exome hyperphenylalaninemia later delay daily additionally improvement old recently reduction developmental despite benefit standard background plasma day deficiency report life mutation outcome conclusion case early phenylalanine diagnosis age year level disorder treatment analysis patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""life mutation outcome conclusion case early phenylalanine diagnosis age year level d""]}}","{""homozygous"": {""freq"": 1, ""string"": [""favorable exercise sapropterin advanced hpa boy homozygous movement tolerance responsive partial d""]}}",{},{},{},{}
735,735,791,10.1155/2018/9541621,30250657.0,assessment tool content information difficult across july visual preference reaction choice well material highlighting faced measurement knowledge element however understandability recent previous engage consistent genomic ensure qualitative psychological tailor language oversample design genetic type eight medicine educational provider main one measure alike white provide population breadth review comprehension aid method work ass evident potential organization test treatment ten precision important key appropriately systematic educated process two opportunity primarily typically scope community limited groundwork field quality underrepresented characteristic research push simplified study patient participant healthcare individual complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140003/,abstract,1,oversample understandability underrepresented faced educated breadth tailor push groundwork alike ensure simplified engage comprehension highlighting appropriately scope july aid preference evident provider visual psychological qualitative primarily educational language element typically choice organization precision white healthcare opportunity community difficult systematic content reaction previous genomic consistent work limited measurement medicine design ass provide characteristic main field knowledge participant assessment process tool measure complex key quality recent information material important test individual type research population review potential genetic method treatment patient study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
736,736,792,10.1016/j.ymgmr.2018.11.003,30705824.0,european cross disorder milk vegetable sectional region single factor formula across essential acceptance throughout grouped choice geographical fruit source effective addition majority month survey pku semi phe allocate caregiver phenylalanine methodsa evidence strategy form mainly optimal higher questionnaire health protein burden usually primary food equivalent austria metabolic prospective question term combination adherence first long low monkey northern interest centre spoonable eastern around replace approach week phenylketonuria method southern ass development stage colleague system second free solid europe gradually important supplement calculated germany diet conclusionsweaning age reduces imd professional healthy determinant standard breast influence analysis longer natural infant multiple identify exchange different feeding study acid dietary predominantly amino acceptable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349955/,abstract,3,grouped conclusionsweaning spoonable colleague allocate replace monkey austria vegetable geographical eastern gradually acceptance southern northern fruit calculated imd europe feeding germany breast solid semi reduces predominantly longer determinant supplement exchange formula usually equivalent milk centre acceptable caregiver methodsa adherence choice identify prospective optimal question mainly burden european majority sectional natural stage professional source survey second questionnaire cross combination free influence essential ass week standard region food form month phe infant healthy addition long multiple primary strategy effective single diet dietary evidence pku amino term higher important phenylketonuria low approach phenylalanine factor acid different protein age development metabolic health method disorder analysis study,"{""phenylalanine"": {""freq"": 2, ""string"": [""term higher important phenylketonuria low approach phenylalanine factor acid different protein a""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""effective single diet dietary evidence pku amino term higher important phenylketonuria l""]}}","{""diet"": {""freq"": 1, ""string"": [""long multiple primary strategy effective single diet dietary evidence pku amino t""]}}",{}
737,737,793,10.1002/prp2.325,28603639.0,preferentially flupentixol architecture asymmetric several demonstrates analog site inhibit insight molecular action capable common tmd mechanistic addition disease abc element family latter protein compound crystal transmembrane mutant manner structural substrate helix result property thus transport cause furthermore modulator cassette ability inhibition transmission formation icls mutation member trafficking transporter coupling structure proper point critical model correct prerequisite corrector concentration important active similarity finding intracellular interface deficient two suggest glycoprotein positioning correlate dependent available nbds domain nucleotide study vulnerable human position loop engagement atp pseudosymmetric correction propafenone contingent asymmetry,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464349/,abstract,2,trafficking tmd pseudosymmetric propafenone nbds icls flupentixol corrector abc modulator helix contingent asymmetry positioning glycoprotein cassette preferentially coupling asymmetric analog prerequisite inhibit vulnerable transmembrane atp engagement loop architecture intracellular suggest demonstrates crystal similarity interface transmission proper position correction capable manner correlate transporter substrate mechanistic correct transport element deficient inhibition action formation member mutant nucleotide structural active domain property dependent insight compound site critical furthermore structure point ability finding addition cause molecular family concentration mutation important common available human model protein result disease study,{},{},{},{},{},{}
738,738,794,10.1177/1099800417725190,28920489.0,inheritance definition linkage knowledge nursing however example nurse discus phenotype discussion genomics current conversation essential brief clinical series goal clarification incorporate basic overview research science method genomic literature genetics primer practice foundational article inconsistently publication significance concept term elucidate association first genetic education fifth mendelian,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858940/,abstract,0,foundational clarification inconsistently fifth conversation nursing primer nurse incorporate elucidate mendelian linkage brief definition inheritance series publication discussion basic significance overview genomics goal concept education science genomic example genetics practice essential phenotype discus knowledge literature association current term article research genetic method clinical,{},"{""inheritance"": {""freq"": 1, ""string"": [""incorporate elucidate mendelian linkage brief definition inheritance series publication discussion basic s""]}, ""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
739,739,795,10.1038/s41598-018-21094-6,29453426.0,carrier necessity aneuploid rate subject pathogenic single screening blastocyst among normal select abnormal approximately analysis total monogenic analyze november technique importance preimplantation egg aneuploidy chip via result diagnosis cycle diagnostic silent pgs thus effect non april transfer embryo disease genetic incidence karyomap gene pgd,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816636/,abstract,6,karyomap aneuploid pgd egg blastocyst aneuploidy silent pgs preimplantation necessity november select chip embryo april analyze transfer monogenic pathogenic carrier cycle abnormal approximately incidence technique importance diagnostic normal screening subject single rate total non diagnosis gene effect genetic analysis result disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""screening"": {""freq"": 1, ""string"": [""approximately incidence technique importance diagnostic normal screening subject single rate total n""]}}","{""egg"": {""freq"": 1, ""string"": [""karyomap aneuploid pgd egg blastocyst aneuploidy silent pgs p""]}}",{}
740,740,796,10.3390/mi7020028,30407401.0,whole monitoring blood rapid practically phenylalanine quantitative volume time current optimal several laboratory therapy reproducibility around point phenylketonuria paper device day together therapeutic optimizing report slow development sufficiently potential detection metabolic testing data effective small patient readout doe disease pku typical care resolution useful return,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190008/,abstract,0,optimizing practically readout return sufficiently slow reproducibility typical device resolution monitoring optimal doe volume useful quantitative rapid point laboratory paper small testing detection day therapeutic effective report care therapy current pku phenylketonuria time phenylalanine blood potential development metabolic data patient disease,"{""phenylalanine"": {""freq"": 2, ""string"": [""care therapy current pku phenylketonuria time phenylalanine blood potential development metabolic d""]}}",{},{},"{""detection"": {""freq"": 1, ""string"": [""rapid point laboratory paper small testing detection day therapeutic effective report c""]}}",{},{}
741,741,797,10.3389/fnins.2019.00647,31281239.0,metabolome male hour pathway affect several glucose periphery serious light subsequently pathology separate investigate sympathetic sham finally significantly cancer unaffected lan obesity role play separated hand wistar recently effect innervation removal denervation change clock selective denervations rat level clearly four one involvement hepatic acute night many able liver branch hepatectomy regulation markedly parasympathetic via expression exposure system tolerance important nevertheless diabetes nerve associated transcript metabolite acutely nervous analysis autonomic conclusion group plus endocrine part study small surgical gene individual total number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6596368/,abstract,3,wistar lan denervations denervation periphery parasympathetic innervation hepatectomy clock sympathetic branch autonomic sham removal night endocrine unaffected separated acutely transcript nerve metabolome surgical hand clearly plus markedly subsequently tolerance hepatic involvement selective light separate hour pathology nervous rat able affect diabetes glucose obesity play acute associated regulation finally cancer recently exposure liver investigate male small metabolite expression change pathway total conclusion important role number individual significantly gene group effect level analysis study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""investigate male small metabolite expression change pathway total conclusion important role n""]}}",{},{},{}
742,742,798,10.1371/journal.pone.0184748,28910364.0,logistic male disorder blood whether prospectively ratio factor information lower hypertensive congenital krec labor neonatal without odds weight irrespective preterm risk stockholm smoking disease gestational section sweden circle account interval screening excision health consistent gestation backgroundbirth april data conclusioncesarean significance receptor immune pregnancy formation low score singleton regression establishment level confidence recombination parity morbidity database week model method perinatal calculate mode sex postnatal delivery aor association diabetes cell trec maternal bmi age future quintile multivariate birth function either characteristic program infant quantity postterm lowest part small deficiency february participant apgar newly malformation lymphocyte,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599043/,abstract,1,postterm conclusioncesarean backgroundbirth aor stockholm quintile hypertensive krec apgar trec irrespective lymphocyte excision recombination parity calculate labor circle sweden february smoking singleton establishment postnatal section prospectively perinatal gestation april newly lowest quantity malformation multivariate odds preterm mode bmi logistic gestational sex significance confidence immune formation receptor diabetes morbidity interval account pregnancy delivery maternal consistent regression weight neonatal database congenital male week characteristic ratio birth small score participant infant screening program future lower association deficiency information cell function low risk model factor blood age health method data level disorder disease,{},{},{},"{""screening"": {""freq"": 1, ""string"": [""ratio birth small score participant infant screening program future lower association d""]}}",{},{}
743,743,799,10.1186/s13039-019-0418-4,30766616.0,conclusionthe specific abnormality factor single pathway puzzle centric several defect polygryphic digryphic molecular due view genetics variation apart common multifactorial distinctly concept backgroundin extension way influential disease tradition issue numerous historical medical suitable ubiquitously however perfectly unique recent hypothetical perspective additionally achievement nature word focus monogenic academic genomic possibility result thus oligogenic etc homeogryphic term genetic formation medicine chromosomal case cellular oligogryphic comorbid phenotype per progression current syndrome polygenic able greek thereby propose system illness simultaneously alteration simultaneous net hundred cascade definition generally griphos two designation pathogenetic biology ancient since monogryphic explore basic currently mechanism consequence different classification presentation human accurately gene idea parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362588/,abstract,0,puzzle polygryphic perfectly oligogryphic monogryphic homeogryphic griphos greek distinctly digryphic tradition designation pathogenetic oligogenic ancient ubiquitously centric hypothetical polygenic influential cascade multifactorial historical extension comorbid apart idea achievement net simultaneous chromosomal academic accurately simultaneously backgroundin illness definition monogenic conclusionthe classification propose numerous basic view suitable progression generally possibility presentation nature formation word able biology concept cellular unique alteration additionally perspective explore way parameter genomic consequence abnormality focus genetics variation syndrome defect currently medicine issue phenotype medical pathway single molecular recent mechanism current term common case human specific factor different gene genetic result disease,{},"{""genetic"": {""freq"": 1, ""string"": [""greek distinctly digryphic tradition designation pathogenetic oligogenic ancient ubiquitously centric h""]}}","{""pathway"": {""freq"": 1, ""string"": [""defect currently medicine issue phenotype medical pathway single molecular recent mechanism c""]}}",{},{},{}
744,744,800,10.4103/jfmpc.jfmpc_74_19,31041292.0,rare male flexion case knowledge disorder delay seizure bos sporadic ever abnormality outlet almost baby ventricle apw failure syndrome clinical present heart developmental confirmation facial feature half without nonspecific week hospital double window body congestive posture difficulty presentation feeding study old right thrive dorv cardiac basis dysmorphic patient first opitz genetic typical aortopulmonary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482752/,abstract,0,opitz flexion dorv congestive apw aortopulmonary ventricle thrive posture bos outlet dysmorphic nonspecific sporadic window facial confirmation feeding typical baby right cardiac seizure half failure double delay presentation difficulty heart basis old abnormality hospital feature developmental syndrome male week knowledge body rare present case genetic disorder clinical patient study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
745,745,801,10.1002/aur.1777,28401679.0,various biological disorder relevant peer progesterone asd evidence autism least abnormality estrogen behalf society testosterone present author wiley mechanism coleman impact research refer literature subsequently development international potential link posit gillberg periodical hypothesis cholesterol kind hormone vitamin cortisol steroid metabolism inc spectrum,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485071/,abstract,2,posit gillberg coleman behalf testosterone progesterone periodical wiley refer cortisol estrogen steroid kind peer cholesterol subsequently author society link vitamin hormone asd hypothesis international autism abnormality biological relevant spectrum literature various mechanism impact evidence present metabolism research potential development disorder,{},{},{},{},{},{}
746,746,802,10.1002/jmri.25356,27351712.0,coefficient tool hour lcmodel ratio difference single content lower glutamate profile tesla methodsfive separate variation average purposeto principle acquisition inter material respectively semi cov spectrum twice measurement refocusing sequence biochemical session rao relevant cramer subject editing marker smaller clinical brain glutathione methodology adiabatic steam quantification resultscrlb selective echo laser one sclerosis proof overall mode concentration test detect aminobutyric along spectroscopy healthy determine reproducibility gaba research pathophysiology also multiple comprehensive biochemicals high acid human gsh patient accuracy metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5167659/,abstract,2,steam resultscrlb refocusing rao lcmodel cramer cov biochemicals adiabatic tesla methodsfive gsh echo aminobutyric twice purposeto gaba laser glutathione editing smaller acquisition sclerosis proof glutamate reproducibility session semi inter detect spectroscopy quantification mode coefficient pathophysiology principle selective separate hour methodology accuracy comprehensive average content sequence profile marker variation measurement relevant determine biochemical ratio overall spectrum metabolite tool healthy subject multiple lower brain single respectively concentration material difference test human research acid high clinical patient,{},{},{},{},{},{}
747,747,803,10.1128/AEM.03595-14,25662979.0,major potent hormonally growth vvc trigger potently menstruation reproductive nutrient virulent artificial genuine formulation well epithelium asf issue pulse yeastlike filamentous tightly subject life introduction resident atmospheric seminal engage developmental fluid albumin candida candidiasis environment contribution efficacy vulvovaginal conversely cause level mimic filamentation synergistically periodic pathogenic temperature woman coitus model concomitant switch unprotected ass contact stage potential exposure serum mode substantial response year fungus cell avf faithfully component within transient virulence induce acetylglucosamine quality act albicans natural intermittent program vaginal high simplified inducer acid even inhibitory amino individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375319/,abstract,0,yeastlike vvc vulvovaginal unprotected tightly potently menstruation genuine fungus filamentous filamentation faithfully coitus candidiasis avf asf albicans acetylglucosamine virulent vaginal inducer hormonally candida atmospheric virulence synergistically seminal switch periodic epithelium simplified engage intermittent conversely concomitant resident albumin induce contact mimic artificial trigger pulse potent inhibitory formulation transient reproductive mode temperature act fluid substantial introduction contribution nutrient pathogenic natural stage component woman environment serum efficacy exposure developmental growth ass issue subject program major cause response quality life amino cell individual model acid potential year high level,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""program major cause response quality life amino cell individual model acid p""]}}",{},{}
748,748,804,10.6065/apem.2016.21.1.1,27104172.0,male specific disorder activity early immunosorbent congenital autosomal defect country gland neonatal liquid molecular virilizing cyp prognosis severity classical cholesterol urinary disease excretion hydroxylase synthesis steroidogenic marker quantitative form hydroxyprogesterone clinical feature crisis disturbance aldosterone hyperplasia diagnosis enzyme qualitative recently data term cortisol long type stature tandem genetic useful period level detection worst case rapid one female short morbidity cover prevent outcome many assignment simple gas salt test sex treatment hormone steroid assay nonclassical mass newborn cah recessive analytes residual approximately radioimmunoassay analysis spectrometry psychosexual also multiple conclusion group adrenal deficiency gene highly confusion metabolite chromatography gender sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835555/,abstract,0,virilizing steroidogenic nonclassical aldosterone worst stature radioimmunoassay psychosexual hydroxyprogesterone immunosorbent cah cyp cortisol confusion assignment salt hyperplasia steroid cover adrenal gland crisis analytes excretion cholesterol prognosis residual disturbance qualitative gas sex urinary gender hormone classical simple sensitive recessive tandem morbidity severity liquid approximately prevent chromatography autosomal useful female quantitative short recently assay neonatal feature marker synthesis rapid spectrometry highly defect congenital male hydroxylase period country detection form metabolite enzyme mass long multiple molecular deficiency newborn activity outcome conclusion term case test early specific type diagnosis gene group genetic data level disorder treatment clinical analysis disease,{},"{""autosomal"": {""freq"": 1, ""string"": [""morbidity severity liquid approximately prevent chromatography autosomal useful female quantitative short r""]}, ""recessive"": {""freq"": 1, ""string"": [""urinary gender hormone classical simple sensitive recessive tandem morbidity severity liquid a""]}, ""genetic"": {""freq"": 1, ""string"": [""early specific type diagnosis gene group genetic data level disorder treatment c""]}}",{},"{""detection"": {""freq"": 1, ""string"": [""defect congenital male hydroxylase period country detection form metabolite enzyme mass l""]}, ""tandem"": {""freq"": 1, ""string"": [""gender hormone classical simple sensitive recessive tandem morbidity severity liquid approximately p""]}, ""spectrometry"": {""freq"": 1, ""string"": [""assay neonatal feature marker synthesis rapid spectrometry highly defect congenital male h""]}, ""newborn"": {""freq"": 1, ""string"": [""enzyme mass long multiple molecular deficiency newborn activity outcome conclusion term c""]}}",{},{}
749,749,805,10.1016/j.neuropharm.2016.03.044,27026110.0,disorder resilience microdialysis anxiety behavioral amygdalar behavior elicits gabaergic moreover extinction experience crfr disease plasticity neuroplasticity relevant family outflow amygdala mouse grm intracerebral like data genetic medial remodeling mediate significant stress member basolateral stressful acute release critical mpfc neurotransmission bla evident dendritic mir expression synaptic exposure prefrontal response emotional process accordingly demonstrate differential function psychiatric facilitation cognitive deletion environmental gaba also mrna aminergic neurochemical complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573597/,abstract,1,grm gabaergic extinction crfr bla amygdalar aminergic mpfc intracerebral basolateral remodeling outflow neuroplasticity microdialysis facilitation elicits neurochemical stressful dendritic mir medial gaba amygdala resilience plasticity neurotransmission mediate prefrontal synaptic release emotional accordingly mrna evident differential deletion psychiatric anxiety demonstrate member behavioral acute experience stress behavior exposure critical environmental relevant like mouse process cognitive expression complex response family function significant genetic data disorder disease,"{""behavioral"": {""freq"": 1, ""string"": [""differential deletion psychiatric anxiety demonstrate member behavioral acute experience stress behavior e""]}, ""emotional"": {""freq"": 1, ""string"": [""plasticity neurotransmission mediate prefrontal synaptic release emotional accordingly mrna evident differential d""]}, ""psychiatric"": {""freq"": 1, ""string"": [""emotional accordingly mrna evident differential deletion psychiatric anxiety demonstrate member behavioral a""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
750,750,806,10.1016/j.ymgmr.2016.03.003,27114916.0,matter correlation trajectory age relationship however longitudinal continuously region hierarchical difference early among healthy comparison specifically white across present abnormal child range fully population brain phenylketonuria tensor research diffusion methodology stronger development dti group result integrity investigate pearson diffusivity study control little decrease elucidate linear pku microstructural poorer regression,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832081/,abstract,4,microstructural pearson hierarchical dti tensor elucidate diffusivity trajectory poorer continuously stronger integrity diffusion fully longitudinal matter methodology specifically white little linear abnormal decrease regression comparison investigate correlation relationship region healthy range brain pku difference phenylketonuria present early control research population child age development group result study,{},{},{},{},{},{}
751,751,807,10.1007/s40262-014-0196-4,25338975.0,conclusionthe disorder blood synthetic daily powered prospectively factor across adult half elevated weight behavior tetrahydrobiopterin severe disease objective significantly pku hydroxylase material hereditary phe flip subset supplementary phenylalanine covariate life pharmacokinetics methodsoral dihydrochloride clinical user input distribution body comparable thus metabolic effect data design first genetic level significant rate mutation one flop volume clearance dose terminal naturally population model phenylketonuria method nonmem compartment slow exposure concentration pharmacokinetic online article tolerance iii electronic year best phase version materialthe age two endogenous pediatric appropriate order estimate determine sapropterin neurologic residual precise validated elimination analysis background available optimization pah group plasma study similar cofactor patient linear absorption preparation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306193/,abstract,2,powered nonmem methodsoral flop flip covariate naturally dihydrochloride pharmacokinetics clearance slow optimization pharmacokinetic compartment neurologic terminal elimination prospectively absorption validated input sapropterin iii hereditary residual precise tolerance preparation endogenous subset conclusionthe comparable synthetic half cofactor distribution linear elevated daily volume tetrahydrobiopterin dose estimate phase best appropriate pediatric weight pah behavior exposure materialthe determine design hydroxylase order similar severe body background phe supplementary objective plasma user version electronic online adult rate life concentration mutation pku material article phenylketonuria available significantly model phenylalanine factor blood population age significant metabolic group year effect genetic method data level disorder clinical analysis patient disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""material article phenylketonuria available significantly model phenylalanine factor blood population age s""]}}","{""genetic"": {""freq"": 1, ""string"": [""age significant metabolic group year effect genetic method data level disorder c""]}}",{},{},{},{}
752,752,808,10.1007/s10545-015-9843-7,25875217.0,disorder iem single technical profile require platform retrospective capable iems state majority well disease excellent material semi achievable utility intra biochemical understanding dozen however supplementary quantitative unique possible screening user clinical value range compound doi global great error inborn result diagnosis metabolic data prospective novel metabolism score detection one established biomarkers certain current sensitivity overall capability approach workflow method potential technology online article test electronic assay false finding version materialthe specificity wide advance sample untargeted mass negative screen analytes reproducibility currently analysis spectrometry routinely available metabolomic multiple tested diagnostic plasma otherwise high study human yield patient linear individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626538/,abstract,2,achievable established dozen tested require untargeted intra analytes workflow reproducibility routinely metabolomic capability iems semi retrospective capable excellent doi yield technical false screen prospective platform great linear certain iem utility unique majority advance specificity global profile quantitative compound understanding assay sensitivity negative spectrometry biomarkers materialthe currently wide biochemical technology overall score diagnostic finding detection possible inborn supplementary screening state mass plasma user range multiple version value electronic error online single novel current material article sample approach available metabolism test individual human diagnosis potential metabolic high method data disorder clinical analysis result patient disease study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""biochemical technology overall score diagnostic finding detection possible inborn supplementary screening s""]}, ""spectrometry"": {""freq"": 1, ""string"": [""quantitative compound understanding assay sensitivity negative spectrometry biomarkers materialthe currently wide b""]}, ""screening"": {""freq"": 1, ""string"": [""diagnostic finding detection possible inborn supplementary screening state mass plasma user r""]}}",{},{}
753,753,809,10.1038/mt.2016.34,26857843.0,tool dos growth factor serotype among lower loxp efficient vascular endothelial virus thermogenesis preferential manipulate vegf therapy mouse six contrast novel oral aav recombinant level gastrointestinal transduction administration dose systemic naturally brown liver therapeutic via cold delivery response track raav genetically fat mass application order vehicle adipose demonstrate enhanced cre adeno natural research attractive tissue high vector serotypes muscle absence successful gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923319/,abstract,0,vegf thermogenesis manipulate track serotypes raav preferential loxp serotype cre cold brown vehicle enhanced adipose naturally attractive aav adeno transduction muscle gastrointestinal endothelial recombinant dos vascular vector fat systemic virus absence efficient demonstrate genetically successful oral dose contrast natural administration delivery liver tissue growth order mouse tool application mass response therapeutic lower novel therapy factor research gene high level,{},{},{},{},{},{}
754,754,810,10.1093/nutrit/nux029,28969366.0,various biological specific example micronutrient factor nutrition time necessary nutrient homeostasis due variation number concept formulation finally status account relevant introduction strategy maintain health wellness fast real therefore diagnosis thus combine tailor complement basis genetic metabolism macro area appreciation flexibility scientific requirement current considers evaluation societal intervention formulate approach development people thereby system interact recommendation person best challenge process public biology reality goal environmental mechanism multiple nutritional practice tissue technological dietary performance complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5914356/,abstract,0,wellness macro tailor considers combine appreciation reality formulate maintain interact societal flexibility complement micronutrient technological fast formulation person requirement real introduction homeostasis scientific people nutrient biology goal concept nutrition account necessary best basis recommendation finally nutritional example variation environmental tissue practice evaluation biological relevant public status performance various process area challenge multiple complex strategy mechanism intervention dietary current approach number metabolism time specific factor diagnosis development health genetic,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
755,755,811,10.1136/bmjpo-2017-000115,29637139.0,staff level palestine jordan considerable neighbouring stress rate lebanon resilience poor reduction new jerusalem million recent requirement morbidity access problem nutrition country child despite health around speed worker refugee currently crisis citizen affected hospital comparable travel palestinian mental ambulance result difficulty shortage towards high live faltered transfer specialist equipment syria year visa greatly violence healthcare mortality show occupation arab particularly initiative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862189/,abstract,1,visa violence syria palestinian palestine occupation neighbouring lebanon jerusalem faltered ambulance travel refugee jordan arab worker shortage equipment citizen staff resilience live greatly crisis speed transfer requirement specialist initiative million comparable considerable affected access difficulty morbidity nutrition healthcare poor mortality mental stress hospital reduction particularly currently despite problem country recent rate new child health year high level result,{},{},{},{},{},{}
756,756,813,10.1038/s41598-019-44772-5,31171819.0,specific tool bioinformatics african apoptosis pathway time positive selection hedgehog modification teeth molecular lycaon dentition variation shh investigate dog addition display prey amongst coat ungulate subject unique spatial pictus digit forefoot putative genomic color result canid large basis change specie term mya coloration first divergence genetic running cursorial eater four three wild variable one signal evolutionary obligate genomics pigmentation regard cusp comparative diversification history meat bodied mode loss evolution sonic signaling scan canidae coinciding wide robust within specialized suite adaptation deletion analysis mechanism also cursoriality acid mammal molar powerful hypercanivory amino gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554312/,abstract,0,ungulate shh running prey pictus mya lycaon hypercanivory forefoot eater dentition cursoriality cursorial coinciding canidae canid bodied teeth molar hedgehog diversification divergence cusp coloration coat sonic obligate dog digit pigmentation suite evolutionary specialized scan mammal color meat apoptosis african comparative display bioinformatics regard adaptation signaling spatial putative evolution mode powerful specie modification deletion wild signal genomics robust unique selection history genomic basis variable loss variation investigate wide tool addition subject change positive large pathway molecular mechanism amino term time specific acid gene genetic analysis result,{},"{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""tool addition subject change positive large pathway molecular mechanism amino term t""]}}","{""amino"": {""freq"": 1, ""string"": [""change positive large pathway molecular mechanism amino term time specific acid g""]}}",{},{}
757,757,816,10.1038/mp.2015.12,25754080.0,intelligence correlation disorder relationship autism memory among examine positively positive scotland superior genetics common variation deficit state adhd beta risk partly control spectrum relevant however family evidence observed clinical health consistent verbal logical sfhs lothian intelligent report attention overlap bat data generation quotient ability genetic score full three asd independent polygenic population brisbane twin people calculated association year finding wide find age sample negative scale birth adolescent function influence psychiatric cognitive impairment aspect aim scottish genome general consortium cohort study hyperactivity even individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759203/,abstract,3,sfhs lothian brisbane scotland intelligent bat scottish logical quotient polygenic overlap twin consortium verbal partly calculated beta intelligence adhd superior positively hyperactivity psychiatric examine asd memory people adolescent aspect independent autism genome observed consistent deficit negative genetics impairment generation attention variation influence correlation ability relevant wide general scale cohort birth relationship spectrum score finding cognitive aim state positive association report family evidence common function sample individual risk control population age health year genetic data disorder clinical study,"{""hyperactivity"": {""freq"": 1, ""string"": [""calculated beta intelligence adhd superior positively hyperactivity psychiatric examine asd memory p""]}, ""psychiatric"": {""freq"": 1, ""string"": [""beta intelligence adhd superior positively hyperactivity psychiatric examine asd memory people a""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
758,758,817,10.1136/bmjopen-2019-031474,31444193.0,case resultsthe four cluster methodsdata newborn northern conclusionschina region information spatial per among effort local country higher database overall substantially analysis neonate focus global phenylketonuria province geographic china southern ass spatially moran result system part high study qinghai mild severity classical intermediate autocorrelation shanxi gansu disease pku highest incidence ningxia chinese period,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707664/,abstract,6,spatially shanxi ningxia moran gansu conclusionschina autocorrelation qinghai methodsdata geographic southern northern intermediate substantially spatial neonate province cluster chinese china classical resultsthe local highest mild severity effort global incidence focus database ass period overall country region information newborn pku higher phenylketonuria case high analysis result disease study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""ass period overall country region information newborn pku higher phenylketonuria case h""]}}",{},{}
759,759,818,10.1038/srep43479,28252043.0,wide complex inside tool rate subcellular cellular challenge ratiometric almost single technical dynamic across fluorescent higher explore series glucose protein range highly readily environment constant moreover open histidine mitochondrion state potential face sensor plasma sensitive high transport inner free concentration metabolic spatiotemporal organelle similar cytosolic mammalian responsive signaling cell resolution membrane mitochondrial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333150/,abstract,0,ratiometric spatiotemporal subcellular organelle cytosolic inside inner histidine fluorescent mitochondrion sensor constant readily signaling mammalian series face membrane technical responsive transport resolution mitochondrial dynamic sensitive open glucose cellular explore environment free highly wide similar tool state plasma challenge range complex single rate concentration higher cell potential protein metabolic high,{},{},{},{},{},{}
760,760,819,10.1098/rsob.180265,31185809.0,major asds disorder autism new discus fmr pathway world despite five action molecular common deficit highlight onto shank origin typical pathobiology spectrum pharmacological strategy neurodevelopmental therapy recovery brain mouse therefore analogous great possibility conventional thus effect symptomatic design cause genetic node non functional mutation society one phenotype normal problem population review approach model ndds therapeutic method neurnexins pathological aberration development social consequently disability towards mecp emotional challenge process syngap corrective timely aetiological dependent cognitive environmental characteristic alleviation multiple group intellectual study successfully similar convergence highly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597757/,abstract,0,syngap pathobiology neurnexins fmr corrective ndds alleviation aberration shank convergence aetiological mecp analogous node asds timely emotional recovery typical symptomatic pathological origin conventional consequently successfully society pharmacological possibility neurodevelopmental action great world intellectual autism dependent deficit disability environmental highly highlight social despite design problem functional characteristic phenotype discus spectrum similar mouse process cognitive normal major challenge multiple cause strategy therapeutic pathway brain molecular therapy mutation non common approach new model population review development group effect genetic method disorder study,"{""intellectual"": {""freq"": 1, ""string"": [""pharmacological possibility neurodevelopmental action great world intellectual autism dependent deficit disability e""]}, ""emotional"": {""freq"": 1, ""string"": [""aetiological mecp analogous node asds timely emotional recovery typical symptomatic pathological o""]}, ""social"": {""freq"": 1, ""string"": [""dependent deficit disability environmental highly highlight social despite design problem functional c""]}}","{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""major challenge multiple cause strategy therapeutic pathway brain molecular therapy mutation n""]}}",{},{},{}
761,761,820,10.3390/nu10111794,30453665.0,blood synthetic better difference essential palatability native bias need supplementation appraisal risk source control pku glycomacropeptide phe phenylalanine evidence adequate form nature protein secondary body comparable primary methodology scarcity term low eight acceptability use although four rate gmp short biomarkers tyrosine database intervention review phenylketonuria underline work article recommendation electronic diet best still two residual systematically quality analysis impact alternative nutritional june study acid meta intact small patient amino,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266274/,abstract,2,underline scarcity appraisal palatability intact acceptability native gmp june systematically residual glycomacropeptide bias comparable synthetic adequate methodology meta nature alternative secondary best recommendation supplementation source short work nutritional database biomarkers tyrosine essential small need better body form phe primary electronic quality use diet impact intervention rate evidence pku amino term article difference phenylketonuria low risk phenylalanine control blood review acid protein analysis patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""term article difference phenylketonuria low risk phenylalanine control blood review acid p""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""diet impact intervention rate evidence pku amino term article difference phenylketonuria l""]}}","{""diet"": {""freq"": 1, ""string"": [""form phe primary electronic quality use diet impact intervention rate evidence p""]}}",{}
762,762,821,10.1001/jamaneurol.2015.4800,26953778.0,logistic whether region factor early examine importancevitamin resultsover maternity utero risk average control increase vitamin gestational whose fmc adulthood however later trimester life interval relative chemiluminescence previous higher range fold finland diagnosis date decrease pregnancy studysettingfinnish first nmol regression level significant case confidence main sclerosis participantswe designprospective child woman overall outcome hydroxyvitamin used season exposure serum sex mother collection measuresmain assay nearly maternal age sample deficient conditional exposuresserum estimate relevanceinsufficient birth available multiple conclusion december cohort trend study insufficient objectiveto deficiency linear individual statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861670/,abstract,4,studysettingfinnish relevanceinsufficient participantswe measuresmain importancevitamin fmc exposuresserum designprospective chemiluminescence season resultsover maternity hydroxyvitamin finland nmol conditional trimester utero sclerosis used insufficient december nearly objectiveto logistic gestational adulthood trend sex examine deficient vitamin fold confidence later statistically linear mother interval relative date average estimate pregnancy collection previous maternal woman decrease serum regression assay exposure cohort main birth overall region range multiple increase deficiency life outcome conclusion higher sample case available individual risk early control factor diagnosis child age significant level study,{},{},{},{},{},{}
763,763,822,10.3233/BPL-160033,29765849.0,resonance implication specific vivo content factor time brief present accurate condition injury spinal gradient neurodegenerative transfer control validation acquisition disease neurofibromatosis plasticity tensor angle measurement animal debris quantitative neuromyelitis relaxation brain diffusion niemann concussion data fraction type non histological magnetization whole water multi least sclerosis imaging measure discussion provide damage critical review approach mortem model phenylketonuria technique method work post development potential myelin important finding cord specificity overview alternate process negative healthy standard demonstrate function analysis mcdespot also multiple exchange tissue high stroke study magnetic successfully human undergo optica minute square schizophrenia myelination presence sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928546/,abstract,1,optica neuromyelitis magnetization debris stroke concussion neurofibromatosis mortem mcdespot alternate undergo spinal niemann relaxation gradient histological angle myelination plasticity cord tensor schizophrenia myelin acquisition sclerosis minute transfer brief diffusion square exchange imaging injury neurodegenerative successfully resonance fraction discussion accurate validation multi damage water overview demonstrate sensitive magnetic post vivo specificity content implication quantitative work animal negative critical presence tissue measurement technique provide standard finding process measure healthy multiple brain condition non important function phenylketonuria approach present time human model specific control factor type review potential development high method data analysis disease study,{},{},{},{},{},{}
764,764,824,10.3389/fpubh.2017.00308,29250518.0,cross activity among stricter strengthen concern half experience concept conjunction traditional survey ethical opinion issue geneticist medical extensive element pediatrician family evidence protection screening project support psychological data abuse selective genetic underlined non whole rate one current border overall personal population feasible ass stage potential online response important key nevertheless option attitude wgs newborn collaboration bulgaria conducted analysis currently aim program genome study sequencing objectivethe participant gene individual total complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715396/,abstract,2,stricter underlined border bulgaria abuse wgs strengthen pediatrician objectivethe geneticist conducted personal conjunction attitude protection opinion collaboration feasible psychological ethical project selective traditional extensive element half option concept concern stage experience genome survey cross sequencing currently ass issue overall participant support aim screening program complex key response online medical family rate total newborn activity evidence current non important individual population potential gene genetic data analysis study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""newborn"": {""freq"": 1, ""string"": [""response online medical family rate total newborn activity evidence current non i""]}, ""screening"": {""freq"": 1, ""string"": [""ass issue overall participant support aim screening program complex key response o""]}}",{},{}
765,765,825,10.3390/ijns1010013,26309908.0,blood disorder daily instance difference effort technical proficiency positive laboratory accurate molecular severe state mean control reliable avoid disease doe biochemical family largest life baby achievement health improvement great report ensure century diagnosis bmsl thus large specimen minimizes thousand first long genetic mqip assurance united service confidence one death volume many aid nstri nsqap disability test ten network year false public mass newborn spot achieve quality cognitive impairment program spectrometry research translation prevention comprehensive high sustains center performance accuracy initiative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545740/,abstract,2,sustains nstri mqip minimizes bmsl proficiency nsqap ensure assurance instance avoid achievement century largest aid achieve specimen thousand initiative baby technical false reliable accurate united translation confidence great doe daily volume accuracy network comprehensive effort death center service improvement mean impairment disability spectrometry prevention spot laboratory biochemical public performance severe cognitive state mass long program positive quality large molecular report family life newborn difference test control blood diagnosis research health year high genetic disorder disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""spectrometry"": {""freq"": 1, ""string"": [""center service improvement mean impairment disability spectrometry prevention spot laboratory biochemical p""]}, ""newborn"": {""freq"": 1, ""string"": [""quality large molecular report family life newborn difference test control blood d""]}}",{},{}
766,766,826,10.1038/s41598-017-18038-x,29247206.0,specific blood disorder bioinformatics past reliability region fluctuation unrelated capacity difficulty unexplained publication reliable material amount sequence sanger decade adequate previous perspective range inconsistent focus genomic result thus metabolic generation whole mutation one pathogenic prediction implementation database critical identification causal exome technology polymorphism nevertheless insertion fifteen overview future sample drawback variant newborn application spot pilot next dna quality deletion analysis previously widely coverage also multiple identify general study sequencing patient gene readily,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732277/,abstract,0,drawback unexplained fluctuation inconsistent insertion readily bioinformatics reliability sanger unrelated coverage causal pilot publication adequate reliable deletion prediction exome capacity identify overview difficulty pathogenic widely past polymorphism decade perspective sequence previous genomic dna implementation focus generation critical sequencing database spot previously identification general technology region application range multiple variant quality future newborn mutation material sample specific blood metabolic gene disorder analysis result patient study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""application range multiple variant quality future newborn mutation material sample specific b""]}}",{},{}
767,767,827,10.1371/journal.pone.0147741,26840411.0,epidemiological assessment lead growth single factor collate among positive across world present behavioral prenatal choice physical literature chemical course eligible number unravel majority well traditional related understanding cumulative life evidence rather recent mainly inherent health inconsistent consistent home sleep real environment result effect non period water three etiology database child review product pollutant aid separately development social exposure school mother association diet help inconsistency systematic lifestyle future within negative mostly collective determinant community stressor cognitive either natural research multiple identify general interaction study even variability consistently complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739499/,abstract,2,collate pollutant stressor unravel inherent separately collective inconsistency inconsistent cumulative eligible aid sleep consistently determinant epidemiological home school lifestyle traditional real prenatal choice variability identify course water chemical mainly etiology mother majority world behavioral community systematic natural help environment physical consistent understanding negative exposure lead database product social growth general related period interaction literature assessment cognitive multiple complex positive future single association recent diet life evidence non number present factor research review child development health effect result study,"{""behavioral"": {""freq"": 1, ""string"": [""chemical mainly etiology mother majority world behavioral community systematic natural help e""]}, ""social"": {""freq"": 1, ""string"": [""understanding negative exposure lead database product social growth general related period i""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""complex positive future single association recent diet life evidence non number p""]}}",{}
768,768,828,10.1177/1753495X15576442,27512458.0,multidisciplinary rare pregnant inheritance specific disorder decompensation respiratory organ teratogenicity involvement advice liaison energy information appropriate whilst renal limited counselling therapy obstetrician child woman health outcome guidance many replacement management condition impact phenylketonuria available due general potential reproduction enzyme risk metabolic good cardiac newer prepregnancy term specialist pregnancy intoxication close best long pku significantly metabolism rarity safe option number issue maternal joint teratogenic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935010/,abstract,0,obstetrician liaison prepregnancy counselling teratogenicity teratogenic newer reproduction intoxication decompensation joint rarity whilst advice multidisciplinary respiratory guidance inheritance close safe specialist renal replacement pregnant cardiac involvement organ option energy pregnancy best good appropriate maternal woman limited general issue enzyme long management rare impact therapy information pku outcome term condition phenylketonuria number available metabolism significantly risk specific potential child metabolic health disorder,{},"{""inheritance"": {""freq"": 1, ""string"": [""rarity whilst advice multidisciplinary respiratory guidance inheritance close safe specialist renal r""]}}",{},{},{},{}
769,769,829,,28451536.0,disorder tool cross clinic sectional new ratio congenital time laboratory neonatal without condition province due cost improve increase iranian respectively medical suitable utility trade life quantitative screening applied health kazemi therefore science nader sum result effectiveness annually university qualitative metabolic effect incremental design far use necessity society step tree economic prevent damage intervention population model shiraz method people system viewpoint resource important best decision care option lifestyle policymakers two galactosemia iran newborn limited rail quality analysis background program infant conclusion policy group study patient financial treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401919/,abstract,3,shiraz rail nader kazemi incremental viewpoint trade policymakers annually tree galactosemia applied necessity sum financial iranian province lifestyle qualitative iran far society improve suitable university damage treat economic people option utility science decision resource prevent clinic sectional effectiveness step policy best quantitative neonatal cross limited cost laboratory congenital design ratio background tool infant screening program increase quality medical use respectively intervention care life newborn conclusion condition important time new model population metabolic health group effect method disorder analysis result patient study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""medical use respectively intervention care life newborn conclusion condition important time n""]}, ""screening"": {""freq"": 1, ""string"": [""congenital design ratio background tool infant screening program increase quality medical u""]}}",{},{}
770,770,830,10.21037/atm.2018.09.18,30306077.0,various biological specific blood tool disorder new information early pathway several laboratory insight accurate iems locus well conjunction disease whose individual relevant however chemometrics clinical range fluid ideal genomic structural predicting error inborn diagnosis knockout thus metabolic base integration data expansion computational extend change novel genetic metabolism interference medicine interconnection functional neonatology interest biomarkers crucial phenotype standardization current expand recognition generate approach associate identification potential metabolically concentration nosology treatment alteration active broadens phase discover prognostication challenge untargeted mass biochemistry newborn lack community timely involved goal analysis basic metabolomics spectrometry metabolomic group diagnostic preanalytical study human patient gene hmdb metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174193/,abstract,3,prognostication preanalytical nosology neonatology interconnection hmdb broadens predicting chemometrics metabolically extend generate standardization interference expand associate discover biochemistry untargeted ideal knockout conjunction timely metabolomic iems expansion base recognition computational integration crucial locus fluid accurate basic involved goal metabolomics structural alteration active community phase genomic insight lack spectrometry biomarkers biological relevant laboratory medicine identification functional phenotype diagnostic various inborn metabolite tool mass challenge change range error pathway novel information concentration newborn current approach metabolism individual new human early specific blood diagnosis potential metabolic gene group genetic data disorder treatment clinical analysis patient disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""blood diagnosis potential metabolic gene group genetic data disorder treatment clinical a""]}}","{""pathway"": {""freq"": 1, ""string"": [""tool mass challenge change range error pathway novel information concentration newborn c""]}}","{""spectrometry"": {""freq"": 1, ""string"": [""active community phase genomic insight lack spectrometry biomarkers biological relevant laboratory m""]}, ""newborn"": {""freq"": 1, ""string"": [""range error pathway novel information concentration newborn current approach metabolism individual n""]}}",{},{}
771,771,831,10.1517/17425247.2015.1060218,26165848.0,bench investigation pathway effort centric despite platform modification need expert affordability regulatory formulation way status opinion introduction pharmaceutical recent accessibility developmental geriatrics critically project conventional scientist efficacy data forward novel acceptability medicine area licensed pediatrics administration market scientific requirement current drug implementation population approach product device aid development plan system technology safety collaborative harmonization delivery incentive age still regulator pediatric packaging field speed benefit manufacture also patient industry academia acceptable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673516/,abstract,0,manufacture licensed geriatrics harmonization academia packaging bench pediatrics incentive centric affordability collaborative accessibility critically acceptability scientist speed market aid forward opinion formulation industry requirement regulator plan device conventional pharmaceutical acceptable project modification introduction expert scientific platform safety effort way administration regulatory delivery investigation pediatric implementation efficacy developmental product despite medicine benefit technology status need field area drug pathway recent novel current approach population age development data patient,{},{},"{""pathway"": {""freq"": 1, ""string"": [""technology status need field area drug pathway recent novel current approach p""]}}",{},{},{}
772,772,832,10.3389/fpsyg.2019.00042,30804825.0,process fatigue executive however rate wild evidence allocation gaze tracker unique walk elaborate higher adult stable child nature mobile cognitive suggestion tracking eye benefit mechanism natural counteract environment task mental sub min support movement exposure technology sufficient urban attention effect pattern study link data faster way network first restoration participant performance fixation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370667/,abstract,0,gaze walk tracker fixation fatigue counteract restoration tracking elaborate allocation suggestion mobile faster urban eye sub min movement sufficient link executive stable wild nature task unique network natural way mental environment pattern exposure attention benefit technology performance participant process cognitive support adult mechanism rate evidence higher child effect data study,{},{},{},{},{},{}
773,773,833,10.1007/s11306-017-1166-2,28190990.0,various specific blood relationship whether milk better class growth early lower difficult profile formula nutrition selection without pressure due separate investigate risk hypothesis validation month material exclusively however later supplementary life childhood baby possible introductionlinks obesity user mixed health programming procedure cbgs error backward metabolic lipidomic data pregnancy long lipid validate young regression level three profiled datasets biomarkers prediction disentangle discovery outcome collectively able infusion differentiate method development exposure mode online article electronic iterative version materialthe process age sample forest two mass methodwe lack spot determine breast elimination cognitive analysis either benefit aim mechanism spectrometry available infant group infancy nutritional cohort part high classification feeding study pop objectiveour direct small random cambridge resolution complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5272886/,abstract,1,pop lipidomic introductionlinks cbgs profiled objectiveour forest disentangle methodwe cambridge backward datasets differentiate infusion exclusively programming iterative elimination validate feeding breast collectively infancy mixed random mode formula baby milk pressure class classification resolution separate lipid validation young prediction later able discovery hypothesis nutrition obesity procedure selection difficult pregnancy profile direct childhood regression nutritional lack exposure investigate spectrometry biomarkers materialthe spot growth determine cohort benefit small relationship better possible various process cognitive aim month infant supplementary mass long user complex version electronic error online lower mechanism life material outcome article sample available risk early specific blood age development metabolic health group high method data level analysis study,{},{},{},"{""spectrometry"": {""freq"": 1, ""string"": [""childhood regression nutritional lack exposure investigate spectrometry biomarkers materialthe spot growth d""]}}",{},{}
774,774,834,10.1136/bmjopen-2015-008400,26438137.0,blood relationship delay growth registration lower among widespread nutrition across brief despite throughout increasingly aged weight province finger severe poverty participantsin virtually anaemic month survey status village underweight significantly adulthood life childhood health psychomotor programming resultswe china numberisrctn length effect large april bayley contrast force confounders design little term first long count low area objectivesresearch level significant rate classify main labour problem failure october child outcome population critical window measuresinfants conclusionsthe rural southern development potential test year public sample haemoglobin likely scale demographic approximately quality cognitive anaemia characteristic infant importance also trial consequence eventually nutritional nationally practice shaanxi feeding study stunted deficiency prick linear even township performance caregiver county,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611485/,abstract,4,underweight township stunted participantsin objectivesresearch numberisrctn measuresinfants labour anaemic shaanxi classify village poverty haemoglobin count confounders anaemia virtually county bayley eventually psychomotor nationally programming prick finger southern october window force april feeding registration brief rural widespread province resultswe demographic length caregiver adulthood failure china conclusionsthe delay increasingly little linear nutrition approximately contrast consequence aged childhood survey nutritional weight likely critical practice growth despite design importance problem scale characteristic main public relationship status performance severe cognitive area month infant long trial quality large lower deficiency rate life outcome term sample low test significantly blood population potential child significant development health year effect level study,{},{},{},{},{},{}
775,775,835,10.1155/2018/4060527,30245899.0,ltecs factor congenital embryological affected additional due moreover severe separate ltec termino month contribute repair later life haploinsufficiency role underlie fundoplication developmental neonate laryngotracheoesophageal genomic thoracotomy genetic type rere extrapleural mandatory three one anterior crucial phenotype failure thoracic terminal approach week management day esophageal causal esophagus second susceptibility multiteam parental iii reflux trachea gastroesophageal age future obese anomaly deletion cervical environmental cleft different epigenomic right study thrive patient elucidate successful gene individual malformation anastomosis atresia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136558/,abstract,1,thoracotomy thoracic termino rere multiteam ltecs ltec laryngotracheoesophageal fundoplication extrapleural embryological anastomosis trachea thrive gastroesophageal esophagus epigenomic haploinsufficiency esophageal cervical underlie reflux cleft atresia repair mandatory elucidate anterior terminal obese malformation anomaly iii neonate causal susceptibility right crucial contribute parental separate deletion failure affected later successful genomic second environmental developmental congenital week additional phenotype severe month management day future life role approach individual factor type different age gene genetic patient study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
776,776,836,10.1093/jlb/lsv008,26339500.0,surgery information segment adult laboratory medically without condition onset genetics aca affordability expert state regulatory acmg disease medical college however actionable protection recent accessibility screening follow clinical preventive health focus affordable body equitable asymptomatic predict equate change genetic medication use whole brca panel variable society prophylactic genomics provide intervention minimize legislature system mandate american test treatment recommendation care address list predictive variant access disparity reality act mechanism available coverage genome prevention policy sequencing federal patient incidental insurance circumvent individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555880/,abstract,0,legislature equate brca aca prophylactic mandate incidental equitable circumvent affordability acmg reality predict minimize disparity medically accessibility segment federal affordable actionable insurance college surgery protection asymptomatic preventive coverage list american act society medication predictive expert access genomics panel address policy follow regulatory recommendation genome variable focus genetics onset sequencing prevention laboratory provide body screening state change variant medical adult recent use mechanism intervention care information condition available test individual health genetic treatment clinical patient disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""screening"": {""freq"": 1, ""string"": [""onset sequencing prevention laboratory provide body screening state change variant medical a""]}}",{},{}
777,777,837,10.1210/jc.2015-3872,27383112.0,male blood relationship growth ratio context lower positively adult reproductive modification weight secondhand increase objective respectively genital interval distance sexually dysfunction higher value neonate fold body agd length effect little fetal level confidence dimorphic main measure size local outcome pmol gonadal development exposure serum thyroid free sex overt mother hormone association tsh cord maternal anogenital two mass newborn relation birth adolescent function circumference longer hospital aim index infant head also conclusion different cohort interaction study human participant absence total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010576/,abstract,3,sexually secondhand genital dimorphic anogenital agd pmol gonadal overt distance cord tsh circumference thyroid longer neonate reproductive positively head length modification sex fetal absence hormone fold confidence local little relation adolescent mother interval size maternal index serum weight hospital exposure dysfunction context free growth male cohort main ratio birth relationship interaction participant body aim measure infant objective mass value increase lower association adult respectively total newborn outcome conclusion higher function human blood different development effect level study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""increase lower association adult respectively total newborn outcome conclusion higher function h""]}}",{},{}
778,778,838,10.1186/1471-2164-16-S8-S4,26110739.0,major splice subsequent specific investigation class new vivo information resultshere site molecular frequency missense common locus risk control number addition hypothesis close disease doe contribute sequence relevant wtccc disequilibrium trait possible role protein play candidate distribution putative primary effect change fraction wellcome type low level case seven three one signal least involvement overall many catalog assignment abundance markedly conclusionsthe remote expression association directly incidence altered transcript wide linkage snp variant function dna analysis previously mechanism impact auxiliary genome except trust consequence classic consortium high study human meta direct similar backgroundthere gene complex parameter gwa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480957/,abstract,2,wtccc wellcome gwa resultshere catalog backgroundthere auxiliary disequilibrium assignment splice trust remote transcript consortium altered linkage putative abundance close markedly snp locus contribute class involvement subsequent fraction classic missense conclusionsthe candidate meta signal doe distribution seven hypothesis trait play vivo directly parameter sequence investigation genome consequence dna direct incidence site previously frequency relevant wide overall similar possible addition major expression change complex primary variant association molecular mechanism impact information role common function low number case new human risk specific control type protein gene effect high level analysis disease study,{},{},{},{},{},{}
779,779,840,10.1007/s11606-017-4295-4,29374360.0,specific pcp cardiometabolic difference content discus context among audio across present increasingly behavior five prompt common share risk disease status material resultsfor visit physician medical supplementary family quantitative sharing trait pharmacogenetics user clinical role home word monogenic primary genomic report message result approachpatients change type eight medicine use commonly four member one communication scientific code office current overall evaluation polygenic management describe backgroundgenomics judgment online article designqualitative analyzed treatment recommendation key electronic remember decision care version fifth carrier conclusionspcps generally future variant estimate healthy category participantspcps analysis available importance genome except rationale substantive objectiveto patient limitation prominent individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975138/,abstract,1,remember participantspcps designqualitative conclusionspcps backgroundgenomics approachpatients audio resultsfor pharmacogenetics pcp substantive fifth analyzed judgment cardiometabolic sharing office polygenic message code prompt rationale prominent visit share home monogenic objectiveto physician commonly generally category scientific increasingly communication word member limitation carrier trait decision estimate content genomic recommendation genome quantitative behavior context evaluation medicine importance discus status overall supplementary healthy management user change primary version variant key electronic online medical future use report family care current material article role difference common present available individual risk specific type treatment clinical analysis result patient disease,{},{},{},{},{},{}
780,780,841,10.1155/2015/192761,26064996.0,hematological suffer disorder relationship pain visceral primarily recessive problem autosomal defect clinical structure bone chronic proinflammatory osteonecrosis osteolytic crisis review mechanism due summarize macrophage pathology state mononuclear hand stimulation system prevalent skeletal latest lineage osteopenia osteoporosis glucosylceramide lesion accumulation alteration well deficiency patient immune disease metabolism cell hallmark glucocerebrosidase gaucher,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433682/,abstract,0,osteonecrosis glucosylceramide glucocerebrosidase proinflammatory osteolytic osteopenia visceral lineage suffer mononuclear hematological gaucher summarize osteoporosis macrophage latest skeletal hallmark crisis lesion stimulation hand pain bone prevalent primarily pathology immune recessive accumulation alteration autosomal chronic structure defect problem relationship state deficiency mechanism cell metabolism review disorder clinical patient disease,{},"{""autosomal"": {""freq"": 1, ""string"": [""primarily pathology immune recessive accumulation alteration autosomal chronic structure defect problem r""]}, ""recessive"": {""freq"": 1, ""string"": [""pain bone prevalent primarily pathology immune recessive accumulation alteration autosomal chronic s""]}}",{},{},{},{}
781,781,842,10.1002/ajmg.a.37156,25975229.0,oxidoreductase activity growth apoptosis early pathway exhibit abnormal several adult present behavioral despite neonatal prenatal inflammation surface onset molecular fetus separate euploid grasp deficit manifest investigate differentially addition embryonic forelimb evidence marker observed therapy protein brain mouse cliff cje solute stat embryo experiment versus fetal combination type hemisphere period significant wild cellular jak pre phenotype transporter aversion syndrome fox model regulation day therapeutic perinatal neurogenesis post development bioinformatic stage expression pup test postnatal alteration cell carrier process age vocalization rna negative neurocognition scale demonstrate natal differential analysis prenatally ultrasonic trial array cycle rationale study human acid littermates amino gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844354/,abstract,0,ultrasonic grasp fox forelimb euploid cliff cje vocalization pup neurocognition littermates jak stat prenatally oxidoreductase hemisphere aversion neurogenesis bioinformatic solute natal manifest apoptosis fetus array rationale postnatal perinatal embryo differentially embryonic exhibit surface transporter experiment rna inflammation separate differential versus prenatal fetal demonstrate wild carrier cycle cellular abnormal alteration behavioral post stage pre regulation observed deficit neonatal negative marker combination onset investigate syndrome growth despite scale period phenotype mouse process addition day trial expression therapeutic pathway brain molecular adult therapy activity evidence amino cell present test human model early type acid protein age significant development gene analysis study,"{""behavioral"": {""freq"": 1, ""string"": [""wild carrier cycle cellular abnormal alteration behavioral post stage pre regulation o""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""process addition day trial expression therapeutic pathway brain molecular adult therapy a""]}}","{""amino"": {""freq"": 1, ""string"": [""brain molecular adult therapy activity evidence amino cell present test human m""]}}",{},{}
782,782,843,10.4274/jcrpe.galenos.2019.2018.0255,30630811.0,dyshormonogenesis clinic prospectively final congenital time present gland neonatal initial median elevated admission heel majority etiological increase objective month respectively initiation dysgenesis equal later follow clinical endocrinology ectopia stimulating hyperplasia result diagnosis first eight case rate one referral etiology normal evaluation normalization day method national second thyroid free concentration treatment hormone tsh incidence age transient newborn pediatric situ hypothyroidism hypoplasia aim program infant conclusion study agenesis patient prick,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745463/,abstract,7,ectopia agenesis hypoplasia dyshormonogenesis dysgenesis normalization endocrinology etiological hyperplasia heel stimulating prick situ tsh gland equal admission prospectively initiation final referral transient thyroid hypothyroidism hormone initial later etiology elevated majority clinic follow median pediatric incidence second neonatal national free evaluation congenital aim month infant normal objective day program increase respectively rate concentration newborn conclusion present case time diagnosis age method treatment clinical result patient study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""day program increase respectively rate concentration newborn conclusion present case time d""]}}",{},{}
783,783,844,10.1136/bmjopen-2018-027505,31196899.0,surgery hour rescue registration nausea world site aged literature laparoscopic common cost ethic improve effective publication conference anaesthesia significantly numberactrn chewy unit committee anaesthetic intravenous complete primary result efficacy effect large gum prospective novel analysisthis medication disseminationthe international non peer administration one recurrence female requirement pre postanaesthesia side drug cessation outcome multicentre around method conduct via national inferiority potential safety free treatment ten response vomiting year ponv care pacu volatile within million definitive breast ondansetron introductionpostoperative aim alternative research peppermint dissatisfaction trial min general dissemination human surgical patient complication treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6575709/,abstract,5,postanaesthesia ponv peppermint pacu ondansetron numberactrn laparoscopic introductionpostoperative disseminationthe dissatisfaction chewy analysisthis anaesthesia inferiority gum anaesthetic nausea recurrence cessation vomiting volatile dissemination multicentre intravenous conference rescue surgery definitive conduct surgical ethic peer breast registration committee min requirement unit million publication hour medication improve prospective treat complication complete safety world international alternative administration pre aged female site efficacy national cost free general literature aim trial primary drug response effective large novel care outcome non common significantly human research potential year effect method treatment result patient,{},{},{},{},{},{}
784,784,845,10.2147/IJGM.S180706,31213878.0,hexose disorder uridylyltransferase retardation milk acidosis energy early affect essential autosomal country neonatal serious prevents condition severe cost effective logistically well neurological galactose however life rather recent screening logistics renal role protein curative result asymptomatic effectiveness enzyme exogenous long type metabolism formation mortality detection inability death communication morbidity others failure intervention many liver mental ceramides national tubular potential sheath myelin incidence cell rare hence endogenous galactosemia production newborn galactosylation apparently cataract healthy facilitation program upon classic biotechnology galactokinase deficiency prebiotic resolution,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537461/,abstract,0,tubular sheath logistically galactosylation galactokinase ceramides uridylyltransferase hexose facilitation acidosis logistics cataract prebiotic curative galactosemia galactose biotechnology apparently prevents inability myelin exogenous asymptomatic retardation renal milk endogenous resolution classic failure formation communication energy affect morbidity production neurological autosomal death effectiveness mortality mental incidence neonatal liver national cost essential country detection severe enzyme healthy screening long program effective recent deficiency rare intervention life newborn condition role cell metabolism early type potential protein disorder result,"{""neurological"": {""freq"": 1, ""string"": [""formation communication energy affect morbidity production neurological autosomal death effectiveness mortality m""]}}","{""autosomal"": {""freq"": 1, ""string"": [""communication energy affect morbidity production neurological autosomal death effectiveness mortality mental i""]}}",{},"{""detection"": {""freq"": 1, ""string"": [""neonatal liver national cost essential country detection severe enzyme healthy screening l""]}, ""newborn"": {""freq"": 1, ""string"": [""effective recent deficiency rare intervention life newborn condition role cell metabolism e""]}, ""screening"": {""freq"": 1, ""string"": [""essential country detection severe enzyme healthy screening long program effective recent d""]}}",{},{}
785,785,846,10.7727/wimj.2013.107,25303249.0,clinic delicately country world throughout unfortunately disease unit cannot life recent screening additionally health consistent burden improvement therefore equitable result hand island mortality period significant learnt sickle morbidity volume scd implementation structure child strength intervention toward management model simple governance organization technology resource recommendation care challenge cell wide future lie two newborn working lack survival appropriate access since limited approximately quality currently policy comprehensive high lesson stride,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655669/,abstract,1,scd delicately stride learnt island equitable working lie governance sickle unfortunately lesson strength hand unit survival organization simple access burden morbidity world volume approximately additionally comprehensive resource clinic policy mortality appropriate recommendation implementation improvement consistent lack limited structure currently wide period technology country screening management challenge quality future recent intervention care life newborn cell model child significant health high result disease,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""quality future recent intervention care life newborn cell model child significant h""]}, ""screening"": {""freq"": 1, ""string"": [""structure currently wide period technology country screening management challenge quality future r""]}}",{},{}
786,786,847,10.1093/femsle/fny291,30561594.0,tool lactic new describes probiotic necessary insight tractable meaning mechanistic build traditional account understanding rather variety perspective role legislation mutant genomic food bacteria property focused design recombinant level use lab rapid one crucial current review product technique workflow development propose factory system test strongly iterative cell challenge construction mini library genetically wide traditionally future still production lack application biology limited speed dna research available also multiple grade cycle acid beyond number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322438/,abstract,0,tractable meaning factory describes mini lactic probiotic traditionally legislation focused construction iterative build workflow speed library lab recombinant grade bacteria mechanistic crucial traditional propose strongly genetically variety mutant biology cycle account perspective production necessary property genomic dna insight understanding lack rapid limited product technique wide design food tool application challenge multiple future use current role cell number available test new research review acid development level,{},{},{},{},{},{}
787,787,848,10.1007/8904_2016_538,26920905.0,phenotypic blood chain lactic disorder succinyl abnormality hour acidosis growth butyryl ratio single new frozen lower congenital abnormal defect neonatal prenatal median restriction elevated onset severe apart highlight echs cardiomyopathy methylbutyric hypothesis majority dysmorphic disease respectively expectancy spectrum biochemical understanding life dihydroxy previous methylmalonyl dysfunction hydroxybutyryl coa range secondary comparable error report pyruvate support inborn result hydratase recently intrauterine metabolic first inhibition metabolism level case enoyl mutation dehydrogenase short valine derangement end normal syndrome lactate evaluation liver day delivery fatty year dysmorphia within two oligohydramnios premature sibling omim approximately leigh facial previously also acid suspect deficiency patient carnitine complex mitochondrial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110442/,abstract,4,succinyl oligohydramnios methylbutyric leigh hydroxybutyryl hydratase enoyl echs dysmorphia dihydroxy butyryl suspect frozen dysmorphic acidosis methylmalonyl lactic derangement cardiomyopathy valine expectancy pyruvate intrauterine omim lactate sibling apart facial carnitine premature coa comparable dehydrogenase hour mitochondrial prenatal phenotypic inhibition end restriction elevated hypothesis majority abnormal approximately fatty secondary delivery median previous short abnormality understanding recently neonatal liver dysfunction onset chain syndrome evaluation defect previously highlight growth congenital biochemical ratio spectrum severe inborn support normal day range complex error lower single deficiency report respectively life mutation case metabolism new blood acid metabolic year level disorder result patient disease,{},{},{},{},{},{}
788,788,850,10.1177/0192623316675768,28068892.0,matter cornerstone biotransformation related toxicology three society life example brush scientific order symposium timing graph annual dose perspective relevance many basic review san milestone real tenant broad interactive pathology variation diego people toxicologic june presentation data principle basis focused response thing change doe metabolism historical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228358/,abstract,1,toxicologic thing tenant symposium diego cornerstone brush biotransformation toxicology san graph timing focused interactive historical milestone annual june relevance broad principle society real pathology basic matter scientific presentation people doe dose perspective basis example variation related order change response life metabolism review data,{},{},{},{},{},{}
789,789,852,10.2147/PHMT.S49329,29388626.0,prescription example vegetable micronutrient lead abnormal time essential preference restriction coincide severe left fruit accumulation newer well pku glycomacropeptide contribute phe peak oil later phenylalanine life much profound mainly obesity therapy health protein replacement ideal error food inborn enzyme large combination metabolism untreated low non commonly although three slpf neutral child fully many phenylketonuria work disability free treatment carbohydrate bioavailability important supplement fatty year diet option traditionally fat poor professional likely irreversible appetite subgroup sapropterin special program available consumption intermittent foundation consequence intellectual nutritional practice part high satiety sugar substitute acid dietary supplemented deficiency patient amino,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683291/,abstract,0,slpf coincide newer left oil traditionally prescription intermittent appetite vegetable supplemented satiety ideal bioavailability peak fruit substitute micronutrient irreversible profound carbohydrate sugar sapropterin preference supplement neutral glycomacropeptide foundation subgroup replacement fat contribute fully untreated special commonly later consumption mainly restriction option accumulation abnormal obesity fatty poor intellectual professional consequence work nutritional example likely lead combination disability free practice essential severe inborn food enzyme phe program error large deficiency diet dietary therapy life pku amino non important phenylketonuria low available metabolism time phenylalanine acid child protein health year high treatment patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""important phenylketonuria low available metabolism time phenylalanine acid child protein health y""]}, ""intellectual"": {""freq"": 1, ""string"": [""option accumulation abnormal obesity fatty poor intellectual professional consequence work nutritional e""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""deficiency diet dietary therapy life pku amino non important phenylketonuria low a""]}}","{""diet"": {""freq"": 1, ""string"": [""enzyme phe program error large deficiency diet dietary therapy life pku a""]}}",{}
790,790,853,10.1002/aur.1916,29316350.0,disorder relationship autism whether youth factor positively anxiety uncertainty without behavior condition together due deficit risk control severity experience neurological spectrum maladaptive dysregulation recent summaryyouth feature lay effect psychological data genetic controlling hierarchal repetitive regression level significant intolerance underpinnings asd variable independent communication certain possibly child predictor social disability year directly particularly predictive age dispositional likely emotion aspect also intellectual high study linear participant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903967/,abstract,4,summaryyouth hierarchal dispositional controlling maladaptive lay emotion underpinnings youth intolerance dysregulation repetitive uncertainty possibly positively psychological predictor anxiety predictive asd communication linear certain severity aspect independent directly neurological intellectual experience autism variable regression deficit feature behavior likely disability particularly social relationship spectrum participant recent condition risk control factor child age significant year effect high genetic data level disorder study,"{""neurological"": {""freq"": 1, ""string"": [""linear certain severity aspect independent directly neurological intellectual experience autism variable r""]}, ""intellectual"": {""freq"": 1, ""string"": [""certain severity aspect independent directly neurological intellectual experience autism variable regression d""]}, ""social"": {""freq"": 1, ""string"": [""deficit feature behavior likely disability particularly social relationship spectrum participant recent c""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
791,791,854,10.1016/j.apsb.2015.07.004,26579479.0,intra monitoring although mass internal standard time positive sensitivity clinical ionization throughput range reaction word analysis matrix real spectrometry nitrotyrosine method determination day also research multiple plasma mode high effect human direct simultaneous precision mrm key novel chlorotyrosine transition linear limit tandem ion assay inter accuracy respectively potentially determintion useful detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629445/,abstract,1,nitrotyrosine mrm determintion chlorotyrosine ionization intra simultaneous throughput ion inter matrix mode internal transition determination real precision limit monitoring word linear tandem accuracy useful potentially reaction direct assay sensitivity spectrometry standard detection mass plasma day range multiple positive key respectively novel time human research effect high method clinical analysis,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""reaction direct assay sensitivity spectrometry standard detection mass plasma day range m""]}, ""tandem"": {""freq"": 1, ""string"": [""real precision limit monitoring word linear tandem accuracy useful potentially reaction d""]}, ""spectrometry"": {""freq"": 1, ""string"": [""useful potentially reaction direct assay sensitivity spectrometry standard detection mass plasma d""]}}",{},{}
792,792,855,10.3390/jcm4050884,26239454.0,immunodeficiency inflammatory mimic infestation subset disorder one smaller graft new scale dermatitis timely several optimal infection adult drug child critical pruritus atopic condition onset coexist infant erythema host also common correct induration eruption nutritional diagnosis complicate skin treatment versus persistent disease genetic familiarity typical spectrum malignancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470205/,abstract,0,infestation induration eruption pruritus erythema complicate coexist familiarity dermatitis atopic graft malignancy persistent immunodeficiency smaller mimic timely host typical skin correct subset versus optimal inflammatory infection nutritional onset critical scale spectrum infant drug adult condition common new diagnosis child genetic disorder treatment disease,"{""skin"": {""freq"": 1, ""string"": [""immunodeficiency smaller mimic timely host typical skin correct subset versus optimal i""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
793,793,856,10.1186/s13023-016-0539-3,27908281.0,conclusionthe statistic assessment canadian new rct positive reimbursement half publicly due included common cost supportive drd average partly disease respectively biochemical evidence pharmaceutical possible clinical health range double effectiveness payer design type case although government one least agency size per annual resultsfrom drug database comprehensively cadth review descriptive private reason people technology towards article treatment recommendation year challenge rare regulator public two poor negative lack submission prevalence pan since explore responsible quality backgrounda aim research trial multiple trend high study insufficient blind patient industry cdr number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134221/,abstract,13,submission pan cdr cadth resultsfrom payer backgrounda rct publicly supportive included drd canadian reimbursement agency comprehensively private partly government annual insufficient industry reason statistic regulator descriptive blind pharmaceutical conclusionthe trend half responsible double people explore average poor effectiveness size recommendation negative lack cost database design prevalence biochemical public technology possible assessment aim trial challenge range multiple positive drug quality rare respectively evidence article common number case new type research review health year high treatment clinical patient disease study,{},{},{},{},{},{}
794,794,857,10.3390/ijms17060964,27322259.0,interestingly tool culture self islet oxidative condition microscopy contributes partly toxicity addition pancreatic hiapp benzbromarone form secreted role compound metabolic effect data ability type amylin formation transmission completely ultimately three one mellitus death inhibitor aggregation drug damage able thioflavin insulinoma model therapeutic turbidimetry pathological slow hormone diabetes assay cell aggregate library cytotoxic amyloid apoptotic order abnormally electron mechanism vitro reduce propensity polypeptide fiber insulin human acid quercetin small deficiency patient hallmark,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926496/,abstract,0,turbidimetry quercetin insulinoma hiapp benzbromarone thioflavin amylin abnormally secreted polypeptide islet cytotoxic propensity pancreatic fiber apoptotic microscopy slow hallmark electron contributes partly mellitus library aggregate transmission interestingly amyloid ultimately aggregation toxicity pathological completely reduce culture insulin inhibitor oxidative hormone damage formation able diabetes vitro death compound assay self ability order small form tool addition drug therapeutic deficiency mechanism condition role cell human model type acid metabolic effect data patient,{},{},{},{},{},{}
795,795,858,10.1016/j.ymgmr.2019.100467,30963030.0,blood cross activity estonian difference time laboratory median half old classical providing pku hydroxylase respectively third adulthood phenylalanine life value clinical abolish result six good conversely late adherence first eight level significant one phenotype individually database fully collectively phenylketonuria ass national occurred recommendation electronic fitting adolescence year best surprisingly wide unified threshold generally age mildly two variant opportunity percentage poor spot especially approximately cognitive pah group practice dietary patient individual deviation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434493/,abstract,2,occurred estonian unified providing fitting abolish surprisingly mildly conversely threshold individually collectively adolescence deviation percentage adulthood fully half adherence generally classical late approximately opportunity poor best median good recommendation old pah cross national especially database practice spot wide laboratory ass hydroxylase phenotype cognitive value variant electronic respectively dietary life activity pku difference phenylketonuria individual time phenylalanine blood age significant group year level clinical result patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""activity pku difference phenylketonuria individual time phenylalanine blood age significant group y""]}}",{},{},{},{},{}
796,796,859,10.5582/irdr.2019.01066,31218158.0,epidemiological cross sectional registration information commission promotion amenable country action literature common share source disease status timeliness ascertain actively screening mainly health regional tease china diagnosis recently data reference republic first official greatly website level use case current collect database provide model development national people guide uniformity treatment incidence challenge list rare typically prevalence order estimate monograph comparison hospital available policy rationale study though accuracy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557238/,abstract,7,uniformity timeliness tease monograph collect republic ascertain commission website promotion official amenable actively rationale greatly registration regional share epidemiological guide list typically china action people mainly reference accuracy sectional estimate policy incidence source recently hospital comparison cross national database provide prevalence order status country literature screening challenge use rare information current common case available model diagnosis development health data level treatment disease study,{},{},{},"{""screening"": {""freq"": 1, ""string"": [""provide prevalence order status country literature screening challenge use rare information c""]}}",{},{}
797,797,860,10.3390/jcm6040037,28338638.0,utility coenzyme biochemical monitoring ubiquitously rapid blood beneficial possible early coq oxidative role phosphorylation insight either environmental condition secondary synthesized primary determination identification also fibroblast result mononuclear plasma different tissue good skin treatment specimen urinary key deficiency muscle status lipid genetic potentially metabolism platelet cell cultured mitochondrial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406769/,abstract,0,synthesized coq platelet ubiquitously mononuclear coenzyme cultured phosphorylation muscle specimen fibroblast skin determination lipid mitochondrial urinary oxidative beneficial monitoring utility secondary potentially good insight rapid environmental tissue identification biochemical status possible plasma primary key deficiency condition role cell metabolism early blood different genetic treatment result,"{""skin"": {""freq"": 1, ""string"": [""coenzyme cultured phosphorylation muscle specimen fibroblast skin determination lipid mitochondrial urinary o""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
798,798,861,10.1007/s40290-018-0243-9,30174435.0,sweetener subsequent european epidemiological explicit assessment new discus information early context authorization neonatal awareness need solvent highlight facilitate risk toxicity effective taste addition preservative formulation justification paediatrics extensive suitable knowledge life pharmacokinetics pharmacology sharing repository clinical engage compound neonate modeling project surfactant result like data stability term pharmacotherapy esnee flexibility step pre propylene problem drug child product excipients development plan exposure safety excipient active decision colorant challenge feasibility progress access vehicle stakeholder enable quality analysis benefit impact framework also shelf building different study similar small assist thanks safe initiative sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105181/,abstract,0,shelf propylene excipient esnee colorant surfactant repository preservative excipients thanks pharmacotherapy justification explicit authorization building paediatrics engage solvent sharing vehicle taste modeling enable pharmacology pharmacokinetics sweetener flexibility assist stakeholder formulation neonate toxicity epidemiological safe awareness initiative plan feasibility progress project subsequent facilitate extensive stability suitable access sensitive safety framework european active decision step pre compound neonatal exposure context product highlight problem benefit like small discus need knowledge similar assessment addition challenge drug quality effective impact information life term new risk early child different development data clinical analysis result study,{},{},{},{},{},{}
799,799,862,10.1016/j.ymgme.2014.11.007,25481106.0,matter age two phenylalanine variable continuously childhood early relation estimate widespread standard compromise white carefully child throughout deviation elevated previously spike accumulative without index particularly diffusion retrospectively multiple predictor dti slope lifetime elevation detrimental exposure integrity average mean effect study diffusivity control dietary powerful pku liberalization finding variability eight microstructural phe tensor,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277899/,abstract,0,liberalization accumulative spike slope detrimental microstructural compromise dti carefully tensor retrospectively diffusivity continuously lifetime integrity elevation diffusion widespread powerful deviation predictor variability matter white relation elevated average estimate index childhood variable mean exposure particularly previously standard finding phe multiple dietary pku early phenylalanine control child age effect study,"{""phenylalanine"": {""freq"": 2, ""string"": [""finding phe multiple dietary pku early phenylalanine control child age effect s""]}}",{},{},{},{},{}
800,800,863,10.1542/peds.2018-1099C,30600265.0,ratio difference information concern open risk clinician majority objective survey discrimination confident utility screening enrollment clinical health project genomic result theme although optimism interest toward method technology parent baseline response strongly care attitude newborn favorable explore privacy stem benefit background aware prior impact infant trial conclusion group study sequencing beyond perception,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480393/,abstract,0,optimism confident enrollment privacy aware discrimination favorable attitude perception stem theme project strongly prior clinician open baseline utility majority explore concern genomic survey sequencing parent benefit ratio technology background infant screening objective trial response impact care information newborn conclusion difference risk health group method clinical result study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""objective trial response impact care information newborn conclusion difference risk health g""]}, ""screening"": {""freq"": 1, ""string"": [""parent benefit ratio technology background infant screening objective trial response impact c""]}}",{},{}
801,801,864,10.3389/fpsyg.2016.00684,27242598.0,disorder better region difference factor lower country present despite behavior variation deficit origin essentially measurement executive however normative neurodevelopmental relative speech frontal verbal regional fluency task result diagnosis attention purpose effect data language change cause term cultural ability area use letter significant three dyslexia linguistic produce correlational provide child variance development older year geopolitical education brazil consensus age category function cognitive basic analysis aspect auxiliary importance also fluent group high study hyperactivity neuropsychological participant performance gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861882/,abstract,1,geopolitical fluent fluency correlational auxiliary dyslexia normative linguistic letter essentially speech frontal cultural verbal regional brazil produce variance neuropsychological origin hyperactivity consensus older language executive basic gender neurodevelopmental category task aspect education relative deficit behavior purpose attention variation measurement ability despite importance provide performance country better region participant cognitive area change cause lower use term difference function present factor diagnosis child age significant development group year effect high data disorder analysis result study,"{""hyperactivity"": {""freq"": 1, ""string"": [""regional brazil produce variance neuropsychological origin hyperactivity consensus older language executive b""]}}",{},{},{},{},{}
802,802,865,10.2174/1570159X15666171123201142,29173175.0,major mood disorder relationship activity threat better region anxiety glutamate mdd methodsthis behavioral inflammation behavior basal traumatic reward horizon motor well contribute cingulate related relevant circuit evidence marker strategy recent variety clinical role protein demonstrating neurocircuitry resultsinflammation brain focus amygdala conclusionneuroimaging neurotransmitter result effect novel ganglion significant stress administration anterior biomarkers acute cytokine sensitivity release relevance review motivation therapeutic work backgroundstudies translational development insula system stimulus proportion circuitry phase bipolar inflammatory future peripheral reduced impact translation depressive also cortical cortex reliably high study monoamine similar patient consistently treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997866/,abstract,0,resultsinflammation mdd insula conclusionneuroimaging backgroundstudies neurocircuitry cingulate bipolar traumatic horizon ganglion circuitry amygdala threat motivation depressive cortical stimulus reward reliably basal anterior circuit mood glutamate monoamine release demonstrating cytokine cortex consistently translational methodsthis peripheral relevance contribute inflammation neurotransmitter anxiety translation treat reduced variety proportion motor inflammatory behavioral acute phase administration stress work sensitivity focus behavior marker biomarkers relevant related relationship better similar region major strategy therapeutic future brain recent impact novel activity evidence role review protein significant development effect high disorder clinical result patient study,"{""behavioral"": {""freq"": 1, ""string"": [""treat reduced variety proportion motor inflammatory behavioral acute phase administration stress w""]}}",{},{},{},{},{}
803,803,866,10.3390/jcm8050627,31071994.0,line specific biopsy importantly application easy ipscs time adipose drug therapy pluripotent invasive field procedure feature review approach model vitro converted method broad replacing also cost diagnostic tissue regenerative modelling source good study urine skin consuming specimen patient novel disease traditional muscle directly genetic low cell medicine non,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572423/,abstract,0,replacing converted ipscs regenerative modelling pluripotent adipose biopsy consuming easy muscle specimen skin importantly invasive broad traditional line procedure vitro directly urine good source feature cost tissue medicine field diagnostic application drug novel therapy non cell low approach time model specific review genetic method patient disease study,"{""skin"": {""freq"": 1, ""string"": [""adipose biopsy consuming easy muscle specimen skin importantly invasive broad traditional l""]}, ""urine"": {""freq"": 1, ""string"": [""broad traditional line procedure vitro directly urine good source feature cost t""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
804,804,867,10.1101/cshperspect.a023358,26330522.0,third respect advance although however three much trait recent difference factor crucial individually dynamic time quite across ago continental ancestry many population environmental distribution action frequency need view globe also common apart result thus second diverse epigenetic contrast turn force human display classical machine little origin nongenetic disease year first genetic susceptible gene individual modifiable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563709/,abstract,0,nongenetic globe continental modifiable susceptible quite ancestry machine apart ago turn force display individually epigenetic respect origin crucial dynamic view classical diverse action distribution little trait contrast advance second environmental frequency need recent difference common individual time human factor population gene year genetic result disease,{},"{""genetic"": {""freq"": 1, ""string"": [""ago turn force display individually epigenetic respect origin crucial dynamic v""]}}",{},{},{},{}
805,805,868,10.1007/s11010-017-3060-7,28534121.0,various coenzyme blood rise synthetic xenopus lead ratio vivo pathway oat tetrahydrobiopterin probenecid common supplementation vascular urinary increase sepiapterin disease responsive synthases phenylalanine organ form uptake previous dysfunction therapy alkylglycerol role scavenging fold distribution manner substrate result attention exogenous urine rat llc use level rapid administration cellular roughly involvement crucial oocyte transporter tyrosine slice exclusion back phenylketonuria system loss unknown baseline success strongly cell particularly excess reduces endogenous limited cardio acutely gateway tryptophan also medicinally study deficiency show kidney sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632347/,abstract,0,xenopus probenecid medicinally gateway scavenging llc synthases slice roughly alkylglycerol oat cardio oocyte rise acutely sepiapterin coenzyme excess uptake exclusion exogenous reduces vascular manner kidney transporter substrate responsive endogenous crucial tryptophan synthetic involvement success urinary organ strongly fold rat sensitive distribution cellular baseline tetrahydrobiopterin vivo urine unknown administration previous supplementation loss dysfunction rapid limited lead attention particularly tyrosine ratio various form increase pathway use deficiency therapy role common cell phenylketonuria phenylalanine blood level result disease study,"{""urine"": {""freq"": 1, ""string"": [""sensitive distribution cellular baseline tetrahydrobiopterin vivo urine unknown administration previous supplementation l""]}, ""phenylalanine"": {""freq"": 2, ""string"": [""deficiency therapy role common cell phenylketonuria phenylalanine blood level result disease s""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""particularly tyrosine ratio various form increase pathway use deficiency therapy role c""]}}",{},{},{}
806,806,869,,28450817.0,enteropathy specific tool sole cure isolate discus vsl nutrition specifically probiotic condition fda severe ulcerative pouchitis principle enteragam vivonex addition formulation well disease traditional physician medical concentrate crohn irritable variety dysfunction therapy extensively protein guidance diarrhea food efficacy predominant enterally gastrointestinal whole administration scientific requirement drug syndrome evaluation hiv management history alzheimer development ibd serum article bovine active help diet phase wide inflammatory manage chronic immunoglobulin bowel prior tract distinctive upon nutritional dietary patient elemental safe modulen treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402682/,abstract,0,vsl vivonex pouchitis modulen enteropathy enterally enteragam ulcerative isolate irritable elemental crohn ibd distinctive concentrate sole probiotic manage bovine diarrhea cure fda immunoglobulin hiv bowel predominant extensively guidance gastrointestinal formulation tract safe requirement alzheimer principle traditional physician treat scientific prior variety specifically nutrition inflammatory active phase administration history help serum nutritional efficacy dysfunction chronic syndrome evaluation wide discus severe food tool addition management drug medical diet dietary therapy condition article specific protein development patient disease,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""food tool addition management drug medical diet dietary therapy condition article s""]}}",{}
807,807,870,10.1186/s13006-016-0060-2,26813701.0,milk composition laboratory malawian liquid condition trans difficulty percent facilitate docosahexaenoic validation material respectively supplementary resultsboth backgroundthe slight user value storage role health range primary report conclusionsvalid result transport effect itfa stability experiment obstacle level shipping lab four three interest measure temperature room stable woman outcome week reason method development gas system online article collection electronic fatty strongly year particularly materialthe version robust sample two within spot unclear breast industrially dha available infant different part study acid variability total deviation chromatography acceptable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727292/,abstract,2,itfa industrially conclusionsvalid shipping malawian slight resultsboth docosahexaenoic dha obstacle trans lab percent breast room reason milk transport deviation acceptable gas temperature experiment backgroundthe facilitate validation stability variability strongly stable composition storage robust unclear difficulty liquid fatty chromatography collection woman particularly materialthe spot laboratory week measure infant supplementary user range primary version value electronic online report respectively total material outcome condition article role sample available acid different development health year effect method level result study,{},{},{},{},{},{}
808,808,872,10.1038/srep34321,27694983.0,activity inactivation investigation physiological single melanin time essential defect adult despite lifespan insight insect severe hemimetabolous physiology regulatory accumulation hydroxylase neurological embryonic typical extensive sequence dsappah phenylalanine phylogenetic aphid defective role consistent developmental contribution never thus enzyme metabolic embryo first level significant catalytic biosynthetic end shortens holometabolous tyrosine morphological generate disruption development expression pisum treatment parental important key temporal associated metazoan acyrthosiphon process newborn upstream act analysis closely precursor nymph hplc pah pattern domain mrna considerably deficiency fecundity successful gene number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5046115/,abstract,0,pisum nymph metazoan melanin holometabolous hemimetabolous fecundity dsappah aphid acyrthosiphon shortens phylogenetic insect upstream generate morphological inactivation biosynthetic temporal closely defective considerably lifespan embryo disruption hplc embryonic catalytic physiology typical mrna act parental extensive contribution physiological precursor end successful accumulation domain neurological associated regulatory sequence investigation insight pattern consistent pah developmental tyrosine defect essential despite hydroxylase severe process enzyme expression key single adult deficiency newborn activity important role number time phenylalanine significant development metabolic gene level treatment analysis,"{""phenylalanine"": {""freq"": 2, ""string"": [""newborn activity important role number time phenylalanine significant development metabolic gene l""]}, ""neurological"": {""freq"": 1, ""string"": [""physiological precursor end successful accumulation domain neurological associated regulatory sequence investigation i""]}, ""melanin"": {""freq"": 1, ""string"": [""pisum nymph metazoan melanin holometabolous hemimetabolous fecundity dsappah a""]}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""enzyme expression key single adult deficiency newborn activity important role number t""]}}",{},{}
809,809,873,10.15171/apb.2019.016,31011567.0,repeatability correlation activity past investigation surface microscopy superior buffer morphology solution peak pulse dpv pharmaceutical dodecyl oxidation cntpe range recovery real sodium voltammetric examination result sensor cyclic purpose quantification novel medicine sulfate bare detection neutral phosphate emission current electrochemical sensitivity tyrosine method trough towards electrocatalytic fesem concentration response limit carbon electrode bcntpe sample nanotube differential electron field reproducibility analysis keywords also conclusion constancy study voltammetry linearly optimum show sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468228/,abstract,2,voltammetry voltammetric trough fesem electrocatalytic dpv dodecyl constancy cntpe bcntpe bare nanotube sulfate repeatability linearly cyclic optimum electrochemical electrode buffer microscopy sensor electron carbon phosphate peak pulse reproducibility morphology sodium emission superior recovery neutral surface quantification oxidation pharmaceutical differential real solution keywords limit examination sensitive past investigation sensitivity purpose tyrosine correlation medicine field detection range response novel concentration activity current conclusion sample method analysis result study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""sensitivity purpose tyrosine correlation medicine field detection range response novel concentration a""]}}",{},{}
810,810,874,10.1186/s12881-019-0860-5,31382905.0,backgroundphenylketonuria new single pathway autosomal necessary accurate molecular frequency common resultsdouble tube methodswe reliable disease pku hydroxylase respectively amount suitable phenylalanine screening clinical fast therefore genotype diagnosis metabolic large urine novel genetic chinese pcr hybridization mutation tyrosine population technique simple method conclusionsthe technology multiplex specificity sample recessive dna analysis pah diagnostic successfully rapidly sequencing blind deficiency accurately gene accuracy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683507/,abstract,1,resultsdouble tube multiplex hybridization backgroundphenylketonuria accurately fast rapidly blind successfully pcr chinese reliable accurate suitable conclusionsthe simple recessive accuracy genotype urine autosomal methodswe specificity necessary dna pah sequencing tyrosine technique frequency hydroxylase technology diagnostic screening large pathway single molecular deficiency respectively novel mutation pku common sample new phenylalanine diagnosis population metabolic gene genetic method clinical analysis disease,"{""urine"": {""freq"": 1, ""string"": [""suitable conclusionsthe simple recessive accuracy genotype urine autosomal methodswe specificity necessary d""]}, ""phenylalanine"": {""freq"": 2, ""string"": [""novel mutation pku common sample new phenylalanine diagnosis population metabolic gene g""]}}","{""autosomal"": {""freq"": 1, ""string"": [""conclusionsthe simple recessive accuracy genotype urine autosomal methodswe specificity necessary dna p""]}, ""recessive"": {""freq"": 1, ""string"": [""chinese reliable accurate suitable conclusionsthe simple recessive accuracy genotype urine autosomal m""]}, ""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""frequency hydroxylase technology diagnostic screening large pathway single molecular deficiency respectively n""]}}","{""screening"": {""freq"": 1, ""string"": [""tyrosine technique frequency hydroxylase technology diagnostic screening large pathway single molecular d""]}}",{},{}
811,811,875,10.1186/s12887-019-1580-x,31202265.0,disorder blood activity dominant extremely early several country present author deterioration presentationwe initial without biosynthesis homeostasis dopa marked testing backgroundtetrahydrobiopterin institution practical control unexplained month responsive neurological recurrent synthesis issue knowledge later phenylalanine hyperthermia broader form screening dysfunction clinical reductase symptom noticeable error report inborn diagnosis metabolic cyclohydrolase first south detection level yet case normal child evaluation markedly dystonia test treatment neopterin vomiting initially universal rare gtpch variant newborn hyperphenylalaninemia spot screen serotonin especially whilst birth residual omim autonomic pteridine program gtp decelerated high presentation deficiency patient asian complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6570886/,abstract,1,pteridine noticeable decelerated neopterin hyperthermia presentationwe backgroundtetrahydrobiopterin gtpch autonomic vomiting unexplained deterioration omim marked dopa dystonia whilst reductase cyclohydrolase initially gtp asian broader recurrent south extremely dominant institution residual markedly universal responsive biosynthesis practical author serotonin screen hyperphenylalaninemia homeostasis initial later presentation neurological synthesis dysfunction especially evaluation spot issue birth testing knowledge country detection inborn symptom form month normal screening program complex variant error deficiency report rare newborn activity present case test early phenylalanine control blood diagnosis child metabolic high level disorder treatment clinical patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""newborn activity present case test early phenylalanine control blood diagnosis child m""]}, ""neurological"": {""freq"": 1, ""string"": [""screen hyperphenylalaninemia homeostasis initial later presentation neurological synthesis dysfunction especially evaluation s""]}}",{},{},"{""detection"": {""freq"": 1, ""string"": [""spot issue birth testing knowledge country detection inborn symptom form month n""]}, ""newborn"": {""freq"": 1, ""string"": [""complex variant error deficiency report rare newborn activity present case test e""]}, ""screening"": {""freq"": 1, ""string"": [""detection inborn symptom form month normal screening program complex variant error d""]}}",{},{}
812,812,876,10.1016/j.cell.2018.02.015,29522743.0,level frame microbiota invasion resilience subject member outsider recent microbe information scale biotic community across adaptive range ecosystem persist diversification composite pressure work host adapt highlight face exchange system foreign evolution abiotic lineage transfer progeny distinct finally selective preservation acquisition novel genetic perturbation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846202/,abstract,0,outsider invasion persist diversification biotic abiotic foreign ecosystem progeny lineage composite adapt preservation frame resilience microbe perturbation acquisition host transfer microbiota exchange evolution adaptive face pressure selective distinct member community finally work highlight scale subject range recent novel information genetic level,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
813,813,877,10.1186/s13023-017-0600-x,28274234.0,male synthetic daily growth profile paediatric weight mean addition favour formulation well responsive material flip supplementary phenylalanine gov neuromotor interval pharmacokinetics higher clinical mixed user consistent spark improvement backgroundsapropterin result kuvan efficacy effect good mild term oral adherence type non significant confidence one female per flop text normal monthly child stable registrationclinicaltrials population week model phenylketonuria conclusionsthe day resultsin development older compartment behaviour safety pharmacokinetic substantial online article tolerance europe treatment electronic year diet best initially version materialthe sample adjustment approval hyperphenylalaninemia intention sapropterin analysis aim available nct trial pah group plus june study dietary cofactor patient linear randomly total parameter acceptable treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343543/,abstract,8,spark backgroundsapropterin neuromotor flop flip kuvan favour monthly intention pharmacokinetics registrationclinicaltrials pharmacokinetic compartment approval initially adjustment europe paediatric june formulation sapropterin resultsin behaviour plus mixed randomly tolerance responsive acceptable synthetic nct older gov substantial adherence conclusionsthe stable hyperphenylalaninemia confidence treat cofactor safety linear mild oral interval daily text parameter best good profile female improvement consistent efficacy weight pah mean materialthe growth male week aim supplementary normal addition day trial user version electronic online diet dietary total material term higher non article sample phenylketonuria available model phenylalanine type population child significant development group year effect treatment clinical analysis result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""non article sample phenylketonuria available model phenylalanine type population child significant d""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""day trial user version electronic online diet dietary total material term h""]}}",{}
814,814,878,10.1038/s41598-018-35373-9,30459323.0,phenotypic disorder tool pahd difference factor among synonymous across neonatal cpku five missense common nonsynonymous testing significantly hydroxylase pku respectively spectrum however phenylalanine observed distribution genotype china data mild novel genetic mpku significant case seven three one pathogenic phenotype abundant overall provide outcome many population management phenylketonuria valuable modifier incidence future two variant allele hyperphenylalaninemia influence mhp mutational classic different cohort deficiency patient null complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244417/,abstract,5,pahd cpku nonsynonymous mhp mpku synonymous null mutational modifier abundant valuable classic missense china phenotypic hyperphenylalaninemia distribution pathogenic seven mild genotype allele observed incidence neonatal influence provide cohort hydroxylase phenotype testing overall spectrum tool management complex variant future deficiency respectively novel pku outcome difference common phenylketonuria case significantly phenylalanine factor population different significant genetic data disorder patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""outcome difference common phenylketonuria case significantly phenylalanine factor population different significant g""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
815,815,879,10.1002/14651858.CD001069.pub5,27420164.0,immediate blood nutritive tool pain cochrane assessment milk respiratory search physiological inconclusive ratio difference single investigation extremely lower maximum among duration profile time dioxide across present criteriarcts author glucose neonatal selection cinahl restriction without bias serious central action additional literature due need separate preterm wmd continuous heel contextual risk methodswe nirs tube injection electroencephalogram control effective subcutaneous objectivesto painful register grimace issue analysisour beneficial evidence interval pharmacological event anaesthetic dosage moderate neurodevelopmental intramuscular optimal pacifier procedure neonate minor arterial eeg secondary composite examination alone tcpo harm result effectiveness efficacy saturation effect infrared data language procedural term oral orogastric combination long low score non use circumcision stress confidence water administration rate four main measure size relief local lance dose side outcome nasogastric bladder intervention week tcpco model puncture day method catherization frequently unstable cry minimally gas system pipp safety unknown behavioural categorical test postnatal treatment collection proportion electronic intensity medline carbon inconsistency insertion near library resultsseventy age sample transcutaneous randomised positioning spectroscopy premature peripheral manual standard determine breast embase heart quality facial impose analysis venipuncture adverse eye benefit prior research infant indicator oxygen trial revman conclusionssucrose exchange grade group backgroundadministration high study heterogeneity orally skin meta similar small relieving february echocardiography postmenstrual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457867/,abstract,12,transcutaneous tcpo tcpco resultsseventy relieving pipp pacifier orogastric nirs nasogastric lance impose grimace criteriarcts conclusionssucrose circumcision catherization bladder backgroundadministration analysisour wmd revman relief postmenstrual painful saturation randomised positioning electroencephalogram dioxide categorical anaesthetic unstable puncture procedural minimally intramuscular infrared contextual composite venipuncture arterial echocardiography nutritive manual tube subcutaneous orally heel february minor inconsistency inconclusive harm eeg register objectivesto immediate cinahl carbon facial dosage postnatal maximum insertion library eye behavioural respiratory oxygen cochrane intensity extremely breast indicator premature grade pain neonate exchange spectroscopy skin embase preterm near medline peripheral milk duration bias injection gas continuous author separate language beneficial physiological water pharmacological meta neurodevelopmental confidence prior local examination action optimal safety restriction proportion moderate heterogeneity event glucose oral interval frequently dose procedure selection search methodswe secondary effectiveness unknown heart administration investigation collection size adverse profile central stress efficacy neonatal combination determine week benefit issue additional main ratio small need score standard similar literature assessment tool measure infant long day trial electronic quality effective lower single use intervention rate evidence outcome term non difference sample low present test time risk model control blood research age group effect high method data treatment analysis result study,"{""skin"": {""freq"": 1, ""string"": [""premature grade pain neonate exchange spectroscopy skin embase preterm near medline p""]}}","{""heterogeneity"": {""freq"": 1, ""string"": [""action optimal safety restriction proportion moderate heterogeneity event glucose oral interval f""]}}",{},{},{},{}
816,816,881,10.1530/EC-17-0289,29074613.0,worldwide blood region dos ratio early lower among autonomous congenital time venous elevated slightly subsequently investigate average course close significantly respectively temporary estimated methodsdata backgroundthe screening optimal higher value therapy health determined cutoff china diagnosis thus design call first young period level case seven fluorescence reevaluation rate ethnicity normal dose child evaluation pmol permanent day conclusionsthe predictor tch thyroid test respective treatment zhuang important filter year tsh incidence assay hyperthyrotropinemia maternal predictive age earlier sample transient newborn resultsamong january prevalence appropriate subtypes differentiation hypothyroidism birth function approximately hospital paper program infant electrochemiluminescence withdrawal different whereas objectiveto similar patient highest accuracy individual unnecessary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704446/,abstract,12,tch reevaluation hyperthyrotropinemia electrochemiluminescence zhuang temporary pmol subtypes estimated autonomous methodsdata withdrawal resultsamong unnecessary respective cutoff venous tsh permanent ethnicity fluorescence slightly transient thyroid dos filter earlier close hypothyroidism subsequently objectiveto january differentiation predictor backgroundthe determined worldwide young china predictive course conclusionsthe optimal highest seven elevated dose approximately accuracy average appropriate maternal incidence assay hospital investigate evaluation congenital design prevalence paper period ratio birth similar region infant normal screening day program value lower respectively therapy rate newborn higher important function sample case test individual time significantly early blood diagnosis child different age health year level treatment patient,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""program value lower respectively therapy rate newborn higher important function sample c""]}, ""screening"": {""freq"": 1, ""string"": [""ratio birth similar region infant normal screening day program value lower r""]}}",{},{}
817,817,882,10.1055/s-0036-1593843,28180027.0,treatable advance public disorder although one newborn challenge morbidity screening phenotype current expand therapy storage health many critical review presymptomatic candidate condition onset infant identification due development state technology consequently appraisal date important lysosomal late novel mortality number initiative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288002/,abstract,0,presymptomatic appraisal expand lysosomal treatable initiative consequently candidate storage late morbidity date advance mortality onset critical identification public technology phenotype infant screening state challenge novel therapy newborn current condition important number review development health disorder,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""infant screening state challenge novel therapy newborn current condition important number r""]}, ""screening"": {""freq"": 1, ""string"": [""critical identification public technology phenotype infant screening state challenge novel therapy n""]}}",{},{}
818,818,883,10.5607/en.2016.25.1.1,26924928.0,major disorder autism architecture vivo single factor behavioral insight behavior utero territory reward deficit uncharted limbic stimulation mainstay risk horizon affective typical spectrum numerous neuroimaging understanding circuit life subject pharmacological deep childhood neurodevelopmental recent interfere broadly cognition role brain amygdala improvement body factorial report besides cortico change striatothalamo first gesture genetic non educational although multi mutation asd one interventional structure nonverbal many management axon neurodevelopment work pathological contact development target social expression system treatment important key response year neuropathological component synaptogenesis still especially involved reduced facial eye benefit motility also cortical interaction study nucleus loop patient gene complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766109/,abstract,1,uncharted synaptogenesis striatothalamo gesture cortico affective limbic nonverbal motility interfere factorial territory axon neuropathological neurodevelopment horizon neuroimaging mainstay interventional amygdala nucleus cortical utero reward loop architecture contact facial deep circuit eye broadly cognition stimulation typical pathological educational multi numerous involved pharmacological neurodevelopmental asd reduced behavioral vivo autism component insight improvement childhood deficit work understanding behavior structure especially social benefit spectrum target interaction body subject management major expression change complex key response brain single recent report life mutation non important role risk factor development gene year genetic disorder treatment patient study,"{""behavioral"": {""freq"": 1, ""string"": [""numerous involved pharmacological neurodevelopmental asd reduced behavioral vivo autism component insight i""]}, ""social"": {""freq"": 1, ""string"": [""deficit work understanding behavior structure especially social benefit spectrum target interaction b""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
819,819,884,10.1371/journal.pone.0163234,27695036.0,assessment relationship sectional lead biomechanical greater energy composition content lower femur maximum oxidative lesser despite glucose density inflammation fracture brittle promotes weight due fed capacity source control increase backgroundglycomacropeptide subcutaneous significantly intake summary palmitate beneficial evidence oxidation relative anti femoral health protein consistent determined mouse absorptiometry body food kcal property length effect casein negatively little bmd displacement mediate area yet female dual phenotype mineral cytokine infers strength point brown liver week resultsfemale post development concentration test ray dxa hormone fatty diet stronger inflammatory fat age reduces mass adiposity load unclear gastrocnemius determine brittleness adipose mineralization bone reduced quality impairment ductility either impact conclusionsfemale regardless plasma tissue high satiety feeding acid objectiveto extent dietary prebiotic muscle amino performance total gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047596/,abstract,2,resultsfemale palmitate infers gastrocnemius ductility conclusionsfemale brittleness brittle biomechanical backgroundglycomacropeptide mineralization femur fed displacement promotes adiposity kcal fracture femoral dxa bmd lesser brown absorptiometry prebiotic adipose subcutaneous satiety dual casein mediate ray mineral maximum stronger muscle load feeding regardless cytokine strength reduces bone negatively density oxidation objectiveto length fat summary inflammation determined oxidative extent capacity beneficial gender hormone composition reduced unclear anti little energy glucose inflammatory post relative fatty sectional content property female source consistent weight liver impairment lead point tissue intake greater determine despite week phenotype relationship performance mouse body assessment food area mass plasma increase quality lower diet impact dietary concentration total evidence amino test significantly control acid protein age development health effect high,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""diet impact dietary concentration total evidence amino test significantly control acid p""]}}","{""diet"": {""freq"": 1, ""string"": [""area mass plasma increase quality lower diet impact dietary concentration total e""]}}",{}
820,820,885,10.1212/NXG.0000000000000006,27066545.0,various whole biochemical chain however panel evidence variant respiratory abnormality cellular rna capn abnormal demonstrate orai next mitoexome analysis five secondary molecular method degradation heterogeneous report neuromuscular exosc conclusion colq exome diagnosis ano enzyme cohort study data deficiency patient generation objective disease messenger metabolism gene transmission mitochondrial calcium nonmitochondrial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821083/,abstract,2,orai nonmitochondrial mitoexome messenger exosc capn ano colq neuromuscular respiratory calcium transmission heterogeneous rna degradation mitochondrial exome demonstrate cellular panel abnormal secondary abnormality generation chain cohort biochemical various enzyme objective variant molecular deficiency report evidence conclusion metabolism diagnosis gene method data analysis patient disease study,{},{},{},{},{},{}
821,821,886,10.5005/jp-journals-10005-1350,27365935.0,rare significant case disorder self lesch pediatr partial perioral lower aggressive boy jathar injurious raise syndrome int mutilation lns behavior lip destruction finger head error severe dent prevention inborn difficulty hand tissue article cheek old characterized mutilating nyhan persistent oral gawali disease month limb clin metabolism total hallmark injury biting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921883/,abstract,0,mutilation mutilating lns jathar gawali dent cheek biting perioral pediatr nyhan lesch int clin characterized limb injurious destruction lip aggressive persistent finger hallmark raise hand head boy injury partial difficulty oral old behavior self tissue prevention syndrome severe inborn month error lower rare total article case metabolism significant disorder disease,{},{},{},{},{},{}
822,822,887,10.18632/oncotarget.25071,29854317.0,major specific phalanx disorder importantly abnormality new pathway among congenital laminopathy district severe showing highlight beta canonical lamina clavicle disease ossification severely lethal activate knowledge form lmna developmental restrictive symptom data genetic non mutation one nuclear involvement spine cranial current lamin terminal collectively laminopathies review approach therapeutic mandible muscular dystrophy osteolysis specificity process rare typically bone dependent dermopathy turnover scoliosis osteolytic mechanism also osteoclastogenesis tgf osteoporosis fine number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978267/,abstract,0,scoliosis osteolysis ossification mandible lmna laminopathy laminopathies lamina lamin dermopathy clavicle tgf showing osteolytic osteoclastogenesis activate phalanx district cranial muscular spine dystrophy canonical turnover restrictive osteoporosis fine lethal terminal severely beta collectively bone importantly involvement typically nuclear specificity dependent abnormality developmental highlight congenital knowledge severe symptom process form major therapeutic pathway mechanism rare current mutation non approach number new specific review genetic data disorder disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""severe symptom process form major therapeutic pathway mechanism rare current mutation n""]}}",{},{},{}
823,823,888,10.1161/JAHA.118.009624,30608180.0,male major notably atrioventricular synthetic abnormality outlet factor congenital commitment defect synthase prevents tetrahydrobiopterin backgroundtetrahydrobiopterin endothelial increase significantly embryonic spectrum enos pregnant transcription pregestational form ventricular outflow double mouse dimerization gestation result kuvan thus effect lineage absent specie oral furthermore fetal histological level administration female mellitus myocardium ventricle normal produce coupling critical method therapeutic progenitor development reactive expression potential second streptozotocin treatment mother active dam diabetes incidence offspring cell conclusionssapropterin maternal cushion production vehicle sapropterin heart field analysis diabetic tract oxygen group orally right cardiac cofactor septal proliferation endocardial preventing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404194/,abstract,0,pregestational endocardial atrioventricular ventricle streptozotocin cushion conclusionssapropterin commitment septal preventing outlet outflow myocardium backgroundtetrahydrobiopterin progenitor lineage kuvan dam enos dimerization ventricular coupling vehicle histological orally offspring absent prevents mellitus notably gestation diabetic oxygen reactive embryonic endothelial tract sapropterin proliferation produce right pregnant synthase specie cardiac synthetic fetal transcription double cofactor diabetes mother oral tetrahydrobiopterin active production heart administration maternal female incidence second abnormality critical furthermore defect congenital male field spectrum mouse form normal major expression increase therapeutic cell significantly factor potential development group effect method level treatment analysis result,{},{},{},{},{},{}
824,824,889,10.1177/2382120518777770,29845119.0,subsequent relationship resilience search class difference content context student promotes examiner lecture cost metacognitively course retrieve transfer principle experience underlying disease objective significantly exam issue medical creates knowledge organ retrieval higher storage health reflect friday science methodology support result encounter store conceptual script question theory first medicine educational metacognitive integrates theme main scientific integrate retain problem relevance evaluation outcome feedback intervention humanistic approach week reflection method via national propose system illness free test curricular school treatment response inductively year education care stronger doctor application comparison category goal basic aspect board framework pathophysiology also foundation curriculum december june human lesson barrier patient empathy complication total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967154/,abstract,4,retrieve metacognitively metacognitive friday examiner curricular creates script retrieval retain reflect inductively humanistic promotes lecture integrate empathy curriculum integrates encounter store reflection feedback exam conceptual resilience doctor board lesson stronger transfer june theory illness student december foundation theme school pathophysiology relevance class principle educational underlying subsequent propose organ basic course barrier methodology storage category scientific complication question goal framework aspect education science search content experience comparison national cost context free evaluation medicine problem week issue main relationship knowledge support application objective response medical intervention care total outcome higher difference approach test significantly human health year method treatment result patient disease,{},{},{},{},{},{}
825,825,890,10.1016/j.ymgmr.2015.01.001,28649530.0,various case deficient phenylalanine iran hyperphenylalaninemia resultsamong single moderate prevalence duration determine dose category child mol phenylketonuria tetrahydrobiopterin responder conclusionbh classic kuvan different prevalent classification mild treatment center patient responsive pku type respectively medical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471163/,abstract,5,conclusionbh kuvan resultsamong responder responsive duration prevalent iran classification classic deficient hyperphenylalaninemia category mol moderate mild tetrahydrobiopterin dose center determine prevalence various medical single respectively pku phenylketonuria case phenylalanine type child different treatment patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""medical single respectively pku phenylketonuria case phenylalanine type child different treatment p""]}}",{},{},{},{},{}
826,826,891,10.4155/fsoa-2015-0014,28031956.0,infectious future tool disorder cancer pain complementary compliance application form scale genomics clinical invasive feces pulmonary probable necessary breath review discomfort render manner method evident iatrogenic minimally potential diagnosis diagnostic different like metabolic rheumatic participation biomatrices article study neurodegenerative large urine saliva validation noninvasive term patient powerful unsuitable associated disease proteomics injury painless sweat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137983/,abstract,0,biomatrices unsuitable painless discomfort iatrogenic sweat rheumatic render minimally feces breath probable saliva proteomics noninvasive pulmonary complementary participation pain evident manner powerful infectious injury neurodegenerative invasive compliance validation genomics urine associated necessary cancer scale like diagnostic form tool application large future term article diagnosis review potential different metabolic method disorder clinical patient disease study,"{""breath"": {""freq"": 1, ""string"": [""iatrogenic sweat rheumatic render minimally feces breath probable saliva proteomics noninvasive p""]}, ""urine"": {""freq"": 1, ""string"": [""injury neurodegenerative invasive compliance validation genomics urine associated necessary cancer scale l""]}}",{},{},{},{},{}
827,827,892,10.1136/medethics-2016-104050,28588147.0,yet plutocratic peer prolong life company entirely possible early place proposal respectable neglect drug responsible clinical outline intervention many fund either mechanism central aside paper research therapeutic trial scientist potential university often part large human publication treatment funding innumerable patient novel agent phase medication suffering idea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749301/,abstract,0,respectable plutocratic neglect innumerable prolong fund entirely aside suffering proposal company funding idea scientist outline peer place publication medication responsible university agent phase central paper possible trial drug therapeutic large mechanism intervention novel life human early research potential treatment clinical patient,{},{},{},{},{},{}
828,828,893,,31516187.0,major court immigration new davenport country world half molecular state principle avoid racial advent era galton nazi clinical legislation supreme movement century first genetic medicine full cellular scientific already sterilization many population critical upheld model sharply war american germany decision advance public earlier superiority biology eugenics legally aware program makeup america part aryan extent lesson power compulsory,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736015/,abstract,1,war upheld supreme sterilization nazi legally galton davenport compulsory aryan superiority racial eugenics sharply makeup immigration court legislation avoid aware century america advent lesson germany era power earlier movement american principle half extent scientific biology cellular world decision advance critical medicine public country state program major molecular new model population genetic clinical,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
829,829,894,10.1016/j.htct.2018.08.003,31084764.0,coefficient conclusionthe suitable correlation knowledge consistency tool four within provider committee reliability resultsthe acceptability internal professional sickle moderate software content pre statistical instrument retest methodstudy reproducibility analysis validity index cell environment choice expert intraclass development multiple stage check web average test data objectiveto agreement validation dfconhecimento question cultural disease calculation acquisition adequacy healthcare brazilian acceptable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517610/,abstract,1,methodstudy dfconhecimento check retest intraclass adequacy sickle cultural agreement consistency acceptability acquisition calculation reproducibility reliability brazilian validity committee software internal instrument web coefficient objectiveto provider acceptable conclusionthe validation choice suitable expert resultsthe question moderate healthcare statistical average content stage pre professional index environment correlation knowledge tool multiple cell test development data analysis disease,{},{},{},{},{},{}
830,830,895,10.3390/ijerph15102212,30309015.0,hematologic registry male considerable specific disorder region information pathway congenital adult despite neoplasm paediatric onset need inhabitant fact clinician majority increase transition disease longitudinal subset adulthood childhood broader value health consistent fold result data epidemiology young area period service female size intervention population method web valuable veneto year care planner rare monitoring age public anomaly million order since minimum dedicated background eye impact framework available phenomenon conclusion group policy december cohort vrrdr study patient number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210512/,abstract,6,vrrdr veneto planner neoplasm inhabitant hematologic dedicated minimum broader eye paediatric fact phenomenon epidemiology registry anomaly december web transition million adulthood subset valuable young considerable longitudinal fold monitoring clinician framework majority policy size service female consistent childhood onset despite congenital male cohort period public order need region background area value increase pathway adult rare impact intervention care information conclusion number available specific population age health group year method data disorder result patient disease study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""need region background area value increase pathway adult rare impact intervention c""]}}",{},{},{}
831,831,896,10.1186/s13023-017-0718-x,29096663.0,registry explicit tool psychometric whether daily new greater discus largely concern preference incorporate fit together fullest fall experience route concept objective disease material opinion matter however supplementary family much quantitative observed select perspective user clinical value mixed range input fast science translate core methodology adapt effectiveness qualitative purpose data genuinely ability tandem capture ultimately full hope multi one short measure current outcome pcom anchor method thereby potential propose online article interpretable treatment electronic help best track care argue version rare sample collaboration efficiently contract stakeholder opts systematically benefit aim research framework available importance unmet practice brand small center patient powerful deliver beyond pcoms consistently,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667521/,abstract,0,pcoms pcom opts interpretable genuinely fullest brand anchor track deliver explicit contract hope adapt incorporate fall unmet translate route psychometric select fit efficiently argue stakeholder opinion fast consistently collaboration registry input capture preference ultimately systematically mixed core powerful qualitative largely multi propose matter methodology tandem framework concept daily perspective science concern effectiveness center experience best observed help quantitative short purpose practice greater ability importance benefit small discus aim tool measure supplementary objective user range version value electronic online rare family care current material outcome article sample available new research potential method data treatment clinical patient disease,{},{},{},"{""tandem"": {""freq"": 1, ""string"": [""qualitative largely multi propose matter methodology tandem framework concept daily perspective s""]}}",{},{}
832,832,897,10.1186/s13023-014-0197-2,25433678.0,various specific blood information early amenable present require awareness frequency literature expert iems anecdotally methodswe effective clinician underlying disease neurological material opinion emergency treatable biochemical supplementary evidence atypical screening sometimes user nature feature resultswe improvement symptom primary error report diagnosis like metabolic effect large remainder urine incomplete metabolism eight level significant mimic although individually progression prevent damage intervention minimize review ready target potential online article test treatment proportion important supplement reversed regimen electronic year directly surprisingly systematic version backgroundinborn rare age palsy collective appropriate category invasive either available pathophysiology preventative identify exerts different often study cerebral elucidate thirty total number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273454/,abstract,7,reversed anecdotally remainder preventative palsy exerts surprisingly incomplete require minimize ready backgroundinborn atypical emergency collective amenable elucidate mimic regimen individually thirty opinion cerebral iems supplement treatable resultswe awareness pathophysiology invasive underlying progression identify damage expert category nature clinician proportion directly urine prevent neurological methodswe systematic appropriate improvement feature frequency like biochemical target literature various symptom supplementary screening user primary version electronic error online effective large report rare intervention information total evidence material article important number present available metabolism test early specific blood diagnosis review potential different age significant metabolic year effect level treatment disease study,"{""urine"": {""freq"": 1, ""string"": [""expert category nature clinician proportion directly urine prevent neurological methodswe systematic a""]}, ""neurological"": {""freq"": 1, ""string"": [""nature clinician proportion directly urine prevent neurological methodswe systematic appropriate improvement f""]}}",{},{},"{""screening"": {""freq"": 1, ""string"": [""biochemical target literature various symptom supplementary screening user primary version electronic e""]}}",{},{}
833,833,898,10.1007/8904_2017_61,28956315.0,phenotypic cluster present couple density programme retrospective frequency altogether variation origin pku hydroxylase material supplementary phenylalanine ground baby relative east user therapy additionally particular diagnosis data late south low clearly one least independent arg week phenylketonuria national potential online article genealogical response electronic incidence version materialthe overview two newborn allele hotspot especially birth analysis wherein available pah group different cohort high study trp estonia distinct patient highest variability gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122019/,abstract,5,estonia genealogical hotspot ground couple altogether trp east arg south clearly retrospective density cluster baby origin programme variability phenotypic distinct overview late highest additionally independent relative allele particular incidence pah national variation especially materialthe frequency cohort week hydroxylase birth supplementary user version response electronic online therapy newborn pku material article phenylketonuria low present available phenylalanine diagnosis potential different gene group high data analysis patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""material article phenylketonuria low present available phenylalanine diagnosis potential different gene g""]}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""user version response electronic online therapy newborn pku material article phenylketonuria l""]}}",{},{}
834,834,899,10.1371/journal.pone.0147843,26807790.0,coefficient male correlation cross relationship assessment better sectional factor mma aimsnormal offs parametric methodsthis median actual additional cut state risk testing well vitamin evaluate status respectively medical cancer weak poorly sometimes discriminatory clinical regional define homocysteine mol therefore alone symptom april first quotient nmol suggestive non rho level significant case functional female gold conclusionvitamin spearman curve methymalonic method accordance serum baseline treatment important receiver year best consecutive operating tabulation age deficient fedosov negative prevalence appropriate ctca standard series resultsmean analysis previously characteristic research indicator regardless roc diagnostic america june high presentation study acid power deficiency patient center thorough accuracy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725715/,abstract,8,tabulation methymalonic fedosov ctca conclusionvitamin aimsnormal offs discriminatory resultsmean parametric rho quotient nmol mma weak suggestive spearman accordance thorough homocysteine cut actual roc america operating define consecutive gold april receiver regardless june regional indicator power series curve methodsthis coefficient poorly deficient vitamin presentation mol baseline accuracy sectional center evaluate best median appropriate female serum cancer negative cross previously correlation male functional characteristic prevalence additional relationship status testing diagnostic standard better assessment symptom state medical deficiency respectively non important case risk factor research acid age significant year high method level treatment clinical analysis patient study,{},{},{},{},{},{}
835,835,900,10.1136/bcr-2015-211673,26837939.0,major case valproic within functional activity beneficial evidence daily haloperidol walk present despite girl fully antibiotic intravenous impairment week immunoglobulin therefore symptom day severe evident worsen difficulty result reminds effect old ivig acid barely treatment patient chorea month year help option sydenham severely,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746543/,abstract,3,valproic sydenham reminds ivig haloperidol worsen walk chorea barely intravenous immunoglobulin antibiotic severely girl evident fully beneficial difficulty option daily help old impairment despite functional week severe symptom month day major activity evidence present case acid year effect treatment result patient,{},{},{},{},{},{}
836,836,901,10.1002/aur.1517,26171787.0,operation disorder autism whether investigation fundamental information uncertainty time essential across present adult behavior awareness condition capacity deficit constraint control underlying spectrum flexible however neurodevelopmental relative adaptive nature inefficient task result reach complement theory novel repetitive non although three asd interest constrains mental efficiency social associated sequential finding process load typically efficiently unclear communicative systematically cognitive prior group high study conscious elucidate prioritize presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713391/,abstract,2,constrains conscious prioritize inefficient communicative constraint sequential flexible repetitive reach elucidate operation efficiently uncertainty complement load theory adaptive systematically fundamental awareness underlying efficiency typically capacity neurodevelopmental asd prior nature unclear task relative associated autism mental investigation deficit behavior presence social essential spectrum finding process cognitive adult novel information condition non present time control group high disorder result study,"{""social"": {""freq"": 1, ""string"": [""autism mental investigation deficit behavior presence social essential spectrum finding process c""]}}",{},{},{},{},{}
837,837,902,10.1007/s00787-016-0908-4,27695954.0,efficacious suffer knowledge disorder relevant psychiatry autism main investigation search lead lack remarkably centre conducted counselling adolescent proper psychiatric child occurrence sign many criterion inclusion psychiatrist characteristic therefore symptom literature broad also adhd diagnosis psychosis abstract metabolic risk clear article title manifestation recommendation term patient underlying disease first thorough visit hereditary overview learning,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306168/,abstract,3,title psychiatrist counselling suffer psychosis psychiatry efficacious thorough remarkably conducted learning abstract visit occurrence adhd proper hereditary sign centre broad underlying clear psychiatric manifestation overview adolescent inclusion search autism investigation recommendation lack criterion lead relevant characteristic main knowledge literature symptom term article risk diagnosis child metabolic disorder patient disease,"{""psychiatric"": {""freq"": 1, ""string"": [""hereditary sign centre broad underlying clear psychiatric manifestation overview adolescent inclusion s""]}}",{},{},{},{},{}
838,838,904,10.5582/irdr.2016.01020,27672536.0,worldwide new single largely prenatal nipt action molecular billion due share testing effective clinician noninvasive well disease advent largest recent chromosome health affordable burden monogenic china affirmative large cause generation genetic chinese whole provider government one current surrogate implementation syndrome child recognition unprecedented population development exome potential technology treatment ten greatest year care rare opportunity lack million estimate scale paucity next available genome unmet sequencing patient individual number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995420/,abstract,0,billion affirmative nipt unprecedented paucity unmet surrogate affordable greatest noninvasive advent largest government chromosome share recognition monogenic provider million chinese worldwide largely prenatal exome china action clinician burden opportunity estimate genome implementation lack generation sequencing syndrome scale technology testing cause effective large single molecular recent rare care current number available individual new population potential child development health year genetic treatment patient disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
839,839,905,10.1371/journal.pone.0188451,29190700.0,assessment beverage difference among bad hygiene caries acidogenicity control status intake respectively related subject microflora higher value environment plaque bacteria metabolic good oral type adjuvant low eight international non detection checkerboard significant sucrose variable main rinse hybridisation cariogenic child method prone system free snack habit conclusionsdiabetic might year age prevalence dna diabetic except group high similar dietary even aimto number gender statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708823/,abstract,4,rinse hybridisation conclusionsdiabetic acidogenicity microflora hygiene checkerboard snack plaque cariogenic caries sucrose bad adjuvant aimto prone habit diabetic beverage bacteria gender statistically oral international good dna environment variable free intake related prevalence main status similar detection assessment subject value respectively dietary higher non difference low number control type child age significant metabolic group year high method,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""intake related prevalence main status similar detection assessment subject value respectively d""]}}",{},{}
840,840,906,10.1097/TIN.0000000000000010,25382934.0,level blood beverage administration phenylalanine hour certain partial information lower sapropterin present drug mixed tablet powder either phenylketonuria tetrahydrobiopterin complete food solubility difficulty facilitate study testing stability formulation active conjunction patient diet responsive mixing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213132/,abstract,1,mixing tablet solubility powder conjunction formulation sapropterin beverage mixed responsive partial hour facilitate stability complete difficulty certain tetrahydrobiopterin active administration testing food drug lower diet information phenylketonuria present phenylalanine blood level patient study,"{""phenylalanine"": {""freq"": 2, ""string"": []}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""active administration testing food drug lower diet information phenylketonuria present phenylalanine b""]}}",{}
841,841,907,,25558491.0,relationship economically growth economy discus early among across country adult attainment labor prenatal throughout supplemental condition variation state effective well status lifecycle however family evidence life childhood profound poorly relative mixed health home attachment global practitioner environment effectiveness link contrast first united educational market fare nurse wic current economic provide woman child outcome strength population review competitiveness degree leave education care robust disadvantage standard limited quality meaningful special paper research program infant indicator also consequence policy different high center discipline individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773906/,abstract,0,wic competitiveness lifecycle fare attachment leave economically economy attainment disadvantage nurse labor supplemental discipline practitioner market meaningful profound strength indicator mixed home poorly educational degree special prenatal link united robust economic education relative contrast effectiveness center policy global consequence woman environment childhood limited variation growth provide paper relationship discus status country standard infant state program quality effective adult family care life evidence current outcome condition individual early research population review child different health high,{},{},{},{},{},{}
842,842,908,10.1186/s13023-018-0879-2,30115094.0,training microorganism disorder availability bioinformatics iem new contributed effort several country acidurias affected organic advocacy facilitate experience addition well close disease knowledge understanding clinical therapy health protein replacement global error report inborn diagnosis large colombian reference design metabolism recombinant use level main local discussion inclusion management peroxisomal frequently translational development system towards test treatment important nevertheless year education construction advance aminoacidopathies production along specialized professional collaboration appropriate noteworthy basic impact paper alternative research group different last study vector center patient gene number divulgation initiative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097205/,abstract,1,peroxisomal divulgation colombian noteworthy contributed advocacy aminoacidopathies specialized construction acidurias microorganism bioinformatics training collaboration recombinant translational close initiative vector replacement discussion facilitate basic affected organic local availability reference iem frequently education production inclusion alternative advance effort center experience appropriate global professional understanding design paper main knowledge country inborn addition management error large use report impact therapy important number metabolism test new diagnosis research different protein development health gene group year level disorder treatment clinical patient disease study,{},{},{},{},{},{}
843,843,909,10.1038/srep30390,27462005.0,tetrameric activity region conformation representative talon unstructured site helical sax partially characterization maltose host stabilization mechanistic catecholamine regulatory reliable hydroxylase amount angle remarkably form dopamine role protein crystal amylose purified structural dmax neurotransmitter report enzyme length large cobalt data isoform fusion pure recombinant tail level full rate functional catalytic motif step purification inhibitor structure tyrosine stable provide terminal scattering feedback conformationally phosphorylation model regulation resin partner ray rich active terminus protocol iron truncated quality natural kinetically ala different high domain human intact small arrangement preparation highly complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961952/,abstract,2,unstructured truncated talon resin maltose kinetically helical dmax cobalt amylose tetrameric conformationally scattering sax purified purification pure isoform terminus stabilization tail feedback angle ala fusion arrangement motif iron intact conformation ray catecholamine remarkably phosphorylation partner terminal host crystal representative recombinant catalytic rich partially preparation mechanistic length characterization reliable inhibitor neurotransmitter stable dopamine protocol structural active domain step natural regulatory regulation site structure tyrosine highly provide functional hydroxylase small region form enzyme complex quality large report rate activity role human model different protein high data level,{},{},{},{},{},{}
844,844,910,10.1371/journal.pone.0119570,25786237.0,pathogenesis surgery single early pathway among pseudophakic odds detailed malay amd risk significantly status cfh singapore indian higher role principal examination lamp genotype macular photography effect contrast aphakic first genetic significant slit main measure outcome resultsno method potential system polymorphism association component age degeneration within snp variant cataract maculopathy differential eye lens fundus conclusion aimsto interaction study arm synergistic wisconsin participant individual gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364964/,abstract,1,slit pseudophakic photography malay maculopathy fundus aphakic amd cfh aimsto wisconsin singapore resultsno macular lens lamp indian synergistic cataract surgery principal arm degeneration eye detailed odds pathogenesis snp differential gender examination polymorphism genotype contrast component main status interaction participant measure variant pathway single association outcome conclusion higher role individual significantly risk early potential age significant effect genetic method study,{},"{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""main status interaction participant measure variant pathway single association outcome conclusion h""]}}",{},{},{}
845,845,911,10.1158/1541-7786.MCR-15-0057-T,25724429.0,activity synthetic abnormality shift ratio growth vivo pathway lower synthase tetrahydrobiopterin diverse control endothelial synthesize sepiapterin disease synthases kinase promoter summary cancer evidence anti dysfunction protein deoxyglucose anion property kuvan contrast pet fdg cause tomography novel epidermoid type metabolism significant neck emission normal dihydrobiopterin approach phenylketonuria treat expression reconstitution important salvage signaling elevate assay cell downstream superoxide nitric apoptotic testable breast dependent reduced catenin analysis colorectal mechanism vitro precursor head hplc consequence pkg tissue clonogenic peroxynitrite oxide predominantly positron patient tumor cgmp,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470720/,abstract,0,pkg epidermoid deoxyglucose clonogenic reconstitution peroxynitrite neck fdg catenin testable synthases salvage synthesize kuvan elevate pet dihydrobiopterin cgmp colorectal apoptotic anion positron kinase sepiapterin superoxide tomography signaling hplc emission breast endothelial shift predominantly head nitric promoter downstream oxide tumor synthase synthetic summary diverse treat reduced precursor anti tetrahydrobiopterin vitro vivo contrast property consequence dependent cancer abnormality assay dysfunction tissue growth ratio normal expression cause lower pathway mechanism novel activity evidence important cell phenylketonuria approach metabolism control type protein significant analysis patient disease,{},{},"{""pathway"": {""freq"": 1, ""string"": [""growth ratio normal expression cause lower pathway mechanism novel activity evidence i""]}}",{},{},{}
846,846,912,10.1038/gim.2016.57,27195819.0,subsequent clinic information nationwide time interquartile accomplished median condition state visit emergency subject form enrollment rusp follow screening clinical health range error support inborn result diagnosis metabolic data prospective metabolism mortality capture letter ibem conclusionlarge aggregation child outcome point critical management day history plan system purposethe treatment collection person methodsthirty electronic accessible year decision rare public newborn likely scale sick exclusive impact program collecting center individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116297/,abstract,4,ibem conclusionlarge collecting rusp sick purposethe methodsthirty accomplished interquartile exclusive nationwide enrollment letter emergency visit accessible capture person aggregation plan subsequent prospective decision clinic center follow mortality median history collection likely critical point scale public inborn form support screening state subject management day program range electronic error rare impact information newborn outcome condition metabolism individual time diagnosis child metabolic health year data treatment clinical result,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""range electronic error rare impact information newborn outcome condition metabolism individual t""]}, ""screening"": {""freq"": 1, ""string"": [""point scale public inborn form support screening state subject management day p""]}}",{},{}
847,847,913,10.1002/ana.24883,28133863.0,correlation phenotypic specific assessment early objectivewe laboratory without interpretationwe onset molecular detailed piga variation methodswe testing csf characterize pyridoxal myoclonic third seizure clinical electroclinical clinically brain feature eeg genotype diagnosis cause ohtahara genetic low scn level case suppression panel one phosphate pnpo pathogenic phenotype referral syndrome evaluation resultsin development stxbp exome epileptic epilepsy landscape feasibility variant homozygous sepsecs mri previously prior encephalopathy distinguished research available cortical otherwise presentation sequencing patient gene malformation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366084/,abstract,3,sepsecs piga ohtahara interpretationwe electroclinical stxbp scn pyridoxal pnpo myoclonic distinguished objectivewe csf epileptic cortical encephalopathy eeg suppression phosphate landscape epilepsy referral malformation resultsin mri detailed homozygous feasibility characterize seizure exome phenotypic prior presentation pathogenic panel genotype methodswe clinically feature onset variation sequencing syndrome evaluation previously correlation laboratory phenotype testing assessment cause variant brain molecular low case available early specific diagnosis research development gene genetic level clinical patient,{},"{""homozygous"": {""freq"": 1, ""string"": [""epilepsy referral malformation resultsin mri detailed homozygous feasibility characterize seizure exome p""]}, ""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
848,848,914,10.1542/peds.2016-2252,28096516.0,public availability rapid however newborn opportunity pediatric application screening scale widespread technical clinical addressed health societal many analysis monogenic condition symptom genomic modality widely development cost technology diagnostic manifest practice consortium diagnosis plausible article sequencing extent patient powerful disease genetic care ethical challenge medicine overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260149/,abstract,0,addressed manifest plausible societal consortium modality widespread powerful monogenic technical ethical extent overview availability widely opportunity genomic pediatric rapid cost sequencing practice medicine scale public technology diagnostic symptom application screening challenge care newborn condition article diagnosis development health genetic clinical analysis patient disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""newborn"": {""freq"": 1, ""string"": [""diagnostic symptom application screening challenge care newborn condition article diagnosis development h""]}, ""screening"": {""freq"": 1, ""string"": [""scale public technology diagnostic symptom application screening challenge care newborn condition a""]}}",{},{}
849,849,915,10.1016/j.ymgmr.2018.02.005,29560316.0,phenotypic correlation biochemical disorder phenylalanine clinic variant newborn better pathogenic screen phenotype community plain provide management confirmatory frequency due genotype pah common closed result university metabolic effect presentation study symptomatic data testing deficiency inform help genetic wisconsin care individual founder characterize medical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857495/,abstract,1,wisconsin plain closed founder confirmatory symptomatic inform characterize screen university phenotypic presentation pathogenic genotype community clinic help pah correlation frequency provide biochemical phenotype testing better management variant medical deficiency care newborn common individual phenylalanine metabolic effect genetic data disorder result study,"{""phenylalanine"": {""freq"": 2, ""string"": [""medical deficiency care newborn common individual phenylalanine metabolic effect genetic data d""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""newborn"": {""freq"": 1, ""string"": [""better management variant medical deficiency care newborn common individual phenylalanine metabolic e""]}}",{},{}
850,850,917,10.1038/s41598-018-26124-x,29777128.0,immediately new difference factor pathway present platform thrombosis biosynthesis moreover genetics risk embolism related understanding life pharmacological deep strategy trna result metabolic aminoacyl change cause genetic rat lipid metabolism seven nuclear death biomarkers morbidity provide proton model technique pathological diagnose target nmr serum dvt carbohydrate multivariate vein statistical pulmonary quality analysis mechanism metabolomics foundation different high study magnetic acid metpa patient amino metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959905/,abstract,3,thrombosis metpa embolism dvt vein proton aminoacyl trna diagnose deep immediately pulmonary nmr carbohydrate multivariate foundation pathological biosynthesis lipid nuclear pharmacological platform rat seven morbidity metabolomics magnetic statistical death serum understanding genetics biomarkers technique provide related target metabolite change cause strategy quality pathway mechanism life amino difference present metabolism new risk model factor acid different metabolic high genetic analysis result patient study,{},"{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""target metabolite change cause strategy quality pathway mechanism life amino difference p""]}}","{""amino"": {""freq"": 1, ""string"": [""cause strategy quality pathway mechanism life amino difference present metabolism new r""]}}",{},{}
851,851,918,,29531845.0,palindromic specific interestingly tool clinic new vivo growth region single modify homology inhibit without finger break hdr nuclease facilitate mean bhk majority repeat disease significantly intake activator fork amount transcription however nucleoprotein baby mainly uptake role protein play double dsbs peptide result bacteria like recently fraction crispr fusion novel formation completely bind effector functional mutation cellular recombination short involvement certain progression soluble prevent reca hamster ready usage technique correct expression system replication test important associated filament cell order talen field zfns regularly vitro genome ssdna whereas direct zinc powerful gene idea kidney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840312/,abstract,0,talen reca nucleoprotein fork bhk zfns ssdna filament dsbs hdr hamster palindromic break regularly nuclease homology usage recombination ready modify inhibit fusion finger effector activator idea soluble crispr replication bind uptake zinc interestingly repeat powerful kidney completely bacteria baby correct peptide involvement fraction facilitate progression transcription double formation mainly certain cellular majority vitro play vivo prevent clinic associated genome direct short recently mean intake technique growth functional like order field region tool expression single novel mutation important role cell test significantly new specific protein gene result disease,{},{},{},{},{},{}
852,852,919,10.1159/000456610,28413401.0,matter age disorder retardation levodopa signal deep imaging lead moderate hydroxytryptophan single favorable early mri dopamine parkinsonism paralysis htp bilateral dihydropteridine frontal white transporter normal fluctuation man spastic outcome recovery brain fluid replacement reductase spect tetrahydrobiopterin mental due image report photon supplementation flair diagnosis high inversion coronal loss old dhpr motor treatment pyramidal deficiency tomography patient month year intensity metabolism dopaminergic cell dyskinesia area,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346942/,abstract,1,spect spastic paralysis htp coronal levodopa inversion hydroxytryptophan flair dyskinesia photon man dhpr parkinsonism dopaminergic pyramidal dihydropteridine fluctuation frontal reductase deep image bilateral favorable tomography intensity retardation mri recovery imaging transporter replacement fluid matter signal moderate white motor dopamine tetrahydrobiopterin mental supplementation old loss lead area month normal brain single deficiency report outcome cell metabolism early diagnosis age year high disorder treatment patient,{},{},{},{},{},{}
853,853,920,10.1097/MD.0000000000006090,28178169.0,training logistic milk respiratory neural vegetable ratio hazard congenital abnormal defect july odds province gravidity artificial fruit risk testing control disease significantly respectively pregnant individual subject family fill place questionnaire fish soymilk input output layer chd large forward feed regression area level significant case stress bpnn surveillance variable yuden parity size curve prediction paternal infection sensitivity woman propagation around many hunan back model mental history predictor egg meat reproduction exposure univariate test network receiver best education maternal specificity dwelling sample neuron pollution standard birth heart chronic analysis environmental hospital index tract research shrimp upper trial occupational matlab june study ann randomly performance accuracy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313026/,abstract,7,yuden soymilk shrimp matlab gravidity dwelling bpnn ann hunan hazard propagation paternal egg pollution occupational univariate parity reproduction feed vegetable upper meat fish artificial layer july fruit output training respiratory receiver neuron forward june tract surveillance input chd province odds curve randomly place neural milk logistic pregnant predictor prediction abnormal infection education accuracy network specificity heart best mental history size maternal index woman stress variable regression sensitivity questionnaire hospital exposure environmental chronic defect congenital ratio birth performance testing standard area subject trial large family respectively sample case test individual significantly risk model control research significant level analysis disease study,{},{},{},{},"{""egg"": {""freq"": 1, ""string"": [""bpnn ann hunan hazard propagation paternal egg pollution occupational univariate parity r""]}, ""shrimp"": {""freq"": 1, ""string"": [""yuden soymilk shrimp matlab gravidity dwelling bpnn a""]}, ""fish"": {""freq"": 1, ""string"": [""parity reproduction feed vegetable upper meat fish artificial layer july fruit o""]}}",{}
854,854,921,10.1186/s13229-019-0284-2,31406558.0,major disorder consultation autism importantly investigation region greater across adult site workup five genetics severe improve testing institution fragile disease significantly material spectrum sequence backgroundneurogenetics supplementary much atypical moderate neurodevelopmental heterozygous higher clinical value user compound procedure paris alone environment error inborn metabolic recently ambulatory novo copy generation first metabolism young chromosomal service yet case rate cnvs asd pathogenic fail syndrome child methodsto evaluation many day disability online article team gradually proportion electronic year resultsfragile care materialthe version still within variant cgh specialized likely access recessive especially standard since limited throughput systematically next analysis hospital stepwise impact available syndromic larger array diagnostic intellectual cohort high last sequencing yield patient gene number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686526/,abstract,7,resultsfragile paris cgh backgroundneurogenetics fail ambulatory methodsto consultation workup cnvs syndromic stepwise fragile atypical specialized gradually array chromosomal throughput copy novo heterozygous team systematically institution importantly yield young improve larger neurodevelopmental asd access proportion pathogenic moderate recessive procedure intellectual autism sequence investigation service environment compound site recently hospital genetics likely limited generation disability sequencing especially syndrome materialthe evaluation greater cohort testing spectrum diagnostic standard region severe inborn supplementary day major user version value variant electronic error online adult impact care rate material higher article number case available metabolism significantly child metabolic gene year high disorder clinical analysis patient disease,"{""intellectual"": {""freq"": 1, ""string"": [""access proportion pathogenic moderate recessive procedure intellectual autism sequence investigation service e""]}}","{""recessive"": {""freq"": 1, ""string"": [""neurodevelopmental asd access proportion pathogenic moderate recessive procedure intellectual autism sequence i""]}, ""heterozygous"": {""freq"": 1, ""string"": [""gradually array chromosomal throughput copy novo heterozygous team systematically institution importantly y""]}}",{},{},{},{}
855,855,922,10.1038/s41598-018-33788-y,30374111.0,logistic phenotypic blood abnormality better mcda growth new difference factor pathway xenobiotics gee restriction monochorionic utero genetics pair iugr mcdc discordance control umbilical well significantly pertubations rather strategy global provides thus metabolic intrauterine diamniotic cause siugr selective metabolism singleton regression level separation etiology placenta management model therapeutic identification twin gas exposure concentration fatty cord within untargeted mass multivariate screen fingerprint uncomplicated explore equation analysis environmental spectrometry metabolomic prevention high study extrauterine acid elucidate linear amino metabolite chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206027/,abstract,3,xenobiotics siugr provides pertubations monochorionic mcdc mcda iugr gee diamniotic extrauterine discordance fingerprint uncomplicated placenta umbilical intrauterine equation utero untargeted twin singleton cord separation elucidate pair metabolomic multivariate logistic gas selective screen phenotypic etiology restriction linear fatty explore chromatography global regression abnormality genetics exposure environmental spectrometry prevention growth identification better metabolite mass management cause strategy therapeutic pathway concentration amino difference metabolism significantly new model control factor blood acid metabolic high level analysis study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""metabolite mass management cause strategy therapeutic pathway concentration amino difference metabolism s""]}}","{""amino"": {""freq"": 1, ""string"": [""management cause strategy therapeutic pathway concentration amino difference metabolism significantly new m""]}, ""spectrometry"": {""freq"": 1, ""string"": [""global regression abnormality genetics exposure environmental spectrometry prevention growth identification better m""]}}",{},{}
856,856,923,,26351554.0,blood chain better lead insufficiency present reaction elevated restriction province frequency polymerase origin objective pku hydroxylase material respectively knowledge phenylalanine family west distribution error report inborn result enzyme length kind first genetic metabolism level pcr case delg mutation hepatic population phenylketonuria method azerbaijan rflp polymorphism sample iran allele analysis pah conclusion group heterogeneity highest gene total fragment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556756/,abstract,2,delg azerbaijan rflp insufficiency west fragment kind polymerase province origin length hepatic iran pcr distribution restriction highest heterogeneity elevated polymorphism allele reaction pah lead chain frequency hydroxylase knowledge better inborn enzyme objective error report family respectively total mutation pku material conclusion sample phenylketonuria present case metabolism phenylalanine blood population gene group genetic method level analysis result,"{""phenylalanine"": {""freq"": 2, ""string"": [""conclusion sample phenylketonuria present case metabolism phenylalanine blood population gene group g""]}}","{""genetic"": {""freq"": 1, ""string"": []}, ""heterogeneity"": {""freq"": 1, ""string"": [""hepatic iran pcr distribution restriction highest heterogeneity elevated polymorphism allele reaction p""]}}",{},{},{},{}
857,857,924,10.3892/mmr.2015.3432,25760982.0,assessment disorder investigation early among time present liquid easily prognosis gradient risk source reliable suitable cancer however inducible nipple higher protein fluid separated card diagnosis apoliprotein band flight inexpensive painless non water one dimensional biomarkers temperature room abundant woman quadrupole technique method potential concentration collection gel feasibility prolactin electrophoresis within mass guthrie spot breast invasive analysis previously spectrometry multiple different high study advantage assist patient page individual resolution chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438942/,abstract,2,nipple apoliprotein prolactin painless band inducible guthrie quadrupole page gradient separated flight electrophoresis inexpensive gel easily abundant assist card dimensional breast room prognosis feasibility invasive temperature fluid resolution reliable suitable water advantage liquid chromatography investigation collection woman source cancer spectrometry biomarkers spot previously technique assessment mass multiple concentration higher non present individual time risk early diagnosis potential different protein high method disorder analysis patient study,{},{},{},"{""spectrometry"": {""freq"": 1, ""string"": [""chromatography investigation collection woman source cancer spectrometry biomarkers spot previously technique a""]}, ""guthrie"": {""freq"": 1, ""string"": [""nipple apoliprotein prolactin painless band inducible guthrie quadrupole page gradient separated f""]}}",{},{}
858,858,925,10.1371/journal.pone.0124232,25885414.0,european exon hearing slovakia conclusionswe early among slovak bilateral country present hungarian unrelated caucasian central onset frequency common methodswe testing control addition hypothesis backgroundin well origin sensorineural establish marker moderate profound possible previous higher clinical biallelic rom resultsone haplotype support result case deaf mutation dfnb ancestor normal fourteen provide around pakistani rflp loss simultaneously impaired romany carrier marveld homozygote czech snp homozygous allele negative hungary prevalence impact also group different prelingual study patient gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401708/,abstract,10,romany marveld hungarian dfnb slovakia rom prelingual pakistani ancestor slovak sensorineural hungary deaf resultsone biallelic rflp homozygote czech fourteen hearing caucasian bilateral conclusionswe haplotype profound simultaneously backgroundin unrelated impaired homozygous establish origin snp exon moderate hypothesis european carrier methodswe allele previous central negative loss marker onset frequency provide prevalence testing country possible support normal addition impact mutation higher common present case early control different gene group clinical result patient study,{},"{""homozygous"": {""freq"": 1, ""string"": [""haplotype profound simultaneously backgroundin unrelated impaired homozygous establish origin snp exon m""]}}",{},{},{},{}
859,859,926,10.4331/wjbc.v6.i4.389,26629322.0,striatum region selectively single early ventral frequency ice investigate injection control electroencephalogram increase significantly microarray animal largest gamma brain amygdala report chip result six change experiment midbrain oscillation electrocorticogram first spectral rat low whole acute dose systemic removed regulation method post expression functionally second baseline treatment wide nacl reveal synchrony vehicle frontoparietal function series analysis aim impact genome min cortex conclusion different high pattern rapidly cerebral power hippocampus gene individual number hypothalamus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657125/,abstract,4,synchrony midbrain electrocorticogram spectral removed nacl ice gamma frontoparietal oscillation hypothalamus electroencephalogram ventral vehicle selectively amygdala striatum microarray chip functionally largest hippocampus cortex cerebral reveal rapidly power min series injection experiment systemic rat baseline dose post acute regulation genome pattern second animal investigate frequency wide region aim expression change increase brain single report impact conclusion function low number individual significantly early control different gene high method treatment analysis result,{},{},{},{},{},{}
860,860,927,10.1111/ejn.14019,29904960.0,male decarboxylase disorder availability activity memory greater adult retention deficit dawley sprague dopa neuropsychiatric control accumulation hydroxylase contribute synthesis chronoamperometry adulthood however later dopamine previous differ decline protein developmental equally result mid like absent decrease similarly rat medial inhibition stress local clearance transporter current tyrosine release pfc mpfc hypofunction nsd infusion autoreceptor via target expression social exposure viable treatment prefrontal adolescence quinpirole along defeat reliant adolescent function psychiatric cognitive teenage previously either also extracellular cortex upon part acid amino total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105450/,abstract,1,quinpirole nsd hypofunction defeat chronoamperometry autoreceptor teenage reliant mpfc pfc sprague dawley mid decarboxylase viable equally medial differ infusion dopa clearance absent prefrontal extracellular retention decline neuropsychiatric release cortex adolescence similarly transporter contribute adulthood psychiatric inhibition local later memory rat availability dopamine adolescent accumulation previous decrease stress deficit exposure synthesis developmental tyrosine greater previously social male like hydroxylase target cognitive expression adult total activity current amino function control acid protein disorder treatment result,"{""social"": {""freq"": 1, ""string"": [""exposure synthesis developmental tyrosine greater previously social male like hydroxylase target c""]}, ""psychiatric"": {""freq"": 1, ""string"": [""absent prefrontal extracellular retention decline neuropsychiatric release cortex adolescence similarly t"", ""ransporter contribute adulthood psychiatric inhibition local later memory r""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""cognitive expression adult total activity current amino function control acid protein d""]}}",{},{}
861,861,928,10.1016/j.ymgmr.2017.01.016,28377889.0,correlation disorder nine clinic psychometric ratio pathway early progressive methodologytwelve time autosomal defect onset regular risk neurocognitive mean month hydroxylase phe respect aimsdescribe phenylalanine life nitisinone recent follow tyr decline protein range psychomotor developmental symptom report diagnosis six enzyme bayley term first long type eight conclusionsome yet significant full four rate three one measure fsiq normal implementation tyrosine child mental development older disability concentration test treatment school diet dramatically within introductiontyrosinemia two survival recessive scale cognitive impairment index program also intellectual plasma different part mdi preschool patient individual performance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369864/,abstract,5,methodologytwelve introductiontyrosinemia fsiq conclusionsome aimsdescribe mdi preschool bayley nitisinone psychomotor psychometric dramatically decline neurocognitive respect regular school progressive tyr older survival recessive autosomal clinic intellectual follow mental index implementation mean impairment onset disability developmental tyrosine defect correlation scale hydroxylase ratio performance symptom cognitive enzyme measure month phe normal long plasma program range pathway recent diet report rate life concentration term test individual time risk early phenylalanine type diagnosis child different protein significant development disorder treatment patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""term test individual time risk early phenylalanine type diagnosis child different p""]}, ""intellectual"": {""freq"": 1, ""string"": [""tyr older survival recessive autosomal clinic intellectual follow mental index implementation m""]}}","{""autosomal"": {""freq"": 1, ""string"": [""school progressive tyr older survival recessive autosomal clinic intellectual follow mental i""]}, ""recessive"": {""freq"": 1, ""string"": [""regular school progressive tyr older survival recessive autosomal clinic intellectual follow m""]}}","{""pathway"": {""freq"": 1, ""string"": [""phe normal long plasma program range pathway recent diet report rate l""]}}",{},"{""diet"": {""freq"": 1, ""string"": [""long plasma program range pathway recent diet report rate life concentration t""]}}",{}
862,862,929,10.1007/8904_2015_408,25701269.0,various european disorder inequality activity modular information country acidurias platform www organic detailed improve vary risk course extension objective disease teaching ucd material expectancy knowledge family life strategy clinical harmonisation core result metabolic data reference language guideline furthermore intoxication type website international establishment significant three one step scientific centre overall provide outcome constrained method therapeutic partner disability towards urea treatment important meeting network year care systematic component consensus rare within two imd professional collaboration disparity quality background stepwise extended oad conclusion cycle diagnostic consortium small patient org individual number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486274/,abstract,3,oad constrained harmonisation extended ucd modular vary teaching inequality disparity stepwise intoxication expectancy website acidurias extension meeting org establishment consortium partner imd collaboration www detailed core urea consensus centre language improve course organic scientific platform reference guideline european cycle network international systematic step component professional disability furthermore provide small overall knowledge diagnostic country various background objective strategy quality therapeutic rare family care information life activity material outcome conclusion important number individual risk type significant metabolic year method data disorder treatment clinical result patient disease,{},{},{},{},{},{}
863,863,930,10.1021/acs.chemrev.6b00790,28558231.0,major biological tool investigation information pathway difficult half insight interpret mechanistic highlight well way solution assembly overlaid line biochemical pharmaceutical recent staple macromolecule role protein allosteric play invaluable diffraction crystal focus secondary particular structural century thus metabolic large change theory furthermore type detection crystallography interest conformational diffuse dynamic motion review technique method via potential system ray key probe process complex flux advance lack application biology uniquely analysis historically pattern study limitation metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562295/,abstract,0,overlaid staple macromolecule invaluable diffraction crystallography motion flux diffuse interpret uniquely conformational ray century allosteric historically crystal probe theory assembly mechanistic pharmaceutical half dynamic solution line biology limitation structural play difficult advance secondary way investigation particular insight pattern focus lack furthermore highlight technique biological biochemical detection process metabolite tool application major change complex key large pathway recent information role type review potential protein metabolic method analysis study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""application major change complex key large pathway recent information role type r""]}}","{""detection"": {""freq"": 1, ""string"": [""lack furthermore highlight technique biological biochemical detection process metabolite tool application m""]}}",{},{}
864,864,931,10.1159/000445351,26967659.0,edition car coefficient correlation disorder relationship blood activity autism memory early immunosorbent among boy mean biomarker control severity significantly spectrum subject childhood possible rating dysfunction higher clinical role protein word cytoskeleton diagnosis enzyme arc score elisa level significant mann whitney variable spearman arg child conclusionsthe mental identification dsm ass potential test key assay methodsthe scale healthy regulated manual comparison statistical explore diagnostic plasma different objectiveto patient,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588424/,abstract,2,car arc immunosorbent dsm cytoskeleton whitney mann spearman regulated manual elisa edition arg rating boy coefficient objectiveto methodsthe biomarker conclusionsthe memory word severity statistical explore autism mental childhood variable assay mean comparison dysfunction correlation ass identification scale relationship spectrum score diagnostic possible enzyme healthy subject plasma key activity higher role test significantly early control blood diagnosis potential child different protein significant level disorder clinical patient,{},{},{},{},{},{}
865,865,932,10.1007/s11906-014-0490-4,25182162.0,exaggerated harbor lead cat tubule synthase homolog state vascular ace endothelial addition display synthesis unique uptake role play angiotensin mouse dimerization transmembrane arginine knockout enzyme protective generation furthermore novel lat tmem catalytic collectrin phenotype transporter sensitivity model therapeutic hypertension endothelium localized target expression salt impaired treatment associated proximal cell extravascular deficient superoxide suggest glycoprotein nitric deletion precursor research tissue domain oxide acid amino highly featured kidney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164340/,abstract,1,tmem featured extravascular exaggerated collectrin homolog cat localized lat harbor glycoprotein ace tubule endothelium dimerization angiotensin salt transmembrane proximal suggest hypertension protective uptake knockout display superoxide endothelial arginine catalytic vascular impaired nitric kidney transporter oxide synthase deletion deficient precursor unique play domain associated sensitivity synthesis lead generation furthermore tissue highly phenotype target mouse enzyme addition state expression therapeutic novel amino role cell model research acid treatment,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""enzyme addition state expression therapeutic novel amino role cell model research a""]}}",{},{}
866,866,933,10.1080/1047840X.2015.1015367,27030789.0,experimental various statistic disorder past example greater single discus information deeper across psychopathology insight adoption neurobiology stringent substance due testing evaluate solution demonstration pitfall issue decade understanding much weak rather follow broadly inference integrative alone concrete methodology depression attention conceptual integration data overreliance design little theory adequacy variable scientific etiology discussion quasi descriptive model mental work twin technology test theoretical two progress lack correlate criterion research relatively provocative different domain study insufficient extent advantage latent,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809358/,abstract,0,provocative overreliance concrete quasi neurobiology pitfall inference stringent psychopathology adequacy weak latent conceptual theoretical deeper adoption demonstration twin integrative substance broadly theory insufficient statistic correlate integration descriptive depression progress discussion extent solution methodology scientific advantage etiology little past relatively decade experimental domain follow evaluate mental insight variable work understanding example lack criterion attention greater design issue technology discus testing various single information test model research different data disorder study,{},{},{},{},{},{}
867,867,934,10.1074/jbc.M114.597229,25540198.0,importantly new selectively factor content pathway hepg ladder elevated without gfp affected trans moreover altogether control accumulation cholesterol activator transcription proteasome animal however evidence reduction ups previous protein compound mouse degradation effect hepatocyte proteasomal receptor fusion ubiquitin level suppression functional administration cellular nuclear involvement hepatic autophagy inhibitor dose block multiubiquitination hamster model concomitant regulation markedly dependently expression system concentration bbr treatment hyperlipidemic lysosomal hnf cell probe circulating aspect cytoplasm mechanism vitro natural bortezomib mrna pattern study bafilomycin inhibitory gene show ldl,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326815/,abstract,0,multiubiquitination ladder hyperlipidemic cytoplasm bbr bafilomycin ups gfp dependently circulating bortezomib ubiquitin proteasomal hamster autophagy proteasome hepg selectively concomitant altogether ldl fusion activator suppression trans lysosomal probe inhibitory cholesterol block mrna importantly hnf markedly hepatic involvement hepatocyte inhibitor degradation affected transcription nuclear receptor elevated cellular aspect accumulation dose vitro natural content administration previous regulation pattern compound animal reduction functional mouse expression pathway mechanism concentration evidence cell new model control factor protein gene effect level treatment study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""compound animal reduction functional mouse expression pathway mechanism concentration evidence cell n""]}}",{},{},{}
868,868,935,10.1371/journal.pone.0130770,26121677.0,statistic beverage lower gain nutrition across adult british ssbs findingswe disease survey intake ndns cancer evidence life price obesity previous health sugary body result data worryingly type young area level case per volume local office provide intervention population week method national potential conclusionsthis manufacturer drink person usefully year diet million estimate tier approximately heart authority refined england quality analysis benefit impact biggest also ssb fewer coronary stroke urban sugar study inform,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486083/,abstract,6,worryingly usefully sugary ndns findingswe stroke ssb british ssbs refined england biggest price manufacturer coronary authority tier office drink urban fewer sugar person conclusionsthis beverage statistic gain inform million young local nutrition volume obesity approximately estimate heart previous survey cancer national intake provide week benefit body area quality lower adult diet impact intervention life evidence case type population potential health year method data level analysis result disease study,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""benefit body area quality lower adult diet impact intervention life evidence c""]}}",{}
869,869,936,10.1021/acschemneuro.6b00441,28418237.0,contributor disorder blood cross abnormality search observation factor pathway several insight due neuropsychiatric hypothesis preliminary increase underlying synthesis subset relevant neurodevelopmental poorly dopamine dysfunction developmental brain gap mouse therefore thus psychological contrast innervation negatively speculatively genetic type perturbation metabolism level case although bridge mutation one possibly current sensitivity database around many vulnerability neurotransmission talk drive target potential system neuroanatomy nevertheless directly list neuron opportunity likely serotonin ontology involved responsible complicated analysis intrinsic either mechanism impact research fewer often whereas monoamine limitation another gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493142/,abstract,0,talk speculatively neuroanatomy innervation bridge drive contributor intrinsic ontology neurotransmission vulnerability perturbation preliminary fewer neuropsychiatric complicated monoamine neuron possibly negatively observation poorly psychological list subset gap underlying serotonin responsible involved neurodevelopmental limitation dopamine hypothesis opportunity directly contrast search insight abnormality sensitivity synthesis likely dysfunction cross developmental database relevant target mouse increase pathway brain mechanism impact current mutation case metabolism factor blood type research potential gene genetic level disorder analysis,{},"{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""developmental database relevant target mouse increase pathway brain mechanism impact current m""]}}",{},{},{}
870,870,937,10.1093/jisesa/iex064,29117372.0,various breeding related life antimicrobial completion short application certain size organism time economic silkworm additionally highly review environmental background model candidate therefore research science insect genomic genome homologous cost bombyx potentiality clear safety article large study resource human addition modern advantage important bombycidae rich generation disease agent genetic antitumor lepidoptera low gene hereditary numerous area,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633739/,abstract,0,potentiality lepidoptera breeding bombyx bombycidae silkworm antitumor insect homologous completion antimicrobial modern hereditary rich organism clear numerous candidate advantage economic agent safety certain additionally science resource genomic size genome short generation cost environmental highly related various background area application addition large life article important low time human model research review gene genetic disease study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
871,871,938,10.3389/fpsyt.2019.00647,,various asds disorder tool autism abnormality profile onset deficit mean principle cholesterol folate spectrum utility biochemical however childhood recent possible screening dysfunction acylcarnitine portion methodology behind like metabolic novel metabolism area case although communication etiology child review neurodevelopment diagnose social technology unknown treatment care exact future untargeted pilot limited manage metabolomics group plasma interaction study acid patient amino mitochondrial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746843/,abstract,0,portion neurodevelopment manage asds acylcarnitine folate untargeted exact diagnose cholesterol pilot principle mitochondrial methodology communication etiology metabolomics utility unknown autism profile childhood deficit abnormality mean dysfunction limited onset social like biochemical technology spectrum interaction possible various area tool screening plasma future recent novel care amino case metabolism review acid child metabolic group disorder treatment patient study,"{""social"": {""freq"": 1, ""string"": [""deficit abnormality mean dysfunction limited onset social like biochemical technology spectrum i""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""screening plasma future recent novel care amino case metabolism review acid c""]}, ""screening"": {""freq"": 1, ""string"": [""spectrum interaction possible various area tool screening plasma future recent novel c""]}}",{},{}
872,872,939,10.1186/s13023-015-0321-y,26289392.0,tetrameric heterozygote worldwide activity demyelination whether abnormality benign lead lower effort subunit present summarizes synthase restriction together frequency due catalyze supplementation fall evaluate isoenzymes adenosylmethionine discussionthe hypermethioninemia evidence possible form mainly optimal encodes defective higher tentative compound clinically homocysteine usually indication genotype elevation result purpose data mild cause pregnancy forth mutation one provide outcome damage suggestion liver management cystathionine adomet frequent concentration treatment best subnormal finding homozygote pathophysiological two occur adenosyltransferase newborn mri studythe determine function goal currently either mechanism paper program available relatively thcy group plasma dimeric often whereas methionine dietary patient conversion atp mat individual total cns,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/,abstract,5,subnormal studythe mat hypermethioninemia catalyze adomet adenosyltransferase adenosylmethionine thcy tetrameric tentative isoenzymes forth heterozygote dimeric cystathionine discussionthe demyelination homozygote fall atp homocysteine defective summarizes encodes cns suggestion occur benign subunit methionine pathophysiological elevation conversion mri usually indication synthase worldwide damage frequent optimal mainly restriction mild goal relatively genotype effort clinically pregnancy evaluate best supplementation compound abnormality liver lead purpose currently frequency determine provide paper finding possible form plasma management program cause lower mechanism dietary concentration total newborn activity evidence mutation outcome higher function present available individual group data treatment result patient,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""cause lower mechanism dietary concentration total newborn activity evidence mutation outcome h""]}}",{},{}
873,873,940,10.1007/s12687-017-0333-5,28905227.0,service knowledge decade still advancement ancestral completion reduction professional reflective genomics diversity community across perspective time field health researcher meaningful population enhance critical global special milestone benefit research project together genomic genetics support international century cost technology second often integration landscape human publication sequencing everyone isolated journal well barrier engagement far care address achievable enters,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614891/,abstract,0,ancestral achievable reflective enters completion engagement milestone journal century isolated landscape meaningful advancement diversity integration enhance publication project far special researcher barrier genomics decade perspective international community address global genomic service professional second reduction genetics critical cost sequencing benefit technology field knowledge support care time human research population health,{},{},{},{},{},{}
874,874,941,10.1016/j.dib.2017.06.004,28664173.0,early pathway adult controlled researcher median supplemental battery due clinician classical well glycomacropeptide intake typical deli medical utility executive phenylalanine subject evidence milder form clinical food report result kynurenine glycomacropetide kaplan data change design combination first crossover metabolism low size ingestion end tyrosine week management phenylketonuria day via system article test treatment bioavailability diet original public sample variant demonstrate adolescent function natural tryptophan trial metabolomic nutritional comprehensive acid similar dietary neuropsychological amino cambridge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480823/,abstract,8,kaplan glycomacropetide deli controlled cambridge kynurenine ingestion supplemental milder battery bioavailability original metabolomic crossover typical neuropsychological glycomacropeptide tryptophan executive researcher classical demonstrate end clinician adolescent utility comprehensive natural median size nutritional combination intake tyrosine design week public similar food form subject management day trial change variant medical pathway adult diet report dietary evidence amino article function sample phenylketonuria low metabolism test early phenylalanine acid data treatment clinical result,"{""phenylalanine"": {""freq"": 2, ""string"": [""sample phenylketonuria low metabolism test early phenylalanine acid data treatment clinical r""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""management day trial change variant medical pathway adult diet report dietary e""]}}","{""amino"": {""freq"": 1, ""string"": [""pathway adult diet report dietary evidence amino article function sample phenylketonuria l""]}}","{""diet"": {""freq"": 1, ""string"": [""trial change variant medical pathway adult diet report dietary evidence amino a""]}}",{}
875,875,942,10.4274/jcrpe.galenos.2018.2018.0117,30111524.0,male blood assessment clinic ratio androstenedione insufficiency congenital positive turkey neonatal initial liquid weight due included common improve effective classical objective hydroxylase gestational life strategy baby form previous hydroxyprogesterone clinical higher health endocrinology therefore primary report hyperplasia six efficacy cortisol first tandem mortality use case four panel one female step measure deoxycortisol child population march week day simple method september ohd second salt test steroid incidence false city public protocol sample two mass newborn cah pediatric spot turkish estimate pilot tier birth fluoroimmunoassay authority aim characteristic spectrometry infant conclusion diagnostic adrenal study deficiency ohp number chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398187/,abstract,3,ohd fluoroimmunoassay deoxycortisol androstenedione ohp hydroxyprogesterone cah endocrinology cortisol authority turkish tier salt included hyperplasia steroid insufficiency march turkey adrenal september city pilot baby gestational false improve classical simple initial tandem protocol panel liquid chromatography clinic estimate step mortality previous female pediatric incidence second efficacy weight neonatal spectrometry spot congenital male week characteristic hydroxylase ratio public birth diagnostic assessment form aim measure infant objective mass day primary positive strategy effective use deficiency report life newborn conclusion higher common sample number case test blood population child health method clinical study,{},{},{},"{""tandem"": {""freq"": 1, ""string"": [""gestational false improve classical simple initial tandem protocol panel liquid chromatography c""]}, ""spectrometry"": {""freq"": 1, ""string"": [""pediatric incidence second efficacy weight neonatal spectrometry spot congenital male week c""]}, ""newborn"": {""freq"": 1, ""string"": [""strategy effective use deficiency report life newborn conclusion higher common sample n""]}}","{""turkey"": {""freq"": 1, ""string"": [""salt included hyperplasia steroid insufficiency march turkey adrenal september city pilot b""]}}",{}
876,876,943,10.1007/s12687-018-0369-1,29860645.0,process rare account disorder tool two supplementary one search strategy anomaly prevalence income community congenital ceniso country user present database bibliographical authorized health population review stepwise paper priority available literature report rumor like high online large article version important electronic disease genetic planning middle material low systematic anecdotal materialthe brazil,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325042/,abstract,3,rumor ceniso bibliographical anecdotal stepwise planning anomaly brazil priority income middle authorized account community search systematic database materialthe congenital like prevalence paper country literature process tool supplementary user version strategy electronic online large report rare material article important low present available population review health high genetic disorder disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
877,877,944,10.1093/hmg/ddv074,25721401.0,biological correlation phenotypic chain activity whether respiratory physiological factor inverse capacity abundantly enzymatic partly severity counteracting assembly prokaryotic evidence oxidation dysfunction clinical coa role retains acyl fibroblast result knockout enzyme acad effect cause first long type controversial level significant full mutation wild dehydrogenase phenotype relevance provide liver expression system loss frequent treatment important fatty strongly cell hek specificity deficient minimal neuron along accordingly residual aim vitro also tissue high study skin acid deficiency patient complex mitochondrial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424958/,abstract,3,retains hek counteracting acad prokaryotic abundantly inverse partly controversial knockout acyl respiratory neuron fibroblast accordingly assembly skin residual enzymatic oxidation minimal relevance coa dehydrogenase mitochondrial deficient capacity strongly physiological phenotypic wild frequent severity vitro fatty specificity loss liver dysfunction chain tissue correlation biological provide phenotype aim enzyme long expression complex cause deficiency activity evidence mutation important role cell factor type acid significant effect high level treatment clinical result patient study,"{""skin"": {""freq"": 1, ""string"": [""acyl respiratory neuron fibroblast accordingly assembly skin residual enzymatic oxidation minimal r""]}}",{},{},{},{},{}
878,878,945,10.1097/MD.0000000000015242,31008957.0,assessment pain benign abdomen time nausea concern malignant choice menarche old increase exam marker ovariectomy laparotomy oncologist teenager symptom report diagnosis dysgerminoma first suggestive case rapid functional one female volume acute diffuse ovarian histopathological proper sign outcome intervention abdominal management therapeutic plan potential serum year rare age mass pediatric favorable cyst uncomplicated teratoma girl particularity laparoscopy adnexectomy intermittent adnexal rationale pelvic lesson ultrasound patient underwent tumor,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494269/,abstract,4,teratoma particularity oncologist menarche laparotomy laparoscopy dysgerminoma adnexectomy adnexal abdomen pelvic ovariectomy histopathological uncomplicated teenager nausea diffuse cyst malignant intermittent exam suggestive ovarian benign abdominal rationale ultrasound lesson favorable underwent proper girl pain sign plan tumor choice volume acute concern female pediatric serum old marker rapid functional assessment symptom mass management increase therapeutic report rare intervention outcome case time diagnosis potential age year patient,{},{},{},{},{},{}
879,879,946,10.1136/bmjopen-2017-021442,30030317.0,european surgery delay registration attenuate time present without oncology common ethic course institution publication journal aes stomatitis organisation cancer anorexia life event reduction higher clinical therapy questionnaire institutional double therefore secondary primary foot result hand efficacy numberumin april data cause prospective adherence adjuvant score international qlq four rate multi peer introductionalthough completion size pre placebo japanese disseminationethical dose syndrome november method accordance safety analysisa treatment proportion undergoing phase incidence diarrhoea ctcae version capecitabine protocol sample theanine approval cystine jcog scale standard determine terminology quality adverse criterion either colorectal module research also trial prevention group grade often study patient chemotherapy total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059283/,abstract,3,theanine qlq numberumin jcog introductionalthough ctcae capecitabine analysisa undergoing stomatitis disseminationethical diarrhoea organisation foot chemotherapy attenuate anorexia aes institutional cystine japanese colorectal adjuvant terminology oncology completion accordance november module journal approval surgery ethic april peer registration hand grade institution placebo publication multi adherence course prospective double delay safety proportion event protocol european dose international secondary phase pre size adverse incidence cancer efficacy questionnaire reduction criterion prevention syndrome determine scale score standard trial primary cause version quality therapy rate life total higher common sample present time research group method data treatment clinical result patient study,{},{},{},{},{},{}
880,880,947,10.3390/ma12132158,31284393.0,infectious biological assessment tool sample cancer advancement marker breakthrough nucleic application recent particle purification analyte early bioassay involved implementation laboratory clinical reality sensitivity field area enhance review aim benefit improvement molecular therefore isolation method emphasis genetics analytical expression highlight diagnosis stage study magnetic principle acid gradually tremendous term furthermore disease discrimination thorough gene accuracy preparation medicine extraction specificity detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651565/,abstract,0,bioassay purification particle isolation reality nucleic tremendous breakthrough thorough analyte gradually discrimination advancement emphasis infectious extraction preparation enhance principle involved analytical magnetic accuracy specificity stage implementation improvement cancer sensitivity marker genetics furthermore highlight biological laboratory medicine benefit field detection assessment area aim tool application expression molecular recent term sample early diagnosis review acid gene method clinical disease study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""highlight biological laboratory medicine benefit field detection assessment area aim tool a""]}}",{},{}
881,881,948,10.5582/irdr.2014.01025,25606364.0,male cross disorder assessment past cure sectional factor information commitment time laboratory recruitment mind improve institute davis fragile survey unwillingness related knowledge neurodevelopmental clinical portion symptom result diagnosis university purpose etc data household significance appointment low relieve level significant urm one least female annual syndrome child minority participation test school treatment fxs unsure association year education particularly age lack income statistical motivational underrepresented also trial california high study barrier participant show demographic willing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298644/,abstract,3,urm unwillingness davis unsure underrepresented commitment california motivational fxs appointment relieve portion mind willing household fragile cure minority recruitment institute annual participation income school demographic improve barrier university significance neurodevelopmental past education statistical sectional female survey lack cross purpose syndrome particularly laboratory related male knowledge participant assessment symptom trial association information low test time factor diagnosis child age significant year high data level disorder treatment clinical result study,{},{},{},{},{},{}
882,882,949,10.1155/2018/7697210,29850564.0,emphasize rate relevant iran life newborn search prevalence order estimate country turkey overall societal total seek background review burden phenylketonuria efficient paper program daly method literature keywords ranged national result conclusion diagnosis lowest comprehensive system disability existence article study whereas classical uae objective establishment help pku type highest finding year computer arab consanguinity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932526/,abstract,1,daly uae seek arab ranged emphasize turkey societal establishment existence consanguinity computer lowest iran keywords efficient classical burden highest comprehensive search estimate help national disability relevant prevalence paper order overall country finding literature background objective program rate life total newborn pku conclusion article phenylketonuria type diagnosis review year method result study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""background objective program rate life total newborn pku conclusion article phenylketonuria t""]}}","{""turkey"": {""freq"": 1, ""string"": [""daly uae seek arab ranged emphasize turkey societal establishment existence consanguinity c""]}}",{}
883,883,950,10.1186/s13063-017-2327-3,29258568.0,registry disorder chain past search single early forum methodsthis present standardized set paediatric listing condition due capacity common eligible clinician disease survey pku material contribute establish synthesis measurement reviewer knowledge element supplementary family life evidence unique strategy user clinical therapy coa health gap launch acyl core effectiveness metabolic large data design question extraction rapid provider three dehydrogenase member step measure crucial independently instrument outline child exclusion outcome intervention comparative review inclusion phenylketonuria participate method development stage system parent online article comet collection delphi important electronic detail address decision challenge version rare consensus protocol two opportunity typically discussionthis advisory mcad field quality meaningful currently criterion round priority available relatively trial policy group comprehensive part high study medium maker deficiency patient highest gene healthcare caregiver citation initiative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735866/,abstract,2,listing forum comet round mcad launch discussionthis reviewer delphi citation participate advisory maker outline comparative exclusion eligible acyl standardized paediatric meaningful registry priority core instrument set independently extraction establish methodsthis initiative consensus provider crucial coa contribute caregiver gap dehydrogenase medium element typically capacity clinician question member highest past protocol relatively unique healthcare opportunity inclusion comprehensive decision search address effectiveness step policy stage collection survey criterion synthesis rapid chain measurement currently parent design field knowledge measure supplementary trial challenge user version strategy electronic quality online large single deficiency rare family intervention therapy life evidence pku material outcome condition article important common phenylketonuria present available early review child development metabolic health gene group high method data disorder clinical patient disease study,{},{},{},{},{},{}
884,884,951,10.1038/s41598-017-13990-0,29057979.0,various biological tool evolvability activity synthetic herein new effort ammonia five choice variation annotation enzymatic diverse effective contribute medical sequence commercial respect however phenylalanine desirable strategy trait innovation nature protein feature report thus enzyme obtain bioenergy design novelty scientific certain diversity structure relevance intervention therapeutic method identification potential system functionally industrial pal challenge advancement suite application previously background importance lyase biotechnology immensely similar,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651878/,abstract,0,immensely evolvability bioenergy novelty suite desirable innovation biotechnology industrial commercial annotation pal functionally obtain lyase advancement ammonia respect diversity enzymatic relevance contribute synthetic choice diverse scientific nature certain trait effort sequence feature variation structure previously biological design importance identification similar various background tool enzyme application challenge strategy therapeutic effective medical report intervention activity new phenylalanine potential protein method,"{""phenylalanine"": {""freq"": 2, ""string"": []}}",{},{},{},{},{}
885,885,952,10.1016/j.rpped.2014.08.001,25623728.0,implication counseling training statistic thalassemia inconclusive difference information abnormal specifically time positive neonatal need southeast risk addition objective disease issue physician hemoglobinopathy carlos family trait scenario questionnaire health improvement primary result pregnancy genetic case sickle child descriptive accounting analyze method seventeen correct test mother care cell future hemoglobin professional lack series hospital program conclusion study alpha,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436952/,abstract,13,carlos seventeen southeast hemoglobinopathy thalassemia counseling sickle scenario inconclusive accounting hemoglobin analyze training series statistic descriptive correct alpha physician specifically mother trait abnormal pregnancy professional implication improvement questionnaire neonatal hospital lack issue need objective addition program primary positive future family care information conclusion difference cell case test time risk child health genetic method result disease study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
886,886,953,10.3390/nu11010038,30586933.0,cluster better new single gain nutrition citation across present lifespan throughout weight five literature publication majority way extensive account relevant however rather broadly nature health focus large data date thousand versus combination potentially educational theme size narrow conclude text map intervention review technique iodine older stage interdisciplinary landscape topic ten network lifestyle specificity future healthy manual cognitive analysis currently distinguished research broad infancy nutritional study deficiency total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356193/,abstract,1,narrow distinguished interdisciplinary manual citation iodine conclude lifespan landscape map broadly thousand topic infancy gain cluster theme lifestyle broad publication educational older extensive versus nature nutrition majority account text network date specificity potentially way stage size nutritional weight focus combination currently technique relevant better literature cognitive healthy large future single deficiency intervention total present new research review health data analysis study,{},{},{},{},{},{}
887,887,954,10.1371/journal.pone.0157513,27336782.0,blood clostridiaceae dominant whether abnormality class difference factor composition early gut genus glucose coprococcus platform contains together control disease pku neurological ion phe prevotella microbiota phenylalanine family lachnospira strategy starch veillonella odoribacter dorea lachnospiraceae firmicutes error inborn result bacteria effect microbial metabolism rrna akkermansia level significant microbiome main erysipelotrichaceae prediction enrichment peptostreptococcaceae phenylketonuria abundance phylum taxonomic concentration treatment associated diet finding within unclear healthy ruminococcus commensal function environmental bacteroidetes torrent consequence group plasma often high trillion study acid human dietary supplemented distinct patient amino individual presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918959/,abstract,2,veillonella trillion starch prevotella peptostreptococcaceae lachnospira erysipelotrichaceae dorea coprococcus clostridiaceae akkermansia torrent taxonomic ruminococcus odoribacter lachnospiraceae phylum genus commensal bacteroidetes rrna firmicutes supplemented contains microbial enrichment ion gut microbiota microbiome abundance dominant bacteria class prediction distinct composition platform unclear glucose neurological associated consequence abnormality presence environmental main finding inborn phe healthy plasma strategy error diet family dietary concentration pku amino difference function phenylketonuria metabolism individual human early phenylalanine control factor blood acid significant group effect high level treatment result patient disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""function phenylketonuria metabolism individual human early phenylalanine control factor blood acid s""]}, ""neurological"": {""freq"": 1, ""string"": [""prediction distinct composition platform unclear glucose neurological associated consequence abnormality presence e""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""error diet family dietary concentration pku amino difference function phenylketonuria metabolism i""]}}","{""diet"": {""freq"": 1, ""string"": [""inborn phe healthy plasma strategy error diet family dietary concentration pku a""]}}",{}
888,888,956,10.1093/phe/phx013,30619507.0,unintentionally implication ethicist new context epigenetics brief present biomedical discussing central literature genetics gross ethic epigenetic concept appeal ethical issue summary reconceptualization knowledge understanding discourse value health environment science mischaracterization recently effect equality theory novel fallacious genetic consideration extrapolation theme three end undue current provide counterpoint bioethics work exceptionalism social intergenerational mode contrary reasoning finding argue challenge determinism within opportunity relation equity emergent mechanism importance phenomenon policy necessitate justice modest,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307350/,abstract,0,unintentionally undue reconceptualization necessitate mischaracterization intergenerational fallacious exceptionalism ethicist discussing counterpoint extrapolation determinism bioethics appeal reasoning equality justice gross discourse epigenetics emergent contrary equity modest ethic biomedical argue phenomenon epigenetic theory brief mode theme ethical summary consideration end relation concept opportunity science policy environment implication central work understanding recently genetics context social importance provide issue knowledge finding literature challenge value mechanism novel current present new health effect genetic,"{""social"": {""freq"": 1, ""string"": [""central work understanding recently genetics context social importance provide issue knowledge f""]}}","{""genetic"": {""freq"": 1, ""string"": [""modest ethic biomedical argue phenomenon epigenetic theory brief mode theme e""]}}",{},{},{},{}
889,889,957,10.1186/s13023-018-0923-2,30373601.0,blood record self micronutrient difference lower among time across laboratory adult set nutrient tetrahydrobiopterin need responder regular supplementation percent control experience methodsfifty month survey pku status intake responsive material ndsr folate phe medical supplementary phenylalanine interval reduction adequate dependence follow backgroundpeople user value therapy health range decline complete examination nonparametric food result resultsmedical attention data significance calorie decrease eight non level significant certain biomarkers experienced point known phenylketonuria day method national system serum baseline concentration online article tolerance dris response supplement quest electronic year diet materialthe version conclusionalthough age iron within pediatric statistical analysis special research available monitor diagnostics group nutritional often study intact dietary patient though nhanes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206913/,abstract,9,ndsr methodsfifty resultsmedical quest nonparametric nhanes dris conclusionalthough backgroundpeople known dependence folate iron intact experienced responder calorie decline micronutrient monitor percent supplement regular diagnostics set tolerance responsive adequate special record significance examination complete nutrient certain interval baseline tetrahydrobiopterin statistical follow experience supplementation decrease pediatric survey serum nutritional reduction national self attention point intake biomarkers materialthe laboratory status need food month phe supplementary day user range version value response electronic online medical lower adult diet dietary therapy concentration pku material non article difference phenylketonuria available time phenylalanine control blood research age significant health group year method data level analysis result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""non article difference phenylketonuria available time phenylalanine control blood research age s""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""response electronic online medical lower adult diet dietary therapy concentration pku m""]}}",{}
890,890,958,10.3389/fnbeh.2016.00233,28066199.0,notably specific disorder blood activity example memory new seem difference factor anxiety behavioral countless behavior literature due state investigate clear diseased physiology motor unravel underlying disease pku hydroxylase phe paradigm biochemical related relevant however equal phenylalanine much strategy previous inherent role brain mouse therefore alone comparable genotype neurotransmitter equally link depression like metabolic contrast change cause genetic type level although four mutation wild one assumption phenotype toxic outcome point model phenylketonuria coding concentration test treatment nevertheless year directly address strain still future pathophysiological two primarily healthy especially influence field identical either background mechanism research pah consequence different often domain study namely inheritable acid btbr patient amino gene performance parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5167755/,abstract,0,countless inheritable diseased equally unravel inherent identical btbr coding equal assumption strain pathophysiological notably paradigm physiology toxic depression comparable primarily underlying clear neurotransmitter link anxiety wild memory motor behavioral genotype directly domain contrast address parameter previous consequence example pah behavior investigate point influence especially relevant related like hydroxylase biochemical phenotype performance field mouse literature background phe healthy state change cause strategy future brain mechanism concentration activity mutation pku amino outcome role difference phenylketonuria test new model phenylalanine specific factor blood type research acid different metabolic gene year genetic level disorder treatment patient disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""role difference phenylketonuria test new model phenylalanine specific factor blood type r""]}, ""behavioral"": {""freq"": 1, ""string"": [""neurotransmitter link anxiety wild memory motor behavioral genotype directly domain contrast a""]}}","{""genetic"": {""freq"": 1, ""string"": [""research acid different metabolic gene year genetic level disorder treatment patient d""]}}",{},"{""amino"": {""freq"": 1, ""string"": [""brain mechanism concentration activity mutation pku amino outcome role difference phenylketonuria t""]}}",{},{}
891,891,959,10.1002/jgh3.12006,30483531.0,picosulfate activity daily better morning greater time weakness without ease ottawa resultsa magnesium adenoma clear institution experience satisfaction endpoint poorly inferior citrate margin procedure fluid sachet sodium polyethylene primary preferred efficacy pico combination low score interference innovative non detection rate per volume white dose peg residue day inferiority success conclusionbowel diet detriment hunger protocol two intention standard aimbowel analysis either background bowel prior withdrawal group plus often similar patient successful preparation total treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207054/,abstract,2,pico margin detriment conclusionbowel aimbowel sachet picosulfate inferiority ottawa inferior hunger citrate adenoma satisfaction withdrawal weakness interference preferred morning intention magnesium endpoint polyethylene peg ease innovative bowel sodium resultsa residue plus institution preparation poorly fluid success clear treat prior white successful protocol daily volume dose procedure experience efficacy combination greater score standard better similar detection background day primary diet rate total activity non low time group analysis patient,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""combination greater score standard better similar detection background day primary diet r""]}}","{""diet"": {""freq"": 1, ""string"": [""better similar detection background day primary diet rate total activity non l""]}}",{}
892,892,960,10.1097/HJH.0000000000000587,25882860.0,pathogenesis stress advance within superoxide production lead rather strategy recent nitric current oxidative produce dysfunction responsible induce function initial synthase review focus mechanism tetrahydrobiopterin molecular therapeutic hypertension substantiating endothelium anion consequence vascular potential enzyme loss oxide endothelial isoform bioavailability cofactor novel enos,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816601/,abstract,0,substantiating isoform enos endothelium anion induce bioavailability hypertension superoxide endothelial vascular produce nitric oxide pathogenesis synthase responsible oxidative initial cofactor tetrahydrobiopterin production advance consequence stress focus loss dysfunction lead enzyme strategy therapeutic molecular recent mechanism novel current function review potential,{},{},{},{},{},{}
893,893,961,10.3389/fnagi.2017.00298,28993728.0,implication interestingly disorder blood assessment memory shift lead ratio factor cbf anxiety time gut behavioral inflammation necessary deleterious onset characterization bbb vascular risk old neurodegenerative advancing well increase underlying disease month significantly numerous microbiota biochemical decade however crosstalk evidence axis reduction recent cognition clinical role play top define brain mouse firmicutes integrative contribution thus metabolic immune metabolism low young learning level microbiome biomarkers etiology diversity normal structure critical alzheimer pathological development via potential system impaired response association fatty assay process age future profiling occur unclear peripheral function chronic goal cognitive impairment analysis mechanism flow bacteroidetes also grade group comprehensive often alpha acid barrier cerebral patient amino highly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622159/,abstract,0,advancing cbf bbb profiling crosstalk bacteroidetes firmicutes axis occur learning integrative define deleterious gut cognition microbiota microbiome interestingly cerebral shift grade vascular diversity impaired flow pathological alzheimer peripheral neurodegenerative characterization alpha underlying inflammation young anxiety numerous contribution barrier immune memory unclear etiology goal decade behavioral play fatty comprehensive necessary implication old assay reduction impairment lead onset critical chronic structure biomarkers highly biochemical ratio mouse assessment process cognitive month normal increase response future brain association recent mechanism evidence amino role function low metabolism time significantly risk factor blood acid potential age development metabolic group level disorder clinical analysis patient disease,"{""behavioral"": {""freq"": 1, ""string"": [""immune memory unclear etiology goal decade behavioral play fatty comprehensive necessary i""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""future brain association recent mechanism evidence amino role function low metabolism t""]}}",{},{}
894,894,962,10.1177/0300060516672129,27834306.0,service presence knowledge methodsthe however resultstwo new unique software paediatrics context organizational several present adult health interesting home paediatric conclusionall characteristic impact paper research science optimization used organization trend analyse study publication concept response important finally novel transition objective long bibliometric respectively care year show acquisition discipline citation beauty medical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536771/,abstract,0,resultstwo conclusionall bibliometric beauty organizational paediatrics citation optimization discipline interesting acquisition analyse paediatric used software home transition methodsthe publication trend organization concept unique science service finally context presence characteristic paper knowledge objective long response medical adult respectively impact novel care important present new research health year study,{},{},{},{},{},{}
895,895,964,10.1186/s13023-015-0379-6,26693825.0,striatal memory better search improved time across conclusionsdystonic visual reaction bad without due resultsbads coordination continuous constraint risk obvious testing motor control well disease significantly slower dystonic demand supplementary glutaryl screening higher user coa developmental symptom result asymptomatic metabolic data stability exponential type score gcdh yet dehydrogenase tracking model simple dystonia development online article test electronic detail version materialthe barry generally age degeneration srt load negative vwm scale healthy backgroundglutaric function speed cognitive impairment aciduria available except albright group trend high asymptote whereas similar predominantly deficiency patient even performance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689061/,abstract,2,vwm srt resultsbads conclusionsdystonic barry backgroundglutaric asymptote albright glutaryl gcdh exponential dystonic constraint slower striatal bad tracking obvious dystonia improved aciduria coordination speed degeneration load demand asymptomatic predominantly visual coa continuous dehydrogenase trend stability generally simple memory motor search reaction negative impairment developmental materialthe scale performance testing score better similar symptom cognitive supplementary healthy screening user version electronic online deficiency higher article function available test time significantly risk model control type age development metabolic group high data result patient disease,{},{},{},"{""screening"": {""freq"": 1, ""string"": [""better similar symptom cognitive supplementary healthy screening user version electronic online d""]}}",{},{}
896,896,965,,29892150.0,lorestan exon relationship region difference defect country present province molecular frequency moreover common prognosis consanguineous investigate testing severity repeat disease pku status respectively iranian spectrum sequence phenylalanine additionally distribution mutant genotype result metabolic ability tandem useful vntr four mutation three variable one phenotype provide phenylketonuria confirmatory identification efficiency frequent western finding future two iran along allele relation character intronic analysis special relatively keywords also pah mutational diagnostic part study nucleotide similar predominantly distinct patient gene kermanshah number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993902/,abstract,6,lorestan kermanshah character intronic vntr mutational iranian consanguineous confirmatory repeat predominantly prognosis province western iran efficiency special exon keywords distinct frequent distribution mutant relation nucleotide tandem severity relatively additionally genotype useful allele sequence variable pah investigate defect frequency ability identification provide phenotype relationship status testing spectrum diagnostic country finding similar region future molecular respectively mutation pku difference common phenylketonuria number present phenylalanine metabolic gene analysis result patient disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""pku difference common phenylketonuria number present phenylalanine metabolic gene analysis result p""]}}",{},{},"{""tandem"": {""freq"": 1, ""string"": [""distinct frequent distribution mutant relation nucleotide tandem severity relatively additionally genotype u""]}}",{},{}
897,897,967,10.3390/jcm8010039,30609770.0,specific activity neural factor early anxiety abnormal positive involuntary without condition onset due admission continuous risk electroencephalogram smoking disease status neurological schematic recurrent neuronal medical related unit seizure family pharmacological dosage adequate therapy brain irreversibly eeg symptom support diagnosis like abuse cause guideline pregnancy first epilepticus useful international abrupt administration multi main death measure infection drug vital occurrence prevent child sign evaluation airway population comorbidity approach management identification history pathological stage parent latest treatment mother excessive recommendation care cell generally synchronous transient pediatric appropriate premature especially birth goal intensive mechanism counteract fever general diagnostic skeletal alcohol similar muscle,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352402/,abstract,0,synchronous schematic irreversibly abrupt epilepticus airway involuntary electroencephalogram counteract abuse fever latest comorbidity smoking eeg skeletal dosage admission excessive recurrent occurrence muscle intensive alcohol vital transient premature pathological sign neural unit neuronal continuous adequate seizure multi anxiety generally pharmacological goal mother guideline abnormal infection international prevent neurological useful death pregnancy administration stage history appropriate recommendation pediatric onset especially evaluation parent identification general related like main birth status diagnostic similar symptom support measure management cause positive drug medical brain mechanism family care therapy activity condition cell approach risk early specific factor diagnosis population child treatment disease,"{""neurological"": {""freq"": 1, ""string"": [""mother guideline abnormal infection international prevent neurological useful death pregnancy administration s""]}}",{},{},{},{},{}
898,898,968,10.3892/ijo.2018.4245,29344635.0,major specific inactivation encoding apoptosis growth single almost positive hpv without hairpin host transfer injection effective virus subcutaneously line utility cancer evidence observed onco additionally protein shrna mouse therefore result effect alternatively novel aav type inhibition completely transduction administration three short inhibitor normal stable provide papilloma approach markedly therapeutic efficiency via suppressor expression propose treatment prb viral associated phase cell skg carcinogenesis rna causative induce arrest analysis cervical adverse adeno vitro siha transplanted tissue different high boku study whereas human direct vector agent serotypes tumor gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807046/,abstract,1,subcutaneously skg siha papilloma onco hpv boku serotypes prb transplanted hairpin cervical arrest shrna carcinogenesis alternatively suppressor inactivation induce apoptosis aav adeno transduction host transfer causative encoding viral markedly completely vector injection tumor rna efficiency virus inhibitor propose stable inhibition line agent utility additionally vitro associated phase administration adverse observed direct short cancer tissue growth provide mouse normal major expression positive therapeutic effective single novel evidence cell approach human specific type different protein gene effect high treatment analysis result study,{},{},{},{},{},{}
899,899,969,10.1186/s13148-019-0638-9,30832715.0,various biological disorder blood conclusionswe region difference factor among nationwide congenital profile widespread defect largely comparing without lip common epigenetic old control differentially finally underlying clo doe significantly material supplementary evidence clasrp baby possible previous differ user value clp role orofacial report support result epigenome ewas cpg combination genetic potentially significant case although three one palate etiology norway population day resultsin unknown online article electronic association dmrs near materialthe version wide threshold methodsin sample two subtypes cpo comparison birth analysis facial environmental mechanism cleft bonferroni infant available also larger multiple tested group cpgs study methylation dmr gene individual total complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399917/,abstract,11,ewas dmrs dmr cpo cpgs clp clo clasrp palate epigenome subtypes orofacial cpg comparing cleft nationwide lip tested norway bonferroni differ methylation facial threshold conclusionswe differentially epigenetic resultsin methodsin widespread near baby underlying largely larger etiology doe unknown potentially previous finally profile old comparison combination environmental materialthe defect biological wide congenital birth region possible various support infant supplementary day user multiple complex version value electronic online association mechanism report total evidence material article role difference common sample case available individual significantly control factor blood population significant gene group genetic disorder analysis result study,{},"{""genetic"": {""freq"": 1, ""string"": [""methylation facial threshold conclusionswe differentially epigenetic resultsin methodsin widespread near b""]}}",{},{},{},{}
900,900,970,10.1016/j.ymgme.2015.10.010,26643207.0,european epidemiological bioinformatics chain activity cholestanol african early profile bilateral progressive essential adult necessary unrelated prevents accurate onset frequency literature additional trans cyp addition cholesterol disease neurological calculation synthesis paradigm treatable later family oxidation place east dysfunction clinical role play latino global determined diarrhea error elevation inborn result enzyme cause xanthomatosis xanthoma perturbation potentially genetic metabolism south yet commonly three mutation one pathogenic progression side intervention population separately work american juvenile exceedingly incidence rare variant bile allele typically recessive cataract order estimate determine chronic chenodeoxycholic analysis criterion previously tendinous reduce infant classic plus cohort high presentation study acid patient asian null cerebrotendinous gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767010/,abstract,2,xanthomatosis xanthoma tendinous exceedingly cholestanol chenodeoxycholic cerebrotendinous latino juvenile cyp cataract null diarrhea separately bile prevents perturbation east african bilateral asian trans calculation bioinformatics south elevation paradigm unrelated cholesterol plus epidemiological treatable reduce place oxidation progressive american determined classic accurate commonly typically progression later presentation pathogenic recessive european play neurological estimate potentially necessary allele global profile incidence work criterion synthesis dysfunction onset chronic chain previously frequency essential determine cohort additional order literature inborn enzyme infant addition cause variant error adult rare family intervention activity mutation role metabolism early population acid gene high genetic clinical analysis result patient disease study,"{""neurological"": {""freq"": 1, ""string"": [""later presentation pathogenic recessive european play neurological estimate potentially necessary allele g""]}}","{""recessive"": {""freq"": 1, ""string"": [""commonly typically progression later presentation pathogenic recessive european play neurological estimate p""]}, ""genetic"": {""freq"": 1, ""string"": [""metabolism early population acid gene high genetic clinical analysis result patient d""]}}",{},{},{},{}
901,901,971,10.3389/fpsyg.2015.01418,26441789.0,mood disorder assessment relationship self whether difference information anxiety time visual present adult student reaction identity without accurate five condition physical cut deficit adhd conners well close specialization dimensionally tapping however subject applied rating inattention clinical nominal brain therefore task lateralization support depression university attention effect symptomatology medication hemisphere regression level letter stress variable one comorbid dimensional problem eighty processing dimensionality many population approach identification test lateralized fixation sample two scale comparison field shape analysis conclusive group high matching study right hyperactivity visuospatial patient linear,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585266/,abstract,0,tapping specialization lateralization dimensionally visuospatial lateralized dimensionality matching inattention hemisphere conners symptomatology fixation conclusive eighty nominal letter identity applied comorbid cut shape mood dimensional adhd rating student processing close hyperactivity visual right depression accurate medication anxiety university linear task reaction physical stress variable regression deficit comparison self attention identification problem scale relationship field assessment support subject brain adult information condition difference sample approach present test time population group effect high level disorder clinical analysis patient study,"{""hyperactivity"": {""freq"": 1, ""string"": [""dimensional adhd rating student processing close hyperactivity visual right depression accurate m""]}}",{},{},{},{},{}
902,902,972,10.1007/s10967-018-5932-z,30100649.0,phenylalanine isotope past specifically tyrosine compound reaction kinetic review mechanism precursor research method tryptophan solvent derivative via chemical aromatic group dopa enzymatic effect hydrogen acid year amino carbon synthesis characterize,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061101/,abstract,1,solvent isotope hydrogen kinetic dopa carbon derivative enzymatic aromatic characterize tryptophan chemical specifically precursor past reaction compound synthesis tyrosine mechanism amino phenylalanine research review acid group year effect method,"{""phenylalanine"": {""freq"": 2, ""string"": [""reaction compound synthesis tyrosine mechanism amino phenylalanine research review acid group y""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""past reaction compound synthesis tyrosine mechanism amino phenylalanine research review acid g""]}}",{},{}
903,903,973,10.2147/JMDH.S132848,28721064.0,conclusionthe thalassemia blood better inexpressible colaizzi present physical difficulty experience addition disease consanguinity family trait phenomenological role health range procedure burden ideal worry familial result saturation effect interview data purposive hopelessness theme guilt four main society member problem marriage economic child descriptive approach zabol socio introductionthalassemia therapeutic method mental social parent team treatment valuable active help emotional wide future methodsthe dimension explore responsible chronic adverse aspect research gray different study turn center patient participant number bear,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499950/,abstract,1,zabol purposive introductionthalassemia inexpressible hopelessness colaizzi worry phenomenological guilt bear saturation thalassemia gray socio dimension ideal marriage turn familial consanguinity emotional team theme descriptive methodsthe conclusionthe valuable interview society responsible economic difficulty member burden trait aspect procedure active explore center experience mental adverse help physical chronic social wide parent problem main better participant addition range therapeutic future family role approach number present blood research child different health effect method data treatment result patient disease study,"{""emotional"": {""freq"": 1, ""string"": [""dimension ideal marriage turn familial consanguinity emotional team theme descriptive methodsthe c""]}, ""social"": {""freq"": 1, ""string"": [""experience mental adverse help physical chronic social wide parent problem main b""]}}",{},{},{},{},{}
904,904,974,10.1016/j.neuroimage.2015.10.034,26499810.0,demyelination estimation observation ratio region vivo single energy difficult algorithm amplitude surface render fit posterior due average remains disease doe monte pulse extensive third however resolution carlo moderate spatial nature nuisance brain marginalization distribution probability multicomponent conventional image bayesian relaxometry snr fraction first ability low numerical non mapping full water rapid three variable stochastic signal least dimensional datasets likewise local assumes implementation dimensionality normalization src approach model noise markedly method determination thereby simulation second unknown free flatness treatment pool myelin precision directly observe two mwf contraction simplest estimate especially space minimum residual analysis mcdespot different high study magnetic equilibrium human even square accurately accuracy myelination presence parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854306/,abstract,0,snr nuisance marginalization flatness assumes stochastic src simplest relaxometry monte dimensionality carlo observe numerical noise mcdespot contraction bayesian render multicomponent demyelination normalization likewise datasets mwf amplitude remains posterior pool myelination space fit equilibrium minimum myelin mapping image pulse probability estimation accurately dimensional simulation spatial square surface residual markedly observation conventional algorithm resolution fraction determination extensive precision water signal local nature doe distribution moderate energy magnetic accuracy vivo directly average difficult estimate unknown parameter implementation variable second rapid presence free especially ability ratio region brain single non low approach human model different high method treatment analysis disease study,{},{},{},{},{},{}
905,905,975,10.1371/journal.pone.0185342,28949985.0,implication blood menten secondly lower profile defect present despite together supplementation deficit lnaa investigate partly well disease firstly threefold however phenylalanine methodsdata adequate higher value role brain introductionhereditary therefore degradation thus metabolic recently effect large type far low thirdly clearly neutral independent nitro possibly current tyrosine child therapeutic resultsin target influx sufficient calculate concentration article treatment theoretically trifluoromethylbenoyl diet earlier sample minimal biochemistry especially determine cyclohexanedione influence impairment aim pathophysiology presumptive also plasma high study acid neuropsychological patient vmax conclusionthis amino total parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614617/,abstract,4,thirdly presumptive menten introductionhereditary vmax trifluoromethylbenoyl theoretically threefold secondly nitro influx cyclohexanedione methodsdata firstly lnaa calculate biochemistry conclusionthis partly possibly clearly resultsin neutral earlier neuropsychological minimal pathophysiology far sufficient adequate degradation independent parameter supplementation profile implication deficit recently impairment investigate influence especially tyrosine defect determine despite target aim plasma value therapeutic large lower brain diet concentration total current amino higher article role sample low present phenylalanine blood type acid child metabolic effect high treatment patient disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""higher article role sample low present phenylalanine blood type acid child m""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""lower brain diet concentration total current amino higher article role sample l""]}}","{""diet"": {""freq"": 1, ""string"": [""plasma value therapeutic large lower brain diet concentration total current amino h""]}}",{}
906,906,976,10.1002/epi4.12102,29881795.0,infectious various pathogenesis case biochemical disorder life abnormality evidence neurodevelopmental discus pyridoxine early lysosome oxidation etiology molecule dependency syndrome clinical approximately acidurias glucose recognition multifocal intervention amplitude rest impairment west background spike review feature eeg encephalopathy metal organic interictal contribution structural due error pathology electroencephalography mitochondrion hypsarrhythmia epileptic often high metabolic unknown spasm course acid treatment well infantile patient fatty deficiency disease genetic amino metabolism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983207/,abstract,0,multifocal lysosome interictal hypsarrhythmia spike spasm rest electroencephalography dependency amplitude pyridoxine infantile epileptic acidurias west mitochondrion encephalopathy eeg metal recognition infectious oxidation pathogenesis pathology course contribution organic neurodevelopmental etiology glucose structural approximately molecule fatty unknown abnormality feature impairment syndrome biochemical discus various background error deficiency intervention life evidence amino case metabolism early review acid metabolic high genetic disorder treatment clinical patient disease,{},"{""genetic"": {""freq"": 1, ""string"": [""metabolism early review acid metabolic high genetic disorder treatment clinical patient d""]}}",{},"{""amino"": {""freq"": 1, ""string"": [""background error deficiency intervention life evidence amino case metabolism early review a""]}}",{},{}
907,907,977,10.2147/DMSO.S138084,28740413.0,beverage activity self among promotion adult aged physical regular facilitate effective revealed exercise objective subcutaneous respectively maintained session phenylalanine methodsa interval event reduction follow double primary arginine effectiveness april resultsof data tomography low validate area period confidence tracker conclusioncompared placebo smartphone dose monthly outcome abdominal total week november alanine japan sufficient test habit active year randomized lifestyle fat mito monitoring visceral january pilot intention determine statistical analysis wearable adverse larger trial group high study medium acid blind similar power randomly objectivethe participant amino physically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505547/,abstract,4,wearable conclusioncompared mito tracker revealed visceral physically maintained smartphone monthly intention subcutaneous promotion objectivethe japan november abdominal habit resultsof alanine exercise april validate tomography session randomized power arginine regular beverage randomly pilot lifestyle january blind placebo fat methodsa sufficient facilitate medium larger double monitoring confidence event interval dose active statistical effectiveness follow aged adverse physical reduction self determine week period similar participant area objective trial primary effective adult respectively total activity amino outcome low test phenylalanine acid group year high data analysis study,"{""phenylalanine"": {""freq"": 2, ""string"": [""total activity amino outcome low test phenylalanine acid group year high d""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""primary effective adult respectively total activity amino outcome low test phenylalanine a""]}}",{},{}
908,908,978,10.1186/s12913-016-1704-z,27578294.0,immediate activity clinic self single information registration present initial weight programme recruitment condition physical compare state risk effective number exercise month evaluate material gestational medical pregnant measurement session supplementary user pragmatic health range anthropometrics telephone body gestation retrospectively support result effectiveness university antenatal date versus pregnancy routine first ability appointment score singleton acceptability innovative english period service level one registrationactrn measure pre implementation child woman outcome intervention population week model eligibility method post ass target potential backgroundexcessive baseline free online article excessive electronic association year limit diet care lifestyle version maternal materialthe bmi wide two mass poor discussionthis prevalence appropriate estimate healthy birth reduced height provision hospital aim index prior program qualified impact available trial coach plus june rationale study dietary restricted designthis australia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006383/,abstract,11,registrationactrn qualified coach backgroundexcessive anthropometrics pragmatic designthis appointment telephone discussionthis eligibility compare restricted antenatal singleton retrospectively immediate english acceptability recruitment innovative rationale australia excessive gestation exercise june session registration height provision plus bmi lifestyle programme gestational pregnant routine versus university limit initial reduced prior baseline post date poor clinic estimate effectiveness pregnancy evaluate pre appropriate service maternal index woman implementation physical weight hospital self free measurement materialthe ability wide ass week prevalence period birth score target body support aim measure month supplementary healthy state mass trial program user range version electronic online effective medical single association diet impact intervention dietary care information activity material outcome condition article number present available risk model population potential child health year method level result study,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""electronic online effective medical single association diet impact intervention dietary care i""]}}",{}
909,909,980,10.1001/jamapediatrics.2018.3227,30452504.0,whether better new information maximum duration july median fda resultsa pharmacovigilance vary investigate eligible disease characterize third pharmaceutical strategy enrollment legislative anti clinical therapy focus primary indication food support sufficiently efficacy recently design term first long consider calendar use commonly administration main step relevancepediatric drug vital child outcome review approach week infective therapeutic frequently september potential exposure mandate safety treatment measuresmaximum year best nearly importancethe age two approval pediatric prevalence community equity statistical limited category neurologic minimum chronic pulmonary systematically analysis relatively trial conclusion december objectiveto patient total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526087/,abstract,7,relevancepediatric pharmacovigilance measuresmaximum legislative importancethe calendar infective mandate consider enrollment vary equity fda sufficiently approval neurologic minimum september maximum july pulmonary eligible vital resultsa december systematically indication nearly objectiveto duration pharmaceutical characterize commonly category anti safety relatively frequently statistical community step administration best median pediatric recently efficacy focus exposure limited investigate chronic design week prevalence main better food support long trial primary drug strategy therapeutic use therapy information total outcome conclusion term approach new review potential child age year treatment clinical analysis patient disease,{},{},{},{},{},{}
910,910,983,10.3389/fneur.2017.00167,28491049.0,assessment disorder activity better epworth pathway among explain adult present behavior together detailed additional deficit fall experience pku passive understanding munich phenylalanine norepinephrine explorative strategy possible relative dopamine dysfunction brain disturbance sleep mouse improvement indication neurotransmitter result metabolic infrared cause first asleep untreated non ultimately period four problem others holland degree chronotype day target pittsburgh recorded treatment active help directly modulators latency recorder future serotonin scale healthy sleepiness quality characteristic index research pathophysiology consequence often part pattern study patient individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405067/,abstract,0,recorder recorded holland explorative chronotype pittsburgh munich modulators epworth asleep sleepiness infrared passive fall norepinephrine latency explain sleep ultimately detailed disturbance indication pathophysiology untreated degree serotonin neurotransmitter dopamine active relative directly experience index consequence help pattern improvement deficit understanding behavior dysfunction problem scale characteristic additional period target better mouse possible assessment healthy day cause strategy quality future pathway brain adult activity pku non present individual phenylalanine research metabolic disorder treatment result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""adult activity pku non present individual phenylalanine research metabolic disorder treatment r""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""healthy day cause strategy quality future pathway brain adult activity pku n""]}}",{},{},{}
911,911,984,10.1017/mdh.2019.7,30912502.0,activity culture self organisational creation homogenise prenatal researcher identity due variation homogeneous risk clinician number homogeneity termination autonomy ethical amount decine agence medical advent quantitative rather idiosyncratic modernity maintain recovers health analysing practitioner particular authorisation diagnosis thus data pregnancy first official medicine multidisciplinary variable one scientific certain pnd foetal local centre apparent many regulation therapeutic method history national technology towards disability article tolerance fieldwork year decision process legal two professional lack collective cpdpns ethnographic framework keywords cpdpn prevention policy nationally considerably france another individual malformation initiative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434644/,abstract,0,recovers modernity homogenise fieldwork decine cpdpns cpdpn authorisation analysing agence organisational idiosyncratic ethnographic pnd homogeneity homogeneous foetal autonomy termination nationally maintain identity official france creation collective considerably practitioner advent multidisciplinary apparent legal malformation initiative culture tolerance centre ethical prenatal researcher keywords scientific local clinician framework certain decision pregnancy policy history regulation professional particular quantitative variable lack national self disability variation prevention medicine technology process therapeutic medical activity article number individual risk diagnosis health year method data,{},{},{},{},{},{}
912,912,985,10.1007/s12687-015-0224-6,25893505.0,inheritance coalition difference information comprehensiveness incorporate necessary genetics common difficulty dentist specialist disease survey answering issue knowledge family strategy dysmorphias counselling perspective questionnaire clinical health practitioner whereby contribution genomic primary nchpeg result situation data ongoing genetic level nurse referral discovery able descriptive analyze history competency national system skill fisher parent test nevertheless education care challenge attitude doctor brazil exact process unified percentage professional achieve terminology basic facial aim program group practice pattern study rapidly participant brazilian,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524835/,abstract,2,nchpeg fisher dysmorphias comprehensiveness coalition unified dentist competency answering counselling terminology nurse incorporate doctor exact practitioner facial brazilian attitude analyze achieve ongoing referral rapidly brazil inheritance situation specialist skill descriptive percentage basic contribution difficulty able discovery education perspective necessary history genomic professional pattern survey questionnaire genetics national practice parent issue knowledge participant process aim program challenge primary strategy family care information difference common test health group genetic data level clinical result disease study,{},"{""inheritance"": {""freq"": 1, ""string"": [""analyze achieve ongoing referral rapidly brazil inheritance situation specialist skill descriptive p""]}, ""genetic"": {""freq"": 1, ""string"": [""information difference common test health group genetic data level clinical result d""]}}",{},{},{},{}
913,913,986,10.1186/s12888-017-1463-3,28830387.0,various mood generally trajectory disorder assessment later neurobiological challenge life evidence strategy prevalence early morbidity scale anxiety comorbidities strong adult psychiatric clinical validated recognition personal psychopathology population burden management benefit condition symptom substance frequently general familial deficit adhd diagnosis link potential high attention substantial complicate frequent coexists hyperactivity treatment change yield guideline question personality disease similarity first potentially individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567978/,abstract,0,coexists personality complicate psychopathology neurobiological comorbidities trajectory personal familial mood substance similarity adhd validated recognition yield hyperactivity psychiatric substantial link anxiety generally later frequent question burden strong morbidity guideline frequently potentially deficit attention general scale benefit prevalence various assessment symptom management challenge change strategy adult life evidence condition individual early diagnosis population potential high disorder treatment clinical disease,"{""hyperactivity"": {""freq"": 1, ""string"": [""substance similarity adhd validated recognition yield hyperactivity psychiatric substantial link anxiety g""]}, ""psychiatric"": {""freq"": 1, ""string"": [""similarity adhd validated recognition yield hyperactivity psychiatric substantial link anxiety generally l""]}}",{},{},{},{},{}
914,914,987,10.1007/s10802-016-0160-x,27138748.0,specific self memory difference lower among time reaction onset adhd survey amongst material poorer supplementary trail life higher user composite retrospectively depression interview effect data change score international significant functioning neither classify main comorbid point maintenance model ass baseline analyse online article response electronic year version age poor healthy adolescent cognitive longer available conclusion group diagnostic plus cohort domain study neuropsychological linear absence variability individual presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219031/,abstract,5,classify trail composite comorbid retrospectively poorer analyse functioning adhd maintenance longer plus neuropsychological depression interview variability absence memory linear adolescent baseline international domain poor reaction survey self onset presence point ass cohort main score diagnostic cognitive supplementary healthy user change version response electronic online lower life material conclusion higher article difference available individual time model specific age significant group year effect data study,{},{},{},{},{},{}
915,915,988,,25987866.0,utility pathogenesis knowledge public merit era rapid advocate new communication information hub proposal timely current dynamic limited academy fashion author clinical reimbursement vital goal health biomedical outcome omics taxonomy validity approach toward explosion research molecular simple science together need national thereby taxonomic purpose integration data modern precision delivery network disease iterative care consideration medicine psychiatry revolution medical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421904/,abstract,0,hub taxonomic explosion taxonomy merit advocate academy psychiatry proposal revolution fashion reimbursement modern iterative omics biomedical timely vital validity era integration pathogenesis author dynamic precision consideration simple communication goal utility network science delivery rapid national limited purpose medicine public need knowledge medical molecular care information current outcome approach new research health data clinical disease,{},{},{},{},{},{}
916,916,989,10.7861/clinmedicine.16-4-383,27481387.0,line surgery age disorder pharmacological deep tourette psychoactive tic mainly dopamine parkinsonism aetiology place aetiological syndrome tremor systemic hyperkinetic involuntary medically cardinal blocker brain feature management distribution condition hypokinetic myoclonus onset body dystonia primary substance also comprise correct movement diagnosis stimulation mainstay alpha behavioural neurodegenerative considerably motor manifestation symptomatic treatment reach important well receptor refractory chorea first neurological encompassing non,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280205/,abstract,0,tremor tourette tic psychoactive hypokinetic hyperkinetic encompassing cardinal myoclonus chorea involuntary aetiological parkinsonism comprise blocker refractory aetiology medically mainstay dystonia considerably reach surgery deep substance behavioural stimulation symptomatic place movement neurodegenerative correct alpha systemic manifestation pharmacological line mainly distribution receptor motor dopamine neurological feature onset syndrome body management primary brain condition non important diagnosis age disorder treatment,"{""neurological"": {""freq"": 1, ""string"": [""line mainly distribution receptor motor dopamine neurological feature onset syndrome body m""]}}",{},{},{},{},{}
917,917,990,10.1186/s12913-017-2083-9,28209157.0,conclusionthe specific disorder tool culture constellation organisational single responsibility uncertainty country categorise need practical backgroundin formally transition material semi demand supplementary desirability counselling resultsbarriers user therefore structural broadening interview expansion guideline cultural genetic disagreement level neither three one scientific sense division current implementation structure methodsseventeen many population approach attune development plan strategically online simultaneously landscape article important key electronic education challenge undecidedness version carrier public two professional lack collective stakeholder mainstream field ancestry universally priority available regardless general practice different study technological embedding barrier agent even absence urgency healthcare financial initiative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314610/,abstract,0,undecidedness strategically resultsbarriers methodsseventeen mainstream embedding desirability categorise broadening attune organisational disagreement urgency universally formally counselling constellation sense division responsibility ancestry collective cultural financial uncertainty landscape technological stakeholder regardless demand simultaneously backgroundin semi expansion priority initiative culture plan transition practical conclusionthe interview barrier absence scientific agent guideline carrier structural healthcare education professional implementation lack structure practice general public need field country tool supplementary challenge user version key electronic online single current material article important approach available specific population different development genetic level disorder study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
918,918,991,10.1136/bmj.k1612,29743278.0,blood whether search ratio difference early selectionjournal across country document restriction extractiontwo condition abstract way conference disease respectively designsystematic reviewer unit evidence interval probability report harm result data date language sourceswebsite international detection confidence independently many review eligibility method national potential article test key systematic rare legal newborn totalling screen spot reduced analysis criterion either benefit paper policy part presentation study meta objectiveto overdiagnosis analysisthe accuracy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941220/,abstract,11,totalling sourceswebsite selectionjournal overdiagnosis extractiontwo designsystematic analysisthe reviewer eligibility conference harm probability abstract legal document independently objectiveto unit language screen meta confidence reduced presentation restriction interval accuracy international date search systematic way policy criterion national spot benefit paper ratio country detection key report rare respectively newborn evidence condition article difference test early blood review potential method data analysis result disease study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""national spot benefit paper ratio country detection key report rare respectively n""]}, ""newborn"": {""freq"": 1, ""string"": [""country detection key report rare respectively newborn evidence condition article difference t""]}}",{},{}
919,919,992,10.2196/11122,30361192.0,training blueprint specific gagne bioinformatics structured activity fundamental pedagogical context backgroundwith essential present student researcher need employed genetics course effective well objective teaching physician medical knowledge workshop blended event strategy schon scenario lastly clinical health instructional gap practitioner resultsfirst contribution familial instruction integration design undergraduate first medicine use rapid four step disseminate implementation outline outcome approach model introductory evident plan development skill second web free conclusionsto best streamlined education address care methodsthe professional lack favorable achieve reflective basic hypercholesterolemia module curriculum dissemination practice study similar lesson peyton absence objectivethe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231819/,abstract,1,undergraduate streamlined schon resultsfirst peyton pedagogical gagne disseminate blended introductory hypercholesterolemia conclusionsto blueprint reflective instructional curriculum backgroundwith employed teaching structured lastly instruction dissemination workshop objectivethe scenario module practitioner outline familial lesson bioinformatics favorable training achieve student fundamental evident web skill plan integration methodsthe gap physician researcher basic course contribution absence event education address step best professional implementation second lack genetics rapid context free practice essential medicine design need knowledge similar objective strategy effective medical use care activity outcome approach present model specific development health clinical study,{},{},{},{},{},{}
920,920,993,10.3390/molecules24040678,30769819.0,major wide potent biological designing advance chemistry activity advancement pharmacological class diterpene interest application recent chemist steviosides among effort analogue drug present field compound naturally resistance medicinal biologically isosteviol outstanding research importance derivative chemical group potential effectiveness recently design active synthesis selective constitute novel disease ability potentially spectrum,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412665/,abstract,0,steviosides outstanding isosteviol diterpene chemist designing constitute biologically analogue naturally medicinal chemistry derivative potent advancement resistance class selective pharmacological chemical active advance effort effectiveness potentially compound recently synthesis biological ability wide design importance field spectrum application major drug recent novel activity present research potential group disease,{},{},{},{},{},{}
921,921,994,10.1371/journal.pone.0133247,26204268.0,disorder example autism single subunit platform timothy suggested common share investigate testing significantly respectively spectrum line multisystem channel however family evidence preferential neurodevelopmental previous role play global haplotype result permutation significance furthermore first genetic type transmission chinese sequenom level significant mutation asd haploview software size phenotype etiology strong syndrome many population han voltage test polymorphism association offspring component rare still two snp variant allele statistical psychiatric dependent analysis research trio multiple eighteen group trend study alpha nucleotide fbat correction schizophrenia calcium,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512676/,abstract,4,timothy haploview fbat sequenom preferential permutation multisystem voltage trio suggested han eighteen offspring subunit channel schizophrenia haplotype calcium transmission share correction software snp alpha chinese trend psychiatric significance neurodevelopmental line asd platform etiology strong nucleotide polymorphism play statistical allele autism previous global component size dependent example investigate furthermore syndrome phenotype testing spectrum multiple variant single association rare family respectively evidence mutation role common test significantly type research population significant group genetic level disorder analysis result study,"{""psychiatric"": {""freq"": 1, ""string"": [""correction software snp alpha chinese trend psychiatric significance neurodevelopmental line asd p""]}}","{""genetic"": {""freq"": 1, ""string"": [""significantly type research population significant group genetic level disorder analysis result s""]}}",{},{},{},{}
922,922,995,10.1007/8904_2016_12,27718212.0,level coefficient correlation four phenylalanine vegetable percentage knowing table content composition dependence scarce spearman possible estimate positively bilateral statistical essential sometimes subgroup protein analysis background phenylketonuria method nonparametric tcfa food conclusion chemical international result different fruit mean study test data hypothesis significance varied patient diet wilcoxon type exclusively anvisa multiplying phe brazil,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509543/,abstract,5,tcfa multiplying knowing anvisa nonparametric wilcoxon table scarce dependence vegetable spearman exclusively fruit bilateral brazil positively varied subgroup coefficient percentage composition significance chemical hypothesis statistical international estimate content mean correlation essential possible food background phe diet conclusion phenylketonuria test phenylalanine type different protein method data level analysis result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""background phe diet conclusion phenylketonuria test phenylalanine type different protein method d""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""correlation essential possible food background phe diet conclusion phenylketonuria test phenylalanine t""]}}",{}
923,923,996,10.3233/JAD-170280,28671127.0,various pathogenesis significant flux age tool assessment better radiotracer new factor early effort ftd emission pathway analogue dementia differential role dependent glucose play clinically brain tracking frontotemporal biometal additional pathophysiology due identification radiopharmaceutical alzheimer elucidation also target prevention mechanistic diagnosis different risk metabolic pattern fluoro alteration fdg change treatment cerebral positron tomography disease metabolism radiotracers versatile,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573585/,abstract,0,radiopharmaceutical ftd frontotemporal fluoro biometal radiotracers radiotracer fdg flux elucidation dementia versatile tracking analogue positron tomography emission cerebral alzheimer pathophysiology mechanistic pathogenesis differential glucose alteration play effort clinically dependent pattern prevention identification additional target better various assessment tool change pathway brain role metabolism new risk early factor diagnosis different age significant metabolic treatment disease,{},{},"{""pathway"": {""freq"": 1, ""string"": [""target better various assessment tool change pathway brain role metabolism new r""]}}",{},{},{}
924,924,997,,28315651.0,male cross activity lower item laboratory behavioral site without behavior condition additional highlight route exercise wheel circle confounding animal however evidence dopamine predisposition nature arhgap brain mouse effect inner genetic ear level case stress pronounced mutation sense possibly normal current many enrichment model permanent abbreviation second unknown test alteration dihydroxyphenylacetic proportion genetically metabolite likely serotonin function simulates environmental aspect background importance also socially singly cohort study human acid distinct show presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361047/,abstract,0,simulates arhgap wheel singly dihydroxyphenylacetic confounding pronounced predisposition ear socially sense inner circle route permanent exercise enrichment item possibly abbreviation serotonin distinct genetically nature proportion dopamine aspect alteration behavioral unknown stress second site animal behavior likely cross presence environmental highlight laboratory importance male cohort additional mouse background metabolite normal lower brain activity evidence current mutation condition function case test human model acid effect genetic level study,"{""behavioral"": {""freq"": 1, ""string"": [""genetically nature proportion dopamine aspect alteration behavioral unknown stress second site a""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
925,925,998,10.1186/s40246-018-0147-5,29636096.0,wide various knowledge challenge along step protection discus information context among volume effort depository current unite across essential storage database field biomedical range damage privacy population analysis paper research project governance potential dissemination thus high loss source observational data corruption collection instrumental cause important patient contemporary best type performance healthcare issue construction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894154/,abstract,0,unite depository corruption instrumental governance contemporary dissemination privacy construction biomedical protection project observational damage storage volume healthcare effort step best collection source loss context database essential wide paper issue discus performance field knowledge various challenge range cause information current important type research population potential high data analysis patient,{},{},{},{},{},{}
926,926,999,10.1186/s13023-015-0376-9,26714856.0,european disorder tool record search new almost ngc methodological information early among effort item time largely document increasingly advisable clearinghouse resultsa common improve appraisal fabry methodswe elaboration institute course majority disease month devoted material whose adulthood however later evidence supplementary sharing user clinical health doi determined symptom project particular diagnosis thus like guideline conclusionsgreater first applicability score international seven one involvement scarcely instrument overall sign nice management inclusion development national online article badly manifestation treatment recommendation lysosomal key electronic appraiser network strongly year care systematic hundred version neurometabolic gaucher rare generally age still professional january favorable pivotal unclear stakeholder timely determine neurologic excellence goal validated quality cognitive criterion aim scottish available identify group inmd different often june domain heterogeneity whereas inmds patient intercollegiate though even total number acceptable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696316/,abstract,8,scarcely nice ngc inmds inmd conclusionsgreater clearinghouse badly appraiser intercollegiate elaboration devoted advisable scottish excellence pivotal gaucher appraisal applicability sharing neurometabolic fabry methodological neurologic institute lysosomal favorable timely item stakeholder june validated resultsa document instrument doi sign january acceptable adulthood project involvement determined largely manifestation improve strongly identify generally course record later increasingly unclear seven heterogeneity goal guideline european majority network international inclusion domain search methodswe effort systematic recommendation professional particular criterion national determine like overall score symptom cognitive aim tool month supplementary management user version key electronic quality online rare care information total evidence material article common number available time new early diagnosis different age development health group year disorder treatment clinical patient disease,{},"{""heterogeneity"": {""freq"": 1, ""string"": [""course record later increasingly unclear seven heterogeneity goal guideline european majority n""]}}",{},{},{},{}
927,927,1000,10.3389/fneur.2018.00857,30369906.0,various pathogenesis considerable disorder notion activity factor discus pathway parkinsonism insight parallel common highlight risk neurodegenerative addition etiological underlying increase disease objective neurological extensive biochemical decade intermediary evidence clue strategy recent clinical overlapping feature contribution primary movement result metabolic genetic metabolism mutation interest pathogenic point review therapeutic disruption development system manifestation treatment association imds genetically future deficient facilitation parkinson environmental mechanism voluntary research multiple presentation patient convergence individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194353/,abstract,0,overlapping facilitation convergence clue intermediary voluntary parkinsonism imds etiological parkinson notion disruption movement neurodegenerative pathogenesis parallel underlying extensive considerable manifestation deficient contribution genetically presentation pathogenic decade neurological insight feature environmental point highlight biochemical discus various objective addition multiple primary strategy increase therapeutic future pathway association recent mechanism activity evidence mutation common metabolism individual risk factor research review development metabolic genetic disorder treatment clinical result patient disease,"{""neurological"": {""freq"": 1, ""string"": [""deficient contribution genetically presentation pathogenic decade neurological insight feature environmental point h""]}}","{""genetic"": {""freq"": 1, ""string"": [""risk factor research review development metabolic genetic disorder treatment clinical result p""]}}","{""pathway"": {""freq"": 1, ""string"": [""multiple primary strategy increase therapeutic future pathway association recent mechanism activity e""]}}",{},{},{}
928,928,1001,10.1007/8904_2015_498,26440798.0,balance activity content positively oxidative prevents without coordination radical neurodegenerative motor control antioxidant beam exercise disease pku material wheel sulfhydryl animal supplementary phenylalanine marker sedwt tar higher value user demonstrating exepku brain mouse glutathione improvement dismutase result pahenu effect change type reactivity level verify stress although sedpku wild intervention phenylketonuria day method potential trap exe online test glucogenic electronic associated sedentary version materialthe hence superoxide poor hyperphenylalaninemia comparison function cage reduced quality imbalance analysis background available conclusion plasma high sod study exewt acid gsh twenty amino total chapter parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580734/,abstract,2,tar sedwt sedpku exewt exepku exe wheel verify sulfhydryl sod reactivity glucogenic trap sedentary gsh beam dismutase cage imbalance glutathione radical prevents pahenu coordination chapter superoxide exercise balance demonstrating antioxidant positively neurodegenerative oxidative hyperphenylalaninemia wild reduced motor poor associated content parameter improvement stress animal comparison marker materialthe mouse background supplementary plasma day user change version value electronic quality online brain intervention total activity pku material amino conclusion higher function phenylketonuria available test phenylalanine control type acid potential effect high method level analysis result disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""conclusion higher function phenylketonuria available test phenylalanine control type acid potential e""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""brain intervention total activity pku material amino conclusion higher function phenylketonuria a""]}}",{},{}
929,929,1002,10.1186/s12881-015-0240-8,26542245.0,disorder delay blood dominant autism importantly abnormality herein bilateral time autosomal present germline presentationwe unrelated molecular due missense gross iris testing threonine motor lesion backgroundin activation brother origin neurological material kinase spectrum gof ubiquitously cancer supplementary family evidence recent integrator previous encodes user protein developmental brain symptom genomic mosaicism report result thus recently effect mild coloboma cause rapamycin non level use case mutation three cellular asd least independent pathogenic hemimegalencephaly etiology somatic many phosphorylation gonadal serine mtor target exome skill disability parent online article alteration electronic association year directly particularly version process exact age sample two segregated variant causative application likely mosaic megalencephaly limited kda function cognitive impairment either previously mechanism available trio multiple identify exerts diagnostic cryptorchidism intellectual high human sequencing mammalian indirectly rarely absence tumor successful individual total number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635597/,abstract,4,segregated megalencephaly integrator hemimegalencephaly gof cryptorchidism coloboma iris rapamycin presentationwe mosaic gonadal brother ubiquitously threonine mosaicism exerts indirectly mtor kda gross trio somatic kinase germline encodes serine exact phosphorylation rarely bilateral lesion causative backgroundin mammalian unrelated dominant importantly skill origin tumor activation exome missense identify absence asd delay etiology pathogenic successful motor mild cellular alteration independent directly neurological autosomal intellectual autism previous genomic cancer abnormality recently likely impairment limited disability developmental sequencing particularly previously parent testing spectrum diagnostic target symptom process cognitive supplementary application user multiple cause version variant electronic online brain association molecular recent use mechanism report family total evidence mutation material non article function sample number present case available individual time human blood protein age year effect high level disorder result,"{""neurological"": {""freq"": 1, ""string"": [""motor mild cellular alteration independent directly neurological autosomal intellectual autism previous g""]}, ""intellectual"": {""freq"": 1, ""string"": [""cellular alteration independent directly neurological autosomal intellectual autism previous genomic cancer a""]}}","{""autosomal"": {""freq"": 1, ""string"": [""mild cellular alteration independent directly neurological autosomal intellectual autism previous genomic c""]}}",{},{},{},{}
930,930,1003,10.3389/fnins.2018.00154,29615849.0,male disorder activity autism whether abnormality striatum region apparatus examine glutamate time behavioral adult substantially neurobiology genetics enu significantly pku plasticity animal pharmacological spatial displaced dysfunction therapy role protein brain mouse therefore depression arena metabolic effect isoform change receptor term long type untreated exploration level effector unchanged three novelty wild short isoforms systemic recognition phenylketonuria scaffold hippocampal object correct expression synaptic disability sequentially test treatment prefrontal antagonist blockade original strain lack appropriate locomotor homer act analysis cognitive metabotropic corpus precluded pathophysiology also cortex group intellectual mrna whereas human position btbr hippocampus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864888/,abstract,0,scaffold precluded metabotropic homer displaced apparatus neurobiology locomotor sequentially isoforms isoform arena novelty hippocampal blockade exploration striatum object enu btbr antagonist plasticity unchanged effector prefrontal synaptic corpus substantially glutamate strain original hippocampus cortex spatial position mrna recognition pathophysiology correct depression act untreated systemic examine pharmacological wild receptor behavioral intellectual autism appropriate short abnormality animal lack genetics dysfunction disability male mouse region cognitive long expression change brain adult therapy activity pku term role phenylketonuria test time significantly human type protein metabolic group effect level disorder treatment analysis,"{""intellectual"": {""freq"": 1, ""string"": [""systemic examine pharmacological wild receptor behavioral intellectual autism appropriate short abnormality a""]}, ""behavioral"": {""freq"": 1, ""string"": [""untreated systemic examine pharmacological wild receptor behavioral intellectual autism appropriate short a""]}}",{},{},{},{},{}
931,931,1004,10.1038/tp.2014.136,25629685.0,disorder activity autism abnormality single content reporter abnormal presumably five deficit investigate neuropsychiatric mean regulatory spectrum transcriptional element reduction childhood strategy partial rating observed snap protein recovery mouse eeg sodium luciferase result attention effect decrease novel low score level significant functional child occurrence valproate day therapeutic synaptosomal expression social exposure behaviour salt behavioural frequent polymorphism alteration treatment association western snp allele correlate scale kda adolescent responsible cognitive analysis impairment spike also consequence autistic different nucleotide human vlp hyperactivity hippocampus consistently schizophrenia gene presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312830/,abstract,3,vlp synaptosomal snap spike valproate luciferase salt presumably kda eeg reporter autistic schizophrenia neuropsychiatric occurrence hippocampus behavioural sodium consistently rating behaviour recovery transcriptional correlate western hyperactivity snp partial element responsible frequent nucleotide adolescent polymorphism abnormal alteration content allele regulatory autism consequence decrease observed childhood deficit abnormality mean reduction exposure impairment attention presence investigate social scale functional spectrum score mouse cognitive day expression strategy therapeutic single association novel activity low human child different protein significant gene effect level disorder treatment analysis result,"{""hyperactivity"": {""freq"": 1, ""string"": [""rating behaviour recovery transcriptional correlate western hyperactivity snp partial element responsible f""]}, ""social"": {""freq"": 1, ""string"": [""reduction exposure impairment attention presence investigate social scale functional spectrum score m""]}}",{},{},{},{},{}
932,932,1005,10.17179/excli2015-639,27330526.0,disorder assessment pain dos difference among analgesic musculoskeletal world present visual medicinal parallel common course severity ibuprofen well disease amount angustifolia beneficial event reduction partial analogue anti lpfi double global determined osteoarthritis symptom comparable result property university efficacy effect change term pga long medication plant low score significant mcmaster three womac one extract end knee intervention week day method kaempferol treatment active western randomized arthritic inflammatory two reveal elaeagnus scale comparison function adverse index impact available ontario trial hplc group high aqueous study blind patient safe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908661/,abstract,4,womac pga osteoarthritis mcmaster lpfi kaempferol ibuprofen elaeagnus arthritic angustifolia ontario knee aqueous musculoskeletal extract analgesic analogue medicinal plant hplc randomized reveal dos pain safe western blind visual parallel partial comparable determined medication beneficial course university double end anti event severity world inflammatory active property global index adverse efficacy comparison reduction scale week score assessment symptom long day trial change impact intervention term difference common function low present available significant group effect high method disorder treatment result patient disease study,{},{},{},{},{},{}
933,933,1007,10.3348/kjr.2015.16.2.419,25741204.0,case dysgenesis radionuclide dyshormonogenesis disorder transient mass newborn imaging grave congenital normal cyst diffuse hypothyroidism adolescent hashimoto palpable thyroiditis child gland additionally hypoplasia feature review ultrasonography primary modality pictorial development nodule scintigraphy thyroid guide aplasia essay evaluate disease ectopy aspiration thyroglossal suppurative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4347278/,abstract,0,ultrasonography thyroiditis thyroglossal suppurative scintigraphy radionuclide palpable nodule hashimoto grave ectopy aplasia pictorial hypoplasia dyshormonogenesis aspiration essay dysgenesis diffuse cyst gland modality transient thyroid imaging hypothyroidism guide adolescent additionally evaluate feature congenital normal mass primary newborn case review child development disorder disease,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""evaluate feature congenital normal mass primary newborn case review child development d""]}}",{},{}
934,934,1008,10.1371/journal.pgen.1006022,27166630.0,considerable specific activity abnormality observation defect adult segregate together moreover gross plk deficit segregation consanguineous morphology control mitotic well biorientation kinase murine line however family evidence chromosome defective role protein demonstrating brain feature structural possibility substrate fibroblast report synapse support large contrast detectable novel cultured level significant pronounced rate mutation independent pathogenic requirement progression normal localisation aetiology apparent proper postmitotic provide sirna phosphorylation maintenance model development expression synaptic system disability phosphatase strongly cell drosophila carrier two neuron homozygous accelerated kinetochore causative nervous function mitosis arrest cognitive mechanism relatively aberrant intellectual cycle tissue mrna human bod deficiency patient absence gene individual show hela localization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864283/,abstract,0,postmitotic plk localisation kinetochore hela bod biorientation segregate mitotic mitosis segregation pronounced arrest sirna phosphatase localization aberrant synapse gross aetiology accelerated kinase drosophila defective cultured synaptic phosphorylation detectable consanguineous murine morphology apparent neuron fibroblast demonstrating chromosome causative proper maintenance mrna requirement homozygous substrate observation nervous considerable strongly progression absence possibility line pathogenic carrier relatively cycle structural independent contrast intellectual deficit abnormality feature disability tissue defect provide cognitive support normal expression large brain adult deficiency mechanism report family novel rate activity evidence mutation role cell function individual human model specific control protein significant development gene level patient,"{""intellectual"": {""freq"": 1, ""string"": [""carrier relatively cycle structural independent contrast intellectual deficit abnormality feature disability t""]}}","{""homozygous"": {""freq"": 1, ""string"": [""chromosome causative proper maintenance mrna requirement homozygous substrate observation nervous considerable s""]}}",{},{},{},{}
935,935,1009,10.1016/j.ymgme.2017.10.009,29331172.0,maximal activity striatal content behavioral despite restriction without behavior central partially severe deficit neuropsychiatric enu pku hydroxylase respectively synthesis neuronal reversible initiation adulthood phenylalanine life reduction dopamine dysfunction therapy protein euthanasia brain mouse improvement primary neurotransmitter pahenu tph enzyme effect maximally cause late type inhibition hpa level significant rate wild hyperphenylalaninemic apparent tyrosine occurrence already model phenylketonuria nesting abundance unable correct attendant propose system substantial juvenile alteration treatment association neuropathology along serotonin comparison competitive nervous chronic cognitive impairment adverse either pathophysiology tryptophan study monoamine human dietary deficiency constitutively correction gene cns,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786171/,abstract,1,nesting maximally euthanasia hyperphenylalaninemic constitutively juvenile attendant unable tph neuropathology competitive striatal enu maximal cns reversible pahenu neuropsychiatric initiation occurrence monoamine apparent abundance hpa correction partially pathophysiology correct tryptophan neuronal adulthood serotonin nervous substantial neurotransmitter propose inhibition wild late restriction dopamine alteration behavioral content adverse central improvement deficit comparison behavior reduction synthesis impairment dysfunction chronic tyrosine despite hydroxylase mouse severe cognitive enzyme primary cause brain association deficiency respectively dietary therapy rate life activity pku phenylketonuria human model phenylalanine type protein significant gene effect level treatment study,"{""phenylalanine"": {""freq"": 2, ""string"": [""life activity pku phenylketonuria human model phenylalanine type protein significant gene e""]}, ""behavioral"": {""freq"": 1, ""string"": [""inhibition wild late restriction dopamine alteration behavioral content adverse central improvement d""]}}",{},{},{},{},{}
936,936,1010,10.1186/s13023-014-0177-6,25425461.0,disorder delay activity clinic daily iem outpatient greater lower boy hrqol paediatric diagnosed behavior awareness five wherever physical expert plead severity majority specialist disease significantly material respectively spectrum supplementary life childhood conclusionsa possible form adaptive user clinical health vineland resultswe therefore examination error never movement ataxia six rheumatic metabolic data inventory cause type metabolism malignancy significant functioning case although tended panel mellitus overall child diminish population dystonia frequently ass evident development online article concordant treatment important electronic diabetes existent version backgroundinborn age pediatric relation scale psychiatric chronic systematically reduced quality impact myoclonus available broad upon methodschildren domain study patient psychosocial participant treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254263/,abstract,2,vineland tended plead existent diminish myoclonus diagnosed concordant methodschildren rheumatic ataxia malignancy backgroundinborn conclusionsa hrqol dystonia outpatient mellitus functioning paediatric inventory psychosocial adaptive systematically evident boy resultswe awareness specialist movement broad psychiatric expert treat reduced examination delay relation diabetes severity iem panel majority daily frequently domain clinic pediatric physical childhood behavior chronic greater ass scale overall spectrum participant possible form supplementary user cause version electronic error quality online lower respectively impact life activity material article important case available metabolism significantly type population child age significant development metabolic health data disorder treatment clinical patient disease study,"{""psychiatric"": {""freq"": 1, ""string"": [""boy resultswe awareness specialist movement broad psychiatric expert treat reduced examination d""]}}",{},{},{},{},{}
937,937,1011,10.1074/jbc.M117.796516,28765282.0,major cluster blood nine whether difference greater discus pathway molecule gut tubule complexity nutrient oat intimate affected molecular organic view derivative toxin clear number hypothesis physicochemical inter axis organ hold role consistent play feature possibility substrate anion support movement knockout property transport contrast data urine versus furthermore far lipid intestine metabolism flavonoid level microbiome one least member involvement communication size transporter drug systemic critical liver product remote via important key undergoing signaling proximal phase particularly specificity hydrophobicity endogenous bile uremic organismal demonstrate ring elimination analysis previously metabolomics tryptophan importance also relatively group different acid similar glucuronidation distinct connection amino metabolite kidney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612110/,abstract,1,organismal intimate hydrophobicity flavonoid undergoing glucuronidation uremic physicochemical oat tubule hold remote anion ring toxin proximal intestine bile axis elimination derivative connection knockout gut signaling microbiome inter complexity kidney cluster movement transporter substrate endogenous transport tryptophan involvement far systemic clear lipid versus organ affected view organic distinct demonstrate possibility communication nutrient member metabolomics hypothesis relatively play molecule contrast urine specificity phase property size consistent feature liver critical furthermore particularly product greater previously importance discus similar support metabolite major drug key pathway molecular amino important role difference number metabolism blood acid different group data level analysis,"{""urine"": {""freq"": 1, ""string"": [""metabolomics hypothesis relatively play molecule contrast urine specificity phase property size c""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""similar support metabolite major drug key pathway molecular amino important role d""]}}","{""amino"": {""freq"": 1, ""string"": [""metabolite major drug key pathway molecular amino important role difference number m""]}}",{},{}
938,938,1012,10.1155/2016/2108909,26881241.0,disorder chain ratio hyperinsulinaemia glucose longitudinally programme weight risk hba significantly longitudinal related gov marker obesity clinical precede degradation metabolic contrast change negatively oral branched type metabolism score period level clinicaltrials yet one end conclude text tyrosine child intervention bcaa loss baseline substantial test tolerance alteration identifier association year lifestyle bmi acylcarnitines obese standard homa resistance adverse analysis cardiovascular index nct trial consequence insulin acid another amino metabolite deviation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736430/,abstract,4,precede hyperinsulinaemia longitudinally homa hba bcaa identifier conclude branched acylcarnitines obese negatively bmi tolerance lifestyle clinicaltrials programme insulin deviation resistance nct gov degradation substantial longitudinal cardiovascular end glucose oral baseline obesity alteration text contrast index consequence adverse weight loss marker chain tyrosine related period ratio score standard metabolite trial change association intervention amino metabolism test significantly risk type acid child metabolic year level disorder clinical analysis,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""standard metabolite trial change association intervention amino metabolism test significantly risk t""]}}",{},{}
939,939,1013,10.1212/WNL.0000000000003454,27903815.0,logistic blood observation ratio lower among examine insufficiency neonatal liquid light odds utero continuous risk control danish increase vitamin objective pregnant interval quintiles previous health top neonate result date nmol low regression level case confidence variable sclerosis biobank relevance woman hydroxyvitamin model method exposure concentration bottom sex association every public sample quintile mass newborn spot spectroscopy conditional prevalence birth analysis research importance multiple conclusion lowest different high study direct patient highest individual chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5200855/,abstract,2,quintiles quintile hydroxyvitamin danish nmol biobank insufficiency conditional utero sclerosis lowest neonate spectroscopy odds observation relevance logistic pregnant continuous light sex examine vitamin confidence highest interval liquid date chromatography previous woman direct variable regression neonatal exposure spot importance prevalence ratio public birth objective mass multiple increase lower association concentration newborn conclusion sample low case individual risk model control blood research different health high method level analysis result patient study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""mass multiple increase lower association concentration newborn conclusion sample low case i""]}}",{},{}
940,940,1015,10.19082/3048,27957302.0,various greater content early information among effort country several present necessary awareness five efficient refuse expert ministry pku semi medical transcription family purposively health respondent subthemes result diagnosis qualitative interview data mortality level use theme case main measure morbidity problem implementation management phenylketonuria reason identification national face system manager parent treatment education care challenge policymakers methodsin public resultsthe legal iran newborn appropriate stakeholder category analysis program framework infant coverage interaction study patient insurance heath introductionnewborn,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133027/,abstract,2,purposively heath subthemes refuse introductionnewborn manager policymakers ministry insurance stakeholder legal semi methodsin coverage respondent reason face awareness theme qualitative iran interview transcription efficient expert resultsthe category morbidity framework education effort necessary content mortality appropriate implementation national greater parent identification problem main public country interaction various measure infant management program challenge medical use family care information newborn pku phenylketonuria present case early diagnosis health data level treatment analysis result patient study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""purposively heath subthemes refuse introductionnewborn manager policymakers ministry insurance s"", ""challenge medical use family care information newborn pku phenylketonuria present case e""]}}",{},{}
941,941,1017,10.1155/2017/2845173,28932251.0,correlation cluster hierarchical energy heat abnormal five together action uplc increase traditional briefly oil related understanding phenylalanine mainly integral additionally disturbance modeling purine arginine perturbed efficacy metabolic effect fraction change furthermore rat metabolism chinese medicine proline relieve ultimately four extract biomarkers map syndrome tyrosine overall diagram meanwhile model reverse method polarity potential network sophia hca fat load qtof explore heart analysis aspect mechanism metabolomics research lung tryptophan conclusion seed different insufficient cardiac extent powerful inhibitory pathologic injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592412/,abstract,1,sophia diagram uplc seed qtof perturbed hca relieve purine polarity extract proline oil integral modeling heat pathologic briefly hierarchical reverse map load lung inhibitory insufficient arginine ultimately disturbance powerful cluster injury fat tryptophan cardiac fraction chinese traditional extent action rat mainly energy metabolomics aspect abnormal additionally network explore heart understanding efficacy furthermore biomarkers syndrome tyrosine correlation medicine related overall change increase mechanism conclusion metabolism model phenylalanine research potential different metabolic effect method analysis,"{""phenylalanine"": {""freq"": 2, ""string"": [""change increase mechanism conclusion metabolism model phenylalanine research potential different metabolic e""]}}",{},{},{},{},{}
942,942,1018,10.3390/jcm4030479,26239250.0,pathogenesis biological specific blood tool better new discus dermatitis tarc signature friendliness venous enhance increasingly superior cost biomarker source effective severity saliva activation objective disease suitable offer understanding however marker individualization capillary perspective user clinical therapy role play atopic great predicting diagnosis efficacy recently purpose medicine non panel biomarkers current many confirmation simple method therapeutic determination translational development potential serum safety treatment response important care overview future application invasive precise currently paper alternative research chemokine also different patient individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470140/,abstract,0,tarc friendliness predicting individualization chemokine dermatitis atopic saliva venous capillary signature confirmation superior translational precise offer invasive pathogenesis enhance determination biomarker activation suitable overview simple increasingly great safety severity panel perspective play alternative source serum understanding recently efficacy marker purpose cost biomarkers currently biological medicine paper discus better tool application objective user response therapeutic effective future care therapy current non important role individual new specific blood diagnosis research potential different development method treatment clinical patient disease,{},{},{},{},{},{}
943,943,1019,10.3390/nu7095390,26404369.0,sweetener beverage nutritive example despite without corresponding choice capacity increase consumer however form place health cautious usually taxation link contrast force expectation low unwanted non significant sale market government current failure intervention regulation work frequently behaviour convenience contrary assertion challenge public advocate relation involved indulgence adverse consequence trend high marketplace sugar regulating barrier small conscious dietary absence individual australia willing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586584/,abstract,0,unwanted taxation sale indulgence marketplace conscious corresponding cautious assertion advocate willing convenience nutritive contrary expectation sweetener regulating australia market force government sugar behaviour consumer beverage usually place trend link failure choice capacity barrier absence involved relation frequently contrast regulation consequence adverse work example despite public small form challenge increase intervention dietary current non low individual significant health high,{},{},{},{},{},{}
944,944,1020,10.1111/bioe.12425,29442381.0,blood disorder whether instance new information time author present labor fit literature capacity heel testing silence ethical issue biochemical decade family life baby empowers perspective value nature health conviction particular debate century moral purpose good expansion first genetic type appreciation mandatory decide interest division child lot evaluation review reflection private reason abundance leave development technology parent free collection decision care argue liberal rare future newborn aspect impact voluntary program also policy inheritable substantive sequencing show individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838405/,abstract,0,silence empowers conviction moral liberal inheritable decide lot leave appreciation substantive voluntary division reflection labor instance heel mandatory fit private century argue debate abundance expansion reason baby ethical author capacity nature decade aspect perspective decision policy good collection particular purpose free sequencing evaluation parent issue biochemical technology testing literature program value future rare family impact care information life newborn present individual time new blood type review child development health genetic disorder,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""newborn"": {""freq"": 1, ""string"": [""rare family impact care information life newborn present individual time new b""]}}",{},{}
945,945,1021,10.6065/apem.2015.20.3.119,26512346.0,entire major various disorder tool availability new factor early laboratory expert regular improve diverse testing specialist disease significantly physician medical biochemical treatable era understanding beneficial screening clinical focus integrated scientist result diagnosis metabolic purpose data generation genetic tandem detection multidisciplinary technician main vital approach confirmatory evident diagnose technology test manifestation treatment important option process future earliest mass newborn pediatric likely scale accordingly differential start precise analysis nutritionist spectrometry program broad diagnostic powerful complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623338/,abstract,0,earliest technician nutritionist start diagnose integrated scientist confirmatory multidisciplinary entire vital era accordingly regular evident precise treatable powerful specialist broad differential physician manifestation improve beneficial expert diverse option availability tandem pediatric understanding focus likely generation purpose spectrometry laboratory scale main biochemical technology testing diagnostic detection various process tool screening mass program major complex medical future newborn important approach test significantly new early factor diagnosis metabolic genetic data disorder treatment clinical analysis result disease,{},"{""genetic"": {""freq"": 1, ""string"": [""significantly new early factor diagnosis metabolic genetic data disorder treatment clinical a""]}}",{},"{""detection"": {""freq"": 1, ""string"": [""scale main biochemical technology testing diagnostic detection various process tool screening m""]}, ""tandem"": {""freq"": 1, ""string"": [""improve beneficial expert diverse option availability tandem pediatric understanding focus likely g""]}, ""spectrometry"": {""freq"": 1, ""string"": [""pediatric understanding focus likely generation purpose spectrometry laboratory scale main biochemical t""]}, ""newborn"": {""freq"": 1, ""string"": [""mass program major complex medical future newborn important approach test significantly n""]}, ""screening"": {""freq"": 1, ""string"": [""testing diagnostic detection various process tool screening mass program major complex m""]}}",{},{}
946,946,1022,10.1038/ejhg.2015.271,26980105.0,european considerable specific disorder better new discus context autosomal laboratory couple document reproductive affected condition frequency geographic genetics common facilitate risk testing advertised pose origin disease status expectancy sequence commercial decade family life priori previous higher clinical health date expansion basis guideline genetic detection significant learnt panel society one certain morbidity discussion implementation child personal population history partner technology person decision care challenge informed carrier public variant professional typically recessive order responsible ancestry enable criterion relatively regardless multiple identify practice often human lesson gene individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867464/,abstract,0,advertised learnt priori informed couple pose expectancy geographic enable ancestry commercial partner personal lesson regardless person expansion document reproductive origin discussion society facilitate considerable typically responsible affected identify recessive morbidity guideline european certain carrier relatively decade panel decision date autosomal sequence history previous basis professional implementation genetics criterion context practice frequency laboratory public technology order discus status testing better detection challenge multiple variant family care life higher condition common individual new human risk specific population child significant health gene genetic disorder clinical disease,{},"{""autosomal"": {""freq"": 1, ""string"": [""carrier relatively decade panel decision date autosomal sequence history previous basis p""]}, ""recessive"": {""freq"": 1, ""string"": [""facilitate considerable typically responsible affected identify recessive morbidity guideline european certain c""]}, ""genetic"": {""freq"": 1, ""string"": []}}",{},"{""detection"": {""freq"": 1, ""string"": [""technology order discus status testing better detection challenge multiple variant family c""]}}",{},{}
947,947,1023,10.1186/s12955-017-0620-1,28274259.0,italy major specific netherlands disorder blood self backgroundphenylketonuria difference formula defect country adult turkey dietician throughout elevated native state cracker clinician validation objective disease pku phe issue medical later phenylalanine life understandability holiday raise questionnaire linguistically health consistent word brain punctuation food syntactic semantic syntax interview dietitian language basis guideline cultural first genetic metabolism validate united english level seven four provider appropriateness vacation idiomatic step linguistic problem proof current instrument translator child critical review living phenylketonuria conclusionsthe describe ass development kingdom expression parent simultaneously treatment supplement valuable germany emotional qol version mom hrql process rare mum managing resultsthe methodsthe two spain wording adolescent adaptation terminology validated quality cognitive impact available translation biscuit different clarity study acid spelling patient france psychosocial amino usual healthcare caregiver mixture,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343404/,abstract,1,wording vacation translator syntactic punctuation mum mom managing linguistically idiomatic hrql cracker understandability semantic holiday biscuit spelling clarity appropriateness syntax linguistic dietician usual terminology netherlands spain qol kingdom france turkey italy cultural english living dietitian proof native raise backgroundphenylketonuria validate adaptation psychosocial germany simultaneously validated emotional supplement mixture instrument formula provider caregiver methodsthe valuable interview language validation united translation conclusionsthe resultsthe later clinician word seven elevated adolescent guideline healthcare step basis consistent questionnaire self critical defect parent ass problem issue country food process cognitive phe objective state major expression version quality medical brain adult rare impact life current pku amino difference phenylketonuria available metabolism phenylalanine specific blood review acid child different development health genetic level disorder treatment patient disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""pku amino difference phenylketonuria available metabolism phenylalanine specific blood review acid c""]}, ""emotional"": {""freq"": 1, ""string"": [""validate adaptation psychosocial germany simultaneously validated emotional supplement mixture instrument formula p""]}}","{""genetic"": {""freq"": 1, ""string"": [""review acid child different development health genetic level disorder treatment patient d""]}}",{},"{""amino"": {""freq"": 1, ""string"": [""adult rare impact life current pku amino difference phenylketonuria available metabolism p""]}}","{""turkey"": {""freq"": 1, ""string"": [""terminology netherlands spain qol kingdom france turkey italy cultural english living d""]}}",{}
948,948,1024,10.2147/PROM.S146849,29263707.0,coefficient correlation consistency disorder chain clinic reliability psychometric self early among hrqol time document researcher pro intraclass clear mean amyloidosis misfolding severity varied validation disease survey severely related backgroundlight methodsdata life evidence clinical health protein consistent gap conceptually property qualitative observational data date cronbach change cause ability score variable internal measure strong drug resultsscale outcome damage population frequently ass development test treatment response rare detect sample convergent scale community retest validated quality criterion validity aim impact available trial group study alpha patient conclusionthis acceptable sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724409/,abstract,0,resultsscale cronbach backgroundlight misfolding convergent conceptually amyloidosis retest intraclass methodsdata psychometric hrqol consistency conclusionthis severely reliability validity validated pro detect document internal varied coefficient acceptable qualitative alpha observational gap clear validation researcher damage sensitive strong severity frequently community date clinic property consistent variable survey mean criterion self chain correlation ability ass scale related score aim measure trial change cause drug response quality rare impact life evidence outcome sample available test time early population protein development health group data disorder treatment clinical patient disease study,{},{},{},{},{},{}
949,949,1025,10.1007/s10803-014-2229-0,25231287.0,logistic balance disorder assessment deficient three asd evidence autism typically scale item specifically visual child feedback comparing point developmental impairment battery odds model sub score static deficit movement adhd group skill disability attention membership regression motor guide hyperactivity negatively temporal decrease evaluate significantly respectively performance mabc spectrum specificity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342267/,abstract,3,mabc static membership comparing feedback temporal battery balance item adhd sub odds negatively skill movement hyperactivity guide visual logistic typically deficient asd specifically motor specificity evaluate autism decrease regression deficit impairment disability attention point developmental scale performance spectrum score assessment respectively evidence significantly model child group disorder,"{""hyperactivity"": {""freq"": 1, ""string"": [""adhd sub odds negatively skill movement hyperactivity guide visual logistic typically d""]}}",{},{},{},{},{}
950,950,1026,10.4331/wjbc.v10.i1.7,30622681.0,yet various disorder pathophysiological two family asd autism beneficial production interest communication factor single energy information limited present stereotypical many summarizes environmental lysine behavior homeostasis review onset action available also derivative deficit social people supplementation enzyme interaction metabolic base pattern large topic acid methionine dietary deficiency patient origin cofactor genetic amino metabolism carnitine spectrum,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314880/,abstract,0,stereotypical summarizes lysine methionine carnitine derivative pathophysiological topic base origin beneficial homeostasis asd action communication cofactor people energy production autism supplementation pattern deficit behavior limited onset environmental social spectrum interaction various enzyme large single deficiency family dietary information amino present available metabolism factor review acid metabolic genetic disorder patient,"{""social"": {""freq"": 1, ""string"": [""pattern deficit behavior limited onset environmental social spectrum interaction various enzyme l""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""amino"": {""freq"": 1, ""string"": [""large single deficiency family dietary information amino present available metabolism factor r""]}}",{},{}
951,951,1027,10.1186/s13023-015-0283-0,26025111.0,registry assessment montenegro region country laboratory romania neonatal southeastern throughout tetrahydrobiopterine fluorometric regular state croatia survey pku material herzegovina pediatrician supplementary methodsa cumulative phenylalanine screening place bosnia user questionnaire doi distribution behind moldova internationally psychological dietitian macedonia guideline question routine furthermore south genetic mio area level yet commonly three main member society kosovo certain serbia albania current eastern many population march management resultsresponses conclusionsthe method frequently ass via national nation online article europe team collection important electronic incidence care challenge version wide professional bulgaria standard responsible aspect characteristic available backgroundwe diagnostics december center patient slovenia participant number mail,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451731/,abstract,24,tetrahydrobiopterine serbia resultsresponses montenegro moldova mio kosovo croatia albania southeastern macedonia backgroundwe slovenia romania herzegovina fluorometric bosnia bulgaria nation internationally pediatrician mail march eastern dietitian europe cumulative south registry december regular diagnostics team doi place psychological methodsa routine society commonly responsible conclusionsthe question member distribution guideline certain aspect frequently center collection professional incidence survey questionnaire neonatal national furthermore wide laboratory ass characteristic main country standard region participant assessment area supplementary screening state management challenge user version electronic online care current pku material article important number available phenylalanine population genetic method level patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""pku material article important number available phenylalanine population genetic method level p""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""screening"": {""freq"": 1, ""string"": [""standard region participant assessment area supplementary screening state management challenge user v""]}, ""fluorometric"": {""freq"": 1, ""string"": [""southeastern macedonia backgroundwe slovenia romania herzegovina fluorometric bosnia bulgaria nation internationally p""]}}",{},{}
952,952,1028,10.3390/ijms19092731,30213089.0,biochemical future chemistry advancement cellular pipeline new fundamental recent application single early easy progression timely current fluorescent drug laboratory clinical pathogenicity discovery platform many initial analysis insight review toward summarizes approach behavior precursor device technique easier cell identification also capable inexpensive enhancement development highlight antibody technology diagnosis high study heterogeneity microfluidic success treatment well novel disease genetic assay nanoparticle capture characterize sensitive detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164778/,abstract,0,nanoparticle microfluidic easier pathogenicity enhancement pipeline fluorescent summarizes inexpensive chemistry easy timely advancement capture fundamental capable antibody device characterize success progression initial platform precursor sensitive heterogeneity discovery cellular insight assay behavior highlight technique laboratory identification biochemical technology detection application drug future single recent novel current cell approach new early diagnosis review development high genetic treatment clinical analysis disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""new early diagnosis review development high genetic treatment clinical analysis disease s""]}, ""heterogeneity"": {""freq"": 1, ""string"": [""success progression initial platform precursor sensitive heterogeneity discovery cellular insight assay b""]}}",{},"{""detection"": {""freq"": 1, ""string"": [""highlight technique laboratory identification biochemical technology detection application drug future single r""]}}",{},{}
953,953,1029,10.1016/j.biopsych.2015.10.003,26602589.0,chain activity memory example among abnormal enhance implicates common deficit mechanistic contributes abundantly risk biomarker potentiation endophenotype empirical treatable generator animal channel understanding evidence recent delineate consolidation cognition encodes role protein feature sleep disciplinary mouse symptom particular movement knockout diagnosis large oscillation novel long genetic potentially pharmacologically non although rapid cellular spindle schizophrenia highly critical review waking causal stage potential treatment cacna association heritable wide advance future deficient defining scale correlate healthy thalamocortical function dependent cognitive impairment eye mechanism research importance genome prevention phenomenon study human thalamic gene individual calcium,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833702/,abstract,1,waking thalamocortical generator consolidation cacna spindle potentiation pharmacologically implicates defining thalamic oscillation endophenotype disciplinary delineate abundantly empirical heritable encodes contributes channel schizophrenia knockout eye sleep phenomenon cognition calcium causal correlate treatable movement mechanistic enhance biomarker deficient memory cellular abnormal advance potentially stage genome dependent particular deficit understanding animal example feature impairment rapid critical chain prevention highly wide importance scale mouse symptom cognitive healthy long large future association recent mechanism novel activity evidence non role common function individual human risk diagnosis research review potential protein gene genetic treatment study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
954,954,1031,10.7717/peerj.5410,30186675.0,major tool assessment cluster chain sole whether cardiometabolic ratio factor pathway adult aminoadipic set nondiabetics without bcaas detailed view separate unwellness aromatic risk unwell well increase disease significantly respectively spectrum utility biochemical phenylalanine subject granular possible propionylcarnitine distinguish obesity higher wellness health acylcarnitine jonckheere leucine sum backgroundmetabolic metabolic effect large data besides unhealthy significance specie decrease branched type metabolism mortality completely use neither one neutral short aminoadipate derangement morbidity discreet malonylcarnitine controversy carnitines syndrome tyrosine overall lmw obmuw lysine adjust alanine obmw obdm metabolically bcaa dipeptides towards forty test person iii discussionlevels diabetes physiologic wilcoxon bmi acylcarnitines public sample obese along ohbutyrylcarnitine rank application cystine healthy lean correlate comparison statistical terpstra suggests criterion analysis currently cardiovascular diabetic research tryptophan counterpart also metabolomic multiple consequence group plasma trend alpha turn acid yield distinct patient asparagine even amino newly individual total metabolite parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120443/,abstract,5,unwellness unwell terpstra suggests ohbutyrylcarnitine obmw obmuw obdm nondiabetics malonylcarnitine lmw jonckheere discussionlevels carnitines backgroundmetabolic aminoadipic aminoadipate wellness unhealthy lean discreet dipeptides bcaas propionylcarnitine physiologic metabolically granular controversy adjust wilcoxon cystine counterpart sole rank derangement cardiometabolic bcaa asparagine acylcarnitine sum lysine distinguish branched turn alanine acylcarnitines diabetic leucine newly obese metabolomic iii person detailed neutral correlate set completely cluster bmi yield aromatic tryptophan alpha specie trend separate view distinct significance cardiovascular diabetes morbidity utility obesity statistical parameter mortality consequence decrease short comparison criterion chain syndrome tyrosine currently biochemical ratio public overall spectrum possible assessment metabolite tool healthy application subject plasma major multiple increase large pathway adult use respectively total amino higher sample metabolism test individual significantly risk phenylalanine factor type research acid metabolic health group effect data analysis patient disease,"{""phenylalanine"": {""freq"": 2, ""string"": [""sample metabolism test individual significantly risk phenylalanine factor type research acid m""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""subject plasma major multiple increase large pathway adult use respectively total a""]}}","{""amino"": {""freq"": 1, ""string"": [""large pathway adult use respectively total amino higher sample metabolism test i""]}}",{},{}
955,955,1032,10.1111/bph.13877,29055034.0,major tool record content information time nomenclature www substantially knowledgebase detailed view open facilitate survive conjunction close material ion section summary bph related channel committee pharmacological pharmacology previous clinical protein guidance therefore property link mid enzyme data reference receptor selective official eight website com although full catalytic one nuclear supersedes transporter format others drug database wiley point suggestion concise permanent emphasis guidetopharmacology ligand target voltage landscape guide key hormone best onlinelibrary nearly iuphar overview alongside appropriate access comparison approximately basic citable available plus classification human union page org contemporary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650666/,abstract,2,supersedes survive onlinelibrary iuphar guidetopharmacology citable bph knowledgebase concise union nomenclature com wiley mid contemporary voltage page website format pharmacology official ligand alongside suggestion org permanent channel substantially section landscape conjunction ion guidance committee www catalytic emphasis detailed plus close nearly transporter guide classification summary selective facilitate link basic view record nuclear hormone pharmacological overview access receptor open reference approximately content property best appropriate previous comparison point database related target tool enzyme major drug key information material available time human protein data clinical,{},{},{},{},{},{}
956,956,1033,10.3390/ijms20133193,31261867.0,entire greater single mismatch organism dpacs positive fragment selection site synthase restriction photosystem heterogeneous pair effective respectively suitable employ individual glyphosate carboxylase unambiguously dip coa procedure therefore mutant primer enzyme base metaphortm specie novel type proline detection weed pcr wild one phosphate software cover horizontal sensitivity notable around simple method alanine serine acetyl target rflp polymorphism investigated key gel herbicide isoleucine conservation insertion grass electrophoresis sample snp variant opportunity application determinant dependent resistance deletion except polymorphic diagnostic confer nucleotide advantage broadleaf newly highly transferable versatile,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651057/,abstract,1,weed unambiguously transferable photosystem metaphortm horizontal grass dpacs dip broadleaf investigated glyphosate mismatch herbicide confer employ conservation rflp proline polymorphic versatile primer carboxylase notable fragment electrophoresis cover acetyl gel serine phosphate insertion alanine isoleucine pair newly entire determinant base software heterogeneous organism coa snp synthase specie resistance pcr deletion suitable wild simple advantage restriction mutant nucleotide polymorphism procedure opportunity selection dependent site sensitivity highly greater diagnostic target detection enzyme application positive variant key effective single respectively novel sample individual type method,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""site sensitivity highly greater diagnostic target detection enzyme application positive variant k""]}}",{},{}
957,957,1034,10.3390/pathogens7010025,29473896.0,estimation serological information among difficult congenital country prenatal serious gondii bias central onset fetus view regular cost risk clear testing symptomless severity avoid disease pregnant toxoplasmosis recent retinochoroiditis burden usually body support austria effectiveness diagnosis efficacy like situation antenatal data debatable late pregnancy miscarriage fetal significant case rapid surveillance provider involvement others infection provide woman many population reason system test treatment toxoplasma organized care systematic attitude maternal consensus reduces birth nervous precise impact program consequence discrepant study subclinical ocular france another,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874751/,abstract,0,symptomless retinochoroiditis organized discrepant debatable toxoplasmosis toxoplasma serological gondii ocular miscarriage austria subclinical france antenatal avoid fetus attitude estimation surveillance reduces regular reason situation precise usually consensus bias provider pregnant involvement clear nervous prenatal view fetal late burden severity infection difficult systematic effectiveness pregnancy maternal consequence woman central efficacy rapid onset cost congenital provide like birth testing country body support program recent impact care information case test risk diagnosis population significant data treatment disease study,{},{},{},{},{},{}
958,958,1035,10.3389/fnins.2019.00281,30971885.0,dentate lateral availability tool caudate physiological region pathway compact ventral essential several despite gland nigrostriatal native together express drd majority true well elusive tegmental dopaminergic hypothalamic paraventricular phenylalanine pharmacological raphe gpr dopamine mesolimbic tuberoinfundibular compound consistent brain double mouse distribution olfactory alone layer habenula effect data substantia specie receptor rat medial area stress hybridization functional transduction anterior tubercle able technique interpeduncular expression mobilization functionally putamen septum stimulus response similarity assay arcuate cell lobe antagonist rnascope within two rna pituitary negative situ determine nigra function either vitro tryptophan also part interaction pattern mrna acid human nucleus position predominantly pyramidal hippocampus gyrus amino calcium,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443882/,abstract,0,tuberoinfundibular tubercle tegmental substantia rnascope raphe paraventricular nigra interpeduncular arcuate putamen nigrostriatal mobilization habenula gpr septum olfactory mesolimbic lobe dentate compact caudate ventral lateral hypothalamic elusive dopaminergic pyramidal gyrus express drd medial pituitary nucleus antagonist stimulus situ anterior transduction hybridization gland functionally layer native hippocampus similarity calcium true predominantly position mrna tryptophan specie rna physiological pharmacological double rat able distribution receptor availability dopamine majority vitro pattern stress consistent compound assay negative technique essential determine despite functional interaction mouse region area tool expression response pathway brain amino cell function human phenylalanine acid effect data,"{""phenylalanine"": {""freq"": 2, ""string"": []}}",{},"{""pathway"": {""freq"": 1, ""string"": [""mouse region area tool expression response pathway brain amino cell function h""]}}","{""amino"": {""freq"": 1, ""string"": [""area tool expression response pathway brain amino cell function human phenylalanine a""]}}",{},{}
959,959,1036,10.1016/j.ymgmr.2018.03.008,30023297.0,mood correlation disorder relationship activity clinic ratio anxiety positive adult central risk average control reliable evaluate disease doe pku phe suitable phenylalanine marker possible tyr value additionally symptom error inborn depression metabolic purpose term cortisol long metabolism score non level significant stress resultsthere spearman tyrosine synopsissalivary method behavioural sex year bmi monitoring age negative serotonin scale correlate peripheral conclusionsalivary determine invasive turnover das currently analysis introductionphenylketonuria also plasma study dietary patient salivary parameter statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047111/,abstract,0,synopsissalivary conclusionsalivary introductionphenylketonuria das salivary cortisol turnover spearman resultsthere mood behavioural correlate bmi peripheral invasive depression tyr serotonin reliable sex anxiety suitable monitoring statistically doe additionally average clinic parameter evaluate central stress negative marker purpose tyrosine currently correlation determine scale ratio relationship score possible inborn symptom phe long plasma positive value error adult dietary activity pku term non metabolism risk phenylalanine control age significant metabolic year method level disorder analysis patient disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""activity pku term non metabolism risk phenylalanine control age significant metabolic y""]}}",{},{},{},{},{}
960,960,1037,10.1016/j.nicl.2019.101980,31446316.0,correlation specific statistic hearing abnormality early lower congenital bilateral widespread behavioral despite fractional biologically battery severe left spherical mean control anisotropy significantly poorer matter intra adjacent sensorimotor spatial radial observed higher brain cerebellum diffusion integrity microscopic fraction neurite area significant communication measure transverse volume normal white child thalamus technique albeit skill diffusivity treatment temporal callosum limit lobe particularly generally within newborn along occipital correlate healthy standard hypothyroidism metric corpus tract also eighteen group study right underwent microstructural parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713841/,abstract,1,spherical thalamus sensorimotor neurite microscopic lobe transverse cerebellum adjacent radial occipital microstructural left biologically anisotropy albeit temporal eighteen battery hearing callosum metric diffusivity fractional corpus poorer intra bilateral integrity underwent tract spatial diffusion widespread statistic correlate hypothyroidism skill right fraction generally matter limit communication white volume behavioral parameter observed abnormality mean particularly correlation technique despite congenital standard severe area measure normal healthy lower brain newborn higher significantly early specific control child significant group treatment study,"{""behavioral"": {""freq"": 1, ""string"": [""generally matter limit communication white volume behavioral parameter observed abnormality mean p""]}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""area measure normal healthy lower brain newborn higher significantly early specific c""]}}",{},{}
961,961,1038,10.3892/ijmm.2016.2461,26797017.0,hematologic male various specific activity extremely reticulum factor difficult time deterioration necessary action moreover fda common cyp connexin effective addition activation hep significantly promoter emergency endoplasmic proteasome however experimentally recent clinical therapy mouse manner indication elevation result thus enzyme effect contrast hepatocyte proteasomal cause novel furthermore inhibition malignancy case stress main nuclear individually acute inhibitor possibly failure drug liver model markedly therapeutic urgently development via expression potential solid treatment acetaminophen cell donor approval application cytochrome order usa function dependent ccl previously prior available transplantation also induction bortezomib different matching study apap dili human hepatotoxicity patient another injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771096/,abstract,2,hepatotoxicity dili connexin apap hep ccl bortezomib acetaminophen proteasomal matching hematologic proteasome urgently cytochrome cyp reticulum experimentally endoplasmic malignancy deterioration emergency fda usa approval induction individually possibly extremely elevation solid donor manner promoter markedly indication injury transplantation hepatocyte inhibitor activation failure nuclear inhibition prior action contrast difficult acute necessary dependent stress liver furthermore previously male main order mouse various enzyme application addition expression cause drug therapeutic effective recent novel therapy activity common cell function case available time significantly human model specific factor potential different development effect treatment clinical result patient study,{},{},{},{},{},{}
962,962,1039,10.1093/hropen/hox015,31486804.0,male inheritance european cross time prenatal germline anonymity together gamete genetics expert parallel epigenetic testing evaluate consumer issue third related editing screening clinical additionally replacement fast cause genetic embryology generational non panel society female utilisation oocyte highlighted september reproduction topic important donor interface carrier consensus advance two professional application massively since invasive advanced ivf impact infertility research paper genome preimplantation practice human direct mitochondrial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276693/,abstract,1,generational gamete embryology anonymity massively ivf utilisation preimplantation highlighted oocyte infertility reproduction editing germline september interface fast epigenetic topic inheritance donor consumer advanced consensus invasive replacement parallel society mitochondrial prenatal expert european carrier panel additionally advance evaluate professional genome female direct genetics cross practice related male paper issue testing application screening cause impact non important time human research genetic clinical,{},"{""inheritance"": {""freq"": 1, ""string"": [""germline september interface fast epigenetic topic inheritance donor consumer advanced consensus i""]}, ""genetic"": {""freq"": 1, ""string"": [""editing germline september interface fast epigenetic topic inheritance donor consumer a""]}}",{},"{""screening"": {""freq"": 1, ""string"": [""related male paper issue testing application screening cause impact non important t""]}}",{},{}
963,963,1040,10.1111/pcmr.12695,29473999.0,carrier melanoma relationship functional mutation phenylalanine three two causative newborn investigation lead hydroxlase greater factor effort demonstrate pigmentation value germline caucasian melanomagenesis fold determined enrichment phenylketonuria therefore available frequency report prevention national state classic link risk publically data informs patient novel united association hydroxylase genetic status gene untreated characterize,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013363/,abstract,0,publically melanomagenesis melanoma informs hydroxlase pigmentation germline caucasian enrichment causative characterize untreated determined classic link united fold demonstrate carrier effort investigation national lead prevention greater frequency functional hydroxylase relationship status state value association report novel newborn mutation phenylketonuria available risk phenylalanine factor gene genetic data patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""novel newborn mutation phenylketonuria available risk phenylalanine factor gene genetic data p""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""newborn"": {""freq"": 1, ""string"": [""status state value association report novel newborn mutation phenylketonuria available risk p""]}}",{},{}
964,964,1041,10.1016/j.ijpam.2018.04.001,30805535.0,various quantitate disorder tool relationship availability clinic growth syrup nutrition methodologywe several student riyadh retrospective hcu due microsoft investigate backgroundin specialist disease significantly pku phe issue medical biochemical however family phenylalanine life compliance impracticality tyr questionnaire value protein improvement food saudi result metabolic data urine prospective decrease tandem metabolism low non level significant case variable one main valine measure king pre tyrosinemia centre outcome total management product phenylketonuria reason usage post concentration test kfsh treatment important supplement year diet isoleucine finding randomized maple sample resultsthe comple mass access ago msud conclusionlow quality hospital specially available research spectrometry also faisal policy arabia plus plasma study homocystinuria acid patient amino successful caregiver parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363253/,abstract,2,methodologywe kfsh impracticality faisal comple specially riyadh king hcu conclusionlow quantitate microsoft arabia valine usage msud homocystinuria saudi tyrosinemia maple ago syrup isoleucine randomized backgroundin student retrospective supplement reason plus specialist centre tyr caregiver compliance prospective resultsthe access availability successful tandem nutrition post urine clinic policy parameter pre decrease improvement variable questionnaire hospital investigate spectrometry product growth issue main biochemical relationship finding various food tool measure phe mass plasma management value quality medical diet family life concentration total pku amino outcome non important sample phenylketonuria low case available metabolism test significantly phenylalanine research acid protein significant metabolic year data level disorder treatment result patient disease study,"{""urine"": {""freq"": 1, ""string"": [""access availability successful tandem nutrition post urine clinic policy parameter pre d""]}, ""phenylalanine"": {""freq"": 2, ""string"": [""low case available metabolism test significantly phenylalanine research acid protein significant m""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""diet family life concentration total pku amino outcome non important sample p""]}, ""tandem"": {""freq"": 1, ""string"": [""compliance prospective resultsthe access availability successful tandem nutrition post urine clinic p""]}, ""spectrometry"": {""freq"": 1, ""string"": [""decrease improvement variable questionnaire hospital investigate spectrometry product growth issue main b""]}}","{""diet"": {""freq"": 1, ""string"": [""mass plasma management value quality medical diet family life concentration total p""]}}",{}
965,965,1044,10.1590/1678-4685-GMB-2018-0096,30985854.0,epidemiological disorder tool activity physiological extremely new creation several machado condition due geographic elucidation genetics highlight practical number instrumental homogeneity disease numerous medical related family town output project joseph contribution result term first genetic area significant integrates rate three scientific develop inagemp population review spotlight total southern helpful national success proportion year northeast brazil process rare newborn favorable order pilot community ancestry currently importance different high twinning study small azorian patient discipline successful brazilian complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687347/,abstract,2,twinning machado joseph inagemp azorian town spotlight northeast homogeneity integrates instrumental develop elucidation geographic ancestry creation helpful southern discipline output favorable brazilian extremely brazil epidemiological pilot practical project success numerous contribution physiological scientific proportion successful community genetics national currently highlight importance related order small process area tool complex medical rare family rate total newborn activity term condition number new population review different significant year high genetic disorder result patient disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""population review different significant year high genetic disorder result patient disease s""]}}",{},"{""newborn"": {""freq"": 1, ""string"": [""complex medical rare family rate total newborn activity term condition number n""]}}",{},{}
966,966,1045,10.1111/desc.12371,26613685.0,specific interestingly availability whether difference single lower effort several visual adult maoa necessary sustained lundwall drd course addition repeat poorer marker childhood bar dopamine previous higher brain analogous task neurotransmitter genotype attention reflexive term genetic tandem significant although variable dannemiller measure child outcome elucidates development polymorphism association year version two chrna typically serotonin involved influence previously either igf infant comt group infancy bdnf interaction study nucleotide apoe gene show performance number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884175/,abstract,1,reflexive maoa lundwall dannemiller chrna apoe comt bdnf elucidates igf bar analogous sustained drd poorer interestingly repeat infancy visual serotonin neurotransmitter typically course involved availability nucleotide dopamine tandem polymorphism task genotype effort necessary previous childhood variable marker attention influence previously performance interaction measure infant addition version lower brain single association adult outcome term higher difference number specific child significant development gene group year genetic study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""tandem"": {""freq"": 1, ""string"": [""typically course involved availability nucleotide dopamine tandem polymorphism task genotype effort n""]}}",{},{}
967,967,1046,10.1016/j.yebeh.2015.06.040,26209946.0,male youth factor early among positive socioeconomic concern severe course aed month status antiepileptic longitudinal medical trajectory knowledge seizure family life moderate questionnaire diagnosis effect large observational prospective adherence conclusionthere chart modifiable fear non significant functioning stress variable one communication problem drug side outcome intervention point review predictor parent epilepsy treatment key year two methodthis resultsparticipants previously part high study psychosocial beyond newly demographic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562817/,abstract,1,methodthis aed resultsparticipants conclusionthere modifiable fear youth chart antiepileptic socioeconomic trajectory functioning psychosocial newly epilepsy demographic observational predictor seizure adherence longitudinal course prospective communication moderate concern stress variable questionnaire point previously parent problem male status knowledge severe month positive drug key medical large family intervention life outcome non early factor diagnosis review significant year effect high treatment study,{},{},{},{},{},{}
968,968,1047,10.1297/cpe.24.107,26594093.0,technician intelligence hereinafter committee mass subject society new pediatric early japanese congenital problem current hypothyroidism birth positive differential adult user laboratory document population endocrinology practitioner condition primary due subsequently japan target prognosis general diagnosis continuous purpose subclinical treatment facility version guideline avoid specialist disease patient charge phase incidence finding unnecessary physician medical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639532/,abstract,2,hereinafter technician subclinical endocrinology japanese unnecessary facility charge japan avoid practitioner intelligence committee prognosis document hypothyroidism subsequently specialist continuous society differential physician guideline phase pediatric incidence purpose laboratory congenital general problem birth target finding mass subject user primary positive version medical adult current condition new early diagnosis population treatment patient disease,{},{},{},{},{},{}
969,969,1048,10.1515/sjph-2015-0013,27646913.0,whole third future sample beneficial immunoassay newborn new would congenital resultsfrom hypothyroidism birth fluorescent implementation child neonatal introductionnewborn conclusionssuccessful programme serious aim affected phenylketonuria lanthanide day method fluorometric heel disability metabolic analyse study data dissociation slovenia disease pku respectively incidence methodsblood fifth period,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820172/,abstract,9,lanthanide methodsblood introductionnewborn immunoassay dissociation conclusionssuccessful slovenia resultsfrom fluorometric fifth fluorescent heel analyse hypothyroidism programme beneficial affected incidence implementation neonatal disability congenital period birth aim day future respectively newborn pku sample phenylketonuria new child metabolic method data disease study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""lanthanide methodsblood introductionnewborn immunoassay dissociation conclusionssuccessful slovenia r"", ""period birth aim day future respectively newborn pku sample phenylketonuria new c""]}, ""fluorometric"": {""freq"": 1, ""string"": [""introductionnewborn immunoassay dissociation conclusionssuccessful slovenia resultsfrom fluorometric fifth fluorescent heel analyse h""]}}",{},{}
970,970,1050,10.4103/0019-5154.182433,27293243.0,major various revelation future disorder understanding dissertation update dermatitis current connotation dermatology enigmatic clinical differential provide percolate trainee feature attempt criterion minor benefit insight atopic view periodically diagnosis thus metabolic intriguing entity susceptibility addition varied dermatosis etiopathogenesis genetic far complication undertone highlighting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885175/,abstract,0,undertone periodically percolate intriguing dissertation dermatosis connotation trainee revelation enigmatic dermatology etiopathogenesis dermatitis atopic highlighting minor attempt update entity varied susceptibility far differential view complication insight understanding feature criterion provide benefit various addition major future current diagnosis metabolic genetic disorder clinical,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
971,971,1051,10.3343/alm.2016.36.6.561,27578510.0,epidemiologic implication epidemiological blood preventable positive platform accurate additional multigene highlight testing disease recurrent issue explanation utility duoxa biochemical korea korean health galt haplotype environment bottleneck asymptomatic metabolic imprecision effect conclusionsthrough generation routine pccb genetic duox detection rate panel mutation current implementation overall population model test false incidence imds consecutive detect methodsin public resultsthe newborn imd spot birth effectively approximately next analysis backgrounda characteristic prior program pfs also study sequencing faster gene total newbornseq founder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011110/,abstract,4,pfs newbornseq multigene duoxa duox conclusionsthrough pccb korean galt imprecision bottleneck backgrounda korea imds explanation preventable epidemiologic founder faster consecutive imd recurrent haplotype asymptomatic methodsin detect epidemiological effectively routine false accurate resultsthe prior platform utility panel approximately environment implication incidence implementation generation sequencing spot highlight characteristic issue additional biochemical public birth testing overall detection program positive rate total newborn current mutation test model blood population metabolic health gene effect genetic analysis disease study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""detection"": {""freq"": 1, ""string"": [""additional biochemical public birth testing overall detection program positive rate total n""]}, ""newborn"": {""freq"": 1, ""string"": [""overall detection program positive rate total newborn current mutation test model b""]}}",{},{}
972,972,1052,10.1186/s13023-015-0378-7,26693706.0,italy european netherlands specific jelly single composition content energy essential country turkey careful median need expert sub regular enep varied cereal bread objective vitamin pku knowledge cookie equal phenylalanine desirable baby bar higher denmark protein range food kcal belgium data portugal chocolate low eight use seven panel variable slpf one member mineral management product phenylketonuria free cooky germany fat resultsthe spain backgroundspecial access standard portuguese limited analysis nutritionist special available widely identify group nutritional different high study patient individual number methodseuropean splf,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688958/,abstract,9,splf methodseuropean jelly enep cooky cookie backgroundspecial slpf portugal chocolate cereal portuguese nutritionist kcal bread bar belgium netherlands desirable spain denmark turkey italy careful mineral equal germany sub regular varied baby fat special vitamin identify composition expert resultsthe access member seven energy widely european panel content median variable nutritional limited free product essential need knowledge country standard food objective management range single use pku higher phenylketonuria low number available individual phenylalanine specific different protein group high data analysis patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""higher phenylketonuria low number available individual phenylalanine specific different protein group h""]}}",{},{},{},"{""turkey"": {""freq"": 1, ""string"": [""bar belgium netherlands desirable spain denmark turkey italy careful mineral equal g""]}}",{}
973,973,1053,10.3389/fchem.2018.00261,30003079.0,component coefficient biochemical fourier knowledge sample tool chemometrics least lead destructive application spectroscopy biomarkers partial acute alp poisoning protein analysis principal ftir without model particular work due diagnostics discriminate convenient potential plasma chemometric investigate consequently infrared regression discriminant objective first best square rat spectral pca spectrum non pls,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031737/,abstract,0,ftir fourier destructive chemometric spectral poisoning pca chemometrics alp pls convenient infrared discriminate discriminant principal square diagnostics spectroscopy coefficient consequently partial rat acute best component particular regression work lead investigate biomarkers biochemical knowledge spectrum tool application objective plasma non sample model potential protein analysis,{},{},{},{},{},{}
974,974,1054,10.3390/ijns4030025,30123850.0,assessment hearing information early examine decisive document adoption territorial state cost improve pertain finally ehdi formal month later evidence argument role support effectiveness language first united detection service level educational deaf although rapid society hard economic child evaluation outcome intervention review roll unhs national system loss universal age newborn screen access timely analysis benefit paper program infant pas conclusion policy diagnostic informal promote,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094389/,abstract,4,unhs territorial informal decisive roll pertain ehdi pas deaf promote formal argument hard adoption hearing timely document universal educational society language examine united improve screen access later economic effectiveness policy service finally loss rapid national cost evaluation benefit paper diagnostic detection assessment support month infant state program intervention information newborn evidence outcome conclusion role early review child age level analysis,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""national cost evaluation benefit paper diagnostic detection assessment support month infant s""]}, ""newborn"": {""freq"": 1, ""string"": [""month infant state program intervention information newborn evidence outcome conclusion role e""]}}",{},{}
975,975,1055,10.1186/s13023-016-0564-2,28103898.0,chain pain difference greater among across decrement physical additional need highlight stratified diverse amyloidosis well disease survey significantly deposit summary physician worse quantify backgroundlight gov life largest organ clinical health protein generic clinically burden registered support recently little term type eight service clinicaltrials involvement measure end text current vital overall october registrationclinicaltrials point population variance mental towards online respective treatment important key help norm rare future sample resultsthe minimal amyloid scale community subgroup quality meaningful analysis nct widely counterpart also trial general unmet tissue study ancillary cardiac patient exception bodily,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244523/,abstract,1,decrement registered deposit backgroundlight norm bodily ancillary amyloidosis stratified counterpart worse unmet respective registrationclinicaltrials october generic largest exception quantify meaningful vital amyloid pain variance subgroup minimal clinicaltrials cardiac involvement summary nct gov physician organ resultsthe diverse end burden little widely text community clinically mental service help physical survey recently point chain tissue greater highlight general scale additional need overall support measure trial key quality online future rare life current term important difference sample significantly type population protein health treatment clinical analysis patient disease study,{},{},{},{},{},{}
976,976,1056,10.1186/s40814-019-0487-5,31508239.0,various blood nine backgroundnewborn lead new region ill hypothyroid information early registration cystic congenital positive across methodsthis present despite selection initial bad affected condition cost geographical improve dissatisfied principle effective experience addition well disease suitable discussionthe cancer family evidence strategy baby possible form mixed health guidance underpin nominal news output minimise fibrosis result diagnosis sequela metabolic purpose inconsistently good date basis design finite theory bloodspot implement use registrationisrctn four one main death communication measure sickle current economic child prevent evaluation outcome around intervention many ready technique method development potential system disability parent theoretical resource normalisation delivery parental undertake diabetes year help phase challenge cell carrier process future newborn poor negative spot definitive determine chronic england currently analysis extrapolate also trial keywords group practice different study inform healthcare newly indicative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724281/,abstract,1,undertake underpin registrationisrctn normalisation hypothyroid extrapolate finite news inconsistently england dissatisfied discussionthe backgroundnewborn minimise bad ready nominal implement theoretical indicative geographical bloodspot sickle sequela ill definitive output newly theory registration guidance cystic mixed methodsthis baby inform fibrosis principle parental improve affected suitable keywords initial economic communication diabetes carrier healthcare selection date resource prevent poor death phase experience delivery good basis help cancer negative lead purpose disability cost chronic practice evaluation spot currently technique determine despite parent congenital design main region possible various process form measure addition trial challenge positive strategy effective future use family intervention information newborn evidence current outcome condition cell present new early blood diagnosis potential child different development metabolic health group year method analysis result disease study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""news inconsistently england dissatisfied discussionthe backgroundnewborn minimise bad ready nominal i"", ""effective future use family intervention information newborn evidence current outcome condition c""]}}",{},{}
977,977,1058,10.3390/nu10050551,29710825.0,specific blood self cardiometabolic micronutrient lead greater factor composition profile weight homeostasis condition additional magnesium supplementation risk urinary well excretion significantly resultant beneficial life axis anthropometric dysfunction higher questionnaire clinical preventive protein double improvement verum body sum food exhaustion effect psq urine versus score stress serotonergic taurine placebo overall week work system serum concentration folic mass pituitary serotonin waist nervous chronic height circumference impairment autonomic aim index tryptophan group adrenal study whereas acid blind dietary participant amino total parameter hypothalamus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986431/,abstract,2,verum serotonergic psq exhaustion taurine hypothalamus waist autonomic cardiometabolic resultant pituitary magnesium sum axis adrenal folic anthropometric micronutrient circumference excretion height preventive blind placebo tryptophan serotonin versus nervous urinary beneficial homeostasis composition double urine parameter index supplementation profile improvement stress serum work weight questionnaire impairment dysfunction lead self chronic greater week additional overall score participant body food aim mass dietary life concentration total amino higher condition significantly risk specific factor blood acid protein group effect clinical study,"{""urine"": {""freq"": 1, ""string"": [""verum serotonergic psq exhaustion taurine hypothalamus waist autonomic cardiometabolic r"", ""nervous urinary beneficial homeostasis composition double urine parameter index supplementation profile i""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""aim mass dietary life concentration total amino higher condition significantly risk s""]}}",{},{}
978,978,1059,10.3945/ajcn.115.116368,26537945.0,beverage whether syrup energy content fructose difference trigger adult glucose malabsorption liquid without homeostasis ssbs compare inadequate objective significantly intake amount however subject gov drinking mainly relative higher clinical hfc double equivalent food result effect overconsumption libitum design calorie term aspartame crossover type clinicaltrials mandatory signal requirement volume text independently overall corn solid response key investigated phase likely unclear healthy acutely background consumption nct trial conclusion high satiety sugar study blind consistently individual total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658464/,abstract,4,overconsumption libitum investigated hfc ssbs malabsorption corn fructose drinking compare aspartame acutely satiety calorie mandatory trigger syrup inadequate crossover consistently solid sugar beverage requirement independently equivalent clinicaltrials blind nct gov homeostasis double signal consumption unclear mainly energy glucose liquid volume text relative content phase likely intake design overall food background healthy objective subject trial key response adult total conclusion term higher difference individual significantly type effect high clinical result study,{},{},{},{},"{""aspartame"": {""freq"": 1, ""string"": [""ssbs malabsorption corn fructose drinking compare aspartame acutely satiety calorie mandatory t""]}}",{}
979,979,1060,10.1037/bul0000131,29083200.0,implication intelligence correlation extremely immigration difference early reservoir difficult time across lifespan initial attempt adoption continuous source solution status issue empirical interplay related offer evidence trait consequent decline top environment contribution property thus effect large unusual malleability novel genetic privileged dissipation inability controversy problem current slowdown economic implementation paradox societal intervention population socio aid method frequently development via guide network education particularly age future clarify estimate flynn standard influence heritability metric start cognitive environmental benefit program research head also policy interaction high barrier powerful gene individual malleable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754247/,abstract,0,slowdown reservoir paradox malleable malleability flynn dissipation privileged unusual immigration controversy start consequent clarify socio adoption empirical societal interplay inability metric lifespan heritability attempt decline aid intelligence extremely head offer powerful guide continuous solution contribution barrier initial economic trait frequently education network difficult estimate policy property environment implication implementation source environmental influence particularly correlation problem related benefit issue status standard interaction cognitive program large future intervention novel evidence current difference individual time early research population age development gene effect high genetic method,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
980,980,1061,10.1038/s41467-019-09601-3,30962431.0,nanofiber self pathway molecule biomedical modification without neuroinflammation easily moreover subsequently highlight significantly excellent assembly reversible knowledge noncovalent dephosphorylate therapy structural degradation report equivalent like effect stability little receptor long bind three toll translocation nuclear interest dimensional microglia rhein current drug release able product free stimulus response network gel limit directly cell carrier lack application premature neuroinflammatory herbal act natural cytotoxicity interaction hydrogel study direct small show,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453967/,abstract,0,rhein noncovalent neuroinflammatory nanofiber dephosphorylate toll neuroinflammation microglia translocation herbal hydrogel cytotoxicity stimulus gel reversible easily bind biomedical release dimensional premature assembly excellent subsequently equivalent act modification degradation stability nuclear limit able receptor little carrier structural network molecule directly natural direct lack self free product highlight like small knowledge interaction application long drug response pathway report therapy current cell significantly effect study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""knowledge interaction application long drug response pathway report therapy current cell s""]}}",{},{},{}
981,981,1062,10.1186/s12916-016-0706-3,27814705.0,major resonance chain activity herein growth factor signature profile time present prenatal contains throughout weight physical resultsa variation risk methodswe source urinary well increase vitamin inter disease material respectively longitudinal conclusionssignificant characterize intra third related trimester later supplementary life sabadell user clinical doi reproducibly leucine gestation environment great backgroundmaternal predict metabolic personalize data urine pregnancy novel fetal first branched metabolism significant progesterone nuclear signal independent valine measure phenotype coffee outcome variance product week choline approach management alanine development stage nmr potential online methyl reproducible article uterine electronic hormone association steroid isoleucine associated lifestyle donor maternal predictive version sample two estrogen newborn opportunity hydroxyisobutyrate spectroscopy determinant birth placental inma gipuzkoa consumption available multiple identify cohort magnetic acid predominantly power amino individual total metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5097405/,abstract,7,sabadell inma hydroxyisobutyrate gipuzkoa conclusionssignificant backgroundmaternal reproducibly personalize uterine progesterone coffee placental valine reproducible predict estrogen steroid choline trimester branched contains signature intra alanine isoleucine gestation nmr leucine methyl power resultsa predominantly inter determinant donor spectroscopy variance doi lifestyle characterize resonance prenatal urinary longitudinal vitamin predictive identify fetal nuclear hormone signal later consumption great magnetic opportunity independent urine methodswe associated pregnancy stage maternal profile environment source physical weight variation chain product growth related cohort week phenotype birth metabolite measure supplementary management major user multiple version increase electronic online association respectively novel life total newborn activity material amino outcome article sample approach present available metabolism individual time risk factor acid potential significant development metabolic data clinical disease,"{""urine"": {""freq"": 1, ""string"": [""later consumption great magnetic opportunity independent urine methodswe associated pregnancy stage m""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""novel life total newborn activity material amino outcome article sample approach p""]}, ""newborn"": {""freq"": 1, ""string"": [""online association respectively novel life total newborn activity material amino outcome a""]}}",{},{}
982,982,1064,10.1136/bmjopen-2015-010956,26932144.0,blood lead registration commission time visual protects elevated slightly affected recruitment central onset pressure preparatory parallel ethic institute analysistreatment persistent doe objective month disease whose pulse medical measurement however unit estimated event introductionoptic neurodegeneration clinical therapy recovery helsinki law double global gcp tone symptom layer primary thrombotic efficacy effect contrast ich declaration term first type low international malignancy non recombinant ganglion period significant erythropoietin fibre saline sclerosis retinal optic size placebo acute local text randomisation shortens drug prevent exclusion multicentre decimal inclusion axon device day method history national system treatment methylprednisolone important nerve phase myopia cell consecutive thickness german acuity within degeneration sample two freiburg disseminationtone standard determine function impairment criterion either eye prior intravenously nct trial episode multiple study arm hyperopia astigmatism rnflt ocular human blind power federal patient preparation show number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785322/,abstract,8,thrombotic rnflt preparatory methylprednisolone introductionoptic intravenously ich hyperopia helsinki gcp freiburg disseminationtone declaration decimal astigmatism analysistreatment shortens randomisation protects myopia erythropoietin tone ocular fibre estimated acuity saline optic neurodegeneration axon thickness ganglion multicentre malignancy german commission persistent federal nerve retinal law recruitment institute arm layer consecutive sclerosis pulse exclusion episode degeneration eye ethic registration slightly power recombinant recovery preparation device blind visual placebo unit parallel pressure nct affected double prior local doe event elevated text international inclusion contrast prevent acute phase history global size central efficacy criterion impairment national lead onset measurement determine period standard symptom month objective day trial multiple primary drug medical therapy term non important cell function sample low number time human blood type significant effect method treatment clinical patient disease study,{},{},{},{},{},{}
983,983,1065,10.1016/j.csbj.2016.01.001,26929792.0,phenotypic instance greater factor composition elaborate context epigenetics effort signature profile across complexity increasingly genetics state diverse finally disease medical individual biochemical microbiota element much today health define move broaden therefore integrative behind like metabolic large reach combination ability medicine level although microbiome variable measure biomarkers diversity surrogate comprehensively population review toward work frequently ass technology functionally treatment precision key active detail myriad challenge component generally influence influencers currently environmental metabolomics also closer high study human even aspiration precisely metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744241/,abstract,0,influencers closer aspiration precisely myriad broaden instance epigenetics elaborate surrogate comprehensively reach today functionally signature integrative define microbiota microbiome diversity complexity element generally precision phenotypic composition diverse increasingly metabolomics frequently active effort component finally profile variable work genetics combination context environmental influence biomarkers greater currently ability medicine ass like biochemical technology metabolite measure state challenge key medical large individual human factor population review metabolic health high level treatment disease study,{},{},{},{},{},{}
984,984,1066,10.4103/ijpvm.IJPVM_171_18,30967920.0,intelligence relationship search immigration region nutrition time country prevents without central condition due magiran moreover common valid investigate mean motor practical increase respectively poorer medical suitable related subject interval baby adequate verbal academic science familial result effect deeply decrease pregnancy sid quotient low score area level springer significant confidence one northern software problem current proper database eastern personal review model southern reviewing used scopus social people web article free important limit year directly western systematic version age sample two iran estimate scale wechsler statistical elite iranmedex google analysis index research keywords also occupational prevention medlib stata study heterogeneity medium meta direct scholar charge random participant performance total number citation parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425765/,abstract,3,springer reviewing medlib iranmedex elite magiran wechsler sid immigration stata scholar occupational google quotient valid scopus deeply citation charge eastern prevents southern northern verbal poorer personal familial academic intelligence used proper software random web western baby iran practical adequate medium suitable keywords meta limit confidence people motor heterogeneity interval nutrition statistical science directly search systematic estimate pregnancy parameter index decrease direct central mean investigate free prevention database social problem scale related relationship performance score country region participant area subject version increase medical respectively total current condition article important common sample low number time model research review age significant year effect level analysis result study,"{""social"": {""freq"": 1, ""string"": [""central mean investigate free prevention database social problem scale related relationship p""]}}","{""heterogeneity"": {""freq"": 1, ""string"": [""keywords meta limit confidence people motor heterogeneity interval nutrition statistical science d""]}}",{},{},{},{}
985,985,1068,10.1007/s10875-016-0347-5,27873105.0,blood nine lower prematurity thirteen krec abnormal time positive defect median due severe unclassified tacrolimus trisomy beta control stockholm scid material sweden circle mercaptopurine reversible supplementary quantitative milder follow user excision digeorge cutoff prematurely primary result large cause copy pid receptor pregnancy first artemis low sixty period level detection yet pcr four three recombination one apparent syndrome child atm method identification online simultaneously article actin mother simultaneous electronic year cell trec version materialthe immunodeficiency still two hypogammaglobulinemia newborn spot pilot scale lymphopenia birth dna quality program available quantity also spontaneously diagnostic immunosuppressive study patient agent twenty number county,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226987/,abstract,4,unclassified tacrolimus mercaptopurine hypogammaglobulinemia digeorge atm artemis stockholm immunosuppressive prematurely pid lymphopenia krec trec spontaneously actin trisomy excision thirteen scid recombination county prematurity circle milder sweden immunodeficiency cutoff reversible simultaneous copy beta apparent simultaneously quantity pilot pcr agent receptor mother abnormal pregnancy follow median dna quantitative syndrome materialthe spot defect identification scale period birth diagnostic detection severe supplementary program user primary cause positive version electronic quality online large lower newborn material article cell low number available time control blood child year method level result patient study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""defect identification scale period birth diagnostic detection severe supplementary program user p""]}, ""newborn"": {""freq"": 1, ""string"": [""version electronic quality online large lower newborn material article cell low n""]}}",{},{}
986,986,1069,10.1080/10937404.2016.1215772,27759495.0,biological blood past new establishing effort despite throughout central additional due chemical risk fact source practical effective accumulation noninvasive disease briefly medical infectious decade subset relevant biofluid strategy exposome clinical health science environment link metabolic exogenous effect contrast biofluids urine change term long genetic biomonitoring use personnel biomarkers certain code external current measurable outcome intervention many breath review living product pollutant reason method compartment bioindicators lifetime propose exposure response person waste cell every public future sample endogenous typically application pollution community decode demonstrate setting interacts adverse analysis environmental aim research genome interaction often medium human similar gene individual indicative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6147038/,abstract,0,personnel biomonitoring bioindicators biofluid decode measurable interacts pollution pollutant biofluids waste exposome setting breath briefly indicative code noninvasive establishing compartment external living lifetime fact exogenous person reason infectious endogenous subset practical medium link typically propose demonstrate chemical past certain decade accumulation science community contrast urine effort genome adverse environment central source exposure environmental biomarkers product biological relevant despite additional public interaction similar aim application long change strategy response effective medical future use intervention current outcome term cell sample individual new human risk blood research review metabolic health gene effect genetic method clinical analysis disease,"{""breath"": {""freq"": 1, ""string"": [""pollution pollutant biofluids waste exposome setting breath briefly indicative code noninvasive e""]}, ""urine"": {""freq"": 1, ""string"": [""certain decade accumulation science community contrast urine effort genome adverse environment c""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
987,987,1070,10.1177/1744806916637699,27030720.0,major pathogenesis pain whether pathway behavioral inflammation slightly homolog moreover spinal injection motor significantly kinase prostaglandin nociceptive later allodynia poorly snap clinical protein mouse complete contribution result horn like root contrast interacting change type inhibition adjuvant ganglion level conclusionsthese although wild signal problem phosphorylation sized mediator via stage expression test important response signaling phase tactile cell cord particularly resultsnociceptive inflammatory deficient neuron backgroundchronic nitrophenylphosphatase unclear peripheral determine carrageenan mechanism nipsnap nocistatin camp extracellular min dorsal different mrna domain medium small formalin nonneuronal freund,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956003/,abstract,0,tactile resultsnociceptive nonneuronal nocistatin nitrophenylphosphatase nipsnap horn freund formalin conclusionsthese carrageenan backgroundchronic allodynia snap prostaglandin nociceptive interacting homolog root dorsal camp spinal sized ganglion adjuvant kinase mediator cord extracellular phosphorylation neuron signaling slightly pain min mrna peripheral poorly pathogenesis injection inflammation medium deficient contribution inhibition wild signal later complete unclear motor inflammatory behavioral domain contrast phase stage particularly determine problem like small mouse major expression change response pathway mechanism important cell test significantly type different protein level clinical result,"{""behavioral"": {""freq"": 1, ""string"": [""signal later complete unclear motor inflammatory behavioral domain contrast phase stage p""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""small mouse major expression change response pathway mechanism important cell test s""]}}",{},{},{}
988,988,1071,10.3390/nu10020248,29470410.0,specific micronutrient lead factor among cosmos nutrition segment adult concern nutrient multimineral insight additional state risk build nutrigenomics vitamin disease intake spectrum advent cancer dozen endpoint form role health inconsistent large observational ongoing ability tolerable genetic potentially united controversial ultimately area level multivitamin three mvms certain mineral others outcome population maintenance product conduct expression potential excessive supplement directly particularly folic definition two reduces progress variant scale untoward cocoa inadequacy field chronic cardiovascular research upper widely broad trial prevention consequence interaction study acid deficiency,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852824/,abstract,0,mvms multimineral inadequacy cosmos cocoa untoward tolerable multivitamin dozen segment nutrigenomics endpoint upper build inconsistent advent mineral folic controversial conduct excessive micronutrient ongoing reduces maintenance definition ultimately supplement progress broad observational united vitamin cardiovascular nutrient widely certain nutrition directly concern potentially consequence insight cancer lead chronic intake prevention particularly product ability scale additional field spectrum interaction form area state trial expression variant large adult deficiency outcome role risk specific factor research population acid potential health genetic level disease study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
989,989,1072,10.1186/s13052-015-0147-1,26021374.0,italy training interestingly new region early reassured item time uncertainty positive neonatal insight condition efficient additional need severe risk methodswe practical specialist disease organizing survey familiarity material visit opinion numerous biochemical knowledge pediatrician understanding however family supplementary backgroundthe baby unaffected screening lombardy follow user questionnaire role respondent clinically procedure italian task primary result diagnosis ability tandem genetic greatly untreated mortality period level yet rate member least morbidity fulfill discussion underway implementation prevent confirmation conclusionssuccessful compile confirmatory technique simple identification evident ass contact system sufficient parent online article test treatment important response electronic active association care version materialthe universal process resultsthe mass newborn access conducted picture birth authorized goal spectrometry available program infant relatively consequence general high part campania even highest successful number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462014/,abstract,3,reassured organizing lombardy campania conclusionssuccessful compile underway fulfill familiarity picture unaffected pediatrician italian italy contact conducted greatly confirmatory confirmation uncertainty visit training item opinion interestingly respondent evident authorized specialist baby universal practical untreated sufficient discussion backgroundthe numerous efficient simple resultsthe access member highest successful goal tandem morbidity task relatively procedure active prevent methodswe clinically follow mortality consequence insight implementation survey understanding questionnaire neonatal spectrometry materialthe technique ability parent ass identification general additional period biochemical birth need knowledge region severe process infant supplementary screening mass program user primary positive version response electronic online association family care rate newborn material condition article important role number available test time new risk early diagnosis high genetic level treatment result disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""tandem"": {""freq"": 1, ""string"": [""resultsthe access member highest successful goal tandem morbidity task relatively procedure a""]}, ""spectrometry"": {""freq"": 1, ""string"": [""insight implementation survey understanding questionnaire neonatal spectrometry materialthe technique ability parent a""]}, ""newborn"": {""freq"": 1, ""string"": [""electronic online association family care rate newborn material condition article important r""]}, ""screening"": {""freq"": 1, ""string"": [""knowledge region severe process infant supplementary screening mass program user primary p""]}}",{},{}
990,990,1073,10.1021/acsomega.7b01234,30023539.0,biological considerable culture activity synthetic herein fundamental among largely hepg acceptance biomedical alg peroxide semisynthetic detoxification characterization open separate artificial buffer concept solution assembly however planar microfluidics particle form role windowthe layer report catalase fabrication removal combination first functional droplet toward model polymer partner assay aggregate cell maturation progress alginate application contributing either natural loaded microreactors hydrogen assist absence successful,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045345/,abstract,0,semisynthetic planar peroxide microreactors droplet alg microfluidics loaded catalase alginate windowthe hepg fabrication detoxification removal particle hydrogen contributing buffer maturation polymer acceptance partner artificial layer assist biomedical aggregate assembly fundamental culture characterization progress synthetic separate largely considerable solution absence open successful concept natural assay combination biological functional form application report activity role cell model,{},{},{},{},{},{}
991,991,1074,10.1186/s12910-017-0184-y,28388916.0,specific culture gain time across present consent trading need state risk ethical amount issue suitable utility account impossible subject protection bloc form compatible law milieu harmonisation improvement examination possibility large data language long low consideration period use case seven member requirement provide approach method identification albeit biobanks thereby social consequently sufficient mandate licence future supranational legal comparison standard circumstance enable act framework research policy jurisdiction different tissue similar advantage critique healthcare,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385067/,abstract,0,trading supranational licence bloc impossible harmonisation critique mandate milieu biobanks jurisdiction compatible circumstance albeit enable law protection consent legal gain requirement culture consequently ethical act sufficient language suitable consideration possibility examination advantage member seven framework utility account healthcare policy improvement comparison tissue social identification provide issue period need standard similar form state subject long large future use low approach present case time risk specific research different method data,"{""social"": {""freq"": 1, ""string"": [""account healthcare policy improvement comparison tissue social identification provide issue period n""]}}",{},{},{},{},{}
992,992,1075,10.1111/iep.12176,27256515.0,adversely cross relationship whether dos growth among restriction weight easily molecular choice utero apds psychosis multifactorial risperidone lesion trophoblast classical prescribed establish issue organogenesis physician teratogenic line pregnant dysregulation atypical form anti dysfunction clinical enter morphometrically mol therefore gestation examination layer report equivalent like intrauterine effect trophoblastic necrosis pregnancy first rat sketchy size foetal drug side placenta histopathological structure outcome management day therapeutic disruption development potential organization exposure dystrophy cytoarchitectural septum dam interface maternal thickness psychotic hence minimal poor involved limited function placental aapds bloodstream mechanism available widely extra different study disturbed barrier pyramidal even,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926043/,abstract,0,trophoblast sketchy risperidone prescribed organogenesis morphometrically enter cytoarchitectural bloodstream apds aapds trophoblastic psychotic septum necrosis histopathological extra disturbed placenta foetal dam teratogenic psychosis placental adversely thickness pyramidal dystrophy dysregulation atypical intrauterine multifactorial utero easily layer lesion gestation disruption interface dos establish minimal equivalent pregnant physician choice organization barrier involved classical line examination rat anti restriction mol widely poor pregnancy size maternal weight exposure dysfunction cross limited structure growth like issue relationship form management day drug therapeutic molecular mechanism report outcome function available potential different development effect clinical study,{},{},{},{},{},{}
993,993,1076,10.1371/journal.pone.0156359,27243974.0,utility case biochemical specific sanger resultsgenetic methodsthe rate panel two subject rapid iem studied custom biomarkers conclusionsa final suspicion promotion category clinical field consistent classified unspecific increasingly total approach aim compare indication error inborn group diagnosis technology diagnostic cohort study addition yield validation faster effective backgroundnext generation patient evaluate genetic finding metabolism inexpensive gene particularly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887012/,abstract,5,unspecific resultsgenetic backgroundnext suspicion custom compare conclusionsa promotion inexpensive faster sanger final classified studied indication yield methodsthe validation category increasingly iem utility panel evaluate consistent rapid generation biomarkers particularly cohort biochemical technology field diagnostic finding inborn aim addition subject error effective rate total approach case metabolism specific diagnosis gene group genetic clinical patient study,{},"{""genetic"": {""freq"": 1, ""string"": [""unspecific resultsgenetic backgroundnext suspicion custom compare c""]}}",{},{},{},{}
994,994,1077,10.1097/MD.0000000000016381,31277194.0,male blood enterography assessment pain early lower time essential pjs present laboratory concern ileum condition lip onset due colonoscopy old lesion close month decade later family life much follow clinical barium usually rectal familial diagnosis recto transfusion oral first malignancy gastrointestinal case least mucocutaneous size acute annual hamartomatous syndrome prevent outcome intervention abdominal polyposis jeghers history development potential test mother recommendation association polyp year surgically rare every detect age stomach within anal favorable order especially since polys quite endoscopy currently bowel tract upper also multiple different rationale orifice mucosa lesson small surgical patient complication peutz,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635162/,abstract,7,surgically recto rectal polys polyposis pjs peutz orifice mucocutaneous jeghers hamartomatous enterography endoscopy barium anal transfusion stomach polyp ileum mucosa lip colonoscopy malignancy quite upper abdominal rationale familial bowel lesson surgical lesion favorable annual gastrointestinal tract detect pain close usually later complication mother oral decade prevent acute concern follow history size recommendation old onset especially syndrome currently essential laboratory male order small assessment month multiple lower association rare family intervention life outcome condition present case test time early blood diagnosis potential different age development year clinical patient,{},{},{},{},{},{}
995,995,1078,10.1038/npp.2014.232,25182180.0,specific disorder autism example factor context pathway phenocopies substantially insight onset oncology common neuropsychiatric risk regulatory fragile kinase spectrum trajectory shortly animal cancer understanding later rather neurodevelopmental broader clinical overlapping range protein developmental nonspecific move portion mouse symptom diagnosis like similarly genetic type medication yet although hope phenocopy cellular discussion inhibitor syndrome prevent intervention point critical review model neurodevelopment disruption development target helpful potential ameliorate test treatment help best teach finding rare wide age within opportunity subgroup next either environmental benefit pathophysiology also trial array rett upon molecularly patient chemotherapy tumor schizophrenia number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262912/,abstract,0,phenocopy phenocopies teach overlapping chemotherapy rett molecularly shortly portion nonspecific hope neurodevelopment oncology fragile kinase helpful array trajectory schizophrenia substantially neuropsychiatric broader ameliorate disruption similarly subgroup pathophysiology tumor discussion inhibitor medication neurodevelopmental later cellular opportunity prevent regulatory best autism help insight cancer understanding animal example onset critical context environmental point developmental syndrome wide benefit like spectrum target finding mouse symptom trial range pathway rare intervention common number test risk model specific factor type diagnosis review potential protein age development genetic disorder treatment clinical patient,{},"{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""target finding mouse symptom trial range pathway rare intervention common number t""]}}",{},{},{}
996,996,1079,10.12688/f1000research.7134.1,27127621.0,transcriptional functioning worldwide disorder autism organ ontology congenital adaptive syndrome developmental focus review environmental known behavior analysis candidate condition frequency mental syndromic common deficit intellectual disability often like attention part heterogeneity hyperactivity cause limitation succinct genetic greatly gene prioritization malformation spectrum non,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830215/,abstract,0,succinct prioritization known syndromic ontology greatly functioning malformation adaptive transcriptional hyperactivity worldwide organ candidate limitation heterogeneity intellectual autism mental deficit focus behavior disability attention environmental developmental syndrome frequency congenital like spectrum cause condition non common review gene genetic disorder analysis,"{""hyperactivity"": {""freq"": 1, ""string"": [""ontology greatly functioning malformation adaptive transcriptional hyperactivity worldwide organ candidate limitation h""]}, ""intellectual"": {""freq"": 1, ""string"": [""hyperactivity worldwide organ candidate limitation heterogeneity intellectual autism mental deficit focus b""]}}","{""genetic"": {""freq"": 1, ""string"": []}, ""heterogeneity"": {""freq"": 1, ""string"": [""transcriptional hyperactivity worldwide organ candidate limitation heterogeneity intellectual autism mental deficit f""]}}",{},{},{},{}
997,997,1080,10.1039/C7AY00532F,29181095.0,entire coefficient potent correlation quantitate blood greater opioids venous analog fentanyl without cost mean control varied alfentanil material sufentanil labeled calibration carfentanil quantitation storage range compound spectrometric error effect tandem extraction detection level seven four internal volume analyte curve isotopically method target exposure concentration methyl solid limit rsd detect sample overdose minimal mass spot elution standard lofentanil analytes quality analysis benefit matrix multiple human hematocrit linear confirms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701286/,abstract,1,sufentanil overdose opioids lofentanil labeled fentanyl carfentanil alfentanil rsd isotopically confirms quantitate calibration hematocrit spectrometric analog elution quantitation analyte venous analytes potent methyl entire solid detect matrix internal varied extraction curve minimal coefficient limit storage seven linear tandem volume compound mean exposure cost spot greater correlation benefit target standard detection mass range multiple error quality concentration material sample human control blood effect method level analysis,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""spot greater correlation benefit target standard detection mass range multiple error q""]}, ""tandem"": {""freq"": 1, ""string"": [""minimal coefficient limit storage seven linear tandem volume compound mean exposure c""]}}",{},{}
998,998,1081,10.1038/nchem.2754,28837163.0,potent sequence considerable third animal reproduces however activity minimal self event much interest region conformational lack conformation amyloid form solid remarkably gain aggregation propagating microtubule map induce propagation fibril residue diffraction tau hexapeptide behavior model vitro slowly deuterium extended peptide underlies alzheimer exchange seed nmr beta thus neurodegenerative rapidly fiber nucleus gradually hydrogen repeat small active disease dissection ability show cell,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759337/,abstract,1,tau propagating hexapeptide reproduces microtubule extended dissection deuterium underlies seed propagation diffraction hydrogen fiber nucleus fibril slowly induce gradually conformational conformation remarkably map beta nmr potent amyloid solid repeat rapidly residue exchange aggregation gain minimal alzheimer neurodegenerative peptide considerable event active vitro sequence animal behavior lack self ability small region form activity cell model disease,{},{},{},{},{},{}
999,999,1082,10.1007/s13311-017-0551-x,28608171.0,specific relationship better context light condition genetics variation neuropsychiatric unfamiliar concept way etiological transition objective material summary extensive knowledge microarray supplementary sharing rather recent neurodevelopmental fill user therapy clinically word doi gap particular expertise genotype seemingly diagnosis primer like large data force forward ramification reach design copy combination genetic swath rational biotype interpreting phenotype drug provide discovery review approach emphasis development technology consequently mode online article key electronic probe version microarrays quantifiable variant biology cohesive underscore category psychiatric field path currently previously mechanism impact available general subfields diagnostic different study heterogeneity human unanticipated barrier patient gene number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509640/,abstract,0,unanticipated swath subfields cohesive biotype ramification quantifiable unfamiliar microarrays interpreting seemingly rational sharing etiological primer microarray underscore reach expertise neuropsychiatric force path copy forward probe emphasis mode doi transition consequently gap summary light extensive psychiatric barrier neurodevelopmental category word biology heterogeneity discovery concept genotype clinically way particular genetics combination context variation currently previously design general provide like technology phenotype relationship field knowledge diagnostic better supplementary objective user drug version variant key electronic online large recent mechanism impact therapy material condition article approach number available human specific diagnosis review different development gene genetic data patient study,"{""psychiatric"": {""freq"": 1, ""string"": [""primer microarray underscore reach expertise neuropsychiatric force path copy forward p"", ""transition consequently gap summary light extensive psychiatric barrier neurodevelopmental category word b""]}}","{""genetic"": {""freq"": 1, ""string"": []}, ""heterogeneity"": {""freq"": 1, ""string"": [""psychiatric barrier neurodevelopmental category word biology heterogeneity discovery concept genotype clinically w""]}}",{},{},{},{}
1000,1000,1083,10.1177/0883073815624762,26719496.0,delay exon glial dominant whether boy epilepsia due aag substitution motor disease glutamic gfap seizure unique heterozygous dysfunction clinical hypertonia alexander protein acidic developmental global determined mutant astrocyte change cause novel genetic four leukodystrophy mutation phenotype normal unilateral produce child sign point lysine fibrillary association year adenine genetically age gag guanine perioral continuum analysis partialis previously acid position muscle gene pathologic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865433/,abstract,2,unilateral partialis hypertonia epilepsia alexander perioral glutamic gag fibrillary aag glial gfap guanine adenine astrocyte leukodystrophy continuum acidic pathologic lysine muscle substitution heterozygous produce dominant position boy sign seizure determined exon genetically delay mutant motor unique global dysfunction point developmental previously phenotype normal change cause association novel mutation acid child protein age gene year genetic clinical analysis disease,{},"{""heterozygous"": {""freq"": 1, ""string"": [""continuum acidic pathologic lysine muscle substitution heterozygous produce dominant position boy s""]}, ""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1001,1001,1084,10.1093/gerona/glw116,27365368.0,growth single factor pathway among across present attainment aged connective frequency variation contributes average old extreme egfr life korean observed role consistent play haplotype genotype genetic span suggestive level significant case japanese white block population epidermal american polymorphism respective key association year excess age two snp allele comparison ancestry analysis research bonferroni conclusion tissue nucleotide study human advantage men longevity correction gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861942/,abstract,6,korean connective epidermal egfr attainment longevity japanese extreme bonferroni suggestive ancestry respective span contributes men excess haplotype block correction snp american advantage white nucleotide polymorphism play genotype average allele aged observed consistent old comparison variation tissue frequency growth key pathway single association life conclusion role present case human factor research population age significant gene year genetic level analysis study,{},"{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""comparison variation tissue frequency growth key pathway single association life conclusion r""]}}",{},{},{}
1002,1002,1085,10.1371/journal.pone.0183430,28850618.0,major blood delay abnormality new early difficult time several adult behavioral present despite partially onset common clear motor acquisition enu disease significantly pku hydroxylase murine shortly however phenylalanine amine smaller compliance profound mainly totally developmental brain mouse indication error report inborn pahenu result effect date first genetic metabolism low untreated area level significant one pnd biogenic preclinical instrument tyrosine overall prevent evaluation population model phenylketonuria reflex development social skill disability free manifestation treatment alteration recommendation regimen diet assay strict dietetic hyperphenylalaninemia lifelong order since birth adolescent communicative cognitive comprehensive high study whereas human advantage cerebral btbr deficiency neurochemical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574541/,abstract,0,reflex totally pnd communicative neurochemical shortly biogenic dietetic amine enu btbr smaller pahenu acquisition regimen preclinical murine profound cerebral strict lifelong instrument partially indication skill compliance untreated clear manifestation hyperphenylalaninemia delay advantage mainly motor adolescent alteration behavioral comprehensive date prevent difficult recommendation abnormality assay onset disability free developmental tyrosine evaluation social despite hydroxylase order birth overall mouse inborn cognitive area major error brain adult deficiency diet report pku common phenylketonuria low present metabolism time significantly new human model early phenylalanine blood population significant development effect high genetic level treatment result disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""time significantly new human model early phenylalanine blood population significant development e""]}, ""behavioral"": {""freq"": 1, ""string"": [""delay advantage mainly motor adolescent alteration behavioral comprehensive date prevent difficult r""]}, ""social"": {""freq"": 1, ""string"": [""onset disability free developmental tyrosine evaluation social despite hydroxylase order birth o""]}}","{""genetic"": {""freq"": 1, ""string"": [""blood population significant development effect high genetic level treatment result disease s""]}}",{},{},"{""diet"": {""freq"": 1, ""string"": [""area major error brain adult deficiency diet report pku common phenylketonuria l""]}}",{}
1003,1003,1086,10.1155/2015/718492,26090437.0,component stress hypoxic upregulation evidence member reduction myocardium apoptosis cardiomyocyte survival hypoxia acyanotic congenital strong binding defect function present additionally child chronic heart protein neonatal role paediatric provide gab grb vitro regulation program model condition fibroblast partner altogether expression tissue study data cardiac human hypothesis response little demonstrated myocardial important docking associated rat cultured cell cyanotic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452271/,abstract,0,grb gab demonstrated cyanotic acyanotic myocardium cardiomyocyte myocardial hypoxic docking upregulation hypoxia altogether binding apoptosis cultured partner paediatric fibroblast cardiac survival rat member strong little hypothesis additionally vitro associated heart component regulation stress neonatal reduction chronic tissue defect congenital provide program expression response evidence condition important role cell function present human model child protein data study,{},{},{},{},{},{}
1004,1004,1088,10.3390/healthcare3040964,27417806.0,staff implication training assessment disorder pcp better counselor abnormal platform half condition additional need genetics southeast state deficit number addition formal close significantly survey issue geneticist medical third knowledge biochemical family follow respondent regional telephone primary never metabolic dietitian term long genetic adequacy infrastructure educational four provider one least communication fourteen regard uniformly fax development via serc parent web resource collaborative directly address care protocol within two minimal newborn opportunity appropriate involved category flow program importance multiple informational insufficient understand coordinator center inform though,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934624/,abstract,1,serc informational fax coordinator uniformly pcp counselor telephone southeast infrastructure understand formal collaborative adequacy staff fourteen geneticist dietitian training regard regional insufficient respondent flow close web minimal provider inform educational half involved category platform communication protocol abnormal opportunity directly resource address center follow appropriate implication survey deficit genetics parent importance issue additional biochemical need knowledge better assessment addition state long program multiple primary medical family care newborn term condition number significantly development metabolic genetic disorder,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""newborn"": {""freq"": 1, ""string"": [""program multiple primary medical family care newborn term condition number significantly d""]}}",{},{}
1005,1005,1089,10.1016/j.mce.2016.01.021,26808453.0,male encoding factor pathway among binding parallel open regulatory differentially epithelial peak transcriptional measurement transcription element participates subject phi deep role protein determined environment contribution sperm chip transport hepatocyte fertility non significant water nuclear phosphate seq prediction sirna upregulated many critical enrichment bicarbonate bioinformatic target expression chromatin important hnf associated cell intracellular maturation immunoprecipitation transcript wide process within rna epididymis depletion ontology repression comparison luminal function differential dependent analysis impact program hee human sequencing gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799753/,abstract,3,sperm phi luminal hee epididymis participates bicarbonate upregulated sirna repression bioinformatic immunoprecipitation fertility chromatin seq maturation transcript ontology binding depletion intracellular chip phosphate epithelial deep peak enrichment differentially encoding hnf transcriptional transport parallel rna hepatocyte differential determined element prediction contribution transcription nuclear water open associated regulatory dependent environment comparison critical sequencing measurement wide male target process subject program expression pathway impact non important role cell function human factor protein significant gene analysis,{},{},"{""pathway"": {""freq"": 1, ""string"": [""male target process subject program expression pathway impact non important role c""]}}",{},{},{}
1006,1006,1090,10.1038/srep30059,27444653.0,blood vivo early time half elevated due state colitis ulcerative manifest telotristat chlorophenylalanine increase disease hydroxylase synthesis heavy para measurement resultant life amine faceted screening obesity clinical possibility fibrosis tph enzyme effect change quantification combination long rat appearance level rapid rate multi administration short step biogenic pre inhibitor dose syndrome stable model therapeutic method predictor potential opening etiprate response hormone blockade robust bleomycin serotonin scale peripheral mechanism lung tryptophan monitor study trp dietary steady conversion pharmacodynamic total number enables,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956766/,abstract,3,telotristat faceted etiprate chlorophenylalanine bleomycin ulcerative para opening colitis steady appearance tph pharmacodynamic blockade biogenic manifest amine resultant heavy enables trp monitor lung conversion quantification peripheral fibrosis tryptophan predictor serotonin inhibitor multi half stable hormone possibility robust rat elevated obesity dose vivo step administration pre short synthesis rapid combination measurement syndrome scale hydroxylase enzyme screening state long change increase response therapeutic mechanism dietary rate life total number time model early blood potential effect method level clinical disease study,{},{},{},"{""screening"": {""freq"": 1, ""string"": [""combination measurement syndrome scale hydroxylase enzyme screening state long change increase r""]}}",{},{}
1007,1007,1091,10.1155/2016/8048170,27413257.0,tregs collagen affect inhibit macrophage enhancing regulatory significantly treg resorbed coculture marrow anti previous higher additionally mouse property thus effect data osteoclast metabolism triptolide area level although cytokine enhances upregulated many regulation therapeutic arthritis hook target potential system treatment inflammatory resorption production likely unclear differentiation explore influence bone reduced mechanism suppress destruction secretion tgf bmms immunosuppressive study rheumatoid suppressive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930824/,abstract,0,triptolide treg suppressive resorbed osteoclast enhances coculture bmms tregs tgf resorption immunosuppressive hook rheumatoid destruction upregulated collagen arthritis suppress enhancing marrow inhibit macrophage secretion cytokine bone differentiation reduced unclear anti affect inflammatory additionally production explore regulatory property previous regulation likely influence target mouse area therapeutic mechanism higher metabolism significantly potential effect data level treatment study,{},{},{},{},{},{}
1008,1008,1092,10.1186/s13059-016-1106-x,27884205.0,european backgroundblood exon african region factor among insight condition frequency pair common locus risk average regulatory disease significantly material promoter synthesis paradigm sequence supplementary quantitative strategy trait observed encodes user underlie protein minor environment degradation error inborn result six effect data novel aspartylglucosaminidase type genetic metabolism low level whole four three multi motif independent biomarkers individually discovery population variance window resultsin technology replication substantial american online article important electronic association help version materialthe mendelian rare wide variant allele ethnic analyzing influence omic analysis available also genome ranged general interaction cohort acid asparagine amino gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123402/,abstract,5,backgroundblood aspartylglucosaminidase analyzing underlie omic ranged asparagine motif minor ethnic encodes window african replication mendelian individually pair paradigm resultsin variance promoter locus american degradation substantial multi exon discovery european trait independent average allele regulatory sequence genome observed help environment insight quantitative synthesis influence biomarkers materialthe frequency wide general cohort technology interaction region inborn supplementary user version strategy variant electronic error online association rare novel material amino condition article important common low available metabolism significantly risk factor type population acid protein gene effect genetic data level analysis result disease,{},"{""genetic"": {""freq"": 1, ""string"": [""type population acid protein gene effect genetic data level analysis result d""]}}",{},"{""amino"": {""freq"": 1, ""string"": [""error online association rare novel material amino condition article important common l""]}}",{},{}
1009,1009,1093,10.1186/s40246-018-0144-8,29506557.0,disorder blood cross whether sectional factor information among autonomous affect gain pertinent positive essential adult incorporate onset choice view expert open majority doe survey autonomy ethical geneticist issue knowledge beneficial subject quantitative relative raise clinical health range burden genomic possibility thus qualitative interview data guideline genetic non interest backgroundgenomic child able critical inclusion mental conclusionour potential towards parent web participation important person valuable nevertheless emotional attitude donor wide consensus generally future legal methodsqualitative psychiatric resultsparticipants aim research disclosing informant study right disclosure incidental participant complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839067/,abstract,2,methodsqualitative disclosing backgroundgenomic informant resultsparticipants pertinent disclosure autonomous incidental autonomy incorporate conclusionour geneticist raise attitude legal participation emotional person donor gain web consensus right qualitative ethical valuable interview psychiatric choice beneficial view generally expert possibility able doe burden open affect guideline majority relative inclusion sectional mental genomic quantitative survey cross onset critical essential wide parent issue knowledge participant aim subject range complex positive future adult information non important factor blood research potential child health genetic data disorder clinical study,"{""emotional"": {""freq"": 1, ""string"": [""conclusionour geneticist raise attitude legal participation emotional person donor gain web c""]}, ""psychiatric"": {""freq"": 1, ""string"": [""consensus right qualitative ethical valuable interview psychiatric choice beneficial view generally e""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1010,1010,1094,10.1007/s11060-015-1891-1,26290144.0,blood mycn kmt single pathway neonatal germline hedgehog stringent variation common risk testing control publication hypothesis disease gli material sweden however supplementary subject childhood recent ctnnb user denmark role putative smarca support result ddx genetic eight annotating ptch significant case three ccnd myc method frequently development online article polymorphism ten key electronic associated sonic signaling finding altered version materialthe sample variant spot authorized medulloblastoma dna bonferroni available mll multiple study nucleotide correction tumor gene number statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592490/,abstract,3,ptch mycn mll ctnnb ccnd smarca myc medulloblastoma kmt hedgehog gli ddx annotating sonic stringent bonferroni denmark sweden germline altered signaling putative correction authorized tumor publication statistically nucleotide polymorphism hypothesis frequently associated dna childhood neonatal variation materialthe spot testing finding support supplementary subject user multiple version variant key electronic online pathway single recent material article role common sample number case available risk control blood significant development gene genetic method result disease study,{},"{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""multiple version variant key electronic online pathway single recent material article r""]}}",{},{},{}
1011,1011,1095,10.1017/S0954422418000173,30284526.0,summarise blood delay better physiological growth greater factor composition discus context profile fluctuation present kinetics severe supplementation improve mainstay addition hydroxylase neurological pku intake synthesis disposition however phenylalanine quantitative today therapy role protein word nitrogen body sensation possibility rhythm minimise support sequela effect assimilation ability metabolism low consideration non level circadian mimic rate utilisation normal tyrosine discovery outcome management phenylketonuria free treatment important key glycaemia year diet nearly strict mimicking likely healthy since influence aim impact paper also plasma satiety substitute acid dietary intact supplemented deficiency patient absorption amino mixture,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536823/,abstract,2,sensation glycaemia disposition assimilation summarise mimicking rhythm circadian kinetics utilisation minimise mainstay nitrogen fluctuation supplemented satiety intact sequela today mimic substitute absorption strict mixture nearly improve physiological composition consideration possibility delay word discovery neurological supplementation profile quantitative synthesis likely context free intake influence tyrosine greater ability growth paper hydroxylase discus better severe body support aim normal healthy addition plasma management key deficiency diet impact dietary therapy rate pku amino outcome non important role phenylketonuria low present metabolism phenylalanine factor blood acid protein year effect level treatment patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""important role phenylketonuria low present metabolism phenylalanine factor blood acid protein y""]}, ""neurological"": {""freq"": 1, ""string"": [""composition consideration possibility delay word discovery neurological supplementation profile quantitative synthesis l""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""diet impact dietary therapy rate pku amino outcome non important role p""]}}","{""diet"": {""freq"": 1, ""string"": [""healthy addition plasma management key deficiency diet impact dietary therapy rate p""]}}",{}
1012,1012,1096,10.3389/fmicb.2016.01666,27818654.0,experimental toruloides tool new region content rescue exhibit reporter difficult biosynthesis condition molecular capable tight egfp regulatory repressed assembly promoter transformation element however inducible rhodotorula biotechnological controllable determined mutant great genomic situation large routine lipid genetic level four rate independent transgene biomass rhodosporidium saccharomyces ctr regulation plasmid method yeast expression potential carotenoid rich robust minimal accumulating appropriate conditional repression manipulation dna deletion oleaginous basidiomycete available screened induction nar different high small vector dry gene show cerevisiae,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073140/,abstract,1,toruloides rhodosporidium oleaginous egfp ctr basidiomycete screened saccharomyces rhodotorula repressed nar controllable cerevisiae accumulating carotenoid repression inducible tight biotechnological biomass manipulation dry conditional yeast transgene plasmid rescue transformation reporter induction exhibit assembly capable situation rich promoter minimal vector biosynthesis routine lipid determined deletion element robust great mutant experimental independent difficult content regulatory appropriate genomic regulation dna small region tool expression large molecular rate condition available new potential different gene high genetic method level,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1013,1013,1097,10.1007/8904_2016_39,28130717.0,coefficient correlation disorder relationship blood record prescription synthetic micronutrient ratio energy positively density parathyroid nutrient pth percent source vitamin significantly intake medical however phenylalanine marker compliance supply partial adequate follow relative higher value synopsis protein absorptiometry sodium food enzyme consume negatively genetic formation low score metabolism sixty four three female dual spearman mineral normal overall day ass serum free ray hormone year diet particularly bmi fat age resorption ctx favorable bone younger turnover impact indicator pah plasma btm high intact dietary zinc deficiency patient uncoupled total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680279/,abstract,8,synopsis parathyroid ctx resorption btm uncoupled pth absorptiometry prescription consume turnover spearman intact dual younger supply ray mineral zinc micronutrient favorable sodium percent indicator bone positively negatively density bmi coefficient fat partial synthetic compliance adequate vitamin record hormone formation nutrient energy relative follow female source serum pah marker free intake particularly correlation ass ratio relationship overall score food enzyme normal plasma day value medical deficiency diet impact dietary total higher low metabolism significantly phenylalanine blood protein age year high genetic disorder patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""dietary total higher low metabolism significantly phenylalanine blood protein age year h""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},"{""diet"": {""freq"": 1, ""string"": [""normal plasma day value medical deficiency diet impact dietary total higher l""]}}",{}
1014,1014,1098,10.21037/atm.2018.11.68,30740399.0,iem effort condition severe common state regulatory funding ethical physician medical lethal however uniform screening resolve clinical health symptom primary error inborn metabolic symptomatic guideline term long potentially metabolism consideration mortality united panel society short agency pre morbidity independently outcome intervention review workflow identification ameliorate article manifestation recommendation help year care process every public administers professional million involved birth prior program framework federal center successful,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331354/,abstract,3,administers resolve funding federal uniform lethal agency workflow ameliorate symptomatic independently million ethical society physician united manifestation involved consideration prior successful morbidity guideline framework iem panel effort potentially center regulatory pre mortality recommendation professional help short identification public birth severe inborn symptom process screening state long program primary error medical intervention care outcome term condition article common metabolism review metabolic health year clinical,{},{},{},"{""screening"": {""freq"": 1, ""string"": [""public birth severe inborn symptom process screening state long program primary e""]}}",{},{}
1015,1015,1099,10.1371/journal.pgen.1005510,26401656.0,european correlation subsequent blood tool ratio factor pathway several laboratory adult light central additional trans common hydroxyisovalerylcarnitine locus mononuclear physiology disease shed related evidence quantitative trait chromosome form propionylcarnitine observed acylcarnitine jam putative integrative arginine error report inborn result diagnosis six thus metabolic effect data overlap novel genetic metabolism whole stearoylcarnitine functional arg strong provide point regulation method identification via expression serum replication concentration ten aspartic association modifier altered cell wide acylcarnitines mass snp causative spot determinant contributing analysis hlcs previously spectrometry also identify conclusion plasma cohort rationale study acid human powerful amino gene total metabolite gwa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581711/,abstract,1,stearoylcarnitine jam hydroxyisovalerylcarnitine hlcs gwa propionylcarnitine aspartic mononuclear contributing acylcarnitine shed overlap modifier replication rationale integrative trans altered acylcarnitines arg chromosome causative putative arginine determinant physiology powerful snp locus subsequent light identify strong european trait regulation observed central quantitative serum point spectrometry spot previously correlation wide laboratory identification provide related functional cohort additional ratio inborn form metabolite tool mass plasma expression error pathway association adult report novel concentration total evidence amino conclusion common cell metabolism human factor blood diagnosis acid metabolic gene effect genetic method data analysis result disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""blood diagnosis acid metabolic gene effect genetic method data analysis result d""]}}","{""pathway"": {""freq"": 1, ""string"": [""metabolite tool mass plasma expression error pathway association adult report novel c""]}}","{""amino"": {""freq"": 1, ""string"": [""adult report novel concentration total evidence amino conclusion common cell metabolism h""]}, ""spectrometry"": {""freq"": 1, ""string"": [""regulation observed central quantitative serum point spectrometry spot previously correlation wide l""]}}",{},{}
1016,1016,1100,10.1038/s41598-017-09247-5,28851938.0,notably tool record hour region additional subsequently parallel average inadequate control conjunction disease enough however clinical putative primary thus purpose data generation novel genetic node mutation step advice local database method causal supercomputer correct technology parent discover feasibility doctor rare computation public fulfilling variant screen appropriate megabase next analysis study insufficient sequencing patient participant gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574920/,abstract,5,supercomputer megabase fulfilling node computation doctor discover advice inadequate notably conjunction putative insufficient causal subsequently feasibility correct parallel hour screen record local average step appropriate generation purpose sequencing database parent additional public technology region participant tool primary variant rare novel mutation control gene genetic method data clinical analysis patient disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""variant rare novel mutation control gene genetic method data clinical analysis p""]}}",{},{},{},{}
1017,1017,1101,10.1016/j.jmau.2016.02.002,30023217.0,various pathogenesis epidemiological lead new factor nutrition essential world adult throughout nutrient variation state highlight contributes fact nutrigenomics concept disease intake emergence interplay account knowledge cancer evidence much role health play instability science support recognizable cause predominant genetic mortality variable morbidity vital management work development expression polymorphism alteration response proportion key help characterizes variant relation especially nutrigenetics differential basic environmental aim mechanism also aberrant high methylation turn dietary gene individual total complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014201/,abstract,0,recognizable characterizes instability nutrigenetics aberrant nutrigenomics methylation interplay emergence contributes turn predominant fact vital epidemiological pathogenesis differential basic nutrient proportion relation polymorphism morbidity concept nutrition account world alteration play science mortality help variable cancer work lead variation environmental intake especially highlight essential knowledge various support aim state management expression complex cause variant key response adult mechanism dietary total evidence role individual new factor development health gene high genetic disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1018,1018,1103,10.3389/fnut.2019.00041,31024923.0,major various biological shift factor discus nutrition time present complexity nutrient molecular due moreover tight well way finally influential disease era understanding channel relevant ever strategy hacking perspective clinical health clinically define body science thus conceptual personalize data deeply generation ongoing metabolism medicine whole functional internal communication update external dynamic current ultimate intervention omics maintenance model work translational functionality potential system technology interdisciplinary holistic landscape recommendation important key precision network readout systematic unveil interface hence future application relation scale space field throughput goal path basic analysis actionability metabolomics importance also nutritional different interaction high practice study connection healthcare highly metabolite intrinsic enables,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465639/,abstract,0,unveil hacking actionability personalize readout tight interdisciplinary ultimate deeply conceptual intrinsic influential functionality enables space holistic external channel define connection landscape update throughput path omics ongoing interface era shift maintenance translational internal complexity dynamic basic precision communication nutrient relation goal metabolomics nutrition healthcare perspective network science systematic clinically way recommendation finally work understanding nutritional generation practice highly biological relevant medicine importance scale functional technology discus field interaction various body metabolite application major strategy key future molecular intervention current important present metabolism time model factor potential different health high data clinical analysis disease study,{},{},{},{},{},{}
1019,1019,1104,10.3389/fpsyg.2019.01602,31428005.0,mindful resilience self pain compassion context adult highlight practical crucially perhaps finally objective third family childhood adaptive therapy support recently conceptual design theory first stress case direction contemplative outline child intervention population review approach model mental work development illness parent second mindfulness parental response promise future facing professional application adaptation chronic impact paper framework research modality building cmbis burnout successful healthcare caregiver,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690403/,abstract,0,mindfulness mindful facing crucially contemplative compassion cmbis burnout building conceptual resilience outline modality adaptation theory direction illness pain adaptive promise caregiver practical parental successful framework healthcare mental professional finally stress childhood second work recently self context chronic highlight parent design paper support application objective response future adult family impact intervention therapy approach case model research population review child development,{},{},{},{},{},{}
1020,1020,1106,10.1128/AEM.00573-15,25934616.0,male decarboxylase specific pathway aggressive essential present adult reproductive behavior biosynthesis insect host chemical control well competition significantly transcriptional initiation quantitative observed role fly brain critically neurotransmitter octopamine bacteria melanogaster effect ability olfaction level alter infection tyrosine somatic many able system mate wolbachia important aggression best uninfected cell drosophila two determine influence approximately analysis head also tissue though tyramine gene total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551182/,abstract,0,wolbachia uninfected olfaction octopamine mate competition tyramine insect melanogaster aggression fly decarboxylase aggressive somatic drosophila critically initiation alter host reproductive head transcriptional bacteria biosynthesis neurotransmitter chemical able infection approximately best observed quantitative behavior tissue influence tyrosine essential ability determine male pathway brain adult total important role cell present significantly specific control gene effect level analysis,{},{},"{""pathway"": {""freq"": 1, ""string"": [""influence tyrosine essential ability determine male pathway brain adult total important r""]}}",{},{},{}
1021,1021,1107,10.1007/s10545-015-9881-1,26209272.0,specific self iem representative twelve uncertainty consent voice need view sub iems state methodswe experience increase transition disease contribute struggle family life health resultswe error support inborn positioned qualitative interview backgroundpatient data metabolism united theme three provider canada child outcome intervention descriptive approach toward september kingdom parent important key associated care challenge rare navigate frame within progress collective conclusionhealth uniquely community organizational explore category voluntarily priority research group patient february participant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710640/,abstract,3,voluntarily positioned navigate conclusionhealth backgroundpatient voice struggle organizational frame kingdom uniquely february collective canada september uncertainty consent representative iems sub priority resultswe theme descriptive transition provider qualitative progress contribute interview united view category iem explore community methodswe associated experience self parent need participant inborn support state challenge increase key error rare family intervention care life outcome important approach metabolism specific research child health group data patient disease,{},{},{},{},{},{}
1022,1022,1108,10.1002/jat.3476,28589558.0,major component biological future nanoparticles rapid accumulate unique application recent composition accordingly molecule drug clinical field health site concern suggestion device molecular body therapeutic widely image physical also trial biosafety work development nanomedicine chemical potential property nanomaterials risk biosensors morphology implant study article human research delivery nanotechnology well finally year agent gene nanoelectronic medicine complex medical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506719/,abstract,0,nanoelectronic biosafety nanomedicine implant nanotechnology nanomaterials nanoparticles biosensors accumulate suggestion image morphology accordingly device composition chemical agent widely unique molecule concern property delivery component finally physical work site rapid biological medicine field body application trial major complex drug therapeutic medical future molecular recent article human risk research potential development health gene year clinical study,{},{},{},{},{},{}
1023,1023,1109,10.3389/fneur.2017.00254,28634468.0,although disorder decade however understanding autism discus prevalence several country syndrome clinical always field many population basic gap review monogenic research science relatively china common prevention intellectual disability facilitate large fragile treatment cause fxs little underdiagnosed patient disease even potentially western chinese indeed number spectrum,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459883/,abstract,0,underdiagnosed fxs fragile western monogenic gap chinese facilitate china basic little relatively decade science intellectual potentially autism understanding disability prevention syndrome prevalence discus field spectrum country cause large common number research population review disorder treatment clinical patient disease,"{""intellectual"": {""freq"": 1, ""string"": [""china basic little relatively decade science intellectual potentially autism understanding disability p""]}}",{},{},{},{},{}
1024,1024,1110,10.1007/8904_2017_63,29030855.0,male european dos almost lower adult concern tetrahydrobiopterin effective clinician well increase pku responsive phe life dosage therapy range mol improvement genotype report mild term adherence long young level significant case four surveillance female pre dose responsiveness irish day tolerance treatment recommendation response year age newborn sapropterin adolescent quality currently dietary patient,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121967/,abstract,16,irish responsiveness dosage surveillance sapropterin dos tolerance responsive young adherence clinician mol mild adolescent european tetrahydrobiopterin dose genotype concern pre recommendation female improvement currently male phe long day range increase response quality effective lower adult report dietary therapy life newborn pku term case age significant year level treatment patient,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""lower adult report dietary therapy life newborn pku term case age s""]}}",{},{}
1025,1025,1111,10.1187/cbe.15-04-0101,27909030.0,passive training college biological decade workshop activity faculty example one class new transform content mathematics time engineering student outcome instructional overwhelmed teacher approach lecture efficient paper science task manner popular biggest classroom support backward instruction curriculum cycle technology part study course effective instrumental barrier design active help even material engaging instructor learning,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132379/,abstract,0,transform overwhelmed mathematics instructor engaging classroom faculty lecture instructional curriculum biggest instrumental backward teacher instruction workshop passive popular college learning engineering training student manner class course barrier efficient task decade cycle active science content help example biological design paper technology support effective activity material outcome approach time new study,{},{},{},{},{},{}
1026,1026,1112,10.1093/hmg/ddu607,25489051.0,correlation specific cross benign cystic difficult positive binding algorithm additional missense variation continuous risk testing algorithmic severity validation classifier finally disease significantly spectrum sweat measurement relevant quantitative rather trait value clinical health garbage clinically transmembrane error fibrosis six stratify furthermore novel genetic eight useful seven four functional three measure cftr prediction able population work causal prone labeling binary potential important assay promising challenge regulator within two variant negative problematic explore category differential impact discrete framework also diagnostics phenomenon often nucleotide human blind arrangement patient though chloride accuracy conductance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366609/,abstract,2,garbage stratify labeling classifier algorithmic discrete sweat problematic conductance chloride cftr binary transmembrane arrangement prone binding benign phenomenon diagnostics cystic causal regulator algorithm promising fibrosis blind continuous differential validation prediction missense category able seven nucleotide framework trait severity accuracy explore difficult useful clinically finally quantitative work assay negative cross variation furthermore measurement correlation relevant functional additional testing spectrum measure challenge positive value variant error impact novel important significantly human risk specific population potential health genetic clinical patient disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1027,1027,1113,10.3390/ijms18071384,28671587.0,refractoriness specific disorder delay dominant greater discus pathway across amenable present behavioral condition share investigate clinician finally biochemical treatable seizure life anti clinical developmental feature focus error inborn diagnosis enzyme metabolic effect cause term metabolism span regression drug outcome recognition intervention critical review approach management frequently propose epileptic epilepsy treatment tiered rare morbid hence primarily appropriate timely since systematically impairment intellectual often deficiency patient treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535877/,abstract,0,tiered refractoriness morbid epileptic amenable span timely epilepsy share dominant systematically recognition treatable primarily seizure propose treat delay clinician anti frequently behavioral intellectual appropriate finally regression focus feature impairment critical investigate developmental greater biochemical discus inborn enzyme management cause drug error pathway deficiency rare intervention life outcome term condition approach present metabolism specific diagnosis review metabolic effect disorder treatment clinical patient,"{""intellectual"": {""freq"": 1, ""string"": [""treat delay clinician anti frequently behavioral intellectual appropriate finally regression focus f""]}, ""behavioral"": {""freq"": 1, ""string"": [""propose treat delay clinician anti frequently behavioral intellectual appropriate finally regression f""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""inborn enzyme management cause drug error pathway deficiency rare intervention life o""]}}",{},{},{}
1028,1028,1114,10.1186/s12913-015-0890-4,26041470.0,registry contributor clinic whether ratio arcgis difference mechanical time median embolic native travel geographical average ttr disease road shorter amongst respectively town backgroundlack verified distance coordinate spatial achievement range home shortest replacement global rhd result rheumatic observational fraction versus adherence international mapping significant conclusionsthere interpolation three one methodsresidential map database inr population maintenance therapeutic method residence association address valve component monitoring within resided cardio heart google resultsrhd warfarin remedy longer cape reading study patient linear complication,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456049/,abstract,1,valve shortest road rhd resultsrhd residence resided methodsresidential interpolation inr embolic cape backgroundlack arcgis warfarin ttr travel town coordinate verified rheumatic remedy mechanical google conclusionsthere cardio shorter contributor reading geographical distance achievement mapping native map spatial registry maintenance longer home replacement observational fraction versus adherence monitoring complication linear international average address clinic heart median global component database ratio range therapeutic association respectively difference time population significant method result patient disease study,{},{},{},{},{},{}
1029,1029,1115,10.1371/journal.pone.0127294,26043082.0,male italy phalanx self difference lower boy student amplitude aged weight thin status respectively subject normative quantitative igea higher value sound color data reference percentile equipment chart score carpus female independent measure normal child evaluation method predictor sex year sonic age monitoring sample methodsthe obese adolescent bone dependent height speed resultsgirls qus group aimsto dbm skin ultrasound derive brazilian parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456168/,abstract,4,resultsgirls igea dbm carpus qus aimsto sonic phalanx sound derive normative chart amplitude equipment color percentile italy ultrasound speed brazilian obese height student bone skin boy methodsthe predictor sex monitoring reference adolescent independent parameter aged dependent female quantitative weight self evaluation male status score measure normal subject value lower respectively higher difference sample child age group year method data,"{""skin"": {""freq"": 1, ""string"": [""speed brazilian obese height student bone skin boy methodsthe predictor sex m""]}}",{},{},{},{},{}
1030,1030,1116,10.5414/CP203097,29350176.0,nicorette maximal hour ratio single maximum profile time adult half median behavior open mean well way increase cmax objective significantly material bioequivalence prototype life interval geometric lozenge therapy replacement probability globally data reference versus furthermore crossover secondarily confidence although four rate three tobacco label dose cessation product method constant predictor nicotine pharmacokinetic concentration test auc safety iii kel bioequivalent dissolution locally india healthy comparison firm smoker elimination longer vitro keywords conclusion plasma study nrt extent center absorption performance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822134/,abstract,0,nrt nicorette lozenge kel dissolution bioequivalent bioequivalence geometric firm cmax tobacco smoker secondarily nicotine prototype locally cessation maximal label india globally pharmacokinetic constant auc maximum elimination probability absorption crossover longer iii replacement predictor hour versus half extent keywords confidence safety open reference interval dose vitro center way median profile mean comparison behavior furthermore product ratio performance healthy objective plasma increase single adult therapy rate life concentration material conclusion test time significantly method data study,{},{},{},{},{},{}
1031,1031,1117,10.1074/jbc.M115.709998,26823465.0,specific full activity phenylalanine two variant mutation monomer spectroscopy per pheh side isotopically location protein site allosteric consistent act residue dimer liver five rdpheh affinity nmr result six enzyme domain concentration regulatory isolated basis intact activation interface hydroxylase ability rat stabilize formation intermolecular unlabeled incorporation presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817173/,abstract,0,rdpheh intermolecular unlabeled pheh isotopically stabilize intact incorporation dimer allosteric monomer location isolated affinity nmr interface residue spectroscopy act activation formation rat domain regulatory basis consistent site liver presence ability hydroxylase enzyme variant concentration activity mutation phenylalanine specific protein result,"{""phenylalanine"": {""freq"": 2, ""string"": []}}",{},{},{},{},{}
1032,1032,1118,10.1016/j.ajhg.2017.01.002,28132689.0,dramatic delay disorder activity preventable harbor hydroxytryptophan early exhibit heat progressive uncertainty positive undetectable unrelated without affected tetrahydrobiopterin onset additional wes dopa pku hydroxylase respectively treatable beneficial phenylalanine family unique neurodevelopmental screening dopamine resolve encodes biallelic symptom error neurotransmitter report fibroblast inborn result diagnosis six thus enzyme effect metabolism hpa whole four mutation member one tyrosine child dnajc phenylketonuria dystonia exome disability shock treatment proportion newborn hyperphenylalaninemia serotonin chaperone differential hydroxylases precursor tryptophan pah prevention intellectual small deficiency conversion gene individual presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294665/,abstract,0,hydroxytryptophan undetectable wes shock hydroxylases harbor dnajc biallelic dramatic resolve preventable heat dopa encodes dystonia uncertainty chaperone fibroblast conversion unrelated exhibit hpa treatable progressive tryptophan serotonin differential neurotransmitter exome beneficial affected hyperphenylalaninemia neurodevelopmental delay precursor member proportion dopamine unique tetrahydrobiopterin intellectual pah onset disability presence prevention tyrosine hydroxylase additional small inborn symptom enzyme screening positive error deficiency report family respectively newborn activity mutation pku phenylketonuria metabolism individual early phenylalanine diagnosis child gene effect disorder treatment result,"{""phenylalanine"": {""freq"": 2, ""string"": [""mutation pku phenylketonuria metabolism individual early phenylalanine diagnosis child gene effect d""]}, ""intellectual"": {""freq"": 1, ""string"": [""precursor member proportion dopamine unique tetrahydrobiopterin intellectual pah onset disability presence p""]}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""positive error deficiency report family respectively newborn activity mutation pku phenylketonuria m""]}, ""screening"": {""freq"": 1, ""string"": [""hydroxylase additional small inborn symptom enzyme screening positive error deficiency report f""]}}",{},{}
1033,1033,1119,10.1186/s13044-015-0017-3,25908941.0,iodothyronine dyshormonogenesis disorder everyday abnormality lead tbp factor early among congenital defect laboratory gland neonatal tuberculosis affected frequency hyperthyroidism neoplastic adenoma disease gestational hypothalamic gnas infectious dysgenesis cancer understanding organ thrb thra defective clinical role protein psychomotor play albumin usually secondary transmembrane diagnosis transport sarcoidosis like recently trophoblastic cause term receptor genetic metabolism non unchanged case commonly although mutation per euthyroidism normal sensitivity vital endocrinologist many frequently development frequent thyroid concentration test free treatment alteration person key hormone tshr process rare inflammatory still transient progress pituitary primarily rth hypothyroidism differential function classified resistance relatively importance also different practice high tissue study entity limitation etiopathogenesis rarely gene affinity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407423/,abstract,1,tshr thrb thra tbp sarcoidosis rth hyperthyroidism gnas euthyroidism endocrinologist tuberculosis trophoblastic iodothyronine neoplastic etiopathogenesis dyshormonogenesis everyday dysgenesis adenoma hypothalamic transmembrane psychomotor pituitary defective albumin unchanged gland rarely affinity entity classified vital transient thyroid person usually infectious hypothyroidism transport gestational progress resistance primarily differential commonly organ affected hormone frequent receptor limitation relatively inflammatory frequently alteration play secondary cancer abnormality understanding recently sensitivity neonatal lead free tissue practice defect frequency laboratory congenital importance like process normal cause key rare concentration mutation term non role function case metabolism test early factor diagnosis different protein development gene high genetic disorder treatment clinical disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""diagnosis different protein development gene high genetic disorder treatment clinical disease s""]}}",{},{},{},{}
1034,1034,1120,10.3390/ijns3040034,29376140.0,staff new affect congenital time several present substantially summarizes prompt state usd effective well disease doe instrumentation pulse account element however life reduction previous perspective health crisis china effectiveness diagnosis six low united cchd mandatory death assumption per department child critical review used kingdom treatment year education care oximetry likely estimate heart analysis previously program available infant monitor larger prevention policy conservative consumables study critique healthcare newly number sector,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784211/,abstract,0,consumables instrumentation critique conservative cchd sector oximetry usd staff kingdom summarizes prompt mandatory crisis assumption substantially pulse monitor newly department used element united china larger doe affect account healthcare education perspective death estimate effectiveness heart policy previous reduction likely critical prevention previously congenital infant state program effective care life low number present available time new diagnosis review child health year treatment analysis disease study,{},{},{},{},{},{}
1035,1035,1121,10.1371/journal.pcbi.1004374,26340370.0,sequence specific generally although pathophysiological degeneration still mutation cellular cancer one neutral organ better dysregulations broader unclear aggregation toxic disorder involved function protein inflammation burden homeostasis mechanism silico impact therefore molecular biophysical mutant additional propensity pathology disruption consequence variation potential multifactorial often diverse toxicity human overt addition immune increase disease survey significantly beyond potentially aggregate hallmark parameter statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560525/,abstract,1,dysregulations overt biophysical propensity multifactorial silico hallmark degeneration broader pathophysiological disruption aggregate aggregation toxicity neutral toxic inflammation pathology organ generally involved homeostasis diverse immune statistically unclear burden mutant cellular potentially parameter sequence consequence survey cancer variation additional better addition increase molecular mechanism impact mutation function significantly human specific potential protein disorder disease,{},{},{},{},{},{}
1036,1036,1122,10.1186/s12874-016-0120-8,26846420.0,epidemiologic logistic conclusionparental blood availability hispanic absolute new ratio difference factor information york among consent odds slightly preterm chemical percent biomarker varied evaluate month significantly status ventilator longitudinal punch circle utility however retrieval certificate obesity demonstrating postpartum comparable report purpose quantification pregnancy borderline ability singleton non regression use significant full ethnicity one least parity volume cytokine infection child population kid development twin potential exposure sufficient parent resource mother delivery parental proportion association year city feasibility particularly maternal age sample two multivariate newborn spot birth residual analysis environmental characteristic research available infant identify group cohort part high study successfully alcohol small successful county upstate,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741027/,abstract,8,ventilator upstate conclusionparental retrieval york punch kid hispanic certificate borderline postpartum parity county circle twin singleton epidemiologic absolute ethnicity consent alcohol percent demonstrating cytokine slightly multivariate city odds residual quantification preterm varied feasibility logistic successfully comparable parental sufficient biomarker longitudinal identify chemical proportion availability successful mother utility volume obesity infection resource pregnancy evaluate delivery maternal regression exposure purpose environmental particularly spot ability parent cohort characteristic ratio birth small status month infant association use report information newborn non difference sample available significantly new factor blood research population potential child age significant development group year high analysis study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""month infant association use report information newborn non difference sample available s""]}}",{},{}
1037,1037,1123,10.1590/1678-4685-GMB-2018-0105,30985856.0,specific considerable disorder blood early present acidurias deleterious organic iems clear disease geneticist treatable pediatrician life reduction protein error report inborn analytical diagnosis transport enzyme metabolic effect symptomatic data promptly urine tandem potentially metabolism mortality detection service case mutation crucial morbidity possibly reverse technique stage gas loss frequent treatment important help phase acidemia cell future sample mass aminoacidopathies newborn spot since function analysis aware spectrometry available program group high acid patient amino gene individual performance number chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687352/,abstract,3,promptly aminoacidopathies pediatrician acidurias aware reverse geneticist deleterious possibly iems acidemia symptomatic treatable transport crucial gas clear considerable organic analytical frequent tandem morbidity urine chromatography potentially phase stage mortality service help loss reduction spectrometry spot technique performance detection inborn enzyme mass program error future report life newborn mutation amino important cell function sample number present case available metabolism individual early specific blood diagnosis acid protein metabolic gene group effect high data disorder treatment analysis patient disease,"{""urine"": {""freq"": 1, ""string"": [""considerable organic analytical frequent tandem morbidity urine chromatography potentially phase stage m""]}}",{},{},"{""detection"": {""freq"": 1, ""string"": [""loss reduction spectrometry spot technique performance detection inborn enzyme mass program e""]}, ""amino"": {""freq"": 1, ""string"": [""error future report life newborn mutation amino important cell function sample n""]}, ""tandem"": {""freq"": 1, ""string"": [""gas clear considerable organic analytical frequent tandem morbidity urine chromatography potentially p""]}, ""spectrometry"": {""freq"": 1, ""string"": [""stage mortality service help loss reduction spectrometry spot technique performance detection i""]}, ""newborn"": {""freq"": 1, ""string"": [""mass program error future report life newborn mutation amino important cell f""]}}",{},{}
1038,1038,1124,10.1016/j.trsl.2017.12.002,29291380.0,tool investigation new hepatorenal pathway among gfr signature hydroxyphenyl prognostic liquid insight trans mechanistic average biomarker race glomerular severity preliminary disease significantly subject unique dysfunction aconitate clinical value protein fold candidate encounter recently metabolic purpose change tandem potentially metabolism low mortality ultrahigh non erythronate significant rate three concomitantly one independent carbamoylthreonyladenosine death biomarkers clearance lactate provide liver therapeutic important association discover hundred stronger iothalamate age mass application acetamidobutanoate demographic invasive spectrometry transplantation metabolomic filtration plasma high ascorbate last study methylation ureidopropionate cirrhosis aldarate glucuronidation powerful even highest square performance metabolite kidney gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037419/,abstract,3,ureidopropionate iothalamate gfr erythronate carbamoylthreonyladenosine aldarate aconitate acetamidobutanoate ultrahigh hepatorenal glucuronidation concomitantly hydroxyphenyl glomerular cirrhosis ascorbate filtration encounter prognostic discover race methylation lactate clearance preliminary signature trans stronger metabolomic square powerful kidney demographic transplantation mechanistic invasive biomarker gender candidate fold highest tandem severity unique liquid independent average death potentially mortality investigation insight recently liver dysfunction purpose spectrometry biomarkers provide performance metabolite tool application mass subject plasma change value therapeutic pathway association rate non important low metabolism significantly new protein age significant metabolic high clinical disease study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""mass subject plasma change value therapeutic pathway association rate non important l""]}}","{""tandem"": {""freq"": 1, ""string"": [""invasive biomarker gender candidate fold highest tandem severity unique liquid independent a""]}, ""spectrometry"": {""freq"": 1, ""string"": [""investigation insight recently liver dysfunction purpose spectrometry biomarkers provide performance metabolite t""]}}",{},{}
1039,1039,1125,10.1007/s11064-017-2288-7,28508995.0,subsequent considerable disorder chain memory better growth energy glutamate oxidative adult neonatal central condition additional traumatic derivative improve number glutamine disease status alcar evidence protection recent oxidation acetylcholine therapy ischemia brain coas acyl degradation error inborn transport metabolic decrease term long lipid rat neuroprotection metabolism stress administration functional interest compelling death hypoxia preclinical provide prevent outcome many model therapeutic alzheimer moiety acetyl potential system pup ameliorate treatment fatty year cell urgent pediatric peripheral explore function nervous imbalance precursor gaba study carnitine myelination injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621476/,abstract,0,coas alcar pup neuroprotection acetylcholine ischemia traumatic moiety compelling urgent hypoxia gaba myelination imbalance glutamine acetyl carnitine derivative glutamate ameliorate preclinical acyl protection oxidation injury alzheimer peripheral transport subsequent lipid degradation nervous considerable oxidative improve precursor memory rat energy fatty explore prevent death administration decrease pediatric central stress neonatal chain growth provide functional additional status better inborn long error therapeutic brain adult recent therapy evidence outcome term condition cell function number metabolism model potential metabolic year disorder treatment disease study,{},{},{},{},{},{}
1040,1040,1126,10.1186/s13023-016-0522-z,28100251.0,decarboxylase disorder delay lead representative early autosomal world laboratory awareness onset severe aromatic improve practical disease material medical supplementary norepinephrine life evidence identified dopamine user clinical aadcd developmental crisis intd symptom hypotonia neurotransmitter methodology movement diagnosis guideline furthermore international non imaging sign around dystonia face combined online hypokinesia article topic treatment recommendation key electronic care version neurometabolic rare consensus oculogyric serotonin recessive epinephrine definitive whilst limited autonomic electroencephalograpy research available general group grade acid deficiency patient amino,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241937/,abstract,0,oculogyric intd electroencephalograpy aadcd hypokinesia identified epinephrine autonomic decarboxylase neurometabolic hypotonia norepinephrine combined dystonia whilst definitive crisis representative grade topic face imaging awareness sign movement consensus aromatic practical serotonin neurotransmitter improve methodology delay recessive dopamine guideline world international autosomal recommendation limited lead onset furthermore developmental laboratory general severe symptom supplementary user version key electronic online medical deficiency rare care life evidence material amino non article available early diagnosis research acid group disorder treatment clinical patient disease,{},"{""autosomal"": {""freq"": 1, ""string"": [""delay recessive dopamine guideline world international autosomal recommendation limited lead onset f""]}, ""recessive"": {""freq"": 1, ""string"": [""practical serotonin neurotransmitter improve methodology delay recessive dopamine guideline world international a""]}}",{},"{""amino"": {""freq"": 1, ""string"": [""deficiency rare care life evidence material amino non article available early d""]}}",{},{}
1041,1041,1127,10.1186/s12883-017-0875-5,28545419.0,resonance male various major prisma nine mers search ratio difference item adult selection symmetrical condition onset retention literature common methodswe resultstwenty old lesion experience clinician varied urinary well virus month disease spectrum reversible matter however splenial retension sometimes clinical feature science report bacteria radiological cause guideline backgroundmild completely case female imaging acute pathophysiologiccal white infection database child many march review japan headache web manifestation callosum reporting year asia systematic process rare age within order clinico especially analysis mechanism corpus encephalopathy characteristic available relatively broad januarary also fever magnetic entity meta similar patient encephalitis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445341/,abstract,4,splenial retension pathophysiologiccal mers januarary clinico backgroundmild prisma encephalitis symmetrical asia resultstwenty radiological headache fever march japan encephalopathy callosum reversible retention corpus reporting lesion item entity imaging web varied completely bacteria broad resonance virus urinary manifestation matter meta clinician white magnetic guideline relatively infection selection science search acute methodswe systematic experience female old feature onset especially database male characteristic ratio order spectrum similar literature various process month major cause adult mechanism report rare condition difference common case available review child age year clinical analysis patient disease,{},{},{},{},{},{}
1042,1042,1128,,28149263.0,specific blood search discus information affect time across several selection researcher initial together comparability clinician addition conjunction measurement interval introduction broadly clinical value extensively word neonate spectrometric equivalent analytical result hand reference conclusionsdbs language quantification experiment enthusiastic consideration english non period establishment bridge independent measure pre likewise rule current drug sensitivity overall database methodsto review technique analyst method therapeutic post potential face serum online introductionthrough key limit medline address challenge bring process monitoring sample two mass newborn adjustment application spot scope manual resultsas throughput advanced become reproducibility criterion analysis matrix spectrometry keywords facet plasma presentation human advantage accuracy individual total parameter toxicological,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282914/,abstract,1,introductionthrough conclusionsdbs resultsas facet enthusiastic comparability analyst toxicological bring methodsto bridge likewise spectrometric manual rule establishment english scope adjustment throughput reproducibility extensively conjunction broadly hand neonate advanced matrix face quantification medline equivalent experiment language researcher introduction keywords limit consideration monitoring initial analytical advantage presentation clinician word affect reference interval accuracy post independent selection search address parameter pre serum sensitivity criterion measurement spectrometry database spot technique period discus overall process measure application addition mass plasma challenge drug value key online therapeutic information total newborn current non sample individual time human specific blood review potential method clinical analysis result,{},{},{},"{""spectrometry"": {""freq"": 1, ""string"": [""parameter pre serum sensitivity criterion measurement spectrometry database spot technique period d""]}, ""newborn"": {""freq"": 1, ""string"": [""value key online therapeutic information total newborn current non sample individual t""]}}",{},{}
1043,1043,1129,10.1177/2049936119851464,31205689.0,blood tool assessment cure campaign lower country largely laboratory characterization leukaemia sub saharan control well virus close respectively medical htlv however recent follow clinical therapy virological ghana genotype result diagnosis large good absent specimen facility predominant type seroprevalence hepatitis area rate infection hbv subtype vaccine hiv population rural method identification unaware helpful people potential frequent success resource overt treatment viral encourage cell consecutive occult universal advance variant spot prevalence retrovirus especially chronic dependent noteworthy transporting either background conclusion reliably high whereas crf human antiviral confirms total number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535694/,abstract,3,virological seroprevalence retrovirus occult leukaemia ghana encourage crf campaign unaware transporting htlv confirms noteworthy saharan vaccine subtype overt antiviral hbv facility cure absent helpful reliably hiv hepatitis consecutive predominant specimen rural sub viral close universal characterization success virus largely frequent people infection genotype resource advance follow good dependent chronic especially spot laboratory identification prevalence country assessment background area tool variant medical large lower recent respectively therapy rate total conclusion cell number human control blood type diagnosis population potential high method treatment clinical result,{},{},{},{},{},{}
1044,1044,1130,10.1002/14651858.CD012069.pub2,29744873.0,edition intelligence disorder cross tool pain search sectional lead ratio time several author methylphenidate selection psycinfo cinahl serious aged without bias central actual additional due must capacity common responder deficit adhd difficulty risk control severity true formulation well increase disease objectivesto register lethal criteriawe committee life evidence event interval pharmaceutical childhood dosage neurodevelopmental moderate possible follow rating analytic higher clinical range resultswe sleep secondary symptom primary robin report diagnosis certainty effect large data reference psychostimulant arrhythmia versus quotient favourable asleep susceptible medication low international non period qualitatively confidence analysisfourteen theinternational comorbid least main conclusionsour independently normal problem drug sensitivity database child intervention point comparative review critical abdominal reason mental frequently ass people headache unknown backgroundattention treatment collection harmonization proportion insomnia association important associated year medline finding list systematic methodsin age psychotic two company along january prevalence estimate scale accordingly manual conducted appetite statistical subgroup adolescent embase series magnitude quality adverse analysis benefit also trial rcts withdrawal group grade diagnostic intellectual different cohort high classification often heterogeneity outcomesin meta hyperactivity patient accurately another total number treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494554/,abstract,38,theinternational robin psychostimulant outcomesin arrhythmia analysisfourteen qualitatively psychotic methylphenidate insomnia harmonization criteriawe backgroundattention asleep rcts psycinfo favourable certainty withdrawal quotient company analytic susceptible headache appetite manual conclusionsour lethal edition comorbid responder actual register objectivesto cinahl abdominal magnitude dosage conducted comparative sleep intelligence accurately adhd true formulation committee rating methodsin grade accordingly pain series reason embase subgroup resultswe medline independently january hyperactivity bias pharmaceutical list classification author versus medication capacity meta neurodevelopmental confidence treat difficulty people proportion moderate reference heterogeneity event adolescent severity interval frequently statistical selection international search systematic sectional secondary intellectual estimate associated unknown follow mental collection aged adverse central childhood deficit sensitivity cross lead critical point database ass problem scale cohort benefit prevalence additional period main ratio diagnostic finding possible symptom tool normal trial range primary drug increase quality large association report intervention life total evidence higher non important common low number time risk control diagnosis review child different age group year effect high data disorder treatment clinical analysis patient disease,"{""hyperactivity"": {""freq"": 1, ""string"": [""embase subgroup resultswe medline independently january hyperactivity bias pharmaceutical list classification a""]}, ""intellectual"": {""freq"": 1, ""string"": [""selection international search systematic sectional secondary intellectual estimate associated unknown follow m""]}}","{""heterogeneity"": {""freq"": 1, ""string"": [""treat difficulty people proportion moderate reference heterogeneity event adolescent severity interval f""]}}",{},{},{},{}
1045,1045,1131,10.1038/srep20681,26864449.0,pathogenesis correlation disorder exon delay encoding difference early progressive insight dominantly molecular together pair state constraint old neurodegenerative motor control differentially repeat disease doe wise hyper quantitative cag therapy role play presymptomatic cerebellum symptom rhythm metabolic expansion change furthermore circadian wild one progression huntington abundant strong ovt critical comparative liver model abundance evident disruption gas consequently overt alteration fatty year phase devastating specificity transgenic within mass htt sheep characteristic spectrometry cortex tissue study acid human predominantly hippocampus amino metabolite chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749952/,abstract,2,wise sheep ovt htt dominantly cag rhythm presymptomatic hyper circadian huntington constraint cerebellum overt devastating transgenic abundant comparative hippocampus disruption pair differentially cortex repeat predominantly abundance expansion encoding evident progressive neurodegenerative pathogenesis consequently gas exon progression wild delay doe strong motor alteration play fatty chromatography specificity phase insight quantitative old liver critical furthermore tissue spectrometry correlation characteristic symptom metabolite state mass change molecular therapy amino role difference human model early control acid metabolic year disorder disease study,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""metabolite state mass change molecular therapy amino role difference human model e""]}, ""spectrometry"": {""freq"": 1, ""string"": [""quantitative old liver critical furthermore tissue spectrometry correlation characteristic symptom metabolite s""]}}",{},{}
1046,1046,1132,10.1136/medethics-2014-102126,26139851.0,service differently subsequent traditionally public cross solidarity two activity involvement new relation raise database field health dna citizen aspect reflection inclusion paper flow conceptualisation research framework separate trust biobanks debate criminal system forensic often participation domain boundary concept question justice forensics engagement genetic ethical consideration medicine issue legitimisation medical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621370/,abstract,0,solidarity legitimisation criminal forensic conceptualisation justice forensics biobanks differently trust traditionally reflection citizen boundary engagement raise debate participation flow ethical involvement subsequent separate consideration question relation framework concept aspect inclusion domain service dna cross database medicine paper issue public field medical activity new research health genetic,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1047,1047,1133,10.1002/mgg3.610,30829006.0,conclusionthe rise estimation probable tetrahydrobiopterin partially frequency due resultsa severe responder common vary discordance heterozygosis doe hydroxylase pku responsive biopku phe spectrum methodsphenotype subset phenylalanine moderate form observed value tentative compound pretreatment genotype result like metabolic mild combination low level although rate mutation measure phenotype prediction database responsiveness backgroundgenetic phenylketonuria overloading rio potential system test tolerance resource arbitrary treatment important genotyping association inconsistency brazil erratic hyperphenylalaninemia genotypic especially standard janeiro previously concordance also classic high study heterogeneity dietary overload deficiency patient cofactor total parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503030/,abstract,2,overloading methodsphenotype heterozygosis erratic biopku tentative rio janeiro discordance backgroundgenetic pretreatment genotyping arbitrary overload genotypic vary rise probable responsiveness responder inconsistency concordance estimation resultsa brazil partially tolerance responsive subset conclusionthe classic prediction hyperphenylalaninemia cofactor doe moderate mild heterogeneity tetrahydrobiopterin genotype resource parameter observed compound combination especially database previously frequency like hydroxylase phenotype spectrum standard severe form measure phe value association deficiency dietary rate total mutation pku important common phenylketonuria low test phenylalanine potential metabolic high level treatment result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""pku important common phenylketonuria low test phenylalanine potential metabolic high level t""]}}","{""heterogeneity"": {""freq"": 1, ""string"": [""prediction hyperphenylalaninemia cofactor doe moderate mild heterogeneity tetrahydrobiopterin genotype resource parameter o""]}}",{},{},{},{}
1048,1048,1134,10.1177/0269881114565141,25586395.0,various specific tool disorder chain atpd content modification partially lactalbumin render separate common control effective formulation glycomacropeptide atl phe template suitable related phenylalanine truly latter tyr role protein minor ideal symptom methodology atd fraction young use gmp standardization acute current dose tyrosine participate recommend bcaa behaviour test rodent specificity poor lack depletion community responsible loading either alternative research tryptophan disposal plus high trp whereas whey acid human faster cerebral powerful absence amino mixture,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516789/,abstract,1,truly lactalbumin atpd atd atl render recommend standardization disposal bcaa rodent whey minor loading ideal depletion template participate faster trp gmp formulation cerebral behaviour mixture plus glycomacropeptide powerful partially tyr tryptophan modification fraction separate young responsible suitable absence methodology dose community alternative acute poor specificity content lack chain tyrosine related various symptom tool phe effective use current amino role common test human phenylalanine specific control research acid protein high disorder,"{""phenylalanine"": {""freq"": 2, ""string"": [""current amino role common test human phenylalanine specific control research acid p""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""symptom tool phe effective use current amino role common test human p""]}}",{},{}
1049,1049,1135,10.22074/cellj.2016.4318,27540528.0,chain multiplexing shift explain present str reaction electrophoretic efficient tetra cost locus addition polymerase repeat objective inter significantly material slower peak intra phenylalanine family marker tetramethylrhodamine disequilibrium capillary screening relative resolve haplotype error methodology result sufficiently diagnosis primer thus forward reference genetic tandem tamra vntr non significant pcr dye predictable rate multi three variable cheaper one short software size carboxyfluorescein descriptive variance product reverse feasible informative method system multiplex genotyping hundred allelic carrier electrophoresis linkage allele scanner analysis trio pah diagnostic different otherwise high study nucleotide accurately fam carboxy variability number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988422/,abstract,0,tetramethylrhodamine tetra tamra multiplexing fam electrophoretic carboxyfluorescein carboxy predictable genotyping cheaper str disequilibrium vntr slower scanner informative dye trio resolve primer electrophoresis sufficiently allelic explain capillary reverse multiplex peak intra polymerase haplotype forward accurately linkage repeat shift inter variance software descriptive feasible locus pcr multi variability efficient methodology reference nucleotide tandem carrier relative allele reaction size short variable pah marker cost chain product diagnostic screening objective addition error family rate material non number present significantly phenylalanine diagnosis different significant high genetic method analysis result study,"{""phenylalanine"": {""freq"": 2, ""string"": [""rate material non number present significantly phenylalanine diagnosis different significant high g""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""tandem"": {""freq"": 1, ""string"": [""multi variability efficient methodology reference nucleotide tandem carrier relative allele reaction s""]}, ""screening"": {""freq"": 1, ""string"": [""pah marker cost chain product diagnostic screening objective addition error family r""]}}",{},{}
1050,1050,1136,10.3390/nu9070710,28684688.0,phenotypic relationship activity milk difference factor information nutrition preference literature genetics variation average risk gender addition well nonetheless influential disease status neolithic intake account adulthood however nutrigenomic trait optimal health food purpose etc genetic type level mutation one nutrigenetic personalized diversity digest outcome many review interindividual differs interact response person diet revolution mendelian component dairy age future variant million order persistence since responsible nutrigenetics influence field next dna aim transcriptomic characteristic available also metabolomic nutritional pattern epigenomic sugar study human dietary proteomic individual enables,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537825/,abstract,1,neolithic interindividual personalized epigenomic digest proteomic nutrigenomic nutrigenetic differs transcriptomic nutrigenetics revolution nonetheless persistence influential interact enables dairy mendelian metabolomic sugar preference person diversity milk million adulthood responsible gender phenotypic optimal trait nutrition account average component dna pattern nutritional genetics purpose variation intake influence characteristic order relationship status field literature food aim addition variant response future diet dietary information activity mutation outcome difference available individual human risk factor type review age health genetic level disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""personalized epigenomic digest proteomic nutrigenomic nutrigenetic differs transcriptomic nutrigenetics revolution n""]}}",{},{},"{""diet"": {""freq"": 1, ""string"": [""food aim addition variant response future diet dietary information activity mutation o""]}}",{}
1051,1051,1137,10.1186/s12909-016-0756-4,27589999.0,counseling final counselor country student elevated need genetics correspondingly effective well finally formal disease significantly excellent material contribute medical third however resultsboth supplementary strategy user scoring role health instructional mastery examination china military university efficacy large finished official genetic score non level significant neither train communication pre point backgroundgenetic feasible post ass skill online test article key electronic year challenge attitude version materialthe component public future percentage professional likely pilot methodsquestionnaires certification board program available also practice study randomly participant performance conclusionsrole number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010759/,abstract,11,methodsquestionnaires mastery correspondingly conclusionsrole train finished certification backgroundgenetic resultsboth military instructional counselor scoring formal counseling official board attitude final student excellent skill randomly pilot feasible percentage contribute china university examination communication elevated post pre component professional finally efficacy genetics likely point practice materialthe ass public performance need score country participant supplementary program challenge user version strategy key electronic online effective medical large future material non article role number available test significantly significant health year genetic level disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""correspondingly conclusionsrole train finished certification backgroundgenetic resultsboth military instructional counselor s""]}}",{},{},{},{}
1052,1052,1138,10.1155/2014/434519,25548658.0,coefficient wide cross mass region energy tyrosine contain total molecular alanine variation photon aspartate nonessential interaction attenuation effective acid aspartic mev electronic calculated glycine glutamine asparagine amino section cysteine atomic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273595/,abstract,0,mev nonessential attenuation photon contain atomic aspartic aspartate asparagine glutamine glycine cysteine calculated alanine section coefficient energy cross variation tyrosine wide interaction region mass electronic effective molecular total amino acid,{},{},{},"{""amino"": {""freq"": 1, ""string"": []}}",{},{}
1053,1053,1139,10.1186/s13023-017-0622-4,28399928.0,male specific conclusionparents better ill information early among frustration anxiety median reproductive aged awareness due included difficulty facilitate risk dissatisfied experience well way disease survey material biochemical australian knowledge supplementary family life user always health gap telephone burden symptom error support inborn result diagnosis resultsof data psychological genetic planning metabolism eight letter significant stress confidence case although four wrong chi scarce progression backgroundchildren economic child prevent intervention reason constant correct via parent loss online article test treatment undiagnosed response person electronic accessible year education address initially hundred version materialthe doctor rare complex avoidable age future professional lack likely access definitive approximately chronic systematically impact available regardless inappropriate policy consequence group diagnostic different often empathy twenty psychosocial australia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387276/,abstract,5,wrong frustration conclusionparents backgroundchildren avoidable undiagnosed empathy dissatisfied telephone inappropriate australian included scarce letter doctor ill chi definitive constant resultsof initially australia regardless psychosocial planning accessible person systematically reproductive reason awareness correct psychological gap facilitate anxiety progression confidence access economic difficulty burden education approximately prevent address way policy experience median professional consequence aged stress survey loss lack likely chronic materialthe parent male biochemical knowledge diagnostic better inborn symptom support supplementary user complex version response electronic error online future rare family impact intervention information life material article case available metabolism test risk early specific diagnosis child different age significant health group year genetic data treatment result disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1054,1054,1140,10.4103/2230-8210.149315,25729682.0,level pregnant endemic age sac goiter rate hence family administrator india poor lead among observed visible current optimal adolescent world higher present child country girl health implementation neonatal median neonate review cutoff research program district mental view iodine development organization nutritional different manager part concentration study thyroid school mother urinary deficiency hormone strongly total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319260/,abstract,2,goiter sac administrator district manager endemic visible iodine india cutoff thyroid girl neonate school pregnant urinary view strongly organization hormone optimal adolescent mother world poor mental median observed implementation nutritional neonatal lead country program deficiency family rate concentration total current higher present research review child different age development health level study,{},{},{},{},{},{}
1055,1055,1141,10.3390/genes9090454,30208644.0,major abnormality congenital several defect country largely cytogenetic serious province frequency argentina risk vessel repeat disease summary subset relevant distal form fluorescent fish clinically ligation great genomic chd duplication barely transposition low tbx latin cchd non case although hybridization cnvs etiology argentinean population accounting unknown american artery multiplex tgv probe amplification variant anomaly situ birth approximately heart deletion imbalance analysis tract none syndromic also group different cohort conotruncal study cardiac patient number mlpa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162499/,abstract,2,tgv tbx argentinean transposition cytogenetic conotruncal cchd barely argentina mlpa latin ligation distal cnvs vessel syndromic imbalance fluorescent duplication artery accounting situ multiplex hybridization fish amplification probe tract repeat anomaly chd province american subset cardiac summary deletion largely great etiology approximately clinically unknown heart genomic abnormality defect frequency relevant congenital cohort birth country form major variant non low number case risk population different group analysis patient disease study,{},{},{},{},"{""fish"": {""freq"": 1, ""string"": [""duplication artery accounting situ multiplex hybridization fish amplification probe tract repeat a""]}}",{}
1056,1056,1142,10.1038/s41436-018-0403-z,30546086.0,disorder availability purposephenylketonuria new among adult statement appraisal palynziq experience pku phe medical resultsguidance committee phenylalanine manuscript life methodsa evidence clinical therapy health range guidance methodology enzyme metabolic guideline long consideration use four instrument wider evaluation approach management describe development face concentration delphi treatment recommendation meeting best care rare consensus within two prescribe professional demonstrate category series goal provision round prior program research steering group optimize conclusionhere pegvaliase dietary patient total treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752676/,abstract,2,resultsguidance palynziq steering purposephenylketonuria conclusionhere prescribe round appraisal pegvaliase manuscript wider delphi statement meeting optimize guidance committee provision series face instrument consensus methodsa methodology demonstrate consideration category treat prior availability goal guideline experience best recommendation professional evaluation enzyme phe long management program range medical adult use rare dietary care therapy life concentration total evidence pku approach new phenylalanine research development metabolic health group disorder treatment clinical patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""concentration total evidence pku approach new phenylalanine research development metabolic health g""]}}",{},{},{},{},{}
1057,1057,1143,10.1016/j.joto.2018.11.007,30936895.0,conclusionthe cross hearing self abnormality sectional ratio greater factor congenital student audiometry researcher restriction without otoacoustic frequency purposeto evaluate disease evidence quantitative moderate speech higher questionnaire clinical tonal analytical diagnosis metabolic mild hhie auditory significance question adherence genetic non level significant resultsthere immitance chi emission normal instrument syndrome relevance population product people social loss participation test convenience alteration treatment association methodsan emotional sample prevalence statistical hypothyroidism exploratory analysis group domain study subclinical distortion patient underwent square participant individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424694/,abstract,4,tonal immitance hhie distortion audiometry otoacoustic methodsan subclinical purposeto convenience auditory speech hearing resultsthere exploratory chi underwent emission participation emotional student square instrument hypothyroidism relevance conclusionthe adherence researcher significance analytical question people restriction moderate mild alteration statistical domain sectional evaluate quantitative abnormality questionnaire loss cross self syndrome product greater social frequency congenital prevalence ratio participant normal association evidence higher non sample test individual factor diagnosis population significant metabolic group genetic level treatment clinical analysis patient disease study,"{""emotional"": {""freq"": 1, ""string"": [""resultsthere exploratory chi underwent emission participation emotional student square instrument hypothyroidism r""]}, ""social"": {""freq"": 1, ""string"": [""loss cross self syndrome product greater social frequency congenital prevalence ratio p""]}}","{""genetic"": {""freq"": 1, ""string"": [""factor diagnosis population significant metabolic group genetic level treatment clinical analysis p""]}}",{},{},{},{}
1058,1058,1144,10.1371/journal.pone.0108944,25295723.0,specific among congenital positive defect author graphically risk methodswe source control backgroundepidemiological increase origin nulliparous summary relevant however relative observed chds conflicting chd result effect live data reference versus furthermore regression significant case plot one parity per independently galbraith overall woman march total model eligibility ass retrieved article response association medline offspring parous maternal robust resultsthe two estimate birth embase heart analysis conclusionin inception also lowest cohort study heterogeneity meta random highest number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189919/,abstract,3,retrieved parous nulliparous graphically galbraith backgroundepidemiological conflicting chds inception conclusionin parity plot eligibility offspring march live lowest chd embase random medline independently origin author summary versus meta resultsthe robust highest reference heterogeneity relative methodswe estimate heart maternal woman observed source regression furthermore defect relevant congenital ass cohort birth overall positive increase response association total article number case risk model specific control significant effect data analysis result study,{},"{""heterogeneity"": {""freq"": 1, ""string"": [""versus meta resultsthe robust highest reference heterogeneity relative methodswe estimate heart m""]}}",{},{},{},{}
1059,1059,1145,10.1111/japp.12249,28919655.0,objection case tool permissible editing morally indeed desirable argument examine strong germline intervention research therapeutic relatively prevention development stronger potential moral analyse article favour gge funding strongly type gene ethical argue enormous uncontroversial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573992/,abstract,0,uncontroversial permissible morally gge objection moral enormous favour desirable argument funding editing germline analyse stronger argue ethical examine strongly strong relatively prevention tool therapeutic intervention article case type research potential development gene,{},{},{},{},{},{}
1060,1060,1146,10.1152/physrev.00006.2014,25540143.0,operation oxidoreductase chain physiological discus pathway context molecule redox several ubiquinol motive site reaction condition molecular state highlight enzymatic physiology regulatory addition membranous bioenergetic well inter membrane reversible element actively reduction opposite monomer recent oxidation diffusible feature manner substrate mitochondrion link sensor enzyme force generation intermembrane four water catalytic one acting side release soluble fully mobile proton point dimer regulation respiration accomplish potential functionally system unknown quinone pool important electronic signaling process advance within superoxide two cytochrome space function electron contributing mechanism flow also homodimeric physiologically cofactor connection freely complex mitochondrial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281590/,abstract,0,ubiquinol motive membranous intermembrane diffusible bioenergetic acting respiration homodimeric accomplish oxidoreductase quinone proton freely cytochrome contributing physiologically opposite redox pool mitochondrion space sensor reversible mobile electron soluble functionally dimer actively operation monomer connection force superoxide release signaling inter catalytic physiology manner flow membrane enzymatic oxidation substrate fully mitochondrial element link physiological water cofactor molecule advance unknown regulatory reaction regulation site feature reduction generation context point chain highlight discus process enzyme addition state complex electronic pathway molecular recent mechanism condition important function potential,{},{},"{""pathway"": {""freq"": 1, ""string"": [""process enzyme addition state complex electronic pathway molecular recent mechanism condition i""]}}",{},{},{}
1061,1061,1147,10.3389/fgene.2018.00587,30564269.0,major phenotypic considerable record new information www unimd recall molecular due rdad effective clinician machine way disease significantly medical however clinical always top candidate real therefore support result diagnosis cause genetic learning four phenotype hard prediction discovery outcome model method technology system article resource precision accessible similarity best list mendelian rare sample lack application auxiliary diagnostics diagnostic high sequencing assist org highest performance freely number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288202/,abstract,1,unimd rdad auxiliary recall freely hard machine org learning mendelian assist similarity accessible www diagnostics list real prediction considerable candidate record precision phenotypic clinician highest discovery resource way best lack sequencing technology phenotype performance diagnostic support application major cause effective medical molecular rare information outcome article sample number significantly new model diagnosis high genetic method clinical result disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1062,1062,1148,10.1161/JAHA.118.011264,30995883.0,specific cochrane whether search ratio early among congenital july present developing without odds bias rubella risk control publication virus disease uncertain significantly however evidence additionally role consistent conclusionsalthough complete chd result effect observational date question pregnancy chinese case pubmed end experienced infection sensitivity database woman inclusion model backgroundat method seventeen history potential mother association viral address maternal overview library carefully embase heart google analysis criterion yielded prestated study heterogeneity meta cytomegalovirus scholar random parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512143/,abstract,2,rubella prestated backgroundat yielded seventeen developing scholar google cytomegalovirus conclusionsalthough pubmed experienced carefully uncertain july library cochrane chd odds embase viral random bias publication observational chinese virus overview meta complete end question heterogeneity mother infection additionally inclusion date search address heart pregnancy parameter history maternal woman consistent sensitivity criterion database congenital ratio association evidence role present case significantly risk model early specific control potential effect method analysis result disease study,{},"{""heterogeneity"": {""freq"": 1, ""string"": [""virus overview meta complete end question heterogeneity mother infection additionally inclusion d""]}}",{},{},{},{}
1063,1063,1149,10.1002/14651858.CD005436.pub5,27996088.0,cochrane whether hour diarrhoeain search ratio difference greater mrct duration country world author dichotomous selection researcher cinahl half aged bias serious central five supplementation continuous probably risk methodswe average dysentery severity number backgroundin well persistent evaluate disease month doe objectivesto enough register issue whose infectious however evidence interval event moderate health primary support annually six certainty effect malnutrition data reference conversely oral low united analysisboth area use confidence seven three one main death placebo acute current child outcome sign around fund able review approach inclusion model eligibility day resultsthirty september older organization nation collection lilac vomiting year medline list diarrhoea library age still reduces appropriate prevalence unicef embase younger currently analysis either criterion adverse benefit available none also trial conclusionsin diarrhoeathere group grade high heterogeneity meta zinc deficiency asian random,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450879/,abstract,18,unicef resultsthirty mrct dysentery dichotomous diarrhoeathere diarrhoeain analysisboth lilac diarrhoea fund malnutrition conclusionsin certainty nation vomiting annually probably eligibility conversely persistent younger register objectivesto cinahl september asian library zinc cochrane backgroundin reduces grade embase random medline infectious sign duration bias placebo list continuous author older hour half united researcher organization meta confidence able doe moderate seven reference heterogeneity event severity oral interval world selection inclusion average search acute methodswe death evaluate collection appropriate aged supplementation adverse central criterion greater currently benefit prevalence issue main ratio country area support month day trial primary use deficiency evidence current outcome difference low approach number available risk model review child age health group year effect high data analysis disease,{},"{""heterogeneity"": {""freq"": 1, ""string"": [""confidence able doe moderate seven reference heterogeneity event severity oral interval w""]}}",{},{},{},{}
1064,1064,1150,10.1016/j.phrp.2014.09.005,25562044.0,blood chain estimation single frozen positive housekeeping reaction buffer beta polymerase validation traditional pharmaco suitable optimized incubation screening clinical storage card tris purpose extraction toxicokinetic resultsdna pcr saline phosphate temperature volume room drug stable gapdh evaluation discovery whatman simple method convenient conclusionour biobanks technology serum actin filter edta protocol sample methodsthe efficiently spot elution standard overnight dna quality paper alternative quantity general nonclinical diagnostic plasma study fta small developed purity gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281615/,abstract,1,toxicokinetic resultsdna pharmaco nonclinical housekeeping gapdh edta tris purity optimized fta overnight frozen convenient saline incubation developed biobanks actin whatman elution buffer conclusionour phosphate efficiently card beta polymerase estimation room quantity filter extraction temperature pcr methodsthe traditional validation suitable stable storage simple discovery protocol volume alternative reaction dna serum purpose chain evaluation spot general paper technology small diagnostic standard screening plasma positive drug quality single sample blood gene method clinical study,{},{},{},"{""screening"": {""freq"": 1, ""string"": [""general paper technology small diagnostic standard screening plasma positive drug quality s""]}}",{},{}
1065,1065,1151,10.1186/s41687-019-0093-6,30671727.0,specific disorder greater representative lower among resultsmore warrant time adult preference condition onset severe state cost mean elicited disease survey material caregiver utility trade adulthood supplementary family methodsa life evidence childhood moderate screening perspective user health respondent range symptom effectiveness effect mild infantile backgroundmeasurement spillover regression level three disutility measure economic child evaluation approach inclusion krabbe phenylketonuria model evident predictor ass stage conclusionsrare parent loss plausible substantial online article parental electronic calculated year heritable version consecutive materialthe rare pompe frame age sample newborn negative estimate community quality currently analysis binomial research available infant infancy fewer nationally lowest study federal patient even,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342747/,abstract,2,spillover resultsmore krabbe elicited conclusionsrare binomial backgroundmeasurement pompe disutility trade frame infantile warrant nationally federal plausible heritable fewer consecutive calculated lowest representative preference respondent infancy evident caregiver adulthood methodsa parental predictor substantial economic moderate mild utility perspective inclusion community estimate effectiveness stage childhood survey regression negative mean loss onset cost materialthe evaluation greater currently parent ass severe symptom measure infant supplementary screening state user range version electronic quality online lower adult rare family life newborn evidence material condition article sample phenylketonuria approach available time model specific research child age health year effect level disorder analysis patient disease study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""online lower adult rare family life newborn evidence material condition article s""]}, ""screening"": {""freq"": 1, ""string"": [""ass severe symptom measure infant supplementary screening state user range version e""]}}",{},{}
1066,1066,1152,,28316720.0,various edition tehran mofid lower examine world physical due moreover average old well significantly pku material medical subject life questionnaire health census therefore improvement result metabolic attention data late greatly low suffering ali period level educational one bref software current child spss inferential population persian descriptive phenylketonuria spring method mental via social organization whoqol year diet finding qol age still two iran asghar order limited dependent quality environmental aspect background hospital special research also conclusion group study center patient even gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319252/,abstract,3,asghar ali whoqol spring persian census bref mofid inferential suffering tehran qol edition greatly spss software descriptive iran educational special examine organization gender late aspect world average center mental dependent physical improvement old questionnaire hospital limited attention environmental social period order finding various background subject quality medical lower diet life current pku material conclusion phenylketonuria low significantly research population child age metabolic health group year method data level result patient study,"{""social"": {""freq"": 1, ""string"": [""old questionnaire hospital limited attention environmental social period order finding various b""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""various background subject quality medical lower diet life current pku material c""]}}",{}
1067,1067,1154,10.3945/ajcn.115.129650,27357093.0,major beverage whether cardiometabolic syrup difference energy fructose trigger intestinal affect adult standardized glucose inflammation malabsorption weight without ssbs mechanistic interleukin lipopolysaccharide differentially disease objective significantly intake amount subject evidence gov drinking endpoint fetuin hfc clinical attrs protein consistent lactulose double secondary body primary result link effect libitum change design mannitol calorie term type crossover low period clinicaltrials three one measure requirement end text independently normal systemic permeability intervention corn reactive expression potential concentration test excessive diabetes diet phase component detect obese determine adipose acutely influence differential chronic previously background cardiovascular impact consumption nct also trial except conclusion grade group ssb lowest plasma tissue high sugar study blind dietary participant adiponectin gene total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962158/,abstract,5,mannitol lactulose fetuin adiponectin ssb lipopolysaccharide libitum hfc ssbs permeability malabsorption interleukin corn fructose cardiometabolic drinking adipose acutely endpoint calorie trigger syrup intestinal excessive standardized differentially attrs reactive lowest obese crossover sugar grade detect beverage requirement independently mechanistic clinicaltrials blind systemic nct inflammation gov differential link double cardiovascular end consumption energy affect diabetes glucose text secondary phase component consistent weight chronic tissue intake influence previously determine design period participant body background measure normal objective subject plasma trial major expression change primary adult diet impact intervention dietary concentration total evidence conclusion term difference low test significantly type potential protein gene group effect high clinical result disease study,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""trial major expression change primary adult diet impact intervention dietary concentration t""]}}",{}
1068,1068,1155,,29234174.0,better methodological present weakness researcher common cost effective addition majority journal iranian calculation allocate suitable comply checklist select role health play feature valuation drummond therefore purpose fault guideline term english economic structure database evaluation fully flaw intervention correctly persian review inclusion accordance article resource important electronic care order standard quality criterion research program policy study maker number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722959/,abstract,1,valuation fault drummond persian flaw allocate checklist comply weakness accordance correctly methodological select journal english maker iranian calculation fully researcher suitable economic guideline majority play inclusion resource policy feature criterion purpose cost structure database evaluation order standard better addition program electronic quality effective intervention care term article important role common number present research review health study,{},{},{},{},{},{}
1069,1069,1157,10.3390/ijerph16040658,30813406.0,worldwide disorder delay autism pathophysiologic factor early country cooperation enhance insight behavior accurate literature common prognosis nrxn multidimensional shank effective concept increase survey antiepileptic plasticity spectrum numerous designing knowledge pharmacological strategy neurodevelopmental dysfunction perspective clinical role protein play diagnosis recently good council language design novel genetic transmission repetitive international asd one communication drug excitatory provide review product reason therapeutic development synaptic test impaired treatment monitoring still appropriate prevalence especially currently environmental aim psychotropic available nlgn also depth diagnostic comprehensive interaction pattern study though even gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406800/,abstract,0,nrxn nlgn psychotropic designing council shank multidimensional excitatory pathophysiologic antiepileptic cooperation repetitive plasticity depth synaptic transmission prognosis reason impaired enhance language accurate worldwide numerous pharmacological neurodevelopmental monitoring asd delay communication concept perspective play international comprehensive autism good appropriate insight pattern survey recently behavior dysfunction environmental especially product currently design provide prevalence knowledge spectrum diagnostic country interaction literature aim drug strategy increase therapeutic effective novel role common available test early factor diagnosis review protein development gene genetic disorder treatment clinical study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1070,1070,1158,10.1371/journal.pone.0146240,26752287.0,inheritance major correlation statistic new information rigorous among dataset difficult epistatic positive raising set affected frequency genetics common locus stratified penetrance risk testing reliable well disease computer issue presence resultant unstratified cannot family marker strategy exhaustively previous differ range procedure feature therefore genotype recently effect data detectable genetic score detection conditioning rate one member step sense phenotype current hampered population approach lod model method work simulation second substantial test rich important proportion exploit association false allelic wide detect definition linkage robust within two allele negative additive explore multipoint elimination analysis either falsely priority widely also multiple except interaction heterogeneity successfully detectability powerful correction gene individual show complex parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709060/,abstract,1,unstratified raising multipoint hampered exhaustively epistatic detectability falsely conditioning penetrance lod stratified exploit sense rigorous differ resultant dataset allelic detectable elimination computer additive linkage simulation detect definition inheritance priority correction statistic rich set powerful locus successfully false reliable substantial affected robust member proportion widely heterogeneity procedure genotype explore difficult step allele parameter previous second work recently negative feature marker genetics presence correlation frequency wide issue phenotype testing score interaction detection major range multiple complex positive strategy association family information rate current important common approach test individual new risk model population gene effect genetic method data analysis disease,{},"{""inheritance"": {""freq"": 1, ""string"": [""computer additive linkage simulation detect definition inheritance priority correction statistic rich s""]}, ""genetic"": {""freq"": 1, ""string"": []}, ""heterogeneity"": {""freq"": 1, ""string"": [""substantial affected robust member proportion widely heterogeneity procedure genotype explore difficult s""]}}",{},"{""detection"": {""freq"": 1, ""string"": [""wide issue phenotype testing score interaction detection major range multiple complex p""]}}",{},{}
1071,1071,1159,10.1002/gepi.21895,25809955.0,phenotypic european lead region single positive student trinity genetics common control lawley covariates well traditional extensive sequence individual biochemical connect much quantitative trait detects kernel optimal trace distribution error effect data combine wilks genetic type lipid low eight significant case four functional three rate one pleiotropy skat bartlett overall provide approach model method separately univariate test simultaneous association false multivariate variant comparison pillai analysis multiple cohort study power linear gene performance show sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443751/,abstract,0,wilks trinity skat pleiotropy pillai lawley kernel bartlett detects covariates connect combine univariate trace separately simultaneous power student multivariate false traditional lipid extensive phenotypic optimal sensitive distribution linear european trait sequence quantitative comparison genetics lead provide functional cohort biochemical performance overall region multiple positive variant error single association rate common low approach case test individual model control type significant gene effect genetic method data analysis study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1072,1072,1160,10.1128/MCB.00491-17,29378828.0,confocal coenzyme specific activity ratio single several propionyl microscopy injection well transcription propionylcarnitine carboxylase mouse peptide fibroblast mitochondrion result tat enzyme furthermore far level fluorescence size normal colocalization hiv toward model potential delivery active limit acidemia western assay cell intracellular deficient import situ cargo propionic matrix vitro transactivator also blot push acetylcarnitine pcc intraperitoneal isolated deficiency patient show mitochondrial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829486/,abstract,0,transactivator tat pcc colocalization cargo import acetylcarnitine push propionylcarnitine propionyl intraperitoneal confocal carboxylase microscopy mitochondrion coenzyme blot situ intracellular hiv isolated propionic fluorescence fibroblast acidemia matrix western injection peptide far mitochondrial deficient transcription limit active vitro delivery size assay furthermore ratio mouse enzyme normal single deficiency activity cell model specific potential level result patient,{},{},{},{},{},{}
1073,1073,1161,10.1186/s13287-016-0330-3,27176654.0,level inflammatory biological interestingly lhmcss modulate factor secrete apoptotic multitude msc marrow differentiation anti adipose cytokine higher function therapy bone reaction stem liver summarizes angiogenic benefit characteristic paper research posse differentiate pro attractive due moreover therapeutic capacity general potential thus tissue recently trophic morphology source risk umbilical human treatment mesenchymal immune disease ability type cell cord,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866276/,abstract,0,trophic secrete lhmcss multitude msc mesenchymal angiogenic umbilical differentiate modulate marrow apoptotic adipose posse attractive summarizes cord morphology cytokine interestingly pro bone stem differentiation capacity immune anti inflammatory reaction source recently liver tissue biological ability general benefit characteristic paper therapeutic therapy higher cell function human risk factor type research potential level treatment disease,{},{},{},{},{},{}
1074,1074,1162,10.1007/s40142-018-0143-z,30581653.0,specific relationship better new factor information nutrition across nutrient easily variation summarythe state ace risk effective apoas disease findingsevidence streamline respect cvd evidence recent consistent focus science globally thus purpose effect etc data computational genetic united macronutrients significant fad although death scientific biomarkers comparatively progression genomics intervention population review approach identification development plan stage susceptibility collection precision response important diet age future still progress limited field meaningful cardiovascular tcf fto group bdnf purposecardiovascular nutritional interaction study whereas ample dietary inform gene individual gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300156/,abstract,0,tcf streamline purposecardiovascular findingsevidence cvd apoas summarythe fto comparatively bdnf ample macronutrients fad ace globally easily meaningful respect computational plan susceptibility inform progress united progression gender precision cardiovascular scientific genomics nutrient nutrition science death stage collection consistent nutritional focus limited purpose variation biomarkers identification relationship field interaction better state response effective future recent diet intervention dietary information evidence important approach individual new risk specific factor population review age significant development gene group effect genetic data disease study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},"{""diet"": {""freq"": 1, ""string"": [""better state response effective future recent diet intervention dietary information evidence i""]}}",{}
1075,1075,1163,10.12659/PJR.901791,28656068.0,reversible matter various resonance mimic however posthypoxic abnormality signal along reader early familiarize toxic white clinical differential damage many initial brain critical without leukoencephalopathy week action diffusion pictorial result potential toxin prognosis thus often diagnosis presentation purpose metabolic magnetic treatment change cause essay disease agent familiarity exception mesh presence particularly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478246/,abstract,0,posthypoxic familiarize pictorial familiarity leukoencephalopathy essay reader mesh toxin reversible mimic exception diffusion prognosis toxic resonance differential matter damage initial signal action presentation agent white magnetic abnormality purpose critical presence particularly week various change cause brain early diagnosis potential metabolic treatment clinical result disease,{},{},{},{},{},{}
1076,1076,1164,10.3390/nano8121050,30558215.0,diamond process biological significant enantiomer activity phenylalanine simply pharmacological physiological opposite strong interfacial stable sonication reusable platform recognition graphene cyclodextrin half therefore simple great due casting potential sensor different regenerative stereochemistry successfully addition significance even highly completely electrode,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316030/,abstract,0,stereochemistry sonication reusable interfacial enantiomer diamond casting cyclodextrin regenerative graphene simply electrode opposite sensor recognition completely successfully half stable physiological significance pharmacological simple platform great strong highly biological process addition activity phenylalanine potential different significant,"{""phenylalanine"": {""freq"": 2, ""string"": []}}",{},{},{},{},{}
1077,1077,1165,10.1101/mcs.a000588,27148576.0,level complex biological disorder chemistry activity metabolite new biomarkers scope phenotype derangement hold standard current clinical underlie discovery precise analysis either monogenic metabolomics technique detailed characterization therapeutic monitor error metabolomic capable diagnose inborn target historically technology comprehensive practice consequently metabolic specimen precision small well thousand inform disease promise beyond metabolism hundred medicine number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850886/,abstract,0,underlie derangement hold chemistry diagnose scope historically monitor specimen metabolomic thousand detailed promise capable precise monogenic inform consequently characterization precision discovery metabolomics comprehensive biomarkers practice technique biological medicine technology phenotype small target standard inborn metabolite complex error therapeutic activity current number metabolism new metabolic level disorder clinical analysis disease,{},{},{},{},{},{}
1078,1078,1166,10.1007/s10803-015-2359-z,25618212.0,account disorder rate however asd autism one comorbid neural negative emotion rating comorbidities time positive internalizing adult subjective accumbens cognitive amygdala regulation reappraisal cortex instruction deficit mechanistic face group potential high pupilometry nucleus change response activation prefrontal increase respectively emotional dorsolateral spectrum,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515208/,abstract,0,reappraisal pupilometry internalizing accumbens dorsolateral emotion instruction amygdala subjective nucleus comorbid comorbidities prefrontal cortex rating emotional face neural mechanistic activation asd account autism regulation deficit negative spectrum cognitive change positive increase response adult respectively rate time potential group high disorder,"{""emotional"": {""freq"": 1, ""string"": [""nucleus comorbid comorbidities prefrontal cortex rating emotional face neural mechanistic activation a""]}}",{},{},{},{},{}
1079,1079,1167,10.1161/CIRCRESAHA.117.303776,28360348.0,blood wall production opportunity discus nitric function soluble aspect homeostasis approach cardiovascular particular therapeutic indication also endothelium multiple vascular proportional quiescence guanylate oxide control endothelial vessel cyclase bioavailability important activation governs vasomotor novel generation preserve cell,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391494/,abstract,0,vasomotor quiescence guanylate governs cyclase wall proportional preserve endothelium vessel bioavailability soluble endothelial vascular nitric indication oxide activation homeostasis cardiovascular aspect opportunity production particular generation discus multiple therapeutic novel important cell function approach control blood,{},{},{},{},{},{}
1080,1080,1168,10.14196/mjiri.32.21,30159272.0,carrier splice disorder blood sample mutation phenylalanine exon chain three variant iran spot hot time explore intronic reaction population background phenylketonuria technique method keywords also missense heterogeneous common disruption conclusion result nonsense different silent metabolic study testing polymorphism sequencing polymerase patient novel first hydroxylase genetic status iranian gene eight useful prove area,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108261/,abstract,7,silent prove intronic hot splice nonsense iranian disruption polymerase heterogeneous iran missense exon keywords polymorphism carrier explore useful reaction chain sequencing spot technique hydroxylase status testing background area variant novel mutation conclusion common sample phenylketonuria time phenylalanine blood population different metabolic gene genetic method disorder result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""mutation conclusion common sample phenylketonuria time phenylalanine blood population different metabolic g""]}}","{""genetic"": {""freq"": 1, ""string"": [""phenylalanine blood population different metabolic gene genetic method disorder result patient s""]}}",{},{},{},{}
1081,1081,1169,10.1186/s12887-018-1372-8,30579351.0,abnormality mainland ratio factor among congenital french guiana aged due need territory deformation risk methodswe backgroundin objective disease significantly neurological infectious explanation pregnant quantify interval certificate higher circulatory crude predispose data genetic mortality chromosomal international confidence rate death annual toxic infection database child woman overall conclusionsthe inserm resultsin social system prevalent calculated year incidence excess age category environmental infant nutritional classification study france malformation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303914/,abstract,9,inserm guiana deformation crude predispose french circulatory certificate mainland territory explanation france excess calculated quantify chromosomal annual backgroundin malformation resultsin infectious toxic prevalent pregnant classification conclusionsthe confidence category interval infection international neurological methodswe death mortality aged woman incidence abnormality nutritional environmental database social congenital ratio need overall infant objective rate higher significantly risk factor child age year genetic data disease study,"{""neurological"": {""freq"": 1, ""string"": [""conclusionsthe confidence category interval infection international neurological methodswe death mortality aged w""]}, ""social"": {""freq"": 1, ""string"": [""woman incidence abnormality nutritional environmental database social congenital ratio need overall i""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1082,1082,1170,10.3389/fncel.2019.00150,31114480.0,major biological pathogenesis disorder autism fluctuation behavioral present algorithm voting accurate organic gradient clear old testing machine extreme spectrum characterize summary xgboost strategy neurodevelopmental partial possible distinguish top focus feature complicates diagnosis metabolic purpose good urine novel exploration non detection svm full three asd least independent biomarkers etiology child intervention model method potential gas collection valuable year pls future mass lack typically younger reduced analysis characteristic spectrometry research diagnostic autistic study acid vector patient discriminant square performance chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502994/,abstract,6,xgboost voting svm complicates pls discriminant gradient extreme exploration fluctuation machine younger distinguish autistic square algorithm vector pathogenesis characterize gas partial valuable summary clear accurate typically organic neurodevelopmental asd reduced etiology behavioral independent urine chromatography autism good collection old focus feature lack purpose spectrometry biomarkers biological characteristic performance testing spectrum diagnostic detection possible mass major strategy future intervention novel non present model diagnosis research acid potential child metabolic year method disorder analysis patient study,"{""urine"": {""freq"": 1, ""string"": [""neurodevelopmental asd reduced etiology behavioral independent urine chromatography autism good collection o""]}, ""behavioral"": {""freq"": 1, ""string"": [""typically organic neurodevelopmental asd reduced etiology behavioral independent urine chromatography autism g""]}}",{},{},"{""detection"": {""freq"": 1, ""string"": [""biological characteristic performance testing spectrum diagnostic detection possible mass major strategy f""]}, ""spectrometry"": {""freq"": 1, ""string"": [""collection old focus feature lack purpose spectrometry biomarkers biological characteristic performance t""]}}",{},{}
1083,1083,1171,10.32607/20758251-2019-11-2-42-46,31413878.0,carrier rare use phenotypic blood mutation two phenylalanine example one mass homozygous hyperphenylalaninemia elaborate screening sibling present therapy analysis spectrometric model phenylketonuria easily spectrometry particular method efficiency history error pah missense diagnosis diagnostic different efficacy practice concentration study manifestation mild treatment patient excellent pku hydroxylase solely carnitine metabolite phe gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643343/,abstract,0,solely spectrometric elaborate sibling easily carnitine excellent homozygous efficiency missense manifestation gender phenotypic hyperphenylalaninemia mild carrier history particular efficacy example pah spectrometry practice hydroxylase diagnostic metabolite phe screening mass error use rare therapy concentration mutation pku phenylketonuria present model phenylalanine blood diagnosis different method treatment analysis patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""concentration mutation pku phenylketonuria present model phenylalanine blood diagnosis different method t""]}}","{""homozygous"": {""freq"": 1, ""string"": [""spectrometric elaborate sibling easily carnitine excellent homozygous efficiency missense manifestation gender p""]}}",{},"{""spectrometry"": {""freq"": 1, ""string"": [""carrier history particular efficacy example pah spectrometry practice hydroxylase diagnostic metabolite p""]}, ""screening"": {""freq"": 1, ""string"": [""spectrometry practice hydroxylase diagnostic metabolite phe screening mass error use rare t""]}}",{},{}
1084,1084,1172,10.1007/s11154-018-9460-5,30209646.0,sunlight balance disorder activity encompass abnormality growth factor early rickets condition physical frequency pathology well hypophosphatasia disease amongst spectrum physician intermediary mainly marrow higher storage health secondary symptom particular primary error inborn metabolic problem ovarian failure outcome recognition intervention many frequently development exposure hypophosphatemic treatment important lysosomal strict mucopolysaccharidoses wide primarily influence mineralization bone impact optimization importance often skeletal osteoporosis dietary patient complication calcium,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208570/,abstract,0,hypophosphatemic hypophosphatasia encompass sunlight rickets mineralization mucopolysaccharidoses intermediary marrow osteoporosis ovarian optimization skeletal lysosomal balance calcium strict bone recognition primarily pathology physician failure storage complication mainly frequently secondary particular physical abnormality exposure influence frequency growth wide importance problem spectrum inborn symptom primary error impact intervention dietary activity outcome higher condition important early factor development metabolic health disorder treatment patient disease,{},{},{},{},{},{}
1085,1085,1173,10.4103/0971-4065.139492,25838642.0,process component transcriptional considerable disorder rapid understanding tool functional progress homeoprotein nuclear interest apoptosis lending factor information cystic renal genomics differentiation cyst function role precise focus review toward homeostasis mechanism regulation molecular pathophysiology importance also partner development target expression comprehensive tissue recently heterogeneity besides hepatocyte regulatory unravel well key disease epithelial gene cell proliferation kidney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379628/,abstract,0,lending homeoprotein cyst unravel apoptosis partner epithelial proliferation cystic transcriptional precise kidney renal pathophysiology progress differentiation hepatocyte considerable nuclear homeostasis genomics heterogeneity comprehensive regulatory component regulation understanding recently focus rapid tissue importance functional target process tool expression key molecular mechanism information role cell function factor review development gene disorder disease,{},"{""heterogeneity"": {""freq"": 1, ""string"": [""differentiation hepatocyte considerable nuclear homeostasis genomics heterogeneity comprehensive regulatory component regulation u""]}}",{},{},{},{}
1086,1086,1175,10.1186/s12916-017-0938-x,28934987.0,major biological blood herein factor largely chronically glucose elevated weight behavior physical need literature ineffective risk biomarker material emergence inactivity however supplementary strategy obesity user clinical health global prediabetic regress behind thus effect force epidemic pharmacotherapy type modifiable medicine innovative rational current drug systemic intervention many population review therapeutic people technology system loss concentration tackle online article precision electronic nevertheless diabetes challenge lifestyle sedentary version traditionally obese scale resistance normoglycemia either unlike available translation prevention overweight often human dietary though pursuance individual hallmark,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609030/,abstract,1,regress pursuance prediabetic normoglycemia tackle sedentary pharmacotherapy ineffective inactivity unlike rational modifiable epidemic traditionally hallmark emergence chronically overweight innovative force obese lifestyle resistance systemic biomarker largely translation precision people elevated diabetes glucose obesity global physical weight loss behavior prevention biological medicine scale technology need literature supplementary major challenge user drug version strategy electronic online therapeutic intervention dietary concentration current material article available individual human risk factor blood type population review health effect clinical,{},{},{},{},{},{}
1087,1087,1176,10.2147/DMSO.S153151,29520158.0,beverage activity difference single promotion adult physically physical parallel supplementation august subcutaneous significantly respectively maintained session phenylalanine methodsa interval event reduction follow range double comparable primary arginine efficacy purpose resultsof data tomography combination area period confidence ingestion placebo per conclusiona monthly outcome intervention abdominal week day alanine japan minato test mix purposethe active year randomized lifestyle fat age protocol within visceral unfavorable analysis trial group december overweight june study blind tokyo center randomly participant total mixture,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833794/,abstract,11,unfavorable tokyo minato purposethe mix visceral physically maintained conclusiona monthly ingestion august subcutaneous promotion japan abdominal overweight resultsof alanine tomography june session randomized arginine december mixture beverage randomly lifestyle blind placebo fat parallel methodsa comparable double confidence event protocol interval active center follow supplementation physical efficacy reduction combination purpose week period participant area day trial range primary single adult respectively intervention total activity outcome difference test significantly phenylalanine age group year data analysis study,"{""phenylalanine"": {""freq"": 2, ""string"": [""total activity outcome difference test significantly phenylalanine age group year data a""]}}",{},{},{},{},{}
1088,1088,1177,10.1590/1984-0462/;2017;35;3;00012,28977297.0,male specific cross disorder delay retardation abnormality investigation iem sectional acidosis outpatient growth factor early among twelve laboratory initial median organic expert difficulty hypothesis objective disease status respectively knowledge seizure family clinical storage developmental hyperammonemia symptom error inborn result diagnosis metabolic observational data reference facility metabolism case four three variable main referral exclusion sign descriptive inclusion method identification history ass test school collection urea treatment lysosomal hepatomegaly year acidemia care challenge age still two majorly aminoacidopathies poor pediatric january access statistical cognitive criterion analysis impairment prior impact prevention conclusion december diagnostic cycle practice dissemination presentation study patient neuropsychomotor healthcare number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606180/,abstract,2,neuropsychomotor majorly hepatomegaly acidosis hyperammonemia dissemination aminoacidopathies facility outpatient lysosomal exclusion retardation referral acidemia december urea sign school january descriptive observational seizure organic expert storage initial access prior delay presentation difficulty reference hypothesis iem cycle healthcare statistical inclusion poor sectional median investigation history collection pediatric variable abnormality criterion impairment cross developmental prevention practice growth laboratory ass identification male main status knowledge diagnostic inborn symptom cognitive objective challenge error family respectively impact care conclusion number case metabolism test early specific factor diagnosis age metabolic year method data disorder treatment clinical analysis result patient disease study,{},{},{},{},{},{}
1089,1089,1178,10.1007/8904_2017_72,29147990.0,major coefficient male daily herein dos lower liquid biosynthesis variation catecholamine mean hiaa urinary increase excretion significantly material normetadrenaline later nitisinone possible therapy aku determined manner neurotransmitter report result metabolic urine tandem metabolism hydroxyindole one pre interassay dose tyrosine week method baseline concentration treatment year methoxytyramine age sample mass acetic metabolite serotonin dependent alkaptonuria background spectrometry nma metadrenaline trial consequence conclusion cohort study acid patient show chromatography treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122050/,abstract,12,normetadrenaline nma metadrenaline interassay hydroxyindole methoxytyramine hiaa aku acetic nitisinone alkaptonuria catecholamine excretion dos manner coefficient biosynthesis serotonin determined neurotransmitter urinary treat later tandem baseline liquid daily dose urine chromatography pre consequence dependent mean variation spectrometry tyrosine male cohort week possible background metabolite mass trial major increase lower report therapy concentration material conclusion sample metabolism significantly acid age metabolic year method treatment result patient study,"{""urine"": {""freq"": 1, ""string"": [""later tandem baseline liquid daily dose urine chromatography pre consequence dependent m""]}}",{},{},"{""tandem"": {""freq"": 1, ""string"": [""serotonin determined neurotransmitter urinary treat later tandem baseline liquid daily dose u""]}, ""spectrometry"": {""freq"": 1, ""string"": [""chromatography pre consequence dependent mean variation spectrometry tyrosine male cohort week p""]}}",{},{}
1090,1090,1179,10.3109/08958378.2014.955932,25264934.0,definition cancer example member negative screen curve technical several dose optimal present sensitivity positive carefully selection careful necessary population benefit characteristic cutoff particular choice lung widely importance need ass consequence group likelihood article test psa mammography key tomography specificity disease receiver limitation false low consideration calculation medicine overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389712/,abstract,0,psa mammography likelihood cutoff carefully careful calculation receiver tomography lung definition curve technical false choice screen overview consideration optimal member limitation widely dose selection specificity necessary consequence particular cancer sensitivity example negative medicine ass importance benefit characteristic need positive key article low present test population group disease,{},{},{},{},{},{}
1091,1091,1180,10.5582/irdr.2018.01129,30560025.0,service rare training related clinic region accessibility information screening pathway always clinical child provision meanwhile burden forefront great importance moreover china also prevention development diagnosis system reference treatment significance important shanghai center specialist patient disease february greatly area medical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290848/,abstract,0,shanghai forefront accessibility february greatly training provision specialist china significance great burden reference clinic center service prevention importance related region area screening medical pathway rare information important diagnosis child development treatment clinical patient disease,{},{},"{""pathway"": {""freq"": 1, ""string"": [""importance related region area screening medical pathway rare information important diagnosis c""]}}","{""screening"": {""freq"": 1, ""string"": [""service prevention importance related region area screening medical pathway rare information i""]}}",{},{}
1092,1092,1181,10.25100/cm.v48i3.2180,29213153.0,male blood iem sectional contributed difference positive accurate due offering pathology classical related life introduction observed consequent higher value health neonate error inborn result diagnosis metabolic fifty contrast reference tandem metabolism low establishment level significant untimely seven rate female death problem current implementation sensitivity succinylacetone child evaluation day method concentration treatment simultaneous important associated false city acylcarnitines age public mass reveal newborn poor application spot healthy determine analytes precise quality colombia spectrometry program multiple conclusion different high study quibdo whereas acid patient linear limitation amino usual metabolite gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687862/,abstract,4,untimely quibdo colombia succinylacetone contributed consequent usual offering establishment analytes simultaneous acylcarnitines reveal neonate city precise false accurate pathology introduction gender classical seven linear limitation reference tandem iem contrast poor death sectional associated observed female implementation sensitivity spectrometry evaluation spot determine problem related male public inborn metabolite healthy application mass day program multiple positive value error quality rate life concentration newborn current amino conclusion higher important difference low metabolism blood diagnosis acid child different age significant metabolic health high method level treatment result patient study,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""quality rate life concentration newborn current amino conclusion higher important difference l""]}, ""tandem"": {""freq"": 1, ""string"": [""gender classical seven linear limitation reference tandem iem contrast poor death s""]}, ""spectrometry"": {""freq"": 1, ""string"": [""sectional associated observed female implementation sensitivity spectrometry evaluation spot determine problem r""]}, ""newborn"": {""freq"": 1, ""string"": [""value error quality rate life concentration newborn current amino conclusion higher i""]}}",{},{}
1093,1093,1183,10.1016/j.ymgme.2016.09.002,27665271.0,registry disorder example new among demonstrates selection researcher enhance recruitment literature due heterogeneous mechanistic enhancing advocacy risk biomarker challenging regulatory effective clinician vitamin disease issue knowledge workshop evidence pharmaceutical enrollment perspective clinical clinically gap sponsor phenotypically primary effectiveness diagnosis thus efficacy base design little term combination long low united area use pmd seven short discussion capability intervention approach management model history partner nih potential organization technology safety landscape preface agenda resource treatment key supplement care address challenge rare genetically within opportunity professional collaboration access stakeholder community standard goal basic benefit natural research modality trial foundation trust group historically singly december nutritional presentation study dietary barrier federal cofactor patient though even industry individual mitochondrial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083179/,abstract,0,sponsor preface pmd singly phenotypically advocacy nih enrollment enhancing workshop trust challenging agenda federal recruitment partner landscape historically demonstrates modality stakeholder collaboration capability registry december supplement industry base foundation heterogeneous mechanistic pharmaceutical enhance gap discussion biomarker mitochondrial united researcher basic vitamin organization barrier genetically access presentation clinician cofactor safety seven little goal perspective opportunity selection community resource address effectiveness clinically natural regulatory history professional short nutritional efficacy example combination design benefit issue technology knowledge standard literature area long management trial challenge primary key effective use rare intervention dietary care evidence term low approach individual new risk model diagnosis research potential group disorder treatment clinical patient disease study,{},{},{},{},{},{}
1094,1094,1184,10.1155/2017/1909101,28546877.0,record greater density wks subsequently magnesium hypothesis urinary increase excretion objective significantly pku glycomacropeptide intake phe medical measurement gov renal higher clinical attrs protein fold determined mouse absorptiometry fragility degradation food result microarchitectural pral urine consuming negatively bmd term combination crossover type low score clinicaltrials dual size mineral text provide strength phenylketonuria potential ray net diet age sample two reduces load likely bone reduced trabecular background nct trial conclusion skeletal high acid similar dietary participant complication amino calcium,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436062/,abstract,1,wks trabecular pral microarchitectural fragility bmd absorptiometry magnesium dual consuming skeletal ray net mineral load excretion attrs calcium strength crossover reduces bone negatively glycomacropeptide density subsequently renal clinicaltrials nct gov determined degradation urinary record fold reduced complication hypothesis text urine size likely combination intake measurement greater provide score similar mouse participant food background phe objective trial increase medical diet dietary pku amino conclusion term higher sample phenylketonuria low significantly type acid potential protein age high clinical result,"{""urine"": {""freq"": 1, ""string"": [""record fold reduced complication hypothesis text urine size likely combination intake m""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""trial increase medical diet dietary pku amino conclusion term higher sample p""]}}","{""diet"": {""freq"": 1, ""string"": [""background phe objective trial increase medical diet dietary pku amino conclusion t""]}}",{}
1095,1095,1185,10.1038/s41598-017-18358-y,29317692.0,region single early prenatal synthase five tetrahydrobiopterin accurate fetus testing noninvasive hydroxylase gestational deduce phenylalanine family heterozygous probands consistent fluid amniotic haplotype gestation genomic genotype diagnosis pregnancy fetal hpa capture hybridization four mutation three one pyruvoyltetrahydropterin normal week pyruvoyl feasible method parent polymorphism parental probe feasibility allelic maternal carrier linkage within two variant hyperphenylalaninemia invasive identical validated dna also pah plasma nucleotide successfully developed accuracy highly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760544/,abstract,2,amniotic pyruvoyltetrahydropterin deduce pyruvoyl developed probands identical noninvasive allelic hybridization fetus gestation haplotype probe linkage validated heterozygous capture hpa feasibility invasive feasible gestational synthase successfully parental fluid accurate prenatal fetal hyperphenylalaninemia nucleotide polymorphism carrier tetrahydrobiopterin accuracy genotype pregnancy genomic maternal dna consistent pah highly parent week hydroxylase testing region normal plasma variant single family mutation early phenylalanine diagnosis method,"{""phenylalanine"": {""freq"": 2, ""string"": []}}","{""heterozygous"": {""freq"": 1, ""string"": [""fetus gestation haplotype probe linkage validated heterozygous capture hpa feasibility invasive f""]}}",{},{},{},{}
1096,1096,1186,10.1177/1178623X17694346,28579794.0,various specific disorder methodological information largely prognostic platform addressing due fact urinary way disease status briefly account related cancer organ optimal health clinically particular error inborn rejection analytical metabolic attention purpose urine furthermore snapshot type metabolism consideration useful transplant although cellular nuclear biomarkers infection provide discovery many critical review product development via potential article test diabetes downstream hence application field analysis special metabolomics diagnostics eventually diagnostic different tissue study magnetic rapidly discipline number kidney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428226/,abstract,0,snapshot rejection addressing prognostic eventually briefly methodological transplant discipline fact rapidly diagnostics kidney downstream special largely urinary organ nuclear consideration platform analytical optimal discovery diabetes metabolomics magnetic cellular account infection urine useful clinically way particular cancer purpose critical attention furthermore tissue biomarkers product provide related status field diagnostic various inborn application error information article number metabolism test specific type review potential different development metabolic health disorder analysis disease study,"{""urine"": {""freq"": 1, ""string"": [""diabetes metabolomics magnetic cellular account infection urine useful clinically way particular c""]}}",{},{},{},{},{}
1097,1097,1187,10.3390/ijms20102576,31130665.0,quantifiable whole advance cancer understanding culture mass better new strategy ultra biomarkers transcriptomics recent genomics strong essential drug implementation therapy field protein omics biologically either global review metabolomics spectrometry technique biomedicine identification pathophysiology oncological prevention development target analytical diagnosis technology towards tissue rationale domain study human treatment thousand active term routine well disease proteomics successful performance cell amount bodily metabolite argue detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567119/,abstract,0,quantifiable oncological biomedicine bodily transcriptomics biologically ultra proteomics rationale omics argue thousand culture pathophysiology routine genomics analytical strong successful metabolomics active domain advance global implementation cancer understanding tissue spectrometry prevention biomarkers technique essential identification technology performance field target better detection metabolite mass drug strategy recent therapy term cell new human diagnosis review protein development treatment disease study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""identification technology performance field target better detection metabolite mass drug strategy r""]}, ""spectrometry"": {""freq"": 1, ""string"": [""advance global implementation cancer understanding tissue spectrometry prevention biomarkers technique essential i""]}}",{},{}
1098,1098,1188,10.1186/s12913-017-2430-x,28724420.0,conclusionthe court filing judicial inequality sole threat herein fundamental glargine commission methodsthis despite programme superior state source ministry backgroundin increase characterize sistema physician demand evidence pharmaceutical lawyer nature health demonstrating judicialization distribution improvement secondary request lawsuit data prescribers predominant medication disagreement medicine period service significant case neither scientific code department normal evidencing regard descriptive product private secretary assistance resultsin via national system technology concentration computerized treatment diabetes sus incorporation care defendant brazil universal nico process component advance protocol paulo specialized access constitution approximately either characteristic policy right study insulin human aspart individual brazilian number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517947/,abstract,3,sistema prescribers paulo nico lawyer judicialization judicial glargine filing evidencing defendant aspart sus lawsuit disagreement constitution secretary computerized court sole request inequality ministry commission assistance threat specialized code incorporation private predominant brazilian regard department demonstrating demand backgroundin superior resultsin brazil fundamental methodsthis universal descriptive programme insulin right pharmaceutical characterize conclusionthe physician medication access scientific nature distribution diabetes protocol approximately advance secondary policy component service source improvement national product despite medicine characteristic period technology process normal state increase care concentration evidence number case individual human significant health data treatment study,{},{},{},{},{},{}
1099,1099,1189,10.1534/genetics.114.174110,25808955.0,caenorhabditis monooxygenase activity synthetic among specifically several behavioral limiting tetrahydrobiopterin condition due host bacterial state aromatic enzymatic fragile synthesize synthases synthesis amine rather dopamine dysfunction alkylglycerol putative epidermis mutant cuticular neurotransmitter knockout enzyme metabolic exogenous nematode lipid metabolism level cuticle rate three one biogenic phenotype hypersensitive indistinguishable sensitivity pathogen loss generally deficient lack agmo nitric serotonin aaah regeneration function alters dependent natural widely also interaction oxide acid cofactor deficiency steady agent amino gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423366/,abstract,0,monooxygenase limiting indistinguishable cuticular cuticle agmo aaah nematode hypersensitive epidermis caenorhabditis synthases alters alkylglycerol synthesize steady biogenic fragile amine regeneration pathogen knockout host exogenous putative nitric enzymatic bacterial aromatic oxide synthetic serotonin lipid neurotransmitter deficient generally specifically agent cofactor mutant widely dopamine tetrahydrobiopterin behavioral natural dependent sensitivity loss lack synthesis dysfunction phenotype interaction enzyme state deficiency rate activity amino condition function metabolism acid metabolic gene level,"{""behavioral"": {""freq"": 1, ""string"": [""agent cofactor mutant widely dopamine tetrahydrobiopterin behavioral natural dependent sensitivity loss l""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""interaction enzyme state deficiency rate activity amino condition function metabolism acid m""]}}",{},{}
1100,1100,1190,10.1017/jns.2016.13,27293559.0,surgery considerable blood investigation energy composition hibw lower profile formula present glucose initial liquid weight pressure additional need mean majority well respectively severely measurement however subject reduction surgeryabbreviations anthropometric higher denmark word absorptiometry improvement body kcal efficacy metabolic decrease low diastolic safely dual systolic week plan prerequisite loss free preoperative ray dxa key diet lcd bariatric bmi fat within libw mass obese percentage sem achieve aim tag part study whereas insulin mmhg undergo patient thirty cambridge preparation total parameter ldl,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891557/,abstract,8,surgeryabbreviations mmhg libw lcd hibw bariatric sem preoperative tag undergo safely kcal dxa cambridge diastolic absorptiometry systolic prerequisite ldl denmark dual ray surgery anthropometric severely achieve thirty obese formula bmi preparation plan insulin fat percentage pressure considerable composition initial word energy glucose majority liquid parameter investigation decrease profile improvement efficacy weight mean loss reduction free measurement week additional need body aim mass subject key lower diet respectively total higher low present blood metabolic patient study,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""body aim mass subject key lower diet respectively total higher low p""]}}",{}
1101,1101,1191,10.1038/srep18031,26658758.0,experimental dramatic nine investigation absolute growth energy amorpha liquid molecular fungi symbionts increase material membrane synthesis transcription mycorrhizal woody form isobaric relative defense leguminous protein degradation result transport metabolic root effect change quantification colonization tandem mycorrhiza plant metabolism level significant perennial stress transduction cellular dimensional structure provide fungal amf expression stage unknown free arbuscular treatment gel signaling intensity maturation two mass colonize category shrub function classified mechanism characteristic spectrometry itraq also foundation tag fruticosa study total chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674871/,abstract,5,woody shrub perennial mycorrhizal mycorrhiza leguminous itraq fruticosa colonize arbuscular amorpha amf symbionts isobaric fungi tag root colonization fungal dramatic defense maturation gel absolute transduction plant signaling intensity dimensional classified quantification foundation membrane transport degradation transcription category energy tandem cellular liquid experimental relative chromatography unknown stage investigation stress synthesis structure free spectrometry growth provide characteristic form mass expression change increase molecular mechanism total material function metabolism protein significant metabolic effect level treatment result study,{},{},{},"{""tandem"": {""freq"": 1, ""string"": [""membrane transport degradation transcription category energy tandem cellular liquid experimental relative c""]}, ""spectrometry"": {""freq"": 1, ""string"": [""stage investigation stress synthesis structure free spectrometry growth provide characteristic form m""]}}",{},{}
1102,1102,1192,10.3791/56613,29443066.0,implication complex strain cancer mutation multi example inducible transgene vivo vein application transposon step regeneration constitutive achieve cover specifically variety manipulation adult induce cre advanced inflammation procedure analysis liver approach mouse model efficient shrna loxp research hydrodynamic together method choice technique fibrosis mir expression system tissue injection addition treatment reliable crispr creer combination disease genetic gene highly hepatocytes preparation useful beauty flexible tail,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912325/,abstract,0,creer transposon loxp beauty constitutive vein inducible cre shrna tail mir manipulation hydrodynamic flexible transgene regeneration cover induce crispr strain achieve hepatocytes advanced preparation fibrosis injection inflammation reliable multi choice efficient variety specifically procedure vivo useful step implication cancer example liver combination tissue highly technique mouse application addition expression complex adult mutation approach model research gene genetic method treatment analysis disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1103,1103,1193,10.1186/s12887-015-0323-x,25886474.0,tool cochrane self iem among across complexity researcher five additional literature abstract conclusionspatient methodswe eligible well disease material reviewer relevant supplementary family strategy unique user health doi primary error report support inborn result title data focused metabolism use full one independent measure pre etiology text child outcome review approach management mental frequently second epilepsy article online manifestation electronic diabetes backgroundimprovements medline care liberal version materialthe informed rare consensus protocol future two accelerated palsy pediatric discrepancy embase chronic field criterion emergent characteristic priority research program available broad importance relatively foundation comprehensive domain study similar cerebral patient citation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334411/,abstract,3,conclusionspatient backgroundimprovements liberal title discrepancy palsy reviewer informed accelerated emergent focused citation abstract eligible cochrane epilepsy cerebral priority embase foundation complexity medline doi consensus broad researcher manifestation etiology diabetes protocol relatively iem unique frequently text independent comprehensive domain methodswe pre mental pediatric second criterion self chronic materialthe relevant importance characteristic additional field similar literature inborn support tool measure supplementary management program user primary version strategy electronic error online future use report rare family care material outcome article approach available metabolism research review child health data result patient disease study,{},{},{},{},{},{}
1104,1104,1194,10.1093/molehr/gaw034,27256483.0,major italy implication specific biopsy tool collation whether wanted example proposal embryologist specifically positive newest complexity cleavage reproductive five slowly cautioncare molecular together view expert vitrification parallel genetics geographical clear outside eset experience publication favour reliable well funding specialist solution amongst material opinion chancethe issue spectrum third account actively however methodsa introduction unique lacking chromosome form perspective questionnaire role range distribution ideal alone layer expertise indication mosaicism massive china implantation result debate large belgium obtain reference embryo basis design question furthermore first combination genetic ongoing fertility useful area use redaction peer hybridization three fortiori main interest scientific blastocyst possibly discussion current serial wider outcome comparative approach reason participate method efficiency conduct development stage colleague potential technology towards second participation europe meeting germany address probe overview wide robust future sample spain lack rank scope timing scale findingsthis greece carefully biologist ivf currently analysis aspect benefit paper widely coverage array preimplantation pgs questionwe general group comprehensive practice different high presentation study sequencing scepticism distinct patient limitation thirty participant thawing explains,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986417/,abstract,1,wanted thawing redaction questionwe greece fortiori findingsthis eset embryologist collation chancethe cautioncare vitrification scepticism newest colleague biologist serial blastocyst pgs mosaicism lacking ivf explains cleavage rank proposal preimplantation implantation belgium massive fertility favour wider timing spain funding biopsy slowly geographical outside meeting italy ideal carefully participate hybridization expertise array actively scope obtain layer conduct comparative europe embryo debate thirty probe possibly peer opinion ongoing germany chromosome participation coverage reproductive reason complexity indication specialist parallel methodsa publication efficiency discussion clear reliable introduction china view solution distinct overview expert scientific specifically robust presentation question distribution limitation widely reference unique aspect account perspective comprehensive address useful stage experience basis implication second questionnaire example lack genetics combination furthermore sequencing practice currently wide design general scale benefit paper issue main technology spectrum participant form area tool major range positive large future molecular use current material outcome role sample approach specific potential different development group high genetic method analysis result patient study,{},"{""genetic"": {""freq"": 1, ""string"": [""specific potential different development group high genetic method analysis result patient s""]}}",{},{},{},{}
1105,1105,1195,10.1080/20016689.2017.1299665,28473888.0,italy european specific correlation assessment relationship country inverse median due cost highlight orphan objective disease sweden price higher value support result data payer significance website medicine non regression significant although agency per discussion annual norway drug simple method attribute rarest factory analyse treatment germany pricing decision stronger process rare consensus spain prevalence statistical currently analysis background except conclusion different high study france patient rarity idea complex statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405566/,abstract,2,rarest pricing factory attribute price payer norway inverse website spain sweden france agency italy rarity idea orphan analyse stronger annual germany consensus discussion significance simple statistically european statistical decision median regression cost currently highlight correlation medicine prevalence relationship country assessment background process support objective complex drug value rare conclusion higher non specific different significant high method data treatment analysis result patient disease study,{},{},{},{},{},{}
1106,1106,1198,10.1038/srep38140,27905536.0,specific blood viability difference pathway among microtubule initial elevated without molecular due moreover addition increase pku synthesis phe tyrosination reversible phenylalanine event place dysfunction value retraction brain mouse possibility transfection cyclic exogenous effect novo neurite first greatly level significant vii rate normal dynamic tyrosine terminal known phenylketonuria plasmid post translational antibody unknown proportion iii incorporation cell terminus detyrosination conceivable undergoes mechanism characteristic also high human patient inhibitory beyond proliferation presence return,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131269/,abstract,0,tyrosination retraction detyrosination conceivable vii neurite microtubule undergoes cyclic viability transfection terminus known return plasmid incorporation reversible terminal greatly inhibitory exogenous novo proliferation iii antibody translational place dynamic possibility initial proportion event elevated post unknown synthesis dysfunction presence tyrosine characteristic mouse phe normal addition value increase pathway brain molecular mechanism rate pku difference cell phenylketonuria human phenylalanine specific blood significant effect high level patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""rate pku difference cell phenylketonuria human phenylalanine specific blood significant effect h""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""mouse phe normal addition value increase pathway brain molecular mechanism rate p""]}}",{},{},{}
1107,1107,1199,10.3748/wjg.v24.i8.894,29491683.0,major conclusionthe coenzyme considerable physiological difference pathway among profile hyperalgesia feces without biosynthesis together host supplementation differentially addition well significantly biochemical relevant phenylalanine irritable role coa mouse diarrhea symptom fecal metabolic microbial clostridium phenylethylamine metabolism stress water progression current syndrome modulation approach model day gas exposure treatment ten key hormone steroid ibs process methodsin sample multivariate mass appropriate butyricum analysis benefit bowel spectrometry avoidance pantothenate metabolomic group study total aimto metabolite chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829153/,abstract,3,phenylethylamine hyperalgesia butyricum pantothenate irritable ibs clostridium modulation feces fecal avoidance steroid diarrhea aimto coenzyme microbial bowel host differentially metabolomic methodsin multivariate coa biosynthesis gas conclusionthe considerable progression physiological hormone water chromatography appropriate supplementation profile stress exposure spectrometry syndrome relevant benefit biochemical mouse symptom process metabolite addition mass day major key pathway total current role difference sample approach metabolism significantly model phenylalanine metabolic group treatment analysis study,"{""phenylalanine"": {""freq"": 2, ""string"": [""difference sample approach metabolism significantly model phenylalanine metabolic group treatment analysis s""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""metabolite addition mass day major key pathway total current role difference s""]}}","{""spectrometry"": {""freq"": 1, ""string"": [""chromatography appropriate supplementation profile stress exposure spectrometry syndrome relevant benefit biochemical m""]}}",{},{}
1108,1108,1200,10.3892/etm.2016.3260,27347028.0,experimental intelligence correlation pathogenesis blood abnormality neural factor early among examine abnormal largely intractable present encephalic organic common prognosis hypoevolutism optical risk encephalon spasm motor control experience etiological influential disease significantly family partial possible screening anti brain inborn result six metabolic symptomatic urine auditory change tomography routine infantile tandem type case one hepatic retrogression drug child simple imageology history gas potential epileptic epilepsy test attack treatment nevertheless fatty sample two mass biochemistry especially function stem analysis aim spectrometry also multiple conclusion group often study magnetic successfully skin acid patient underwent amino total chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907171/,abstract,23,retrogression imageology hypoevolutism encephalon encephalic intractable spasm attack etiological optical infantile influential epileptic auditory biochemistry intelligence underwent tomography epilepsy prognosis symptomatic skin stem neural hepatic pathogenesis gas successfully partial routine largely examine organic simple anti motor tandem magnetic abnormal experimental fatty urine chromatography experience history abnormality spectrometry especially correlation possible inborn aim screening mass change multiple drug brain family total amino conclusion common function sample present case test significantly risk early control factor blood type acid potential child metabolic group treatment analysis result patient disease study,"{""skin"": {""freq"": 1, ""string"": [""intelligence underwent tomography epilepsy prognosis symptomatic skin stem neural hepatic pathogenesis g""]}, ""urine"": {""freq"": 1, ""string"": [""motor tandem magnetic abnormal experimental fatty urine chromatography experience history abnormality s""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""change multiple drug brain family total amino conclusion common function sample p""]}, ""tandem"": {""freq"": 1, ""string"": [""largely examine organic simple anti motor tandem magnetic abnormal experimental fatty u""]}, ""spectrometry"": {""freq"": 1, ""string"": [""fatty urine chromatography experience history abnormality spectrometry especially correlation possible inborn a""]}, ""screening"": {""freq"": 1, ""string"": [""spectrometry especially correlation possible inborn aim screening mass change multiple drug b""]}}",{},{}
1109,1109,1201,10.3389/fphys.2018.00171,29593549.0,major various contributor neurovascular blood asymmetric vivo among explain reproduce essential across homeostasis mbecs lnaas trans bbb stimulation injection endothelial hypothesis finally nvu membrane homeostatic unit however phenylalanine experimentally uptake brain fluid distribution astrocyte transport solute effect large data basis computational far lat rat low functional neutral inhibitor dynamic transporter proper tyrosine mbec passage model accounting regulation affinity method polarity concentration response cell perfusion robust neuron intraendothelial primarily interstitial standard competitive function either vitro available also microvascular upon interaction acid intraperitoneal barrier limitation circumvent amino precisely complex intrinsic asymmetry,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859092/,abstract,0,passage mbecs mbec intraendothelial reproduce nvu bbb asymmetry perfusion neurovascular lnaas precisely polarity microvascular lat interstitial homeostatic circumvent solute intraperitoneal competitive astrocyte experimentally contributor asymmetric intrinsic accounting explain uptake trans affinity neuron endothelial stimulation proper neutral computational membrane transporter transport unit injection primarily fluid far inhibitor dynamic barrier homeostasis robust rat distribution limitation hypothesis vitro vivo basis regulation finally tyrosine essential functional standard interaction various major complex response large brain concentration amino cell function low available model phenylalanine blood acid effect method data,"{""phenylalanine"": {""freq"": 2, ""string"": [""amino cell function low available model phenylalanine blood acid effect method d""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""major complex response large brain concentration amino cell function low available m""]}}",{},{}
1110,1110,1202,10.1016/j.ymgmr.2015.01.002,28649533.0,positive intractable document grandparent condition old control hcps pku excellent intake phe however later phenylalanine resort childhood possible follow place home burden food thereafter foster effect decrease kinship adherence first low consideration non service case referral discussion child approach management phenylketonuria frequently persistently abbreviation social sufficient parent second concentration treatment adolescence year diet placement strict two professional lifelong chronic girl importance foundation high last study dietary patient rarely caregiver,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471161/,abstract,0,resort kinship hcps grandparent placement intractable persistently foster rarely abbreviation adolescence strict referral lifelong girl document home foundation excellent place caregiver sufficient discussion adherence consideration later burden frequently follow service professional decrease childhood second old chronic intake social parent importance possible food phe management positive diet dietary concentration pku condition non phenylketonuria low approach case phenylalanine control child year effect high treatment patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""condition non phenylketonuria low approach case phenylalanine control child year effect h""]}, ""social"": {""freq"": 1, ""string"": [""decrease childhood second old chronic intake social parent importance possible food p""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""importance possible food phe management positive diet dietary concentration pku condition n""]}}",{}
1111,1111,1203,10.3390/nano9060858,31195669.0,factor information invertebrate biomedical physical severe derivative chemical toxicity rgo physicochemical commercial life unique oxidation broadly generalization higher health range gbns therefore body environment property nanomaterials effect purpose design little terrestrial mortality commonly although full rate toxic ecosystem collectively degree ass exposure reproduction concentration test key wide two crypticus urgent application correlate especially limited field graphene adverse impairment aim posse ecotoxicity cycle high study oxide safe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631203/,abstract,1,terrestrial rgo generalization gbns ecotoxicity crypticus physicochemical ecosystem nanomaterials invertebrate graphene urgent reproduction posse commercial derivative broadly biomedical collectively toxicity correlate safe oxidation oxide toxic degree commonly chemical little cycle unique property mortality adverse environment physical exposure impairment limited purpose especially wide design ass field severe body aim application range key information rate life concentration higher test factor health effect high study,{},{},{},{},{},{}
1112,1112,1205,10.1007/s10544-019-0412-y,31418068.0,process blood sample future challenge shift actionable interest disadvantage discus time current invasive field platform point clinically analysis review technique improvement molecular body quantity conventional variation closer potential diagnosis diagnostic often safer skin effective regulatory reliable turnaround advantage faster quantification patient miniaturization disease though even significantly look care highly amount detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695349/,abstract,0,safer turnaround miniaturization closer look disadvantage actionable faster quantity shift skin quantification conventional invasive reliable platform advantage clinically regulatory improvement variation point highly technique discus field diagnostic detection body process challenge effective future molecular care current sample time significantly blood diagnosis review potential analysis patient disease,"{""skin"": {""freq"": 1, ""string"": [""look disadvantage actionable faster quantity shift skin quantification conventional invasive reliable p""]}}",{},{},"{""detection"": {""freq"": 1, ""string"": [""point highly technique discus field diagnostic detection body process challenge effective f""]}}",{},{}
1113,1113,1206,10.1186/s12889-018-5882-y,30068393.0,major specific beverage activity allocation whether vegetable difference backgroundobesity registration adult present student consent platform dietician weight adoption recruitment condition physical moreover parallel cost ethic inhabitant fruit methodswe principle effective intake assessor issue committee covariate form obesity clinical attrs health feature secondary body mina primary university efficacy large anticipate comprises change basis term pregnancy type low regression gerais three one independent requirement text problem exclusion outcome intervention population week assistance ass predictor social potential behaviour web loss participation online baseline gamification test habit treatment recommendation important network accessible year diet incidence discussionwe randomized challenge lifestyle bmi brazil universal protocol minimal mass access intention healthy minimum ufmg criterion analysis employee aim index prior program consumption research nct widely trial group plus overweight high last study arm dietary federal linear february participant healthcare brazilian number perception treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090922/,abstract,5,ufmg gamification employee backgroundobesity assessor anticipate discussionwe mina inhabitant gerais comprises covariate dietician assistance vegetable intention federal allocation adoption february recruitment overweight minimum habit arm fruit exclusion ethic brazilian consent attrs accessible registration randomized committee participation student brazil behaviour beverage plus perception web requirement bmi minimal universal lifestyle parallel principle predictor nct university access treat prior platform consumption linear widely protocol baseline obesity healthcare text network independent methodswe secondary pregnancy basis recommendation index incidence physical regression efficacy weight loss feature criterion cost intake social ass problem week issue participant body form aim healthy mass trial program major challenge change primary online effective large adult diet intervention dietary activity outcome term condition important difference low number present test specific type research population potential health group year high treatment clinical analysis study,"{""social"": {""freq"": 1, ""string"": [""weight loss feature criterion cost intake social ass problem week issue p""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""change primary online effective large adult diet intervention dietary activity outcome t""]}}",{}
1114,1114,1207,10.1136/bcr-2015-213742,27118741.0,case life investigation much fishy improved boy laboratory arguably dietician quality modification analysis secondary foot report diagnosis hand consequently presentation old testing trimethylaminuria unusual urine saliva dietary odour patient year genetic care geneticist,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854139/,abstract,0,odour fishy trimethylaminuria arguably unusual foot dietician saliva improved geneticist hand boy consequently modification presentation urine secondary investigation old laboratory testing quality report dietary care life case diagnosis year genetic analysis patient,"{""urine"": {""freq"": 1, ""string"": [""geneticist hand boy consequently modification presentation urine secondary investigation old laboratory t""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1115,1115,1208,,30279715.0,significant case methodsin age seizure two iran uti febrile resultsamong difference factor among acute determine involved infection present pyelonephritis child word critical without central objectivesfebrile tract cystitis therefore simple identification common fever group conclusionurinary risk study control urinary key term association patient month qazvin type material highly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160625/,abstract,10,uti pyelonephritis objectivesfebrile cystitis conclusionurinary febrile qazvin resultsamong fever tract methodsin iran seizure urinary involved simple word infection acute central critical highly determine identification month key association material term difference common present case risk control factor type child age significant group patient study,{},{},{},{},{},{}
1116,1116,1209,10.1016/j.beha.2016.10.018,27890263.0,biological huge search new region content pathway among several defect innate splicing molecular physical need genetics publication classical way finally lasted transformation sequence element understanding concerted adaptive protein mouse candidate usually positional recently forward cause immune first immunity genetic susceptible mapping mutation three step microbe phenotype hard produce discovery many coding instantaneously system technology second response year heritable circumscribed particularly breakthrough function analysis genome turn faster show gene unnecessary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179328/,abstract,1,instantaneously circumscribed lasted concerted positional susceptible huge breakthrough unnecessary splicing microbe innate hard heritable transformation immunity faster coding turn mapping forward produce adaptive usually publication element candidate classical immune discovery search step content way sequence genome finally physical second understanding recently genetics particularly defect biological technology phenotype need mouse region cause response pathway molecular mutation function new protein gene year genetic analysis,{},"{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""phenotype need mouse region cause response pathway molecular mutation function new p""]}}",{},{},{}
1117,1117,1210,10.1007/s10545-017-0132-5,29423830.0,disorder blood abnormality early ammonia visual present laboratory prognostic ald despite condition need regular deficit mean motor well longitudinal biochemical distal marker cumulative endpoint citrullinemia clinical primary arginine report support equally link metabolic data score mortality level significant full citrulline asd biomarkers measure toxic synthetase evaluation outcome damage population management day identification history older exposure skill test treatment urea valuable greatest year generally age scale correlate argininosuccinic argd arginase natural indicator importance group cycle lyase often high domain study acid neuropsychological deficiency even participant prominent performance highly sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041144/,abstract,8,arginase argd ald argininosuccinic synthetase citrullinemia equally distal citrulline prognostic greatest endpoint prominent cumulative lyase indicator ammonia arginine regular urea neuropsychological correlate skill visual toxic valuable older link longitudinal generally damage asd sensitive motor cycle domain natural mortality history deficit abnormality mean marker exposure biomarkers highly evaluation despite laboratory importance identification scale biochemical performance need score participant support measure management day primary deficiency report outcome condition present test early blood population acid age significant metabolic group year high data level disorder treatment clinical study,{},{},{},{},{},{}
1118,1118,1211,10.1007/s10519-017-9863-1,28776207.0,disorder assessment blood notion daily better greater early present adult largely despite throughout additional fact mean motor control increase significantly pku transitory executive adulthood phenylalanine life evidence childhood poorly health range mol task thereafter result metabolic low period level flexibility onwards problem outcome phenylketonuria mental history target treatment adolescence year age poor influence cognitive analysis index upper relatively group often study dietary patient individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574956/,abstract,8,transitory onwards upper notion flexibility fact adolescence poorly adulthood largely executive mol motor task relatively daily poor mental history index childhood mean influence greater despite problem additional period target better assessment cognitive range increase adult dietary life evidence pku outcome phenylketonuria low present individual significantly early phenylalanine control blood age metabolic health group year level disorder treatment analysis result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""phenylketonuria low present individual significantly early phenylalanine control blood age metabolic h""]}}",{},{},{},{},{}
1119,1119,1212,10.1007/s12311-014-0592-1,25132500.0,respiratory search region difference lower adult frequency control hypercapnic well increase significantly slower purkinje lurcher however smaller reduction hypercapnia sudden mediating role developmental brain focus mouse wildtype body mutant contribution sids integration victim significance initiate mediate period level responsivity significant commonly whole although hypoxic four death compensatory volume hypoxia room plethysmography failure syndrome structure vulnerability breath model markedly flawed exposure loss sequentially response network help chemoreceptor initially cell neuropathology deficient continuously typically unclear determine since medullary chemosensitivity cerebellar magnitude reduced mechanism cardiovascular infant monitor also except cortex interaction high ventilatory nucleus tidal twenty minute air return,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462133/,abstract,0,ventilatory tidal sids responsivity purkinje medullary lurcher hypercapnic hypercapnia chemosensitivity chemoreceptor wildtype victim plethysmography mediating flawed cerebellar sudden sequentially hypoxic slower neuropathology compensatory initiate breath air hypoxia return nucleus vulnerability mediate smaller magnitude initially continuously minute respiratory monitor room cortex markedly integration commonly typically failure deficient contribution significance cardiovascular reduced unclear mutant volume network search death help focus loss reduction exposure structure developmental syndrome frequency determine period interaction mouse region body infant increase response lower brain adult mechanism role difference cell significantly model control significant high level,"{""breath"": {""freq"": 1, ""string"": [""sequentially hypoxic slower neuropathology compensatory initiate breath air hypoxia return nucleus v""]}}",{},{},{},{},{}
1120,1120,1213,10.1080/15476286.2016.1219832,27618201.0,experimental pathogenesis disorder maximal culture respiratory vivo lower motile cloned reporter time several despite stimulation aag disturb effective way termination epithelial ptc line transcription pharmacological uag observed dysfunction transiently higher protein compound range ciliogenesis ptcs flagellum symptom primary stimulating ciliary experiment combination readthrough genetic susceptible type uaa construct suppression functional mutation wild cilium dual individually efficiency translational expression potential system sufficient concentration aminoglycosides susceptibility cell donor order premature healthy dyskinesia involved magnitude vitro translation except uga different vector highest gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056772/,abstract,5,uag uaa motile flagellum cloned cilium ciliogenesis ciliary aminoglycosides uga readthrough ptcs ptc dyskinesia disturb aag transiently construct susceptible termination maximal dual stimulating reporter suppression magnitude epithelial individually respiratory stimulation premature donor translational culture vector susceptibility pathogenesis experiment sufficient efficiency translation transcription involved pharmacological wild line highest experimental vitro vivo way observed compound dysfunction combination despite functional order symptom healthy expression range primary effective lower concentration mutation higher cell time type potential different protein gene genetic disorder,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1121,1121,1214,10.1590/1678-4685-GMB-2017-0235,30235399.0,wide inflammatory mood phenotypic commonly individual although disorder microbiome relationship two still utmost autism iem organ new strategy phenotype exert obesity strong variety influence structure incipient many brain light review liver monogenic bowel condition research body alone genetics error genotype host iems inborn also importance multifactorial interaction effect study human treatment patient disease diet long enough metabolism variability adjuvant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136378/,abstract,0,incipient utmost adjuvant exert multifactorial bowel mood host microbiome iems monogenic light commonly organ variability phenotypic variety strong iem obesity inflammatory genotype autism genetics liver structure influence wide importance phenotype relationship interaction body inborn long strategy error brain diet condition metabolism individual new human research review effect disorder treatment patient disease study,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""body inborn long strategy error brain diet condition metabolism individual new h""]}}",{}
1122,1122,1215,10.1016/j.ymgmr.2019.100464,30891420.0,various specific disorder single vus among counselor time laboratory platform molecular need minnesota cost august testing institution disease uncertain ophthalmology pathologist hereditary flexible subset till meet analytic clinical clinically academic report duplication effectiveness diagnosis university data significance generation genetic capture detection gastrointestinal panel one least blinded hybrid gold specialty ordering volume individually dermatology implementation many informatically potential sufficient test assay feasibility library rare sample variant custom standard pulmonary throughput next classified deletion analysis broad also december diagnostic lowest high sequencing yield patient steady highest accuracy preparation gene number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403447/,abstract,4,ophthalmology informatically vus ordering minnesota dermatology blinded pathologist counselor till steady specialty hybrid analytic meet custom flexible duplication august uncertain pulmonary library gold throughput individually academic lowest classified gastrointestinal capture hereditary december institution yield preparation feasibility subset broad sufficient deletion university significance platform highest panel volume accuracy effectiveness clinically implementation assay generation cost sequencing laboratory need testing diagnostic standard detection various variant single molecular report rare sample number test time specific diagnosis potential gene high genetic data disorder clinical analysis patient disease,{},"{""genetic"": {""freq"": 1, ""string"": [""time specific diagnosis potential gene high genetic data disorder clinical analysis p""]}}",{},"{""detection"": {""freq"": 1, ""string"": [""sequencing laboratory need testing diagnostic standard detection various variant single molecular r""]}}",{},{}
1123,1123,1216,10.5863/1551-6776-23.6.432,30697128.0,wide efficacious find robust case disorder dos pediatric single tertiary difficult involved limited dysfunction therapy outcome herbal adverse review attempt product mechanism usually natural routinely manner literature pathophysiology error conduct plan inborn state report common pharmacist often metabolic applicable effect article theoretical resource treatment patient disease limit ability agent medication metabolism complication rarity care,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336179/,abstract,0,pharmacist herbal efficacious theoretical rarity attempt conduct applicable tertiary routinely dos manner usually plan pathophysiology medication involved limit complication robust agent resource difficult natural adverse pediatric dysfunction limited product ability wide literature inborn state error single mechanism report care therapy outcome article common case metabolism review metabolic effect disorder treatment patient disease,{},{},{},{},{},{}
1124,1124,1217,10.1371/journal.pone.0127465,26020623.0,correlation notably unaltered growth composition essential signalling nutrient bckdha control close embryonic amount twice supply adequate higher protein fluid fold leucine cavity degradation rabbit result link sensor enzyme embryo pregnancy fetal branched lat metabolism ketoacid level three bcat dehydrogenase blastocyst transporter phosphorylation liver abundance day markedly development target mtor expression endometrium bcaa concentration isoleucine altered maternal transcript rna healthy comparison adipose demonstrate influence approximately diabetic impact aminotransferase dld plasma tissue high skeletal mrna whereas acid direct dehydrolipoyl mammalian muscle amino,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447349/,abstract,3,unaltered signalling endometrium dehydrolipoyl bckdha bcat ketoacid dld cavity rabbit blastocyst lat aminotransferase twice mtor bcaa adipose transcript supply branched skeletal sensor phosphorylation isoleucine altered notably embryo diabetic muscle leucine embryonic mammalian abundance mrna close markedly transporter fluid rna dehydrogenase adequate degradation link fetal composition fold demonstrate nutrient approximately pregnancy maternal direct comparison liver tissue influence correlation essential growth target enzyme healthy plasma day expression impact concentration amino higher metabolism control acid protein development high level result,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""healthy plasma day expression impact concentration amino higher metabolism control acid p""]}}",{},{}
1125,1125,1218,10.1101/mcs.a001842,28487886.0,rare future tool disorder however era newborn new interest discus screening especially genomics technical current positive expand many omics serious metabolomics extraordinarily development article landscape turn guide success lesson advantage important patient first genetic best initiative acknowledge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411690/,abstract,0,extraordinarily acknowledge expand turn lesson landscape omics era initiative technical guide success genomics advantage metabolomics best especially discus tool screening positive future rare newborn current article important new development genetic disorder patient,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""newborn"": {""freq"": 1, ""string"": [""discus tool screening positive future rare newborn current article important new d""]}, ""screening"": {""freq"": 1, ""string"": [""advantage metabolomics best especially discus tool screening positive future rare newborn c""]}}",{},{}
1126,1126,1219,,29259526.0,specific momentum vivo transformative molecule warrant time laboratory germline modification increasingly moreover effective number disease ethical emergence issue quick sequence recruit animal endonuclease clinical therapy move double globally base crispr genetic potentially non period use bind yet although cheap short scientific fully generate review model technique development target potential system consequently technology towards simultaneously guide topic important introduce still within legal rna complementary easy since influence dna framework also infancy rapidly patient highly complex contentious,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733851/,abstract,0,introduce contentious transformative momentum endonuclease cheap recruit generate quick warrant globally germline emergence easy crispr bind complementary simultaneously legal rapidly topic infancy base guide consequently ethical fully rna modification double scientific increasingly framework molecule vivo potentially sequence dna short animal influence highly technique laboratory issue period technology target complex effective use therapy non important number time model specific review potential development genetic clinical patient disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1127,1127,1220,10.1038/pr.2015.167,26322415.0,activity among necessary tetrahydrobiopterin responder responsive hydroxylase pku phenylalanine observed body genotype china undergone data term generation novel first long administration mutation least scarce prediction responsiveness known phenylketonuria technique method frequently potential test response association challenge two accordingly residual loading next background research pah conclusion distinct patient total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700046/,abstract,5,undergone known scarce responsiveness responder loading accordingly residual responsive prediction china distinct tetrahydrobiopterin frequently genotype necessary administration observed pah generation technique hydroxylase body background long challenge response association novel total activity mutation pku conclusion term phenylketonuria test phenylalanine research potential method data patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""mutation pku conclusion term phenylketonuria test phenylalanine research potential method data p""]}}",{},{},{},{},{}
1128,1128,1221,,31037078.0,experimental training qods statistic disorder nine clinic difference lower objectivesphenylketonuria methodsthis reaction necessary need investigate control disease significantly pku material semi session workshop family form northwestern questionnaire word burden thus effect interview data routine genetic score service educational significant zarit software pre overall child spss intervention inferential able descriptive divided model phenylketonuria mental post prone resultsin parent holistic test treatment mother collection empowerment key qazvin diet care city particularly dimension lifelong demographic psychiatric adverse hospital characteristic program also conclusion group high endocrine study pamphlet randomly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451866/,abstract,1,qods pamphlet objectivesphenylketonuria empowerment zarit northwestern qazvin inferential divided endocrine workshop dimension prone holistic spss training session lifelong semi resultsin city statistic software randomly methodsthis demographic descriptive educational routine interview psychiatric word able burden mother experimental post clinic necessary pre mental collection reaction service adverse questionnaire hospital investigate particularly parent characteristic need overall score form program key lower diet family intervention care pku material conclusion difference phenylketonuria test significantly model control child significant group effect high genetic data disorder treatment disease study,"{""psychiatric"": {""freq"": 1, ""string"": [""methodsthis demographic descriptive educational routine interview psychiatric word able burden mother e""]}}","{""genetic"": {""freq"": 1, ""string"": [""control child significant group effect high genetic data disorder treatment disease s""]}}",{},{},"{""diet"": {""freq"": 1, ""string"": [""overall score form program key lower diet family intervention care pku m""]}}",{}
1129,1129,1223,10.1007/s10803-017-3262-6,28856504.0,yet presence disorder within asd autism evidence opportunity interest communication prevalence speech whilst present prevent consistent many quality review provision symptom extant literature widely recessively difficulty diagnosis behaviour like metabolic study misdiagnosis language treatment well iii late genetic mucopolysaccharidosis type systematic total repetitive spectrum,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633638/,abstract,1,mucopolysaccharidosis extant misdiagnosis recessively speech repetitive whilst provision iii behaviour language asd communication late difficulty widely opportunity prevent systematic autism consistent presence like prevalence spectrum literature symptom quality total evidence present type diagnosis review metabolic genetic disorder treatment study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1130,1130,1224,10.1093/cdn/nzz007,30882062.0,biological statistic factor information nutrition brief behavioral half weight recruitment additional variation saliva well survey visit measurement trajectory account however socioecological family gov life strategy obesity intent clinical health home move nondiverse environment report multilevel portend term theory first type clinicaltrials backgrounddietary measure text strong child descriptive stool model conclusionsthe temperament kid predictor contact social organization habit team mother collection prepregnancy diet care maternal overview age future sample methodsthe obese lifelong breastfeed biology community limited birth influence height basic either socioemotional characteristic research program nct infant relatively trial multiple prevention policy group cohort pattern study synergistic direct dietary inform objectivethe individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417908/,abstract,10,socioecological portend nondiverse breastfeed backgrounddietary temperament socioemotional prepregnancy intent kid synergistic stool multilevel objectivethe saliva contact recruitment habit trajectory visit theory obese height brief lifelong team statistic home descriptive clinicaltrials inform methodsthe predictor nct gov half basic organization conclusionsthe overview strong biology mother relatively nutrition account obesity text behavioral community policy collection maternal environment direct pattern survey weight limited variation measurement prevention influence social biological cohort characteristic additional birth measure infant trial program multiple strategy future diet report family dietary care information life term sample individual model factor type research child age health group clinical study,"{""behavioral"": {""freq"": 1, ""string"": [""mother relatively nutrition account obesity text behavioral community policy collection maternal e""]}, ""social"": {""freq"": 1, ""string"": [""weight limited variation measurement prevention influence social biological cohort characteristic additional b""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""infant trial program multiple strategy future diet report family dietary care i""]}}",{}
1131,1131,1225,10.1007/s12687-017-0318-4,28730583.0,level finnish specific knowledge mutation opportunity unique local enriched health selection population attempt review special background monogenic research genomic identification diagnostics development finland hand different like differs treatment well way disease genetic care medicine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614886/,abstract,0,finnish finland differs enriched attempt hand diagnostics monogenic special local unique opportunity selection way genomic medicine identification like knowledge background care mutation specific research population review different development health genetic level treatment disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1132,1132,1226,10.1038/srep45178,28345601.0,biological correlation specific blood whether importantly single technical several reaction median inaccurate biomarker control transition measurement utility fundamentally relative clinical protein determined peptide large data run change quantification combination medicine detection use yet although interest measure strong eighty discovery approach abundance technique minimally potential serum collection original monitoring sample two mass spot scale statistical invasive throughput reproducibility quality analysis spectrometry also multiple group high part study medium proteomics highly number sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366927/,abstract,0,inaccurate fundamentally minimally eighty run proteomics throughput reproducibility original abundance importantly quantification technical transition invasive peptide determined biomarker medium monitoring sensitive strong discovery utility statistical relative median collection reaction serum combination measurement spectrometry highly spot correlation technique biological medicine scale detection measure mass change multiple quality large single use sample approach number specific control blood potential protein group high data clinical analysis study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""spot correlation technique biological medicine scale detection measure mass change multiple q""]}, ""spectrometry"": {""freq"": 1, ""string"": [""median collection reaction serum combination measurement spectrometry highly spot correlation technique b""]}}",{},{}
1133,1133,1227,10.1017/S1368980019001071,31104648.0,expensive self hour observation among nutrition adult medically pantry throughout supplemental five condition cost highlight poverty grocery well disease objective survey philadelphia mentally month demand related family procurement obesity clinical home burden particular primary food result store qualitative interview household design pennsylvania reliance member least one shopper dual end monthly child intervention population chop maintenance management elucidates assistance illness charitable help soup nearly within negative appropriate healthy chronic quality cognitive kitchen benefit hospital impact program depth eighteen conclusion cycle overweight often dietary shortfall participant financial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6641996/,abstract,2,soup shortfall shopper procurement philadelphia pennsylvania pantry kitchen grocery chop charitable mentally reliance elucidates poverty store monthly medically household assistance supplemental eighteen dual expensive depth financial overweight demand illness maintenance home nearly observation qualitative interview hour end member burden cycle nutrition obesity appropriate particular help survey negative hospital self cost chronic highlight design related benefit participant food cognitive month healthy objective management program primary quality adult family impact intervention dietary conclusion condition population child clinical result disease,{},{},{},{},{},{}
1134,1134,1228,10.3791/52619,25867233.0,entire blood disorder new final automated essential standardized platform subsequently inappropriately pair testing essen finally virus disease transportation infectious decade marker today variety user storage card analytical century effectiveness diagnosis metabolic recently purpose comprises first hepatitis innovative variable step pre cover infection drug many second serum resource collection active year emerge phase systematic city immunodeficiency german protocol berlin newborn application spot pilot especially elution since limited ago field analysis background paper diagnostic comprehensive study human predominantly even exception preparation idea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397000/,abstract,0,inappropriately essen automated transportation emerge comprises berlin german elution immunodeficiency cover idea hepatitis today innovative century ago exception card standardized pair final entire predominantly city infectious subsequently pilot preparation virus storage platform analytical variety protocol decade infection active comprehensive resource systematic effectiveness step phase pre collection finally variable serum second recently marker limited purpose especially spot essential paper field testing diagnostic background application user drug newborn new human blood diagnosis metabolic year disorder analysis disease study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""testing diagnostic background application user drug newborn new human blood diagnosis m""]}}",{},{}
1135,1135,1229,10.1016/j.tibtech.2018.11.002,30497870.0,process various microorganism future tool understanding synthetic advancement biomaterials new application recent discus improved biology today effort biotechnological community bioproduction engineering expand millennium function biologist ecosystem increasingly review behavior approach natural program fermentation development biotechnology consortium diverse biofuels microbial source treatment waste vastly ongoing agriculture carbon inexpensive medicine engineer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340809/,abstract,0,bioproduction biofuels millennium biologist ecosystem biomaterials fermentation engineer agriculture waste vastly biotechnological expand biotechnology microorganism inexpensive consortium carbon today improved microbial engineering ongoing advancement synthetic diverse increasingly biology community effort natural source understanding behavior medicine discus various process tool application program future recent function approach new review development treatment,{},{},{},{},{},{}
1136,1136,1230,10.1002/cctc.201402894,26925171.0,original significant specific covalent rate two phenylalanine acrylic enantiopure activity three single bar palii ammonia nanotube stable microreactor reaction racemic kinetic thiophen swcntcooh propanoic productive mol flow method min support immobilization six cycle lyase different mode continuous pali loss study system biocatalyst parsley acid pal nanostructured yield addition batch limitation carbon low diffusional amino resolution mixture,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744988/,abstract,8,thiophen swcntcooh racemic parsley palii pali nanostructured microreactor enantiopure diffusional biocatalyst acrylic propanoic productive nanotube covalent immobilization bar batch kinetic pal carbon original lyase ammonia mixture min mode flow yield continuous resolution stable mol limitation cycle reaction loss support addition single rate activity amino low phenylalanine specific acid different significant method study,"{""phenylalanine"": {""freq"": 2, ""string"": [""addition single rate activity amino low phenylalanine specific acid different significant m""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""loss support addition single rate activity amino low phenylalanine specific acid d""]}}",{},{}
1137,1137,1231,10.3748/wjg.v21.i6.1938,25684963.0,better prospectively morning difference colon palatability retake restriction ottawa superior colonoscopy ascorbic candy afternoon inadequate endoscopists well significantly excellent respectively willingness however gov adequate rating clinicaltrial higher clinical attrs subsegmental secondary polyethylene examination result efficacy ambulatory term type score acceptability significant rate main completion menthol elective per volume text overall outcome peg assignment electrolyte method free identifier associated randomized tasty split future minimal scale reduced quality either nct trial conclusion group plus different sugar arm study acid aronchick dietary supplemented patient ascpeg linear palatable disgusting preparation willing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323474/,abstract,8,tasty subsegmental retake menthol endoscopists electrolyte disgusting colon clinicaltrial candy ascpeg aronchick afternoon willingness split ottawa elective ambulatory palatable ascorbic colonoscopy assignment willing palatability morning completion supplemented identifier polyethylene peg acceptability arm prospectively inadequate attrs randomized rating superior sugar plus excellent minimal preparation nct adequate gov reduced examination restriction linear volume text secondary associated efficacy free scale main overall score better trial quality future respectively dietary rate outcome conclusion term higher difference significantly type acid different significant group method clinical result patient study,{},{},{},{},{},{}
1138,1138,1232,10.1297/cpe.27.67,29662265.0,process level biological iodothyronine selenoprotein element however neither selenium dio clarify form involved essential prevent trace together severe supplementation expression thereby serum biomarker thyroid study free human well deficiency hormone association conversion patient status increase tsh deiodinase respectively low useful severely numerous,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897581/,abstract,1,dio deiodinase selenoprotein iodothyronine clarify trace selenium tsh severely conversion thyroid biomarker element numerous involved hormone prevent useful supplementation serum free essential biological status severe process form expression increase association deficiency respectively low human level patient study,{},{},{},{},{},{}
1139,1139,1233,10.1212/WNL.0000000000004197,28701500.0,resonance csm correlation demyelination ratio difference content maximum spinal deficit control however evidence reduction myelopathy sseps define compression body conduction great conventional result column purpose fraction whole water functional signal independent imaging provide outcome technique method potential impaired myelin readout associated intensity finding cord specificity latency age somatosensory complementary electrophysiologic mscc mri healthy compromise limited scanner analysis cervical ssep also conclusion dorsal group high magnetic extent spondylotic patient canal mcc pathologic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562959/,abstract,2,sseps ssep spondylotic somatosensory myelopathy mscc electrophysiologic csm conduction compression canal mcc dorsal cervical spinal readout demyelination column scanner compromise pathologic latency cord myelin maximum define complementary intensity mri impaired imaging conventional resonance fraction extent water signal great magnetic independent specificity associated content deficit reduction limited purpose correlation technique provide functional ratio finding body healthy evidence outcome conclusion difference control potential age group high method analysis result patient,{},{},{},{},{},{}
1140,1140,1235,10.4183/aeb.2017.203,31149174.0,detect dispersion resultstypical squared blood methodsthe two phenylalanine densitometry example newborn extremely hyperphenylalaninemia spot adequate screening calibration appropriate confirm curve visible standard higher value equation usefulness range chromatogram mol determined phenylketonuria conclusionsthe infant determination image parallel tlc hplc methodology plate severe plasma high concentrated concentration contrast acid objectiveto linearity small patient selective pku hpa amino low show phe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516440/,abstract,2,resultstypical tlc squared dispersion densitometry concentrated linearity chromatogram usefulness calibration plate visible equation image confirm hplc extremely detect hpa curve objectiveto parallel methodsthe selective determination adequate determined conclusionsthe hyperphenylalaninemia methodology mol contrast appropriate example spot small standard severe phe infant screening plasma range value concentration newborn pku amino higher phenylketonuria low phenylalanine blood acid high patient,"{""phenylalanine"": {""freq"": 2, ""string"": []}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""plasma range value concentration newborn pku amino higher phenylketonuria low phenylalanine b""]}, ""newborn"": {""freq"": 1, ""string"": [""infant screening plasma range value concentration newborn pku amino higher phenylketonuria l""]}, ""screening"": {""freq"": 1, ""string"": [""spot small standard severe phe infant screening plasma range value concentration n""]}}",{},{}
1141,1141,1236,10.1186/s12887-018-1090-2,29534692.0,male disorder blood iem single early among nationwide neonatal affected organic cut testing addition well respectively biochemical screening oxidation clinical value symptom china error inborn result diagnosis six metabolic percentile combination tandem metabolism low mortality ultimately area detection backgroundmandatory case rapid mutation female crucial morbidity volume sensitivity child markedly method via treatment fatty city specificity sample resultsthe conclusionsfifty mass newborn percentage poor spot survival healthy especially reduced dna analysis spectrometry program infant part high acid advantage deficiency patient amino,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850921/,abstract,8,conclusionsfifty backgroundmandatory nationwide percentile cut ultimately city markedly oxidation crucial percentage survival china affected organic resultsthe reduced advantage tandem morbidity iem volume fatty poor specificity mortality dna female sensitivity neonatal rapid combination spectrometry especially spot male biochemical testing detection inborn symptom area infant healthy screening addition mass program value error single deficiency respectively newborn mutation amino sample low case metabolism early blood diagnosis acid child metabolic high method disorder treatment clinical analysis result patient,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""spectrometry especially spot male biochemical testing detection inborn symptom area infant h""]}, ""amino"": {""freq"": 1, ""string"": [""error single deficiency respectively newborn mutation amino sample low case metabolism e""]}, ""tandem"": {""freq"": 1, ""string"": [""china affected organic resultsthe reduced advantage tandem morbidity iem volume fatty p""]}, ""spectrometry"": {""freq"": 1, ""string"": [""dna female sensitivity neonatal rapid combination spectrometry especially spot male biochemical t""]}, ""newborn"": {""freq"": 1, ""string"": [""program value error single deficiency respectively newborn mutation amino sample low c""]}, ""screening"": {""freq"": 1, ""string"": [""detection inborn symptom area infant healthy screening addition mass program value e""]}}",{},{}
1142,1142,1237,10.1007/s12687-014-0206-0,25533753.0,activity transparency examine several across concern bloodspots five print common inter discrimination element storage citizen secondary debate result recently purpose lawsuit bloodspot controversial non mandatory theme case main confidentiality compelling concerned spotlight governance national people parent boundary response help journalist public sample legal newborn stigmatization million ownership residual analysis paper research destruction coverage importance trust inappropriate policy jurisdiction practice medium center engagement,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356669/,abstract,0,stigmatization journalist spotlight print ownership lawsuit confidentiality transparency destruction bloodspots inappropriate jurisdiction governance concerned compelling trust citizen boundary engagement bloodspot mandatory discrimination controversial debate legal inter coverage residual theme million medium element examine storage people concern secondary center policy help recently national purpose practice parent importance paper main public response newborn activity non common sample case research analysis result,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""parent importance paper main public response newborn activity non common sample c""]}}",{},{}
1143,1143,1238,10.1161/CIRCRESAHA.117.311949,29343526.0,inside exon chain activity lead rationaleorthostatic encoding reporter time adult gland reaction secretory molecular metanephrine due severe missense common catecholamine polymerase disease hydroxylase sanger transcription however family norepinephrine life quantitative dopamine clinical protein brain dutch real particular ntac favorably hypotension neurotransmitter nonsense six knockout cause novel fetal first genetic type metabolism low mapping yet whole four functional mutation wild pathogenic phenotype problem normal arg fully gly many converted normetanephrine method post expression exome shortage conclusionsthis unknown concentration american dbh treatment directly vesicle downstream cdna orthostatic variant rna homozygous allele cytochrome resultsas cre deletion analysis background mechanism homozygosity dihydroxyphenylserine plasma different tissue adrenal cyb ascorbate study trp human deficiency patient gene total metabolite homogenate,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924476/,abstract,3,secretory rationaleorthostatic orthostatic ntac normetanephrine metanephrine dihydroxyphenylserine dbh cyb resultsas hypotension homogenate converted vesicle gly favorably homozygosity cre ascorbate cytochrome shortage inside cdna dutch norepinephrine nonsense adrenal reporter catecholamine trp gland mapping knockout arg polymerase sanger encoding conclusionsthis homozygous downstream american fully rna deletion real neurotransmitter exome missense exon fetal transcription wild pathogenic dopamine post directly unknown allele reaction particular quantitative lead chain tissue problem functional hydroxylase phenotype severe background metabolite normal plasma expression cause variant brain molecular adult deficiency mechanism family novel life concentration total activity mutation common low metabolism time human type different protein gene genetic method treatment clinical analysis patient disease study,{},"{""homozygous"": {""freq"": 1, ""string"": [""knockout arg polymerase sanger encoding conclusionsthis homozygous downstream american fully rna d""]}, ""genetic"": {""freq"": 1, ""string"": [""time human type different protein gene genetic method treatment clinical analysis p""]}}",{},{},{},{}
1144,1144,1239,10.1186/s13023-016-0394-2,26822130.0,age resultsthe later however whether backgroundit one conclusionsboth negative adequate rule positive value higher loading neonatal responsiveness median mol hospital tetrahydrobiopterin therefore alternative day cut except diagnose tested result diagnosis unknown baseline concentration test term versus decrease patient doe year significantly long pku respectively phe predictive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731980/,abstract,6,conclusionsboth backgroundit tested rule responsiveness loading cut diagnose adequate versus predictive resultsthe later doe mol baseline tetrahydrobiopterin alternative unknown median decrease neonatal negative hospital phe long day positive value respectively concentration pku term higher test significantly diagnosis age year result patient,{},{},{},{},{},{}
1145,1145,1240,10.1007/s40265-014-0297-2,25274536.0,use age subset consideration two appropriateness example supplementary better opportunity new viscosity difference factor size relation facilitates adult user authorized child shape tablet many medicinal population review aspect product liquid doi impact particular available smell conventional development older group highlight people online article effective taste version formulation key electronic patient similarity material medication safe acceptability medicine young acceptable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210646/,abstract,0,viscosity smell tablet appropriateness facilitates taste medicinal acceptability shape similarity formulation authorized safe doi conventional acceptable subset older young medication consideration people relation liquid aspect opportunity size particular example product highlight medicine better supplementary user version key electronic online effective adult use impact material article difference available new factor population review child age development group patient,{},{},{},{},{},{}
1146,1146,1241,10.1186/s12887-017-0873-1,28482885.0,implication structured relationship enbs backgroundwith difficult positive programme condition view thematic improve testing experience number turnaround way hcps workload material conclusionsas element supplementary family user consistent doi support result diagnosis interview effect expansion question potentially united mediate period theme rapid communication scheduling child point intervention approach confirmatory work kingdom technology parent online article ten key electronic finding communicated materialthe version within newborn professional negative timely determine involved journey path analysis benefit impact available larger depth interaction part study healthcare enables,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422997/,abstract,1,scheduling conclusionsas communicated journey hcps enbs workload turnaround backgroundwith thematic structured kingdom enables mediate depth confirmatory path timely expansion doi theme programme interview element united improve view larger involved communication question healthcare difficult potentially way experience professional implication consistent work negative rapid point materialthe determine parent benefit period technology relationship testing finding interaction support supplementary user positive version key electronic online family impact intervention newborn material condition article approach number available diagnosis child effect analysis result study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""key electronic online family impact intervention newborn material condition article approach n""]}}",{},{}
1147,1147,1242,10.14336/AD.2015.0827,26425393.0,stress mitochondrial animal phenylalanine life main better lead strategy discus context oxidative dysfunction sign protein damage quality fluid brain review disturbance aim model phenylketonuria condition body symptom therapeutic pathophysiology elucidation error neurotransmitter inborn improve tissue metabolic accumulation alteration well deficiency patient synthesis disease help hydroxylase metabolism metabolite phe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567221/,abstract,0,elucidation disturbance sign pathophysiology fluid mitochondrial neurotransmitter oxidative improve damage accumulation alteration help stress animal synthesis dysfunction lead context tissue hydroxylase main discus better body inborn symptom aim metabolite phe strategy error quality therapeutic brain deficiency life condition phenylketonuria metabolism model phenylalanine review protein metabolic patient disease,"{""phenylalanine"": {""freq"": 2, ""string"": [""deficiency life condition phenylketonuria metabolism model phenylalanine review protein metabolic patient d""]}}",{},{},{},{},{}
1148,1148,1243,10.1155/2016/4121837,27493451.0,major chemistry factor organism cfi laboratory innate inflammation inversely virulent pathology risk igg vitamin disease cfh medical related family marker nonvirulent distinguish glitch variety clinical thus microbial data resistant complement long genetic immunity low warehouse use level whole lab four aligns assumption microbiology genomics personal model technique bank microbiological work sufficient serum immunology incessant serve assay list component whilst haematology heritability field big antibiotic linking sufficiency routinely nonresistant speciality genome pattern gene sector,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963559/,abstract,0,warehouse sufficiency speciality nonvirulent nonresistant microbiology linking incessant immunology haematology glitch cfi aligns virulent cfh microbiological big bank sector serve inversely igg innate resistant distinguish chemistry immunity heritability whilst antibiotic personal microbial assumption complement routinely lab organism list sufficient inflammation pathology vitamin genomics variety component genome pattern serum work assay marker technique laboratory related field long major medical use family low risk model factor gene genetic data level clinical disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1149,1149,1244,10.1186/s12883-016-0674-4,27552976.0,registry major balance specific biogen better prospectively registration congenital time defect weight resultsa macdp risk mean disease month termination gestational pregnant committee gov interval follow crohn higher clinical ectopic consistent global conclusionsalthough effect metropolitan observational backgroundpatients term pregnancy fetal type planning confidence abortion rate sclerosis independent elective text drug overall woman evaluation outcome registrationclinicaltrials population review week therapeutic twin potential exposure accordance loss treatment discover option conception age stillbirth within methodsthe suggest birth spontaneous currently benefit prior program nct infant natalizumab trial multiple general classification pattern study patient total malformation atlanta,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995778/,abstract,11,natalizumab metropolitan macdp biogen stillbirth ectopic crohn atlanta elective backgroundpatients conclusionsalthough abortion termination spontaneous discover conception accordance twin registrationclinicaltrials suggest sclerosis prospectively balance planning registration committee registry malformation resultsa gestational pregnant methodsthe observational classification nct gov fetal confidence prior option interval text independent pregnancy follow global woman pattern consistent weight mean loss exposure evaluation defect currently congenital general week benefit birth overall better month infant trial program major multiple drug therapeutic rate total outcome term higher time risk specific type population review potential age effect treatment clinical patient disease study,{},{},{},{},{},{}
1150,1150,1245,10.1007/8904_2014_347,25716610.0,staff clinic canadian difference country laboratory site dietician paediatric half additional need descriptively common capacity variation source testing experience majority disease survey hereditary physician biochemical beneficial introduction previous variety questionnaire respondent health complete quebec equitable result metabolic telehealth genetic service one least main size centre canada located child outcome population method southern organization system web test resource treatment response association care nearly every future imd scope order access dedicated priority research available ontario identify conclusion policy practice high email ancillary human barrier patient inform variability,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470950/,abstract,2,telehealth quebec descriptively ontario located email ancillary equitable dietician dedicated staff canadian canada southern scope imd paediatric hereditary respondent priority web nearly inform centre physician half introduction capacity beneficial variability organization identify barrier access complete variety majority resource clinic policy experience previous size service source survey site questionnaire variation practice laboratory additional main biochemical order need testing country response future association care outcome conclusion difference common available test human research population child metabolic health high genetic method treatment result patient disease,{},"{""genetic"": {""freq"": 1, ""string"": [""research population child metabolic health high genetic method treatment result patient d""]}}",{},{},{},{}
1151,1151,1246,10.3389/fmolb.2018.00076,30211169.0,various specific cluster biopsy almost single early molecule require selection medically germ modification molecular oncology tight cup well origin disease hereditary egfr shed line medical cancer relevant marker actionable strategy clinical therapy integral preventive always protein fluid body great primary diagnosis portrait novel non detection significant surveillance mutation administration inhibitor drug syndrome intervention expression unknown test treatment promise cell systematic braf carrier cytotoxic rna efficiently application likely healthy multitude invasive dna analysis benefit routinely multiple alk often part tissue tumor parp presence fragment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119963/,abstract,0,portrait parp alk multitude braf germ egfr cup tight cytotoxic require integral oncology medically shed biopsy actionable fragment efficiently routinely surveillance preventive hereditary promise cluster origin invasive tumor fluid rna modification inhibitor line great carrier molecule selection systematic unknown administration dna cancer marker likely presence tissue syndrome relevant benefit detection various body healthy application expression multiple primary drug strategy medical single molecular intervention novel therapy mutation non cell test early specific diagnosis protein significant treatment clinical analysis disease,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""likely presence tissue syndrome relevant benefit detection various body healthy application e""]}}",{},{}
1152,1152,1247,10.1186/s40001-016-0212-2,27169416.0,male various correlation cross whether sectional ratio present adult gland methodswe monocentric significantly pku phe phenylalanine tyr dopamine prl hyperprolactinemia intracerebral level significant main female postulated tyrosine child resultsno phenylketonuria separately thyroid association tsh prolactin regulator backgroundit production pituitary newborn clarify relation since birth adolescent dependent previously either aim secretion conclusionsin group high study patient gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864969/,abstract,1,prl monocentric hyperprolactinemia prolactin postulated intracerebral backgroundit resultsno conclusionsin clarify pituitary separately tsh gland secretion thyroid regulator tyr gender relation dopamine adolescent production methodswe sectional dependent female cross tyrosine previously correlation male main ratio birth various aim phe association adult newborn pku phenylketonuria present significantly phenylalanine child significant group high level patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""adult newborn pku phenylketonuria present significantly phenylalanine child significant group high l""]}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""birth various aim phe association adult newborn pku phenylketonuria present significantly p""]}}",{},{}
1153,1153,1248,10.3389/fmolb.2019.00015,30968029.0,disorder tool almost pathway exhibit platform insight additional moreover common mechanistic diverse neurodegenerative canonical accumulation hypothesis addition well extension disease assembly neurological solely line decade recent protein contribution error aggregative inborn like recently exogenous specie first type formation metabolism non establishment dye mutation one oligomeric huntington drug structure soluble review model therapeutic describe alzheimer yeast development malady expression thereby system potential salvage diabetes intracellular adenine future two endogenous amyloid apoptotic ago parkinson basic currently characteristic impact research available cytotoxicity mammalian agent gene metabolite indicative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439353/,abstract,0,aggregative solely salvage malady huntington adenine oligomeric dye cytotoxicity canonical apoptotic yeast indicative extension parkinson intracellular establishment soluble ago exogenous amyloid mammalian exhibit assembly alzheimer mechanistic endogenous neurodegenerative specie basic contribution line diverse platform formation agent diabetes hypothesis decade accumulation neurological insight recently structure currently like characteristic additional inborn metabolite tool addition expression drug error therapeutic future pathway recent impact mutation non common available metabolism model type research review potential protein development gene disorder disease,"{""neurological"": {""freq"": 1, ""string"": [""formation agent diabetes hypothesis decade accumulation neurological insight recently structure currently l""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""addition expression drug error therapeutic future pathway recent impact mutation non c""]}}",{},{},{}
1154,1154,1249,10.1186/s12936-015-0558-x,25652763.0,coefficient blood new time volumetrically contains without malaria molecular contamination additional cut need common mean testing onto way traditional material respectively quick resultant unit supplementary conclusionsa variety quickly user real comparable lamp conventional methodology scissors result store chelex type extraction pure international absorb laser pcr whole nucleic per volume prevent variance plasmodium whatman device simple method shaped technology qiagen online article collection precision electronic filter version mini amplification sample resultsthe spot standard falciparum dna analysis prior paper available medium acid patient accuracy number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4327959/,abstract,3,volumetrically shaped scissors chelex absorb qiagen lamp falciparum pure plasmodium mini whatman contamination store nucleic malaria quick resultant quickly laser conclusionsa cut contains amplification filter variance extraction coefficient device conventional unit pcr comparable traditional real medium precision methodology simple resultsthe prior variety volume accuracy international prevent way collection dna mean spot paper additional technology need testing standard supplementary user version electronic online molecular respectively material article common sample number available time new blood type acid method analysis result patient,{},{},{},{},{},{}
1155,1155,1250,10.1007/s10534-016-9977-6,27785728.0,nicotiana lead organism time invertebrate protects despite scavenger restriction proapoptotic substance bright moreover radical antioxidant well increase significantly serf line animal recent possible pcd role protein pretreatment indirect result bacteria property protective like exogenous effect first distant plant yellow level death evolutionary tobacco inhibitor tabacum damage bax expression free melatonin cell process photoperiod analysis impact also suspension study direct vertebrate mammalian proliferation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116310/,abstract,2,tabacum scavenger proapoptotic photoperiod nicotiana bright bax yellow protects distant vertebrate tobacco suspension pretreatment pcd invertebrate serf evolutionary melatonin radical indirect protective substance plant exogenous antioxidant mammalian proliferation organism bacteria inhibitor damage line restriction death property direct animal lead free despite like possible process expression increase recent impact role cell time significantly protein effect level analysis result study,{},{},{},{},{},{}
1156,1156,1251,10.1093/toxsci/kfv312,26660635.0,potent male specific agonist activity single lower visible oxidative specifically probable weight slightly homeostasis manganese hydrocarbon dawley sprague investigate injection toxicity increase oil pentachlorobiphenyl profound metallothioneins role protein mol metal body dismutase mitochondrion transport effect cause receptor decrease rat aryl level stress enlargement ppm pcb dose evaluation liver week corn dependently strongly deficient superoxide heart mechanism stepwise keywords also induces mrna study dietary small fenton metallothionein,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009614/,abstract,3,pentachlorobiphenyl pcb metallothioneins metallothionein hydrocarbon fenton enlargement ppm dependently aryl manganese corn sprague dismutase dawley agonist induces oil stepwise visible probable mitochondrion metal superoxide profound potent slightly toxicity mrna transport injection oxidative deficient strongly keywords homeostasis specifically rat receptor mol dose heart decrease stress weight liver investigate evaluation male week small body cause increase lower single mechanism dietary activity role specific protein effect level study,{},{},{},{},{},{}
1157,1157,1252,10.18632/oncotarget.19720,28938645.0,logistic age whether variant snp evidence allele marker difference single genotypic estimate determine preventive woman define population cad model haplotype frequency genotype han smarca group technology diagnostic coronary risk study nucleotide sex artery control polymorphism susceptibility ten association patient men disease massarray genetic respectively gene chinese useful allelic regression,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601741/,abstract,4,cad smarca massarray genotypic coronary han artery allelic men define haplotype preventive susceptibility logistic snp chinese sex nucleotide polymorphism genotype useful estimate allele woman regression marker frequency determine technology diagnostic variant single association respectively evidence difference risk model control population age gene group genetic patient disease study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1158,1158,1253,10.1007/s10545-016-9995-0,27832415.0,correlation disorder blood catastrophic lead backgroundphenylketonuria time across reimbursement complexity median oopcs severe variation usd inadequate classical evaluate disease pku material phe medical supplementary family friendship methodsa quantitative follow dysfunction user questionnaire expense mol burden manner china inborn metabolic observational household first untreated chinese non formidable yet one imperative annual interventional neurobehavioral current economic management conclusionsthe older national target system parent unknown concentration online article treatment proportion electronic expenditure version findingsthe rare threshold age still negative income authorized hospital impact paper available pocket policy group different practice study insufficient center patient financial total caregiver,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393103/,abstract,0,oopcs friendship formidable neurobehavioral findingsthe catastrophic usd pocket expense interventional imperative household reimbursement financial expenditure threshold inadequate backgroundphenylketonuria annual insufficient income manner complexity authorized caregiver methodsa observational untreated chinese older china conclusionsthe classical economic burden proportion mol unknown center policy follow evaluate median quantitative questionnaire negative hospital dysfunction national lead variation practice correlation parent paper target severe inborn phe supplementary management user version electronic online medical rare family impact concentration total current pku material non article available time blood different age metabolic group disorder treatment patient disease study,{},{},{},{},{},{}
1159,1159,1254,10.1038/s41598-017-14497-4,29066752.0,native homeostasis partially molecular additional solvent stabilization benzene favor well assembly impair subcellular pharmacological screening therapy nucleophosmin protein compound leukemia candidate particular mutant support like length effect nucleolar stability computational ability full mutation three conformational acute aggregation terminal polar residue aml identification potential phenyl hydrophobic accessible best stabilize promising cell ribosome two since chaperone npm throughput mechanism also pocket group interaction high domain myeloid thermal show localization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655693/,abstract,0,nucleophosmin nucleolar npm myeloid benzene aml ribosome subcellular polar hydrophobic stabilize stabilization pocket phenyl localization leukemia thermal solvent impair favor conformational terminal native throughput chaperone accessible residue assembly aggregation computational partially promising length stability candidate homeostasis pharmacological mutant domain acute best particular compound ability identification like additional interaction support screening molecular mechanism therapy mutation cell potential protein group effect high,{},{},{},"{""screening"": {""freq"": 1, ""string"": [""ability identification like additional interaction support screening molecular mechanism therapy mutation c""]}}",{},{}
1160,1160,1255,10.1007/8904_2017_23,28382600.0,disorder relationship blood resilience positive present despite boost pku establish longitudinal related phenylalanine family compliance dependency clinical additionally protein range focus primary support result distress metabolic parenting effect psychological design adherence ability adhere level stress member measure size child intervention phenylketonuria causal older social illness parent concentration treatment parental proportion year diet strict rare age within sample unless whilst cognitive impairment benefit mechanism research larger wellbeing high study restricted caregiver,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740045/,abstract,1,wellbeing parenting boost unless adhere dependency resilience restricted distress whilst strict illness causal establish psychological caregiver parental compliance older adherence longitudinal larger member proportion additionally size stress focus impairment social ability despite parent design related benefit relationship cognitive support measure range primary positive mechanism diet rare family intervention concentration pku sample phenylketonuria present phenylalanine blood research child protein age metabolic year effect high level disorder treatment clinical result study,"{""phenylalanine"": {""freq"": 2, ""string"": [""intervention concentration pku sample phenylketonuria present phenylalanine blood research child protein a""]}, ""social"": {""freq"": 1, ""string"": [""proportion additionally size stress focus impairment social ability despite parent design r""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""support measure range primary positive mechanism diet rare family intervention concentration p""]}}",{}
1161,1161,1256,10.1371/journal.pone.0177685,28542346.0,inheritance exon chain dominant collagen progressive autosomal reaction heterogeneous severe missense encode substitution effective polymerase glycine respectively spectrum sequence sanger quantitative strategy probands col clinical nephropathy clinically acidic candidate diagnosis nonsense large design generation novel routine type genetic capture pcr rapid sixteen mutation four pathogenic size hot expand syndrome approach analyze method technology simultaneously manifestation fifteen genetically spot genotypic order recessive comparison next validated deletion complicated analysis alport none mutational classic different hiseq acid sequencing patient absence amino gene individual fragment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436713/,abstract,6,alport encode col nephropathy hiseq collagen hot genotypic sixteen probands expand acidic nonsense mutational fragment glycine complicated analyze polymerase sanger substitution simultaneously validated capture inheritance dominant heterogeneous progressive pcr routine deletion classic missense manifestation exon candidate absence genetically pathogenic recessive autosomal clinically sequence reaction size quantitative comparison rapid generation chain sequencing syndrome spot design technology order spectrum severe strategy effective large respectively novel mutation amino approach individual type diagnosis acid different gene genetic method clinical analysis patient,{},"{""inheritance"": {""freq"": 1, ""string"": [""polymerase sanger substitution simultaneously validated capture inheritance dominant heterogeneous progressive pcr r""]}, ""autosomal"": {""freq"": 1, ""string"": [""exon candidate absence genetically pathogenic recessive autosomal clinically sequence reaction size q""]}, ""recessive"": {""freq"": 1, ""string"": [""manifestation exon candidate absence genetically pathogenic recessive autosomal clinically sequence reaction s""]}, ""genetic"": {""freq"": 1, ""string"": []}}",{},"{""amino"": {""freq"": 1, ""string"": [""strategy effective large respectively novel mutation amino approach individual type diagnosis a""]}}",{},{}
1162,1162,1257,10.1371/journal.pone.0166213,27846247.0,major gada blood new difficult islet time positive znt condition onset risk control reliable validation disease titration measurement however subject autoantibody relative clinical fluid identifies miaa large obtain stability first type whole predictable four measure sensitivity iab approach degree method serum unknown filter strongly year ketoacidosis phase incidence false specificity generally negative positivity spot screen scale elution radioimmunoassay venipuncture previously prior diabetic paper trial prevention reliably patient individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112938/,abstract,1,miaa iab gada znt positivity ketoacidosis radioimmunoassay predictable autoantibody titration venipuncture islet elution identifies reliably obtain diabetic filter fluid false degree reliable validation stability strongly screen generally prior relative difficult specificity unknown phase incidence serum sensitivity negative onset measurement prevention spot previously scale paper measure subject trial major positive large condition approach individual time new risk control blood type year method clinical patient disease,{},{},{},{},{},{}
1163,1163,1259,10.3390/jcm3041291,26237604.0,analysis therapeutic future lie clinical laboratory development prenatal embryonic diagnosis technology genetic intervention applicable approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470183/,abstract,0,lie applicable embryonic prenatal laboratory technology therapeutic future intervention approach diagnosis development genetic clinical analysis,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1164,1164,1260,10.4103/ijt.ijt_47_18,30607038.0,exact esteem age although disorder dye self main african premature white present syndrome concern word caucasian population modality gray supplementation autoimmune nutritional unknown american cosmetic treatment canities key graying patient disease year etiopathogenesis metabolism individual hair severely,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290285/,abstract,2,graying esteem canities etiopathogenesis cosmetic hair gray dye autoimmune caucasian exact african severely modality premature american word white concern unknown supplementation nutritional self syndrome main key present metabolism individual population age year disorder treatment patient disease,"{""hair"": {""freq"": 1, ""string"": [""graying esteem canities etiopathogenesis cosmetic hair gray dye autoimmune caucasian e""]}}",{},{},{},{},{}
1165,1165,1261,10.1093/hmg/ddy180,29771303.0,disorder abnormality new studied effort congenital progressive synonymous defect visual despite photoreceptors molecular severe consanguineous disease severely establishes extensive individual evolutionarily family reduction developmental structural equivalent recording link large data fraction cause term type non significant case three mutation one member signal size phenotype text arg gly pakistani population par entrez development expression exome unknown loss substantial frequent degeneration reduces variant causative opportunity homozygous likely recessive mark since function impairment eye also multiple identify induces often nucleotide human sequencing patient gene highly homologue vision,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048992/,abstract,0,recording photoreceptors mark pakistani homologue evolutionarily par gly vision establishes induces entrez synonymous consanguineous degeneration severely eye arg causative reduces studied homozygous equivalent progressive visual fraction extensive substantial link exome identify signal frequent member recessive nucleotide structural text opportunity effort unknown size abnormality loss reduction likely impairment developmental sequencing highly defect despite congenital phenotype severe expression multiple cause variant large molecular family mutation term non function case individual new human type population significant development gene data disorder patient disease,{},"{""recessive"": {""freq"": 1, ""string"": [""link exome identify signal frequent member recessive nucleotide structural text opportunity e""]}, ""homozygous"": {""freq"": 1, ""string"": [""severely eye arg causative reduces studied homozygous equivalent progressive visual fraction e""]}}",{},{},{},{}
1166,1166,1262,10.1002/mgg3.597,30767419.0,disorder bioinformatics single time prenatal set nipt fetus sub variation aneuploidy trisomy locus methodswe testing noninvasive disease cnv pipeline costly demand backgroundthe possible screening clinical value therefore complete great genotype diagnosis date routine novel fetal first type capture chromosomal detection full functional cnvs panel multi rate three cheaper approach model method associate target system test conclusionfor year best near detect future sample resultsthe progress order estimate suited research also larger multiple foundation practice pseudo last successfully whereas faster distinct performance gene newly accuracy number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465655/,abstract,3,conclusionfor pseudo nipt costly cheaper aneuploidy suited trisomy cnv cnvs associate pipeline noninvasive faster fetus chromosomal bioinformatics newly demand capture detect sub near foundation set progress locus successfully routine backgroundthe prenatal multi larger fetal distinct resultsthe complete great panel accuracy genotype date methodswe estimate best variation practice functional order performance testing target detection possible screening multiple value future single novel rate sample approach number test time model type diagnosis research gene year method disorder clinical disease,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""practice functional order performance testing target detection possible screening multiple value f""]}, ""screening"": {""freq"": 1, ""string"": [""order performance testing target detection possible screening multiple value future single n""]}}",{},{}
1167,1167,1263,10.1037/adb0000229,27819431.0,beverage self hour dos energy time laboratory reaction condition separate stimulation investigate risk heightening mean cup significantly slower consumer session however equal subject drinking rating higher fast double therefore alone task result thus purpose consume versus combination period use rapid rate drinker placebo sedation dose day social safety test drink binge within two occur approximately subjective vodka aware consumption conclusion study alcohol similar blind faster even minute participant performance gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344720/,abstract,4,heightening vodka binge cup sedation slower drinker drinking consume subjective drink occur faster aware equal minute alcohol fast session stimulation rating dos consumer beverage blind placebo separate hour versus gender double consumption safety energy task dose approximately reaction mean rapid combination self purpose investigate social laboratory period performance similar participant subject day use rate conclusion higher condition test time significantly risk result study,"{""social"": {""freq"": 1, ""string"": [""mean rapid combination self purpose investigate social laboratory period performance similar p""]}}",{},{},{},{},{}
1168,1168,1264,10.21037/atm.2018.11.05,30740401.0,soon biochemical advance disorder assessment however decompensation iem specialized biomarkers morbidity form early easy take acute ordering possible implementation laboratory clinical proper many initial prevents without efficient onset symptom molecular program alone relatively due also error severe general inborn result diagnosis potential thus metabolic simplified article test guide treatment majority guideline late patient routine initiate help metabolism variability mortality overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331366/,abstract,0,ordering simplified initiate soon decompensation specialized prevents easy proper guide routine variability efficient overview initial late morbidity guideline relatively iem majority advance acute mortality help implementation onset biomarkers laboratory general biochemical severe possible assessment inborn symptom form program error molecular article metabolism test early diagnosis potential metabolic disorder treatment clinical result patient,{},{},{},{},{},{}
1169,1169,1265,10.1007/s10545-018-0150-y,29520738.0,mood blood activity gfrp lead studied content exhibit anxiety tetrahydrobiopterin condition severe supplementation regulatory hydroxyphenylglycol hiaa well enu hydroxylase status phe revers phenylalanine evidence partial remarkably protein recovery brain fold mouse neurotransmitter elevation indirect pahenu depression tph sensor effect mild cyclohydrolase methoxy furthermore type hpa metabolism level significant suboptimal wild hepatic conclude normal toxic problem current systemic tyrosine mhpg feedback toward model enteral ameliorate concentration treatment diet gtpch still serotonin comparison loading benefit gtp tryptophan pah consequence monoamine acid similar hydroxyindolacetic deficiency cofactor patient parenteral complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041158/,abstract,1,mhpg methoxy hydroxyphenylglycol hydroxyindolacetic gfrp revers hiaa gtpch enteral tph parenteral feedback enu loading indirect conclude suboptimal sensor remarkably pahenu cyclohydrolase gtp mood ameliorate monoamine elevation exhibit recovery studied hpa hepatic toxic depression tryptophan partial systemic serotonin neurotransmitter anxiety fold wild cofactor mild tetrahydrobiopterin content regulatory consequence supplementation pah comparison lead furthermore tyrosine problem benefit hydroxylase status similar mouse severe phe normal complex brain deficiency diet concentration activity evidence current condition metabolism model phenylalanine blood type acid protein significant effect level treatment patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""activity evidence current condition metabolism model phenylalanine blood type acid protein s""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""severe phe normal complex brain deficiency diet concentration activity evidence current c""]}}",{}
1170,1170,1266,10.1080/21675511.2016.1153777,27141413.0,abnormality new realistic energy discus myogenic inconsequential sarcolemma light affected central homeostasis autophagic due severe pathology common ablation effective hypothesis disease purinoceptor however evidence axis pharmacological argument contradict therapy protein range mouse dmd therefore symptom fragility mdx belief stimulating result recently effect attenuation detectable term receptor furthermore long genetic inhibition metabolism young non clearly hope functional mutation dystrophic death phenotype discussion current produce vital already intervention model therapeutic myofibres urgently translational target via stage potential expression disability muscular dystrophy treatment impaired response cell inflammatory downstream upregulation dystrophin harmful regeneration differentiation purinergic function duchenne plethora modality attractive extracellular aberrant men muscle absence eatp proliferation establishing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838315/,abstract,0,sarcolemma purinoceptor purinergic myogenic myofibres mdx inconsequential eatp dystrophin dmd autophagic realistic dystrophic duchenne contradict attenuation ablation fragility belief harmful urgently plethora muscular hope aberrant dystrophy upregulation argument regeneration attractive stimulating establishing axis extracellular detectable men muscle modality vital clearly proliferation produce impaired translational downstream differentiation light discussion pathology young affected absence homeostasis pharmacological inhibition receptor energy hypothesis inflammatory death stage central abnormality recently disability furthermore functional phenotype discus target mouse severe symptom long expression range response therapeutic effective intervention therapy evidence current mutation term non common cell function metabolism new model potential protein effect genetic treatment result disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1171,1171,1267,10.1093/hmg/ddv263,26160913.0,metabotypes new discus brief biomedical identity increasingly variation hypothesis disease individuality summary knowledge understanding pharmaceutical strategy trait recent clinical result metabolic recently effect large design furthermore novel genetic metabolism finish functional panel interest update biomarkers size end genomics ensemble provide point many review approach identification correct gims system resource driven key valuable association modifier heritable dysregulations wide genetically every downstream sample metabolite application testable community function analysis aspect metabolomics research genome comprehensive part study human gene complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572003/,abstract,0,metabotypes gims finish individuality ensemble driven testable dysregulations identity heritable modifier update biomedical brief downstream correct pharmaceutical valuable summary genetically genomics increasingly end metabolomics hypothesis trait panel aspect comprehensive community resource size genome understanding recently variation furthermore point biomarkers wide design identification provide functional discus knowledge metabolite application complex strategy key large association recent novel function sample approach metabolism new human research review metabolic gene effect genetic clinical analysis result disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""human research review metabolic gene effect genetic clinical analysis result disease s""]}}",{},{},{},{}
1172,1172,1268,10.1155/2018/5124035,29854440.0,specific blood disorder sectional factor information thirteen diverge time throughout median liquid caucasian slightly preadolescence race glycine objective intake establish measurement glutamic phenylalanine interval childhood anthropometric previous analytic optimal higher clinical leucine particular arginine thai result diagnosis metabolic reference percentile tandem middle low regression level citrulline child many population management method sharply quantile recommendation year isoleucine age mass pediatric spot healthy birth influence analysis background paper spectrometry hplc conclusion different practice study whereas acid methionine dietary amino chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960525/,abstract,2,quantile preadolescence diverge glutamic thai sharply thirteen citrulline analytic race percentile glycine caucasian methionine anthropometric isoleucine leucine hplc slightly arginine middle establish optimal reference tandem interval liquid chromatography sectional median previous recommendation particular pediatric childhood regression intake measurement spectrometry influence practice spot paper birth background healthy objective mass management dietary information amino conclusion higher low time phenylalanine specific factor blood diagnosis population acid child different age metabolic year method level disorder clinical analysis result study,"{""phenylalanine"": {""freq"": 2, ""string"": [""information amino conclusion higher low time phenylalanine specific factor blood diagnosis p""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""healthy objective mass management dietary information amino conclusion higher low time p""]}, ""tandem"": {""freq"": 1, ""string"": [""slightly arginine middle establish optimal reference tandem interval liquid chromatography sectional m""]}, ""spectrometry"": {""freq"": 1, ""string"": [""particular pediatric childhood regression intake measurement spectrometry influence practice spot paper b""]}}",{},{}
1173,1173,1269,10.1007/s13197-016-2278-9,27765976.0,fat dairy syneresis disorder sample permeate two retardation phe cure milk content accordingly higher storage child analog protein creamer special benefit yogurt phenylketonuria humidity onset symptom mental subsequently ultrafiltered acidity different non concentration study good yoghurt patient dry diet pku genetic significantly low adhere acceptable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052174/,abstract,5,yoghurt ultrafiltered syneresis permeate creamer yogurt humidity acidity adhere analog dry cure dairy retardation accordingly subsequently milk fat acceptable special storage content mental good onset benefit symptom phe diet concentration pku higher non sample phenylketonuria low significantly child different protein genetic disorder patient study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},"{""diet"": {""freq"": 1, ""string"": [""mental good onset benefit symptom phe diet concentration pku higher non s""]}}",{}
1174,1174,1270,10.3945/ajcn.115.117689,26791187.0,repeatedly assessment chain example daily energy affect profile weight bcaas homeostasis aromatic risk average addition objective significantly respectively however phenylalanine subject concurrent gov reduction strategy clinical protein mol leucine improvement result effect change design little term decrease novel long type use clinicaltrials independent valine kilogram per text log tyrosine aaa intervention pound model alanine potential bcaa loss concentration association isoleucine directly diet finding stronger obese along underscore resistance background nct importance trial conclusion plasma high insulin acid direct dietary beyond participant amino consistently,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733257/,abstract,5,kilogram pound bcaas repeatedly aaa valine bcaa concurrent log underscore alanine isoleucine stronger leucine obese consistently clinicaltrials aromatic insulin resistance nct gov homeostasis mol little energy affect daily text independent directly average decrease profile direct improvement weight example loss reduction chain tyrosine design importance finding participant assessment background objective addition subject long plasma trial change strategy association use diet respectively intervention dietary novel concentration amino conclusion term significantly risk model phenylalanine type acid potential protein effect high clinical result,"{""phenylalanine"": {""freq"": 2, ""string"": [""amino conclusion term significantly risk model phenylalanine type acid potential protein e""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""diet respectively intervention dietary novel concentration amino conclusion term significantly risk m""]}}","{""diet"": {""freq"": 1, ""string"": [""plasma trial change strategy association use diet respectively intervention dietary novel c""]}}",{}
1175,1175,1271,,26505062.0,specific delay disorder search growth tape early ovidsp congenital concern condition physical common mean nonelastic urinary well eyebrow specialist physician measurement later family evidence ophthalmologic distance renal therapy developmental brain focus reference language term routine chart first ear level service plot case although main update measure step referral provide child around intervention critical review back approach concomitant identification conclusionearly helpful disability interdisciplinary sex care microcephaly age messageserial palsy anomaly pediatric appropriate embase quality provision circumference benefit tract program infant head importance occupational intellectual skeletal cardiac objectiveto dietary surgical cerebral show strabismus idiopathic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541430/,abstract,2,tape strabismus ovidsp ophthalmologic nonelastic messageserial idiopathic eyebrow conclusionearly palsy occupational ear interdisciplinary chart plot concomitant helpful distance skeletal microcephaly update surgical circumference cerebral tract referral anomaly provision head embase specialist renal objectiveto cardiac routine language sex physician urinary later delay reference search concern intellectual step appropriate service pediatric physical focus mean disability critical developmental measurement growth congenital importance identification provide benefit main measure infant program quality brain family intervention dietary care therapy evidence term condition common approach case early specific review child age level disorder,"{""microcephaly"": {""freq"": 1, ""string"": [""chart plot concomitant helpful distance skeletal microcephaly update surgical circumference cerebral t""]}, ""intellectual"": {""freq"": 1, ""string"": [""urinary later delay reference search concern intellectual step appropriate service pediatric p""]}}",{},{},{},{},{}
1176,1176,1272,10.1371/journal.pone.0177110,28493909.0,blood hour ratio greater factor difference early pathway lower gut defect standardized glucose median liquid insulinotropic onset showing beta investigate methodswe hba control however subject matsuda resultswe monogenic peptide like metabolic esterified cause decrease mody type lipid low incretins young non diminution period level significant nuclear experienced sensitivity relevance polygenic many regulation post glucagon prandial test response hormone fatty triglyceride diabetes cell purposehepatocyte carrier meal hemoglobin standard dependent conclusionin diabetic ghrelin index relatively larger secretion polypeptide group mature alpha nefa insulin acid similar minute participant iqr,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426708/,abstract,5,purposehepatocyte prandial matsuda esterified diminution showing nefa incretins insulinotropic polypeptide ghrelin mody hba conclusionin mature iqr glucagon triglyceride polygenic meal experienced hemoglobin secretion minute diabetic beta standardized gut resultswe monogenic insulin relevance alpha peptide lipid hour young larger nuclear hormone diabetes glucose carrier relatively liquid post fatty methodswe median regulation index dependent decrease sensitivity onset investigate greater defect like period ratio standard similar participant subject cause response lower pathway non difference cell low test early control factor blood type acid significant metabolic group level,{},{},"{""pathway"": {""freq"": 1, ""string"": [""similar participant subject cause response lower pathway non difference cell low t""]}}",{},{},{}
1177,1177,1273,10.3390/jcm8050640,31075927.0,various biological blood disorder assessment physiological extremely new molecule nutrition technical profile several present liquid light pressure oncology due moreover prognosis fact reliable well increase disease intake membrane synthesis issue tumour measurement amine pharmacology recent capillary oxidation follow value therapy additionally clinical role alkaloid protein compound chemically health tendency focus endocrinology real body critically possibility methodology diagnosis thus decomposition like stability decrease quantification psychology low extraction useful area level significant transduction signal nucleic biomarkers biogenic likewise temperature many approach regulation technique method determination unstable bioanalytical gas concentration article important hormone net challenge cell overview process electrophoresis future sample endogenous application problematic differentiation spontaneous parkinson analysis special matrix cardiovascular priority research posse bioactive trend high acid human proliferation schizophrenia neuroendocrine chromatography sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572256/,abstract,0,neuroendocrine decomposition alkaloid psychology bioanalytical unstable tumour problematic chemically likewise endocrinology biogenic tendency nucleic oncology amine spontaneous posse pharmacology electrophoresis parkinson critically capillary bioactive transduction schizophrenia net fact extremely proliferation prognosis priority matrix quantification membrane extraction oxidation technical endogenous gas temperature pressure differentiation light determination trend special reliable real stability physiological hormone overview methodology possibility cardiovascular signal sensitive nutrition liquid additionally molecule chromatography useful follow regulation decrease profile compound focus synthesis intake measurement biomarkers technique biological like issue various body assessment process area application challenge value increase future recent therapy concentration article important role cell sample low approach present new human blood diagnosis research acid protein significant health high method level disorder clinical analysis disease,{},{},{},{},{},{}
1178,1178,1275,10.1007/s11825-018-0206-2,30459487.0,dominant sporadic new early pathway abnormal autosomal selection easily onset wes heterogeneous severe challenging varies measurement understanding seizure childhood milder adaptive clinical therapy body novo deeply kind generation first detection use reasonable whole although rate panel mutation least step measure arid many identification development exome technology disability substantial xlid year rare adid still wgs mostly prevalence recessive function next advanced unidentified classified cognitive meaningful impairment analysis research trio intellectual diagnostic different last namely entity sequencing gene individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223758/,abstract,3,xlid adid arid unidentified wes wgs varies reasonable trio deeply challenging milder sporadic kind easily meaningful entity classified novo dominant advanced adaptive heterogeneous seizure substantial exome recessive panel abnormal selection autosomal intellectual step childhood understanding impairment generation onset disability sequencing measurement identification prevalence technology diagnostic detection severe body cognitive measure pathway use rare therapy rate mutation function individual new early research different development gene year clinical analysis,"{""intellectual"": {""freq"": 1, ""string"": [""exome recessive panel abnormal selection autosomal intellectual step childhood understanding impairment g""]}}","{""autosomal"": {""freq"": 1, ""string"": [""substantial exome recessive panel abnormal selection autosomal intellectual step childhood understanding i""]}, ""recessive"": {""freq"": 1, ""string"": [""advanced adaptive heterogeneous seizure substantial exome recessive panel abnormal selection autosomal i""]}}","{""pathway"": {""freq"": 1, ""string"": [""diagnostic detection severe body cognitive measure pathway use rare therapy rate m""]}}","{""detection"": {""freq"": 1, ""string"": [""sequencing measurement identification prevalence technology diagnostic detection severe body cognitive measure p""]}}",{},{}
1179,1179,1276,10.1371/journal.pone.0205281,30307998.0,conclusionthe correlation summer region early among examine boy country present aged finger stimulation experience month significantly climate monsoon childhood previous continental higher psychomotor winter environment china movement effect bayley similarly score area involvement size point suggestion rural season development hemocue system cold concentration test western finding sample hemoglobin methodwe poor opportunity scale limited birth shape cognitive aspect infant policy study ample objectiveto prick resultsinfants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181351/,abstract,1,winter resultsinfants monsoon hemocue summer season ample continental methodwe cold climate bayley psychomotor prick finger suggestion shape hemoglobin stimulation similarly rural boy western movement objectiveto conclusionthe involvement examine china aspect opportunity poor policy experience previous size aged environment childhood limited point correlation scale birth score country finding region cognitive area month infant concentration higher sample present test significantly early development effect study,{},{},{},{},{},{}
1180,1180,1277,10.1371/journal.pone.0153253,27089011.0,registry blood difference information lower adult neonatal microgram programme slightly additional ref investigate close disease raw material respectively subject reduction sharing screening observed value pairwise health replica project great data reference call similarly disc genetic type eight prepared whole seven rate three filtering extract measure overall population efficiency post national exome combined resource valuable calculated similarity best future sample two snp variant spot pilot comparison limited dependent dna quality analysis concordance research genome diagnostic otherwise different high study similar accuracy robustness wgadna,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835089/,abstract,0,wgadna replica ref microgram filtering pairwise disc extract prepared sharing robustness raw combined concordance calculated similarity slightly registry similarly close pilot programme snp valuable project efficiency exome great seven reference accuracy post resource best genome dna dependent observed neonatal comparison reduction national limited investigate spot additional overall diagnostic similar measure screening subject value variant quality future lower adult respectively information rate material difference sample blood type research population different health high genetic data analysis disease study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""screening"": {""freq"": 1, ""string"": [""spot additional overall diagnostic similar measure screening subject value variant quality f""]}}",{},{}
1181,1181,1278,10.1038/s41598-017-10890-1,28883610.0,experimental expensive new know time algorithm accurate hydrolysate control climate hyper demand allergy optimal adaptive higher fish protein inference global therefore project intelligent food result large consuming expressive level lab rapid functional step current prediction others whale neuro conduct system consequently concentration test fuzzy help year challenge every production allergic scale especially quite quality paper optimization bioactive nutritional different acid patient economics industry amino performance parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589738/,abstract,0,whale know intelligent hydrolysate fuzzy expressive hyper economics allergic neuro inference climate allergy quite optimization expensive consuming bioactive fish conduct lab demand industry adaptive algorithm consequently project accurate prediction optimal experimental production step parameter global help nutritional rapid especially scale functional paper performance food challenge quality large concentration current amino higher test time new control acid different protein year level result patient,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""food challenge quality large concentration current amino higher test time new c""]}}","{""fish"": {""freq"": 1, ""string"": [""allergy quite optimization expensive consuming bioactive fish conduct lab demand industry a""]}}",{}
1182,1182,1279,10.1016/j.ymgmr.2016.01.002,27014576.0,self resultspatient investigation methodsparticipants preadolescents early among adult interquartile pam set behavior activation increase month significantly respectively individual phenylalanine higher questionnaire range support result efficacy phone change score significant measure changekeywords problem monthly intervention approach management phenylketonuria older abbreviation stage disability baseline online iep year education feasibility age determine demonstrate adolescent goal motivational soc program indicator also group intellectual different study objectiveto dietary patient participant conclusionthese,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789343/,abstract,1,soc preadolescents pam iep changekeywords resultspatient methodsparticipants motivational interquartile conclusionthese phone monthly abbreviation indicator set objectiveto feasibility older activation demonstrate goal adolescent baseline education intellectual stage investigation efficacy questionnaire behavior self disability determine problem score participant support measure month management program change range increase online adult respectively intervention dietary higher phenylketonuria approach individual significantly early phenylalanine different age significant group year result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""higher phenylketonuria approach individual significantly early phenylalanine different age significant group y""]}, ""intellectual"": {""freq"": 1, ""string"": [""activation demonstrate goal adolescent baseline education intellectual stage investigation efficacy questionnaire b""]}}",{},{},{},{},{}
1183,1183,1280,10.1007/8904_2015_447,25967232.0,blood activity daily estimation among final positive several heel objective performed biotinidase interval partial profound screening biotin higher clinical mina symptom primary result six thus qualitative like purpose large prospective oral novel eight international gerais case confidence seven mutation one pathogenic size child outcome silico confirmatory method ass september behaves serum parent test colorimetric filter year incidence assay brazil age sample two newborn homozygous apparently pilot birth approximately analysis paper larger conclusion cohort june study sequencing supplemented deficiency prick gene unnecessary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582019/,abstract,3,performed behaves colorimetric mina gerais biotinidase biotin unnecessary supplemented heel apparently prick silico september confirmatory estimation profound june final brazil filter homozygous pilot qualitative partial larger prospective confidence pathogenic seven oral interval daily approximately international size incidence serum assay purpose sequencing parent ass cohort like paper birth symptom screening objective primary positive large deficiency novel newborn activity mutation outcome conclusion higher sample case test blood child age gene year method clinical analysis result study,{},"{""homozygous"": {""freq"": 1, ""string"": [""estimation profound june final brazil filter homozygous pilot qualitative partial larger p""]}}",{},"{""newborn"": {""freq"": 1, ""string"": [""objective primary positive large deficiency novel newborn activity mutation outcome conclusion h""]}, ""screening"": {""freq"": 1, ""string"": [""ass cohort like paper birth symptom screening objective primary positive large d""]}}",{},{}
1184,1184,1281,10.21037/cdt.2016.05.04,27747169.0,male statistic better region early tertiary among congenital parametric skewed student package median nineteen awareness need sub common saharan state increase disease month survey nigeria subject lasuth methodsprospective clinically west distribution science indication report diagnosis university data significance late cyanosis non period level case variable one chi per child spss evaluation outcome review descriptive tof social prevalent article predominance test proportion commonest conclusionstof nigerian year best hundred tetralogy version consecutive age hence within percentage january appropriate prevalence normally especially africa standard statistical heart hospital december cohort part pattern presentation study patient fallot square echocardiography deviation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059393/,abstract,4,skewed methodsprospective lasuth cyanosis conclusionstof nineteen nigerian nigeria commonest saharan parametric normally tetralogy predominance fallot tof echocardiography package africa west chi consecutive tertiary spss student december sub square statistic indication awareness january descriptive deviation prevalent percentage university significance presentation late distribution proportion statistical science clinically heart best median appropriate pattern variable survey hospital especially evaluation social congenital male cohort prevalence period need standard better region month state subject version increase report outcome non article common case test early diagnosis review child age year data level patient disease study,"{""social"": {""freq"": 1, ""string"": [""pattern variable survey hospital especially evaluation social congenital male cohort prevalence p""]}}",{},{},{},{},{}
1185,1185,1282,10.1007/s11306-016-1129-z,27840599.0,specific assessment sitosterol ratio early pathway context essential allograft liquid recipient risk cholesterol well esterification ltx month material supplementary form dysfunction user value clinical scoring additionally acylcarnitine disturbance ead metabolic lanosterol routine tandem metabolism plant low postoperative mortality detection one hepatic pre stigmasterol meaf outcome intervention liver model day therapeutic post introductionsensitive free concentration substantial online article electronic associated phase version consecutive predictive materialthe acylcarnitines methodsthe mass function conclusionlow analysis precursor spectrometry available transplantation roc plasma high acid objectiveshere parameter amino sterol metabolite chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078158/,abstract,7,stigmasterol sterol sitosterol objectiveshere meaf ltx lanosterol introductionsensitive esterification ead allograft conclusionlow postoperative scoring recipient acylcarnitine roc consecutive acylcarnitines plant cholesterol disturbance transplantation hepatic methodsthe routine substantial predictive precursor tandem liquid additionally post chromatography associated phase parameter pre mortality liver dysfunction context free spectrometry materialthe essential ratio detection assessment form metabolite month supplementary mass plasma day user version value electronic online therapeutic pathway intervention concentration material amino outcome article function low available metabolism risk model early specific acid metabolic high clinical analysis,{},{},"{""pathway"": {""freq"": 1, ""string"": [""user version value electronic online therapeutic pathway intervention concentration material amino o""]}}","{""detection"": {""freq"": 1, ""string"": [""context free spectrometry materialthe essential ratio detection assessment form metabolite month s""]}, ""amino"": {""freq"": 1, ""string"": [""online therapeutic pathway intervention concentration material amino outcome article function low a""]}, ""tandem"": {""freq"": 1, ""string"": [""hepatic methodsthe routine substantial predictive precursor tandem liquid additionally post chromatography a""]}, ""spectrometry"": {""freq"": 1, ""string"": [""pre mortality liver dysfunction context free spectrometry materialthe essential ratio detection a""]}}",{},{}
1186,1186,1283,10.1007/s10578-018-0810-z,29752662.0,executive disorder relationship mildly three two self one sadness poor childhood film emotion whilst boy anxiety problem child evocative reaction without aspect mechanism sympathy condition regulation task view report common state empathic support skill different situation attention odd study mother stimulus important empathy clip year first finding performance highly particularly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208975/,abstract,0,sympathy evocative empathic clip sadness odd film empathy emotion mildly stimulus whilst situation boy skill executive anxiety view mother task aspect poor reaction regulation childhood self attention particularly highly problem relationship performance finding support state mechanism report condition important common child different year disorder study,{},{},{},{},{},{}
1187,1187,1284,10.1093/dnares/dsz013,31230075.0,disorder factor mismatch among site without molecular frequency due pair measuring coldspots canonical repair computer flexible sequence related observed permanently higher excision contain base attention novo cpg cytosine flexibility biased mutation main motif deamination curve dynamic population chance target system simulation replication contrary altered czech primarily likely effectively spontaneous dna environmental elasticity also spontaneously conclusion mutability human rarely dinucleotides gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704406/,abstract,0,mutability elasticity dinucleotides cytosine coldspots permanently biased mismatch deamination spontaneously cpg contain measuring excision czech canonical contrary spontaneous flexible repair motif chance replication rarely flexibility computer altered pair simulation novo base curve effectively primarily dynamic sequence dna observed site likely attention environmental frequency related main target molecular mutation conclusion higher human factor population gene disorder,{},{},{},{},{},{}
1188,1188,1285,10.1074/jbc.M114.597914,25288802.0,dramatic disorder cluster activity hepatopathy vivo conformation catalysis present glucose site central characterization missense cardiomyopathy well exercise disease solution severely catalytically biochemical reduction recent possible relative previous role protein play mutant result enzyme metabolic contrast complement first type greatly metabolism recombinant flexibility case inability intolerance mutation wild catalytic certain phenotype aggregation apparent soluble serine expression prerequisite key active kcat two variant pgm involved impairment vitro also multiple group often study human deficiency patient modest show,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231678/,abstract,2,hepatopathy kcat catalytically catalysis pgm dramatic cardiomyopathy intolerance prerequisite modest inability conformation serine soluble greatly flexibility complement severely exercise apparent recombinant catalytic aggregation cluster characterization missense solution involved wild mutant glucose certain active vitro play vivo relative contrast previous central site reduction impairment biochemical phenotype possible enzyme expression multiple variant key recent deficiency activity mutation role present case metabolism human type protein metabolic group disorder result patient disease study,{},{},{},{},{},{}
1189,1189,1286,10.1002/mgg3.408,29749107.0,major heterozygote phenotypic european conclusionthe blood african backgroundphenylketonuria factor vfs inframe autosomal splicing missense common state geographical source origin disease pku respectively spectrum sanger however methodsa heterozygous observed role compound haplotype mutant genomic genotype duplication nonsense iberian effect large remainder portugal drift novel genetic admixed mutation three one pathogenic population identification rio predominance frequent rare variant homozygous allele spain peninsula spot brazilian recessive janeiro ancestry dna deletion analysis characteristic also pah amerindian del study frameshift sequencing small patient variability gene total founder mlpa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081236/,abstract,3,vfs peninsula inframe iberian drift amerindian rio portugal janeiro admixed remainder heterozygote mlpa frameshift predominance del splicing spain duplication ancestry nonsense geographical founder african brazilian backgroundphenylketonuria haplotype sanger heterozygous homozygous origin methodsa conclusionthe deletion missense variability phenotypic frequent pathogenic mutant recessive european genotype autosomal allele genomic dna observed source compound pah sequencing spot identification characteristic small spectrum state major variant large rare respectively novel total mutation pku role common factor blood population gene effect genetic analysis patient disease study,{},"{""autosomal"": {""freq"": 1, ""string"": [""frequent pathogenic mutant recessive european genotype autosomal allele genomic dna observed s""]}, ""recessive"": {""freq"": 1, ""string"": [""missense variability phenotypic frequent pathogenic mutant recessive european genotype autosomal allele g""]}, ""homozygous"": {""freq"": 1, ""string"": [""african brazilian backgroundphenylketonuria haplotype sanger heterozygous homozygous origin methodsa conclusionthe deletion m""]}, ""heterozygous"": {""freq"": 1, ""string"": [""founder african brazilian backgroundphenylketonuria haplotype sanger heterozygous homozygous origin methodsa conclusionthe d""]}, ""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1190,1190,1287,10.3945/ajcn.115.124222,26791179.0,new nutrition neonatal eunice nutrient preterm state thematic institute practical gestational issue summary knowledge unit workshop evidence academy clinical role health guidance gap project task globally food support report specification basis guideline question united service gastrointestinal significant theme pediatrics administration society asn pre current drug child outcome ultimate review used nih development national sufficient enteral american topic agenda agricultural serve care address challenge systematic kennedy informed overview library process age public cdc dietetics constitution standard birth series analysis intensive universally priority research infant group nutritional practice consortium feeding human surgical center parenteral shriver,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459075/,abstract,2,shriver kennedy eunice specification constitution agricultural dietetics cdc asn universally pediatrics enteral academy thematic nih ultimate serve informed workshop parenteral agenda globally consortium institute library surgical intensive feeding guidance gastrointestinal used topic series priority preterm theme gestational unit american practical project gap summary sufficient society united overview question nutrient guideline task nutrition address systematic center administration pre basis service nutritional neonatal national practice issue public birth knowledge standard food process support infant state challenge drug report care evidence current outcome role new human research review child age significant development health group clinical analysis,{},{},{},{},{},{}
1191,1191,1288,10.5665/sleep.5968,27166238.0,activity daily epworth dos greater registration anxiety nausea adult narcolepsy controlled impression due parallel common state average mean khayrallah well objective significantly aes dopaminergic gov event doekel feldman clinical bream double sleep global secondary improvement diarrhea symptom primary adx result efficacy effect rosenberg change term versus generation oral ability type score clinicaltrials three ruoff noradrenergic placebo text emsellem maintenance week day method headache second safety wakefulness baseline test awake treatment excessive identifier insomnia phase randomized latency mwt swick percentage scale sleepiness subjective adverse jzp nct trial min conclusion wake group cgi study blind black center patient agent citation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909620/,abstract,8,wakefulness wake swick ruoff rosenberg noradrenergic narcolepsy mwt khayrallah jzp impression feldman emsellem doekel cgi bream adx insomnia epworth controlled sleepiness awake aes nausea dopaminergic headache black subjective latency diarrhea citation identifier excessive sleep registration randomized maintenance dos min clinicaltrials blind placebo percentage parallel nct gov versus anxiety double agent safety event oral baseline daily text average secondary center phase global adverse improvement second efficacy mean generation greater ability scale week score symptom objective state day trial change primary adult activity conclusion term common test significantly type group effect method treatment clinical result patient study,{},{},{},{},{},{}
1192,1192,1289,10.5812/ijem.31790,26633983.0,major male subsequent activity whether daily neighborhood youth morning difference among behavior frequency state race objective discrimination material longitudinal follow higher midwest symptom result six base effect psychological data negatively design cortisol hpa united regression area level yet significant stress differently female current white cope outcome hypothalamo living socio model regulation method daytime predictor potential baseline participation test sex wave response association year religiosity complex age future sample pituitary determine adolescent function chronic background mechanism religious also conclusion disadvantaged cohort urban adrenal study black linear economics salivary demographic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659332/,abstract,6,religious religiosity midwest hypothalamo disadvantaged cope daytime neighborhood economics salivary cortisol youth differently wave morning black socio pituitary race adrenal urban living discrimination participation base hpa negatively demographic psychological subsequent predictor sex united longitudinal white linear adolescent baseline daily follow regulation female stress regression behavior chronic frequency determine design male cohort background symptom area objective state major complex response future association mechanism activity current material outcome conclusion higher difference function sample test model potential age significant year effect method data level result study,{},{},{},{},{},{}
1193,1193,1290,10.1152/ajprenal.00166.2016,27147669.0,resonance rare case specific although threat experimentally rather certain information correlate relative etiology widespread others systemic clinical largely laboratory site inversely gadolinium condition widely pathophysiology litigation report fibrosis chronicity pertain risk unknown contrast magnetic conjecture scourge vastly experiment disease agent ion altered affinity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967166/,abstract,0,scourge gadolinium conjecture chronicity pertain litigation vastly experimentally inversely threat altered affinity ion widespread correlate pathophysiology fibrosis resonance experiment systemic largely agent etiology widely magnetic certain relative contrast unknown site laboratory report rare information condition case risk specific clinical disease,{},{},{},{},{},{}
1194,1194,1291,10.1038/gim.2015.102,26270765.0,propiogenic disorder chain allowance daily sectional prospectively growth rda ratio content composition conclusionincreased mma www weight need supplementation threonine propionate close disease intake respectively medical measurement however gov registrationthis oxidation anthropometric clinical attrs protein cbla leucine body complete food equivalent mut efficacy metabolic effect negatively guideline term type low methodscross score methylmalonic clinicaltrials biomarkers url text outcome history via safety concentration purposemedical isoleucine imbalanced diet acidemia age minimal resultspatients propionic paradoxical height adverse natural consumption nct keywords trial iatrogenic plasma cohort often acid methionine dietary deficiency patient amino parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752925/,abstract,3,resultspatients purposemedical propiogenic paradoxical conclusionincreased url registrationthis rda cbla methodscross imbalanced iatrogenic threonine propionate mut allowance mma methionine anthropometric prospectively propionic isoleucine methylmalonic leucine attrs height www acidemia negatively close oxidation minimal equivalent clinicaltrials nct gov keywords composition complete consumption safety guideline daily text sectional natural content parameter history supplementation adverse efficacy weight chain intake measurement biomarkers growth cohort ratio need score body food plasma trial medical deficiency diet respectively dietary concentration amino outcome term low type acid protein age metabolic effect disorder clinical patient disease,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""medical deficiency diet respectively dietary concentration amino outcome term low type a""]}}","{""diet"": {""freq"": 1, ""string"": [""body food plasma trial medical deficiency diet respectively dietary concentration amino o""]}}",{}
1195,1195,1292,10.1371/journal.pone.0118413,25774510.0,component genetically robust case circuit mutation one complementary versa measure phenotype crucial pathway determinant organism space time mathematical prevent discovery polygenic many population background model irrelevant mechanism output molecular cast importance mutational multiple phenomenon causal ability non effect regulatory insulin human extent virtually cause change call diabetes disease genetic type randomly another show robustness vice complex parameter whose,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361548/,abstract,2,irrelevant cast vice versa mathematical virtually robustness polygenic mutational space circuit output complementary phenomenon determinant causal randomly organism insulin crucial extent genetically robust discovery diabetes prevent parameter regulatory component ability importance phenotype background measure change multiple complex cause pathway molecular mechanism mutation non case time human model type population effect genetic disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""background measure change multiple complex cause pathway molecular mechanism mutation non c""]}}",{},{},{}
1196,1196,1293,10.1016/j.jacc.2017.09.008,29073951.0,interpretation better prospectively difference lower positively duration time fractional centralized common improve control respectively haart era evidence introduction strategy higher therapy decline health echocardiographic ventricular cardiotoxicity antiretroviral effect negatively term long score mortality rate diastolic measure pre morbidity per end infection structure child hiv systolic chaart exposure treatment active association year decision thickness monitoring protocol methodsthe conclusionscardiac vertically mass dimension healthy function equation heart pulmonary echocardiogram perinatally cardiovascular identify group study cardiac objectiveto similar estimating inform backgroundbefore septal contractility complication highly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687306/,abstract,5,vertically perinatally haart echocardiographic contractility conclusionscardiac chaart cardiotoxicity backgroundbefore estimating echocardiogram antiretroviral septal centralized ventricular thickness diastolic systolic dimension equation hiv fractional decline pulmonary prospectively era positively negatively interpretation objectiveto duration inform methodsthe cardiac introduction improve identify monitoring cardiovascular complication end protocol morbidity infection active decision heart pre mortality exposure structure highly score better similar measure healthy mass long strategy lower association respectively therapy rate evidence term higher difference common function time control child health group year effect treatment study,{},{},{},{},{},{}
1197,1197,1294,10.7759/cureus.4949,31453023.0,worldwide chorioretinitis hearing clinic abnormality growth petechia congenital progressive positive defect despite restriction fit physical need highlight igg old course igm clinician ganciclovir display addition sensorineural month neurological jaundice seizure neurodevelopmental baby ups suspicion purpura health hepatosplenomegaly symptom examination possibility report asymptomatic sequela intrauterine cardiology symptomatic basis cause term first long consider mortality significant case three one morbidity murmur complaint normal infection child prevent evaluation outcome intervention week degree day frequently history tof development serum loss association finding tetralogy cmv maternal microcephaly public two newborn timely heart adverse infant episode fever ccmv high entity infected cytomegalovirus fallot prominent echocardiography presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701899/,abstract,0,purpura petechia murmur hepatosplenomegaly ganciclovir chorioretinitis ccmv ups cmv sensorineural infected igm consider cardiology tetralogy jaundice fallot cytomegalovirus tof suspicion echocardiography igg complaint intrauterine fever sequela hearing fit microcephaly prominent episode display timely entity asymptomatic symptomatic baby progressive degree seizure worldwide course possibility neurodevelopmental examination clinician restriction morbidity infection frequently prevent neurological clinic heart mortality history basis maternal adverse physical serum old abnormality loss presence evaluation defect highlight growth despite congenital week public need finding symptom month infant normal addition long day cause positive association report intervention newborn outcome term case child significant development health high,"{""neurological"": {""freq"": 1, ""string"": [""clinician restriction morbidity infection frequently prevent neurological clinic heart mortality history b""]}, ""microcephaly"": {""freq"": 1, ""string"": [""complaint intrauterine fever sequela hearing fit microcephaly prominent episode display timely e""]}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""day cause positive association report intervention newborn outcome term case child s""]}}",{},{}
1198,1198,1295,10.1371/journal.pcbi.1006734,30640898.0,consistency ratio single pathway among unmatched difficult time across set biologically pairup stringent match retention pair variation annotation validation well finally biochemical cannot imputation annotate body manner comparable result annotated metabolic data computational thousand experiment knowns expectation genetic significant signal biomarkers measure many correctly generate approach method functionally unknown reconstitution infer association challenge bmi robust untargeted mass variant suite likely biology standard enriched next path meaningful analysis index metabolomics spectrometry available multiple consequence comprehensive different often study meta charge powerful random even gene readily metabolite enables,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347288/,abstract,0,unmatched pairup knowns annotated reconstitution infer imputation annotate match stringent generate enriched suite biologically expectation charge enables correctly annotation untargeted consistency retention functionally readily path pair meaningful thousand random manner computational set powerful bmi comparable experiment validation meta signal robust biology metabolomics comprehensive difficult unknown index finally consequence likely variation spectrometry biomarkers biochemical ratio standard body metabolite measure mass challenge multiple variant pathway single association approach available time different significant metabolic gene genetic method data analysis result study,{},"{""genetic"": {""freq"": 1, ""string"": [""available time different significant metabolic gene genetic method data analysis result s""]}}","{""pathway"": {""freq"": 1, ""string"": [""metabolite measure mass challenge multiple variant pathway single association approach available t""]}}","{""spectrometry"": {""freq"": 1, ""string"": [""unknown index finally consequence likely variation spectrometry biomarkers biochemical ratio standard b""]}}",{},{}
1199,1199,1296,10.1371/journal.pone.0114029,25437004.0,process implication however new possible form observed aggregation chaperone responsible present extensively macromolecular despite calcium protein prevent act mechanism condition affinity fibrillation due propensity capable alzheimer result effect amyloidogenic study direct exacerbating apo disease inhibitory another formation finding aggregate holo non,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250181/,abstract,0,macromolecular holo fibrillation exacerbating apo amyloidogenic propensity extensively chaperone affinity inhibitory calcium aggregate aggregation capable alzheimer act responsible formation prevent observed implication direct despite finding possible process form mechanism condition non present new protein effect result disease study,{},{},{},{},{},{}
1200,1200,1297,10.1016/j.ymgmr.2017.01.011,28224082.0,multidisciplinary significant specific pathophysiological disorder delay appropriate order dependence department drug adult clinical storage subtype feature hospital approach characteristic condition phenylketonuria symptom onset degree great physical error iems inborn policy group gaucher system diagnosis common cohort metabolic classification prevalent second study fabry heterogeneity existence spanish acid treatment important lysosomal patient disease respectively metabolism healthcare amino number whose implement,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310594/,abstract,4,spanish subtype gaucher implement fabry dependence existence multidisciplinary lysosomal pathophysiological department iems prevalent classification degree storage delay great heterogeneity healthcare policy appropriate physical second hospital feature onset cohort characteristic order inborn symptom drug error adult respectively amino condition important common phenylketonuria approach number metabolism specific diagnosis acid significant metabolic group disorder treatment clinical patient disease study,{},"{""heterogeneity"": {""freq"": 1, ""string"": [""prevalent classification degree storage delay great heterogeneity healthcare policy appropriate physical s""]}}",{},"{""amino"": {""freq"": 1, ""string"": [""inborn symptom drug error adult respectively amino condition important common phenylketonuria a""]}}",{},{}
1201,1201,1298,10.1371/journal.pone.0138532,26389596.0,logistic conclusionthe blood cross sectional region ratio difference lower prematurity formula resultshigher odds preterm gestational amount designthis phenylalanine partial value intravenous observational data strictly percentile call consideration regression level monitored moment fully outcome week model degree day method analyse concentration collection association finding age monitoring sample multivariate newborn caution since breast carefully birth infant also plus plasma feeding study spanish acid objectiveto linear amino gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577102/,abstract,2,resultshigher monitored spanish designthis strictly moment caution prematurity intravenous percentile carefully analyse feeding breast multivariate plus odds preterm formula objectiveto logistic gestational partial conclusionthe observational fully degree gender consideration monitoring linear sectional collection regression cross week ratio birth finding region infant plasma day value lower association concentration newborn amino outcome difference sample model phenylalanine blood acid age method data level study,"{""phenylalanine"": {""freq"": 2, ""string"": [""newborn amino outcome difference sample model phenylalanine blood acid age method d""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""day value lower association concentration newborn amino outcome difference sample model p""]}, ""newborn"": {""freq"": 1, ""string"": [""plasma day value lower association concentration newborn amino outcome difference sample m""]}}",{},{}
1202,1202,1299,10.1186/s12889-018-5947-y,30103721.0,miao major specific past region difference factor lower across defect musculoskeletal several five uptrend province yao risk average obvious number gestational visit related backgroundthe relative observed environment china antenatal large data cultural combination genetic epidemiology dong ethnicity resultsthere per craniofacial description perinatal han potential susceptibility zhuang year guangxi care city maternal complex age within custom ethnic prevalence birth environmental hospital cardiovascular research infant group comprehensive interaction study urogenital highest conclusionthis total malformation methodssurveillance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090596/,abstract,6,yao urogenital uptrend miao methodssurveillance dong zhuang guangxi musculoskeletal craniofacial obvious custom han antenatal ethnic cultural resultsthere conclusionthis description ethnicity visit perinatal epidemiology malformation city province susceptibility gestational backgroundthe china cardiovascular highest past relative comprehensive average maternal observed environment hospital combination environmental defect related prevalence birth interaction region infant major complex large lower care total difference number risk specific factor research potential age group year genetic data study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1203,1203,1300,10.1186/s12263-017-0584-0,29270237.0,efficacious interpretation whether difference information context unregulated nutrition present careful nutrient choice defensible state clear practical addition avoid examines inter semi utility knowledge subject evidence actionable quantitative relative health guidance generic biennially body genotype food sound debate effect data basis guideline official genetic art area level educational protect clearly although advice nutrigenetic scientific requirement code implementation outcome strength personal ass propose consequently test resource recommendation response scientifically draft component commercially public within still minimal professional lack application standard subgroup nutrigenetics validity research framework misuse infancy practice study transparent dietary though beyond individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732517/,abstract,0,unregulated scientifically misuse defensible biennially nutrigenetic examines draft transparent sound protect nutrigenetics commercially efficacious actionable official code careful avoid art generic advice personal debate validity strength guidance clearly semi inter infancy subgroup requirement interpretation minimal consequently practical educational clear propose choice scientific nutrient guideline framework utility nutrition genotype relative resource component basis recommendation professional quantitative implementation lack context practice ass public knowledge standard body food area application addition state subject response dietary information evidence outcome difference present test individual research health effect genetic data level study,{},"{""genetic"": {""freq"": 1, ""string"": [""unregulated scientifically misuse defensible biennially nutrigenetic examines draft transparent sound p""]}}",{},{},{},{}
1204,1204,1301,10.4103/ijpvm.IJPVM_378_16,29184640.0,exon chain retardation among present reaction unrelated restriction five province frequency severe common investigate mazandaran varied polymerase disease hydroxylase pku respectively golestan spectrum consanguinity intron related phenylalanine observed clinical leukocyte genomic result length effect long genetic untreated extraction mutation three main population phenylketonuria method mental qiagen forty manifestation polymorphism kit allele responsible dna background pah conclusion different high study patient highest gene fragment founder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686925/,abstract,7,qiagen golestan mazandaran leukocyte intron kit fragment founder consanguinity polymerase retardation unrelated province varied extraction length untreated responsible manifestation exon restriction highest polymorphism allele mental reaction genomic dna observed pah investigate chain frequency related hydroxylase main spectrum severe background long respectively mutation pku conclusion common phenylketonuria present phenylalanine population different gene effect high genetic method clinical result patient disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""mutation pku conclusion common phenylketonuria present phenylalanine population different gene effect h""]}}","{""genetic"": {""freq"": 1, ""string"": [""phenylalanine population different gene effect high genetic method clinical result patient d""]}}",{},{},{},{}
1205,1205,1303,10.2196/11213,30567693.0,tool cluster sparse region difference among final positive world www half attempt without behavior province resultsa suggested methodswe control backgroundin material village respectively pregnant unit however gov smaller recent conclusionsadequate confirm follow clinical attrs health range launch primary report message large data phone webcite term type inexpensive chinese mortality use service level significant clinicaltrials instant rate short communication death text alike normal implementation october woman registrationclinicaltrials mobile intervention hunan perinatal remote randomization organization resource year education care maternal webcitation scale achieve explore worker analysis intensive benefit impact program available nct infant widely keywords trial december objectivethis study arm org randomly individual total county statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315224/,abstract,8,instant conclusionsadequate webcite webcitation randomization hunan objectivethis alike launch worker village sparse county remote phone suggested message inexpensive smaller registrationclinicaltrials org october mobile attempt arm perinatal confirm intensive attrs achieve final backgroundin www resultsa december province cluster randomly clinicaltrials unit pregnant nct chinese gov half organization keywords statistically communication widely world education text explore resource methodswe death follow mortality service maternal woman implementation short behavior scale benefit region tool infant normal trial program range primary positive large recent use report respectively impact intervention care rate total material term difference available individual control type significant health year data level clinical analysis study,{},{},{},{},{},{}
1206,1206,1304,10.1007/s10519-015-9724-8,26026879.0,various disorder cluster dominant memory abnormality harbor growth profile autosomal behavioral adult partially moreover deficit control well finally respectively feingold subset animal adulthood norepinephrine dysmorphism possible spatial heterozygous dopamine developmental brain mouse body draw link thus data selective stature type genetic medial ability span level although novelty short scientific syndrome description recognition neurotransmission model esophageal evident development mir social disability alteration prefrontal digital duodenal wide microcephaly vocalization anomaly serotonin healthy comparison responsible hip deletion cognitive facial aim array cortex intellectual tissue study human deficiency patient hippocampus atresia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561592/,abstract,0,feingold dysmorphism duodenal vocalization stature hip esophageal harbor atresia novelty draw digital mir medial norepinephrine neurotransmission span prefrontal facial description array microcephaly hippocampus cortex spatial heterozygous anomaly dominant evident recognition partially cluster adulthood subset selective serotonin deletion link responsible scientific memory dopamine alteration behavioral autosomal intellectual finally profile short deficit abnormality animal comparison disability tissue developmental syndrome social ability growth wide mouse possible various body cognitive aim healthy brain adult deficiency respectively human model control type development genetic data level disorder patient study,"{""microcephaly"": {""freq"": 1, ""string"": [""neurotransmission span prefrontal facial description array microcephaly hippocampus cortex spatial heterozygous a""]}, ""intellectual"": {""freq"": 1, ""string"": [""scientific memory dopamine alteration behavioral autosomal intellectual finally profile short deficit a""]}, ""behavioral"": {""freq"": 1, ""string"": [""link responsible scientific memory dopamine alteration behavioral autosomal intellectual finally profile s""]}, ""social"": {""freq"": 1, ""string"": [""animal comparison disability tissue developmental syndrome social ability growth wide mouse p""]}}","{""autosomal"": {""freq"": 1, ""string"": [""responsible scientific memory dopamine alteration behavioral autosomal intellectual finally profile short d""]}, ""heterozygous"": {""freq"": 1, ""string"": [""description array microcephaly hippocampus cortex spatial heterozygous anomaly dominant evident recognition p""]}, ""genetic"": {""freq"": 1, ""string"": [""respectively human model control type development genetic data level disorder patient s""]}}",{},{},{},{}
1207,1207,1305,10.3389/fpsyt.2019.00551,31428003.0,coefficient correlation assessment tool disorder reliability autism difference difficult boy waso time essential behavioral onset choice hospitalization intraclass state common valid mean agreement objective spectrum measurement knowledge clinically sleep altman equivalence particular rhythm methodology icc good first ability validate art non yet significant plot asd main one interest measure gold ebe psg night comorbidities sensitivity child population method dsm efficiency tst prevalent test bland year specificity latency age within suggest epoch scale comparison standard determine since function invasive girl validated act cognitive criterion analysis validity impact also min diagnostic high polysomnography study actigraphy highly total parameter acceptable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688709/,abstract,2,waso tst psg polysomnography epoch ebe actigraphy icc equivalence rhythm intraclass dsm night bland altman valid plot latency hospitalization comorbidities agreement art suggest gold reliability validate sleep validity validated girl min boy coefficient invasive acceptable prevalent act efficiency choice methodology asd behavioral difficult specificity clinically parameter autism good particular sensitivity mean comparison criterion onset measurement highly correlation essential ability determine scale main knowledge spectrum diagnostic standard assessment cognitive tool measure objective state impact total non difference common function test time population child age significant year high method disorder analysis study,"{""behavioral"": {""freq"": 1, ""string"": [""prevalent act efficiency choice methodology asd behavioral difficult specificity clinically parameter a""]}}",{},{},{},{},{}
1208,1208,1306,10.1016/j.ymgmr.2019.100507,31497506.0,subsequent blood self daily backgroundphenylketonuria behavioral preference reaction choice difficulty risk dissatisfied substitution severity accumulation swing disease survey pku respectively methodsadult satisfaction phenylalanine life dysfunction clinical therapy define mol burden probability report enzyme effect mab level feeling current many ordinal isolation hypersensitivity social following web treatment diet conclusionmost two reduces resultsamong burdensome make standard neurologic minimum psychiatric quality cognitive benefit weighting thresholding also socially pegvaliase objectiveto patient tolerate participant deviation acceptable willing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722251/,abstract,1,weighting thresholding swing ordinal methodsadult mab feeling conclusionmost tolerate following burdensome dissatisfied socially satisfaction isolation willing pegvaliase hypersensitivity resultsamong make neurologic minimum define probability backgroundphenylketonuria substitution reduces preference web objectiveto deviation acceptable subsequent psychiatric choice difficulty burden mol severity daily accumulation behavioral reaction survey dysfunction self social benefit standard participant cognitive enzyme quality diet report respectively therapy life current pku risk phenylalanine blood effect level treatment clinical patient disease,"{""phenylalanine"": {""freq"": 2, ""string"": [""respectively therapy life current pku risk phenylalanine blood effect level treatment c""]}, ""behavioral"": {""freq"": 1, ""string"": [""difficulty burden mol severity daily accumulation behavioral reaction survey dysfunction self s""]}, ""social"": {""freq"": 1, ""string"": [""accumulation behavioral reaction survey dysfunction self social benefit standard participant cognitive e""]}, ""psychiatric"": {""freq"": 1, ""string"": [""preference web objectiveto deviation acceptable subsequent psychiatric choice difficulty burden mol s""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""benefit standard participant cognitive enzyme quality diet report respectively therapy life c""]}}",{}
1209,1209,1307,10.1186/s12918-018-0528-3,29671395.0,biological summarizes efficient literature conclusionsside state toxicity contribute integer however reduction rather optimal role compound play programming hku therefore backgroundtraditional result thus efficacy enzyme metabolic effect computational combination software crucial graph problem completeness drug side discovery damage approach model method identification resultsin development target propose topic theoretical important network minimal lack hkumath minimum formalism wkc analysis impact paper available zip identify study apbc unintended linear successful,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907190/,abstract,0,zip wkc integer hkumath hku formalism conclusionsside backgroundtraditional apbc unintended completeness graph theoretical programming summarizes minimum resultsin topic toxicity software computational minimal crucial contribute propose identify efficient damage optimal linear successful discovery network play compound efficacy reduction lack combination biological identification problem paper target literature enzyme state drug impact important role approach available model development metabolic effect method analysis result study,{},{},{},{},{},{}
1210,1210,1308,10.1186/s13023-018-0958-4,30567582.0,specific interpretation assessment difference effort among showcase brief algorithm despite contains slr literature pro due need deficit difficulty neurocognitive modelling partly validation well disease solution material related offer symbol trail life withstand however supplementary adequate possible form unassessed digit perspective user clinical coa health generic global bdi usually improvement symptom task result depression six subscales data design first level mapping yet reasonable case cushingqol measure size pre economic syndrome instrument fully population review comorbidity inclusion mediator post online article treatment electronic year systematic challenge version scrutiny materialthe rare within sample two suggest persistence scale stakeholder statistical limited dedicated quality cognitive aspect research available widely depressive multiple tuebingen often high last study similar small patient inform absence show performance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299940/,abstract,2,unassessed tuebingen symbol slr showcase cushingqol withstand scrutiny subscales digit bdi trail reasonable modelling persistence dedicated depressive mediator comorbidity contains suggest generic partly mapping stakeholder neurocognitive brief pro offer instrument usually interpretation algorithm inform depression coa fully adequate validation solution absence economic difficulty widely task aspect perspective post statistical inclusion effort systematic pre global size improvement deficit limited syndrome materialthe despite design scale related small performance need similar literature possible assessment symptom form cognitive measure supplementary challenge user multiple version electronic quality online rare life material article difference sample case available specific research population review health year high data level treatment clinical result patient disease study,{},{},{},{},{},{}
1211,1211,1309,10.4103/0971-5916.200882,28256465.0,interpretation blood estimation difference factor present cyanmethaemoglobin aged condition mean cent agreement true objective respectively establish however interval value conventional equivalent indirect result regression level whole confidence although per prediction sensitivity feasible method ass finding specificity hence haemoglobin slum prevalence adolescent equation field girl anaemia analysis background widely urban study successfully direct correction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345303/,abstract,2,slum cyanmethaemoglobin cent haemoglobin anaemia equation indirect agreement urban estimation true girl correction interpretation establish equivalent conventional feasible successfully prediction confidence widely adolescent interval specificity aged direct regression sensitivity mean ass prevalence field finding background objective value respectively condition difference present factor blood method level analysis result study,{},{},{},{},{},{}
1212,1212,1311,10.1016/j.ymgme.2015.12.008,26740382.0,phenotypic disorder blood chain culture better conclusionswe lower subunit ammonia time defect propionyl molecular retention supplementation state beta morphology old control disease respectively utility relevant understanding intermediary pcca restore possible relative carboxylase coa protein milieu primary fibroblast effectiveness transport enzyme metabolic hepatocyte pccb first metabolism hepatocytes level backgroundpropionic valine normal examining liver day therapeutic ass expression potential system concentration hemodynamic actin urea response year isoleucine acidemia donor methodsin stably resultsprimary biology healthy peripheral underscore previously pathophysiology consequence tissue physiologically alpha study medium human acid patient agent absence amino gene successful presence parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852394/,abstract,2,resultsprimary pcca examining backgroundpropionic stably pccb propionyl hemodynamic restore milieu intermediary actin valine physiologically carboxylase underscore subunit retention isoleucine conclusionswe morphology beta fibroblast ammonia acidemia methodsin hepatocytes donor urea culture peripheral pathophysiology transport coa alpha hepatocyte medium absence phenotypic agent biology successful utility relative effectiveness parameter consequence supplementation old understanding liver presence chain tissue defect previously relevant ass better possible enzyme normal healthy state day expression primary response therapeutic lower molecular respectively concentration amino metabolism time human control blood acid potential protein metabolic gene year level disorder patient disease study,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""response therapeutic lower molecular respectively concentration amino metabolism time human control b""]}}",{},{}
1213,1213,1312,10.1152/physrev.00025.2013,25540139.0,major various milk factor subfamily pathway context molecule gut across half nutrient oat central organic common deal interorganismal toxin physiology hypothesis well conjunction vitamin disease retina prostaglandin transcription microarray family recent anti role diuretic play brain fluid putative olfactory body particular great anion movement knockout cyclic enzyme aristolochic solute attention nonsteroidal data ramification receptor novel uric intestine metabolism nkt level selectivity microbiome nuclear roughly isoforms communication certain transporter strong drug placenta many liver remote via expression system sex key detail hnf steroid interorgan phase odorants plexus carrier inflammatory complex volatile mercury biology uremic breast quite function originally placental antibiotic sensing metabolomics also study mucosa nucleotide acid barrier small antiviral metabolite kidney choroid,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281586/,abstract,0,odorants nonsteroidal nkt interorganismal diuretic choroid aristolochic subfamily ramification prostaglandin plexus interorgan uremic sensing roughly olfactory mucosa mercury retina placenta originally oat isoforms cyclic solute placental deal volatile uric selectivity remote antiviral anion steroid quite toxin microarray intestine antibiotic knockout conjunction gut breast microbiome putative physiology hnf kidney movement transporter milk fluid sex half vitamin barrier transcription organic nuclear communication great nutrient anti strong receptor biology nucleotide metabolomics hypothesis certain carrier inflammatory play molecule phase particular central liver context attention small various body metabolite enzyme major expression complex drug key pathway brain recent family novel role common function metabolism factor acid data level disease study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""enzyme major expression complex drug key pathway brain recent family novel r""]}}",{},{},{}
1214,1214,1314,10.1152/japplphysiol.00589.2017,28729391.0,pathogenesis specific blood biopsy better vivo microdialysis heat pathway across laboratory doppler lifespan throughout aged state vascular mechanistic control endothelial vessel well circulation disease bed warm biochemical merit cutaneous understanding event variety dysfunction role microcirculation focus body particular vasodilation large change term furthermore first long ability provocation laser redundant progression outcome review approach model technique method used predictor vasodilate attendant cold impaired stimulus important pharmacodissection response accessible associated vasoconstrict vasoreactivity age sample earliest nitric fashion flowmetry intradermal adverse analysis mechanism cardiovascular impact flow vitro indicator multiple microvascular often tissue study thermal oxide skin human similar dilator distinct,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792098/,abstract,0,warm vasoreactivity vasodilate vasoconstrict provocation pharmacodissection intradermal dilator bed flowmetry earliest doppler cutaneous vasodilation redundant microdialysis microcirculation attendant microvascular merit cold thermal vessel heat laser fashion circulation biopsy stimulus lifespan accessible indicator endothelial used vascular skin impaired nitric flow mechanistic oxide pathogenesis predictor progression distinct cardiovascular variety event vitro vivo associated aged adverse particular understanding focus dysfunction furthermore tissue technique ability laboratory biochemical better similar body state long change multiple response large pathway mechanism impact outcome term important role sample approach human model specific control blood review age method analysis disease study,"{""skin"": {""freq"": 1, ""string"": [""lifespan accessible indicator endothelial used vascular skin impaired nitric flow mechanistic o""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""state long change multiple response large pathway mechanism impact outcome term i""]}}",{},{},{}
1215,1215,1315,10.1038/s41467-018-07966-5,30622276.0,invokes dramatic strain downstream disorder dye however notion self vivo growth amyloid pathway inhibitor anti dose structure occurrence dependent protein reduced model vitro adenine cytotoxicity error polyphenol pathology yeast antibody like enzymatic concentration toxicity direct hypothesis accumulation treatment extension increase linear associated assembly far demonstration inhibition metabolism intracellular metabolite non paradigm indicative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325136/,abstract,0,polyphenol invokes adenine dramatic dye cytotoxicity yeast indicative extension demonstration intracellular notion strain occurrence amyloid paradigm assembly toxicity antibody enzymatic downstream far inhibitor pathology inhibition reduced anti linear hypothesis accumulation dose vitro vivo associated dependent direct self structure growth like metabolite increase error pathway concentration non metabolism model protein disorder treatment,{},{},"{""pathway"": {""freq"": 1, ""string"": [""structure growth like metabolite increase error pathway concentration non metabolism model p""]}}",{},{},{}
1216,1216,1316,10.3390/jcm8010021,30585183.0,polyangiitis disorder clinic claudication reaction prompt onset lupus gingivitis due erythematosus course practical lesion giant disease joint periodontal offer reader possible anti clinical dysphagia symptom rheumatological diagnosis rheumatic like oral first potentially main advice local systemic drug sign granulomatosis recognition review frequently expression frequent manifestation treatment alteration appropriately cell peculiar rare temporomandibular adverse aim also xerostomia practice aphthosis dental patient hyposalivation jaw dangerous number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351952/,abstract,0,xerostomia temporomandibular rheumatological polyangiitis lupus hyposalivation granulomatosis giant erythematosus dysphagia claudication aphthosis periodontal peculiar jaw gingivitis dangerous rheumatic reader joint dental appropriately prompt advice lesion recognition offer sign practical systemic manifestation course local frequent anti oral frequently alteration clinic potentially reaction adverse onset practice like main possible symptom aim expression drug rare cell number diagnosis review disorder treatment clinical patient disease,{},{},{},{},{},{}
1217,1217,1317,10.1159/000465529,28334709.0,erythrocyte blood cross investigation micronutrient sectional early warrant essential despite density fracture nutrient deleterious aged prevents elevated slightly due severe supplementation vitamin pku status intake respectively conclusionsdutch adequate value protein resultsselenium dutch comparable arginine term long low score multi mineral normal population phenylketonuria history lifetime prevalent concentration treatment introductionin fatty year diet near strict folic fat occur selenium prevalence bone cognitive impairment natural general plasma study acid dietary zinc deficiency patient center safe total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516403/,abstract,2,resultsselenium conclusionsdutch introductionin fracture erythrocyte dutch warrant prevents selenium occur mineral folic deleterious zinc micronutrient lifetime strict slightly arginine bone near density safe fat prevalent comparable adequate multi vitamin nutrient elevated fatty sectional natural center investigation history aged supplementation impairment cross intake essential despite general prevalence status score severe cognitive normal long plasma value deficiency diet respectively dietary concentration total pku term phenylketonuria low early blood population acid protein year treatment patient study,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""cognitive normal long plasma value deficiency diet respectively dietary concentration total p""]}}",{}
1218,1218,1318,10.3390/children4060047,28598357.0,specific disorder abnormality cure congenital present prenatal workup serious condition injury physical common prognosis testing virus neurological emergence worse later life evidence much recent brain news usually symptom examination zika diagnosis metabolic intrauterine cause first genetic chromosomal case step scientific certain experienced infection syndrome child evaluation sign confirmatory perinatal history prevalent test postnatal strongly maternal microcephaly age two lifelong mri community standard since birth next circumference head teratogen diagnostic often magnetic whereas rapidly thorough presence deviation gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483622/,abstract,0,teratogen news zika workup worse intrauterine cure thorough experienced emergence postnatal microcephaly confirmatory chromosomal perinatal circumference rapidly lifelong mri prognosis head usually sign injury deviation prevalent virus prenatal strongly gender scientific later examination magnetic certain infection community neurological step history maternal physical abnormality presence syndrome evaluation congenital birth testing diagnostic standard symptom cause brain recent life evidence condition common present case test specific diagnosis child age metabolic genetic disorder,"{""neurological"": {""freq"": 1, ""string"": [""later examination magnetic certain infection community neurological step history maternal physical a""]}, ""microcephaly"": {""freq"": 1, ""string"": [""intrauterine cure thorough experienced emergence postnatal microcephaly confirmatory chromosomal perinatal circumference r""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1219,1219,1319,10.1007/s12035-015-9342-8,26215833.0,correlation corr relationship nine shift palatogenesis factor without central lip dopa risk motor control nscl disease responsive neurological contribute respectively evidence higher fold global haplotype orofacial neurotransmitter hyperphenylalaninaemia result purpose oral type metabolism non significant functional palate morphological dystonia system analyse polymorphism association hpabh best two variant nervous cleft gtp syndromic also polymorphic group trend study deficiency patient gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703629/,abstract,2,palatogenesis nscl hpabh corr palate orofacial cleft lip hyperphenylalaninaemia polymorphic morphological syndromic dopa dystonia gtp analyse haplotype shift responsive contribute trend nervous neurotransmitter fold motor polymorphism oral neurological best global central purpose correlation functional relationship variant association deficiency respectively evidence higher non metabolism risk control factor type significant gene group result patient disease study,"{""neurological"": {""freq"": 1, ""string"": [""nervous neurotransmitter fold motor polymorphism oral neurological best global central purpose c""]}}",{},{},{},{},{}
1220,1220,1320,10.1186/s13195-015-0094-5,25780390.0,resonance male memory new vivo difference former early examine glutamate molecule time weight five posterior sub traumatic variation neuropsychologist control concussive increase glutamine respectively offer channel phenylalanine life coil career conclusionsa higher clinical brain symptom examination inositol introductionthe elevation result diagnosis depression effect symptomatic concussion data large significance sport first repetitive impulse level significant size acute experienced problem methodsto myo approach choline method history contact judgment acetyl technology exposure headache loss athlete trauma fucose aggression year age monitoring resultsthe sample professional spectroscopy phantom rbt healthy goal chronic scanner previously encephalopathy relatively larger multiple aspartate cohort cosy study magnetic small power men neurochemical gyrus confusion injury statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361214/,abstract,4,rbt inositol impulse concussive coil trauma sport phantom neuropsychologist myo introductionthe fucose cosy concussion career athlete neurochemical methodsto aggression traumatic judgment confusion scanner gyrus headache aspartate posterior conclusionsa choline repetitive glutamine experienced acetyl encephalopathy contact channel men glutamate elevation power sub symptomatic spectroscopy offer injury depression resonance examine larger significance resultsthe monitoring examination statistically memory goal magnetic relatively molecule vivo acute history size professional weight loss exposure variation chronic previously problem male cohort technology small symptom healthy multiple increase large brain respectively life higher difference sample approach time new early phenylalanine control diagnosis age significant year effect method data level clinical result study,"{""phenylalanine"": {""freq"": 2, ""string"": [""difference sample approach time new early phenylalanine control diagnosis age significant y""]}}",{},{},{},{},{}
1221,1221,1321,10.1002/ajmg.a.38220,28374951.0,worldwide consultation importantly new early among largely adult prenatal concern inaccurate condition due spinal favor experience majority disease traditional survey however family unique screening wilson value clinical spite launch possibility report support preferred diagnosis qualitative interview symptomatic data cause sma genetic type obstacle acceptability non significant inability one member short death pre child population toward reason jungner therapeutic potential muscular treatment important key challenge attitude conception particularly wide public within newborn positioning lack subgroup underscore criterion previously impact program infant trial except general historically cohort study direct atrophy participant typing treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485005/,abstract,0,typing sma inaccurate positioning jungner wilson spinal launch consultation muscular atrophy spite preferred favor conception inability underscore obstacle acceptability historically attitude symptomatic reason importantly subgroup qualitative interview traditional worldwide largely prenatal possibility treat member unique majority death concern experience pre direct short survey lack criterion particularly previously wide general cohort public participant support infant screening trial program challenge cause value key therapeutic adult report family impact newborn condition non important new early type diagnosis population potential child significant genetic data treatment clinical disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""type diagnosis population potential child significant genetic data treatment clinical disease s""]}}",{},"{""newborn"": {""freq"": 1, ""string"": [""key therapeutic adult report family impact newborn condition non important new e""]}, ""screening"": {""freq"": 1, ""string"": [""general cohort public participant support infant screening trial program challenge cause v""]}}",{},{}
1222,1222,1322,10.1007/s10545-017-0131-6,29453510.0,various iem lead single pathway time present laboratory package platform liquid xcms need subsequently iems diverse testing control way significantly uncertain material amount spectrum biochemical related supplementary screening form user clinical feature identifies error inborn perturbed diagnosis metabolic data forward significance term generation ngms novel first genetic metabolism flight yet whole functional three panel main software biomarkers implementation database evaluation approach quadrupole workflow method identification correct propose exome potential second unknown holistic concentration online article electronic filter assay version materialthe complex sample mass untargeted variant qtof statistical limited authorized field next analysis metabolomics spectrometry available modality diagnostics plasma high last human sequencing patient individual resolution metabolite chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959972/,abstract,2,xcms ngms qtof perturbed quadrupole package flight identifies untargeted holistic uncertain workflow modality forward iems diagnostics filter software authorized subsequently correct resolution exome propose significance diverse platform metabolomics iem panel liquid statistical chromatography unknown way implementation second assay feature limited lead generation sequencing spectrometry database biomarkers materialthe evaluation laboratory identification related functional main biochemical need field testing spectrum various inborn form metabolite supplementary screening mass plasma user complex version variant electronic error online pathway single novel concentration material term article sample approach present available metabolism individual time significantly human control diagnosis potential metabolic high genetic method data clinical analysis patient,{},"{""genetic"": {""freq"": 1, ""string"": [""human control diagnosis potential metabolic high genetic method data clinical analysis p""]}}","{""pathway"": {""freq"": 1, ""string"": [""complex version variant electronic error online pathway single novel concentration material t""]}}","{""spectrometry"": {""freq"": 1, ""string"": [""assay feature limited lead generation sequencing spectrometry database biomarkers materialthe evaluation l""]}, ""screening"": {""freq"": 1, ""string"": [""spectrum various inborn form metabolite supplementary screening mass plasma user complex v""]}}",{},{}
1223,1223,1323,10.5812/ircmj.17(4)2015.25880,26023343.0,disorder activity daily morning difference fragrance time aromatherapy labor cylindrical cotton difficulty mean inadequate control effective essence objective ball medical life pharmacological deep pharmaceutical moderate container distance clinical health procedure postpartum sleep improvement zanjan science result university eighth effect pillow data change decrease fourth lavender nightly score useful non period significant independent stressful certain measure placebo problem instrument woman spss intervention breath total inclusion week variance method used judgment stage pittsburgh loss baseline concentration test mother delivery maternal sample two determine beside barij quality criterion analysis background index research trial conclusion group disposal different study deprivation similar center patient irritability even randomly participant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443384/,abstract,7,pillow nightly lavender irritability fragrance cylindrical cotton barij ball aromatherapy zanjan pittsburgh eighth container fourth essence stressful postpartum judgment disposal breath morning labor distance deprivation deep inadequate spss sleep used variance instrument randomly placebo pharmaceutical university pharmacological difficulty moderate mother certain baseline daily procedure independent science inclusion useful center stage delivery maternal index woman decrease improvement mean loss criterion determine problem week period score similar participant background measure objective trial change quality effective medical intervention life concentration total activity conclusion non difference sample test time control research different significant health group effect method data disorder clinical analysis result patient study,"{""breath"": {""freq"": 1, ""string"": [""fourth essence stressful postpartum judgment disposal breath morning labor distance deprivation d""]}}",{},{},{},{},{}
1224,1224,1324,10.3389/fncel.2014.00314,25339865.0,interestingly lateral neurotoxic studied growth effort molecule essential surface summarizes weight adhesion molecular pro diverse morphology neurodegenerative regulatory addition disease neuronal transcription decade however family cone dysregulation recent form extensively role protein guidance cytoskeleton particular rac result link type potentially low rho effector cellular member signal sclerosis involvement death spine progression etiology collectively many critical review axon regulation dendritic development organization insult rhoa actin important key finding cell indeed neuron guanine cdc morphogenesis survival amyotrophic underscore kda function arborization either superfamily also upon cycle last nucleotide study regulating gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187614/,abstract,0,superfamily rhoa rac arborization morphogenesis cone amyotrophic insult cdc adhesion neurotoxic guanine cytoskeleton actin lateral axon spine rho kda dysregulation dendritic summarizes effector underscore regulating sclerosis morphology extensively neuron interestingly guidance collectively pro studied surface neurodegenerative neuronal involvement survival link progression organization transcription diverse signal member etiology nucleotide decade cycle cellular molecule effort death potentially regulatory regulation particular weight critical essential growth finding form addition key molecular recent family important role cell function low type review protein development gene result disease study,{},{},{},{},{},{}
1225,1225,1325,10.1016/j.dib.2015.07.026,26322328.0,level biochemical related percentage selenium hyperphenylalaninemia order mineral prealbumin optimal crujeiras protein special natural research folic food serum high concentration free article data acid treatment dietary well deficiency patient vitamin diet pku status amino low phe parameter mixture,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543207/,abstract,1,crujeiras prealbumin selenium mineral folic mixture percentage special vitamin hyperphenylalaninemia optimal natural parameter serum free related biochemical order status food phe deficiency diet dietary concentration pku amino article low research acid protein high data level treatment patient,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""phe deficiency diet dietary concentration pku amino article low research acid p""]}}","{""diet"": {""freq"": 1, ""string"": [""biochemical order status food phe deficiency diet dietary concentration pku amino a""]}}",{}
1226,1226,1326,10.1042/BSR20180111,29899168.0,male pathogenesis blood activity greater difference lower hypertensive twelve oxidative synthase tetrahydrobiopterin implicated pressure enzymatic old remains increase significantly drinking relative renal ims higher tempol result shr exogenous inner effect decrease generation rat level stress although biopterin water female conclude dihydrobiopterin critical week day hypertension via unknown sex treatment bioavailability assay age nitric vehicle medulla responsible previously either mechanism spontaneously peroxynitrite oxide cofactor deficiency total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028750/,abstract,1,tempol shr peroxynitrite medulla ims implicated hypertensive spontaneously dihydrobiopterin inner vehicle remains drinking biopterin conclude bioavailability hypertension exogenous nitric enzymatic renal oxide pathogenesis synthase pressure sex responsible oxidative water rat cofactor tetrahydrobiopterin relative unknown decrease female stress old assay generation critical greater previously male week day increase lower deficiency mechanism total activity higher difference significantly blood age effect level treatment result,{},{},{},{},{},{}
1227,1227,1327,10.4066/AMJ.2015.2482,26464586.0,specific activity progressive country serious programme condition literature expert coordination methodswe principle experience formal ethical australian relevant reform family backgroundthe screening clinical therapy aimsin health minor environment adapt oversight council operational expansion bloodspot genetic resultsaustralian consideration international non area multidisciplinary separation service soon government direction local conclusiona child prevent formulate minister governance slow development target national social plan system disability article guide recommendation key decision address universal rare public legal newborn irreversible order initiative advisory birth adaptation aim framework policy maker inform commence healthcare australia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592945/,abstract,0,resultsaustralian reform minister aimsin oversight operational council commence conclusiona governance australian adapt formulate formal soon bloodspot slow minor separation advisory maker coordination australia multidisciplinary government irreversible adaptation legal direction expansion initiative universal progressive plan guide programme inform ethical principle backgroundthe expert consideration local framework healthcare international decision prevent address methodswe policy experience service recommendation environment national disability social relevant public order birth country target literature area aim screening key rare family therapy newborn activity condition non article specific child development health genetic clinical,"{""social"": {""freq"": 1, ""string"": [""experience service recommendation environment national disability social relevant public order birth c""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""newborn"": {""freq"": 1, ""string"": [""aim screening key rare family therapy newborn activity condition non article s""]}, ""screening"": {""freq"": 1, ""string"": [""birth country target literature area aim screening key rare family therapy n""]}}",{},{}
1228,1228,1328,10.1371/journal.pone.0215162,30995231.0,dihydropteridine essential positive insight tetrahydrobiopterin pro zone accumulation phospho mitotic well transition glutamine embryonic neurological neuronal seizure phenylalanine marker homologues poorly dopamine astroglial truncal role developmental reductase symptom hypotonia embryo change novel metabolism hypomorphic qdpra tectum concomitantly size optic pigmentation model regulation neuropathogenesis development expression qdprb disability hypokinesia proliferative biochemically cell microcephaly deficient zebrafish serotonin differentiation function pathomechanisms eye intellectual histone cofactor patient deficiency qdpr gene proliferation number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469847/,abstract,0,zone truncal tectum qdprb qdpra pathomechanisms neuropathogenesis astroglial zebrafish qdpr mitotic hypomorphic hypokinesia homologues concomitantly proliferative phospho pigmentation optic biochemically dihydropteridine hypotonia histone glutamine reductase microcephaly eye embryo embryonic proliferation pro transition poorly neuronal differentiation serotonin seizure deficient cofactor dopamine accumulation tetrahydrobiopterin neurological intellectual size regulation insight marker disability developmental essential symptom expression change positive deficiency novel role cell function number metabolism model phenylalanine development gene patient,"{""phenylalanine"": {""freq"": 2, ""string"": []}, ""neurological"": {""freq"": 1, ""string"": [""seizure deficient cofactor dopamine accumulation tetrahydrobiopterin neurological intellectual size regulation insight m""]}, ""microcephaly"": {""freq"": 1, ""string"": [""biochemically dihydropteridine hypotonia histone glutamine reductase microcephaly eye embryo embryonic proliferation p""]}, ""intellectual"": {""freq"": 1, ""string"": [""deficient cofactor dopamine accumulation tetrahydrobiopterin neurological intellectual size regulation insight marker d""]}}",{},{},{},{},{}
1229,1229,1330,10.3390/nu10091179,30154357.0,beverage sensory difference context formula present bitter cata artificial taste formulation pku glycomacropeptide suitable phenylalanine subject compliance driver higher questionnaire range food color ambulatory mild obtain chocolate low score aroma significant onwards neutral strong description overall approach product phenylketonuria method sweet check treatment school year age sample since odor salty tomato aim natural also conclusion lowest different study acid dietary participant amino,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165379/,abstract,4,tomato salty cata odor chocolate bitter aroma check ambulatory sweet onwards taste driver color sensory description artificial obtain lowest formulation beverage neutral glycomacropeptide formula school compliance suitable strong mild natural questionnaire context product overall score participant food aim subject range dietary pku amino conclusion higher difference sample phenylketonuria low approach present phenylalanine acid different age significant year method treatment study,"{""phenylalanine"": {""freq"": 2, ""string"": [""difference sample phenylketonuria low approach present phenylalanine acid different age significant y""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""food aim subject range dietary pku amino conclusion higher difference sample p""]}}",{},{}
1230,1230,1331,10.3389/fimmu.2019.01894,31447861.0,microorganism shift mytilus invertebrate modify inflammation respond efficient splendidus pro mussel injection differentially close significantly numerous hemocyte transcriptional however rather adaptive distribution manner bacteria sublethal live change immune first inhibition hemocytes level case stress functional cellular vibrio infection damage able population mediterranean feeder pathogen work sessile contact reencounter expression system marine exposure second response filter challenge consecutive transcript inflammatory two production lack regulated environmental transcriptomic also tissue tolerate gene show resolution injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697025/,abstract,0,vibrio sublethal splendidus sessile reencounter mytilus mussel hemocytes hemocyte feeder tolerate marine invertebrate transcriptomic mediterranean respond modify regulated transcript microorganism pathogen contact live consecutive differentially shift pro adaptive filter transcriptional manner close injury bacteria injection resolution inflammation numerous efficient damage inhibition immune able distribution cellular inflammatory infection production stress second work lack exposure environmental tissue functional challenge expression change response case significantly population gene level,{},{},{},{},{},{}
1231,1231,1332,10.1371/journal.pone.0188547,29190767.0,logistic blood chain ambient several fragment reaction elevated weight molecular minicapsules altogether average institution validation preservation coat compatibility atmosphere however adequate possible dependence value storage law procedure environment conventional degradation century buffy result good fraction run lysates term qpcr experiment novel routine long extraction low hermetic confinement rate one independent size temperature white economic product accelerate method cold anoxic gel cell original downstream sample lately biospecimens anhydrous validated dna quality analysis either larger high last yield advantage,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708797/,abstract,1,minicapsules lysates lately hermetic confinement buffy biospecimens anoxic anhydrous compatibility coat atmosphere accelerate cold qpcr preservation dependence altogether run ambient fragment law gel century original validated institution extraction downstream yield conventional logistic temperature experiment routine fraction adequate degradation validation larger storage advantage economic white elevated procedure independent average good reaction size dna environment weight chain product possible long value quality molecular novel rate term cell sample low blood high method analysis result,{},{},{},{},{},{}
1232,1232,1333,10.3389/fnins.2018.00499,30140200.0,implication notably worldwide specific disorder notion better greater pathway glutamate present inflammation light condition tetrahydrobiopterin due altogether tight continuous effective well player medical knowledge evidence rather strategy recent dopamine anti clinical stagnation symptom particular conventional report kynurenine depression efficacy metabolic large antidepressant symptomatology medication metabolism adjuvant rate comorbidities preclinical drug intervention vulnerability review toward therapeutic urgently development substantial treatment alteration proportion key valuable help process inflammatory dimension likely prevalence order serotonin accordingly chronic treated mechanism pathophysiology depressive interaction namely patient treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095005/,abstract,0,treated stagnation player symptomatology antidepressant urgently tight kynurenine adjuvant altogether dimension depressive vulnerability comorbidities notion glutamate preclinical notably accordingly pathophysiology conventional depression continuous valuable light inflammation serotonin worldwide substantial medication treat anti proportion dopamine tetrahydrobiopterin inflammatory alteration particular help implication efficacy likely chronic greater prevalence order knowledge interaction better symptom process drug strategy key therapeutic effective medical large pathway recent mechanism report intervention rate evidence condition present metabolism specific review development metabolic disorder treatment clinical patient,{},{},"{""pathway"": {""freq"": 1, ""string"": [""strategy key therapeutic effective medical large pathway recent mechanism report intervention r""]}}",{},{},{}
1233,1233,1334,10.1016/j.ymgmr.2015.09.006,28649540.0,daily vegetable difference content lower among resultsmedian median necessary aged five enhancing fruit investigate control well month significantly pku intake documentation calculation phe respect however phenylalanine rather poorest questionnaire protein range mol separated food max metabolic effect good data regime low acceptability significant least child evaluation management model phenylketonuria day method therapeutic abbreviation helpful system simplification concentration conclusionexact habit rich nevertheless year limit diet feasibility strict loose age within simply percentage achieve standard adolescent backgrounda special impact upper also group different high simplified insufficient dietary patient accuracy acceptable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471407/,abstract,5,simplification resultsmedian poorest loose conclusionexact max documentation regime backgrounda simply simplified enhancing separated vegetable upper helpful acceptability habit fruit calculation achieve abbreviation strict insufficient respect rich feasibility acceptable percentage special limit mol adolescent daily accuracy necessary content median good aged questionnaire investigate intake evaluation standard food month phe management day range therapeutic lower diet impact dietary concentration pku difference phenylketonuria low significantly model phenylalanine control child different protein age significant metabolic group year effect high method data patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""pku difference phenylketonuria low significantly model phenylalanine control child different protein a""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""phe management day range therapeutic lower diet impact dietary concentration pku d""]}}",{}
1234,1234,1335,10.1007/8904_2018_109,29754208.0,major male disorder chain availability daily herein ratio pathway several liquid biosynthesis aromatic outside mean increased month material visit biochrom biochemical homogentisic supplementary phenylalanine nitisinone user range mol fold aku arginine neurotransmitter report result metabolic fifty large reference change eight detection use period seven neutral female pre normal tyrosine ninhydrin liver day method post system serum baseline concentration online article treatment hypertyrosinaemia aspartic electronic year version rare every age sample standard cation function noteworthy alkaptonuria background available also consequence conclusion group exchange high acid patient agent amino performance deviation chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122054/,abstract,11,biochrom ninhydrin hypertyrosinaemia noteworthy cation aspartic aku increased homogentisic nitisinone alkaptonuria outside visit arginine exchange neutral aromatic deviation biosynthesis neurotransmitter fold agent mol availability seven reference baseline liquid daily post chromatography pre consequence female serum mean liver chain tyrosine male period biochemical ratio performance standard detection background month supplementary normal day major user change range version electronic online large pathway use report rare concentration material amino conclusion article function sample available phenylalanine acid age metabolic group year high method disorder treatment result patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""amino conclusion article function sample available phenylalanine acid age metabolic group y""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""change range version electronic online large pathway use report rare concentration m""]}}","{""detection"": {""freq"": 1, ""string"": [""male period biochemical ratio performance standard detection background month supplementary normal d""]}, ""amino"": {""freq"": 1, ""string"": [""pathway use report rare concentration material amino conclusion article function sample a""]}}",{},{}
1235,1235,1336,10.1038/s41598-017-16926-w,29209068.0,cluster chemistry self architecture fibrillar tunable exhibit molecule light microscopy pair substitution solution assembly thiol material demonstration dichroism synthesis whose orientation unit form thio evaporation crystal metal result property length multimeric furthermore first formation bilayers low medicine cysteine crystallography water motif methanol emission dynamic side structure bonding proton sized degree closo slow nmr potential concentration ray offset mass opportunity application biology carborane field electron micron propanoic ethanol spectrometry circular dodecacarboranyl interaction high study polyhedron boron acid hydrogen random absence amino resolution,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717241/,abstract,5,tunable thio polyhedron offset multimeric micron methanol evaporation dodecacarboranyl dichroism closo carborane boron bonding bilayers thiol propanoic orientation fibrillar circular proton crystallography sized ethanol hydrogen microscopy motif demonstration slow cysteine chemistry architecture ray electron metal pair nmr crystal emission substitution exhibit assembly random cluster length unit resolution light degree dynamic solution absence water formation biology opportunity molecule property synthesis self furthermore structure spectrometry medicine field interaction form application mass concentration material amino low acid potential high result study,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""interaction form application mass concentration material amino low acid potential high r""]}, ""spectrometry"": {""freq"": 1, ""string"": [""molecule property synthesis self furthermore structure spectrometry medicine field interaction form a""]}}",{},{}
1236,1236,1337,10.4103/2230-8210.190556,27730080.0,various disorder cross record lead sectional growth syrup context pathway tertiary time defect country socioeconomic despite half aged condition province frequency hospitalization consanguineous convulsion old accumulation well disease status synthesis biochemical third subject quantitative screening east higher clinical protein developmental symptom result isfahan qualitative metabolic interview live urine run design middle although rate one measure referral tyrosinemia marriage overall spss many population method history development prevalent intermediate year incidence maple rare age iran aminoacidopathies metabolite pediatric prevalence statistical subgroup birth analysis hospital characteristic research refer infant larger conclusion group part presentation study acid center patient highest amino demographic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040050/,abstract,0,convulsion isfahan refer aminoacidopathies run hospitalization socioeconomic tyrosinemia maple intermediate marriage east syrup live consanguineous tertiary spss referral province middle subgroup demographic qualitative prevalent iran interview half larger record presentation highest accumulation statistical urine sectional center history aged pediatric quantitative incidence old hospital synthesis cross lead context developmental defect frequency growth despite design characteristic prevalence biochemical birth status overall country various symptom metabolite measure infant screening subject pathway rare rate amino conclusion higher condition time research population acid protein age development metabolic group year method disorder clinical analysis result patient disease study,"{""urine"": {""freq"": 1, ""string"": [""larger record presentation highest accumulation statistical urine sectional center history aged p""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""symptom metabolite measure infant screening subject pathway rare rate amino conclusion h""]}}","{""amino"": {""freq"": 1, ""string"": [""infant screening subject pathway rare rate amino conclusion higher condition time r""]}, ""screening"": {""freq"": 1, ""string"": [""country various symptom metabolite measure infant screening subject pathway rare rate a""]}}",{},{}
1237,1237,1338,10.3892/mmr.2017.7891,29115600.0,notably blood respiratory factor pathway exert among present innate neonatal surface without onset additional due severe pathology regulatory underlying disease serf numerous however family form applied alveolar nrds clinical therapy role replacement therefore primary surfactant distress data perpetual tandem inflation seq phenotype hypoxemia acute syndrome immunological regulation pathogen expression system insult manifestation alteration response important alveolus cell particularly two lack peripheral function analysis mechanism infant lung importance hypercarbia cycle mrna study similar tension gene injury treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780146/,abstract,0,perpetual nrds inflation hypoxemia hypercarbia alveolus alveolar surfactant insult tension serf immunological exert seq innate applied distress pathogen notably respiratory lung mrna surface injury peripheral replacement underlying pathology numerous manifestation treat tandem cycle alteration acute regulatory regulation neonatal lack onset syndrome particularly importance additional phenotype similar severe form infant expression primary response pathway mechanism family therapy important role cell function present factor blood gene data clinical analysis disease study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""severe form infant expression primary response pathway mechanism family therapy important r""]}}","{""tandem"": {""freq"": 1, ""string"": [""replacement underlying pathology numerous manifestation treat tandem cycle alteration acute regulatory r""]}}",{},{}
1238,1238,1339,10.3390/nu11051092,31100942.0,major biological specific assessment self physiological new information nutrition time enhance without bias capable variation state valid reliable well disease inter intake amount measurement understanding quantify objectively optimal inherent questionnaire role health global body particular food effect data useful use main biomarkers certain phenotype possibly dynamic provide formulate regard omics approach method pathological system analyse holistic recommendation response person precision help diet challenge component generally relation determine goal analysis currently impact consumption nutritional high study dietary deficiency limitation another individual indicative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567133/,abstract,0,objectively formulate valid inherent indicative holistic quantify analyse omics regard possibly inter person capable pathological bias enhance reliable dynamic generally precision physiological consumption optimal limitation relation goal certain nutrition useful global component recommendation particular help understanding nutritional questionnaire self variation intake measurement biomarkers currently biological determine provide main phenotype body assessment food state major challenge response use deficiency diet impact dietary information role approach individual time new specific health effect high method data analysis disease study,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""state major challenge response use deficiency diet impact dietary information role a""]}}",{}
1239,1239,1340,10.1186/s13023-019-1063-z,31023387.0,various epidemiological disorder record estimation region mma country literature heterogeneous accumulation disease material respectively synthesis supplementary quantitative screening form methylmalonyl east user coa focus therefore mena mut metabolic data type middle epidemiology methylmalonic detection clearly full rate ultra per text pacific implementation subtype point review compile eligibility mutase ass article online europe electronic asia biochemically systematic version materialthe rare genetically newborn north primarily prevalence estimate africa birth omim analysis aciduria paper available group america study acid meta isolated deficiency exception,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485056/,abstract,7,mena compile pacific methylmalonyl biochemically asia subtype mut mutase mma eligibility africa omim ultra east america aciduria isolated exception north europe methylmalonic estimation epidemiology clearly epidemiological middle heterogeneous coa primarily record meta genetically accumulation text systematic estimate quantitative implementation focus synthesis point materialthe ass prevalence paper birth country region literature detection various form supplementary screening user version electronic online deficiency rare respectively rate newborn material article available type review acid metabolic group data disorder analysis disease study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""prevalence paper birth country region literature detection various form supplementary screening u""]}, ""newborn"": {""freq"": 1, ""string"": [""electronic online deficiency rare respectively rate newborn material article available type r""]}, ""screening"": {""freq"": 1, ""string"": [""region literature detection various form supplementary screening user version electronic online d""]}}",{},{}
1240,1240,1341,10.4102/ajlm.v5i1.283,28879104.0,entire marginally conclusionthe blood cross chain african sectional studied difference positive july methodsthis laboratory despite reaction retrospective molecular province offering testing polymerase virus amongst era equal backgroundthe poorly higher value clinically academic diagnosis routine south hepatitis non service significant rate independent pre chi referral problem infection overall hbv child hiv population method pearson test proportion kwazulu viral finding sample resultsthe negative spot prevalence objectiveswe africa statistical natal residual dna infant general group december diagnostic cohort high study though square total statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436393/,abstract,7,kwazulu marginally objectiveswe natal offering pearson hbv africa hiv hepatitis chi african july equal academic south polymerase entire era referral retrospective december square studied province viral residual methodsthis poorly conclusionthe routine backgroundthe virus resultsthe statistically proportion infection independent statistical sectional clinically pre reaction service dna negative cross chain spot despite laboratory general problem cohort prevalence testing overall diagnostic finding infant positive value molecular rate total higher non difference sample test blood diagnosis population child significant group high method study,{},{},{},{},{},{}
1241,1241,1342,10.4103/0019-5154.160507,26288425.0,logistic epidemiological disorder cross observation sectional region greater factor profile site caucasian aged androgenetic severe geographical risk alopecia varied increase significantly material understanding subject mainly higher questionnaire body indirect effect data design type epidemiology website young international non regression use vii rate photograph overall evaluation population method norwood prevalent unknown success year every age sample resultsthe two mass prevalence environmental background aim index conclusion study internet direct men,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533555/,abstract,4,photograph norwood androgenetic alopecia vii internet website geographical indirect caucasian men epidemiology epidemiological varied observation logistic prevalent success young resultsthe mainly international sectional unknown index aged profile direct regression understanding site questionnaire cross environmental evaluation greater design prevalence overall region severe body background aim mass subject increase use rate material conclusion higher non sample significantly risk factor type population age year effect method data disorder study,{},{},{},{},{},{}
1242,1242,1343,10.1371/journal.pone.0159047,27410226.0,coefficient pwi major blood withney whether benign ratio difference single among cbf time radc fractional malignant contralateral enhancing mean abscess biomarker purposeto lesion rmtt preliminary evaluate anisotropy excellent material tensor glioblastoma joint matter session succinate relative neuroradiologists alone lesional diffusion cavity conventional resultsfive enhancement result contrast good peri reach combination lipid edema appearance naa area significant mann variable internal main imaging biomarkers size volume curve normal dynamic apparent white lactate sign transit regard approach choline technique feasible method acetyl test susceptibility creatine receiver perfusion conclusionalthough hemorrhage rcbv two mass spectroscopy order mri definitive differentiation pyogenic ring advanced analysis characteristic flow cnawm larger dwi multiple roc dti aspartate conclusion diagnostic different histologically cohort study magnetic metastasis similar small cerebral patient limitation absence lac accuracy cho presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943588/,abstract,6,withney rmtt rcbv radc pyogenic pwi neuroradiologists naa metastasis lesional lac glioblastoma dwi cnawm abscess transit succinate resultsfive histologically contralateral conclusionalthough cho cbf cavity peri perfusion edema creatine hemorrhage appearance purposeto enhancing mann malignant enhancement aspartate anisotropy ring choline lactate joint acetyl dti tensor reach benign roc preliminary fractional definitive lesion apparent regard receiver session cerebral diffusion mri advanced spectroscopy internal imaging flow excellent curve sign coefficient conventional susceptibility feasible differentiation lipid biomarker dynamic larger absence matter white limitation magnetic volume accuracy relative contrast evaluate good size variable mean combination presence biomarkers technique cohort characteristic main ratio order small diagnostic similar area normal mass major multiple single material conclusion difference approach test time blood different significant method analysis result patient study,{},{},{},{},{},{}
1243,1243,1344,10.1186/s13023-016-0548-2,27927250.0,specific disorder canadian clinic better among warrant positive concern organic need coordination highlight outside unfamiliar source old explicitly experience well disease semi respect however family life strategy oxidation place value role health resultswe telephone support diagnosis result metabolic methodsfrom interview data routine proactive consideration theme stress four provider direction centre child point management conclusionsthe social potential system parent treatment urea important fatty year care challenge complex age protocol sample within future imd specialized order involved stressor emergent aim impact backgroundwe larger cycle interaction cohort study acid patient inform participant amino successful caregiver perception,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142351/,abstract,5,proactive explicitly backgroundwe unfamiliar methodsfrom telephone stressor emergent warrant specialized canadian outside coordination imd direction semi respect perception urea resultswe theme place oxidation provider inform centre caregiver routine interview larger conclusionsthe organic involved consideration successful protocol cycle fatty concern clinic experience source stress old point highlight social parent cohort order need interaction better participant support aim management challenge complex positive strategy value future family impact care life amino important role sample specific diagnosis acid potential child age metabolic health year data disorder treatment result patient disease study,"{""social"": {""freq"": 1, ""string"": [""experience source stress old point highlight social parent cohort order need i""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""value future family impact care life amino important role sample specific d""]}}",{},{}
1244,1244,1345,10.1172/jci.insight.91981,28469071.0,blood disorder energy factor exhibit essential present glucose synthase central tetrahydrobiopterin together stimulation investigate regulatory control sympathetic endothelial vessel addition increase hydroxylase noradrenaline ameliorated organ obesity hph role clinically disturbance mouse metabolic effect bat metabolism useful although intolerance systemic tyrosine brown critical approach model regulation via sufficient participation treatment strongly expenditure nerve diabetes adiposity nitric unclear adipose function resistance act transplantation tissue study oxide insulin direct cofactor deficiency,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414566/,abstract,0,ameliorated bat noradrenaline adiposity sympathetic hph intolerance brown vessel adipose nerve expenditure endothelial stimulation participation exhibit nitric disturbance transplantation oxide insulin synthase resistance act systemic sufficient organ strongly unclear cofactor energy diabetes glucose tetrahydrobiopterin obesity useful clinically regulatory regulation direct central critical investigate tissue tyrosine essential hydroxylase mouse addition increase deficiency role function approach present metabolism model control factor blood metabolic effect disorder treatment study,{},{},{},{},{},{}
1245,1245,1346,10.1007/8904_2015_500,26458887.0,dexa correlation disorder chain tool activity whether blockage syrup difference energy composition information greater lower autosomal keto aged basal physical moreover average bckdh control accumulation disease objective tee status neurological respectively introduction value clinically leucine body comparable indirect result thus urine calorie branched level use significant case variable dehydrogenase requirement beer current child damage feasible method determination calorimetry predictor bcaa underestimate recommendation association expenditure year best maple predictive bee recessive healthy determine limited equation msud concordance conclusion group nutritional different stata study acid total metabolite statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864776/,abstract,1,tee keto dexa beer bee bckdh underestimate blockage stata calorimetry msud bcaa equation indirect calorie branched maple basal expenditure concordance syrup leucine requirement feasible comparable predictor determination dehydrogenase introduction predictive damage composition statistically energy recessive accumulation average urine neurological autosomal clinically best recommendation aged physical variable nutritional limited chain greater correlation determine status body metabolite tool healthy objective value lower association use respectively information total activity current conclusion difference case control acid child different significant group year method level disorder result disease study,"{""urine"": {""freq"": 1, ""string"": [""composition statistically energy recessive accumulation average urine neurological autosomal clinically best r""]}, ""neurological"": {""freq"": 1, ""string"": [""statistically energy recessive accumulation average urine neurological autosomal clinically best recommendation a""]}}","{""autosomal"": {""freq"": 1, ""string"": [""energy recessive accumulation average urine neurological autosomal clinically best recommendation aged p""]}, ""recessive"": {""freq"": 1, ""string"": [""introduction predictive damage composition statistically energy recessive accumulation average urine neurological a""]}}",{},{},{},{}
1246,1246,1347,10.1038/s41598-017-11924-4,28900272.0,tool activity new information effort profile myeloma unrelated malaria structurally cost risk chemoresistance line query plip cancer pharmacology anti compound candidate structural indication report data computational novel case prediction drug approach silico work development potential characterise serendipity safety test bvdu viable ten exploit viral emerge promising cell screen chaperone function currently available reduce brivudine also multiple identify hsp interaction suppresses pattern agent,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595859/,abstract,0,serendipity query plip myeloma bvdu brivudine suppresses chemoresistance emerge characterise structurally hsp exploit viable malaria pharmacology silico chaperone unrelated viral computational indication reduce promising prediction screen identify candidate line agent anti safety structural effort profile pattern compound cancer work cost currently interaction tool multiple drug report novel information activity cell function approach case available test new risk potential development data,{},{},{},{},{},{}
1247,1247,1348,10.1038/mt.2015.208,26581161.0,forth complex interplay notably specific cushion load rna herein region mechanistically sponge tumorigenesis positive provide role set play dna cooperates phosphorylation myc act lysine promoter prolonging trf malignant accelerate tri telomere expression thereby potential link hand like length methyl methylation hepatocyte histone epigenetically cudr position prb important cause overexpression excessive repeat long first demonstration finding show cell transformation ultimately hepatocarcinogenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817816/,abstract,0,trf telomere sponge prolonging hepatocarcinogenesis epigenetically cooperates tri prb myc forth cushion cudr accelerate tumorigenesis mechanistically malignant overexpression histone methylation demonstration lysine interplay transformation phosphorylation excessive notably load methyl repeat hand ultimately position set promoter length act rna hepatocyte link play dna provide like finding region long expression complex cause positive important role cell specific potential,{},{},{},{},{},{}
1248,1248,1349,10.5539/gjhs.v8n8p145,27045395.0,disorder eagger delay investigation better search region factor early gain neonatal prenatal initial necessary bias magiran risk publication journal status iranian material respectively extensive respect perspective developmental probability result six effect data basis cause sid international pubmed beggs economic database child intervention inclusion model socio method perinatal development scopus article test important calculated version iran prevalence order standard determine systematically quality criterion analysis background index keywords conclusion group different stata study heterogeneity meta random sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016360/,abstract,3,eagger beggs magiran sid stata pubmed scopus socio journal iranian calculated probability perinatal respect systematically random gain bias iran publication extensive prenatal keywords meta initial delay economic sensitive heterogeneity perspective international inclusion search necessary investigation basis index neonatal criterion developmental database determine prevalence order status standard better region background cause version quality respectively intervention material conclusion article important test risk model early factor child different development group effect method data disorder analysis result study,{},"{""heterogeneity"": {""freq"": 1, ""string"": [""keywords meta initial delay economic sensitive heterogeneity perspective international inclusion search n""]}}",{},{},{},{}
1249,1249,1351,10.3390/s18061924,29899282.0,past lower reaction transducer literature enzymatic principle numerous medical decade reader recent perspective range economical biomolecule output conventional food analytical sensor enzyme biosensor etc novel type detection rapid main measure provide review device technique antibody system biosensors key year cell overview wide advance reveal application category analytes field classified environmental immunosensors paper also comprehensive ssdna last study organelle industry sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021829/,abstract,0,immunosensors ssdna biomolecule transducer biosensor organelle biosensors reader economical sensor analytes output classified reveal industry antibody enzymatic device conventional principle numerous overview category analytical sensitive past decade perspective comprehensive advance reaction rapid environmental technique wide provide paper main field literature detection food enzyme measure application range key medical lower recent novel cell type review year study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""wide provide paper main field literature detection food enzyme measure application r""]}}",{},{}
1250,1250,1353,10.1007/8904_2016_579,27450369.0,matter executive relationship functional phe phenylalanine two memory neural region parietal cso factor strategic occipital among white demonstrate exploratory processing child nonverbal outcome verbal mediates procedure brain phenylketonuria modeling posterior diffusion semiovale importance mediation dti lifetime exposure integrity metabolic diffusivity control hypothesis ability pku ppo individual tensor sophisticated centrum,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413446/,abstract,0,ppo cso semiovale parietal mediation mediates centrum nonverbal sophisticated strategic occipital modeling posterior dti tensor exploratory diffusivity verbal lifetime integrity diffusion processing neural executive matter demonstrate memory white hypothesis procedure exposure ability importance functional relationship region phe brain pku outcome phenylketonuria individual phenylalanine control factor child metabolic,"{""phenylalanine"": {""freq"": 2, ""string"": []}}",{},{},{},{},{}
1251,1251,1354,10.1177/2333794X14567193,27335934.0,major nsp case third deficient within transient mildly two newborn region greater factor order congenital progressive hypothyroidism value approximately population either background miu permanent program method frequency due china iodine conclusion result high thyroid study data guideline hormone patient deficiency year guangxi type respectively incidence total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784601/,abstract,8,nsp miu guangxi mildly iodine permanent transient thyroid hypothyroidism progressive deficient china hormone guideline approximately incidence greater frequency congenital order region background program major value deficiency respectively total newborn conclusion case factor type population year high method data result patient study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""program major value deficiency respectively total newborn conclusion case factor type p""]}}",{},{}
1252,1252,1355,10.4103/1817-1745.193361,27857784.0,refractoriness male various surgery disorder activity absolute almost concern insight need view due severe zero apart supportive cost convulsion motor control majority well inpatient disease excellent antiepileptic spectrum initiation account seizure family independence introduction therapy word burden global therefore complete great result situation metabolic effect good reference resistant palliative cause medication international mandatory suffer per dose drug economic side child league week neurodevelopment method evident development epilepsy team treatment response key constituted year nearly neurometabolic land wide rare within india pediatric million pyridoxine anticonvulsant appropriate especially manipulation minimum series dependent elimination cognitive criterion relatively consequence conclusion group last study refractory dietary small patient psychosocial ilae,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108118/,abstract,2,league land ilae refractoriness convulsion anticonvulsant palliative inpatient constituted independence suffer zero supportive refractory neurodevelopment pyridoxine neurometabolic manipulation antiepileptic resistant india apart mandatory absolute surgery minimum elimination initiation psychosocial epilepsy team series evident situation excellent nearly million seizure medication introduction view complete economic word great burden reference motor relatively majority account dose international concern good appropriate global consequence dependent pediatric insight criterion cost especially wide male week small need spectrum severe various cognitive cause drug key response rare family dietary therapy activity conclusion control child development metabolic group year effect method disorder treatment result patient disease study,{},{},{},{},{},{}
1253,1253,1357,10.1038/npp.2016.143,27480574.0,major disorder preferentially availability activity retardation striatal importantly abnormality pathophysiologic relationship neural discus pathway affect ventral difficult corticostriatal inflammation elevated behavior basal common reward deficit highlight motor finally synthesis evidence reduction strategy recent dopamine mesolimbic variety neurocircuitry protein demonstrating fluid brain daergic symptom depression thus efficacy data anhedonia decrease novel cerebrospinal ganglion significant administration one biomarkers acute cytokine release relevance review motivation neurotransmission therapeutic mesostriatal target alteration proportion stimulus response circuitry phase finding inflammatory pharmacotherapies relation standard function psychiatric motivational mechanism impact depressive also often reliably high similar patient anticipation metabolite treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143486/,abstract,0,mesostriatal daergic corticostriatal anhedonia pharmacotherapies neurocircuitry motivational mesolimbic ventral cerebrospinal anticipation preferentially pathophysiologic striatal ganglion circuitry motivation depressive neurotransmission stimulus reward reliably basal release demonstrating cytokine retardation importantly neural relevance depression fluid inflammation psychiatric treat variety proportion availability affect relation motor elevated dopamine inflammatory alteration difficult acute phase administration finally decrease deficit abnormality efficacy behavior reduction synthesis biomarkers highlight relationship discus target standard finding similar symptom metabolite major strategy response therapeutic pathway brain recent mechanism impact novel activity evidence common function review protein significant high data disorder patient,"{""psychiatric"": {""freq"": 1, ""string"": [""importantly neural relevance depression fluid inflammation psychiatric treat variety proportion availability a""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""symptom metabolite major strategy response therapeutic pathway brain recent mechanism impact n""]}}",{},{},{}
1254,1254,1358,10.1002/mgg3.684,30968598.0,specific disorder huge sporadic abnormality iem ratio tertiary positive hpo concern tong unrelated half odds without homeostasis condition molecular wes common cost backgroundrare severity neurogenetic disease month significantly medical life evidence definite strategy atypical recent broader ninety observed higher clinical range affordable monogenic affiliated symptom indication error inborn hua diagnosis university term generation first metabolism low eight chinese medicine period whole case seven rate mutation variable phenotype xin exome test manifestation success school year myriad nearly mendelian age within methodsnext mostly negative pediatric jiao scope trs next analysis currently previously hospital infant relatively resultsclinical diagnostic different high study considerably yield shanghai patient twenty conclusionthis variability gene highly complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6565546/,abstract,5,xin trs tong resultsclinical methodsnext jiao hua hpo affiliated shanghai wes neurogenetic myriad backgroundrare ninety huge definite atypical affordable sporadic considerably conclusionthis scope tertiary mendelian broader unrelated odds indication school nearly monogenic yield success chinese half exome manifestation variability university homeostasis seven severity relatively iem concern observed pediatric variable abnormality negative hospital generation cost highly currently previously medicine period ratio phenotype diagnostic inborn symptom month infant range complex positive strategy error medical molecular recent rate life evidence mutation term higher condition common low case metabolism test significantly specific diagnosis different age gene year high disorder clinical analysis patient disease study,{},{},{},{},{},{}
1255,1255,1359,10.1371/journal.pone.0110072,25310850.0,sporadic ratio single among msc congenital carrying odds additional risk control number evaluate disease respectively eprs synthesis interval dosage trna form observed predisposition additionally irs protein manner core chd thus effect aminoacyl potentially rrs eight chinese nonenzymatic non significant case confidence functional three cellular population multisynthetase han susceptibility polymorphism association component within snp variant allele comparison influence function heart analysis translation multiple different trend domain nucleotide study charge beyond gene individual complex versatile,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195700/,abstract,3,rrs irs eprs nonenzymatic multisynthetase msc predisposition aminoacyl trna carrying versatile han charge sporadic dosage chd odds core manner susceptibility snp chinese trend translation confidence nucleotide polymorphism interval cellular additionally domain potentially heart allele evaluate component observed comparison synthesis influence congenital functional additional ratio form multiple complex variant single association respectively non function number case individual risk control population different protein significant gene effect analysis disease study,{},{},{},{},{},{}
1256,1256,1360,10.3945/an.116.012120,27184271.0,entire major usda cross activity early among examine promotion nutrition concern expansive nutrient aged behavior detailed physical literature expert overconsumed common risk effective formally disease status intake dgac numerous hhs committee evidence recent clinical health input feature sodium environment food report conceptual change guideline question service theme sustainability scientific dga department current overall outcome strength around intervention underconsumed population review model method safety american topic recommendation diet finding address systematic jointly consensus every original fat public opportunity relation determinant healthy advisory community quality characteristic impact priority framework program research multiple prevention conclusion nutritional comprehensive trend high pattern transparent sugar human dietary individual initiative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863277/,abstract,5,usda underconsumed overconsumed hhs expansive dgac dga transparent sustainability jointly formally conceptual promotion advisory original sodium entire department strength committee input sugar determinant topic detailed priority theme initiative consensus fat american trend examine numerous expert scientific question nutrient safety relation guideline framework nutrition opportunity comprehensive community address concern systematic service recommendation aged environment physical pattern nutritional feature behavior cross intake prevention characteristic public status overall finding literature food healthy program major change multiple quality effective recent diet report impact intervention dietary activity evidence current outcome conclusion common individual human risk model early research population review health high method clinical disease,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""major change multiple quality effective recent diet report impact intervention dietary a""]}}",{}
1257,1257,1361,10.1007/s10578-017-0749-5,28755013.0,stress flexibility executive disorder defiant evidence memory stressful typically boy problem adaptive clinical oppositional adaptation child cognitive impairment condition impact environment conduct result attention odd understudied test testing contrast whereas impaired change inhibition typical performance show non,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856866/,abstract,0,understudied oppositional odd defiant stressful flexibility conduct adaptation adaptive typical impaired boy executive typically inhibition memory contrast environment stress impairment attention problem performance testing cognitive change impact evidence condition non test child disorder clinical result,{},{},{},{},{},{}
1258,1258,1362,10.3389/fnut.2019.00008,30838211.0,various experimental difference factor composition information pathway profile nutrition athletic nutrient fit physical additional variation testing nutrigenomics excretion bioactives status however strategy form adept uptake role health generic body science genomic food utilization metabolic effect dietitian basis guideline sport long genetic metabolism ultimately use ergogenic although one biomarkers size population review markedly technology athlete recommendation response diet modifier scrutiny component modifying still nutrigenetics field accommodate nutritionist impact research trial foundation general nutritional optimize interaction dietary absorption performance individual gene number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389634/,abstract,0,ergogenic bioactives athletic adept sport scrutiny modifying athlete accommodate nutritionist nutrigenetics nutrigenomics utilization optimize modifier fit generic dietitian uptake absorption excretion ultimately foundation markedly composition nutrient guideline nutrition experimental science genomic component basis size recommendation profile physical nutritional variation biomarkers general additional technology status performance field testing interaction various body food form long trial strategy response pathway use diet impact dietary information role difference number metabolism individual factor research population review metabolic health gene effect genetic,{},"{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""food form long trial strategy response pathway use diet impact dietary i""]}}",{},"{""diet"": {""freq"": 1, ""string"": [""long trial strategy response pathway use diet impact dietary information role d""]}}",{}
1259,1259,1363,10.1053/j.semperi.2015.03.004,25937517.0,universal immunodeficiency future blood era functional panel uniform newborn direction new spot early biology lymphopenia cover current implementation excision neonatal period review condition infant core severe development state asymptomatic diagnosis system test treatment receptor scid immune united disease first restoration assay cell trec circle detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433840/,abstract,1,lymphopenia trec excision scid restoration circle uniform immunodeficiency cover asymptomatic era direction core universal united immune receptor biology panel implementation assay neonatal spot functional period detection severe infant state future newborn current condition cell test new early blood diagnosis review development treatment disease,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""implementation assay neonatal spot functional period detection severe infant state future n""]}, ""newborn"": {""freq"": 1, ""string"": [""period detection severe infant state future newborn current condition cell test n""]}}",{},{}
1260,1260,1364,10.1016/j.ymgmr.2016.05.003,28649556.0,age variable decompensation iem death early propionic sudden eventual clinical present woman neonatal protein reproductive population postpartum without encephalopathy organic describe error seemingly inborn abbreviation asymptomatic thus often metabolic presentation cardiomyopathy course cardiac delivery amish pregnancy first acidemia metabolism complication individual care period,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471548/,abstract,0,amish sudden eventual seemingly postpartum cardiomyopathy decompensation encephalopathy propionic asymptomatic abbreviation acidemia reproductive cardiac course organic complication presentation iem death pregnancy delivery woman variable neonatal period inborn error care present metabolism individual early population protein age metabolic clinical,{},{},{},{},{},{}
1261,1261,1365,10.1186/s13023-015-0234-9,25758715.0,major specific disorder investigation new single early hydroxyindol dihydropteridine defect methodsthis july synthase light retrospective due backgroundinherited institution unravel doe hydroxylase csf shed measurement treatable homovanillic rather neurodevelopmental clinical fluid feature conclusionprevalence reductase tetrahydropterin primary neurotransmitter movement diagnosis metabolic purpose date term cyclohydrolase genetic metabolism eight cerebrospinal suggestive non whole four mutation resultsthere main one phosphate short normal tyrosine october outcome inclusion lumbar puncture pyruvoyl guanosine exome epilepsy oxidase near triphosphate future two acetic prevalence pyridoxine favorable category dependent criterion prior importance genome diagnostic cohort study aldh acid direct deficiency patient twenty gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342151/,abstract,4,hydroxyindol conclusionprevalence backgroundinherited triphosphate guanosine tetrahydropterin pyruvoyl puncture homovanillic cerebrospinal aldh acetic lumbar dihydropteridine csf unravel pyridoxine suggestive shed oxidase resultsthere october reductase phosphate cyclohydrolase july favorable epilepsy retrospective institution near treatable movement methodsthis synthase fluid light neurotransmitter exome neurodevelopmental category prior doe inclusion date investigation genome dependent direct short feature criterion purpose measurement tyrosine defect importance cohort prevalence hydroxylase main diagnostic normal major primary future single deficiency mutation outcome term non metabolism new early specific diagnosis acid metabolic gene genetic disorder clinical patient study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1262,1262,1366,10.1007/s10639-017-9647-5,29713237.0,activity self hour new early improved phonological cursive time world stay despite instill mind deficit reminder effective finally kokopelli significantly buckminister computer struggle session pay manuscript covariate thompson observed word programming contribution task instruction syntax efficacy attention question oral saccade first inhibition story regression letter four three one society handwriting dyslexia motion block child tanimoto morphological intervention correctly comprehension week fuller introductory skill disability online hawk computerized school important construction subword two write next prior orthographic indicator grade study spelling lesson loop participant hallmark sentence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921925/,abstract,3,write thompson tanimoto saccade reminder kokopelli instill hawk fuller cursive buckminister subword sentence phonological pay introductory struggle story spelling orthographic handwriting computerized syntax dyslexia covariate stay motion mind comprehension morphological instruction manuscript letter construction programming correctly loop hallmark improved computer lesson session indicator grade block skill school society hour contribution inhibition prior word question task oral world finally observed regression deficit efficacy self disability attention despite week participant online effective intervention activity important time significantly new early child study,{},{},{},{},{},{}
1263,1263,1367,10.1016/j.pbb.2015.01.014,25636601.0,mood cross beverage relationship whether affect among time adult despite committed reaction slowly central together additional moreover reward catecholamine significantly extensive passive phenylalanine punishment reduction dopamine consistent global particular task error effect date change design negatively incorrect non level significant female per acute tyrosine overall woman correct pal impaired response year age deficient sample depletion determine precursor avoidance reinforcement also fewer trend study acid similar small men participant amino deterministic performance sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369455/,abstract,1,punishment reinforcement deterministic committed incorrect avoidance passive slowly reward depletion pal catecholamine men fewer mood beverage impaired negatively correct trend extensive deficient precursor sensitive affect dopamine task date acute reaction global woman particular female central consistent reduction cross tyrosine determine despite design additional small relationship performance overall similar participant change response error adult amino non sample time significantly phenylalanine acid age significant year effect level study,"{""phenylalanine"": {""freq"": 2, ""string"": [""adult amino non sample time significantly phenylalanine acid age significant year e""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""similar participant change response error adult amino non sample time significantly p""]}}",{},{}
1264,1264,1368,10.2217/PME.14.68,25642274.0,stratification use utility whole idea interpretation wide evidence information inevitable genomics pharmacogenetics limited brief clinical mixed practicing analysis currently behavior impact cardiologist method primary describe genome potential risk methodswe interview study integration data conclusionphysicians sequencing language change resultsphysicians patient underwent survey material education uncertain care semi decision aimto medicine physician medical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306284/,abstract,1,resultsphysicians practicing conclusionphysicians inevitable cardiologist pharmacogenetics stratification aimto idea uncertain underwent brief semi mixed interpretation integration interview language physician genomics utility education decision methodswe genome survey behavior limited sequencing currently wide medicine change primary medical use impact care information evidence material risk potential method data clinical analysis patient study,{},{},{},{},{},{}
1265,1265,1369,10.5455/msm.2017.29.73-75,28484359.0,operation surgery clinic region early congenital defect present sarajevo complexity pacemaker weight common deal ablation ucc institution number modern evaluate circulation herzegovina joint shunt introduction childhood reoperation mainly bosnia clinical procedure complete body chd result university contractual cardiology april peri palliative type postoperative cyanotic period level case acyanotic extracorporeal interventional others child bosnian population method herzegovinian development simultaneously team treatment year placement tetralogy age two pediatric anomaly january arrhytmology heart goal invasive obstructive intensive research program also conclusion cardiosurgery last study right cardiac position surgical center patient radiofrequency underwent correction fallot highest complication individual total complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402366/,abstract,18,ucc shunt sarajevo reoperation radiofrequency herzegovinian extracorporeal contractual cardiosurgery bosnian arrhytmology pacemaker obstructive cyanotic acyanotic ablation postoperative placement peri palliative herzegovina bosnia cardiology tetralogy fallot deal interventional circulation joint modern surgery operation surgical april intensive underwent simultaneously anomaly chd team position institution correction complexity january invasive right cardiac introduction university complication complete mainly highest goal procedure clinic heart center evaluate pediatric childhood weight defect congenital period region body program complex total conclusion common number present case individual early type research population child age development year method level treatment clinical result patient study,{},{},{},{},{},{}
1266,1266,1370,10.3892/etm.2018.6346,30116364.0,experimental significant four rate culture activity neural apoptosis survival early apoptotic affect schizophrenia present stem cytometry total divided neurotoxicity flow hippocampal therapeutic describe aspartate stage group result nmda dizocilpine nsc investigate towards effect purpose methyl study proliferative treatment response late receptor combination significantly randomly novel proliferation cell untreated,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090289/,abstract,0,nmda dizocilpine neurotoxicity proliferative nsc hippocampal divided cytometry aspartate apoptotic apoptosis schizophrenia methyl proliferation flow stem randomly neural culture untreated survival late receptor affect experimental stage combination purpose investigate response therapeutic novel rate total activity cell present significantly early significant group effect treatment result study,{},{},{},{},{},{}
1267,1267,1371,10.1186/s13167-016-0074-2,27980697.0,rare major knowledge advance pathophysiological mutation marker causative rds new lack biomarkers recent early screening affect context follow pathway difficult timely since dynamic world drug therapy discovery individualized protein many population prime enable omics management research identification importance also prevention prognosis diagnosis technology pillar biomarker effective human treatment concept important valuable response origin furthermore disease combination genetic gene medicine metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143439/,abstract,2,prime pillar rds individualized enable pathophysiological omics timely causative prognosis origin valuable biomarker dynamic affect discovery concept world difficult advance follow marker lack combination context furthermore prevention biomarkers medicine importance identification technology knowledge metabolite screening management major drug response effective pathway recent rare therapy mutation important new human early diagnosis research population protein gene genetic treatment disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""screening management major drug response effective pathway recent rare therapy mutation i""]}}","{""screening"": {""freq"": 1, ""string"": [""medicine importance identification technology knowledge metabolite screening management major drug response e""]}}",{},{}
1268,1268,1372,10.1007/8904_2015_435,26450566.0,specific disorder decompensation iem glycogen syrup information final specifically ssiem adult present specialise needed common fabry clinician disease survey amongst material spectrum physician knowledge supplementary optimal user storage distribution error inborn result diagnosis ornithine metabolic urine facility date ability type metabolism hemochromatosis four interest acute centre phenylketonuria method frequently transcarbamylase online treatment urea lysosomal electronic serve year care list maple particularly gaucher materialthe version wide age within manage bone analysis background available conclusion group cycle different deficiency patient twenty chapter number mitochondrial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580735/,abstract,2,specialise ssiem needed hemochromatosis glycogen transcarbamylase gaucher serve ornithine manage fabry decompensation facility maple syrup chapter lysosomal final bone urea centre list mitochondrial physician storage specifically clinician optimal distribution iem cycle frequently date urine acute survey particularly materialthe ability wide knowledge spectrum inborn background supplementary user version electronic error online adult deficiency care information material conclusion common phenylketonuria number present available metabolism specific type diagnosis different age metabolic group year method disorder treatment analysis result patient disease,"{""urine"": {""freq"": 1, ""string"": [""optimal distribution iem cycle frequently date urine acute survey particularly materialthe a""]}}",{},{},{},{},{}
1269,1269,1373,,10634319.0,specific activity inactivation factor exhibit bipotential without hbc ebp control well virus embryonic oncogenesis murine promoter transcriptional sequence transcription relevant however compatible albumin mouse primary fibroblast transfection type hepatitis hepatocytes completely hepatocytic pres hybrid hepatic enhancer hbv somatic liver pluripotential analyze abundance plasmid nih progenitor expression alteration active viral hnf assay nonpermissive cell specificity transient endogenous understood persistence repression differentiation inactive stem analysis mechanism mature cotransfections different weakly regulating gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157367/,abstract,0,pres pluripotential nonpermissive hepatocytic cotransfections weakly understood oncogenesis ebp bipotential inactive repression progenitor hbc transfection nih enhancer mature inactivation hybrid somatic persistence compatible hbv plasmid albumin hepatitis regulating murine analyze fibroblast embryonic transient hepatocytes exhibit abundance hnf viral transcriptional stem promoter completely endogenous hepatic differentiation virus transcription alteration active specificity sequence assay liver relevant mouse expression primary mechanism activity cell specific control factor type different gene analysis,{},{},{},{},{},{}
1270,1270,1374,10.1590/1984-0462/;2017;35;2;00010,28977324.0,statistic information among time package researcher microsoft ministry objective puerperal physician name third knowledge form screening mainly higher health mina science primary result fifty purpose data seventh genetic period gerais case four main superficial morbidity etiology office october child spss woman total descriptive day method unable unaware ass correct social test team mother collection association discharge education care maternal informed sample newborn guthrie professional especially statistical birth prenatally hospital program also importance conclusion practice study power february participant usual brazilian,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496718/,abstract,6,puerperal unaware superficial seventh prenatally mina microsoft gerais guthrie unable informed discharge usual package office ministry february october spss brazilian power team statistic descriptive correct physician researcher mainly etiology mother morbidity education statistical science collection professional maternal woman hospital purpose especially practice social ass importance period main birth knowledge participant form screening objective day program primary association care information total newborn conclusion higher sample case test time child health genetic method data result study,"{""social"": {""freq"": 1, ""string"": [""maternal woman hospital purpose especially practice social ass importance period main b""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""newborn"": {""freq"": 1, ""string"": [""program primary association care information total newborn conclusion higher sample case t""]}, ""screening"": {""freq"": 1, ""string"": [""period main birth knowledge participant form screening objective day program primary a""]}, ""guthrie"": {""freq"": 1, ""string"": [""superficial seventh prenatally mina microsoft gerais guthrie unable informed discharge usual p""]}}",{},{}
1271,1271,1375,10.1016/j.ymgmr.2016.08.008,27622144.0,considerable cross assessment blood allowance hour sectional information among time oopc present dietician median oopcs aged need due substance regular cost ethic control clinician severity classical specialist survey pku status intake respectively hydroxylase phe medical arises committee phenylalanine event moderate poorly holiday mainly health attendance burden phenylketonuriakeywords monetary metabolic earnings data mild borderline equipment adherence potentially low completely prepared service methodscaregivers four introductionmanagement one per discussion child personal living management week dla phenylketonuria participate via abbreviation national disability acbs concentration expenditure limit diet year care lifestyle conclusionsdietary strict monitoring resultsthe pediatric burdensome advisory reduced nres aspect specially research job also extra pah different study dietary center patient financial caregiver,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009233/,abstract,7,oopc nres methodscaregivers job introductionmanagement earnings dla conclusionsdietary attendance arises acbs specially phenylketonuriakeywords oopcs holiday burdensome monetary extra borderline prepared allowance dietician equipment participate financial advisory expenditure personal living substance ethic abbreviation committee strict regular completely specialist lifestyle poorly caregiver discussion hour considerable adherence classical limit resultsthe monitoring reduced clinician mainly burden moderate mild event severity aspect sectional potentially center median service aged pediatric survey pah cross national disability cost intake week hydroxylase status need assessment phe management medical diet respectively dietary care information concentration pku phenylketonuria low present time phenylalanine control blood research child different metabolic health year data patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""concentration pku phenylketonuria low present time phenylalanine control blood research child d""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""status need assessment phe management medical diet respectively dietary care information c""]}}",{}
1272,1272,1376,10.1371/journal.pone.0152253,27007889.0,blood chain culture febrile growth among ambient time positive several world despite site reaction throughout ease accurate central molecular additional resultsa methodsbetween cost risk testing onto polymerase repeat evaluate disease respectively infectious nigeria subject clinical storage backgroundnigeria nonspecific bacteremia burden ideal real result pneumoniae six question low non detection cautionary pcr case surveillance one northern gold volume temperature infection sensitivity overall child able approach whatman pathogen method illness resource important filter nigerian year promise assay streptococcus conclusionsrt definition amplification age sample two minimal negative spot standard involved limited precise hospital falsely paper pneumococcal also diagnostic high study fta bottle highest show total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805257/,abstract,10,pneumoniae pneumococcal methodsbetween conclusionsrt bacteremia backgroundnigeria nigerian nigeria fta febrile falsely cautionary bottle streptococcus whatman nonspecific ambient ideal pathogen northern ease gold amplification polymerase surveillance repeat illness resultsa definition promise filter precise infectious minimal culture temperature pcr accurate real involved storage able question burden highest world volume infection resource evaluate reaction central site assay sensitivity negative hospital limited cost chain spot growth despite paper additional testing overall diagnostic standard detection subject positive molecular respectively total non important sample low approach case time risk blood child age year high method clinical result disease study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""paper additional testing overall diagnostic standard detection subject positive molecular respectively t""]}}",{},{}
1273,1273,1377,10.1155/2015/254868,26089596.0,letter stress disorder sample cross two self whether one within comorbid symptomology dimensional difference single indexed applied rating scale especially anxiety problem time across visual present adult student field identical speed reaction fast either approach condition symptom match task target deficit grade adhd conners depression interaction attention interhemispheric study test right mean weakly hyperactivity first significantly participant performance finding hemisphere presence fixation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452317/,abstract,0,symptomology indexed weakly interhemispheric match hemisphere conners fixation letter identical applied comorbid speed fast dimensional adhd rating student grade hyperactivity visual right depression anxiety task reaction stress deficit mean cross self attention presence especially problem scale performance field target finding interaction participant symptom single adult condition difference sample approach present test time significantly disorder study,"{""hyperactivity"": {""freq"": 1, ""string"": [""fast dimensional adhd rating student grade hyperactivity visual right depression anxiety t""]}}",{},{},{},{},{}
1274,1274,1378,10.7759/cureus.4948,31453022.0,specific although full disorder seizure assessment evidence possible early acute etiology anti judicious scenario essential dysfunction higher nervous birth clinical prevent neonatal dependent outcome intervention damage brain neonate complicated weight management central permanent eeg opportune research infant identification evident cortical prognosis multifactorial system diagnosis subtle presentation study manifestation subclinical treatment cerebral term nevertheless incidence low medication injury non,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701909/,abstract,0,judicious opportune subclinical cortical subtle multifactorial scenario eeg permanent complicated cerebral prognosis neonate evident injury seizure nervous medication manifestation damage presentation etiology anti prevent acute dependent central incidence weight neonatal dysfunction essential identification birth possible assessment infant management brain intervention evidence outcome term higher non low early specific diagnosis research disorder treatment clinical study,{},{},{},{},{},{}
1275,1275,1379,10.1542/neo.16-2-e94,26236171.0,various measurement third knowledge interpretation activity discus prevalence clinical proper sensitivity neonatal causation necessary basic review analysis bias scholarly research core effectiveness article study principle design incidence decision epidemiology physician,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517623/,abstract,0,scholarly causation epidemiology proper core interpretation bias principle physician basic decision effectiveness necessary incidence sensitivity neonatal measurement design prevalence discus knowledge various activity article research review clinical analysis study,{},{},{},{},{},{}
1276,1276,1380,10.1111/mmi.13384,27010356.0,inhibits inside coenzyme herein growth organism unchecked ammonia specifically biosynthesis deaminase hydrolysis elicits detoxification highlight rida toxicity accumulation serf understanding strategy aminoacrylate additionally nature role protein unbound degradation pyruvate result thus metabolic effect cause diaminopropionate dpal dap metabolism proline enterica non stress rate siderophores requirement neurotoxin normal prevent damage many critical reactive potential unknown intermediate isoleucine proceeds cell process endogenous production likely dependent antibiotic previously mechanism precursor lyase acid catalyzing inform amino,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384650/,abstract,0,unbound siderophores rida proceeds neurotoxin enterica dpal diaminopropionate deaminase dap catalyzing aminoacrylate unchecked elicits inhibits hydrolysis detoxification serf proline inside pyruvate coenzyme intermediate antibiotic isoleucine lyase reactive ammonia toxicity requirement organism endogenous inform biosynthesis degradation damage specifically precursor nature accumulation additionally production prevent unknown dependent stress understanding likely critical previously highlight growth process normal cause strategy mechanism rate amino non role cell metabolism acid potential protein metabolic effect result,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""process normal cause strategy mechanism rate amino non role cell metabolism a""]}}",{},{}
1277,1277,1381,10.1038/srep35794,27786189.0,activity oligodeoxynucleotide lead single rescue zsgreen frequency hdr severe common concept disease hydroxylase pku neurological employ phenylalanine editing restore endonuclease monogenic symptom particular recently metabolic crispr late fusion metabolism medicine normal arg proof enhancer dcas approach toward model phenylketonuria technique plasmid efficiency correct expression potential system guide precision cell variant rna allele foki inactive function residual vitro also pah study trp acid neuropsychological correction amino gene presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081532/,abstract,0,zsgreen oligodeoxynucleotide foki dcas endonuclease inactive hdr restore employ enhancer fusion editing plasmid rescue trp crispr proof arg correction residual neuropsychological monogenic guide correct rna efficiency precision late concept vitro neurological allele particular recently pah lead presence technique frequency medicine hydroxylase severe symptom normal expression variant single activity pku amino common cell function phenylketonuria approach metabolism model phenylalanine acid potential metabolic gene disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""cell function phenylketonuria approach metabolism model phenylalanine acid potential metabolic gene d""]}, ""neurological"": {""freq"": 1, ""string"": [""rna efficiency precision late concept vitro neurological allele particular recently pah l""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""normal expression variant single activity pku amino common cell function phenylketonuria a""]}}",{},{}
1278,1278,1382,10.1111/pedi.12414,27444539.0,intelligence cross relationship memory importantly youth better sectional lead hierarchical greater difference lower time across visual onset average methodswe hba control longitudinal slower maintained trajectory worse however later much childhood spatial resultsyouth relative cognition value developmental task effect decrease ability type non three mellitus hyperglycemia processing point objectivealthough treatment person adolescence diabetes year stronger process age earlier within negative sibling explore influence function conclusionson speed cognitive diabetic glycemic study faster linear performance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912686/,abstract,1,resultsyouth objectivealthough conclusionson hyperglycemia maintained slower hba glycemic youth worse sibling hierarchical faster trajectory mellitus speed stronger diabetic intelligence cognition adolescence spatial person processing importantly earlier visual longitudinal later memory linear diabetes task relative explore average methodswe sectional decrease childhood negative cross lead onset point developmental influence greater ability relationship performance better process cognitive value lower non difference function time control type age year effect treatment study,{},{},{},{},{},{}
1279,1279,1383,10.1186/s12970-017-0191-x,28919843.0,male specific maximal respiratory ratio single ergometer backgroundwhen registrationumin serious supplementation effective increase exercise workload significantly however phenylalanine subject event oxidation observed body methodssix result effect crossover significant whole pre ingestion placebo dose method mobilization glucagon concentration active fat glycerol resultsoral unclear healthy adverse either consumption oxygen also trial secretion exchange cycle plasma study restrospectively acid dietary minute volunteer thirty amino conclusionthese,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596463/,abstract,2,resultsoral restrospectively registrationumin methodssix ergometer backgroundwhen mobilization workload glycerol conclusionthese glucagon ingestion maximal secretion minute exercise volunteer respiratory oxygen thirty crossover exchange oxidation placebo fat consumption unclear event cycle dose active pre supplementation adverse observed male ratio body healthy subject plasma trial increase effective single dietary concentration amino significantly phenylalanine specific acid significant effect method result study,"{""phenylalanine"": {""freq"": 2, ""string"": [""effective single dietary concentration amino significantly phenylalanine specific acid significant effect m""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""trial increase effective single dietary concentration amino significantly phenylalanine specific acid s""]}}",{},{}
1280,1280,1384,10.1016/j.ymgme.2015.01.006,25649058.0,matter consensus epidemiologic definition case public disorder leukodystrophy permit abnormality interpretationa involvement lack hamper effort white systemic relevance health set precise currently criterion approach leukoencephalopathies objectivean detailed primary due expert resultsa separate multiple building classification study institution manifestation gle addition delphi methodthirteen meeting term doe survey iterative genetic heritable prominent epidemiology total neuronal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390457/,abstract,1,methodthirteen interpretationa hamper objectivean leukoencephalopathies gle building permit leukodystrophy delphi meeting iterative heritable epidemiologic prominent epidemiology resultsa definition detailed institution precise set consensus relevance neuronal involvement classification systemic separate manifestation matter expert doe white effort survey abnormality lack criterion currently public addition multiple primary total term approach case health genetic disorder study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1281,1281,1385,10.1038/s41538-017-0002-4,31304244.0,major various mood phenotypic nutritive memory physiological pathway epigenetics context molecule difficult positive transducer together physiology regulatory well way exquisitely neurological neuroplasticity neuronal transcriptional interplay subject marker axis poorly cognition lastly adaptive define epitranscriptomics brain reproducibly layer environment food like combinatorially effect term mediate non although interdependent measure ingestion strong apparent produce neuroscience model dsms neurogenesis development expression system evolution stimulus response association network year diet signaling genomically process robust within lack million understood ancient biology statistical ago nervous function cognitive emergent mechanism impact program importance bioactive study digestion power mammalian inextricably excitability even accurately complex sensitive establishing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548416/,abstract,0,interdependent inextricably genomically epitranscriptomics dsms combinatorially understood reproducibly exquisitely neuroscience neuroplasticity excitability ancient transducer neurogenesis digestion lastly nutritive ingestion epigenetics emergent stimulus mediate interplay establishing axis bioactive ago layer define mood apparent accurately signaling cognition power mammalian produce physiology evolution adaptive transcriptional poorly neuronal million nervous physiological phenotypic robust memory sensitive strong biology network molecule statistical neurological difficult way regulatory environment marker lack context importance like various food process cognitive measure subject program major expression complex positive response pathway brain association mechanism diet impact term non function model development year effect study,"{""neurological"": {""freq"": 1, ""string"": [""sensitive strong biology network molecule statistical neurological difficult way regulatory environment m""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""program major expression complex positive response pathway brain association mechanism diet i""]}}",{},"{""diet"": {""freq"": 1, ""string"": [""positive response pathway brain association mechanism diet impact term non function m""]}}",{}
1282,1282,1386,10.1177/1178635318820923,30643419.0,monolayer physiological new molecule deeper defect dppc site liquid surface insight behavior dipole state morphology significantly reorientation membrane phe angle phenylalanine monomer form place higher glycero feature dimyristoyl great image perturbs property effect change cause insert lipid non adsorption area water dehydration cooperative compressibility direction independent packing structure dmpc degree pathological modulus bam binary system article adsorb important phase aggregate cell dipalmitoyl process congruent phosphocholine background coexist coverage importance multiple conclusion hydration different interaction high study acid synergistic understand tension arrangement amino affinity brewster mixture,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322106/,abstract,1,reorientation phosphocholine perturbs packing modulus hydration glycero dmpc dipole dipalmitoyl dimyristoyl cooperative compressibility brewster bam monolayer insert dppc dehydration coexist adsorption adsorb congruent tension understand synergistic binary angle deeper arrangement monomer image morphology affinity aggregate direction coverage mixture surface pathological membrane place degree lipid physiological water great liquid molecule independent phase property insight site feature behavior structure defect importance interaction background process form area phe state change multiple cause amino conclusion higher non article important cell significantly new phenylalanine acid different effect high study,"{""phenylalanine"": {""freq"": 2, ""string"": [""non article important cell significantly new phenylalanine acid different effect high s""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""area phe state change multiple cause amino conclusion higher non article i""]}}",{},{}
1283,1283,1387,10.1002/mrd.22880,28834577.0,biological phenotypic caenorhabditis example new organism pathway context occasional set unrelated insight molecular silent doe numerous animal vulval variety candidate seemingly thus effect good mek cause type level orthologous mutation cellular one phenotype raf many review model therapeutic emphasis identification target suppressor mode important cell process screen likely biology demonstrate phenologs widely also induction different tissue study human similar elegans mammalian gene highly proliferation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690827/,abstract,0,vulval raf phenologs mek elegans orthologous occasional caenorhabditis silent seemingly suppressor induction mammalian unrelated proliferation emphasis mode set organism numerous screen candidate phenotypic demonstrate variety doe biology widely cellular good insight animal example likely context tissue highly biological identification phenotype target similar process cause therapeutic pathway molecular mutation important cell new human model type review different gene effect level study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""phenotype target similar process cause therapeutic pathway molecular mutation important cell n""]}}",{},{},{}
1284,1284,1388,10.1038/s41390-018-0070-4,29892036.0,level acylcarnitines subsequent robust specific pathogenesis relationship two past life newborn inspire childhood pediatric resultsseveral morbidity early pathway etiology involved birth infection pulmonary prevent population critical gap insight program method infant episode development target potential exposure practice cohort conclusionsidentification study asthma susceptibility data number temporal backgroundthere association month year first rsv middle significantly metabolite tennessee,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274622/,abstract,3,tennessee rsv resultsseveral inspire conclusionsidentification backgroundthere asthma temporal pulmonary episode acylcarnitines middle susceptibility pathogenesis gap subsequent involved robust etiology past morbidity infection prevent pediatric insight childhood exposure critical practice cohort birth relationship target metabolite month infant program pathway association life newborn number significantly early specific population potential development year method data level study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""relationship target metabolite month infant program pathway association life newborn number s""]}}","{""newborn"": {""freq"": 1, ""string"": [""month infant program pathway association life newborn number significantly early specific p""]}}",{},{}
1285,1285,1389,10.3390/foods8080347,31443236.0,chain economy elaborate context concern organic due moreover zero separate enhancing concept nonetheless renewable transition respect lactose recent supply mainly value protein recovery integrated cheese therefore complete food thus foster large biorefinery focused design novel far sustainability full one imperative likewise end implementation valorization exploitation formulate approach product thereby potential holistic article resource waste exploit particularly advance within reported load application order environmental either aim circular high study whey predominantly conversion industry number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723228/,abstract,0,valorization renewable biorefinery reported lactose exploitation circular cheese sustainability foster exploit economy waste likewise enhancing zero nonetheless formulate imperative elaborate whey focused supply holistic integrated load conversion predominantly respect recovery industry transition far separate organic complete end mainly concept resource advance concern implementation context environmental chain particularly product design order food aim application value large recent novel article approach number potential protein high study,{},{},{},{},{},{}
1286,1286,1390,10.1007/s11306-016-1084-8,27524956.0,specific blood notion pathway difficult time methodsthis avenue mboat additional injection control severity disease significantly material transcriptional related supplementary user additionally brain integrated support result distress symptomatic data change little generation tandem metabolism level significant mutation phosphatidylcholine one pre huntington database exploitation electrospray workflow frequently conclusionour serine minimally expression serum concentration online mtrr article alteration electronic association version materialthe carrier introductionmetabolic sample mass order objectiveswe peripheral especially resultsby ionization invasive next analysis previously metabolomics spectrometry available identify tissue aldh sequencing patient gene metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963448/,abstract,8,resultsby mboat mtrr introductionmetabolic phosphatidylcholine exploitation electrospray minimally huntington aldh objectiveswe avenue ionization distress conclusionour serine notion integrated workflow symptomatic transcriptional methodsthis peripheral invasive injection identify little tandem metabolomics carrier severity frequently alteration additionally difficult pre serum generation tissue sequencing spectrometry especially database materialthe previously related additional order support metabolite supplementary mass user expression change version electronic online pathway brain association concentration mutation material article sample available metabolism time significantly specific control blood significant gene data level analysis result patient disease,{},{},"{""pathway"": {""freq"": 1, ""string"": [""user expression change version electronic online pathway brain association concentration mutation m""]}}","{""tandem"": {""freq"": 1, ""string"": [""methodsthis peripheral invasive injection identify little tandem metabolomics carrier severity frequently a""]}, ""spectrometry"": {""freq"": 1, ""string"": [""difficult pre serum generation tissue sequencing spectrometry especially database materialthe previously r""]}}",{},{}
1287,1287,1391,10.1038/srep15902,26510963.0,structured new affect time light microscopy moreover deficit chemical toxicity route well disease assembly neuronal paradigm angle line aetiopathology phenylalanine experimentally preventive protein consistent physico brain mouse primary paralleling result property like effect counteracts force cause selective furthermore first formation innovative non level fibre millimolar possibly local aggregation toxic structure scattering immortalized approach model phenylketonuria dendritic development via stage synaptic concentration amyloidogenic ray alteration address cell aggregate atomic transgenic wide future crystalline neuron amyloid cognitive impairment modulating vitro also different dietary small patient agent shedding presence doxycycline,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625134/,abstract,0,physico paralleling millimolar immortalized doxycycline counteracts aetiopathology shedding crystalline scattering modulating fibre amyloidogenic atomic structured experimentally dendritic transgenic angle route microscopy ray synaptic innovative force neuron possibly aggregate amyloid preventive paradigm assembly aggregation toxicity toxic neuronal selective light chemical line local formation agent affect alteration vitro address stage property consistent deficit impairment presence furthermore structure wide like small mouse cognitive primary cause future brain dietary concentration non cell phenylketonuria approach time new model phenylalanine different protein development effect level result patient disease,"{""phenylalanine"": {""freq"": 2, ""string"": [""cell phenylketonuria approach time new model phenylalanine different protein development effect l""]}}",{},{},{},{},{}
1288,1288,1393,10.1007/8904_2015_441,26006720.0,case disorder deficient rate activity mutation iran family newborn marker pcbd hyperphenylalaninemia since marriage several gch encodes higher responsible str quickly necessary population analysis previously biosynthesis tetrahydrobiopterin due pah common consanguineous practice enzyme high dhpr cause multiplex deficiency cofactor disease pku novel incidence gene qdpr total finding show,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470949/,abstract,2,pcbd qdpr str dhpr gch quickly encodes multiplex marriage consanguineous biosynthesis iran responsible deficient hyperphenylalaninemia cofactor tetrahydrobiopterin necessary incidence pah marker practice previously finding enzyme cause deficiency family novel rate total newborn activity mutation pku higher common case population gene high disorder analysis disease,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""cause deficiency family novel rate total newborn activity mutation pku higher c""]}}",{},{}
1289,1289,1394,10.1155/2018/2468457,29636836.0,disorder importantly whether bench physiological fundamental among redox oxidative despite selection homeostasis molecular literature ineffective physiology neurodegenerative virtually antioxidant finally preliminary evaluate disease status overproduction account animal cancer restore strategy dysfunction clinical therapy range bedside nitrogen translate indispensable result effectiveness arena effect geographically basis specie level stress cellular variable interpreting crucial etiology progression local dose others failure systemic drug intervention many critical approach model reason therapeutic reactive propose unsuccessful success delivery limit promise within accordingly cardiovascular translation oxygen trial often namely patient successful,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832094/,abstract,0,unsuccessful overproduction interpreting ineffective geographically bench bedside restore indispensable arena virtually translate redox nitrogen preliminary oxygen reactive antioxidant accordingly physiology reason promise importantly fundamental neurodegenerative crucial specie systemic success translation propose oxidative failure progression physiological homeostasis limit cardiovascular local etiology successful cellular account dose selection effectiveness evaluate delivery basis finally stress variable cancer animal dysfunction critical despite status literature trial range drug strategy therapeutic molecular intervention therapy approach model effect level disorder clinical result patient disease,{},{},{},{},{},{}
1290,1290,1396,10.1016/j.ymgmr.2016.07.003,27493880.0,specific disorder difficult formula positive adult palatability concern frequency due view common difficulty tube inadequate effective experience hypothesis number survey contribute pill respectively physician medical family methodsa strategy conclusionsdespite perspective scavenging respondent nitrogen sodium arginine food result effectiveness thus metabolic effect cause adherence medication non mitigate gastrointestinal commonly administration citrulline one least ranked volume acute dose drug infection side intervention living week day face illness online tolerance treatment urea supplement regimen year reflux gastric poor pediatric indiscretion paper episode cycle hyperammonemic high last phenylbutyrate benzoate acid dietary barrier patient amino preparation caregiver,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963256/,abstract,3,ranked pill indiscretion hyperammonemic benzoate scavenging phenylbutyrate conclusionsdespite mitigate gastric reflux citrulline palatability nitrogen tube living regimen inadequate episode sodium gastrointestinal illness arginine supplement respondent face urea formula tolerance preparation contribute caregiver methodsa physician medication commonly adherence view barrier difficulty hypothesis cycle volume infection dose perspective difficult acute poor concern effectiveness administration experience pediatric survey frequency week paper food day cause positive drug strategy online effective medical adult family respectively intervention dietary amino non common number specific acid metabolic year effect high disorder treatment result patient,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""medical adult family respectively intervention dietary amino non common number specific a""]}}",{},{}
1291,1291,1397,10.1186/s13023-019-1011-y,30770754.0,blood ratio growth single difference formula time essential modification median weight additional parallel partly source control addition formulation aima increase close month significantly glycomacropeptide status pku contribute semi material amount longitudinal phe biochemical however supplementary phenylalanine subject marker tyr optimal higher user protein abstractin range mol suitability equivalent remainder casein undefined score completely whole three per end child point able week phenylketonuria target baseline free concentration online article gradually electronic version materialthe bmi age monitoring within two biochemistry selenium carefully available group nutritional methodschildren plasma study anthropometry substitute acid amino total cgmp,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377744/,abstract,22,abstractin undefined aima remainder methodschildren suitability anthropometry cgmp casein biochemistry gradually carefully selenium partly substitute formulation semi glycomacropeptide formula close completely bmi equivalent tyr parallel contribute modification longitudinal monitoring end optimal able mol baseline median source nutritional weight marker point free materialthe essential growth week additional biochemical ratio status score target month phe supplementary addition subject plasma user range version increase electronic online single concentration total pku material amino higher article difference phenylketonuria available time significantly phenylalanine control blood acid child protein age group study,"{""phenylalanine"": {""freq"": 2, ""string"": [""article difference phenylketonuria available time significantly phenylalanine control blood acid child p""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""online single concentration total pku material amino higher article difference phenylketonuria a""]}}",{},{}
1292,1292,1398,10.1007/s10522-015-9600-1,26306600.0,major contributor balance disorder example antagonistic factor context among attenuate positive serious bad central condition physical pro common risk old increase disease trade knowledge beneficial evidence trait role health play paradoxically environment result like situation effect good delicate change long genetic mortality emphasize internal one neutral death current external overall many vulnerability review chance detrimental development people iii senescence argue age variant allele negative survival conditional especially compromise depend influence research available reduce importance also multiple phenomenon prevention different interaction human longevity another gene complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724477/,abstract,0,delicate antagonistic paradoxically detrimental depend attenuate senescence trade longevity contributor compromise bad emphasize conditional vulnerability external chance balance argue phenomenon pro iii neutral situation internal reduce survival beneficial people trait play death allele mortality good environment central physical old example negative context prevention influence especially importance like overall knowledge interaction long major change multiple complex positive variant increase evidence current condition role common available human risk factor research review different age development health gene effect genetic disorder result disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1293,1293,1399,10.5935/0103-507X.20190030,31141086.0,blood record whether investigation prematurity cystic congenital nutrition abnormal essential present neonatal prenatal aged weight condition pathology heel well methodsretrospective visit longitudinal medical pregnant unit quantitative health secondary complete therefore fibrosis hyperplasia six university data transfusion fetal conclusionthere low resultsthere measure child woman population descriptive approach predominance test guide mother year education care maternal newborn premature especially statistical birth approximately analysis intensive hospital characteristic adrenal study objectiveto prick complication parenteral,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649207/,abstract,4,transfusion methodsretrospective conclusionthere predominance prematurity parenteral hyperplasia heel prick adrenal resultsthere visit intensive premature cystic objectiveto guide descriptive fibrosis unit pregnant pathology prenatal longitudinal fetal university record complication complete mother nutrition abnormal education approximately statistical secondary investigation maternal aged woman quantitative weight neonatal hospital especially essential congenital characteristic birth measure medical care newborn condition low approach present test blood population child health year data analysis study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""congenital characteristic birth measure medical care newborn condition low approach present t""]}}",{},{}
1294,1294,1400,10.1097/NNR.0000000000000211,28252579.0,various nursing focal exemplar meaning need challenging clinician objective issue utility relevant understanding screening clinical integral role candidate therefore science pharmacogenomics aimthe utilization explicate data approacha microbiome multi member nurse vantage genomics point omics critical approach abundance method history translational potential technology team recommendation best dramatically overview linkage discussionthis dna quality omic special impact paper research genome backgroundadvances patient wealth proteomics healthcare gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334658/,abstract,0,explicate exemplar backgroundadvances vantage approacha wealth meaning focal aimthe pharmacogenomics omic discussionthis nursing integral nurse challenging utilization proteomics dramatically omics linkage microbiome abundance team translational special multi candidate overview genomics clinician member utility healthcare science best history recommendation genome dna understanding critical point relevant paper issue technology need various screening objective quality impact role approach research potential gene method data clinical patient,{},{},{},"{""screening"": {""freq"": 1, ""string"": [""relevant paper issue technology need various screening objective quality impact role a""]}}",{},{}
1295,1295,1401,10.3389/fpubh.2015.00214,26442241.0,consistency example new almost pathway country condition state highlight effective addition well zealand evidence environment support behind recently internationally contrast call bloodspot united international government current provide review model ass development national kingdom technology treatment detail year decision operating process robust within newborn lack community currently benefit program also policy america transparent successfully number australia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4564656/,abstract,1,transparent internationally zealand kingdom bloodspot consistency america operating australia government successfully united robust international community decision contrast policy environment recently example lack national currently highlight ass provide benefit technology country process support addition state program effective pathway newborn evidence current condition number new model review development year treatment,{},{},"{""pathway"": {""freq"": 1, ""string"": [""process support addition state program effective pathway newborn evidence current condition n""]}}","{""newborn"": {""freq"": 1, ""string"": [""support addition state program effective pathway newborn evidence current condition number n""]}}",{},{}
1296,1296,1402,10.1186/s12881-014-0134-1,25714468.0,implication interpretation record single information illumina brief laboratory platform geneinsight molecular additional highlight effective experience medseq disease material summary physician medical supplementary evidence backgroundthe methodsgenome user clinical health consistent resultswe project genomic report result diagnosis guideline consideration medicine communication step software conclusionsour current description relevance approach management concise method partner ass potential online article delivery important electronic reporting succinct randomized version materialthe variant along professional suite appropriate validated impact framework available trial genome prevention practice hiseq patient page healthcare gene curation return,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342199/,abstract,0,methodsgenome medseq geneinsight curation succinct illumina hiseq concise suite page return conclusionsour partner description reporting randomized brief validated software resultswe interpretation relevance project summary backgroundthe physician record consideration platform communication guideline framework healthcare step experience delivery appropriate genomic professional genome implication consistent prevention practice materialthe highlight laboratory medicine ass additional supplementary management trial user version variant electronic online effective medical single molecular report impact information evidence current material article important approach available diagnosis potential health gene method clinical result patient disease,{},{},{},{},{},{}
1297,1297,1403,10.1900/RDS.2015.12.299,27111117.0,major oji european cree canadian example whether hispanic african difference single representative information deeper several despite complexity summarizes insight frequency locus risk average origin disease offer however uniform smaller much indian abcc demonstrating environment effect large date basis thousand novel pima genetic type non size strong white polygenic highly population review enrichment identification causal parent ten valuable diabetes hnf lifestyle rare tbc sample advancement variant causative allele typically ethnic prevalence definitive currently previously group different study advantage black greenlandic kcnq asian modest variability individual gene hallmark complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5275756/,abstract,1,tbc pima oji kcnq greenlandic cree abcc indian hispanic black polygenic deeper canadian uniform summarizes modest ethnic smaller hallmark definitive african asian enrichment demonstrating advancement causative thousand representative hnf causal offer complexity origin lifestyle locus valuable typically variability advantage strong white diabetes european date average allele basis size environment insight example highly currently previously frequency despite parent identification prevalence major complex variant large single rare novel information non difference sample individual risk type population review different gene group effect genetic disease study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1298,1298,1404,10.4103/JPN.JPN_177_17,29899773.0,male considerable blood delay record nine retardation hypo observation ratio region positive defect laboratory set elevated restriction symmetrical eczematous need common regular state consanguineous parieto course testing varied well rash disease pku neurological ferric spectrum phe consanguinity however seizure family introduction dnph stone clinical developmental feature controllable global diffusion hypotonia image retrospectively error inborn result color diagnosis metabolic attention large data urine change ear tandem genetic metabolism low mortality non area regression level case lab one hypertelorism fallow normal tyrosine child blond prevent spasticity hyperintensities mental history flair seborrhea phenyl test team mother excessive detail year mile microcephaly ketonuria age mass spectroscopy occipital persistence mri available conclusion last arm acid ocular patient chloride amino complication total hair,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982494/,abstract,6,seborrhea rash parieto mile ketonuria hypertelorism hyperintensities fallow eczematous dnph blond stone hypo flair ferric controllable spasticity ocular symmetrical ear phenyl occipital hair chloride persistence hypotonia color retrospectively arm microcephaly image consanguinity consanguineous excessive lab retardation diffusion mri regular team spectroscopy varied set observation seizure considerable introduction course record delay complication restriction elevated tandem mother urine prevent neurological mortality mental history global regression feature attention developmental tyrosine defect laboratory male ratio need testing spectrum region inborn area phe normal state mass change positive error large family total pku amino conclusion non common low case available metabolism test blood diagnosis acid child age metabolic year genetic data level clinical result patient disease,"{""urine"": {""freq"": 1, ""string"": [""delay complication restriction elevated tandem mother urine prevent neurological mortality mental h""]}, ""neurological"": {""freq"": 1, ""string"": [""restriction elevated tandem mother urine prevent neurological mortality mental history global r""]}, ""hair"": {""freq"": 1, ""string"": [""spasticity ocular symmetrical ear phenyl occipital hair chloride persistence hypotonia color r""]}, ""microcephaly"": {""freq"": 1, ""string"": [""chloride persistence hypotonia color retrospectively arm microcephaly image consanguinity consanguineous excessive l""]}}","{""genetic"": {""freq"": 1, ""string"": [""diagnosis acid child age metabolic year genetic data level clinical result p""]}}",{},"{""amino"": {""freq"": 1, ""string"": [""positive error large family total pku amino conclusion non common low c""]}, ""tandem"": {""freq"": 1, ""string"": [""course record delay complication restriction elevated tandem mother urine prevent neurological m""]}}",{},{}
1299,1299,1405,10.11604/pamj.2018.30.115.13634,30364427.0,blood disorder new effort duration onset literature methodswe hfh perhaps vitamin objective ethical spectrum biochemical biotinidase value resultswe gap anion food support metabolic data urine displacement low significant case hope rehabilitation asd internal idp akin centre syndrome child moh irb review acetyl exposure towards treatment associated similarity help version bmi age approval community since ugandan analysis environmental camp multiple episode high stata study human deficiency conclusionthese carnitine indicative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195236/,abstract,3,ugandan irb hfh moh displacement akin idp camp stata rehabilitation hope conclusionthese biotinidase anion indicative acetyl approval carnitine episode similarity internal resultswe bmi duration centre ethical gap vitamin asd community urine methodswe effort associated help exposure onset environmental syndrome biochemical spectrum literature food support objective multiple version value deficiency low case new human blood review child age significant metabolic high data disorder treatment analysis study,"{""urine"": {""freq"": 1, ""string"": [""centre ethical gap vitamin asd community urine methodswe effort associated help e""]}}",{},{},{},{},{}
1300,1300,1406,10.1038/mt.2014.178,25195597.0,potent specific bioinformatics cluster chain synthetic new vivo factor serotype reporter signature site molecular need regulatory spc increase disease promoter hereditary heavy transcriptional transcription myosin strategy therapy putative therefore conserved novo design novel rational significant interest evolutionary correspond stable approach therapeutic crms expression potential quintessential treatment viral promising crm wide robust hence underscore heart afflict adeno module cardiovascular modality genome cardiac cytomegalovirus vector muscle gene robustness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426801/,abstract,1,spc quintessential crms afflict myosin crm correspond serotype conserved rational cytomegalovirus robustness evolutionary heavy module underscore reporter adeno signature bioinformatics muscle modality potent novo putative hereditary viral transcriptional promoter cluster vector promising cardiac synthetic transcription stable cardiovascular robust vivo heart regulatory genome site chain wide design need expression strategy increase therapeutic molecular novel therapy approach new specific factor potential significant gene treatment disease,{},{},{},{},{},{}
1301,1301,1407,10.14814/phy2.12164,25318748.0,chain maximal essential rhythmically rest tetrahydrobiopterin condition catheter supplementation vascular dawley stimulation sprague control sympathetic hypothesis contractile vasoconstrictor femoral consistent stimulating vasodilation thus force change decrease rat blunt acute mcf surae lumbar fvc muscular artery response probe electrode contraction production percentage nitric contract dependent flow also brachial contracting anesthetized skeletal oxide cofactor muscle conductance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254091/,abstract,17,vasoconstrictor surae rhythmically fvc contracting contractile brachial blunt mcf catheter anesthetized vasodilation contraction contract sympathetic sprague femoral dawley rest muscular conductance lumbar electrode maximal stimulating artery skeletal force muscle probe stimulation vascular nitric flow oxide percentage rat cofactor hypothesis tetrahydrobiopterin production acute supplementation dependent decrease consistent chain essential change response condition control,{},{},{},{},{},{}
1302,1302,1409,10.26508/lsa.201900360,31416893.0,inhibits example lead pathway nutrient elevated homeostasis supplementation ketoisocaproate transfer control transcription knowledge relevant however event higher role protein therefore metabolic effect vastly genetic metabolism cysteine level toxic ncl tricarboxylic block approach model translational yeast decouples system concentration cell process methyltransferase excess rna screen survival limited alters metabolomics translation nutritional comprehensive cycle physiologically regulating acid conversion limitation absence proteomics amino presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696984/,abstract,0,ncl ketoisocaproate decouples tricarboxylic methyltransferase alters inhibits vastly physiologically yeast proteomics cysteine regulating excess transfer conversion block translational toxic rna survival translation screen absence transcription homeostasis nutrient limitation event elevated metabolomics cycle comprehensive supplementation nutritional example limited lead presence relevant knowledge process pathway concentration amino higher role cell approach metabolism model control acid protein metabolic effect genetic level,{},"{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""limited lead presence relevant knowledge process pathway concentration amino higher role c""]}}","{""amino"": {""freq"": 1, ""string"": [""presence relevant knowledge process pathway concentration amino higher role cell approach m""]}}",{},{}
1303,1303,1410,10.3390/nu11030598,30870995.0,major inflammatory biological gastrointestinal various knowledge disorder beneficial gmp activity milk vivo information pathway exert current several value health protein compilation many review special mechanism vitro condition characteristic body action therapeutic peptide structural food bioactivity bioactive property nutritional system comprehensive endocrine attention effect physiology namely human addition important immune disease glycomacropeptide safe number model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471465/,abstract,0,compilation bioactivity endocrine exert bioactive gmp gastrointestinal physiology glycomacropeptide safe milk peptide special beneficial immune action structural inflammatory vitro vivo comprehensive property nutritional attention biological characteristic knowledge various body food addition major value therapeutic pathway mechanism information activity current condition important number human model review protein health effect disorder disease,{},{},"{""pathway"": {""freq"": 1, ""string"": [""body food addition major value therapeutic pathway mechanism information activity current c""]}}",{},{},{}
1304,1304,1411,10.5582/irdr.2018.01056,29862160.0,line rare staff incentive level related availability past government interest strategy greater effort standard drug raise health societal cooperation safeguard regard enhance management awareness research china development common national diagnosis facilitate attention classification right officially treatment orphan increase patient disease year first ability planning list chinese medicine international medical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982625/,abstract,1,officially incentive safeguard staff cooperation societal orphan raise government regard planning awareness right enhance list classification chinese facilitate china line availability past international effort national attention greater ability medicine related standard management drug strategy increase medical rare common diagnosis research development health year level treatment patient disease,{},{},{},{},{},{}
1305,1305,1412,10.1007/8904_2017_52,28840576.0,disorder blood nine growth factor examine despite severe included build control varied preliminary pku material supplementary cannot phenylalanine family beneficial evidence user clinical protein focus therefore examination support sufficiently metabolic base cause adherence first genetic area level although four one database child intervention many review inclusion phenylketonuria parent article concentration online treatment recommendation electronic association limit diet systematic particularly strict materialthe version rare age poor irreversible lifelong paucity statistical adolescent influence quality cognitive impairment aim natural research available consequence conclusion robustly practice study acid twenty psychosocial amino chapter demographic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953888/,abstract,0,paucity included robustly sufficiently build preliminary chapter irreversible psychosocial strict lifelong base varied demographic examine adherence beneficial limit examination adolescent statistical inclusion poor systematic natural recommendation consequence focus impairment influence database practice particularly materialthe growth despite parent severe cognitive area support aim supplementary user cause version electronic quality online association diet rare family intervention concentration evidence pku material amino conclusion article phenylketonuria available phenylalanine control factor blood research review acid child protein age metabolic genetic level disorder treatment clinical study,"{""phenylalanine"": {""freq"": 2, ""string"": [""material amino conclusion article phenylketonuria available phenylalanine control factor blood research r""]}}","{""genetic"": {""freq"": 1, ""string"": [""review acid child protein age metabolic genetic level disorder treatment clinical s""]}}",{},"{""amino"": {""freq"": 1, ""string"": [""family intervention concentration evidence pku material amino conclusion article phenylketonuria available p""]}}","{""diet"": {""freq"": 1, ""string"": [""cause version electronic quality online association diet rare family intervention concentration e""]}}",{}
1306,1306,1413,10.1074/jbc.RA118.004909,30287685.0,experimental disorder new conformation subunit defect present selection platform elevated insight molecular detailed computing hairpin sens state mechanistic investigate hypothesis activation finally transition doe hydroxylase phe extensive phenylalanine monomer observed protein consistent allosteric home structural regulates absent genetic msms level effector functional conformational dynamic motion mobile dimer toward model phenylketonuria gromacs regulation tetramer development correct simulation msm concentration strongly association detail gating interface markov transient variant suite hyperphenylalaninemia testable spontaneous sensing act analysis neurotoxicity mechanism also pah different high domain equilibrium perform loop mammal highly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314134/,abstract,0,sens msms gromacs tetramer regulates neurotoxicity msm gating computing testable sensing markov hairpin perform motion suite spontaneous mammal absent loop effector conformational conformation mobile equilibrium subunit dimer allosteric monomer interface simulation transient detailed home mechanistic transition correct act extensive activation dynamic strongly hyperphenylalaninemia platform doe elevated hypothesis structural experimental selection domain regulation finally observed insight consistent pah investigate highly defect functional hydroxylase phe state variant association molecular mechanism concentration phenylketonuria present new model phenylalanine different protein development high genetic level disorder analysis,"{""phenylalanine"": {""freq"": 2, ""string"": [""mechanism concentration phenylketonuria present new model phenylalanine different protein development high g""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1307,1307,1414,10.3748/wjg.v22.i33.7604,27672281.0,blood clinic past outpatient venous positive nat five hbc finger methodswe outside prison testing chc control well virus drop subject life capillary screening anti health real prospective hepatitis low detection level three nucleic infection drug sensitivity hbv hiv correctly hcv feasible method system test treatment filter viral care donor specificity immunodeficiency sample rna negative spot chronic dna analysis paper hbsag conclusiondbs human acid center patient aimto,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011674/,abstract,4,prison nat hbsag chc conclusiondbs hcv hbc drop nucleic hbv aimto immunodeficiency correctly outside finger venous outpatient hiv hepatitis capillary donor filter viral feasible rna virus real prospective anti past infection methodswe clinic specificity center dna sensitivity negative chronic spot paper testing detection screening subject positive drug care life sample low test human control blood acid health method level treatment analysis patient,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""sensitivity negative chronic spot paper testing detection screening subject positive drug c""]}, ""screening"": {""freq"": 1, ""string"": [""negative chronic spot paper testing detection screening subject positive drug care l""]}}",{},{}
1308,1308,1415,10.1371/journal.pone.0110199,25310815.0,resonance disorder striatal abnormality technical bilateral adult fractional attributable stimulant radiata superior moreover heterogeneous deficit adhd precentral neuroanatomical partly motor control well anisotropy microstructure longitudinal tensor neuroimaging matter supplementary circuit subject hiperactivity methodsa corona reduction odvba relative mainly volumetric visuomotor higher trace usually body diffusion great structural conventional result understudied data date significance optimally voxel middle medication area use level least measure splenium conclusionsour white population analyze method history prevalent diffusivity multimodal backgroundattention treatment temporal callosum circuitry fronto emotional fasciculus process age still occipital mri paucity especially healthy morphometric cognitive analysis corpus available relatively also gray dti trend angular study right magnetic discriminative patient gyrus limitation postcentral newly gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195718/,abstract,2,precentral postcentral odvba neuroanatomical morphometric microstructure hiperactivity fronto discriminative angular understudied radiata multimodal backgroundattention visuomotor stimulant voxel optimally fasciculus corona volumetric occipital gray striatal paucity gyrus splenium neuroimaging circuitry anisotropy trace temporal conclusionsour dti callosum tensor diffusivity fractional corpus circuit partly bilateral attributable analyze newly adhd emotional diffusion superior mri middle usually heterogeneous technical conventional right prevalent methodsa resonance trend medication longitudinal gender matter significance great mainly white limitation motor magnetic relatively structural relative date history deficit abnormality reduction especially body process cognitive area measure supplementary healthy subject adult use higher available control population age method data level disorder treatment analysis result patient study,"{""emotional"": {""freq"": 1, ""string"": [""partly bilateral attributable analyze newly adhd emotional diffusion superior mri middle u""]}}",{},{},{},{},{}
1309,1309,1416,10.15171/ijhpm.2016.158,28812845.0,considerable tool search explain maximum technical country present selection document condition moreover advocacy experience ministry iranian sociopolitical prioritization issue summary medical implementing however unit evidence form innovation variety user maxqda senior health procedure burden improvement support result adapt preferred utilization qualitative attention interview data mohme basis friendly guideline term long consideration technician multi least short software local economic sensitivity implementation intervention highly moh critical approach window model degree method ass development organization manager article topic agenda collection year education decision option feasibility particularly process urgent iran opportunity likely order stakeholder standard purposeful setting try quality analysis criterion background research framework alternative keywords policy conclusion different classification readiness study pyramid scholar maker participant financial individual idea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553214/,abstract,3,sociopolitical senior pyramid purposeful mohme maxqda implementing try moh technician readiness scholar manager friendly advocacy prioritization adapt urgent setting preferred ministry agenda innovation utilization idea financial explain window maker maximum iranian stakeholder topic document software technical feasibility unit qualitative iran classification summary interview degree multi considerable organization keywords consideration local variety economic burden option guideline framework education procedure opportunity selection alternative decision search policy experience collection basis implementation short improvement sensitivity criterion likely critical attention particularly highly ass issue order country standard participant background process form support tool long user quality medical intervention evidence conclusion term condition article approach present individual model research different development health year method data analysis result study,{},{},{},{},{},{}
1310,1310,1417,10.3389/fgene.2019.00086,30838026.0,edition various blood assessment disorder iem illumina abnormal defect consent platform necessary five province organic outside jiangsu repeat disease offer identified baby oxidation heterozygous clinical value error inborn result effectiveness diagnosis metabolic data generation first tandem type metabolism eight clearly case three panel one certain centre others overall meanwhile plan test ten fatty incidence process two mass variant newborn homozygous spot next analysis characteristic spectrometry infant eventually hiseq study acid sequencing center underwent amino gene total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382741/,abstract,5,jiangsu illumina identified hiseq eventually edition outside consent underwent repeat heterozygous clearly province offer homozygous oxidation baby plan centre organic platform tandem certain iem panel abnormal fatty effectiveness necessary center incidence generation sequencing spectrometry spot defect characteristic overall various assessment inborn process infant mass value variant error total newborn amino case metabolism test blood type diagnosis acid metabolic gene data disorder clinical analysis result disease study,{},"{""homozygous"": {""freq"": 1, ""string"": [""underwent repeat heterozygous clearly province offer homozygous oxidation baby plan centre o""]}, ""heterozygous"": {""freq"": 1, ""string"": [""eventually edition outside consent underwent repeat heterozygous clearly province offer homozygous o""]}}",{},"{""amino"": {""freq"": 1, ""string"": [""mass value variant error total newborn amino case metabolism test blood t""]}, ""tandem"": {""freq"": 1, ""string"": [""oxidation baby plan centre organic platform tandem certain iem panel abnormal f""]}, ""spectrometry"": {""freq"": 1, ""string"": [""effectiveness necessary center incidence generation sequencing spectrometry spot defect characteristic overall v""]}, ""newborn"": {""freq"": 1, ""string"": [""infant mass value variant error total newborn amino case metabolism test b""]}}",{},{}
1311,1311,1418,10.1186/s13023-015-0227-8,25757997.0,phenotypic coenzyme disorder class backgroundphenylketonuria new ratio resultsforty factor lower among autosomal unnecessarily longitudinally restriction tetrahydrobiopterin actual open responder prot interpret percent control effective pku hydroxylase status material subset supplementary phenylalanine methodsa subject life aifa higher user therapy italian real genotype report farm diagnosis efficacy metabolic effect besides data good term oral long medicine level four agency assumption label interventional proof tyrosine responsiveness therapeutic predictor ass safety ameliorate online test article tolerance treatment response electronic best directly diet option version materialthe conclusionslong along recessive subgroup dependent quality profit available trial withdrawal group nutritional matc dietary deficiency patient conversion safe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351928/,abstract,4,unnecessarily resultsforty prot matc farm conclusionslong aifa profit longitudinally withdrawal italian interventional interpret label coenzyme agency responsiveness responder actual assumption proof ameliorate backgroundphenylketonuria percent conversion subgroup safe tolerance subset methodsa class predictor real phenotypic safety restriction option open recessive oral tetrahydrobiopterin genotype directly autosomal best good dependent nutritional efficacy materialthe tyrosine medicine ass hydroxylase ratio status supplementary subject long trial user version response electronic quality online therapeutic effective lower deficiency diet report dietary therapy life pku material term higher article available test new phenylalanine control factor diagnosis metabolic group effect data level disorder treatment patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""term higher article available test new phenylalanine control factor diagnosis metabolic g""]}}","{""autosomal"": {""freq"": 1, ""string"": [""open recessive oral tetrahydrobiopterin genotype directly autosomal best good dependent nutritional e""]}, ""recessive"": {""freq"": 1, ""string"": [""real phenotypic safety restriction option open recessive oral tetrahydrobiopterin genotype directly a""]}}",{},{},"{""diet"": {""freq"": 1, ""string"": [""quality online therapeutic effective lower deficiency diet report dietary therapy life p""]}}",{}
1312,1312,1419,10.1186/s13023-018-0987-z,30760309.0,coenzyme disorder record cochrane estimation search region across cinahl propionyl serious literature due geographic eligible nonetheless objective disease material respectively synthesis supplementary life quantitative carboxylase broadly east user coa academic complete mena primary enzyme metabolic data middle epidemiology website detection full rate ultra text pacific implementation database point population review eligibility conduct prospero organization article frequent online europe crd electronic asia medline acidemia systematic version materialthe rare newborn north prevalence propionic africa birth embase omim analysis program available also multiple america study meta similar deficiency exception rarity mitochondrial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375193/,abstract,4,prospero crd mena propionyl pacific asia nonetheless eligibility carboxylase website geographic africa omim coenzyme ultra rarity cinahl east america exception conduct propionic north europe eligible broadly academic estimation cochrane epidemiology acidemia embase middle medline coa mitochondrial organization record meta complete frequent text search systematic quantitative implementation synthesis point database materialthe prevalence birth similar region literature detection enzyme supplementary objective program user multiple primary version electronic online deficiency rare respectively rate life newborn material article available population review metabolic data disorder analysis disease study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""materialthe prevalence birth similar region literature detection enzyme supplementary objective program u""]}, ""newborn"": {""freq"": 1, ""string"": [""online deficiency rare respectively rate life newborn material article available population r""]}}",{},{}
1313,1313,1420,10.1186/s13023-018-0810-x,29688860.0,new item essential throughout necessary voice central condition view difficulty cost highlight valid facilitate testing backgroundrare modern dearth disease solution status computer issue matter family life reduction adaptive clinical pragmatic health input symptom efficacy qualitative interview large capture use significant main textthis outlined utilisation measure current implementation instrument outcome around intervention population review therapeutic development people potential resource treatment psychometrics key appropriately decision care rare conclusionpatient creative quality impact research trial practice small patient prom number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5914068/,abstract,0,textthis psychometrics outlined conclusionpatient voice prom dearth creative pragmatic backgroundrare utilisation valid appropriately modern computer item input capture adaptive instrument qualitative interview facilitate view solution matter difficulty people decision resource necessary central implementation efficacy reduction cost practice highlight essential issue main small status testing symptom measure trial key quality therapeutic large use rare family impact intervention care life current outcome condition number new research population review potential significant development health treatment clinical patient disease,{},{},{},{},{},{}
1314,1314,1421,10.1371/journal.pone.0155538,27227410.0,activity context positive across gratitude genetics kindness highlight control well however clue subject trait innovation value health developmental matched improvement symptom task behind result like effect stability change genetic non significant emphasize measure overall stable provide intervention tracking variance week mental ass twin stage online response important strongly component sample multivariate explore influence adolescent heritability magnitude analysis environmental mechanism impact also different high study even complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881940/,abstract,1,matched kindness gratitude clue tracking innovation emphasize twin heritability magnitude multivariate variance stability strongly stable adolescent trait task explore stage mental component improvement genetics context environmental developmental influence highlight ass provide week like overall symptom measure subject change complex positive value response online mechanism impact intervention activity non important sample control different significant health effect high genetic analysis result study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1315,1315,1422,10.1097/FTD.0000000000000302,27015245.0,correlation specific blood daily hour shipment ratio greater lower time laboratory necessary without slowly condition finger teriflunomide average practical validation month intraday deposit measurement subject relative clinical storage range compound word procedure methodology analytical result imprecision effect facility quantification oral selective level selectivity sclerosis least independent volume temperature room current stable immunomodulator switch simple method determination efficiency constant bioanalytical potential charcoal concentration convenience treatment mcg precision key assay specificity process monitoring sample within endogenous accelerated spot healthy interday inaccuracy field reproducibility elimination analysis background matrix humidity alternative centrifugation multiple conclusion cholestyramine plasma rapidly position hematocrit prick remitting accuracy acceptable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949010/,abstract,2,teriflunomide shipment remitting intraday immunomodulator cholestyramine charcoal interday inaccuracy humidity deposit centrifugation mcg imprecision bioanalytical switch hematocrit convenience accelerated selectivity facility slowly prick finger constant elimination sclerosis reproducibility room rapidly position matrix quantification endogenous acceptable temperature practical selective efficiency determination hour validation stable precision methodology storage simple monitoring analytical word oral daily volume accuracy procedure independent relative alternative average specificity necessary compound assay measurement spot greater correlation laboratory ratio field background process month healthy subject plasma range multiple key lower concentration current conclusion condition sample time specific blood potential effect method level treatment clinical analysis result,{},{},{},{},{},{}
1316,1316,1423,10.3748/wjg.v25.i33.4999,31543689.0,major backgrounddiarrhea lgg notably worldwide european cochrane difference early lower duration central mean control effective evaluate respectively infectious cfu relevant however beneficial atcc evidence interval reduction childhood recent enrollment clinical therapy diarrhea science conclusionhigh effectiveness efficacy effect april data cause mortality resultsnineteen confidence administration morbidity per acute rhamnosus dose database child intervention review inclusion stool day stage manager web treatment rotavirus medline future methodsthe reduces effectively embase analysis criterion trial rcts group high meta similar lactobacillus patient asian participant aimto number treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737314/,abstract,4,rotavirus rhamnosus resultsnineteen lgg conclusionhigh backgrounddiarrhea atcc cfu lactobacillus rcts manager stool enrollment diarrhea aimto asian notably april cochrane reduces embase web medline infectious duration effectively methodsthe worldwide beneficial meta confidence treat morbidity european interval dose science inclusion acute effectiveness evaluate administration stage mortality central childhood efficacy mean reduction criterion database relevant similar participant day trial major cause effective future lower recent respectively intervention therapy evidence difference number early control review child group effect high data treatment clinical analysis patient,{},{},{},{},{},{}
1317,1317,1424,10.1038/srep40067,28051181.0,confocal interestingly neural vivo dos early affect specifically malformation addressing mosquito central virus increase doe embryonic lethal line gfap drinking facs suspicion compound brain zika zikv result recently effect data change cause quantification use yet significant case whole although water volume population pyriproxyfen model neurodevelopment development system strongly cell transgenic microcephaly neuron newborn zebrafish nervous stem analysis america different high nestin vertebrate though larvicide reconstruction number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5209666/,abstract,0,pyriproxyfen nestin larvicide facs zikv zebrafish reconstruction mosquito vertebrate gfap addressing zika confocal suspicion neurodevelopment transgenic drinking lethal america microcephaly neuron embryonic interestingly malformation dos quantification stem neural virus nervous strongly water line specifically doe affect volume vivo central compound recently change cause increase brain use newborn cell number case model early population different significant development effect high data analysis result,"{""microcephaly"": {""freq"": 1, ""string"": [""suspicion neurodevelopment transgenic drinking lethal america microcephaly neuron embryonic interestingly malformation d""]}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""recently change cause increase brain use newborn cell number case model e""]}}",{},{}
1318,1318,1425,10.1016/j.ajpath.2015.12.001,26724389.0,stratification process rare biological element pathophysiological decade cancer three two application possible early dementia driver clinical complexity intervention cognitive impairment review focus approach management parkinson mechanism action molecular broad currency alzheimer common alignment risk presentation neurodegenerative precision cause key disease even address individual medicine detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816691/,abstract,0,currency alignment stratification dementia driver parkinson pathophysiological complexity alzheimer neurodegenerative broad element precision action presentation decade address cancer focus impairment biological medicine detection possible process cognitive application management cause key molecular mechanism rare intervention common approach individual risk early review clinical disease,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""address cancer focus impairment biological medicine detection possible process cognitive application m""]}}",{},{}
1319,1319,1426,10.2147/NDT.S130196,28458548.0,male operation specific cross assessment clinic investigation sectional studied factor among positive methodsthis laboratory neonatal workup detailed need conclusionmetabolic consanguineous admission risk testing control objective significantly ferric joint measurement treatable unit family life possible anthropometric higher value clinical range examination saudi diagnosis metabolic neurology urine routine chromosomal case pedigree marriage resultspositive paternal child outcome intervention mental history older development kingdom gas disability test sex treatment year khafji care maternal age mass pediatric spot appropriate apparently healthy conducted determine sibling toluidine psychiatric quality intensive hospital impact nonsyndromic spectrometry blue electroencephalography arabia group intellectual study patient objectivethe thorough chloride individual total chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403001/,abstract,4,toluidine resultspositive nonsyndromic khafji conclusionmetabolic ferric paternal pedigree arabia workup electroencephalography blue chloride saudi neurology kingdom thorough objectivethe joint apparently sibling marriage conducted operation consanguineous anthropometric admission chromosomal intensive detailed studied treatable methodsthis unit gas routine older sex psychiatric examination urine chromatography clinic sectional intellectual mental investigation history appropriate maternal pediatric neonatal hospital cross disability measurement spectrometry spot determine laboratory male need testing possible assessment healthy objective mass range positive value quality family impact intervention care life total outcome higher case test individual significantly risk specific control factor diagnosis child age development metabolic group year treatment clinical patient study,"{""urine"": {""freq"": 1, ""string"": [""gas routine older sex psychiatric examination urine chromatography clinic sectional intellectual m""]}, ""intellectual"": {""freq"": 1, ""string"": [""psychiatric examination urine chromatography clinic sectional intellectual mental investigation history appropriate m""]}, ""psychiatric"": {""freq"": 1, ""string"": [""methodsthis unit gas routine older sex psychiatric examination urine chromatography clinic s""]}}",{},{},"{""spectrometry"": {""freq"": 1, ""string"": [""pediatric neonatal hospital cross disability measurement spectrometry spot determine laboratory male n""]}}",{},{}
1320,1320,1427,10.15537/smj.2016.1.13183,26739971.0,male correlation chemistry autism lower baghdad positive sader severe control severity objective disease significantly college subject marker moderate possible remarkably dysfunction prof possibility result diagnosis university april data mild good decrease medicine level significant case nahrain department child november oxytocin method social serum test melatonin association receiver operating age biochemistry pediatric subgroup cognitive analysis hospital characteristic general conclusion diagnostic autistic study patient iraq parameter gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724675/,abstract,4,sader nahrain baghdad prof oxytocin iraq melatonin biochemistry november college chemistry autistic remarkably operating april receiver department subgroup gender university possibility moderate mild severity parameter autism good decrease pediatric serum hospital marker dysfunction correlation social medicine general male characteristic diagnostic severe possible cognitive objective subject positive lower association conclusion case test significantly control diagnosis child age significant method data level analysis result patient disease study,"{""social"": {""freq"": 1, ""string"": [""pediatric serum hospital marker dysfunction correlation social medicine general male characteristic d""]}}",{},{},{},{},{}
1321,1321,1428,10.18632/oncotarget.18955,29137252.0,nine progressive abnormal missense motor neuroblastoma disease transcriptional however marker atypical dysfunction clinical protein brain feature mutant result effect radiological data novo term experiment generation cpg novel genetic type cultured level yet whole mutation pathogenic volume linguistic text arg conclusiona syndrome lysine entrez hook loss methyl overexpression mecp cell age resultsthe methodsthe variant causative screen function girl next analysis either repressor vitro rett domain nucleotide methylation magnetic histone hyperactivity patient backgroundmutations gene myelination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669878/,abstract,7,repressor neuroblastoma hook backgroundmutations rett mecp cpg conclusiona radiological entrez linguistic overexpression histone atypical myelination methylation lysine cultured arg methyl novo causative girl transcriptional progressive hyperactivity methodsthe experiment missense screen resultsthe pathogenic mutant nucleotide motor magnetic abnormal volume text vitro domain loss feature marker dysfunction generation syndrome variant brain novel mutation term cell function type protein age gene effect genetic data level clinical analysis result patient disease,"{""hyperactivity"": {""freq"": 1, ""string"": [""methyl novo causative girl transcriptional progressive hyperactivity methodsthe experiment missense screen r""]}}","{""genetic"": {""freq"": 1, ""string"": [""function type protein age gene effect genetic data level clinical analysis r""]}}",{},{},{},{}
1322,1322,1429,10.1097/MOP.0000000000000418,27606958.0,findingsseveral notion new information lower context across adult consent serious condition onset detailed deference due genetics cost testing experience ethical issue utility microarray relevant however recent screening raise clinical role range guidance secondary result purpose embryo question generation genetic controversial use proper child personal management development organization technology sufficient frequent test precision parental finding care decision predictive summaryuse legal newborn primarily professional lack scope authority field analysis adverse impact research available genome justify policy human powerful psychosocial individual readily number reviewdevelopments,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5300789/,abstract,0,summaryuse reviewdevelopments justify deference findingsseveral authority microarray notion scope personal controversial readily raise embryo consent psychosocial legal guidance proper detailed powerful ethical primarily parental sufficient predictive organization precision frequent question utility decision secondary policy experience professional genome adverse lack genetics generation purpose onset cost context relevant issue technology field testing finding screening management range lower adult recent use impact care information newborn condition role number available test individual new human research child development genetic clinical analysis result,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""newborn"": {""freq"": 1, ""string"": [""adult recent use impact care information newborn condition role number available t""]}, ""screening"": {""freq"": 1, ""string"": [""relevant issue technology field testing finding screening management range lower adult r""]}}",{},{}
1323,1323,1430,10.1152/japplphysiol.00729.2015,26494450.0,blood rise greater difference heat examine twelve venous adult doppler throughout synthase aged central pressure open capacity wash increase exercise passive related ingesting circuit hyperthermia subject double principal integrated output secondary suit core posture effect design decrease skbf vasodilatory furthermore crossover untreated young laser stress water placebo temperature dynamic fully upright older supine treatment response directly randomized challenge age nitric opposed relation peripheral healthy comparison determine sapropterin acutely flowmetry impairment aim cardiovascular flow group study acetylene skin cardiac blind eleven cofactor heating absence presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683344/,abstract,3,wash vasodilatory upright suit skbf opposed ingesting acetylene supine posture hyperthermia heating flowmetry doppler passive heat rise laser acutely venous principal integrated circuit output exercise randomized crossover sapropterin skin core nitric flow peripheral blind placebo temperature synthase pressure cardiac fully untreated older young examine dynamic capacity absence water double cardiovascular cofactor open relation directly secondary aged decrease central stress comparison impairment presence furthermore greater determine design related aim healthy subject challenge increase response adult difference blood age group effect treatment study,"{""skin"": {""freq"": 1, ""string"": [""circuit output exercise randomized crossover sapropterin skin core nitric flow peripheral b""]}}",{},{},{},{},{}
1324,1324,1431,10.1371/journal.pone.0143639,26605791.0,blood diagnostically assessment activity ultrasonication sax accurate stabilization buffer facilitate enzymatic reliable well vitamin status respectively enough temporary folate quantify quantitation clinical storage procedure conventional data focused term quantification long nmol extraction level whole three isotope internal step isotopologue stable unprecedented feasible method conjugase solid treatment collection phase assay sample two minimal mass spot cartridge elution standard analysis matrix prior easier available methyltetrahydrofolic conclusive dilution plasma thermal acid digestion advantage parameter triton sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659665/,abstract,1,ultrasonication triton isotopologue conjugase temporary methyltetrahydrofolic diagnostically cartridge sax conclusive stabilization easier dilution digestion unprecedented thermal nmol isotope elution buffer folate focused quantitation quantify solid matrix quantification internal extraction enzymatic minimal conventional feasible reliable facilitate accurate vitamin stable storage prior advantage sensitive procedure step phase parameter collection assay spot status standard assessment mass long plasma respectively activity term sample available blood acid method data level treatment clinical analysis,{},{},{},{},{},{}
1325,1325,1432,10.1111/acer.13521,29112285.0,repeatedly assessment blood self whether observation energy portable examine several standardized stimulant methodssixteen pressure separate open common coordination stimulation testing motor increase police ingest consumer pulse medical session equal biodex neuromotor much backgroundthe rating sway impairs double someone body alone caffeine purpose stability little combination bartender type prototypical four administration rate diastolic measure drinker sedation acute current dose drug systolic work frequently social system antagonize nicotine sobriety drink inc fatigue future resultsthe conclusionsvisual biosway determine subjective field impairment longer eye consumption also coadministration reliably high part study alcohol blind similar modest participant individual gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750124/,abstract,0,sway sobriety prototypical police methodssixteen ingest conclusionsvisual coadministration biosway biodex bartender antagonize caffeine stimulant neuromotor sedation repeatedly portable nicotine fatigue drinker impairs diastolic systolic subjective drink modest reliably equal coordination pulse eye standardized alcohol session stimulation rating longer consumer observation blind pressure backgroundthe separate examine stability gender double resultsthe consumption open little energy motor frequently dose acute administration work impairment combination self purpose social determine field testing similar participant body assessment measure drug increase medical future rate current common individual blood type high study,"{""social"": {""freq"": 1, ""string"": [""administration work impairment combination self purpose social determine field testing similar p""]}}",{},{},{},{},{}
1326,1326,1433,10.3390/ijerph16122069,31212740.0,male correlation relationship pedsql impetus shift factor duration specifically positive median partially physical religion mean multidimensional hypothesis well significantly paradigm life singapore higher health leukemia diagnosis effect inventory household score chinese non area service significant variable ethnicity size current others overall child approach social holistic treatment school delivery year phase emotional qol age pediatric income comparison standard quality aspect research available ranged study medium patient asian psychosocial total deviation gender statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617504/,abstract,3,religion impetus singapore multidimensional pedsql leukemia ranged household qol holistic ethnicity asian inventory psychosocial paradigm emotional shift income partially school duration deviation chinese medium gender statistically specifically hypothesis aspect phase delivery median size service pediatric physical variable mean comparison correlation social male relationship overall score standard area positive quality life total current higher non approach available significantly factor diagnosis research child age significant health year effect treatment patient study,"{""emotional"": {""freq"": 1, ""string"": [""holistic ethnicity asian inventory psychosocial paradigm emotional shift income partially school d""]}, ""social"": {""freq"": 1, ""string"": [""qol holistic ethnicity asian inventory psychosocial paradigm emotional shift income p"", ""pediatric physical variable mean comparison correlation social male relationship overall score s""]}}",{},{},{},{},{}
1327,1327,1434,10.1007/s11064-015-1678-y,26224289.0,disorder retardation abnormality representative cmrglc abnormal defect behavioral glucose chronically persist severe common neuromuscular hyperglycinemia testing injection accumulation acquisition disease evaluate phe animal phenylalanine observed frontal pallidus regional spite brain environment error inborn utilization thus mild basis cause change selective rat metabolism period level rate three least persisted step local acute produce tyrosine cessation convert thalamus many critical week model phenylketonuria competence day mental identification development exposure globus adequately diet associated placement age poor likely timely chronic characteristic cortex different study human acid similar advantage patient hippocampus limitation restricted amino individual performance readily,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733436/,abstract,2,persisted pallidus hyperglycinemia globus cmrglc thalamus persist placement neuromuscular competence cessation spite adequately restricted frontal convert utilization chronically acquisition readily hippocampus timely retardation regional cortex representative produce injection selective local advantage rat limitation mild glucose accumulation abnormal behavioral acute poor associated step evaluate mental basis observed environment abnormality animal exposure likely critical chronic tyrosine defect identification week characteristic period performance testing similar severe inborn phe day change cause error brain diet rate amino common phenylketonuria metabolism individual human model phenylalanine acid different age development level disorder patient disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""common phenylketonuria metabolism individual human model phenylalanine acid different age development l""]}, ""behavioral"": {""freq"": 1, ""string"": [""rat limitation mild glucose accumulation abnormal behavioral acute poor associated step e""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""change cause error brain diet rate amino common phenylketonuria metabolism individual h""]}}","{""diet"": {""freq"": 1, ""string"": [""phe day change cause error brain diet rate amino common phenylketonuria m""]}}",{}
1328,1328,1435,10.1590/1984-0462/;2019;37;1;00014,30183803.0,phenotypic disorder cross consultation hearing memory sectional among congenital boy time anamnesis aged central condition frequency investigate old objective medical presence dysgenesis form irregular audiologists distribution symptom stimulating result attention interview data auditory ability level case chi problem complaint instrument processing child regard descriptive lag method parent prevalent serum thyroid test sex manifestation frequent school hormone year tsh particularly protocol statistical hypothyroidism exploratory function girl cognitive analysis background research routinely conclusion high study similar patient square performance show caregiver,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362372/,abstract,1,lag audiologists anamnesis irregular dysgenesis consultation complaint auditory stimulating hearing exploratory chi tsh routinely regard thyroid girl square processing instrument boy hypothyroidism school descriptive prevalent caregiver interview sex manifestation phenotypic hormone memory frequent distribution protocol statistical sectional aged central serum old cross attention presence investigate particularly frequency ability parent congenital problem performance similar background symptom form cognitive objective medical conclusion condition function case test time research child year high method data level disorder analysis result patient study,{},{},{},{},{},{}
1329,1329,1436,10.1371/journal.pone.0159627,27467780.0,biological better swap region early positively positive owing hinge average amyloidosis control machine finally physicochemical disease sequence understanding much applied value protein tendency distribution putative complete property attention etc whole functional one involvement conformational retain prediction sensitivity many serpinopathies management enrichment model emphasis important association nearly specificity predictive realisation ontology function analysis special mechanism importance also phenomenon domain oligomerization human acid mcc amino accuracy gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965083/,abstract,0,swap serpinopathies realisation hinge retain owing mcc physicochemical oligomerization amyloidosis tendency applied ontology machine conformational enrichment phenomenon putative emphasis positively nearly involvement special prediction predictive complete distribution accuracy domain average specificity property sequence finally understanding sensitivity attention biological importance functional better region management positive value association mechanism amino important function human model early control acid protein gene analysis disease,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""region management positive value association mechanism amino important function human model e""]}}",{},{}
1330,1330,1437,10.1097/MD.0000000000015601,31096465.0,entire male pain clinic simplex factor lower barr positive adult laboratory despite concern slowly condition odynophagia onset malaise additional severe common whitish igg epstein old acyclovir virus month exam amount empirical account anorexia chest hsv possible seroconversion follow teenager anti clinical therapy hypoglycaemia fluid candida herpetic tenderness report food diagnosis heartburn middle young herpes area immunocompetent refusal histological pallor case palpation biomarkers acute normal complaint child outcome epigastric hiv intervention abdominal history esophageal esophagus radiography evolution test solid treatment year leukocytosis cmv immunodeficiency rare inflammatory within allergic negative bloating ulceration monocytosis favorable healthy especially exudate immunoglobulin outstandingly upper except fever ebv multiple friable otherwise part rationale serology entity mucosa eosinophilic skin human lesson turgor refractory small cytomegalovirus ultrasound patient even rarity individual antipyretic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531067/,abstract,1,whitish ulceration turgor tenderness seroconversion refusal radiography palpation pallor outstandingly odynophagia monocytosis malaise leukocytosis immunocompetent hypoglycaemia hsv herpetic heartburn friable exudate epstein eosinophilic ebv bloating antipyretic acyclovir serology herpes esophagus epigastric cmv chest candida barr simplex mucosa esophageal anorexia allergic teenager cytomegalovirus refractory igg histological exam complaint fever slowly immunodeficiency empirical upper immunoglobulin rarity hiv abdominal rationale ultrasound lesson favorable entity entire solid pain evolution skin middle fluid virus young anti account inflammatory acute concern clinic follow history old negative onset especially biomarkers despite laboratory male additional small severe possible food area month normal healthy multiple positive lower adult report rare intervention therapy outcome condition common case test individual human factor diagnosis child year treatment clinical patient,"{""skin"": {""freq"": 1, ""string"": [""favorable entity entire solid pain evolution skin middle fluid virus young a""]}}",{},{},{},{},{}
1331,1331,1438,10.3390/polym11030471,30960455.0,immunohistochemistry culture viability better herein micro growth collagen factor content diameter density surface without condition encapsulation regenerative average eosin cytotherapy cartilage chondrocytes respectively bfgf synthesis uniform particle form col extensively bromide determined distribution possibility fibroblast static result dimethylmethylene qualitative large good electrostatic gravity design type ethidium cultured microgravity medicine smooth detection three dimensional size alcian safranin day chitosan method determination cck voltage glycosaminoglycan sphericity treatment orange assay cell aggregate kit future within gag hematoxylin alginate application regeneration engineering basic benefit vitro loaded secretion blue different tissue high hydrogel dmb acridine proliferation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473345/,abstract,2,sphericity safranin orange microgravity hematoxylin gravity glycosaminoglycan ethidium eosin dmb dimethylmethylene cytotherapy chondrocytes chitosan cck cartilage bromide bfgf alcian acridine smooth loaded gag electrostatic col alginate static micro encapsulation regenerative immunohistochemistry hydrogel collagen viability particle diameter blue voltage kit uniform regeneration cultured engineering secretion extensively fibroblast dimensional aggregate proliferation surface density culture qualitative determination determined basic possibility distribution vitro average content good size assay synthesis tissue growth medicine design benefit better detection form application day large future respectively condition cell factor type different high method treatment result,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""tissue growth medicine design benefit better detection form application day large f""]}}",{},{}
1332,1332,1439,10.1097/MCG.0000000000000362,26106846.0,reasonable hence public interested government involvement scientific information gastroenterology obesity nutrition author clinical word nutrient busy audience practitioner parlance board editorial academic research science view also conclusion national abstract nutritional lay necessarily article topic gastroenterologist well key center patient essay year diet teaching finally metabolism opinion issue medical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530728/,abstract,1,parlance gastroenterologist busy audience lay gastroenterology editorial interested necessarily essay reasonable teaching board practitioner abstract government academic opinion topic involvement author view scientific word nutrient nutrition obesity science center finally nutritional national issue public key medical diet information conclusion article metabolism research year clinical patient,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""nutritional national issue public key medical diet information conclusion article metabolism r""]}}",{}
1333,1333,1440,10.1038/ncomms13316,27824329.0,pogz asds european phenotypic disorder autism cdkl dock odds highlight leveraged shank gigyf increase significantly recurrent spectrum prove sequence myt previous probands global candidate dscam chd cul large novo significance novel expectation chinese scn mutation asd one neutral recurrence individually lgd model stxbp exome potential prevalent mecp aggregate ash wide rare primarily likely subtypes disruptive ncor trio cohort wdfy patient gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105161/,abstract,2,wdfy pogz ncor myt lgd leveraged gigyf dscam dock disruptive cdkl ash stxbp scn cul subtypes shank prove mecp recurrence probands asds trio expectation recurrent individually aggregate novo chd odds neutral prevalent primarily chinese exome candidate phenotypic significance asd european autism sequence previous global likely highlight wide cohort spectrum increase large rare novel mutation significantly model potential gene disorder patient,{},{},{},{},{},{}
1334,1334,1441,10.12688/f1000research.11495.1,28781759.0,measurement refinement earlier rapid advancement along growth application fundamental unique recent biology current statistical drug clinical newest capability health discovery next enable omics analysis review metabolomics research technique complete methodology diagnosis system highlight human addition advantage generation even discipline performance successful medicine richer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521158/,abstract,0,richer newest refinement enable discipline omics advancement capability fundamental earlier methodology complete advantage biology successful discovery metabolomics unique statistical rapid generation measurement highlight technique growth medicine performance application addition drug recent current human diagnosis research review health clinical analysis,{},{},{},{},{},{}
1335,1335,1442,10.1016/j.aninu.2015.05.006,29766986.0,inflammatory three trail daily milk growth pathogenic content additive intestinal acute gain piglet function infection permeability damage powder basal day peptide multiple eighteen conclusion group bioactive potential result bacteria supplementation average effect morphology study orally casein barrier response escherichia feed decrease increase diet glycomacropeptide coli randomly significantly performance amount lasted cgmp,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884472/,abstract,1,piglet lasted permeability trail powder cgmp coli feed escherichia eighteen orally casein bioactive basal intestinal additive morphology glycomacropeptide gain randomly bacteria milk peptide barrier damage pathogenic daily inflammatory infection average acute content supplementation decrease growth performance day multiple increase response diet conclusion function significantly potential group effect result study,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""growth performance day multiple increase response diet conclusion function significantly potential g""]}}",{}
1336,1336,1443,10.1371/journal.pone.0158568,27355821.0,epidemiological blood tool better dataset gut adult www pear phenolic trans apart bacterial fruit investigate testing evaluate disease intake transformation family marker largest ffq compound top candidate particular food result effect large fasting data date novel capture non regression level significant three female direction twinsuk red biomarkers overall database discovery discordant targeted predictor meat twin potential exposure unknown online hydroxyproline association batch diet dietmetab bmi age habitual ergothioneine reproducibility analysis relatedness metabolomics consumption mushroom multiple metabolomic group nutritional different cohort study meta dietary phenylpropionate linear metabolite apple,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927065/,abstract,10,twinsuk relatedness ffq discordant dietmetab apple targeted phenylpropionate pear hydroxyproline fasting ergothioneine mushroom phenolic habitual batch red dataset twin meat apart transformation largest fruit trans reproducibility gut metabolomic direction www capture epidemiological bmi bacterial predictor candidate meta consumption linear discovery metabolomics date unknown evaluate particular female regression compound nutritional marker exposure investigate intake database biomarkers cohort testing overall better food metabolite tool multiple online large association adult diet family dietary novel non blood potential different age significant group effect data level analysis result disease study,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""tool multiple online large association adult diet family dietary novel non b""]}}",{}
1337,1337,1444,10.5966/sctm.2015-0260,27245366.0,major biological considerable specific assessment culture new factor rigorous among effort widespread time several positive standardized require medicinal native compensation efficient need hospitalization improve recipient clear regulatory clinician well disease month solution raw material medical knowledge ever deep biotechnological permanency clinical therapy consistent move launch error inborn result metabolic effect data immunosuppression type metabolism hepatocytes innovative use bypass significant although bridge least interest standardization population critical liver approach product toward progressively therapeutic post development target shortage substantial treatment strongly engraftment accessible help best lct initially cell donor wide hence deficient future breakthrough poor cryopreservation function resistance vitro framework widely transplantation also trial unmet isolated patient limitation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4954449/,abstract,1,permanency lct compensation cryopreservation launch immunosuppression bypass bridge progressively biotechnological standardization shortage rigorous require recipient raw engraftment breakthrough unmet hospitalization medicinal innovative deep isolated initially native standardized accessible hepatocytes widespread donor culture transplantation resistance clear substantial considerable improve deficient strongly solution efficient clinician limitation widely framework vitro post poor effort regulatory best help consistent liver critical product biological wide need knowledge target assessment inborn month trial major positive error therapeutic medical future use therapy material cell function approach metabolism time new specific factor type population significant development metabolic effect data treatment clinical result patient disease,{},{},{},{},{},{}
1338,1338,1445,10.1016/j.synbio.2018.10.003,30370342.0,tool actively antimicrobial nucleic studied application context immunotherapy since variety defense present therapy field protein regulation mutant describe moreover development bacterial expression chromatin system epigenome technology recently live acid addition treatment crispr antiviral novel disease usability gene cell feasibility detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199817/,abstract,0,immunotherapy usability epigenome nucleic defense chromatin antiviral antimicrobial crispr actively live studied bacterial feasibility variety mutant regulation recently context technology field detection tool application addition expression novel therapy cell present acid protein development gene treatment disease,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""mutant regulation recently context technology field detection tool application addition expression n""]}}",{},{}
1339,1339,1447,10.1371/journal.pbio.2000532,28350856.0,npy fat excess observe although regulator four activity reduces neuron signal likely rescue mechanistically homologue appetite adult release fly act brain reductase biosynthesis without tetrahydrobiopterin action body upon expression sptr express thus enzyme enzymatic loss induces satiety accumulation neuropeptide purple cofactor deficiency sepiapterin vertebrate sequential npf show physically drosophila punch,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369665/,abstract,0,sptr purple npy npf neuropeptide homologue vertebrate punch observe physically induces fly sequential mechanistically express appetite sepiapterin satiety drosophila rescue reductase excess release neuron reduces regulator enzymatic fat biosynthesis act signal action cofactor accumulation tetrahydrobiopterin loss likely body enzyme expression brain adult deficiency activity,{},{},{},{},{},{}
1340,1340,1448,10.22038/ijbms.2018.30596.7373,30627368.0,resonance memory difference factor pathway oxidative without central vascular investigate risk biomarker neurodegenerative control differentially agreement disease objective material respectively animal dysfunction clinical role word result diagnosis metabolic good peruse ability rat area significant stress panel nuclear curve approach model technique therapeutic method work identification differentiate alzheimer nmr system serum auc treatment key receiver predictive operating profiling multivariate healthy statistical nervous cognitive analysis ghrelin characteristic metabolomics roc conclusion group high magnetic osteoporosis power another metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312673/,abstract,2,peruse profiling ghrelin differentiate osteoporosis agreement roc auc operating receiver nmr differentially power vascular multivariate curve alzheimer neurodegenerative resonance biomarker nervous oxidative predictive nuclear memory word rat metabolomics magnetic panel statistical good central stress serum work animal dysfunction investigate technique ability identification characteristic cognitive area metabolite healthy objective key therapeutic pathway respectively material conclusion role difference approach risk model control factor diagnosis significant metabolic group high method treatment clinical analysis result disease,{},{},"{""pathway"": {""freq"": 1, ""string"": [""area metabolite healthy objective key therapeutic pathway respectively material conclusion role d""]}}",{},{},{}
1341,1341,1450,10.1371/journal.pone.0195580,29659612.0,nine estimation region almost duration time voxelwise without slightly condition voxels injection fragile synthesis twice later subject interval protein regional brain leucine tracer rcps result length effect data pet basis furthermore whole full rate three ending sedation syndrome stable sedated model method loss awake precision fxs scan estimate healthy comparison statistical beginning function identical scanner kinetic previously also min group high study propofol cerebral thirty volunteer resolution parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901930/,abstract,11,voxelwise sedated propofol ending voxels rcps tracer fxs beginning awake sedation twice pet scanner fragile scan kinetic identical volunteer leucine estimation thirty regional cerebral slightly min duration length injection resolution stable precision later interval statistical estimate parameter basis loss comparison synthesis furthermore syndrome previously region healthy subject brain rate condition function time model protein group effect high method data result study,{},{},{},{},{},{}
1342,1342,1451,10.1016/j.jhep.2016.12.017,28027971.0,disorder biopsy cluster preparative blood assessment better early difficult methodspreparative segment backgroundhepatocyte despite half partially retrospective xenograft additional need anecdotally risk old effective radiation classical month primate phe engrafted supervised phenylalanine subject strategy follow anti therapy inconsistent comprise rejection mitoses hepatocyte immunosuppression immune term resultsporcine long genetic adequacy hepatocytes non period level transplant conclusionsradiation graft female hepatic pre acute normal produce serial failure liver phenylketonuria post ass immunosuppressed target loss frequent treatment urea irradiated engraftment year cell donor two survival peripheral limited function irradiation goal transplantation also induction multiple transplanted cycle human small reversal deficiency patient number lymphocyte,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395353/,abstract,3,supervised resultsporcine preparative mitoses methodspreparative irradiated immunosuppressed engrafted conclusionsradiation backgroundhepatocyte reversal anecdotally xenograft transplanted serial rejection irradiation immunosuppression lymphocyte comprise radiation primate graft adequacy engraftment segment biopsy transplant inconsistent induction retrospective hepatocytes produce donor urea partially cluster transplantation peripheral hepatic hepatocyte survival half failure classical immune frequent anti goal cycle post difficult acute follow pre female old loss liver limited despite ass additional period small need target better assessment month phe normal subject long multiple strategy effective deficiency therapy term non cell function phenylketonuria number human risk early phenylalanine blood year genetic level disorder treatment patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""function phenylketonuria number human risk early phenylalanine blood year genetic level d""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1343,1343,1452,10.5152/TurkPediatriArs.2018.5389,30083069.0,training hearing ratio factor taksim bilateral present otoacustic rest brainstem severe percent risk month material third family methodsa screening audiology academy compatible implantation diagnosis six resultsof auditory resistant guideline conclusionninety first three one step emission acute march aid gaziosmanpa loss american test treatment response aimthis age transient two newborn determine advanced hospital concordance research otitis except june study medium center patient total cochlear,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070220/,abstract,8,taksim otoacustic otitis gaziosmanpa conclusionninety aimthis brainstem audiology cochlear academy rest implantation compatible auditory resistant march hearing concordance resultsof bilateral aid training percent june emission transient advanced american methodsa medium guideline acute step center loss hospital determine ratio severe month screening response family total newborn material present test risk factor diagnosis research age treatment patient study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""severe month screening response family total newborn material present test risk f""]}, ""screening"": {""freq"": 1, ""string"": [""loss hospital determine ratio severe month screening response family total newborn m""]}}",{},{}
1344,1344,1453,10.1093/ijnp/pyy012,29726996.0,chain activity striatum single manic profile time behavioral chronically selection elevated behavior affected action subsequently well glycomacropeptide backgroundcasein synthesis phenylalanine reduction dopamine frontal brain leucine peptide efficacy like effect casein branched rat inhibition level hyperlocomotion conclusionscasein acute prepulse mania tyrosine amphetamine week methodscasein test treatment promise assay antimanic lack serotonin fashion explore chronic dependent deplete tryptophan also plasma plus tissue maze study orally monoamine acid hippocampus amino total mixture,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932479/,abstract,6,prepulse methodscasein manic mania hyperlocomotion deplete conclusionscasein backgroundcasein antimanic maze amphetamine striatum fashion orally frontal casein branched chronically monoamine hippocampus leucine mixture promise plus glycomacropeptide subsequently tryptophan peptide serotonin affected inhibition action rat elevated dopamine behavioral selection explore acute dependent profile efficacy assay behavior reduction lack synthesis chronic chain tissue tyrosine week like plasma brain single total activity amino test time phenylalanine acid effect level treatment study,"{""phenylalanine"": {""freq"": 2, ""string"": [""single total activity amino test time phenylalanine acid effect level treatment s""]}, ""behavioral"": {""freq"": 1, ""string"": [""affected inhibition action rat elevated dopamine behavioral selection explore acute dependent p""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""like plasma brain single total activity amino test time phenylalanine acid e""]}}",{},{}
1345,1345,1454,10.1016/j.ymgme.2015.11.012,26653793.0,subsequent blood activity synthetic daily absolute content affect despite elevated weight central tetrahydrobiopterin ascorbic neuropsychiatric hiaa hypothesis increase enu doe pku hydroxylase respectively competitively amount synthesis measurement phenylalanine homovanillic form dopamine dysfunction dihydrochloride therapy brain mouse body neurotransmitter pahenu tph oral followed type metabolism unchanged significant alter biopterin rate wild hyperphenylalaninemic step tyrosine release hydroxyindoleacetic model phenylketonuria day persistently synaptic system concentration treatment directly metabolite likely gavage sapropterin hva nervous either pathophysiology tryptophan also human acid deficiency cofactor highest cns,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706464/,abstract,3,followed competitively hyperphenylalaninemic hydroxyindoleacetic hva gavage persistently homovanillic hiaa ascorbic tph enu dihydrochloride biopterin unchanged cns absolute synaptic pahenu neuropsychiatric alter release sapropterin pathophysiology tryptophan synthetic subsequent nervous neurotransmitter wild cofactor doe highest affect elevated dopamine hypothesis oral daily tetrahydrobiopterin directly step content central weight synthesis likely dysfunction measurement tyrosine despite hydroxylase mouse body form metabolite day increase brain deficiency respectively therapy rate concentration activity pku phenylketonuria metabolism human model phenylalanine blood type acid significant treatment,"{""phenylalanine"": {""freq"": 2, ""string"": [""activity pku phenylketonuria metabolism human model phenylalanine blood type acid significant t""]}}",{},{},{},{},{}
1346,1346,1455,10.1038/jcbfm.2014.183,25352046.0,specific blood inverse inversely elevated lnaas voxels disturb phe synthesis phenylalanine nonsignificant tyr protein ventricular brain fluid arterial determined tracer voi transport large data tomography non regression rate three variable neutral interest volume emission tyrosine phenylketonuria supraventricular constant predictor concentration association incorporation spectroscopy cps since multiple vois conclusion plasma tissue study magnetic acid cerebral positron linear amino highly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426736/,abstract,3,vois voi supraventricular cps voxels disturb tracer nonsignificant lnaas arterial ventricular inverse inversely positron incorporation constant tomography emission cerebral spectroscopy neutral transport tyr fluid predictor determined linear elevated magnetic volume variable regression synthesis tissue tyrosine highly phe plasma multiple large brain association rate concentration amino conclusion non phenylketonuria phenylalanine specific blood acid protein data study,"{""phenylalanine"": {""freq"": 2, ""string"": [""rate concentration amino conclusion non phenylketonuria phenylalanine specific blood acid protein d""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""multiple large brain association rate concentration amino conclusion non phenylketonuria phenylalanine s""]}}",{},{}
1347,1347,1456,10.1002/mnfr.201500220,26012425.0,conclusionthe biological correlation blood new information maximum time present carcinogenicity document half scopein efficient advisable frequency average mean toxicity resultsfor amount consumer mycotoxin possible observed questionnaire approx compound degradation food result thus little first detection level case ota established drinker coffee product technique method exposure concentration sample ochratoxin spot comparison since validated analysis previously consumption available group high study noncoffee thermal human even preparation sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744763/,abstract,0,scopein ota ochratoxin noncoffee carcinogenicity approx mycotoxin resultsfor established coffee advisable drinker thermal maximum validated document consumer toxicity preparation conclusionthe degradation half efficient consumption sensitive little average observed compound questionnaire mean comparison exposure product spot previously correlation technique frequency biological detection possible food information concentration sample present case available time new human blood group high method level analysis result study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""spot previously correlation technique frequency biological detection possible food information concentration s""]}}",{},{}
1348,1348,1457,10.4269/ajtmh.18-0177,29943720.0,entire lateral tool positively positive present laboratory reaction five malaria solution however biotin mixed procedure suitability complete lamp amidite diagnosis primer specie detection rapid fluorescein end infection sensitivity point approach product plasmodium device method potential resource nonmalaria assay care donor robust amplification knowlesi future sample isothermal negative healthy approximately aim flow diagnostic high study whereas infected lfd loop minute,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169156/,abstract,1,nonmalaria lfd knowlesi fluorescein amidite lamp isothermal infected suitability plasmodium lateral malaria biotin primer loop minute amplification entire donor positively mixed flow device specie solution complete robust end infection approximately procedure resource reaction assay sensitivity negative rapid point product laboratory diagnostic detection aim tool healthy positive future care sample approach present diagnosis potential high method study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""negative rapid point product laboratory diagnostic detection aim tool healthy positive f""]}}",{},{}
1349,1349,1458,10.3390/ijerph16081427,31010095.0,implication biological considerable disorder activity inequality early pathway several essential metalloenzymes insight together molecular manganese additional moreover magnesium chemical neuropsychiatric risk course neurodegenerative well disease intake line element impair cancer modulate evidence life neurodevelopmental role health protein brain enzyme metabolic attention effect glycolytic pregnancy long short etiology cytokine normal vital provide unprecedented intervention window development expression potential exposure loss susceptibility bioavailability hormone finding interface modifying fluoride function pulmonary chronic impairment mechanism cardiovascular research pathophysiology infancy interaction study atpase atp show gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518254/,abstract,0,metalloenzymes fluoride modifying glycolytic manganese atpase unprecedented inequality impair modulate atp magnesium bioavailability window pulmonary neuropsychiatric interface cytokine vital infancy pathophysiology susceptibility neurodegenerative element considerable course hormone chemical neurodevelopmental line cardiovascular etiology pregnancy insight implication short cancer loss exposure impairment attention chronic intake essential biological provide additional finding interaction enzyme normal long expression pathway brain molecular mechanism intervention life activity evidence role function risk early research potential protein development metabolic health gene effect disorder disease study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""finding interaction enzyme normal long expression pathway brain molecular mechanism intervention l""]}}",{},{},{}
1350,1350,1459,10.3389/fpsyg.2018.01973,30386282.0,memory whether neural difference greater factor switching profile positively across adult behavioral standardized selection increasingly recruitment literature contributes mean old varies increase homogenous demand intra recruit executive much previous cognition engage decline inconsistent consistent brain task thoughtful report equivalent result qualitative contrast good significance negatively term call middle planning score young regression level educational dispersion although short measure compensatory possibly others overall provide approach method older propose test resource association year education inconsistency age future within sample prolong efficiently updating healthy uniquely standard function series cognitive either aim mechanism index research available also general group reserve cohort pattern study turn similar distinct neuropsychological engagement variability performance individual number deviation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198726/,abstract,3,thoughtful reserve homogenous dispersion switching prolong updating varies recruit engage compensatory uniquely engagement inconsistency inconsistent recruitment contributes turn intra efficiently decline standardized possibly planning demand cognition series positively neuropsychological negatively middle neural equivalent deviation qualitative educational older young executive propose variability distinct significance memory increasingly task education behavioral selection contrast resource good previous index profile short pattern consistent regression old mean greater general provide cohort performance overall score standard similar literature cognitive aim measure healthy increase future brain association adult mechanism report term difference function sample approach number available test individual factor research age group year method level result study,"{""behavioral"": {""freq"": 1, ""string"": [""distinct significance memory increasingly task education behavioral selection contrast resource good p""]}}",{},{},{},{},{}
1351,1351,1460,10.12669/pjms.334.12975,29067088.0,expensive backdrop disorder thalassemia lsd extremely early molecule progressive country present couple without affected compare literature severe cost ethic risk course testing well disease ert ethical issue related however family life introduction reduction strategy recent form clinical storage therapy health economical word replacement pakistan substrate thus enzyme metabolic antenatal language middle genetic low mortality english case morbidity economic database model spring people system article treatment lysosomal key describing year care challenge option cascade rare income natural paper trial prevention group otherwise screeningfor prioritiesof similar small total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648935/,abstract,5,screeningfor prioritiesof spring pakistan describing backdrop lsd ert thalassemia couple economical compare cascade antenatal expensive english lysosomal ethic extremely income middle substrate progressive replacement ethical language introduction affected course storage economic word people option morbidity molecule natural mortality reduction cost prevention database related paper issue small testing country similar literature severe form enzyme trial challenge strategy key recent rare family care therapy life total article low present case risk model early metabolic health group year genetic disorder treatment clinical disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1352,1352,1461,10.1080/03009734.2016.1206152,27434227.0,inheritance stress future evidence life ethnic among disparity promotion toxic time optimal effectively racial across area health woman outcome reduced intervention point reproductive adverse critical approach paper research view perinatal mediator multigenerational paradigm phenomenon state group ahead non epigenetic weathering course chromosomal human key theory men pregnancy generation finally year preconception potentially united span innovative barker summary historical period,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098483/,abstract,0,weathering multigenerational barker racial ahead disparity promotion preconception mediator historical span ethnic innovative men chromosomal perinatal phenomenon epigenetic theory paradigm inheritance reproductive effectively toxic summary united view course reduced optimal potentially pregnancy finally woman adverse stress generation critical point paper period area state key future intervention life evidence outcome non approach time human research health group year,{},"{""inheritance"": {""freq"": 1, ""string"": [""chromosomal perinatal phenomenon epigenetic theory paradigm inheritance reproductive effectively toxic summary u""]}}",{},{},{},{}
1353,1353,1462,10.1186/s13023-017-0685-2,29025426.0,european blood better across autosomal country statement literature severe sub appraisal addition pku hydroxylase knowledge relevant phenylalanine evidence optimal brain gap therefore error inborn result enzyme cause guideline little design standardize metabolism untreated level although consultant problem external tyrosine convert evaluation sign many critical management phenylketonuria convincing method disability concentration behavioural delphi recommendation important network care future professional recessive order quality scottish research available widely intellectual optimize different study direct agree deficiency intercollegiate patient highest number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639803/,abstract,2,convincing consultant agree standardize intercollegiate scottish appraisal delphi convert statement optimize external behavioural sub sign gap untreated optimal highest little widely recessive guideline european network autosomal intellectual recommendation professional direct disability critical tyrosine evaluation relevant design problem hydroxylase order knowledge country better literature severe inborn enzyme addition management cause error quality future brain deficiency care concentration evidence pku important phenylketonuria number available metabolism phenylalanine blood research different method level result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""pku important phenylketonuria number available metabolism phenylalanine blood research different method l""]}, ""intellectual"": {""freq"": 1, ""string"": [""widely recessive guideline european network autosomal intellectual recommendation professional direct disability c""]}}","{""autosomal"": {""freq"": 1, ""string"": [""little widely recessive guideline european network autosomal intellectual recommendation professional direct d""]}, ""recessive"": {""freq"": 1, ""string"": [""gap untreated optimal highest little widely recessive guideline european network autosomal i""]}}",{},{},{},{}
1354,1354,1463,10.1007/s13668-018-0223-4,29892784.0,hunger component biological integrates correlation implication however satiation one advice pediatric trait recent difference size correlate etiology obesity current strong appetite innate heritability child prevent focus review environmental behavior move model approach drive fit need also summarythe robustly purpose appetitive satiety data newer underlying findingscaregiver etiological delineates genetic heritable individual caregiver cascade,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002846/,abstract,0,satiation findingscaregiver appetitive summarythe hunger delineates integrates newer etiological drive appetite robustly innate cascade satiety heritable heritability fit advice correlate caregiver underlying etiology strong trait obesity prevent component size pediatric implication focus behavior purpose environmental correlation biological need recent current difference approach individual model review child genetic data,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1355,1355,1464,10.1002/wdev.247,27626243.0,genetically lab disorder understanding spectrum discus elaborate organism pathway defect developmental stem analysis review environmental model tractable ethanol environment structural teratogen development multifactorial different interaction substantial susceptibility human embryo number alcohol predominantly vastly fetal genetic jump gene malformation geneticist,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5191946/,abstract,0,jump teratogen tractable vastly ethanol elaborate multifactorial geneticist embryo lab alcohol malformation predominantly stem organism susceptibility substantial fetal genetically structural environment understanding environmental developmental defect discus spectrum interaction pathway number human model review different development gene genetic disorder analysis,{},"{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""environmental developmental defect discus spectrum interaction pathway number human model review d""]}}",{},{},{}
1356,1356,1465,10.1371/journal.pone.0161970,27564234.0,specific considerable chain activity better organism among molecule homeostasis condition molecular parallel state control machine increase disease doe semi membrane measurement family experimentally reader allow role protein putative manner report transport protective thus dissection susceptible art significant stress cellular direction measure current abundant infection capability damage living technique method thereby test key process nascent chaperone function throughput reproducibility quality plethora adverse benefit mechanism vitro plate also high barrier playing accuracy highly number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5001627/,abstract,0,nascent dissection playing allow plethora plate experimentally susceptible reader machine art abundant protective living throughput reproducibility chaperone direction capability putative semi manner membrane organism transport parallel considerable barrier homeostasis damage doe cellular infection accuracy vitro molecule adverse stress chain measurement highly technique benefit better process measure state increase key quality molecular mechanism report family activity current condition role function number test specific control protein significant high method disease,{},{},{},{},{},{}
1357,1357,1466,10.1016/j.ymgmr.2015.12.004,27014571.0,disorder blood clinic physiological new alliance almost anxiety formula time adult half discontinue genetics difficulty old injection clinician accumulation acmg npkua increase survey pku neurological status quarter intake hydroxylase phe medical college resultant third phenylalanine reduction clinical therapy health respondent range protein home input mol phenylketonuriakeywords food result preferred depression metabolic payer cause little oral untreated low consider administration government one interest agency genomics current tyrosine maintenance phenylketonuria therapeutic mental keeping partner ass abbreviation national disability concentration american treatment year diet rare excess within desire two younger natural reduce also pah general intellectual membership deficiency patient conversion restricted industry successful newly individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789336/,abstract,4,npkua discontinue quarter phenylketonuriakeywords keeping alliance membership desire payer consider acmg preferred resultant restricted agency younger college partner excess government newly abbreviation conversion input maintenance respondent industry home formula reduce depression injection american untreated half anxiety physiological genomics clinician difficulty mol little successful oral accumulation neurological clinic intellectual natural administration mental survey old pah reduction genetics national disability intake tyrosine ass general hydroxylase status food phe range cause increase therapeutic medical adult deficiency diet rare therapy concentration current pku phenylketonuria low individual time new phenylalanine blood protein metabolic health year disorder treatment clinical result patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""pku phenylketonuria low individual time new phenylalanine blood protein metabolic health y""]}, ""neurological"": {""freq"": 1, ""string"": [""difficulty mol little successful oral accumulation neurological clinic intellectual natural administration m""]}, ""intellectual"": {""freq"": 1, ""string"": [""little successful oral accumulation neurological clinic intellectual natural administration mental survey o""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""cause increase therapeutic medical adult deficiency diet rare therapy concentration current p""]}}",{}
1358,1358,1467,10.1007/8904_2017_60,28940169.0,correlation blood assessment clinic self memory outpatient visual neonatal awareness retention due regular deficit risk subtle mean practical control increase month significantly related supplementary phenylalanine poorly follow observed teenager dysfunction higher value procedure brain result metabolic attention good basis routine adherence low score period detection strong many phenylketonuria identification consequently safety concentration test contrary treatment valuable detect age within poor hyperphenylalaninemia order correlate since effectively adolescent quality prior group often high last neuropsychological patient benton rarely performance individual presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122018/,abstract,1,benton teenager contrary subtle outpatient retention rarely detect regular neuropsychological correlate awareness poorly effectively visual consequently practical valuable routine adherence hyperphenylalaninemia prior memory strong safety adolescent procedure poor clinic follow good basis observed deficit neonatal mean dysfunction self attention presence correlation identification related period order performance score detection assessment month supplementary value increase quality brain concentration higher phenylketonuria low test individual significantly risk phenylalanine control blood age metabolic group high treatment result patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""phenylketonuria low test individual significantly risk phenylalanine control blood age metabolic g""]}}",{},{},"{""detection"": {""freq"": 1, ""string"": [""identification related period order performance score detection assessment month supplementary value i""]}}",{},{}
1359,1359,1468,10.1021/acs.jproteome.7b00467,28938075.0,various interpretation blood hppp past discus early several across present modification match additional ambiguous build well finally disease spectrum historical sequence individual understanding evidence recent achievement health protein distribution project outlook peptide globally data complement design guideline experiment consideration non level mapping full cellular least review back window catalog abundance history target organization latest ten accessible year assay component advance future sample two fdr progress rna mass million uniquely since category inception spectrometry coverage also general plasma study human acid yield distinct proteomics amino highly affinity localization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864247/,abstract,5,hppp outlook match fdr catalog localization inception ambiguous uniquely latest historical proteomics globally build achievement window mapping complement affinity accessible coverage abundance interpretation yield progress million project peptide experiment rna modification organization distinct consideration category distribution past guideline cellular advance sequence history component finally understanding assay spectrometry highly design general additional discus spectrum target various mass plasma future recent evidence amino non sample present individual human early blood review acid protein health year data level disease study,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""various mass plasma future recent evidence amino non sample present individual h""]}, ""spectrometry"": {""freq"": 1, ""string"": [""sequence history component finally understanding assay spectrometry highly design general additional d""]}}",{},{}
1360,1360,1469,10.1186/s12884-019-2474-5,31470807.0,efficacious male disorder investigation hydroxocobalamin growth normocytic early essential defect positive weight awareness condition molecular due presentationhere cblc disease megaloblastic possible renal clinical homocysteine report diagnosis metabolic intrauterine cause term late pregnancy first metabolism low methylmalonic level case full prophylactic death normal dose woman outcome management emphasis correct consequently second conclusionsthis manifestation treatment foetus delivery adequately rare heparin age backgroundcobalamin appropriate order apparently healthy function anaemia aciduria importance also plasma morphologically homocystinuria patient cyanocobalamin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716909/,abstract,0,presentationhere normocytic morphologically hydroxocobalamin cyanocobalamin backgroundcobalamin megaloblastic prophylactic heparin foetus cblc anaemia homocystinuria efficacious adequately intrauterine homocysteine apparently aciduria methylmalonic emphasis conclusionsthis awareness renal correct consequently manifestation late dose death pregnancy delivery investigation appropriate woman second weight defect essential growth importance male order possible normal healthy plasma management cause positive molecular report rare outcome term condition function low case metabolism early diagnosis age metabolic level disorder treatment clinical patient disease,{},{},{},{},{},{}
1361,1361,1470,10.1007/s10545-017-0128-1,29362952.0,exciting interpretation clinic participatory investigation pathophysiologic single transcriptomics information organism world laboratory platform researcher garrod action expert open capstone contextual testing clinician validation disease computer physician medical biochemical offer era family lipidomics actionable stone wish screening epigenomics clinical daunting preventive role clinically cautious science task expertise glycomics diagnosis metabolic integration data amazing novel first medicine case functional mutation table genomics others discovery around intervention omics management ready model phenylketonuria therapeutic plan potential exome technology system participation holistic test team treatment precision important key promise connector assay challenge dramatically predictive lie certainly newborn opportunity adjustment collaboration biology scale since reality throughput precise big individualized alkaptonuria meaningful basic metabolomics translation importance keywords diagnostic high right sequencing patient proteomics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959952/,abstract,0,participatory lipidomics glycomics epigenomics connector capstone amazing stone daunting wish garrod cautious big table contextual certainly pathophysiologic lie transcriptomics reality ready individualized alkaptonuria exciting actionable proteomics holistic expertise dramatically computer adjustment throughput omics meaningful era collaboration preventive participation team promise precise offer interpretation organism plan integration right validation physician exome translation researcher basic predictive keywords precision expert platform genomics action clinician biology open discovery metabolomics task world opportunity science clinic clinically investigation assay sequencing laboratory medicine importance scale functional biochemical technology testing diagnostic screening management challenge key therapeutic medical single family intervention novel information newborn mutation important role phenylketonuria case test model diagnosis potential metabolic high data treatment clinical patient disease,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""medical single family intervention novel information newborn mutation important role phenylketonuria c""]}, ""screening"": {""freq"": 1, ""string"": [""scale functional biochemical technology testing diagnostic screening management challenge key therapeutic m""]}}",{},{}
1362,1362,1472,10.1002/wsbm.1405,28960879.0,phenotypic finer activity example class discus context effort molecule across present respond state toxicity control regulatory well finally disease responsive transcription biochemical life endpoint role payload great represent bacteria efficacy transport first potentially metabolism consideration use level three cue direction biomarkers tree block ultimate many critical review regulation therapeutic describe success delivery important valuable fatty promise cell particularly future within application engineering function natural also extracellular building different quorum acid small prominent aspiration amino,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899512/,abstract,0,quorum payload finer represent aspiration cue building ultimate respond tree endpoint extracellular engineering prominent direction block toxicity promise bacteria responsive transport class valuable success transcription phenotypic consideration great molecule fatty effort potentially natural regulatory delivery regulation finally efficacy example critical context biomarkers particularly biochemical small discus application state therapeutic future use life activity amino important role cell function present metabolism control review acid different level disease,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""state therapeutic future use life activity amino important role cell function p""]}}",{},{}
1363,1363,1473,10.1186/s12915-016-0279-9,27380775.0,splice immediately exon whether vivo factor hnrnp pseudoexons location resultshere site splicing together moreover regulatory backgroundmany well disease significantly material establish activate sequence element intron however supplementary user therapy sso besides cassette genetic sres mutation pseudoexon motif pathogenic compensate constitutive map block approach inclusion model conclusionsthe therapeutic repressing ska potential online article mtrr treatment important key electronic associated proximal deregulation version materialthe immunoprecipitation consensus downstream snp variant ssos oligonucleotides alternative available identify eventually mrna nucleotide disrupt show individual resolution,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932749/,abstract,1,ssos sso sres ska repressing pseudoexons pseudoexon hnrnp mtrr disrupt deregulation compensate activate resultshere oligonucleotides constitutive backgroundmany cassette immunoprecipitation splice intron eventually splicing proximal motif location immediately map block mrna establish downstream consensus snp resolution element exon identify conclusionsthe pathogenic nucleotide vivo inclusion alternative associated regulatory sequence site materialthe supplementary user version variant key electronic online therapeutic therapy mutation material article important approach available individual significantly model factor potential genetic treatment disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1364,1364,1474,10.1155/2015/128697,25695045.0,implication various example information lesser contamination artificial chemical soft risk preservative intake misleading consumer issue numerous medical extensive knowledge however possible place purchase storage health legislation particular ensure result property link attention ingredient controversial international area functional scientific label problem processing product emphasis microbiological national safety manufacturer nevertheless year decision false overview still public standard quality aspect paper consumption available broad also trust policy study industry safe highly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324883/,abstract,0,purchase misleading preservative microbiological soft ingredient ensure manufacturer contamination lesser trust legislation label artificial controversial industry emphasis consumer processing safe place broad false extensive link numerous overview chemical storage scientific consumption safety aspect international decision policy property particular implication example national attention intake product highly problem functional paper issue public knowledge standard possible various area quality medical information available risk health year result study,{},{},{},{},{},{}
1365,1365,1475,10.1002/cnma.201800147,30713827.0,process implication biological although nanoscale supramolecular future envision self synthetic much architecture herein fundamental application single discus simplest discreet form order block structure notable unmodified field many review light natural science physical peptide importance also capable organization property nanostructures fabrication metabolic attention hydrogel article study topic acid well association disease devoted assembly ability material amino prospect shed,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352958/,abstract,0,nanoscale simplest envision discreet devoted unmodified supramolecular nanostructures hydrogel fabrication prospect shed notable architecture block topic assembly fundamental capable synthetic peptide light organization science natural property implication physical self attention structure biological ability importance order discus field process form application future single association material amino article review acid metabolic disease study,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""form application future single association material amino article review acid metabolic d""]}}",{},{}
1366,1366,1476,10.2174/0929867324666170718101946,28721829.0,inheritance european specific worldwide disorder digenic new region discus half light causality due common difficulty epigenetic way disease typic emergence spectrum account determina neurodevelopmental therapy focus mosaicism diagnosis thus novo cians generation novel first genetic enormous non rapid mutation cheap one problem detec somatic population review milestone workflow simple coding clini technology loss article american bolic pheno tion tralian promising challenge particularly near ond rare wide overcome advance future variant million sec mosaic since approximately next research diagnostic part meta unprecedent patient limitation healthcare gene presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815091/,abstract,1,unprecedent typic tralian tion pheno ond digenic determina detec clini cians bolic sec mosaic cheap overcome mosaicism enormous causality somatic milestone emergence coding workflow epigenetic novo inheritance near promising million american light worldwide half meta simple neurodevelopmental difficulty limitation european account healthcare approximately advance way focus loss rapid generation presence particularly wide problem technology discus spectrum diagnostic region challenge variant future rare novel therapy mutation non article common new specific diagnosis research population review gene genetic disorder patient disease,{},"{""inheritance"": {""freq"": 1, ""string"": [""milestone emergence coding workflow epigenetic novo inheritance near promising million american l""]}, ""genetic"": {""freq"": 1, ""string"": [""somatic milestone emergence coding workflow epigenetic novo inheritance near promising m""]}}",{},{},{},{}
1367,1367,1477,10.1053/j.semperi.2015.03.003,25935354.0,implication loinc registry operation example observation information effort laboratory nomenclature condition together state facilitate effective well computer name readable unit disaster quantitative poc follow clinical health regional guidance contain snomed logical report message result situation term assurance medicine level rapid panel communication measure code implementation point many national people organization test guide identifier reporting stake help care newborn continuity stakeholder standard quality program research multiple nationally high patient ucum,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433800/,abstract,0,ucum stake snomed readable loinc disaster continuity nomenclature logical contain poc assurance nationally message identifier code reporting operation computer stakeholder regional guidance registry situation observation guide unit facilitate organization communication people panel effort follow help implication quantitative implementation example rapid national point laboratory medicine standard measure state program multiple quality effective report care information newborn term condition test research health high level clinical result patient,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""multiple quality effective report care information newborn term condition test research h""]}}",{},{}
1368,1368,1479,10.1038/gt.2014.104,25427612.0,car specific blood simplicity selectively specifically transposase cost express stimulation transfer control interferon immunodeficient line suitable retroviral strategy therapy tol mouse result effectiveness recently receptor mediate malignancy level transgene transposon progression normal stable plasmid method nih lymphoma expression system treatment adoptive viral promising cell rag donor genetically stably nonviral chimeric peripheral demonstrate advanced widely upon high human raji advantage refractory vector tumor gene lymphocyte,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548386/,abstract,0,transposase tol raji rag nonviral immunodeficient chimeric adoptive transposon stably retroviral lymphoma car simplicity interferon nih lymphocyte refractory express selectively malignancy transgene plasmid mediate transfer stimulation donor advanced viral peripheral vector promising tumor suitable progression stable demonstrate line genetically advantage specifically receptor widely effectiveness recently cost mouse normal expression strategy therapy cell human specific control blood gene high method level treatment result,{},{},{},{},{},{}
1369,1369,1480,10.1371/journal.pone.0159205,27410482.0,chain relationship constellation ratio former context lower examine literature due aromatic prognosis investigate risk disease significantly individual phenylalanine cumulative backgroundthe follow higher value role play particular citrated tertiles worsen result furthermore branched metabolism low mortality score panel three hepatic biomarkers tyrosine fischer liver orthotopic method therapeutic predictor target stage potential concentration recommendation key valuable association strongly meld dramatically pathophysiological mass survival sarcopenia conclusionsamino analysis encephalopathy spectrometry transplantation also importance group plasma study acid dietary patient amino complex parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943589/,abstract,1,tertiles meld fischer conclusionsamino citrated worsen sarcopenia orthotopic constellation encephalopathy branched dramatically cumulative pathophysiological prognosis transplantation aromatic hepatic valuable predictor backgroundthe survival examine strongly panel play parameter follow stage mortality recommendation particular liver context investigate furthermore chain spectrometry biomarkers tyrosine importance ratio relationship score target literature mass plasma complex value key therapeutic lower association dietary concentration amino higher role low metabolism individual significantly risk phenylalanine acid potential group method analysis result patient disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""role low metabolism individual significantly risk phenylalanine acid potential group method a""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""tertiles meld fischer conclusionsamino citrated worsen sarcopenia orthotopic c"", ""key therapeutic lower association dietary concentration amino higher role low metabolism i""]}, ""spectrometry"": {""freq"": 1, ""string"": [""particular liver context investigate furthermore chain spectrometry biomarkers tyrosine importance ratio r""]}}",{},{}
1370,1370,1481,10.1515/jomb-2016-0004,28356871.0,disorder activity hour recycling factor among autosomal reaction superior due resultsbtd source well vitamin evaluate month respectively cutaneous unit biotinidase conclusionsfluorimetric partial biotin higher clinical complete btd recessively enzyme university genetic metabolism untreated area water temperature curve room current sensitivity stable soluble methodsstudy child day method parent specificity endogenous fluorimetric carboxylation newborn disadvantage pediatric neurologic spectrophotometric aim research consequence roc group practice study whereas dietary advantage deficiency patient total number backgroundbiotin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346788/,abstract,5,resultsbtd methodsstudy conclusionsfluorimetric carboxylation backgroundbiotin spectrophotometric recycling cutaneous fluorimetric btd recessively disadvantage biotinidase biotin soluble roc neurologic room superior curve endogenous unit temperature partial untreated hour vitamin university stable water complete advantage autosomal specificity evaluate reaction consequence pediatric source sensitivity practice parent area aim enzyme month day deficiency respectively dietary total newborn activity current higher number metabolism factor research child group genetic method disorder clinical patient study,{},"{""autosomal"": {""freq"": 1, ""string"": [""vitamin university stable water complete advantage autosomal specificity evaluate reaction consequence p""]}, ""genetic"": {""freq"": 1, ""string"": [""number metabolism factor research child group genetic method disorder clinical patient s""]}}",{},"{""newborn"": {""freq"": 1, ""string"": [""month day deficiency respectively dietary total newborn activity current higher number m""]}}",{},{}
1371,1371,1482,10.1016/j.ymgmr.2017.08.005,28971021.0,full rate mutation biotinidase one newborn two allele partial profound screening confirm among harbored department since positive biotin present therapy clinical outcome compound adverse affected homozygosity secondary complete heterozygosity day symptom program trans missense common prevention protective effect effective deficiency patient novel center excellent respectively incidence false complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608602/,abstract,2,harbored homozygosity heterozygosity biotinidase biotin protective trans confirm profound department excellent partial false missense affected complete secondary center allele adverse incidence compound prevention symptom screening day program complex positive effective deficiency respectively novel therapy rate newborn mutation outcome common present effect clinical patient,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""effective deficiency respectively novel therapy rate newborn mutation outcome common present e""]}, ""screening"": {""freq"": 1, ""string"": [""allele adverse incidence compound prevention symptom screening day program complex positive e""]}}",{},{}
1372,1372,1483,10.3389/fpls.2019.00720,31244868.0,specific former discus widespread acceptance platform offering capacity difficulty cost partly niche cosmetic effective well prokaryotic commercial decade however pharmaceutical latter mainly protein inconsistent biopharmaceutical conventional bottleneck utilization reluctant furthermore plant low recombinant area case although three market economic processing strength product switch compete expression system valuable nevertheless address cell process downstream still future production application scale competitive resistance quality alternative research relatively larger high last yield advantage mammalian industry complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579924/,abstract,0,niche compete reluctant prokaryotic biopharmaceutical cosmetic bottleneck switch competitive offering commercial utilization acceptance inconsistent partly market plant strength mammalian recombinant widespread industry processing downstream yield conventional pharmaceutical resistance valuable capacity larger platform advantage economic difficulty mainly relatively decade production alternative address cost furthermore product scale discus process area application expression complex quality effective future cell low case specific research protein high,{},{},{},{},{},{}
1373,1373,1484,10.3390/ijms20143516,31323740.0,major specific investigation herein nutrition several modification nutrient frequency literature risk source disease intake relevant however cancer obesity select health global superpopulations environment genotype food metabolic data guideline genetic type yet alter ethnicity agency nutrigenetic syndrome database evaluation superpopulation many population approach model potential susceptibility interact manually key diabetes hundred generally future variant since consolidated background colorectal paper genome historically different interaction study human house dietary distinct gene individual prioritize,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678450/,abstract,3,superpopulations superpopulation manually prioritize nutrigenetic house consolidated colorectal interact agency select ethnicity historically alter susceptibility modification generally distinct nutrient diabetes guideline nutrition obesity genotype investigation global genome environment source cancer intake database syndrome evaluation frequency relevant paper interaction literature food background major variant key future dietary approach individual human risk model specific type population potential different metabolic health gene genetic data disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""superpopulations superpopulation manually prioritize nutrigenetic house consolidated colorectal interact a""]}}",{},{},{},{}
1374,1374,1485,10.1016/j.optom.2014.10.002,25435188.0,disorder hypo ophthalmological neural sensory difference early visual amplitude due deficit adhd chromatic testing control well objective significantly dopaminergic exam account however cone strategy achromatic inconsistent input green tone task speculate color resultno diagnosis attention intergroup yellow peer one red cvep measure retinal compensatory problem methodthirty processing conclusionlarger potential response particularly component latency age electrophysiological lack healthy accordingly adolescent function larger backgroundindividuals blue group study hyperactivity perception gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401829/,abstract,2,resultno ophthalmological methodthirty intergroup cvep conclusionlarger chromatic achromatic yellow hypo electrophysiological cone tone speculate green backgroundindividuals dopaminergic compensatory blue amplitude exam red latency color sensory retinal inconsistent peer adhd input accordingly processing perception neural hyperactivity visual larger gender adolescent task account component deficit lack attention particularly problem testing measure healthy objective strategy response difference function significantly early control diagnosis potential age group disorder study,"{""hyperactivity"": {""freq"": 1, ""string"": [""adhd input accordingly processing perception neural hyperactivity visual larger gender adolescent t""]}}",{},{},{},{},{}
1375,1375,1487,10.1016/j.mgene.2016.07.004,27617217.0,major male thalassemia delay occipitofrontal inactivation self retardation abnormality boy congenital pws cytogenetic behavior five hdac additional fetus neuromuscular bromodeoxyuridine difficulty variation old phospho disease cnv activator recurrent jpx seizure family partial chromosome brdu speech obesity injurious clinical fish additionally developmental feature candidate phenotypically hypotonia pcdh genomic report duplication diagnosis like solute creatinine xist copy infantile tomography stature completely fluorescence hybridization three acgh one pubertal female nuclear short member proband phenotype problem normal syndrome ofc many gynecomastia comparative mental deacetylase abbreviation nmr disability mother overexpression year finding particularly carrier transcript maternally situ involved differential atrx breakpoint circumference previously pchd keywords also multiple protocadherin intellectual ckt endocrine alpha magnetic histone similar patient gene mitochondriopathies total number mitochondrial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006134/,abstract,2,xist pws protocadherin pchd pcdh mitochondriopathies maternally jpx hdac gynecomastia deacetylase ckt bromodeoxyuridine brdu atrx acgh ofc occipitofrontal cytogenetic breakpoint stature phospho phenotypically injurious neuromuscular thalassemia solute pubertal proband cnv inactivation endocrine overexpression infantile hypotonia histone duplication transcript speech creatinine activator situ hybridization fish fetus comparative recurrent fluorescence copy circumference nmr tomography chromosome abbreviation retardation boy completely alpha partial seizure differential mitochondrial keywords candidate nuclear involved delay difficulty member mother magnetic carrier obesity additionally intellectual mental genomic female short old abnormality feature behavior self disability variation developmental syndrome particularly previously congenital problem male like additional phenotype finding similar normal major multiple report family total number diagnosis gene year clinical patient disease,"{""intellectual"": {""freq"": 1, ""string"": [""member mother magnetic carrier obesity additionally intellectual mental genomic female short o""]}}",{},{},{},"{""fish"": {""freq"": 1, ""string"": [""transcript speech creatinine activator situ hybridization fish fetus comparative recurrent fluorescence c""]}}",{}
1376,1376,1488,10.3389/fgene.2017.00129,28993790.0,wide related disorder cancer asd autism region recent order context scale relation epigenetics strong several function syndrome role many prioritizations synapsis approach comorbidity module analyze cell adhesion molecular diffusion underline work neuronal used genome variation multiple development result cycle different functionally marked risk study heterogeneity overlap human network disease significantly genetic underlined list low gene spectrum jointly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622537/,abstract,0,underlined underline prioritizations adhesion synapsis jointly epigenetics overlap marked comorbidity module functionally analyze used diffusion neuronal list asd strong relation heterogeneity cycle network autism genome cancer work context variation syndrome wide scale related order spectrum region multiple molecular recent role cell function low approach significantly human risk different development gene genetic disorder result disease study,{},"{""genetic"": {""freq"": 1, ""string"": []}, ""heterogeneity"": {""freq"": 1, ""string"": [""diffusion neuronal list asd strong relation heterogeneity cycle network autism genome c""]}}",{},{},{},{}
1377,1377,1489,10.1016/j.physbeh.2017.01.023,28089706.0,schedule conventionally beverage better new greater difference lower duration time behavioral liquid together pressure measuring reward continuous marked cup taste addition reliable sham intake wanting amount animal cumulative straw rating raise value sleep yogurt output food result effect contrast consume consuming design experiment crossover useful non period significant three variable main sipping short measure sipometer pre night strength motivation device progressively work pictorial sweet potential test spit two permit habitual access scale pilot especially dependent validated breakpoint either longer consumption reinforcement deprivation human similar though participant willing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769686/,abstract,2,wanting straw spit sipping sipometer yogurt reinforcement conventionally breakpoint pictorial cup sweet habitual sham progressively night measuring willing schedule permit taste consume motivation marked reward deprivation consuming cumulative raise output sleep strength crossover validated rating longer beverage pilot duration device continuous pressure experiment reliable access consumption liquid behavioral contrast useful pre dependent short variable work animal intake especially greater design scale period main better similar participant food measure addition value lower non difference test time new human potential significant effect result,"{""behavioral"": {""freq"": 1, ""string"": [""pressure experiment reliable access consumption liquid behavioral contrast useful pre dependent s""]}}",{},{},{},{},{}
1378,1378,1490,10.1038/s41598-017-10911-z,28894147.0,erythrocyte cross preferentially abnormality physiological fundamental trigger molecule several largely fibril psychoneurological native condition physical sheet severe diverse build severity accumulation well origin disease assembly pku neurological enough membrane issue zwitterionic resultant relevant however phenylalanine unique higher inherent hemolysis health protein developmental body behind property like electrostatic cause initiate ability genetic untreated problem aggregation structure relevance phenylketonuria propose sufficient trap unknown hydrophobic interact particularly component excess mostly amyloid order prevalence since effectively induce plethora mechanism characteristic rbc interaction entity direct arrangement patient highly promote,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593866/,abstract,0,zwitterionic psychoneurological hemolysis electrostatic trap sheet rbc hydrophobic preferentially plethora promote initiate erythrocyte resultant inherent fibril arrangement interact induce build trigger excess native entity amyloid assembly aggregation fundamental membrane origin effectively relevance untreated sufficient largely propose physiological diverse severity unique accumulation molecule neurological unknown property component direct physical abnormality cross structure developmental particularly highly ability relevant problem like characteristic prevalence issue order interaction severe body cause mechanism pku higher condition phenylketonuria phenylalanine protein health genetic patient disease,"{""phenylalanine"": {""freq"": 2, ""string"": [""cause mechanism pku higher condition phenylketonuria phenylalanine protein health genetic patient d""]}, ""neurological"": {""freq"": 1, ""string"": [""zwitterionic psychoneurological hemolysis electrostatic trap sheet r"", ""physiological diverse severity unique accumulation molecule neurological unknown property component direct p""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1379,1379,1491,10.5001/omj.2019.59,31360317.0,jordan delay cross disorder iem sectional syrup factor information early abnormal positive essential laboratory five organic common amman methodswe resultstwenty unexplained misan majority disease respectively consanguinity however family conclusionsa suspicion clinical therapy role developmental particular error inborn result diagnosis urine type tandem metabolism period significant case rate one referral implementation child phenylketonuria medlabs history parent fatty year maple generally two mass newborn collaboration prevalence appropriate objectiveswe determine spectrometry infant high study acid direct iraq amino,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642708/,abstract,1,misan medlabs amman jordan iraq resultstwenty objectiveswe unexplained suspicion conclusionsa maple syrup consanguinity collaboration referral generally organic delay tandem iem majority abnormal fatty urine methodswe sectional history appropriate particular direct implementation cross developmental spectrometry essential determine parent laboratory prevalence period inborn infant mass positive error family respectively therapy information rate newborn amino role common phenylketonuria case metabolism early factor type diagnosis acid child significant year high disorder clinical result disease study,"{""urine"": {""freq"": 1, ""string"": [""delay tandem iem majority abnormal fatty urine methodswe sectional history appropriate p""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""family respectively therapy information rate newborn amino role common phenylketonuria case m""]}, ""tandem"": {""freq"": 1, ""string"": [""consanguinity collaboration referral generally organic delay tandem iem majority abnormal fatty u""]}, ""spectrometry"": {""freq"": 1, ""string"": [""appropriate particular direct implementation cross developmental spectrometry essential determine parent laboratory p""]}, ""newborn"": {""freq"": 1, ""string"": [""error family respectively therapy information rate newborn amino role common phenylketonuria c""]}}",{},{}
1380,1380,1492,10.1210/er.2015-1116,27035557.0,major dominant single factor subfamily adult glucose neonatal inflammation onset potassium moreover common locus control well gli embryonic proliferator peroxisome transcription third channel understanding identified autoantibody unique form heterozygous hyperinsulinemia role invaluable kcnj candidate monogenic hyperproinsulinemia thus inconsistently date basis cause receptor mody type perturbation young case mutation one member mellitus compensatory preproinsulin drug sensitivity review model permanent development target second susceptibility key association strongly cell wide pparg pathophysiological antidiabetic two variant production negative relation differentiation function approximately impairment impact also secretion multiple tissue study insulin human similar glis another gene proliferation maturity inward,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890265/,abstract,7,preproinsulin pparg kcnj inward hyperproinsulinemia glis subfamily proliferator peroxisome hyperinsulinemia gli antidiabetic inconsistently identified autoantibody maturity invaluable potassium mody compensatory perturbation permanent channel mellitus secretion pathophysiological embryonic heterozygous proliferation dominant monogenic susceptibility insulin locus differentiation inflammation young strongly candidate transcription member receptor relation glucose unique approximately production date basis second understanding sensitivity neonatal negative impairment onset tissue wide target similar form major multiple cause drug variant key single association adult impact mutation role common cell function case human model control factor type review development gene study,{},"{""heterozygous"": {""freq"": 1, ""string"": [""permanent channel mellitus secretion pathophysiological embryonic heterozygous proliferation dominant monogenic susceptibility i""]}}",{},{},{},{}
1381,1381,1493,10.2147/CLEP.S179083,31372058.0,epidemiological record constellation discus registration among technical present elderly insight ease open cost emigration source danish finally medical third unlimited element life event follow relative clinical denmark health complete primary possibility effectiveness large data term generation routine first long type administrative level full death dynamic database overall point population review product history contact potential system organization second delivery key network detail care overview exact universal linkage psychiatric quality provision path hospital routinely available cohort high individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6634267/,abstract,0,unlimited emigration administrative danish constellation elderly denmark exact ease contact path routinely linkage registration provision epidemiological universal technical routine psychiatric element dynamic organization record overview possibility complete open event network relative death effectiveness follow delivery history finally insight source second hospital generation cost point database product cohort discus overall long primary key quality medical large care life term present available individual type population review potential health high data level clinical,"{""psychiatric"": {""freq"": 1, ""string"": [""registration provision epidemiological universal technical routine psychiatric element dynamic organization record o""]}}",{},{},{},{},{}
1382,1382,1494,10.1136/archdischild-2016-311271,29054862.0,implication delay availability disorder assessment clinic investigation present introductionglobal paediatric condition irrespective additional literature common cost methodswe unexplained severity line treatable trajectory microarray evidence recent thought higher clinical guidance developmental resultswe examination metabolic exogenous date change cause first genetic type non one update vital child already population review approach history second article recommendation year discussionwe age advance previously available biotechnology gdd yield patient sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738593/,abstract,6,introductionglobal gdd thought discussionwe irrespective unexplained biotechnology microarray trajectory update paediatric exogenous vital guidance treatable resultswe yield line examination delay sensitive availability severity date advance methodswe clinic investigation history recommendation implication second cost developmental previously additional literature assessment change cause recent evidence higher condition non article common approach present available type population review child age metabolic year genetic disorder clinical patient,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1383,1383,1495,10.1186/s13023-015-0251-8,25887186.0,european specific consultation allocation setback new context final commission uncertainty time revision world country www prevents adoption open expert orpha contributes beta mean testing addition ascertainment funding disease assembly professionalism template willingness foreseen unique strategic clinical health layer task resultsso thus ambition inventory orphanet significance genetic type planning far international level significant mapping update code representation experienced current database overall outcome recognition hurdle around comment product disappointing november conclusionsthe coding orphadata organization potential system topic resource identifier linearization recommendation initially version rare public lack scope advisory limited terminology backgroundbecause field goal methodsorphanet currently research available importance also foundation group classification rarity healthcare individual freely,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377208/,abstract,2,setback resultsso professionalism orphadata methodsorphanet linearization foreseen backgroundbecause ambition orphanet orpha disappointing ascertainment willingness revision consultation strategic representation hurdle freely comment terminology commission funding allocation adoption identifier experienced code prevents november template rarity coding advisory contributes scope mapping layer initially uncertainty update beta inventory planning final www topic assembly recognition foundation far classification organization conclusionsthe significance expert open goal european task unique world healthcare international resource recommendation mean lack limited context database product currently importance public field testing overall country addition version rare current outcome available individual time new specific type research potential significant health group genetic level clinical disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1384,1384,1496,10.3389/fpsyt.2015.00085,26089803.0,tool retardation memory better lead factor discus organism pathway several defect creb despite insight without onset due severe unfortunately fruit clinician finally synthesis neuronal third element understanding family pharmacological adaptive clinical adenosine role fly protein candidate symptom neurotransmitter cyclic cause receptor first ability genetic type learning use one pace current drug discovery monophosphate population review model regulation mental describe development disability second ameliorate treatment response key valuable important associated year signaling drosophila wide age function previously research camp general intellectual human patient gene proliferation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453272/,abstract,1,monophosphate creb adenosine camp cyclic pace fly drosophila unfortunately learning fruit ameliorate signaling retardation proliferation adaptive organism neuronal valuable element neurotransmitter candidate pharmacological memory clinician receptor discovery intellectual associated mental regulation finally insight second understanding synthesis lead onset disability defect previously ability despite wide general discus better severe symptom tool cause drug key response pathway use family current important role function human model factor type research population review protein age development gene year genetic treatment clinical patient,"{""intellectual"": {""freq"": 1, ""string"": [""candidate pharmacological memory clinician receptor discovery intellectual associated mental regulation finally i""]}}","{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""symptom tool cause drug key response pathway use family current important r""]}}",{},{},{}
1385,1385,1497,10.2105/AJPH.2014.302289,25393173.0,service although public provider life professional certain greater caveat uptake rule nuance clinical preventive health deductible payment many act provision population affordable without broad coverage also potential charging improve important maximize copays care,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265933/,abstract,0,deductible copays charging caveat nuance maximize payment affordable rule uptake preventive provision coverage provider broad act improve certain service professional greater public care life important population potential health clinical,{},{},{},{},{},{}
1386,1386,1498,,27057188.0,coefficient correlation statistic investigation difference factor lower focal objectivewe time methodsthis researcher weight onset frequency due common risk control clinician majority disease month guilan material respectively medical seizure shahrivar form obesity anthropometric therapy word lipoid therefore body science backward university effect data zheight predominant type score regression significant case although resultsthere child spss descriptive approach therapeutic ass daytime epilepsy pearson test sex leptin key bmi zweight multivariate mass iran relation healthy poly standard birth analysis hospital index characteristic group tissue study refractory patient conclusionthis multinomial demographic deviation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815487/,abstract,1,zweight zheight shahrivar multinomial lipoid guilan leptin daytime focal poly backward objectivewe refractory pearson resultsthere conclusionthis anthropometric spss predominant epilepsy multivariate statistic bmi methodsthis demographic coefficient descriptive deviation iran seizure sex researcher university clinician word relation majority obesity science investigation index regression weight hospital onset tissue correlation frequency ass characteristic birth score standard body form month healthy mass key therapeutic medical lower respectively therapy material difference common approach case test time risk control factor type child significant group effect data analysis patient disease study,{},{},{},{},{},{}
1387,1387,1499,,25392440.0,pregnant although however daily better moderate certain agency affect standard answer determine child fully regularly adverse research available utero exposure effect sugar data substitute regulatory question patient pregnancy intake tell option amount acceptable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229159/,abstract,0,tell answer regularly agency utero substitute sugar acceptable pregnant fully question option moderate affect certain daily pregnancy regulatory adverse exposure intake determine standard better available research child effect data patient,{},{},{},{},{},{}
1388,1388,1500,10.1111/bph.13202,26014146.0,experimental disorder maximal vivo implicationsbiophysical spr essential binding restores surface elevated without biosynthesis tetrahydrobiopterin characterization unfortunately vascular dissociation regulatory endothelial activation activator phe synthesis numerous presence phenylalanine subject evidence pharmacological erythro form clinical protein allosteric intravenous mouse therefore biophysical manner substrate elevation bioavailable efficacy enzyme purpose effect aortic data absent forward cyclohydrolase oral feed furthermore level significant mimic alter rate gch systemic feedback affinity therapeutic slow ligand potential substantial treatment key association elevate challenge endogenous nitric limited function dependent plasmon background resultsgch cardiovascular gtp conclusion interaction orally oxide cofactor patient eightfold constitutively agent absence complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543619/,abstract,1,resultsgch restores plasmon implicationsbiophysical eightfold erythro dissociation constitutively bioavailable spr elevate biophysical gch feedback feed orally maximal ligand intravenous binding absent slow aortic activator unfortunately mimic cyclohydrolase allosteric gtp alter affinity forward elevation endothelial vascular surface nitric manner substrate endogenous oxide characterization biosynthesis systemic activation substantial numerous absence pharmacological cardiovascular agent cofactor elevated oral tetrahydrobiopterin experimental vivo regulatory dependent efficacy synthesis limited purpose presence furthermore essential interaction mouse background form enzyme phe subject challenge complex key therapeutic association rate evidence conclusion function phenylalanine potential protein significant effect data level disorder treatment clinical patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""therapeutic association rate evidence conclusion function phenylalanine potential protein significant effect d""]}}",{},{},{},{},{}
1389,1389,1501,10.1007/s12687-015-0217-5,25666434.0,expensive region responsibility context country world prenatal unproven governmental need genetics argentina inequitable corporation requisite average risk poverty testing principle surprising inequity discrimination ethical issue medical utility individualism clinical health focus therefore diagnosis hand situation internationally contrast anglo genetic low latin service market main fail genomics implementation intervention population review approach private regulation development plan social dilemma system technology bioethical industrial arbitrary expenditure decision care particularly predictive advance public mostly lack access equity saxon heart provision meaningful validity index gini paper impressive diagnostic america right human justice insurance complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524838/,abstract,1,unproven saxon inequitable individualism impressive gini dilemma bioethical anglo surprising requisite inequity governmental fail corporation argentina arbitrary latin justice poverty internationally responsibility equity industrial insurance expensive private expenditure america discrimination market meaningful validity hand provision situation plan right ethical principle prenatal predictive access genomics utility world decision contrast average advance heart service regulation index implementation focus lack genetics context particularly social paper issue main public technology need testing diagnostic country region complex medical intervention care low approach human risk diagnosis population review development health genetic clinical,"{""social"": {""freq"": 1, ""string"": [""implementation focus lack genetics context particularly social paper issue main public t""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1390,1390,1502,,29398747.0,disorder assessment clinic outpatient difference registration methylphenidate stimulant aged weight psychiatrist moreover ahwaz deficit conners average effective number well significantly golestan measurement however subject anthropometric clinical questionnaire double symptom body diagnosis like attention effect data medication use sucrose mann whitney measure software placebo dose child spss week anova method parent baseline test year randomized folic age irct mass iran appetite statistical adolescent psychiatric height adverse analysis background hospital index keywords trial conclusion group plus study acid hyperactivity blind randomly highly gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776000/,abstract,9,irct ahwaz methylphenidate golestan stimulant psychiatrist conners whitney sucrose mann appetite anova outpatient folic anthropometric spss registration randomized height plus software randomly hyperactivity blind placebo iran psychiatric medication keywords gender double adolescent baseline dose statistical average clinic index aged adverse deficit weight questionnaire hospital attention measurement highly parent week like body assessment background symptom measure mass subject trial effective use conclusion difference number test significantly diagnosis acid child age group year effect method data disorder clinical analysis study,"{""hyperactivity"": {""freq"": 1, ""string"": [""registration randomized height plus software randomly hyperactivity blind placebo iran psychiatric m""]}, ""psychiatric"": {""freq"": 1, ""string"": [""software randomly hyperactivity blind placebo iran psychiatric medication keywords gender double a""]}}",{},{},{},{},{}
1391,1391,1503,10.1074/jbc.M115.679068,26546682.0,experimental various monocyte bioinformatics daily search pathway inflammation macrophage principle control disease significantly membrane linoleic resident mainly therapy brain mouse autoimmune property six linolenic like metabolic stability oral lipid metabolism commonly rate administration sclerosis phenotype progression proof preclinical drug discovery model pufa fatty false altered cell downstream endogenous application function chronic resolvin analysis metabolomics eae microglial multiple autoreactive decreased plasma study acid patient encephalitis metabolite mitochondrial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692201/,abstract,2,resolvin eae autoreactive microglial encephalitis monocyte linolenic decreased pufa linoleic autoimmune macrophage resident sclerosis proof bioinformatics altered preclinical membrane downstream endogenous principle inflammation false lipid mitochondrial commonly stability progression mainly discovery metabolomics oral daily experimental fatty search administration property chronic like phenotype mouse various metabolite application plasma multiple drug pathway brain therapy rate cell function metabolism significantly model control acid metabolic analysis patient disease study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""various metabolite application plasma multiple drug pathway brain therapy rate cell f""]}}",{},{},{}
1392,1392,1505,10.2147/OTT.S104691,27274282.0,carrier wide biological erythrocyte specific however smart past marker negative unique application biocompatible targeting achieve problem drug extensively nanomaterial enhance surface albumin review immunological efficient therapeutic modality also property system efficacy high facilitate effect treatment delivery advantage disease year agent even limitation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876107/,abstract,0,smart nanomaterial biocompatible targeting immunological erythrocyte albumin extensively modality achieve surface enhance facilitate efficient advantage agent limitation past carrier unique property delivery efficacy negative marker biological wide problem application drug therapeutic specific review year effect high treatment disease,{},{},{},{},{},{}
1393,1393,1507,10.1007/s12687-018-0361-9,29504050.0,major relying disorder whether lead discus information responsibility context instead israeli positive autosomal prenatal abort reproductive parenthood condition common highlight testing disease semi whose normative baby hypothetical screening argument therefore possibility support rejection diagnosis prospective script pregnancy selective genetic perfect theme case abortion three pursue diversity child already point many naturally toward face parent test parental assertion decision challenge attitude interface mendelian carrier future newborn negative screen dream recessive order sick infant importance also conclusion classic often study another,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325039/,abstract,1,relying pursue perfect parenthood israeli dream abort script sick rejection assertion normative hypothetical abortion argument responsibility naturally mendelian instead attitude interface semi diversity reproductive face theme baby parental selective classic prenatal screen prospective possibility recessive carrier decision autosomal pregnancy negative lead context point highlight parent importance order discus testing support infant screening major challenge positive future information newborn conclusion condition common case test diagnosis child genetic disorder disease study,{},"{""autosomal"": {""freq"": 1, ""string"": [""screen prospective possibility recessive carrier decision autosomal pregnancy negative lead context p""]}, ""recessive"": {""freq"": 1, ""string"": [""selective classic prenatal screen prospective possibility recessive carrier decision autosomal pregnancy n""]}, ""genetic"": {""freq"": 1, ""string"": []}}",{},"{""newborn"": {""freq"": 1, ""string"": [""screening major challenge positive future information newborn conclusion condition common case t""]}, ""screening"": {""freq"": 1, ""string"": [""importance order discus testing support infant screening major challenge positive future i""]}}",{},{}
1394,1394,1508,10.1038/s41467-017-00047-z,28638095.0,laser biological inside mito confocal scanning tool preferentially specific supramolecular phenylalanine self cellular investigation opportunity new lack strategy apoptosis phosphonium form aggregation time fibrous dysfunction owing function present electron complexity actuation fibril critical cell molecular dipeptide environment characterization peptide therapeutic localized moiety mitochondrion nanostructure via disruption system triphenyl depth concentration fate spatiotemporal control organelle cause amphiphile powerful associated assembly first transmission challenge membrane mitochondrial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479829/,abstract,0,triphenyl phosphonium nanostructure fibrous dipeptide amphiphile actuation spatiotemporal owing mito supramolecular scanning localized fate preferentially organelle moiety confocal inside laser fibril mitochondrion depth apoptosis electron disruption transmission assembly aggregation complexity powerful membrane characterization peptide mitochondrial cellular opportunity associated investigation environment lack dysfunction self critical biological form tool challenge cause strategy therapeutic molecular concentration cell function present time new phenylalanine specific control,"{""phenylalanine"": {""freq"": 2, ""string"": []}}",{},{},{},{},{}
1395,1395,1509,10.1038/nchem.2058,25343606.0,galactose complex use selectivity hexose specific monitoring functional phenylalanine ternary example subject class situ fructose scarce distinguish follow achieve molecule oligonucleotides epitope clinical glucose organometallic alone organic differentiate method broad report functionality general target group aromatic aptamers high oligonucleotide mix interact acid human wave monosaccharide small receptor strongly postprandial ability amino low affinity particularly non detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339820/,abstract,0,organometallic oligonucleotide monosaccharide aptamers ternary hexose epitope oligonucleotides mix postprandial fructose differentiate wave selectivity scarce galactose interact functionality distinguish situ affinity achieve aromatic class broad strongly organic monitoring receptor glucose molecule follow example particularly ability general functional small target detection subject complex use report amino non low human phenylalanine specific acid group high method clinical,"{""phenylalanine"": {""freq"": 2, ""string"": [""use report amino non low human phenylalanine specific acid group high m""]}}",{},{},"{""detection"": {""freq"": 1, ""string"": [""particularly ability general functional small target detection subject complex use report a""]}, ""amino"": {""freq"": 1, ""string"": [""target detection subject complex use report amino non low human phenylalanine s""]}}",{},{}
1396,1396,1510,10.1155/2018/6352919,29511574.0,blood synthetic profile time visual due biomarker well objective pku glycomacropeptide intake visit amount phe suitable related phenylalanine introduction nonsignificant lacprodan analogue mixture protein determined minor cheese peptide food result purpose effect casein term combination low score significant four short biomarkers overall evaluation management phenylketonuria method baseline free concentration drink diet meal sample fsaa scale aim ghrelin natural min conclusion plasma satiety study whey small patient minute absorption amino presence cgmp,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817308/,abstract,4,lacprodan fsaa nonsignificant cheese ghrelin cgmp analogue whey satiety meal drink casein minor visit minute absorption mixture min glycomacropeptide visual synthetic peptide determined biomarker introduction suitable baseline natural profile short combination purpose presence free intake biomarkers evaluation scale related small overall score food aim phe objective plasma management diet concentration pku amino conclusion term sample phenylketonuria low time phenylalanine blood protein significant effect method result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""conclusion term sample phenylketonuria low time phenylalanine blood protein significant effect m""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""objective plasma management diet concentration pku amino conclusion term sample phenylketonuria l""]}}","{""diet"": {""freq"": 1, ""string"": [""food aim phe objective plasma management diet concentration pku amino conclusion t""]}}",{}
1397,1397,1511,10.1002/14651858.CD010331.pub2,28160271.0,considerable cross cluster pain cochrane search ratio difference single time author selection venepuncture cinahl reaction desaturation restriction attempt central additional due expert preterm abstract heel risk methodswe statistically inadequate methaemoglobinaemia injection evaluate conference significantly uncertain painful objectivesto typical gestational register homogenous needledata evidence event interval reduction anaesthetic moderate neurodevelopmental redness intramuscular previous needle clinical higher emla methaemoglobin procedure neonate apnoea complete report support effectiveness efficacy effect data language significance term similarly first long topical low level significant confidence although conclusionsoverall three one main short measure nnth pubmed placebo local evaluation outcome intervention quasi inclusion puncture lumbar method unable eutectic frequently cry treat disability safety analyse collection recommendation reporting directly insertion penetration resultseight age future two newborn bradycardia application harmful especially statistical embase invasive analysisfrom quality adverse criterion either prior infant oxygen trial cannulation episode group grade amethocaine tissue high informant study heterogeneity skin meta small undergo prick successful individual number mixture,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464546/,abstract,2,venepuncture topical redness penetration nnth needledata needle methaemoglobinaemia methaemoglobin eutectic emla desaturation cannulation apnoea analysisfrom amethocaine resultseight painful informant homogenous conclusionsoverall bradycardia quasi anaesthetic undergo puncture intramuscular harmful unable pubmed lumbar heel conference prick register objectivesto cinahl attempt uncertain reporting insertion inadequate episode analyse abstract oxygen cochrane similarly grade pain neonate mixture typical skin embase preterm cluster invasive placebo gestational injection author language considerable significance meta expert neurodevelopmental confidence treat prior local complete statistically safety restriction moderate successful heterogeneity event interval frequently procedure statistical selection inclusion directly search methodswe effectiveness evaluate collection reaction previous recommendation adverse central short efficacy reduction criterion cross disability tissue especially evaluation additional main ratio small support measure infant application long trial quality future single report intervention newborn evidence outcome term higher difference low number individual time significantly risk age significant group effect high method data level clinical study,"{""skin"": {""freq"": 1, ""string"": [""similarly grade pain neonate mixture typical skin embase preterm cluster invasive p""]}}","{""heterogeneity"": {""freq"": 1, ""string"": [""complete statistically safety restriction moderate successful heterogeneity event interval frequently procedure s""]}}",{},"{""newborn"": {""freq"": 1, ""string"": [""trial quality future single report intervention newborn evidence outcome term higher d""]}}",{},{}
1398,1398,1512,10.1111/petr.12741,27329540.0,multidisciplinary transplant significant complex specific suffer disorder treatable life strategy decompensations variety stressor systemic vital despite careful quality perioperative restriction liver approach management review therapeutic due transplantation indication error severe inborn improve metabolic risk article manifestation effective dietary surgical recommendation term patient disease significantly even long metabolism complication successful option metabolite medical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142218/,abstract,0,decompensations perioperative suffer stressor careful transplant multidisciplinary surgical vital treatable indication transplantation systemic manifestation improve complication variety restriction option successful recommendation liver despite severe inborn metabolite long management complex strategy error quality therapeutic effective medical dietary life term article approach metabolism significantly risk specific review significant metabolic disorder patient disease,{},{},{},{},{},{}
1399,1399,1513,10.1371/journal.pone.0194416,29561882.0,male sweetener conclusionasp rationaleaspartame nursing nutritive beverage daily factor subunit glutamate oxidative adult present glucose gland nns asp behavior homeostasis degs together utero catecholamine locomotion risk old differentially cholesterol antagonism amongst status responsive significantly hypothalamic synthesis whose pregnant microarray doubling adulthood however phenylalanine axis pharmaceutical recent spatial mainly cognition previous consistent developmental mouse alone nmdar effect prospective receptor pregnancy aspartame metabolism hpa affymetrix non use stress functional certain drug child detrimentally damage product anova neurogenesis expression exposure methyl mother treatment rich response network year steroid antagonist cell blockade inflammatory public adiposity pituitary regulated since competitive involved ester chronic analysis previously aspect gaba general aspartate robustly adrenal part pattern study neurosteroidogenesis dietary aspartyl cgp absence gene highly cns presence hypothalamus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862471/,abstract,6,rationaleaspartame nmdar neurosteroidogenesis locomotion ester doubling detrimentally degs conclusionasp cgp aspartyl antagonism affymetrix nns hypothalamus adiposity neurogenesis asp hypothalamic competitive blockade nursing nutritive gaba aspartate aspartame anova steroid robustly regulated pituitary antagonist microarray utero cns axis adrenal sweetener catecholamine subunit gland glutamate differentially methyl cognition spatial cholesterol beverage hpa rich responsive pharmaceutical pregnant adulthood oxidative absence involved homeostasis damage prospective mainly receptor mother glucose certain daily aspect inflammatory network pregnancy previous pattern stress consistent old behavior exposure synthesis presence chronic developmental product highly previously general male functional public status mouse expression drug response adult recent use dietary non cell present metabolism significantly risk phenylalanine factor child gene year effect treatment analysis study,"{""phenylalanine"": {""freq"": 2, ""string"": [""non cell present metabolism significantly risk phenylalanine factor child gene year e""]}}",{},{},{},"{""aspartame"": {""freq"": 1, ""string"": [""rationaleaspartame nmdar neurosteroidogenesis locomotion ester d"", ""competitive blockade nursing nutritive gaba aspartate aspartame anova steroid robustly regulated p""]}}",{}
1400,1400,1514,10.2147/NDT.S120509,29296085.0,disorder autism whether almost factor early lower anxiety present condition onset common deficit perhaps status spectrum peak suitable account relevant however evidence much childhood broader higher kleffner role play feature focus sleep determined result attention contraindication genetic medication epilepticus regression lose rate asd one current drug syndrome occurrence child people disability epilepsy landau plausible important adolescence greatest finding challenge generally two certainly nonconvulsive likely prevalence subgroup approximately criterion environmental mechanism research infancy intellectual autistic interaction hyperactivity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739118/,abstract,0,nonconvulsive lose landau kleffner contraindication epilepticus certainly plausible greatest autistic peak broader occurrence sleep epilepsy adolescence infancy subgroup hyperactivity determined medication anxiety suitable generally asd people account approximately play intellectual autism childhood regression deficit focus feature criterion likely onset disability attention environmental syndrome relevant prevalence status spectrum finding interaction challenge drug lower mechanism rate evidence current higher condition important role common present early factor research child genetic disorder result,"{""hyperactivity"": {""freq"": 1, ""string"": [""occurrence sleep epilepsy adolescence infancy subgroup hyperactivity determined medication anxiety suitable g""]}, ""intellectual"": {""freq"": 1, ""string"": [""generally asd people account approximately play intellectual autism childhood regression deficit f""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1401,1401,1515,10.3390/molecules22060858,28632186.0,biological strain related activity past application biotechnological produce several author structure capability additionally nature alkaloid interesting many cyclodepsipeptides review environmental aspect insight secondary penicillium pathogen great meroterpenoids also genomic summarize share bioactive potential diketopiperazines different enzyme metabolic diverse source polyketides soil year ability plant brasilianum metabolite onion,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152788/,abstract,0,polyketides penicillium onion meroterpenoids diketopiperazines cyclodepsipeptides brasilianum alkaloid soil biotechnological summarize pathogen bioactive interesting strain plant capability share produce author diverse nature great past aspect additionally secondary genomic insight source environmental structure biological ability related metabolite enzyme application activity review potential different metabolic year,{},{},{},{},{},{}
1402,1402,1516,10.1371/journal.pone.0164305,27711248.0,potent considerable lowered blood synthetic hour extremely early pathway time essential present initial synthase oat without elevated tetrahydrobiopterin together organic supplementation aromatic mean course effective orphan vitamin disease excretion however family organ relative uptake dysfunction role brain expense exogenously distribution body symptom anion attention effect urine cause decrease rat low period level biopterin rapid administration certain crucial compensatory inhibitor metabolized transporter drug nadph dihydrobiopterin liver back efficiency via metabolically concentration simultaneously treatment gradually salvage particularly process within bile application inevitable since limited hydroxylases elimination cardiovascular prior also min high practice otherwise interchangeable oxide acid human similar cofactor patient conversion counter amino kidney sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053593/,abstract,1,lowered interchangeable metabolized inevitable exogenously counter salvage metabolically oat nadph hydroxylases expense dihydrobiopterin compensatory anion biopterin bile gradually elimination uptake orphan excretion potent extremely simultaneously conversion min kidney transporter aromatic oxide crucial synthase synthetic efficiency inhibitor hour considerable organ vitamin course organic initial cardiovascular prior rat cofactor sensitive distribution elevated certain tetrahydrobiopterin relative urine administration supplementation decrease mean liver dysfunction rapid limited attention practice particularly essential period similar body symptom process application cause drug effective pathway brain family concentration amino role low present time human early blood acid effect high level treatment patient disease,"{""urine"": {""freq"": 1, ""string"": [""sensitive distribution elevated certain tetrahydrobiopterin relative urine administration supplementation decrease mean l""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""symptom process application cause drug effective pathway brain family concentration amino r""]}}","{""amino"": {""freq"": 1, ""string"": [""drug effective pathway brain family concentration amino role low present time h""]}}",{},{}
1403,1403,1518,10.1093/jlb/lsu027,27774176.0,implication disorder rise past almost information positive present without condition severe state probably principle disease medical treatable biochemical however marker thought form contradict health economical clinically purpose data forward expansion cause first genetic type infrastructure use whole mutation current expand many management evident potential sufficient parent article care challenge dramatically every public wgs newborn negative likely birth accommodate path alternative program quantity genome historically often insufficient sequencing look preparation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033535/,abstract,0,thought contradict accommodate look infrastructure wgs expand probably economical rise dramatically historically path forward quantity insufficient expansion evident treatable preparation principle sufficient past alternative clinically genome implication negative marker likely purpose sequencing parent biochemical public birth severe form state management program challenge cause positive medical use care information newborn current mutation condition article present type potential health genetic data disorder disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},"{""newborn"": {""freq"": 1, ""string"": [""cause positive medical use care information newborn current mutation condition article p""]}}",{},{}
1404,1404,1519,10.1016/j.ssmph.2017.08.005,29349257.0,considerable pla better ratio pafs difference factor malm information fundamental hazard examine rct positive demonstrates density attributable fpf substantially mdc odds crp pro moreover ice ace probabilistic risk average modern majority cholesterol true way disease traditional hydroxylase pku phospholipase cancer however phenylalanine subject strategy recent distinguish relative discriminatory raise value clinical tpf preventive role health protein brain ntbnp therefore natriuretic peptide paf chd diagnosis multilevel effect fraction change lipoprotein little novel ability planning overtreatment epidemiology low medicine area use bypass although pci neither variable graft measure biomarkers percutaneous curve discussion already woman terminal around intervention regard population model phenylketonuria simple causal reactive abbreviation thereby baseline auc sex artery criticism association receiver year diet false operating age public alongside magnitude heart hdl plethora analysis characteristic research also trial pah general roc group cohort coronary high study heterogeneity insufficient fractionkeywords men even individual cabg demographic ldl,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769103/,abstract,2,tpf probabilistic phospholipase percutaneous pci pafs paf overtreatment ntbnp natriuretic mdc malm fractionkeywords fpf crp cabg pla ice hazard discriminatory criticism bypass ace rct plethora coronary multilevel hdl graft lipoprotein ldl alongside modern distinguish artery roc magnitude auc terminal operating men attributable substantially demonstrates raise regard receiver reactive planning abbreviation true epidemiology preventive insufficient pro cholesterol chd odds fundamental causal density curve demographic peptide fraction false discussion traditional sex examine considerable simple little heterogeneity baseline majority relative average heart way woman variable cancer pah biomarkers ability medicine general cohort characteristic hydroxylase ratio public better area measure subject trial change positive strategy value brain association recent use diet intervention novel information pku role difference phenylketonuria low individual risk model phenylalanine factor diagnosis research population protein age health group year effect high clinical analysis disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""difference phenylketonuria low individual risk model phenylalanine factor diagnosis research population p""]}}","{""heterogeneity"": {""freq"": 1, ""string"": [""traditional sex examine considerable simple little heterogeneity baseline majority relative average h""]}}",{},{},"{""diet"": {""freq"": 1, ""string"": [""strategy value brain association recent use diet intervention novel information pku r""]}}",{}
1405,1405,1521,10.1016/j.redox.2017.08.002,28803128.0,experimental significant still disorder delay availability mutation hypoxic one evidence biosynthetic palsy childhood factor possible ischemic biology especially hypoxia redox maintain produce dysfunction oxidative function ischemia child decline occurrence role necessary brain impairment developmental mechanism tetrahydrobiopterin encephalopathy central coincides neurotransmitter development deficit antenatal loss motor cause important cerebral well cofactor deficiency immature elucidated response status genetic neurological injury neuronal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554922/,abstract,0,elucidated coincides ischemic ischemia palsy hypoxic immature biosynthetic hypoxia redox maintain antenatal encephalopathy decline occurrence cerebral produce injury neuronal neurotransmitter oxidative delay cofactor biology availability motor tetrahydrobiopterin experimental neurological necessary central childhood deficit loss impairment dysfunction developmental especially status possible cause response brain deficiency mechanism evidence mutation important role function factor child significant development genetic disorder,"{""neurological"": {""freq"": 1, ""string"": [""cofactor biology availability motor tetrahydrobiopterin experimental neurological necessary central childhood deficit l""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1406,1406,1522,10.1177/1745691615617439,26817721.0,genetically intelligence specific adulthood four size context explain current behavioral heritability discovery concern big top impact reason research science environment also robustly potential infancy sensitive replication effect psychological linearly term genetic replicate finding,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739500/,abstract,1,replicate linearly big robustly heritability explain replication intelligence infancy reason psychological adulthood genetically sensitive discovery behavioral science concern size environment context finding impact current term specific research potential effect genetic,"{""behavioral"": {""freq"": 1, ""string"": [""reason psychological adulthood genetically sensitive discovery behavioral science concern size environment c""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1407,1407,1524,10.1038/s41598-018-29640-y,30050108.0,clearly various correlation four mutation phenylalanine homoallelic three nine main mainland encoding factor phenotype among heterozygous next compound consistent mhp define population analysis aim five phenylketonuria degree heteroallelic frequently pah support hyperphenylalaninaemia classic del hemizygous functionally mild sequencing hypothesis ten eleven generation patient hydroxylase pku gene consistently chinese fifteen,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062512/,abstract,1,homoallelic heteroallelic hemizygous mhp mainland hyperphenylalaninaemia del functionally define consistently heterozygous clearly encoding degree chinese classic mild hypothesis frequently consistent compound pah generation sequencing correlation hydroxylase main phenotype various support aim mutation pku phenylketonuria phenylalanine factor population gene analysis patient,"{""phenylalanine"": {""freq"": 2, ""string"": [""various support aim mutation pku phenylketonuria phenylalanine factor population gene analysis p""]}}","{""heterozygous"": {""freq"": 1, ""string"": [""mainland hyperphenylalaninaemia del functionally define consistently heterozygous clearly encoding degree chinese c""]}}",{},{},{},{}
1408,1408,1525,10.1038/srep35809,27805010.0,correlation specific caudate striatum selectively difficult visual motor activation discrimination primate associative however latter postmortem dopamine value role play brain shrna task contrast anatomically pet marmoset receptor tomography voxel level separation hybridization emission current apparent critical technique ligand expression potential dorsomedial putamen important rodent finding challenge dorsolateral anatomical genetically situ function cognitive analysis mechanism mrna successfully positron performance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5090965/,abstract,0,dorsomedial putamen postmortem dorsolateral associative anatomically marmoset caudate voxel anatomical shrna pet primate selectively rodent striatum positron ligand situ separation hybridization discrimination apparent tomography emission mrna visual successfully activation genetically receptor motor dopamine task play contrast difficult critical correlation technique performance finding cognitive challenge expression value brain mechanism current important role function specific potential level analysis,{},{},{},{},{},{}
1409,1409,1526,10.1016/j.csbj.2018.08.003,30237866.0,major specific example antimicrobial new technical time laboratory selection initial molecular bacterial soft succinctly regulatory finally acquisition computer automation era discourse phylogenetic unleashing isobaric quantitation perspective clinical role protein critically expertise genomic structural analytical undergone recently metabolic conceptual effect microbial data urine novel first tandem flight interference detection laser service significant rapid requirement hard underway current instrument outline replace fungal review quadrupole technique electrospray identification determination post tof development target gas potential technology unknown evolution susceptibility orbitrap important hormone desorption filter assay challenge maturation mini toxicology mass variant application biology space maldi adaptation ionization electron field next resistance basic matrix spectrometry general classification limitation metabolite spectrometer chromatography versatile sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138949/,abstract,0,unleashing succinctly orbitrap maldi automation phylogenetic isobaric desorption underway undergone toxicology replace electrospray soft mini fungal tof quadrupole interference discourse versatile ionization conceptual antimicrobial maturation laser hard flight spectrometer quantitation space critically electron expertise outline microbial computer acquisition adaptation era evolution matrix filter instrument requirement bacterial technical susceptibility gas resistance classification determination basic hormone initial analytical sensitive biology limitation tandem structural perspective post selection urine chromatography unknown regulatory genomic service finally recently assay example rapid spectrometry technique laboratory identification general technology field target detection metabolite application mass major challenge variant molecular novel current important role time new specific review potential protein significant development metabolic effect data clinical,"{""urine"": {""freq"": 1, ""string"": [""limitation tandem structural perspective post selection urine chromatography unknown regulatory genomic s""]}}",{},{},"{""detection"": {""freq"": 1, ""string"": [""laboratory identification general technology field target detection metabolite application mass major c""]}, ""tandem"": {""freq"": 1, ""string"": [""hormone initial analytical sensitive biology limitation tandem structural perspective post selection u""]}, ""spectrometry"": {""freq"": 1, ""string"": [""service finally recently assay example rapid spectrometry technique laboratory identification general t""]}}",{},{}
1410,1410,1527,10.2105/AJPH.2017.303655,28272952.0,interpretation culture dominant allocation example better ill factor effort several erroneously site attributable behavior action physical view clear risk surprising influential whose historical numerous third cancer equal clinical nature health causation refutation science environment sum error debate force deeply cause extend versus first doll current economic population critical review back approach model chance method work social flawed peto web article resource publicity year care public earlier still two opus equity analysis roadmaps faulty high nurture county,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343713/,abstract,3,roadmaps refutation publicity peto opus nurture erroneously doll surprising flawed faulty extend county causation deeply influential equity allocation historical sum ill chance equal attributable force debate dominant earlier web interpretation culture clear versus numerous view action nature economic science resource effort environment physical cancer work site example behavior critical social public better cause error care current article approach risk model factor population review health year high method clinical analysis,"{""social"": {""freq"": 1, ""string"": [""cancer work site example behavior critical social public better cause error c""]}}",{},{},{},{},{}
1411,1411,1528,10.1089/hum.2016.160,27897038.0,advent specific decade disorder future understanding administration past remarkable organ hemophilia serotype context current therapy clinical field historic currently review liver adeno focus particular trial development rapidly number response well immune virus novel aav ongoing stride gene challenge promoter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5177998/,abstract,0,historic stride hemophilia serotype remarkable aav adeno advent ongoing rapidly promoter virus organ immune past decade administration particular understanding focus liver context currently field trial challenge response future novel therapy current number specific review development gene disorder clinical,{},{},{},{},{},{}
1412,1412,1529,10.1186/s13023-019-1130-5,31248438.0,operation specific unrealistic structured neighborhood reconsideration outpatient effort commission action realization additional due sub continuous diverse well specialist disease month imbursement physician medical measurement demand account knowledge respect however cme therefore probability structural support hematology university metabolic rheumatology reference initiate low administrative privileged period three resultsbetween requirement gastroenterology structure already participate conclusionsthe work slow plan development national diagnose organization introductionin person germany education care rare german berlin load lack ethnic nap prevalence access contract especially since excellence quality brandenburg either hospital background framework program none high direct center patient methodsour number interested,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598233/,abstract,4,rheumatology resultsbetween imbursement hematology cme brandenburg reconsideration privileged nap methodsour gastroenterology unrealistic neighborhood interested contract berlin administrative introductionin excellence realization structured initiate german commission slow ethnic participate outpatient diagnose operation probability load germany demand sub respect person requirement specialist plan continuous physician organization conclusionsthe university diverse access action reference framework structural account education effort center direct work hospital lack national structure measurement especially prevalence additional period knowledge background support month program quality medical rare care low number specific development metabolic high patient disease,{},{},{},{},{},{}
1413,1413,1530,10.21037/atm.2018.12.12,30740402.0,carboxylic disorder iem growth energy single discus pathway creation nutrition formula essential defect recycled garrod genetics common endogenously source addition concept repair issue homogentisic unique screening dysfunction role protein aka error food inborn enzyme metabolic kreb term intoxication metabolism medicine ketogenic block structure tyrosine vital review approach evolution oxidase intermediate treatment glucogenic key diet archibald carbon cell tca biochemistry survival regeneration architect field precursor also group historically cycle different acid human deficiency amino gene chapter metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331359/,abstract,2,recycled kreb architect tca ketogenic glucogenic carboxylic archibald aka garrod endogenously homogentisic intoxication repair regeneration oxidase creation biochemistry intermediate carbon chapter historically vital block evolution formula survival precursor energy concept iem cycle unique nutrition source genetics dysfunction structure tyrosine defect essential growth medicine issue discus field inborn food metabolite enzyme screening addition key error pathway single deficiency diet amino term role common cell approach metabolism human review acid different protein metabolic gene group disorder treatment,{},{},"{""pathway"": {""freq"": 1, ""string"": [""metabolite enzyme screening addition key error pathway single deficiency diet amino t""]}}","{""amino"": {""freq"": 1, ""string"": [""key error pathway single deficiency diet amino term role common cell a""]}, ""screening"": {""freq"": 1, ""string"": [""discus field inborn food metabolite enzyme screening addition key error pathway s""]}}","{""diet"": {""freq"": 1, ""string"": [""addition key error pathway single deficiency diet amino term role common c""]}}",{}
1414,1414,1531,10.1007/s00335-017-9697-4,28634692.0,specific tool activity secondly information organism subunit exhibit site efficient stringent molecular physical parallel bacterial cost facilitate nuclease diverse effective firstly issue sequence related adjacent strategy possible particle lastly toolbox range protein improvement genomic structural property enzyme crispr specie furthermore level effector commonly orthologues motif requirement size pyogenes discovery recognition residue model therapeutic efficiency target potential system delivery key viral limit address challenge cell shortcoming streptococcus specificity component robust rna application engineering contributing mutagenesis available also array different high mutagenizing advantage thanks wealth show accuracy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569134/,abstract,0,toolbox pyogenes orthologues mutagenizing wealth thanks shortcoming secondly streptococcus adjacent stringent particle nuclease mutagenesis firstly lastly contributing motif effector subunit crispr array engineering residue exhibit viral recognition requirement organism bacterial parallel specie rna efficiency facilitate commonly efficient limit diverse advantage robust discovery structural accuracy address specificity property delivery sequence genomic component size physical improvement site cost furthermore related issue target possible tool enzyme application challenge range strategy key therapeutic effective molecular information activity cell available model specific potential different protein high level,{},{},{},{},{},{}
1415,1415,1532,10.1177/2050640616684696,29163958.0,assessment tool backgroundan better difference single secure author selection bias slightly superior magnesium colonoscopy risk methodswe conclusionsspmc effective favour significantly resultsthirteen citrate sodium polyethylene equally aimthe effect large data good little term tolerable tolerability extraction significant phosphate independently side database overall spmc peg picosulphate article important electronic vomiting two randomised dizziness january nap unclear standard validated quality aim bowel alternative also trial except rcts study heterogeneity similar agent preparation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676539/,abstract,0,spmc resultsthirteen picosulphate conclusionsspmc backgroundan tolerable nap dizziness secure randomised aimthe tolerability rcts citrate colonoscopy vomiting favour equally magnesium polyethylene peg phosphate bowel sodium validated slightly superior independently extraction preparation january bias author agent unclear little heterogeneity selection alternative methodswe good database overall standard better similar assessment aim tool trial electronic quality effective large single term article important difference significantly risk significant effect data study,{},"{""heterogeneity"": {""freq"": 1, ""string"": [""january bias author agent unclear little heterogeneity selection alternative methodswe good d""]}}",{},{},{},{}
1416,1416,1533,10.1093/advances/nmy027,30060014.0,male balance specific bulk daily ratio factor tertiary ammonia glutamate dioxide essential present adult resynthesis glucose skeleton condition bond conditionally capable source canonical addition glycine glutamine intake amount synthesis glucosamine sequence suitable related equal phenylalanine possible maintain gluconeogenesis additionally role protein compound chemically nutritionally spermatogenesis nitrogen glutathione secondary body leucine peptide primary degradation arginine histidine indispensable ornithine thus creatinine polyamines consume similarly pregnancy uric metabolism proline quantitatively cysteine gastrointestinal although citrulline female interest concerned taurine discussion others tyrosine many able lysine product day polymer alanine serine via sufficient viewpoint free ketone urea important nonprotein creatine hormone directly isoleucine physiologic carbon cell quaternary nitric limited function turnover dna quality precursor tract quantity tryptophan also nutritional plus nucleotide oxide acid human methionine dietary small asparagine even exception amino individual pathologic aminobutyrate,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140426/,abstract,6,spermatogenesis skeleton resynthesis quaternary polyamines nonprotein ketone glucosamine conditionally aminobutyrate taurine gluconeogenesis viewpoint quantitatively physiologic nutritionally dioxide creatine bulk indispensable chemically bond concerned proline ornithine citrulline canonical uric histidine consume asparagine turnover pathologic nitrogen maintain glutathione glutamine polymer lysine glycine cysteine creatinine serine carbon methionine exception equal alanine tertiary isoleucine glutamate balance leucine quantity gastrointestinal ammonia tract arginine similarly plus capable urea nitric oxide tryptophan peptide sufficient discussion degradation suitable hormone precursor able nucleotide glucose daily additionally directly secondary pregnancy sequence dna female source compound nutritional synthesis limited free intake tyrosine product essential related male ratio small possible body addition day primary quality adult dietary amino condition important role cell function present metabolism individual human phenylalanine specific factor acid protein,"{""phenylalanine"": {""freq"": 2, ""string"": []}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""addition day primary quality adult dietary amino condition important role cell f""]}}",{},{}
1417,1417,1535,10.1128/AAC.00692-18,29891609.0,pain daily investigation difference multidose maximum teaes adult site median weight bacterial cabp well characterize subject covariate gov event pharmacokinetics clinical attrs range consistent intravenous diarrhea body capsule six enzyme solithromycin data term novel oral first type pneumonia clinicaltrials significant pediatrics four administration hepatic size text fluoroketolide eighty child population accounting model infusion day frequently compartment simulation exposure safety treatment identifier year phase age sample two pediatric community adolescent antibiotic analysis adverse previously emergent paper nct keywords trial seventy suspension study phlebitis postmenstrual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105834/,abstract,24,teaes solithromycin phlebitis multidose fluoroketolide cabp postmenstrual suspension pneumonia pediatrics covariate seventy eighty capsule emergent infusion diarrhea pharmacokinetics intravenous identifier accounting compartment antibiotic maximum attrs simulation pain bacterial clinicaltrials hepatic characterize nct gov keywords safety event adolescent oral daily frequently text community phase administration median investigation size adverse pediatric consistent site weight exposure previously paper body enzyme subject day trial range adult novel term difference sample model type population child age significant year data treatment clinical analysis study,{},{},{},{},{},{}
1418,1418,1536,10.1016/j.omtm.2019.05.002,31194088.0,phenotypic assessment single outclassed together control regulatory classical mfp finally virus disease geneswitch murine promoter transcription element inducible transiently therapy protein mouse whereby mifepristone data advantageous change aav applicability level rapid one transgene clearance dynamic liver window plasmid therapeutic via expression system treatment delivery detail viral inducibility within two continuously comparison limited analysis adeno head importance also induction multiple depth plasma tissue mrna regulating inducer vector patient gene show metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551379/,abstract,0,outclassed mifepristone mfp inducibility geneswitch inducer transiently inducible advantageous applicability transgene plasmid clearance depth aav adeno window regulating induction continuously murine mrna head viral promoter vector virus element dynamic transcription phenotypic classical regulatory delivery finally comparison liver rapid limited tissue importance mouse assessment metabolite plasma expression change multiple therapeutic single therapy control protein gene data level treatment analysis patient disease,{},{},{},{},{},{}
1419,1419,1537,10.1002/jsfa.8953,29427307.0,major backdrop discus effort nutrition july author increasingly chemical journal conference son climate consumer issue demand discourse planting meet place variety perspective role health protein global ltd science food change generation international sustainability water three society behalf sustainable wiley unprecedented population john face system second article topic resource collaborative important key year diet challenge livelihood future access healthy stakeholder environmental group seed nutritional namely nexus soil industry agriculture nestl,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033153/,abstract,1,son planting nestl livelihood john nexus behalf backdrop soil seed sustainable sustainability climate agriculture wiley unprecedented discourse collaborative meet conference journal july stakeholder demand topic industry consumer face place author society water chemical access variety increasingly nutrition perspective science international resource effort global second nutritional generation environmental issue discus food healthy major challenge change key future diet article important role population protein health group year,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""healthy major challenge change key future diet article important role population p""]}}",{}
1420,1420,1538,10.21037/atm.2019.05.16,31355225.0,sectional difference positive splicing condition resultsa missense highlight hydroxylase village phe spectrum characterize medical sanger phenylalanine screening regional neonate genotype nonsense data novel first hpa low eight methodscross rate mutation three one hot economic database population national system calculate conclusionsthis frequent reporting diet incidence carrier uygur within two variant newborn poor hyperphenylalaninemia spot backgroundneonatal pah different study frameshift direct patient twenty gene total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614323/,abstract,6,uygur backgroundneonatal methodscross frameshift village hot calculate splicing nonsense reporting sanger regional resultsa neonate conclusionsthis hpa characterize missense hyperphenylalaninemia frequent economic carrier genotype poor sectional direct incidence pah national database spot highlight hydroxylase spectrum phe screening positive variant medical diet novel rate total newborn mutation condition difference low phenylalanine population different gene data patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""total newborn mutation condition difference low phenylalanine population different gene data p""]}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""variant medical diet novel rate total newborn mutation condition difference low p""]}, ""screening"": {""freq"": 1, ""string"": [""database spot highlight hydroxylase spectrum phe screening positive variant medical diet n""]}}","{""diet"": {""freq"": 1, ""string"": [""spectrum phe screening positive variant medical diet novel rate total newborn m""]}}",{}
1421,1421,1539,10.1093/aje/kwx230,28978190.0,availability assessment example factor single pathway several ethnically insight literature moreover diverse principle disease longitudinal related broadly select range focus candidate therefore environment pharmacogenomics large geographically genetic metabolism level functional measure size multiplicative population approach inclusion model exposure system article susceptibility success year wide future scale additive quality environmental benefit impact research different interaction high last study lesson accurately gene complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5860326/,abstract,0,ethnically multiplicative geographically pharmacogenomics select additive lesson broadly accurately susceptibility principle success longitudinal candidate diverse availability inclusion size environment insight focus example exposure environmental wide scale related functional benefit interaction literature assessment measure range complex quality large future pathway single impact article approach metabolism model factor research population different gene year high genetic level disease study,{},"{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""measure range complex quality large future pathway single impact article approach m""]}}",{},{},{}
1422,1422,1540,10.1007/s12291-017-0688-8,29062170.0,major various scanning bioinformatics new single information technical widespread several selection together molecular elucidation genetics open risk display pinpoint disease issue concentrate sequence interplay advent microarray related knowledge era however event pharmaceutical role play commercialization structural chip thus etc large computational thousand generation genetic obstacle exploration phage detection multidisciplinary level service pcr hybridization functional mutation rapid hybrid pathogenic genomics current implementation database discovery recognition exploitation many critical approach management development via expression dispersal antibody technology simultaneously polymorphism alteration treatment important response promising challenge microarrays two snp application biology engineering function field next dna currently analysis criterion benefit vista also pinpointed diagnostic outbreak biotechnology pattern nucleotide sequencing marketing patient industry gene individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634985/,abstract,0,vista pinpointed pinpoint phage outbreak dispersal commercialization microarrays marketing exploitation concentrate scanning elucidation hybrid exploration biotechnology microarray interplay obstacle chip hybridization advent engineering multidisciplinary display bioinformatics simultaneously era thousand widespread industry antibody recognition computational technical promising pharmaceutical snp pcr genomics pathogenic biology open nucleotide event discovery polymorphism structural alteration play selection sequence service dna implementation pattern genetics criterion rapid generation critical sequencing database currently related functional benefit issue technology field knowledge diagnostic detection various application management major challenge expression response large single molecular information current mutation important role function approach individual new risk development gene genetic level treatment analysis patient disease,{},"{""genetic"": {""freq"": 1, ""string"": [""approach individual new risk development gene genetic level treatment analysis patient d""]}}",{},"{""detection"": {""freq"": 1, ""string"": [""benefit issue technology field knowledge diagnostic detection various application management major c""]}}",{},{}
1423,1423,1542,10.1111/eva.12523,29387151.0,operation balance worldwide statistic domestic relationship past ratio twelve urbanization country largely selection attributable inversely aged physical due gross toxin average accumulation smoking increase virus expectancy inactivity cancer life reduction caput obesity mutant six like confounders genetic mortality fertility significant seven rate mutation one per aetiology external strong relaxed many population product constant older people potential pool strongly year incidence gdp fifteen process genetically age opportunity allele heritability background index natural multiple group lowest human twenty highest gene individual statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775494/,abstract,3,relaxed urbanization inactivity gdp domestic caput confounders gross fertility aetiology inversely expectancy pool toxin smoking heritability external constant operation attributable balance lowest statistic virus older worldwide largely strongly genetically statistically people strong mutant highest seven past accumulation obesity opportunity selection average natural allele mortality index aged incidence physical cancer reduction product like ratio relationship country background process multiple increase rate life mutation individual human population potential age significant gene group year genetic,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1424,1424,1543,10.3941/jrcr.v12i1.3207,29875981.0,resonance matter extensive commonly case mimic disorder biologic abnormality signal likely discus toxic unreported white demonstrates present therapy betaine synthase previously review mechanism cystathionine basal pressure literature also vascular potential metabolic magnetic manifestation homocystinuria methionine cause deficiency tomography intracranial underlying finding ganglion,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965393/,abstract,0,unreported betaine intracranial cystathionine biologic homocystinuria ganglion basal mimic methionine demonstrates tomography vascular toxic synthase pressure resonance underlying extensive commonly manifestation matter signal white magnetic abnormality likely previously discus finding literature cause deficiency mechanism therapy present case review potential metabolic disorder,{},{},{},{},{},{}
1425,1425,1544,10.1186/s11689-018-9238-9,29890955.0,specific statistic disorder tool autism harbor backgroundalthough region factor among several largely standardized contains posterior moreover risk intrafamilial majority well way essentially objective inter material spectrum supplementary family evidence much unique confirm user appreciable bap manner probability familial result bayesian novo methodsasd genetic chromosomal level case pedigree three asd least nuclear phenotype conclusionsinclusion apparent strength outcome quasi model method sporadically free online article interfamilial electronic allelic materialthe version wide robust linkage sample resultsthe two occur progress variant scale usa underscore ppl analysis available broad widely genome high study heterogeneity subclinical though even individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996536/,abstract,1,sporadically ppl methodsasd intrafamilial interfamilial conclusionsinclusion bap backgroundalthough appreciable quasi bayesian pedigree harbor subclinical essentially posterior usa allelic underscore occur contains familial probability chromosomal confirm apparent standardized linkage strength novo inter statistic manner progress broad largely nuclear resultsthe asd robust widely heterogeneity unique majority way autism genome free materialthe wide scale phenotype spectrum region tool supplementary objective user version variant electronic online family evidence material outcome article sample case available individual risk model specific factor high genetic method level disorder analysis result study,{},"{""genetic"": {""freq"": 1, ""string"": [""individual risk model specific factor high genetic method level disorder analysis r""]}, ""heterogeneity"": {""freq"": 1, ""string"": [""largely nuclear resultsthe asd robust widely heterogeneity unique majority way autism g""]}}",{},{},{},{}
1426,1426,1545,10.1155/2017/5728742,28900547.0,epidemiological pain new early context among endemicity salvador present pacemaker electrocardiographic physical state highlight immigrant risk cardiomyopathy old course majority etiological disease exam recurrent endemic however family chest adequate today health diagnosis symptomatic change cause ccm united suffering consideration latin area significant case sister remarkable etiology sinus economic provide woman population living history diagnose stage people syncopal american treatment year challenge traditionally public bradycardia underrecognized differential hospital importance also chaga study serology ancillary identifiable similar patient salvadoran presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576390/,abstract,0,underrecognized syncopal sinus salvadoran salvador immigrant endemicity electrocardiographic chaga ccm sister serology pacemaker chest bradycardia ancillary latin identifiable suffering cardiomyopathy etiological traditionally remarkable exam endemic diagnose today living recurrent pain symptomatic epidemiological american adequate differential united course consideration economic people etiology majority stage history woman physical old hospital context presence highlight importance provide public similar area state challenge change cause family present case new risk early diagnosis population significant health year treatment patient disease study,{},{},{},{},{},{}
1427,1427,1546,10.1007/8904_2016_4,27469133.0,shift ratio among positive laboratory present together additional centralized common continuous risk testing severity swedish increase disease doe pku hydroxylase material sweden phe spectrum supplementary phenylalanine marker introduction milder form tyr east user value doi improvement result diagnosis genetic middle level mutation one phenotype prediction tyrosine confirmation inclusion phenylketonuria confirmatory method identification southern development towards online europe treatment electronic year version predictive age earlier newborn continuum impact program available also pah heterogeneity patient chapter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509542/,abstract,3,swedish centralized continuum milder sweden southern east confirmatory confirmation chapter europe shift earlier middle doi tyr continuous prediction introduction predictive doe heterogeneity severity inclusion improvement pah marker tyrosine laboratory identification hydroxylase additional ratio phenotype testing spectrum form phe supplementary program user positive version value increase electronic online impact newborn mutation pku material common phenylketonuria present available risk phenylalanine diagnosis age development year genetic method level treatment result patient disease,"{""phenylalanine"": {""freq"": 2, ""string"": [""material common phenylketonuria present available risk phenylalanine diagnosis age development year g""]}}","{""genetic"": {""freq"": 1, ""string"": [""risk phenylalanine diagnosis age development year genetic method level treatment result p""]}, ""heterogeneity"": {""freq"": 1, ""string"": [""tyr continuous prediction introduction predictive doe heterogeneity severity inclusion improvement pah m""]}}",{},"{""newborn"": {""freq"": 1, ""string"": [""version value increase electronic online impact newborn mutation pku material common p""]}}",{},{}
1428,1428,1547,10.1101/cshperspect.a023150,26438605.0,utility whole yet advance disorder rapid newborn economically unique application recent pediatric possible pace since quickly clinical present expanding many population benefit examination infant relatively also development exome potential technological sequencing expansion ethical challenge number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665041/,abstract,0,expanding economically pace quickly technological expansion ethical exome examination relatively utility unique advance pediatric rapid sequencing benefit possible infant application challenge recent newborn number present population potential development disorder clinical,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""benefit possible infant application challenge recent newborn number present population potential d""]}}",{},{}
1429,1429,1548,10.1523/JNEUROSCI.1465-14.2014,25471567.0,major various specific lateral glial activity pathway glutamate behavioral without behavior lhb due open activation increase neuronal intriguingly monoaminergic animal however evidence pharmacological uptake defective role disinhibition disturbance sleep mouse symptom astrocyte habenula movement result depression like recently cause genetic inhibition avoidant psychiatry area tail level significant stress rapid rate novelty interest phenotype clearance transporter motivation model glt pathological expression frequent test susceptibility neuron unclear locomotor chronic habenular dysfunctional field analysis eye characteristic pathophysiology depressive also extracellular induces suspension pattern study hyperactivity patient excitability,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6608483/,abstract,0,lhb intriguingly habenular dysfunctional disinhibition avoidant monoaminergic habenula glt suspension locomotor glial excitability psychiatry novelty lateral induces astrocyte tail motivation depressive defective clearance extracellular uptake glutamate eye sleep neuron disturbance pathological movement transporter pathophysiology hyperactivity susceptibility depression neuronal activation pharmacological inhibition frequent unclear open behavioral pattern stress recently animal behavior rapid chronic like characteristic phenotype field mouse various symptom area major expression cause increase pathway rate activity evidence role test model specific significant genetic level analysis result patient study,"{""hyperactivity"": {""freq"": 1, ""string"": [""neuron disturbance pathological movement transporter pathophysiology hyperactivity susceptibility depression neuronal activation p""]}, ""behavioral"": {""freq"": 1, ""string"": [""activation pharmacological inhibition frequent unclear open behavioral pattern stress recently animal b""]}}","{""genetic"": {""freq"": 1, ""string"": [""evidence role test model specific significant genetic level analysis result patient s""]}}","{""pathway"": {""freq"": 1, ""string"": [""symptom area major expression cause increase pathway rate activity evidence role t""]}}",{},{},{}
1430,1430,1549,10.1007/s00253-016-7611-8,27209039.0,glutinis wide oil whole linoleic third commonly crustacean significant phenylalanine production pharmaceutical palmitic oleic rhodotorula composition biomass additive livestock fodder ammonia fish capability health compound biodiesel usage torulene characteristic particular microbiological due also capable food yeast substrate carotenoid enzyme lyase source torularhodin acid industrial pal pool carotene valuable fatty generation industry aspartame lipid useful synthesis sweetener numerous,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916194/,abstract,0,torulene torularhodin palmitic oleic livestock glutinis fodder crustacean biodiesel rhodotorula carotene microbiological carotenoid linoleic biomass usage oil aspartame pool yeast industrial sweetener pal fish additive lyase capability ammonia industry capable substrate pharmaceutical valuable lipid commonly numerous composition production fatty useful particular source compound synthesis generation wide characteristic food enzyme phenylalanine acid significant health,"{""phenylalanine"": {""freq"": 2, ""string"": []}}",{},{},{},"{""aspartame"": {""freq"": 1, ""string"": [""microbiological carotenoid linoleic biomass usage oil aspartame pool yeast industrial sweetener p""]}, ""fish"": {""freq"": 1, ""string"": [""aspartame pool yeast industrial sweetener pal fish additive lyase capability ammonia i""]}}",{}
1431,1431,1550,10.1097/COH.0000000000000203,26371462.0,new discus information attainment strengthen researcher increasingly communicable sub saharan well conjunction disease significantly establish enters related decade family event unique recent broader innovation spatial migration additionally health broaden contribution purpose large data phone term routine novel welfare long non service educational surveillance administration biomarkers economic child outcome hiv intervention mobile population review findingsnovel approach causal social potential system exposure second summaryas substantial behavioural agenda treatment collection important iii network education near cascade reviewhealth linkage public opportunity scale africa analysis impact research hdss policy cohort demographic sector,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982533/,abstract,0,summaryas reviewhealth hdss findingsnovel welfare enters sector saharan broaden attainment strengthen migration communicable phone agenda innovation cascade africa mobile hiv broader conjunction behavioural linkage surveillance spatial iii sub causal near establish demographic educational routine substantial researcher contribution increasingly economic event decade unique education additionally opportunity network policy administration collection service second exposure purpose biomarkers social scale related cohort public discus long large recent family impact intervention novel information outcome term non important approach significantly new research population review potential child health data treatment analysis disease,"{""social"": {""freq"": 1, ""string"": [""collection service second exposure purpose biomarkers social scale related cohort public d""]}}",{},{},{},{},{}
1432,1432,1551,10.4103/0972-2327.160093,26425001.0,male various major specific worldwide epidemiological factor among country socioeconomic despite due variation contributes marked risk course pwe control effective varied majority transition status sociodemographic understanding life hics recent perspective higher nature health burden global distribution secondary comparable methodology data call first low rate one per ncc etiology economic overall occurrence population approach management preponderance rural older towards epilepsy unknown person neuroinfections year manageable incidence nearly stronger age public two sixth neurotrauma india along million prevalence income equity birth differential series characteristic paper program depth prevention general group part high pattern study neurocysticercosis injury gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4564458/,abstract,2,pwe neurotrauma neuroinfections neurocysticercosis ncc preponderance hics sixth manageable sociodemographic equity marked india socioeconomic depth contributes stronger occurrence epilepsy rural person series income epidemiological varied nearly injury transition million comparable older differential worldwide gender course methodology nature economic etiology distribution burden majority perspective secondary unknown global incidence pattern understanding variation prevention despite general male characteristic prevalence paper public birth status overall country various management program major effective recent rate life higher low approach risk specific control factor population age health group year high data study,{},{},{},{},{},{}
1433,1433,1552,10.7717/peerj.4561,29637020.0,lower affect duration congenital time defect methodsthis standardized concern due view fact challenging remains experience addition vessel traditional significantly properly line measurement visualization trimester operator backgroundthe adequate screening mainly discussionto scenario higher procedure subanalysis real therefore complete gestation examination expertise great diagnosis aortic observational prospective pregnancy routine novel fetal first greatly low singleton detection level case although arch four rate three dimensional anterior transverse spine normal woman sonographic able back technique feasible method correct xplane skill second reproducible chamber trachea feasibility indeed detect still resultsthe two anomaly order especially since uncomplicated influence heart benefit also different conotruncal study cardiac position ultrasound patient ductal echocardiography number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890721/,abstract,4,xplane subanalysis sonographic arch trachea operator discussionto conotruncal visualization uncomplicated transverse ductal chamber spine reproducible properly echocardiography vessel remains challenging trimester singleton scenario aortic anterior expertise greatly ultrasound gestation standardized fact dimensional anomaly detect position skill methodsthis feasibility duration feasible correct cardiac observational routine backgroundthe adequate traditional real view fetal prospective resultsthe line examination complete great able mainly affect procedure concern heart pregnancy experience woman second measurement influence especially defect technique congenital benefit order detection normal screening addition lower novel rate higher low number case time significantly diagnosis different method level patient study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""especially defect technique congenital benefit order detection normal screening addition lower n""]}, ""screening"": {""freq"": 1, ""string"": [""technique congenital benefit order detection normal screening addition lower novel rate h""]}}",{},{}
1434,1434,1553,10.2147/CLEP.S142940,29563838.0,specific epidemiological textbook new almost discus brief complexity researcher cutting partially fit need valid mean source course undertaking essence objective clinical focus real never away foster question similarly scheme first use step assumption scientific table structure already ready feasible method conduct sharpen test best draft attitude process protocol pilot creative next worth paper research study anything latent preparation idea unnecessary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846748/,abstract,0,undertaking sharpen cutting worth creative textbook draft table foster essence scheme away valid ready latent unnecessary idea fit conduct assumption attitude brief similarly epidemiological complexity partially pilot preparation feasible real researcher course scientific question protocol step best source focus mean structure paper discus need process objective use test new specific research method clinical study,{},{},{},{},{},{}
1435,1435,1554,10.5005/jp-journals-10005-1515,30131645.0,wide disorder cannot issue autism communication update pediatr etiology chandrashekhar complaint problem office variety int systemic behavioral clinical child health reaction developmental brain complicated summarizes behavior special cerebellum management symptom organic emphasis also social limbic intellectual abstract disability interaction system diagnosis autistic study article language display insidious concept dental small change patient oral clin care spectrum deformity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102426/,abstract,0,chandrashekhar pediatr limbic int insidious deformity clin cerebellum office complaint dental summarizes autistic display complicated abstract update emphasis systemic special language organic variety communication etiology concept oral behavioral intellectual autism reaction behavior disability developmental social wide problem issue small spectrum interaction symptom management change brain care article diagnosis child health disorder clinical patient study,"{""intellectual"": {""freq"": 1, ""string"": [""variety communication etiology concept oral behavioral intellectual autism reaction behavior disability d""]}, ""behavioral"": {""freq"": 1, ""string"": [""organic variety communication etiology concept oral behavioral intellectual autism reaction behavior d""]}, ""social"": {""freq"": 1, ""string"": [""intellectual autism reaction behavior disability developmental social wide problem issue small s""]}}",{},{},{},{},{}
1436,1436,1555,10.1186/s12881-017-0467-7,28982351.0,conclusionthe various notably exon backgroundphenylketonuria single composition present prenatal contains throughout necessary pro resultsa common variation gln race pku hydroxylase material spectrum characterize sanger supplementary phenylalanine family subject val tyr user impairs clinically ligation error china inborn duplication result diagnosis base novo novel predominant genetic metabolism ethnicity one northern proband arg database population phenylketonuria development via differs sequentially online article postnatal multiplex electronic biochemically incidence probe particularly construction version methodsin amplification within cys two variant primarily ethnic dependent cognitive deletion previously available also pah foundation group study direct distinct deficiency patient gene total mlpa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629770/,abstract,11,val sequentially mlpa gln differs cys biochemically proband ligation impairs duplication construction race ethnic northern contains multiplex postnatal ethnicity predominant notably backgroundphenylketonuria arg amplification sanger probe novo resultsa pro methodsin base foundation characterize tyr conclusionthe primarily deletion prenatal exon china distinct composition clinically necessary dependent direct incidence pah variation database particularly previously hydroxylase spectrum various inborn cognitive supplementary subject user version variant electronic error online single deficiency family novel total pku material article common phenylketonuria present available metabolism phenylalanine diagnosis population development gene group genetic result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""article common phenylketonuria present available metabolism phenylalanine diagnosis population development gene g""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1437,1437,1556,10.1097/AUD.0000000000000443,28471783.0,disseminated training hearing responsibility early among objectivesall several throughout necessary efficient prompt action territory regular state coordination facilitate ehdi survey status third however comply compliance audiology newsletter audiologists health outreach improvement report result facility call designthe united detection service mandatory compliant deaf provider conclusionssurvey requirement hard room normal already evaluation intervention reason regulation frequently via article important reporting finding care heavily public two newborn notice pediatric resultsamong program infant another,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570651/,abstract,4,objectivesall newsletter disseminated conclusionssurvey notice heavily ehdi designthe audiology audiologists outreach deaf comply compliant territory resultsamong responsibility hard facility hearing prompt mandatory reporting coordination training room regular reason requirement provider compliance facilitate united efficient action frequently necessary service regulation pediatric improvement survey evaluation public status finding detection infant normal state program report intervention care newborn article important early health result,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""improvement survey evaluation public status finding detection infant normal state program r""]}, ""newborn"": {""freq"": 1, ""string"": [""normal state program report intervention care newborn article important early health r""]}}",{},{}
1438,1438,1557,10.1007/8904_2014_349,25681079.0,inheritance relationship new pathway concern site novogalt missense common state substitution well disease lethal galactose extensive profound heterozygous raise leloir higher compound genomic report result enzyme first genetic potentially middle metabolism rate mutation pathogenic obligate rule child degree parent loss mother active near carrier galactosemia variant allele function dna impairment either previously classic introduces study patient exception,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501235/,abstract,0,novogalt leloir introduces obligate galactosemia galactose lethal rule exception raise profound substitution heterozygous inheritance near middle degree extensive classic missense pathogenic mother carrier active concern potentially allele genomic dna compound site loss impairment previously parent relationship enzyme state variant pathway report rate mutation higher common function metabolism new child genetic result patient disease study,{},"{""inheritance"": {""freq"": 1, ""string"": [""rule exception raise profound substitution heterozygous inheritance near middle degree extensive c""]}, ""heterozygous"": {""freq"": 1, ""string"": [""lethal rule exception raise profound substitution heterozygous inheritance near middle degree e""]}, ""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""previously parent relationship enzyme state variant pathway report rate mutation higher c""]}}",{},{},{}
1439,1439,1558,10.3389/fnut.2017.00009,28459050.0,tool blood diagnostically herein new time present pancreas accurate need superior minimization cost enzymatic uplc sida effective avoid inter status respectively measurement verified deconjugation volumetric quantitation clinical recovery distribution degradation polyglutamate error methodology sufficiently thus recently effect chicken vams nmol rat microsamplers extraction applicability low detection level separation significant whole isotope internal main least step analyte temperature volume room instrument absorptive stable provide uneven population toward week sampling technique determination serum substantial reproducible analyzed treatment collection precision nevertheless assay promising feasibility within endogenous miniaturizing progress newborn fresh spot pilot especially elution standard precise background matrix alternative centrifugation methyltetrahydrofolic trial conclusive dilution study acid hematocrit heating volunteer individual mixture,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394109/,abstract,8,uneven sida polyglutamate minimization miniaturizing microsamplers deconjugation vams methyltetrahydrofolic heating diagnostically chicken centrifugation uplc sampling verified pancreas conclusive analyzed absorptive volumetric hematocrit fresh dilution applicability reproducible nmol isotope elution quantitation analyte sufficiently avoid separation volunteer room superior inter recovery mixture matrix precise internal instrument extraction enzymatic pilot feasibility endogenous promising progress temperature determination degradation accurate substantial stable precision methodology rat distribution volume alternative step collection serum recently assay cost measurement especially spot technique provide week main status need standard detection background tool trial error effective respectively newborn low present individual time new blood population acid significant effect level treatment clinical study,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""provide week main status need standard detection background tool trial error e""]}, ""newborn"": {""freq"": 1, ""string"": [""background tool trial error effective respectively newborn low present individual time n""]}}","{""chicken"": {""freq"": 1, ""string"": [""microsamplers deconjugation vams methyltetrahydrofolic heating diagnostically chicken centrifugation uplc sampling verified p""]}}",{}
1440,1440,1560,10.1186/s13023-018-0927-y,30396361.0,european availability absolute difference lower country reimbursement conclusionsstandard medicinal state average favour orphan well disease objective status material objectivesto however supplementary pharmaceutical caput higher user role play gap omps austria belgium basis kind methodsinformation term republic poland level rate member per annual map eastern product technique eur method resultsin substantial online article europe proportion important electronic calculated expenditure accessible year western gdp challenge version consecutive materialthe rare public czech two hungary order bulgaria income access retail standard equity special hospital available identify policy exchange different pharmacy union patient france participant healthcare individual total number deviation budget,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219168/,abstract,7,retail methodsinformation conclusionsstandard pharmacy omps eur poland hungary gdp union caput bulgaria austria czech budget belgium republic favour equity reimbursement france eastern medicinal objectivesto kind absolute expenditure consecutive calculated orphan europe map annual accessible resultsin exchange income western pharmaceutical deviation gap special substantial identify access member proportion availability european healthcare play average policy basis hospital materialthe product technique public order status country standard participant supplementary objective state challenge user version electronic online lower rare rate total material term higher article important role difference number available individual different year method level patient disease,{},{},{},{},{},{}
1441,1441,1561,10.1371/journal.pone.0213391,30875376.0,male balance specific blood memory abnormality new early pathway time specifically despite nutrient condition together additional severe open deficit supplementation motor control experience accumulation concept well beam month pku material phe initiation snc however phenylalanine norepinephrine till introduction strategy spatial brain mouse symptom task neurotransmitter six metabolic term experiment novel combination first long type low functioning although mutation three wild female end postulated current prevent recognition intervention point able phenylketonuria day object method resultsin combined ameliorate concentration test postnatal treatment introductionin diet shortcoming age still homozygous serotonin influence function field cognitive sor btbrpah group plus high study master dietary btbr patient conclusionthis gene consistently performance show,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420157/,abstract,6,sor snc btbrpah postulated shortcoming beam till master introductionin object norepinephrine combined btbr conclusionthis postnatal initiation ameliorate functioning balance consistently spatial resultsin plus recognition homozygous experiment serotonin neurotransmitter introduction wild specifically memory end able nutrient open motor concept task accumulation prevent experience supplementation female deficit abnormality combination point influence despite male additional performance field mouse severe symptom cognitive month phe long day strategy pathway brain diet intervention dietary novel concentration current mutation pku material term condition function phenylketonuria low test time new early phenylalanine specific control blood type age metabolic gene group high method treatment patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""phenylketonuria low test time new early phenylalanine specific control blood type a""]}}","{""homozygous"": {""freq"": 1, ""string"": [""balance consistently spatial resultsin plus recognition homozygous experiment serotonin neurotransmitter introduction w""]}}","{""pathway"": {""freq"": 1, ""string"": [""cognitive month phe long day strategy pathway brain diet intervention dietary n""]}}",{},"{""diet"": {""freq"": 1, ""string"": [""phe long day strategy pathway brain diet intervention dietary novel concentration c""]}}",{}
1442,1442,1562,10.1128/CMR.00014-16,27281741.0,relationship new factor barr difficult congenital several country world guillain despite couple concern prenatal serious mosquito condition fetus additional prognosis course control number well virus increase month disease neurological emergency medical denv endemic later evidence expectant higher clinical role health brain cautious practitioner analogous leading zika support zikv existence epidemic guideline thousand question long transmission international area case rapid rate mutation agency naive current infection syndrome sign meanwhile chance pathogen urgently causal development potential organization consequently replication association viral care maternal microcephaly public two virulence newborn teratogenicity anomaly prevalence answer magnitude dengue currently impact available prevention america tissue study human vector center february presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978612/,abstract,0,naive leading guillain denv dengue zikv mosquito barr virulence expectant cautious answer analogous zika urgently teratogenicity epidemic couple endemic emergency february agency pathogen practitioner magnitude fetus chance america replication microcephaly existence transmission thousand anomaly prognosis causal viral sign vector consequently virus prenatal organization course later question guideline world infection international neurological difficult concern center maternal rapid presence tissue prevention syndrome currently despite congenital prevalence additional public relationship country area support month long increase medical brain association impact care rate newborn evidence current mutation higher condition role number case available new human control factor potential development health clinical disease study,"{""neurological"": {""freq"": 1, ""string"": [""later question guideline world infection international neurological difficult concern center maternal r""]}, ""microcephaly"": {""freq"": 1, ""string"": [""practitioner magnitude fetus chance america replication microcephaly existence transmission thousand anomaly p""]}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""medical brain association impact care rate newborn evidence current mutation higher c""]}}",{},{}
1443,1443,1563,10.1186/s12887-016-0668-9,27549856.0,immediately blood iem ethically growth early profile country present maya presentationwe initial increasingly respond severe old well month therapy protein developmental improvement alone error food inborn diagnosis malnutrition late kaqchikel metabolism untreated low regression significant case argininemia provider assumption imperative child feasible rural identification development conclusionsthis serum test treatment diet initially rare locally spot guatemala standard stunting girl available backgroundargininemia infancy acid suspect patient restricted amino,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994184/,abstract,0,stunting maya kaqchikel guatemala ethically backgroundargininemia argininemia suspect presentationwe malnutrition locally respond imperative restricted initially immediately assumption rural girl infancy conclusionsthis provider feasible untreated initial increasingly late iem profile improvement serum regression old developmental spot growth identification country standard severe inborn food month error diet rare therapy amino low present case available metabolism test early blood diagnosis acid child protein significant development treatment patient,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""food month error diet rare therapy amino low present case available m""]}}","{""diet"": {""freq"": 1, ""string"": [""standard severe inborn food month error diet rare therapy amino low p""]}}",{}
1444,1444,1564,10.1002/btm2.10093,30065967.0,various clinic past example new discus displace realization open source formulation disease microbiota actively perspective clinical range fecal effect design generation biologics area transplant gastrointestinal case microbiome biologic pathogenic microbe local current preclinical drug side vagina review approach model therapeutic constant factory system success treatment delivery address genetically opportunity next advanced either modulating vitro tract research modality also trial unmet skin inform treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063871/,abstract,0,vagina displace biologics modulating factory realization biologic fecal unmet microbe transplant constant actively preclinical modality microbiota microbiome gastrointestinal formulation tract advanced skin inform success genetically treat local pathogenic open past perspective opportunity vitro address clinic delivery source example generation design discus various area trial range drug therapeutic current approach case new model research review effect treatment clinical disease,"{""skin"": {""freq"": 1, ""string"": [""microbiota microbiome gastrointestinal formulation tract advanced skin inform success genetically treat l""]}}",{},{},{},{},{}
1445,1445,1565,10.19082/6689,29881532.0,male disorder relationship record ratio congenital methodsthis present province retrospective common mazandaran survey respectively medical family quantitative higher value health backgroundcongenital determined primary diagnosis qualitative resultsof term type definitively area period significant variable one northern female chi per child spss descriptive permanent prevalent test mother father city stronger particularly transient iran north prevalence hypothyroidism birth characteristic infant group june endocrine study objectiveto center square conclusionthese demographic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984024/,abstract,13,definitively backgroundcongenital mazandaran father conclusionthese endocrine northern chi permanent resultsof north stronger spss june transient retrospective square city province hypothyroidism methodsthis demographic objectiveto descriptive qualitative prevalent iran determined record mother center female quantitative variable survey particularly congenital male characteristic prevalence period ratio birth relationship area infant primary value medical family respectively term higher common present test type diagnosis child significant health group disorder study,{},{},{},{},{},{}
1446,1446,1566,10.1038/ncomms12360,27453504.0,metabolome rare generates wide understanding xanthosine phenylalanine variant signal independent allele architecture single humanexome hal determinant community illumina across picture heritability heart beadchip analysis prior metabolomics complete examination frequency coding view framingham error pah histidine inborn exome highlight locus plasma upb risk replication study test build atherosclerosis meta gmps association novel genetic participant metabolism gene show metabolite spectrum highlighting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962516/,abstract,1,xanthosine upb humanexome hal gmps framingham generates beadchip illumina picture highlighting atherosclerosis histidine build architecture metabolome heritability coding replication determinant locus exome view meta signal prior examination complete metabolomics independent community heart allele understanding pah highlight frequency wide spectrum participant inborn metabolite plasma variant error single association rare novel metabolism test risk phenylalanine gene genetic analysis study,"{""phenylalanine"": {""freq"": 2, ""string"": []}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1447,1447,1567,10.1007/8904_2016_568,27300702.0,metabolome resonance pathogenesis correlation specific disorder prospectively explain analyzer signature oxidative positive adult inverse elevated asp partially pro common gln control finally pku material status excellent phe synthesis relevant supplementary succinate tyr user clinical protein indirect result diagnosis thus metabolic urine metabolism low stress nuclear involvement discussion arg exclusion energetic approach model phenylketonuria method glu univariate unknown concentration online electronic directly version materialthe pathophysiological multivariate aminobutyric spectroscopy explore analysis previously background mechanism metabolomics available multiplatform consequence ala plasma different pattern alpha magnetic acid patient discriminant amino chapter metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362559/,abstract,2,glu energetic succinate multiplatform gln asp aminobutyric univariate discriminant analyzer inverse ala indirect metabolome explain signature chapter prospectively exclusion pathophysiological arg pro multivariate spectroscopy excellent partially pathogenesis tyr alpha resonance involvement discussion oxidative nuclear elevated metabolomics magnetic explore directly urine unknown finally consequence pattern stress synthesis materialthe previously correlation relevant status background metabolite phe supplementary plasma user positive version electronic online adult mechanism concentration pku material amino common phenylketonuria low approach available metabolism model specific control diagnosis acid different protein metabolic method disorder clinical analysis result patient,"{""urine"": {""freq"": 1, ""string"": [""nuclear elevated metabolomics magnetic explore directly urine unknown finally consequence pattern s""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""online adult mechanism concentration pku material amino common phenylketonuria low approach a""]}}",{},{}
1448,1448,1568,10.1111/bcp.12935,26991455.0,whether better widespread nutrition uncertainty inventor medicinal serious programme lecture supplementation favour formulation well preservation disease restoration related evidence designate pharmaceutical designer sometimes preventive health demonstrating compound therefore contradiction nondiscriminatory food efficacy internationally vegetarianism kind term nutraceuticals furthermore long compounding functional nitrate end prevent many unhelpful mediterranean product therapeutic work rich quest supplement regimen diet inconsistency folic definition still actually systematically herbal precise confessing nutraceutical widely vague quantity also similar dietary deficiency foodstuff individual confusion wholesale treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338166/,abstract,1,wholesale vegetarianism unhelpful nondiscriminatory nitrate inventor designate contradiction confessing compounding vague quest nutraceuticals nutraceutical foodstuff designer lecture herbal actually mediterranean internationally confusion restoration preservation favour medicinal inconsistency kind folic uncertainty regimen demonstrating quantity formulation preventive definition widespread supplement systematically rich precise programme pharmaceutical treat end widely nutrition prevent supplementation compound work efficacy furthermore product related functional better similar food long therapeutic deficiency diet dietary evidence term individual health disease,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""better similar food long therapeutic deficiency diet dietary evidence term individual h""]}}",{}
1449,1449,1569,10.21037/atm.2019.05.47,31392193.0,yet significant pompe earlier glucosidase variant newborn better update biomarkers baby discus screening timely current clinical therapy outcome modification population review without aim method also pseudodeficiency prevalent evolution alpha manifestation acid treatment deficiency patient disease limitation address challenge predictive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642927/,abstract,0,pseudodeficiency glucosidase pompe update timely evolution earlier baby prevalent alpha modification manifestation predictive limitation address biomarkers discus better aim screening challenge variant deficiency therapy newborn current outcome population review acid significant method treatment clinical patient disease,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""aim screening challenge variant deficiency therapy newborn current outcome population review a""]}, ""screening"": {""freq"": 1, ""string"": [""limitation address biomarkers discus better aim screening challenge variant deficiency therapy n""]}}",{},{}
1450,1450,1570,10.1212/NXG.0000000000000135,28243630.0,phenotypic alsp abnormality asymmetric rarefaction adult present confluent occasionally leukoencephalopathy central onset literature glia common share highlight periventricular mean transfer institution motor addition objective disease aar leukodystrophies matter sequence axonal deep dot frontal clinical pathologically ventricular clinically recovery radiologically fluid determined symptom diffusion result data mild change case leukodystrophy mutation female involvement imaging phenotype alanyl ovarian white synthetase failure database overall review calcification highlighted method callosal disproportionately key callosum pigmented year finding overview spheroid age rna subcortical mri frontoparietal exclusive cognitive corpus characteristic tract also conclusion inversion suppresses pattern fiber similar predominantly pyramidal atrophy prominent total pathologic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312114/,abstract,6,spheroid rarefaction radiologically pigmented periventricular confluent callosal calcification alsp alanyl aar suppresses subcortical pathologically occasionally inversion glia frontoparietal axonal leukodystrophies synthetase leukoencephalopathy exclusive dot disproportionately highlighted atrophy ventricular pyramidal leukodystrophy asymmetric fiber pathologic ovarian frontal callosum deep corpus prominent transfer tract share diffusion predominantly mri recovery institution imaging involvement fluid rna determined failure phenotypic matter overview white motor mild clinically sequence female central pattern abnormality mean onset database highlight characteristic phenotype overall finding similar literature symptom cognitive objective addition change key adult total mutation conclusion common present case review age year method data clinical result disease,{},{},{},{},{},{}
1451,1451,1571,10.3389/fneur.2019.00762,31379716.0,various endeavor intellectually iem healthier economy information early among analyzer country amenable present set disabled detailed due common iems way disease enough treatable biochemical related subset however family life pharmacological screening oxidation place lessen clinical therapy burden therefore pakistan task error inborn analytical thus like etc large data scarcity genetic type potentially metabolism society step size sitosterolemia around population technique frequent pave treatment fatty diet incidence mucopolysaccharidoses methyltransferase rare advance earlier sample newborn aminoacidopathies poor screen prevalence especially uhplc since gamt start program available group different cohort study homocystinuria acid deficiency patient highest amino guanidinoacetate total initiative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650569/,abstract,8,uhplc sitosterolemia lessen healthier guanidinoacetate gamt endeavor disabled pakistan scarcity pave mucopolysaccharidoses methyltransferase intellectually economy start analyzer homocystinuria aminoacidopathies amenable iems detailed earlier treatable set place oxidation initiative subset society screen pharmacological analytical frequent burden highest task iem fatty advance poor step potentially way size incidence especially technique related cohort like prevalence biochemical country various inborn screening program error large deficiency diet rare family therapy information life total newborn amino common sample present available metabolism early type population acid different group genetic data treatment clinical patient disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""early type population acid different group genetic data treatment clinical patient d""]}}",{},"{""amino"": {""freq"": 1, ""string"": [""family therapy information life total newborn amino common sample present available m""]}, ""newborn"": {""freq"": 1, ""string"": [""rare family therapy information life total newborn amino common sample present a""]}, ""screening"": {""freq"": 1, ""string"": [""like prevalence biochemical country various inborn screening program error large deficiency d""]}}","{""diet"": {""freq"": 1, ""string"": [""inborn screening program error large deficiency diet rare family therapy information l""]}}",{}
1452,1452,1573,10.1253/circj.CJ-16-1343,28381817.0,pathogenesis abnormality investigation pathway congenital defect highlight risk gestational third evidence today developmental milieu monogenic body chd attention effect large novo embryo fraction detectable basis little significance combination genetic metabolism chromosomal case logically mutation one pathogenic individually review model via mother year directly maternal two variant estimate ago heart act refer also prevention interaction identifiable insofar cardiac small twenty gene precisely readily explains,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715472/,abstract,0,insofar logically precisely milieu identifiable explains refer today detectable ago readily chromosomal individually embryo novo chd monogenic pathogenesis gestational cardiac act fraction significance pathogenic little mother directly estimate heart investigation basis maternal abnormality combination attention developmental prevention defect highlight congenital small interaction body variant large pathway evidence mutation case metabolism risk model review gene year effect genetic,{},"{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""congenital small interaction body variant large pathway evidence mutation case metabolism r""]}}",{},{},{}
1453,1453,1574,10.1007/s12529-015-9488-9,25929332.0,logistic whether seem ratio among examine congenital across aged odds slightly disease doe respectively sweden account knowledge however family largest cumulative interval objectivesthe higher clinical chd result multilevel purpose data confounders versus hospitalisation first type far low regression period level significant confidence full rate least independent per comorbidities paternal economic child population accounting socio model hypertension history potential second conclusionsthis important association year incidence maternal age january category methodsall influence heart neighbourhood characteristic december high study deprivation individual total demographic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808140/,abstract,8,objectivesthe neighbourhood methodsall hospitalisation paternal confounders multilevel socio sweden deprivation comorbidities accounting hypertension largest cumulative slightly december conclusionsthis chd odds demographic january logistic far versus examine confidence category economic doe interval account independent heart history maternal aged incidence second regression purpose influence congenital characteristic period ratio knowledge association family respectively rate total higher important low individual model type population potential child age significant year high data level clinical result disease study,{},{},{},{},{},{}
1454,1454,1575,10.1016/j.ecresq.2017.09.007,29403148.0,sociodemographic age executive sample self cue much childhood factor single early among rating problem statistical structure function child sensitivity neonatal outcome intervention analysis focus effortful separated socioemotional prematurely regulation research academic competence environment particularly infant preterm general conclusion supportive six predict risk high control differentially date extent mother parental association month year low promoting maternal medical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796547/,abstract,0,effortful socioemotional promoting prematurely cue competence supportive sociodemographic predict separated academic differentially rating preterm parental executive extent mother statistical date regulation maternal environment childhood sensitivity focus neonatal self structure particularly general problem month infant medical single association intervention outcome conclusion function sample low risk early control factor research child age year high analysis,{},{},{},{},{},{}
1455,1455,1576,10.1186/s13023-018-0978-0,30621767.0,blood assessment record canadian growth difference factor early uncertainty present awareness due genetics variation gmdi subtle neurocognitive outside methodswe old severity agreement acmg ferritin disease milligram survey hydroxylase intake disabling phe medical college initiation ascertain however phenylalanine family evidence individualization screening noncompliance optimal perspective clinical health range respondent protein resultswe mol alone diagnosis metabolic recently dietitian term combination ongoing long genetic cimdrn count international level suboptimal rate provider one pre possibly gram genomics current tyrosine child many population approach management participate day older american treatment gradually network year diet care robust generally within newborn conclusionwhile imd continuously north pediatric objectiveswe relation aligned goal criterion analysis aspect natural research optimization pah prevention nutritional practice trend turn similar dietary deficiency patient participant complication backgroundphenylalanine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323774/,abstract,4,milligram gmdi ferritin disabling conclusionwhile cimdrn backgroundphenylalanine aligned noncompliance individualization gram objectiveswe count acmg ascertain canadian subtle outside optimization gradually college agreement suboptimal participate turn dietitian uncertainty north initiation imd continuously possibly ongoing neurocognitive respondent resultswe awareness provider american trend older generally record genomics complication robust optimal mol relation goal severity aspect perspective network international methodswe natural pre pediatric survey old recently nutritional pah genetics criterion combination variation intake prevention practice tyrosine growth hydroxylase similar participant assessment phe screening long management day range medical deficiency diet family dietary care rate newborn evidence current term difference approach present early phenylalanine factor blood diagnosis research population child protein metabolic health year genetic level treatment clinical analysis patient disease,"{""phenylalanine"": {""freq"": 2, ""string"": [""gmdi ferritin disabling conclusionwhile cimdrn backgroundphenylalanine aligned noncompliance individualization gram o"", ""current term difference approach present early phenylalanine factor blood diagnosis research p""]}}","{""genetic"": {""freq"": 1, ""string"": [""population child protein metabolic health year genetic level treatment clinical analysis p""]}}",{},"{""newborn"": {""freq"": 1, ""string"": [""deficiency diet family dietary care rate newborn evidence current term difference a""]}, ""screening"": {""freq"": 1, ""string"": [""growth hydroxylase similar participant assessment phe screening long management day range m""]}}","{""diet"": {""freq"": 1, ""string"": [""long management day range medical deficiency diet family dietary care rate n""]}}",{}
1456,1456,1577,10.1038/s41467-019-09722-9,30979906.0,yet commercial transcription beverage relevant synthetic signal hybrid modular application factor molecule time strong limited dynamic variety provide range clinically many fast engineer workflow translation great work capable foundation chemical potential system metabolic high biosensors free medium concentration urine human addition detectable response small network cell complex cascade,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461607/,abstract,0,modular engineer hybrid biosensors cascade commercial detectable workflow fast beverage capable foundation synthetic medium dynamic translation transcription chemical signal variety great strong network molecule urine clinically work limited free relevant provide small application addition range complex response concentration cell time human factor potential metabolic high,"{""urine"": {""freq"": 1, ""string"": [""signal variety great strong network molecule urine clinically work limited free r""]}}",{},{},{},{},{}
1457,1457,1578,10.1186/s13023-014-0195-4,25757705.0,predictability specific disorder example new greater pathway among early final creation qualification acceptance enhance serious without need fda expert state highlight fdasia regulatory tremendous disease material opinion section medical infectious cancer relevant supplementary life evidence expedite endpoint adequate innovation user therapy extensively guidance focus critically primary food support request like situation type use flexibility case administration scientific biomarkers surrogate white drug provide discovery endorse many review therapeutic determination development expression safety online article treatment important electronic best challenge version devastating materialthe process rare accelerated opportunity approval application appropriate access stakeholder reasonably provision act currently paper framework program available unmet group jurisdiction otherwise high rationale applicable study patient successful acceptable treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4347559/,abstract,0,qualification fdasia expedite endorse predictability reasonably request jurisdiction devastating accelerated tremendous unmet surrogate innovation fda endpoint creation critically acceptance approval rationale flexibility applicable section extensively stakeholder opinion final guidance provision situation infectious enhance acceptable act determination adequate expert access treat scientific safety white successful discovery framework opportunity administration regulatory best appropriate cancer focus example biomarkers materialthe greater currently highlight relevant provide like paper need food process support supplementary application state program challenge user expression primary drug version electronic online therapeutic medical pathway use rare therapy life evidence material article important case available new early specific type review development group high disorder treatment patient disease study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""drug version electronic online therapeutic medical pathway use rare therapy life e""]}}",{},{},{}
1458,1458,1579,10.1038/s41467-019-11889-0,31462649.0,experimental biological tool synthetic neural information present analog transducer weight computing finally computer perceptron medical circuit subject scalable input contribution sum logic metabolic data computational term combination first far implement commonly four rapid weighted implementation processing approach model regulation device expression binary system free concentration industrial multiplex digital adder perceptrons cell sophisticated computation two application biology engineering groundwork next advanced environmental multiple different classification gene metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713752/,abstract,0,weighted scalable perceptrons perceptron adder logic computing groundwork transducer sophisticated digital computation analog implement binary industrial sum multiplex circuit engineering computer input advanced processing computational neural device synthetic far classification commonly contribution biology experimental regulation finally implementation weight rapid combination environmental free biological metabolite tool application subject expression multiple medical information concentration term cell approach present model different metabolic gene data,{},{},{},{},{},{}
1459,1459,1580,10.3389/fimmu.2019.00505,30941138.0,experimental various monocyte specific blood activity search composition pathway inflammation rankl without literature common facilitate clear obvious control addition classical activation disease csf demand denominator relevant however cancer place role osteocyte body particular core away long formation level main barcodes local cytokine systemic already point review approach toward arthritis second prevalent loss osteopenia collection periodontitis intrinsically unstimulated systematic cell particularly inflammatory future minimal likely peripheral healthy differentiation bone vitro precursor tnf research unequivocally osteoclastogenesis different tissue study rheumatoid osteoporosis human patient ocp individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434996/,abstract,0,rankl periodontitis osteocyte ocp barcodes unstimulated unequivocally osteoclastogenesis denominator tnf rheumatoid osteopenia monocyte intrinsically arthritis csf away obvious osteoporosis demand cytokine bone core place minimal peripheral prevalent differentiation systemic inflammation clear facilitate activation composition classical local precursor formation inflammatory experimental vitro search systematic collection particular second cancer loss likely point tissue particularly relevant main literature various body healthy addition long future pathway activity role common cell approach individual human specific control blood research review different level patient disease study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""various body healthy addition long future pathway activity role common cell a""]}}",{},{},{}
1460,1460,1581,10.3389/fbioe.2019.00001,30705882.0,experimental biological hence circuit minimal synthetic two challenge signal short communication modular biology among progressive scenario others hoc present already complexity protein population review branch liposome research manner molecular chemical expression exchange technology system like often free study bottom presentation rapidly success well derive type genetic promise gene cell count briefly innovative synthesis numerous customizable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344414/,abstract,0,liposome customizable modular hoc derive branch count briefly scenario innovative circuit rapidly exchange promise manner complexity minimal progressive synthetic success numerous chemical signal presentation communication biology experimental short synthesis free biological like technology challenge expression molecular cell present type research population review protein gene genetic study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1461,1461,1582,10.1080/87565641.2016.1243109,27805419.0,individual executive blood phenylalanine evidence lifelong prevalence placebo estimate inattention anxiety adult quality population analysis review double maintenance affected phenylketonuria impact symptom due support general deficit depression high neuropsychiatric study whereas meta blind hyperactivity investigates neurological low systematic performance number phe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152552/,abstract,0,investigates inattention neuropsychiatric lifelong maintenance hyperactivity blind placebo depression executive anxiety affected meta double neurological systematic estimate deficit general prevalence performance symptom support phe quality adult impact evidence phenylketonuria low number individual phenylalanine blood population review high analysis study,"{""phenylalanine"": {""freq"": 2, ""string"": [""impact evidence phenylketonuria low number individual phenylalanine blood population review high a""]}, ""neurological"": {""freq"": 1, ""string"": [""depression executive anxiety affected meta double neurological systematic estimate deficit general p""]}, ""hyperactivity"": {""freq"": 1, ""string"": [""investigates inattention neuropsychiatric lifelong maintenance hyperactivity blind placebo depression executive a""]}}",{},{},{},{},{}
1462,1462,1583,10.1186/s12920-018-0420-4,30367635.0,expensive balance assessment fundamental across country adoption awareness indonesia efficient need southeast cost highlight clear diverse effective progressed funding notwithstanding status significantly material emergence issue adopt however supplementary discourse singapore strategy backgroundthe champion user health regional focus broaden distribution therefore expertise pharmacogenomics six interview data novel investment low medicine theme four multi society imperative current implementation many population critical review governance efficiency development potential system technology thailand online landscape article resource delivery sea key electronic network asia finding challenge version policymakers methodsthe opportunity access order especially disparity stakeholder equity political limited malaysia mechanism framework program research available policy infancy study leverage barrier tension absence healthcare financial budget,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203971/,abstract,0,thailand sea progressed notwithstanding indonesia champion malaysia singapore adopt tension southeast political pharmacogenomics broaden asia governance budget policymakers leverage investment disparity discourse imperative funding equity adoption expensive financial emergence expertise landscape balance stakeholder regional infancy fundamental awareness theme methodsthe interview efficiency clear backgroundthe society multi barrier absence efficient diverse access distribution framework healthcare opportunity network resource policy delivery implementation focus limited critical cost especially highlight medicine issue technology order status need country finding assessment supplementary program challenge user version strategy key electronic online effective mechanism novel current material article low available significantly research population review potential development health data study,{},{},{},{},{},{}
1463,1463,1584,10.1161/JAHA.115.002762,26896473.0,subsequent relationship daily studied difference single factor time inflammation synthase condition tetrahydrobiopterin due parallel separate common supplementation share risk mean endothelial velocity disease pulse beneficial dysfunction resultswe double improvement result thus conclusionboth effect aortic term versus similarly oral crossover dilatation potentially backgroundrheumatoid although short blinded placebo acute systemic stiffness week method arthritis causal consequently treatment wave regimen phase randomized stiffening inflammatory occur nitric function cardiovascular flow reduce study rheumatoid whereas oxide patient,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802470/,abstract,12,stiffening dilatation conclusionboth backgroundrheumatoid blinded rheumatoid velocity arthritis stiffness wave aortic occur regimen pulse randomized endothelial crossover share similarly studied causal nitric flow resultswe reduce oxide placebo consequently parallel synthase systemic subsequent inflammation separate versus beneficial double cardiovascular oral daily tetrahydrobiopterin inflammatory acute potentially phase supplementation short improvement mean dysfunction week relationship single term condition difference common function time risk factor effect method treatment result patient disease study,{},{},{},{},{},{}
1464,1464,1585,10.2147/PGPM.S67876,25342916.0,consistency information package need obvious increase material section knowledge understanding however adequate pharmacogenetics health inconsistent therefore food date insert administration provider communication biomarkers table label drug regard unlikely review inclusion development via minority test response directly inconsistency process advance unclear order determine provision adverse analysis criterion research also pharmacogenomic pattern extent pharmacogenetic patient presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4205933/,abstract,1,pharmacogenomic pharmacogenetic insert pharmacogenetics table unlikely package obvious minority label inconsistency inconsistent consistency section regard provision provider adequate extent communication unclear inclusion directly date advance administration adverse pattern understanding criterion presence biomarkers determine order need knowledge food process drug increase response information material test research review development health analysis patient,{},{},{},{},{},{}
1465,1465,1586,10.1016/j.stemcr.2018.03.002,29606616.0,notably disorder culture clinic extremely factor exhibit several bipotential severe capacity display notch disease epithelium precludes however biliary cholangiocyte accessibility ihepscs previous mouse therefore secondary fibroblast thus like cause cholangiopathies generation novel combination low cholangiocytes functional hepatic step foxa convert liver approach work efficiency progenitor expression potential hnf directly cell dramatically two bile irreversible differentiation limited enhanced stem vitro translation mature high study conversion purity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995161/,abstract,0,notch ihepscs cholangiopathies cholangiocytes cholangiocyte purity precludes foxa bipotential biliary progenitor epithelium mature enhanced accessibility convert bile dramatically display notably irreversible fibroblast extremely conversion exhibit hnf stem culture hepatic differentiation efficiency translation capacity vitro directly clinic secondary step previous work liver limited generation combination functional like mouse severe expression cause novel cell low approach factor potential high disorder disease study,{},{},{},{},{},{}
1466,1466,1587,,28461971.0,notably disorder availability autism lead early widespread defect homeostasis partially condition onset pathology risk neurodegenerative control severity addition cholesterol disease neurological membrane spectrum synthesis animal raft pharmacological previous arise dysfunction oxysterols brain thus effect genetic lipid metabolism transmission oxysterol level case communication step progression review neurotransmission model frequently alzheimer disruption development modulates synaptic polymorphism alteration key directly particularly rare production traffic manipulation imbalance parkinson keywords gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406657/,abstract,0,raft oxysterol oxysterols traffic modulates manipulation arise imbalance neurotransmission parkinson synaptic notably disruption transmission cholesterol widespread partially membrane alzheimer neurodegenerative lipid pathology progression keywords homeostasis pharmacological communication availability polymorphism severity frequently alteration production directly neurological step autism previous animal synthesis dysfunction lead onset particularly defect spectrum addition key brain rare condition case metabolism risk model early control review development gene effect genetic level disorder disease,"{""neurological"": {""freq"": 1, ""string"": [""polymorphism severity frequently alteration production directly neurological step autism previous animal s""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1467,1467,1588,10.1016/j.cct.2018.09.015,30287268.0,disorder structured blood tool new factor information effort positive country substantially behavior recruitment efficient genetics state locus control effective well scid traditional amenorrhea register sweden zealand utility suitable recruit anorexia gov nervosa remarkably questionnaire clinical denmark procedure pronged draw result diagnosis large term first genetic type icd united international clinicaltrials significant case rapid multi text genomics woman highly population approach model method dsm history ass via national social lifetime online treatment collection predictive wide cond sample negative collaboration rank angi scale initiative ancestrally psychiatric criterion validity background module characteristic research nct also trial genome conclusion group diagnostic high consortium medium rapidly internet center anz individual presence australia acceptable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338222/,abstract,1,pronged nervosa cond anz angi ancestrally amenorrhea icd anorexia dsm recruit rank draw zealand structured scid internet denmark sweden module register consortium remarkably recruitment australia substantially lifetime validity collaboration rapidly initiative clinicaltrials acceptable locus nct traditional gov psychiatric medium multi united suitable predictive efficient genomics utility text procedure international effort center history collection genome woman questionnaire negative behavior genetics criterion rapid national presence highly social wide ass scale characteristic diagnostic country background tool state trial positive online effective large information conclusion term sample approach case individual new model control factor blood type diagnosis research population significant group high genetic method disorder treatment clinical result,"{""social"": {""freq"": 1, ""string"": [""genetics criterion rapid national presence highly social wide ass scale characteristic d""]}, ""psychiatric"": {""freq"": 1, ""string"": [""clinicaltrials acceptable locus nct traditional gov psychiatric medium multi united suitable p""]}}","{""genetic"": {""freq"": 1, ""string"": [""diagnosis research population significant group high genetic method disorder treatment clinical r""]}}",{},{},{},{}
1468,1468,1589,10.1098/rsif.2018.0420,30232242.0,blood tool assessment activity quadratic lower time across segment neonatal additional stimulation heel sympathetic objective outperformed stick randomness reduction higher value raise entropy neonate feature tone possibility term regression stress rate multi short drawing external lag model method separately parasympathetic hrv simulation forty phase resting two healthy stressor influence heart analysis nonlinear framework multiple roc diagnostic high study linear variability performance accuracy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170777/,abstract,0,randomness outperformed nonlinear drawing resting parasympathetic lag entropy tone quadratic hrv sympathetic stick stressor segment separately heel roc external raise simulation stimulation neonate multi variability possibility linear framework accuracy heart phase short stress regression neonatal feature reduction influence additional performance diagnostic assessment tool healthy objective multiple value lower rate activity term higher time model blood high method analysis study,{},{},{},{},{},{}
1469,1469,1590,10.12659/MSM.907288,29405179.0,refinement disorder sporadic new synonymous carrying site deleterious insight molecular variation dopa drd assembly responsive material hydroxylase spectrum sequence dystonic understanding dopamine clinical protein resultsone genotype diagnosis nonsense data server cyclohydrolase novel genetic conclusionspatients chinese non mutation three ethnicity remarkable dimensional phenotype gch methodsrelevant structure tyrosine residue model dystonia han treatment active help iterative atomic variant clarify tasser function analysis mechanism gtp keywords mutational different study patient mesh,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810615/,abstract,3,tasser methodsrelevant dystonic conclusionspatients server resultsone atomic carrying refinement drd synonymous remarkable mesh gch clarify han nonsense mutational dopa sporadic iterative dystonia cyclohydrolase gtp ethnicity deleterious dimensional residue assembly responsive chinese keywords dopamine active genotype sequence help insight understanding site variation structure tyrosine hydroxylase phenotype spectrum variant molecular mechanism novel mutation material non function new model diagnosis different protein genetic data disorder treatment clinical analysis patient study,{},"{""genetic"": {""freq"": 1, ""string"": [""function new model diagnosis different protein genetic data disorder treatment clinical a""]}}",{},{},{},{}
1470,1470,1591,10.1002/2211-5463.12100,27761358.0,scanning disorder inactivation shift compulsive catalysis initial half biosynthesis characterization due state buffer facilitate regulatory addition increase transition polyphasic significantly respectively reside phe obsessive threefold life monomer poorly variety inherent higher fold instability analytical depression tph length effect change experiment low full rate three catalytic step oligomeric purification temperature apparent htph stable dimer residue toward calorimetry gel associated terminus two variant serotonin premature differential fluorimetry quantity tryptophan filtration domain trp equilibrium human truncation yield schizophrenia presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055035/,abstract,2,polyphasic obsessive htph fluorimetry truncation reside compulsive threefold catalysis scanning purification instability calorimetry tph terminus oligomeric filtration inactivation buffer inherent gel equilibrium trp dimer schizophrenia monomer apparent quantity shift residue premature catalytic yield transition poorly length depression characterization biosynthesis tryptophan temperature experiment serotonin facilitate differential half stable fold initial analytical variety domain associated step regulatory presence phe addition state change variant increase respectively rate life higher low significantly human effect disorder,{},{},{},{},{},{}
1471,1471,1592,10.1002/lt.24057,25482651.0,disorder greater single reporter fah time lentiviral longitudinally photon injection control noninvasive disease promoter hereditary concentrate animal relevant however organ strategy clinical demonstrating clinically mouse curable wildtype sodium iodide primary image report methodology knockout efficacy hepatocyte dexamethasone tomography novel symporter first type hepatocytes non thyroidal transduction globulin imaging fumarylacetoacetate emission tyrosinemia preclinical failure many liver congenic model method work efficiency identification iodine thereby potential parenchymal treatment engraftment rodent cell robust thyroxine visualize hydrolase survival regeneration invasive field next stem currently transplantation also prevention robustly tissue study direct noninvasively vector conclusionthis gene individual readily presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5957080/,abstract,0,thyroidal symporter parenchymal iodide curable congenic wildtype noninvasively globulin dexamethasone visualize thyroxine photon longitudinally fah concentrate lentiviral hydrolase fumarylacetoacetate rodent engraftment robustly regeneration iodine noninvasive tyrosinemia reporter conclusionthis transduction image readily knockout preclinical tomography sodium emission demonstrating hereditary hepatocytes imaging stem promoter transplantation vector invasive injection hepatocyte efficiency survival organ failure methodology robust clinically direct work efficacy animal liver presence tissue prevention greater currently relevant identification field mouse primary strategy single report novel non cell individual time model control type potential gene method disorder treatment clinical disease study,{},{},{},{},{},{}
1472,1472,1593,10.3390/nano8060400,29865274.0,dye super sample three activity logarithm signal new derived film spectroscopy analyte normal strong diazotization coupling tyrosine reaction surface approach simple method great sers phenolic substrate subsequently moreover silver potential raman concentration hydrophobic nanocubes urine azo agncs linearly human novel indirectly diazonium limit ion typical intensity low highly spectrum peak sensitive detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027368/,abstract,0,nanocubes diazotization diazonium derived azo agncs super silver logarithm sers raman linearly film phenolic hydrophobic indirectly dye coupling analyte peak ion intensity typical spectroscopy surface subsequently substrate limit simple signal great sensitive strong urine reaction tyrosine highly spectrum detection normal novel concentration activity sample low approach new human potential method,"{""urine"": {""freq"": 1, ""string"": [""limit simple signal great sensitive strong urine reaction tyrosine highly spectrum d""]}}",{},{},"{""detection"": {""freq"": 1, ""string"": [""strong urine reaction tyrosine highly spectrum detection normal novel concentration activity s""]}}",{},{}
1473,1473,1594,10.1038/aps.2017.141,29417940.0,early immunosorbent among synthase without onset due risk control clusterin validation apolipoprotein significantly summary ami myosin event trna value retinol protein albumin fold global comparable image predict serotransferrin interacting aminoacyl prospective myocardial titin type elisa multifunctional level haptoglobin significant transthyretin caspase rate least mellitus dimensional biomarkers progenesis acute prediction strong discovery intervention abundance identification rad via potential serum attack infarction gel fnger incidence false assay particularly electrophoresis sample two fdr mass samespots screen spot amyloid comparison effectively heart dna analysis closely spectrometry group upon plasma cohort high pattern study alpha cardiac antitrypsin zinc patient connection though volunteer tetranectin complex statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289394/,abstract,3,titin tetranectin serotransferrin samespots retinol rad progenesis infarction haptoglobin fnger clusterin caspase ami transthyretin myosin multifunctional interacting antitrypsin fdr apolipoprotein myocardial immunosorbent attack aminoacyl trna predict elisa closely electrophoresis albumin gel mellitus image connection zinc volunteer dimensional amyloid abundance effectively alpha synthase comparable cardiac summary false validation prediction screen prospective fold statistically strong event discovery acute heart global dna incidence pattern serum assay comparison onset spectrometry biomarkers particularly spot identification cohort mass plasma complex value intervention rate sample significantly risk early control type potential protein significant group high level analysis patient study,{},{},{},"{""spectrometry"": {""freq"": 1, ""string"": [""incidence pattern serum assay comparison onset spectrometry biomarkers particularly spot identification c""]}}",{},{}
1474,1474,1595,10.1042/EBC20170053,30509934.0,process advance disorder cancer understanding alongside difference greater single appropriate epigenetics considers function lesser therapy role play dna provision imbalance review management alone environment genetics variation diagnosis human technological extent basis patient disease combination genetic contribute gene lifestyle complex chromosomal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279436/,abstract,0,considers lesser epigenetics imbalance alongside chromosomal technological provision lifestyle contribute extent play advance appropriate basis dna environment cancer understanding genetics combination variation greater process management complex single therapy role difference function human diagnosis review gene genetic disorder patient disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1475,1475,1596,10.1021/acsomega.9b01686,,major nanoparticles disorder simplicity new content strengthen surface condition sers solvent open separate chemical addition increase solution compactness phe measurement phenylalanine quantitative screening mixed trace rough powder real substrate support result raman effect purpose urine uric first polyvinylpyrrolidone formation interference roughness prepared detection level rapid signal size analyte coffee strong colloidal deposition sensitivity highly minimize agc phenylketonuria feasible method determination thereby silver concentrated solid adsorb component sample agnps hotspot space determine pvp ring analytes reduced reproducibility analysis prior also considerably whereas acid zno robustness mixture,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751712/,abstract,0,zno roughness rough pvp polyvinylpyrrolidone compactness colloidal agnps agc silver deposition concentrated adsorb simplicity sers raman hotspot coffee prepared powder nanoparticles strengthen solvent robustness minimize interference uric trace ring analyte space considerably analytes reproducibility solid mixture mixed surface substrate feasible determination separate real solution chemical signal reduced prior formation strong open urine content component size quantitative sensitivity rapid purpose measurement highly determine detection support phe screening addition major increase condition sample phenylketonuria new phenylalanine acid effect method level disorder analysis result,"{""urine"": {""freq"": 1, ""string"": [""signal reduced prior formation strong open urine content component size quantitative s""]}, ""phenylalanine"": {""freq"": 2, ""string"": [""major increase condition sample phenylketonuria new phenylalanine acid effect method level d""]}}",{},{},"{""detection"": {""freq"": 1, ""string"": [""sensitivity rapid purpose measurement highly determine detection support phe screening addition m""]}, ""screening"": {""freq"": 1, ""string"": [""measurement highly determine detection support phe screening addition major increase condition s""]}}",{},{}
1476,1476,1597,10.3389/fnhum.2017.00154,28439231.0,specific memory better neural new fundamental switching across behavioral adult complexity careful aged gingerale partially common effective activation influential add typical measurement executive decade understanding however evidence much coordinate overlapped integral nature developmental focus integrative task structural support debate result existence furthermore inhibition brainmap consideration capture period level commonly functional one fmri diversity structure capability child contention suggestion population model degree development expression social unitary year emotional systematic process component age separable updating function cognitive analysis aim also different part study magnetic meta individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383671/,abstract,1,unitary gingerale brainmap separable contention switching coordinate add updating overlapped fmri integral influential careful suggestion integrative existence debate capability emotional capture diversity typical fundamental complexity partially neural degree activation executive commonly meta inhibition consideration nature memory magnetic task decade structural behavioral systematic component aged understanding focus furthermore structure developmental measurement social functional period better process cognitive support aim expression effective adult evidence common function individual new model specific population child different age development year level analysis result study,"{""behavioral"": {""freq"": 1, ""string"": [""nature memory magnetic task decade structural behavioral systematic component aged understanding f""]}, ""emotional"": {""freq"": 1, ""string"": [""careful suggestion integrative existence debate capability emotional capture diversity typical fundamental c""]}, ""social"": {""freq"": 1, ""string"": [""understanding focus furthermore structure developmental measurement social functional period better process c""]}}",{},{},{},{},{}
1477,1477,1598,10.11613/BM.2015.018,26110030.0,various biological disorder past physiological among several present prognostic affected condition contamination variation diverse effective saliva disease utility knowledge decade however marker possible storage health recovery word procedure spite analytical utilization large data oral non use circadian variable interest biomarkers pre standardization analyte systemic drug overall many review technique method identification pathological diagnose development system towards evolution latest collection key systematic challenge kit monitoring advance sample two application biology relation easy carefully invasive matrix research monitor also prevention diagnostic trend salivary number sensitive treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470107/,abstract,0,circadian salivary contamination standardization spite prognostic kit latest analyte utilization saliva carefully diagnose easy monitor recovery evolution matrix pathological invasive systemic trend affected physiological storage monitoring diverse treat analytical word sensitive biology relation past oral decade utility procedure advance systematic pre collection variable marker variation prevention biomarkers technique biological identification overall knowledge diagnostic possible various application challenge drug key effective large use condition non sample number present research review development health method data disorder disease,{},{},{},{},{},{}
1478,1478,1599,10.1016/j.ymgmr.2018.10.004,30386727.0,male various phenotypic activity region difference among defect country splicing onset molecular missense taiwan fabry risk substitution urinary globotriaosylsphingosine well disease biochemical understanding later subject unique possible form leukocyte protein galactosidase core result nonsense hand data basis type chinese useful level commonly functional mutation one female pathogenic japanese frequently japan system polymorphism insertion variant globotriaosylceramide peripheral since gla deletion analysis characteristic classic group plasma high study acid patient elucidate underwent amino gene individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205336/,abstract,12,globotriaosylsphingosine globotriaosylceramide gla taiwan galactosidase leukocyte japanese fabry splicing nonsense japan elucidate insertion underwent substitution hand core peripheral chinese deletion classic commonly urinary missense phenotypic later pathogenic polymorphism unique frequently useful basis female understanding onset defect male functional characteristic biochemical country region possible various form subject plasma variant molecular activity mutation amino difference individual risk type acid protein gene group high data level analysis result patient disease study,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""subject plasma variant molecular activity mutation amino difference individual risk type a""]}}",{},{}
1479,1479,1600,10.1038/mt.2015.166,26347501.0,activity herein factor trigger abnormal positive esc polii modification enhance hulc insight malignant epigenetic embryonic demonstration promoter transformation recruit offer cancer tumorigenesis role play hand link like hepatocyte oncogenic resistant strikingly seventh novel first long formation trimethylation crucial enhancer drug upregulated many lysine liver expression potential chromatin excessive signaling lncrna cell cascade rna mechanistically differentiation function catenin stem methylation histone human cudr twenty tumor highly complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700108/,abstract,0,trimethylation polii oncogenic hulc esc seventh lncrna cudr catenin upregulated tumorigenesis strikingly recruit enhancer mechanistically malignant histone chromatin cascade resistant methylation demonstration lysine transformation trigger excessive signaling epigenetic embryonic hand offer stem promoter enhance crucial tumor differentiation rna modification hepatocyte link formation abnormal play insight cancer liver highly like long expression complex positive drug novel activity role cell function human factor potential,{},{},{},{},{},{}
1480,1480,1601,10.1289/EHP140,27258438.0,biological subsequent specific past information context difficult across author lifespan throughout initial totality smith molecular interactive due suggested chemical mechanistic improve ehp majority concept underlying disease objective month excellent however understanding withstand exposome additionally health compound body environment recently exogenous effect term long mitigate one scientific discussion miller environ outline provide highly many vulnerability able week describe spira target lifetime exposure response year help downstream transient minimal endogenous sumner vast biology balshaw determine fingerprint ago originally analysis adverse environmental background auerbach perspect impact framework research importance conclusion comprehensive interaction part often fallin human connection org individual resilient citation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047763/,abstract,1,sumner spira smith resilient perspect miller fallin environ ehp balshaw auerbach withstand totality mitigate fingerprint originally exposome vast suggested citation interactive vulnerability org lifespan ago outline connection lifetime exogenous transient excellent downstream minimal mechanistic endogenous author underlying subsequent discussion improve chemical initial scientific able biology past framework concept majority additionally comprehensive difficult adverse help environment compound understanding recently exposure context environmental highly biological determine importance provide week target interaction body background month objective long response molecular impact information conclusion term individual human specific research health year effect analysis disease,{},{},{},{},{},{}
1481,1481,1602,10.1016/j.humpath.2015.12.002,26997447.0,immunohistochemistry various steatohepatitis inactivation thirteen differentiated hcas due adenoma common institution well transformation subset however evidence definite possible hepatocellular lfabp raise role protein therefore complete possibility support diagnosis thus recently hepatitis consideration case liver regulation degree expression loss fatty hnf carcinoma hca particularly rare inflammatory within carcinogenesis variant differentiation background characteristic noncirrhotic phenomenon acid cirrhosis twenty tumor total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224915/,abstract,9,steatohepatitis noncirrhotic lfabp hcas differentiated hca immunohistochemistry hepatocellular cirrhosis adenoma carcinogenesis thirteen inactivation carcinoma definite transformation hepatitis raise phenomenon institution hnf tumor subset differentiation degree consideration possibility complete inflammatory fatty regulation recently loss liver particularly characteristic possible various background support expression variant rare total evidence role common case diagnosis acid protein,{},{},{},{},{},{}
1482,1482,1603,10.1038/gim.2017.101,28771246.0,immediate blood hepatorenal early positive autosomal condition literature superior genetics state favor risk effective experience majority way survey establish physician medical biochemical marker evidence uniform follow hepatocellular renal optimal clinical nominal neonate practitioner symptom result asymptomatic diagnosis metabolic symptomatic dietitian term scheme long type psychologist eight level hepatic nitro end tyrosinemia canada comorbidities strong failure succinylacetone tyrosine child confirmation review management identification via face system treatment recommendation meeting appropriately carcinoma care process consensus two newborn trifluoromethylbenzoyl recessive cyclohexanedione neurologic nutritionist infant group diagnostic presentation patient,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729346/,abstract,1,trifluoromethylbenzoyl hepatorenal succinylacetone psychologist nutritionist nitro hepatocellular cyclohexanedione scheme carcinoma nominal favor uniform canada appropriately meeting comorbidities tyrosinemia immediate practitioner neurologic dietitian confirmation asymptomatic superior neonate symptomatic face establish renal consensus hepatic physician failure presentation end optimal strong recessive majority autosomal way follow experience recommendation survey marker genetics tyrosine identification biochemical diagnostic literature symptom process infant state long management positive effective medical care newborn evidence term condition risk early blood type diagnosis review child metabolic group level treatment clinical result patient,{},"{""autosomal"": {""freq"": 1, ""string"": [""presentation end optimal strong recessive majority autosomal way follow experience recommendation s""]}, ""recessive"": {""freq"": 1, ""string"": [""physician failure presentation end optimal strong recessive majority autosomal way follow e""]}}",{},"{""newborn"": {""freq"": 1, ""string"": [""long management positive effective medical care newborn evidence term condition risk e""]}}",{},{}
1483,1483,1605,10.1002/jcph.1304,30192386.0,major european assessment disorder new dos factor final authorization due august experience orphan disease summary third related animal optimal clinical always determined indication report thus metabolic type case involvement pre end dose drug point population product oncologic development important phase finding process objection robust public two mostly healthy special characteristic program importance trial conclusion study extent marketing patient volunteer absence rarity number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585723/,abstract,9,oncologic objection marketing authorization august rarity orphan volunteer final dos indication involvement summary special determined extent absence robust end optimal european dose phase experience pre animal point product importance related characteristic public finding assessment process healthy trial program major drug report conclusion important number case new factor type population development metabolic disorder clinical patient disease study,{},{},{},{},{},{}
1484,1484,1606,10.1007/s12687-017-0309-5,28555434.0,carrier rare genetically use specific worldwide disorder mutation provider panel whether prevalence appropriate autosomal population dutch five aware therefore great offering result thus high test isolated majority important preconception genetic show founder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614881/,abstract,0,offering dutch preconception founder aware isolated provider worldwide genetically great carrier panel majority autosomal appropriate prevalence use rare mutation important test specific population high genetic disorder result,{},"{""autosomal"": {""freq"": 1, ""string"": [""worldwide genetically great carrier panel majority autosomal appropriate prevalence use rare m""]}, ""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1485,1485,1607,10.12659/AJCR.909749,30482890.0,italy abnormality investigation respiratory search congenital deeper defect present prenatal literature need common closed vascular trunk institute addition well pulse failuremedication third ductus relevant life anomalous foramen archsymptoms fluorescent clinical dilation value ventricular procedure medico feature arterial circulatory improvement report diagnosis university cardiology aortic cause fusion newbornfinal routine fetal medicine suggestive case hybridization female death hypertrophy dimensional dispute specialty acute normal discussed failure syndrome description around review branch day perinatal pathological atrial free artery postnatal septum finding discover oximetry rare collapse ovale legal variant newborn aorta situ order heart pulmonary cardiologyobjective hypoplasia botalli analysis karyotype program keywords conclusion diagnostic coronary right extrauterine microdeletion cardiac ultrasound chieti patient show mesh malformation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280717/,abstract,0,trunk ovale newbornfinal microdeletion medico hypertrophy foramen failuremedication dispute dilation collapse chieti cardiologyobjective botalli atrial archsymptoms karyotype extrauterine ductus discussed septum hypoplasia circulatory anomalous oximetry closed cardiology branch aorta coronary arterial ventricular specialty mesh suggestive fusion fluorescent discover deeper italy artery aortic situ institute hybridization description postnatal ultrasound pulse pulmonary perinatal respiratory dimensional legal malformation vascular pathological right cardiac routine prenatal failure keywords fetal university procedure search acute death heart investigation female improvement abnormality feature free syndrome defect relevant congenital medicine order need diagnostic finding literature normal addition day program cause value variant report rare life newborn conclusion common present case diagnosis review clinical analysis patient,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""cause value variant report rare life newborn conclusion common present case d""]}}",{},{}
1486,1486,1608,10.1155/2019/7096416,31346512.0,worldwide nomadic ratio factor composition lower profile essential standardized necessary liquid weight hydrolysis moose lnaa modern traditional significantly respectively synthesis naoh homeostatic dependence relative previous higher fish ultraperformance health protein brain gap principal indigenous neurotransmitter food result transport large subarctic change thousand colonization game hcl alter wild one neutral northern canada overall wet anova meat people substantial important proportion year diet finding lifestyle component traditionally regulator sample within serotonin disparity community limited analysis tryptophan nutritional different often trp acid human dietary amino chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620842/,abstract,0,ultraperformance subarctic nomadic moose game wet naoh indigenous hcl colonization hydrolysis homeostatic lnaa disparity traditionally dependence anova canada modern meat northern trp principal fish alter standardized thousand neutral regulator lifestyle transport tryptophan gap traditional serotonin worldwide substantial neurotransmitter composition wild people proportion liquid relative community chromatography necessary previous component profile nutritional weight synthesis limited essential ratio overall finding food change large lower brain diet respectively dietary amino higher important sample significantly human factor acid different protein health year analysis result,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""large lower brain diet respectively dietary amino higher important sample significantly h""]}}","{""diet"": {""freq"": 1, ""string"": [""finding food change large lower brain diet respectively dietary amino higher i""]}, ""fish"": {""freq"": 1, ""string"": [""canada modern meat northern trp principal fish alter standardized thousand neutral r""]}}",{}
1487,1487,1609,10.1186/s12920-018-0326-1,29504900.0,microcephaly genetically case mutation example homozygous allele proband single conclusionsour backgroundprimary syndrome aspm clinical continuum clinically seckel deletion delc population previously condition frequency primary additional heterogeneous preterm support karachay exome presentationclinical nucleotide sequencing republic novel termination initially gene cherkess,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836840/,abstract,0,seckel presentationclinical backgroundprimary delc aspm karachay cherkess proband republic continuum termination conclusionsour microcephaly initially preterm homozygous heterogeneous deletion exome genetically nucleotide clinically allele example sequencing syndrome previously frequency additional support primary single novel mutation condition case population gene clinical,"{""microcephaly"": {""freq"": 1, ""string"": [""cherkess proband republic continuum termination conclusionsour microcephaly initially preterm homozygous heterogeneous d""]}}","{""homozygous"": {""freq"": 1, ""string"": [""continuum termination conclusionsour microcephaly initially preterm homozygous heterogeneous deletion exome genetically n""]}}",{},{},{},{}
1488,1488,1610,10.3390/mps1030030,31164572.0,carrier suitable bypass entire sequence intron blood rapid rate mutation phenylalanine exon example variant interpretation new spot possible screening end bulgaria tier positive omim denmark approximately neonatal confirmation population neonate italian phenylketonuria molecular simple method southern also pah thereby hyperphenylalaninemias second high frequent test successfully boundary sequencing reach question germany pku hydroxylase poland western gene sweden useful detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481045/,abstract,2,hyperphenylalaninemias poland bypass bulgaria tier intron italian denmark boundary sweden omim southern reach confirmation germany entire neonate interpretation western successfully exon suitable simple frequent end question carrier approximately useful sequence second example pah neonatal rapid sequencing spot hydroxylase detection possible screening positive variant molecular rate mutation pku phenylketonuria test new phenylalanine blood population gene high method,"{""phenylalanine"": {""freq"": 2, ""string"": [""rate mutation pku phenylketonuria test new phenylalanine blood population gene high m""]}}",{},{},"{""detection"": {""freq"": 1, ""string"": [""pah neonatal rapid sequencing spot hydroxylase detection possible screening positive variant m""]}, ""screening"": {""freq"": 1, ""string"": [""rapid sequencing spot hydroxylase detection possible screening positive variant molecular rate m""]}}",{},{}
1489,1489,1611,10.1186/s12961-017-0187-7,28420381.0,operation availability better search outlet representative context across amenable present five literature geographic common highlight optimisation effective varied finally material issue element subset relevant however supplementary innovation select driver clinical user summaryherein health gap global distribution narrative analytical represent data medicine international area theme case seven four three main communication description database critical review contextually model aid method emphasis system simulation analyse online conclusionpoor article success collection proportion key electronic detail decision systematic challenge particularly backgroundoperations materialthe version public collaboration application appropriate stakeholder equity advanced quality analysis impact research available also policy practice study namely small discipline complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395767/,abstract,2,summaryherein optimisation contextually conclusionpoor backgroundoperations represent outlet narrative innovation geographic equity driver amenable select discipline description operation analyse aid stakeholder simulation collaboration representative emphasis advanced varied theme subset gap success element analytical communication distribution proportion availability seven international decision search systematic policy collection appropriate global finally critical context database practice particularly materialthe highlight relevant medicine issue main public small better literature area supplementary application challenge user complex version key electronic quality online effective impact material article common present case available model research review health method data clinical analysis study,{},{},{},{},{},{}
1490,1490,1612,10.1080/15476286.2015.1068497,26176195.0,process sequence presence frame interplay suppression one application factor context premature variety therapy protein next compound necessary identity approach background mechanism efficient natural suppress reading translation efficiency translational pas stimulating mrna disease termination readthrough ribosome number synthesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615788/,abstract,0,ribosome readthrough pas suppress frame reading termination identity stimulating interplay suppression premature mrna translational efficiency translation efficient variety necessary natural sequence compound synthesis context presence background process application mechanism therapy approach number factor protein disease,{},{},{},{},{},{}
1491,1491,1613,10.1177/2050640614561668,25922671.0,disorder search difficult several world literature severe cost abstract risk methodswe resultscd publication effective disease objectivesto relevant life evidence strategy higher clinical conclusionscurrent health support asymptomatic date detection yet case although death current proof population review comorbidity organization sufficient impaired treatment excessive active detail western finding qol still lifelong prevalence appropriate relation approximately quality criterion benefit paper available reduce fulfills group june high patient complication,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406899/,abstract,2,resultscd fulfills conclusionscurrent qol comorbidity objectivesto proof excessive abstract june asymptomatic lifelong impaired western reduce publication sufficient organization complication relation world approximately active date search difficult methodswe death appropriate criterion cost relevant benefit prevalence paper finding literature detection severe support strategy quality effective life evidence current higher case available risk population review health group high disorder treatment clinical patient disease,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""relevant benefit prevalence paper finding literature detection severe support strategy quality e""]}}",{},{}
1492,1492,1614,10.1007/8904_2016_2,27515243.0,disorder delay activity abnormality early abnormal incidentally without supplementation highlight neurocognitive subtle seizure uniform nature range protein developmental nonspecific symptom arginine possibility report elevation result mild hypomorphic learning case full citrulline mutation panel one least pathogenic end normal aversion sign review management therapeutic disability epilepsy ameliorate urea retrospect best finding two asl newborn allele usa residual argininosuccinic omim asa importance cycle intellectual lyase part presentation identifiable pleiotropic acid dietary deficiency patient even gene readily,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509549/,abstract,0,retrospect incidentally asl asa hypomorphic aversion argininosuccinic identifiable pleiotropic nonspecific citrulline uniform subtle omim usa learning readily ameliorate lyase neurocognitive elevation epilepsy arginine urea residual sign seizure possibility delay presentation nature end pathogenic mild cycle panel abnormal intellectual allele best supplementation abnormality disability developmental highlight importance finding symptom normal management range therapeutic deficiency report dietary newborn activity mutation case early review acid protein gene disorder result patient,"{""intellectual"": {""freq"": 1, ""string"": [""end pathogenic mild cycle panel abnormal intellectual allele best supplementation abnormality d""]}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""management range therapeutic deficiency report dietary newborn activity mutation case early r""]}}",{},{}
1493,1493,1616,10.1523/JNEUROSCI.2010-17.2017,29217683.0,male disorder blood autism abnormality growth factor pathway abnormal several defect behavioral itpr synapsis statement behavior molecular basal deficit effective well typical spectrum executive reproduces revers therapy developmental brain mouse core report thus like effect symptomatology significance receptor novel genetic repetitive learning level administration mutation asd current enhancer systemic child model therapeutic urgently mtor via target social potential disability ameliorate test treatment key active associated occur suggest reflective function dependent cognitive act impairment currently igf translation also interaction high insulin barrier btbr ampk show number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783959/,abstract,0,itpr ampk revers reproduces reflective synapsis symptomatology igf urgently enhancer mtor btbr repetitive statement occur basal suggest learning ameliorate typical core insulin act systemic executive translation barrier significance asd receptor abnormal behavioral active associated administration autism dependent deficit abnormality behavior impairment disability developmental defect currently social growth male like spectrum target interaction mouse cognitive key therapeutic effective pathway brain molecular report novel therapy current mutation function number test model factor blood potential child effect high genetic level disorder treatment,"{""behavioral"": {""freq"": 1, ""string"": [""translation barrier significance asd receptor abnormal behavioral active associated administration autism d""]}, ""social"": {""freq"": 1, ""string"": [""behavior impairment disability developmental defect currently social growth male like spectrum t""]}}","{""genetic"": {""freq"": 1, ""string"": []}}","{""pathway"": {""freq"": 1, ""string"": [""interaction mouse cognitive key therapeutic effective pathway brain molecular report novel t""]}}",{},{},{}
1494,1494,1617,10.1371/journal.pcbi.1005615,28671947.0,blueprint correlation specific interestingly statistic relationship river neural new growth hierarchical diameter time morphology topological true exquisitely neuronal summary relevant latter possible form distinguish input brain candidate identifies therefore strahler report scheme type functional measure local tree structure branch model dendritic binary potential synaptic faithful voltage unknown centripetal response important network strongly universal computation order horton function originally metric dependent dendrite importance also predominantly number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515450/,abstract,0,strahler river horton faithful dendrite centripetal topological exquisitely blueprint originally branch scheme diameter computation voltage dendritic binary tree identifies hierarchical distinguish metric synaptic morphology true interestingly input predominantly statistic neural universal neuronal summary strongly candidate local network unknown dependent structure correlation relevant growth importance functional order relationship possible form measure response brain report important function number time new model specific type potential,{},{},{},{},{},{}
1495,1495,1618,10.1007/s40265-017-0788-z,28752290.0,european assessment factor methodological representative early among difficult authorization several world half medicinal literature expert interpret methodswe institute effective orphan doe disease material contribute related relevant supplementary endpoint possible relative user always clinical resultswe gap dutch omps real primary report effectiveness thus efficacy metabolic interview effect data good type eight score website prespecified correspond surrogate population product post national system conclusionsthis online article introductionauthorization important electronic associated version materialthe rare hence public january prevalence unclear pivotal stakeholder since explore available upon often dialogue extent marketing patient healthcare,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577060/,abstract,4,prespecified introductionauthorization dialogue omps correspond marketing authorization pivotal dutch website surrogate interpret endpoint methodological medicinal institute orphan stakeholder representative conclusionsthis resultswe january contribute gap interview real half extent expert unclear doe european world healthcare post relative explore difficult methodswe effectiveness associated good efficacy national materialthe product relevant related prevalence public score literature possible assessment supplementary user primary version electronic online effective report rare material article important available early factor type population metabolic effect data clinical patient disease,{},{},{},{},{},{}
1496,1496,1619,10.3389/fcimb.2019.00101,31058098.0,major microorganism availability chain chromatographic daily shift vegetable region difference dataset positively unifrac lesser despite literature unweighted mainstay spp biomarker old control increase pku status intake ruminococcaceae microbiota respect beneficial phenylalanine subject family distance observed faecalibacterium higher divergent protein lachnospiraceae firmicutes hypervariable substrate roseburia vegan microbial mild consuming change negatively clostridium specie low rrna separation significant member one main short diversity child population butyrate phenylketonuria producer fermentation gas phylum scfas treatment carbohydrate response fatty year diet indeed within load hyperphenylalaninemia bromii healthy ruminococcus community enriched mhp blautia quality unrestricted analysis previously index indicator quantity group different glycemic high study alpha whereas fiber acid sequencing extent dietary gene individual total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477998/,abstract,2,unweighted unrestricted unifrac ruminococcaceae roseburia hypervariable faecalibacterium bromii blautia vegan spp ruminococcus producer lachnospiraceae butyrate scfas phylum mhp clostridium rrna firmicutes fermentation divergent glycemic enriched chromatographic lesser mainstay fiber vegetable microorganism dataset distance consuming separation microbial load quantity microbiota indicator carbohydrate shift respect diversity positively negatively substrate gas alpha specie biomarker extent beneficial hyperphenylalaninemia member availability mild daily fatty community index observed short old chain intake sequencing previously despite main status region literature healthy subject major change increase response quality diet family dietary total pku higher difference phenylketonuria low individual phenylalanine control population acid child different protein significant gene group year high treatment analysis study,"{""phenylalanine"": {""freq"": 2, ""string"": [""pku higher difference phenylketonuria low individual phenylalanine control population acid child d""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""subject major change increase response quality diet family dietary total pku h""]}}",{}
1497,1497,1621,10.1117/1.JMI.2.3.036002,26213695.0,resonance operation gmt vivo difference time platform tesla density condition interactive heterogeneous open pathology infiltration source carr control neurological glioma establish murine sequence quantitative geometric confirm relative brain axial mouse distribution real improvement examination analytical histogram integrity data fraction expansion voxel significant water cellular imaging compartmentalization software code normal map slice overall evaluation many workflow method pathological substantial manufacturer alteration numeric quantitativet feasibility multiecho advancement gill intuitive invasive advanced scanner analysis matrix characteristic program decay extracellular anesthetized tissue study magnetic extent histology tumor complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509667/,abstract,2,quantitativet multiecho histology histogram gmt glioma gill compartmentalization carr tesla numeric geometric decay anesthetized slice voxel infiltration axial manufacturer intuitive scanner interactive code extracellular operation workflow murine map integrity confirm advancement expansion advanced matrix software imaging density pathological heterogeneous establish feasibility invasive tumor resonance fraction real pathology substantial extent water platform examination analytical distribution open magnetic cellular alteration vivo relative neurological sequence quantitative source improvement tissue evaluation characteristic overall mouse normal program complex brain condition difference time control significant method data analysis study,"{""neurological"": {""freq"": 1, ""string"": [""open magnetic cellular alteration vivo relative neurological sequence quantitative source improvement t""]}}",{},{},{},{},{}
1498,1498,1622,10.1038/srep23125,26975732.0,implication disorder activity cystic due transfections clear mean addition formulation persistent epithelial minicircle persisting amount decade equal subject organ materialise higher clinical therapy clinically mouse inefficient luciferase transfection fibrosis large far non yet fluorescence administration transgene airway product week plasmid expression system viable minicircles viral intensity cell inflammatory two mass percentage equimolar reduced dna intensive vitro research lung trial part study gene number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792149/,abstract,1,persisting minicircles materialise equimolar transfections airway minicircle inefficient luciferase transfection viable persistent transgene plasmid epithelial equal fluorescence intensive lung intensity formulation cystic viral fibrosis percentage far clear organ reduced decade inflammatory vitro clinically administration dna implication mean product week mouse addition mass subject trial expression large therapy activity higher non cell number research gene disorder clinical study,{},{},{},{},{},{}
1499,1499,1623,10.3390/ijms18030618,28287497.0,implication specific epidemiological disorder autism investigation new hierarchical single early laboratory necessary psychiatrist molecular genetics source practical severity number dysmorphic objective neurological geneticist spectrum neuroimaging extensive knowledge pediatrician strategy follow clinical developmental feature practitioner eeg symptom examination result diagnosis psychological collaborate observational copy first genetic chromosomal detection asd step morbidity diversity syndrome child evaluation review milestone technique identification development propose consequently second article treatment iii neuropediatricians progress variant order psychiatric stepwise prevention general diagnostic different study neuropediatric show gene malformation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372633/,abstract,0,neuropediatricians neuropediatric collaborate psychiatrist dysmorphic stepwise pediatrician neuroimaging hierarchical eeg milestone practitioner geneticist chromosomal copy malformation iii diversity epidemiological psychological consequently progress practical observational extensive psychiatric propose asd examination morbidity severity neurological step necessary follow autism investigation implication source second feature genetics developmental prevention syndrome evaluation technique laboratory identification general order knowledge spectrum diagnostic detection symptom objective strategy variant single molecular article number new early specific diagnosis review child different development gene genetic disorder treatment clinical result study,"{""neurological"": {""freq"": 1, ""string"": [""psychiatric propose asd examination morbidity severity neurological step necessary follow autism i""]}, ""psychiatric"": {""freq"": 1, ""string"": [""psychological consequently progress practical observational extensive psychiatric propose asd examination morbidity s""]}}","{""genetic"": {""freq"": 1, ""string"": [""diagnosis review child different development gene genetic disorder treatment clinical result s""]}}",{},"{""detection"": {""freq"": 1, ""string"": [""identification general order knowledge spectrum diagnostic detection symptom objective strategy variant s""]}}",{},{}
1500,1500,1624,10.3892/br.2017.868,28413636.0,various commonly decade two one nuclear spectroscopy recent acute statistical present notable field chronic protein procedure currently liver aspect management aim analysis metabolomics technique method widely transplantation nmr diagnosis result investigate last study magnetic data human publication addition carbohydrate key acquisition powerful disease type metabolism numerous,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374905/,abstract,0,notable acquisition nmr carbohydrate spectroscopy powerful transplantation publication commonly numerous nuclear widely metabolomics magnetic decade aspect procedure statistical acute liver investigate chronic currently technique field various aim addition management key recent present metabolism human type diagnosis protein method data analysis result disease study,{},{},{},{},{},{}
1501,1501,1625,10.1038/s41418-018-0157-9,30038385.0,worldwide investigation new early pathway congenital time avenue enhance condition common ascorbic mesenchymal transition disease embryonic epithelial emt marker subject pluripotent role compound play replacement cardiomyoctyes degradation chd report specification effect biocatalysis term generation furthermore uric fetal lengthened mortality useful period level morbidity ubiquitylation abundant pscs critical day development treatment mesoderm directly phase cell hescs upregulation anomaly differentiation heart stem mesodermal ubiquitination indicator robustly hipscs physiologically cardiac human acid ultrasound consistently,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461775/,abstract,0,pscs mesodermal mesoderm lengthened hipscs hescs emt cardiomyoctyes biocatalysis ubiquitylation ubiquitination specification mesenchymal ascorbic pluripotent avenue uric upregulation physiologically robustly epithelial abundant ultrasound embryonic indicator consistently anomaly chd stem transition replacement enhance differentiation cardiac degradation worldwide fetal morbidity play directly useful heart phase mortality investigation compound marker generation critical furthermore congenital period subject day pathway report term condition role common cell time new human early acid development effect level treatment disease,{},{},"{""pathway"": {""freq"": 1, ""string"": [""critical furthermore congenital period subject day pathway report term condition role c""]}}",{},{},{}
1502,1502,1626,10.1097/MD.0000000000011071,29901615.0,assessment abnormality growth congenital july present posterior morphologic facilitate mean agreement true inter excellent gestational calculation computer genu organ rostum distance screening value range clinically body complete result length large observational data reference percentile least anterior splenium volume curve virtural evaluation population week technique feasible day method identification callosum thickness age anomaly january analysis aim corpus available also trend study intraobserver ultrasound assist square parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024229/,abstract,5,virtural rostum intraobserver morphologic genu thickness splenium posterior percentile distance callosum agreement anterior corpus july computer ultrasound calculation assist true anomaly inter square excellent curve january length feasible gestational observational trend facilitate organ complete reference volume clinically parameter abnormality mean evaluation technique growth congenital identification week body assessment aim screening day range value large present available population age method data analysis result study,{},{},{},"{""screening"": {""freq"": 1, ""string"": [""congenital identification week body assessment aim screening day range value large p""]}}",{},{}
1503,1503,1627,10.3389/fpsyg.2016.02020,28119644.0,specific assessment self effort difficult present condition realization due moreover cost improve mean course control experience clinician increase preliminary disease objective teaching medical measurement satisfaction knowledge session relevant evidence introduction strategy today mainly perspective questionnaire value clinical role health range play practitioner report support effectiveness six purpose large change design term ability long useful area verify educational case confidence measure nurse crucial pre discussion evaluation fully critical motivated management competence feasible method post ass skill forty test active net education care address feasibility attitude process didactic professional relation pilot journey goal chronic validated benefit impact priority program paper research conclusion group upon practice presentation study small patient engagement limitation participant healthcare,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222845/,abstract,1,didactic verify journey motivated competence satisfaction realization teaching nurse engagement today preliminary practitioner net attitude session validated priority skill pilot feasibility feasible crucial fully educational discussion introduction improve course confidence presentation clinician mainly limitation relation goal healthcare education perspective active post play difficult address useful effort effectiveness experience pre professional questionnaire mean self purpose critical cost chronic measurement practice evaluation ability relevant design ass benefit paper small knowledge participant assessment process area support measure objective long management program change range strategy value increase medical large report impact care evidence conclusion term condition role present case test specific control research health group method clinical patient disease study,{},{},{},{},{},{}
1504,1504,1628,10.3390/cells8080867,31405045.0,decarboxylase disorder delay blood tool early autonomous difficult spr dihydropteridine present synthase biosynthesis tetrahydrobiopterin supplementation aromatic catecholamine diverse dhpr classical aadc sepiapterin disease hydroxylase amount csf carbinolamine however norepinephrine quantitative childhood dopamine pcd therapy protein clinically fluid reductase monogenic tetrahydropterin symptom hypotonia degradation error neurotransmitter inborn movement analytical diagnosis like urine cyclohydrolase type metabolism cerebrospinal quantitatively detection fluorescence electrochemical tyrosine dnajc review product pyruvoyl dehydratase dysregulations rare gtpch sample variant pterins epinephrine pterin especially determine aim precursor routinely gtp keywords hplc different monoamine acid predominantly cofactor patient amino gene summarizing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721669/,abstract,1,summarizing pterins aadc carbinolamine quantitatively pcd epinephrine dysregulations dehydratase autonomous tetrahydropterin spr pyruvoyl gtpch dnajc dhpr cerebrospinal pterin electrochemical decarboxylase dihydropteridine csf hypotonia norepinephrine sepiapterin catecholamine reductase cyclohydrolase gtp monoamine fluorescence routinely hplc predominantly movement monogenic aromatic biosynthesis synthase fluid degradation neurotransmitter keywords classical diverse delay analytical precursor cofactor dopamine tetrahydrobiopterin urine difficult clinically supplementation quantitative childhood especially tyrosine product determine like hydroxylase detection inborn symptom aim tool variant error rare therapy amino sample present metabolism early blood type diagnosis review acid different protein gene disorder patient disease,"{""urine"": {""freq"": 1, ""string"": [""delay analytical precursor cofactor dopamine tetrahydrobiopterin urine difficult clinically supplementation quantitative c""]}}",{},{},"{""detection"": {""freq"": 1, ""string"": [""especially tyrosine product determine like hydroxylase detection inborn symptom aim tool v""]}, ""amino"": {""freq"": 1, ""string"": [""aim tool variant error rare therapy amino sample present metabolism early b""]}}",{},{}
1505,1505,1629,10.3389/fnut.2017.00034,28791292.0,interpretational disorder whether bifidobacteria cardiometabolic better composition gut fermentable supplemental deleterious insight without condition host supplementation bacterial clear increase disease reside bacteroides microbiota account subject obesity optimal health great food harm effect drastic change cause immunity controversial non area secondarily alter microbiome member direction certain conclude possibly diversity problem implementation overall relevance prebiotics microbiocentric review immunological abundance determination via potential article treatment carbohydrate alteration directly indeed overview inflammatory future obese likely healthy adverse benefit characteristic alternative research relatively also prevention different interaction whereas lactobacillus bidirectional dietary circumvent individual idea complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523113/,abstract,0,prebiotics microbiocentric interpretational fermentable drastic reside bacteroides secondarily lactobacillus bifidobacteria bidirectional circumvent cardiometabolic immunological supplemental harm conclude immunity idea controversial deleterious alter host gut possibly obese microbiota microbiome direction carbohydrate abundance diversity bacterial relevance determination clear composition overview optimal great member certain relatively account obesity inflammatory alteration directly alternative supplementation adverse insight implementation likely prevention problem benefit characteristic overall interaction better food area healthy subject change complex cause increase future dietary condition non article individual research review potential different health effect disorder treatment disease,{},{},{},{},{},{}
1506,1506,1630,10.1186/s40985-017-0058-3,29450084.0,major worldwide disorder neural dime information early among congenital essential defect committed awareness five polio preterm advocacy tube sponsoring virus conference mission preconception material knowledge family screening optimal additionally role health focus global zika globally diagnosis recently data cause mortality level surveillance toll society grain infection child woman march national attain accordance fortification treatment active education care folic every newborn giving opportunity usa birth influence girl dedicated worker currently paper research program networking foundation prevention policy exchange acid maker,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810010/,abstract,1,sponsoring polio networking mission giving dime attain toll grain committed fortification advocacy zika worker dedicated accordance tube preconception march conference usa globally maker folic surveillance girl exchange preterm foundation awareness neural virus society worldwide optimal infection education additionally opportunity active policy mortality global woman recently focus national prevention influence defect currently essential congenital paper birth knowledge screening program major cause family care information newborn material role early diagnosis research acid child health data level disorder treatment,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""program major cause family care information newborn material role early diagnosis r""]}, ""screening"": {""freq"": 1, ""string"": [""currently essential congenital paper birth knowledge screening program major cause family c""]}}",{},{}
1507,1507,1631,10.1093/jpepsy/jsu117,25622593.0,utility assessment disorder tool future self psychometric evidence least one autism observation primarily pediatric measure factor division cystic strong across exploratory overall child chronic subjective many population criterion review analysis inclusion behavior confirmatory research available task method literature report development fibrosis conclusion property illness parent base feeding force eligible direct recommendation validation well objective mealtime promising systematic total show spectrum,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281003/,abstract,7,mealtime division subjective psychometric exploratory confirmatory force eligible feeding illness cystic base observation promising fibrosis primarily validation strong task utility inclusion systematic property autism recommendation pediatric direct behavior criterion self chronic parent overall spectrum literature assessment tool measure objective future report total evidence conclusion available factor research population review child development method disorder analysis,{},{},{},{},{},{}
1508,1508,1632,10.4178/epih/e2015026,26137845.0,experimental animal cancer relationship subject evidence korea rather scientific factor discus tobacco explanatory cigarette community laboratory occurrence causation attributable population affected causality probability lung contribution history litigation causal variation group thus different risk applicable article study observational human fraction smoking calculated patient association disease inter ability south individual issue,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505180/,abstract,0,litigation tobacco cigarette korea explanatory causation causality smoking calculated attributable applicable probability occurrence south lung inter causal observational fraction affected contribution scientific experimental community history cancer animal variation ability laboratory issue relationship discus subject association evidence article individual human risk factor population different group patient disease study,{},{},{},{},{},{}
1509,1509,1633,10.1136/bmjopen-2018-023688,29844103.0,implication specific disorder relationship whether edi almost region difference representative early lower among time country socioeconomic aged including without province onset hamilton additional territory ethic investigate tremendous dearth objective status contribute establish poorer sociodemographic trajectory third however life evidence childhood strategy relative health census developmental methodology result diagnosis data date first young level service full rate three step canada instrument database child outcome disseminationstudy intervention population method development social skill second school treatment delivery association year education stronger age public lack typically prevalence relation determinant explore analysisstudy currently analysis neighbourhood impact characteristic research board framework policy nationally trend study advantage introductionhealth individual presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988180/,abstract,5,introductionhealth hamilton edi disseminationstudy analysisstudy neighbourhood dearth census including territory sociodemographic tremendous nationally canada socioeconomic board trajectory poorer stronger ethic representative determinant province instrument establish skill school contribute trend young typically methodology advantage relation framework education relative explore date step policy delivery service aged implication childhood second lack onset presence investigate developmental database currently social characteristic prevalence additional public relationship status country region objective strategy lower association impact intervention rate life evidence outcome difference individual time early specific diagnosis research population child age development health year method data level disorder treatment analysis result study,"{""social"": {""freq"": 1, ""string"": [""onset presence investigate developmental database currently social characteristic prevalence additional public r""]}}",{},{},{},{},{}
1510,1510,1634,10.1186/s13023-018-0847-x,29945661.0,caloric cross assessment multicenter sectional studied difference content lower molecule present adult glucose aged homeostasis tetrahydrobiopterin basal resultsa supplementation favor probably risk methodswe statistically control backgroundin objective significantly pku material intake phe biochemical related supplementary phenylalanine marker adequate form anthropometric dependency higher user therapy protein body food diagnosis metabolic mild little postprandial adherence metabolism low rho level significant intolerance one biomarkers mpha miu phenylketonuria analyze model markedly evident conclusionsthis free online article sex tolerance treatment carbohydrate rich electronic year diet version materialthe bmi age mass hyperphenylalaninemia waist healthy homa resistance circumference mhpa index available also classic overweight high study insulin acid similar dietary supplemented patient amino total parameter mixture,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020344/,abstract,3,mpha mhpa miu caloric waist postprandial multicenter homa dependency rho intolerance probably favor supplemented basal overweight anthropometric circumference analyze carbohydrate backgroundin resultsa mixture conclusionsthis studied evident rich markedly bmi tolerance insulin resistance adequate classic sex adherence hyperphenylalaninemia homeostasis statistically little mild glucose tetrahydrobiopterin molecule methodswe sectional content parameter index aged supplementation marker cross free intake biomarkers materialthe related biochemical similar body assessment food form phe supplementary healthy objective mass user version electronic online lower adult diet dietary therapy total pku material amino higher article difference phenylketonuria low present available metabolism significantly risk model phenylalanine control diagnosis acid protein age significant metabolic year high level treatment patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""present available metabolism significantly risk model phenylalanine control diagnosis acid protein a""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""diet dietary therapy total pku material amino higher article difference phenylketonuria l""]}}","{""diet"": {""freq"": 1, ""string"": [""user version electronic online lower adult diet dietary therapy total pku m""]}}",{}
1511,1511,1635,10.1016/j.physbeh.2017.09.009,28899680.0,sweetener blood nutritive beverage rise reliability sensory greater among positive adult cephalic present glucose fed facilitate addition sham increase significantly associative subset interval form obesity role body food ingestive result property purpose effect calorie decrease similarly oral low sixty period significant sucrose four woman week post exposure serum baseline test solid stimulus response proportion phase bmi fat age future sample load obese percentage especially analysis overweight study insulin men minute randomly participant individual presence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634742/,abstract,10,ingestive fed cephalic associative sucrose sham nutritive rise stimulus sensory calorie sweetener overweight men reliability minute load obese solid similarly beverage bmi randomly insulin fat percentage subset facilitate proportion glucose oral interval baseline obesity post phase property woman decrease serum exposure purpose presence especially greater week period participant body food form addition positive increase response future adult role sample low present test individual significantly blood age significant effect analysis result study,{},{},{},{},{},{}
1512,1512,1637,10.1038/srep23748,27049649.0,disorder activity observation autosomal site disrupts regulatory addition increase solution disease hydroxylase phe phenylalanine evidence monomer previous consistent allosteric crystal fold dimerization whereby therefore mutant structural substrate report support result enzyme data change cause genetic bind multi mutation catalytic conformational hydroxylation structure tyrosine terminal dimer model phenylketonuria regulation work ligand via homodimer active associated interface delivers recessive unclear act mechanism module also pah domain study equilibrium human dietary deficiency resolution,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822156/,abstract,0,delivers hydroxylation homodimer disrupts dimerization ligand module conformational equilibrium dimer allosteric terminal monomer bind crystal interface catalytic substrate observation act resolution multi solution fold unclear mutant recessive structural active domain autosomal associated regulatory previous regulation consistent work site pah structure tyrosine hydroxylase support enzyme phe addition change cause increase deficiency mechanism report dietary activity evidence mutation phenylketonuria human model phenylalanine genetic data disorder result disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""activity evidence mutation phenylketonuria human model phenylalanine genetic data disorder result d""]}}","{""autosomal"": {""freq"": 1, ""string"": [""unclear mutant recessive structural active domain autosomal associated regulatory previous regulation c""]}, ""recessive"": {""freq"": 1, ""string"": [""resolution multi solution fold unclear mutant recessive structural active domain autosomal a""]}, ""genetic"": {""freq"": 1, ""string"": [""evidence mutation phenylketonuria human model phenylalanine genetic data disorder result disease s""]}}",{},{},{},{}
1513,1513,1638,10.3349/ymj.2018.59.5.652,29869463.0,specific interpretation methodsten benign new single early newborndiscovery condition molecular resultsa variation testing course evaluate disease uncertain material respectively biochemical related screening clinical clinically result diagnosis metabolic significance design genetic purposewe pathogenic phenotype analyte genomics current comprehensively confirmation approach workflow efficiency assay insertion variant newborn causative imd along allele negative likely pilot since classified deletion analysis benefit concordance also group diagnostic high study nucleotide yield small patient participant conclusionthis gene individual number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990675/,abstract,10,purposewe newborndiscovery methodsten analyte comprehensively conclusionthis benign concordance uncertain insertion confirmation workflow imd classified causative resultsa interpretation pilot yield efficiency deletion course significance genomics pathogenic nucleotide clinically allele evaluate assay negative likely variation design related benefit biochemical phenotype small testing diagnostic participant screening variant single molecular respectively newborn current material condition approach number individual new early specific diagnosis metabolic gene group high genetic clinical analysis result patient disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""specific diagnosis metabolic gene group high genetic clinical analysis result patient d""]}}",{},"{""newborn"": {""freq"": 1, ""string"": [""participant screening variant single molecular respectively newborn current material condition approach n""]}, ""screening"": {""freq"": 1, ""string"": [""biochemical phenotype small testing diagnostic participant screening variant single molecular respectively n""]}}",{},{}
1514,1514,1639,10.1177/0009922815591881,26149849.0,gentle level sample milk percentage lactose difference representative specialty income among lower nutrition formula cow younger health product consumption examination infant regular national state nationally different free soy old contrary household majority recommendation varied month year survey type education sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703581/,abstract,4,gentle soy lactose cow specialty household contrary nationally younger representative regular income formula varied milk percentage examination consumption sensitive nutrition majority education recommendation survey old national free product month infant state lower difference sample type different health year level,{},{},{},{},{},{}
1515,1515,1640,10.1186/s12263-016-0527-1,27551313.0,considerable blood relationship self factor composition difficult feces nutrient accurate finger variation modern well objective disease vitamin status material intake amount atmosphere much health protein procedure body particular peptide food scientist thus transport like large data obtain phone combination lipid type extraction non area one interest biomarkers temperature mineral room drug sensitivity mobile many able population development people thereby potential exposure technology resource collection important filter diet specificity operating monitoring sample metabolite professional relation standard analytes precise analysis environmental background alternative available nutritional different tissue high trend often turn advantage small dry even another individual interesting mail,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968438/,abstract,0,atmosphere feces phone mail dry modern finger mobile turn scientist operating obtain mineral interesting analytes room filter precise extraction transport temperature peptide trend lipid accurate considerable vitamin composition monitoring advantage able people nutrient relation procedure alternative resource difficult specificity collection professional particular nutritional sensitivity exposure combination self variation environmental tissue intake biomarkers like technology small relationship status standard body food background area metabolite objective drug large diet material non important sample available individual factor blood type population potential different protein development health high data analysis disease,{},{},{},{},"{""diet"": {""freq"": 1, ""string"": [""background area metabolite objective drug large diet material non important sample a""]}}",{}
1516,1516,1641,10.1016/j.biopsych.2014.11.001,25483344.0,entire epidemiologic pathogenesis phenotypic disorder autism estimation new factor effort characterization literature open capacity horizon course hypothesis tremendous ascertainment disease typical spectrum measurement animal clue marker strategy neurodevelopmental recent daunting role play broaden environment examination task substrate etiologic dense design cause genetic perturbation epidemiology consideration capture ultimately significant asd one paradigmatic step dimensional biomarkers size etiology discovery population review approach model ndds method development categorical test interact treatment important association modifier address stratification rare wide future sample progress variant along comparison statistical gxe heritability next precise environmental validity paper larger multiple prevention interaction study even another gene accuracy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260177/,abstract,0,paradigmatic gxe dense ndds daunting ascertainment etiologic clue categorical stratification broaden horizon tremendous interact epidemiologic perturbation modifier heritability estimation entire dimensional validity epidemiology capture ultimately typical precise substrate pathogenesis characterization progress capacity larger course phenotypic consideration neurodevelopmental asd examination etiology open discovery hypothesis task accuracy play statistical address effort step autism size environment animal comparison marker environmental measurement prevention biomarkers wide design paper spectrum interaction literature multiple cause strategy variant future association recent rare important role sample approach test new model factor population review significant development gene genetic method disorder treatment disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""factor population review significant development gene genetic method disorder treatment disease s""]}}",{},{},{},{}
1517,1517,1642,10.21037/atm.2016.03.05,27127760.0,major specific disorder past factor discus effort cystic world common state concept disease spectrum extensive individual knowledge cancer recent form select dementia clinical pathologically clinically particular environment fibrosis cause genetic obstacle medicine significant government society death scientific integrate wider around review approach model day alzheimer development prevalent article treatment precision year western lifestyle monogenetic every advance sixth application benefit prevention practice pattern variability highly complex initiative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828743/,abstract,0,monogenetic pathologically sixth integrate dementia wider select obstacle government cystic western initiative alzheimer lifestyle fibrosis prevalent society extensive variability precision scientific past concept world advance effort death clinically particular environment pattern cancer prevention practice highly medicine benefit discus knowledge spectrum form application state day major complex cause recent article common approach individual model specific factor review significant development year genetic disorder treatment clinical disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1518,1518,1643,10.1542/peds.2014-3549C,25733722.0,implication pervasive whether importantly new responsibility early time several bodily biologically physical open institution philosophical ethical bearing later much childhood protection recent form argument follow hold broadly conscript previous nature health demonstrating role safeguard burden harm result equality first fiduciary society subordination independently strong child collectively method mental used causal social dominance lifetime second parent school hierarchy promise argue stronger conception age future obligation opportunity determinant dependent reasonably background impact research conclusion socially right direct justice rigid playing show consistently entail,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257420/,abstract,0,subordination philosophical obligation hierarchy fiduciary entail conscript bearing dominance rigid reasonably playing pervasive equality bodily justice socially safeguard hold biologically argument responsibility conception harm stronger lifetime broadly argue protection demonstrating consistently collectively used determinant promise institution importantly causal independently school right ethical society later nature burden strong open opportunity follow mental previous dependent implication direct physical childhood second social parent background form future recent impact conclusion role time new early research child age health method result,"{""social"": {""freq"": 1, ""string"": [""dependent implication direct physical childhood second social parent background form future r""]}}",{},{},{},{},{}
1519,1519,1645,,16355724.0,male biopsy whether studied difference specifically undetectable neonatal enhance sexual moreover well significantly promoter summary equal weekly ovariectomy organ cag observed role play word comparable report result androgen contrast change predominant rat histological significant administration female transgene hepatic fully many liver week gonadectomy stage expression sex treatment important key hormone dimorphism finding transgenic upregulation endogenous castration negative testosterone mosaic especially determine demonstrate pattern fate ubiquitous gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009120/,abstract,2,ubiquitous gonadectomy castration androgen ovariectomy dimorphism cag undetectable testosterone sexual mosaic fate weekly upregulation transgenic histological biopsy transgene equal predominant studied promoter endogenous hepatic enhance comparable fully summary sex organ hormone demonstrate specifically word rat play contrast administration stage observed female pattern neonatal negative liver especially determine male week finding expression change key report important role difference significantly significant gene treatment result,{},{},{},{},{},{}
1520,1520,1646,10.1007/8904_2015_508,26683466.0,major blood defect surface weight severe state catabolic identically urinary increase excretion month significantly pku phe related phenylalanine distal childhood possible renal protein acidic fold body equivalent hyperphenylalaninaemia analytical result metabolic transamination besides data mild ohpaa change type hpa formation level mimic least phenotype per child model phenylketonuria day method constant test tolerance collaborative response iii year german age protocol determinant loading elimination analysis kinetic background conclusion disposal plus part high study medium whereas acid patient blaskovics hydroxyphenylacetic metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059183/,abstract,15,transamination ohpaa identically blaskovics hydroxyphenylacetic hyperphenylalaninaemia distal disposal collaborative catabolic acidic german kinetic loading mimic constant elimination excretion iii determinant plus hpa surface renal equivalent tolerance medium urinary fold analytical formation mild protocol childhood weight defect related phenotype severe possible body background metabolite month phe state day major change increase response pku conclusion phenylketonuria test significantly model phenylalanine blood type acid child protein age metabolic year high method data level analysis result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""pku conclusion phenylketonuria test significantly model phenylalanine blood type acid child p""]}}",{},{},{},{},{}
1521,1521,1647,10.1007/s10815-017-1039-7,28932969.0,major dramatic disorder search new factor discus insufficiency difficult oxidative author present neonatal reproductive literature highlight clear publication addition majority underlying preservation specialist issue extensive galactose accumulate adulthood however screening relative dysfunction role focus gap symptom primary error inborn metabolic effect data term long metabolism fertility story medicine stress one female pathogenic pubmed morbidity acute ovarian ovary failure child woman population review markedly face system article success treatment response challenge option advance galactosemia newborn collaboration january timing unclear determine limited function girl mechanism pathophysiology keywords also consequence classic group dietary successful complication rarity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758462/,abstract,1,story ovary dramatic pubmed preservation fertility accumulate timing insufficiency galactosemia galactose ovarian rarity collaboration girl reproductive face markedly specialist pathophysiology january adulthood publication gap author underlying success clear extensive classic oxidative failure keywords complication unclear pathogenic option successful morbidity majority relative search difficult advance acute consequence woman female stress focus neonatal dysfunction limited highlight determine medicine issue discus literature inborn symptom screening addition long major challenge primary response error mechanism dietary newborn term article role function present metabolism new factor population review child metabolic group effect data disorder treatment,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""challenge primary response error mechanism dietary newborn term article role function p""]}, ""screening"": {""freq"": 1, ""string"": [""medicine issue discus literature inborn symptom screening addition long major challenge p""]}}",{},{}
1522,1522,1648,10.3390/nu8040185,27102170.0,dentate specific blood whether striatum new difference affect specifically positive density nutrient synapsis without affected supplementation deficit morphology control disease pku matter phenylalanine marker granular reduction protein brain mouse layer immunostaining indication neurotransmitter synapse metabolic effect ammonis combination first type metabolism formation significant wild normal cornu white approach week phenylketonuria day hippocampal post expression synaptic concentration postnatal treatment prefrontal diet cell function consequence cortex nutritional trend study similar supplemented pyramidal hippocampus gyrus isocaloric interesting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848654/,abstract,4,cornu ammonis immunostaining isocaloric granular dentate synapsis hippocampal synapse pyramidal gyrus striatum supplemented prefrontal synaptic postnatal layer interesting morphology hippocampus cortex density indication trend neurotransmitter affected matter wild specifically formation nutrient white affect post consequence supplementation deficit nutritional reduction marker combination week similar mouse normal day expression positive brain diet concentration pku difference cell function phenylketonuria approach metabolism new phenylalanine specific control blood type protein significant metabolic effect treatment disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""cell function phenylketonuria approach metabolism new phenylalanine specific control blood type p""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""mouse normal day expression positive brain diet concentration pku difference cell f""]}}",{}
1523,1523,1649,10.1093/advances/nmy037,30721958.0,sweetener nutritive synthetic bifidobacteria polyols content composition intestinal time several glycyrrhizin glucose concern necessary thaumatin partially steviol xylitol taste well activation increase stevia isomaltose nonnutritive passive microbiota however evidence saccharin health advantame critically diffusion dihydrochalcone food effect large reach change ingredient calorie thousand receptor aspartame far intestine low controversial nnss sucrose although intolerance microbiome least maltitol neohesperidin review product frequently sweet free glucoside alteration nondigestible lactitol monellin hundred definition cyclamate bowel natural research consumption neotame high sugar substitute alcohol human small prebiotic safe number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363527/,abstract,0,thaumatin steviol polyols nondigestible nnss neohesperidin monellin maltitol lactitol isomaltose glycyrrhizin glucoside dihydrochalcone xylitol neotame cyclamate advantame stevia saccharin nonnutritive bifidobacteria sweet ingredient sucrose intolerance taste prebiotic passive nutritive aspartame intestine critically calorie sweetener reach intestinal controversial bowel substitute alcohol microbiota microbiome thousand diffusion sugar definition safe partially synthetic far activation composition consumption receptor glucose frequently alteration concern necessary natural content free product small food change increase large evidence low number time human research review health effect high,{},{},{},{},"{""aspartame"": {""freq"": 1, ""string"": [""sucrose intolerance taste prebiotic passive nutritive aspartame intestine critically calorie sweetener r""]}}",{}
1524,1524,1650,10.1038/s41436-018-0407-8,30626901.0,mpku level pregnant third blood trimester however age phenylalanine mass sample nomogram spot per healthy tyr standard since time quickly storage stable woman micromol range decline supplemental week phenylketonuria spectrometry day gestation method relatively constant card conclusion result practice second purpose provide data reference control resource collection valuable pregnancy first raw tandem gestational care singleton phe maternal strict,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620164/,abstract,2,nomogram micromol mpku raw supplemental quickly trimester singleton constant decline gestation card strict gestational tyr pregnant valuable stable storage reference tandem relatively resource pregnancy collection maternal woman second purpose spectrometry practice spot provide week standard phe healthy mass day range care conclusion sample phenylketonuria time phenylalanine control blood age method data level result,"{""phenylalanine"": {""freq"": 2, ""string"": [""range care conclusion sample phenylketonuria time phenylalanine control blood age method d""]}}",{},{},"{""tandem"": {""freq"": 1, ""string"": [""tyr pregnant valuable stable storage reference tandem relatively resource pregnancy collection m""]}, ""spectrometry"": {""freq"": 1, ""string"": [""pregnancy collection maternal woman second purpose spectrometry practice spot provide week s""]}}",{},{}
1525,1525,1651,10.1186/s12913-019-4243-6,31286940.0,fulfil availability self among resulted opt despite necessary enhance light aged condition break methodswe contribute shed knowledge element relevant however life motivator sharing wish form role health symptom food support qualitative interview little theory expectation ability resultsour uncomfortable service clearly significant main crucial woman highly hindrance motivation management work determination assistance competency hypersensitivity social people conclusionswomen important person network year care conservation indeed meal desire two negative lack order shame explore manage chronic dependent basic aim priority research relatively consequence whereas patient participant individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615186/,abstract,1,uncomfortable shame resulted opt motivator hindrance fulfil conclusionswomen competency wish desire conservation break sharing manage hypersensitivity resultsour assistance shed motivation expectation meal theory clearly person priority enhance crucial qualitative contribute light interview determination element basic people availability little relatively network explore methodswe necessary service consequence aged woman dependent work negative lack self chronic highly social ability relevant despite main order knowledge participant food symptom form support aim management care life condition important role individual research significant health year patient,"{""social"": {""freq"": 1, ""string"": [""work negative lack self chronic highly social ability relevant despite main o""]}}",{},{},{},{},{}
1526,1526,1652,10.1515/pterid-2016-0006,28943719.0,male experimental correlation microorganism specific blood self lead ratio factor lower positively aggressive positive present liquid gondii behavior titer igg dopaminergic phe endophenotype seropositive phenylalanine trait tyr dopamine questionnaire additionally immunoabsorbant determined therefore enzyme subscales reciprocal decrease potentially low score elisa level female measure tyrosine point suicidal intervention bus toward older moderation faf toxoplasma aggression association psychiatrically assay hostility version german age sample production negative healthy previously precursor propensity hplc interaction high seropositivity participant performance individual total durkee intrinsic chromatography gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608274/,abstract,1,suicidal seropositivity seropositive psychiatrically immunoabsorbant hostility faf durkee bus toxoplasma reciprocal gondii subscales moderation endophenotype aggression titer dopaminergic aggressive propensity igg german intrinsic elisa microorganism hplc positively tyr older determined gender precursor dopamine trait liquid experimental additionally production chromatography potentially decrease female assay questionnaire negative behavior lead self point tyrosine previously correlation male ratio performance score interaction participant enzyme measure phe healthy positive version lower association intervention total sample low present individual phenylalanine specific factor blood age high level,"{""phenylalanine"": {""freq"": 2, ""string"": [""intervention total sample low present individual phenylalanine specific factor blood age h""]}}",{},{},{},{},{}
1527,1527,1653,10.1371/journal.pgen.1006184,27448207.0,factor pathway subunit homeostasis ligase missense investigate control addition accumulation cytosolic kinase accumulate impair poorly protein mutant degradation substrate guk result proteasomal degradative ability gim ubiquitin mutation cellular toxic aggregation soluble prevent inclusion model unstable ubr yeast solubility target propose important stabilize cell aggregate challenge thermosensitive allele screen chaperone function quality cytometry flow interacted ubiquitination also consequence study whereas prefoldin absence terminally number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957761/,abstract,0,ubr thermosensitive terminally prefoldin ligase interacted guk gim degradative ubiquitination ubiquitin proteasomal unstable solubility stabilize cytosolic impair cytometry accumulate kinase yeast subunit soluble chaperone aggregate aggregation flow substrate poorly toxic degradation propose missense screen absence homeostasis mutant cellular accumulation inclusion prevent allele consequence investigate ability target addition challenge quality pathway mutation important cell function number model control factor protein result study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""investigate ability target addition challenge quality pathway mutation important cell function n""]}}",{},{},{}
1528,1528,1654,10.1038/s41431-017-0016-z,29199274.0,male inheritance european cross time prenatal germline anonymity together gamete genetics expert parallel epigenetic testing evaluate consumer issue third related editing screening clinical additionally replacement fast cause genetic embryology generational non panel society female utilisation oocyte highlighted september reproduction topic important donor interface carrier consensus advance two professional application massively since invasive advanced ivf impact infertility research paper genome preimplantation practice human direct mitochondrial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839000/,abstract,1,generational gamete embryology anonymity massively ivf utilisation preimplantation highlighted oocyte infertility reproduction editing germline september interface fast epigenetic topic inheritance donor consumer advanced consensus invasive replacement parallel society mitochondrial prenatal expert european carrier panel additionally advance evaluate professional genome female direct genetics cross practice related male paper issue testing application screening cause impact non important time human research genetic clinical,{},"{""inheritance"": {""freq"": 1, ""string"": [""germline september interface fast epigenetic topic inheritance donor consumer advanced consensus i""]}, ""genetic"": {""freq"": 1, ""string"": [""editing germline september interface fast epigenetic topic inheritance donor consumer a""]}}",{},"{""screening"": {""freq"": 1, ""string"": [""related male paper issue testing application screening cause impact non important t""]}}",{},{}
1529,1529,1655,10.1155/2018/9209873,30050717.0,case however retardation one herein adequate intestinal congenital hirschsprung hypothyroidism influence clinical present child tablet critical bowel motility sodium mental due levothyroxine potential constipation dysmotility aganglionosis risk thyroid old mimicked hormone disease year rarely emergency,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046164/,abstract,0,mimicked levothyroxine hirschsprung constipation aganglionosis tablet motility dysmotility emergency rarely intestinal bowel sodium retardation thyroid hypothyroidism adequate hormone mental old critical influence congenital present case risk potential child year clinical disease,{},{},{},{},{},{}
1530,1530,1656,10.1038/s41598-017-15063-8,29116116.0,decarboxylase case related disorder mutation dominant subject pyruvoyltetrahydropterin serotonin recessive among healthy inhibitor estimate uptake normal sulphatoxymelatonin dihydropteridine especially autosomal value therapy brain synthase reductase biosynthesis aim without precursor guanosine frequently severe conclusion aromatic thus biomarker purpose good melatonin urine acid treatment monoamine urinary patient cyclohydrolase deficiency sepiapterin serotoninergic status genetic selective excretion amino gene low total triphosphate,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676966/,abstract,14,sulphatoxymelatonin serotoninergic pyruvoyltetrahydropterin triphosphate guanosine decarboxylase dihydropteridine melatonin sepiapterin reductase cyclohydrolase uptake monoamine excretion dominant aromatic biosynthesis synthase selective serotonin inhibitor biomarker urinary precursor recessive frequently urine autosomal estimate good purpose especially related status severe aim normal healthy subject value brain deficiency therapy total mutation amino conclusion low case acid gene genetic disorder treatment patient,"{""urine"": {""freq"": 1, ""string"": [""inhibitor biomarker urinary precursor recessive frequently urine autosomal estimate good purpose e""]}}","{""autosomal"": {""freq"": 1, ""string"": [""biomarker urinary precursor recessive frequently urine autosomal estimate good purpose especially r""]}, ""recessive"": {""freq"": 1, ""string"": [""selective serotonin inhibitor biomarker urinary precursor recessive frequently urine autosomal estimate g""]}, ""genetic"": {""freq"": 1, ""string"": []}}",{},"{""amino"": {""freq"": 1, ""string"": [""value brain deficiency therapy total mutation amino conclusion low case acid g""]}}",{},{}
1531,1531,1657,10.1007/s10897-018-0227-7,29468336.0,implication immediately immediate disorder responsibility examine country acceptance central literature severe control experience way pku neurological material supplementary assume quantitative phenomenological perspective user clinical role underpinning result link metabolic data little theory first interpretative normality psychology untreated significant theme seven three main child prevent damage suggestion management phenylketonuria parent analyse online article treatment electronic version materialthe process rare age two newborn relation stressor explore continuum analysis research available prevention consequence study psychosocial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132571/,abstract,0,underpinning normality phenomenological interpretative assume psychology stressor continuum responsibility acceptance suggestion immediate immediately analyse psychosocial theory theme untreated link examine damage seven little relation perspective explore prevent neurological way experience consequence implication central quantitative prevention materialthe parent main country literature severe process supplementary management user version electronic online rare newborn pku material article role phenylketonuria available control research child age significant metabolic data disorder treatment clinical analysis result study,"{""neurological"": {""freq"": 1, ""string"": [""seven little relation perspective explore prevent neurological way experience consequence implication c""]}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""management user version electronic online rare newborn pku material article role p""]}}",{},{}
1532,1532,1658,10.1002/hep4.1315,30976745.0,major monolayer assessment culture cure hour vivo single pathway gain adult despite homology weight break hdr favor locus recipient reprogram nuclease hypothesis disease nonhomologous repair hereditary template biochemical related however editing organ quantitative therapy double dsbs mouse primary curative result knockout metabolic effect hepatocyte crispr term qpcr predominant long type cultured hepatocytes pcr mutation strand fumarylacetoacetate end progression tyrosinemia preclinical failure normalization point liver approach model regulation therapeutic ass functionality quiescent target expression potential guide delivery engraftment viral within two rna hydrolase demonstrate function mitosis precise dna cytometry adeno alternative transplantation prevention robustly conclusion study vector limitation correction gene proliferation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442694/,abstract,3,reprogram quiescent nonhomologous monolayer mitosis dsbs hdr strand break nuclease normalization hydrolase homology fumarylacetoacetate recipient qpcr cytometry favor engraftment curative robustly editing cure repair functionality tyrosinemia template cultured adeno crispr knockout predominant preclinical proliferation hereditary hepatocytes correction viral precise gain culture transplantation guide vector locus pcr rna hepatocyte hour organ failure progression double demonstrate end limitation hypothesis vivo alternative delivery regulation dna quantitative weight liver point prevention despite ass related biochemical target mouse assessment long major expression primary therapeutic pathway single adult therapy mutation conclusion term function approach model type potential metabolic gene effect result disease study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""assessment long major expression primary therapeutic pathway single adult therapy mutation c""]}}",{},{},{}
1533,1533,1659,10.1016/j.omtn.2017.04.013,28624210.0,subsequent blood activity synthetic physiological factor duration insertional profile native due risk injection control pose enu significantly hydroxylase pku minicircle promoter murine transcriptional sequence intron offer phenylalanine partial therapy demonstrating mouse hydrodynamic comparable report efficacy integration hepatocyte copy combination cassette non diploid transgene hepatic size naked per enhancer dose many liver model phenylketonuria hepatectomy therapeutic via expression loss safety delivery viral limit associated challenge cdna homozygous lack favorable regeneration limited dna mutagenesis pah conclusion human vector limitation correction gene number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423318/,abstract,0,diploid insertional hepatectomy naked minicircle cassette mutagenesis enhancer intron cdna pose hydrodynamic enu transgene regeneration native murine favorable copy demonstrating correction viral transcriptional offer promoter homozygous integration duration vector hepatic injection partial comparable synthetic subsequent hepatocyte physiological limit safety limitation dose associated delivery sequence size dna profile efficacy pah loss lack liver limited combination hydroxylase mouse challenge expression therapeutic report therapy activity pku conclusion non phenylketonuria number significantly human risk model phenylalanine control factor blood gene,"{""phenylalanine"": {""freq"": 2, ""string"": []}}","{""homozygous"": {""freq"": 1, ""string"": [""demonstrating correction viral transcriptional offer promoter homozygous integration duration vector hepatic i""]}}",{},{},{},{}
1534,1534,1660,,28706611.0,exon assessment single among str asp without affected genetics consanguineous locus old codon classical repeat well acmg disease termination hydroxylase pku iranian medical college sanger phenylalanine family haplotype symptom result change glufs guideline term novel genetic tandem type vntr detection pedigree mutation variable signal short pathogenic phenotype text genomics notable population entrez phenylketonuria silico method american boundary genotyping year insertion allelic adenine mini causative homozygous allele premature taa responsible omim girl analysis previously pah conclusion classic study nucleotide heterogeneity sequencing position patient gene number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501143/,abstract,4,taa glufs genotyping codon str pedigree mini asp adenine vntr entrez acmg termination notable boundary omim college allelic silico iranian insertion consanguineous haplotype sanger causative repeat premature girl position homozygous locus american classic responsible exon affected classical signal genomics pathogenic nucleotide heterogeneity tandem guideline text allele short variable old pah genetics sequencing previously hydroxylase phenotype detection assessment symptom change medical single family novel mutation pku conclusion term phenylketonuria number phenylalanine type population gene year genetic method analysis result patient disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""mutation pku conclusion term phenylketonuria number phenylalanine type population gene year g""]}}","{""homozygous"": {""freq"": 1, ""string"": [""sanger causative repeat premature girl position homozygous locus american classic responsible e""]}, ""genetic"": {""freq"": 1, ""string"": [""number phenylalanine type population gene year genetic method analysis result patient d""]}, ""heterogeneity"": {""freq"": 1, ""string"": [""affected classical signal genomics pathogenic nucleotide heterogeneity tandem guideline text allele s""]}}",{},"{""detection"": {""freq"": 1, ""string"": [""pah genetics sequencing previously hydroxylase phenotype detection assessment symptom change medical s""]}, ""tandem"": {""freq"": 1, ""string"": [""classical signal genomics pathogenic nucleotide heterogeneity tandem guideline text allele short v""]}}",{},{}
1535,1535,1661,10.1186/s12974-017-0955-x,28874201.0,retinopathy angiogenesis neurovascular vivo factor lower essential deleterious homeostasis injury pro oir supplementation iris backgroundtetrahydrobiopterin display well activation persistent increase significantly material retina synthesis neuronal characterize norrin supplementary anti hph user role play fold mouse angiogenic thrombospondin integrity metabolic effect receptor qpcr fetal type resultsour area level significant wild retinal maintenance model markedly method conclusionour development expression vasculature microvasculature online article juvenile alteration fzd important key electronic associated finding cell version materialthe process inflammatory age degeneration reveal tsp responsible function hyperoxia vitro available microglial oxygen multiple microvascular different study nrlp cofactor deficiency atrophy number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586016/,abstract,0,thrombospondin retinopathy oir nrlp norrin microvasculature hyperoxia fzd angiogenesis tsp microglial iris neurovascular juvenile backgroundtetrahydrobiopterin angiogenic vasculature retina microvascular hph atrophy qpcr resultsour persistent retinal conclusionour display deleterious degeneration integrity oxygen reveal pro maintenance markedly injury characterize neuronal activation responsible fetal homeostasis fold wild cofactor anti receptor inflammatory alteration vitro play vivo associated supplementation synthesis materialthe essential finding mouse process area supplementary user expression multiple version increase key electronic online lower deficiency material article important role cell function number available significantly model factor type different age significant development metabolic effect method level study,{},{},{},{},{},{}
1536,1536,1662,10.1038/s41436-018-0387-8,30531811.0,specific worldwide reliability whether search consent cinahl addressing bloodspots interrater purposeresidual literature expert resultsa state control publication well objective disease template issue methodsa evidence nature health input secondary science large data observational design type united com use case ebsco outcome review inclusion coding summarize via social unknown web resource proportion meeting valuable electronic year medline protocol within public future newborn primarily advisory embase residual systematically criterion analysis board index research study identifiable extent small individual total number citation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557682/,abstract,1,purposeresidual interrater ebsco bloodspots addressing identifiable com summarize citation meeting template coding cinahl board advisory reliability consent input resultsa systematically embase residual web medline methodsa valuable publication primarily observational worldwide united extent expert nature proportion protocol science inclusion search resource secondary unknown index criterion social design issue public small literature objective state electronic large future use total newborn evidence outcome number case individual specific control type research review health year data analysis disease study,"{""social"": {""freq"": 1, ""string"": [""search resource secondary unknown index criterion social design issue public small l""]}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""state electronic large future use total newborn evidence outcome number case i""]}}",{},{}
1537,1537,1663,10.5409/wjcp.v7.i5.105,30479975.0,process threshold matter line sure pediatrician relevant safely life dispatch new pre information order standard essential clinical laboratory child currently fast without academic priority action workflow need determination primary post analytical century result eventually classification mode fate handle promptly alert charge exercise inform applying controversial issue physician paramount,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6242778/,abstract,0,sure dispatch applying paramount handle promptly safely fate alert pediatrician eventually charge century controversial workflow threshold exercise academic fast priority mode inform classification determination physician matter line analytical action post pre currently essential relevant laboratory issue order need standard process primary information life new child clinical result,{},{},{},{},{},{}
1538,1538,1664,10.21037/atm.2018.11.36,30740398.0,edition exciting disorder textbook availability blood past new time garrod sir horizon albinism disease unwieldy ert subject book screening anticipating therapy pentosuria replacement genomic error inborn century diagnosis metabolic eighth reference basis term first revolutionize metabolism medicine four one volume text current many online treatment key filter archibald promise initially near future still certainly newborn spot definitive covering field alkaptonuria analysis previously paper metabolomic cystinuria page gene chapter untreatable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331363/,abstract,6,unwieldy untreatable sir revolutionize pentosuria cystinuria covering anticipating albinism eighth book archibald textbook garrod ert certainly page horizon alkaptonuria exciting edition definitive century initially chapter metabolomic promise filter near replacement availability reference past volume text genomic basis spot previously medicine paper field inborn screening subject key error online future therapy newborn current term metabolism time new blood diagnosis metabolic gene disorder treatment analysis disease,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""subject key error online future therapy newborn current term metabolism time n""]}, ""screening"": {""freq"": 1, ""string"": [""spot previously medicine paper field inborn screening subject key error online f""]}}",{},{}
1539,1539,1665,10.1371/journal.pone.0151100,26938936.0,male blood disorder autism diary hour methodseighty abnormal aged deficit aromatic adhd control urinary well contribute intake spectrum synthesis explanation phenylalanine backgroundthe dopamine questionnaire role protein symptom support result transport attention effect large cause first metabolism three defiant comorbid normal current tyrosine aaa child oppositional teacher conduct expression calculate parent conclusionsthis concentration treatment alteration association year future sample catabolism typically serotonin relation psychiatric aim impact relatively tryptophan nutritional resultschildren study acid hyperactivity dietary deficiency amino,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777504/,abstract,3,resultschildren methodseighty diary oppositional defiant teacher catabolism aaa explanation calculate comorbid conduct adhd conclusionsthis hyperactivity aromatic transport tryptophan contribute backgroundthe serotonin hour psychiatric urinary typically relation dopamine relatively abnormal alteration autism aged deficit nutritional questionnaire synthesis attention intake tyrosine parent male spectrum symptom support aim normal expression cause large future association deficiency impact dietary concentration current amino role sample metabolism phenylalanine control blood acid child protein year effect disorder treatment result study,"{""phenylalanine"": {""freq"": 2, ""string"": [""concentration current amino role sample metabolism phenylalanine control blood acid child p""]}, ""hyperactivity"": {""freq"": 1, ""string"": [""explanation calculate comorbid conduct adhd conclusionsthis hyperactivity aromatic transport tryptophan contribute b""]}, ""psychiatric"": {""freq"": 1, ""string"": [""transport tryptophan contribute backgroundthe serotonin hour psychiatric urinary typically relation dopamine r""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""association deficiency impact dietary concentration current amino role sample metabolism phenylalanine c""]}}",{},{}
1540,1540,1666,10.1590/1414-431X20176709,29267500.0,relationship pedsql self difference early lower explain hrqol proxy country present median substantially capacity difficulty inadequate control significantly pku phe related phenylalanine life unaffected adequate possible observed value health range core error report inborn result data inventory reference negatively adherence first adequacy metabolism score period level significant functioning although scarce normal child population phenylketonuria therapeutic development target system parent concentration respective treatment school year within two dimension percentage poor pediatric harmful brazilian income scale especially adolescent quality cognitive also consequence intellectual high last study dietary patient healthcare financial total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731329/,abstract,0,pedsql harmful adequacy unaffected scarce proxy dimension respective hrqol financial explain substantially inadequate functioning brazilian inventory income core negatively school percentage adequate adherence capacity difficulty reference adolescent healthcare poor intellectual median consequence observed pediatric self especially parent scale related period relationship score country target possible inborn cognitive phe normal range value error quality therapeutic lower report dietary life concentration total pku difference phenylketonuria present metabolism significantly early phenylalanine control population child significant development health year high data level treatment result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""difference phenylketonuria present metabolism significantly early phenylalanine control population child significant d""]}, ""intellectual"": {""freq"": 1, ""string"": [""capacity difficulty reference adolescent healthcare poor intellectual median consequence observed pediatric s""]}}",{},{},{},{},{}
1541,1541,1667,10.1093/aje/kwu279,25395027.0,venerable various example absolute unitless ratio difference positive demonstrates lesser attributable together separate risk principle smoking calculation joint graphic cancer unit reduction quantitative hypothetical health inference particular sum algebra effect data fraction first mortality use measure intervention population separately potential exposure article public commentary estimate additive scale pollution community comparison metric rothman meaningful impact program lung interaction synergy similar epidemiol spreadsheet show air applies turner,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262440/,abstract,2,venerable unitless turner rothman graphic epidemiol algebra synergy spreadsheet commentary applies pollution inference lesser hypothetical air separately joint sum smoking metric absolute attributable additive demonstrates calculation meaningful lung unit principle fraction separate community estimate mortality particular quantitative cancer example comparison reduction exposure scale ratio public interaction similar various measure program positive use impact intervention article difference risk population potential health effect data,{},{},{},{},{},{}
1542,1542,1668,10.7860/JCDR/2017/24811.9419,28511418.0,textbook example whether search time essential occasionally platform elevated condition biosis due common state risk partly clear source control effective publication concept journal way well essentially evaluate material infectious relevant subject life contradictory health consistent science introductionthe support asymptomatic term initiate type conclusionvoluntary epidemiology detection case seven peer four surveillance provider one located infection many review usage eligibility emphasis scopus people potential participation article test success gradually important medline profession policymakers definition public embase biostatics terminology chronic criterion benefit aim program available ovid head methodscommonly resultsdescriptions trust dictionary different part high patient prominent confusion aimto,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427344/,abstract,1,resultsdescriptions methodscommonly dictionary contradictory conclusionvoluntary biostatics biosis profession occasionally located introductionthe textbook ovid confusion usage policymakers initiate trust terminology scopus essentially eligibility aimto gradually journal partly prominent peer asymptomatic epidemiology surveillance participation definition emphasis head embase medline infectious provider publication success clear platform people seven elevated concept infection science search way evaluate source consistent example criterion chronic essential relevant benefit public detection support aim state subject program effective life material term condition article important common case available test time risk control type review potential different health high patient,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""criterion chronic essential relevant benefit public detection support aim state subject p""]}}",{},{}
1543,1543,1669,10.1093/ijnp/pyu074,25522413.0,passive immobility stress specific disorder whether aminobutyric basolateral strategy new difference greater crucial serotonin lower depletion observed corticolimbic determine higher behavioral neurochemistry therapy role dependent swimming outflow point amygdala background mouse behavior gaba regulation method widely open cortex conclusion liability system test susceptibility gabab acid prefrontal response receptor selective dba genetic medial transmission show prospect innovative neuronal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360254/,abstract,1,swimming neurochemistry immobility gabab corticolimbic liability dba basolateral outflow aminobutyric prospect passive medial gaba amygdala depletion prefrontal innovative transmission cortex susceptibility crucial neuronal selective serotonin receptor open widely behavioral regulation dependent observed stress behavior point greater determine mouse background strategy response lower therapy conclusion higher role difference test new specific acid genetic method disorder,"{""behavioral"": {""freq"": 1, ""string"": [""neuronal selective serotonin receptor open widely behavioral regulation dependent observed stress b""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1544,1544,1670,10.1002/gepi.21869,25417853.0,sparse observation single discus information present fractional prioritizations identity weight slightly easily llarrma genetics ambiguous variation true well underlying penalization prioritization joint explanation however marker dosage sometimes imputation procedure identifies equivalent effect translates combination genetic yet case multi signal assumption dawg phenotype additivity current prioritizing provide disentangle model method causal dominance substantial simultaneously association lasso help best genomewide snp variant efficiently outperforms additive statistical reduced analysis either faulty unequivocally also multiple identify group pattern study power powerful even robustness performance number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314429/,abstract,0,penalization outperforms llarrma lasso genomewide dawg unequivocally translates prioritizations imputation faulty dominance additivity disentangle sparse prioritizing prioritization ambiguous robustness explanation identity joint identifies fractional easily dosage efficiently assumption additive true simultaneously slightly power causal powerful equivalent observation snp underlying substantial multi identify signal reduced procedure statistical best help pattern weight marker genetics combination variation provide phenotype discus performance multiple variant single association information current number present case model group effect genetic method analysis study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1545,1545,1671,10.1007/s10815-017-0905-7,28299548.0,blood purposethis whether difference factor single among reproductive frequency variation risk control methodsone material ascertain supplementary conclusionsa higher user doi genomic polycystic genotype university besides hepatocyte shandong thousand massarray eight chinese sequenom level significant one nuclear ovary syndrome woman han system serum online article polymorphism electronic hormone association hnf hundred version materialthe bmi age two snp allele testosterone healthy peripheral adjusted dna hospital aim research available alpha study nucleotide patient pcos thirty gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446327/,abstract,2,shandong purposethis methodsone sequenom pcos massarray testosterone adjusted polycystic ovary ascertain han conclusionsa thirty thousand reproductive hnf doi bmi peripheral snp alpha hepatocyte chinese university nuclear hormone nucleotide polymorphism genotype allele genomic woman dna serum hospital variation syndrome materialthe frequency aim supplementary healthy user version electronic online single association material higher article difference available risk control factor blood research age significant gene level patient study,{},{},{},{},{},{}
1546,1546,1672,10.1038/s41598-018-26617-9,29872072.0,logistic coefficient subsequent growth factor single early gradual aged molecular macrophage prognosis risk effective disease significantly measurement however subject moderate migration higher value protein clinically acidic cutoff diagnosis like basis combination score area cysteine level regression use case appendicular biomarkers normal sensitivity older potential serum loss auc rich receiver year best specificity operating mass working sarcopenia effectively function index characteristic group diagnostic skeletal entity insulin patient asian muscle inhibitory accuracy individual statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988732/,abstract,5,sarcopenia appendicular gradual working migration acidic macrophage cutoff cysteine skeletal auc operating asian receiver muscle inhibitory entity prognosis rich coefficient insulin effectively logistic subsequent older statistically moderate accuracy specificity clinically best basis index aged serum regression sensitivity loss combination measurement biomarkers growth like characteristic score diagnostic area normal mass subject value effective single molecular use higher function case individual significantly risk early factor diagnosis potential protein group year level patient disease,{},{},{},{},{},{}
1547,1547,1674,10.1038/s41598-018-20834-y,29445163.0,resonance metabolome facies among affect profile time several interesting state clear control significantly discrimination presence subject dosage rather trait chromosome remarkably consistent krebs pyruvate result effect urine detectable cause first genetic significant three main nuclear normal syndrome supernumerary accounting model hsa nmr disability univariate frequent concentration sex alteration key altered age sample two multivariate sibling beginning formate cognitive impairment analysis fumarate distinctive metabolomic group intellectual plasma cycle part magnetic human accuracy gene metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813015/,abstract,3,supernumerary hsa fumarate facies krebs formate distinctive beginning univariate pyruvate sibling accounting metabolome remarkably dosage detectable interesting discrimination altered nmr chromosome metabolomic multivariate resonance clear sex nuclear frequent affect magnetic trait cycle alteration accuracy urine intellectual profile consistent impairment disability presence syndrome main cognitive metabolite normal state subject plasma cause key concentration sample time significantly human model control age significant gene group effect genetic analysis result,"{""urine"": {""freq"": 1, ""string"": [""affect magnetic trait cycle alteration accuracy urine intellectual profile consistent impairment d""]}, ""intellectual"": {""freq"": 1, ""string"": [""magnetic trait cycle alteration accuracy urine intellectual profile consistent impairment disability p""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1548,1548,1675,10.1002/ajmg.b.32329,26079129.0,entire european disorder exon blood constellation african region among objectivewe across caucasian frequency deficit mononuclear neuropsychiatric risk regulatory disease htr maf subject mainly role brain resultswe minor attention effect change significance intergenic significant rate three one signal independent comprehensively discovery around methodfive expression association false hundred cell rare wide ipo within snp variant rna allele peripheral explore analysis eqtl also seventy different cohort tissue conclusionwe replicable human hyperactivity correction descent gene individual total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851708/,abstract,4,replicable methodfive ipo intergenic htr eqtl descent conclusionwe maf constellation seventy objectivewe mononuclear minor comprehensively caucasian african neuropsychiatric entire correction resultswe peripheral hyperactivity snp rna false exon significance signal mainly discovery european independent explore allele regulatory deficit attention tissue frequency wide cohort region subject expression change variant brain association rare rate total role cell individual human risk blood different significant gene effect disorder analysis disease,"{""hyperactivity"": {""freq"": 1, ""string"": [""african neuropsychiatric entire correction resultswe peripheral hyperactivity snp rna false exon s""]}}",{},{},{},{},{}
1549,1549,1676,10.1016/j.ymgmr.2018.10.002,30364670.0,major mood relationship anxiety difficult adult common difficulty neurocognitive practical cent survey pku friend issue family largest questionnaire health focus complete symptom conventional report result depression fifty psychological antidepressant medication obstacle low educational gastrointestinal significant one society per anxiolytic problem introductionwe child exclusion management phenylketonuria nspku november isolation mental national social parent online limit methodsin january socialisation general stigma dietary participant caregiver perception,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198120/,abstract,2,stigma socialisation introductionwe nspku friend anxiolytic cent antidepressant isolation november obstacle largest mood exclusion neurocognitive gastrointestinal methodsin perception january conventional psychological depression caregiver practical educational society medication anxiety limit complete difficulty difficult mental survey questionnaire focus national social parent general problem issue relationship participant symptom management major online adult report family dietary pku common phenylketonuria low child significant health result,"{""social"": {""freq"": 1, ""string"": [""difficult mental survey questionnaire focus national social parent general problem issue r""]}}",{},{},{},{},{}
1550,1550,1677,10.1155/2017/4083293,29057118.0,flexibility blood three phenylalanine clinic strategy healthy especially difficult implementation outline approach phenylketonuria easier alternative choice paper error food inborn deficit historically state often high neurocognitive simplified concentration metabolic patient united traditional diet pku education metabolism challenge caregiver strict,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615976/,abstract,0,simplified easier outline flexibility historically neurocognitive strict caregiver traditional united choice education alternative difficult clinic implementation deficit especially paper inborn food healthy state challenge strategy error diet concentration pku phenylketonuria approach metabolism phenylalanine blood metabolic high patient,"{""phenylalanine"": {""freq"": 2, ""string"": []}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""food healthy state challenge strategy error diet concentration pku phenylketonuria approach m""]}}",{}
1551,1551,1678,10.1186/s12911-016-0315-2,27454118.0,experimental interpretation huge preserving lead information pertinent time algorithm increasingly literature due ambiguous difficulty disconnected outsourced source way disease however much backgroundthe want scoring protein recovery result tighter link metabolic etc large integration data date complement fusion furthermore novel mining node placing biomolecules although four novelty one step certain integrate text map external noisy discovery comorbidity abundance method emphasis originality unknown auc edge proportion association network preserve original robust methodsin still complementary lack interactome anchoring recovered research available vague also group interaction study insufficient connection circumvent conclusionthis gene performance show metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959382/,abstract,0,tighter recovered placing outsourced noisy interactome disconnected anchoring want vague preserving originality edge biomolecules preserve pertinent integrate mining circumvent novelty node ambiguous scoring huge fusion comorbidity conclusionthis external auc connection complement original map complementary insufficient methodsin abundance recovery emphasis interpretation integration algorithm backgroundthe link robust increasingly difficulty proportion discovery certain experimental text network date unknown step way source lack lead furthermore performance interaction literature metabolite large association novel information available time research protein metabolic gene group method data result disease study,{},{},{},{},{},{}
1552,1552,1679,10.1002/14651858.CD010263.pub2,28009052.0,major registry surgery cross assessment backgroundpain pain cochrane self orthodontic hour search inconclusive difference factor methodological information early twelve world author location selection platform comparing wafer music restriction adjunct bias central five separate cost continuous risk eligible messaging publication reliable specialist lllt objectivesto mouth register section issue line cannot gov evidence interval pharmacological compliance possible form clinical therapy questionnaire nature health range brain resultswe therefore emptive message effectiveness harm six recently effect data gum methodscochrane reference date language prospective term oral combination ongoing first type extraction ethos low international non use clinicaltrials level laser confidence seven although four conclusionsoverall three main least one short communication measure pre placebo relief text independently database october intervention review approach management inclusion model device day ass post stage organization prevalent behavioural treatment viable collection electronic associated help intensity medline finding bite address particularly library future two entirely lack vibratory scale unclear comparison embase alleviate orthognathic irradiation quality cognitive adverse either alleviation alternative available ovid reduce research importance also trial prevention orthodontics comfort high study heterogeneity dental patient random jaw participant another,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463902/,abstract,8,wafer vibratory orthognathic orthodontics orthodontic music methodscochrane messaging lllt ethos bite backgroundpain alleviate relief jaw emptive conclusionsoverall alleviation mouth gum entirely comfort ovid irradiation comparing adjunct viable message laser dental methodological inconclusive harm register october objectivesto surgery location section library eligible behavioural cochrane ongoing intensity registry pain embase random resultswe medline independently extraction specialist reduce device clinicaltrials bias placebo prevalent continuous publication compliance author separate reliable language hour gov organization prospective pharmacological line confidence platform nature communication unclear restriction seven reference heterogeneity oral interval world text post selection international inclusion alternative date search address effectiveness associated stage pre collection adverse help central short recently questionnaire comparison lack cross combination self cost prevention database particularly ass importance scale issue main finding participant possible assessment form cognitive measure management day trial major range electronic quality future brain use intervention therapy information evidence term non difference low approach available risk model early factor type research review health effect high data level treatment clinical patient study,{},"{""heterogeneity"": {""freq"": 1, ""string"": [""nature communication unclear restriction seven reference heterogeneity oral interval world text p""]}}",{},{},{},{}
1553,1553,1680,10.7717/peerj.2090,27366637.0,logistic european disorder ratio factor single among country world adult inflammation five recruitment due subsequently common mexico beta continuous interleukin testing related relevant however family evidence trait possible obesity previous value role consistent nominal feature retn report six metabolic data hepatocyte necrosis little receptor genetic low eight admixed mexican regression level rate one nuclear discussion diversity centre child population model tnfa method hypertension history causal binary sex polymorphism leptin ten association city age sample snp variant resistin lepr demonstrate cardio chronic background multiple grade high alpha nucleotide linear correction highest tumor complication gene ldl,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924140/,abstract,1,tnfa retn resistin lepr mexican leptin admixed necrosis mexico interleukin cardio nominal binary ldl recruitment hypertension beta grade diversity city correction causal subsequently logistic centre snp continuous alpha tumor inflammation hepatocyte discussion sex nuclear demonstrate complication receptor highest little linear nucleotide polymorphism european trait world obesity history previous consistent regression feature chronic relevant related ratio testing country possible background multiple value variant single association adult report family rate evidence role common sample low model factor population child age metabolic gene high genetic method data level disorder,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1554,1554,1681,10.1007/s13353-018-00480-w,30627967.0,male presence rare whole knowledge although disorder hybridization asd autism variant female neuron communication ratio neurodevelopmental factor single prevalence encoding etiology problem current largely function algorithm role protein population comparative brain environmental review behavior genomic also genome common general development synapse group social exome state propose diagnostic interaction average heterogenous unknown article study nucleotide sequencing number cause important well patient genetic formation gene repetitive spectrum,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373410/,abstract,0,heterogenous synapse repetitive hybridization comparative neuron encoding algorithm largely exome propose neurodevelopmental asd formation communication etiology nucleotide average unknown autism genomic genome female behavior presence environmental sequencing social general problem male prevalence ratio knowledge spectrum diagnostic interaction state cause variant brain single rare current article important role common function number factor population review protein development gene group genetic disorder patient study,"{""social"": {""freq"": 1, ""string"": [""genome female behavior presence environmental sequencing social general problem male prevalence r""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1555,1555,1682,10.1002/pbc.26873,29090524.0,efficacious pegcrisantaspase activity whether glycol dos reaction half immunogenicity oncology effective activation nonetheless pose line presence backgrounderwinia life pharmacokinetics strategy anti clinical intravenous leukemia polyethylene food report six data erwinia question immune first aall recombinant commonly resultsthree four administration lymphoblastic rapid three one short pegaspargase pegylation acute clearance hypersensitive dose drug child peg pegcristantaspase antiasparaginase moiety hypersensitivity lymphoma jazz antibody conclusionsthis serum treatment response phase assay incidence procedurepediatric pediatric determine series immunoglobulin larger trial group optimize cohort study small escherichia patient agent coli,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839116/,abstract,1,procedurepediatric pegcristantaspase pegcrisantaspase pegaspargase jazz erwinia backgrounderwinia antiasparaginase aall lymphoma lymphoblastic hypersensitive resultsthree pegylation glycol moiety leukemia nonetheless hypersensitivity efficacious coli pose oncology escherichia pharmacokinetics intravenous immunogenicity clearance immunoglobulin polyethylene peg optimize recombinant dos conclusionsthis series antibody activation half commonly larger line immune agent question anti dose acute phase administration reaction pediatric incidence short serum assay rapid presence determine cohort small food trial drug strategy response effective report life activity child group data treatment clinical patient study,{},{},{},{},{},{}
1556,1556,1683,10.1002/hep4.1278,30620000.0,specific cluster growth apoptosis factor exhibit among profile gunn positive adult yap without lenti insight connective physical host chemical morphology control ugt underlying increase competition month disease ert extensive repopulated presence najjar however strategy repopulation tumorigenesis peptidase therapy decline protein top replacement fold monogenic purified thus integration hepatocyte versus term dppiv long far genetic rat type hepatocytes fluorescence translocation yes nuclear hepatic bilirubin hyap normal syndrome microenvironment liver model regulation therapeutic ligand expression dysplasia potential rnaseq proliferative uridinediphosphoglucuronate response dedifferentiation year western cell glucuronosyltransferase deficient estrogen survival category function analysis transcriptomic mechanism alternative attractive transplantation plate conclusion blot crigler tissue domain advantage gene proliferation injury homogenate,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312667/,abstract,6,uridinediphosphoglucuronate ugt rnaseq repopulated najjar lenti hyap gunn glucuronosyltransferase dppiv crigler yes yap peptidase microenvironment homogenate dedifferentiation connective competition translocation repopulation purified proliferative ert tumorigenesis transcriptomic plate dysplasia bilirubin estrogen ligand blot attractive apoptosis decline morphology fluorescence host proliferation hepatocytes exhibit cluster western monogenic injury transplantation integration hepatic replacement far underlying hepatocyte extensive versus survival deficient nuclear fold chemical category advantage rat alternative domain regulation profile insight physical liver presence tissue syndrome growth month normal long expression positive strategy increase response therapeutic adult mechanism therapy conclusion term cell function model specific control factor type potential protein gene year genetic analysis disease,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1557,1557,1684,10.1186/2055-5784-1-5,27965785.0,activity allocation satisfied single registration time specifically methodsthis adult despite researcher weight physical control well preliminary month evidence attrition backgroundthe follow obesity anthropometric higher clinical health body effectiveness six data design little acceptability sixty period level full rate multi three isrctn measure randomisation carers intervention point population management conclusionsthe development disability behaviour baseline recommendation active help education feasibility sedentary bmi component fat future mass obese percentage negative prevalence waist estimate scale pilot determine circumference winner aim index impact research indicator trial general group intellectual study blind patient inform randomly participant consistently acceptable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066520/,abstract,3,winner carers randomisation sedentary isrctn attrition waist satisfied allocation acceptability preliminary anthropometric circumference registration obese indicator consistently behaviour bmi randomly pilot methodsthis feasibility inform blind fat acceptable percentage backgroundthe multi researcher conclusionsthe specifically little baseline obesity education active intellectual estimate effectiveness follow component recommendation index help physical weight negative disability point determine despite design general scale prevalence period participant body aim measure month mass management trial future single adult impact intervention rate activity evidence higher time control research population development health group data level clinical patient study,"{""intellectual"": {""freq"": 1, ""string"": [""specifically little baseline obesity education active intellectual estimate effectiveness follow component r""]}}",{},{},{},{},{}
1558,1558,1685,10.1016/j.jgeb.2017.07.010,30647685.0,level flour demand related sample exon functional phenylalanine one production female reduction per troublesome ammonia current white therapy stable convert evaluation colour quality damage mouse characteristic alternative determination efficiency subsequently trans egg mushroom also cinnamic expression result lyase enzyme investigate concentration study good cent acid control pal similar expansion way patient adherence diet pku genetic material low extraction gene untreated metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296627/,abstract,0,troublesome flour mushroom egg colour cinnamic cent convert pal trans lyase demand ammonia expansion extraction subsequently untreated efficiency determination adherence exon stable damage white production alternative way good female reduction investigate evaluation related functional characteristic similar mouse metabolite enzyme expression quality diet therapy concentration current pku material sample low phenylalanine control acid gene genetic level result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""concentration current pku material sample low phenylalanine control acid gene genetic l""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},"{""diet"": {""freq"": 1, ""string"": [""similar mouse metabolite enzyme expression quality diet therapy concentration current pku m""]}, ""egg"": {""freq"": 1, ""string"": [""troublesome flour mushroom egg colour cinnamic cent convert p""]}}",{}
1559,1559,1686,10.3390/cells7120264,30544931.0,blood tool investigation factor energy signature time oxidative several essential deeper glucose liquid insight homeostasis central supplementation stimulation regulatory addition avoid circulation synthesis characterize however circuit volumetric microsampling impairs therapy fitness programming mouse glutathione therefore secondary primary krebs metabolic vams little novel formation low useful cysteine level stress one systemic absorptive lactate overall hydroxybutyric phosphorylation liver model reactive sufficient urea excessive aspartic associated diet process hence mitochondrial monitoring iron mass pointing production appropriate peripheral standard loading dependent either spectrometry oxygen upon cycle plasma tissue high acid dietary overload patient resolution metabolite chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315421/,abstract,0,pointing microsampling vams krebs hydroxybutyric fitness overload aspartic absorptive volumetric impairs glutathione deeper circulation programming lactate iron loading cysteine avoid phosphorylation circuit signature excessive oxygen reactive stimulation urea peripheral characterize systemic sufficient resolution mitochondrial oxidative homeostasis monitoring formation little energy glucose cycle liquid production chromatography useful secondary associated regulatory investigation appropriate supplementation dependent insight central stress synthesis liver tissue spectrometry essential overall standard mouse process metabolite tool addition mass plasma primary diet dietary novel therapy low time model factor blood acid metabolic high level patient,{},{},{},"{""spectrometry"": {""freq"": 1, ""string"": [""insight central stress synthesis liver tissue spectrometry essential overall standard mouse p""]}}","{""diet"": {""freq"": 1, ""string"": [""metabolite tool addition mass plasma primary diet dietary novel therapy low t""]}}",{}
1560,1560,1687,10.1186/s12992-014-0063-y,26130160.0,european inequality activity hic commission promotion country lmic cinahl literature open capacity common outside build covered control publication transfer knowledge largest hics lmics nature health home focus project conceptually support result effectiveness depression antenatal purpose parenting april facility term type low implement mapping categorised provider main pubmed map oecd database child woman around intervention review inclusion assistance post behaviour conclusionsthis postnatal topic address care systematic maternal protocol within methodsthe future opportunity professional january income community birth natal backgroundthis mascot research refer trial identify rcts group different part high study preventing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487953/,abstract,3,oecd mascot lmic hic covered parenting hics categorised preventing lmics conceptually backgroundthis rcts refer natal pubmed inequality implement commission assistance facility promotion antenatal outside build cinahl postnatal mapping largest map april transfer behaviour topic conclusionsthis income home january provider depression methodsthe publication project capacity identify nature open protocol european opportunity post inclusion community address systematic effectiveness professional maternal woman focus purpose database main birth knowledge country literature support trial future intervention care activity term common low control type research review child different health group high result study,{},{},{},{},{},{}
1561,1561,1688,10.3389/fmolb.2016.00065,27774450.0,experimental disorder notion whether investigation vivo almost ratio factor subunit chaperonin molecular literature due missense variation spasm profoundly evaluate month disease amount phe whose cannot phenylalanine clinical protein replacement spectrometric fold spite leucine mutant fibroblast report never support attention effect data novo barely detectable cause decrease infantile level yet unchanged although functional mutation strong database proteolytic exome treatment strongly age public superoxide mass causative likely approximately spontaneous resistance analysis matrix heterozygosity infant propensity hsp consequence sod study thermal sequencing position patient gene complex mitochondrial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053987/,abstract,2,proteolytic chaperonin sod profoundly barely spasm hsp heterozygosity thermal spite spectrometric propensity infantile spontaneous unchanged subunit notion detectable superoxide leucine fibroblast novo causative position matrix replacement resistance mitochondrial exome missense strongly fold strong mutant experimental approximately vivo evaluate investigation consequence decrease likely attention variation sequencing database functional ratio public literature support month phe infant mass complex cause molecular report mutation phenylalanine factor protein age gene effect data level disorder treatment clinical analysis patient disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""mass complex cause molecular report mutation phenylalanine factor protein age gene e""]}}",{},{},{},{},{}
1562,1562,1689,10.1007/s40471-017-0104-1,29399433.0,registry biological european prescription assessment record estimation prospectively factor information rigorous nationwide several country essential reimbursement reproductive increasingly partially condition additional source survey gestational medical offer findingsresearch recent follow health regional procedure identifies alone complete primary diagnosis encounter purpose live interview data summaryclaims term pregnancy chart long incomplete medication capture short certain possibly completeness database provide strength outcome confirmation critical review exposure safety american mother collection electronic reviewadministrative lifestyle maternal augment linkage age generally north typically birth quality research infant regardless episode reliably study advantage limitation healthcare accuracy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780544/,abstract,0,summaryclaims reviewadministrative findingsresearch completeness nationwide incomplete encounter rigorous chart augment prescription reimbursement identifies reliably live confirmation prospectively north episode estimation regardless possibly linkage strength regional registry capture reproductive offer partially lifestyle gestational american interview medication typically generally record complete advantage increasingly safety limitation mother european certain healthcare accuracy procedure pregnancy follow collection maternal source short survey exposure purpose critical database essential biological provide additional birth country assessment infant long primary electronic quality medical recent information outcome term condition factor diagnosis research review age health data study,{},{},{},{},{},{}
1563,1563,1690,10.1371/journal.pone.0183975,28886061.0,inside specific activity reticulum pathway tertiary binding inflammation modification condition molecular common chemical bip radical upr thermodynamic smoking well significantly membrane numerous endoplasmic however role protein play biophysical body secondary structural result property stability basis term generation lipid completely non bind significant stress cellular one aggregation failure structure peroxidation product reactive free attack important key response cell particularly oxononenal nbd million healthy chaperone function quality immunoglobulin mechanism consumption also phenomenon upon domain study nucleotide human alcohol atpase atp show highly affinity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590874/,abstract,0,upr oxononenal nbd bip thermodynamic peroxidation atpase attack biophysical reticulum inside endoplasmic atp radical binding smoking immunoglobulin bind tertiary chaperone affinity alcohol reactive phenomenon aggregation membrane completely million modification inflammation lipid stability numerous failure chemical consumption nucleotide cellular structural play domain secondary property basis stress generation structure free particularly product highly body healthy key response quality pathway molecular mechanism activity term condition non important role common cell function significantly human specific protein significant result study,{},{},"{""pathway"": {""freq"": 1, ""string"": [""highly body healthy key response quality pathway molecular mechanism activity term c""]}}",{},{},{}
1564,1564,1691,10.1093/ije/dyw046,27118561.0,level epidemiological future rate multi direction recent biomarkers single biology scale gain inferring outline reaction population omics insight analysis approach mechanism causality currently research feasible method also analytical potential highlight system simulation study data success practical human leverage technological infer key well furthermore disease survey limitation cell highlighting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100607/,abstract,0,inferring infer leverage highlighting causality outline omics technological simulation direction epidemiological gain feasible practical success multi analytical biology limitation reaction insight survey furthermore biomarkers currently highlight scale key future single recent mechanism rate cell approach human research population potential method data level analysis disease study,{},{},{},{},{},{}
1565,1565,1692,10.1038/s41598-018-28885-x,30038322.0,activity memory physiological specifically largely glycolysis elevated moreover enzymatic disease significantly kinase phe passive reversible biochemical phenylalanine reduction mainly acetylcholine brain mouse pyruvate speculate knockout enzyme metabolic furthermore type metabolism low fear level lao wild one donepezil inhibitor many participate hippocampal alzheimer propose oxidase test impaired treatment important phenylpyruvic directly function cognitive impairment analysis mechanism avoidance importance metabolomic esterase mrna acid hippocampus indirectly amino metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056520/,abstract,0,phenylpyruvic lao esterase donepezil acetylcholine speculate indirectly hippocampal fear avoidance passive glycolysis pyruvate kinase oxidase reversible participate knockout hippocampus metabolomic mrna impaired enzymatic alzheimer inhibitor largely propose physiological wild specifically memory mainly elevated directly reduction impairment furthermore importance biochemical mouse cognitive metabolite enzyme phe brain mechanism activity amino important function low metabolism test significantly phenylalanine type acid metabolic level treatment analysis disease,"{""phenylalanine"": {""freq"": 2, ""string"": [""important function low metabolism test significantly phenylalanine type acid metabolic level t""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""metabolite enzyme phe brain mechanism activity amino important function low metabolism t""]}}",{},{}
1566,1566,1693,10.1007/s12687-016-0281-5,27714667.0,chain syrup ill early difficult several concern aside admission transfer specialist disease properly medical supply possible follow observed protein intravenous improvement critically error inborn diagnosis metabolic urine reach late first alive metabolism ketoacid eight low non area period case dehydrogenase implementation infection outcome critical management nosocomial encountered disability success resource collection year septicemia challenge maple rare earlier newborn lack access logistical philippine neurologic dependent msud antibiotic aspect hospital mechanism program also alpha study deficiency patient complication healthcare complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222756/,abstract,5,septicemia philippine nosocomial encountered alive ketoacid logistical aside properly msud intravenous supply critically reach maple ill neurologic antibiotic syrup admission transfer earlier specialist alpha success dehydrogenase access complication late aspect infection healthcare urine resource difficult concern follow collection dependent observed implementation improvement hospital lack disability critical chain period possible inborn area management program challenge complex error medical deficiency mechanism rare newborn outcome non low case metabolism early diagnosis protein metabolic year patient disease study,"{""urine"": {""freq"": 1, ""string"": [""access complication late aspect infection healthcare urine resource difficult concern follow c""]}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""complex error medical deficiency mechanism rare newborn outcome non low case m""]}}",{},{}
1567,1567,1694,10.1016/j.ebiom.2018.10.038,30366815.0,specific blood early ammonia profile time positive adult laboratory fundbiomarin throughout immunogenicity interpretationdespite igg igm activation ige month pku phe titration haes phenylalanine evidence event organ reduction dosage pharmaceutical cic consistent polyethylene efficacy upward complement immune type formation anabaena recombinant level administration end acute variabilis systemic peg damage maintenance antidrug phenylketonuria post hypersensitivity antibody hae safety baseline frequent substantial pal treatment response regimen manageable inc near universal component findingsall transient methodsimmunogenicity backgroundthis ada adverse immunoglobulin impact induction plasma lyase study pegvaliase patient highest total complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286649/,abstract,5,upward methodsimmunogenicity interpretationdespite haes hae fundbiomarin findingsall cic ada ige antidrug variabilis backgroundthis anabaena titration manageable igm pegvaliase hypersensitivity igg immunogenicity immunoglobulin polyethylene peg pal dosage induction regimen complement lyase ammonia transient recombinant maintenance antibody near universal pharmaceutical systemic activation substantial organ damage immune frequent formation end safety highest event baseline post acute administration component adverse profile consistent efficacy reduction laboratory month phe plasma complex positive response adult impact total evidence pku phenylketonuria time early phenylalanine specific blood type level treatment patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""total evidence pku phenylketonuria time early phenylalanine specific blood type level t""]}}",{},{},{},{},{}
1568,1568,1695,10.1542/peds.2015-3570,26620065.0,disorder discretionary herein extremely greater early exhibit noncholestatic difficult warrant necessary native need unfortunately common state cost effective evaluate disease jaundice committee biliary evidence life strategy obstruction indication card color effectiveness diagnosis first potentially united end bilirubin discussion child outcome liver week stool identification stage potential cholestatic serum concentration drainage heritable feasibility rare hence within bile newborn pediatric survival advisory timely birth criterion analysis infant transplantation infancy study surgical successful atresia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920543/,abstract,0,noncholestatic drainage discretionary cholestatic obstruction biliary atresia stool jaundice bilirubin warrant color bile heritable unfortunately advisory native surgical card timely extremely committee exhibit infancy indication transplantation feasibility discussion survival united end successful difficult effectiveness potentially necessary evaluate stage pediatric serum criterion liver cost greater identification week birth need infant state strategy effective rare life concentration newborn evidence outcome common early diagnosis potential child disorder analysis disease study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""state strategy effective rare life concentration newborn evidence outcome common early d""]}}",{},{}
1569,1569,1697,10.1039/c7lc00633k,28752875.0,representative analyzer laboratory fibronectin selection resonant platform liquid light tri capable videoand optical microfluidic onto diode spectrum illumination handheld measurement stick phenylalanine poc reader unique fluorescent user health protein demonstrating crystal diffraction green comparable image conventional camera biosensor term photonic fetal type microplate capture elisa detection laser selects case flexibility fluorescence rapid internal software pre smartphone rear emission white instrument point reflection phenylketonuria simple compartment via system test chamber automatically directly assay care maternal flash commercially sample cartridge birth field path either available infant indicator modality translation high fiber direct grating linear absorption resolution spectrometer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614857/,abstract,0,videoand selects rear microplate illumination handheld grating flash fibronectin diode tri resonant photonic cartridge camera automatically green stick diffraction biosensor smartphone poc microfluidic commercially chamber analyzer reflection reader optical fiber laser fluorescent elisa spectrometer compartment image flexibility path fluorescence absorption modality crystal emission demonstrating indicator representative capture capable software internal instrument conventional comparable resolution light translation fetal simple platform white linear unique liquid selection directly pre maternal direct assay rapid point measurement laboratory birth field spectrum detection infant user care term sample phenylketonuria case available test phenylalanine type protein health high,"{""phenylalanine"": {""freq"": 2, ""string"": []}}",{},{},"{""detection"": {""freq"": 1, ""string"": [""point measurement laboratory birth field spectrum detection infant user care term s""]}}",{},{}
1570,1570,1698,10.1007/8904_2016_567,27295196.0,implication factor early audio positive adult enhance condition thematic experience well pku amongst semi adulthood family childhood clinical burden support result thus effect psychological term long south eight significant peer verbatim australia child woman outcome intervention population management equivocal phenylketonuria method people potential parental adolescence finding challenge explore analysis background aim impact general conclusion different study underwent psychosocial perception,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362557/,abstract,0,equivocal verbatim audio thematic australia south underwent psychosocial peer adolescence semi perception psychological enhance adulthood parental people burden explore experience woman implication childhood general finding background support aim long management challenge positive adult family impact intervention pku outcome conclusion term condition phenylketonuria early factor population potential child different significant effect method clinical analysis result study,{},{},{},{},{},{}
1571,1571,1699,10.1093/jlb/lsz002,31143453.0,restrictively court imperfect interpretation consistency information among definitional necessary gina meaning choice genetics state difficulty patchwork adheres finally conflict discrimination medical congress however uniform protection broader possible broadly plain health law language strictly interpretive genetic fear non one allay strong prevent interprets approach people preemptively second prevalent article contrary ten year address option nondiscrimination robust definition public defining would unclear achieve ago goal act employment remedy confusing research also part last statutory federal distinguishing insurance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534748/,abstract,0,statutory restrictively preemptively patchwork nondiscrimination interprets gina distinguishing definitional confusing conflict allay adheres interpretive imperfect employment defining congress meaning strictly remedy plain court fear contrary federal uniform law insurance consistency ago discrimination broader broadly protection achieve definition interpretation prevalent act language choice robust unclear difficulty people strong option goal prevent address necessary finally second genetics public possible state medical information non article approach research health year genetic,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1572,1572,1700,10.1155/2014/491316,25349607.0,various biological disorder catastrophic self lead energy toxicant increasingly central inert subsystem cosmetic disrupts well fluorine element glyphosate however beneficial circuit crust recent form macromolecule entropy role protein global metal refining therefore food harmless thus biosemiotic negatively specie mining water transduction death crucial toxic dynamic abundant failure vaccine aluminum naturally disruption system exposure industrial invariably year cell process smelting earth progress rna mercury prevalence beginning interacts nervous dna prior impact indicator occupational last human medicinals biophysics complex sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202242/,abstract,1,toxicant subsystem smelting refining medicinals inert harmless fluorine crust biosemiotic aluminum invariably glyphosate entropy earth biophysics mercury macromolecule interacts disrupts cosmetic catastrophic beginning occupational mining vaccine naturally industrial transduction circuit abundant metal disruption indicator negatively toxic crucial progress specie rna nervous element dynamic failure beneficial water prior increasingly sensitive energy death global dna central exposure lead self biological prevalence various food process form complex recent impact role cell human protein year disorder,{},{},{},{},{},{}
1573,1573,1701,10.1371/journal.pone.0197938,29856793.0,backgroundhyperbilirubinemia tool self whether hour consent neonatal caucasian light equipped pressure common investigate source old lesion severity significantly discrimination respectively gestational medical measurement however channel form clinical consistent requires neonate mol green practitioner improvement smartphones image camera result potentially resultsonly level iphone red bilirubin smartphone problem sensitivity exclusion total inclusion management week reason device designa day conclusionsthe simple method contact via system pearson treatment parental hyperbilirubinemia digital iii filter accessible limit directly intensity specificity age progress newborn application glabella easy healthy wratten colour currently facial available dermatoscope blue plasma study skin objectiveto patient randomly healthcare,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983497/,abstract,5,wratten smartphones resultsonly requires iphone glabella dermatoscope backgroundhyperbilirubinemia equipped camera green colour hyperbilirubinemia smartphone digital designa blue bilirubin red pearson caucasian contact practitioner facial easy channel image discrimination exclusion lesion consent intensity accessible iii neonate skin reason filter randomly objectiveto device gestational progress pressure parental light hour conclusionsthe limit simple mol severity healthcare inclusion directly specificity potentially source improvement consistent old sensitivity neonatal self investigate measurement currently problem week form tool healthy application plasma management day medical respectively total newborn common available significantly age method level treatment clinical result patient study,"{""skin"": {""freq"": 1, ""string"": [""lesion consent intensity accessible iii neonate skin reason filter randomly objectiveto d""]}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""plasma management day medical respectively total newborn common available significantly age m""]}}",{},{}
1574,1574,1702,10.1038/pr.2017.323,29278642.0,disorder record retardation resultspatient physiological ammonia adult severe unfortunately common artificial backgrounduntreated methodswe substitution severity significantly pku hydroxylase phe pregnant adulthood phenylalanine compliance noncompliance clinical therapy protein conclusionpal mouse usually complete mutant result pahenu enzyme efficacy contrast data cause pregnancy fetal first genetic untreated level although one female normal problem syndrome prevent woman outcome phenylketonuria mental ass potential pal treatment dam year diet incidence offspring maternal poor survival since limited ago corrects lyase often high lethality human dietary btbr complication show,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023696/,abstract,1,corrects conclusionpal backgrounduntreated resultspatient noncompliance lethality dam btbr offspring unfortunately pal pahenu artificial ago lyase substitution retardation ammonia usually pregnant adulthood compliance untreated survival fetal record physiological complication complete mutant severity contrast prevent poor methodswe pregnancy mental maternal woman female incidence efficacy limited syndrome ass problem hydroxylase mouse severe enzyme phe normal cause adult diet dietary therapy pku outcome common phenylketonuria significantly human phenylalanine potential protein year high genetic data level disorder treatment clinical result,"{""phenylalanine"": {""freq"": 2, ""string"": [""pku outcome common phenylketonuria significantly human phenylalanine potential protein year high g""]}}","{""genetic"": {""freq"": 1, ""string"": [""human phenylalanine potential protein year high genetic data level disorder treatment c""]}}",{},{},"{""diet"": {""freq"": 1, ""string"": [""severe enzyme phe normal cause adult diet dietary therapy pku outcome c""]}}",{}
1575,1575,1703,10.1371/journal.pone.0160892,27513937.0,blood relationship nine backgroundphenylketonuria among adult due responder supplementation slope neurocognitive biomarker hypothesis increase objective pku hydroxylase methodsnine phe synthesis phenylalanine concurrent subject void dopamine dysfunction defective therapy brain neurotransmitter result transport enzyme effect large differing change first metabolism use level differently significant whole four three neutral hepatic biomarkers overall toward week serum concentration washout melatonin treatment association phase conclusionblood monitoring protocol negative serotonin peripheral determine sapropterin overnight individualized precursor also plasma trend high sulfatoxymelatonin study monoamine acid synergistic assist deficiency amino individual metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981358/,abstract,0,void methodsnine differing conclusionblood washout sulfatoxymelatonin slope overnight synergistic differently melatonin individualized concurrent defective responder assist monoamine backgroundphenylketonuria neurocognitive sapropterin neutral peripheral hepatic transport trend serotonin biomarker neurotransmitter monitoring precursor dopamine protocol hypothesis phase supplementation serum negative synthesis dysfunction biomarkers determine week hydroxylase relationship overall metabolite enzyme phe objective subject plasma change increase large brain association adult use deficiency therapy concentration pku amino metabolism individual phenylalanine blood acid significant effect high level treatment result study,"{""phenylalanine"": {""freq"": 2, ""string"": [""therapy concentration pku amino metabolism individual phenylalanine blood acid significant effect h""]}}",{},{},"{""amino"": {""freq"": 1, ""string"": [""adult use deficiency therapy concentration pku amino metabolism individual phenylalanine blood a""]}}",{},{}
1576,1576,1704,10.3389/fimmu.2018.00289,29503650.0,counseling male specific disorder blood vietnam agammaglobulinemia boy time several defect country laboratory across location molecular together regular cost gdna mean source onto btk circle physician sequence sanger account life strategy continent possible confirm previous overseas clinical vietnamese backgroundnew clinically primary mosaicism card envelope diagnosis resulthigh specimen basis pid inexpensively genetic type completely xla three sister mutation temperature room normal tyrosine child able review ready gonadal sized cumbersome technique method identification albeit national sufficient treatment mother filter appropriately western factual immunodeficiency carrier every generally methodblood protocol age two minimal bruton newborn guthrie collaboration spot survival airmail reduced dna quality analysis hospital paper available reduce quantity also cohort high study conclusiondbs sequencing similar patient gene mail sensitive establishing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820318/,abstract,6,vietnamese resulthigh overseas methodblood gdna factual cumbersome bruton backgroundnew airmail xla vietnam sister inexpensively envelope continent conclusiondbs btk agammaglobulinemia pid gonadal mosaicism guthrie sized ready mail counseling circle albeit immunodeficiency appropriately establishing location confirm card specimen sanger room quantity collaboration regular filter boy completely western reduce minimal temperature sufficient survival physician generally reduced able sensitive protocol mother carrier account clinically sequence previous basis dna source mean hospital national cost sequencing tyrosine spot defect technique laboratory identification male cohort paper country similar possible normal primary strategy quality molecular life newborn mutation available time specific blood type diagnosis review child age gene high genetic method disorder treatment clinical analysis patient study,{},"{""genetic"": {""freq"": 1, ""string"": [""diagnosis review child age gene high genetic method disorder treatment clinical a""]}}",{},"{""newborn"": {""freq"": 1, ""string"": [""normal primary strategy quality molecular life newborn mutation available time specific b""]}, ""guthrie"": {""freq"": 1, ""string"": [""conclusiondbs btk agammaglobulinemia pid gonadal mosaicism guthrie sized ready mail counseling c""]}}",{},{}
1577,1577,1705,10.1038/srep15860,26507003.0,activity whether ratio factor lower congenital time frequency variation risk oct control disease significantly embryonic contribute transcription however maf family previous predisposition role minor mouse pluripotency luciferase chd result furthermore first genetic low chinese level case functional cardiomyocyte pou model development stage expression potential key association assay cell two variant allele morphogenesis depletion unclear additive differentiation function heart stem analysis confer study cardiac gene total malformation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623744/,abstract,0,pou pluripotency oct morphogenesis maf confer cardiomyocyte predisposition luciferase minor depletion additive embryonic malformation chd stem contribute differentiation cardiac chinese transcription unclear heart allele stage previous assay variation furthermore frequency congenital functional ratio mouse expression variant key lower association family total activity role cell function low case time significantly risk model control factor potential development gene genetic level analysis result disease study,{},"{""genetic"": {""freq"": 1, ""string"": [""model control factor potential development gene genetic level analysis result disease s""]}}",{},{},{},{}
1578,1578,1706,10.3389/fnmol.2018.00458,30666185.0,level various presence commonly computation dialog disorder animal seizure activity clinic autism evidence pharmacological lead anomalous moderate context acute etiology independently abnormal transiently influence clinical processing chronic ictal cognitive brain impairment review model eeg available cortical deficit like neuropsychiatric epilepsy often epileptiform excitation testing data mild overt alteration cause hyperexcitability disease even genetic absence inhibition performance indeed bipolar non paradigm,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330286/,abstract,0,ictal hyperexcitability epileptiform dialog bipolar anomalous transiently excitation overt computation cortical eeg neuropsychiatric epilepsy paradigm processing independently seizure commonly absence pharmacological inhibition etiology moderate mild abnormal alteration acute clinic autism deficit animal impairment lead context presence chronic influence like performance testing various cognitive cause brain activity evidence non available model review genetic data level disorder clinical disease,{},"{""genetic"": {""freq"": 1, ""string"": [""activity evidence non available model review genetic data level disorder clinical d""]}}",{},{},{},{}
1579,1579,1707,10.1016/j.arr.2016.03.005,27039887.0,biological pathogenesis new pathway abnormal oxidative homeostasis bacterial contributes radical fact effective accumulation increase disease related phenylalanine marker evidence hydroxyl defense demonstrating elevation result metabolic effect benzyl specie formation plant metabolism ultimately area stress cellular biologic produce tyrosine damage mediator alzheimer reactive exposure oxidize consequently concentration pool directly cell particularly age future isomer likely clarify cataract ring function elimination adverse mechanism research oxygen also tissue study acid meta mammalian amino atherosclerosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841466/,abstract,0,oxidize hydroxyl benzyl isomer cataract biologic atherosclerosis defense clarify ring pool radical mediator contributes elimination plant oxygen fact reactive elevation demonstrating mammalian ultimately produce bacterial alzheimer pathogenesis consequently specie oxidative homeostasis damage meta formation cellular accumulation abnormal directly adverse stress marker exposure likely tissue particularly tyrosine biological related area increase effective future pathway mechanism concentration evidence amino cell function metabolism new phenylalanine research acid age metabolic effect result disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""evidence amino cell function metabolism new phenylalanine research acid age metabolic e""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""biological related area increase effective future pathway mechanism concentration evidence amino c""]}}","{""amino"": {""freq"": 1, ""string"": [""effective future pathway mechanism concentration evidence amino cell function metabolism new p""]}}",{},{}
1580,1580,1709,10.1108/AMHID-10-2015-0050,27066217.0,implication specific disorder whether new single factor final instead synonymous revision world synonym document throughout central condition expert severe existing severity concept well acquisition conference disease name utility knowledge account evidence moderate neurodevelopmental profound mirror adaptive inherent clinical mixed health nominal developmental feature focus distinction core report methodology debate diagnosis qualitative purpose mild combine basis design complement valuewithin first official ability international approacha service significant educational functioning scientific problem current structure syndrome known reflection approach conceptualisation causal development originality social organization face skill disability combined behaviour parent ontological produced recommendation meeting qualifier findingsthe process component consensus complex two application access advisory category function series cognitive impairment criterion aspect prior impact paper framework available counterpart also policy synset group intellectual diagnostic different classification rationale meta idd distinct limitation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822711/,abstract,0,valuewithin synset synonym qualifier produced ontological idd existing originality mirror conceptualisation approacha revision findingsthe distinction combine counterpart known synonymous reflection nominal inherent combined official conference meeting advisory rationale acquisition instead complement functioning debate profound final behaviour document adaptive series mixed face core causal skill consensus qualitative educational classification organization distinct methodology meta expert neurodevelopmental category access scientific prior moderate limitation mild framework concept severity utility aspect account world international intellectual policy component basis service recommendation implication central focus feature criterion impairment purpose disability structure developmental syndrome social ability parent design problem paper knowledge diagnostic severe process cognitive application complex single report impact evidence current condition function approach available new specific factor diagnosis different significant development health group disorder clinical disease,"{""intellectual"": {""freq"": 1, ""string"": [""severity utility aspect account world international intellectual policy component basis service r""]}, ""social"": {""freq"": 1, ""string"": [""impairment purpose disability structure developmental syndrome social ability parent design problem p""]}}",{},{},{},{},{}
1581,1581,1710,10.5487/TR.2018.34.3.259,30057700.0,nana disorder milk new difference concern inflammation toxicity control disease glycomacropeptide uvra sialic evidence chromosome protein acetylneuraminic separated mouse therefore food effect similarly immune type genetic use level significant neu functional gmp three mutation produce dose anticancer evident aberration development system safety test salmonella cell typhimurium negative glycolylneuraminic differentiation function nervous chronic micronucleus study whey acid escherichia antiviral coli another icr cho,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057297/,abstract,0,uvra typhimurium salmonella nana micronucleus icr glycolylneuraminic neu cho acetylneuraminic aberration sialic anticancer coli separated escherichia antiviral whey gmp chromosome similarly produce toxicity evident glycomacropeptide milk differentiation inflammation nervous immune safety dose concern negative chronic functional mouse food use evidence mutation difference cell function test new control type acid protein significant development effect genetic level disorder disease study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1582,1582,1711,10.2196/12702,31033449.0,logistic smcs tool record synthetic conclusionswe secure final dataset time world algorithm biomedical concern researcher site complexity without awareness efficient backgroundbiomedical need expert methodswe securely raw ethical calculation heavy extensive however meet form estimator nonsecure raise user real support effectiveness thus large data good handle dsc design term experiment resultsour regression communication step datasets independently around collectively many approach model method conduct plan potential face calculate loss incurs multiparty smc computation protocol legal reveal application million collective protecting involved statistical usable privacy party research attractive multiple min general often objectivethis study linear accuracy performance number,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658266/,abstract,2,smcs smc securely protecting party nonsecure multiparty incurs dsc backgroundbiomedical usable handle estimator secure objectivethis datasets computation calculate resultsour raw meet privacy heavy dataset collective attractive conduct conclusionswe calculation raise biomedical final legal collectively reveal min face complexity independently awareness plan algorithm logistic million ethical synthetic experiment extensive real researcher record involved efficient expert communication linear protocol world accuracy statistical methodswe concern effectiveness step good regression site loss design general performance need form support tool application user multiple large term approach number time model research potential method data study,{},{},{},{},{},{}
1583,1583,1712,10.1136/bmjopen-2016-011234,27799239.0,cross sectional conclusionswe difference registration effort interventioncomplementary aged province august control vitamin month survey village respectively semi line measurement numberchictrprc much follow place higher measureseffect protein secondary limitationswe primary china food result effectiveness mid thus large data qinghai participantscaregivers term decrease score area level use significant although variable one settingone train pre diversity child outcome strength intervention designa rural ass national baseline solid carbohydrate delivery rich proportion supplement education doctor folic fat age future iron two poor complementary haemoglobin prevalence community minimum height systematically analysis longer infant also trial practice high feeding study acid objectiveto dietary zinc participant number calcium county,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093399/,abstract,8,settingone participantscaregivers numberchictrprc measureseffect limitationswe interventioncomplementary train qinghai village mid haemoglobin designa county doctor august iron minimum folic conclusionswe zinc feeding complementary calcium strength registration height carbohydrate solid semi rural longer supplement diversity systematically province rich place objectiveto fat china vitamin line proportion baseline education community poor effort sectional secondary effectiveness follow delivery pre aged decrease variable survey cross national measurement practice ass prevalence score participant food area month infant trial primary large future use respectively intervention dietary outcome term higher difference number control acid child protein age significant high data level analysis result study,{},{},{},{},{},{}
1584,1584,1713,10.1093/advances/nmy001,29659694.0,past whether sparse inconclusive new factor discus information behavioral modification additional continuous testing disease transition intake consumer matter sequence knowledge decade era however evidence nutrigenomic rather strategy trait obesity clinical therapy health therefore genomic behind debate purpose data change type genetic equip potentially medicine service rapid nuclear scientific genomics overall prevent polygenic vulnerability review dtc sufficient precision recommendation diabetes promise lifestyle particularly commercially public likely prevalence effectively adverse aim cardiovascular available makeup genome dissemination nutritional different direct dietary individual initiative treat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916428/,abstract,1,equip dtc nutrigenomic makeup sparse commercially dissemination polygenic vulnerability inconclusive debate era consumer promise initiative lifestyle transition effectively continuous sufficient modification precision nuclear matter cardiovascular treat scientific genomics past diabetes trait decade obesity behavioral prevent potentially sequence genomic service recommendation genome adverse direct nutritional likely rapid purpose intake particularly medicine prevalence additional public discus testing overall knowledge aim change strategy dietary therapy information evidence available individual new factor type review different health genetic data clinical disease,"{""behavioral"": {""freq"": 1, ""string"": [""genomics past diabetes trait decade obesity behavioral prevent potentially sequence genomic s""]}}","{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1585,1585,1714,10.1007/s12687-015-0236-2,26021874.0,entire smallest epidemiological disorder tool chain blood new discus cystic congenital country largely uruguay programme otoacoustic physical institution mph ministry disease material medical related decade era however supplementary recent strategic screening illustrates pidcer user coa health legislation law doi burden imr therefore examination science genomic acyl fibrosis hyperplasia situation middle south mortality unchanged mandatory rate dehydrogenase emission current bioethics population phenylketonuria plan via national social lifetime development disability free online test article electronic associated year care systematic version universal rare public two newborn anomaly million spot income hypothyroidism birth hip ago quality provision characteristic available infant prevention policy america comprehensive adrenal high last medium similar ultrasound demographic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524831/,abstract,1,uruguay pidcer mph imr illustrates smallest otoacoustic bioethics hip strategic ministry legislation hyperplasia unchanged law adrenal mandatory america ago ultrasound lifetime acyl south entire emission era anomaly provision cystic institution income epidemiological situation middle hypothyroidism doi demographic universal plan programme fibrosis coa million dehydrogenase medium largely examination burden decade science comprehensive systematic associated policy mortality genomic physical national disability free chain prevention spot social congenital related characteristic public birth discus country similar tool infant supplementary screening user version electronic quality online medical recent rare care rate newborn current material article phenylketonuria available test new blood population development health year high disorder disease,"{""social"": {""freq"": 1, ""string"": [""national disability free chain prevention spot social congenital related characteristic public b""]}}",{},{},"{""newborn"": {""freq"": 1, ""string"": [""online medical recent rare care rate newborn current material article phenylketonuria a""]}, ""screening"": {""freq"": 1, ""string"": [""discus country similar tool infant supplementary screening user version electronic quality o""]}}",{},{}
1586,1586,1715,10.1037/neu0000337,28080075.0,assessment memory better early affect across adult present literature due moreover deficit control number accumulation objective disease pku establish phe executive phenylalanine verbal brain task result metabolic good low completely clearly inability measure toxic normal current processing outcome unprecedented product phenylketonuria method treatment important diet education particularly age still sizable lack especially effectively speed cognitive impairment previously orthographic also conclusion policy group comprehensive high domain study participant variability performance complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328133/,abstract,2,sizable orthographic unprecedented inability verbal speed clearly processing establish completely effectively toxic executive variability memory affect task accumulation education comprehensive domain policy good deficit lack impairment especially particularly product previously performance better participant literature assessment cognitive measure phe normal objective complex brain adult diet current pku outcome conclusion important phenylketonuria low number present early phenylalanine control age metabolic group high method treatment result disease study,"{""phenylalanine"": {""freq"": 2, ""string"": [""important phenylketonuria low number present early phenylalanine control age metabolic group h""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""phe normal objective complex brain adult diet current pku outcome conclusion i""]}}",{}
1587,1587,1716,10.1177/1971400918764016,29517408.0,resonance specific statistic disorder tool clinic abnormality investigation tertiary positive adult algorithm present condition retrospective cohen abstract facilitate wmsas old clinician agreement neurogenetic pose month inter matter utility biochemical childhood possible clinical value conclusionsalthough result diagnosis etiologic metabolic neurology good wmas genetic non wma one signal cranial etiology white sensitivity approach aid unknown year promise care challenge kappa scan neurometabolic specificity age resultsthe methodsthe two appropriate mri pilot differential validity hospital benefit diagnostic high study magnetic radiologist assist patient twenty backgroundwhite limitation establishing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111436/,abstract,4,wmsas wmas wma radiologist backgroundwhite cohen kappa etiologic cranial neurogenetic conclusionsalthough pose neurometabolic neurology scan establishing agreement tertiary assist abstract aid validity retrospective mri inter promise statistic pilot algorithm methodsthe resonance facilitate differential matter resultsthe signal clinician etiology white limitation magnetic utility clinic specificity unknown investigation good appropriate childhood old abnormality sensitivity hospital benefit biochemical diagnostic possible tool month challenge positive value adult care condition non approach present specific diagnosis age metabolic year high genetic disorder clinical result patient study,{},"{""genetic"": {""freq"": 1, ""string"": [""backgroundwhite cohen kappa etiologic cranial neurogenetic conclusionsalthough pose neurometabolic neurology s"", ""specific diagnosis age metabolic year high genetic disorder clinical result patient s""]}}",{},{},{},{}
1588,1588,1717,10.1038/npp.2015.294,26391599.0,experimental biological striking physiological difference early context positive present subpopulation complexity unusually inherently behavior partially condition physical literature interactive variation contextual epigenetic survey neuronal trajectory animal beneficial remarkably adaptive health brain environment bidirectionally observational design genetic swiftly level neurobiological volume sensitivity product attribute mediator temperament development social moderation minority system susceptibility circuitry assertion process within sample poor circumstance character subgroup differential function adverse currently environmental mechanism paper upon study human individual contingent,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677150/,abstract,0,swiftly striking bidirectionally unusually temperament inherently contingent character subpopulation moderation attribute contextual assertion circumstance circuitry neurobiological minority mediator interactive remarkably trajectory epigenetic adaptive complexity subgroup partially susceptibility neuronal observational differential beneficial physiological volume experimental poor adverse environment physical survey animal sensitivity behavior context variation environmental product currently social biological design paper literature process positive brain mechanism condition difference function sample present individual human early development health genetic level study,"{""social"": {""freq"": 1, ""string"": [""behavior context variation environmental product currently social biological design paper literature p""]}}","{""genetic"": {""freq"": 1, ""string"": [""minority mediator interactive remarkably trajectory epigenetic adaptive complexity subgroup partially s""]}}",{},{},{},{}
1589,1589,1718,10.1016/j.omtn.2017.05.005,28624219.0,interestingly whether lead cystic binding directed homology frequency addition significantly however phenylalanine family editing abcc higher protein guidance transmembrane comparable mutant fibrosis thus multidrug mrp crispr decrease combination cassette type guiderna grnas rate three safely mutation recombination member one wild cftr transporter side grna provide correct system associated insertion donor regulator complementary efficiently especially dna resistance deletion genome nucleotide atp absence another conductance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443964/,abstract,1,multidrug mrp guiderna grnas grna directed abcc safely cassette homology conductance recombination cftr transmembrane editing atp binding crispr insertion efficiently complementary interestingly guidance donor cystic regulator transporter fibrosis correct resistance comparable deletion absence wild member mutant nucleotide associated genome dna decrease lead combination especially frequency provide addition family rate mutation higher significantly phenylalanine type protein,"{""phenylalanine"": {""freq"": 2, ""string"": []}}",{},{},{},{},{}
1590,1590,1719,10.4103/0253-7613.182888,27298490.0,sweetener disorder everyday inconclusive intense medicinal increasingly nns weight causality due state fruit risk true objective status stevia properly nonnutritive migraine consumer pregnant subset however ever life evidence opposite recent obesity variety word advantame food support sweetness six efficacy nowadays metabolic effect swingle observational guideline calorie aspartame far susceptible united controversial use administration utmost acesulfame extract amply current drug overall woman child population product reverse ass potential loss epilepsy hint key diabetes year finding list generally earlier two lack caution plethora adverse previously benefit diabetic consumption fewer neotame different often part sugar study whereas dietary patient agent even safe promote,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899993/,abstract,0,swingle hint amply neotame migraine advantame utmost sweetness stevia nonnutritive nns acesulfame nowadays extract everyday caution plethora intense properly promote causality susceptible opposite aspartame medicinal inconclusive calorie sweetener reverse fruit fewer controversial diabetic true epilepsy sugar consumer earlier safe pregnant list subset observational far united generally variety increasingly consumption agent word diabetes guideline obesity administration woman adverse efficacy weight loss lack product previously ass benefit status overall finding food support objective state drug key recent use dietary life evidence current risk population potential child different metabolic year effect disorder patient study,{},{},{},{},"{""aspartame"": {""freq"": 1, ""string"": [""intense properly promote causality susceptible opposite aspartame medicinal inconclusive calorie sweetener r""]}}",{}
1591,1591,1720,,28465730.0,significant pcr case sample allele introduction vntrpolymorphisms turkish difference heterozygous comparison normal determine azerbaijani higher value azeri outcome population adverse west phenylketonuria frequency method genotype report pah conclusion risk study control polymorphism position well patient disease significantly iranian pku material respectively first gene type vntr statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394437/,abstract,5,vntrpolymorphisms azerbaijani azeri vntr turkish west iranian heterozygous position pcr introduction statistically polymorphism genotype allele adverse pah comparison frequency determine normal value report respectively pku material outcome conclusion higher difference sample phenylketonuria case significantly risk control type population significant gene method patient disease study,{},"{""heterozygous"": {""freq"": 1, ""string"": [""azerbaijani azeri vntr turkish west iranian heterozygous position pcr introduction statistically p""]}}",{},{},{},{}
1592,1592,1721,10.3390/nu10121944,30544518.0,whether glycerophospholipid dos relevantly behavior together gross supplementation deficit subtle motor docosahexaenoic month significantly neurological intake status contribute amount synthesis supply higher protein double determined negligible genotype six linolenic situation effect level unchanged visually functional per dose child outcome intervention phenylketonuria day prone potential concentration fatty diet multicentric latency minimal endogenous function nervous dha precursor impact also trial arachidonic infancy intellectual plasma proportional tissue alpha acid dietary patient fine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316534/,abstract,5,relevantly negligible multicentric glycerophospholipid visually proportional linolenic gross arachidonic latency fine docosahexaenoic subtle prone unchanged supply dha dos infancy situation minimal endogenous contribute alpha determined nervous double precursor motor dose genotype fatty neurological intellectual supplementation deficit behavior synthesis tissue intake functional status month plasma day trial diet impact intervention dietary concentration outcome higher function phenylketonuria significantly acid potential child protein effect level patient,"{""neurological"": {""freq"": 1, ""string"": [""double precursor motor dose genotype fatty neurological intellectual supplementation deficit behavior s""]}, ""intellectual"": {""freq"": 1, ""string"": [""precursor motor dose genotype fatty neurological intellectual supplementation deficit behavior synthesis t""]}}",{},{},{},"{""diet"": {""freq"": 1, ""string"": [""functional status month plasma day trial diet impact intervention dietary concentration o""]}}",{}
1593,1593,1722,10.1093/alcalc/agv120,26519350.0,alcoholism blood assessment new content lower time positive largely adult prenatal initial ease condition retrospective due repeated mexico highlight onto addition month respectively transportation emergency however backgroundthe capillary confirm storage degradation invasiveness card result university effect advantageous stability prospective first level significant encouraging three one measure per temperature conclusionspeth room department successive stable unm lod week model phosphatidylethanol history potential exposure unknown baseline collection promising allocated sample within resultsthe peth minimal newborn application spot especially analysis ethanol relatively cohort interaction alcohol direct fasd patient dry linear metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830409/,abstract,7,unm successive repeated phosphatidylethanol peth invasiveness encouraging conclusionspeth allocated transportation fasd alcoholism mexico lod advantageous ethanol dry emergency ease capillary confirm card alcohol department room retrospective minimal promising temperature backgroundthe degradation largely prenatal stability university stable prospective storage resultsthe initial linear relatively baseline unknown content history collection direct exposure especially spot highlight cohort week interaction assessment metabolite measure month application addition positive lower adult respectively newborn condition sample time new model blood potential significant effect level analysis result patient,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""application addition positive lower adult respectively newborn condition sample time new m""]}}",{},{}
1594,1594,1723,10.1074/jbc.R116.714576,27325705.0,sequence cross one vivo nucleate difference factor discus amyloid clarify context progression intimately sometimes others clinical despite arguably protein many able aim vitro molecular peptide structural alzheimer share potential different interaction risk large study accumulation experiment association disease similarity connection material directly another amino formation argue cascade,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974365/,abstract,0,nucleate intimately arguably clarify cascade connection argue similarity amyloid share alzheimer peptide experiment progression formation able structural accumulation vitro vivo directly sequence cross context despite discus interaction aim large association molecular material amino difference risk factor potential different protein clinical disease study,{},{},{},"{""amino"": {""freq"": 1, ""string"": [""interaction aim large association molecular material amino difference risk factor potential d""]}}",{},{}
1595,1595,1724,10.1186/s12884-016-1190-7,28061833.0,tool new backgroundapplication abnormal essential defect methodsthis prenatal contains increasingly weight condition retrospective pair source effective severity enrollee medicaid homogeneity significantly material antiepileptic medical supplementary independence trait higher user pcoc doi unexposed modeling aeds live data obstetrical pregnancy florida low score singleton rho period conclusionslatent four rate variable internal female morbidity local acnb lbw drug overall evaluation outcome model valproate perinatal ass exposure online article mother delivery unidimentionality electronic year materialthe version rare component comparison subgroup birth adverse validity hospital index research available infant popular group cohort study whereas statewide latent complication total,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219655/,abstract,2,unidimentionality unexposed pcoc obstetrical medicaid lbw florida enrollee conclusionslatent backgroundapplication aeds acnb statewide homogeneity valproate independence rho modeling latent antiepileptic popular singleton contains live perinatal pair validity retrospective internal subgroup doi methodsthis prenatal local complication increasingly mother morbidity trait severity abnormal pregnancy delivery component index adverse female source variable weight hospital comparison exposure materialthe evaluation defect essential ass cohort period birth overall score tool infant supplementary user drug version electronic online effective medical rare rate total material outcome higher condition article low available significantly new model research group year data study,{},{},{},{},{},{}
1596,1596,1725,10.1038/srep06802,25354816.0,chromatographic studied single early pathway time propionylcholine liquid five due cost obvious control reliable saliva increase evaluate firstly utility phenylalanine strategy clinical global candidate result diagnosis six metabolic oral novel combination flight eight low non cysteine oscc separation rate phytosphingosine biomarkers sphinganine sensitivity approach simple method polarity acetyl stage potential auc receiver help carcinoma phase cell specificity operating hydrophilic mass endogenous survival squamous invasive analysis characteristic carboxymethyl attractive also group diagnostic comprehensive different interaction study metabonomics successfully advantage power patient limitation salivary satisfactory accuracy metabolite spectrometer chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213796/,abstract,1,squamous sphinganine propionylcholine phytosphingosine oscc metabonomics carboxymethyl polarity salivary hydrophilic firstly chromatographic satisfactory carcinoma obvious flight spectrometer attractive acetyl saliva cysteine separation auc operating receiver power studied endogenous invasive successfully reliable survival candidate simple advantage limitation oral utility liquid accuracy comprehensive chromatography specificity phase evaluate stage global help sensitivity combination cost biomarkers characteristic diagnostic interaction metabolite mass strategy increase pathway single novel rate non cell low approach time early phenylalanine control diagnosis potential different metabolic group method clinical analysis result patient study,"{""phenylalanine"": {""freq"": 2, ""string"": [""non cell low approach time early phenylalanine control diagnosis potential different m""]}}",{},"{""pathway"": {""freq"": 1, ""string"": [""diagnostic interaction metabolite mass strategy increase pathway single novel rate non c""]}}",{},{},{}
1597,1597,1726,10.4183/aeb.2018.556,31149312.0,conclusionthe detected blood chromatographic difference greater visible present laboratory neonatal intense liquid cut due severe control addition modern specialist thin pku material respectively enough phe measurement suitable decade however subject life introduction backgroundthe detects higher value range procedure brain mol layer unexperienced tlc error methodology routine first hpa low level significant case although four three dimensional child confirmation chromatogram management week phenylketonuria determination resultsin concentration analyzed treatment limit diet decision fifteen within two newborn hyperphenylalaninemia spot estimate since influence usefulness relatively hplc plasma high study dietary methodssamples even performance highly chromatography statistically,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516402/,abstract,2,unexperienced methodssamples detected tlc detects chromatogram usefulness analyzed intense chromatographic visible modern cut layer confirmation hplc dimensional resultsin hpa specialist conclusionthe routine determination backgroundthe introduction suitable hyperphenylalaninemia methodology limit statistically mol relatively decade liquid procedure decision chromatography estimate neonatal measurement influence highly spot greater laboratory week performance severe phe addition subject plasma management range value error brain diet respectively dietary life concentration newborn pku material higher difference phenylketonuria low present case control blood child significant high level treatment study,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""brain diet respectively dietary life concentration newborn pku material higher difference p""]}}","{""diet"": {""freq"": 1, ""string"": [""plasma management range value error brain diet respectively dietary life concentration n""]}}",{}
1598,1598,1727,10.1186/s12881-018-0566-0,29678161.0,entire specific disorder chain monocarboxylic slovakia backgroundshort region slovak profile uncertainty time specifically autosomal algorithm country pathogenicity selection elevated restriction programme condition molecular organic frequency due severe state cost biomarker substitution majority urinary well evaluate respectively sequence biochemical life oxidation follow probands clinical value preventive coa ethylmalonic acylcarnitine rom principal symptom genomic acyl inborn asymptomatic metabolic length data expansion change delgag genetic tandem resultsour low mortality sixty level case pcr three dehydrogenase short pathogenic belong morbidity occurrence outcome population methodsbiochemical coding pathological via gas rflp test polymorphism recommendation important hundred conclusionsanalogous allelic rare two mass variant newborn ethnic appropriate recessive prevalence relation since sequenced deletion analysis spectrometry available quantity consequence group cohort high pattern study acid deficiency patient gene individual healthcare presence mitochondrial chromatography,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910552/,abstract,0,sequenced monocarboxylic methodsbiochemical ethylmalonic delgag conclusionsanalogous belong backgroundshort slovakia rom slovak rflp probands pathogenicity resultsour acylcarnitine ethnic allelic coding principal uncertainty occurrence acyl entire asymptomatic substitution quantity preventive expansion pathological oxidation algorithm programme length coa gas pcr dehydrogenase deletion biomarker mitochondrial urinary organic specifically restriction pathogenic relation recessive elevated tandem polymorphism morbidity majority healthcare selection chromatography autosomal follow evaluate sequence mortality appropriate genomic recommendation consequence profile short pattern cost presence chain spectrometry frequency cohort prevalence biochemical country region severe inborn symptom state mass change value variant molecular deficiency rare respectively life newborn outcome condition important low case available test individual time specific population acid metabolic gene group high genetic data level disorder clinical analysis patient study,{},"{""autosomal"": {""freq"": 1, ""string"": [""polymorphism morbidity majority healthcare selection chromatography autosomal follow evaluate sequence mortality a""]}, ""recessive"": {""freq"": 1, ""string"": [""urinary organic specifically restriction pathogenic relation recessive elevated tandem polymorphism morbidity m""]}, ""genetic"": {""freq"": 1, ""string"": [""population acid metabolic gene group high genetic data level disorder clinical a""]}}",{},"{""tandem"": {""freq"": 1, ""string"": [""specifically restriction pathogenic relation recessive elevated tandem polymorphism morbidity majority healthcare s""]}, ""spectrometry"": {""freq"": 1, ""string"": [""profile short pattern cost presence chain spectrometry frequency cohort prevalence biochemical c""]}, ""newborn"": {""freq"": 1, ""string"": [""variant molecular deficiency rare respectively life newborn outcome condition important low c""]}}",{},{}
1599,1599,1728,10.2147/IJN.S155021,29588582.0,transparency time methodsthis demonstrates despite site surface identity diverse fact well however vibrational corona particle dot wrapping therapy role protein biocatalytic range integrative primary great report cationic analytical enzyme efficacy effect nano gqds generation modulator first use yet biologic direction quantum modulation ultimate residue trypsin method bio work conclusionour potential system bioavailability active backgroundprotein finding cell interface specificity wide future hydrophilic application spectroscopy likely pivotal determine responsible physiochemical resultsdefinitive graphene paper widely wetting interaction high fate,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858831/,abstract,0,wrapping wetting vibrational trypsin resultsdefinitive physiochemical gqds cationic backgroundprotein quantum nano modulator biocatalytic transparency modulation graphene fate dot corona pivotal particle hydrophilic biologic bio ultimate identity conclusionour bioavailability integrative demonstrates fact interface direction residue spectroscopy surface methodsthis responsible diverse analytical great widely active specificity work site efficacy likely generation determine despite wide paper finding interaction enzyme application range primary future use report therapy role cell time potential protein effect high method,{},{},{},{},{},{}
1600,1600,1729,10.1007/s11051-018-4217-3,30713467.0,various operation disorder self example physiological new semiconductive essential several organic moreover pathology physiology neurodegenerative canonical addition route glycine assembly material typical amyloidal fluorescent compatible role nature protein crystal piezoelectric therefore peptide structural color property fabrication like recently metabolic nanomaterials similarly non yet functional remarkable believe film fulfill normal night structure notable feline many device bio important electronic associated cell guanine amyloid order responsible function indigo eye characteristic vitro natural also similar understand metabolite vision,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354908/,abstract,0,semiconductive piezoelectric indigo feline believe amyloidal fulfill film vision nanomaterials guanine fabrication understand night bio canonical remarkable compatible route notable fluorescent color glycine operation eye crystal amyloid similarly physiology assembly typical device neurodegenerative peptide pathology responsible physiological organic nature structural vitro associated natural property recently example self structure essential functional like characteristic order similar various metabolite normal addition electronic material non important role cell function new protein metabolic disorder,{},{},{},{},{},{}
1601,1601,1730,10.1038/gim.2017.211,29240076.0,service public decade relationship two past example opportunity application discus emergence genomics current essential responsible function provide field health contributing population focus review benefit paper priority science translation genomic core genetics also evidentiary state allofus evolution effective publication precision term illustrate united medicine near initiative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384815/,abstract,0,allofus illustrate evidentiary contributing emergence evolution priority core near initiative publication united translation responsible precision genomics past decade opportunity science genomic service focus example genetics essential medicine provide benefit paper public relationship discus field application state effective current term function population review health,{},{},{},{},{},{}
1602,1602,1731,10.1186/s12881-017-0433-4,28705149.0,conclusionswe information creation visible time present nomenclature standardized contains adoption condition adobe choice client physical sheet capable simplifies gender addition status material medical name consanguinity supplementary custody family resident backgroundthe fill resultsf variety east user questionnaire health feature real project manner gestation great genomic primary air interview alternatively large data password default date foldable run term generation pregnancy fetal chart first genetic international area compliant pedigree three proband software local tree biobank marriage surrogate format database child fully history japan via system file online article genealogical automatically recommendation electronic care donor materialthe version entry process original age tohoku screen overlay order scale birth function authorized field cousin next identical enable inspection aim infertility program paper earthquake available genome multiple general cohort study interviewer rapidly human even accurately absence healthcare individual startup megabank presence show,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512935/,abstract,0,tohoku startup resultsf password overlay megabank foldable earthquake default custody cousin adobe simplifies interviewer genealogical file client automatically sheet pedigree nomenclature inspection compliant proband alternatively infertility entry chart biobank air visible tree surrogate run identical format enable adoption resident japan creation contains marriage east consanguinity conclusionswe original gestation standardized accurately rapidly donor capable software manner authorized project fully interview backgroundthe real choice screen gender fetal absence local variety great healthcare international date pregnancy history genomic recommendation genome physical questionnaire feature generation presence database materialthe general scale cohort paper order birth status field process area aim supplementary addition program user multiple primary version electronic online medical large family care information material term condition article function present available individual time human child age health genetic data study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1603,1603,1732,10.1080/15287394.2015.1053646,26267522.0,wide sweetener commonly implication sample beverage market nursing whether acesulfame milk habitual information lactating saccharin early determine breast variety apparent present clinical necessary population currently nns irrespective potassium consumption infant splenda frequently food except lactation general share via exposure thus often study data whereas human date prospective sucralose pregnancy aspartame volunteer intake participant safe nonnutritive maternal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583633/,abstract,1,splenda lactating sucralose lactation saccharin nonnutritive nns acesulfame irrespective habitual potassium nursing aspartame sweetener market apparent volunteer breast share beverage safe milk commonly prospective variety consumption frequently date necessary pregnancy maternal implication exposure intake currently determine wide general participant food infant information sample present human early population data clinical study,{},{},{},{},"{""aspartame"": {""freq"": 1, ""string"": [""nns acesulfame irrespective habitual potassium nursing aspartame sweetener market apparent volunteer b""]}}",{}
1604,1604,1733,10.3390/s18041087,29617319.0,major assessment chemistry past herein new information effort final time world laboratory accurate choice purchasing expert moreover risk effective well raw material consumer offer however strategy allergy bioassay clinical allergen health range compound gap real science food ensure analytical nanomaterials design selective equipment novel investment useful area detection significant nanobiosensing case rapid one main interest processing outcome residue product device development technology safety concentration biosensors online industrial year decision wide advance still allergic collaboration application comparison nanobiosensors field analysis matrix impact research also infancy different biotechnology last industry even safe individual complex sensitive,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948517/,abstract,0,purchasing nanobiosensors nanobiosensing allergen bioassay allergic nanomaterials ensure allergy investment biosensors raw equipment biotechnology industrial chemistry final collaboration residue infancy industry consumer processing matrix offer safe device gap selective accurate real choice expert analytical sensitive safety past world science decision advance useful effort compound comparison rapid product wide laboratory design main technology field detection assessment food area application major range complex strategy online effective impact novel information concentration material outcome case individual time new risk research different significant development health year clinical analysis,{},{},{},"{""detection"": {""freq"": 1, ""string"": [""wide laboratory design main technology field detection assessment food area application m""]}}",{},{}
1605,1605,1734,10.1038/nbt.4101,29621222.0,metabolome biological activity transcriptomics information organism pathway molecule amenable set oligodendrocyte literature open macrophage diverse biomarker virtually modulate broadly role protein possibility report metabolic data immune use although phenotype discovery omics functionality system response cell maturation endogenous survival biology differentiation closest throughput stem unlike metabolomics program available also identify often high insulin small proteomics discipline gene readily metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937131/,abstract,0,closest oligodendrocyte unlike virtually transcriptomics modulate maturation macrophage functionality amenable proteomics metabolome discipline readily throughput omics broadly stem set organism endogenous insulin differentiation biomarker survival identify possibility diverse immune biology open discovery metabolomics molecule biological phenotype small literature metabolite program response pathway use report information activity role cell available protein metabolic gene high data,{},{},"{""pathway"": {""freq"": 1, ""string"": [""phenotype small literature metabolite program response pathway use report information activity r""]}}",{},{},{}
1606,1606,1735,10.1007/8904_2014_373,25712381.0,edition correlation disorder assessment greater difficult brief adult adjunct behavior together due deficit risk mean testing status executive supplementary normative follow rating oxidation adaptive clinical developmental result metabolic inventory term long score confidently significant functioning rate functional child evaluation aba phenylketonuria day method system second test urea fatty galactosemia opportunity standard limited function cognitive validity concordance research infant cycle comprehensive study acid neuropsychological individual deviation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470946/,abstract,3,confidently aba adjunct normative galactosemia edition concordance functioning inventory validity brief rating adaptive urea neuropsychological oxidation deviation executive cycle opportunity fatty comprehensive difficult follow second deficit mean behavior limited developmental evaluation greater correlation functional status testing score standard assessment cognitive infant supplementary long day adult rate term function phenylketonuria test individual risk research acid child significant metabolic method disorder clinical result study,{},{},{},{},{},{}
1607,1607,1736,10.2337/dc17-0166,28663383.0,level every case considerable dissipates two family least autoantibody teddy negative conclusionsinfant determinant heighten anxiety normal islet time positive birth child anxious environmental longer research inception particularly methodsparent history ass thereafter state annually parent risk high study old inventory sai test mother design response experience diabetes month year genetic type father score young faced period,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566282/,abstract,9,teddy sai methodsparent heighten dissipates conclusionsinfant faced anxious autoantibody father islet inception annually inventory longer determinant young considerable anxiety diabetes mother experience history old negative environmental particularly parent design ass period birth score month normal state positive response family case test time risk type research child year high genetic level study,{},"{""genetic"": {""freq"": 1, ""string"": []}}",{},{},{},{}
1608,1608,1737,10.1177/0884533615586201,26079521.0,multidisciplinary level fat monitoring disorder adulthood deficient blood within member newborn main micronutrient introduction new growth typically childhood protein careful normal chronic therapy goal reduced range many population critical maintenance either management product throughout lifespan review basic quantity macronutrient error development inborn highlight infancy nutritional mainstay thus metabolic dietitian principle team treatment carbohydrate dietary small patient significantly diet intake metabolism completely metabolite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515158/,abstract,0,macronutrient mainstay careful lifespan dietitian multidisciplinary micronutrient quantity carbohydrate maintenance infancy team completely fat adulthood principle typically introduction deficient basic monitoring reduced member goal childhood nutritional critical chronic intake product highlight growth main small inborn metabolite normal management range error diet dietary therapy newborn metabolism significantly new blood population review protein development metabolic level disorder treatment patient,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""management range error diet dietary therapy newborn metabolism significantly new blood p""]}}","{""diet"": {""freq"": 1, ""string"": [""inborn metabolite normal management range error diet dietary therapy newborn metabolism s""]}}",{}
1609,1609,1738,10.1111/1468-0009.12196,27265561.0,disorder chain ratio discus among minus cystic uncertainty document serious affected efficient prompt additional literature severe capacity state washington methodswe addition scid calculation family life evidence reduction broadly coa health range consistent developmental project equivalent report fibrosis diagnosis monetary metabolic expansion late immune mortality use although peer rate panel dehydrogenase internal death assumption department rule economic implementation evaluation societal point approach model conclusionsthe summarize disability plausible article treatment net year decision care findingsthe process robust age public newborn percentage discount since mcad quality benefit program infant contexteconomic also policy part medium successfully deficiency inform spreadsheet complication individual parameter,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911729/,abstract,7,washington minus discount contexteconomic spreadsheet monetary findingsthe mcad scid summarize plausible societal rule prompt net assumption uncertainty calculation broadly peer department expansion document cystic internal equivalent inform fibrosis coa percentage successfully project dehydrogenase medium capacity affected conclusionsthe efficient immune complication robust economic late panel decision methodswe death policy parameter mortality implementation consistent reduction disability point chain developmental evaluation benefit additional ratio public discus literature severe process infant addition state program range quality use deficiency report family care rate life newborn evidence article approach individual model diagnosis age metabolic health year disorder treatment,{},{},{},"{""newborn"": {""freq"": 1, ""string"": [""deficiency report family care rate life newborn evidence article approach individual m""]}}",{},{}
1610,1610,1739,10.1107/S2053230X16007305,27303899.0,activity region difference signature glutamate dehydrogenases nad oxidative segment chimaeric preference reaction apart bacterial state subtle apo sequence possible place crystal move body substrate symbiosum helix enzyme clostridium versus junction flexibility although functional catalytic dehydrogenase deamination interdomain symmetry structure terminal catalyse fully predictor parent clostridial pivot two determinant unambiguous cleft polypeptide domain nucleotide escherichia distinct cofactor rigid coli absence ketoglutarate,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909246/,abstract,1,unambiguous symmetry symbiosum pivot ketoglutarate dehydrogenases clostridial chimaeric catalyse nad junction interdomain helix apo rigid deamination clostridium polypeptide cleft coli escherichia segment subtle apart terminal signature flexibility glutamate crystal preference determinant catalytic place bacterial substrate fully predictor dehydrogenase versus oxidative absence distinct cofactor nucleotide domain sequence reaction structure parent functional region possible body enzyme state activity difference,{},{},{},{},{},{}
